,Unnamed: 0,#AlleleID,Type,Name,GeneID,GeneSymbol,HGNC_ID,ClinicalSignificance,ClinSigSimple,LastEvaluated,RS# (dbSNP),nsv/esv (dbVar),RCVaccession,PhenotypeIDS,PhenotypeList,Origin,OriginSimple,Assembly,ChromosomeAccession,Chromosome,Start,Stop,ReferenceAllele,AlternateAllele,Cytogenetic,ReviewStatus,NumberSubmitters,Guidelines,TestedInGTR,OtherIDs,SubmitterCategories,VariationID,PositionVCF,ReferenceAlleleVCF,AlternateAlleleVCF,mutant,Gold_Stars,Coarse_Grained_Clin_Sig,Starry_Coarse_Grained_Clin_Sig,uniprot,Entry,Reviewed,Entry Name,Protein names,Gene Names,Organism,Length,Sequence,Pfam,PDB,mutant_pos,mutant_wt,mutant_mut,WT_match,Cluster
12780,822,18654,single nucleotide variant,NM_000155.4(GALT):c.221T>C (p.Leu74Pro),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,24-Sep-20,111033663,-,RCV000003799|RCV000723459,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline,germline,GRCh38,NC_000009.12,9,34647227,34647227,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA252846,UniProtKB:P07902#VAR_002557,OMIM:606999.0007",3,3615,34647227,T,C,L74P,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,74,L,P,True,806
12781,821,18653,single nucleotide variant,NM_000155.4(GALT):c.563A>G (p.Gln188Arg),2592,GALT,HGNC:4135,Conflicting interpretations of pathogenicity,1,22-Jul-20,75391579,-,RCV000003798|RCV000185917|RCV000825563,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202|Human Phenotype Ontology:HP:0004919,MONDO:MONDO:0018116,MedGen:C0016952,OMIM:PS230400,Orphanet:352",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia,germline;maternal;unknown,germline,GRCh38,NC_000009.12,9,34648170,34648170,na,na,9p13.3,"criteria provided, conflicting interpretations",21,-,Y,"ClinGen:CA312566,UniProtKB:P07902#VAR_002587,OMIM:606999.0006",3,3614,34648170,A,G,Q188R,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,188,Q,R,True,806
12782,820,18652,single nucleotide variant,NM_000155.4(GALT):c.940A>G (p.Asn314Asp),2592,GALT,HGNC:4135,"Conflicting interpretations of pathogenicity, other",1,29-Dec-20,2070074,-,RCV000003797|RCV000022233|RCV000078243|RCV000243200|RCV000309989,"|MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202|MedGen:CN169374|Human Phenotype Ontology:HP:0004919,MONDO:MONDO:0018116,MedGen:C0016952,OMIM:PS230400,Orphanet:352","GALT POLYMORPHISM (DUARTE, D2)|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|not specified|Galactosemia",germline;unknown,germline,GRCh38,NC_000009.12,9,34649445,34649445,na,na,9p13.3,"criteria provided, conflicting interpretations",17,-,Y,"OMIM:606999.0012,OMIM:606999.0005,ClinVar:3620,ClinVar:140570,UniProtKB:P07902#VAR_002613,ClinGen:CA116380",3,3613,34649445,A,G,N314D,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,314,N,D,True,806
12783,819,18651,single nucleotide variant,NM_000155.4(GALT):c.184C>A (p.Leu62Met),2592,GALT,HGNC:4135,Benign,0,4-Dec-12,1800461,-,RCV000003796|RCV000022064,"|MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",GALT POLYMORPHISM|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline,germline,GRCh38,NC_000009.12,9,34647190,34647190,na,na,9p13.3,no assertion criteria provided,2,-,N,"ClinGen:CA116378,UniProtKB:P07902#VAR_002555,OMIM:606999.0004",3,3612,34647190,C,A,L62M,0,benign,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,62,L,M,True,806
12784,13577,265226,single nucleotide variant,NM_000155.4(GALT):c.776G>A (p.Arg259Gln),2592,GALT,HGNC:4135,Likely pathogenic,1,4-Dec-19,886042070,-,RCV000319697|RCV000723422,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34648850,34648850,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA10603771,UniProtKB:P07902#VAR_068548",2,280989,34648850,G,A,R259Q,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,259,R,Q,True,806
12785,818,18650,single nucleotide variant,NM_000155.4(GALT):c.130G>A (p.Val44Met),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033647,-,RCV000003795,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline,germline,GRCh38,NC_000009.12,9,34647136,34647136,na,na,9p13.3,no assertion criteria provided,2,-,N,"ClinGen:CA252845,UniProtKB:P07902#VAR_002552,OMIM:606999.0003",3,3611,34647136,G,A,V44M,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,44,V,M,True,806
12786,817,18649,single nucleotide variant,NM_000155.4(GALT):c.997C>T (p.Arg333Trp),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,8-Nov-19,111033800,-,RCV000003794|RCV000723400,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34649502,34649502,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA252844,UniProtKB:P07902#VAR_002627,OMIM:606999.0002",3,3610,34649502,C,T,R333W,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,333,R,W,True,806
12787,830,18663,single nucleotide variant,NM_000155.4(GALT):c.580T>C (p.Phe194Leu),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033726,-,RCV000003808,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline,germline,GRCh38,NC_000009.12,9,34648349,34648349,na,na,9p13.3,no assertion criteria provided,2,-,N,"ClinGen:CA252849,UniProtKB:P07902#VAR_002589,OMIM:606999.0016",3,3624,34648349,T,C,F194L,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,194,F,L,True,806
12788,8997,98431,single nucleotide variant,NM_000155.4(GALT):c.772C>T (p.Arg258Cys),2592,GALT,HGNC:4135,Conflicting interpretations of pathogenicity,1,19-Nov-18,368166217,-,RCV000078235|RCV000493672,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34648846,34648846,na,na,9p13.3,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA266764,UniProtKB:P07902#VAR_002605",2,92522,34648846,C,T,R258C,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,258,R,C,True,806
12789,826,18658,single nucleotide variant,NM_000155.4(GALT):c.547C>A (p.Pro183Thr),2592,GALT,HGNC:4135,Uncertain significance,1,14-May-18,111033721,-,RCV000003803,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline;unknown,germline,GRCh38,NC_000009.12,9,34648154,34648154,na,na,9p13.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA252848,UniProtKB:P07902#VAR_002585,OMIM:606999.0011",3,3619,34648154,C,A,P183T,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,183,P,T,True,806
12790,827,18660,single nucleotide variant,NM_000155.4(GALT):c.855G>T (p.Lys285Asn),2592,GALT,HGNC:4135,Pathogenic,1,7-Jul-20,111033773,-,RCV000003805|RCV000224446,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34649032,34649032,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",13,-,Y,"OMIM:606999.0013,ClinGen:CA340107,UniProtKB:P07902#VAR_002609",3,3621,34649032,G,T,K285N,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,285,K,N,True,806
12791,816,18648,single nucleotide variant,NM_000155.4(GALT):c.425T>A (p.Met142Lys),2592,GALT,HGNC:4135,Pathogenic,1,11-Nov-19,111033695,-,RCV000003793|RCV000185916,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34647879,34647879,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA252843,UniProtKB:P07902#VAR_002574,OMIM:606999.0001",3,3609,34647879,T,A,M142K,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,142,M,K,True,806
12792,828,18661,single nucleotide variant,NM_000155.4(GALT):c.607G>A (p.Glu203Lys),2592,GALT,HGNC:4135,Conflicting interpretations of pathogenicity,1,17-Sep-18,111033736,-,RCV000003806|RCV000727661|RCV001271243,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202|Human Phenotype Ontology:HP:0004919,MONDO:MONDO:0018116,MedGen:C0016952,OMIM:PS230400,Orphanet:352",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia,germline;unknown,germline,GRCh38,NC_000009.12,9,34648376,34648376,na,na,9p13.3,"criteria provided, conflicting interpretations",8,-,N,"ClinGen:CA340108,UniProtKB:P07902#VAR_002595,OMIM:606999.0014",3,3622,34648376,G,A,E203K,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,203,E,K,True,806
12793,829,18662,single nucleotide variant,NM_000155.4(GALT):c.997C>G (p.Arg333Gly),2592,GALT,HGNC:4135,Pathogenic,1,23-Oct-19,111033800,-,RCV000003807,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline;unknown,germline,GRCh38,NC_000009.12,9,34649502,34649502,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",6,-,N,"OMIM:606999.0015,ClinGen:CA340109,UniProtKB:P07902#VAR_002625",3,3623,34649502,C,G,R333G,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,333,R,G,True,806
12794,824,18656,single nucleotide variant,NM_000155.4(GALT):c.957C>A (p.His319Gln),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,1-Aug-18,111033792,-,RCV000003801|RCV000727567,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34649462,34649462,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA252847,UniProtKB:P07902#VAR_002616,OMIM:606999.0009",3,3617,34649462,C,A,H319Q,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,319,H,Q,True,806
12795,825,18657,single nucleotide variant,NM_000155.4(GALT):c.404C>T (p.Ser135Leu),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,30-Dec-19,111033690,-,RCV000003802|RCV000185915,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34647858,34647858,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",15,-,Y,"UniProtKB:P07902#VAR_002571,OMIM:606999.0010,ClinGen:CA312565",3,3618,34647858,C,T,S135L,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,135,S,L,True,806
12796,823,18655,single nucleotide variant,NM_000155.4(GALT):c.512T>C (p.Phe171Ser),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,12-Dec-19,111033715,-,RCV000003800|RCV000723392,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34648119,34648119,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA340106,UniProtKB:P07902#VAR_002583,OMIM:606999.0008",3,3616,34648119,T,C,F171S,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,171,F,S,True,806
12797,5619,36466,single nucleotide variant,NM_000155.4(GALT):c.134C>T (p.Ser45Leu),2592,GALT,HGNC:4135,Uncertain significance,1,18-Sep-15,111033652,-,RCV000022059|RCV000078214,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline,germline,GRCh38,NC_000009.12,9,34647140,34647140,na,na,9p13.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA220416,UniProtKB:P07902#VAR_008042",2,25132,34647140,C,T,S45L,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,45,S,L,True,806
12798,5650,36537,single nucleotide variant,NM_000155.4(GALT):c.524G>A (p.Gly175Asp),2592,GALT,HGNC:4135,Pathogenic,1,6-Feb-17,111033718,-,RCV000022139|RCV000507314|RCV001276270,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN169374|Human Phenotype Ontology:HP:0004919,MONDO:MONDO:0018116,MedGen:C0016952,OMIM:PS230400,Orphanet:352",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not specified|Galactosemia,germline,germline,GRCh38,NC_000009.12,9,34648131,34648131,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA259424,UniProtKB:P07902#VAR_072796",2,25203,34648131,G,A,G175D,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,175,G,D,True,806
12799,5659,36554,single nucleotide variant,NM_000155.4(GALT):c.575G>A (p.Ser192Asn),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033734,-,RCV000022156,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648344,34648344,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259444,UniProtKB:P07902#VAR_002588",2,25220,34648344,G,A,S192N,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,192,S,N,True,806
12800,5658,36553,single nucleotide variant,NM_000155.4(GALT):c.574A>G (p.Ser192Gly),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033830,-,RCV000022155,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648343,34648343,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259443,UniProtKB:P07902#VAR_068543",2,25219,34648343,A,G,S192G,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,192,S,G,True,806
12801,5657,36547,single nucleotide variant,NM_000155.4(GALT):c.554C>T (p.Pro185Leu),2592,GALT,HGNC:4135,Uncertain significance,1,5-Jun-19,111033722,-,RCV000022149,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline;unknown,germline,GRCh38,NC_000009.12,9,34648161,34648161,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA259436,UniProtKB:P07902#VAR_068828",2,25213,34648161,C,T,P185L,2,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,185,P,L,True,806
12802,5656,36546,single nucleotide variant,NM_000155.4(GALT):c.554C>A (p.Pro185His),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033722,-,RCV000022148,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648161,34648161,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259435,UniProtKB:P07902#VAR_068541",2,25212,34648161,C,A,P185H,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,185,P,H,True,806
12803,5688,36615,single nucleotide variant,NM_000155.4(GALT):c.872A>T (p.Glu291Val),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033841,-,RCV000022224,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649049,34649049,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259524,UniProtKB:P07902#VAR_068552",2,25281,34649049,A,T,E291V,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,291,E,V,True,806
12804,5655,36545,single nucleotide variant,NM_000155.4(GALT):c.553C>T (p.Pro185Ser),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033826,-,RCV000022147,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648160,34648160,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259434,UniProtKB:P07902#VAR_068542",2,25211,34648160,C,T,P185S,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,185,P,S,True,806
12805,5654,36544,single nucleotide variant,NM_000155.4(GALT):c.552C>A (p.His184Gln),2592,GALT,HGNC:4135,Conflicting interpretations of pathogenicity,1,27-Nov-17,111033717,-,RCV000022146|RCV000493954,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34648159,34648159,na,na,9p13.3,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA259433,UniProtKB:P07902#VAR_002586",2,25210,34648159,C,A,H184Q,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,184,H,Q,True,806
12806,5689,36617,single nucleotide variant,NM_000155.4(GALT):c.881T>A (p.Phe294Tyr),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033781,-,RCV000022226,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649058,34649058,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259525,UniProtKB:P07902#VAR_008048",2,25283,34649058,T,A,F294Y,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,294,F,Y,True,806
12807,5653,36542,single nucleotide variant,NM_000155.4(GALT):c.542C>T (p.Ser181Phe),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,367543259,-,RCV000022144,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648149,34648149,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259430,UniProtKB:P07902#VAR_068827",2,25208,34648149,C,T,S181F,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,181,S,F,True,806
12808,5652,36541,single nucleotide variant,NM_000155.4(GALT):c.541T>G (p.Ser181Ala),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033828,-,RCV000022143,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648148,34648148,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259429,UniProtKB:P07902#VAR_068540",2,25207,34648148,T,G,S181A,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,181,S,A,True,806
12809,5651,36539,single nucleotide variant,NM_000155.4(GALT):c.536G>A (p.Gly179Asp),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033720,-,RCV000022141,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648143,34648143,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259426,UniProtKB:P07902#VAR_002584",2,25205,34648143,G,A,G179D,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,179,G,D,True,806
12810,5649,36533,single nucleotide variant,NM_000155.4(GALT):c.509T>C (p.Ile170Thr),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033839,-,RCV000022135,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648116,34648116,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259419,UniProtKB:P07902#VAR_068539",2,25199,34648116,T,C,I170T,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,170,I,T,True,806
12811,5690,36623,single nucleotide variant,NM_000155.4(GALT):c.922G>A (p.Glu308Lys),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033784,-,RCV000022232,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649427,34649427,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259532,UniProtKB:P07902#VAR_002612",2,25289,34649427,G,A,E308K,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,308,E,K,True,806
12812,6277,45907,single nucleotide variant,NM_000155.4(GALT):c.386T>C (p.Met129Thr),2592,GALT,HGNC:4135,Pathogenic,1,12-Sep-14,111033683,-,RCV000022099|RCV000724284,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline,germline,GRCh38,NC_000009.12,9,34647840,34647840,na,na,9p13.3,"criteria provided, single submitter",2,-,N,"UniProtKB:P07902#VAR_008043,ClinGen:CA259378",2,37356,34647840,T,C,M129T,1,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,129,M,T,True,806
12813,5691,36628,single nucleotide variant,NM_000155.4(GALT):c.951G>T (p.Gln317His),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033787,-,RCV000022239,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649456,34649456,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259538,UniProtKB:P07902#VAR_002614",2,25294,34649456,G,T,Q317H,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,317,Q,H,True,806
12814,5693,36634,single nucleotide variant,NM_000155.4(GALT):c.967T>G (p.Tyr323Asp),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033796,-,RCV000022245,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649472,34649472,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259547,UniProtKB:P07902#VAR_002618",2,25300,34649472,T,G,Y323D,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,323,Y,D,True,806
12815,5694,36635,single nucleotide variant,NM_000155.4(GALT):c.967T>C (p.Tyr323His),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033796,-,RCV000022246,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649472,34649472,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259548,UniProtKB:P07902#VAR_002619",2,25301,34649472,T,C,Y323H,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,323,Y,H,True,806
12816,5695,36637,single nucleotide variant,NM_000155.4(GALT):c.970C>T (p.Pro324Ser),2592,GALT,HGNC:4135,Uncertain significance,1,5-May-17,111033798,-,RCV000022248,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,unknown,unknown,GRCh38,NC_000009.12,9,34649475,34649475,na,na,9p13.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA259551,UniProtKB:P07902#VAR_002620",2,25303,34649475,C,T,P324S,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,324,P,S,True,806
12817,5696,36639,single nucleotide variant,NM_000155.4(GALT):c.974C>T (p.Pro325Leu),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,13-Dec-19,111033794,-,RCV000022250|RCV001091819,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34649479,34649479,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA259554,UniProtKB:P07902#VAR_002621",2,25305,34649479,C,T,P325L,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,325,P,L,True,806
12818,5648,36523,single nucleotide variant,NM_000155.4(GALT):c.502G>T (p.Val168Leu),2592,GALT,HGNC:4135,Likely pathogenic,1,20-Nov-19,367543258,-,RCV000022125,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline;unknown,germline,GRCh38,NC_000009.12,9,34647956,34647956,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA259410,UniProtKB:P07902#VAR_068538",2,25189,34647956,G,T,V168L,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,168,V,L,True,806
12819,5647,36522,single nucleotide variant,NM_000155.4(GALT):c.499T>C (p.Trp167Arg),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033708,-,RCV000022124,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647953,34647953,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259409,UniProtKB:P07902#VAR_008044",2,25188,34647953,T,C,W167R,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,167,W,R,True,806
12820,5646,36521,single nucleotide variant,NM_000155.4(GALT):c.496C>G (p.Pro166Ala),2592,GALT,HGNC:4135,Uncertain significance,1,24-Aug-17,367543257,-,RCV000022123,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,unknown,unknown,GRCh38,NC_000009.12,9,34647950,34647950,na,na,9p13.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA259408,UniProtKB:P07902#VAR_068826",2,25187,34647950,C,G,P166A,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,166,P,A,True,806
12821,5645,36515,single nucleotide variant,NM_000155.4(GALT):c.460T>G (p.Trp154Gly),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033702,-,RCV000022117,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647914,34647914,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259397,UniProtKB:P07902#VAR_002582",2,25181,34647914,T,G,W154G,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,154,W,G,True,806
12822,5644,36514,single nucleotide variant,NM_000155.4(GALT):c.452T>C (p.Val151Ala),2592,GALT,HGNC:4135,Conflicting interpretations of pathogenicity,1,30-May-17,111033701,-,RCV000022116|RCV000505985,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN169374",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not specified,germline;unknown,germline,GRCh38,NC_000009.12,9,34647906,34647906,na,na,9p13.3,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA259396,UniProtKB:P07902#VAR_002581",2,25180,34647906,T,C,V151A,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,151,V,A,True,806
12823,5643,36513,single nucleotide variant,NM_000155.4(GALT):c.448G>C (p.Val150Leu),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033699,-,RCV000022115,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647902,34647902,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259395,UniProtKB:P07902#VAR_002580",2,25179,34647902,G,C,V150L,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,150,V,L,True,806
12824,5697,36642,single nucleotide variant,NM_000155.4(GALT):c.980T>C (p.Leu327Pro),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033832,-,RCV000022253,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649485,34649485,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259557,UniProtKB:P07902#VAR_068553",2,25308,34649485,T,C,L327P,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,327,L,P,True,806
12825,5698,36643,single nucleotide variant,NM_000155.4(GALT):c.983G>A (p.Arg328His),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,26-Nov-18,111033802,-,RCV000022254|RCV001271248,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|Human Phenotype Ontology:HP:0004919,MONDO:MONDO:0018116,MedGen:C0016952,OMIM:PS230400,Orphanet:352",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|Galactosemia,germline,germline,GRCh38,NC_000009.12,9,34649488,34649488,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA259558,UniProtKB:P07902#VAR_002622",2,25309,34649488,G,A,R328H,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,328,R,H,True,806
12826,5699,36644,single nucleotide variant,NM_000155.4(GALT):c.986C>T (p.Ser329Phe),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033803,-,RCV000022255,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649491,34649491,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259559,UniProtKB:P07902#VAR_002623",2,25310,34649491,C,T,S329F,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,329,S,F,True,806
12827,5692,36632,single nucleotide variant,NM_000155.4(GALT):c.958G>A (p.Ala320Thr),2592,GALT,HGNC:4135,Conflicting interpretations of pathogenicity,1,26-Sep-20,111033795,-,RCV000022243|RCV000319347,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34649463,34649463,na,na,9p13.3,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA259544,UniProtKB:P07902#VAR_002617",2,25298,34649463,G,A,A320T,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,320,A,T,True,806
12828,5642,36512,single nucleotide variant,NM_000155.4(GALT):c.443G>A (p.Arg148Gln),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,11-Feb-19,111033694,-,RCV000022114|RCV000723398,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34647897,34647897,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA259394,UniProtKB:P07902#VAR_002578",2,25178,34647897,G,A,R148Q,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,148,R,Q,True,806
12829,5687,36614,single nucleotide variant,NM_000155.4(GALT):c.871G>A (p.Glu291Lys),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033780,-,RCV000022223,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649048,34649048,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259523,UniProtKB:P07902#VAR_002611",2,25280,34649048,G,A,E291K,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,291,E,K,True,806
12830,5685,36612,single nucleotide variant,NM_000155.4(GALT):c.865C>T (p.Leu289Phe),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033774,-,RCV000022221,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649042,34649042,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259521,UniProtKB:P07902#VAR_068551",2,25278,34649042,C,T,L289F,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,289,L,F,True,806
12831,6101,44187,single nucleotide variant,NM_000155.4(GALT):c.152G>A (p.Arg51Gln),2592,GALT,HGNC:4135,Uncertain significance,1,1-Mar-18,111033648,-,RCV000022061,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,unknown,unknown,GRCh38,NC_000009.12,9,34647158,34647158,na,na,9p13.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA259331,UniProtKB:P07902#VAR_023328",2,35522,34647158,G,A,R51Q,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,51,R,Q,True,806
12832,5669,36574,single nucleotide variant,NM_000155.4(GALT):c.658G>A (p.Glu220Lys),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033747,-,RCV000022176,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648427,34648427,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259468,UniProtKB:P07902#VAR_068545",2,25240,34648427,G,A,E220K,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,220,E,K,True,806
12833,5670,36576,single nucleotide variant,NM_000155.4(GALT):c.667C>A (p.Arg223Ser),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033750,-,RCV000022178,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648436,34648436,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259470,UniProtKB:P07902#VAR_068546",2,25242,34648436,C,A,R223S,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,223,R,S,True,806
12834,5667,36566,single nucleotide variant,NM_000155.4(GALT):c.626A>C (p.Tyr209Ser),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033744,-,RCV000022168,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648395,34648395,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259457,UniProtKB:P07902#VAR_002597",2,25232,34648395,A,C,Y209S,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,209,Y,S,True,806
12835,5666,36565,single nucleotide variant,NM_000155.4(GALT):c.626A>G (p.Tyr209Cys),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,13-Dec-19,111033744,-,RCV000022167|RCV000185918,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34648395,34648395,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA312567,UniProtKB:P07902#VAR_002596",3,25231,34648395,A,G,Y209C,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,209,Y,C,True,806
12836,5665,36563,single nucleotide variant,NM_000155.4(GALT):c.611G>C (p.Arg204Pro),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033740,-,RCV000022165,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648380,34648380,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259454,UniProtKB:P07902#VAR_008045",2,25229,34648380,G,C,R204P,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,204,R,P,True,806
12837,5664,36561,single nucleotide variant,NM_000155.4(GALT):c.602G>A (p.Arg201His),2592,GALT,HGNC:4135,Pathogenic,1,9-Dec-19,111033735,-,RCV000022163|RCV000723397,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34648371,34648371,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA259451,UniProtKB:P07902#VAR_002594",2,25227,34648371,G,A,R201H,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,201,R,H,True,806
12838,5663,36560,single nucleotide variant,NM_000155.4(GALT):c.601C>T (p.Arg201Cys),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-19,111033739,-,RCV000022162|RCV000506881|RCV000723434|RCV001271242,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN169374|MedGen:CN517202|Human Phenotype Ontology:HP:0004919,MONDO:MONDO:0018116,MedGen:C0016952,OMIM:PS230400,Orphanet:352",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not specified|not provided|Galactosemia,germline,germline,GRCh38,NC_000009.12,9,34648370,34648370,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"UniProtKB:P07902#VAR_068544,ClinGen:CA259450",2,25226,34648370,C,T,R201C,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,201,R,C,True,806
12839,5662,36558,single nucleotide variant,NM_000155.4(GALT):c.595G>A (p.Ala199Thr),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033730,-,RCV000022160,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648364,34648364,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259448,UniProtKB:P07902#VAR_002593",2,25224,34648364,G,A,A199T,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,199,A,T,True,806
12840,5661,36557,single nucleotide variant,NM_000155.4(GALT):c.594T>G (p.Ile198Met),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033729,-,RCV000022159,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648363,34648363,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259447,UniProtKB:P07902#VAR_002591",2,25223,34648363,T,G,I198M,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,198,I,M,True,806
12841,5660,36556,single nucleotide variant,NM_000155.4(GALT):c.584T>C (p.Leu195Pro),2592,GALT,HGNC:4135,Pathogenic,1,9-Dec-19,111033728,-,RCV000022158|RCV000224416,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34648353,34648353,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",11,-,Y,"ClinGen:CA342595,UniProtKB:P07902#VAR_002590",3,25222,34648353,T,C,L195P,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,195,L,P,True,806
12842,5671,36577,single nucleotide variant,NM_000155.4(GALT):c.677T>C (p.Leu226Pro),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033752,-,RCV000022180,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648446,34648446,na,na,9p13.3,no assertion criteria provided,1,-,N,"UniProtKB:P07902#VAR_002600,ClinGen:CA259473",2,25243,34648446,T,C,L226P,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,226,L,P,True,806
12843,11589,186785,single nucleotide variant,NM_000155.4(GALT):c.775C>T (p.Arg259Trp),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,8-Jun-15,786204763,-,RCV000169625|RCV000723394,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34648849,34648849,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA274482,UniProtKB:P07902#VAR_002606",2,189191,34648849,C,T,R259W,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,259,R,W,True,806
12844,5686,36613,single nucleotide variant,NM_000155.4(GALT):c.866T>G (p.Leu289Arg),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033775,-,RCV000022222,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649043,34649043,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259522,UniProtKB:P07902#VAR_002610",2,25279,34649043,T,G,L289R,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,289,L,R,True,806
12845,5672,36578,single nucleotide variant,NM_000155.4(GALT):c.687G>T (p.Lys229Asn),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033753,-,RCV000022182,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648456,34648456,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259475,UniProtKB:P07902#VAR_023330",2,25244,34648456,G,T,K229N,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,229,K,N,True,806
12846,5674,36581,single nucleotide variant,NM_000155.4(GALT):c.692G>A (p.Arg231His),2592,GALT,HGNC:4135,Pathogenic,1,2-Apr-18,111033754,-,RCV000022185,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline,germline,GRCh38,NC_000009.12,9,34648766,34648766,na,na,9p13.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA259478,UniProtKB:P07902#VAR_002601",2,25247,34648766,G,A,R231H,1,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,231,R,H,True,806
12847,5675,36585,single nucleotide variant,NM_000155.4(GALT):c.745T>C (p.Trp249Arg),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033757,-,RCV000022189,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648819,34648819,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259484,UniProtKB:P07902#VAR_002602",2,25251,34648819,T,C,W249R,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,249,W,R,True,806
12848,6275,45903,single nucleotide variant,NM_000155.4(GALT):c.416T>C (p.Leu139Pro),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033687,-,RCV000022108,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647870,34647870,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259388,UniProtKB:P07902#VAR_002573",2,37352,34647870,T,C,L139P,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,139,L,P,True,806
12849,6276,45904,single nucleotide variant,NM_000155.4(GALT):c.950A>G (p.Gln317Arg),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033786,-,RCV000022238,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649455,34649455,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259537,UniProtKB:P07902#VAR_002615",2,37353,34649455,A,G,Q317R,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,317,Q,R,True,806
12850,5676,36587,single nucleotide variant,NM_000155.4(GALT):c.752A>G (p.Tyr251Cys),2592,GALT,HGNC:4135,Uncertain significance,1,15-May-17,111033755,-,RCV000022192,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,unknown,unknown,GRCh38,NC_000009.12,9,34648826,34648826,na,na,9p13.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA259489,UniProtKB:P07902#VAR_002603",2,25253,34648826,A,G,Y251C,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,251,Y,C,True,806
12851,5677,36588,single nucleotide variant,NM_000155.4(GALT):c.752A>C (p.Tyr251Ser),2592,GALT,HGNC:4135,Uncertain significance,1,19-Feb-16,111033755,-,RCV000022193|RCV000347842,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline,germline,GRCh38,NC_000009.12,9,34648826,34648826,na,na,9p13.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA259490,UniProtKB:P07902#VAR_002604",2,25254,34648826,A,C,Y251S,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,251,Y,S,True,806
12852,5678,36590,single nucleotide variant,NM_000155.4(GALT):c.756G>T (p.Gln252His),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033769,-,RCV000022195,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648830,34648830,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259493,UniProtKB:P07902#VAR_023331",2,25256,34648830,G,T,Q252H,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,252,Q,H,True,806
12853,5679,36597,single nucleotide variant,NM_000155.4(GALT):c.785G>C (p.Arg262Pro),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033763,-,RCV000022204,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648859,34648859,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259502,UniProtKB:P07902#VAR_002607",2,25263,34648859,G,C,R262P,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,262,R,P,True,806
12854,5680,36599,single nucleotide variant,NM_000155.4(GALT):c.793C>G (p.Pro265Ala),2592,GALT,HGNC:4135,Uncertain significance,1,20-Aug-20,111033764,-,RCV000022206|RCV000595522|RCV001255517|RCV001271245,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202|MedGen:CN169374|Human Phenotype Ontology:HP:0004919,MONDO:MONDO:0018116,MedGen:C0016952,OMIM:PS230400,Orphanet:352",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|not specified|Galactosemia,germline,germline,GRCh38,NC_000009.12,9,34648867,34648867,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA259503,UniProtKB:P07902#VAR_068549",2,25265,34648867,C,G,P265A,2,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,265,P,A,True,806
12855,5681,36602,single nucleotide variant,NM_000155.4(GALT):c.814C>G (p.Arg272Gly),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033766,-,RCV000022209,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648888,34648888,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259506,UniProtKB:P07902#VAR_008047",2,25268,34648888,C,G,R272G,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,272,R,G,True,806
12856,5682,36608,single nucleotide variant,NM_000155.4(GALT):c.833T>A (p.Ile278Asn),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033778,-,RCV000022216,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649010,34649010,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259514,UniProtKB:P07902#VAR_068550",2,25274,34649010,T,A,I278N,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,278,I,N,True,806
12857,5683,36610,single nucleotide variant,NM_000155.4(GALT):c.844C>G (p.Leu282Val),2592,GALT,HGNC:4135,Conflicting interpretations of pathogenicity,1,17-Mar-20,111033772,-,RCV000022218|RCV000723391,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline,germline,GRCh38,NC_000009.12,9,34649021,34649021,na,na,9p13.3,"criteria provided, conflicting interpretations",3,-,N,"UniProtKB:P07902#VAR_002608,ClinGen:CA259517",2,25276,34649021,C,G,L282V,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,282,L,V,True,806
12858,5684,36611,single nucleotide variant,NM_000155.4(GALT):c.854A>G (p.Lys285Arg),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,367543263,-,RCV000022220,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649031,34649031,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259520,UniProtKB:P07902#VAR_068829",2,25277,34649031,A,G,K285R,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,285,K,R,True,806
12859,5673,36580,single nucleotide variant,NM_000155.4(GALT):c.691C>T (p.Arg231Cys),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,15-Nov-19,111033749,-,RCV000022184|RCV000185919,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34648765,34648765,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA259477,UniProtKB:P07902#VAR_072797",2,25246,34648765,C,T,R231C,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,231,R,C,True,806
12860,5641,36511,single nucleotide variant,NM_000155.4(GALT):c.442C>G (p.Arg148Gly),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033693,-,RCV000022112,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647896,34647896,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259392,UniProtKB:P07902#VAR_002577",2,25177,34647896,C,G,R148G,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,148,R,G,True,806
12861,5668,36570,single nucleotide variant,NM_000155.4(GALT):c.650T>C (p.Leu217Pro),2592,GALT,HGNC:4135,Pathogenic,1,26-Sep-19,111033741,-,RCV000022172,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline,germline,GRCh38,NC_000009.12,9,34648419,34648419,na,na,9p13.3,no assertion criteria provided,2,-,N,"UniProtKB:P07902#VAR_002599,ClinGen:CA259464",2,25236,34648419,T,C,L217P,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,217,L,P,True,806
12862,5639,36509,single nucleotide variant,NM_000155.4(GALT):c.424A>G (p.Met142Val),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033692,-,RCV000022109,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647878,34647878,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259389,UniProtKB:P07902#VAR_002575",2,25175,34647878,A,G,M142V,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,142,M,V,True,806
12863,5620,36467,single nucleotide variant,NM_000155.4(GALT):c.152G>T (p.Arg51Leu),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033648,-,RCV000022060,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647158,34647158,na,na,9p13.3,no assertion criteria provided,1,-,N,"UniProtKB:P07902#VAR_002553,ClinGen:CA259330",2,25133,34647158,G,T,R51L,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,51,R,L,True,806
12864,5618,36463,single nucleotide variant,NM_000155.4(GALT):c.130G>T (p.Val44Leu),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033647,-,RCV000022056,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647136,34647136,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259328,UniProtKB:P07902#VAR_002551",2,25129,34647136,G,T,V44L,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,44,V,L,True,806
12865,5617,36461,single nucleotide variant,NM_000155.4(GALT):c.113A>C (p.Gln38Pro),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033646,-,RCV000022054,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647119,34647119,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259325,UniProtKB:P07902#VAR_002550",2,25127,34647119,A,C,Q38P,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,38,Q,P,True,806
12866,5616,36459,single nucleotide variant,NM_000155.4(GALT):c.100T>A (p.Tyr34Asn),2592,GALT,HGNC:4135,Conflicting interpretations of pathogenicity,1,28-May-19,111033836,-,RCV000022052|RCV000726020,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34647106,34647106,na,na,9p13.3,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA259324,UniProtKB:P07902#VAR_068535",2,25125,34647106,T,A,Y34N,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,34,Y,N,True,806
12867,5615,36458,single nucleotide variant,NM_000155.4(GALT):c.98G>A (p.Arg33His),2592,GALT,HGNC:4135,Likely pathogenic,1,9-Apr-18,111033829,-,RCV000022051,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline,germline,GRCh38,NC_000009.12,9,34647104,34647104,na,na,9p13.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA259323,UniProtKB:P07902#VAR_068534",2,25124,34647104,G,A,R33H,1,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,33,R,H,True,806
12868,5614,36457,single nucleotide variant,NM_000155.4(GALT):c.95T>A (p.Ile32Asn),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033644,-,RCV000022050,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647101,34647101,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259322,UniProtKB:P07902#VAR_002549",2,25123,34647101,T,A,I32N,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,32,I,N,True,806
12869,5613,36452,single nucleotide variant,NM_000155.4(GALT):c.67A>G (p.Thr23Ala),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033635,-,RCV000022044,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34646771,34646771,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259315,UniProtKB:P07902#VAR_068532",2,25118,34646771,A,G,T23A,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,23,T,A,True,806
12870,5612,36449,single nucleotide variant,NM_000155.4(GALT):c.27G>C (p.Gln9His),2592,GALT,HGNC:4135,Uncertain significance,1,8-Nov-17,111033637,-,RCV000022041,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,unknown,unknown,GRCh38,NC_000009.12,9,34646731,34646731,na,na,9p13.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA259311,UniProtKB:P07902#VAR_068531",2,25115,34646731,G,C,Q9H,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,9,Q,H,True,806
12871,5702,36648,single nucleotide variant,NM_000155.4(GALT):c.1001A>G (p.Lys334Arg),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033809,-,RCV000022260,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649506,34649506,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259563,UniProtKB:P07902#VAR_002628",2,25314,34649506,A,G,K334R,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,334,K,R,True,806
12872,5703,36649,single nucleotide variant,NM_000155.4(GALT):c.1006A>T (p.Met336Leu),2592,GALT,HGNC:4135,Uncertain significance,1,28-Dec-17,111033810,-,RCV000022261,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,unknown,unknown,GRCh38,NC_000009.12,9,34649511,34649511,na,na,9p13.3,"criteria provided, single submitter",2,-,N,"UniProtKB:P07902#VAR_002629,ClinGen:CA259564",2,25315,34649511,A,T,M336L,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,336,M,L,True,806
12873,5704,36653,single nucleotide variant,NM_000155.4(GALT):c.1024C>A (p.Leu342Ile),2592,GALT,HGNC:4135,Uncertain significance,1,13-Dec-19,111033812,-,RCV000022265,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline,germline,GRCh38,NC_000009.12,9,34649529,34649529,na,na,9p13.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA259571,UniProtKB:P07902#VAR_068554",2,25319,34649529,C,A,L342I,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,342,L,I,True,806
12874,5640,36510,single nucleotide variant,NM_000155.4(GALT):c.425T>C (p.Met142Thr),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033695,-,RCV000022110,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647879,34647879,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259390,UniProtKB:P07902#VAR_072795",2,25176,34647879,T,C,M142T,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,142,M,T,True,806
12875,5706,36655,single nucleotide variant,NM_000155.4(GALT):c.1034C>A (p.Ala345Asp),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033815,-,RCV000022267,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649539,34649539,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259573,UniProtKB:P07902#VAR_068555",2,25321,34649539,C,A,A345D,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,345,A,D,True,806
12876,5707,36657,single nucleotide variant,NM_000155.4(GALT):c.1048A>G (p.Thr350Ala),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033817,-,RCV000022269,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649553,34649553,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259575,UniProtKB:P07902#VAR_002631",2,25323,34649553,A,G,T350A,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,350,T,A,True,806
12877,6279,45909,single nucleotide variant,NM_000155.4(GALT):c.428C>T (p.Ser143Leu),2592,GALT,HGNC:4135,Likely pathogenic,1,13-Oct-20,111033697,-,RCV000022111,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline,germline,GRCh38,NC_000009.12,9,34647882,34647882,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA259391,UniProtKB:P07902#VAR_002576",2,37358,34647882,C,T,S143L,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,143,S,L,True,806
12878,6280,45910,single nucleotide variant,NM_000155.4(GALT):c.442C>T (p.Arg148Trp),2592,GALT,HGNC:4135,Pathogenic,1,15-Nov-19,111033693,-,RCV000022113|RCV000414362,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;paternal,germline,GRCh38,NC_000009.12,9,34647896,34647896,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA259393,UniProtKB:P07902#VAR_002579",2,37359,34647896,C,T,R148W,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,148,R,W,True,806
12879,6281,45911,single nucleotide variant,NM_000155.4(GALT):c.680T>C (p.Leu227Pro),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033846,-,RCV000022181,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34648449,34648449,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259474,UniProtKB:P07902#VAR_068547",2,37360,34648449,T,C,L227P,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,227,L,P,True,806
12880,6306,46840,single nucleotide variant,NM_000155.4(GALT):c.163G>T (p.Gly55Cys),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033654,-,RCV000022063|RCV000767304,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,not applicable,not applicable,GRCh38,NC_000009.12,9,34647169,34647169,na,na,9p13.3,no assertion criteria provided,2,-,N,"ClinGen:CA259334,UniProtKB:P07902#VAR_002554",2,38285,34647169,G,T,G55C,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,55,G,C,True,806
12881,6307,46843,single nucleotide variant,NM_000155.4(GALT):c.998G>A (p.Arg333Gln),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,24-Oct-19,111033808,-,RCV000022258,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline;unknown,germline,GRCh38,NC_000009.12,9,34649503,34649503,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA259561,UniProtKB:P07902#VAR_002626",2,38288,34649503,G,A,R333Q,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,333,R,Q,True,806
12882,5621,36471,single nucleotide variant,NM_000155.4(GALT):c.199C>T (p.Arg67Cys),2592,GALT,HGNC:4135,Pathogenic,1,31-Oct-18,111033658,-,RCV000022067|RCV000723719,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline,germline,GRCh38,NC_000009.12,9,34647205,34647205,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA259339,UniProtKB:P07902#VAR_002556",2,25137,34647205,C,T,R67C,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,67,R,C,True,806
12883,5622,36475,single nucleotide variant,NM_000155.4(GALT):c.241G>A (p.Ala81Thr),2592,GALT,HGNC:4135,Uncertain significance,1,18-Sep-15,111033665,-,RCV000022071|RCV000723449,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline,germline,GRCh38,NC_000009.12,9,34647247,34647247,na,na,9p13.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA259345,UniProtKB:P07902#VAR_002558",2,25141,34647247,G,A,A81T,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,81,A,T,True,806
12884,5705,36654,single nucleotide variant,NM_000155.4(GALT):c.1030C>A (p.Gln344Lys),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,18-Dec-19,111033814,-,RCV000022266|RCV000224058,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34649535,34649535,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA259572,UniProtKB:P07902#VAR_002630",2,25320,34649535,C,A,Q344K,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,344,Q,K,True,806
12885,5624,36480,single nucleotide variant,NM_000155.4(GALT):c.290A>G (p.Asn97Ser),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,6-Sep-19,111033669,-,RCV000022077|RCV000723577,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline,germline,GRCh38,NC_000009.12,9,34647529,34647529,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA259355,UniProtKB:P07902#VAR_002559",2,25146,34647529,A,G,N97S,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,97,N,S,True,806
12886,5634,36501,single nucleotide variant,NM_000155.4(GALT):c.379A>G (p.Lys127Glu),2592,GALT,HGNC:4135,Conflicting interpretations of pathogenicity,1,3-May-18,111033682,-,RCV000022098|RCV000723539,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34647833,34647833,na,na,9p13.3,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA259377,UniProtKB:P07902#VAR_002568",2,25167,34647833,A,G,K127E,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,127,K,E,True,806
12887,5632,36496,single nucleotide variant,NM_000155.4(GALT):c.368G>A (p.Arg123Gln),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033675,-,RCV000022093,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647696,34647696,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259373,UniProtKB:P07902#VAR_002566",2,25162,34647696,G,A,R123Q,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,123,R,Q,True,806
12888,5631,36495,single nucleotide variant,NM_000155.4(GALT):c.354A>C (p.Gln118His),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033673,-,RCV000022092,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647682,34647682,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259372,UniProtKB:P07902#VAR_002564",2,25161,34647682,A,C,Q118H,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,118,Q,H,True,806
12889,5635,36502,single nucleotide variant,NM_000155.4(GALT):c.389G>A (p.Cys130Tyr),2592,GALT,HGNC:4135,Uncertain significance,1,19-Sep-17,367543255,-,RCV000022100|RCV000270852,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34647843,34647843,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA259379,UniProtKB:P07902#VAR_002569",2,25168,34647843,G,A,C130Y,2,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,130,C,Y,True,806
12890,5636,36504,single nucleotide variant,NM_000155.4(GALT):c.396C>A (p.His132Gln),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,4-Jun-19,367543256,-,RCV000022103|RCV000723453,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline,germline,GRCh38,NC_000009.12,9,34647850,34647850,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA259383,UniProtKB:P07902#VAR_068537",2,25170,34647850,C,A,H132Q,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,132,H,Q,True,806
12891,5623,36478,single nucleotide variant,NM_000155.4(GALT):c.265T>C (p.Tyr89His),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033666,-,RCV000022075,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647504,34647504,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259352,UniProtKB:P07902#VAR_068824",2,25144,34647504,T,C,Y89H,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,89,Y,H,True,806
12892,5637,36506,single nucleotide variant,NM_000155.4(GALT):c.404C>G (p.Ser135Trp),2592,GALT,HGNC:4135,Likely pathogenic,1,2-Dec-14,111033690,-,RCV000022105,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,unknown,unknown,GRCh38,NC_000009.12,9,34647858,34647858,na,na,9p13.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA259385,UniProtKB:P07902#VAR_023329",2,25172,34647858,C,G,S135W,1,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,135,S,W,True,806
12893,5700,36645,single nucleotide variant,NM_000155.4(GALT):c.989C>T (p.Ala330Val),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033804,-,RCV000022256,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649494,34649494,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259560,UniProtKB:P07902#VAR_002624",2,25311,34649494,C,T,A330V,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,330,A,V,True,806
12894,5630,36494,single nucleotide variant,NM_000155.4(GALT):c.350T>C (p.Phe117Ser),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033679,-,RCV000022091,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647678,34647678,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259371,UniProtKB:P07902#VAR_002563",2,25160,34647678,T,C,F117S,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,117,F,S,True,806
12895,5701,36647,single nucleotide variant,NM_000155.4(GALT):c.998G>T (p.Arg333Leu),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033808,-,RCV000022259,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34649503,34649503,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259562,UniProtKB:P07902#VAR_068830",2,25313,34649503,G,T,R333L,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,333,R,L,True,806
12896,5633,36497,single nucleotide variant,NM_000155.4(GALT):c.374T>C (p.Val125Ala),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033680,-,RCV000022094,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647702,34647702,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259374,UniProtKB:P07902#VAR_002567",2,25163,34647702,T,C,V125A,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,125,V,A,True,806
12897,5629,36493,single nucleotide variant,NM_000155.4(GALT):c.341A>T (p.His114Leu),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033678,-,RCV000022090,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647669,34647669,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259370,UniProtKB:P07902#VAR_002562",2,25159,34647669,A,T,H114L,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,114,H,L,True,806
12898,5627,36486,single nucleotide variant,NM_000155.4(GALT):c.308A>G (p.Gln103Arg),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,367543252,-,RCV000022083,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647547,34647547,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259360,UniProtKB:P07902#VAR_068825",2,25152,34647547,A,G,Q103R,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,103,Q,R,True,806
12899,5638,36508,single nucleotide variant,NM_000155.4(GALT):c.413C>T (p.Thr138Met),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,28-Sep-20,111033686,-,RCV000022107,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline;unknown,germline,GRCh38,NC_000009.12,9,34647867,34647867,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA259387,UniProtKB:P07902#VAR_002572",2,25174,34647867,C,T,T138M,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,138,T,M,True,806
12900,5626,36482,single nucleotide variant,NM_000155.4(GALT):c.292G>A (p.Asp98Asn),2592,GALT,HGNC:4135,Pathogenic/Likely pathogenic,1,9-Oct-20,111033670,-,RCV000022079|RCV000723399,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239|MedGen:CN517202",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,34647531,34647531,na,na,9p13.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA259357,UniProtKB:P07902#VAR_002560",2,25148,34647531,G,A,D98N,2,pathogenic,pathogenic,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,98,D,N,True,806
12901,5625,36481,single nucleotide variant,NM_000155.4(GALT):c.367C>G (p.Arg123Gly),2592,GALT,HGNC:4135,Uncertain significance,1,12-Oct-17,111033674,-,RCV000022078,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline,germline,GRCh38,NC_000009.12,9,34647695,34647695,na,na,9p13.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA259356,UniProtKB:P07902#VAR_002565",2,25147,34647695,C,G,R123G,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,123,R,G,True,806
12902,5628,36492,single nucleotide variant,NM_000155.4(GALT):c.337G>A (p.Asp113Asn),2592,GALT,HGNC:4135,Pathogenic,1,4-Dec-12,111033677,-,RCV000022089,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,not provided,not provided,GRCh38,NC_000009.12,9,34647665,34647665,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259369,UniProtKB:P07902#VAR_002561",2,25158,34647665,G,A,D113N,0,pathogenic,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,113,D,N,True,806
12903,6278,45908,single nucleotide variant,NM_000155.4(GALT):c.394C>T (p.His132Tyr),2592,GALT,HGNC:4135,Conflicting interpretations of pathogenicity,1,17-Apr-19,111033688,-,RCV000022102,"MONDO:MONDO:0009258,MedGen:C0268151,OMIM:230400,Orphanet:352,Orphanet:79239",Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,germline;unknown,germline,GRCh38,NC_000009.12,9,34647848,34647848,na,na,9p13.3,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA259382,UniProtKB:P07902#VAR_002570",2,37357,34647848,C,T,H132Y,1,uncertain,uncertain,P07902,P07902,reviewed,GALT_HUMAN,"Galactose-1-phosphate uridylyltransferase, Gal-1-P uridylyltransferase, EC 2.7.7.12 (UDP-glucose--hexose-1-phosphate uridylyltransferase)",GALT,Homo sapiens (Human),379.0,MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWNHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA,PF02744;PF01087;,5IN3;6GQD;,132,H,Y,True,806
12904,6479,48310,single nucleotide variant,NM_018486.3(HDAC8):c.539A>G (p.His180Arg),55869,HDAC8,HGNC:13315,Pathogenic,1,13-Sep-12,397515416,-,RCV000032916,"MONDO:MONDO:0010471,MedGen:C3550903,OMIM:300882,Orphanet:199",Cornelia de Lange syndrome 5,germline,germline,GRCh38,NC_000023.11,X,72495167,72495167,na,na,Xq13.1,no assertion criteria provided,1,-,N,"ClinGen:CA261206,UniProtKB:Q9BY41#VAR_069140,OMIM:300269.0003",1,39711,72495167,T,C,H180R,0,pathogenic,uncertain,Q9BY41,Q9BY41,reviewed,HDAC8_HUMAN,"Histone deacetylase 8, HD8, EC 3.5.1.98 (Protein deacetylase HDAC8, EC 3.5.1.-) (Protein decrotonylase HDAC8, EC 3.5.1.-)",HDAC8 HDACL1 CDA07,Homo sapiens (Human),377.0,MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVV,PF00850;,1T64;1T67;1T69;1VKG;1W22;2V5W;2V5X;3EW8;3EWF;3EZP;3EZT;3F06;3F07;3F0R;3MZ3;3MZ4;3MZ6;3MZ7;3RQD;3SFF;3SFH;4QA0;4QA1;4QA2;4QA3;4QA4;4QA5;4QA6;4QA7;4RN0;4RN1;4RN2;5BWZ;5D1B;5D1C;5D1D;5DC5;5DC6;5DC7;5DC8;5FCW;5THS;5THT;5THU;5THV;5VI6;6HSK;6ODA;6ODB;6ODC;7JVU;7JVV;7JVW;,180,H,R,True,807
12905,6480,48311,single nucleotide variant,NM_018486.3(HDAC8):c.932C>T (p.Thr311Met),55869,HDAC8,HGNC:13315,Pathogenic,1,8-Mar-18,397515417,-,RCV000032917|RCV000624803,"MONDO:MONDO:0010471,MedGen:C3550903,OMIM:300882,Orphanet:199|MeSH:D030342,MedGen:C0950123",Cornelia de Lange syndrome 5|Inborn genetic diseases,de novo;germline,germline,GRCh38,NC_000023.11,X,72462077,72462077,na,na,Xq13.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"OMIM:300269.0004,ClinGen:CA261207,UniProtKB:Q9BY41#VAR_069141",3,39712,72462077,G,A,T311M,2,pathogenic,pathogenic,Q9BY41,Q9BY41,reviewed,HDAC8_HUMAN,"Histone deacetylase 8, HD8, EC 3.5.1.98 (Protein deacetylase HDAC8, EC 3.5.1.-) (Protein decrotonylase HDAC8, EC 3.5.1.-)",HDAC8 HDACL1 CDA07,Homo sapiens (Human),377.0,MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVV,PF00850;,1T64;1T67;1T69;1VKG;1W22;2V5W;2V5X;3EW8;3EWF;3EZP;3EZT;3F06;3F07;3F0R;3MZ3;3MZ4;3MZ6;3MZ7;3RQD;3SFF;3SFH;4QA0;4QA1;4QA2;4QA3;4QA4;4QA5;4QA6;4QA7;4RN0;4RN1;4RN2;5BWZ;5D1B;5D1C;5D1D;5DC5;5DC6;5DC7;5DC8;5FCW;5THS;5THT;5THU;5THV;5VI6;6HSK;6ODA;6ODB;6ODC;7JVU;7JVV;7JVW;,311,T,M,True,807
12906,6482,48313,single nucleotide variant,NM_018486.3(HDAC8):c.1001A>G (p.His334Arg),55869,HDAC8,HGNC:13315,Pathogenic,1,13-Sep-12,397515418,-,RCV000032919,"MONDO:MONDO:0010471,MedGen:C3550903,OMIM:300882,Orphanet:199",Cornelia de Lange syndrome 5,germline,germline,GRCh38,NC_000023.11,X,72462008,72462008,na,na,Xq13.1,no assertion criteria provided,1,-,N,"ClinGen:CA261209,UniProtKB:Q9BY41#VAR_069143,OMIM:300269.0006",1,39714,72462008,T,C,H334R,0,pathogenic,uncertain,Q9BY41,Q9BY41,reviewed,HDAC8_HUMAN,"Histone deacetylase 8, HD8, EC 3.5.1.98 (Protein deacetylase HDAC8, EC 3.5.1.-) (Protein decrotonylase HDAC8, EC 3.5.1.-)",HDAC8 HDACL1 CDA07,Homo sapiens (Human),377.0,MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVV,PF00850;,1T64;1T67;1T69;1VKG;1W22;2V5W;2V5X;3EW8;3EWF;3EZP;3EZT;3F06;3F07;3F0R;3MZ3;3MZ4;3MZ6;3MZ7;3RQD;3SFF;3SFH;4QA0;4QA1;4QA2;4QA3;4QA4;4QA5;4QA6;4QA7;4RN0;4RN1;4RN2;5BWZ;5D1B;5D1C;5D1D;5DC5;5DC6;5DC7;5DC8;5FCW;5THS;5THT;5THU;5THV;5VI6;6HSK;6ODA;6ODB;6ODC;7JVU;7JVV;7JVW;,334,H,R,True,807
12907,6481,48312,single nucleotide variant,NM_018486.3(HDAC8):c.958G>A (p.Gly320Arg),55869,HDAC8,HGNC:13315,Conflicting interpretations of pathogenicity,1,7-Oct-19,398122909,-,RCV000032918|RCV000211117|RCV001030829,"MONDO:MONDO:0010471,MedGen:C3550903,OMIM:300882,Orphanet:199|MedGen:CN169374|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,Human Phenotype Ontology:HP:HP:0001249,MONDO:MONDO:0001071,MedGen:C3714756",Cornelia de Lange syndrome 5|not specified|Intellectual disability,de novo;germline,germline,GRCh38,NC_000023.11,X,72462051,72462051,na,na,Xq13.1,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA261208,UniProtKB:Q9BY41#VAR_069142,OMIM:300269.0005",3,39713,72462051,C,T,G320R,1,uncertain,uncertain,Q9BY41,Q9BY41,reviewed,HDAC8_HUMAN,"Histone deacetylase 8, HD8, EC 3.5.1.98 (Protein deacetylase HDAC8, EC 3.5.1.-) (Protein decrotonylase HDAC8, EC 3.5.1.-)",HDAC8 HDACL1 CDA07,Homo sapiens (Human),377.0,MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVV,PF00850;,1T64;1T67;1T69;1VKG;1W22;2V5W;2V5X;3EW8;3EWF;3EZP;3EZT;3F06;3F07;3F0R;3MZ3;3MZ4;3MZ6;3MZ7;3RQD;3SFF;3SFH;4QA0;4QA1;4QA2;4QA3;4QA4;4QA5;4QA6;4QA7;4RN0;4RN1;4RN2;5BWZ;5D1B;5D1C;5D1D;5DC5;5DC6;5DC7;5DC8;5FCW;5THS;5THT;5THU;5THV;5VI6;6HSK;6ODA;6ODB;6ODC;7JVU;7JVV;7JVW;,320,G,R,True,807
12908,13085,249357,single nucleotide variant,NM_004565.3(PEX14):c.959G>A (p.Arg320Lys),5195,PEX14,HGNC:8856,Benign,0,31-Dec-19,12070353,-,RCV000243092|RCV000399202|RCV000957776,"MedGen:CN169374|MONDO:MONDO:0013952,MedGen:C3554004,OMIM:614887,Orphanet:912|MedGen:C1866257","not specified|Peroxisome biogenesis disorder 13A|Peroxisome biogenesis disorder, complementation group K",germline,germline,GRCh38,NC_000001.11,1,10629812,10629812,na,na,1p36.22,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA584005,UniProtKB:O75381#VAR_051271",2,259439,10629812,G,A,R320K,2,benign,benign,O75381,O75381,reviewed,PEX14_HUMAN,Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14),PEX14,Homo sapiens (Human),377.0,MASSEQAEQPSQPSSTPGSENVLPREPLIATAVKFLQNSRVRQSPLATRRAFLKKKGLTDEEIDMAFQQSGTAADEPSSLGPATQVVPVQPPHLISQPYSPAGSRWRDYGALAIIMAGIAFGFHQLYKKYLLPLILGGREDRKQLERMEAGLSELSGSVAQTVTQLQTTLASVQELLIQQQQKIQELAHELAAAKATTSTNWILESQNINELKSEINSLKGLLLNRRQFPPSPSAPKIPSWQIPVKSPSPSSPAAVNHHSSSDISPVSNESTSSSPGKEGHSPEGSTVTYHLLGPQEEGEGVVDVKGQVRMEVQGEEEKREDKEDEEDEEDDDVSHVDEEDCLGVQREDRRGGDGQINEQVEKLRRPEGASNESERD,PF04695;,2W84;2W85;4BXU;,320,R,K,True,808
12909,11894,194925,single nucleotide variant,NM_004565.3(PEX14):c.349G>T (p.Ala117Ser),5195,PEX14,HGNC:8856,Benign/Likely benign,0,31-Dec-19,12061667,-,RCV000178893|RCV000362194|RCV000960527,"MedGen:CN169374|MONDO:MONDO:0013952,MedGen:C3554004,OMIM:614887,Orphanet:912|MedGen:C1866257","not specified|Peroxisome biogenesis disorder 13A|Peroxisome biogenesis disorder, complementation group K",germline,germline,GRCh38,NC_000001.11,1,10618382,10618382,na,na,1p36.22,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA203068,UniProtKB:O75381#VAR_051269",2,197764,10618382,G,T,A117S,2,benign,benign,O75381,O75381,reviewed,PEX14_HUMAN,Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14),PEX14,Homo sapiens (Human),377.0,MASSEQAEQPSQPSSTPGSENVLPREPLIATAVKFLQNSRVRQSPLATRRAFLKKKGLTDEEIDMAFQQSGTAADEPSSLGPATQVVPVQPPHLISQPYSPAGSRWRDYGALAIIMAGIAFGFHQLYKKYLLPLILGGREDRKQLERMEAGLSELSGSVAQTVTQLQTTLASVQELLIQQQQKIQELAHELAAAKATTSTNWILESQNINELKSEINSLKGLLLNRRQFPPSPSAPKIPSWQIPVKSPSPSSPAAVNHHSSSDISPVSNESTSSSPGKEGHSPEGSTVTYHLLGPQEEGEGVVDVKGQVRMEVQGEEEKREDKEDEEDEEDDDVSHVDEEDCLGVQREDRRGGDGQINEQVEKLRRPEGASNESERD,PF04695;,2W84;2W85;4BXU;,117,A,S,True,808
12910,5251,33219,single nucleotide variant,NM_000669.5(ADH1C):c.1048A>G (p.Ile350Val),126,ADH1C,HGNC:251,protective,0,1-Jun-08,698,-,RCV000019811,"MONDO:MONDO:0007079,MedGen:C0001973,OMIM:103780",Alcohol dependence,germline,germline,GRCh38,NC_000004.12,4,99339632,99339632,na,na,4q23,no assertion criteria provided,1,-,N,"ClinGen:CA127870,UniProtKB:P00326#VAR_000429,OMIM:103730.0002",1,18180,99339632,T,C,I350V,0,uncertain,uncertain,P00326,P00326,reviewed,ADH1G_HUMAN,"Alcohol dehydrogenase 1C, EC 1.1.1.1 (Alcohol dehydrogenase subunit gamma)",ADH1C ADH3,Homo sapiens (Human),375.0,MSTAGKVIKCKAAVLWELKKPFSIEEVEVAPPKAHEVRIKMVAAGICRSDEHVVSGNLVTPLPVILGHEAAGIVESVGEGVTTVKPGDKVIPLFTPQCGKCRICKNPESNYCLKNDLGNPRGTLQDGTRRFTCSGKPIHHFVGVSTFSQYTVVDENAVAKIDAASPLEKVCLIGCGFSTGYGSAVKVAKVTPGSTCAVFGLGGVGLSVVMGCKAAGAARIIAVDINKDKFAKAKELGATECINPQDYKKPIQEVLKEMTDGGVDFSFEVIGRLDTMMASLLCCHEACGTSVIVGVPPDSQNLSINPMLLLTGRTWKGAIFGGFKSKESVPKLVADFMAKKFSLDALITNILPFEKINEGFDLLRSGKSIRTVLTF,PF08240;PF00107;,1HT0;1U3W;,350,I,V,True,809
12911,5250,33218,single nucleotide variant,NM_000669.5(ADH1C):c.815G>A (p.Arg272Gln),126,ADH1C,HGNC:251,protective,0,1-Jun-08,1693482,-,RCV000019810,"MONDO:MONDO:0007079,MedGen:C0001973,OMIM:103780",Alcohol dependence,germline,germline,GRCh38,NC_000004.12,4,99342808,99342808,na,na,4q23,no assertion criteria provided,1,-,N,"ClinGen:CA127868,UniProtKB:P00326#VAR_000428,OMIM:103730.0001",1,18179,99342808,C,T,R272Q,0,uncertain,uncertain,P00326,P00326,reviewed,ADH1G_HUMAN,"Alcohol dehydrogenase 1C, EC 1.1.1.1 (Alcohol dehydrogenase subunit gamma)",ADH1C ADH3,Homo sapiens (Human),375.0,MSTAGKVIKCKAAVLWELKKPFSIEEVEVAPPKAHEVRIKMVAAGICRSDEHVVSGNLVTPLPVILGHEAAGIVESVGEGVTTVKPGDKVIPLFTPQCGKCRICKNPESNYCLKNDLGNPRGTLQDGTRRFTCSGKPIHHFVGVSTFSQYTVVDENAVAKIDAASPLEKVCLIGCGFSTGYGSAVKVAKVTPGSTCAVFGLGGVGLSVVMGCKAAGAARIIAVDINKDKFAKAKELGATECINPQDYKKPIQEVLKEMTDGGVDFSFEVIGRLDTMMASLLCCHEACGTSVIVGVPPDSQNLSINPMLLLTGRTWKGAIFGGFKSKESVPKLVADFMAKKFSLDALITNILPFEKINEGFDLLRSGKSIRTVLTF,PF08240;PF00107;,1HT0;1U3W;,272,R,Q,True,809
12912,686,17707,single nucleotide variant,NM_182760.4(SUMF1):c.1006T>C (p.Cys336Arg),285362,SUMF1,HGNC:20376,Pathogenic,1,16-May-03,137852848,-,RCV000002787,"MONDO:MONDO:0010088,MedGen:C0268263,OMIM:272200,Orphanet:585",Multiple sulfatase deficiency,germline,germline,GRCh38,NC_000003.12,3,4376338,4376338,na,na,3p26.1,no assertion criteria provided,1,-,N,"ClinGen:CA115673,UniProtKB:Q8NBK3#VAR_016056,OMIM:607939.0006",1,2668,4376338,A,G,C336R,0,pathogenic,uncertain,Q8NBK3,Q8NBK3,reviewed,SUMF1_HUMAN,"Formylglycine-generating enzyme, FGE, EC 1.8.3.7 (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)",SUMF1 PSEC0152 UNQ3037/PRO9852,Homo sapiens (Human),374.0,MAAPALGLVCGRCPELGLVLLLLLLSLLCGAAGSQEAGTGAGAGSLAGSCGCGTPQRPGAHGSSAAAHRYSREANAPGPVPGERQLAHSKMVPIPAGVFTMGTDDPQIKQDGEAPARRVTIDAFYMDAYEVSNTEFEKFVNSTGYLTEAEKFGDSFVFEGMLSEQVKTNIQQAVAAAPWWLPVKGANWRHPEGPDSTILHRPDHPVLHVSWNDAVAYCTWAGKRLPTEAEWEYSCRGGLHNRLFPWGNKLQPKGQHYANIWQGEFPVTNTGEDGFQGTAPVDAFPPNGYGLYNIVGNAWEWTSDWWTVHHSVEETLNPKGPPSGKDRVKKGGSYMCHRSYCYRYRCAARSQNTPDSSASNLGFRCAADRLPTMD,PF03781;,1Y1E;1Y1F;1Y1G;1Y1H;1Y1I;1Y1J;1Z70;2AFT;2AFY;2AII;2AIJ;2AIK;2HI8;2HIB;,336,C,R,True,810
12913,684,17705,single nucleotide variant,NM_182760.4(SUMF1):c.1045C>T (p.Arg349Trp),285362,SUMF1,HGNC:20376,Pathogenic/Likely pathogenic,1,1-Jul-19,137852846,-,RCV000002785,"MONDO:MONDO:0010088,MedGen:C0268263,OMIM:272200,Orphanet:585",Multiple sulfatase deficiency,germline;unknown,germline,GRCh38,NC_000003.12,3,4362224,4362224,na,na,3p26.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA115671,UniProtKB:Q8NBK3#VAR_016060,OMIM:607939.0004",3,2666,4362224,G,A,R349W,2,pathogenic,pathogenic,Q8NBK3,Q8NBK3,reviewed,SUMF1_HUMAN,"Formylglycine-generating enzyme, FGE, EC 1.8.3.7 (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)",SUMF1 PSEC0152 UNQ3037/PRO9852,Homo sapiens (Human),374.0,MAAPALGLVCGRCPELGLVLLLLLLSLLCGAAGSQEAGTGAGAGSLAGSCGCGTPQRPGAHGSSAAAHRYSREANAPGPVPGERQLAHSKMVPIPAGVFTMGTDDPQIKQDGEAPARRVTIDAFYMDAYEVSNTEFEKFVNSTGYLTEAEKFGDSFVFEGMLSEQVKTNIQQAVAAAPWWLPVKGANWRHPEGPDSTILHRPDHPVLHVSWNDAVAYCTWAGKRLPTEAEWEYSCRGGLHNRLFPWGNKLQPKGQHYANIWQGEFPVTNTGEDGFQGTAPVDAFPPNGYGLYNIVGNAWEWTSDWWTVHHSVEETLNPKGPPSGKDRVKKGGSYMCHRSYCYRYRCAARSQNTPDSSASNLGFRCAADRLPTMD,PF03781;,1Y1E;1Y1F;1Y1G;1Y1H;1Y1I;1Y1J;1Z70;2AFT;2AFY;2AII;2AIJ;2AIK;2HI8;2HIB;,349,R,W,True,810
12914,687,17708,single nucleotide variant,NM_182760.4(SUMF1):c.836C>T (p.Ala279Val),285362,SUMF1,HGNC:20376,Conflicting interpretations of pathogenicity,1,23-Oct-20,137852849,-,RCV000002788|RCV000082716,"MONDO:MONDO:0010088,MedGen:C0268263,OMIM:272200,Orphanet:585|MedGen:CN517202",Multiple sulfatase deficiency|not provided,germline;maternal;unknown,germline,GRCh38,NC_000003.12,3,4417132,4417132,na,na,3p26.1,"criteria provided, conflicting interpretations",13,-,N,"OMIM:607939.0007,ClinGen:CA115674,UniProtKB:Q8NBK3#VAR_016055",3,2669,4417132,G,A,A279V,1,uncertain,uncertain,Q8NBK3,Q8NBK3,reviewed,SUMF1_HUMAN,"Formylglycine-generating enzyme, FGE, EC 1.8.3.7 (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)",SUMF1 PSEC0152 UNQ3037/PRO9852,Homo sapiens (Human),374.0,MAAPALGLVCGRCPELGLVLLLLLLSLLCGAAGSQEAGTGAGAGSLAGSCGCGTPQRPGAHGSSAAAHRYSREANAPGPVPGERQLAHSKMVPIPAGVFTMGTDDPQIKQDGEAPARRVTIDAFYMDAYEVSNTEFEKFVNSTGYLTEAEKFGDSFVFEGMLSEQVKTNIQQAVAAAPWWLPVKGANWRHPEGPDSTILHRPDHPVLHVSWNDAVAYCTWAGKRLPTEAEWEYSCRGGLHNRLFPWGNKLQPKGQHYANIWQGEFPVTNTGEDGFQGTAPVDAFPPNGYGLYNIVGNAWEWTSDWWTVHHSVEETLNPKGPPSGKDRVKKGGSYMCHRSYCYRYRCAARSQNTPDSSASNLGFRCAADRLPTMD,PF03781;,1Y1E;1Y1F;1Y1G;1Y1H;1Y1I;1Y1J;1Z70;2AFT;2AFY;2AII;2AIJ;2AIK;2HI8;2HIB;,279,A,V,True,810
12915,685,17706,single nucleotide variant,NM_182760.4(SUMF1):c.1046G>A (p.Arg349Gln),285362,SUMF1,HGNC:20376,Pathogenic,1,16-May-03,137852847,-,RCV000002786,"MONDO:MONDO:0010088,MedGen:C0268263,OMIM:272200,Orphanet:585",Multiple sulfatase deficiency,germline,germline,GRCh38,NC_000003.12,3,4362223,4362223,na,na,3p26.1,no assertion criteria provided,1,-,N,"ClinGen:CA115672,UniProtKB:Q8NBK3#VAR_016059,OMIM:607939.0005",1,2667,4362223,C,T,R349Q,0,pathogenic,uncertain,Q8NBK3,Q8NBK3,reviewed,SUMF1_HUMAN,"Formylglycine-generating enzyme, FGE, EC 1.8.3.7 (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)",SUMF1 PSEC0152 UNQ3037/PRO9852,Homo sapiens (Human),374.0,MAAPALGLVCGRCPELGLVLLLLLLSLLCGAAGSQEAGTGAGAGSLAGSCGCGTPQRPGAHGSSAAAHRYSREANAPGPVPGERQLAHSKMVPIPAGVFTMGTDDPQIKQDGEAPARRVTIDAFYMDAYEVSNTEFEKFVNSTGYLTEAEKFGDSFVFEGMLSEQVKTNIQQAVAAAPWWLPVKGANWRHPEGPDSTILHRPDHPVLHVSWNDAVAYCTWAGKRLPTEAEWEYSCRGGLHNRLFPWGNKLQPKGQHYANIWQGEFPVTNTGEDGFQGTAPVDAFPPNGYGLYNIVGNAWEWTSDWWTVHHSVEETLNPKGPPSGKDRVKKGGSYMCHRSYCYRYRCAARSQNTPDSSASNLGFRCAADRLPTMD,PF03781;,1Y1E;1Y1F;1Y1G;1Y1H;1Y1I;1Y1J;1Z70;2AFT;2AFY;2AII;2AIJ;2AIK;2HI8;2HIB;,349,R,Q,True,810
12916,688,17711,single nucleotide variant,NM_182760.4(SUMF1):c.463T>C (p.Ser155Pro),285362,SUMF1,HGNC:20376,Pathogenic/Likely pathogenic,1,18-Dec-19,137852850,-,RCV000002791|RCV000082715,"MONDO:MONDO:0010088,MedGen:C0268263,OMIM:272200,Orphanet:585|MedGen:CN517202",Multiple sulfatase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000003.12,3,4449322,4449322,na,na,3p26.1,"criteria provided, multiple submitters, no conflicts",7,-,Y,"ClinGen:CA115675,UniProtKB:Q8NBK3#VAR_016053,OMIM:607939.0010",3,2672,4449322,A,G,S155P,2,pathogenic,pathogenic,Q8NBK3,Q8NBK3,reviewed,SUMF1_HUMAN,"Formylglycine-generating enzyme, FGE, EC 1.8.3.7 (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)",SUMF1 PSEC0152 UNQ3037/PRO9852,Homo sapiens (Human),374.0,MAAPALGLVCGRCPELGLVLLLLLLSLLCGAAGSQEAGTGAGAGSLAGSCGCGTPQRPGAHGSSAAAHRYSREANAPGPVPGERQLAHSKMVPIPAGVFTMGTDDPQIKQDGEAPARRVTIDAFYMDAYEVSNTEFEKFVNSTGYLTEAEKFGDSFVFEGMLSEQVKTNIQQAVAAAPWWLPVKGANWRHPEGPDSTILHRPDHPVLHVSWNDAVAYCTWAGKRLPTEAEWEYSCRGGLHNRLFPWGNKLQPKGQHYANIWQGEFPVTNTGEDGFQGTAPVDAFPPNGYGLYNIVGNAWEWTSDWWTVHHSVEETLNPKGPPSGKDRVKKGGSYMCHRSYCYRYRCAARSQNTPDSSASNLGFRCAADRLPTMD,PF03781;,1Y1E;1Y1F;1Y1G;1Y1H;1Y1I;1Y1J;1Z70;2AFT;2AFY;2AII;2AIJ;2AIK;2HI8;2HIB;,155,S,P,True,810
12917,689,17714,single nucleotide variant,NM_182760.4(SUMF1):c.1033C>T (p.Arg345Cys),285362,SUMF1,HGNC:20376,Pathogenic,1,3-Jan-19,137852852,-,RCV000002794,"MONDO:MONDO:0010088,MedGen:C0268263,OMIM:272200,Orphanet:585",Multiple sulfatase deficiency,germline,germline,GRCh38,NC_000003.12,3,4362236,4362236,na,na,3p26.1,no assertion criteria provided,2,-,N,"ClinGen:CA115678,UniProtKB:Q8NBK3#VAR_016057,OMIM:607939.0013",1,2675,4362236,G,A,R345C,0,pathogenic,uncertain,Q8NBK3,Q8NBK3,reviewed,SUMF1_HUMAN,"Formylglycine-generating enzyme, FGE, EC 1.8.3.7 (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)",SUMF1 PSEC0152 UNQ3037/PRO9852,Homo sapiens (Human),374.0,MAAPALGLVCGRCPELGLVLLLLLLSLLCGAAGSQEAGTGAGAGSLAGSCGCGTPQRPGAHGSSAAAHRYSREANAPGPVPGERQLAHSKMVPIPAGVFTMGTDDPQIKQDGEAPARRVTIDAFYMDAYEVSNTEFEKFVNSTGYLTEAEKFGDSFVFEGMLSEQVKTNIQQAVAAAPWWLPVKGANWRHPEGPDSTILHRPDHPVLHVSWNDAVAYCTWAGKRLPTEAEWEYSCRGGLHNRLFPWGNKLQPKGQHYANIWQGEFPVTNTGEDGFQGTAPVDAFPPNGYGLYNIVGNAWEWTSDWWTVHHSVEETLNPKGPPSGKDRVKKGGSYMCHRSYCYRYRCAARSQNTPDSSASNLGFRCAADRLPTMD,PF03781;,1Y1E;1Y1F;1Y1G;1Y1H;1Y1I;1Y1J;1Z70;2AFT;2AFY;2AII;2AIJ;2AIK;2HI8;2HIB;,345,R,C,True,810
12918,690,17715,single nucleotide variant,NM_182760.4(SUMF1):c.1042G>C (p.Ala348Pro),285362,SUMF1,HGNC:20376,Pathogenic,1,16-May-03,137852853,-,RCV000002795,"MONDO:MONDO:0010088,MedGen:C0268263,OMIM:272200,Orphanet:585",Multiple sulfatase deficiency,germline,germline,GRCh38,NC_000003.12,3,4362227,4362227,na,na,3p26.1,no assertion criteria provided,1,-,N,"ClinGen:CA115679,UniProtKB:Q8NBK3#VAR_016058,OMIM:607939.0014",1,2676,4362227,C,G,A348P,0,pathogenic,uncertain,Q8NBK3,Q8NBK3,reviewed,SUMF1_HUMAN,"Formylglycine-generating enzyme, FGE, EC 1.8.3.7 (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)",SUMF1 PSEC0152 UNQ3037/PRO9852,Homo sapiens (Human),374.0,MAAPALGLVCGRCPELGLVLLLLLLSLLCGAAGSQEAGTGAGAGSLAGSCGCGTPQRPGAHGSSAAAHRYSREANAPGPVPGERQLAHSKMVPIPAGVFTMGTDDPQIKQDGEAPARRVTIDAFYMDAYEVSNTEFEKFVNSTGYLTEAEKFGDSFVFEGMLSEQVKTNIQQAVAAAPWWLPVKGANWRHPEGPDSTILHRPDHPVLHVSWNDAVAYCTWAGKRLPTEAEWEYSCRGGLHNRLFPWGNKLQPKGQHYANIWQGEFPVTNTGEDGFQGTAPVDAFPPNGYGLYNIVGNAWEWTSDWWTVHHSVEETLNPKGPPSGKDRVKKGGSYMCHRSYCYRYRCAARSQNTPDSSASNLGFRCAADRLPTMD,PF03781;,1Y1E;1Y1F;1Y1G;1Y1H;1Y1I;1Y1J;1Z70;2AFT;2AFY;2AII;2AIJ;2AIK;2HI8;2HIB;,348,A,P,True,810
12919,13173,251147,single nucleotide variant,NM_182760.4(SUMF1):c.188G>A (p.Ser63Asn),285362,SUMF1,HGNC:20376,Benign,0,16-Jun-18,2819590,-,RCV000244602|RCV000362882|RCV000675762,"MedGen:CN169374|MONDO:MONDO:0010088,MedGen:C0268263,OMIM:272200,Orphanet:585|MedGen:CN517202",not specified|Multiple sulfatase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000003.12,3,4467058,4467058,na,na,3p26.1,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA2230698,UniProtKB:Q8NBK3#VAR_016052",2,263004,4467058,C,T,S63N,2,benign,benign,Q8NBK3,Q8NBK3,reviewed,SUMF1_HUMAN,"Formylglycine-generating enzyme, FGE, EC 1.8.3.7 (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)",SUMF1 PSEC0152 UNQ3037/PRO9852,Homo sapiens (Human),374.0,MAAPALGLVCGRCPELGLVLLLLLLSLLCGAAGSQEAGTGAGAGSLAGSCGCGTPQRPGAHGSSAAAHRYSREANAPGPVPGERQLAHSKMVPIPAGVFTMGTDDPQIKQDGEAPARRVTIDAFYMDAYEVSNTEFEKFVNSTGYLTEAEKFGDSFVFEGMLSEQVKTNIQQAVAAAPWWLPVKGANWRHPEGPDSTILHRPDHPVLHVSWNDAVAYCTWAGKRLPTEAEWEYSCRGGLHNRLFPWGNKLQPKGQHYANIWQGEFPVTNTGEDGFQGTAPVDAFPPNGYGLYNIVGNAWEWTSDWWTVHHSVEETLNPKGPPSGKDRVKKGGSYMCHRSYCYRYRCAARSQNTPDSSASNLGFRCAADRLPTMD,PF03781;,1Y1E;1Y1F;1Y1G;1Y1H;1Y1I;1Y1J;1Z70;2AFT;2AFY;2AII;2AIJ;2AIK;2HI8;2HIB;,63,S,N,True,810
12920,691,17716,single nucleotide variant,NM_182760.4(SUMF1):c.653G>A (p.Cys218Tyr),285362,SUMF1,HGNC:20376,Pathogenic,1,16-May-03,137852854,-,RCV000002796,"MONDO:MONDO:0010088,MedGen:C0268263,OMIM:272200,Orphanet:585",Multiple sulfatase deficiency,germline,germline,GRCh38,NC_000003.12,3,4418082,4418082,na,na,3p26.1,no assertion criteria provided,1,-,N,"ClinGen:CA115680,UniProtKB:Q8NBK3#VAR_016054,OMIM:607939.0015",1,2677,4418082,C,T,C218Y,0,pathogenic,uncertain,Q8NBK3,Q8NBK3,reviewed,SUMF1_HUMAN,"Formylglycine-generating enzyme, FGE, EC 1.8.3.7 (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)",SUMF1 PSEC0152 UNQ3037/PRO9852,Homo sapiens (Human),374.0,MAAPALGLVCGRCPELGLVLLLLLLSLLCGAAGSQEAGTGAGAGSLAGSCGCGTPQRPGAHGSSAAAHRYSREANAPGPVPGERQLAHSKMVPIPAGVFTMGTDDPQIKQDGEAPARRVTIDAFYMDAYEVSNTEFEKFVNSTGYLTEAEKFGDSFVFEGMLSEQVKTNIQQAVAAAPWWLPVKGANWRHPEGPDSTILHRPDHPVLHVSWNDAVAYCTWAGKRLPTEAEWEYSCRGGLHNRLFPWGNKLQPKGQHYANIWQGEFPVTNTGEDGFQGTAPVDAFPPNGYGLYNIVGNAWEWTSDWWTVHHSVEETLNPKGPPSGKDRVKKGGSYMCHRSYCYRYRCAARSQNTPDSSASNLGFRCAADRLPTMD,PF03781;,1Y1E;1Y1F;1Y1G;1Y1H;1Y1I;1Y1J;1Z70;2AFT;2AFY;2AII;2AIJ;2AIK;2HI8;2HIB;,218,C,Y,True,810
12921,10547,138090,single nucleotide variant,NM_022725.3(FANCF):c.959C>T (p.Pro320Leu),2188,FANCF,HGNC:3587,Benign,0,31-Dec-19,45451294,-,RCV000121025|RCV000231249|RCV001104345,"MedGen:CN169374|MONDO:MONDO:0019391,MedGen:C0015625,OMIM:PS227650,Orphanet:84|MONDO:MONDO:0011325,MedGen:C3469526,OMIM:603467,Orphanet:84","not specified|Fanconi anemia|Fanconi anemia, complementation group F",germline,germline,GRCh38,NC_000011.10,11,22624852,22624852,na,na,11p14.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"UniProtKB:Q9NPI8#VAR_022270,ClinGen:CA159572",2,134351,22624852,G,A,P320L,2,benign,benign,Q9NPI8,Q9NPI8,reviewed,FANCF_HUMAN,"Fanconi anemia group F protein, Protein FACF",FANCF,Homo sapiens (Human),374.0,MESLLQHLDRFSELLAVSSTTYVSTWDPATVRRALQWARYLRHIHRRFGRHGPIRTALERRLHNQWRQEGGFGRGPVPGLANFQALGHCDVLLSLRLLENRALGDAARYHLVQQLFPGPGVRDADEETLQESLARLARRRSAVHMLRFNGYRENPNLQEDSLMKTQAELLLERLQEVGKAEAERPARFLSSLWERLPQNNFLKVIAVALLQPPLSRRPQEELEPGIHKSPGEGSQVLVHWLLGNSEVFAAFCRALPAGLLTLVTSRHPALSPVYLGLLTDWGQRLHYDLQKGIWVGTESQDVPWEELHNRFQSLCQAPPPLKDKVLTALETCKAQDGDFEVPGLSIWTDLLLALRSGAFRKRQVLGLSAGLSSV,PF11107;,2IQC;7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,320,P,L,True,811
12922,12238,212925,single nucleotide variant,NM_022725.3(FANCF):c.883G>A (p.Val295Ile),2188,FANCF,HGNC:3587,Benign,0,31-Dec-19,7103293,-,RCV000196284,"MONDO:MONDO:0019391,MedGen:C0015625,OMIM:PS227650,Orphanet:84",Fanconi anemia,germline,germline,GRCh38,NC_000011.10,11,22624928,22624928,na,na,11p14.3,"criteria provided, single submitter",1,-,N,"ClinGen:CA336298,UniProtKB:Q9NPI8#VAR_050988",2,215922,22624928,C,T,V295I,1,benign,benign,Q9NPI8,Q9NPI8,reviewed,FANCF_HUMAN,"Fanconi anemia group F protein, Protein FACF",FANCF,Homo sapiens (Human),374.0,MESLLQHLDRFSELLAVSSTTYVSTWDPATVRRALQWARYLRHIHRRFGRHGPIRTALERRLHNQWRQEGGFGRGPVPGLANFQALGHCDVLLSLRLLENRALGDAARYHLVQQLFPGPGVRDADEETLQESLARLARRRSAVHMLRFNGYRENPNLQEDSLMKTQAELLLERLQEVGKAEAERPARFLSSLWERLPQNNFLKVIAVALLQPPLSRRPQEELEPGIHKSPGEGSQVLVHWLLGNSEVFAAFCRALPAGLLTLVTSRHPALSPVYLGLLTDWGQRLHYDLQKGIWVGTESQDVPWEELHNRFQSLCQAPPPLKDKVLTALETCKAQDGDFEVPGLSIWTDLLLALRSGAFRKRQVLGLSAGLSSV,PF11107;,2IQC;7KZP;7KZQ;7KZR;7KZS;7KZT;7KZV;,295,V,I,True,811
12923,13905,306038,single nucleotide variant,NM_003630.3(PEX3):c.245A>G (p.Gln82Arg),8504,PEX3,HGNC:8858,Benign,0,12-Jan-18,35220041,-,RCV000361936|RCV000676116,"MONDO:MONDO:0013948,MedGen:C3553999,OMIM:614882,Orphanet:912|MedGen:CN517202",Peroxisome biogenesis disorder 10A|not provided,germline;unknown,germline,GRCh38,NC_000006.12,6,143462955,143462955,na,na,6q24.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA4029509,UniProtKB:P56589#VAR_053572",2,355575,143462955,A,G,Q82R,1,benign,benign,P56589,P56589,reviewed,PEX3_HUMAN,Peroxisomal biogenesis factor 3 (Peroxin-3) (Peroxisomal assembly protein PEX3),PEX3,Homo sapiens (Human),373.0,MLRSVWNFLKRHKKKCIFLGTVLGGVYILGKYGQKKIREIQEREAAEYIAQARRQYHFESNQRTCNMTVLSMLPTLREALMQQLNSESLTALLKNRPSNKLEIWEDLKIISFTRSTVAVYSTCMLVVLLRVQLNIIGGYIYLDNAAVGKNGTTILAPPDVQQQYLSSIQHLLGDGLTELITVIKQAVQKVLGSVSLKHSLSLLDLEQKLKEIRNLVEQHKSSSWINKDGSKPLLCHYMMPDEETPLAVQACGLSPRDITTIKLLNETRDMLESPDFSTVLNTCLNRGFSRLLDNMAEFFRPTEQDLQHGNSMNSLSSVSLPLAKIIPIVNGQIHSVCSETPSHFVQDLLTMEQVKDFAANVYEAFSTPQQLEK,PF04882;,3AJB;3MK4;,82,Q,R,True,812
12924,4539,31123,single nucleotide variant,NM_001033044.4(GLUL):c.1021C>T (p.Arg341Cys),2752,GLUL,HGNC:4341,Pathogenic,1,3-Nov-05,80358215,-,RCV000017464,"MONDO:MONDO:0012393,MedGen:C1864910,OMIM:610015,Orphanet:71278",Congenital brain dysgenesis due to glutamine synthetase deficiency,germline,germline,GRCh38,NC_000001.11,1,182384506,182384506,na,na,1q25.3,no assertion criteria provided,1,-,N,"UniProtKB:P15104#VAR_026561,OMIM:138290.0002,ClinGen:CA126193",1,16084,182384506,G,A,R341C,0,pathogenic,uncertain,P15104,P15104,reviewed,GLNA_HUMAN,"Glutamine synthetase, GS, EC 6.3.1.2 (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL, EC 2.3.1.225)",GLUL GLNS,Homo sapiens (Human),373.0,MTTSASSHLNKGIKQVYMSLPQGEKVQAMYIWIDGTGEGLRCKTRTLDSEPKCVEELPEWNFDGSSTLQSEGSNSDMYLVPAAMFRDPFRKDPNKLVLCEVFKYNRRPAETNLRHTCKRIMDMVSNQHPWFGMEQEYTLMGTDGHPFGWPSNGFPGPQGPYYCGVGADRAYGRDIVEAHYRACLYAGVKIAGTNAEVMPAQWEFQIGPCEGISMGDHLWVARFILHRVCEDFGVIATFDPKPIPGNWNGAGCHTNFSTKAMREENGLKYIEEAIEKLSKRHQYHIRAYDPKGGLDNARRLTGFHETSNINDFSAGVANRSASIRIPRTVGQEKKGYFEDRRPSANCDPFSVTEALIRTCLLNETGDEPFQYKN,PF00120;PF03951;,2OJW;2QC8;7EVT;,341,R,C,True,813
12925,4538,31122,single nucleotide variant,NM_001033044.4(GLUL):c.970C>T (p.Arg324Cys),2752,GLUL,HGNC:4341,Pathogenic,1,3-Nov-05,80358214,-,RCV000017463,"MONDO:MONDO:0012393,MedGen:C1864910,OMIM:610015,Orphanet:71278",Congenital brain dysgenesis due to glutamine synthetase deficiency,germline,germline,GRCh38,NC_000001.11,1,182384557,182384557,na,na,1q25.3,no assertion criteria provided,1,-,N,"ClinGen:CA126191,UniProtKB:P15104#VAR_026560,OMIM:138290.0001",1,16083,182384557,G,A,R324C,0,pathogenic,uncertain,P15104,P15104,reviewed,GLNA_HUMAN,"Glutamine synthetase, GS, EC 6.3.1.2 (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL, EC 2.3.1.225)",GLUL GLNS,Homo sapiens (Human),373.0,MTTSASSHLNKGIKQVYMSLPQGEKVQAMYIWIDGTGEGLRCKTRTLDSEPKCVEELPEWNFDGSSTLQSEGSNSDMYLVPAAMFRDPFRKDPNKLVLCEVFKYNRRPAETNLRHTCKRIMDMVSNQHPWFGMEQEYTLMGTDGHPFGWPSNGFPGPQGPYYCGVGADRAYGRDIVEAHYRACLYAGVKIAGTNAEVMPAQWEFQIGPCEGISMGDHLWVARFILHRVCEDFGVIATFDPKPIPGNWNGAGCHTNFSTKAMREENGLKYIEEAIEKLSKRHQYHIRAYDPKGGLDNARRLTGFHETSNINDFSAGVANRSASIRIPRTVGQEKKGYFEDRRPSANCDPFSVTEALIRTCLLNETGDEPFQYKN,PF00120;PF03951;,2OJW;2QC8;7EVT;,324,R,C,True,813
12926,2803,26466,single nucleotide variant,NM_015922.3(NSDHL):c.613G>A (p.Gly205Ser),50814,NSDHL,HGNC:13398,Pathogenic,1,1-Feb-11,104894901,-,RCV000012180,"MONDO:MONDO:0010621,MedGen:C0265267,OMIM:308050,Orphanet:139",Child syndrome,germline,germline,GRCh38,NC_000023.11,X,152865888,152865888,na,na,Xq28,no assertion criteria provided,2,-,N,"ClinGen:CA341091,UniProtKB:Q15738#VAR_010208,OMIM:300275.0002",1,11427,152865888,G,A,G205S,0,pathogenic,uncertain,Q15738,Q15738,reviewed,NSDHL_HUMAN,"Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating, EC 1.1.1.170 (Protein H105e3)",NSDHL H105E3,Homo sapiens (Human),373.0,MEPAVSEPMRDQVARTHLTEDTPKVNADIEKVNQNQAKRCTVIGGSGFLGQHMVEQLLARGYAVNVFDIQQGFDNPQVRFFLGDLCSRQDLYPALKGVNTVFHCASPPPSSNNKELFYRVNYIGTKNVIETCKEAGVQKLILTSSASVIFEGVDIKNGTEDLPYAMKPIDYYTETKILQERAVLGANDPEKNFLTTAIRPHGIFGPRDPQLVPILIEAARNGKMKFVIGNGKNLVDFTFVENVVHGHILAAEQLSRDSTLGGKAFHITNDEPIPFWTFLSRILTGLNYEAPKYHIPYWVAYYLALLLSLLVMVISPVIQLQPTFTPMRVALAGTFHYYSCERAKKAMGYQPLVTMDDAMERTVQSFRHLRRVK,PF01073;,6JKG;6JKH;,205,G,S,True,814
12927,2804,26469,single nucleotide variant,NM_015922.3(NSDHL):c.544G>C (p.Ala182Pro),50814,NSDHL,HGNC:13398,Pathogenic,1,1-Apr-02,104894904,-,RCV000012183,"MONDO:MONDO:0010621,MedGen:C0265267,OMIM:308050,Orphanet:139",Child syndrome,germline,germline,GRCh38,NC_000023.11,X,152865819,152865819,na,na,Xq28,no assertion criteria provided,1,-,N,"ClinGen:CA255884,UniProtKB:Q15738#VAR_065289,OMIM:300275.0005",1,11430,152865819,G,C,A182P,0,pathogenic,uncertain,Q15738,Q15738,reviewed,NSDHL_HUMAN,"Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating, EC 1.1.1.170 (Protein H105e3)",NSDHL H105E3,Homo sapiens (Human),373.0,MEPAVSEPMRDQVARTHLTEDTPKVNADIEKVNQNQAKRCTVIGGSGFLGQHMVEQLLARGYAVNVFDIQQGFDNPQVRFFLGDLCSRQDLYPALKGVNTVFHCASPPPSSNNKELFYRVNYIGTKNVIETCKEAGVQKLILTSSASVIFEGVDIKNGTEDLPYAMKPIDYYTETKILQERAVLGANDPEKNFLTTAIRPHGIFGPRDPQLVPILIEAARNGKMKFVIGNGKNLVDFTFVENVVHGHILAAEQLSRDSTLGGKAFHITNDEPIPFWTFLSRILTGLNYEAPKYHIPYWVAYYLALLLSLLVMVISPVIQLQPTFTPMRVALAGTFHYYSCERAKKAMGYQPLVTMDDAMERTVQSFRHLRRVK,PF01073;,6JKG;6JKH;,182,A,P,True,814
12928,2802,26465,single nucleotide variant,NM_015922.3(NSDHL):c.314C>T (p.Ala105Val),50814,NSDHL,HGNC:13398,Pathogenic,1,1-Feb-11,104894909,-,RCV000012179,"MONDO:MONDO:0010621,MedGen:C0265267,OMIM:308050,Orphanet:139",Child syndrome,germline,germline,GRCh38,NC_000023.11,X,152858816,152858816,na,na,Xq28,no assertion criteria provided,2,-,N,"ClinGen:CA341090,UniProtKB:Q15738#VAR_010207,OMIM:300275.0001",1,11426,152858816,C,T,A105V,0,pathogenic,uncertain,Q15738,Q15738,reviewed,NSDHL_HUMAN,"Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating, EC 1.1.1.170 (Protein H105e3)",NSDHL H105E3,Homo sapiens (Human),373.0,MEPAVSEPMRDQVARTHLTEDTPKVNADIEKVNQNQAKRCTVIGGSGFLGQHMVEQLLARGYAVNVFDIQQGFDNPQVRFFLGDLCSRQDLYPALKGVNTVFHCASPPPSSNNKELFYRVNYIGTKNVIETCKEAGVQKLILTSSASVIFEGVDIKNGTEDLPYAMKPIDYYTETKILQERAVLGANDPEKNFLTTAIRPHGIFGPRDPQLVPILIEAARNGKMKFVIGNGKNLVDFTFVENVVHGHILAAEQLSRDSTLGGKAFHITNDEPIPFWTFLSRILTGLNYEAPKYHIPYWVAYYLALLLSLLVMVISPVIQLQPTFTPMRVALAGTFHYYSCERAKKAMGYQPLVTMDDAMERTVQSFRHLRRVK,PF01073;,6JKG;6JKH;,105,A,V,True,814
12929,7498,76370,single nucleotide variant,NM_031157.4(HNRNPA1):c.956A>G (p.Asn319Ser),3178,HNRNPA1,HGNC:5031,Pathogenic,1,28-Mar-13,397518454,-,RCV000055651,"MONDO:MONDO:0014181,MedGen:C3715156,OMIM:615426,Orphanet:803",Amyotrophic lateral sclerosis 20,germline,germline,GRCh38,NC_000012.12,12,54283860,54283860,na,na,12q13.13,no assertion criteria provided,1,-,N,"ClinGen:CA264780,UniProtKB:P09651#VAR_070590,OMIM:164017.0003",1,65453,54283860,A,G,N319S,0,pathogenic,uncertain,P09651,P09651,reviewed,ROA1_HUMAN,"Heterogeneous nuclear ribonucleoprotein A1, hnRNP A1 (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed ]",HNRNPA1 HNRPA1,Homo sapiens (Human),372.0,MSKSESPKEPEQLRKLFIGGLSFETTDESLRSHFEQWGTLTDCVVMRDPNTKRSRGFGFVTYATVEEVDAAMNARPHKVDGRVVEPKRAVSREDSQRPGAHLTVKKIFVGGIKEDTEEHHLRDYFEQYGKIEVIEIMTDRGSGKKRGFAFVTFDDHDSVDKIVIQKYHTVNGHNCEVRKALSKQEMASASSSQRGRSGSGNFGGGRGGGFGGNDNFGRGGNFSGRGGFGGSRGGGGYGGSGDGYNGFGNDGGYGGGGPGYSGGSRGYGSGGQGYGNQGSGYGGSGSYDSYNNGGGGGFGGGSGSNFGGGGSYNDFGNYNNQSSNFGPMKGGNFGGRSSGPYGGGGQYFAKPRNQGGYGGSSSSSSYGSGRRF,PF11627;PF00076;,1HA1;1L3K;1PGZ;1PO6;1U1K;1U1L;1U1M;1U1N;1U1O;1U1P;1U1Q;1U1R;1UP1;2H4M;2LYV;2UP1;4YOE;5MPG;5MPL;5ZGD;5ZGL;6BXX;6DCL;6J60;7BX7;,319,N,S,True,815
12930,7497,76369,single nucleotide variant,NM_031157.4(HNRNPA1):c.940G>A (p.Asp314Asn),3178,HNRNPA1,HGNC:5031,Pathogenic,1,28-Mar-13,397518453,-,RCV000055650,"MONDO:MONDO:0014181,MedGen:C3715156,OMIM:615426,Orphanet:803",Amyotrophic lateral sclerosis 20,germline,germline,GRCh38,NC_000012.12,12,54283844,54283844,na,na,12q13.13,no assertion criteria provided,1,-,N,"ClinGen:CA264779,UniProtKB:P09651#VAR_070588,OMIM:164017.0002",1,65452,54283844,G,A,D314N,0,pathogenic,uncertain,P09651,P09651,reviewed,ROA1_HUMAN,"Heterogeneous nuclear ribonucleoprotein A1, hnRNP A1 (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed ]",HNRNPA1 HNRPA1,Homo sapiens (Human),372.0,MSKSESPKEPEQLRKLFIGGLSFETTDESLRSHFEQWGTLTDCVVMRDPNTKRSRGFGFVTYATVEEVDAAMNARPHKVDGRVVEPKRAVSREDSQRPGAHLTVKKIFVGGIKEDTEEHHLRDYFEQYGKIEVIEIMTDRGSGKKRGFAFVTFDDHDSVDKIVIQKYHTVNGHNCEVRKALSKQEMASASSSQRGRSGSGNFGGGRGGGFGGNDNFGRGGNFSGRGGFGGSRGGGGYGGSGDGYNGFGNDGGYGGGGPGYSGGSRGYGSGGQGYGNQGSGYGGSGSYDSYNNGGGGGFGGGSGSNFGGGGSYNDFGNYNNQSSNFGPMKGGNFGGRSSGPYGGGGQYFAKPRNQGGYGGSSSSSSYGSGRRF,PF11627;PF00076;,1HA1;1L3K;1PGZ;1PO6;1U1K;1U1L;1U1M;1U1N;1U1O;1U1P;1U1Q;1U1R;1UP1;2H4M;2LYV;2UP1;4YOE;5MPG;5MPL;5ZGD;5ZGL;6BXX;6DCL;6J60;7BX7;,314,D,N,True,815
12931,7496,76368,single nucleotide variant,NM_031157.4(HNRNPA1):c.941A>T (p.Asp314Val),3178,HNRNPA1,HGNC:5031,Pathogenic,1,1-May-15,397518452,-,RCV000055649,"MONDO:MONDO:0014179,MedGen:C3809469,OMIM:615424",Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3,germline,germline,GRCh38,NC_000012.12,12,54283845,54283845,na,na,12q13.13,no assertion criteria provided,1,-,N,"ClinGen:CA144797,UniProtKB:P09651#VAR_070589,OMIM:164017.0001",1,65451,54283845,A,T,D314V,0,pathogenic,uncertain,P09651,P09651,reviewed,ROA1_HUMAN,"Heterogeneous nuclear ribonucleoprotein A1, hnRNP A1 (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed ]",HNRNPA1 HNRPA1,Homo sapiens (Human),372.0,MSKSESPKEPEQLRKLFIGGLSFETTDESLRSHFEQWGTLTDCVVMRDPNTKRSRGFGFVTYATVEEVDAAMNARPHKVDGRVVEPKRAVSREDSQRPGAHLTVKKIFVGGIKEDTEEHHLRDYFEQYGKIEVIEIMTDRGSGKKRGFAFVTFDDHDSVDKIVIQKYHTVNGHNCEVRKALSKQEMASASSSQRGRSGSGNFGGGRGGGFGGNDNFGRGGNFSGRGGFGGSRGGGGYGGSGDGYNGFGNDGGYGGGGPGYSGGSRGYGSGGQGYGNQGSGYGGSGSYDSYNNGGGGGFGGGSGSNFGGGGSYNDFGNYNNQSSNFGPMKGGNFGGRSSGPYGGGGQYFAKPRNQGGYGGSSSSSSYGSGRRF,PF11627;PF00076;,1HA1;1L3K;1PGZ;1PO6;1U1K;1U1L;1U1M;1U1N;1U1O;1U1P;1U1Q;1U1R;1UP1;2H4M;2LYV;2UP1;4YOE;5MPG;5MPL;5ZGD;5ZGL;6BXX;6DCL;6J60;7BX7;,314,D,V,True,815
12932,10978,166144,single nucleotide variant,NM_058179.4(PSAT1):c.296C>T (p.Ala99Val),29968,PSAT1,HGNC:19129,Pathogenic,1,4-Sep-14,587777778,-,RCV000144448|RCV001254372,"MONDO:MONDO:0014466,MedGen:C4015019,OMIM:616038,Orphanet:2671|MedGen:CN517202",Neu-laxova syndrome 2|not provided,germline;not applicable;unknown,germline,GRCh38,NC_000009.12,9,78304839,78304839,na,na,9q21.2,no assertion criteria provided,2,-,N,"ClinGen:CA170850,UniProtKB:Q9Y617#VAR_072571,OMIM:610936.0004",3,156364,78304839,C,T,A99V,0,pathogenic,uncertain,Q9Y617,Q9Y617,reviewed,SERC_HUMAN,"Phosphoserine aminotransferase, EC 2.6.1.52 (Phosphohydroxythreonine aminotransferase, PSAT)",PSAT1 PSA,Homo sapiens (Human),370.0,MDAPRQVVNFGPGPAKLPHSVLLEIQKELLDYKGVGISVLEMSHRSSDFAKIINNTENLVRELLAVPDNYKVIFLQGGGCGQFSAVPLNLIGLKAGRCADYVVTGAWSAKAAEEAKKFGTINIVHPKLGSYTKIPDPSTWNLNPDASYVYYCANETVHGVEFDFIPDVKGAVLVCDMSSNFLSKPVDVSKFGVIFAGAQKNVGSAGVTVVIVRDDLLGFALRECPSVLEYKVQAGNSSLYNTPPCFSIYVMGLVLEWIKNNGGAAAMEKLSSIKSQTIYEIIDNSQGFYVCPVEPQNRSKMNIPFRIGNAKGDDALEKRFLDKALELNMLSLKGHRSVGGIRASLYNAVTIEDVQKLAAFMKKFLEMHQL,PF00266;,3E77;,99,A,V,True,816
12933,10977,166143,single nucleotide variant,NM_058179.4(PSAT1):c.536C>T (p.Ser179Leu),29968,PSAT1,HGNC:19129,Pathogenic,1,4-Sep-14,587777777,-,RCV000144447|RCV001254512,"MONDO:MONDO:0014466,MedGen:C4015019,OMIM:616038,Orphanet:2671|MedGen:CN517202",Neu-laxova syndrome 2|not provided,germline;not applicable;unknown,germline,GRCh38,NC_000009.12,9,78306452,78306452,na,na,9q21.2,no assertion criteria provided,2,-,N,"ClinGen:CA170849,UniProtKB:Q9Y617#VAR_072572,OMIM:610936.0005",3,156363,78306452,C,T,S179L,0,pathogenic,uncertain,Q9Y617,Q9Y617,reviewed,SERC_HUMAN,"Phosphoserine aminotransferase, EC 2.6.1.52 (Phosphohydroxythreonine aminotransferase, PSAT)",PSAT1 PSA,Homo sapiens (Human),370.0,MDAPRQVVNFGPGPAKLPHSVLLEIQKELLDYKGVGISVLEMSHRSSDFAKIINNTENLVRELLAVPDNYKVIFLQGGGCGQFSAVPLNLIGLKAGRCADYVVTGAWSAKAAEEAKKFGTINIVHPKLGSYTKIPDPSTWNLNPDASYVYYCANETVHGVEFDFIPDVKGAVLVCDMSSNFLSKPVDVSKFGVIFAGAQKNVGSAGVTVVIVRDDLLGFALRECPSVLEYKVQAGNSSLYNTPPCFSIYVMGLVLEWIKNNGGAAAMEKLSSIKSQTIYEIIDNSQGFYVCPVEPQNRSKMNIPFRIGNAKGDDALEKRFLDKALELNMLSLKGHRSVGGIRASLYNAVTIEDVQKLAAFMKKFLEMHQL,PF00266;,3E77;,179,S,L,True,816
12934,289,16121,single nucleotide variant,NM_058179.4(PSAT1):c.299A>C (p.Asp100Ala),29968,PSAT1,HGNC:19129,Pathogenic,1,1-May-07,118203967,-,RCV000001137|RCV001254373,"MONDO:MONDO:0012596,MedGen:C1970253,OMIM:610992,Orphanet:284417|MedGen:CN517202",Phosphoserine aminotransferase deficiency|not provided,germline;not applicable;unknown,germline,GRCh38,NC_000009.12,9,78304842,78304842,na,na,9q21.2,no assertion criteria provided,2,-,N,"ClinGen:CA114739,UniProtKB:Q9Y617#VAR_037252,OMIM:610936.0002",3,1082,78304842,A,C,D100A,0,pathogenic,uncertain,Q9Y617,Q9Y617,reviewed,SERC_HUMAN,"Phosphoserine aminotransferase, EC 2.6.1.52 (Phosphohydroxythreonine aminotransferase, PSAT)",PSAT1 PSA,Homo sapiens (Human),370.0,MDAPRQVVNFGPGPAKLPHSVLLEIQKELLDYKGVGISVLEMSHRSSDFAKIINNTENLVRELLAVPDNYKVIFLQGGGCGQFSAVPLNLIGLKAGRCADYVVTGAWSAKAAEEAKKFGTINIVHPKLGSYTKIPDPSTWNLNPDASYVYYCANETVHGVEFDFIPDVKGAVLVCDMSSNFLSKPVDVSKFGVIFAGAQKNVGSAGVTVVIVRDDLLGFALRECPSVLEYKVQAGNSSLYNTPPCFSIYVMGLVLEWIKNNGGAAAMEKLSSIKSQTIYEIIDNSQGFYVCPVEPQNRSKMNIPFRIGNAKGDDALEKRFLDKALELNMLSLKGHRSVGGIRASLYNAVTIEDVQKLAAFMKKFLEMHQL,PF00266;,3E77;,100,D,A,True,816
12935,15,15114,single nucleotide variant,NM_000374.5(UROD):c.912C>A (p.Asn304Lys),7389,UROD,HGNC:12591,Pathogenic,1,1-Nov-98,121918065,-,RCV000000093,"MONDO:MONDO:0008296,MedGen:C0268323,OMIM:176100,Orphanet:101330,Orphanet:443062",Familial porphyria cutanea tarda,germline,germline,GRCh38,NC_000001.11,1,45014976,45014976,na,na,1p34.1,no assertion criteria provided,1,-,N,"ClinGen:CA251380,UniProtKB:P06132#VAR_007914,OMIM:613521.0011",1,75,45014976,C,A,N304K,0,pathogenic,uncertain,P06132,P06132,reviewed,DCUP_HUMAN,"Uroporphyrinogen decarboxylase, UPD, URO-D, EC 4.1.1.37",UROD,Homo sapiens (Human),367.0,MEANGLGPQGFPELKNDTFLRAAWGEETDYTPVWCMRQAGRYLPEFRETRAAQDFFSTCRSPEACCELTLQPLRRFPLDAAIIFSDILVVPQALGMEVTMVPGKGPSFPEPLREEQDLERLRDPEVVASELGYVFQAITLTRQRLAGRVPLIGFAGAPWTLMTYMVEGGGSSTMAQAKRWLYQRPQASHQLLRILTDALVPYLVGQVVAGAQALQLFESHAGHLGPQLFNKFALPYIRDVAKQVKARLREAGLAPVPMIIFAKDGHFALEELAQAGYEVVGLDWTVAPKKARECVGKTVTLQGNLDPCALYASEEEIGQLVKQMLDDFGPHRYIANLGHGLYPDMDPEHVGAFVDAVHKHSRLLRQN,PF01208;,1JPH;1JPI;1JPK;1R3Q;1R3R;1R3S;1R3T;1R3V;1R3W;1R3Y;1URO;2Q6Z;2Q71;3GVQ;3GVR;3GVV;3GVW;3GW0;3GW3;,304,N,K,True,817
12936,16,15115,single nucleotide variant,NM_000374.5(UROD):c.995G>A (p.Arg332His),7389,UROD,HGNC:12591,Pathogenic,1,1-Nov-98,121918066,-,RCV000000094,"MONDO:MONDO:0008296,MedGen:C0268323,OMIM:176100,Orphanet:101330,Orphanet:443062",Familial porphyria cutanea tarda,germline,germline,GRCh38,NC_000001.11,1,45015389,45015389,na,na,1p34.1,no assertion criteria provided,1,-,N,"ClinGen:CA251381,UniProtKB:P06132#VAR_007916,OMIM:613521.0012",1,76,45015389,G,A,R332H,0,pathogenic,uncertain,P06132,P06132,reviewed,DCUP_HUMAN,"Uroporphyrinogen decarboxylase, UPD, URO-D, EC 4.1.1.37",UROD,Homo sapiens (Human),367.0,MEANGLGPQGFPELKNDTFLRAAWGEETDYTPVWCMRQAGRYLPEFRETRAAQDFFSTCRSPEACCELTLQPLRRFPLDAAIIFSDILVVPQALGMEVTMVPGKGPSFPEPLREEQDLERLRDPEVVASELGYVFQAITLTRQRLAGRVPLIGFAGAPWTLMTYMVEGGGSSTMAQAKRWLYQRPQASHQLLRILTDALVPYLVGQVVAGAQALQLFESHAGHLGPQLFNKFALPYIRDVAKQVKARLREAGLAPVPMIIFAKDGHFALEELAQAGYEVVGLDWTVAPKKARECVGKTVTLQGNLDPCALYASEEEIGQLVKQMLDDFGPHRYIANLGHGLYPDMDPEHVGAFVDAVHKHSRLLRQN,PF01208;,1JPH;1JPI;1JPK;1R3Q;1R3R;1R3S;1R3T;1R3V;1R3W;1R3Y;1URO;2Q6Z;2Q71;3GVQ;3GVR;3GVV;3GVW;3GW0;3GW3;,332,R,H,True,817
12937,14,15113,single nucleotide variant,NM_000374.5(UROD):c.583C>T (p.Leu195Phe),7389,UROD,HGNC:12591,Pathogenic,1,1-Nov-98,121918064,-,RCV000000092,"MONDO:MONDO:0008296,MedGen:C0268323,OMIM:176100,Orphanet:101330,Orphanet:443062",Familial porphyria cutanea tarda,germline,germline,GRCh38,NC_000001.11,1,45014017,45014017,na,na,1p34.1,no assertion criteria provided,1,-,N,"ClinGen:CA251379,UniProtKB:P06132#VAR_007912,OMIM:613521.0010",1,74,45014017,C,T,L195F,0,pathogenic,uncertain,P06132,P06132,reviewed,DCUP_HUMAN,"Uroporphyrinogen decarboxylase, UPD, URO-D, EC 4.1.1.37",UROD,Homo sapiens (Human),367.0,MEANGLGPQGFPELKNDTFLRAAWGEETDYTPVWCMRQAGRYLPEFRETRAAQDFFSTCRSPEACCELTLQPLRRFPLDAAIIFSDILVVPQALGMEVTMVPGKGPSFPEPLREEQDLERLRDPEVVASELGYVFQAITLTRQRLAGRVPLIGFAGAPWTLMTYMVEGGGSSTMAQAKRWLYQRPQASHQLLRILTDALVPYLVGQVVAGAQALQLFESHAGHLGPQLFNKFALPYIRDVAKQVKARLREAGLAPVPMIIFAKDGHFALEELAQAGYEVVGLDWTVAPKKARECVGKTVTLQGNLDPCALYASEEEIGQLVKQMLDDFGPHRYIANLGHGLYPDMDPEHVGAFVDAVHKHSRLLRQN,PF01208;,1JPH;1JPI;1JPK;1R3Q;1R3R;1R3S;1R3T;1R3V;1R3W;1R3Y;1URO;2Q6Z;2Q71;3GVQ;3GVR;3GVV;3GVW;3GW0;3GW3;,195,L,F,True,817
12938,13,15112,single nucleotide variant,NM_000374.5(UROD):c.494T>G (p.Met165Arg),7389,UROD,HGNC:12591,Pathogenic,1,1-Nov-98,121918063,-,RCV000000091,"MONDO:MONDO:0008296,MedGen:C0268323,OMIM:176100,Orphanet:101330,Orphanet:443062",Familial porphyria cutanea tarda,germline,germline,GRCh38,NC_000001.11,1,45013928,45013928,na,na,1p34.1,no assertion criteria provided,1,-,N,"UniProtKB:P06132#VAR_007911,OMIM:613521.0009,ClinGen:CA251378",1,73,45013928,T,G,M165R,0,pathogenic,uncertain,P06132,P06132,reviewed,DCUP_HUMAN,"Uroporphyrinogen decarboxylase, UPD, URO-D, EC 4.1.1.37",UROD,Homo sapiens (Human),367.0,MEANGLGPQGFPELKNDTFLRAAWGEETDYTPVWCMRQAGRYLPEFRETRAAQDFFSTCRSPEACCELTLQPLRRFPLDAAIIFSDILVVPQALGMEVTMVPGKGPSFPEPLREEQDLERLRDPEVVASELGYVFQAITLTRQRLAGRVPLIGFAGAPWTLMTYMVEGGGSSTMAQAKRWLYQRPQASHQLLRILTDALVPYLVGQVVAGAQALQLFESHAGHLGPQLFNKFALPYIRDVAKQVKARLREAGLAPVPMIIFAKDGHFALEELAQAGYEVVGLDWTVAPKKARECVGKTVTLQGNLDPCALYASEEEIGQLVKQMLDDFGPHRYIANLGHGLYPDMDPEHVGAFVDAVHKHSRLLRQN,PF01208;,1JPH;1JPI;1JPK;1R3Q;1R3R;1R3S;1R3T;1R3V;1R3W;1R3Y;1URO;2Q6Z;2Q71;3GVQ;3GVR;3GVV;3GVW;3GW0;3GW3;,165,M,R,True,817
12939,9,15107,single nucleotide variant,NM_000374.5(UROD):c.499G>A (p.Glu167Lys),7389,UROD,HGNC:12591,Pathogenic,1,1-Apr-91,121918058,-,RCV000000086,"MONDO:MONDO:0019799,MedGen:C0162569,Orphanet:95159",Hepatoerythropoietic porphyria,germline,germline,GRCh38,NC_000001.11,1,45013933,45013933,na,na,1p34.1,no assertion criteria provided,1,-,N,"UniProtKB:P06132#VAR_007714,OMIM:613521.0004,ClinGen:CA251372",1,68,45013933,G,A,E167K,0,pathogenic,uncertain,P06132,P06132,reviewed,DCUP_HUMAN,"Uroporphyrinogen decarboxylase, UPD, URO-D, EC 4.1.1.37",UROD,Homo sapiens (Human),367.0,MEANGLGPQGFPELKNDTFLRAAWGEETDYTPVWCMRQAGRYLPEFRETRAAQDFFSTCRSPEACCELTLQPLRRFPLDAAIIFSDILVVPQALGMEVTMVPGKGPSFPEPLREEQDLERLRDPEVVASELGYVFQAITLTRQRLAGRVPLIGFAGAPWTLMTYMVEGGGSSTMAQAKRWLYQRPQASHQLLRILTDALVPYLVGQVVAGAQALQLFESHAGHLGPQLFNKFALPYIRDVAKQVKARLREAGLAPVPMIIFAKDGHFALEELAQAGYEVVGLDWTVAPKKARECVGKTVTLQGNLDPCALYASEEEIGQLVKQMLDDFGPHRYIANLGHGLYPDMDPEHVGAFVDAVHKHSRLLRQN,PF01208;,1JPH;1JPI;1JPK;1R3Q;1R3R;1R3S;1R3T;1R3V;1R3W;1R3Y;1URO;2Q6Z;2Q71;3GVQ;3GVR;3GVV;3GVW;3GW0;3GW3;,167,E,K,True,817
12940,12,15110,single nucleotide variant,NM_000374.5(UROD):c.932A>G (p.Tyr311Cys),7389,UROD,HGNC:12591,Likely pathogenic,1,3-May-20,121918061,-,RCV000000089|RCV000626082,"MONDO:MONDO:0019799,MedGen:C0162569,Orphanet:95159|MONDO:MONDO:0008295,MedGen:C1867968,OMIM:176090,Orphanet:101330,Orphanet:443057","Hepatoerythropoietic porphyria|Porphyria cutanea tarda, type I",germline;unknown,germline,GRCh38,NC_000001.11,1,45014996,45014996,na,na,1p34.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA251375,UniProtKB:P06132#VAR_009107,OMIM:613521.0007",3,71,45014996,A,G,Y311C,1,pathogenic,pathogenic,P06132,P06132,reviewed,DCUP_HUMAN,"Uroporphyrinogen decarboxylase, UPD, URO-D, EC 4.1.1.37",UROD,Homo sapiens (Human),367.0,MEANGLGPQGFPELKNDTFLRAAWGEETDYTPVWCMRQAGRYLPEFRETRAAQDFFSTCRSPEACCELTLQPLRRFPLDAAIIFSDILVVPQALGMEVTMVPGKGPSFPEPLREEQDLERLRDPEVVASELGYVFQAITLTRQRLAGRVPLIGFAGAPWTLMTYMVEGGGSSTMAQAKRWLYQRPQASHQLLRILTDALVPYLVGQVVAGAQALQLFESHAGHLGPQLFNKFALPYIRDVAKQVKARLREAGLAPVPMIIFAKDGHFALEELAQAGYEVVGLDWTVAPKKARECVGKTVTLQGNLDPCALYASEEEIGQLVKQMLDDFGPHRYIANLGHGLYPDMDPEHVGAFVDAVHKHSRLLRQN,PF01208;,1JPH;1JPI;1JPK;1R3Q;1R3R;1R3S;1R3T;1R3V;1R3W;1R3Y;1URO;2Q6Z;2Q71;3GVQ;3GVR;3GVV;3GVW;3GW0;3GW3;,311,Y,C,True,817
12941,11,15109,single nucleotide variant,NM_000374.5(UROD):c.185C>T (p.Pro62Leu),7389,UROD,HGNC:12591,Pathogenic,1,1-Apr-96,121918060,-,RCV000000088,"MONDO:MONDO:0019799,MedGen:C0162569,Orphanet:95159",Hepatoerythropoietic porphyria,germline,germline,GRCh38,NC_000001.11,1,45013187,45013187,na,na,1p34.1,no assertion criteria provided,1,-,N,"ClinGen:CA251374,UniProtKB:P06132#VAR_009103,OMIM:613521.0006",1,70,45013187,C,T,P62L,0,pathogenic,uncertain,P06132,P06132,reviewed,DCUP_HUMAN,"Uroporphyrinogen decarboxylase, UPD, URO-D, EC 4.1.1.37",UROD,Homo sapiens (Human),367.0,MEANGLGPQGFPELKNDTFLRAAWGEETDYTPVWCMRQAGRYLPEFRETRAAQDFFSTCRSPEACCELTLQPLRRFPLDAAIIFSDILVVPQALGMEVTMVPGKGPSFPEPLREEQDLERLRDPEVVASELGYVFQAITLTRQRLAGRVPLIGFAGAPWTLMTYMVEGGGSSTMAQAKRWLYQRPQASHQLLRILTDALVPYLVGQVVAGAQALQLFESHAGHLGPQLFNKFALPYIRDVAKQVKARLREAGLAPVPMIIFAKDGHFALEELAQAGYEVVGLDWTVAPKKARECVGKTVTLQGNLDPCALYASEEEIGQLVKQMLDDFGPHRYIANLGHGLYPDMDPEHVGAFVDAVHKHSRLLRQN,PF01208;,1JPH;1JPI;1JPK;1R3Q;1R3R;1R3S;1R3T;1R3V;1R3W;1R3Y;1URO;2Q6Z;2Q71;3GVQ;3GVR;3GVV;3GVW;3GW0;3GW3;,62,P,L,True,817
12942,13746,280676,single nucleotide variant,NM_000374.5(UROD):c.758T>A (p.Leu253Gln),7389,UROD,HGNC:12591,Conflicting interpretations of pathogenicity,0,31-Dec-19,36033115,-,RCV000879050|RCV000986297,"MedGen:CN517202|MONDO:MONDO:0008296,MedGen:C0268323,OMIM:176100,Orphanet:101330,Orphanet:443062",not provided|Familial porphyria cutanea tarda,germline;unknown,germline,GRCh38,NC_000001.11,1,45014560,45014560,na,na,1p34.1,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA501133,UniProtKB:P06132#VAR_007913",2,297463,45014560,T,A,L253Q,1,uncertain,uncertain,P06132,P06132,reviewed,DCUP_HUMAN,"Uroporphyrinogen decarboxylase, UPD, URO-D, EC 4.1.1.37",UROD,Homo sapiens (Human),367.0,MEANGLGPQGFPELKNDTFLRAAWGEETDYTPVWCMRQAGRYLPEFRETRAAQDFFSTCRSPEACCELTLQPLRRFPLDAAIIFSDILVVPQALGMEVTMVPGKGPSFPEPLREEQDLERLRDPEVVASELGYVFQAITLTRQRLAGRVPLIGFAGAPWTLMTYMVEGGGSSTMAQAKRWLYQRPQASHQLLRILTDALVPYLVGQVVAGAQALQLFESHAGHLGPQLFNKFALPYIRDVAKQVKARLREAGLAPVPMIIFAKDGHFALEELAQAGYEVVGLDWTVAPKKARECVGKTVTLQGNLDPCALYASEEEIGQLVKQMLDDFGPHRYIANLGHGLYPDMDPEHVGAFVDAVHKHSRLLRQN,PF01208;,1JPH;1JPI;1JPK;1R3Q;1R3R;1R3S;1R3T;1R3V;1R3W;1R3Y;1URO;2Q6Z;2Q71;3GVQ;3GVR;3GVV;3GVW;3GW0;3GW3;,253,L,Q,True,817
12943,8,15105,single nucleotide variant,NM_000374.5(UROD):c.842G>A (p.Gly281Glu),7389,UROD,HGNC:12591,Pathogenic,1,8-Sep-16,121918057,-,RCV000000083|RCV000024023|RCV000240661,"MONDO:MONDO:0019799,MedGen:C0162569,Orphanet:95159|MONDO:MONDO:0015104,MedGen:C0162566,Orphanet:101330|MONDO:MONDO:0008296,MedGen:C0268323,OMIM:176100,Orphanet:101330,Orphanet:443062",Hepatoerythropoietic porphyria|Porphyria cutanea tarda|Familial porphyria cutanea tarda,germline,germline,GRCh38,NC_000001.11,1,45014803,45014803,na,na,1p34.1,no assertion criteria provided,2,-,N,"ClinGen:CA129629,UniProtKB:P06132#VAR_007715,OMIM:613521.0002",1,66,45014803,G,A,G281E,0,pathogenic,uncertain,P06132,P06132,reviewed,DCUP_HUMAN,"Uroporphyrinogen decarboxylase, UPD, URO-D, EC 4.1.1.37",UROD,Homo sapiens (Human),367.0,MEANGLGPQGFPELKNDTFLRAAWGEETDYTPVWCMRQAGRYLPEFRETRAAQDFFSTCRSPEACCELTLQPLRRFPLDAAIIFSDILVVPQALGMEVTMVPGKGPSFPEPLREEQDLERLRDPEVVASELGYVFQAITLTRQRLAGRVPLIGFAGAPWTLMTYMVEGGGSSTMAQAKRWLYQRPQASHQLLRILTDALVPYLVGQVVAGAQALQLFESHAGHLGPQLFNKFALPYIRDVAKQVKARLREAGLAPVPMIIFAKDGHFALEELAQAGYEVVGLDWTVAPKKARECVGKTVTLQGNLDPCALYASEEEIGQLVKQMLDDFGPHRYIANLGHGLYPDMDPEHVGAFVDAVHKHSRLLRQN,PF01208;,1JPH;1JPI;1JPK;1R3Q;1R3R;1R3S;1R3T;1R3V;1R3W;1R3Y;1URO;2Q6Z;2Q71;3GVQ;3GVR;3GVV;3GVW;3GW0;3GW3;,281,G,E,True,817
12944,10,15108,single nucleotide variant,NM_000374.5(UROD):c.874C>G (p.Arg292Gly),7389,UROD,HGNC:12591,Pathogenic,1,1-Jul-92,121918059,-,RCV000000087,"MONDO:MONDO:0019799,MedGen:C0162569,Orphanet:95159",Hepatoerythropoietic porphyria,germline,germline,GRCh38,NC_000001.11,1,45014835,45014835,na,na,1p34.1,no assertion criteria provided,1,-,N,"ClinGen:CA251373,UniProtKB:P06132#VAR_007717,OMIM:613521.0005",1,69,45014835,C,G,R292G,0,pathogenic,uncertain,P06132,P06132,reviewed,DCUP_HUMAN,"Uroporphyrinogen decarboxylase, UPD, URO-D, EC 4.1.1.37",UROD,Homo sapiens (Human),367.0,MEANGLGPQGFPELKNDTFLRAAWGEETDYTPVWCMRQAGRYLPEFRETRAAQDFFSTCRSPEACCELTLQPLRRFPLDAAIIFSDILVVPQALGMEVTMVPGKGPSFPEPLREEQDLERLRDPEVVASELGYVFQAITLTRQRLAGRVPLIGFAGAPWTLMTYMVEGGGSSTMAQAKRWLYQRPQASHQLLRILTDALVPYLVGQVVAGAQALQLFESHAGHLGPQLFNKFALPYIRDVAKQVKARLREAGLAPVPMIIFAKDGHFALEELAQAGYEVVGLDWTVAPKKARECVGKTVTLQGNLDPCALYASEEEIGQLVKQMLDDFGPHRYIANLGHGLYPDMDPEHVGAFVDAVHKHSRLLRQN,PF01208;,1JPH;1JPI;1JPK;1R3Q;1R3R;1R3S;1R3T;1R3V;1R3W;1R3Y;1URO;2Q6Z;2Q71;3GVQ;3GVR;3GVV;3GVW;3GW0;3GW3;,292,R,G,True,817
12945,7,15104,single nucleotide variant,NM_000374.5(UROD):c.842G>T (p.Gly281Val),7389,UROD,HGNC:12591,Pathogenic,1,1-Mar-89,121918057,-,RCV000000082,"MONDO:MONDO:0008296,MedGen:C0268323,OMIM:176100,Orphanet:101330,Orphanet:443062",Familial porphyria cutanea tarda,germline,germline,GRCh38,NC_000001.11,1,45014803,45014803,na,na,1p34.1,no assertion criteria provided,1,-,N,"ClinGen:CA251370,UniProtKB:P06132#VAR_007716,OMIM:613521.0001",1,65,45014803,G,T,G281V,0,pathogenic,uncertain,P06132,P06132,reviewed,DCUP_HUMAN,"Uroporphyrinogen decarboxylase, UPD, URO-D, EC 4.1.1.37",UROD,Homo sapiens (Human),367.0,MEANGLGPQGFPELKNDTFLRAAWGEETDYTPVWCMRQAGRYLPEFRETRAAQDFFSTCRSPEACCELTLQPLRRFPLDAAIIFSDILVVPQALGMEVTMVPGKGPSFPEPLREEQDLERLRDPEVVASELGYVFQAITLTRQRLAGRVPLIGFAGAPWTLMTYMVEGGGSSTMAQAKRWLYQRPQASHQLLRILTDALVPYLVGQVVAGAQALQLFESHAGHLGPQLFNKFALPYIRDVAKQVKARLREAGLAPVPMIIFAKDGHFALEELAQAGYEVVGLDWTVAPKKARECVGKTVTLQGNLDPCALYASEEEIGQLVKQMLDDFGPHRYIANLGHGLYPDMDPEHVGAFVDAVHKHSRLLRQN,PF01208;,1JPH;1JPI;1JPK;1R3Q;1R3R;1R3S;1R3T;1R3V;1R3W;1R3Y;1URO;2Q6Z;2Q71;3GVQ;3GVR;3GVV;3GVW;3GW0;3GW3;,281,G,V,True,817
12946,13072,248651,single nucleotide variant,NM_000374.5(UROD):c.578G>C (p.Arg193Pro),7389,UROD,HGNC:12591,Pathogenic,1,8-Sep-16,143823335,-,RCV000240668,"MONDO:MONDO:0008296,MedGen:C0268323,OMIM:176100,Orphanet:101330,Orphanet:443062",Familial porphyria cutanea tarda,germline,germline,GRCh38,NC_000001.11,1,45014012,45014012,na,na,1p34.1,no assertion criteria provided,1,-,N,"ClinGen:CA10586360,UniProtKB:P06132#VAR_022572",1,254172,45014012,G,C,R193P,0,pathogenic,uncertain,P06132,P06132,reviewed,DCUP_HUMAN,"Uroporphyrinogen decarboxylase, UPD, URO-D, EC 4.1.1.37",UROD,Homo sapiens (Human),367.0,MEANGLGPQGFPELKNDTFLRAAWGEETDYTPVWCMRQAGRYLPEFRETRAAQDFFSTCRSPEACCELTLQPLRRFPLDAAIIFSDILVVPQALGMEVTMVPGKGPSFPEPLREEQDLERLRDPEVVASELGYVFQAITLTRQRLAGRVPLIGFAGAPWTLMTYMVEGGGSSTMAQAKRWLYQRPQASHQLLRILTDALVPYLVGQVVAGAQALQLFESHAGHLGPQLFNKFALPYIRDVAKQVKARLREAGLAPVPMIIFAKDGHFALEELAQAGYEVVGLDWTVAPKKARECVGKTVTLQGNLDPCALYASEEEIGQLVKQMLDDFGPHRYIANLGHGLYPDMDPEHVGAFVDAVHKHSRLLRQN,PF01208;,1JPH;1JPI;1JPK;1R3Q;1R3R;1R3S;1R3T;1R3V;1R3W;1R3Y;1URO;2Q6Z;2Q71;3GVQ;3GVR;3GVV;3GVW;3GW0;3GW3;,193,R,P,True,817
12947,7533,76585,single nucleotide variant,NM_004595.5(SMS):c.200G>A (p.Gly67Glu),6611,SMS,HGNC:11123,Pathogenic,1,1-Sep-13,397515550,-,RCV000055903,"MONDO:MONDO:0010664,MedGen:C0796160,OMIM:309583,Orphanet:3063",Syndromic X-linked intellectual disability Snyder type,germline,germline,GRCh38,NC_000023.11,X,21971926,21971926,na,na,Xp22.11,no assertion criteria provided,1,-,N,"ClinGen:CA345012,UniProtKB:P52788#VAR_076450,OMIM:300105.0005",1,65677,21971926,G,A,G67E,0,pathogenic,uncertain,P52788,P52788,reviewed,SPSY_HUMAN,"Spermine synthase, SPMSY, EC 2.5.1.22 (Spermidine aminopropyltransferase)",SMS,Homo sapiens (Human),366.0,MAAARHSTLDFMLGAKADGETILKGLQSIFQEQGMAESVHTWQDHGYLATYTNKNGSFANLRIYPHGLVLLDLQSYDGDAQGKEEIDSILNKVEERMKELSQDSTGRVKRLPPIVRGGAIDRYWPTADGRLVEYDIDEVVYDEDSPYQNIKILHSKQFGNILILSGDVNLAESDLAYTRAIMGSGKEDYTGKDVLILGGGDGGILCEIVKLKPKMVTMVEIDQMVIDGCKKYMRKTCGDVLDNLKGDCYQVLIEDCIPVLKRYAKEGREFDYVINDLTAVPISTSPEEDSTWEFLRLILDLSMKVLKQDGKYFTQGNCVNLTEALSLYEEQLGRLYCPVEFSKEIVCVPSYLELWVFYTVWKKAKP,PF17284;PF17950;,3C6K;3C6M;,67,G,E,True,818
12948,8711,94346,single nucleotide variant,NM_004595.5(SMS):c.983A>G (p.Tyr328Cys),6611,SMS,HGNC:11123,Pathogenic,1,15-Sep-13,397515553,-,RCV000074415,"MONDO:MONDO:0010664,MedGen:C0796160,OMIM:309583,Orphanet:3063",Syndromic X-linked intellectual disability Snyder type,germline,germline,GRCh38,NC_000023.11,X,21992634,21992634,na,na,Xp22.11,no assertion criteria provided,1,-,N,"ClinGen:CA266199,UniProtKB:P52788#VAR_076452,OMIM:300105.0004",1,88767,21992634,A,G,Y328C,0,pathogenic,uncertain,P52788,P52788,reviewed,SPSY_HUMAN,"Spermine synthase, SPMSY, EC 2.5.1.22 (Spermidine aminopropyltransferase)",SMS,Homo sapiens (Human),366.0,MAAARHSTLDFMLGAKADGETILKGLQSIFQEQGMAESVHTWQDHGYLATYTNKNGSFANLRIYPHGLVLLDLQSYDGDAQGKEEIDSILNKVEERMKELSQDSTGRVKRLPPIVRGGAIDRYWPTADGRLVEYDIDEVVYDEDSPYQNIKILHSKQFGNILILSGDVNLAESDLAYTRAIMGSGKEDYTGKDVLILGGGDGGILCEIVKLKPKMVTMVEIDQMVIDGCKKYMRKTCGDVLDNLKGDCYQVLIEDCIPVLKRYAKEGREFDYVINDLTAVPISTSPEEDSTWEFLRLILDLSMKVLKQDGKYFTQGNCVNLTEALSLYEEQLGRLYCPVEFSKEIVCVPSYLELWVFYTVWKKAKP,PF17284;PF17950;,3C6K;3C6M;,328,Y,C,True,818
12949,2850,26664,single nucleotide variant,NM_004595.5(SMS):c.395T>G (p.Val132Gly),6611,SMS,HGNC:11123,Pathogenic,1,1-Mar-09,267607076,-,RCV000012391,"MONDO:MONDO:0010664,MedGen:C0796160,OMIM:309583,Orphanet:3063",Syndromic X-linked intellectual disability Snyder type,germline,germline,GRCh38,NC_000023.11,X,21977126,21977126,na,na,Xp22.11,no assertion criteria provided,1,-,N,"ClinGen:CA341124,UniProtKB:P52788#VAR_076451,OMIM:300105.0003",1,11625,21977126,T,G,V132G,0,pathogenic,uncertain,P52788,P52788,reviewed,SPSY_HUMAN,"Spermine synthase, SPMSY, EC 2.5.1.22 (Spermidine aminopropyltransferase)",SMS,Homo sapiens (Human),366.0,MAAARHSTLDFMLGAKADGETILKGLQSIFQEQGMAESVHTWQDHGYLATYTNKNGSFANLRIYPHGLVLLDLQSYDGDAQGKEEIDSILNKVEERMKELSQDSTGRVKRLPPIVRGGAIDRYWPTADGRLVEYDIDEVVYDEDSPYQNIKILHSKQFGNILILSGDVNLAESDLAYTRAIMGSGKEDYTGKDVLILGGGDGGILCEIVKLKPKMVTMVEIDQMVIDGCKKYMRKTCGDVLDNLKGDCYQVLIEDCIPVLKRYAKEGREFDYVINDLTAVPISTSPEEDSTWEFLRLILDLSMKVLKQDGKYFTQGNCVNLTEALSLYEEQLGRLYCPVEFSKEIVCVPSYLELWVFYTVWKKAKP,PF17284;PF17950;,3C6K;3C6M;,132,V,G,True,818
12950,2849,26663,single nucleotide variant,NM_004595.5(SMS):c.166G>A (p.Gly56Ser),6611,SMS,HGNC:11123,Pathogenic/Likely pathogenic,1,30-Nov-15,121434610,-,RCV000012390|RCV000210586|RCV000414369,"MONDO:MONDO:0010664,MedGen:C0796160,OMIM:309583,Orphanet:3063|MeSH:D030342,MedGen:C0950123|MedGen:CN517202",Syndromic X-linked intellectual disability Snyder type|Inborn genetic diseases|not provided,germline,germline,GRCh38,NC_000023.11,X,21967312,21967312,na,na,Xp22.11,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA341122,UniProtKB:P52788#VAR_076449,OMIM:300105.0002",3,11624,21967312,G,A,G56S,2,pathogenic,pathogenic,P52788,P52788,reviewed,SPSY_HUMAN,"Spermine synthase, SPMSY, EC 2.5.1.22 (Spermidine aminopropyltransferase)",SMS,Homo sapiens (Human),366.0,MAAARHSTLDFMLGAKADGETILKGLQSIFQEQGMAESVHTWQDHGYLATYTNKNGSFANLRIYPHGLVLLDLQSYDGDAQGKEEIDSILNKVEERMKELSQDSTGRVKRLPPIVRGGAIDRYWPTADGRLVEYDIDEVVYDEDSPYQNIKILHSKQFGNILILSGDVNLAESDLAYTRAIMGSGKEDYTGKDVLILGGGDGGILCEIVKLKPKMVTMVEIDQMVIDGCKKYMRKTCGDVLDNLKGDCYQVLIEDCIPVLKRYAKEGREFDYVINDLTAVPISTSPEEDSTWEFLRLILDLSMKVLKQDGKYFTQGNCVNLTEALSLYEEQLGRLYCPVEFSKEIVCVPSYLELWVFYTVWKKAKP,PF17284;PF17950;,3C6K;3C6M;,56,G,S,True,818
12951,7532,76584,single nucleotide variant,NM_004595.5(SMS):c.174T>A (p.Phe58Leu),6611,SMS,HGNC:11123,Pathogenic,1,30-Jan-20,397515549,-,RCV000055902,"MONDO:MONDO:0010664,MedGen:C0796160,OMIM:309583,Orphanet:3063",Syndromic X-linked intellectual disability Snyder type,germline,germline,GRCh38,NC_000023.11,X,21971900,21971900,na,na,Xp22.11,no assertion criteria provided,1,-,N,"ClinGen:CA345011,UniProtKB:P52788#VAR_072748",1,65676,21971900,T,A,F58L,0,pathogenic,uncertain,P52788,P52788,reviewed,SPSY_HUMAN,"Spermine synthase, SPMSY, EC 2.5.1.22 (Spermidine aminopropyltransferase)",SMS,Homo sapiens (Human),366.0,MAAARHSTLDFMLGAKADGETILKGLQSIFQEQGMAESVHTWQDHGYLATYTNKNGSFANLRIYPHGLVLLDLQSYDGDAQGKEEIDSILNKVEERMKELSQDSTGRVKRLPPIVRGGAIDRYWPTADGRLVEYDIDEVVYDEDSPYQNIKILHSKQFGNILILSGDVNLAESDLAYTRAIMGSGKEDYTGKDVLILGGGDGGILCEIVKLKPKMVTMVEIDQMVIDGCKKYMRKTCGDVLDNLKGDCYQVLIEDCIPVLKRYAKEGREFDYVINDLTAVPISTSPEEDSTWEFLRLILDLSMKVLKQDGKYFTQGNCVNLTEALSLYEEQLGRLYCPVEFSKEIVCVPSYLELWVFYTVWKKAKP,PF17284;PF17950;,3C6K;3C6M;,58,F,L,True,818
12952,11861,193529,single nucleotide variant,NM_003923.3(FOXH1):c.373A>T (p.Thr125Ser),8928,FOXH1,HGNC:3814,Benign/Likely benign,0,14-Feb-20,112028242,-,RCV000177182|RCV000472842|RCV001282838,"MedGen:CN169374|Human Phenotype Ontology:HP:0001360,Human Phenotype Ontology:HP:0009807,MONDO:MONDO:0016296,MedGen:C0079541,OMIM:PS236100,Orphanet:2162|MedGen:CN235283",not specified|Holoprosencephaly sequence|none provided,germline,germline,GRCh38,NC_000008.11,8,144474963,144474963,na,na,8q24.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA202333,UniProtKB:O75593#VAR_011382",2,196368,144474963,T,A,T125S,2,benign,benign,O75593,O75593,reviewed,FOXH1_HUMAN,"Forkhead box protein H1 (Forkhead activin signal transducer 1, Fast-1, hFAST-1) (Forkhead activin signal transducer 2, Fast-2)",FOXH1 FAST1 FAST2,Homo sapiens (Human),365.0,MGPCSGSRLGPPEAESPSQPPKRRKKRYLRHDKPPYTYLAMIALVIQAAPSRRLKLAQIIRQVQAVFPFFREDYEGWKDSIRHNLSSNRCFRKVPKDPAKPQAKGNFWAVDVSLIPAEALRLQNTALCRRWQNGGARGAFAKDLGPYVLHGRPYRPPSPPPPPSEGFSIKSLLGGSGEGAPWPGLAPQSSPVPAGTGNSGEEAVPTPPLPSSERPLWPLCPLPGPTRVEGETVQGGAIGPSTLSPEPRAWPLHLLQGTAVPGGRSSGGHRASLWGQLPTSYLPIYTPNVVMPLAPPPTSCPQCPSTSPAYWGVAPETRGPPGLLCDLDALFQGVPPNKSIYDVWVSHPRDLAAPGPGWLLSWCSL,PF00250;,5XOC;,125,T,S,True,819
12953,9119,100285,single nucleotide variant,NM_003923.3(FOXH1):c.338G>C (p.Ser113Thr),8928,FOXH1,HGNC:3814,Benign/Likely benign,0,31-Dec-19,144830740,-,RCV000080357|RCV000536028,"MedGen:CN169374|Human Phenotype Ontology:HP:0001360,Human Phenotype Ontology:HP:0009807,MONDO:MONDO:0016296,MedGen:C0079541,OMIM:PS236100,Orphanet:2162",not specified|Holoprosencephaly sequence,germline;unknown,germline,GRCh38,NC_000008.11,8,144474998,144474998,na,na,8q24.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA248668,UniProtKB:O75593#VAR_011381",2,94385,144474998,C,G,S113T,2,benign,benign,O75593,O75593,reviewed,FOXH1_HUMAN,"Forkhead box protein H1 (Forkhead activin signal transducer 1, Fast-1, hFAST-1) (Forkhead activin signal transducer 2, Fast-2)",FOXH1 FAST1 FAST2,Homo sapiens (Human),365.0,MGPCSGSRLGPPEAESPSQPPKRRKKRYLRHDKPPYTYLAMIALVIQAAPSRRLKLAQIIRQVQAVFPFFREDYEGWKDSIRHNLSSNRCFRKVPKDPAKPQAKGNFWAVDVSLIPAEALRLQNTALCRRWQNGGARGAFAKDLGPYVLHGRPYRPPSPPPPPSEGFSIKSLLGGSGEGAPWPGLAPQSSPVPAGTGNSGEEAVPTPPLPSSERPLWPLCPLPGPTRVEGETVQGGAIGPSTLSPEPRAWPLHLLQGTAVPGGRSSGGHRASLWGQLPTSYLPIYTPNVVMPLAPPPTSCPQCPSTSPAYWGVAPETRGPPGLLCDLDALFQGVPPNKSIYDVWVSHPRDLAAPGPGWLLSWCSL,PF00250;,5XOC;,113,S,T,True,819
12954,6042,39936,single nucleotide variant,NM_000035.4(ALDOB):c.136A>T (p.Arg46Trp),229,ALDOB,HGNC:417,Uncertain significance,1,9-Nov-17,41281039,-,RCV000023970|RCV000728543,"Human Phenotype Ontology:HP:0005973,MONDO:MONDO:0009249,MedGen:C0016751,OMIM:229600,Orphanet:469|MedGen:CN517202",Hereditary fructosuria|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,101429943,101429943,na,na,9q31.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"UniProtKB:P05062#VAR_075348,OMIM:612724.0014,ClinGen:CA129579",3,30979,101429943,T,A,R46W,2,uncertain,uncertain,P05062,P05062,reviewed,ALDOB_HUMAN,"Fructose-bisphosphate aldolase B, EC 4.1.2.13 (Liver-type aldolase)",ALDOB ALDB,Homo sapiens (Human),364.0,MAHRFPALTQEQKKELSEIAQSIVANGKGILAADESVGTMGNRLQRIKVENTEENRRQFREILFSVDSSINQSIGGVILFHETLYQKDSQGKLFRNILKEKGIVVGIKLDQGGAPLAGTNKETTIQGLDGLSERCAQYKKDGVDFGKWRAVLRIADQCPSSLAIQENANALARYASICQQNGLVPIVEPEVIPDGDHDLEHCQYVTEKVLAAVYKALNDHHVYLEGTLLKPNMVTAGHACTKKYTPEQVAMATVTALHRTVPAAVPGICFLSGGMSEEDATLNLNAINLCPLPKPWKLSFSYGRALQASALAAWGGKAANKEATQEAFMKRAMANCQAAKGQYVHTGSSGAASTQSLFTACYTY,PF00274;,1QO5;1XDL;1XDM;,46,R,W,True,820
12955,6043,39937,single nucleotide variant,NM_000035.4(ALDOB):c.1027T>C (p.Tyr343His),229,ALDOB,HGNC:417,Uncertain significance,1,7-Jul-17,369586696,-,RCV000023971,"Human Phenotype Ontology:HP:0005973,MONDO:MONDO:0009249,MedGen:C0016751,OMIM:229600,Orphanet:469",Hereditary fructosuria,germline;unknown,germline,GRCh38,NC_000009.12,9,101421877,101421877,na,na,9q31.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA129581,UniProtKB:P05062#VAR_075349,OMIM:612724.0015",3,30980,101421877,A,G,Y343H,1,uncertain,uncertain,P05062,P05062,reviewed,ALDOB_HUMAN,"Fructose-bisphosphate aldolase B, EC 4.1.2.13 (Liver-type aldolase)",ALDOB ALDB,Homo sapiens (Human),364.0,MAHRFPALTQEQKKELSEIAQSIVANGKGILAADESVGTMGNRLQRIKVENTEENRRQFREILFSVDSSINQSIGGVILFHETLYQKDSQGKLFRNILKEKGIVVGIKLDQGGAPLAGTNKETTIQGLDGLSERCAQYKKDGVDFGKWRAVLRIADQCPSSLAIQENANALARYASICQQNGLVPIVEPEVIPDGDHDLEHCQYVTEKVLAAVYKALNDHHVYLEGTLLKPNMVTAGHACTKKYTPEQVAMATVTALHRTVPAAVPGICFLSGGMSEEDATLNLNAINLCPLPKPWKLSFSYGRALQASALAAWGGKAANKEATQEAFMKRAMANCQAAKGQYVHTGSSGAASTQSLFTACYTY,PF00274;,1QO5;1XDL;1XDM;,343,Y,H,True,820
12956,13973,315749,single nucleotide variant,NM_000035.4(ALDOB):c.619G>C (p.Glu207Gln),229,ALDOB,HGNC:417,Benign,0,31-Dec-19,3739721,-,RCV000299779|RCV000429664,"Human Phenotype Ontology:HP:0005973,MONDO:MONDO:0009249,MedGen:C0016751,OMIM:229600,Orphanet:469|MedGen:CN169374",Hereditary fructosuria|not specified,germline,germline,GRCh38,NC_000009.12,9,101426560,101426560,na,na,9q31.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA5161521,UniProtKB:P05062#VAR_020825",2,364310,101426560,C,G,E207Q,2,benign,benign,P05062,P05062,reviewed,ALDOB_HUMAN,"Fructose-bisphosphate aldolase B, EC 4.1.2.13 (Liver-type aldolase)",ALDOB ALDB,Homo sapiens (Human),364.0,MAHRFPALTQEQKKELSEIAQSIVANGKGILAADESVGTMGNRLQRIKVENTEENRRQFREILFSVDSSINQSIGGVILFHETLYQKDSQGKLFRNILKEKGIVVGIKLDQGGAPLAGTNKETTIQGLDGLSERCAQYKKDGVDFGKWRAVLRIADQCPSSLAIQENANALARYASICQQNGLVPIVEPEVIPDGDHDLEHCQYVTEKVLAAVYKALNDHHVYLEGTLLKPNMVTAGHACTKKYTPEQVAMATVTALHRTVPAAVPGICFLSGGMSEEDATLNLNAINLCPLPKPWKLSFSYGRALQASALAAWGGKAANKEATQEAFMKRAMANCQAAKGQYVHTGSSGAASTQSLFTACYTY,PF00274;,1QO5;1XDL;1XDM;,207,E,Q,True,820
12957,127,15508,single nucleotide variant,NM_000035.4(ALDOB):c.1005C>G (p.Asn335Lys),229,ALDOB,HGNC:417,Pathogenic,1,1-Nov-20,78340951,-,RCV000000498|RCV000723841,"Human Phenotype Ontology:HP:0005973,MONDO:MONDO:0009249,MedGen:C0016751,OMIM:229600,Orphanet:469|MedGen:CN517202",Hereditary fructosuria|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,101421899,101421899,na,na,9q31.1,"criteria provided, multiple submitters, no conflicts",9,-,Y,"ClinGen:CA339812,UniProtKB:P05062#VAR_000557,OMIM:612724.0006",3,469,101421899,G,C,N335K,2,pathogenic,pathogenic,P05062,P05062,reviewed,ALDOB_HUMAN,"Fructose-bisphosphate aldolase B, EC 4.1.2.13 (Liver-type aldolase)",ALDOB ALDB,Homo sapiens (Human),364.0,MAHRFPALTQEQKKELSEIAQSIVANGKGILAADESVGTMGNRLQRIKVENTEENRRQFREILFSVDSSINQSIGGVILFHETLYQKDSQGKLFRNILKEKGIVVGIKLDQGGAPLAGTNKETTIQGLDGLSERCAQYKKDGVDFGKWRAVLRIADQCPSSLAIQENANALARYASICQQNGLVPIVEPEVIPDGDHDLEHCQYVTEKVLAAVYKALNDHHVYLEGTLLKPNMVTAGHACTKKYTPEQVAMATVTALHRTVPAAVPGICFLSGGMSEEDATLNLNAINLCPLPKPWKLSFSYGRALQASALAAWGGKAANKEATQEAFMKRAMANCQAAKGQYVHTGSSGAASTQSLFTACYTY,PF00274;,1QO5;1XDL;1XDM;,335,N,K,True,820
12958,125,15503,single nucleotide variant,NM_000035.4(ALDOB):c.448G>C (p.Ala150Pro),229,ALDOB,HGNC:417,Pathogenic,1,1-Apr-20,1800546,-,RCV000000493|RCV000224056,"Human Phenotype Ontology:HP:0005973,MONDO:MONDO:0009249,MedGen:C0016751,OMIM:229600,Orphanet:469|MedGen:CN517202",Hereditary fructosuria|not provided,germline;paternal;unknown,germline,GRCh38,NC_000009.12,9,101427574,101427574,na,na,9q31.1,"criteria provided, multiple submitters, no conflicts",21,-,Y,"UniProtKB:P05062#VAR_000553,OMIM:612724.0001,ClinGen:CA339810",3,464,101427574,C,G,A150P,2,pathogenic,pathogenic,P05062,P05062,reviewed,ALDOB_HUMAN,"Fructose-bisphosphate aldolase B, EC 4.1.2.13 (Liver-type aldolase)",ALDOB ALDB,Homo sapiens (Human),364.0,MAHRFPALTQEQKKELSEIAQSIVANGKGILAADESVGTMGNRLQRIKVENTEENRRQFREILFSVDSSINQSIGGVILFHETLYQKDSQGKLFRNILKEKGIVVGIKLDQGGAPLAGTNKETTIQGLDGLSERCAQYKKDGVDFGKWRAVLRIADQCPSSLAIQENANALARYASICQQNGLVPIVEPEVIPDGDHDLEHCQYVTEKVLAAVYKALNDHHVYLEGTLLKPNMVTAGHACTKKYTPEQVAMATVTALHRTVPAAVPGICFLSGGMSEEDATLNLNAINLCPLPKPWKLSFSYGRALQASALAAWGGKAANKEATQEAFMKRAMANCQAAKGQYVHTGSSGAASTQSLFTACYTY,PF00274;,1QO5;1XDL;1XDM;,150,A,P,True,820
12959,126,15504,single nucleotide variant,NM_000035.4(ALDOB):c.524C>A (p.Ala175Asp),229,ALDOB,HGNC:417,Pathogenic,1,31-Dec-19,76917243,-,RCV000000494|RCV000352944,"Human Phenotype Ontology:HP:0005973,MONDO:MONDO:0009249,MedGen:C0016751,OMIM:229600,Orphanet:469|MedGen:CN517202",Hereditary fructosuria|not provided,germline;unknown,germline,GRCh38,NC_000009.12,9,101427498,101427498,na,na,9q31.1,"criteria provided, multiple submitters, no conflicts",13,-,Y,"ClinGen:CA339811,UniProtKB:P05062#VAR_000554,OMIM:612724.0002",3,465,101427498,G,T,A175D,2,pathogenic,pathogenic,P05062,P05062,reviewed,ALDOB_HUMAN,"Fructose-bisphosphate aldolase B, EC 4.1.2.13 (Liver-type aldolase)",ALDOB ALDB,Homo sapiens (Human),364.0,MAHRFPALTQEQKKELSEIAQSIVANGKGILAADESVGTMGNRLQRIKVENTEENRRQFREILFSVDSSINQSIGGVILFHETLYQKDSQGKLFRNILKEKGIVVGIKLDQGGAPLAGTNKETTIQGLDGLSERCAQYKKDGVDFGKWRAVLRIADQCPSSLAIQENANALARYASICQQNGLVPIVEPEVIPDGDHDLEHCQYVTEKVLAAVYKALNDHHVYLEGTLLKPNMVTAGHACTKKYTPEQVAMATVTALHRTVPAAVPGICFLSGGMSEEDATLNLNAINLCPLPKPWKLSFSYGRALQASALAAWGGKAANKEATQEAFMKRAMANCQAAKGQYVHTGSSGAASTQSLFTACYTY,PF00274;,1QO5;1XDL;1XDM;,175,A,D,True,820
12960,11588,186775,single nucleotide variant,NM_000035.4(ALDOB):c.1013C>T (p.Ala338Val),229,ALDOB,HGNC:417,Pathogenic/Likely pathogenic,1,1-Feb-20,77718928,-,RCV000169047|RCV000598061,"Human Phenotype Ontology:HP:0005973,MONDO:MONDO:0009249,MedGen:C0016751,OMIM:229600,Orphanet:469|MedGen:CN517202",Hereditary fructosuria|not provided,germline;inherited;unknown,germline,GRCh38,NC_000009.12,9,101421891,101421891,na,na,9q31.1,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA199050,UniProtKB:P05062#VAR_000558",2,188739,101421891,G,A,A338V,2,pathogenic,pathogenic,P05062,P05062,reviewed,ALDOB_HUMAN,"Fructose-bisphosphate aldolase B, EC 4.1.2.13 (Liver-type aldolase)",ALDOB ALDB,Homo sapiens (Human),364.0,MAHRFPALTQEQKKELSEIAQSIVANGKGILAADESVGTMGNRLQRIKVENTEENRRQFREILFSVDSSINQSIGGVILFHETLYQKDSQGKLFRNILKEKGIVVGIKLDQGGAPLAGTNKETTIQGLDGLSERCAQYKKDGVDFGKWRAVLRIADQCPSSLAIQENANALARYASICQQNGLVPIVEPEVIPDGDHDLEHCQYVTEKVLAAVYKALNDHHVYLEGTLLKPNMVTAGHACTKKYTPEQVAMATVTALHRTVPAAVPGICFLSGGMSEEDATLNLNAINLCPLPKPWKLSFSYGRALQASALAAWGGKAANKEATQEAFMKRAMANCQAAKGQYVHTGSSGAASTQSLFTACYTY,PF00274;,1QO5;1XDL;1XDM;,338,A,V,True,820
12961,128,15514,single nucleotide variant,NM_000035.4(ALDOB):c.442T>C (p.Trp148Arg),229,ALDOB,HGNC:417,Pathogenic,1,1-Apr-95,118204430,-,RCV000000504,"Human Phenotype Ontology:HP:0005973,MONDO:MONDO:0009249,MedGen:C0016751,OMIM:229600,Orphanet:469",Hereditary fructosuria,germline,germline,GRCh38,NC_000009.12,9,101427580,101427580,na,na,9q31.1,no assertion criteria provided,1,-,N,"ClinGen:CA114314,UniProtKB:P05062#VAR_000552,OMIM:612724.0012",1,475,101427580,A,G,W148R,0,pathogenic,uncertain,P05062,P05062,reviewed,ALDOB_HUMAN,"Fructose-bisphosphate aldolase B, EC 4.1.2.13 (Liver-type aldolase)",ALDOB ALDB,Homo sapiens (Human),364.0,MAHRFPALTQEQKKELSEIAQSIVANGKGILAADESVGTMGNRLQRIKVENTEENRRQFREILFSVDSSINQSIGGVILFHETLYQKDSQGKLFRNILKEKGIVVGIKLDQGGAPLAGTNKETTIQGLDGLSERCAQYKKDGVDFGKWRAVLRIADQCPSSLAIQENANALARYASICQQNGLVPIVEPEVIPDGDHDLEHCQYVTEKVLAAVYKALNDHHVYLEGTLLKPNMVTAGHACTKKYTPEQVAMATVTALHRTVPAAVPGICFLSGGMSEEDATLNLNAINLCPLPKPWKLSFSYGRALQASALAAWGGKAANKEATQEAFMKRAMANCQAAKGQYVHTGSSGAASTQSLFTACYTY,PF00274;,1QO5;1XDL;1XDM;,148,W,R,True,820
12962,8707,94325,single nucleotide variant,NM_145064.3(STAC3):c.851G>C (p.Trp284Ser),246329,STAC3,HGNC:28423,Pathogenic,1,2-Dec-19,140291094,-,RCV000074400|RCV001093315,"MONDO:MONDO:0009722,MedGen:C1850625,OMIM:255995,Orphanet:168572|MedGen:CN517202",Bailey-Bloch congenital myopathy|not provided,germline;unknown,germline,GRCh38,NC_000012.12,12,57244322,57244322,na,na,12q13.3,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA145329,UniProtKB:Q96MF2#VAR_071313,OMIM:615521.0001",3,88744,57244322,C,G,W284S,2,pathogenic,pathogenic,Q96MF2,Q96MF2,reviewed,STAC3_HUMAN,SH3 and cysteine-rich domain-containing protein 3,STAC3,Homo sapiens (Human),364.0,MTEKEVLESPKPSFPAETRQSGLQRLKQLLRKGSTGTKEMELPPEPQANGEAVGAGGGPIYYIYEEEEEEEEEEEEPPPEPPKLVNDKPHKFKDHFFKKPKFCDVCARMIVLNNKFGLRCKNCKTNIHEHCQSYVEMQRCFGKIPPGFHRAYSSPLYSNQQYACVKDLSAANRNDPVFETLRTGVIMANKERKKGQADKKNPVAAMMEEEPESARPEEGKPQDGNPEGDKKAEKKTPDDKHKQPGFQQSHYFVALYRFKALEKDDLDFPPGEKITVIDDSNEEWWRGKIGEKVGFFPPNFIIRVRAGERVHRVTRSFVGNREIGQITLKKDQIVVQKGDEAGGYVKVYTGRKVGLFPTDFLEEI,PF00130;PF00018;PF07653;,2DB6;6B29;6UY7;6UY8;6UY9;,284,W,S,True,821
12963,506,17018,single nucleotide variant,NM_000022.4(ADA):c.454C>A (p.Leu152Met),100,ADA,HGNC:186,Conflicting interpretations of pathogenicity,1,9-Oct-20,121908728,-,RCV000002056|RCV000059105|RCV000780817,"MedGen:C1863239|MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|MedGen:CN239264",Partial adenosine deaminase deficiency|Severe combined immunodeficiency due to ADA deficiency|Severe Combined Immune Deficiency,germline;unknown,germline,GRCh38,NC_000020.11,20,44625593,44625593,na,na,20q13.12,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA115292,UniProtKB:P00813#VAR_002225,UniProtKB/Swiss-Prot:VAR_002225,OMIM:608958.0027",3,1979,44625593,G,T,L152M,1,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,152,L,M,True,822
12964,8401,79159,single nucleotide variant,NM_000022.4(ADA):c.596A>C (p.Gln199Pro),100,ADA,HGNC:186,not provided,0,-,121908734,-,RCV000059110,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Severe combined immunodeficiency due to ADA deficiency,unknown,unknown,GRCh38,NC_000020.11,20,44624212,44624212,na,na,20q13.12,no assertion provided,1,-,N,"ClinGen:CA266022,UniProtKB:P00813#VAR_002230,UniProtKB/Swiss-Prot:VAR_002230",1,68268,44624212,T,G,Q199P,0,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,199,Q,P,True,822
12965,507,17019,single nucleotide variant,NM_000022.4(ADA):c.698C>T (p.Thr233Ile),100,ADA,HGNC:186,Pathogenic,1,1-Jul-97,121908729,-,RCV000002057|RCV000059113,"MedGen:C1863239|MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Partial adenosine deaminase deficiency|Severe combined immunodeficiency due to ADA deficiency,germline;unknown,germline,GRCh38,NC_000020.11,20,44622911,44622911,na,na,20q13.12,no assertion criteria provided,2,-,N,"ClinGen:CA115295,UniProtKB:P00813#VAR_002235,UniProtKB/Swiss-Prot:VAR_002235,OMIM:608958.0028",1,1980,44622911,G,A,T233I,0,pathogenic,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,233,T,I,True,822
12966,505,17012,single nucleotide variant,NM_000022.2(ADA):c.22G>A (p.Asp8Asn),100,ADA,HGNC:186,Benign,1,28-May-19,73598374,-,RCV000002050|RCV000351193|RCV000508187,"|MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|MedGen:CN169374",Adenosine deaminase 2 allozyme|Severe combined immunodeficiency due to ADA deficiency|not specified,germline;unknown,germline,GRCh38,NC_000020.11,20,44651586,44651586,na,na,20q13.12,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA115289,UniProtKB:P00813#VAR_002209,OMIM:608958.0021",3,1973,44651586,C,T,D8N,2,benign,benign,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,8,D,N,True,822
12967,504,17010,single nucleotide variant,NM_000022.4(ADA):c.872C>T (p.Ser291Leu),100,ADA,HGNC:186,Pathogenic/Likely pathogenic,1,14-Jun-19,121908721,-,RCV000002048|RCV000788574,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|MedGen:CN517202",Severe combined immunodeficiency due to ADA deficiency|not provided,germline;unknown,germline,GRCh38,NC_000020.11,20,44621121,44621121,na,na,20q13.12,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA252013,UniProtKB:P00813#VAR_002237,UniProtKB/Swiss-Prot:VAR_002237,OMIM:608958.0019",3,1971,44621121,G,A,S291L,2,pathogenic,pathogenic,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,291,S,L,True,822
12968,503,17009,single nucleotide variant,NM_000022.4(ADA):c.466C>T (p.Arg156Cys),100,ADA,HGNC:186,Pathogenic/Likely pathogenic,1,30-Dec-19,121908735,-,RCV000002047|RCV000780816,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|Human Phenotype Ontology:HP:0004430,MONDO:MONDO:0015974,MeSH:D016511,MedGen:C0085110,Orphanet:183660",Severe combined immunodeficiency due to ADA deficiency|Severe combined immunodeficiency disease,germline;unknown,germline,GRCh38,NC_000020.11,20,44625581,44625581,na,na,20q13.12,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA252011,UniProtKB:P00813#VAR_002226,UniProtKB/Swiss-Prot:VAR_002226,OMIM:608958.0018",3,1970,44625581,G,A,R156C,2,pathogenic,pathogenic,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,156,R,C,True,822
12969,502,17007,single nucleotide variant,NM_000022.4(ADA):c.646G>A (p.Gly216Arg),100,ADA,HGNC:186,Pathogenic,1,29-Sep-19,121908723,-,RCV000002045|RCV000256171,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|MedGen:CN517202",Severe combined immunodeficiency due to ADA deficiency|not provided,germline;unknown,germline,GRCh38,NC_000020.11,20,44623039,44623039,na,na,20q13.12,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA252008,UniProtKB:P00813#VAR_002234,OMIM:608958.0016",3,1968,44623039,C,T,G216R,2,pathogenic,pathogenic,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,216,G,R,True,822
12970,501,17006,single nucleotide variant,NM_000022.4(ADA):c.643G>A (p.Ala215Thr),100,ADA,HGNC:186,Uncertain significance,1,7-Dec-20,114025668,-,RCV000002044|RCV000059112|RCV001280563,"MedGen:C1863239|MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|MedGen:CN169374",Partial adenosine deaminase deficiency|Severe combined immunodeficiency due to ADA deficiency|not specified,germline;unknown,germline,GRCh38,NC_000020.11,20,44623042,44623042,na,na,20q13.12,"criteria provided, multiple submitters, no conflicts",5,-,N,"UniProtKB:P00813#VAR_002233,UniProtKB/Swiss-Prot:VAR_002233,OMIM:608958.0015,ClinGen:CA115287",3,1967,44623042,C,T,A215T,2,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,215,A,T,True,822
12971,500,17005,single nucleotide variant,NM_000022.4(ADA):c.631C>T (p.Arg211Cys),100,ADA,HGNC:186,Conflicting interpretations of pathogenicity,1,12-Oct-20,121908740,-,RCV000002043|RCV000059111,"MedGen:C1863239|MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Partial adenosine deaminase deficiency|Severe combined immunodeficiency due to ADA deficiency,germline;unknown,germline,GRCh38,NC_000020.11,20,44623054,44623054,na,na,20q13.12,"criteria provided, conflicting interpretations",6,-,N,"UniProtKB/Swiss-Prot:VAR_002231,OMIM:608958.0014,ClinGen:CA115285,UniProtKB:P00813#VAR_002231",3,1966,44623054,G,A,R211C,1,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,211,R,C,True,822
12972,499,17004,single nucleotide variant,NM_000022.4(ADA):c.320T>C (p.Leu107Pro),100,ADA,HGNC:186,Pathogenic/Likely pathogenic,1,16-Sep-19,121908739,-,RCV000002042|RCV000255602|RCV001194145,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|MedGen:CN517202|MedGen:CN239264",Severe combined immunodeficiency due to ADA deficiency|not provided|Severe Combined Immune Deficiency,germline;unknown,germline,GRCh38,NC_000020.11,20,44626498,44626498,na,na,20q13.12,"criteria provided, multiple submitters, no conflicts",10,-,N,"ClinGen:CA252006,UniProtKB:P00813#VAR_002219,UniProtKB/Swiss-Prot:VAR_002219,OMIM:608958.0013",3,1965,44626498,A,G,L107P,2,pathogenic,pathogenic,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,107,L,P,True,822
12973,508,17020,single nucleotide variant,NM_000022.4(ADA):c.290A>G (p.Tyr97Cys),100,ADA,HGNC:186,no interpretation for the single variant,-1,-,267606634,-,-,-,-,not applicable,not applicable,GRCh38,NC_000020.11,20,44626528,44626528,na,na,20q13.12,no interpretation for the single variant,0,-,N,"UniProtKB:P00813#VAR_076954,OMIM:608958.0029,ClinVar:1981",4,242820,44626528,T,C,Y97C,0,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,97,Y,C,True,822
12974,498,17003,single nucleotide variant,NM_000022.4(ADA):c.821C>T (p.Pro274Leu),100,ADA,HGNC:186,Uncertain significance,1,15-Mar-19,121908738,-,RCV000002041|RCV000059114,"MedGen:C1863239|MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Partial adenosine deaminase deficiency|Severe combined immunodeficiency due to ADA deficiency,germline;unknown,germline,GRCh38,NC_000020.11,20,44622612,44622612,na,na,20q13.12,"criteria provided, multiple submitters, no conflicts",4,-,N,"UniProtKB/Swiss-Prot:VAR_002236,OMIM:608958.0012,ClinGen:CA115283,UniProtKB:P00813#VAR_002236",3,1964,44622612,G,A,P274L,2,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,274,P,L,True,822
12975,496,17001,single nucleotide variant,NM_000022.4(ADA):c.226C>T (p.Arg76Trp),100,ADA,HGNC:186,Conflicting interpretations of pathogenicity,1,21-Nov-19,121908736,-,RCV000002039|RCV000059096|RCV000482569,"MedGen:C1863239|MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|MedGen:CN517202",Partial adenosine deaminase deficiency|Severe combined immunodeficiency due to ADA deficiency|not provided,germline;unknown,germline,GRCh38,NC_000020.11,20,44626592,44626592,na,na,20q13.12,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA115279,UniProtKB:P00813#VAR_002213,UniProtKB/Swiss-Prot:VAR_002213,OMIM:608958.0010",3,1962,44626592,G,A,R76W,1,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,76,R,W,True,822
12976,494,16998,single nucleotide variant,NM_000022.4(ADA):c.986C>T (p.Ala329Val),100,ADA,HGNC:186,Pathogenic/Likely pathogenic,1,18-Dec-19,121908715,-,RCV000002036|RCV000373062|RCV001194143,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|MedGen:CN517202|MONDO:MONDO:0011086,MedGen:C1832322,OMIM:601457,Orphanet:331206","Severe combined immunodeficiency due to ADA deficiency|not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive",germline;unknown,germline,GRCh38,NC_000020.11,20,44620391,44620391,na,na,20q13.12,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinVar:424762,ClinGen:CA252004,UniProtKB:P00813#VAR_002240,UniProtKB/Swiss-Prot:VAR_002240,OMIM:608958.0006",3,1959,44620391,G,A,A329V,2,pathogenic,pathogenic,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,329,A,V,True,822
12977,5720,38420,single nucleotide variant,NM_000022.4(ADA):c.316C>G (p.Leu106Val),100,ADA,HGNC:186,no interpretation for the single variant,-1,-,267606635,-,-,-,-,not applicable,not applicable,GRCh38,NC_000020.11,20,44626502,44626502,na,na,20q13.12,no interpretation for the single variant,0,-,N,"UniProtKB:P00813#VAR_076955,OMIM:608958.0029,ClinVar:1981",4,242738,44626502,G,C,L106V,0,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,106,L,V,True,822
12978,493,16997,single nucleotide variant,NM_000022.4(ADA):c.911T>G (p.Leu304Arg),100,ADA,HGNC:186,Likely pathogenic,1,7-Dec-19,199422327,-,RCV000002035,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Severe combined immunodeficiency due to ADA deficiency,germline,germline,GRCh38,NC_000020.11,20,44621082,44621082,na,na,20q13.12,"criteria provided, single submitter",2,-,N,"UniProtKB:P00813#VAR_002239,OMIM:608958.0005,ClinGen:CA252002",3,1958,44621082,A,C,L304R,1,pathogenic,pathogenic,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,304,L,R,True,822
12979,492,16996,single nucleotide variant,NM_000022.4(ADA):c.632G>A (p.Arg211His),100,ADA,HGNC:186,Pathogenic/Likely pathogenic,1,20-Feb-20,121908716,-,RCV000002034|RCV000756972,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|MedGen:CN517202",Severe combined immunodeficiency due to ADA deficiency|not provided,germline;unknown,germline,GRCh38,NC_000020.11,20,44623053,44623053,na,na,20q13.12,"criteria provided, multiple submitters, no conflicts",10,-,N,"ClinGen:CA252000,UniProtKB:P00813#VAR_002232,UniProtKB/Swiss-Prot:VAR_002232,OMIM:608958.0004",3,1957,44623053,C,T,R211H,2,pathogenic,pathogenic,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,211,R,H,True,822
12980,491,16995,single nucleotide variant,NM_000022.4(ADA):c.302G>A (p.Arg101Gln),100,ADA,HGNC:186,Pathogenic,1,12-Jul-17,121908714,-,RCV000002033|RCV000788281,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|MedGen:CN517202",Severe combined immunodeficiency due to ADA deficiency|not provided,germline;unknown,germline,GRCh38,NC_000020.11,20,44626516,44626516,na,na,20q13.12,"criteria provided, single submitter",3,-,N,"ClinGen:CA251998,UniProtKB:P00813#VAR_002218,UniProtKB/Swiss-Prot:VAR_002218,OMIM:608958.0003",3,1956,44626516,C,T,R101Q,1,pathogenic,pathogenic,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,101,R,Q,True,822
12981,490,16994,single nucleotide variant,NM_000022.4(ADA):c.301C>T (p.Arg101Trp),100,ADA,HGNC:186,Conflicting interpretations of pathogenicity,1,18-Sep-19,121908717,-,RCV000002032,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Severe combined immunodeficiency due to ADA deficiency,germline;unknown,germline,GRCh38,NC_000020.11,20,44626517,44626517,na,na,20q13.12,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA251996,UniProtKB:P00813#VAR_002217,UniProtKB/Swiss-Prot:VAR_002217,OMIM:608958.0002",3,1955,44626517,G,A,R101W,1,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,101,R,W,True,822
12982,489,16993,single nucleotide variant,NM_000022.4(ADA):c.239A>G (p.Lys80Arg),100,ADA,HGNC:186,Benign,0,3-Jan-19,11555566,-,RCV000002031|RCV000247281,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|MedGen:CN169374",Severe combined immunodeficiency due to ADA deficiency|not specified,germline,germline,GRCh38,NC_000020.11,20,44626579,44626579,na,na,20q13.12,"criteria provided, multiple submitters, no conflicts",6,-,N,"OMIM:608958.0001,ClinGen:CA251993,UniProtKB:P00813#VAR_002214",3,1954,44626579,T,C,K80R,2,benign,benign,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,80,K,R,True,822
12983,497,17002,single nucleotide variant,NM_000022.4(ADA):c.446G>A (p.Arg149Gln),100,ADA,HGNC:186,Uncertain significance,1,15-Mar-17,121908737,-,RCV000002040|RCV000059104,"MedGen:C1863239|MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Partial adenosine deaminase deficiency|Severe combined immunodeficiency due to ADA deficiency,germline;unknown,germline,GRCh38,NC_000020.11,20,44625601,44625601,na,na,20q13.12,"criteria provided, single submitter",3,-,N,"ClinGen:CA115281,UniProtKB:P00813#VAR_002223,UniProtKB/Swiss-Prot:VAR_002223,OMIM:608958.0011",3,1963,44625601,C,T,R149Q,1,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,149,R,Q,True,822
12984,509,17023,single nucleotide variant,NM_000022.4(ADA):c.467G>A (p.Arg156His),100,ADA,HGNC:186,Pathogenic/Likely pathogenic,1,10-Oct-19,121908722,-,RCV000002061|RCV000059106|RCV001194144,"MedGen:CN042911|MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|MedGen:CN239264","SCID due to ADA deficiency, delayed onset|Severe combined immunodeficiency due to ADA deficiency|Severe Combined Immune Deficiency",germline;unknown,germline,GRCh38,NC_000020.11,20,44625580,44625580,na,na,20q13.12,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA115299,UniProtKB:P00813#VAR_002227,UniProtKB/Swiss-Prot:VAR_002227,OMIM:608958.0032",3,1984,44625580,C,T,R156H,2,pathogenic,pathogenic,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,156,R,H,True,822
12985,495,17000,single nucleotide variant,NM_000022.4(ADA):c.890C>A (p.Pro297Gln),100,ADA,HGNC:186,Conflicting interpretations of pathogenicity,1,6-May-19,121908718,-,RCV000002038|RCV000059115,"MedGen:C1863239|MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Partial adenosine deaminase deficiency|Severe combined immunodeficiency due to ADA deficiency,germline;unknown,germline,GRCh38,NC_000020.11,20,44621103,44621103,na,na,20q13.12,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA115277,UniProtKB:P00813#VAR_002238,UniProtKB/Swiss-Prot:VAR_002238,OMIM:608958.0009",3,1961,44621103,G,T,P297Q,1,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,297,P,Q,True,822
12986,8395,79153,single nucleotide variant,NM_000022.4(ADA):c.425G>A (p.Arg142Gln),100,ADA,HGNC:186,Conflicting interpretations of pathogenicity,0,31-Dec-19,61732239,-,RCV000059101|RCV000523342,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|MedGen:CN517202",Severe combined immunodeficiency due to ADA deficiency|not provided,germline;unknown,germline,GRCh38,NC_000020.11,20,44625622,44625622,na,na,20q13.12,"criteria provided, conflicting interpretations",7,-,N,"ClinGen:CA266009,UniProtKB:P00813#VAR_002222,UniProtKB/Swiss-Prot:VAR_002222",3,68262,44625622,C,T,R142Q,1,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,142,R,Q,True,822
12987,8390,79148,single nucleotide variant,NM_000022.4(ADA):c.220G>T (p.Gly74Cys),100,ADA,HGNC:186,not provided,0,-,121908730,-,RCV000059095,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Severe combined immunodeficiency due to ADA deficiency,unknown,unknown,GRCh38,NC_000020.11,20,44626598,44626598,na,na,20q13.12,no assertion provided,1,-,N,"ClinGen:CA265999,UniProtKB:P00813#VAR_002212,UniProtKB/Swiss-Prot:VAR_002212",1,68257,44626598,C,A,G74C,0,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,74,G,C,True,822
12988,8397,79155,single nucleotide variant,NM_000022.4(ADA):c.445C>T (p.Arg149Trp),100,ADA,HGNC:186,Uncertain significance,0,23-Mar-17,121908733,-,RCV000059103,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Severe combined immunodeficiency due to ADA deficiency,unknown,unknown,GRCh38,NC_000020.11,20,44625602,44625602,na,na,20q13.12,"criteria provided, single submitter",2,-,N,"ClinGen:CA266014,UniProtKB:P00813#VAR_002224,UniProtKB/Swiss-Prot:VAR_002224",3,68264,44625602,G,A,R149W,1,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,149,R,W,True,822
12989,8396,79154,single nucleotide variant,NM_000022.4(ADA):c.43C>G (p.His15Asp),100,ADA,HGNC:186,Pathogenic/Likely pathogenic,1,1-Apr-19,121908725,-,RCV000059102|RCV000429669,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|MedGen:CN517202",Severe combined immunodeficiency due to ADA deficiency|not provided,germline;unknown,germline,GRCh38,NC_000020.11,20,44636279,44636279,na,na,20q13.12,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA266012,UniProtKB:P00813#VAR_002210,UniProtKB/Swiss-Prot:VAR_002210",3,68263,44636279,G,C,H15D,2,pathogenic,pathogenic,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,15,H,D,True,822
12990,8394,79152,single nucleotide variant,NM_000022.4(ADA):c.419G>A (p.Gly140Glu),100,ADA,HGNC:186,not provided,0,-,121908732,-,RCV000059100,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Severe combined immunodeficiency due to ADA deficiency,unknown,unknown,GRCh38,NC_000020.11,20,44625628,44625628,na,na,20q13.12,no assertion provided,1,-,N,"UniProtKB:P00813#VAR_002221,UniProtKB/Swiss-Prot:VAR_002221,ClinGen:CA266007",1,68261,44625628,C,T,G140E,0,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,140,G,E,True,822
12991,8391,79149,single nucleotide variant,NM_000022.4(ADA):c.248C>A (p.Ala83Asp),100,ADA,HGNC:186,not provided,0,-,121908726,-,RCV000059097,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Severe combined immunodeficiency due to ADA deficiency,unknown,unknown,GRCh38,NC_000020.11,20,44626570,44626570,na,na,20q13.12,no assertion provided,1,-,N,"UniProtKB/Swiss-Prot:VAR_002215,ClinGen:CA266001,UniProtKB:P00813#VAR_002215",1,68258,44626570,G,T,A83D,0,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,83,A,D,True,822
12992,8393,79151,single nucleotide variant,NM_000022.4(ADA):c.385G>A (p.Val129Met),100,ADA,HGNC:186,Pathogenic,1,23-Dec-19,121908731,-,RCV000059099,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Severe combined immunodeficiency due to ADA deficiency,germline;unknown,germline,GRCh38,NC_000020.11,20,44625662,44625662,na,na,20q13.12,"criteria provided, single submitter",2,-,N,"ClinGen:CA266005,UniProtKB:P00813#VAR_002220,UniProtKB/Swiss-Prot:VAR_002220",3,68260,44625662,C,T,V129M,1,pathogenic,pathogenic,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,129,V,M,True,822
12993,8392,79150,single nucleotide variant,NM_000022.4(ADA):c.302G>T (p.Arg101Leu),100,ADA,HGNC:186,not provided,0,-,121908714,-,RCV000059098,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Severe combined immunodeficiency due to ADA deficiency,unknown,unknown,GRCh38,NC_000020.11,20,44626516,44626516,na,na,20q13.12,no assertion provided,1,-,N,"ClinGen:CA266003,UniProtKB:P00813#VAR_002216,UniProtKB/Swiss-Prot:VAR_002216",1,68259,44626516,C,A,R101L,0,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,101,R,L,True,822
12994,8400,79158,single nucleotide variant,NM_000022.4(ADA):c.58G>A (p.Gly20Arg),100,ADA,HGNC:186,Conflicting interpretations of pathogenicity,1,16-Mar-18,121908724,-,RCV000059109|RCV000494092,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277|MedGen:CN517202",Severe combined immunodeficiency due to ADA deficiency|not provided,germline;unknown,germline,GRCh38,NC_000020.11,20,44636264,44636264,na,na,20q13.12,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA266020,UniProtKB:P00813#VAR_002211,UniProtKB/Swiss-Prot:VAR_002211",3,68267,44636264,C,T,G20R,1,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,20,G,R,True,822
12995,8399,79157,single nucleotide variant,NM_000022.4(ADA):c.536C>A (p.Ala179Asp),100,ADA,HGNC:186,not provided,0,-,121908727,-,RCV000059108,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Severe combined immunodeficiency due to ADA deficiency,unknown,unknown,GRCh38,NC_000020.11,20,44624272,44624272,na,na,20q13.12,no assertion provided,1,-,N,"UniProtKB:P00813#VAR_002229,UniProtKB/Swiss-Prot:VAR_002229,ClinGen:CA266018",1,68266,44624272,G,T,A179D,0,uncertain,uncertain,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,179,A,D,True,822
12996,8398,79156,single nucleotide variant,NM_000022.4(ADA):c.529G>A (p.Val177Met),100,ADA,HGNC:186,Pathogenic/Likely pathogenic,1,29-Mar-19,121908719,-,RCV000059107,"MONDO:MONDO:0007064,MedGen:C1863236,OMIM:102700,Orphanet:277",Severe combined immunodeficiency due to ADA deficiency,germline;unknown,germline,GRCh38,NC_000020.11,20,44624279,44624279,na,na,20q13.12,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA266016,UniProtKB:P00813#VAR_002228,UniProtKB/Swiss-Prot:VAR_002228",3,68265,44624279,C,T,V177M,2,pathogenic,pathogenic,P00813,P00813,reviewed,ADA_HUMAN,"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)",ADA ADA1,Homo sapiens (Human),363.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,PF00962;,3IAR;7RTG;,177,V,M,True,822
12997,5353,33486,single nucleotide variant,NM_006563.4(KLF1):c.973G>A (p.Glu325Lys),10661,KLF1,HGNC:6345,Pathogenic,1,28-May-19,267607201,-,RCV000009567|RCV000990153,"MONDO:MONDO:0013355,MedGen:C3150926,OMIM:613673,Orphanet:293825|MedGen:C1292231,OMIM:111150","Congenital dyserythropoietic anemia, type IV|BLOOD GROUP--LUTHERAN INHIBITOR",germline;unknown,germline,GRCh38,NC_000019.10,19,12885001,12885001,na,na,19p13.13,"criteria provided, single submitter",2,-,N,"ClinGen:CA120054,UniProtKB:Q13351#VAR_064901,OMIM:600599.0006",3,18447,12885001,C,T,E325K,1,pathogenic,pathogenic,Q13351,Q13351,reviewed,KLF1_HUMAN,"Krueppel-like factor 1 (Erythroid krueppel-like transcription factor, EKLF)",KLF1 EKLF,Homo sapiens (Human),362.0,MATAETALPSISTLTALGPFPDTQDDFLKWWRSEEAQDMGPGPPDPTEPPLHVKSEDQPGEEEDDERGADATWDLDLLLTNFSGPEPGGAPQTCALAPSEASGAQYPPPPETLGAYAGGPGLVAGLLGSEDHSGWVRPALRARAPDAFVGPALAPAPAPEPKALALQPVYPGPGAGSSGGYFPRTGLSVPAASGAPYGLLSGYPAMYPAPQYQGHFQLFRGLQGPAPGPATSPSFLSCLGPGTVGTGLGGTAEDPGVIAETAPSKRGRRSWARKRQAAHTCAHPGCGKSYTKSSHLKAHLRTHTGEKPYACTWEGCGWRFARSDELTRHYRKHTGQRPFRCQLCPRAFSRSDHLALHMKRHL,PF16832;PF16833;PF00096;,2L2I;2MBH;2N23;,325,E,K,True,823
12998,7408,71504,single nucleotide variant,NM_006563.4(KLF1):c.892G>C (p.Ala298Pro),10661,KLF1,HGNC:6345,Pathogenic,1,-,387907598,-,RCV000050236,"MONDO:MONDO:0013355,MedGen:C3150926,OMIM:613673,Orphanet:293825;MedGen:C1292231,OMIM:111150;MedGen:C3150805,OMIM:613566,Orphanet:251380","Congenital dyserythropoietic anemia, type IV;BLOOD GROUP--LUTHERAN INHIBITOR;Fetal hemoglobin quantitative trait locus 6",not provided,not provided,GRCh38,NC_000019.10,19,12885338,12885338,na,na,19p13.13,no assertion criteria provided,1,-,N,"ClinGen:CA144518,UniProtKB:Q13351#VAR_072737",2,56891,12885338,C,G,A298P,0,pathogenic,uncertain,Q13351,Q13351,reviewed,KLF1_HUMAN,"Krueppel-like factor 1 (Erythroid krueppel-like transcription factor, EKLF)",KLF1 EKLF,Homo sapiens (Human),362.0,MATAETALPSISTLTALGPFPDTQDDFLKWWRSEEAQDMGPGPPDPTEPPLHVKSEDQPGEEEDDERGADATWDLDLLLTNFSGPEPGGAPQTCALAPSEASGAQYPPPPETLGAYAGGPGLVAGLLGSEDHSGWVRPALRARAPDAFVGPALAPAPAPEPKALALQPVYPGPGAGSSGGYFPRTGLSVPAASGAPYGLLSGYPAMYPAPQYQGHFQLFRGLQGPAPGPATSPSFLSCLGPGTVGTGLGGTAEDPGVIAETAPSKRGRRSWARKRQAAHTCAHPGCGKSYTKSSHLKAHLRTHTGEKPYACTWEGCGWRFARSDELTRHYRKHTGQRPFRCQLCPRAFSRSDHLALHMKRHL,PF16832;PF16833;PF00096;,2L2I;2MBH;2N23;,298,A,P,True,823
12999,7409,71505,single nucleotide variant,NM_006563.4(KLF1):c.1012C>T (p.Pro338Ser),10661,KLF1,HGNC:6345,Pathogenic,1,-,387907599,-,RCV000050237,"MONDO:MONDO:0013355,MedGen:C3150926,OMIM:613673,Orphanet:293825;MedGen:C1292231,OMIM:111150;MedGen:C3150805,OMIM:613566,Orphanet:251380","Congenital dyserythropoietic anemia, type IV;BLOOD GROUP--LUTHERAN INHIBITOR;Fetal hemoglobin quantitative trait locus 6",not provided,not provided,GRCh38,NC_000019.10,19,12884962,12884962,na,na,19p13.13,no assertion criteria provided,1,-,N,"ClinGen:CA144519,UniProtKB:Q13351#VAR_072738",2,56892,12884962,G,A,P338S,0,pathogenic,uncertain,Q13351,Q13351,reviewed,KLF1_HUMAN,"Krueppel-like factor 1 (Erythroid krueppel-like transcription factor, EKLF)",KLF1 EKLF,Homo sapiens (Human),362.0,MATAETALPSISTLTALGPFPDTQDDFLKWWRSEEAQDMGPGPPDPTEPPLHVKSEDQPGEEEDDERGADATWDLDLLLTNFSGPEPGGAPQTCALAPSEASGAQYPPPPETLGAYAGGPGLVAGLLGSEDHSGWVRPALRARAPDAFVGPALAPAPAPEPKALALQPVYPGPGAGSSGGYFPRTGLSVPAASGAPYGLLSGYPAMYPAPQYQGHFQLFRGLQGPAPGPATSPSFLSCLGPGTVGTGLGGTAEDPGVIAETAPSKRGRRSWARKRQAAHTCAHPGCGKSYTKSSHLKAHLRTHTGEKPYACTWEGCGWRFARSDELTRHYRKHTGQRPFRCQLCPRAFSRSDHLALHMKRHL,PF16832;PF16833;PF00096;,2L2I;2MBH;2N23;,338,P,S,True,823
13000,14097,332672,single nucleotide variant,NM_006563.4(KLF1):c.544T>C (p.Phe182Leu),10661,KLF1,HGNC:6345,Benign,0,12-Jan-18,2072596,-,RCV000320797,"MONDO:MONDO:0013355,MedGen:C3150926,OMIM:613673,Orphanet:293825","Congenital dyserythropoietic anemia, type IV",germline,germline,GRCh38,NC_000019.10,19,12885686,12885686,na,na,19p13.13,"criteria provided, single submitter",1,-,N,"ClinGen:CA9234043,UniProtKB:Q13351#VAR_043982",2,328316,12885686,A,G,F182L,1,benign,benign,Q13351,Q13351,reviewed,KLF1_HUMAN,"Krueppel-like factor 1 (Erythroid krueppel-like transcription factor, EKLF)",KLF1 EKLF,Homo sapiens (Human),362.0,MATAETALPSISTLTALGPFPDTQDDFLKWWRSEEAQDMGPGPPDPTEPPLHVKSEDQPGEEEDDERGADATWDLDLLLTNFSGPEPGGAPQTCALAPSEASGAQYPPPPETLGAYAGGPGLVAGLLGSEDHSGWVRPALRARAPDAFVGPALAPAPAPEPKALALQPVYPGPGAGSSGGYFPRTGLSVPAASGAPYGLLSGYPAMYPAPQYQGHFQLFRGLQGPAPGPATSPSFLSCLGPGTVGTGLGGTAEDPGVIAETAPSKRGRRSWARKRQAAHTCAHPGCGKSYTKSSHLKAHLRTHTGEKPYACTWEGCGWRFARSDELTRHYRKHTGQRPFRCQLCPRAFSRSDHLALHMKRHL,PF16832;PF16833;PF00096;,2L2I;2MBH;2N23;,182,F,L,True,823
13001,9741,106656,single nucleotide variant,NM_006563.4(KLF1):c.1001C>G (p.Thr334Arg),10661,KLF1,HGNC:6345,Likely pathogenic,1,-,483352841,-,RCV000087154,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000019.10,19,12884973,12884973,na,na,19p13.13,no assertion criteria provided,1,-,N,"ClinGen:CA228971,UniProtKB:Q13351#VAR_074275",2,100796,12884973,G,C,T334R,0,pathogenic,uncertain,Q13351,Q13351,reviewed,KLF1_HUMAN,"Krueppel-like factor 1 (Erythroid krueppel-like transcription factor, EKLF)",KLF1 EKLF,Homo sapiens (Human),362.0,MATAETALPSISTLTALGPFPDTQDDFLKWWRSEEAQDMGPGPPDPTEPPLHVKSEDQPGEEEDDERGADATWDLDLLLTNFSGPEPGGAPQTCALAPSEASGAQYPPPPETLGAYAGGPGLVAGLLGSEDHSGWVRPALRARAPDAFVGPALAPAPAPEPKALALQPVYPGPGAGSSGGYFPRTGLSVPAASGAPYGLLSGYPAMYPAPQYQGHFQLFRGLQGPAPGPATSPSFLSCLGPGTVGTGLGGTAEDPGVIAETAPSKRGRRSWARKRQAAHTCAHPGCGKSYTKSSHLKAHLRTHTGEKPYACTWEGCGWRFARSDELTRHYRKHTGQRPFRCQLCPRAFSRSDHLALHMKRHL,PF16832;PF16833;PF00096;,2L2I;2MBH;2N23;,334,T,R,True,823
13002,2096,24041,single nucleotide variant,NM_006563.4(KLF1):c.895C>T (p.His299Tyr),10661,KLF1,HGNC:6345,Pathogenic,1,1-Sep-08,137852688,-,RCV000009565,"MedGen:C1292231,OMIM:111150",BLOOD GROUP--LUTHERAN INHIBITOR,germline,germline,GRCh38,NC_000019.10,19,12885335,12885335,na,na,19p13.13,no assertion criteria provided,1,-,N,"ClinGen:CA120050,UniProtKB:Q13351#VAR_058108,OMIM:600599.0004",1,9002,12885335,G,A,H299Y,0,pathogenic,uncertain,Q13351,Q13351,reviewed,KLF1_HUMAN,"Krueppel-like factor 1 (Erythroid krueppel-like transcription factor, EKLF)",KLF1 EKLF,Homo sapiens (Human),362.0,MATAETALPSISTLTALGPFPDTQDDFLKWWRSEEAQDMGPGPPDPTEPPLHVKSEDQPGEEEDDERGADATWDLDLLLTNFSGPEPGGAPQTCALAPSEASGAQYPPPPETLGAYAGGPGLVAGLLGSEDHSGWVRPALRARAPDAFVGPALAPAPAPEPKALALQPVYPGPGAGSSGGYFPRTGLSVPAASGAPYGLLSGYPAMYPAPQYQGHFQLFRGLQGPAPGPATSPSFLSCLGPGTVGTGLGGTAEDPGVIAETAPSKRGRRSWARKRQAAHTCAHPGCGKSYTKSSHLKAHLRTHTGEKPYACTWEGCGWRFARSDELTRHYRKHTGQRPFRCQLCPRAFSRSDHLALHMKRHL,PF16832;PF16833;PF00096;,2L2I;2MBH;2N23;,299,H,Y,True,823
13003,9742,106657,single nucleotide variant,NM_006563.4(KLF1):c.1022G>A (p.Cys341Tyr),10661,KLF1,HGNC:6345,Likely pathogenic,1,-,483352839,-,RCV000087155,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000019.10,19,12884952,12884952,na,na,19p13.13,no assertion criteria provided,1,-,N,"UniProtKB:Q13351#VAR_074276,ClinGen:CA228973",2,100797,12884952,C,T,C341Y,0,pathogenic,uncertain,Q13351,Q13351,reviewed,KLF1_HUMAN,"Krueppel-like factor 1 (Erythroid krueppel-like transcription factor, EKLF)",KLF1 EKLF,Homo sapiens (Human),362.0,MATAETALPSISTLTALGPFPDTQDDFLKWWRSEEAQDMGPGPPDPTEPPLHVKSEDQPGEEEDDERGADATWDLDLLLTNFSGPEPGGAPQTCALAPSEASGAQYPPPPETLGAYAGGPGLVAGLLGSEDHSGWVRPALRARAPDAFVGPALAPAPAPEPKALALQPVYPGPGAGSSGGYFPRTGLSVPAASGAPYGLLSGYPAMYPAPQYQGHFQLFRGLQGPAPGPATSPSFLSCLGPGTVGTGLGGTAEDPGVIAETAPSKRGRRSWARKRQAAHTCAHPGCGKSYTKSSHLKAHLRTHTGEKPYACTWEGCGWRFARSDELTRHYRKHTGQRPFRCQLCPRAFSRSDHLALHMKRHL,PF16832;PF16833;PF00096;,2L2I;2MBH;2N23;,341,C,Y,True,823
13004,9744,106660,single nucleotide variant,NM_006563.4(KLF1):c.895C>G (p.His299Asp),10661,KLF1,HGNC:6345,Likely pathogenic,1,-,137852688,-,RCV000087158,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000019.10,19,12885335,12885335,na,na,19p13.13,no assertion criteria provided,1,-,N,"ClinGen:CA228978,UniProtKB:Q13351#VAR_074273",2,100800,12885335,G,C,H299D,0,pathogenic,uncertain,Q13351,Q13351,reviewed,KLF1_HUMAN,"Krueppel-like factor 1 (Erythroid krueppel-like transcription factor, EKLF)",KLF1 EKLF,Homo sapiens (Human),362.0,MATAETALPSISTLTALGPFPDTQDDFLKWWRSEEAQDMGPGPPDPTEPPLHVKSEDQPGEEEDDERGADATWDLDLLLTNFSGPEPGGAPQTCALAPSEASGAQYPPPPETLGAYAGGPGLVAGLLGSEDHSGWVRPALRARAPDAFVGPALAPAPAPEPKALALQPVYPGPGAGSSGGYFPRTGLSVPAASGAPYGLLSGYPAMYPAPQYQGHFQLFRGLQGPAPGPATSPSFLSCLGPGTVGTGLGGTAEDPGVIAETAPSKRGRRSWARKRQAAHTCAHPGCGKSYTKSSHLKAHLRTHTGEKPYACTWEGCGWRFARSDELTRHYRKHTGQRPFRCQLCPRAFSRSDHLALHMKRHL,PF16832;PF16833;PF00096;,2L2I;2MBH;2N23;,299,H,D,True,823
13005,9743,106658,single nucleotide variant,NM_006563.4(KLF1):c.13G>A (p.Glu5Lys),10661,KLF1,HGNC:6345,Benign,0,28-May-19,483352842,-,RCV000087156|RCV000990156,"MedGen:CN517202|MedGen:C1292231,OMIM:111150",not provided|BLOOD GROUP--LUTHERAN INHIBITOR,unknown,unknown,GRCh38,NC_000019.10,19,12887128,12887128,na,na,19p13.13,"criteria provided, single submitter",2,-,N,"ClinGen:CA228975,UniProtKB:Q13351#VAR_074272",2,100798,12887128,C,T,E5K,1,benign,benign,Q13351,Q13351,reviewed,KLF1_HUMAN,"Krueppel-like factor 1 (Erythroid krueppel-like transcription factor, EKLF)",KLF1 EKLF,Homo sapiens (Human),362.0,MATAETALPSISTLTALGPFPDTQDDFLKWWRSEEAQDMGPGPPDPTEPPLHVKSEDQPGEEEDDERGADATWDLDLLLTNFSGPEPGGAPQTCALAPSEASGAQYPPPPETLGAYAGGPGLVAGLLGSEDHSGWVRPALRARAPDAFVGPALAPAPAPEPKALALQPVYPGPGAGSSGGYFPRTGLSVPAASGAPYGLLSGYPAMYPAPQYQGHFQLFRGLQGPAPGPATSPSFLSCLGPGTVGTGLGGTAEDPGVIAETAPSKRGRRSWARKRQAAHTCAHPGCGKSYTKSSHLKAHLRTHTGEKPYACTWEGCGWRFARSDELTRHYRKHTGQRPFRCQLCPRAFSRSDHLALHMKRHL,PF16832;PF16833;PF00096;,2L2I;2MBH;2N23;,5,E,K,True,823
13006,13411,256779,single nucleotide variant,NM_006563.5(KLF1):c.304T>C (p.Ser102Pro),10661,KLF1,HGNC:6345,Benign,0,13-Jan-18,2072597,-,RCV000251710|RCV000350669,"MedGen:CN169374|MONDO:MONDO:0013355,MedGen:C3150926,OMIM:613673,Orphanet:293825","not specified|Congenital dyserythropoietic anemia, type IV",germline,germline,GRCh38,NC_000019.10,19,12885926,12885926,na,na,19p13.13,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA9234065,UniProtKB:Q13351#VAR_043981",2,260001,12885926,A,G,S102P,2,benign,benign,Q13351,Q13351,reviewed,KLF1_HUMAN,"Krueppel-like factor 1 (Erythroid krueppel-like transcription factor, EKLF)",KLF1 EKLF,Homo sapiens (Human),362.0,MATAETALPSISTLTALGPFPDTQDDFLKWWRSEEAQDMGPGPPDPTEPPLHVKSEDQPGEEEDDERGADATWDLDLLLTNFSGPEPGGAPQTCALAPSEASGAQYPPPPETLGAYAGGPGLVAGLLGSEDHSGWVRPALRARAPDAFVGPALAPAPAPEPKALALQPVYPGPGAGSSGGYFPRTGLSVPAASGAPYGLLSGYPAMYPAPQYQGHFQLFRGLQGPAPGPATSPSFLSCLGPGTVGTGLGGTAEDPGVIAETAPSKRGRRSWARKRQAAHTCAHPGCGKSYTKSSHLKAHLRTHTGEKPYACTWEGCGWRFARSDELTRHYRKHTGQRPFRCQLCPRAFSRSDHLALHMKRHL,PF16832;PF16833;PF00096;,2L2I;2MBH;2N23;,102,S,P,True,823
13007,5764,38559,single nucleotide variant,NM_006721.4(ADK):c.89G>A (p.Gly30Glu),132,ADK,HGNC:257,Pathogenic,1,7-Oct-11,397514454,-,RCV000022445,"MONDO:MONDO:0013676,MedGen:C4706555,OMIM:614300,Orphanet:289290,Orphanet:88616",Hypermethioninemia due to adenosine kinase deficiency,germline,germline,GRCh38,NC_000010.11,10,74200787,74200787,na,na,10q22.2,no assertion criteria provided,1,-,N,"ClinGen:CA249480,UniProtKB:P55263#VAR_066640,OMIM:102750.0003",1,29605,74200787,G,A,G30E,0,pathogenic,uncertain,P55263,P55263,reviewed,ADK_HUMAN,"Adenosine kinase, AK, EC 2.7.1.20 (Adenosine 5'-phosphotransferase)",ADK,Homo sapiens (Human),362.0,MAAAEEEPKPKKLKVEAPQALRENILFGMGNPLLDISAVVDKDFLDKYSLKPNDQILAEDKHKELFDELVKKFKVEYHAGGSTQNSIKVAQWMIQQPHKAATFFGCIGIDKFGEILKRKAAEAHVDAHYYEQNEQPTGTCAACITGDNRSLIANLAAANCYKKEKHLDLEKNWMLVEKARVCYIAGFFLTVSPESVLKVAHHASENNRIFTLNLSAPFISQFYKESLMKVMPYVDILFGNETEAATFAREQGFETKDIKEIAKKTQALPKMNSKRQRIVIFTQGRDDTIMATESEVTAFAVLDQDQKEIIDTNGAGDAFVGGFLSQLVSDKPLTECIRAGHYAASIIIRRTGCTFPEKPDFH,PF00294;,1BX4;2I6A;2I6B;4O1L;,30,G,E,True,824
13008,5763,38558,single nucleotide variant,NM_006721.4(ADK):c.704A>C (p.Asp235Ala),132,ADK,HGNC:257,Pathogenic,1,7-Oct-11,397514453,-,RCV000022444,"MONDO:MONDO:0013676,MedGen:C4706555,OMIM:614300,Orphanet:289290,Orphanet:88616",Hypermethioninemia due to adenosine kinase deficiency,germline,germline,GRCh38,NC_000010.11,10,74525404,74525404,na,na,10q22.2,no assertion criteria provided,1,-,N,"ClinGen:CA249478,UniProtKB:P55263#VAR_066641,OMIM:102750.0002",1,29604,74525404,A,C,D235A,0,pathogenic,uncertain,P55263,P55263,reviewed,ADK_HUMAN,"Adenosine kinase, AK, EC 2.7.1.20 (Adenosine 5'-phosphotransferase)",ADK,Homo sapiens (Human),362.0,MAAAEEEPKPKKLKVEAPQALRENILFGMGNPLLDISAVVDKDFLDKYSLKPNDQILAEDKHKELFDELVKKFKVEYHAGGSTQNSIKVAQWMIQQPHKAATFFGCIGIDKFGEILKRKAAEAHVDAHYYEQNEQPTGTCAACITGDNRSLIANLAAANCYKKEKHLDLEKNWMLVEKARVCYIAGFFLTVSPESVLKVAHHASENNRIFTLNLSAPFISQFYKESLMKVMPYVDILFGNETEAATFAREQGFETKDIKEIAKKTQALPKMNSKRQRIVIFTQGRDDTIMATESEVTAFAVLDQDQKEIIDTNGAGDAFVGGFLSQLVSDKPLTECIRAGHYAASIIIRRTGCTFPEKPDFH,PF00294;,1BX4;2I6A;2I6B;4O1L;,235,D,A,True,824
13009,5762,38557,single nucleotide variant,NM_006721.4(ADK):c.953C>A (p.Ala318Glu),132,ADK,HGNC:257,Pathogenic,1,28-Apr-17,397514452,-,RCV000022443,"MONDO:MONDO:0013676,MedGen:C4706555,OMIM:614300,Orphanet:289290,Orphanet:88616",Hypermethioninemia due to adenosine kinase deficiency,biparental;germline,germline,GRCh38,NC_000010.11,10,74670258,74670258,na,na,10q22.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA249476,UniProtKB:P55263#VAR_066642,OMIM:102750.0001",3,29603,74670258,C,A,A318E,1,pathogenic,pathogenic,P55263,P55263,reviewed,ADK_HUMAN,"Adenosine kinase, AK, EC 2.7.1.20 (Adenosine 5'-phosphotransferase)",ADK,Homo sapiens (Human),362.0,MAAAEEEPKPKKLKVEAPQALRENILFGMGNPLLDISAVVDKDFLDKYSLKPNDQILAEDKHKELFDELVKKFKVEYHAGGSTQNSIKVAQWMIQQPHKAATFFGCIGIDKFGEILKRKAAEAHVDAHYYEQNEQPTGTCAACITGDNRSLIANLAAANCYKKEKHLDLEKNWMLVEKARVCYIAGFFLTVSPESVLKVAHHASENNRIFTLNLSAPFISQFYKESLMKVMPYVDILFGNETEAATFAREQGFETKDIKEIAKKTQALPKMNSKRQRIVIFTQGRDDTIMATESEVTAFAVLDQDQKEIIDTNGAGDAFVGGFLSQLVSDKPLTECIRAGHYAASIIIRRTGCTFPEKPDFH,PF00294;,1BX4;2I6A;2I6B;4O1L;,318,A,E,True,824
13010,10172,133960,single nucleotide variant,NM_004993.6(ATXN3):c.634G>A (p.Val212Met),4287,ATXN3,HGNC:7106,Likely benign,0,-,1048755,-,RCV000116481,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000014.9,14,92082441,92082441,na,na,14q32.12,no assertion criteria provided,1,-,N,"ClinGen:CA152005,UniProtKB:P54252#VAR_013688",2,128511,92082441,C,T,V212M,0,benign,uncertain,P54252,P54252,reviewed,ATX3_HUMAN,"Ataxin-3, EC 3.4.19.12 (Machado-Joseph disease protein 1) (Spinocerebellar ataxia type 3 protein)",ATXN3 ATX3 MJD MJD1 SCA3,Homo sapiens (Human),361.0,MESIFHEKQEGSLCAQHCLNNLLQGEYFSPVELSSIAHQLDEEERMRMAEGGVTSEDYRTFLQQPSGNMDDSGFFSIQVISNALKVWGLELILFNSPEYQRLRIDPINERSFICNYKEHWFTVRKLGKQWFNLNSLLTGPELISDTYLALFLAQLQQEGYSIFVVKGDLPDCEADQLLQMIRVQQMHRPKLIGEELAQLKEQRVHKTDLERVLEANDGSGMLDEDEEDLQRALALSRQEIDMEDEEADLRRAIQLSMQGSSRNISQDMTQTSGTNLTSEELRKRREAYFEKQQQKQQQQQQQQQQGDLSGQSSHPCERPATSSGALGSDLGDAMSEEDMLQAAVTMSLETVRNDLKTEGKK,PF02099;PF02809;,1YZB;2AGA;2DOS;2JRI;2KLZ;4WTH;4YS9;,212,V,M,True,825
13011,356,16508,single nucleotide variant,NM_000190.4(HMBS):c.739T>C (p.Cys247Arg),3145,HMBS,HGNC:4982,Pathogenic,1,1-Dec-93,118204111,-,RCV000001534,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092491,119092491,na,na,11q23.3,no assertion criteria provided,1,-,N,"UniProtKB:P08397#VAR_003664,OMIM:609806.0029,ClinGen:CA251828",1,1469,119092491,T,C,C247R,0,pathogenic,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,247,C,R,True,826
13012,355,16506,single nucleotide variant,NM_000190.4(HMBS):c.667G>A (p.Glu223Lys),3145,HMBS,HGNC:4982,Conflicting interpretations of pathogenicity,1,8-Aug-19,118204110,-,RCV000001532|RCV001209137,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:CN517202",Acute intermittent porphyria|not provided,germline;unknown,germline,GRCh38,NC_000011.10,11,119092419,119092419,na,na,11q23.3,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA251826,UniProtKB:P08397#VAR_003659,OMIM:609806.0027",3,1467,119092419,G,A,E223K,1,uncertain,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,223,E,K,True,826
13013,354,16505,single nucleotide variant,NM_000190.4(HMBS):c.530T>G (p.Leu177Arg),3145,HMBS,HGNC:4982,Pathogenic,1,28-Nov-18,118204108,-,RCV000001531|RCV000795368,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:CN517202",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119091444,119091444,na,na,11q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA251824,UniProtKB:P08397#VAR_003655,OMIM:609806.0025",3,1466,119091444,T,G,L177R,1,pathogenic,pathogenic,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,177,L,R,True,826
13014,353,16503,single nucleotide variant,NM_000190.4(HMBS):c.331G>A (p.Gly111Arg),3145,HMBS,HGNC:4982,Pathogenic,1,1-Jan-94,118204107,-,RCV000001529,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119089747,119089747,na,na,11q23.3,no assertion criteria provided,1,-,N,"OMIM:609806.0023,ClinGen:CA251822,UniProtKB:P08397#VAR_003645",1,1464,119089747,G,A,G111R,0,pathogenic,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,111,G,R,True,826
13015,348,16493,single nucleotide variant,NM_000190.4(HMBS):c.91G>A (p.Ala31Thr),3145,HMBS,HGNC:4982,Pathogenic,1,1-Jan-94,118204104,-,RCV000001519,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119088638,119088638,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA251809,UniProtKB:P08397#VAR_003640,OMIM:609806.0016",1,1454,119088638,G,A,A31T,0,pathogenic,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,31,A,T,True,826
13016,347,16489,single nucleotide variant,NM_000190.4(HMBS):c.734T>G (p.Leu245Arg),3145,HMBS,HGNC:4982,Pathogenic,1,8-Oct-99,118204099,-,RCV000001515,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092486,119092486,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA251804,UniProtKB:P08397#VAR_003662,OMIM:609806.0009",1,1450,119092486,T,G,L245R,0,pathogenic,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,245,L,R,True,826
13017,351,16497,single nucleotide variant,NM_000190.4(HMBS):c.163G>T (p.Ala55Ser),3145,HMBS,HGNC:4982,Pathogenic,1,1-Jan-94,118204106,-,RCV000001523,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119089084,119089084,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA251818,UniProtKB:P08397#VAR_003642,OMIM:609806.0018",1,1458,119089084,G,T,A55S,0,pathogenic,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,55,A,S,True,826
13018,357,16510,single nucleotide variant,NM_000190.4(HMBS):c.748G>A (p.Glu250Lys),3145,HMBS,HGNC:4982,Pathogenic,1,1-Jan-94,118204112,-,RCV000001536,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092500,119092500,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA251830,UniProtKB:P08397#VAR_003666,OMIM:609806.0031",1,1471,119092500,G,A,E250K,0,pathogenic,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,250,E,K,True,826
13019,350,16495,single nucleotide variant,NM_000190.4(HMBS):c.499C>T (p.Arg167Trp),3145,HMBS,HGNC:4982,Pathogenic,1,28-Nov-18,118204101,-,RCV000001521|RCV000489906,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:CN517202",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119091413,119091413,na,na,11q23.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA251813,UniProtKB:P08397#VAR_003652,OMIM:609806.0013",3,1456,119091413,C,T,R167W,2,pathogenic,pathogenic,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,167,R,W,True,826
13020,349,16494,single nucleotide variant,NM_000190.4(HMBS):c.100C>A (p.Gln34Lys),3145,HMBS,HGNC:4982,Pathogenic,1,1-Sep-92,118204105,-,RCV000001520,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119088647,119088647,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA251811,UniProtKB:P08397#VAR_003641,OMIM:609806.0017",1,1455,119088647,C,A,Q34K,0,pathogenic,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,34,Q,K,True,826
13021,352,16501,single nucleotide variant,NM_000190.4(HMBS):c.601C>T (p.Arg201Trp),3145,HMBS,HGNC:4982,Pathogenic/Likely pathogenic,1,26-Dec-18,118204109,-,RCV000001527|RCV000432186,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:CN517202",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119091515,119091515,na,na,11q23.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA251820,UniProtKB:P08397#VAR_003657,OMIM:609806.0026",3,1462,119091515,C,T,R201W,2,pathogenic,pathogenic,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,201,R,W,True,826
13022,358,16511,single nucleotide variant,NM_000190.4(HMBS):c.754G>A (p.Ala252Thr),3145,HMBS,HGNC:4982,Uncertain significance,1,27-Apr-17,118204113,-,RCV000001537,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092506,119092506,na,na,11q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA251832,UniProtKB:P08397#VAR_003667,OMIM:609806.0032",3,1472,119092506,G,A,A252T,1,uncertain,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,252,A,T,True,826
13023,11139,171130,single nucleotide variant,NM_000190.4(HMBS):c.674G>A (p.Arg225Gln),3145,HMBS,HGNC:4982,Uncertain significance,0,21-Jun-17,142459647,-,RCV000148511|RCV000498317,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:CN517202",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119092426,119092426,na,na,11q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA272881,UniProtKB:P08397#VAR_025574",2,161253,119092426,G,A,R225Q,1,uncertain,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,225,R,Q,True,826
13024,345,16486,single nucleotide variant,NM_000190.4(HMBS):c.518G>A (p.Arg173Gln),3145,HMBS,HGNC:4982,Pathogenic,1,1-Jan-92,118204096,-,RCV000001512,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119091432,119091432,na,na,11q23.3,no assertion criteria provided,1,-,N,"UniProtKB:P08397#VAR_003653,OMIM:609806.0006,ClinGen:CA251797",1,1447,119091432,G,A,R173Q,0,pathogenic,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,173,R,Q,True,826
13025,342,16482,single nucleotide variant,NM_000190.4(HMBS):c.77G>A (p.Arg26His),3145,HMBS,HGNC:4982,Pathogenic,1,5-Jun-19,118204103,-,RCV000001508|RCV000798844,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:CN517202",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119088298,119088298,na,na,11q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA251791,UniProtKB:P08397#VAR_003639,OMIM:609806.0015",3,1443,119088298,G,A,R26H,1,pathogenic,pathogenic,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,26,R,H,True,826
13026,359,16512,single nucleotide variant,NM_000190.4(HMBS):c.755C>T (p.Ala252Val),3145,HMBS,HGNC:4982,Pathogenic,1,1-Dec-93,118204114,-,RCV000001538,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092507,119092507,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA251834,UniProtKB:P08397#VAR_003668,OMIM:609806.0033",1,1473,119092507,C,T,A252V,0,pathogenic,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,252,A,V,True,826
13027,11137,171128,single nucleotide variant,NM_000190.4(HMBS):c.257A>T (p.Glu86Val),3145,HMBS,HGNC:4982,Likely benign,0,8-Oct-19,150763621,-,RCV000148510,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119089263,119089263,na,na,11q23.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA272879,UniProtKB:P08397#VAR_025564",2,161252,119089263,A,T,E86V,2,benign,benign,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,86,E,V,True,826
13028,343,16484,single nucleotide variant,NM_000190.4(HMBS):c.346C>T (p.Arg116Trp),3145,HMBS,HGNC:4982,Pathogenic,1,24-Jul-19,118204094,-,RCV000001510|RCV001212053,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:CN517202",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119089991,119089991,na,na,11q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA251793,UniProtKB:P08397#VAR_003647,OMIM:609806.0004",3,1445,119089991,C,T,R116W,1,pathogenic,pathogenic,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,116,R,W,True,826
13029,344,16485,single nucleotide variant,NM_000190.4(HMBS):c.500G>A (p.Arg167Gln),3145,HMBS,HGNC:4982,Pathogenic/Likely pathogenic,1,26-Mar-19,118204095,-,RCV000001511|RCV000520560,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:CN517202",Acute intermittent porphyria|not provided,germline;not applicable,germline,GRCh38,NC_000011.10,11,119091414,119091414,na,na,11q23.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA251795,UniProtKB:P08397#VAR_003651,OMIM:609806.0005",3,1446,119091414,G,A,R167Q,2,pathogenic,pathogenic,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,167,R,Q,True,826
13030,11138,171129,single nucleotide variant,NM_000190.4(HMBS):c.583C>T (p.Arg195Cys),3145,HMBS,HGNC:4982,Pathogenic,1,29-Oct-19,34413634,-,RCV000148509|RCV001041963,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:CN517202",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119091497,119091497,na,na,11q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA272877,UniProtKB:P08397#VAR_003656",2,161251,119091497,C,T,R195C,1,pathogenic,pathogenic,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,195,R,C,True,826
13031,346,16488,single nucleotide variant,NM_000190.4(HMBS):c.446G>A (p.Arg149Gln),3145,HMBS,HGNC:4982,Pathogenic,1,8-Oct-99,118204098,-,RCV000001514,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119090213,119090213,na,na,11q23.3,no assertion criteria provided,1,-,N,"OMIM:609806.0008,ClinGen:CA251802,UniProtKB:P08397#VAR_003650",1,1449,119090213,G,A,R149Q,0,pathogenic,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,149,R,Q,True,826
13032,362,16524,single nucleotide variant,NM_000190.4(HMBS):c.242T>C (p.Leu81Pro),3145,HMBS,HGNC:4982,Pathogenic,1,1-Jan-04,118204119,-,RCV000001550,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119089248,119089248,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA251843,UniProtKB:P08397#VAR_025563,OMIM:609806.0045",1,1485,119089248,T,C,L81P,0,pathogenic,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,81,L,P,True,826
13033,361,16517,single nucleotide variant,NM_000190.4(HMBS):c.647G>A (p.Gly216Asp),3145,HMBS,HGNC:4982,Pathogenic,1,1-Jul-97,118204116,-,RCV000001543,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092159,119092159,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA251838,UniProtKB:P08397#VAR_011015,OMIM:609806.0038",1,1478,119092159,G,A,G216D,0,pathogenic,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,216,G,D,True,826
13034,360,16513,single nucleotide variant,NM_000190.4(HMBS):c.766C>A (p.His256Asn),3145,HMBS,HGNC:4982,Pathogenic,1,1-Dec-93,118204115,-,RCV000001539,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092518,119092518,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA251836,UniProtKB:P08397#VAR_003669,OMIM:609806.0034",1,1474,119092518,C,A,H256N,0,pathogenic,uncertain,P08397,P08397,reviewed,HEM3_HUMAN,"Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)",HMBS PBGD UPS,Homo sapiens (Human),361.0,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,PF01379;PF03900;,3ECR;3EQ1;5M6R;5M7F;7AAJ;7AAK;7CCX;7CCY;7CCZ;7CD0;,256,H,N,True,826
13035,1119,19792,single nucleotide variant,NM_020191.3(MRPS22):c.509G>A (p.Arg170His),56945,MRPS22,HGNC:14508,Pathogenic,1,29-Oct-18,119478059,-,RCV000005019|RCV000799575,"MONDO:MONDO:0012718,MedGen:C2673642,OMIM:611719,Orphanet:137908|MedGen:CN517202",Combined oxidative phosphorylation deficiency 5|not provided,germline,germline,GRCh38,NC_000003.12,3,139350183,139350183,na,na,3q23,"criteria provided, single submitter",2,-,N,"ClinGen:CA117061,UniProtKB:P82650#VAR_042733,OMIM:605810.0001",3,4753,139350183,G,A,R170H,1,pathogenic,pathogenic,P82650,P82650,reviewed,RT22_HUMAN,"28S ribosomal protein S22, mitochondrial, MRP-S22, S22mt (Mitochondrial small ribosomal subunit protein mS22)",MRPS22 C3orf5 RPMS22 GK002,Homo sapiens (Human),360.0,MAPLGTTVLLWSLLRSSPGVERVCFRARIQPWHGGLLQPLPCSFEMGLPRRRFSSEAAESGSPETKKPTFMDEEVQSILTKMTGLNLQKTFKPAIQELKPPTYKLMTQAQLEEATRQAVEAAKVRLKMPPVLEERVPINDVLAEDKILEGTETTKYVFTDISYSIPHRERFIVVREPSGTLRKASWEERDRMIQVYFPKEGRKILTPIIFKEENLRTMYSQDRHVDVLNLCFAQFEPDSTEYIKVHHKTYEDIDKRGKYDLLRSTRYFGGMVWYFVNNKKIDGLLIDQIQRDLIDDATNLVQLYHVLHPDGQSAQGAKDQAAEGINLIKVFAKTEAQKGAYIELTLQTYQEALSRHSAAS,PF10245;,3J9M;6NU2;6NU3;6RW4;6RW5;6VLZ;6VMI;6ZM5;6ZM6;6ZS9;6ZSA;6ZSB;6ZSC;6ZSD;6ZSE;6ZSG;7A5F;7A5G;7A5I;7A5K;7L08;7OG4;,170,R,H,True,827
13036,12761,236885,single nucleotide variant,NM_018946.4(NANS):c.452G>A (p.Arg151His),54187,NANS,HGNC:19237,Pathogenic,1,20-Jun-17,140402727,-,RCV000224301,"MONDO:MONDO:0012495,MedGen:C1864872,OMIM:610442,Orphanet:168454","Spondyloepimetaphyseal dysplasia, Genevieve type",germline,germline,GRCh38,NC_000009.12,9,98078196,98078196,na,na,9q22.33,no assertion criteria provided,1,-,N,"ClinGen:CA10581237,UniProtKB:Q9NR45#VAR_076573,OMIM:605202.0004",1,235187,98078196,G,A,R151H,0,pathogenic,uncertain,Q9NR45,Q9NR45,reviewed,SIAS_HUMAN,"Sialic acid synthase (N-acetylneuraminate synthase, EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase, EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase)",NANS SAS,Homo sapiens (Human),359.0,MPLELELCPGRWVGGQHPCFIIAEIGQNHQGDLDVAKRMIRMAKECGADCAKFQKSELEFKFNRKALERPYTSKHSWGKTYGEHKRHLEFSHDQYRELQRYAEEVGIFFTASGMDEMAVEFLHELNVPFFKVGSGDTNNFPYLEKTAKKGRPMVISSGMQSMDTMKQVYQIVKPLNPNFCFLQCTSAYPLQPEDVNLRVISEYQKLFPDIPIGYSGHETGIAISVAAVALGAKVLERHITLDKTWKGSDHSASLEPGELAELVRSVRLVERALGSPTKQLLPCEMACNEKLGKSVVAKVKIPEGTILTMDMLTVKVGEPKGYPPEDIFNLVGKKVLVTVEEDDTIMEELVDNHGKKIKS,PF03102;,1WVO;,151,R,H,True,828
13037,12764,236889,single nucleotide variant,NM_018946.4(NANS):c.709C>T (p.Arg237Cys),54187,NANS,HGNC:19237,Pathogenic,1,20-Jun-17,878852982,-,RCV000224653,"MONDO:MONDO:0012495,MedGen:C1864872,OMIM:610442,Orphanet:168454","Spondyloepimetaphyseal dysplasia, Genevieve type",germline,germline,GRCh38,NC_000009.12,9,98080921,98080921,na,na,9q22.33,no assertion criteria provided,1,-,N,"ClinGen:CA10581241,UniProtKB:Q9NR45#VAR_076576,OMIM:605202.0008",1,235191,98080921,C,T,R237C,0,pathogenic,uncertain,Q9NR45,Q9NR45,reviewed,SIAS_HUMAN,"Sialic acid synthase (N-acetylneuraminate synthase, EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase, EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase)",NANS SAS,Homo sapiens (Human),359.0,MPLELELCPGRWVGGQHPCFIIAEIGQNHQGDLDVAKRMIRMAKECGADCAKFQKSELEFKFNRKALERPYTSKHSWGKTYGEHKRHLEFSHDQYRELQRYAEEVGIFFTASGMDEMAVEFLHELNVPFFKVGSGDTNNFPYLEKTAKKGRPMVISSGMQSMDTMKQVYQIVKPLNPNFCFLQCTSAYPLQPEDVNLRVISEYQKLFPDIPIGYSGHETGIAISVAAVALGAKVLERHITLDKTWKGSDHSASLEPGELAELVRSVRLVERALGSPTKQLLPCEMACNEKLGKSVVAKVKIPEGTILTMDMLTVKVGEPKGYPPEDIFNLVGKKVLVTVEEDDTIMEELVDNHGKKIKS,PF03102;,1WVO;,237,R,C,True,828
13038,12763,236888,single nucleotide variant,NM_018946.4(NANS):c.562T>C (p.Tyr188His),54187,NANS,HGNC:19237,Pathogenic,1,20-Jun-17,878852981,-,RCV000224249,"MONDO:MONDO:0012495,MedGen:C1864872,OMIM:610442,Orphanet:168454","Spondyloepimetaphyseal dysplasia, Genevieve type",germline,germline,GRCh38,NC_000009.12,9,98078306,98078306,na,na,9q22.33,no assertion criteria provided,1,-,N,"ClinGen:CA10581240,UniProtKB:Q9NR45#VAR_076574,OMIM:605202.0007",1,235190,98078306,T,C,Y188H,0,pathogenic,uncertain,Q9NR45,Q9NR45,reviewed,SIAS_HUMAN,"Sialic acid synthase (N-acetylneuraminate synthase, EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase, EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase)",NANS SAS,Homo sapiens (Human),359.0,MPLELELCPGRWVGGQHPCFIIAEIGQNHQGDLDVAKRMIRMAKECGADCAKFQKSELEFKFNRKALERPYTSKHSWGKTYGEHKRHLEFSHDQYRELQRYAEEVGIFFTASGMDEMAVEFLHELNVPFFKVGSGDTNNFPYLEKTAKKGRPMVISSGMQSMDTMKQVYQIVKPLNPNFCFLQCTSAYPLQPEDVNLRVISEYQKLFPDIPIGYSGHETGIAISVAAVALGAKVLERHITLDKTWKGSDHSASLEPGELAELVRSVRLVERALGSPTKQLLPCEMACNEKLGKSVVAKVKIPEGTILTMDMLTVKVGEPKGYPPEDIFNLVGKKVLVTVEEDDTIMEELVDNHGKKIKS,PF03102;,1WVO;,188,Y,H,True,828
13039,12762,236886,single nucleotide variant,NM_018946.4(NANS):c.398G>T (p.Gly133Val),54187,NANS,HGNC:19237,Pathogenic,1,20-Jun-17,878852980,-,RCV000224713,"MONDO:MONDO:0012495,MedGen:C1864872,OMIM:610442,Orphanet:168454","Spondyloepimetaphyseal dysplasia, Genevieve type",germline,germline,GRCh38,NC_000009.12,9,98076967,98076967,na,na,9q22.33,no assertion criteria provided,1,-,N,"ClinGen:CA10581238,UniProtKB:Q9NR45#VAR_076572,OMIM:605202.0005",1,235188,98076967,G,T,G133V,0,pathogenic,uncertain,Q9NR45,Q9NR45,reviewed,SIAS_HUMAN,"Sialic acid synthase (N-acetylneuraminate synthase, EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase, EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase)",NANS SAS,Homo sapiens (Human),359.0,MPLELELCPGRWVGGQHPCFIIAEIGQNHQGDLDVAKRMIRMAKECGADCAKFQKSELEFKFNRKALERPYTSKHSWGKTYGEHKRHLEFSHDQYRELQRYAEEVGIFFTASGMDEMAVEFLHELNVPFFKVGSGDTNNFPYLEKTAKKGRPMVISSGMQSMDTMKQVYQIVKPLNPNFCFLQCTSAYPLQPEDVNLRVISEYQKLFPDIPIGYSGHETGIAISVAAVALGAKVLERHITLDKTWKGSDHSASLEPGELAELVRSVRLVERALGSPTKQLLPCEMACNEKLGKSVVAKVKIPEGTILTMDMLTVKVGEPKGYPPEDIFNLVGKKVLVTVEEDDTIMEELVDNHGKKIKS,PF03102;,1WVO;,133,G,V,True,828
13040,6243,45785,single nucleotide variant,NM_144605.5(SEPTIN12):c.589G>A (p.Asp197Asn),124404,SEPTIN12,HGNC:26348,risk factor,0,1-Apr-12,371195126,-,RCV000030757,"MONDO:MONDO:0013901,MedGen:C3553793,OMIM:614822,Orphanet:276234",Spermatogenic failure 10,germline,germline,GRCh38,NC_000016.10,16,4783690,4783690,na,na,16p13.3,no assertion criteria provided,2,-,N,"UniProtKB:Q8IYM1#VAR_068098,OMIM:611562.0003,ClinGen:CA130083",3,37115,4783690,C,T,D197N,0,uncertain,uncertain,Q8IYM1,Q8IYM1,reviewed,SEP12_HUMAN,Septin-12,SEPTIN12 SEPT12,Homo sapiens (Human),358.0,MDPLRRSPSPCLSSQPSSPSTPPCEMLGPVGIEAVLDQLKIKAMKMGFEFNIMVVGQSGLGKSTMVNTLFKSKVWKSNPPGLGVPTPQTLQLHSLTHVIEEKGVKLKLTVTDTPGFGDQINNDNCWDPILGYINEQYEQYLQEEILITRQRHIPDTRVHCCVYFVPPTGHCLRPLDIEFLQRLCRTVNVVPVIARADSLTMEEREAFRRRIQQNLRTHCIDVYPQMCFDEDINDKILNSKLRDRIPFAVVGADQEHLVNGRCVLGRKTKWGIIEVENMAHCEFPLLRDLLIRSHLQDLKDITHNIHYENYRVIRLNESHLLPRGPGWVNLAPASPGQLTTPRTFKVCRGAHDDSDDEF,PF00735;,6MQ9;6MQB;6MQK;6MQL;,197,D,N,True,829
13041,6242,45784,single nucleotide variant,NM_144605.5(SEPTIN12):c.266C>T (p.Thr89Met),124404,SEPTIN12,HGNC:26348,risk factor,0,1-Apr-12,199696526,-,RCV000030756,"MONDO:MONDO:0013901,MedGen:C3553793,OMIM:614822,Orphanet:276234",Spermatogenic failure 10,germline,germline,GRCh38,NC_000016.10,16,4786006,4786006,na,na,16p13.3,no assertion criteria provided,2,-,N,"ClinGen:CA130082,UniProtKB:Q8IYM1#VAR_068097,OMIM:611562.0002",3,37114,4786006,G,A,T89M,0,uncertain,uncertain,Q8IYM1,Q8IYM1,reviewed,SEP12_HUMAN,Septin-12,SEPTIN12 SEPT12,Homo sapiens (Human),358.0,MDPLRRSPSPCLSSQPSSPSTPPCEMLGPVGIEAVLDQLKIKAMKMGFEFNIMVVGQSGLGKSTMVNTLFKSKVWKSNPPGLGVPTPQTLQLHSLTHVIEEKGVKLKLTVTDTPGFGDQINNDNCWDPILGYINEQYEQYLQEEILITRQRHIPDTRVHCCVYFVPPTGHCLRPLDIEFLQRLCRTVNVVPVIARADSLTMEEREAFRRRIQQNLRTHCIDVYPQMCFDEDINDKILNSKLRDRIPFAVVGADQEHLVNGRCVLGRKTKWGIIEVENMAHCEFPLLRDLLIRSHLQDLKDITHNIHYENYRVIRLNESHLLPRGPGWVNLAPASPGQLTTPRTFKVCRGAHDDSDDEF,PF00735;,6MQ9;6MQB;6MQK;6MQL;,89,T,M,True,829
13042,1003,19231,single nucleotide variant,NM_018972.4(GDAP1):c.482G>A (p.Arg161His),54332,GDAP1,HGNC:15968,Conflicting interpretations of pathogenicity,1,1-Jul-20,104894076,-,RCV000004412|RCV001200307,"MONDO:MONDO:0008961,MedGen:C1859198,OMIM:214400,Orphanet:99948|MedGen:CN517202","Charcot-Marie-Tooth disease, type 4A|not provided",germline,germline,GRCh38,NC_000008.11,8,74360308,74360308,na,na,8q21.11,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA116685,UniProtKB:Q8TB36#VAR_017185,OMIM:606598.0003",3,4192,74360308,G,A,R161H,1,uncertain,uncertain,Q8TB36,Q8TB36,reviewed,GDAP1_HUMAN,"Ganglioside-induced differentiation-associated protein 1, GDAP1",GDAP1,Homo sapiens (Human),358.0,MAERQEEQRGSPPLRAEGKADAEVKLILYHWTHSFSSQKVRLVIAEKALKCEEHDVSLPLSEHNEPWFMRLNSTGEVPVLIHGENIICEATQIIDYLEQTFLDERTPRLMPDKESMYYPRVQHYRELLDSLPMDAYTHGCILHPELTVDSMIPAYATTRIRSQIGNTESELKKLAEENPDLQEAYIAKQKRLKSKLLDHDNVKYLKKILDELEKVLDQVETELQRRNEETPEEGQQPWLCGESFTLADVSLAVTLHRLKFLGFARRNWGNGKRPNLETYYERVLKRKTFNKVLGHVNNILISAVLPTAFRVAKKRAPKVLGTTLVVGLLAGVGYFAFMLFRKRLGSMILAFRPRPNYF,PF13417;,7AIA;7ALM;7B2G;,161,R,H,True,830
13043,1004,19234,single nucleotide variant,NM_018972.4(GDAP1):c.844C>T (p.Arg282Cys),54332,GDAP1,HGNC:15968,Pathogenic,1,15-Nov-19,28937906,-,RCV000004415|RCV000235864|RCV001235354,"MONDO:MONDO:0012014,MedGen:C1842197,OMIM:608340,Orphanet:217055|MedGen:CN517202|MONDO:MONDO:0008961,MedGen:C1859198,OMIM:214400,Orphanet:99948","Charcot-Marie-Tooth disease, recessive intermediate A|not provided|Charcot-Marie-Tooth disease, type 4A",germline,germline,GRCh38,NC_000008.11,8,74364134,74364134,na,na,8q21.11,"criteria provided, multiple submitters, no conflicts",4,-,N,"OMIM:606598.0006,ClinGen:CA116688,UniProtKB:Q8TB36#VAR_017186",3,4195,74364134,C,T,R282C,2,pathogenic,pathogenic,Q8TB36,Q8TB36,reviewed,GDAP1_HUMAN,"Ganglioside-induced differentiation-associated protein 1, GDAP1",GDAP1,Homo sapiens (Human),358.0,MAERQEEQRGSPPLRAEGKADAEVKLILYHWTHSFSSQKVRLVIAEKALKCEEHDVSLPLSEHNEPWFMRLNSTGEVPVLIHGENIICEATQIIDYLEQTFLDERTPRLMPDKESMYYPRVQHYRELLDSLPMDAYTHGCILHPELTVDSMIPAYATTRIRSQIGNTESELKKLAEENPDLQEAYIAKQKRLKSKLLDHDNVKYLKKILDELEKVLDQVETELQRRNEETPEEGQQPWLCGESFTLADVSLAVTLHRLKFLGFARRNWGNGKRPNLETYYERVLKRKTFNKVLGHVNNILISAVLPTAFRVAKKRAPKVLGTTLVVGLLAGVGYFAFMLFRKRLGSMILAFRPRPNYF,PF13417;,7AIA;7ALM;7B2G;,282,R,C,True,830
13044,1218,20309,single nucleotide variant,NM_004252.5(SLC9A3R1):c.328C>G (p.Leu110Val),9368,SLC9A3R1,HGNC:11075,Uncertain significance,1,28-May-19,35910969,-,RCV000005588,"MONDO:MONDO:0012851,MedGen:C2676782,OMIM:612287,Orphanet:244305","Nephrolithiasis/osteoporosis, hypophosphatemic, 2",germline;unknown,germline,GRCh38,NC_000017.11,17,74749174,74749174,na,na,17q25.1,"criteria provided, single submitter",3,-,N,"ClinGen:CA117368,UniProtKB:O14745#VAR_034899,OMIM:604990.0001",3,5270,74749174,C,G,L110V,1,uncertain,uncertain,O14745,O14745,reviewed,NHRF1_HUMAN,"Na(+)/H(+) exchange regulatory cofactor NHE-RF1, NHERF-1 (Ezrin-radixin-moesin-binding phosphoprotein 50, EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1)",SLC9A3R1 NHERF NHERF1,Homo sapiens (Human),358.0,MSADAAAGAPLPRLCCLEKGPNGYGFHLHGEKGKLGQYIRLVEPGSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPETDEQLQKLGVQVREELLRAQEAPGQAEPPAAAEVQGAGNENEPREADKSHPEQRELRPRLCTMKKGPSGYGFNLHSDKSKPGQFIRSVDPDSPAEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASSDTSEELNSQDSPPKQDSTAPSSTSSSDPILDFNISLAMAKERAHQKRSSKRAPQMDWSKKNELFSNL,PF09007;PF00595;,1G9O;1GQ4;1GQ5;1I92;1SGH;2D10;2JXO;2KJD;2KRG;2M0T;2M0U;2M0V;2OZF;4JL7;4LMM;4MPA;4N6X;4PQW;4Q3H;6RQR;,110,L,V,True,831
13045,1219,20310,single nucleotide variant,NM_004252.5(SLC9A3R1):c.458G>A (p.Arg153Gln),9368,SLC9A3R1,HGNC:11075,Uncertain significance,1,28-May-20,41282065,-,RCV000005589|RCV000484640|RCV001171340,"MONDO:MONDO:0012851,MedGen:C2676782,OMIM:612287,Orphanet:244305|MedGen:CN517202|Human Phenotype Ontology:HP:0000106,Human Phenotype Ontology:HP:0001918,Human Phenotype Ontology:HP:0008671,Human Phenotype Ontology:HP:0012622,MONDO:MONDO:0005300,MedGen:C1561643","Nephrolithiasis/osteoporosis, hypophosphatemic, 2|not provided|Chronic kidney disease",germline;unknown,germline,GRCh38,NC_000017.11,17,74762028,74762028,na,na,17q25.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA117369,UniProtKB:O14745#VAR_048021,OMIM:604990.0002",3,5271,74762028,G,A,R153Q,2,uncertain,uncertain,O14745,O14745,reviewed,NHRF1_HUMAN,"Na(+)/H(+) exchange regulatory cofactor NHE-RF1, NHERF-1 (Ezrin-radixin-moesin-binding phosphoprotein 50, EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1)",SLC9A3R1 NHERF NHERF1,Homo sapiens (Human),358.0,MSADAAAGAPLPRLCCLEKGPNGYGFHLHGEKGKLGQYIRLVEPGSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPETDEQLQKLGVQVREELLRAQEAPGQAEPPAAAEVQGAGNENEPREADKSHPEQRELRPRLCTMKKGPSGYGFNLHSDKSKPGQFIRSVDPDSPAEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASSDTSEELNSQDSPPKQDSTAPSSTSSSDPILDFNISLAMAKERAHQKRSSKRAPQMDWSKKNELFSNL,PF09007;PF00595;,1G9O;1GQ4;1GQ5;1I92;1SGH;2D10;2JXO;2KJD;2KRG;2M0T;2M0U;2M0V;2OZF;4JL7;4LMM;4MPA;4N6X;4PQW;4Q3H;6RQR;,153,R,Q,True,831
13046,1220,20311,single nucleotide variant,NM_004252.5(SLC9A3R1):c.673G>A (p.Glu225Lys),9368,SLC9A3R1,HGNC:11075,Likely benign,1,29-Mar-16,119486097,-,RCV000005590|RCV000454997|RCV000662330,"MONDO:MONDO:0012851,MedGen:C2676782,OMIM:612287,Orphanet:244305|MedGen:CN169374|Human Phenotype Ontology:HP:0000102,Human Phenotype Ontology:HP:0000787,MONDO:MONDO:0008171,MedGen:C0392525;Human Phenotype Ontology:HP:0002148,MONDO:MONDO:0000313,MedGen:C0595888","Nephrolithiasis/osteoporosis, hypophosphatemic, 2|not specified|Nephrolithiasis;Hypophosphatemia",germline,germline,GRCh38,NC_000017.11,17,74763436,74763436,na,na,17q25.1,"criteria provided, single submitter",3,-,N,"ClinGen:CA117370,UniProtKB:O14745#VAR_048022,OMIM:604990.0003",3,5272,74763436,G,A,E225K,1,benign,benign,O14745,O14745,reviewed,NHRF1_HUMAN,"Na(+)/H(+) exchange regulatory cofactor NHE-RF1, NHERF-1 (Ezrin-radixin-moesin-binding phosphoprotein 50, EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1)",SLC9A3R1 NHERF NHERF1,Homo sapiens (Human),358.0,MSADAAAGAPLPRLCCLEKGPNGYGFHLHGEKGKLGQYIRLVEPGSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPETDEQLQKLGVQVREELLRAQEAPGQAEPPAAAEVQGAGNENEPREADKSHPEQRELRPRLCTMKKGPSGYGFNLHSDKSKPGQFIRSVDPDSPAEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASSDTSEELNSQDSPPKQDSTAPSSTSSSDPILDFNISLAMAKERAHQKRSSKRAPQMDWSKKNELFSNL,PF09007;PF00595;,1G9O;1GQ4;1GQ5;1I92;1SGH;2D10;2JXO;2KJD;2KRG;2M0T;2M0U;2M0V;2OZF;4JL7;4LMM;4MPA;4N6X;4PQW;4Q3H;6RQR;,225,E,K,True,831
13047,3610,28775,single nucleotide variant,NM_000446.7(PON1):c.163T>A (p.Leu55Met),5444,PON1,HGNC:9204,"association, risk factor",0,18-May-15,854560,-,RCV000014742|RCV000014743|RCV000133465,"MedGen:C1840169|MONDO:MONDO:0012969,MedGen:C2674665,OMIM:612633|MedGen:C1827841","Coronary artery disease, susceptibility to|Microvascular complications of diabetes 5|Enzyme activity finding",germline,germline,GRCh38,NC_000007.14,7,95316772,95316772,na,na,7q21.3,no assertion criteria provided,1,-,N,"ClinGen:CA123413,UniProtKB:P27169#VAR_006043,OMIM:168820.0002",1,13736,95316772,A,T,L55M,0,uncertain,uncertain,P27169,P27169,reviewed,PON1_HUMAN,"Serum paraoxonase/arylesterase 1, PON 1, EC 3.1.1.2, EC 3.1.1.81, EC 3.1.8.1 (Aromatic esterase 1, A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)",PON1 PON,Homo sapiens (Human),355.0,MAKLIALTLLGMGLALFRNHQSSYQTRLNALREVQPVELPNCNLVKGIETGSEDLEILPNGLAFISSGLKYPGIKSFNPNSPGKILLMDLNEEDPTVLELGITGSKFDVSSFNPHGISTFTDEDNAMYLLVVNHPDAKSTVELFKFQEEEKSLLHLKTIRHKLLPNLNDIVAVGPEHFYGTNDHYFLDPYLQSWEMYLGLAWSYVVYYSPSEVRVVAEGFDFANGINISPDGKYVYIAELLAHKIHVYEKHANWTLTPLKSLDFNTLVDNISVDPETGDLWVGCHPNGMKIFFYDSENPPASEVLRIQNILTEEPKVTQVYAENGTVLQGSTVASVYKGKLLIGTVFHKALYCEL,PF01731;,1V04;,55,L,M,True,832
13048,3609,28774,single nucleotide variant,NM_000446.7(PON1):c.575A>G (p.Gln192Arg),5444,PON1,HGNC:9204,"association, risk factor",0,18-May-15,662,-,RCV000014739|RCV000014740|RCV000133464,MedGen:C1840169|MedGen:C3149706|MedGen:C1827841,"Coronary artery disease, susceptibility to|Coronary artery spasm 2, susceptibility to|Enzyme activity finding",germline,germline,GRCh38,NC_000007.14,7,95308134,95308134,na,na,7q21.3,no assertion criteria provided,1,-,N,"ClinGen:CA123411,UniProtKB:P27169#VAR_006044,OMIM:168820.0001",1,13735,95308134,T,C,Q192R,0,uncertain,uncertain,P27169,P27169,reviewed,PON1_HUMAN,"Serum paraoxonase/arylesterase 1, PON 1, EC 3.1.1.2, EC 3.1.1.81, EC 3.1.8.1 (Aromatic esterase 1, A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)",PON1 PON,Homo sapiens (Human),355.0,MAKLIALTLLGMGLALFRNHQSSYQTRLNALREVQPVELPNCNLVKGIETGSEDLEILPNGLAFISSGLKYPGIKSFNPNSPGKILLMDLNEEDPTVLELGITGSKFDVSSFNPHGISTFTDEDNAMYLLVVNHPDAKSTVELFKFQEEEKSLLHLKTIRHKLLPNLNDIVAVGPEHFYGTNDHYFLDPYLQSWEMYLGLAWSYVVYYSPSEVRVVAEGFDFANGINISPDGKYVYIAELLAHKIHVYEKHANWTLTPLKSLDFNTLVDNISVDPETGDLWVGCHPNGMKIFFYDSENPPASEVLRIQNILTEEPKVTQVYAENGTVLQGSTVASVYKGKLLIGTVFHKALYCEL,PF01731;,1V04;,192,Q,R,True,832
13049,13688,274971,single nucleotide variant,NM_004544.4(NDUFA10):c.5C>G (p.Ala2Gly),4705,NDUFA10,HGNC:7684,Benign,0,13-Jan-18,11541494,-,RCV000328287|RCV000378198|RCV000383086|RCV000676560,"MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000,Orphanet:506|MONDO:MONDO:0100224,MedGen:CN257533,OMIM:252010|MedGen:CN169374|MedGen:CN517202","Leigh syndrome|Mitochondrial complex I deficiency, nuclear type 1|not specified|not provided",germline;unknown,germline,GRCh38,NC_000002.12,2,240025297,240025297,na,na,2q37.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA2201190,UniProtKB:O95299#VAR_034149",2,290734,240025297,G,C,A2G,2,benign,benign,O95299,O95299,reviewed,NDUAA_HUMAN,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD, CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit)",NDUFA10,Homo sapiens (Human),355.0,MALRLLKLAATSASARVVAAGAQRVRGIHSSVQCKLRYGMWHFLLGDKASKRLTERSRVITVDGNICTGKGKLAKEIAEKLGFKHFPEAGIHYPDSTTGDGKPLATDYNGNCSLEKFYDDPRSNDGNSYRLQSWLYSSRLLQYSDALEHLLTTGQGVVLERSIFSDFVFLEAMYNQGFIRKQCVDHYNEVKSVTICDYLPPHLVIYIDVPVPEVQRRIQKKGDPHEMKITSAYLQDIENAYKKTFLPEMSEKCEVLQYSAREAQDSKKVVEDIEYLKFDKGPWLKQDNRTLYHLRLLVQDKFEVLNYTSIPIFLPEVTIGAHQTDRVLHQFRELPGRKYSPGYNTEVGDKWIWLK,PF01712;,5XTC;5XTD;5XTH;5XTI;,2,A,G,True,833
13050,9293,103248,single nucleotide variant,NM_000531.6(OTC):c.907T>C (p.Cys303Arg),5009,OTC,HGNC:8512,Pathogenic,1,-,67468335,-,RCV000083604,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38411901,38411901,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224830,UniProtKB:P00480#VAR_004934",2,97356,38411901,T,C,C303R,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,303,C,R,True,834
13051,9213,103001,single nucleotide variant,NM_000531.6(OTC):c.131C>T (p.Thr44Ile),5009,OTC,HGNC:8512,Pathogenic,1,-,72554310,-,RCV000083336,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38367344,38367344,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224459,UniProtKB:P00480#VAR_004848",2,97109,38367344,C,T,T44I,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,44,T,I,True,834
13052,9231,103067,single nucleotide variant,NM_000531.6(OTC):c.374C>T (p.Thr125Met),5009,OTC,HGNC:8512,Uncertain significance,1,23-Jan-19,72554356,-,RCV000083408|RCV000148721|RCV000702655,"MedGen:CN517202|Human Phenotype Ontology:HP:0001987,Human Phenotype Ontology:HP:0008308,Human Phenotype Ontology:HP:0008334,MedGen:C0220994|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",not provided|Hyperammonemia|Ornithine carbamoyltransferase deficiency,germline;unknown,germline,GRCh38,NC_000023.11,X,38381417,38381417,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",4,ACMG2016,N,"ClinGen:CA211702,UniProtKB:P00480#VAR_004874",2,97175,38381417,C,T,T125M,2,uncertain,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,125,T,M,True,834
13053,9232,103069,single nucleotide variant,NM_000531.6(OTC):c.377A>G (p.Asp126Gly),5009,OTC,HGNC:8512,Pathogenic,1,-,72554358,-,RCV000083410,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38381420,38381420,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224564,UniProtKB:P00480#VAR_004875",2,97177,38381420,A,G,D126G,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,126,D,G,True,834
13054,9233,103087,single nucleotide variant,NM_000531.6(OTC):c.416T>C (p.Leu139Ser),5009,OTC,HGNC:8512,Pathogenic,1,-,72556259,-,RCV000083430,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38401304,38401304,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224594,UniProtKB:P00480#VAR_004877",2,97195,38401304,T,C,L139S,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,139,L,S,True,834
13055,9234,103088,single nucleotide variant,NM_000531.6(OTC):c.418G>C (p.Ala140Pro),5009,OTC,HGNC:8512,Likely pathogenic,1,15-Dec-16,72556260,-,RCV000083431|RCV000587672,"MedGen:CN517202|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",not provided|Ornithine carbamoyltransferase deficiency,germline;unknown,germline,GRCh38,NC_000023.11,X,38401306,38401306,na,na,Xp11.4,"criteria provided, single submitter",2,ACMG2016,N,"ClinGen:CA224595,UniProtKB:P00480#VAR_010605",2,97196,38401306,G,C,A140P,1,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,140,A,P,True,834
13056,9279,103214,single nucleotide variant,NM_000531.6(OTC):c.785C>A (p.Thr262Lys),5009,OTC,HGNC:8512,Pathogenic,1,-,67333670,-,RCV000083569,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38408943,38408943,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224784,UniProtKB:P00480#VAR_010608",2,97322,38408943,C,A,T262K,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,262,T,K,True,834
13057,9235,103090,single nucleotide variant,NM_000531.6(OTC):c.422G>C (p.Arg141Pro),5009,OTC,HGNC:8512,Likely pathogenic,1,28-May-19,68026851,-,RCV000083435|RCV000990786,"MedGen:CN517202|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",not provided|Ornithine carbamoyltransferase deficiency,unknown,unknown,GRCh38,NC_000023.11,X,38401310,38401310,na,na,Xp11.4,"criteria provided, single submitter",2,ACMG2016,N,"UniProtKB:P00480#VAR_004878,ClinGen:CA224601",2,97198,38401310,G,C,R141P,1,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,141,R,P,True,834
13058,9278,103204,single nucleotide variant,NM_000531.6(OTC):c.764A>C (p.His255Pro),5009,OTC,HGNC:8512,Pathogenic,1,-,72558440,-,RCV000083558,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38408922,38408922,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224772,UniProtKB:P00480#VAR_004919",2,97312,38408922,A,C,H255P,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,255,H,P,True,834
13059,2714,26051,single nucleotide variant,NM_000531.6(OTC):c.617T>G (p.Met206Arg),5009,OTC,HGNC:8512,Pathogenic,1,27-Aug-99,72558412,-,RCV000011759|RCV000083513,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38403694,38403694,na,na,Xp11.4,no assertion criteria provided,2,ACMG2016,N,"ClinGen:CA224711,UniProtKB:P00480#VAR_004906,OMIM:300461.0027",3,11012,38403694,T,G,M206R,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,206,M,R,True,834
13060,9230,103064,single nucleotide variant,NM_000531.6(OTC):c.350A>T (p.His117Leu),5009,OTC,HGNC:8512,Pathogenic,1,-,66539573,-,RCV000083405,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38381393,38381393,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224560,UniProtKB:P00480#VAR_004872",2,97172,38381393,A,T,H117L,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,117,H,L,True,834
13061,9236,103096,single nucleotide variant,NM_000531.6(OTC):c.444G>T (p.Leu148Phe),5009,OTC,HGNC:8512,Pathogenic,1,-,66741318,-,RCV000083442,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38401332,38401332,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"UniProtKB:P00480#VAR_004880,ClinGen:CA224613",2,97204,38401332,G,T,L148F,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,148,L,F,True,834
13062,9238,103106,single nucleotide variant,NM_000531.6(OTC):c.479T>G (p.Ile160Ser),5009,OTC,HGNC:8512,Pathogenic,1,-,67954347,-,RCV000083453,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38401367,38401367,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224632,UniProtKB:P00480#VAR_012651",2,97214,38401367,T,G,I160S,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,160,I,S,True,834
13063,9239,103108,single nucleotide variant,NM_000531.6(OTC):c.482A>G (p.Asn161Ser),5009,OTC,HGNC:8512,Pathogenic,1,7-Jun-19,72556271,-,RCV000083455|RCV000793302,"MedGen:CN517202|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",not provided|Ornithine carbamoyltransferase deficiency,germline;unknown,germline,GRCh38,NC_000023.11,X,38401370,38401370,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",3,ACMG2016,N,"ClinGen:CA224635,UniProtKB:P00480#VAR_004882",2,97216,38401370,A,G,N161S,2,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,161,N,S,True,834
13064,9240,103109,single nucleotide variant,NM_000531.6(OTC):c.484G>C (p.Gly162Arg),5009,OTC,HGNC:8512,Pathogenic,1,-,66626662,-,RCV000083457,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38401372,38401372,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224637,UniProtKB:P00480#VAR_004883",2,97217,38401372,G,C,G162R,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,162,G,R,True,834
13065,9241,103117,single nucleotide variant,NM_000531.6(OTC):c.503A>G (p.His168Arg),5009,OTC,HGNC:8512,Pathogenic,1,-,66867430,-,RCV000083465,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38401391,38401391,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224651,UniProtKB:P00480#VAR_004885",2,97225,38401391,A,G,H168R,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,168,H,R,True,834
13066,9242,103118,single nucleotide variant,NM_000531.6(OTC):c.504T>A (p.His168Gln),5009,OTC,HGNC:8512,Pathogenic,1,-,72556276,-,RCV000083466,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38401392,38401392,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224652,UniProtKB:P00480#VAR_004884",2,97226,38401392,T,A,H168Q,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,168,H,Q,True,834
13067,9243,103121,single nucleotide variant,NM_000531.6(OTC):c.514A>T (p.Ile172Phe),5009,OTC,HGNC:8512,Pathogenic,1,-,72556279,-,RCV000083469,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38401402,38401402,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224657,UniProtKB:P00480#VAR_009233",2,97229,38401402,A,T,I172F,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,172,I,F,True,834
13068,9244,103122,single nucleotide variant,NM_000531.6(OTC):c.516C>G (p.Ile172Met),5009,OTC,HGNC:8512,Pathogenic,1,-,72556280,-,RCV000083470,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38401404,38401404,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224658,UniProtKB:P00480#VAR_004886",2,97230,38401404,C,G,I172M,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,172,I,M,True,834
13069,9245,103123,single nucleotide variant,NM_000531.6(OTC):c.520G>C (p.Ala174Pro),5009,OTC,HGNC:8512,Pathogenic,1,-,72556281,-,RCV000083471,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38401408,38401408,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224659,UniProtKB:P00480#VAR_004887",2,97231,38401408,G,C,A174P,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,174,A,P,True,834
13070,9237,103103,single nucleotide variant,NM_000531.6(OTC):c.476T>C (p.Ile159Thr),5009,OTC,HGNC:8512,Pathogenic,1,-,72556269,-,RCV000083450,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38401364,38401364,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224627,UniProtKB:P00480#VAR_004881",2,97211,38401364,T,C,I159T,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,159,I,T,True,834
13071,9246,103125,single nucleotide variant,NM_000531.6(OTC):c.524A>T (p.Asp175Val),5009,OTC,HGNC:8512,Pathogenic,1,-,68033093,-,RCV000083473,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38401412,38401412,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224662,UniProtKB:P00480#VAR_004888",2,97233,38401412,A,T,D175V,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,175,D,V,True,834
13072,9229,103063,single nucleotide variant,NM_000531.6(OTC):c.350A>G (p.His117Arg),5009,OTC,HGNC:8512,Pathogenic,1,1-Mar-20,66539573,-,RCV000083404,MedGen:CN517202,not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38381393,38381393,na,na,Xp11.4,"criteria provided, single submitter",2,ACMG2016,N,"UniProtKB:P00480#VAR_004873,ClinGen:CA224559",2,97171,38381393,A,G,H117R,1,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,117,H,R,True,834
13073,9227,103055,single nucleotide variant,NM_000531.6(OTC):c.299G>A (p.Gly100Asp),5009,OTC,HGNC:8512,Pathogenic,1,-,72554349,-,RCV000083396,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38381342,38381342,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA285806,UniProtKB:P00480#VAR_004868",2,97163,38381342,G,A,G100D,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,100,G,D,True,834
13074,9266,103161,single nucleotide variant,NM_000531.6(OTC):c.608C>G (p.Ser203Cys),5009,OTC,HGNC:8512,Pathogenic,1,-,72558410,-,RCV000083511,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403685,38403685,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224708,UniProtKB:P00480#VAR_004905",2,97269,38403685,C,G,S203C,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,203,S,C,True,834
13075,9214,103002,single nucleotide variant,NM_000531.6(OTC):c.133C>G (p.Leu45Val),5009,OTC,HGNC:8512,Pathogenic,1,-,72554311,-,RCV000083337,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38367346,38367346,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224460,UniProtKB:P00480#VAR_004850",2,97110,38367346,C,G,L45V,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,45,L,V,True,834
13076,9282,103218,single nucleotide variant,NM_000531.6(OTC):c.790A>G (p.Thr264Ala),5009,OTC,HGNC:8512,Pathogenic,1,-,72558444,-,RCV000083573,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38408948,38408948,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224789,UniProtKB:P00480#VAR_004922",2,97326,38408948,A,G,T264A,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,264,T,A,True,834
13077,9215,103005,single nucleotide variant,NM_000531.6(OTC):c.140A>T (p.Asn47Ile),5009,OTC,HGNC:8512,Pathogenic,1,-,67939655,-,RCV000083341,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38367353,38367353,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224465,UniProtKB:P00480#VAR_004852",2,97113,38367353,A,T,N47I,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,47,N,I,True,834
13078,9216,103009,single nucleotide variant,NM_000531.6(OTC):c.148G>A (p.Gly50Arg),5009,OTC,HGNC:8512,Pathogenic,1,9-Aug-19,67486158,-,RCV000083345|RCV001027709,"MedGen:CN517202|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",not provided|Ornithine carbamoyltransferase deficiency,unknown,unknown,GRCh38,NC_000023.11,X,38367361,38367361,na,na,Xp11.4,no assertion criteria provided,2,ACMG2016,N,"ClinGen:CA224471,UniProtKB:P00480#VAR_004853",2,97117,38367361,G,A,G50R,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,50,G,R,True,834
13079,9217,103016,single nucleotide variant,NM_000531.6(OTC):c.163T>G (p.Tyr55Asp),5009,OTC,HGNC:8512,Pathogenic,1,-,72554319,-,RCV000083353,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38367376,38367376,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224486,UniProtKB:P00480#VAR_004854",2,97124,38367376,T,G,Y55D,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,55,Y,D,True,834
13080,9218,103017,single nucleotide variant,NM_000531.6(OTC):c.167T>C (p.Met56Thr),5009,OTC,HGNC:8512,Likely pathogenic,1,2-Feb-17,72554320,-,RCV000083354|RCV000507068,MedGen:CN517202|MedGen:CN169374,not provided|not specified,germline;unknown,germline,GRCh38,NC_000023.11,X,38367380,38367380,na,na,Xp11.4,"criteria provided, single submitter",2,ACMG2016,N,"UniProtKB:P00480#VAR_004855,ClinGen:CA224487",2,97125,38367380,T,C,M56T,1,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,56,M,T,True,834
13081,9219,103020,single nucleotide variant,NM_000531.6(OTC):c.179C>T (p.Ser60Leu),5009,OTC,HGNC:8512,Pathogenic,1,-,72554323,-,RCV000083357,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38367392,38367392,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224492,UniProtKB:P00480#VAR_004856",2,97128,38367392,C,T,S60L,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,60,S,L,True,834
13082,9228,103057,single nucleotide variant,NM_000531.6(OTC):c.305C>A (p.Ala102Glu),5009,OTC,HGNC:8512,Pathogenic,1,-,72554350,-,RCV000083398,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38381348,38381348,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224549,UniProtKB:P00480#VAR_004870",2,97165,38381348,C,A,A102E,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,102,A,E,True,834
13083,9220,103021,single nucleotide variant,NM_000531.6(OTC):c.188T>C (p.Leu63Pro),5009,OTC,HGNC:8512,Pathogenic,1,-,72554324,-,RCV000083358,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38367401,38367401,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224493,UniProtKB:P00480#VAR_004857",2,97129,38367401,T,C,L63P,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,63,L,P,True,834
13084,9221,103035,single nucleotide variant,NM_000531.6(OTC):c.247G>C (p.Gly83Arg),5009,OTC,HGNC:8512,Pathogenic,1,-,72554336,-,RCV000083374,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38369826,38369826,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224518,UniProtKB:P00480#VAR_004861",2,97143,38369826,G,C,G83R,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,83,G,R,True,834
13085,9222,103036,single nucleotide variant,NM_000531.6(OTC):c.248G>A (p.Gly83Asp),5009,OTC,HGNC:8512,Pathogenic,1,-,72554337,-,RCV000083375,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38369827,38369827,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224519,UniProtKB:P00480#VAR_004860",2,97144,38369827,G,A,G83D,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,83,G,D,True,834
13086,9281,103217,single nucleotide variant,NM_000531.6(OTC):c.788A>G (p.Asp263Gly),5009,OTC,HGNC:8512,Pathogenic,1,-,72558443,-,RCV000083572,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38408946,38408946,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224788,UniProtKB:P00480#VAR_004920",2,97325,38408946,A,G,D263G,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,263,D,G,True,834
13087,9223,103037,single nucleotide variant,NM_000531.6(OTC):c.264A>T (p.Lys88Asn),5009,OTC,HGNC:8512,Pathogenic,1,-,72554339,-,RCV000083377,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38369843,38369843,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224521,UniProtKB:P00480#VAR_004863",2,97145,38369843,A,T,K88N,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,88,K,N,True,834
13088,9280,103216,single nucleotide variant,NM_000531.6(OTC):c.787G>A (p.Asp263Asn),5009,OTC,HGNC:8512,Pathogenic,1,-,72558442,-,RCV000083571,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38408945,38408945,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"UniProtKB:P00480#VAR_004921,ClinGen:CA224787",2,97324,38408945,G,A,D263N,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,263,D,N,True,834
13089,9224,103040,single nucleotide variant,NM_000531.6(OTC):c.270T>G (p.Ser90Arg),5009,OTC,HGNC:8512,Pathogenic,1,-,72554342,-,RCV000083380,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38369849,38369849,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224526,UniProtKB:P00480#VAR_004864",2,97148,38369849,T,G,S90R,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,90,S,R,True,834
13090,9225,103044,single nucleotide variant,NM_000531.6(OTC):c.275G>A (p.Arg92Gln),5009,OTC,HGNC:8512,Pathogenic,1,7-Dec-19,66550389,-,RCV000083384|RCV000990783,"MedGen:CN517202|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",not provided|Ornithine carbamoyltransferase deficiency,germline;unknown,germline,GRCh38,NC_000023.11,X,38369854,38369854,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",3,ACMG2016,N,"ClinGen:CA285805,UniProtKB:P00480#VAR_004865",2,97152,38369854,G,A,R92Q,2,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,92,R,Q,True,834
13091,9226,103047,single nucleotide variant,NM_000531.6(OTC):c.277A>G (p.Thr93Ala),5009,OTC,HGNC:8512,Pathogenic,1,-,72554344,-,RCV000083387,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38369856,38369856,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224536,UniProtKB:P00480#VAR_004866",2,97155,38369856,A,G,T93A,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,93,T,A,True,834
13092,2715,26052,single nucleotide variant,NM_000531.6(OTC):c.118C>T (p.Arg40Cys),5009,OTC,HGNC:8512,Pathogenic/Likely pathogenic,1,15-Jun-20,72554307,-,RCV000011760|RCV000083332,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38367331,38367331,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",6,ACMG2016,N,"ClinGen:CA090910,UniProtKB:P00480#VAR_004845,OMIM:300461.0028",3,11013,38367331,C,T,R40C,2,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,40,R,C,True,834
13093,9247,103127,single nucleotide variant,NM_000531.6(OTC):c.527A>G (p.Tyr176Cys),5009,OTC,HGNC:8512,Pathogenic,1,-,72556283,-,RCV000083475,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38401415,38401415,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224665,UniProtKB:P00480#VAR_004889",2,97235,38401415,A,G,Y176C,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,176,Y,C,True,834
13094,9248,103129,single nucleotide variant,NM_000531.6(OTC):c.533C>T (p.Thr178Met),5009,OTC,HGNC:8512,Pathogenic,1,1-Jan-19,72556284,-,RCV000083477|RCV001262181,"MedGen:CN517202|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",not provided|Ornithine carbamoyltransferase deficiency,germline;unknown,germline,GRCh38,NC_000023.11,X,38401421,38401421,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",3,ACMG2016,N,"ClinGen:CA224668,UniProtKB:P00480#VAR_004890",2,97237,38401421,C,T,T178M,2,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,178,T,M,True,834
13095,9249,103134,single nucleotide variant,NM_000531.6(OTC):c.540G>C (p.Gln180His),5009,OTC,HGNC:8512,Pathogenic,1,-,72556287,-,RCV000083483,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38401428,38401428,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224674,UniProtKB:P00480#VAR_004892",2,97242,38401428,G,C,Q180H,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,180,Q,H,True,834
13096,9257,103143,single nucleotide variant,NM_000531.6(OTC):c.576C>G (p.Ser192Arg),5009,OTC,HGNC:8512,Pathogenic,1,-,72556298,-,RCV000083493,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403653,38403653,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224683,UniProtKB:P00480#VAR_004898",2,97251,38403653,C,G,S192R,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,192,S,R,True,834
13097,2706,26040,single nucleotide variant,NM_000531.6(OTC):c.259G>A (p.Glu87Lys),5009,OTC,HGNC:8512,Pathogenic,1,1-Jul-92,72554338,-,RCV000011748|RCV000083376,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38369838,38369838,na,na,Xp11.4,no assertion criteria provided,2,ACMG2016,N,"UniProtKB:P00480#VAR_004862,OMIM:300461.0016,ClinGen:CA224520",3,11001,38369838,G,A,E87K,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,87,E,K,True,834
13098,9268,103165,single nucleotide variant,NM_000531.6(OTC):c.621C>A (p.Ser207Arg),5009,OTC,HGNC:8512,Pathogenic,1,-,72558415,-,RCV000083516,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403698,38403698,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224715,UniProtKB:P00480#VAR_004907",2,97273,38403698,C,A,S207R,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,207,S,R,True,834
13099,2699,26028,single nucleotide variant,NM_000531.6(OTC):c.332T>C (p.Leu111Pro),5009,OTC,HGNC:8512,Pathogenic,1,26-Jan-17,1800324,-,RCV000011736,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",Ornithine carbamoyltransferase deficiency,germline,germline,GRCh38,NC_000023.11,X,38381375,38381375,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA255645,UniProtKB:P00480#VAR_004871,OMIM:300461.0004",1,10989,38381375,T,C,L111P,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,111,L,P,True,834
13100,9267,103163,single nucleotide variant,NM_000531.6(OTC):c.618G>C (p.Met206Ile),5009,OTC,HGNC:8512,Pathogenic,1,-,72558413,-,RCV000083514,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403695,38403695,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224712,UniProtKB:P00480#VAR_012653",2,97271,38403695,G,C,M206I,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,206,M,I,True,834
13101,9258,103147,single nucleotide variant,NM_000531.6(OTC):c.583G>A (p.Gly195Arg),5009,OTC,HGNC:8512,Pathogenic,1,14-Nov-19,67294955,-,RCV000083497|RCV001232865,"MedGen:CN517202|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",not provided|Ornithine carbamoyltransferase deficiency,germline;unknown,germline,GRCh38,NC_000023.11,X,38403660,38403660,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",3,ACMG2016,N,"ClinGen:CA285807,UniProtKB:P00480#VAR_004899",2,97255,38403660,G,A,G195R,2,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,195,G,R,True,834
13102,9259,103150,single nucleotide variant,NM_000531.6(OTC):c.586G>T (p.Asp196Tyr),5009,OTC,HGNC:8512,Pathogenic,1,-,66642398,-,RCV000083500,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403663,38403663,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"UniProtKB:P00480#VAR_004901,ClinGen:CA224693",2,97258,38403663,G,T,D196Y,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,196,D,Y,True,834
13103,9260,103151,single nucleotide variant,NM_000531.6(OTC):c.587A>T (p.Asp196Val),5009,OTC,HGNC:8512,Pathogenic,1,-,72556300,-,RCV000083501,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403664,38403664,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224694,UniProtKB:P00480#VAR_004900",2,97259,38403664,A,T,D196V,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,196,D,V,True,834
13104,9269,103166,single nucleotide variant,NM_000531.6(OTC):c.622G>A (p.Ala208Thr),5009,OTC,HGNC:8512,Pathogenic,1,7-May-20,72558416,-,RCV000083517|RCV001218092,"MedGen:CN517202|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",not provided|Ornithine carbamoyltransferase deficiency,germline;unknown,germline,GRCh38,NC_000023.11,X,38403699,38403699,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",4,ACMG2016,N,"ClinGen:CA224716,UniProtKB:P00480#VAR_004908",2,97274,38403699,G,A,A208T,2,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,208,A,T,True,834
13105,9261,103152,single nucleotide variant,NM_000531.6(OTC):c.589G>A (p.Gly197Arg),5009,OTC,HGNC:8512,Pathogenic,1,-,72556301,-,RCV000083502,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403666,38403666,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224695,UniProtKB:P00480#VAR_009235",2,97260,38403666,G,A,G197R,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,197,G,R,True,834
13106,2705,26039,single nucleotide variant,NM_000531.6(OTC):c.674C>T (p.Pro225Leu),5009,OTC,HGNC:8512,Pathogenic,1,29-Aug-19,67120076,-,RCV000011747|RCV000083536,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;inherited;unknown,germline,GRCh38,NC_000023.11,X,38408752,38408752,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",6,ACMG2016,N,"ClinGen:CA224741,UniProtKB:P00480#VAR_004913,OMIM:300461.0015",3,11000,38408752,C,T,P225L,2,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,225,P,L,True,834
13107,2704,26038,single nucleotide variant,NM_000531.6(OTC):c.829C>T (p.Arg277Trp),5009,OTC,HGNC:8512,Pathogenic,1,3-Feb-20,72558454,-,RCV000011746|RCV000083586,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38408987,38408987,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",5,ACMG2016,N,"ClinGen:CA255648,UniProtKB:P00480#VAR_004930,OMIM:300461.0010,OMIM:300461.0014",3,10999,38408987,C,T,R277W,2,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,277,R,W,True,834
13108,2703,26033,single nucleotide variant,NM_000531.6(OTC):c.137A>G (p.Lys46Arg),5009,OTC,HGNC:8512,Benign,0,14-Mar-19,1800321,-,RCV000011741|RCV000079082|RCV000268490|RCV000715362,"|MedGen:CN169374|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:C2711754",ORNITHINE TRANSCARBAMYLASE POLYMORPHISM|not specified|Ornithine carbamoyltransferase deficiency|History of neurodevelopmental disorder,germline,germline,GRCh38,NC_000023.11,X,38367350,38367350,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",9,ACMG2016,N,"ClinGen:CA121291,UniProtKB:P00480#VAR_004851,OMIM:300461.0009",3,10994,38367350,A,G,K46R,2,benign,benign,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,46,K,R,True,834
13109,2702,26032,single nucleotide variant,NM_000531.6(OTC):c.77G>A (p.Arg26Gln),5009,OTC,HGNC:8512,Pathogenic,1,27-Nov-19,68031618,-,RCV000011740|RCV000083565,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38352773,38352773,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",4,ACMG2016,N,"ClinGen:CA255647,UniProtKB:P00480#VAR_004843,OMIM:300461.0008",3,10993,38352773,G,A,R26Q,2,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,26,R,Q,True,834
13110,9263,103155,single nucleotide variant,NM_000531.6(OTC):c.594C>A (p.Asn198Lys),5009,OTC,HGNC:8512,Pathogenic,1,-,72558404,-,RCV000083505,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403671,38403671,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224699,UniProtKB:P00480#VAR_010606",2,97263,38403671,C,A,N198K,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,198,N,K,True,834
13111,2701,26031,single nucleotide variant,NM_000531.6(OTC):c.134T>C (p.Leu45Pro),5009,OTC,HGNC:8512,Pathogenic,1,26-Jan-17,72554312,-,RCV000011739|RCV000083338,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38367347,38367347,na,na,Xp11.4,no assertion criteria provided,2,ACMG2016,N,"ClinGen:CA224461,UniProtKB:P00480#VAR_004849,OMIM:300461.0007",3,10992,38367347,T,C,L45P,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,45,L,P,True,834
13112,9264,103158,single nucleotide variant,NM_000531.6(OTC):c.602T>C (p.Leu201Pro),5009,OTC,HGNC:8512,Pathogenic,1,-,72558407,-,RCV000083508,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403679,38403679,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224704,UniProtKB:P00480#VAR_004903",2,97266,38403679,T,C,L201P,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,201,L,P,True,834
13113,9265,103159,single nucleotide variant,NM_000531.6(OTC):c.604C>T (p.His202Tyr),5009,OTC,HGNC:8512,Pathogenic,1,15-Oct-19,72558408,-,RCV000083509|RCV001265563,"MedGen:CN517202|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",not provided|Ornithine carbamoyltransferase deficiency,germline;unknown,germline,GRCh38,NC_000023.11,X,38403681,38403681,na,na,Xp11.4,"criteria provided, single submitter",2,ACMG2016,N,"ClinGen:CA224705,UniProtKB:P00480#VAR_004904",2,97267,38403681,C,T,H202Y,1,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,202,H,Y,True,834
13114,9262,103153,single nucleotide variant,NM_000531.6(OTC):c.590G>A (p.Gly197Glu),5009,OTC,HGNC:8512,Pathogenic,1,-,72556302,-,RCV000083503,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403667,38403667,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224696,UniProtKB:P00480#VAR_004902",2,97261,38403667,G,A,G197E,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,197,G,E,True,834
13115,9270,103167,single nucleotide variant,NM_000531.6(OTC):c.626C>T (p.Ala209Val),5009,OTC,HGNC:8512,Pathogenic,1,7-Oct-17,72558417,-,RCV000083518|RCV000634844,"MedGen:CN517202|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",not provided|Ornithine carbamoyltransferase deficiency,germline;unknown,germline,GRCh38,NC_000023.11,X,38403703,38403703,na,na,Xp11.4,"criteria provided, single submitter",2,ACMG2016,N,"ClinGen:CA224717,UniProtKB:P00480#VAR_004909",2,97275,38403703,C,T,A209V,1,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,209,A,V,True,834
13116,9256,103142,single nucleotide variant,NM_000531.6(OTC):c.571C>T (p.Leu191Phe),5009,OTC,HGNC:8512,Pathogenic,1,-,72556296,-,RCV000083491,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403648,38403648,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224682,UniProtKB:P00480#VAR_012652",2,97250,38403648,C,T,L191F,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,191,L,F,True,834
13117,2707,26042,single nucleotide variant,NM_000531.6(OTC):c.484G>A (p.Gly162Arg),5009,OTC,HGNC:8512,Pathogenic,1,1-Jul-92,66626662,-,RCV000011750|RCV000083456,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38401372,38401372,na,na,Xp11.4,no assertion criteria provided,2,ACMG2016,N,"ClinGen:CA224636,UniProtKB:P00480#VAR_004883,OMIM:300461.0018",3,11003,38401372,G,A,G162R,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,162,G,R,True,834
13118,9277,103200,single nucleotide variant,NM_000531.6(OTC):c.740C>A (p.Thr247Lys),5009,OTC,HGNC:8512,Pathogenic,1,-,72558437,-,RCV000083554,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38408898,38408898,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA285808,UniProtKB:P00480#VAR_004918",2,97308,38408898,C,A,T247K,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,247,T,K,True,834
13119,2713,26050,single nucleotide variant,NM_000531.6(OTC):c.444G>C (p.Leu148Phe),5009,OTC,HGNC:8512,Pathogenic,1,17-Mar-97,66741318,-,RCV000011758|RCV000083441,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,unknown,unknown,GRCh38,NC_000023.11,X,38401332,38401332,na,na,Xp11.4,no assertion criteria provided,2,ACMG2016,N,"ClinGen:CA224612,UniProtKB:P00480#VAR_004880,OMIM:300461.0026",3,11011,38401332,G,C,L148F,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,148,L,F,True,834
13120,9276,103198,single nucleotide variant,NM_000531.6(OTC):c.731T>A (p.Leu244Gln),5009,OTC,HGNC:8512,Pathogenic,1,-,72558436,-,RCV000083552,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38408889,38408889,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224764,UniProtKB:P00480#VAR_004917",2,97306,38408889,T,A,L244Q,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,244,L,Q,True,834
13121,2712,26049,single nucleotide variant,NM_000531.6(OTC):c.386G>A (p.Arg129His),5009,OTC,HGNC:8512,Pathogenic,1,3-Dec-19,66656800,-,RCV000011757|RCV000083414,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38381429,38381429,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",4,ACMG2016,N,"ClinGen:CA224568,UniProtKB:P00480#VAR_004876,OMIM:300461.0025",3,11010,38381429,G,A,R129H,2,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,129,R,H,True,834
13122,9250,103136,single nucleotide variant,NM_000531.6(OTC):c.542A>G (p.Glu181Gly),5009,OTC,HGNC:8512,Pathogenic,1,-,72556290,-,RCV000083485,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403619,38403619,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224676,UniProtKB:P00480#VAR_004893",2,97244,38403619,A,G,E181G,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,181,E,G,True,834
13123,9275,103197,single nucleotide variant,NM_000531.6(OTC):c.725C>T (p.Thr242Ile),5009,OTC,HGNC:8512,Pathogenic,1,-,72558435,-,RCV000083551,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38408883,38408883,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224763,UniProtKB:P00480#VAR_004916",2,97305,38408883,C,T,T242I,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,242,T,I,True,834
13124,9274,103183,single nucleotide variant,NM_000531.6(OTC):c.674C>G (p.Pro225Arg),5009,OTC,HGNC:8512,Pathogenic,1,-,67120076,-,RCV000083535,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38408752,38408752,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224740,UniProtKB:P00480#VAR_004914",2,97291,38408752,C,G,P225R,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,225,P,R,True,834
13125,9273,103182,single nucleotide variant,NM_000531.6(OTC):c.673C>A (p.Pro225Thr),5009,OTC,HGNC:8512,Pathogenic,1,-,72558428,-,RCV000083534,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38408751,38408751,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224739,UniProtKB:P00480#VAR_004915",2,97290,38408751,C,A,P225T,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,225,P,T,True,834
13126,9272,103173,single nucleotide variant,NM_000531.6(OTC):c.658C>G (p.Pro220Ala),5009,OTC,HGNC:8512,Pathogenic,1,-,72558425,-,RCV000083525,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403735,38403735,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"UniProtKB:P00480#VAR_004912,ClinGen:CA224727",2,97281,38403735,C,G,P220A,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,220,P,A,True,834
13127,9271,103169,single nucleotide variant,NM_000531.6(OTC):c.640C>T (p.His214Tyr),5009,OTC,HGNC:8512,Pathogenic,1,-,72558420,-,RCV000083520,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403717,38403717,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224720,UniProtKB:P00480#VAR_010607",2,97277,38403717,C,T,H214Y,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,214,H,Y,True,834
13128,9251,103137,single nucleotide variant,NM_000531.6(OTC):c.545A>T (p.His182Leu),5009,OTC,HGNC:8512,Pathogenic,1,-,72556291,-,RCV000083486,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403622,38403622,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224677,UniProtKB:P00480#VAR_004894",2,97245,38403622,A,T,H182L,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,182,H,L,True,834
13129,9252,103138,single nucleotide variant,NM_000531.6(OTC):c.547T>G (p.Tyr183Asp),5009,OTC,HGNC:8512,Pathogenic,1,-,72556292,-,RCV000083487,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403624,38403624,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224678,UniProtKB:P00480#VAR_004896",2,97246,38403624,T,G,Y183D,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,183,Y,D,True,834
13130,2711,26048,single nucleotide variant,NM_000531.6(OTC):c.1033T>G (p.Tyr345Asp),5009,OTC,HGNC:8512,Pathogenic,1,1-Feb-02,66469337,-,RCV000011756|RCV000083325,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38421050,38421050,na,na,Xp11.4,no assertion criteria provided,2,ACMG2016,N,"ClinGen:CA224444,UniProtKB:P00480#VAR_004947,OMIM:300461.0024",3,11009,38421050,T,G,Y345D,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,345,Y,D,True,834
13131,2710,26047,single nucleotide variant,NM_000531.6(OTC):c.912G>T (p.Leu304Phe),5009,OTC,HGNC:8512,Likely pathogenic,1,27-Nov-19,72558465,-,RCV000011755|RCV000083607,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38411906,38411906,na,na,Xp11.4,"criteria provided, single submitter",3,ACMG2016,N,"ClinGen:CA224834,UniProtKB:P00480#VAR_004936,OMIM:300461.0023",3,11008,38411906,G,T,L304F,1,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,304,L,F,True,834
13132,2709,26046,single nucleotide variant,NM_000531.6(OTC):c.281G>C (p.Arg94Thr),5009,OTC,HGNC:8512,Pathogenic,1,1-Feb-02,72554345,-,RCV000011754|RCV000083388,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38369860,38369860,na,na,Xp11.4,no assertion criteria provided,2,ACMG2016,N,"UniProtKB:P00480#VAR_004867,OMIM:300461.0022,ClinGen:CA224537",3,11007,38369860,G,C,R94T,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,94,R,T,True,834
13133,9253,103139,single nucleotide variant,NM_000531.6(OTC):c.548A>G (p.Tyr183Cys),5009,OTC,HGNC:8512,Pathogenic,1,1-Nov-19,72556293,-,RCV000083488,MedGen:CN517202,not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38403625,38403625,na,na,Xp11.4,"criteria provided, single submitter",2,ACMG2016,N,"ClinGen:CA224679,UniProtKB:P00480#VAR_004895",2,97247,38403625,A,G,Y183C,1,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,183,Y,C,True,834
13134,9254,103140,single nucleotide variant,NM_000531.6(OTC):c.562G>C (p.Gly188Arg),5009,OTC,HGNC:8512,Pathogenic,1,-,72556294,-,RCV000083489,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403639,38403639,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224680,UniProtKB:P00480#VAR_004897",2,97248,38403639,G,C,G188R,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,188,G,R,True,834
13135,9255,103141,single nucleotide variant,NM_000531.6(OTC):c.563G>T (p.Gly188Val),5009,OTC,HGNC:8512,Pathogenic,1,-,72556295,-,RCV000083490,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38403640,38403640,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224681,UniProtKB:P00480#VAR_009234",2,97249,38403640,G,T,G188V,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,188,G,V,True,834
13136,2708,26045,single nucleotide variant,NM_000531.6(OTC):c.236G>A (p.Gly79Glu),5009,OTC,HGNC:8512,Pathogenic,1,1-Feb-02,72554331,-,RCV000011753|RCV000083369,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38369815,38369815,na,na,Xp11.4,no assertion criteria provided,2,ACMG2016,N,"ClinGen:CA224511,UniProtKB:P00480#VAR_004858,OMIM:300461.0021",3,11006,38369815,G,A,G79E,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,79,G,E,True,834
13137,9212,103000,single nucleotide variant,NM_000531.6(OTC):c.127C>T (p.Leu43Phe),5009,OTC,HGNC:8512,Pathogenic,1,-,72554309,-,RCV000083335,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38367340,38367340,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224457,UniProtKB:P00480#VAR_004847",2,97108,38367340,C,T,L43F,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,43,L,F,True,834
13138,9211,102998,single nucleotide variant,NM_000531.6(OTC):c.115G>T (p.Gly39Cys),5009,OTC,HGNC:8512,Pathogenic,1,-,72554306,-,RCV000083331,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38367328,38367328,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224453,UniProtKB:P00480#VAR_004844",2,97106,38367328,G,T,G39C,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,39,G,C,True,834
13139,2700,26029,single nucleotide variant,NM_000531.6(OTC):c.646C>G (p.Gln216Glu),5009,OTC,HGNC:8512,Pathogenic,1,26-Jan-17,72558423,-,RCV000011737|RCV000083523,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38403723,38403723,na,na,Xp11.4,no assertion criteria provided,2,ACMG2016,N,"ClinGen:CA224724,UniProtKB:P00480#VAR_004911,OMIM:300461.0005",3,10990,38403723,C,G,Q216E,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,216,Q,E,True,834
13140,9283,103220,single nucleotide variant,NM_000531.6(OTC):c.791C>T (p.Thr264Ile),5009,OTC,HGNC:8512,Pathogenic,1,-,67156896,-,RCV000083575,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38408949,38408949,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224792,UniProtKB:P00480#VAR_004923",2,97328,38408949,C,T,T264I,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,264,T,I,True,834
13141,9210,102996,single nucleotide variant,NM_000531.6(OTC):c.1061T>G (p.Phe354Cys),5009,OTC,HGNC:8512,Likely pathogenic,1,-,72558495,-,RCV000083329|RCV001095686,"MedGen:CN517202|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",not provided|Ornithine carbamoyltransferase deficiency,germline;unknown,germline,GRCh38,NC_000023.11,X,38421078,38421078,na,na,Xp11.4,"criteria provided, single submitter",2,ACMG2016,N,"ClinGen:CA224450,UniProtKB:P00480#VAR_004948",2,97104,38421078,T,G,F354C,1,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,354,F,C,True,834
13142,2698,26026,single nucleotide variant,NM_000531.6(OTC):c.422G>A (p.Arg141Gln),5009,OTC,HGNC:8512,Pathogenic,1,11-Dec-19,68026851,-,RCV000011734|RCV000083434,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38401310,38401310,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",5,ACMG2016,N,"ClinGen:CA224600,UniProtKB:P00480#VAR_004879,OMIM:300461.0002",3,10987,38401310,G,A,R141Q,2,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,141,R,Q,True,834
13143,9298,103268,single nucleotide variant,NM_000531.6(OTC):c.988A>G (p.Arg330Gly),5009,OTC,HGNC:8512,Likely pathogenic,1,16-Nov-15,72558478,-,RCV000083625,MedGen:CN517202,not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38411982,38411982,na,na,Xp11.4,"criteria provided, single submitter",2,ACMG2016,N,"ClinGen:CA224864,UniProtKB:P00480#VAR_004939",2,97376,38411982,A,G,R330G,1,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,330,R,G,True,834
13144,9297,103266,single nucleotide variant,NM_000531.6(OTC):c.976G>A (p.Glu326Lys),5009,OTC,HGNC:8512,Pathogenic,1,-,72558476,-,RCV000083623,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38411970,38411970,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"UniProtKB:P00480#VAR_010610,ClinGen:CA224861",2,97374,38411970,G,A,E326K,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,326,E,K,True,834
13145,9296,103264,single nucleotide variant,NM_000531.6(OTC):c.959G>T (p.Arg320Leu),5009,OTC,HGNC:8512,Likely pathogenic,1,16-Dec-19,72558474,-,RCV000083621|RCV001039339,"MedGen:CN517202|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",not provided|Ornithine carbamoyltransferase deficiency,germline;unknown,germline,GRCh38,NC_000023.11,X,38411953,38411953,na,na,Xp11.4,"criteria provided, single submitter",2,ACMG2016,N,"ClinGen:CA224858,UniProtKB:P00480#VAR_004938",2,97372,38411953,G,T,R320L,1,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,320,R,L,True,834
13146,9295,103251,single nucleotide variant,NM_000531.6(OTC):c.914C>A (p.Pro305His),5009,OTC,HGNC:8512,Pathogenic,1,-,67501347,-,RCV000083608,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38411908,38411908,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224835,UniProtKB:P00480#VAR_012655",2,97359,38411908,C,A,P305H,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,305,P,H,True,834
13147,9294,103250,single nucleotide variant,NM_000531.6(OTC):c.908G>A (p.Cys303Tyr),5009,OTC,HGNC:8512,Pathogenic,1,-,72558464,-,RCV000083606,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38411902,38411902,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224833,UniProtKB:P00480#VAR_004935",2,97358,38411902,G,A,C303Y,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,303,C,Y,True,834
13148,9292,103246,single nucleotide variant,NM_000531.6(OTC):c.906C>G (p.His302Gln),5009,OTC,HGNC:8512,Pathogenic,1,-,67870244,-,RCV000083602,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38411900,38411900,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224828,UniProtKB:P00480#VAR_004932",2,97354,38411900,C,G,H302Q,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,302,H,Q,True,834
13149,9291,103245,single nucleotide variant,NM_000531.6(OTC):c.905A>T (p.His302Leu),5009,OTC,HGNC:8512,Pathogenic,1,-,67993095,-,RCV000083601,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38411899,38411899,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224827,UniProtKB:P00480#VAR_004931",2,97353,38411899,A,T,H302L,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,302,H,L,True,834
13150,9290,103243,single nucleotide variant,NM_000531.6(OTC):c.904C>T (p.His302Tyr),5009,OTC,HGNC:8512,Pathogenic,1,-,72558463,-,RCV000083599,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38411898,38411898,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"UniProtKB:P00480#VAR_004933,ClinGen:CA224824",2,97351,38411898,C,T,H302Y,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,302,H,Y,True,834
13151,9289,103242,single nucleotide variant,NM_000531.6(OTC):c.903A>T (p.Leu301Phe),5009,OTC,HGNC:8512,Likely pathogenic,1,16-Oct-20,72558462,-,RCV000083598|RCV001228473,"MedGen:CN517202|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",not provided|Ornithine carbamoyltransferase deficiency,germline;unknown,germline,GRCh38,NC_000023.11,X,38411897,38411897,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",3,ACMG2016,N,"ClinGen:CA224823,UniProtKB:P00480#VAR_012654",2,97350,38411897,A,T,L301F,2,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,301,L,F,True,834
13152,10276,135313,single nucleotide variant,NM_000531.6(OTC):c.809A>G (p.Gln270Arg),5009,OTC,HGNC:8512,Benign/Likely benign,0,31-Dec-19,1800328,-,RCV000117884|RCV000335039|RCV000715832,"MedGen:CN169374|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:C2711754",not specified|Ornithine carbamoyltransferase deficiency|History of neurodevelopmental disorder,germline;unknown,germline,GRCh38,NC_000023.11,X,38408967,38408967,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",10,ACMG2016,N,"ClinGen:CA154208,UniProtKB:P00480#VAR_004927",2,129867,38408967,A,G,Q270R,2,benign,benign,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,270,Q,R,True,834
13153,9288,103231,single nucleotide variant,NM_000531.6(OTC):c.830G>A (p.Arg277Gln),5009,OTC,HGNC:8512,Pathogenic,1,18-Oct-16,66724222,-,RCV000083587|RCV000507904,MedGen:CN517202|MedGen:CN169374,not provided|not specified,germline;unknown,germline,GRCh38,NC_000023.11,X,38408988,38408988,na,na,Xp11.4,"criteria provided, single submitter",2,ACMG2016,N,"ClinGen:CA224808,UniProtKB:P00480#VAR_004929",2,97339,38408988,G,A,R277Q,1,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,277,R,Q,True,834
13154,9286,103225,single nucleotide variant,NM_000531.6(OTC):c.803T>C (p.Met268Thr),5009,OTC,HGNC:8512,Pathogenic,1,14-Mar-18,72558449,-,RCV000083580|RCV000702113,"MedGen:CN517202|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664",not provided|Ornithine carbamoyltransferase deficiency,germline;unknown,germline,GRCh38,NC_000023.11,X,38408961,38408961,na,na,Xp11.4,"criteria provided, single submitter",2,ACMG2016,N,"ClinGen:CA224799,UniProtKB:P00480#VAR_004925",2,97333,38408961,T,C,M268T,1,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,268,M,T,True,834
13155,2716,26053,single nucleotide variant,NM_000531.6(OTC):c.119G>A (p.Arg40His),5009,OTC,HGNC:8512,Pathogenic,1,27-Aug-18,72554308,-,RCV000011761|RCV000083333,"MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN517202",Ornithine carbamoyltransferase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000023.11,X,38367332,38367332,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",7,ACMG2016,N,"ClinGen:CA224454,UniProtKB:P00480#VAR_004846,OMIM:300461.0029",3,11014,38367332,G,A,R40H,2,pathogenic,pathogenic,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,40,R,H,True,834
13156,9209,102993,single nucleotide variant,NM_000531.6(OTC):c.1034A>G (p.Tyr345Cys),5009,OTC,HGNC:8512,Pathogenic,1,-,72558492,-,RCV000083326,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38421051,38421051,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224445,UniProtKB:P00480#VAR_004946",2,97101,38421051,A,G,Y345C,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,345,Y,C,True,834
13157,9208,102991,single nucleotide variant,NM_000531.6(OTC):c.1028C>A (p.Thr343Lys),5009,OTC,HGNC:8512,Pathogenic,1,-,72558491,-,RCV000083323,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38421045,38421045,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224441,UniProtKB:P00480#VAR_004944",2,97099,38421045,C,A,T343K,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,343,T,K,True,834
13158,9287,103226,single nucleotide variant,NM_000531.6(OTC):c.806G>A (p.Gly269Glu),5009,OTC,HGNC:8512,Pathogenic,1,-,72558450,-,RCV000083581,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38408964,38408964,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224800,UniProtKB:P00480#VAR_004926",2,97334,38408964,G,A,G269E,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,269,G,E,True,834
13159,9207,102990,single nucleotide variant,NM_000531.6(OTC):c.1022T>C (p.Leu341Pro),5009,OTC,HGNC:8512,Pathogenic,1,-,72558490,-,RCV000083322,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38421039,38421039,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224440,UniProtKB:P00480#VAR_012657",2,97098,38421039,T,C,L341P,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,341,L,P,True,834
13160,9284,103222,single nucleotide variant,NM_000531.6(OTC):c.794G>T (p.Trp265Leu),5009,OTC,HGNC:8512,Pathogenic,1,-,72558446,-,RCV000083577,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38408952,38408952,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224795,UniProtKB:P00480#VAR_010609",2,97330,38408952,G,T,W265L,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,265,W,L,True,834
13161,9206,102989,single nucleotide variant,NM_000531.6(OTC):c.1018T>C (p.Ser340Pro),5009,OTC,HGNC:8512,Pathogenic,1,-,72558489,-,RCV000083321,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38421035,38421035,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224439,UniProtKB:P00480#VAR_004943",2,97097,38421035,T,C,S340P,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,340,S,P,True,834
13162,9205,102988,single nucleotide variant,NM_000531.6(OTC):c.1015G>C (p.Val339Leu),5009,OTC,HGNC:8512,Pathogenic,1,-,72558488,-,RCV000083320,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38421032,38421032,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224438,UniProtKB:P00480#VAR_004942",2,97096,38421032,G,C,V339L,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,339,V,L,True,834
13163,9204,102987,single nucleotide variant,NM_000531.6(OTC):c.1009G>C (p.Val337Leu),5009,OTC,HGNC:8512,Pathogenic,1,-,72558487,-,RCV000083319,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38421026,38421026,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224437,UniProtKB:P00480#VAR_004941",2,97095,38421026,G,C,V337L,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,337,V,L,True,834
13164,9203,102986,single nucleotide variant,NM_000531.6(OTC):c.1006G>T (p.Ala336Ser),5009,OTC,HGNC:8512,Pathogenic,1,-,72558486,-,RCV000083318,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38421023,38421023,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224436,UniProtKB:P00480#VAR_004940",2,97094,38421023,G,T,A336S,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,336,A,S,True,834
13165,9285,103224,single nucleotide variant,NM_000531.6(OTC):c.799A>C (p.Ser267Arg),5009,OTC,HGNC:8512,Pathogenic,1,-,72558448,-,RCV000083579,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000023.11,X,38408957,38408957,na,na,Xp11.4,no assertion criteria provided,1,ACMG2016,N,"ClinGen:CA224798,UniProtKB:P00480#VAR_004924",2,97332,38408957,A,C,S267R,0,pathogenic,uncertain,P00480,P00480,reviewed,OTC_HUMAN,"Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)",OTC,Homo sapiens (Human),354.0,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,PF00185;PF02729;,1C9Y;1EP9;1FVO;1OTH;,267,S,R,True,834
13166,13067,248575,single nucleotide variant,NM_138348.6(OTULIN):c.815T>C (p.Leu272Pro),90268,OTULIN,HGNC:25118,Pathogenic,1,1-Sep-16,886037885,-,RCV000240607,"MONDO:MONDO:0014912,MedGen:C4310614,OMIM:617099,Orphanet:500062","Autoinflammation, panniculitis, and dermatosis syndrome",germline,germline,GRCh38,NC_000005.10,5,14690259,14690259,na,na,5p15.2,no assertion criteria provided,1,-,N,"ClinGen:CA10586331,UniProtKB:Q96BN8#VAR_076866,OMIM:615712.0001",1,254124,14690259,T,C,L272P,0,pathogenic,uncertain,Q96BN8,Q96BN8,reviewed,OTUL_HUMAN,"Ubiquitin thioesterase otulin, EC 3.4.19.12 (Deubiquitinating enzyme otulin) (OTU domain-containing deubiquitinase with linear linkage specificity) (Ubiquitin thioesterase Gumby)",OTULIN FAM105B,Homo sapiens (Human),352.0,MSRGTMPQPEAWPGASCAETPAREAAATARDGGKAAASGQPRPEMQCPAEHEEDMYRAADEIEKEKELLIHERGASEPRLSVAPEMDIMDYCKKEWRGNTQKATCMKMGYEEVSQKFTSIRRVRGDNYCALRATLFQAMSQAVGLPPWLQDPELMLLPEKLISKYNWIKQWKLGLKFDGKNEDLVDKIKESLTLLRKKWAGLAEMRTAEARQIACDELFTNEAEEYSLYEAVKFLMLNRAIELYNDKEKGKEVPFFSVLLFARDTSNDPGQLLRNHLNQVGHTGGLEQVEMFLLAYAVRHTIQVYRLSKYNTEEFITVYPTDPPKDWPVVTLIAEDDRHYNIPVRVCEETSL,PF16218;,3ZNV;3ZNX;3ZNZ;4KSJ;4KSK;4KSL;4OYK;4P0B;5OE7;6I9C;6SAK;,272,L,P,True,835
13167,13068,248577,single nucleotide variant,NM_138348.6(OTULIN):c.731A>G (p.Tyr244Cys),90268,OTULIN,HGNC:25118,Pathogenic,1,1-Sep-16,886037887,-,RCV000240606,"MONDO:MONDO:0014912,MedGen:C4310614,OMIM:617099,Orphanet:500062","Autoinflammation, panniculitis, and dermatosis syndrome",germline,germline,GRCh38,NC_000005.10,5,14690175,14690175,na,na,5p15.2,no assertion criteria provided,1,-,N,"ClinGen:CA10586333,UniProtKB:Q96BN8#VAR_076865,OMIM:615712.0003",1,254126,14690175,A,G,Y244C,0,pathogenic,uncertain,Q96BN8,Q96BN8,reviewed,OTUL_HUMAN,"Ubiquitin thioesterase otulin, EC 3.4.19.12 (Deubiquitinating enzyme otulin) (OTU domain-containing deubiquitinase with linear linkage specificity) (Ubiquitin thioesterase Gumby)",OTULIN FAM105B,Homo sapiens (Human),352.0,MSRGTMPQPEAWPGASCAETPAREAAATARDGGKAAASGQPRPEMQCPAEHEEDMYRAADEIEKEKELLIHERGASEPRLSVAPEMDIMDYCKKEWRGNTQKATCMKMGYEEVSQKFTSIRRVRGDNYCALRATLFQAMSQAVGLPPWLQDPELMLLPEKLISKYNWIKQWKLGLKFDGKNEDLVDKIKESLTLLRKKWAGLAEMRTAEARQIACDELFTNEAEEYSLYEAVKFLMLNRAIELYNDKEKGKEVPFFSVLLFARDTSNDPGQLLRNHLNQVGHTGGLEQVEMFLLAYAVRHTIQVYRLSKYNTEEFITVYPTDPPKDWPVVTLIAEDDRHYNIPVRVCEETSL,PF16218;,3ZNV;3ZNX;3ZNZ;4KSJ;4KSK;4KSL;4OYK;4P0B;5OE7;6I9C;6SAK;,244,Y,C,True,835
13168,2565,25588,single nucleotide variant,NM_006915.3(RP2):c.353G>T (p.Arg118Leu),6102,RP2,HGNC:10274,Pathogenic,1,1-Aug-01,28933687,-,RCV000011295,"MONDO:MONDO:0010723,MedGen:C2681923,OMIM:312600,Orphanet:791",Retinitis pigmentosa 2,germline,germline,GRCh38,NC_000023.11,X,46853726,46853726,na,na,Xp11.3,no assertion criteria provided,1,-,N,"ClinGen:CA255304,UniProtKB:O75695#VAR_018072,OMIM:300757.0006",1,10549,46853726,G,T,R118L,0,pathogenic,uncertain,O75695,O75695,reviewed,XRP2_HUMAN,Protein XRP2,RP2,Homo sapiens (Human),350.0,MGCFFSKRRKADKESRPENEEERPKQYSWDQREKVDPKDYMFSGLKDETVGRLPGTVAGQQFLIQDCENCNIYIFDHSATVTIDDCTNCIIFLGPVKGSVFFRNCRDCKCTLACQQFRVRDCRKLEVFLCCATQPIIESSSNIKFGCFQWYYPELAFQFKDAGLSIFNNTWSNIHDFTPVSGELNWSLLPEDAVVQDYVPIPTTEELKAVRVSTEANRSIVPISRGQRQKSSDESCLVVLFAGDYTIANARKLIDEMVGKGFFLVQTKEVSMKAEDAQRVFREKAPDFLPLLNKGPVIALEFNGDGAVEVCQLIVNEIFNGTKMFVSESKETASGDVDSFYNFADIQMGI,PF07986;,2BX6;3BH6;3BH7;,118,R,L,True,836
13169,11863,193605,single nucleotide variant,NM_006915.3(RP2):c.844C>T (p.Arg282Trp),6102,RP2,HGNC:10274,Benign/Likely benign,0,2-Oct-18,1805147,-,RCV000177264|RCV000326876|RCV001000370,"MedGen:CN169374|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MONDO:MONDO:0010723,MedGen:C2681923,OMIM:312600,Orphanet:791",not specified|Retinitis pigmentosa|Retinitis pigmentosa 2,germline,germline,GRCh38,NC_000023.11,X,46860063,46860063,na,na,Xp11.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA202379,UniProtKB:O75695#VAR_014535",2,196444,46860063,C,T,R282W,2,benign,benign,O75695,O75695,reviewed,XRP2_HUMAN,Protein XRP2,RP2,Homo sapiens (Human),350.0,MGCFFSKRRKADKESRPENEEERPKQYSWDQREKVDPKDYMFSGLKDETVGRLPGTVAGQQFLIQDCENCNIYIFDHSATVTIDDCTNCIIFLGPVKGSVFFRNCRDCKCTLACQQFRVRDCRKLEVFLCCATQPIIESSSNIKFGCFQWYYPELAFQFKDAGLSIFNNTWSNIHDFTPVSGELNWSLLPEDAVVQDYVPIPTTEELKAVRVSTEANRSIVPISRGQRQKSSDESCLVVLFAGDYTIANARKLIDEMVGKGFFLVQTKEVSMKAEDAQRVFREKAPDFLPLLNKGPVIALEFNGDGAVEVCQLIVNEIFNGTKMFVSESKETASGDVDSFYNFADIQMGI,PF07986;,2BX6;3BH6;3BH7;,282,R,W,True,836
13170,2564,25585,single nucleotide variant,NM_006915.3(RP2):c.353G>A (p.Arg118His),6102,RP2,HGNC:10274,Pathogenic,1,21-Oct-19,28933687,-,RCV000011292|RCV001075110|RCV001215347,"MONDO:MONDO:0010723,MedGen:C2681923,OMIM:312600,Orphanet:791|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862|MedGen:CN517202",Retinitis pigmentosa 2|Retinal dystrophy|not provided,germline;inherited,germline,GRCh38,NC_000023.11,X,46853726,46853726,na,na,Xp11.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA255301,UniProtKB:O75695#VAR_008499,OMIM:300757.0003",3,10546,46853726,G,A,R118H,2,pathogenic,pathogenic,O75695,O75695,reviewed,XRP2_HUMAN,Protein XRP2,RP2,Homo sapiens (Human),350.0,MGCFFSKRRKADKESRPENEEERPKQYSWDQREKVDPKDYMFSGLKDETVGRLPGTVAGQQFLIQDCENCNIYIFDHSATVTIDDCTNCIIFLGPVKGSVFFRNCRDCKCTLACQQFRVRDCRKLEVFLCCATQPIIESSSNIKFGCFQWYYPELAFQFKDAGLSIFNNTWSNIHDFTPVSGELNWSLLPEDAVVQDYVPIPTTEELKAVRVSTEANRSIVPISRGQRQKSSDESCLVVLFAGDYTIANARKLIDEMVGKGFFLVQTKEVSMKAEDAQRVFREKAPDFLPLLNKGPVIALEFNGDGAVEVCQLIVNEIFNGTKMFVSESKETASGDVDSFYNFADIQMGI,PF07986;,2BX6;3BH6;3BH7;,118,R,H,True,836
13171,9149,101210,single nucleotide variant,NM_005765.3(ATP6AP2):c.268C>G (p.Pro90Ala),10159,ATP6AP2,HGNC:18305,Benign,0,31-Dec-19,9014,-,RCV000081328|RCV000549577|RCV000720938,"MedGen:CN169374|MONDO:MONDO:0010319,MedGen:C1845543,OMIM:300423,Orphanet:93952|MedGen:C2711754","not specified|Mental retardation, X-linked, syndromic, Hedera type|History of neurodevelopmental disorder",germline,germline,GRCh38,NC_000023.11,X,40591333,40591333,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA148417,UniProtKB:O75787#VAR_051313",2,95311,40591333,C,G,P90A,2,benign,benign,O75787,O75787,reviewed,RENR_HUMAN,"Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (ER-localized type I transmembrane adapter) (Embryonic liver differentiation factor 10) (N14F) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9, ATP6M8-9, V-ATPase M8.9 subunit) [Cleaved into: Renin receptor N-terminal fragment; Renin receptor C-terminal fragment ]",ATP6AP2 ATP6IP2 CAPER ELDF10 HT028 MSTP009 PSEC0072,Homo sapiens (Human),350.0,MAVFVVLLALVAGVLGNEFSILKSPGSVVFRNGNWPIPGERIPDVAALSMGFSVKEDLSWPGLAVGNLFHRPRATVMVMVKGVNKLALPPGSVISYPLENAVPFSLDSVANSIHSLFSEETPVVLQLAPSEERVYMVGKANSVFEDLSVTLRQLRNRLFQENSVLSSLPLNSLSRNNEVDLLFLSELQVLHDISSLLSRHKHLAKDHSPDLYSLELAGLDEIGKRYGEDSEQFRDASKILVDALQKFADDMYSLYGGNAVVELVTVKSFDTSLIRKTRTILEAKQAKNPASPYNLAYKYNFEYSVVFNMVLWIMIALALAVIITSYNIWNMDPGYDSIIYRMTNQKIRMD,PF07850;,3LBS;3LC8;6WLW;6WM2;6WM3;6WM4;,90,P,A,True,837
13172,10170,133936,single nucleotide variant,NM_005765.3(ATP6AP2):c.868G>C (p.Ala290Pro),10159,ATP6AP2,HGNC:18305,Benign,0,31-Dec-19,35798522,-,RCV000116456|RCV000526186|RCV000720942,"MedGen:CN169374|MONDO:MONDO:0010319,MedGen:C1845543,OMIM:300423,Orphanet:93952|MedGen:C2711754","not specified|Mental retardation, X-linked, syndromic, Hedera type|History of neurodevelopmental disorder",germline,germline,GRCh38,NC_000023.11,X,40605570,40605570,na,na,Xp11.4,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA288697,UniProtKB:O75787#VAR_051314",2,128487,40605570,G,C,A290P,2,benign,benign,O75787,O75787,reviewed,RENR_HUMAN,"Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (ER-localized type I transmembrane adapter) (Embryonic liver differentiation factor 10) (N14F) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9, ATP6M8-9, V-ATPase M8.9 subunit) [Cleaved into: Renin receptor N-terminal fragment; Renin receptor C-terminal fragment ]",ATP6AP2 ATP6IP2 CAPER ELDF10 HT028 MSTP009 PSEC0072,Homo sapiens (Human),350.0,MAVFVVLLALVAGVLGNEFSILKSPGSVVFRNGNWPIPGERIPDVAALSMGFSVKEDLSWPGLAVGNLFHRPRATVMVMVKGVNKLALPPGSVISYPLENAVPFSLDSVANSIHSLFSEETPVVLQLAPSEERVYMVGKANSVFEDLSVTLRQLRNRLFQENSVLSSLPLNSLSRNNEVDLLFLSELQVLHDISSLLSRHKHLAKDHSPDLYSLELAGLDEIGKRYGEDSEQFRDASKILVDALQKFADDMYSLYGGNAVVELVTVKSFDTSLIRKTRTILEAKQAKNPASPYNLAYKYNFEYSVVFNMVLWIMIALALAVIITSYNIWNMDPGYDSIIYRMTNQKIRMD,PF07850;,3LBS;3LC8;6WLW;6WM2;6WM3;6WM4;,290,A,P,True,837
13173,11226,172317,single nucleotide variant,NM_004130.3(GYG1):c.304G>C (p.Asp102His),2992,GYG1,HGNC:4699,Conflicting interpretations of pathogenicity,1,19-Nov-19,143137713,-,RCV000150100|RCV000413263|RCV000703555|RCV001195381,"MONDO:MONDO:0014526,MedGen:C4015452,OMIM:616199,Orphanet:456369|MedGen:CN517202|MONDO:MONDO:0013291,MedGen:C3150754,OMIM:613507,Orphanet:263297;MONDO:MONDO:0014526,MedGen:C4015452,OMIM:616199,Orphanet:456369|MedGen:CN169374",Polyglucosan body myopathy 2|not provided|Glycogen storage disease XV;Polyglucosan body myopathy 2|not specified,germline;unknown,germline,GRCh38,NC_000003.12,3,148996462,148996462,na,na,3q24,"criteria provided, conflicting interpretations",7,-,N,"ClinGen:CA175129,UniProtKB:P46976#VAR_072707,OMIM:603942.0005",3,162663,148996462,G,C,D102H,1,uncertain,uncertain,P46976,P46976,reviewed,GLYG_HUMAN,"Glycogenin-1, GN-1, GN1, EC 2.4.1.186",GYG1 GYG,Homo sapiens (Human),350.0,MTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIYSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQQFGLVKDTCSYVNVLSDLVYTLAFSCGFCRKEDVSGAISHLSLGEIPAMAQPFVSSEERKERWEQGQADYMGADSFDNIKRKLDTYLQ,PF01501;,3Q4S;3QVB;3RMV;3RMW;3T7M;3T7N;3T7O;3U2T;3U2U;3U2V;3U2W;3U2X;6EQJ;6EQL;,102,D,H,True,838
13174,1387,20993,single nucleotide variant,NM_004130.3(GYG1):c.248C>T (p.Thr83Met),2992,GYG1,HGNC:4699,Pathogenic,1,1-Apr-12,267606858,-,RCV000006318,"MONDO:MONDO:0013291,MedGen:C3150754,OMIM:613507,Orphanet:263297",Glycogen storage disease XV,germline,germline,GRCh38,NC_000003.12,3,148996406,148996406,na,na,3q24,no assertion criteria provided,1,-,N,"ClinGen:CA117880,UniProtKB:P46976#VAR_063768,OMIM:603942.0002",1,5954,148996406,C,T,T83M,0,pathogenic,uncertain,P46976,P46976,reviewed,GLYG_HUMAN,"Glycogenin-1, GN-1, GN1, EC 2.4.1.186",GYG1 GYG,Homo sapiens (Human),350.0,MTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIYSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQQFGLVKDTCSYVNVLSDLVYTLAFSCGFCRKEDVSGAISHLSLGEIPAMAQPFVSSEERKERWEQGQADYMGADSFDNIKRKLDTYLQ,PF01501;,3Q4S;3QVB;3RMV;3RMW;3T7M;3T7N;3T7O;3U2T;3U2U;3U2V;3U2W;3U2X;6EQJ;6EQL;,83,T,M,True,838
13175,13035,247414,single nucleotide variant,NM_004625.4(WNT7A):c.304C>T (p.Arg102Trp),7476,WNT7A,HGNC:12786,Pathogenic,1,8-Aug-16,879255548,-,RCV000239449,"MONDO:MONDO:0010164,MedGen:C1848651,OMIM:276820,Orphanet:2879",Schinzel phocomelia syndrome,inherited,germline,GRCh38,NC_000003.12,3,13854798,13854798,na,na,3p25.1,no assertion criteria provided,1,-,N,"ClinGen:CA10586154,UniProtKB:O00755#VAR_077340",2,253008,13854798,G,A,R102W,0,pathogenic,uncertain,O00755,O00755,reviewed,WNT7A_HUMAN,Protein Wnt-7a,WNT7A,Homo sapiens (Human),349.0,MNRKARRCLGHLFLSLGMVYLRIGGFSSVVALGASIICNKIPGLAPRQRAICQSRPDAIIVIGEGSQMGLDECQFQFRNGRWNCSALGERTVFGKELKVGSREAAFTYAIIAAGVAHAITAACTQGNLSDCGCDKEKQGQYHRDEGWKWGGCSADIRYGIGFAKVFVDAREIKQNARTLMNLHNNEAGRKILEENMKLECKCHGVSGSCTTKTCWTTLPQFRELGYVLKDKYNEAVHVEPVRASRNKRPTFLKIKKPLSYRKPMDTDLVYIEKSPNYCEEDPVTGSVGTQGRACNKTAPQASGCDLMCCGRGYNTHQYARVWQCNCKFHWCCYVKCNTCSERTEMYTCK,PF00110;,4UZQ;,102,R,W,True,839
13176,1894,23099,single nucleotide variant,NM_004625.4(WNT7A):c.874C>T (p.Arg292Cys),7476,WNT7A,HGNC:12786,Pathogenic,1,1-Aug-06,104893835,-,RCV000008526,"MONDO:MONDO:0010164,MedGen:C1848651,OMIM:276820,Orphanet:2879",Schinzel phocomelia syndrome,germline,germline,GRCh38,NC_000003.12,3,13819120,13819120,na,na,3p25.1,no assertion criteria provided,1,-,N,"ClinGen:CA119261,UniProtKB:O00755#VAR_030674,OMIM:601570.0001",1,8060,13819120,G,A,R292C,0,pathogenic,uncertain,O00755,O00755,reviewed,WNT7A_HUMAN,Protein Wnt-7a,WNT7A,Homo sapiens (Human),349.0,MNRKARRCLGHLFLSLGMVYLRIGGFSSVVALGASIICNKIPGLAPRQRAICQSRPDAIIVIGEGSQMGLDECQFQFRNGRWNCSALGERTVFGKELKVGSREAAFTYAIIAAGVAHAITAACTQGNLSDCGCDKEKQGQYHRDEGWKWGGCSADIRYGIGFAKVFVDAREIKQNARTLMNLHNNEAGRKILEENMKLECKCHGVSGSCTTKTCWTTLPQFRELGYVLKDKYNEAVHVEPVRASRNKRPTFLKIKKPLSYRKPMDTDLVYIEKSPNYCEEDPVTGSVGTQGRACNKTAPQASGCDLMCCGRGYNTHQYARVWQCNCKFHWCCYVKCNTCSERTEMYTCK,PF00110;,4UZQ;,292,R,C,True,839
13177,6530,48778,single nucleotide variant,NM_004625.4(WNT7A):c.214G>A (p.Glu72Lys),7476,WNT7A,HGNC:12786,Pathogenic,1,1-Feb-11,397514666,-,RCV000033263,"MONDO:MONDO:0010164,MedGen:C1848651,OMIM:276820,Orphanet:2879",Schinzel phocomelia syndrome,germline,germline,GRCh38,NC_000003.12,3,13875031,13875031,na,na,3p25.1,no assertion criteria provided,1,-,N,"ClinGen:CA130821,UniProtKB:O00755#VAR_065765,OMIM:601570.0005",1,40302,13875031,C,T,E72K,0,pathogenic,uncertain,O00755,O00755,reviewed,WNT7A_HUMAN,Protein Wnt-7a,WNT7A,Homo sapiens (Human),349.0,MNRKARRCLGHLFLSLGMVYLRIGGFSSVVALGASIICNKIPGLAPRQRAICQSRPDAIIVIGEGSQMGLDECQFQFRNGRWNCSALGERTVFGKELKVGSREAAFTYAIIAAGVAHAITAACTQGNLSDCGCDKEKQGQYHRDEGWKWGGCSADIRYGIGFAKVFVDAREIKQNARTLMNLHNNEAGRKILEENMKLECKCHGVSGSCTTKTCWTTLPQFRELGYVLKDKYNEAVHVEPVRASRNKRPTFLKIKKPLSYRKPMDTDLVYIEKSPNYCEEDPVTGSVGTQGRACNKTAPQASGCDLMCCGRGYNTHQYARVWQCNCKFHWCCYVKCNTCSERTEMYTCK,PF00110;,4UZQ;,72,E,K,True,839
13178,1895,23100,single nucleotide variant,NM_004625.4(WNT7A):c.325G>A (p.Ala109Thr),7476,WNT7A,HGNC:12786,Pathogenic,1,1-Aug-06,104893832,-,RCV000008527,"MONDO:MONDO:0009232,MedGen:C1856728,OMIM:228930,Orphanet:2854",Fuhrmann syndrome,germline,germline,GRCh38,NC_000003.12,3,13854777,13854777,na,na,3p25.1,no assertion criteria provided,1,-,N,"ClinGen:CA119262,UniProtKB:O00755#VAR_030673,OMIM:601570.0002",1,8061,13854777,C,T,A109T,0,pathogenic,uncertain,O00755,O00755,reviewed,WNT7A_HUMAN,Protein Wnt-7a,WNT7A,Homo sapiens (Human),349.0,MNRKARRCLGHLFLSLGMVYLRIGGFSSVVALGASIICNKIPGLAPRQRAICQSRPDAIIVIGEGSQMGLDECQFQFRNGRWNCSALGERTVFGKELKVGSREAAFTYAIIAAGVAHAITAACTQGNLSDCGCDKEKQGQYHRDEGWKWGGCSADIRYGIGFAKVFVDAREIKQNARTLMNLHNNEAGRKILEENMKLECKCHGVSGSCTTKTCWTTLPQFRELGYVLKDKYNEAVHVEPVRASRNKRPTFLKIKKPLSYRKPMDTDLVYIEKSPNYCEEDPVTGSVGTQGRACNKTAPQASGCDLMCCGRGYNTHQYARVWQCNCKFHWCCYVKCNTCSERTEMYTCK,PF00110;,4UZQ;,109,A,T,True,839
13179,6519,48633,single nucleotide variant,NM_004625.4(WNT7A):c.664C>T (p.Arg222Trp),7476,WNT7A,HGNC:12786,Pathogenic,1,1-Nov-10,397514643,-,RCV000033175,"MONDO:MONDO:0010164,MedGen:C1848651,OMIM:276820,Orphanet:2879",Schinzel phocomelia syndrome,germline,germline,GRCh38,NC_000003.12,3,13819330,13819330,na,na,3p25.1,no assertion criteria provided,1,-,N,"OMIM:601570.0004,ClinGen:CA130747,UniProtKB:O00755#VAR_064480",1,40130,13819330,G,A,R222W,0,pathogenic,uncertain,O00755,O00755,reviewed,WNT7A_HUMAN,Protein Wnt-7a,WNT7A,Homo sapiens (Human),349.0,MNRKARRCLGHLFLSLGMVYLRIGGFSSVVALGASIICNKIPGLAPRQRAICQSRPDAIIVIGEGSQMGLDECQFQFRNGRWNCSALGERTVFGKELKVGSREAAFTYAIIAAGVAHAITAACTQGNLSDCGCDKEKQGQYHRDEGWKWGGCSADIRYGIGFAKVFVDAREIKQNARTLMNLHNNEAGRKILEENMKLECKCHGVSGSCTTKTCWTTLPQFRELGYVLKDKYNEAVHVEPVRASRNKRPTFLKIKKPLSYRKPMDTDLVYIEKSPNYCEEDPVTGSVGTQGRACNKTAPQASGCDLMCCGRGYNTHQYARVWQCNCKFHWCCYVKCNTCSERTEMYTCK,PF00110;,4UZQ;,222,R,W,True,839
13180,852,18716,single nucleotide variant,NM_001008216.2(GALE):c.269G>A (p.Gly90Glu),2582,GALE,HGNC:4116,Pathogenic,1,25-Jan-11,28940882,-,RCV000003862,"MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238",UDPglucose-4-epimerase deficiency,germline,germline,GRCh38,NC_000001.11,1,23798199,23798199,na,na,1p36.11,no assertion criteria provided,2,-,N,"ClinGen:CA340114,UniProtKB:Q14376#VAR_002540,OMIM:606953.0003",1,3677,23798199,C,T,G90E,0,pathogenic,uncertain,Q14376,Q14376,reviewed,GALE_HUMAN,"UDP-glucose 4-epimerase, EC 5.1.3.2 (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase, UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase, UDP-GlcNAc 4-epimerase, EC 5.1.3.7) (UDP-galactose 4-epimerase)",GALE,Homo sapiens (Human),348.0,MAEKVLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSVEFEEMDILDQGALQRLFKKYSFMAVIHFAGLKAVGESVQKPLDYYRVNLTGTIQLLEIMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEEMIRDLCQADKTWNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRREALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKEQCGCRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARREGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA,PF16363;,1EK5;1EK6;1HZJ;1I3K;1I3L;1I3M;1I3N;,90,G,E,True,840
13181,851,18715,single nucleotide variant,NM_001008216.2(GALE):c.101A>G (p.Asn34Ser),2582,GALE,HGNC:4116,Pathogenic,1,1-Jan-16,121908046,-,RCV000003861|RCV000723966,"MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238|MedGen:CN517202",UDPglucose-4-epimerase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000001.11,1,23798907,23798907,na,na,1p36.11,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA340112,UniProtKB:Q14376#VAR_002539,OMIM:606953.0002",3,3676,23798907,T,C,N34S,2,pathogenic,pathogenic,Q14376,Q14376,reviewed,GALE_HUMAN,"UDP-glucose 4-epimerase, EC 5.1.3.2 (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase, UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase, UDP-GlcNAc 4-epimerase, EC 5.1.3.7) (UDP-galactose 4-epimerase)",GALE,Homo sapiens (Human),348.0,MAEKVLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSVEFEEMDILDQGALQRLFKKYSFMAVIHFAGLKAVGESVQKPLDYYRVNLTGTIQLLEIMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEEMIRDLCQADKTWNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRREALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKEQCGCRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARREGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA,PF16363;,1EK5;1EK6;1HZJ;1I3K;1I3L;1I3M;1I3N;,34,N,S,True,840
13182,5410,34025,single nucleotide variant,NM_001008216.2(GALE):c.905G>A (p.Gly302Asp),2582,GALE,HGNC:4116,Pathogenic,1,25-Jan-11,137853861,-,RCV000020295,"MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238",UDPglucose-4-epimerase deficiency,not provided,not provided,GRCh38,NC_000001.11,1,23796234,23796234,na,na,1p36.11,no assertion criteria provided,1,-,N,"ClinGen:CA341701,UniProtKB:Q14376#VAR_037739",1,21173,23796234,C,T,G302D,0,pathogenic,uncertain,Q14376,Q14376,reviewed,GALE_HUMAN,"UDP-glucose 4-epimerase, EC 5.1.3.2 (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase, UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase, UDP-GlcNAc 4-epimerase, EC 5.1.3.7) (UDP-galactose 4-epimerase)",GALE,Homo sapiens (Human),348.0,MAEKVLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSVEFEEMDILDQGALQRLFKKYSFMAVIHFAGLKAVGESVQKPLDYYRVNLTGTIQLLEIMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEEMIRDLCQADKTWNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRREALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKEQCGCRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARREGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA,PF16363;,1EK5;1EK6;1HZJ;1I3K;1I3L;1I3M;1I3N;,302,G,D,True,840
13183,5409,34024,single nucleotide variant,NM_001008216.2(GALE):c.715C>T (p.Arg239Trp),2582,GALE,HGNC:4116,Likely pathogenic,1,18-Mar-16,137853860,-,RCV000020294,"MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238",UDPglucose-4-epimerase deficiency,germline,germline,GRCh38,NC_000001.11,1,23796777,23796777,na,na,1p36.11,"criteria provided, single submitter",2,-,N,"ClinGen:CA341699,UniProtKB:Q14376#VAR_037738",3,21172,23796777,G,A,R239W,1,pathogenic,pathogenic,Q14376,Q14376,reviewed,GALE_HUMAN,"UDP-glucose 4-epimerase, EC 5.1.3.2 (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase, UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase, UDP-GlcNAc 4-epimerase, EC 5.1.3.7) (UDP-galactose 4-epimerase)",GALE,Homo sapiens (Human),348.0,MAEKVLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSVEFEEMDILDQGALQRLFKKYSFMAVIHFAGLKAVGESVQKPLDYYRVNLTGTIQLLEIMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEEMIRDLCQADKTWNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRREALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKEQCGCRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARREGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA,PF16363;,1EK5;1EK6;1HZJ;1I3K;1I3L;1I3M;1I3N;,239,R,W,True,840
13184,855,18719,single nucleotide variant,NM_001008216.2(GALE):c.937C>A (p.Leu313Met),2582,GALE,HGNC:4116,Pathogenic,1,1-Jan-98,3180383,-,RCV000003865,"MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238",UDPglucose-4-epimerase deficiency,germline,germline,GRCh38,NC_000001.11,1,23796202,23796202,na,na,1p36.11,no assertion criteria provided,1,-,N,"ClinGen:CA252858,UniProtKB:Q14376#VAR_002545,OMIM:606953.0006",1,3680,23796202,G,T,L313M,0,pathogenic,uncertain,Q14376,Q14376,reviewed,GALE_HUMAN,"UDP-glucose 4-epimerase, EC 5.1.3.2 (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase, UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase, UDP-GlcNAc 4-epimerase, EC 5.1.3.7) (UDP-galactose 4-epimerase)",GALE,Homo sapiens (Human),348.0,MAEKVLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSVEFEEMDILDQGALQRLFKKYSFMAVIHFAGLKAVGESVQKPLDYYRVNLTGTIQLLEIMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEEMIRDLCQADKTWNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRREALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKEQCGCRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARREGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA,PF16363;,1EK5;1EK6;1HZJ;1I3K;1I3L;1I3M;1I3N;,313,L,M,True,840
13185,854,18718,single nucleotide variant,NM_001008216.2(GALE):c.770A>G (p.Lys257Arg),2582,GALE,HGNC:4116,"Benign/Likely benign, other",1,22-Dec-19,28940884,-,RCV000003864|RCV000592410|RCV000609606,"MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238|MedGen:CN517202|MedGen:CN169374",UDPglucose-4-epimerase deficiency|not provided|not specified,germline;unknown,germline,GRCh38,NC_000001.11,1,23796722,23796722,na,na,1p36.11,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA340116,UniProtKB:Q14376#VAR_002544,OMIM:606953.0005",3,3679,23796722,T,C,K257R,2,benign,benign,Q14376,Q14376,reviewed,GALE_HUMAN,"UDP-glucose 4-epimerase, EC 5.1.3.2 (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase, UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase, UDP-GlcNAc 4-epimerase, EC 5.1.3.7) (UDP-galactose 4-epimerase)",GALE,Homo sapiens (Human),348.0,MAEKVLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSVEFEEMDILDQGALQRLFKKYSFMAVIHFAGLKAVGESVQKPLDYYRVNLTGTIQLLEIMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEEMIRDLCQADKTWNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRREALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKEQCGCRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARREGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA,PF16363;,1EK5;1EK6;1HZJ;1I3K;1I3L;1I3M;1I3N;,257,K,R,True,840
13186,853,18717,single nucleotide variant,NM_001008216.2(GALE):c.308A>G (p.Asp103Gly),2582,GALE,HGNC:4116,Pathogenic,1,1-Jan-98,28940883,-,RCV000003863,"MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238",UDPglucose-4-epimerase deficiency,germline,germline,GRCh38,NC_000001.11,1,23798160,23798160,na,na,1p36.11,no assertion criteria provided,1,-,N,"ClinGen:CA252856,UniProtKB:Q14376#VAR_002541,OMIM:606953.0004",1,3678,23798160,T,C,D103G,0,pathogenic,uncertain,Q14376,Q14376,reviewed,GALE_HUMAN,"UDP-glucose 4-epimerase, EC 5.1.3.2 (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase, UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase, UDP-GlcNAc 4-epimerase, EC 5.1.3.7) (UDP-galactose 4-epimerase)",GALE,Homo sapiens (Human),348.0,MAEKVLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSVEFEEMDILDQGALQRLFKKYSFMAVIHFAGLKAVGESVQKPLDYYRVNLTGTIQLLEIMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEEMIRDLCQADKTWNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRREALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKEQCGCRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARREGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA,PF16363;,1EK5;1EK6;1HZJ;1I3K;1I3L;1I3M;1I3N;,103,D,G,True,840
13187,5408,34023,single nucleotide variant,NM_001008216.2(GALE):c.505C>T (p.Arg169Trp),2582,GALE,HGNC:4116,Pathogenic,1,11-Jun-14,137853859,-,RCV000020293|RCV000723465,"MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238|MedGen:CN517202",UDPglucose-4-epimerase deficiency|not provided,germline,germline,GRCh38,NC_000001.11,1,23797718,23797718,na,na,1p36.11,"criteria provided, single submitter",2,-,N,"ClinGen:CA341697,UniProtKB:Q14376#VAR_037737",3,21171,23797718,G,A,R169W,1,pathogenic,pathogenic,Q14376,Q14376,reviewed,GALE_HUMAN,"UDP-glucose 4-epimerase, EC 5.1.3.2 (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase, UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase, UDP-GlcNAc 4-epimerase, EC 5.1.3.7) (UDP-galactose 4-epimerase)",GALE,Homo sapiens (Human),348.0,MAEKVLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSVEFEEMDILDQGALQRLFKKYSFMAVIHFAGLKAVGESVQKPLDYYRVNLTGTIQLLEIMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEEMIRDLCQADKTWNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRREALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKEQCGCRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARREGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA,PF16363;,1EK5;1EK6;1HZJ;1I3K;1I3L;1I3M;1I3N;,169,R,W,True,840
13188,850,18714,single nucleotide variant,NM_001008216.2(GALE):c.548T>C (p.Leu183Pro),2582,GALE,HGNC:4116,Pathogenic,1,25-Jan-11,121908045,-,RCV000003860,"MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238",UDPglucose-4-epimerase deficiency,germline,germline,GRCh38,NC_000001.11,1,23797128,23797128,na,na,1p36.11,no assertion criteria provided,2,-,N,"UniProtKB:Q14376#VAR_002543,OMIM:606953.0001,ClinGen:CA340110",1,3675,23797128,A,G,L183P,0,pathogenic,uncertain,Q14376,Q14376,reviewed,GALE_HUMAN,"UDP-glucose 4-epimerase, EC 5.1.3.2 (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase, UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase, UDP-GlcNAc 4-epimerase, EC 5.1.3.7) (UDP-galactose 4-epimerase)",GALE,Homo sapiens (Human),348.0,MAEKVLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSVEFEEMDILDQGALQRLFKKYSFMAVIHFAGLKAVGESVQKPLDYYRVNLTGTIQLLEIMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEEMIRDLCQADKTWNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRREALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKEQCGCRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARREGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA,PF16363;,1EK5;1EK6;1HZJ;1I3K;1I3L;1I3M;1I3N;,183,L,P,True,840
13189,857,18721,single nucleotide variant,NM_001008216.2(GALE):c.280G>A (p.Val94Met),2582,GALE,HGNC:4116,Pathogenic/Likely pathogenic,1,1-May-17,121908047,-,RCV000003867|RCV000020292|RCV000727367,"MedGen:C4017048|MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238|MedGen:CN517202","Galactose epimerase deficiency, severe|UDPglucose-4-epimerase deficiency|not provided",germline;unknown,germline,GRCh38,NC_000001.11,1,23798188,23798188,na,na,1p36.11,"criteria provided, multiple submitters, no conflicts",4,-,N,"UniProtKB:Q14376#VAR_010058,OMIM:606953.0008,ClinGen:CA116434",3,3682,23798188,C,T,V94M,2,pathogenic,pathogenic,Q14376,Q14376,reviewed,GALE_HUMAN,"UDP-glucose 4-epimerase, EC 5.1.3.2 (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase, UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase, UDP-GlcNAc 4-epimerase, EC 5.1.3.7) (UDP-galactose 4-epimerase)",GALE,Homo sapiens (Human),348.0,MAEKVLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSVEFEEMDILDQGALQRLFKKYSFMAVIHFAGLKAVGESVQKPLDYYRVNLTGTIQLLEIMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEEMIRDLCQADKTWNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRREALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKEQCGCRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARREGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA,PF16363;,1EK5;1EK6;1HZJ;1I3K;1I3L;1I3M;1I3N;,94,V,M,True,840
13190,856,18720,single nucleotide variant,NM_001008216.2(GALE):c.956G>A (p.Gly319Glu),2582,GALE,HGNC:4116,"Conflicting interpretations of pathogenicity, other",1,6-Oct-20,28940885,-,RCV000003866|RCV000078697,"MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238|MedGen:CN517202",UDPglucose-4-epimerase deficiency|not provided,germline,germline,GRCh38,NC_000001.11,1,23796183,23796183,na,na,1p36.11,"criteria provided, conflicting interpretations",5,-,N,"OMIM:606953.0007,ClinGen:CA220715,UniProtKB:Q14376#VAR_002546",3,3681,23796183,C,T,G319E,1,uncertain,uncertain,Q14376,Q14376,reviewed,GALE_HUMAN,"UDP-glucose 4-epimerase, EC 5.1.3.2 (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase, UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase, UDP-GlcNAc 4-epimerase, EC 5.1.3.7) (UDP-galactose 4-epimerase)",GALE,Homo sapiens (Human),348.0,MAEKVLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSVEFEEMDILDQGALQRLFKKYSFMAVIHFAGLKAVGESVQKPLDYYRVNLTGTIQLLEIMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEEMIRDLCQADKTWNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRREALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKEQCGCRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARREGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA,PF16363;,1EK5;1EK6;1HZJ;1I3K;1I3L;1I3M;1I3N;,319,G,E,True,840
13191,10323,136138,single nucleotide variant,NM_006765.4(TUSC3):c.193A>G (p.Ile65Val),7991,TUSC3,HGNC:30242,Benign/Likely benign,0,31-Dec-19,11545035,-,RCV000118806|RCV000175831|RCV000715846|RCV000988037|RCV001158587,"MedGen:CN517202|MedGen:CN169374|MedGen:C2711754|MONDO:MONDO:0012615,MedGen:C1970197,OMIM:611093,Orphanet:88616|MONDO:MONDO:0015286,MedGen:C0282577,OMIM:PS212065,Orphanet:137","not provided|not specified|History of neurodevelopmental disorder|Mental retardation, autosomal recessive 7|Congenital disorder of glycosylation",germline;unknown,germline,GRCh38,NC_000008.11,8,15623134,15623134,na,na,8p22,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA201651,UniProtKB:Q13454#VAR_045836",2,130692,15623134,A,G,I65V,2,benign,benign,Q13454,Q13454,reviewed,TUSC3_HUMAN,"Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3, Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33)",TUSC3 N33,Homo sapiens (Human),348.0,MGARGAPSRRRQAGRRLRYLPTGSFPFLLLLLLLCIQLGGGQKKKENLLAEKVEQLMEWSSRRSIFRMNGDKFRKFIKAPPRNYSMIVMFTALQPQRQCSVCRQANEEYQILANSWRYSSAFCNKLFFSMVDYDEGTDVFQQLNMNSAPTFMHFPPKGRPKRADTFDLQRIGFAAEQLAKWIADRTDVHIRVFRPPNYSGTIALALLVSLVGGLLYLRRNNLEFIYNKTGWAMVSLCIVFAMTSGQMWNHIRGPPYAHKNPHNGQVSYIHGSSQAQFVAESHIILVLNAAITMGMVLLNEAATSKGDVGKRRIICLVGLGLVVFFFSFLLSIFRSKYHGYPYSDLDFE,PF04756;,4M8G;4M90;4M91;4M92;,65,I,V,True,841
13192,6014,39600,single nucleotide variant,NM_007208.4(MRPL3):c.950C>G (p.Pro317Arg),11222,MRPL3,HGNC:10379,Pathogenic,1,1-Nov-11,387906962,-,RCV000023618,"MONDO:MONDO:0013811,MedGen:C3281234,OMIM:614582,Orphanet:319509",Combined oxidative phosphorylation deficiency 9,germline,germline,GRCh38,NC_000003.12,3,131462820,131462820,na,na,3q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA129386,UniProtKB:P09001#VAR_066676,OMIM:607118.0001",1,30643,131462820,G,C,P317R,0,pathogenic,uncertain,P09001,P09001,reviewed,RM03_HUMAN,"39S ribosomal protein L3, mitochondrial, L3mt, MRP-L3 (Mitochondrial large ribosomal subunit protein uL3m)",MRPL3 MRL3 RPML3,Homo sapiens (Human),348.0,MPGWRLLTQVGAQVLGRLGDGLGAALGPGNRTHIWLFVRGLHGKSGTWWDEHLSEENVPFIKQLVSDEDKAQLASKLCPLKDEPWPIHPWEPGSFRVGLIALKLGMMPLWTKDGQKHVVTLLQVQDCHVLKYTSKENCNGKMATLSVGGKTVSRFRKATSILEFYRELGLPPKQTVKIFNITDNAAIKPGTPLYAAHFRPGQYVDVTAKTIGKGFQGVMKRWGFKGQPATHGQTKTHRRPGAVATGDIGRVWPGTKMPGKMGNIYRTEYGLKVWRINTKHNIIYVNGSVPGHKNCLVKVKDSKLPAYKDLGKNLPFPTYFPDGDEEELPEDLYDENVCQPGAPSITFA,PF00297;,3J7Y;3J9M;5OOL;5OOM;6I9R;6NU2;6NU3;6VLZ;6VMI;6ZM5;6ZM6;6ZS9;6ZSA;6ZSB;6ZSC;6ZSD;6ZSE;6ZSG;7A5F;7A5G;7A5H;7A5I;7A5J;7A5K;7L08;7L20;7O9K;7O9M;7ODR;7ODS;7ODT;7OF0;7OF2;7OF3;7OF4;7OF5;7OF6;7OF7;7OG4;7OI6;7OI7;7OI8;7OI9;7OIA;7OIB;7OIC;7OID;7OIE;7PD3;,317,P,R,True,842
13193,2865,26750,single nucleotide variant,NM_004429.4(EFNB1):c.472A>G (p.Met158Val),1947,EFNB1,HGNC:3226,Pathogenic,1,8-Jun-04,28936071,-,RCV000012477,"MONDO:MONDO:0010570,MedGen:C0220767,OMIM:304110,Orphanet:1520",Craniofrontonasal syndrome,germline,germline,GRCh38,NC_000023.11,X,68839729,68839729,na,na,Xq13.1,no assertion criteria provided,1,-,N,"ClinGen:CA121636,UniProtKB:P98172#VAR_023145,OMIM:300035.0006",1,11711,68839729,A,G,M158V,0,pathogenic,uncertain,P98172,P98172,reviewed,EFNB1_HUMAN,"Ephrin-B1 (EFL-3) (ELK ligand, ELK-L) (EPH-related receptor tyrosine kinase ligand 2, LERK-2) [Cleaved into: Ephrin-B1 C-terminal fragment, Ephrin-B1 CTF; Ephrin-B1 intracellular domain, Ephrin-B1 ICD ]",EFNB1 EFL3 EPLG2 LERK2,Homo sapiens (Human),346.0,MARPGQRWLGKWLVAMVVWALCRLATPLAKNLEPVSWSSLNPKFLSGKGLVIYPKIGDKLDIICPRAEAGRPYEYYKLYLVRPEQAAACSTVLDPNVLVTCNRPEQEIRFTIKFQEFSPNYMGLEFKKHHDYYITSTSNGSLEGLENREGGVCRTRTMKIIMKVGQDPNAVTPEQLTTSRPSKEADNTVKMATQAPGSRGSLGDSDGKHETVNQEEKSGPGASGGSSGDPDGFFNSKVALFAAVGAGCVIFLLIIIFLTVLLLKLRKRHRKHTQQRAAALSLSTLASPKGGSGTAGTEPSDIIIPLRTTENNYCPHYEKVSGDYGHPVYIVQEMPPQSPANIYYKV,PF00812;,6THG;,158,M,V,True,843
13194,2861,26746,single nucleotide variant,NM_004429.4(EFNB1):c.332C>T (p.Thr111Ile),1947,EFNB1,HGNC:3226,Pathogenic,1,1-Jun-04,104894796,-,RCV000012473,"MONDO:MONDO:0010570,MedGen:C0220767,OMIM:304110,Orphanet:1520",Craniofrontonasal syndrome,germline,germline,GRCh38,NC_000023.11,X,68838820,68838820,na,na,Xq13.1,no assertion criteria provided,1,-,N,"ClinGen:CA121632,UniProtKB:P98172#VAR_023131,OMIM:300035.0002",1,11707,68838820,C,T,T111I,0,pathogenic,uncertain,P98172,P98172,reviewed,EFNB1_HUMAN,"Ephrin-B1 (EFL-3) (ELK ligand, ELK-L) (EPH-related receptor tyrosine kinase ligand 2, LERK-2) [Cleaved into: Ephrin-B1 C-terminal fragment, Ephrin-B1 CTF; Ephrin-B1 intracellular domain, Ephrin-B1 ICD ]",EFNB1 EFL3 EPLG2 LERK2,Homo sapiens (Human),346.0,MARPGQRWLGKWLVAMVVWALCRLATPLAKNLEPVSWSSLNPKFLSGKGLVIYPKIGDKLDIICPRAEAGRPYEYYKLYLVRPEQAAACSTVLDPNVLVTCNRPEQEIRFTIKFQEFSPNYMGLEFKKHHDYYITSTSNGSLEGLENREGGVCRTRTMKIIMKVGQDPNAVTPEQLTTSRPSKEADNTVKMATQAPGSRGSLGDSDGKHETVNQEEKSGPGASGGSSGDPDGFFNSKVALFAAVGAGCVIFLLIIIFLTVLLLKLRKRHRKHTQQRAAALSLSTLASPKGGSGTAGTEPSDIIIPLRTTENNYCPHYEKVSGDYGHPVYIVQEMPPQSPANIYYKV,PF00812;,6THG;,111,T,I,True,843
13195,2863,26748,single nucleotide variant,NM_004429.4(EFNB1):c.451G>A (p.Gly151Ser),1947,EFNB1,HGNC:3226,Pathogenic,1,11-Jun-19,28936069,-,RCV000012475,"MONDO:MONDO:0010570,MedGen:C0220767,OMIM:304110,Orphanet:1520",Craniofrontonasal syndrome,de novo;germline,germline,GRCh38,NC_000023.11,X,68839708,68839708,na,na,Xq13.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA121634,UniProtKB:P98172#VAR_023138,OMIM:300035.0004",3,11709,68839708,G,A,G151S,1,pathogenic,pathogenic,P98172,P98172,reviewed,EFNB1_HUMAN,"Ephrin-B1 (EFL-3) (ELK ligand, ELK-L) (EPH-related receptor tyrosine kinase ligand 2, LERK-2) [Cleaved into: Ephrin-B1 C-terminal fragment, Ephrin-B1 CTF; Ephrin-B1 intracellular domain, Ephrin-B1 ICD ]",EFNB1 EFL3 EPLG2 LERK2,Homo sapiens (Human),346.0,MARPGQRWLGKWLVAMVVWALCRLATPLAKNLEPVSWSSLNPKFLSGKGLVIYPKIGDKLDIICPRAEAGRPYEYYKLYLVRPEQAAACSTVLDPNVLVTCNRPEQEIRFTIKFQEFSPNYMGLEFKKHHDYYITSTSNGSLEGLENREGGVCRTRTMKIIMKVGQDPNAVTPEQLTTSRPSKEADNTVKMATQAPGSRGSLGDSDGKHETVNQEEKSGPGASGGSSGDPDGFFNSKVALFAAVGAGCVIFLLIIIFLTVLLLKLRKRHRKHTQQRAAALSLSTLASPKGGSGTAGTEPSDIIIPLRTTENNYCPHYEKVSGDYGHPVYIVQEMPPQSPANIYYKV,PF00812;,6THG;,151,G,S,True,843
13196,2866,26751,single nucleotide variant,NM_004429.4(EFNB1):c.474G>T (p.Met158Ile),1947,EFNB1,HGNC:3226,Pathogenic,1,8-Jun-04,28935170,-,RCV000012478,"MONDO:MONDO:0010570,MedGen:C0220767,OMIM:304110,Orphanet:1520",Craniofrontonasal syndrome,germline,germline,GRCh38,NC_000023.11,X,68839731,68839731,na,na,Xq13.1,no assertion criteria provided,1,-,N,"ClinGen:CA121637,UniProtKB:P98172#VAR_023144,OMIM:300035.0007",1,11712,68839731,G,T,M158I,0,pathogenic,uncertain,P98172,P98172,reviewed,EFNB1_HUMAN,"Ephrin-B1 (EFL-3) (ELK ligand, ELK-L) (EPH-related receptor tyrosine kinase ligand 2, LERK-2) [Cleaved into: Ephrin-B1 C-terminal fragment, Ephrin-B1 CTF; Ephrin-B1 intracellular domain, Ephrin-B1 ICD ]",EFNB1 EFL3 EPLG2 LERK2,Homo sapiens (Human),346.0,MARPGQRWLGKWLVAMVVWALCRLATPLAKNLEPVSWSSLNPKFLSGKGLVIYPKIGDKLDIICPRAEAGRPYEYYKLYLVRPEQAAACSTVLDPNVLVTCNRPEQEIRFTIKFQEFSPNYMGLEFKKHHDYYITSTSNGSLEGLENREGGVCRTRTMKIIMKVGQDPNAVTPEQLTTSRPSKEADNTVKMATQAPGSRGSLGDSDGKHETVNQEEKSGPGASGGSSGDPDGFFNSKVALFAAVGAGCVIFLLIIIFLTVLLLKLRKRHRKHTQQRAAALSLSTLASPKGGSGTAGTEPSDIIIPLRTTENNYCPHYEKVSGDYGHPVYIVQEMPPQSPANIYYKV,PF00812;,6THG;,158,M,I,True,843
13197,2862,26747,single nucleotide variant,NM_004429.4(EFNB1):c.161C>T (p.Pro54Leu),1947,EFNB1,HGNC:3226,Pathogenic/Likely pathogenic,1,14-Nov-17,104894801,-,RCV000012474|RCV000478350,"MONDO:MONDO:0010570,MedGen:C0220767,OMIM:304110,Orphanet:1520|MedGen:CN517202",Craniofrontonasal syndrome|not provided,germline,germline,GRCh38,NC_000023.11,X,68838649,68838649,na,na,Xq13.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA121633,UniProtKB:P98172#VAR_023128,OMIM:300035.0003",3,11708,68838649,C,T,P54L,2,pathogenic,pathogenic,P98172,P98172,reviewed,EFNB1_HUMAN,"Ephrin-B1 (EFL-3) (ELK ligand, ELK-L) (EPH-related receptor tyrosine kinase ligand 2, LERK-2) [Cleaved into: Ephrin-B1 C-terminal fragment, Ephrin-B1 CTF; Ephrin-B1 intracellular domain, Ephrin-B1 ICD ]",EFNB1 EFL3 EPLG2 LERK2,Homo sapiens (Human),346.0,MARPGQRWLGKWLVAMVVWALCRLATPLAKNLEPVSWSSLNPKFLSGKGLVIYPKIGDKLDIICPRAEAGRPYEYYKLYLVRPEQAAACSTVLDPNVLVTCNRPEQEIRFTIKFQEFSPNYMGLEFKKHHDYYITSTSNGSLEGLENREGGVCRTRTMKIIMKVGQDPNAVTPEQLTTSRPSKEADNTVKMATQAPGSRGSLGDSDGKHETVNQEEKSGPGASGGSSGDPDGFFNSKVALFAAVGAGCVIFLLIIIFLTVLLLKLRKRHRKHTQQRAAALSLSTLASPKGGSGTAGTEPSDIIIPLRTTENNYCPHYEKVSGDYGHPVYIVQEMPPQSPANIYYKV,PF00812;,6THG;,54,P,L,True,843
13198,2864,26749,single nucleotide variant,NM_004429.4(EFNB1):c.452G>T (p.Gly151Val),1947,EFNB1,HGNC:3226,Pathogenic,1,8-Jun-04,28936070,-,RCV000012476,"MONDO:MONDO:0010570,MedGen:C0220767,OMIM:304110,Orphanet:1520",Craniofrontonasal syndrome,germline,germline,GRCh38,NC_000023.11,X,68839709,68839709,na,na,Xq13.1,no assertion criteria provided,1,-,N,"UniProtKB:P98172#VAR_023139,OMIM:300035.0005,ClinGen:CA121635",1,11710,68839709,G,T,G151V,0,pathogenic,uncertain,P98172,P98172,reviewed,EFNB1_HUMAN,"Ephrin-B1 (EFL-3) (ELK ligand, ELK-L) (EPH-related receptor tyrosine kinase ligand 2, LERK-2) [Cleaved into: Ephrin-B1 C-terminal fragment, Ephrin-B1 CTF; Ephrin-B1 intracellular domain, Ephrin-B1 ICD ]",EFNB1 EFL3 EPLG2 LERK2,Homo sapiens (Human),346.0,MARPGQRWLGKWLVAMVVWALCRLATPLAKNLEPVSWSSLNPKFLSGKGLVIYPKIGDKLDIICPRAEAGRPYEYYKLYLVRPEQAAACSTVLDPNVLVTCNRPEQEIRFTIKFQEFSPNYMGLEFKKHHDYYITSTSNGSLEGLENREGGVCRTRTMKIIMKVGQDPNAVTPEQLTTSRPSKEADNTVKMATQAPGSRGSLGDSDGKHETVNQEEKSGPGASGGSSGDPDGFFNSKVALFAAVGAGCVIFLLIIIFLTVLLLKLRKRHRKHTQQRAAALSLSTLASPKGGSGTAGTEPSDIIIPLRTTENNYCPHYEKVSGDYGHPVYIVQEMPPQSPANIYYKV,PF00812;,6THG;,151,G,V,True,843
13199,11983,200027,single nucleotide variant,NM_003849.4(SUCLG1):c.110G>C (p.Gly37Ala),8802,SUCLG1,HGNC:11449,Conflicting interpretations of pathogenicity,0,31-Dec-19,369610897,-,RCV000186193|RCV000322795|RCV000377493,"MedGen:CN517202|MONDO:MONDO:0018158,MedGen:C0342782,OMIM:PS603041,Orphanet:35698|MONDO:MONDO:0009504,MedGen:C3151476,OMIM:245400,Orphanet:17",not provided|Mitochondrial DNA depletion syndrome|Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria),germline,germline,GRCh38,NC_000002.12,2,84449740,84449740,na,na,2p11.2,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA313044,UniProtKB:P53597#VAR_076432",2,203968,84449740,C,G,G37A,1,uncertain,uncertain,P53597,P53597,reviewed,SUCA_HUMAN,"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial, EC 6.2.1.4, EC 6.2.1.5 (Succinyl-CoA synthetase subunit alpha, SCS-alpha)",SUCLG1,Homo sapiens (Human),346.0,MTATLAAAADIATMVSGSSGLAAARLLSRSFLLPQNGIRHCSYTASRQHLYVDKNTKIICQGFTGKQGTFHSQQALEYGTKLVGGTTPGKGGQTHLGLPVFNTVKEAKEQTGATASVIYVPPPFAAAAINEAIEAEIPLVVCITEGIPQQDMVRVKHKLLRQEKTRLIGPNCPGVINPGECKIGIMPGHIHKKGRIGIVSRSGTLTYEAVHQTTQVGLGQSLCVGIGGDPFNGTDFIDCLEIFLNDSATEGIILIGEIGGNAEENAAEFLKQHNSGPNSKPVVSFIAGLTAPPGRRMGHAGAIIAGGKGGAKEKISALQSAGVVVSMSPAQLGTTIYKEFEKRKML,PF02629;PF00549;,6G4Q;6WCV;,37,G,A,True,844
13200,5340,33448,single nucleotide variant,NM_003849.4(SUCLG1):c.254G>C (p.Gly85Ala),8802,SUCLG1,HGNC:11449,Pathogenic,1,1-Feb-10,267607097,-,RCV000001040,"MONDO:MONDO:0009504,MedGen:C3151476,OMIM:245400,Orphanet:17",Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria),germline,germline,GRCh38,NC_000002.12,2,84443348,84443348,na,na,2p11.2,no assertion criteria provided,1,-,N,"ClinGen:CA114697,UniProtKB:P53597#VAR_065157,OMIM:611224.0002",1,18409,84443348,C,G,G85A,0,pathogenic,uncertain,P53597,P53597,reviewed,SUCA_HUMAN,"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial, EC 6.2.1.4, EC 6.2.1.5 (Succinyl-CoA synthetase subunit alpha, SCS-alpha)",SUCLG1,Homo sapiens (Human),346.0,MTATLAAAADIATMVSGSSGLAAARLLSRSFLLPQNGIRHCSYTASRQHLYVDKNTKIICQGFTGKQGTFHSQQALEYGTKLVGGTTPGKGGQTHLGLPVFNTVKEAKEQTGATASVIYVPPPFAAAAINEAIEAEIPLVVCITEGIPQQDMVRVKHKLLRQEKTRLIGPNCPGVINPGECKIGIMPGHIHKKGRIGIVSRSGTLTYEAVHQTTQVGLGQSLCVGIGGDPFNGTDFIDCLEIFLNDSATEGIILIGEIGGNAEENAAEFLKQHNSGPNSKPVVSFIAGLTAPPGRRMGHAGAIIAGGKGGAKEKISALQSAGVVVSMSPAQLGTTIYKEFEKRKML,PF02629;PF00549;,6G4Q;6WCV;,85,G,A,True,844
13201,5341,33449,single nucleotide variant,NM_003849.4(SUCLG1):c.509C>G (p.Pro170Arg),8802,SUCLG1,HGNC:11449,Pathogenic,1,1-Oct-10,267607099,-,RCV000001041,"MONDO:MONDO:0009504,MedGen:C3151476,OMIM:245400,Orphanet:17",Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria),germline,germline,GRCh38,NC_000002.12,2,84441269,84441269,na,na,2p11.2,no assertion criteria provided,1,-,N,"UniProtKB:P53597#VAR_065121,OMIM:611224.0003,ClinGen:CA114698",1,18410,84441269,G,C,P170R,0,pathogenic,uncertain,P53597,P53597,reviewed,SUCA_HUMAN,"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial, EC 6.2.1.4, EC 6.2.1.5 (Succinyl-CoA synthetase subunit alpha, SCS-alpha)",SUCLG1,Homo sapiens (Human),346.0,MTATLAAAADIATMVSGSSGLAAARLLSRSFLLPQNGIRHCSYTASRQHLYVDKNTKIICQGFTGKQGTFHSQQALEYGTKLVGGTTPGKGGQTHLGLPVFNTVKEAKEQTGATASVIYVPPPFAAAAINEAIEAEIPLVVCITEGIPQQDMVRVKHKLLRQEKTRLIGPNCPGVINPGECKIGIMPGHIHKKGRIGIVSRSGTLTYEAVHQTTQVGLGQSLCVGIGGDPFNGTDFIDCLEIFLNDSATEGIILIGEIGGNAEENAAEFLKQHNSGPNSKPVVSFIAGLTAPPGRRMGHAGAIIAGGKGGAKEKISALQSAGVVVSMSPAQLGTTIYKEFEKRKML,PF02629;PF00549;,6G4Q;6WCV;,170,P,R,True,844
13202,12044,200982,single nucleotide variant,NM_203290.4(POLR1C):c.326G>A (p.Arg109His),9533,POLR1C,HGNC:20194,Pathogenic/Likely pathogenic,1,3-Nov-16,796052127,-,RCV000186589|RCV000853238,"MONDO:MONDO:0014666,MedGen:C4225305,OMIM:616494,Orphanet:88637|MONDO:MONDO:0009558,MedGen:C1855433,OMIM:248390,Orphanet:861","Leukodystrophy, hypomyelinating, 11|Treacher Collins syndrome 3",germline;maternal,germline,GRCh38,NC_000006.12,6,43519782,43519782,na,na,6p21.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA204044,UniProtKB:O15160#VAR_074660,OMIM:610060.0011",3,204592,43519782,G,A,R109H,2,pathogenic,pathogenic,O15160,O15160,reviewed,RPAC1_HUMAN,"DNA-directed RNA polymerases I and III subunit RPAC1, DNA-directed RNA polymerase I subunit C, RNA polymerases I and III subunit AC1 (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide, RPA40) (RPA39) (RPC40)",POLR1C POLR1E,Homo sapiens (Human),346.0,MAASQAVEEMRSRVVLGEFGVRNVHTTDFPGNYSGYDDAWDQDRFEKNFRVDVVHMDENSLEFDMVGIDAAIANAFRRILLAEVPTMAVEKVLVYNNTSIVQDEILAHRLGLIPIHADPRLFEYRNQGDEEGTEIDTLQFRLQVRCTRNPHAAKDSSDPNELYVNHKVYTRHMTWIPLGNQADLFPEGTIRPVHDDILIAQLRPGQEIDLLMHCVKGIGKDHAKFSPVATASYRLLPDITLLEPVEGEAAEELSRCFSPGVIEVQEVQGKKVARVANPRLDTFSREIFRNEKLKKVVRLARVRDHYIFSVESTGVLPPDVLVSEAIKVLMGKCRRFLDELDAVQMD,PF01000;PF01193;,7A6H;7AE1;7AE3;7AEA;7AST;7D58;7D59;7DN3;7DU2;7FJI;7FJJ;7OB9;7OBA;7OBB;,109,R,H,True,845
13203,6030,39768,single nucleotide variant,NM_203290.4(POLR1C):c.836G>A (p.Arg279Gln),9533,POLR1C,HGNC:20194,Pathogenic/Likely pathogenic,1,31-May-18,191582628,-,RCV000023796|RCV000513700|RCV000788034,"MONDO:MONDO:0009558,MedGen:C1855433,OMIM:248390,Orphanet:861|MedGen:CN517202|MONDO:MONDO:0014666,MedGen:C4225305,OMIM:616494,Orphanet:88637","Treacher Collins syndrome 3|not provided|Leukodystrophy, hypomyelinating, 11",germline;inherited;unknown,germline,GRCh38,NC_000006.12,6,43520962,43520962,na,na,6p21.1,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA259909,UniProtKB:O15160#VAR_064899,OMIM:610060.0001",3,30811,43520962,G,A,R279Q,2,pathogenic,pathogenic,O15160,O15160,reviewed,RPAC1_HUMAN,"DNA-directed RNA polymerases I and III subunit RPAC1, DNA-directed RNA polymerase I subunit C, RNA polymerases I and III subunit AC1 (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide, RPA40) (RPA39) (RPC40)",POLR1C POLR1E,Homo sapiens (Human),346.0,MAASQAVEEMRSRVVLGEFGVRNVHTTDFPGNYSGYDDAWDQDRFEKNFRVDVVHMDENSLEFDMVGIDAAIANAFRRILLAEVPTMAVEKVLVYNNTSIVQDEILAHRLGLIPIHADPRLFEYRNQGDEEGTEIDTLQFRLQVRCTRNPHAAKDSSDPNELYVNHKVYTRHMTWIPLGNQADLFPEGTIRPVHDDILIAQLRPGQEIDLLMHCVKGIGKDHAKFSPVATASYRLLPDITLLEPVEGEAAEELSRCFSPGVIEVQEVQGKKVARVANPRLDTFSREIFRNEKLKKVVRLARVRDHYIFSVESTGVLPPDVLVSEAIKVLMGKCRRFLDELDAVQMD,PF01000;PF01193;,7A6H;7AE1;7AE3;7AEA;7AST;7D58;7D59;7DN3;7DU2;7FJI;7FJJ;7OB9;7OBA;7OBB;,279,R,Q,True,845
13204,6031,39772,single nucleotide variant,NM_203290.4(POLR1C):c.835C>T (p.Arg279Trp),9533,POLR1C,HGNC:20194,Pathogenic,1,27-Dec-16,141156009,-,RCV000023800|RCV000382254|RCV000788033,"MONDO:MONDO:0009558,MedGen:C1855433,OMIM:248390,Orphanet:861|MedGen:CN517202|MONDO:MONDO:0014666,MedGen:C4225305,OMIM:616494,Orphanet:88637","Treacher Collins syndrome 3|not provided|Leukodystrophy, hypomyelinating, 11",germline;inherited,germline,GRCh38,NC_000006.12,6,43520961,43520961,na,na,6p21.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA259912,UniProtKB:O15160#VAR_064900,OMIM:610060.0005",3,30815,43520961,C,T,R279W,2,pathogenic,pathogenic,O15160,O15160,reviewed,RPAC1_HUMAN,"DNA-directed RNA polymerases I and III subunit RPAC1, DNA-directed RNA polymerase I subunit C, RNA polymerases I and III subunit AC1 (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide, RPA40) (RPA39) (RPC40)",POLR1C POLR1E,Homo sapiens (Human),346.0,MAASQAVEEMRSRVVLGEFGVRNVHTTDFPGNYSGYDDAWDQDRFEKNFRVDVVHMDENSLEFDMVGIDAAIANAFRRILLAEVPTMAVEKVLVYNNTSIVQDEILAHRLGLIPIHADPRLFEYRNQGDEEGTEIDTLQFRLQVRCTRNPHAAKDSSDPNELYVNHKVYTRHMTWIPLGNQADLFPEGTIRPVHDDILIAQLRPGQEIDLLMHCVKGIGKDHAKFSPVATASYRLLPDITLLEPVEGEAAEELSRCFSPGVIEVQEVQGKKVARVANPRLDTFSREIFRNEKLKKVVRLARVRDHYIFSVESTGVLPPDVLVSEAIKVLMGKCRRFLDELDAVQMD,PF01000;PF01193;,7A6H;7AE1;7AE3;7AEA;7AST;7D58;7D59;7DN3;7DU2;7FJI;7FJJ;7OB9;7OBA;7OBB;,279,R,W,True,845
13205,12040,200977,single nucleotide variant,NM_203290.4(POLR1C):c.221A>G (p.Asn74Ser),9533,POLR1C,HGNC:20194,Pathogenic,1,-,371802902,-,RCV000186584,"MONDO:MONDO:0014666,MedGen:C4225305,OMIM:616494,Orphanet:88637","Leukodystrophy, hypomyelinating, 11",germline;inherited,germline,GRCh38,NC_000006.12,6,43519412,43519412,na,na,6p21.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA204036,UniProtKB:O15160#VAR_074658,OMIM:610060.0006",3,204587,43519412,A,G,N74S,1,pathogenic,pathogenic,O15160,O15160,reviewed,RPAC1_HUMAN,"DNA-directed RNA polymerases I and III subunit RPAC1, DNA-directed RNA polymerase I subunit C, RNA polymerases I and III subunit AC1 (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide, RPA40) (RPA39) (RPC40)",POLR1C POLR1E,Homo sapiens (Human),346.0,MAASQAVEEMRSRVVLGEFGVRNVHTTDFPGNYSGYDDAWDQDRFEKNFRVDVVHMDENSLEFDMVGIDAAIANAFRRILLAEVPTMAVEKVLVYNNTSIVQDEILAHRLGLIPIHADPRLFEYRNQGDEEGTEIDTLQFRLQVRCTRNPHAAKDSSDPNELYVNHKVYTRHMTWIPLGNQADLFPEGTIRPVHDDILIAQLRPGQEIDLLMHCVKGIGKDHAKFSPVATASYRLLPDITLLEPVEGEAAEELSRCFSPGVIEVQEVQGKKVARVANPRLDTFSREIFRNEKLKKVVRLARVRDHYIFSVESTGVLPPDVLVSEAIKVLMGKCRRFLDELDAVQMD,PF01000;PF01193;,7A6H;7AE1;7AE3;7AEA;7AST;7D58;7D59;7DN3;7DU2;7FJI;7FJJ;7OB9;7OBA;7OBB;,74,N,S,True,845
13206,12041,200978,single nucleotide variant,NM_203290.4(POLR1C):c.95A>T (p.Asn32Ile),9533,POLR1C,HGNC:20194,Pathogenic,1,-,796052124,-,RCV000186585,"MONDO:MONDO:0014666,MedGen:C4225305,OMIM:616494,Orphanet:88637","Leukodystrophy, hypomyelinating, 11",germline;inherited,germline,GRCh38,NC_000006.12,6,43517331,43517331,na,na,6p21.1,"criteria provided, single submitter",2,-,N,"UniProtKB:O15160#VAR_074656,OMIM:610060.0007,ClinGen:CA204038",3,204588,43517331,A,T,N32I,1,pathogenic,pathogenic,O15160,O15160,reviewed,RPAC1_HUMAN,"DNA-directed RNA polymerases I and III subunit RPAC1, DNA-directed RNA polymerase I subunit C, RNA polymerases I and III subunit AC1 (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide, RPA40) (RPA39) (RPC40)",POLR1C POLR1E,Homo sapiens (Human),346.0,MAASQAVEEMRSRVVLGEFGVRNVHTTDFPGNYSGYDDAWDQDRFEKNFRVDVVHMDENSLEFDMVGIDAAIANAFRRILLAEVPTMAVEKVLVYNNTSIVQDEILAHRLGLIPIHADPRLFEYRNQGDEEGTEIDTLQFRLQVRCTRNPHAAKDSSDPNELYVNHKVYTRHMTWIPLGNQADLFPEGTIRPVHDDILIAQLRPGQEIDLLMHCVKGIGKDHAKFSPVATASYRLLPDITLLEPVEGEAAEELSRCFSPGVIEVQEVQGKKVARVANPRLDTFSREIFRNEKLKKVVRLARVRDHYIFSVESTGVLPPDVLVSEAIKVLMGKCRRFLDELDAVQMD,PF01000;PF01193;,7A6H;7AE1;7AE3;7AEA;7AST;7D58;7D59;7DN3;7DU2;7FJI;7FJJ;7OB9;7OBA;7OBB;,32,N,I,True,845
13207,13635,269895,single nucleotide variant,NM_203290.4(POLR1C):c.572G>A (p.Arg191Gln),9533,POLR1C,HGNC:20194,Conflicting interpretations of pathogenicity,1,22-Jan-16,373046018,-,RCV000288773|RCV000788028,"MedGen:CN517202|MONDO:MONDO:0014666,MedGen:C4225305,OMIM:616494,Orphanet:88637","not provided|Leukodystrophy, hypomyelinating, 11",germline;inherited,germline,GRCh38,NC_000006.12,6,43520344,43520344,na,na,6p21.1,"criteria provided, conflicting interpretations",2,-,N,"ClinGen:CA3825493,UniProtKB:O15160#VAR_074663",2,285658,43520344,G,A,R191Q,1,uncertain,uncertain,O15160,O15160,reviewed,RPAC1_HUMAN,"DNA-directed RNA polymerases I and III subunit RPAC1, DNA-directed RNA polymerase I subunit C, RNA polymerases I and III subunit AC1 (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide, RPA40) (RPA39) (RPC40)",POLR1C POLR1E,Homo sapiens (Human),346.0,MAASQAVEEMRSRVVLGEFGVRNVHTTDFPGNYSGYDDAWDQDRFEKNFRVDVVHMDENSLEFDMVGIDAAIANAFRRILLAEVPTMAVEKVLVYNNTSIVQDEILAHRLGLIPIHADPRLFEYRNQGDEEGTEIDTLQFRLQVRCTRNPHAAKDSSDPNELYVNHKVYTRHMTWIPLGNQADLFPEGTIRPVHDDILIAQLRPGQEIDLLMHCVKGIGKDHAKFSPVATASYRLLPDITLLEPVEGEAAEELSRCFSPGVIEVQEVQGKKVARVANPRLDTFSREIFRNEKLKKVVRLARVRDHYIFSVESTGVLPPDVLVSEAIKVLMGKCRRFLDELDAVQMD,PF01000;PF01193;,7A6H;7AE1;7AE3;7AEA;7AST;7D58;7D59;7DN3;7DU2;7FJI;7FJJ;7OB9;7OBA;7OBB;,191,R,Q,True,845
13208,12043,200981,single nucleotide variant,NM_203290.4(POLR1C):c.77C>T (p.Thr26Ile),9533,POLR1C,HGNC:20194,Pathogenic,1,-,796052126,-,RCV000186588,"MONDO:MONDO:0014666,MedGen:C4225305,OMIM:616494,Orphanet:88637","Leukodystrophy, hypomyelinating, 11",germline;paternal,germline,GRCh38,NC_000006.12,6,43517313,43517313,na,na,6p21.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA204042,UniProtKB:O15160#VAR_074655,OMIM:610060.0010",3,204591,43517313,C,T,T26I,1,pathogenic,pathogenic,O15160,O15160,reviewed,RPAC1_HUMAN,"DNA-directed RNA polymerases I and III subunit RPAC1, DNA-directed RNA polymerase I subunit C, RNA polymerases I and III subunit AC1 (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide, RPA40) (RPA39) (RPC40)",POLR1C POLR1E,Homo sapiens (Human),346.0,MAASQAVEEMRSRVVLGEFGVRNVHTTDFPGNYSGYDDAWDQDRFEKNFRVDVVHMDENSLEFDMVGIDAAIANAFRRILLAEVPTMAVEKVLVYNNTSIVQDEILAHRLGLIPIHADPRLFEYRNQGDEEGTEIDTLQFRLQVRCTRNPHAAKDSSDPNELYVNHKVYTRHMTWIPLGNQADLFPEGTIRPVHDDILIAQLRPGQEIDLLMHCVKGIGKDHAKFSPVATASYRLLPDITLLEPVEGEAAEELSRCFSPGVIEVQEVQGKKVARVANPRLDTFSREIFRNEKLKKVVRLARVRDHYIFSVESTGVLPPDVLVSEAIKVLMGKCRRFLDELDAVQMD,PF01000;PF01193;,7A6H;7AE1;7AE3;7AEA;7AST;7D58;7D59;7DN3;7DU2;7FJI;7FJJ;7OB9;7OBA;7OBB;,26,T,I,True,845
13209,13915,307675,single nucleotide variant,NM_203290.4(POLR1C):c.193A>G (p.Met65Val),9533,POLR1C,HGNC:20194,Conflicting interpretations of pathogenicity,1,1-Jan-19,141471029,-,RCV000390190|RCV000778794,"MedGen:CN239394|MONDO:MONDO:0014666,MedGen:C4225305,OMIM:616494,Orphanet:88637","POLR1C-Related Disorders|Leukodystrophy, hypomyelinating, 11",germline;inherited;unknown,germline,GRCh38,NC_000006.12,6,43519384,43519384,na,na,6p21.1,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA3825367,UniProtKB:O15160#VAR_074657",2,356872,43519384,A,G,M65V,1,uncertain,uncertain,O15160,O15160,reviewed,RPAC1_HUMAN,"DNA-directed RNA polymerases I and III subunit RPAC1, DNA-directed RNA polymerase I subunit C, RNA polymerases I and III subunit AC1 (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide, RPA40) (RPA39) (RPC40)",POLR1C POLR1E,Homo sapiens (Human),346.0,MAASQAVEEMRSRVVLGEFGVRNVHTTDFPGNYSGYDDAWDQDRFEKNFRVDVVHMDENSLEFDMVGIDAAIANAFRRILLAEVPTMAVEKVLVYNNTSIVQDEILAHRLGLIPIHADPRLFEYRNQGDEEGTEIDTLQFRLQVRCTRNPHAAKDSSDPNELYVNHKVYTRHMTWIPLGNQADLFPEGTIRPVHDDILIAQLRPGQEIDLLMHCVKGIGKDHAKFSPVATASYRLLPDITLLEPVEGEAAEELSRCFSPGVIEVQEVQGKKVARVANPRLDTFSREIFRNEKLKKVVRLARVRDHYIFSVESTGVLPPDVLVSEAIKVLMGKCRRFLDELDAVQMD,PF01000;PF01193;,7A6H;7AE1;7AE3;7AEA;7AST;7D58;7D59;7DN3;7DU2;7FJI;7FJJ;7OB9;7OBA;7OBB;,65,M,V,True,845
13210,12042,200979,single nucleotide variant,NM_203290.4(POLR1C):c.436T>C (p.Cys146Arg),9533,POLR1C,HGNC:20194,Pathogenic,1,-,796052125,-,RCV000186586,"MONDO:MONDO:0014666,MedGen:C4225305,OMIM:616494,Orphanet:88637","Leukodystrophy, hypomyelinating, 11",germline;inherited,germline,GRCh38,NC_000006.12,6,43520119,43520119,na,na,6p21.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA204040,UniProtKB:O15160#VAR_074662,OMIM:610060.0008",3,204589,43520119,T,C,C146R,1,pathogenic,pathogenic,O15160,O15160,reviewed,RPAC1_HUMAN,"DNA-directed RNA polymerases I and III subunit RPAC1, DNA-directed RNA polymerase I subunit C, RNA polymerases I and III subunit AC1 (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide, RPA40) (RPA39) (RPC40)",POLR1C POLR1E,Homo sapiens (Human),346.0,MAASQAVEEMRSRVVLGEFGVRNVHTTDFPGNYSGYDDAWDQDRFEKNFRVDVVHMDENSLEFDMVGIDAAIANAFRRILLAEVPTMAVEKVLVYNNTSIVQDEILAHRLGLIPIHADPRLFEYRNQGDEEGTEIDTLQFRLQVRCTRNPHAAKDSSDPNELYVNHKVYTRHMTWIPLGNQADLFPEGTIRPVHDDILIAQLRPGQEIDLLMHCVKGIGKDHAKFSPVATASYRLLPDITLLEPVEGEAAEELSRCFSPGVIEVQEVQGKKVARVANPRLDTFSREIFRNEKLKKVVRLARVRDHYIFSVESTGVLPPDVLVSEAIKVLMGKCRRFLDELDAVQMD,PF01000;PF01193;,7A6H;7AE1;7AE3;7AEA;7AST;7D58;7D59;7DN3;7DU2;7FJI;7FJJ;7OB9;7OBA;7OBB;,146,C,R,True,845
13211,58,15260,single nucleotide variant,NM_000027.4(AGA):c.916T>C (p.Cys306Arg),175,AGA,HGNC:318,Pathogenic,1,15-Dec-91,121964906,-,RCV000000245,"Human Phenotype Ontology:HP:0012068,MONDO:MONDO:0008830,MedGen:C0268225,OMIM:208400,Orphanet:93",Aspartylglucosaminuria,germline,germline,GRCh38,NC_000004.12,4,177433238,177433238,na,na,4q34.3,no assertion criteria provided,1,-,N,"ClinGen:CA114057,UniProtKB:P20933#VAR_005075,OMIM:613228.0003",1,221,177433238,A,G,C306R,0,pathogenic,uncertain,P20933,P20933,reviewed,ASPG_HUMAN,"N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, EC 3.5.1.26 (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain ]",AGA,Homo sapiens (Human),346.0,MARKSNLPVLLVPFLLCQALVRCSSPLPLVVNTWPFKNATEAAWRALASGGSALDAVESGCAMCEREQCDGSVGFGGSPDELGETTLDAMIMDGTTMDVGAVGDLRRIKNAIGVARKVLEHTTHTLLVGESATTFAQSMGFINEDLSTTASQALHSDWLARNCQPNYWRNVIPDPSKYCGPYKPPGILKQDIPIHKETEDDRGHDTIGMVVIHKTGHIAAGTSTNGIKFKIHGRVGDSPIPGAGAYADDTAGAAAATGNGDILMRFLPSYQAVEYMRRGEDPTIACQKVISRIQKHFPEFFGAVICANVTGSYGAACNKLSTFTQFSFMVYNSEKNQPTEEKVDCI,PF01112;,1APY;1APZ;,306,C,R,True,846
13212,7324,70592,single nucleotide variant,NM_000027.4(AGA):c.770C>T (p.Thr257Ile),175,AGA,HGNC:318,Likely pathogenic,1,-,386833434,-,RCV000049362,"Human Phenotype Ontology:HP:0012068,MONDO:MONDO:0008830,MedGen:C0268225,OMIM:208400,Orphanet:93",Aspartylglucosaminuria,not provided,not provided,GRCh38,NC_000004.12,4,177434418,177434418,na,na,4q34.3,no assertion criteria provided,1,-,N,"ClinGen:CA144033,UniProtKB:P20933#VAR_015432",2,55953,177434418,G,A,T257I,0,pathogenic,uncertain,P20933,P20933,reviewed,ASPG_HUMAN,"N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, EC 3.5.1.26 (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain ]",AGA,Homo sapiens (Human),346.0,MARKSNLPVLLVPFLLCQALVRCSSPLPLVVNTWPFKNATEAAWRALASGGSALDAVESGCAMCEREQCDGSVGFGGSPDELGETTLDAMIMDGTTMDVGAVGDLRRIKNAIGVARKVLEHTTHTLLVGESATTFAQSMGFINEDLSTTASQALHSDWLARNCQPNYWRNVIPDPSKYCGPYKPPGILKQDIPIHKETEDDRGHDTIGMVVIHKTGHIAAGTSTNGIKFKIHGRVGDSPIPGAGAYADDTAGAAAATGNGDILMRFLPSYQAVEYMRRGEDPTIACQKVISRIQKHFPEFFGAVICANVTGSYGAACNKLSTFTQFSFMVYNSEKNQPTEEKVDCI,PF01112;,1APY;1APZ;,257,T,I,True,846
13213,8958,98219,single nucleotide variant,NM_000027.4(AGA):c.446C>G (p.Thr149Ser),175,AGA,HGNC:318,Benign,0,28-May-19,2228119,-,RCV000077944|RCV000394488|RCV000675818,"MedGen:CN169374|Human Phenotype Ontology:HP:0012068,MONDO:MONDO:0008830,MedGen:C0268225,OMIM:208400,Orphanet:93|MedGen:CN517202",not specified|Aspartylglucosaminuria|not provided,germline;unknown,germline,GRCh38,NC_000004.12,4,177438806,177438806,na,na,4q34.3,"criteria provided, multiple submitters, no conflicts",10,-,N,"ClinGen:CA145609,UniProtKB:P20933#VAR_033533",2,92308,177438806,G,C,T149S,2,benign,benign,P20933,P20933,reviewed,ASPG_HUMAN,"N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, EC 3.5.1.26 (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain ]",AGA,Homo sapiens (Human),346.0,MARKSNLPVLLVPFLLCQALVRCSSPLPLVVNTWPFKNATEAAWRALASGGSALDAVESGCAMCEREQCDGSVGFGGSPDELGETTLDAMIMDGTTMDVGAVGDLRRIKNAIGVARKVLEHTTHTLLVGESATTFAQSMGFINEDLSTTASQALHSDWLARNCQPNYWRNVIPDPSKYCGPYKPPGILKQDIPIHKETEDDRGHDTIGMVVIHKTGHIAAGTSTNGIKFKIHGRVGDSPIPGAGAYADDTAGAAAATGNGDILMRFLPSYQAVEYMRRGEDPTIACQKVISRIQKHFPEFFGAVICANVTGSYGAACNKLSTFTQFSFMVYNSEKNQPTEEKVDCI,PF01112;,1APY;1APZ;,149,T,S,True,846
13214,7322,70590,single nucleotide variant,NM_000027.4(AGA):c.754G>C (p.Gly252Arg),175,AGA,HGNC:318,Likely pathogenic,1,-,386833432,-,RCV000049360,"Human Phenotype Ontology:HP:0012068,MONDO:MONDO:0008830,MedGen:C0268225,OMIM:208400,Orphanet:93",Aspartylglucosaminuria,not provided,not provided,GRCh38,NC_000004.12,4,177434434,177434434,na,na,4q34.3,no assertion criteria provided,1,-,N,"ClinGen:CA144031,UniProtKB:P20933#VAR_015431",2,55951,177434434,C,G,G252R,0,pathogenic,uncertain,P20933,P20933,reviewed,ASPG_HUMAN,"N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, EC 3.5.1.26 (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain ]",AGA,Homo sapiens (Human),346.0,MARKSNLPVLLVPFLLCQALVRCSSPLPLVVNTWPFKNATEAAWRALASGGSALDAVESGCAMCEREQCDGSVGFGGSPDELGETTLDAMIMDGTTMDVGAVGDLRRIKNAIGVARKVLEHTTHTLLVGESATTFAQSMGFINEDLSTTASQALHSDWLARNCQPNYWRNVIPDPSKYCGPYKPPGILKQDIPIHKETEDDRGHDTIGMVVIHKTGHIAAGTSTNGIKFKIHGRVGDSPIPGAGAYADDTAGAAAATGNGDILMRFLPSYQAVEYMRRGEDPTIACQKVISRIQKHFPEFFGAVICANVTGSYGAACNKLSTFTQFSFMVYNSEKNQPTEEKVDCI,PF01112;,1APY;1APZ;,252,G,R,True,846
13215,56,15258,single nucleotide variant,NM_000027.4(AGA):c.488G>C (p.Cys163Ser),175,AGA,HGNC:318,Pathogenic,1,16-Dec-20,121964904,-,RCV000000243|RCV000410114,"MedGen:C4017301|Human Phenotype Ontology:HP:0012068,MONDO:MONDO:0008830,MedGen:C0268225,OMIM:208400,Orphanet:93","Aspartylglucosaminuria, finnish type|Aspartylglucosaminuria",germline;unknown,germline,GRCh38,NC_000004.12,4,177438764,177438764,na,na,4q34.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA114055,UniProtKB:P20933#VAR_005073,OMIM:613228.0001",3,219,177438764,C,G,C163S,2,pathogenic,pathogenic,P20933,P20933,reviewed,ASPG_HUMAN,"N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, EC 3.5.1.26 (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain ]",AGA,Homo sapiens (Human),346.0,MARKSNLPVLLVPFLLCQALVRCSSPLPLVVNTWPFKNATEAAWRALASGGSALDAVESGCAMCEREQCDGSVGFGGSPDELGETTLDAMIMDGTTMDVGAVGDLRRIKNAIGVARKVLEHTTHTLLVGESATTFAQSMGFINEDLSTTASQALHSDWLARNCQPNYWRNVIPDPSKYCGPYKPPGILKQDIPIHKETEDDRGHDTIGMVVIHKTGHIAAGTSTNGIKFKIHGRVGDSPIPGAGAYADDTAGAAAATGNGDILMRFLPSYQAVEYMRRGEDPTIACQKVISRIQKHFPEFFGAVICANVTGSYGAACNKLSTFTQFSFMVYNSEKNQPTEEKVDCI,PF01112;,1APY;1APZ;,163,C,S,True,846
13216,57,15259,single nucleotide variant,NM_000027.4(AGA):c.904G>A (p.Gly302Arg),175,AGA,HGNC:318,Pathogenic,1,15-Dec-91,121964905,-,RCV000000244,"Human Phenotype Ontology:HP:0012068,MONDO:MONDO:0008830,MedGen:C0268225,OMIM:208400,Orphanet:93",Aspartylglucosaminuria,germline,germline,GRCh38,NC_000004.12,4,177433250,177433250,na,na,4q34.3,no assertion criteria provided,1,-,N,"ClinGen:CA114056,UniProtKB:P20933#VAR_005074,OMIM:613228.0002",1,220,177433250,C,T,G302R,0,pathogenic,uncertain,P20933,P20933,reviewed,ASPG_HUMAN,"N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, EC 3.5.1.26 (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain ]",AGA,Homo sapiens (Human),346.0,MARKSNLPVLLVPFLLCQALVRCSSPLPLVVNTWPFKNATEAAWRALASGGSALDAVESGCAMCEREQCDGSVGFGGSPDELGETTLDAMIMDGTTMDVGAVGDLRRIKNAIGVARKVLEHTTHTLLVGESATTFAQSMGFINEDLSTTASQALHSDWLARNCQPNYWRNVIPDPSKYCGPYKPPGILKQDIPIHKETEDDRGHDTIGMVVIHKTGHIAAGTSTNGIKFKIHGRVGDSPIPGAGAYADDTAGAAAATGNGDILMRFLPSYQAVEYMRRGEDPTIACQKVISRIQKHFPEFFGAVICANVTGSYGAACNKLSTFTQFSFMVYNSEKNQPTEEKVDCI,PF01112;,1APY;1APZ;,302,G,R,True,846
13217,7320,70579,single nucleotide variant,NM_000027.4(AGA):c.299G>A (p.Gly100Glu),175,AGA,HGNC:318,Likely pathogenic,1,18-Aug-14,386833421,-,RCV000049349,"Human Phenotype Ontology:HP:0012068,MONDO:MONDO:0008830,MedGen:C0268225,OMIM:208400,Orphanet:93",Aspartylglucosaminuria,unknown,unknown,GRCh38,NC_000004.12,4,177439671,177439671,na,na,4q34.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA144015,UniProtKB:P20933#VAR_015428",2,55940,177439671,C,T,G100E,1,pathogenic,pathogenic,P20933,P20933,reviewed,ASPG_HUMAN,"N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, EC 3.5.1.26 (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain ]",AGA,Homo sapiens (Human),346.0,MARKSNLPVLLVPFLLCQALVRCSSPLPLVVNTWPFKNATEAAWRALASGGSALDAVESGCAMCEREQCDGSVGFGGSPDELGETTLDAMIMDGTTMDVGAVGDLRRIKNAIGVARKVLEHTTHTLLVGESATTFAQSMGFINEDLSTTASQALHSDWLARNCQPNYWRNVIPDPSKYCGPYKPPGILKQDIPIHKETEDDRGHDTIGMVVIHKTGHIAAGTSTNGIKFKIHGRVGDSPIPGAGAYADDTAGAAAATGNGDILMRFLPSYQAVEYMRRGEDPTIACQKVISRIQKHFPEFFGAVICANVTGSYGAACNKLSTFTQFSFMVYNSEKNQPTEEKVDCI,PF01112;,1APY;1APZ;,100,G,E,True,846
13218,60,15262,single nucleotide variant,NM_000027.4(AGA):c.302C>T (p.Ala101Val),175,AGA,HGNC:318,Likely pathogenic,1,31-Jan-20,121964908,-,RCV000000247,"Human Phenotype Ontology:HP:0012068,MONDO:MONDO:0008830,MedGen:C0268225,OMIM:208400,Orphanet:93",Aspartylglucosaminuria,germline;unknown,germline,GRCh38,NC_000004.12,4,177439668,177439668,na,na,4q34.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA114059,UniProtKB:P20933#VAR_005071,OMIM:613228.0005",3,223,177439668,G,A,A101V,2,pathogenic,pathogenic,P20933,P20933,reviewed,ASPG_HUMAN,"N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, EC 3.5.1.26 (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain ]",AGA,Homo sapiens (Human),346.0,MARKSNLPVLLVPFLLCQALVRCSSPLPLVVNTWPFKNATEAAWRALASGGSALDAVESGCAMCEREQCDGSVGFGGSPDELGETTLDAMIMDGTTMDVGAVGDLRRIKNAIGVARKVLEHTTHTLLVGESATTFAQSMGFINEDLSTTASQALHSDWLARNCQPNYWRNVIPDPSKYCGPYKPPGILKQDIPIHKETEDDRGHDTIGMVVIHKTGHIAAGTSTNGIKFKIHGRVGDSPIPGAGAYADDTAGAAAATGNGDILMRFLPSYQAVEYMRRGEDPTIACQKVISRIQKHFPEFFGAVICANVTGSYGAACNKLSTFTQFSFMVYNSEKNQPTEEKVDCI,PF01112;,1APY;1APZ;,101,A,V,True,846
13219,11585,186679,single nucleotide variant,NM_000027.4(AGA):c.34G>T (p.Val12Leu),175,AGA,HGNC:318,Conflicting interpretations of pathogenicity,0,27-Apr-17,74626221,-,RCV000169339|RCV000675822,"Human Phenotype Ontology:HP:0012068,MONDO:MONDO:0008830,MedGen:C0268225,OMIM:208400,Orphanet:93|MedGen:CN517202",Aspartylglucosaminuria|not provided,germline;unknown,germline,GRCh38,NC_000004.12,4,177442342,177442342,na,na,4q34.3,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA199105,UniProtKB:P20933#VAR_015427",2,188964,177442342,C,A,V12L,1,uncertain,uncertain,P20933,P20933,reviewed,ASPG_HUMAN,"N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, EC 3.5.1.26 (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain ]",AGA,Homo sapiens (Human),346.0,MARKSNLPVLLVPFLLCQALVRCSSPLPLVVNTWPFKNATEAAWRALASGGSALDAVESGCAMCEREQCDGSVGFGGSPDELGETTLDAMIMDGTTMDVGAVGDLRRIKNAIGVARKVLEHTTHTLLVGESATTFAQSMGFINEDLSTTASQALHSDWLARNCQPNYWRNVIPDPSKYCGPYKPPGILKQDIPIHKETEDDRGHDTIGMVVIHKTGHIAAGTSTNGIKFKIHGRVGDSPIPGAGAYADDTAGAAAATGNGDILMRFLPSYQAVEYMRRGEDPTIACQKVISRIQKHFPEFFGAVICANVTGSYGAACNKLSTFTQFSFMVYNSEKNQPTEEKVDCI,PF01112;,1APY;1APZ;,12,V,L,True,846
13220,7323,70591,single nucleotide variant,NM_000027.4(AGA):c.755G>A (p.Gly252Glu),175,AGA,HGNC:318,Likely pathogenic,1,-,386833433,-,RCV000049361,"Human Phenotype Ontology:HP:0012068,MONDO:MONDO:0008830,MedGen:C0268225,OMIM:208400,Orphanet:93",Aspartylglucosaminuria,not provided,not provided,GRCh38,NC_000004.12,4,177434433,177434433,na,na,4q34.3,no assertion criteria provided,1,-,N,"ClinGen:CA144032,UniProtKB:P20933#VAR_015430",2,55952,177434433,C,T,G252E,0,pathogenic,uncertain,P20933,P20933,reviewed,ASPG_HUMAN,"N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, EC 3.5.1.26 (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain ]",AGA,Homo sapiens (Human),346.0,MARKSNLPVLLVPFLLCQALVRCSSPLPLVVNTWPFKNATEAAWRALASGGSALDAVESGCAMCEREQCDGSVGFGGSPDELGETTLDAMIMDGTTMDVGAVGDLRRIKNAIGVARKVLEHTTHTLLVGESATTFAQSMGFINEDLSTTASQALHSDWLARNCQPNYWRNVIPDPSKYCGPYKPPGILKQDIPIHKETEDDRGHDTIGMVVIHKTGHIAAGTSTNGIKFKIHGRVGDSPIPGAGAYADDTAGAAAATGNGDILMRFLPSYQAVEYMRRGEDPTIACQKVISRIQKHFPEFFGAVICANVTGSYGAACNKLSTFTQFSFMVYNSEKNQPTEEKVDCI,PF01112;,1APY;1APZ;,252,G,E,True,846
13221,61,15268,single nucleotide variant,NM_000027.4(AGA):c.214T>C (p.Ser72Pro),175,AGA,HGNC:318,Pathogenic,1,18-Nov-19,121964909,-,RCV000000253,"Human Phenotype Ontology:HP:0012068,MONDO:MONDO:0008830,MedGen:C0268225,OMIM:208400,Orphanet:93",Aspartylglucosaminuria,germline,germline,GRCh38,NC_000004.12,4,177440340,177440340,na,na,4q34.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA114062,UniProtKB:P20933#VAR_005070,OMIM:613228.0012",3,229,177440340,A,G,S72P,1,pathogenic,pathogenic,P20933,P20933,reviewed,ASPG_HUMAN,"N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, EC 3.5.1.26 (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain ]",AGA,Homo sapiens (Human),346.0,MARKSNLPVLLVPFLLCQALVRCSSPLPLVVNTWPFKNATEAAWRALASGGSALDAVESGCAMCEREQCDGSVGFGGSPDELGETTLDAMIMDGTTMDVGAVGDLRRIKNAIGVARKVLEHTTHTLLVGESATTFAQSMGFINEDLSTTASQALHSDWLARNCQPNYWRNVIPDPSKYCGPYKPPGILKQDIPIHKETEDDRGHDTIGMVVIHKTGHIAAGTSTNGIKFKIHGRVGDSPIPGAGAYADDTAGAAAATGNGDILMRFLPSYQAVEYMRRGEDPTIACQKVISRIQKHFPEFFGAVICANVTGSYGAACNKLSTFTQFSFMVYNSEKNQPTEEKVDCI,PF01112;,1APY;1APZ;,72,S,P,True,846
13222,7321,70585,single nucleotide variant,NM_000027.4(AGA):c.404T>C (p.Phe135Ser),175,AGA,HGNC:318,Likely pathogenic,1,-,386833427,-,RCV000049355,"Human Phenotype Ontology:HP:0012068,MONDO:MONDO:0008830,MedGen:C0268225,OMIM:208400,Orphanet:93",Aspartylglucosaminuria,not provided,not provided,GRCh38,NC_000004.12,4,177438848,177438848,na,na,4q34.3,no assertion criteria provided,1,-,N,"ClinGen:CA144022,UniProtKB:P20933#VAR_015429",2,55946,177438848,A,G,F135S,0,pathogenic,uncertain,P20933,P20933,reviewed,ASPG_HUMAN,"N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, EC 3.5.1.26 (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain ]",AGA,Homo sapiens (Human),346.0,MARKSNLPVLLVPFLLCQALVRCSSPLPLVVNTWPFKNATEAAWRALASGGSALDAVESGCAMCEREQCDGSVGFGGSPDELGETTLDAMIMDGTTMDVGAVGDLRRIKNAIGVARKVLEHTTHTLLVGESATTFAQSMGFINEDLSTTASQALHSDWLARNCQPNYWRNVIPDPSKYCGPYKPPGILKQDIPIHKETEDDRGHDTIGMVVIHKTGHIAAGTSTNGIKFKIHGRVGDSPIPGAGAYADDTAGAAAATGNGDILMRFLPSYQAVEYMRRGEDPTIACQKVISRIQKHFPEFFGAVICANVTGSYGAACNKLSTFTQFSFMVYNSEKNQPTEEKVDCI,PF01112;,1APY;1APZ;,135,F,S,True,846
13223,59,15261,single nucleotide variant,NM_000027.4(AGA):c.179G>A (p.Gly60Asp),175,AGA,HGNC:318,Uncertain significance,1,15-Dec-17,121964907,-,RCV000000246,"Human Phenotype Ontology:HP:0012068,MONDO:MONDO:0008830,MedGen:C0268225,OMIM:208400,Orphanet:93",Aspartylglucosaminuria,germline;unknown,germline,GRCh38,NC_000004.12,4,177440375,177440375,na,na,4q34.3,"criteria provided, single submitter",2,-,N,"UniProtKB:P20933#VAR_005069,OMIM:613228.0004,ClinGen:CA114058",3,222,177440375,C,T,G60D,1,uncertain,uncertain,P20933,P20933,reviewed,ASPG_HUMAN,"N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, EC 3.5.1.26 (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain ]",AGA,Homo sapiens (Human),346.0,MARKSNLPVLLVPFLLCQALVRCSSPLPLVVNTWPFKNATEAAWRALASGGSALDAVESGCAMCEREQCDGSVGFGGSPDELGETTLDAMIMDGTTMDVGAVGDLRRIKNAIGVARKVLEHTTHTLLVGESATTFAQSMGFINEDLSTTASQALHSDWLARNCQPNYWRNVIPDPSKYCGPYKPPGILKQDIPIHKETEDDRGHDTIGMVVIHKTGHIAAGTSTNGIKFKIHGRVGDSPIPGAGAYADDTAGAAAATGNGDILMRFLPSYQAVEYMRRGEDPTIACQKVISRIQKHFPEFFGAVICANVTGSYGAACNKLSTFTQFSFMVYNSEKNQPTEEKVDCI,PF01112;,1APY;1APZ;,60,G,D,True,846
13224,1753,22641,single nucleotide variant,NM_002542.5(OGG1):c.137G>A (p.Arg46Gln),4968,OGG1,HGNC:8125,Pathogenic,1,1-Sep-00,104893751,-,RCV000008040,"Human Phenotype Ontology:HP:0006770,MedGen:C0279702,Orphanet:319276",Clear cell carcinoma of kidney,somatic,somatic,GRCh38,NC_000003.12,3,9750423,9750423,na,na,3p25.3,no assertion criteria provided,1,-,N,"ClinGen:CA250044,UniProtKB:O15527#VAR_009519,OMIM:601982.0001",1,7602,9750423,G,A,R46Q,0,pathogenic,uncertain,O15527,O15527,reviewed,OGG1_HUMAN,"N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase, EC 3.2.2.-; DNA-(apurinic or apyrimidinic site) lyase, AP lyase, EC 4.2.99.18 ]",OGG1 MMH MUTM OGH1,Homo sapiens (Human),345.0,MPARALLPRRMGHRTLASTPALWASIPCPRSELRLDLVLPSGQSFRWREQSPAHWSGVLADQVWTLTQTEEQLHCTVYRGDKSQASRPTPDELEAVRKYFQLDVTLAQLYHHWGSVDSHFQEVAQKFQGVRLLRQDPIECLFSFICSSNNNIARITGMVERLCQAFGPRLIQLDDVTYHGFPSLQALAGPEVEAHLRKLGLGYRARYVSASARAILEEQGGLAWLQQLRESSYEEAHKALCILPGVGTKVADCICLMALDKPQAVPVDVHMWHIAQRDYSWHPTTSQAKGPSPQTNKELGNFFRSLWGPYAGWAQAVLFSADLRQSRHAQEPPAKRRKGSKGPEG,PF00730;PF07934;,1EBM;1FN7;1HU0;1KO9;1LWV;1LWW;1LWY;1M3H;1M3Q;1N39;1N3A;1N3C;1YQK;1YQL;1YQM;1YQR;2I5W;2NOB;2NOE;2NOF;2NOH;2NOI;2NOL;2NOZ;2XHI;3IH7;3KTU;5AN4;6RLW;6W0M;6W0R;6W13;,46,R,Q,True,847
13225,1419,21201,single nucleotide variant,NM_152384.3(BBS5):c.547A>G (p.Thr183Ala),129880,BBS5,HGNC:970,Pathogenic,1,15-Feb-08,121908582,-,RCV000006537,"MONDO:MONDO:0014434,MedGen:C3892039,OMIM:615983,Orphanet:110",Bardet-Biedl syndrome 5,germline,germline,GRCh38,NC_000002.12,2,169493765,169493765,na,na,2q31.1,no assertion criteria provided,1,-,N,"ClinGen:CA253785,UniProtKB:Q8N3I7#VAR_072380,OMIM:603650.0006",1,6162,169493765,A,G,T183A,0,pathogenic,uncertain,Q8N3I7,Q8N3I7,reviewed,BBS5_HUMAN,Bardet-Biedl syndrome 5 protein,BBS5,Homo sapiens (Human),341.0,MSVLDALWEDRDVRFDLSAQQMKTRPGEVLIDCLDSIEDTKGNNGDRGRLLVTNLRILWHSLALSRVNVSVGYNCILNITTRTANSKLRGQTEALYILTKCNSTRFEFIFTNLVPGSPRLFTSVMAVHRAYETSKMYRDFKLRSALIQNKQLRLLPQEHVYDKINGVWNLSSDQGNLGTFFITNVRIVWHANMNDSFNVSIPYLQIRSIKIRDSKFGLALVIESSQQSGGYVLGFKIDPVEKLQESVKEINSLHKVYSASPIFGVDYEMEEKPQPLEALTVEQIQDDVEIDSDGHTDAFVAYFADGNKQQDREPVFSEELGLAIEKLKDGFTLQGLWEVMS,PF07289;,6XTB;,183,T,A,True,848
13226,9185,102393,single nucleotide variant,NM_152384.3(BBS5):c.620G>A (p.Arg207His),129880,BBS5,HGNC:970,Benign,0,31-Dec-19,35487251,-,RCV000082651|RCV000230046,"MedGen:CN169374|MONDO:MONDO:0015229,MedGen:C0752166,OMIM:PS209900,Orphanet:110",not specified|Bardet-Biedl syndrome,germline,germline,GRCh38,NC_000002.12,2,169497628,169497628,na,na,2q31.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA149557,UniProtKB:Q8N3I7#VAR_025317",2,96499,169497628,G,A,R207H,2,benign,benign,Q8N3I7,Q8N3I7,reviewed,BBS5_HUMAN,Bardet-Biedl syndrome 5 protein,BBS5,Homo sapiens (Human),341.0,MSVLDALWEDRDVRFDLSAQQMKTRPGEVLIDCLDSIEDTKGNNGDRGRLLVTNLRILWHSLALSRVNVSVGYNCILNITTRTANSKLRGQTEALYILTKCNSTRFEFIFTNLVPGSPRLFTSVMAVHRAYETSKMYRDFKLRSALIQNKQLRLLPQEHVYDKINGVWNLSSDQGNLGTFFITNVRIVWHANMNDSFNVSIPYLQIRSIKIRDSKFGLALVIESSQQSGGYVLGFKIDPVEKLQESVKEINSLHKVYSASPIFGVDYEMEEKPQPLEALTVEQIQDDVEIDSDGHTDAFVAYFADGNKQQDREPVFSEELGLAIEKLKDGFTLQGLWEVMS,PF07289;,6XTB;,207,R,H,True,848
13227,9734,106482,single nucleotide variant,NM_152384.3(BBS5):c.551A>G (p.Asn184Ser),129880,BBS5,HGNC:970,Conflicting interpretations of pathogenicity,1,31-Dec-19,137853921,-,RCV000087001|RCV000152843|RCV000504860|RCV001257073,"MedGen:CN517202|MedGen:CN169374|Human Phenotype Ontology:HP:0008020,MONDO:MONDO:0000455,MedGen:C0730290,Orphanet:1871|MONDO:MONDO:0015229,MedGen:C0752166,OMIM:PS209900,Orphanet:110",not provided|not specified|Cone dystrophy|Bardet-Biedl syndrome,germline;unknown,germline,GRCh38,NC_000002.12,2,169493769,169493769,na,na,2q31.1,"criteria provided, conflicting interpretations",7,-,N,"UniProtKB:Q8N3I7#VAR_025316,ClinGen:CA179794",2,100605,169493769,A,G,N184S,1,uncertain,uncertain,Q8N3I7,Q8N3I7,reviewed,BBS5_HUMAN,Bardet-Biedl syndrome 5 protein,BBS5,Homo sapiens (Human),341.0,MSVLDALWEDRDVRFDLSAQQMKTRPGEVLIDCLDSIEDTKGNNGDRGRLLVTNLRILWHSLALSRVNVSVGYNCILNITTRTANSKLRGQTEALYILTKCNSTRFEFIFTNLVPGSPRLFTSVMAVHRAYETSKMYRDFKLRSALIQNKQLRLLPQEHVYDKINGVWNLSSDQGNLGTFFITNVRIVWHANMNDSFNVSIPYLQIRSIKIRDSKFGLALVIESSQQSGGYVLGFKIDPVEKLQESVKEINSLHKVYSASPIFGVDYEMEEKPQPLEALTVEQIQDDVEIDSDGHTDAFVAYFADGNKQQDREPVFSEELGLAIEKLKDGFTLQGLWEVMS,PF07289;,6XTB;,184,N,S,True,848
13228,1418,21200,single nucleotide variant,NM_152384.3(BBS5):c.214G>A (p.Gly72Ser),129880,BBS5,HGNC:970,Pathogenic,1,1-Apr-18,121908581,-,RCV000006536|RCV000787535,"MONDO:MONDO:0014434,MedGen:C3892039,OMIM:615983,Orphanet:110|MONDO:MONDO:0015229,MedGen:C0752166,OMIM:PS209900,Orphanet:110",Bardet-Biedl syndrome 5|Bardet-Biedl syndrome,germline;unknown,germline,GRCh38,NC_000002.12,2,169487811,169487811,na,na,2q31.1,no assertion criteria provided,2,-,N,"ClinGen:CA253784,UniProtKB:Q8N3I7#VAR_066290,OMIM:603650.0005",3,6161,169487811,G,A,G72S,0,pathogenic,uncertain,Q8N3I7,Q8N3I7,reviewed,BBS5_HUMAN,Bardet-Biedl syndrome 5 protein,BBS5,Homo sapiens (Human),341.0,MSVLDALWEDRDVRFDLSAQQMKTRPGEVLIDCLDSIEDTKGNNGDRGRLLVTNLRILWHSLALSRVNVSVGYNCILNITTRTANSKLRGQTEALYILTKCNSTRFEFIFTNLVPGSPRLFTSVMAVHRAYETSKMYRDFKLRSALIQNKQLRLLPQEHVYDKINGVWNLSSDQGNLGTFFITNVRIVWHANMNDSFNVSIPYLQIRSIKIRDSKFGLALVIESSQQSGGYVLGFKIDPVEKLQESVKEINSLHKVYSASPIFGVDYEMEEKPQPLEALTVEQIQDDVEIDSDGHTDAFVAYFADGNKQQDREPVFSEELGLAIEKLKDGFTLQGLWEVMS,PF07289;,6XTB;,72,G,S,True,848
13229,7469,75616,single nucleotide variant,NM_024339.5(THOC6):c.136G>A (p.Gly46Arg),79228,THOC6,HGNC:28369,Pathogenic,1,5-Aug-20,587777030,-,RCV000054832,"MONDO:MONDO:0013362,MedGen:C3150939,OMIM:613680,Orphanet:363444",Beaulieu-Boycott-Innes syndrome,germline,germline,GRCh38,NC_000016.10,16,3025804,3025804,na,na,16p13.3,no assertion criteria provided,2,-,N,"ClinGen:CA144732,UniProtKB:Q86W42#VAR_069779,OMIM:615403.0001",1,64681,3025804,G,A,G46R,0,pathogenic,uncertain,Q86W42,Q86W42,reviewed,THOC6_HUMAN,"THO complex subunit 6 homolog (Functional spliceosome-associated protein 35, fSAP35) (WD repeat-containing protein 58)",THOC6 WDR58 PSEC0006,Homo sapiens (Human),341.0,MERAVPLAVPLGQTEVFQALQRLHMTIFSQSVSPCGKFLAAGNNYGQIAIFSLSSALSSEAKEESKKPVVTFQAHDGPVYSMVSTDRHLLSAGDGEVKAWLWAEMLKKGCKELWRRQPPYRTSLEVPEINALLLVPKENSLILAGGDCQLHTMDLETGTFTRVLRGHTDYIHCLALRERSPEVLSGGEDGAVRLWDLRTAKEVQTIEVYKHEECSRPHNGRWIGCLATDSDWMVCGGGPALTLWHLRSSTPTTIFPIRAPQKHVTFYQDLILSAGQGRCVNQWQLSGELKAQVPGSSPGLLSLSLNQQPAAPECKVLTAAGNSCRVDVFTNLGYRAFSLSF,PF00400;,7APK;,46,G,R,True,849
13230,13431,257222,single nucleotide variant,NM_001083899.2(GP6):c.655C>T (p.Pro219Ser),51206,GP6,HGNC:14388,Benign,0,-,1613662,-,RCV000241611,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000019.10,19,55025227,55025227,na,na,19q13.42,"criteria provided, single submitter",1,-,N,"ClinGen:CA310128585,UniProtKB:Q9HCN6#VAR_060352",2,257422,55025227,G,A,P219S,1,benign,benign,Q9HCN6,Q9HCN6,reviewed,GPVI_HUMAN,"Platelet glycoprotein VI, GPVI (Glycoprotein 6)",GP6,Homo sapiens (Human),339.0,MSPSPTALFCLGLCLGRVPAQSGPLPKPSLQALPSSLVPLEKPVTLRCQGPPGVDLYRLEKLSSSRYQDQAVLFIPAMKRSLAGRYRCSYQNGSLWSLPSDQLELVATGVFAKPSLSAQPGPAVSSGGDVTLQCQTRYGFDQFALYKEGDPAPYKNPERWYRASFPIITVTAAHSGTYRCYSFSSRDPYLWSAPSDPLELVVTGTSVTPSRLPTEPPSPVAEFSEATAELTVSFTNEVFTTETSRSITASPKESDSPAGPARQYYTKGNLVRICLGAVILIILAGFLAEDWHSRRKRLRHRGRAVQRPLPPLPPLPLTRKSNGGQDGGRQDVHSRGLCS,PF13895;,2GI7;5OU7;5OU8;5OU9;7NMU;,219,P,S,True,850
13231,13430,257221,single nucleotide variant,NM_001083899.2(GP6):c.709G>A (p.Glu237Lys),51206,GP6,HGNC:14388,Benign,0,-,1654416,-,RCV000246602,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000019.10,19,55018667,55018667,na,na,19q13.42,"criteria provided, single submitter",1,-,N,"ClinGen:CA310123430,UniProtKB:Q9HCN6#VAR_060353",2,257423,55018667,C,T,E237K,1,benign,benign,Q9HCN6,Q9HCN6,reviewed,GPVI_HUMAN,"Platelet glycoprotein VI, GPVI (Glycoprotein 6)",GP6,Homo sapiens (Human),339.0,MSPSPTALFCLGLCLGRVPAQSGPLPKPSLQALPSSLVPLEKPVTLRCQGPPGVDLYRLEKLSSSRYQDQAVLFIPAMKRSLAGRYRCSYQNGSLWSLPSDQLELVATGVFAKPSLSAQPGPAVSSGGDVTLQCQTRYGFDQFALYKEGDPAPYKNPERWYRASFPIITVTAAHSGTYRCYSFSSRDPYLWSAPSDPLELVVTGTSVTPSRLPTEPPSPVAEFSEATAELTVSFTNEVFTTETSRSITASPKESDSPAGPARQYYTKGNLVRICLGAVILIILAGFLAEDWHSRRKRLRHRGRAVQRPLPPLPPLPLTRKSNGGQDGGRQDVHSRGLCS,PF13895;,2GI7;5OU7;5OU8;5OU9;7NMU;,237,E,K,True,850
13232,13429,257220,single nucleotide variant,NM_001083899.2(GP6):c.745G>A (p.Ala249Thr),51206,GP6,HGNC:14388,Benign,0,-,2304167,-,RCV000251969,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000019.10,19,55015713,55015713,na,na,19q13.42,"criteria provided, single submitter",1,-,N,"ClinGen:CA310122301,UniProtKB:Q9HCN6#VAR_060354",2,257424,55015713,C,T,A249T,1,benign,benign,Q9HCN6,Q9HCN6,reviewed,GPVI_HUMAN,"Platelet glycoprotein VI, GPVI (Glycoprotein 6)",GP6,Homo sapiens (Human),339.0,MSPSPTALFCLGLCLGRVPAQSGPLPKPSLQALPSSLVPLEKPVTLRCQGPPGVDLYRLEKLSSSRYQDQAVLFIPAMKRSLAGRYRCSYQNGSLWSLPSDQLELVATGVFAKPSLSAQPGPAVSSGGDVTLQCQTRYGFDQFALYKEGDPAPYKNPERWYRASFPIITVTAAHSGTYRCYSFSSRDPYLWSAPSDPLELVVTGTSVTPSRLPTEPPSPVAEFSEATAELTVSFTNEVFTTETSRSITASPKESDSPAGPARQYYTKGNLVRICLGAVILIILAGFLAEDWHSRRKRLRHRGRAVQRPLPPLPPLPLTRKSNGGQDGGRQDVHSRGLCS,PF13895;,2GI7;5OU7;5OU8;5OU9;7NMU;,249,A,T,True,850
13233,14234,679353,single nucleotide variant,NM_001083899.2(GP6):c.584G>A (p.Ser195Asn),51206,GP6,HGNC:14388,Pathogenic,1,1-Aug-09,200525940,-,RCV000023462,"MONDO:MONDO:0013623,MedGen:C3280120,OMIM:614201,Orphanet:73271,Orphanet:98885",Platelet-type bleeding disorder 11,germline,germline,GRCh38,NC_000019.10,19,55027604,55027604,na,na,19q13.42,no assertion criteria provided,1,-,N,"UniProtKB:Q9HCN6#VAR_066591,OMIM:605546.0003",1,691634,55027604,C,T,S195N,0,pathogenic,uncertain,Q9HCN6,Q9HCN6,reviewed,GPVI_HUMAN,"Platelet glycoprotein VI, GPVI (Glycoprotein 6)",GP6,Homo sapiens (Human),339.0,MSPSPTALFCLGLCLGRVPAQSGPLPKPSLQALPSSLVPLEKPVTLRCQGPPGVDLYRLEKLSSSRYQDQAVLFIPAMKRSLAGRYRCSYQNGSLWSLPSDQLELVATGVFAKPSLSAQPGPAVSSGGDVTLQCQTRYGFDQFALYKEGDPAPYKNPERWYRASFPIITVTAAHSGTYRCYSFSSRDPYLWSAPSDPLELVVTGTSVTPSRLPTEPPSPVAEFSEATAELTVSFTNEVFTTETSRSITASPKESDSPAGPARQYYTKGNLVRICLGAVILIILAGFLAEDWHSRRKRLRHRGRAVQRPLPPLPPLPLTRKSNGGQDGGRQDVHSRGLCS,PF13895;,2GI7;5OU7;5OU8;5OU9;7NMU;,195,S,N,True,850
13234,5922,39150,single nucleotide variant,NM_000631.5(NCF4):c.314G>A (p.Arg105Gln),4689,NCF4,HGNC:7662,Pathogenic,1,11-Feb-16,387906808,-,RCV000023113|RCV000208606,"MONDO:MONDO:0013507,MedGen:C3151409,OMIM:613960,Orphanet:379|MONDO:MONDO:0018305,MedGen:C0018203,OMIM:PS306400,Orphanet:379","Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III|Chronic granulomatous disease",germline,germline,GRCh38,NC_000022.11,22,36867434,36867434,na,na,22q12.3,no assertion criteria provided,2,-,N,"ClinGen:CA129011,UniProtKB:Q15080#VAR_065949,OMIM:601488.0002",1,30194,36867434,G,A,R105Q,0,pathogenic,uncertain,Q15080,Q15080,reviewed,NCF4_HUMAN,"Neutrophil cytosol factor 4, NCF-4 (Neutrophil NADPH oxidase factor 4) (SH3 and PX domain-containing protein 4) (p40-phox, p40phox)",NCF4 SH3PXD4,Homo sapiens (Human),339.0,MAVAQQLRAESDFEQLPDDVAISANIADIEEKRGFTSHFVFVIEVKTKGGSKYLIYRRYRQFHALQSKLEERFGPDSKSSALACTLPTLPAKVYVGVKQEIAEMRIPALNAYMKSLLSLPVWVLMDEDVRIFFYQSPYDSEQVPQALRRLRPRTRKVKSVSPQGNSVDRMAAPRAEALFDFTGNSKLELNFKAGDVIFLLSRINKDWLEGTVRGATGIFPLSFVKILKDFPEEDDPTNWLRCYYYEDTISTIKDIAVEEDLSSTPLLKDLLELTRREFQREDIALNYRDAEGDLVRLLSDEDVALMVRQARGLPSQKRLFPWKLHITQKDNYRVYNTMP,PF00564;PF00787;PF00018;,1H6H;1OEY;1W6X;1W70;1Z9Q;2DYB;,105,R,Q,True,851
13235,10966,166023,single nucleotide variant,NM_001134665.3(TRMT10A):c.616G>A (p.Gly206Arg),93587,TRMT10A,HGNC:28403,Pathogenic,1,22-Mar-17,587777744,-,RCV000144248|RCV000624590,"MONDO:MONDO:0000208,MedGen:C4014997,OMIM:616033,Orphanet:391408|MeSH:D030342,MedGen:C0950123","Microcephaly, short stature, and impaired glucose metabolism 1|Inborn genetic diseases",germline,germline,GRCh38,NC_000004.12,4,99553814,99553814,na,na,4q23,"criteria provided, single submitter",2,-,N,"ClinGen:CA170799,UniProtKB:Q8TBZ6#VAR_072420,OMIM:616013.0002",3,156230,99553814,C,T,G206R,1,pathogenic,pathogenic,Q8TBZ6,Q8TBZ6,reviewed,TM10A_HUMAN,"tRNA methyltransferase 10 homolog A, EC 2.1.1.221 (RNA (guanine-9-)-methyltransferase domain-containing protein 2) (tRNA (guanine(9)-N(1))-methyltransferase TRMT10A)",TRMT10A RG9MTD2,Homo sapiens (Human),339.0,MSSEMLPAFIETSNVDKKQGINEDQEESQKPRLGEGCEPISKRQMKKLIKQKQWEEQRELRKQKRKEKRKRKKLERQCQMEPNSDGHDRKRVRRDVVHSTLRLIIDCSFDHLMVLKDIKKLHKQIQRCYAENRRALHPVQFYLTSHGGQLKKNMDENDKGWVNWKDIHIKPEHYSELIKKEDLIYLTSDSPNILKELDESKAYVIGGLVDHNHHKGLTYKQASDYGINHAQLPLGNFVKMNSRKVLAVNHVFEIILEYLETRDWQEAFFTILPQRKGAVPTDKACESASHDNQSVRMEEGGSDSDSSEEEYSRNELDSPHEEKQDKENHTESTVNSLPH,PF01746;,4FMW;,206,G,R,True,852
13236,3355,28166,single nucleotide variant,NM_002875.5(RAD51):c.449G>A (p.Arg150Gln),5888,RAD51,HGNC:9817,Conflicting interpretations of pathogenicity,1,31-Dec-19,121917739,-,RCV000014007|RCV000889052|RCV000989293,"MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:CN517202|MONDO:MONDO:0013790,MedGen:C3281089,OMIM:614508,Orphanet:238722",Familial cancer of breast|not provided|Mirror movements 2,germline;unknown,germline,GRCh38,NC_000015.10,15,40718818,40718818,na,na,15q15.1,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA256732,UniProtKB:Q06609#VAR_010899,OMIM:179617.0001",3,13127,40718818,G,A,R150Q,1,uncertain,uncertain,Q06609,Q06609,reviewed,RAD51_HUMAN,"DNA repair protein RAD51 homolog 1, HsRAD51, hRAD51 (RAD51 homolog A)",RAD51 RAD51A RECA,Homo sapiens (Human),339.0,MAMQMQLEANADTSVEEESFGPQPISRLEQCGINANDVKKLEEAGFHTVEAVAYAPKKELINIKGISEAKADKILAEAAKLVPMGFTTATEFHQRRSEIIQITTGSKELDKLLQGGIETGSITEMFGEFRTGKTQICHTLAVTCQLPIDRGGGEGKAMYIDTEGTFRPERLLAVAERYGLSGSDVLDNVAYARAFNTDHQTQLLYQASAMMVESRYALLIVDSATALYRTDYSGRGELSARQMHLARFLRMLLRLADEFGVAVVITNQVVAQVDGAAMFAADPKKPIGGNIIAHASTTRLYLRKGRGETRICKIYDSPCLPEAEAMFAINADGVGDAKD,PF08423;,1B22;1N0W;5H1B;5H1C;5JZC;5NP7;5NWL;7C9A;,150,R,Q,True,853
13237,239,15907,single nucleotide variant,NM_000507.4(FBP1):c.490G>A (p.Gly164Ser),2203,FBP1,HGNC:3606,Pathogenic,1,18-Dec-19,121918188,-,RCV000000916,"MONDO:MONDO:0009251,MedGen:C0016756,OMIM:229700,Orphanet:348",Fructose-biphosphatase deficiency,germline,germline,GRCh38,NC_000009.12,9,94609998,94609998,na,na,9q22.32,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA114584,UniProtKB:P09467#VAR_002380,OMIM:611570.0002",3,868,94609998,C,T,G164S,2,pathogenic,pathogenic,P09467,P09467,reviewed,F16P1_HUMAN,"Fructose-1,6-bisphosphatase 1, FBPase 1, EC 3.1.3.11 (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)",FBP1 FBP,Homo sapiens (Human),338.0,MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYARDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ,PF00316;PF18913;,1FTA;2FHY;2FIE;2FIX;2JJK;2VT5;2WBB;2WBD;2Y5K;2Y5L;3A29;3KBZ;3KC0;3KC1;4MJO;5LDZ;5PZQ;5PZR;5PZS;5PZT;5PZU;5PZV;5PZW;5PZX;5PZY;5PZZ;5Q00;5Q01;5Q02;5Q03;5Q04;5Q05;5Q06;5Q07;5Q08;5Q09;5Q0A;5Q0B;6LS5;6LW2;7C9Q;7CVH;7CVN;7CWE;,164,G,S,True,854
13238,13255,253590,single nucleotide variant,NM_000507.4(FBP1):c.653G>A (p.Arg218Lys),2203,FBP1,HGNC:3606,Benign,0,12-Jan-18,1769259,-,RCV000250848|RCV000336163,"MedGen:CN169374|MONDO:MONDO:0009251,MedGen:C0016756,OMIM:229700,Orphanet:348",not specified|Fructose-biphosphatase deficiency,germline,germline,GRCh38,NC_000009.12,9,94606867,94606867,na,na,9q22.32,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA5136172,UniProtKB:P09467#VAR_022212",2,256323,94606867,C,T,R218K,2,benign,benign,P09467,P09467,reviewed,F16P1_HUMAN,"Fructose-1,6-bisphosphatase 1, FBPase 1, EC 3.1.3.11 (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)",FBP1 FBP,Homo sapiens (Human),338.0,MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYARDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ,PF00316;PF18913;,1FTA;2FHY;2FIE;2FIX;2JJK;2VT5;2WBB;2WBD;2Y5K;2Y5L;3A29;3KBZ;3KC0;3KC1;4MJO;5LDZ;5PZQ;5PZR;5PZS;5PZT;5PZU;5PZV;5PZW;5PZX;5PZY;5PZZ;5Q00;5Q01;5Q02;5Q03;5Q04;5Q05;5Q06;5Q07;5Q08;5Q09;5Q0A;5Q0B;6LS5;6LW2;7C9Q;7CVH;7CVN;7CWE;,218,R,K,True,854
13239,242,15911,single nucleotide variant,NM_000507.4(FBP1):c.851C>G (p.Pro284Arg),2203,FBP1,HGNC:3606,Pathogenic,1,1-Jul-02,121918192,-,RCV000000920,"MONDO:MONDO:0009251,MedGen:C0016756,OMIM:229700,Orphanet:348",Fructose-biphosphatase deficiency,germline,germline,GRCh38,NC_000009.12,9,94603547,94603547,na,na,9q22.32,no assertion criteria provided,1,-,N,"OMIM:611570.0006,ClinGen:CA114592,UniProtKB:P09467#VAR_038813",1,872,94603547,G,C,P284R,0,pathogenic,uncertain,P09467,P09467,reviewed,F16P1_HUMAN,"Fructose-1,6-bisphosphatase 1, FBPase 1, EC 3.1.3.11 (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)",FBP1 FBP,Homo sapiens (Human),338.0,MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYARDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ,PF00316;PF18913;,1FTA;2FHY;2FIE;2FIX;2JJK;2VT5;2WBB;2WBD;2Y5K;2Y5L;3A29;3KBZ;3KC0;3KC1;4MJO;5LDZ;5PZQ;5PZR;5PZS;5PZT;5PZU;5PZV;5PZW;5PZX;5PZY;5PZZ;5Q00;5Q01;5Q02;5Q03;5Q04;5Q05;5Q06;5Q07;5Q08;5Q09;5Q0A;5Q0B;6LS5;6LW2;7C9Q;7CVH;7CVN;7CWE;,284,P,R,True,854
13240,241,15910,single nucleotide variant,NM_000507.4(FBP1):c.581T>C (p.Phe194Ser),2203,FBP1,HGNC:3606,Pathogenic,1,1-Jul-02,121918191,-,RCV000000919,"MONDO:MONDO:0009251,MedGen:C0016756,OMIM:229700,Orphanet:348",Fructose-biphosphatase deficiency,germline,germline,GRCh38,NC_000009.12,9,94606939,94606939,na,na,9q22.32,no assertion criteria provided,1,-,N,"ClinGen:CA114590,UniProtKB:P09467#VAR_038812,OMIM:611570.0005",1,871,94606939,A,G,F194S,0,pathogenic,uncertain,P09467,P09467,reviewed,F16P1_HUMAN,"Fructose-1,6-bisphosphatase 1, FBPase 1, EC 3.1.3.11 (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)",FBP1 FBP,Homo sapiens (Human),338.0,MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYARDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ,PF00316;PF18913;,1FTA;2FHY;2FIE;2FIX;2JJK;2VT5;2WBB;2WBD;2Y5K;2Y5L;3A29;3KBZ;3KC0;3KC1;4MJO;5LDZ;5PZQ;5PZR;5PZS;5PZT;5PZU;5PZV;5PZW;5PZX;5PZY;5PZZ;5Q00;5Q01;5Q02;5Q03;5Q04;5Q05;5Q06;5Q07;5Q08;5Q09;5Q0A;5Q0B;6LS5;6LW2;7C9Q;7CVH;7CVN;7CWE;,194,F,S,True,854
13241,10701,141068,single nucleotide variant,NM_000507.4(FBP1):c.697T>A (p.Phe233Ile),2203,FBP1,HGNC:3606,Benign/Likely benign,0,31-Dec-19,2297085,-,RCV000125097|RCV000631045,"MedGen:CN169374|MONDO:MONDO:0009251,MedGen:C0016756,OMIM:229700,Orphanet:348",not specified|Fructose-biphosphatase deficiency,germline,germline,GRCh38,NC_000009.12,9,94606823,94606823,na,na,9q22.32,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA290921,UniProtKB:P09467#VAR_022213",2,137365,94606823,A,T,F233I,2,benign,benign,P09467,P09467,reviewed,F16P1_HUMAN,"Fructose-1,6-bisphosphatase 1, FBPase 1, EC 3.1.3.11 (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)",FBP1 FBP,Homo sapiens (Human),338.0,MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYARDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ,PF00316;PF18913;,1FTA;2FHY;2FIE;2FIX;2JJK;2VT5;2WBB;2WBD;2Y5K;2Y5L;3A29;3KBZ;3KC0;3KC1;4MJO;5LDZ;5PZQ;5PZR;5PZS;5PZT;5PZU;5PZV;5PZW;5PZX;5PZY;5PZZ;5Q00;5Q01;5Q02;5Q03;5Q04;5Q05;5Q06;5Q07;5Q08;5Q09;5Q0A;5Q0B;6LS5;6LW2;7C9Q;7CVH;7CVN;7CWE;,233,F,I,True,854
13242,240,15908,single nucleotide variant,NM_000507.4(FBP1):c.530C>A (p.Ala177Asp),2203,FBP1,HGNC:3606,Pathogenic,1,1-Oct-97,121918189,-,RCV000000917,"MONDO:MONDO:0009251,MedGen:C0016756,OMIM:229700,Orphanet:348",Fructose-biphosphatase deficiency,germline,germline,GRCh38,NC_000009.12,9,94609958,94609958,na,na,9q22.32,no assertion criteria provided,1,-,N,"ClinGen:CA114586,UniProtKB:P09467#VAR_002381,OMIM:611570.0003",1,869,94609958,G,T,A177D,0,pathogenic,uncertain,P09467,P09467,reviewed,F16P1_HUMAN,"Fructose-1,6-bisphosphatase 1, FBPase 1, EC 3.1.3.11 (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)",FBP1 FBP,Homo sapiens (Human),338.0,MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYARDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ,PF00316;PF18913;,1FTA;2FHY;2FIE;2FIX;2JJK;2VT5;2WBB;2WBD;2Y5K;2Y5L;3A29;3KBZ;3KC0;3KC1;4MJO;5LDZ;5PZQ;5PZR;5PZS;5PZT;5PZU;5PZV;5PZW;5PZX;5PZY;5PZZ;5Q00;5Q01;5Q02;5Q03;5Q04;5Q05;5Q06;5Q07;5Q08;5Q09;5Q0A;5Q0B;6LS5;6LW2;7C9Q;7CVH;7CVN;7CWE;,177,A,D,True,854
13243,11918,195700,single nucleotide variant,NM_006214.4(PHYH):c.734G>A (p.Arg245Gln),5264,PHYH,HGNC:8940,Conflicting interpretations of pathogenicity,1,31-Dec-19,62619919,-,RCV000179914|RCV000665931|RCV000755125|RCV000950185|RCV001258288,"MedGen:CN169374|MONDO:MONDO:0009958,MedGen:C0034960,OMIM:266500,Orphanet:773||MedGen:CN517202|MONDO:MONDO:0010186,MedGen:C0342646,OMIM:277440,Orphanet:93160",not specified|Phytanic acid storage disease|Nonsyndromic cleft lip palate|not provided|Vitamin D-dependent rickets type II with alopecia,germline;inherited;unknown,germline,GRCh38,NC_000010.11,10,13283784,13283784,na,na,10p13,"criteria provided, conflicting interpretations",9,-,N,"ClinGen:CA203488,UniProtKB:O14832#VAR_017491",2,198539,13283784,C,T,R245Q,1,uncertain,uncertain,O14832,O14832,reviewed,PAHX_HUMAN,"Phytanoyl-CoA dioxygenase, peroxisomal, EC 1.14.11.18 (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase, PhyH)",PHYH PAHX,Homo sapiens (Human),338.0,MEQLRAAARLQIVLGHLGRPSAGAVVAHPTSGTISSASFHPQQFQYTLDNNVLTLEQRKFYEENGFLVIKNLVPDADIQRFRNEFEKICRKEVKPLGLTVMRDVTISKSEYAPSEKMITKVQDFQEDKELFRYCTLPEILKYVECFTGPNIMAMHTMLINKPPDSGKKTSRHPLHQDLHYFPFRPSDLIVCAWTAMEHISRNNGCLVVLPGTHKGSLKPHDYPKWEGGVNKMFHGIQDYEENKARVHLVMEKGDTVFFHPLLIHGSGQNKTQGFRKAISCHFASADCHYIDVKGTSQENIEKEVVGIAHKFFGAENSVNLKDIWMFRARLVKGERTNL,PF05721;,2A1X;,245,R,Q,True,855
13244,1746,22619,single nucleotide variant,NM_006214.4(PHYH):c.823C>T (p.Arg275Trp),5264,PHYH,HGNC:8940,Pathogenic/Likely pathogenic,1,8-Oct-19,104894178,-,RCV000008018|RCV000255609|RCV000505105|RCV000665657,"MedGen:C2749345|MedGen:CN517202|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MONDO:MONDO:0009958,MedGen:C0034960,OMIM:266500,Orphanet:773","Refsum disease, adult, 1|not provided|Retinitis pigmentosa|Phytanic acid storage disease",germline;unknown,germline,GRCh38,NC_000010.11,10,13283695,13283695,na,na,10p13,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA118904,UniProtKB:O14832#VAR_005526,OMIM:602026.0001",3,7580,13283695,G,A,R275W,2,pathogenic,pathogenic,O14832,O14832,reviewed,PAHX_HUMAN,"Phytanoyl-CoA dioxygenase, peroxisomal, EC 1.14.11.18 (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase, PhyH)",PHYH PAHX,Homo sapiens (Human),338.0,MEQLRAAARLQIVLGHLGRPSAGAVVAHPTSGTISSASFHPQQFQYTLDNNVLTLEQRKFYEENGFLVIKNLVPDADIQRFRNEFEKICRKEVKPLGLTVMRDVTISKSEYAPSEKMITKVQDFQEDKELFRYCTLPEILKYVECFTGPNIMAMHTMLINKPPDSGKKTSRHPLHQDLHYFPFRPSDLIVCAWTAMEHISRNNGCLVVLPGTHKGSLKPHDYPKWEGGVNKMFHGIQDYEENKARVHLVMEKGDTVFFHPLLIHGSGQNKTQGFRKAISCHFASADCHYIDVKGTSQENIEKEVVGIAHKFFGAENSVNLKDIWMFRARLVKGERTNL,PF05721;,2A1X;,275,R,W,True,855
13245,1747,22621,single nucleotide variant,NM_006214.4(PHYH):c.85C>T (p.Pro29Ser),5264,PHYH,HGNC:8940,Benign,0,28-May-19,28938169,-,RCV000008020|RCV000117911|RCV000306854,"MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0009958,MedGen:C0034960,OMIM:266500,Orphanet:773",not provided|not specified|Phytanic acid storage disease,germline;unknown,germline,GRCh38,NC_000010.11,10,13298236,13298236,na,na,10p13,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA154245,UniProtKB:O14832#VAR_017482,OMIM:602026.0006",3,7582,13298236,G,A,P29S,2,benign,benign,O14832,O14832,reviewed,PAHX_HUMAN,"Phytanoyl-CoA dioxygenase, peroxisomal, EC 1.14.11.18 (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase, PhyH)",PHYH PAHX,Homo sapiens (Human),338.0,MEQLRAAARLQIVLGHLGRPSAGAVVAHPTSGTISSASFHPQQFQYTLDNNVLTLEQRKFYEENGFLVIKNLVPDADIQRFRNEFEKICRKEVKPLGLTVMRDVTISKSEYAPSEKMITKVQDFQEDKELFRYCTLPEILKYVECFTGPNIMAMHTMLINKPPDSGKKTSRHPLHQDLHYFPFRPSDLIVCAWTAMEHISRNNGCLVVLPGTHKGSLKPHDYPKWEGGVNKMFHGIQDYEENKARVHLVMEKGDTVFFHPLLIHGSGQNKTQGFRKAISCHFASADCHYIDVKGTSQENIEKEVVGIAHKFFGAENSVNLKDIWMFRARLVKGERTNL,PF05721;,2A1X;,29,P,S,True,855
13246,1748,22623,single nucleotide variant,NM_006214.4(PHYH):c.805A>C (p.Asn269His),5264,PHYH,HGNC:8940,Pathogenic,1,1-Oct-97,104894179,-,RCV000008022,MedGen:C2749345,"Refsum disease, adult, 1",germline,germline,GRCh38,NC_000010.11,10,13283713,13283713,na,na,10p13,no assertion criteria provided,1,-,N,"ClinGen:CA118905,UniProtKB:O14832#VAR_005525,OMIM:602026.0004",1,7584,13283713,T,G,N269H,0,pathogenic,uncertain,O14832,O14832,reviewed,PAHX_HUMAN,"Phytanoyl-CoA dioxygenase, peroxisomal, EC 1.14.11.18 (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase, PhyH)",PHYH PAHX,Homo sapiens (Human),338.0,MEQLRAAARLQIVLGHLGRPSAGAVVAHPTSGTISSASFHPQQFQYTLDNNVLTLEQRKFYEENGFLVIKNLVPDADIQRFRNEFEKICRKEVKPLGLTVMRDVTISKSEYAPSEKMITKVQDFQEDKELFRYCTLPEILKYVECFTGPNIMAMHTMLINKPPDSGKKTSRHPLHQDLHYFPFRPSDLIVCAWTAMEHISRNNGCLVVLPGTHKGSLKPHDYPKWEGGVNKMFHGIQDYEENKARVHLVMEKGDTVFFHPLLIHGSGQNKTQGFRKAISCHFASADCHYIDVKGTSQENIEKEVVGIAHKFFGAENSVNLKDIWMFRARLVKGERTNL,PF05721;,2A1X;,269,N,H,True,855
13247,1749,22625,single nucleotide variant,NM_006214.4(PHYH):c.526C>A (p.Gln176Lys),5264,PHYH,HGNC:8940,Pathogenic,1,1-May-00,28939672,-,RCV000008024,MedGen:C2749345,"Refsum disease, adult, 1",germline,germline,GRCh38,NC_000010.11,10,13288512,13288512,na,na,10p13,no assertion criteria provided,1,-,N,"ClinGen:CA118906,UniProtKB:O14832#VAR_017484,OMIM:602026.0007",1,7586,13288512,G,T,Q176K,0,pathogenic,uncertain,O14832,O14832,reviewed,PAHX_HUMAN,"Phytanoyl-CoA dioxygenase, peroxisomal, EC 1.14.11.18 (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase, PhyH)",PHYH PAHX,Homo sapiens (Human),338.0,MEQLRAAARLQIVLGHLGRPSAGAVVAHPTSGTISSASFHPQQFQYTLDNNVLTLEQRKFYEENGFLVIKNLVPDADIQRFRNEFEKICRKEVKPLGLTVMRDVTISKSEYAPSEKMITKVQDFQEDKELFRYCTLPEILKYVECFTGPNIMAMHTMLINKPPDSGKKTSRHPLHQDLHYFPFRPSDLIVCAWTAMEHISRNNGCLVVLPGTHKGSLKPHDYPKWEGGVNKMFHGIQDYEENKARVHLVMEKGDTVFFHPLLIHGSGQNKTQGFRKAISCHFASADCHYIDVKGTSQENIEKEVVGIAHKFFGAENSVNLKDIWMFRARLVKGERTNL,PF05721;,2A1X;,176,Q,K,True,855
13248,1750,22626,single nucleotide variant,NM_006214.4(PHYH):c.610G>A (p.Gly204Ser),5264,PHYH,HGNC:8940,Pathogenic,1,1-May-00,104894173,-,RCV000008025,MedGen:C2749345,"Refsum disease, adult, 1",germline,germline,GRCh38,NC_000010.11,10,13288428,13288428,na,na,10p13,no assertion criteria provided,1,-,N,"ClinGen:CA118907,UniProtKB:O14832#VAR_017489,OMIM:602026.0008",1,7587,13288428,C,T,G204S,0,pathogenic,uncertain,O14832,O14832,reviewed,PAHX_HUMAN,"Phytanoyl-CoA dioxygenase, peroxisomal, EC 1.14.11.18 (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase, PhyH)",PHYH PAHX,Homo sapiens (Human),338.0,MEQLRAAARLQIVLGHLGRPSAGAVVAHPTSGTISSASFHPQQFQYTLDNNVLTLEQRKFYEENGFLVIKNLVPDADIQRFRNEFEKICRKEVKPLGLTVMRDVTISKSEYAPSEKMITKVQDFQEDKELFRYCTLPEILKYVECFTGPNIMAMHTMLINKPPDSGKKTSRHPLHQDLHYFPFRPSDLIVCAWTAMEHISRNNGCLVVLPGTHKGSLKPHDYPKWEGGVNKMFHGIQDYEENKARVHLVMEKGDTVFFHPLLIHGSGQNKTQGFRKAISCHFASADCHYIDVKGTSQENIEKEVVGIAHKFFGAENSVNLKDIWMFRARLVKGERTNL,PF05721;,2A1X;,204,G,S,True,855
13249,1751,22627,single nucleotide variant,NM_006214.4(PHYH):c.824G>A (p.Arg275Gln),5264,PHYH,HGNC:8940,Pathogenic,1,1-May-00,104894174,-,RCV000008026,MedGen:C2749345,"Refsum disease, adult, 1",germline,germline,GRCh38,NC_000010.11,10,13283694,13283694,na,na,10p13,no assertion criteria provided,1,-,N,"ClinGen:CA118908,UniProtKB:O14832#VAR_017493,OMIM:602026.0009",1,7588,13283694,C,T,R275Q,0,pathogenic,uncertain,O14832,O14832,reviewed,PAHX_HUMAN,"Phytanoyl-CoA dioxygenase, peroxisomal, EC 1.14.11.18 (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase, PhyH)",PHYH PAHX,Homo sapiens (Human),338.0,MEQLRAAARLQIVLGHLGRPSAGAVVAHPTSGTISSASFHPQQFQYTLDNNVLTLEQRKFYEENGFLVIKNLVPDADIQRFRNEFEKICRKEVKPLGLTVMRDVTISKSEYAPSEKMITKVQDFQEDKELFRYCTLPEILKYVECFTGPNIMAMHTMLINKPPDSGKKTSRHPLHQDLHYFPFRPSDLIVCAWTAMEHISRNNGCLVVLPGTHKGSLKPHDYPKWEGGVNKMFHGIQDYEENKARVHLVMEKGDTVFFHPLLIHGSGQNKTQGFRKAISCHFASADCHYIDVKGTSQENIEKEVVGIAHKFFGAENSVNLKDIWMFRARLVKGERTNL,PF05721;,2A1X;,275,R,Q,True,855
13250,14033,321247,single nucleotide variant,NM_006214.4(PHYH):c.643G>A (p.Gly215Ser),5264,PHYH,HGNC:8940,Benign,0,31-Dec-19,7901902,-,RCV000268787|RCV000886087,"MONDO:MONDO:0009958,MedGen:C0034960,OMIM:266500,Orphanet:773|MedGen:CN517202",Phytanic acid storage disease|not provided,germline,germline,GRCh38,NC_000010.11,10,13288395,13288395,na,na,10p13,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA5412291,UniProtKB:O14832#VAR_050528",2,299249,13288395,C,T,G215S,2,benign,benign,O14832,O14832,reviewed,PAHX_HUMAN,"Phytanoyl-CoA dioxygenase, peroxisomal, EC 1.14.11.18 (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase, PhyH)",PHYH PAHX,Homo sapiens (Human),338.0,MEQLRAAARLQIVLGHLGRPSAGAVVAHPTSGTISSASFHPQQFQYTLDNNVLTLEQRKFYEENGFLVIKNLVPDADIQRFRNEFEKICRKEVKPLGLTVMRDVTISKSEYAPSEKMITKVQDFQEDKELFRYCTLPEILKYVECFTGPNIMAMHTMLINKPPDSGKKTSRHPLHQDLHYFPFRPSDLIVCAWTAMEHISRNNGCLVVLPGTHKGSLKPHDYPKWEGGVNKMFHGIQDYEENKARVHLVMEKGDTVFFHPLLIHGSGQNKTQGFRKAISCHFASADCHYIDVKGTSQENIEKEVVGIAHKFFGAENSVNLKDIWMFRARLVKGERTNL,PF05721;,2A1X;,215,G,S,True,855
13251,10073,132703,single nucleotide variant,NM_003401.5(XRCC4):c.127T>C (p.Trp43Arg),7518,XRCC4,HGNC:12831,Pathogenic/Likely pathogenic,1,23-Oct-20,587779351,-,RCV000115044|RCV000190521|RCV000343573,"MONDO:MONDO:0009876,MedGen:C0342573,OMIM:262400,Orphanet:231662,Orphanet:631|MONDO:MONDO:0014686,MedGen:C4225288,OMIM:616541,Orphanet:436182|MedGen:CN517202","Ateleiotic dwarfism|Short stature, microcephaly, and endocrine dysfunction|not provided",germline,germline,GRCh38,NC_000005.10,5,83105046,83105046,na,na,5q14.2,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA151434,UniProtKB:Q13426#VAR_075822,OMIM:194363.0001",3,127246,83105046,T,C,W43R,2,pathogenic,pathogenic,Q13426,Q13426,reviewed,XRCC4_HUMAN,"DNA repair protein XRCC4, hXRCC4 (X-ray repair cross-complementing protein 4) [Cleaved into: Protein XRCC4, C-terminus, XRCC4/C ]",XRCC4,Homo sapiens (Human),336.0,MERKISRIHLVSEPSITHFLQVSWEKTLESGFVITLTDGHSAWTGTVSESEISQEADDMAMEKGKYVGELRKALLSGAGPADVYTFNFSKESCYFFFEKNLKDVSFRLGSFNLEKVENPAEVIRELICYCLDTIAENQAKNEHLQKENERLLRDWNDVQGRFEKCVSAKEALETDLYKRFILVLNEKKTKIRSLHNKLLNAAQEREKDIKQEGETAICSEMTADRDPVYDESTDEESENQTDLSGLASAAVSKDDSIISSLDVTDIAPSRKRRQRMQRNLGTEPKMAPQENQLQEKENSRPDSSLPETSKKEHISAENMSLETLRNSSPEDLFDEI,PF06632;,1FU1;1IK9;3II6;3MUD;3Q4F;3RWR;3SR2;3W03;4XA4;5CHX;5CJ0;5CJ4;5E50;5WJ7;5WLZ;6ABO;7LSY;7LT3;7M3P;7NFC;7NFE;,43,W,R,True,856
13252,12129,205039,single nucleotide variant,NM_003401.5(XRCC4):c.482G>A (p.Arg161Gln),7518,XRCC4,HGNC:12831,Pathogenic,1,1-Jul-15,797045017,-,RCV000190528,"MONDO:MONDO:0014686,MedGen:C4225288,OMIM:616541,Orphanet:436182","Short stature, microcephaly, and endocrine dysfunction",germline,germline,GRCh38,NC_000005.10,5,83195936,83195936,na,na,5q14.2,no assertion criteria provided,1,-,N,"ClinGen:CA204494,UniProtKB:Q13426#VAR_075823,OMIM:194363.0008",1,208521,83195936,G,A,R161Q,0,pathogenic,uncertain,Q13426,Q13426,reviewed,XRCC4_HUMAN,"DNA repair protein XRCC4, hXRCC4 (X-ray repair cross-complementing protein 4) [Cleaved into: Protein XRCC4, C-terminus, XRCC4/C ]",XRCC4,Homo sapiens (Human),336.0,MERKISRIHLVSEPSITHFLQVSWEKTLESGFVITLTDGHSAWTGTVSESEISQEADDMAMEKGKYVGELRKALLSGAGPADVYTFNFSKESCYFFFEKNLKDVSFRLGSFNLEKVENPAEVIRELICYCLDTIAENQAKNEHLQKENERLLRDWNDVQGRFEKCVSAKEALETDLYKRFILVLNEKKTKIRSLHNKLLNAAQEREKDIKQEGETAICSEMTADRDPVYDESTDEESENQTDLSGLASAAVSKDDSIISSLDVTDIAPSRKRRQRMQRNLGTEPKMAPQENQLQEKENSRPDSSLPETSKKEHISAENMSLETLRNSSPEDLFDEI,PF06632;,1FU1;1IK9;3II6;3MUD;3Q4F;3RWR;3SR2;3W03;4XA4;5CHX;5CJ0;5CJ4;5E50;5WJ7;5WLZ;6ABO;7LSY;7LT3;7M3P;7NFC;7NFE;,161,R,Q,True,856
13253,1096,19527,single nucleotide variant,NM_016489.13(NT5C3A):c.721G>C (p.Gly241Arg),51251,NT5C3A,HGNC:17820,Pathogenic,1,1-Jul-04,104894029,-,RCV000004745,"MONDO:MONDO:0009946,MedGen:C1849507,OMIM:266120,Orphanet:35120","Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to",germline,germline,GRCh38,NC_000007.14,7,33015741,33015741,na,na,7p14.3,no assertion criteria provided,1,-,N,"UniProtKB:Q9H0P0#VAR_023514,OMIM:606224.0010,ClinGen:CA116896",1,4488,33015741,C,G,G241R,0,pathogenic,uncertain,Q9H0P0,Q9H0P0,reviewed,5NT3A_HUMAN,"Cytosolic 5'-nucleotidase 3A, EC 3.1.3.5 (7-methylguanosine phosphate-specific 5'-nucleotidase, 7-methylguanosine nucleotidase, EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3) (Cytosolic 5'-nucleotidase III, cN-III) (Pyrimidine 5'-nucleotidase 1, P5'N-1, P5N-1, PN-I) (Uridine 5'-monophosphate hydrolase 1) (p36)",NT5C3A NT5C3 P5N1 UMPH1 HSPC233,Homo sapiens (Human),336.0,MRAPSMDRAAVARVGAVASASVCALVAGVVLAQYIFTLKRKTGRKTKIIEMMPEFQKSSVRIKNPTRVEEIICGLIKGGAAKLQIITDFDMTLSRFSYKGKRCPTCHNIIDNCKLVTDECRKKLLQLKEKYYAIEVDPVLTVEEKYPYMVEWYTKSHGLLVQQALPKAKLKEIVAESDVMLKEGYENFFDKLQQHSIPVFIFSAGIGDVLEEVIRQAGVYHPNVKVVSNFMDFDETGVLKGFKGELIHVFNKHDGALRNTEYFNQLKDNSNIILLGDSQGDLRMADGVANVEHILKIGYLNDRVDELLEKYMDSYDIVLVQDESLEVANSILQKIL,PF05822;,2CN1;2JGA;2VKQ;,241,G,R,True,857
13254,6003,39530,single nucleotide variant,NM_012200.4(B3GAT3):c.830G>A (p.Arg277Gln),26229,B3GAT3,HGNC:923,Pathogenic/Likely pathogenic,1,1-Sep-17,387906937,-,RCV000023536|RCV000211049|RCV000724894,"MONDO:MONDO:0009511,MedGen:C3278404,OMIM:245600,Orphanet:284139||MedGen:CN517202","Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects|MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH CONGENITAL HEART DEFECTS|not provided",germline,germline,GRCh38,NC_000011.10,11,62616585,62616585,na,na,11q12.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA259833,UniProtKB:O94766#VAR_066624,OMIM:606374.0001",3,30573,62616585,C,T,R277Q,2,pathogenic,pathogenic,O94766,O94766,reviewed,B3GA3_HUMAN,"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3, EC 2.4.1.135 (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I, GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase, GlcUAT-I)",B3GAT3,Homo sapiens (Human),335.0,MKLKLKNVFLAYFLVSIAGLLYALVQLGQPCDCLPPLRAAAEQLRQKDLRISQLQAELRRPPPAPAQPPEPEALPTIYVVTPTYARLVQKAELVRLSQTLSLVPRLHWLLVEDAEGPTPLVSGLLAASGLLFTHLVVLTPKAQRLREGEPGWVHPRGVEQRNKALDWLRGRGGAVGGEKDPPPPGTQGVVYFADDDNTYSRELFEEMRWTRGVSVWPVGLVGGLRFEGPQVQDGRVVGFHTAWEPSRPFPVDMAGFAVALPLLLDKPNAQFDSTAPRGHLESSLLSHLVDPKDLEPRAANCTRVLVWHTRTEKPKMKQEEQLQRQGRGSDPAIEV,PF03360;,1FGG;1KWS;3CU0;,277,R,Q,True,858
13255,12619,227579,single nucleotide variant,NM_012200.4(B3GAT3):c.419C>T (p.Pro140Leu),26229,B3GAT3,HGNC:923,Pathogenic,1,13-May-16,879255269,-,RCV000211050,-,"MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITHOUT CONGENITAL HEART DEFECTS",germline,germline,GRCh38,NC_000011.10,11,62617186,62617186,na,na,11q12.3,no assertion criteria provided,1,-,N,"OMIM:606374.0002,ClinGen:CA10576094,UniProtKB:O94766#VAR_075370",1,225764,62617186,G,A,P140L,0,pathogenic,uncertain,O94766,O94766,reviewed,B3GA3_HUMAN,"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3, EC 2.4.1.135 (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I, GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase, GlcUAT-I)",B3GAT3,Homo sapiens (Human),335.0,MKLKLKNVFLAYFLVSIAGLLYALVQLGQPCDCLPPLRAAAEQLRQKDLRISQLQAELRRPPPAPAQPPEPEALPTIYVVTPTYARLVQKAELVRLSQTLSLVPRLHWLLVEDAEGPTPLVSGLLAASGLLFTHLVVLTPKAQRLREGEPGWVHPRGVEQRNKALDWLRGRGGAVGGEKDPPPPGTQGVVYFADDDNTYSRELFEEMRWTRGVSVWPVGLVGGLRFEGPQVQDGRVVGFHTAWEPSRPFPVDMAGFAVALPLLLDKPNAQFDSTAPRGHLESSLLSHLVDPKDLEPRAANCTRVLVWHTRTEKPKMKQEEQLQRQGRGSDPAIEV,PF03360;,1FGG;1KWS;3CU0;,140,P,L,True,858
13256,12625,227735,single nucleotide variant,NM_012200.4(B3GAT3):c.667G>A (p.Gly223Ser),26229,B3GAT3,HGNC:923,Pathogenic,1,13-May-16,372487178,-,RCV000211124,-,"MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH CONGENITAL HEART DEFECTS",germline,germline,GRCh38,NC_000011.10,11,62616748,62616748,na,na,11q12.3,no assertion criteria provided,1,-,N,"ClinGen:CA6050037,UniProtKB:O94766#VAR_075371,OMIM:606374.0003",1,225924,62616748,C,T,G223S,0,pathogenic,uncertain,O94766,O94766,reviewed,B3GA3_HUMAN,"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3, EC 2.4.1.135 (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I, GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase, GlcUAT-I)",B3GAT3,Homo sapiens (Human),335.0,MKLKLKNVFLAYFLVSIAGLLYALVQLGQPCDCLPPLRAAAEQLRQKDLRISQLQAELRRPPPAPAQPPEPEALPTIYVVTPTYARLVQKAELVRLSQTLSLVPRLHWLLVEDAEGPTPLVSGLLAASGLLFTHLVVLTPKAQRLREGEPGWVHPRGVEQRNKALDWLRGRGGAVGGEKDPPPPGTQGVVYFADDDNTYSRELFEEMRWTRGVSVWPVGLVGGLRFEGPQVQDGRVVGFHTAWEPSRPFPVDMAGFAVALPLLLDKPNAQFDSTAPRGHLESSLLSHLVDPKDLEPRAANCTRVLVWHTRTEKPKMKQEEQLQRQGRGSDPAIEV,PF03360;,1FGG;1KWS;3CU0;,223,G,S,True,858
13257,4681,31547,single nucleotide variant,NM_000043.6(FAS):c.73G>A (p.Ala25Thr),355,FAS,HGNC:11920,Pathogenic,1,1-Apr-99,606231364,-,RCV000017972,MedGen:C1866119,"Autoimmune lymphoproliferative syndrome, type 1a",germline,germline,GRCh38,NC_000010.11,10,89003071,89003071,na,na,10q23.31,no assertion criteria provided,1,-,N,"UniProtKB:P25445#VAR_013416,OMIM:134637.0012,ClinGen:CA212971",1,16508,89003071,G,A,A25T,0,pathogenic,uncertain,P25445,P25445,reviewed,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),FAS APT1 FAS1 TNFRSF6,Homo sapiens (Human),335.0,MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV,PF00531;PF00020;,1DDF;2NA7;3EWT;3EZQ;3THM;3TJE;,25,A,T,True,859
13258,4680,31545,single nucleotide variant,NM_000043.6(FAS):c.809C>T (p.Thr270Ile),355,FAS,HGNC:11920,Pathogenic,1,1-Feb-99,121913081,-,RCV000017970,MedGen:C1866119,"Autoimmune lymphoproliferative syndrome, type 1a",germline,germline,GRCh38,NC_000010.11,10,89014251,89014251,na,na,10q23.31,no assertion criteria provided,1,-,N,"ClinGen:CA126586,UniProtKB:P25445#VAR_013433,OMIM:134637.0010",1,16506,89014251,C,T,T270I,0,pathogenic,uncertain,P25445,P25445,reviewed,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),FAS APT1 FAS1 TNFRSF6,Homo sapiens (Human),335.0,MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV,PF00531;PF00020;,1DDF;2NA7;3EWT;3EZQ;3THM;3TJE;,270,T,I,True,859
13259,4675,31538,single nucleotide variant,NM_000043.6(FAS):c.721A>C (p.Thr241Pro),355,FAS,HGNC:11920,Pathogenic,1,16-Jun-95,121913076,-,RCV000017963,MedGen:C1866119,"Autoimmune lymphoproliferative syndrome, type 1a",germline,germline,GRCh38,NC_000010.11,10,89014163,89014163,na,na,10q23.31,no assertion criteria provided,1,-,N,"ClinGen:CA126567,UniProtKB:P25445#VAR_013425,OMIM:134637.0003",1,16499,89014163,A,C,T241P,0,pathogenic,uncertain,P25445,P25445,reviewed,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),FAS APT1 FAS1 TNFRSF6,Homo sapiens (Human),335.0,MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV,PF00531;PF00020;,1DDF;2NA7;3EWT;3EZQ;3THM;3TJE;,241,T,P,True,859
13260,10549,138111,single nucleotide variant,NM_000043.6(FAS):c.365C>T (p.Thr122Ile),355,FAS,HGNC:11920,Benign,0,31-Dec-19,3218614,-,RCV000121046|RCV000290355,"MedGen:CN169374|MONDO:MONDO:0011158,MedGen:C1328840,OMIM:601859,Orphanet:3261",not specified|Autoimmune lymphoproliferative syndrome,germline,germline,GRCh38,NC_000010.11,10,89008919,89008919,na,na,10q23.31,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA159631,UniProtKB:P25445#VAR_020009",2,134372,89008919,C,T,T122I,2,benign,benign,P25445,P25445,reviewed,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),FAS APT1 FAS1 TNFRSF6,Homo sapiens (Human),335.0,MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV,PF00531;PF00020;,1DDF;2NA7;3EWT;3EZQ;3THM;3TJE;,122,T,I,True,859
13261,4684,31551,single nucleotide variant,NM_000043.6(FAS):c.532T>C (p.Cys178Arg),355,FAS,HGNC:11920,Pathogenic,1,1-Jan-00,121913084,-,RCV000017976,MedGen:C4016044,"SQUAMOUS CELL CARCINOMA, BURN SCAR-RELATED, SOMATIC",somatic,somatic,GRCh38,NC_000010.11,10,89010779,89010779,na,na,10q23.31,no assertion criteria provided,1,-,N,"ClinGen:CA126598,UniProtKB:P25445#VAR_018322,OMIM:134637.0016",1,16512,89010779,T,C,C178R,0,pathogenic,uncertain,P25445,P25445,reviewed,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),FAS APT1 FAS1 TNFRSF6,Homo sapiens (Human),335.0,MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV,PF00531;PF00020;,1DDF;2NA7;3EWT;3EZQ;3THM;3TJE;,178,C,R,True,859
13262,10548,138110,single nucleotide variant,NM_000043.6(FAS):c.46G>A (p.Ala16Thr),355,FAS,HGNC:11920,Benign/Likely benign,0,31-Dec-19,3218619,-,RCV000121045|RCV000259335,"MedGen:CN169374|MONDO:MONDO:0011158,MedGen:C1328840,OMIM:601859,Orphanet:3261",not specified|Autoimmune lymphoproliferative syndrome,germline,germline,GRCh38,NC_000010.11,10,89003044,89003044,na,na,10q23.31,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA159628,UniProtKB:P25445#VAR_020008",2,134371,89003044,G,A,A16T,2,benign,benign,P25445,P25445,reviewed,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),FAS APT1 FAS1 TNFRSF6,Homo sapiens (Human),335.0,MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV,PF00531;PF00020;,1DDF;2NA7;3EWT;3EZQ;3THM;3TJE;,16,A,T,True,859
13263,4677,31542,single nucleotide variant,NM_000043.6(FAS):c.695A>G (p.Tyr232Cys),355,FAS,HGNC:11920,Uncertain significance,1,2-Sep-18,121913079,-,RCV000017967|RCV000814654,"MedGen:C1866119|MONDO:MONDO:0011158,MedGen:C1328840,OMIM:601859,Orphanet:3261","Autoimmune lymphoproliferative syndrome, type 1a|Autoimmune lymphoproliferative syndrome",germline,germline,GRCh38,NC_000010.11,10,89014137,89014137,na,na,10q23.31,"criteria provided, single submitter",2,-,N,"ClinGen:CA126578,UniProtKB:P25445#VAR_013423,OMIM:134637.0007",3,16503,89014137,A,G,Y232C,1,uncertain,uncertain,P25445,P25445,reviewed,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),FAS APT1 FAS1 TNFRSF6,Homo sapiens (Human),335.0,MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV,PF00531;PF00020;,1DDF;2NA7;3EWT;3EZQ;3THM;3TJE;,232,Y,C,True,859
13264,4683,31550,single nucleotide variant,NM_000043.6(FAS):c.353A>G (p.Asn118Ser),355,FAS,HGNC:11920,Pathogenic,1,1-Jan-00,121913083,-,RCV000017975,MedGen:C4016044,"SQUAMOUS CELL CARCINOMA, BURN SCAR-RELATED, SOMATIC",somatic,somatic,GRCh38,NC_000010.11,10,89008907,89008907,na,na,10q23.31,no assertion criteria provided,1,-,N,"ClinGen:CA126593,UniProtKB:P25445#VAR_018321,OMIM:134637.0015",1,16511,89008907,A,G,N118S,0,pathogenic,uncertain,P25445,P25445,reviewed,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),FAS APT1 FAS1 TNFRSF6,Homo sapiens (Human),335.0,MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV,PF00531;PF00020;,1DDF;2NA7;3EWT;3EZQ;3THM;3TJE;,118,N,S,True,859
13265,4682,31549,single nucleotide variant,NM_000043.6(FAS):c.763A>G (p.Asn255Asp),355,FAS,HGNC:11920,Pathogenic,1,1-Jan-00,121913082,-,RCV000017974,MedGen:C4016044,"SQUAMOUS CELL CARCINOMA, BURN SCAR-RELATED, SOMATIC",somatic,somatic,GRCh38,NC_000010.11,10,89014205,89014205,na,na,10q23.31,no assertion criteria provided,1,-,N,"ClinGen:CA126589,UniProtKB:P25445#VAR_018323,OMIM:134637.0014",1,16510,89014205,A,G,N255D,0,pathogenic,uncertain,P25445,P25445,reviewed,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),FAS APT1 FAS1 TNFRSF6,Homo sapiens (Human),335.0,MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV,PF00531;PF00020;,1DDF;2NA7;3EWT;3EZQ;3THM;3TJE;,255,N,D,True,859
13266,14050,323784,single nucleotide variant,NM_000043.6(FAS):c.550A>G (p.Ile184Val),355,FAS,HGNC:11920,Benign/Likely benign,0,31-Dec-19,28362322,-,RCV000343056|RCV000444947,"MONDO:MONDO:0011158,MedGen:C1328840,OMIM:601859,Orphanet:3261|MedGen:CN169374",Autoimmune lymphoproliferative syndrome|not specified,germline,germline,GRCh38,NC_000010.11,10,89010797,89010797,na,na,10q23.31,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA5593154,UniProtKB:P25445#VAR_052347",2,301530,89010797,A,G,I184V,2,benign,benign,P25445,P25445,reviewed,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),FAS APT1 FAS1 TNFRSF6,Homo sapiens (Human),335.0,MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV,PF00531;PF00020;,1DDF;2NA7;3EWT;3EZQ;3THM;3TJE;,184,I,V,True,859
13267,4676,31541,single nucleotide variant,NM_000043.6(FAS):c.361C>T (p.Arg121Trp),355,FAS,HGNC:11920,Pathogenic,1,1-Feb-97,121913078,-,RCV000017966,MedGen:C1866119,"Autoimmune lymphoproliferative syndrome, type 1a",germline,germline,GRCh38,NC_000010.11,10,89008915,89008915,na,na,10q23.31,no assertion criteria provided,1,-,N,"ClinGen:CA126574,UniProtKB:P25445#VAR_013419,OMIM:134637.0006",1,16502,89008915,C,T,R121W,0,pathogenic,uncertain,P25445,P25445,reviewed,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),FAS APT1 FAS1 TNFRSF6,Homo sapiens (Human),335.0,MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV,PF00531;PF00020;,1DDF;2NA7;3EWT;3EZQ;3THM;3TJE;,121,R,W,True,859
13268,4685,31555,single nucleotide variant,NM_000043.6(FAS):c.778G>T (p.Asp260Tyr),355,FAS,HGNC:11920,Pathogenic,1,28-Nov-96,121913086,-,RCV000017980,MedGen:C1866119,"Autoimmune lymphoproliferative syndrome, type 1a",germline,germline,GRCh38,NC_000010.11,10,89014220,89014220,na,na,10q23.31,no assertion criteria provided,1,-,N,"ClinGen:CA126607,UniProtKB:P25445#VAR_013430,OMIM:134637.0020",1,16516,89014220,G,T,D260Y,0,pathogenic,uncertain,P25445,P25445,reviewed,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),FAS APT1 FAS1 TNFRSF6,Homo sapiens (Human),335.0,MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV,PF00531;PF00020;,1DDF;2NA7;3EWT;3EZQ;3THM;3TJE;,260,D,Y,True,859
13269,4678,31543,single nucleotide variant,NM_000043.6(FAS):c.779A>T (p.Asp260Val),355,FAS,HGNC:11920,Pathogenic,1,1-Nov-98,28929498,-,RCV000017968,MedGen:C1866119,"Autoimmune lymphoproliferative syndrome, type 1a",germline,germline,GRCh38,NC_000010.11,10,89014221,89014221,na,na,10q23.31,no assertion criteria provided,1,-,N,"ClinGen:CA126581,UniProtKB:P25445#VAR_013431,OMIM:134637.0008",1,16504,89014221,A,T,D260V,0,pathogenic,uncertain,P25445,P25445,reviewed,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),FAS APT1 FAS1 TNFRSF6,Homo sapiens (Human),335.0,MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV,PF00531;PF00020;,1DDF;2NA7;3EWT;3EZQ;3THM;3TJE;,260,D,V,True,859
13270,4679,31544,single nucleotide variant,NM_000043.6(FAS):c.749G>C (p.Arg250Pro),355,FAS,HGNC:11920,Likely pathogenic,1,12-Apr-18,121913080,-,RCV000017969|RCV000638906,"MedGen:C1866119|MONDO:MONDO:0011158,MedGen:C1328840,OMIM:601859,Orphanet:3261","Autoimmune lymphoproliferative syndrome, type 1a|Autoimmune lymphoproliferative syndrome",germline,germline,GRCh38,NC_000010.11,10,89014191,89014191,na,na,10q23.31,"criteria provided, single submitter",2,-,N,"UniProtKB:P25445#VAR_013426,OMIM:134637.0009,ClinGen:CA126583",3,16505,89014191,G,C,R250P,1,pathogenic,pathogenic,P25445,P25445,reviewed,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),FAS APT1 FAS1 TNFRSF6,Homo sapiens (Human),335.0,MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV,PF00531;PF00020;,1DDF;2NA7;3EWT;3EZQ;3THM;3TJE;,250,R,P,True,859
13271,3914,29604,single nucleotide variant,NM_002300.7(LDHB):c.973T>C (p.Trp325Arg),3945,LDHB,HGNC:6541,Affects,0,1-Sep-99,267607212,-,RCV000015666,"MONDO:MONDO:0013587,MedGen:C3279904,OMIM:614128,Orphanet:284435",Lactate dehydrogenase B deficiency,germline,germline,GRCh38,NC_000012.12,12,21635574,21635574,na,na,12p12.1,no assertion criteria provided,1,-,N,"ClinGen:CA124120,UniProtKB:P07195#VAR_011638,OMIM:150100.0004",1,14565,21635574,A,G,W325R,0,uncertain,uncertain,P07195,P07195,reviewed,LDHB_HUMAN,"L-lactate dehydrogenase B chain, LDH-B, EC 1.1.1.27 (LDH heart subunit, LDH-H) (Renal carcinoma antigen NY-REN-46)",LDHB,Homo sapiens (Human),334.0,MATLKEKLIAPVAEEEATVPNNKITVVGVGQVGMACAISILGKSLADELALVDVLEDKLKGEMMDLQHGSLFLQTPKIVADKDYSVTANSKIVVVTAGVRQQEGESRLNLVQRNVNVFKFIIPQIVKYSPDCIIIVVSNPVDILTYVTWKLSGLPKHRVIGSGCNLDSARFRYLMAEKLGIHPSSCHGWILGEHGDSSVAVWSGVNVAGVSLQELNPEMGTDNDSENWKEVHKMVVESAYEVIKLKGYTNWAIGLSVADLIESMLKNLSRIHPVSTMVKGMYGIENEVFLSLPCILNARGLTSVINQKLKDDEVAQLKKSADTLWDIQKDLKDL,PF02866;PF00056;,1I0Z;1T2F;7DBJ;7DBK;,325,W,R,True,860
13272,3913,29603,single nucleotide variant,NM_002300.7(LDHB):c.19A>G (p.Lys7Glu),3945,LDHB,HGNC:6541,Affects,0,1-Jun-93,118203897,-,RCV000015665,"MONDO:MONDO:0013587,MedGen:C3279904,OMIM:614128,Orphanet:284435",Lactate dehydrogenase B deficiency,germline,germline,GRCh38,NC_000012.12,12,21654653,21654653,na,na,12p12.1,no assertion criteria provided,1,-,N,"ClinGen:CA124118,UniProtKB:P07195#VAR_004173,OMIM:150100.0003",1,14564,21654653,T,C,K7E,0,uncertain,uncertain,P07195,P07195,reviewed,LDHB_HUMAN,"L-lactate dehydrogenase B chain, LDH-B, EC 1.1.1.27 (LDH heart subunit, LDH-H) (Renal carcinoma antigen NY-REN-46)",LDHB,Homo sapiens (Human),334.0,MATLKEKLIAPVAEEEATVPNNKITVVGVGQVGMACAISILGKSLADELALVDVLEDKLKGEMMDLQHGSLFLQTPKIVADKDYSVTANSKIVVVTAGVRQQEGESRLNLVQRNVNVFKFIIPQIVKYSPDCIIIVVSNPVDILTYVTWKLSGLPKHRVIGSGCNLDSARFRYLMAEKLGIHPSSCHGWILGEHGDSSVAVWSGVNVAGVSLQELNPEMGTDNDSENWKEVHKMVVESAYEVIKLKGYTNWAIGLSVADLIESMLKNLSRIHPVSTMVKGMYGIENEVFLSLPCILNARGLTSVINQKLKDDEVAQLKKSADTLWDIQKDLKDL,PF02866;PF00056;,1I0Z;1T2F;7DBJ;7DBK;,7,K,E,True,860
13273,3912,29602,single nucleotide variant,NM_002300.7(LDHB):c.385A>C (p.Ser129Arg),3945,LDHB,HGNC:6541,Affects,0,1-May-92,118203896,-,RCV000015664,"MONDO:MONDO:0013587,MedGen:C3279904,OMIM:614128,Orphanet:284435",Lactate dehydrogenase B deficiency,germline,germline,GRCh38,NC_000012.12,12,21643971,21643971,na,na,12p12.1,no assertion criteria provided,1,-,N,"ClinGen:CA124116,UniProtKB:P07195#VAR_004175,OMIM:150100.0002",1,14563,21643971,T,G,S129R,0,uncertain,uncertain,P07195,P07195,reviewed,LDHB_HUMAN,"L-lactate dehydrogenase B chain, LDH-B, EC 1.1.1.27 (LDH heart subunit, LDH-H) (Renal carcinoma antigen NY-REN-46)",LDHB,Homo sapiens (Human),334.0,MATLKEKLIAPVAEEEATVPNNKITVVGVGQVGMACAISILGKSLADELALVDVLEDKLKGEMMDLQHGSLFLQTPKIVADKDYSVTANSKIVVVTAGVRQQEGESRLNLVQRNVNVFKFIIPQIVKYSPDCIIIVVSNPVDILTYVTWKLSGLPKHRVIGSGCNLDSARFRYLMAEKLGIHPSSCHGWILGEHGDSSVAVWSGVNVAGVSLQELNPEMGTDNDSENWKEVHKMVVESAYEVIKLKGYTNWAIGLSVADLIESMLKNLSRIHPVSTMVKGMYGIENEVFLSLPCILNARGLTSVINQKLKDDEVAQLKKSADTLWDIQKDLKDL,PF02866;PF00056;,1I0Z;1T2F;7DBJ;7DBK;,129,S,R,True,860
13274,3911,29601,single nucleotide variant,NM_002300.7(LDHB):c.515G>A (p.Arg172His),3945,LDHB,HGNC:6541,Affects,0,1-May-92,118203895,-,RCV000015663,"MONDO:MONDO:0013587,MedGen:C3279904,OMIM:614128,Orphanet:284435",Lactate dehydrogenase B deficiency,germline,germline,GRCh38,NC_000012.12,12,21642032,21642032,na,na,12p12.1,no assertion criteria provided,1,-,N,"ClinGen:CA124114,UniProtKB:P07195#VAR_004177,OMIM:150100.0001",1,14562,21642032,C,T,R172H,0,uncertain,uncertain,P07195,P07195,reviewed,LDHB_HUMAN,"L-lactate dehydrogenase B chain, LDH-B, EC 1.1.1.27 (LDH heart subunit, LDH-H) (Renal carcinoma antigen NY-REN-46)",LDHB,Homo sapiens (Human),334.0,MATLKEKLIAPVAEEEATVPNNKITVVGVGQVGMACAISILGKSLADELALVDVLEDKLKGEMMDLQHGSLFLQTPKIVADKDYSVTANSKIVVVTAGVRQQEGESRLNLVQRNVNVFKFIIPQIVKYSPDCIIIVVSNPVDILTYVTWKLSGLPKHRVIGSGCNLDSARFRYLMAEKLGIHPSSCHGWILGEHGDSSVAVWSGVNVAGVSLQELNPEMGTDNDSENWKEVHKMVVESAYEVIKLKGYTNWAIGLSVADLIESMLKNLSRIHPVSTMVKGMYGIENEVFLSLPCILNARGLTSVINQKLKDDEVAQLKKSADTLWDIQKDLKDL,PF02866;PF00056;,1I0Z;1T2F;7DBJ;7DBK;,172,R,H,True,860
13275,13858,298682,single nucleotide variant,NM_014028.4(OSTM1):c.156G>C (p.Leu52Phe),28962,OSTM1,HGNC:21652,Benign,0,12-Jan-18,9480830,-,RCV000320607,"MONDO:MONDO:0009817,MedGen:C1968603,OMIM:259720,Orphanet:85179","Osteopetrosis, autosomal recessive 5",germline,germline,GRCh38,NC_000006.12,6,108074496,108074496,na,na,6q21,"criteria provided, single submitter",1,-,N,"ClinGen:CA3948127,UniProtKB:Q86WC4#VAR_051257",2,354990,108074496,C,G,L52F,1,benign,benign,Q86WC4,Q86WC4,reviewed,OSTM1_HUMAN,Osteopetrosis-associated transmembrane protein 1 (Chloride channel 7 beta subunit),OSTM1 GL HSPC019 UNQ6098/PRO21201,Homo sapiens (Human),334.0,MEPGPTAAQRRCSLPPWLPLGLLLWSGLALGALPFGSSPHRVFHDLLSEQQLLEVEDLSLSLLQGGGLGPLSLPPDLPDLDPECRELLLDFANSSAELTGCLVRSARPVRLCQTCYPLFQQVVSKMDNISRAAGNTSESQSCARSLLMADRMQIVVILSEFFNTTWQEANCANCLTNNSEELSNSTVYFLNLFNHTLTCFEHNLQGNAHSLLQTKNYSEVCKNCREAYKTLSSLYSEMQKMNELENKAEPGTHLCIDVEDAMNITRKLWSRTFNCSVPCSDTVPVIAVSVFILFLPVVFYLSSFLHSEQKKRKLILPKRLKSSTSFANIQENSN,PF09777;,7BXU;7CQ5;7CQ6;7CQ7;7JM7;,52,L,F,True,861
13276,662,17632,single nucleotide variant,NM_000126.4(ETFA):c.470T>G (p.Val157Gly),2108,ETFA,HGNC:3481,Pathogenic,1,1-Nov-92,119458969,-,RCV000002711,MedGen:C3278154,Glutaric acidemia IIA,germline,germline,GRCh38,NC_000015.10,15,76286463,76286463,na,na,15q24.2,no assertion criteria provided,1,-,N,"UniProtKB:P13804#VAR_002367,OMIM:608053.0001,ClinGen:CA115637",1,2593,76286463,A,C,V157G,0,pathogenic,uncertain,P13804,P13804,reviewed,ETFA_HUMAN,"Electron transfer flavoprotein subunit alpha, mitochondrial, Alpha-ETF",ETFA,Homo sapiens (Human),333.0,MFRAAAPGQLRRAASLLRFQSTLVIAEHANDSLAPITLNTITAATRLGGEVSCLVAGTKCDKVAQDLCKVAGIAKVLVAQHDVYKGLLPEELTPLILATQKQFNYTHICAGASAFGKNLLPRVAAKLEVAPISDIIAIKSPDTFVRTIYAGNALCTVKCDEKVKVFSVRGTSFDAAATSGGSASSEKASSTSPVEISEWLDQKLTKSDRPELTGAKVVVSGGRGLKSGENFKLLYDLADQLHAAVGASRAAVDAGFVPNDMQVGQTGKIVAPELYIAVGISGAIQHLAGMKDSKTIVAINKDPEAPIFQVADYGIVADLFKVVPEMTEILKKK,PF01012;PF00766;,1EFV;1T9G;2A1T;2A1U;,157,V,G,True,862
13277,664,17634,single nucleotide variant,NM_000126.4(ETFA):c.346G>A (p.Gly116Arg),2108,ETFA,HGNC:3481,Pathogenic,1,1-Nov-92,119458971,-,RCV000002713,MedGen:C3278154,Glutaric acidemia IIA,germline,germline,GRCh38,NC_000015.10,15,76292436,76292436,na,na,15q24.2,no assertion criteria provided,1,-,N,"ClinGen:CA115639,UniProtKB:P13804#VAR_002366,OMIM:608053.0003",1,2595,76292436,C,T,G116R,0,pathogenic,uncertain,P13804,P13804,reviewed,ETFA_HUMAN,"Electron transfer flavoprotein subunit alpha, mitochondrial, Alpha-ETF",ETFA,Homo sapiens (Human),333.0,MFRAAAPGQLRRAASLLRFQSTLVIAEHANDSLAPITLNTITAATRLGGEVSCLVAGTKCDKVAQDLCKVAGIAKVLVAQHDVYKGLLPEELTPLILATQKQFNYTHICAGASAFGKNLLPRVAAKLEVAPISDIIAIKSPDTFVRTIYAGNALCTVKCDEKVKVFSVRGTSFDAAATSGGSASSEKASSTSPVEISEWLDQKLTKSDRPELTGAKVVVSGGRGLKSGENFKLLYDLADQLHAAVGASRAAVDAGFVPNDMQVGQTGKIVAPELYIAVGISGAIQHLAGMKDSKTIVAINKDPEAPIFQVADYGIVADLFKVVPEMTEILKKK,PF01012;PF00766;,1EFV;1T9G;2A1T;2A1U;,116,G,R,True,862
13278,8986,98352,single nucleotide variant,NM_000126.4(ETFA):c.512C>T (p.Thr171Ile),2108,ETFA,HGNC:3481,Benign,0,30-Apr-20,1801591,-,RCV000078134|RCV000377415|RCV000676979,"MedGen:CN169374|MONDO:MONDO:0009282,MedGen:C0268596,OMIM:231680,Orphanet:26791|MedGen:CN517202",not specified|Multiple acyl-CoA dehydrogenase deficiency|not provided,germline;unknown,germline,GRCh38,NC_000015.10,15,76286421,76286421,na,na,15q24.2,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA285317,UniProtKB:P13804#VAR_008547",2,92443,76286421,G,A,T171I,2,benign,benign,P13804,P13804,reviewed,ETFA_HUMAN,"Electron transfer flavoprotein subunit alpha, mitochondrial, Alpha-ETF",ETFA,Homo sapiens (Human),333.0,MFRAAAPGQLRRAASLLRFQSTLVIAEHANDSLAPITLNTITAATRLGGEVSCLVAGTKCDKVAQDLCKVAGIAKVLVAQHDVYKGLLPEELTPLILATQKQFNYTHICAGASAFGKNLLPRVAAKLEVAPISDIIAIKSPDTFVRTIYAGNALCTVKCDEKVKVFSVRGTSFDAAATSGGSASSEKASSTSPVEISEWLDQKLTKSDRPELTGAKVVVSGGRGLKSGENFKLLYDLADQLHAAVGASRAAVDAGFVPNDMQVGQTGKIVAPELYIAVGISGAIQHLAGMKDSKTIVAINKDPEAPIFQVADYGIVADLFKVVPEMTEILKKK,PF01012;PF00766;,1EFV;1T9G;2A1T;2A1U;,171,T,I,True,862
13279,663,17633,single nucleotide variant,NM_000126.4(ETFA):c.797C>T (p.Thr266Met),2108,ETFA,HGNC:3481,Pathogenic,1,31-Dec-19,119458970,-,RCV000002712|RCV000185868|RCV000332032,"MedGen:C3278154|MedGen:CN517202|MONDO:MONDO:0009282,MedGen:C0268596,OMIM:231680,Orphanet:26791",Glutaric acidemia IIA|not provided|Multiple acyl-CoA dehydrogenase deficiency,germline,germline,GRCh38,NC_000015.10,15,76274431,76274431,na,na,15q24.2,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA115638,UniProtKB:P13804#VAR_002368,OMIM:608053.0002",3,2594,76274431,G,A,T266M,2,pathogenic,pathogenic,P13804,P13804,reviewed,ETFA_HUMAN,"Electron transfer flavoprotein subunit alpha, mitochondrial, Alpha-ETF",ETFA,Homo sapiens (Human),333.0,MFRAAAPGQLRRAASLLRFQSTLVIAEHANDSLAPITLNTITAATRLGGEVSCLVAGTKCDKVAQDLCKVAGIAKVLVAQHDVYKGLLPEELTPLILATQKQFNYTHICAGASAFGKNLLPRVAAKLEVAPISDIIAIKSPDTFVRTIYAGNALCTVKCDEKVKVFSVRGTSFDAAATSGGSASSEKASSTSPVEISEWLDQKLTKSDRPELTGAKVVVSGGRGLKSGENFKLLYDLADQLHAAVGASRAAVDAGFVPNDMQVGQTGKIVAPELYIAVGISGAIQHLAGMKDSKTIVAINKDPEAPIFQVADYGIVADLFKVVPEMTEILKKK,PF01012;PF00766;,1EFV;1T9G;2A1T;2A1U;,266,T,M,True,862
13280,6019,39666,single nucleotide variant,NM_205861.3(DHDDS):c.124A>G (p.Lys42Glu),79947,DHDDS,HGNC:20603,Pathogenic,1,2-Jan-20,147394623,-,RCV000023687|RCV000762902|RCV000778978|RCV001329381,"MONDO:MONDO:0013468,MedGen:C3151227,OMIM:613861,Orphanet:791|MONDO:MONDO:0044326,MedGen:C4693376,OMIM:617836;MONDO:MONDO:0013468,MedGen:C3151227,OMIM:613861,Orphanet:791|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MONDO:MONDO:0044326,MedGen:C4693376,OMIM:617836",Retinitis pigmentosa 59|Developmental delay and seizures with or without movement abnormalities;Retinitis pigmentosa 59|Retinitis pigmentosa|Developmental delay and seizures with or without movement abnormalities,germline;inherited;unknown,germline,GRCh38,NC_000001.11,1,26438228,26438228,na,na,1p36.11,"criteria provided, multiple submitters, no conflicts",11,-,Y,"ClinGen:CA259894,UniProtKB:Q86SQ9#VAR_065356,OMIM:608172.0001",3,30709,26438228,A,G,K42E,2,pathogenic,pathogenic,Q86SQ9,Q86SQ9,reviewed,DHDDS_HUMAN,"Dehydrodolichyl diphosphate synthase complex subunit DHDDS, EC 2.5.1.87 (Cis-isoprenyltransferase, CIT, Cis-IPTase) (Cis-prenyltransferase subunit hCIT) (Epididymis tissue protein Li 189m)",DHDDS HDS,Homo sapiens (Human),333.0,MSWIKEGELSLWERFCANIIKAGPMPKHIAFIMDGNRRYAKKCQVERQEGHSQGFNKLAETLRWCLNLGILEVTVYAFSIENFKRSKSEVDGLMDLARQKFSRLMEEKEKLQKHGVCIRVLGDLHLLPLDLQELIAQAVQATKNYNKCFLNVCFAYTSRHEISNAVREMAWGVEQGLLDPSDISESLLDKCLYTNRSPHPDILIRTSGEVRLSDFLLWQTSHSCLVFQPVLWPEYTFWNLFEAILQFQMNHSVLQKARDMYAEERKRQQLERDQATVTEQLLREGLQASGDAQLRRTRLHKLSARREERVQGFLQALELKRADWLARLGTASA,PF01255;,6W2L;6Z1N;,42,K,E,True,863
13281,13741,280332,single nucleotide variant,NM_205861.3(DHDDS):c.757G>A (p.Val253Met),79947,DHDDS,HGNC:20603,Benign,0,14-Jun-18,3816539,-,RCV000373487|RCV000838160|RCV001277164,"Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MedGen:CN517202|MONDO:MONDO:0013468,MedGen:C3151227,OMIM:613861,Orphanet:791",Retinitis pigmentosa|not provided|Retinitis pigmentosa 59,germline,germline,GRCh38,NC_000001.11,1,26460136,26460136,na,na,1p36.11,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA705442,UniProtKB:Q86SQ9#VAR_028088",2,297075,26460136,G,A,V253M,2,benign,benign,Q86SQ9,Q86SQ9,reviewed,DHDDS_HUMAN,"Dehydrodolichyl diphosphate synthase complex subunit DHDDS, EC 2.5.1.87 (Cis-isoprenyltransferase, CIT, Cis-IPTase) (Cis-prenyltransferase subunit hCIT) (Epididymis tissue protein Li 189m)",DHDDS HDS,Homo sapiens (Human),333.0,MSWIKEGELSLWERFCANIIKAGPMPKHIAFIMDGNRRYAKKCQVERQEGHSQGFNKLAETLRWCLNLGILEVTVYAFSIENFKRSKSEVDGLMDLARQKFSRLMEEKEKLQKHGVCIRVLGDLHLLPLDLQELIAQAVQATKNYNKCFLNVCFAYTSRHEISNAVREMAWGVEQGLLDPSDISESLLDKCLYTNRSPHPDILIRTSGEVRLSDFLLWQTSHSCLVFQPVLWPEYTFWNLFEAILQFQMNHSVLQKARDMYAEERKRQQLERDQATVTEQLLREGLQASGDAQLRRTRLHKLSARREERVQGFLQALELKRADWLARLGTASA,PF01255;,6W2L;6Z1N;,253,V,M,True,863
13282,3823,29370,single nucleotide variant,NM_005912.3(MC4R):c.947T>G (p.Ile316Ser),4160,MC4R,HGNC:6932,Likely pathogenic,1,28-Apr-17,121913564,-,RCV000015407|RCV000778539,"MedGen:C4759928,OMIM:618406|Human Phenotype Ontology:HP:0001513,MONDO:MONDO:0019182,MeSH:D009765,MedGen:C0028754,OMIM:601665,Orphanet:71529",BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20|Obesity,germline,germline,GRCh38,NC_000018.10,18,60371403,60371403,na,na,18q21.32,"criteria provided, single submitter",2,-,N,"ClinGen:CA210720,UniProtKB:P32245#VAR_038653,OMIM:155541.0016",3,14331,60371403,A,C,I316S,1,pathogenic,pathogenic,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,316,I,S,True,864
13283,3822,29369,single nucleotide variant,NM_005912.3(MC4R):c.523G>A (p.Ala175Thr),4160,MC4R,HGNC:6932,Uncertain significance,1,27-Apr-17,121913563,-,RCV000015406|RCV000768579,"Human Phenotype Ontology:HP:0001513,MONDO:MONDO:0019182,MeSH:D009765,MedGen:C0028754,OMIM:601665,Orphanet:71529|MedGen:C4759928,OMIM:618406",Obesity|BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20,germline,germline,GRCh38,NC_000018.10,18,60371827,60371827,na,na,18q21.32,"criteria provided, single submitter",3,-,N,"ClinGen:CA210719,UniProtKB:P32245#VAR_038646,OMIM:155541.0015",3,14330,60371827,C,T,A175T,1,uncertain,uncertain,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,175,A,T,True,864
13284,3821,29368,single nucleotide variant,NM_005912.3(MC4R):c.812G>A (p.Cys271Tyr),4160,MC4R,HGNC:6932,Pathogenic,1,10-Dec-15,121913562,-,RCV000015405|RCV000768578,"Human Phenotype Ontology:HP:0001513,MONDO:MONDO:0019182,MeSH:D009765,MedGen:C0028754,OMIM:601665,Orphanet:71529|MedGen:C4759928,OMIM:618406",Obesity|BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20,germline;maternal;unknown,germline,GRCh38,NC_000018.10,18,60371538,60371538,na,na,18q21.32,"criteria provided, single submitter",4,-,N,"ClinGen:CA210718,UniProtKB:P32245#VAR_038652,OMIM:155541.0014",3,14329,60371538,C,T,C271Y,1,pathogenic,pathogenic,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,271,C,Y,True,864
13285,3820,29363,single nucleotide variant,NM_005912.3(MC4R):c.821A>G (p.Asn274Ser),4160,MC4R,HGNC:6932,Uncertain significance,1,22-Aug-17,121913561,-,RCV000015400|RCV001125885,"MedGen:C4759928,OMIM:618406|Human Phenotype Ontology:HP:0001513,MONDO:MONDO:0019182,MeSH:D009765,MedGen:C0028754,OMIM:601665,Orphanet:71529",BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20|Obesity,germline,germline,GRCh38,NC_000018.10,18,60371529,60371529,na,na,18q21.32,"criteria provided, single submitter",2,-,N,"ClinGen:CA210717,UniProtKB:P32245#VAR_015357,OMIM:155541.0009",3,14324,60371529,T,C,N274S,1,uncertain,uncertain,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,274,N,S,True,864
13286,12396,215036,single nucleotide variant,NM_005912.3(MC4R):c.751A>C (p.Ile251Leu),4160,MC4R,HGNC:6932,Benign/Likely benign,0,31-Dec-19,52820871,-,RCV000202590|RCV000419291|RCV000445524|RCV000501342,"Human Phenotype Ontology:HP:0001513,MONDO:MONDO:0019182,MeSH:D009765,MedGen:C0028754,OMIM:601665,Orphanet:71529|MedGen:CN517202|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625|MedGen:CN169374",Obesity|not provided|Monogenic diabetes|not specified,germline;unknown,germline,GRCh38,NC_000018.10,18,60371599,60371599,na,na,18q21.32,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA214823,UniProtKB:P32245#VAR_010710",2,218329,60371599,T,G,I251L,2,benign,benign,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,251,I,L,True,864
13287,3827,29377,single nucleotide variant,NM_005912.3(MC4R):c.656C>T (p.Ala219Val),4160,MC4R,HGNC:6932,Pathogenic,1,1-Jan-05,121913567,-,RCV000015414,"MedGen:C4759928,OMIM:618406",BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20,germline,germline,GRCh38,NC_000018.10,18,60371694,60371694,na,na,18q21.32,no assertion criteria provided,1,-,N,"ClinGen:CA210726,UniProtKB:P32245#VAR_038648,OMIM:155541.0023",1,14338,60371694,G,A,A219V,0,pathogenic,uncertain,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,219,A,V,True,864
13288,3819,29362,single nucleotide variant,NM_005912.3(MC4R):c.508A>G (p.Ile170Val),4160,MC4R,HGNC:6932,Pathogenic,1,1-Aug-01,121913560,-,RCV000015399,"MedGen:C4759928,OMIM:618406",BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20,germline,germline,GRCh38,NC_000018.10,18,60371842,60371842,na,na,18q21.32,no assertion criteria provided,1,-,N,"UniProtKB:P32245#VAR_038645,OMIM:155541.0008,ClinGen:CA210716",1,14323,60371842,T,C,I170V,0,pathogenic,uncertain,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,170,I,V,True,864
13289,3825,29373,single nucleotide variant,NM_005912.3(MC4R):c.185A>G (p.Asn62Ser),4160,MC4R,HGNC:6932,Pathogenic,1,20-Mar-03,121913566,-,RCV000015410,"MedGen:C4759928,OMIM:618406",BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20,germline,germline,GRCh38,NC_000018.10,18,60372165,60372165,na,na,18q21.32,no assertion criteria provided,1,-,N,"ClinGen:CA210724,UniProtKB:P32245#VAR_038636,OMIM:155541.0019",1,14334,60372165,T,C,N62S,0,pathogenic,uncertain,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,62,N,S,True,864
13290,3818,29361,single nucleotide variant,NM_005912.3(MC4R):c.305T>G (p.Ile102Ser),4160,MC4R,HGNC:6932,Pathogenic,1,1-Oct-05,121913559,-,RCV000015398,"MedGen:C4759928,OMIM:618406",BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20,germline,germline,GRCh38,NC_000018.10,18,60372045,60372045,na,na,18q21.32,no assertion criteria provided,1,-,N,"ClinGen:CA210715,UniProtKB:P32245#VAR_038639,OMIM:155541.0007",1,14322,60372045,A,C,I102S,0,pathogenic,uncertain,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,102,I,S,True,864
13291,3817,29360,single nucleotide variant,NM_005912.3(MC4R):c.172A>T (p.Ser58Cys),4160,MC4R,HGNC:6932,Pathogenic,1,1-Aug-01,121913558,-,RCV000015397,"MedGen:C4759928,OMIM:618406",BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20,germline,germline,GRCh38,NC_000018.10,18,60372178,60372178,na,na,18q21.32,no assertion criteria provided,1,-,N,"ClinGen:CA210714,UniProtKB:P32245#VAR_038635,OMIM:155541.0006",1,14321,60372178,T,A,S58C,0,pathogenic,uncertain,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,58,S,C,True,864
13292,3816,29359,single nucleotide variant,NM_005912.3(MC4R):c.148G>A (p.Val50Met),4160,MC4R,HGNC:6932,Pathogenic,1,1-Aug-01,121913557,-,RCV000015396,"MedGen:C4759928,OMIM:618406",BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20,germline,germline,GRCh38,NC_000018.10,18,60372202,60372202,na,na,18q21.32,no assertion criteria provided,1,-,N,"ClinGen:CA210713,UniProtKB:P32245#VAR_038634,OMIM:155541.0005",1,14320,60372202,C,T,V50M,0,pathogenic,uncertain,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,50,V,M,True,864
13293,3826,29375,single nucleotide variant,NM_005912.3(MC4R):c.380C>T (p.Ser127Leu),4160,MC4R,HGNC:6932,Conflicting interpretations of pathogenicity,1,1-Apr-20,13447331,-,RCV000015412|RCV000414065|RCV000768580,"Human Phenotype Ontology:HP:0001513,MONDO:MONDO:0019182,MeSH:D009765,MedGen:C0028754,OMIM:601665,Orphanet:71529|MedGen:CN517202|MedGen:C4759928,OMIM:618406",Obesity|not provided|BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20,germline,germline,GRCh38,NC_000018.10,18,60371970,60371970,na,na,18q21.32,"criteria provided, conflicting interpretations",8,-,N,"ClinGen:CA210725,UniProtKB:P32245#VAR_038643,OMIM:155541.0021",3,14336,60371970,G,A,S127L,1,uncertain,uncertain,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,127,S,L,True,864
13294,3824,29372,single nucleotide variant,NM_005912.3(MC4R):c.289A>G (p.Asn97Asp),4160,MC4R,HGNC:6932,Pathogenic,1,20-Mar-03,121913565,-,RCV000015409,"MedGen:C4759928,OMIM:618406",BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20,germline,germline,GRCh38,NC_000018.10,18,60372061,60372061,na,na,18q21.32,no assertion criteria provided,1,-,N,"ClinGen:CA210723,UniProtKB:P32245#VAR_038638,OMIM:155541.0018",1,14333,60372061,T,C,N97D,0,pathogenic,uncertain,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,97,N,D,True,864
13295,12397,215037,single nucleotide variant,NM_005912.3(MC4R):c.307G>A (p.Val103Ile),4160,MC4R,HGNC:6932,Benign,0,18-Jan-19,2229616,-,RCV000202600|RCV000445452|RCV000768671|RCV000768672,"Human Phenotype Ontology:HP:0001513,MONDO:MONDO:0019182,MeSH:D009765,MedGen:C0028754,OMIM:601665,Orphanet:71529|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625||MedGen:C5193151","Obesity|Monogenic diabetes|MELANOCORTIN 4 RECEPTOR POLYMORPHISM|OBESITY, RESISTANCE TO",germline;unknown,germline,GRCh38,NC_000018.10,18,60372043,60372043,na,na,18q21.32,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA214825,UniProtKB:P32245#VAR_010707,OMIM:155541.0024",3,218330,60372043,C,T,V103I,2,benign,benign,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,103,V,I,True,864
13296,3815,29358,single nucleotide variant,NM_005912.2(MC4R):c.110A>T (p.Asp37Val),4160,MC4R,HGNC:6932,Conflicting interpretations of pathogenicity,0,1-Jan-19,13447325,-,RCV000015395|RCV000435394|RCV001262822,"Human Phenotype Ontology:HP:0001513,MONDO:MONDO:0019182,MeSH:D009765,MedGen:C0028754,OMIM:601665,Orphanet:71529|MedGen:CN169374|MedGen:C4759928,OMIM:618406",Obesity|not specified|BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20,germline;unknown,germline,GRCh38,NC_000018.10,18,60372240,60372240,na,na,18q21.32,"criteria provided, conflicting interpretations",6,-,N,"ClinVar:917498,ClinGen:CA213428,UniProtKB:P32245#VAR_010705",2,14319,60372240,T,A,D37V,1,uncertain,uncertain,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,37,D,V,True,864
13297,14195,347739,single nucleotide variant,NM_005912.3(MC4R):c.494G>A (p.Arg165Gln),4160,MC4R,HGNC:6932,Pathogenic,1,28-Apr-17,747681609,-,RCV000332082,"Human Phenotype Ontology:HP:0001513,MONDO:MONDO:0019182,MeSH:D009765,MedGen:C0028754,OMIM:601665,Orphanet:71529",Obesity,germline,germline,GRCh38,NC_000018.10,18,60371856,60371856,na,na,18q21.32,"criteria provided, single submitter",2,-,N,"ClinGen:CA8980909,UniProtKB:P32245#VAR_038644",2,327713,60371856,C,T,R165Q,1,pathogenic,pathogenic,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,165,R,Q,True,864
13298,6185,45147,single nucleotide variant,NM_005912.3(MC4R):c.677T>C (p.Ile226Thr),4160,MC4R,HGNC:6932,Uncertain significance,0,12-Jan-18,193922686,-,RCV000030157,"Human Phenotype Ontology:HP:0001513,MONDO:MONDO:0019182,MeSH:D009765,MedGen:C0028754,OMIM:601665,Orphanet:71529",Obesity,germline,germline,GRCh38,NC_000018.10,18,60371673,60371673,na,na,18q21.32,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA214144,UniProtKB:P32245#VAR_038649",2,36485,60371673,A,G,I226T,2,uncertain,uncertain,P32245,P32245,reviewed,MC4R_HUMAN,"Melanocortin receptor 4, MC4-R",MC4R,Homo sapiens (Human),332.0,MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY,PF00001;,6W25;7AUE;7F53;7F54;7F55;7F58;7PIU;7PIV;,226,I,T,True,864
13299,1198,20221,single nucleotide variant,NM_000113.3(TOR1A):c.646G>C (p.Asp216His),1861,TOR1A,HGNC:3098,Benign,0,6-Mar-18,1801968,-,RCV000005490|RCV000020122|RCV000178043,"|MONDO:MONDO:0007492,MedGen:C1851945,OMIM:128100,Orphanet:256|MedGen:CN169374","Dystonia 1, torsion, modifier of|Dystonia 1|not specified",germline,germline,GRCh38,NC_000009.12,9,129818622,129818622,na,na,9q34.11,"criteria provided, multiple submitters, no conflicts",6,-,N,"UniProtKB:O14656#VAR_020449,OMIM:605204.0003,ClinGen:CA117318",3,5182,129818622,C,G,D216H,2,benign,benign,O14656,O14656,reviewed,TOR1A_HUMAN,"Torsin-1A (Dystonia 1 protein) (Torsin ATPase-1A, EC 3.6.4.-) (Torsin family 1 member A)",TOR1A DQ2 DYT1 TA TORA,Homo sapiens (Human),332.0,MKLGRAVLGLLLLAPSVVQAVEPISLGLALAGVLTGYIYPRLYCLFAECCGQKRSLSREALQKDLDDNLFGQHLAKKIILNAVFGFINNPKPKKPLTLSLHGWTGTGKNFVSKIIAENIYEGGLNSDYVHLFVATLHFPHASNITLYKDQLQLWIRGNVSACARSIFIFDEMDKMHAGLIDAIKPFLDYYDLVDGVSYQKAMFIFLSNAGAERITDVALDFWRSGKQREDIKLKDIEHALSVSVFNNKNSGFWHSSLIDRNLIDYFVPFLPLEYKHLKMCIRVEMQSRGYEIDEDIVSRVAEEMTFFPKEERVFSDKGCKTVFTKLDYYYDD,PF06309;,5J1S;5J1T;6OIF;,216,D,H,True,865
13300,5350,33477,single nucleotide variant,NM_000113.3(TOR1A):c.613T>A (p.Phe205Ile),1861,TOR1A,HGNC:3098,Conflicting interpretations of pathogenicity,1,15-Jul-19,267607134,-,RCV000005491|RCV000258917|RCV000296896|RCV000808573|RCV000825647,"MedGen:C4016920|MONDO:MONDO:0007492,MedGen:C1851945,OMIM:128100,Orphanet:256|MedGen:CN517202|Human Phenotype Ontology:HP:0001332,Human Phenotype Ontology:HP:0002328,MONDO:MONDO:0003441,MedGen:C0393593,OMIM:PS128100|MedGen:CN169374","Dystonia 1, torsion, late-onset|Dystonia 1|not provided|Dystonia|not specified",germline;paternal,germline,GRCh38,NC_000009.12,9,129818752,129818752,na,na,9q34.11,"criteria provided, conflicting interpretations",7,-,N,"ClinGen:CA117320,UniProtKB:O14656#VAR_070932,OMIM:605204.0004",3,18438,129818752,A,T,F205I,1,uncertain,uncertain,O14656,O14656,reviewed,TOR1A_HUMAN,"Torsin-1A (Dystonia 1 protein) (Torsin ATPase-1A, EC 3.6.4.-) (Torsin family 1 member A)",TOR1A DQ2 DYT1 TA TORA,Homo sapiens (Human),332.0,MKLGRAVLGLLLLAPSVVQAVEPISLGLALAGVLTGYIYPRLYCLFAECCGQKRSLSREALQKDLDDNLFGQHLAKKIILNAVFGFINNPKPKKPLTLSLHGWTGTGKNFVSKIIAENIYEGGLNSDYVHLFVATLHFPHASNITLYKDQLQLWIRGNVSACARSIFIFDEMDKMHAGLIDAIKPFLDYYDLVDGVSYQKAMFIFLSNAGAERITDVALDFWRSGKQREDIKLKDIEHALSVSVFNNKNSGFWHSSLIDRNLIDYFVPFLPLEYKHLKMCIRVEMQSRGYEIDEDIVSRVAEEMTFFPKEERVFSDKGCKTVFTKLDYYYDD,PF06309;,5J1S;5J1T;6OIF;,205,F,I,True,865
13301,11219,172165,single nucleotide variant,NM_000113.3(TOR1A):c.863G>A (p.Arg288Gln),1861,TOR1A,HGNC:3098,Pathogenic,1,21-Oct-15,727502811,-,RCV000149874|RCV001269843,"MONDO:MONDO:0007492,MedGen:C1851945,OMIM:128100,Orphanet:256|MedGen:CN517202",Dystonia 1|not provided,germline,germline,GRCh38,NC_000009.12,9,129814108,129814108,na,na,9q34.11,"criteria provided, single submitter",3,-,N,"ClinGen:CA273063,UniProtKB:O14656#VAR_070933,OMIM:605204.0005",3,162491,129814108,C,T,R288Q,1,pathogenic,pathogenic,O14656,O14656,reviewed,TOR1A_HUMAN,"Torsin-1A (Dystonia 1 protein) (Torsin ATPase-1A, EC 3.6.4.-) (Torsin family 1 member A)",TOR1A DQ2 DYT1 TA TORA,Homo sapiens (Human),332.0,MKLGRAVLGLLLLAPSVVQAVEPISLGLALAGVLTGYIYPRLYCLFAECCGQKRSLSREALQKDLDDNLFGQHLAKKIILNAVFGFINNPKPKKPLTLSLHGWTGTGKNFVSKIIAENIYEGGLNSDYVHLFVATLHFPHASNITLYKDQLQLWIRGNVSACARSIFIFDEMDKMHAGLIDAIKPFLDYYDLVDGVSYQKAMFIFLSNAGAERITDVALDFWRSGKQREDIKLKDIEHALSVSVFNNKNSGFWHSSLIDRNLIDYFVPFLPLEYKHLKMCIRVEMQSRGYEIDEDIVSRVAEEMTFFPKEERVFSDKGCKTVFTKLDYYYDD,PF06309;,5J1S;5J1T;6OIF;,288,R,Q,True,865
13302,758,18146,single nucleotide variant,NM_005670.4(EPM2A):c.94T>G (p.Trp32Gly),7957,EPM2A,HGNC:3413,Likely pathogenic,1,1-Oct-15,104893955,-,RCV000003253|RCV000494425,"MONDO:MONDO:0009697,MedGen:C0751783,OMIM:254780,Orphanet:501|MedGen:CN517202",Lafora disease|not provided,germline,germline,GRCh38,NC_000006.12,6,145735405,145735405,na,na,6q24.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA252549,UniProtKB:O95278#VAR_019467,OMIM:607566.0010",3,3107,145735405,A,C,W32G,1,pathogenic,pathogenic,O95278,O95278,reviewed,EPM2A_HUMAN,"Laforin, EC 3.1.3.-, EC 3.1.3.16, EC 3.1.3.48 (Glucan phosphatase) (Glycogen phosphatase) (Lafora PTPase, LAFPTPase)",EPM2A,Homo sapiens (Human),331.0,MRFRFGVVVPPAVAGARPELLVVGSRPELGRWEPRGAVRLRPAGTAAGDGALALQEPGLWLGEVELAAEEAAQDGAEPGRVDTFWYKFLKREPGGELSWEGNGPHHDRCCTYNENNLVDGVYCLPIGHWIEATGHTNEMKHTTDFYFNIAGHQAMHYSRILPNIWLGSCPRQVEHVTIKLKHELGITAVMNFQTEWDIVQNSSGCNRYPEPMTPDTMIKLYREEGLAYIWMPTPDMSTEGRVQMLPQAVCLLHALLEKGHIVYVHCNAGVGRSTAAVCGWLQYVMGWNLRKVQYFLMAKRPAVYIDEEALARAQEDFFQKFGKVRSSVCSL,PF00686;PF00782;,4R30;4RKK;,32,W,G,True,866
13303,757,18141,single nucleotide variant,NM_005670.4(EPM2A):c.512G>A (p.Arg171His),7957,EPM2A,HGNC:3413,Uncertain significance,1,16-Oct-18,137852916,-,RCV000003248|RCV000469417,"MONDO:MONDO:0009697,MedGen:C0751783,OMIM:254780,Orphanet:501|MONDO:MONDO:0020074,MedGen:C0751778,OMIM:PS254800,Orphanet:308,Orphanet:98261",Lafora disease|Progressive myoclonic epilepsy,germline,germline,GRCh38,NC_000006.12,6,145635451,145635451,na,na,6q24.3,"criteria provided, single submitter",2,-,N,"UniProtKB:O95278#VAR_019474,OMIM:607566.0005,ClinGen:CA252546",3,3102,145635451,C,T,R171H,1,uncertain,uncertain,O95278,O95278,reviewed,EPM2A_HUMAN,"Laforin, EC 3.1.3.-, EC 3.1.3.16, EC 3.1.3.48 (Glucan phosphatase) (Glycogen phosphatase) (Lafora PTPase, LAFPTPase)",EPM2A,Homo sapiens (Human),331.0,MRFRFGVVVPPAVAGARPELLVVGSRPELGRWEPRGAVRLRPAGTAAGDGALALQEPGLWLGEVELAAEEAAQDGAEPGRVDTFWYKFLKREPGGELSWEGNGPHHDRCCTYNENNLVDGVYCLPIGHWIEATGHTNEMKHTTDFYFNIAGHQAMHYSRILPNIWLGSCPRQVEHVTIKLKHELGITAVMNFQTEWDIVQNSSGCNRYPEPMTPDTMIKLYREEGLAYIWMPTPDMSTEGRVQMLPQAVCLLHALLEKGHIVYVHCNAGVGRSTAAVCGWLQYVMGWNLRKVQYFLMAKRPAVYIDEEALARAQEDFFQKFGKVRSSVCSL,PF00686;PF00782;,4R30;4RKK;,171,R,H,True,866
13304,756,18139,single nucleotide variant,NM_005670.4(EPM2A):c.322C>T (p.Arg108Cys),7957,EPM2A,HGNC:3413,Pathogenic,1,1-Oct-05,137852915,-,RCV000003246,"MONDO:MONDO:0009697,MedGen:C0751783,OMIM:254780,Orphanet:501",Lafora disease,germline,germline,GRCh38,NC_000006.12,6,145686276,145686276,na,na,6q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA252543,UniProtKB:O95278#VAR_019472,OMIM:607566.0003",1,3100,145686276,G,A,R108C,0,pathogenic,uncertain,O95278,O95278,reviewed,EPM2A_HUMAN,"Laforin, EC 3.1.3.-, EC 3.1.3.16, EC 3.1.3.48 (Glucan phosphatase) (Glycogen phosphatase) (Lafora PTPase, LAFPTPase)",EPM2A,Homo sapiens (Human),331.0,MRFRFGVVVPPAVAGARPELLVVGSRPELGRWEPRGAVRLRPAGTAAGDGALALQEPGLWLGEVELAAEEAAQDGAEPGRVDTFWYKFLKREPGGELSWEGNGPHHDRCCTYNENNLVDGVYCLPIGHWIEATGHTNEMKHTTDFYFNIAGHQAMHYSRILPNIWLGSCPRQVEHVTIKLKHELGITAVMNFQTEWDIVQNSSGCNRYPEPMTPDTMIKLYREEGLAYIWMPTPDMSTEGRVQMLPQAVCLLHALLEKGHIVYVHCNAGVGRSTAAVCGWLQYVMGWNLRKVQYFLMAKRPAVYIDEEALARAQEDFFQKFGKVRSSVCSL,PF00686;PF00782;,4R30;4RKK;,108,R,C,True,866
13305,755,18138,single nucleotide variant,NM_005670.4(EPM2A):c.835G>A (p.Gly279Ser),7957,EPM2A,HGNC:3413,Pathogenic/Likely pathogenic,1,24-Apr-17,137852917,-,RCV000003245|RCV000675700,"MONDO:MONDO:0009697,MedGen:C0751783,OMIM:254780,Orphanet:501|MedGen:CN517202",Lafora disease|not provided,germline;unknown,germline,GRCh38,NC_000006.12,6,145627577,145627577,na,na,6q24.3,no assertion criteria provided,2,-,N,"ClinGen:CA252542,UniProtKB:O95278#VAR_019478,OMIM:607566.0002",3,3099,145627577,C,T,G279S,0,pathogenic,uncertain,O95278,O95278,reviewed,EPM2A_HUMAN,"Laforin, EC 3.1.3.-, EC 3.1.3.16, EC 3.1.3.48 (Glucan phosphatase) (Glycogen phosphatase) (Lafora PTPase, LAFPTPase)",EPM2A,Homo sapiens (Human),331.0,MRFRFGVVVPPAVAGARPELLVVGSRPELGRWEPRGAVRLRPAGTAAGDGALALQEPGLWLGEVELAAEEAAQDGAEPGRVDTFWYKFLKREPGGELSWEGNGPHHDRCCTYNENNLVDGVYCLPIGHWIEATGHTNEMKHTTDFYFNIAGHQAMHYSRILPNIWLGSCPRQVEHVTIKLKHELGITAVMNFQTEWDIVQNSSGCNRYPEPMTPDTMIKLYREEGLAYIWMPTPDMSTEGRVQMLPQAVCLLHALLEKGHIVYVHCNAGVGRSTAAVCGWLQYVMGWNLRKVQYFLMAKRPAVYIDEEALARAQEDFFQKFGKVRSSVCSL,PF00686;PF00782;,4R30;4RKK;,279,G,S,True,866
13306,12062,201924,single nucleotide variant,NM_005670.4(EPM2A):c.878A>T (p.Gln293Leu),7957,EPM2A,HGNC:3413,Pathogenic,1,23-May-13,796052427,-,RCV000187395,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000006.12,6,145627534,145627534,na,na,6q24.3,"criteria provided, single submitter",1,-,N,"ClinGen:CA314502,UniProtKB:O95278#VAR_019479",2,205434,145627534,T,A,Q293L,1,pathogenic,pathogenic,O95278,O95278,reviewed,EPM2A_HUMAN,"Laforin, EC 3.1.3.-, EC 3.1.3.16, EC 3.1.3.48 (Glucan phosphatase) (Glycogen phosphatase) (Lafora PTPase, LAFPTPase)",EPM2A,Homo sapiens (Human),331.0,MRFRFGVVVPPAVAGARPELLVVGSRPELGRWEPRGAVRLRPAGTAAGDGALALQEPGLWLGEVELAAEEAAQDGAEPGRVDTFWYKFLKREPGGELSWEGNGPHHDRCCTYNENNLVDGVYCLPIGHWIEATGHTNEMKHTTDFYFNIAGHQAMHYSRILPNIWLGSCPRQVEHVTIKLKHELGITAVMNFQTEWDIVQNSSGCNRYPEPMTPDTMIKLYREEGLAYIWMPTPDMSTEGRVQMLPQAVCLLHALLEKGHIVYVHCNAGVGRSTAAVCGWLQYVMGWNLRKVQYFLMAKRPAVYIDEEALARAQEDFFQKFGKVRSSVCSL,PF00686;PF00782;,4R30;4RKK;,293,Q,L,True,866
13307,11224,172293,single nucleotide variant,NM_005670.4(EPM2A):c.136G>C (p.Ala46Pro),7957,EPM2A,HGNC:3413,Benign,0,31-Dec-19,374338349,-,RCV000173389|RCV000192023|RCV000232414|RCV000711612|RCV000720317,"MedGen:CN169374|MONDO:MONDO:0009697,MedGen:C0751783,OMIM:254780,Orphanet:501|MONDO:MONDO:0020074,MedGen:C0751778,OMIM:PS254800,Orphanet:308,Orphanet:98261|MedGen:CN517202|Human Phenotype Ontology:HP:0001250,Human Phenotype Ontology:HP:0001275,Human Phenotype Ontology:HP:0001303,Human Phenotype Ontology:HP:0002125,Human Phenotype Ontology:HP:0002182,Human Phenotype Ontology:HP:0002279,Human Phenotype Ontology:HP:0002306,Human Phenotype Ontology:HP:0002348,Human Phenotype Ontology:HP:0002391,Human Phenotype Ontology:HP:0002417,Human Phenotype Ontology:HP:0002430,Human Phenotype Ontology:HP:0002431,Human Phenotype Ontology:HP:0002432,Human Phenotype Ontology:HP:0002434,Human Phenotype Ontology:HP:0002437,Human Phenotype Ontology:HP:0002466,Human Phenotype Ontology:HP:0002479,Human Phenotype Ontology:HP:0002794,Human Phenotype Ontology:HP:0006997,Human Phenotype Ontology:HP:0010520,MedGen:C0036572",not specified|Lafora disease|Progressive myoclonic epilepsy|not provided|Seizures,germline,germline,GRCh38,NC_000006.12,6,145735363,145735363,na,na,6q24.3,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA302699,UniProtKB:O95278#VAR_019468",3,162617,145735363,C,G,A46P,2,benign,benign,O95278,O95278,reviewed,EPM2A_HUMAN,"Laforin, EC 3.1.3.-, EC 3.1.3.16, EC 3.1.3.48 (Glucan phosphatase) (Glycogen phosphatase) (Lafora PTPase, LAFPTPase)",EPM2A,Homo sapiens (Human),331.0,MRFRFGVVVPPAVAGARPELLVVGSRPELGRWEPRGAVRLRPAGTAAGDGALALQEPGLWLGEVELAAEEAAQDGAEPGRVDTFWYKFLKREPGGELSWEGNGPHHDRCCTYNENNLVDGVYCLPIGHWIEATGHTNEMKHTTDFYFNIAGHQAMHYSRILPNIWLGSCPRQVEHVTIKLKHELGITAVMNFQTEWDIVQNSSGCNRYPEPMTPDTMIKLYREEGLAYIWMPTPDMSTEGRVQMLPQAVCLLHALLEKGHIVYVHCNAGVGRSTAAVCGWLQYVMGWNLRKVQYFLMAKRPAVYIDEEALARAQEDFFQKFGKVRSSVCSL,PF00686;PF00782;,4R30;4RKK;,46,A,P,True,866
13308,4774,31904,single nucleotide variant,NM_000031.6(ALAD):c.718C>T (p.Arg240Trp),210,ALAD,HGNC:395,Uncertain significance,1,16-May-16,121912982,-,RCV000018361|RCV000604032,"MONDO:MONDO:0013000,MedGen:C0268328,OMIM:612740,Orphanet:100924|MedGen:CN169374",Porphobilinogen synthase deficiency|not specified,germline,germline,GRCh38,NC_000009.12,9,113389521,113389521,na,na,9q32,"criteria provided, single submitter",2,-,N,"ClinGen:CA126935,UniProtKB:P13716#VAR_003635,OMIM:125270.0004",3,16865,113389521,G,A,R240W,1,uncertain,uncertain,P13716,P13716,reviewed,HEM2_HUMAN,"Delta-aminolevulinic acid dehydratase, ALADH, EC 4.2.1.24 (Porphobilinogen synthase)",ALAD,Homo sapiens (Human),330.0,MQPQSVLHSGYFHPLLRAWQTATTTLNASNLIYPIFVTDVPDDIQPITSLPGVARYGVKRLEEMLRPLVEEGLRCVLIFGVPSRVPKDERGSAADSEESPAIEAIHLLRKTFPNLLVACDVCLCPYTSHGHCGLLSENGAFRAEESRQRLAEVALAYAKAGCQVVAPSDMMDGRVEAIKEALMAHGLGNRVSVMSYSAKFASCFYGPFRDAAKSSPAFGDRRCYQLPPGARGLALRAVDRDVREGADMLMVKPGMPYLDIVREVKDKHPDLPLAVYHVSGEFAMLWHGAQAGAFDLKAAVLEAMTAFRRAGADIIITYYTPQLLQWLKEE,PF00490;,1E51;1PV8;5HMS;5HNR;,240,R,W,True,867
13309,4773,31903,single nucleotide variant,NM_000031.6(ALAD):c.177G>C (p.Lys59Asn),210,ALAD,HGNC:395,Benign,1,6-Mar-18,1800435,-,RCV000018360|RCV000371179,"|MONDO:MONDO:0013000,MedGen:C0268328,OMIM:612740,Orphanet:100924","AMINOLEVULINATE DEHYDRATASE, ALAD*1/ALAD*2 POLYMORPHISM|Porphobilinogen synthase deficiency",germline,germline,GRCh38,NC_000009.12,9,113391611,113391611,na,na,9q32,"criteria provided, single submitter",2,-,N,"ClinGen:CA126933,UniProtKB:P13716#VAR_003633,OMIM:125270.0003",3,16864,113391611,C,G,K59N,1,benign,benign,P13716,P13716,reviewed,HEM2_HUMAN,"Delta-aminolevulinic acid dehydratase, ALADH, EC 4.2.1.24 (Porphobilinogen synthase)",ALAD,Homo sapiens (Human),330.0,MQPQSVLHSGYFHPLLRAWQTATTTLNASNLIYPIFVTDVPDDIQPITSLPGVARYGVKRLEEMLRPLVEEGLRCVLIFGVPSRVPKDERGSAADSEESPAIEAIHLLRKTFPNLLVACDVCLCPYTSHGHCGLLSENGAFRAEESRQRLAEVALAYAKAGCQVVAPSDMMDGRVEAIKEALMAHGLGNRVSVMSYSAKFASCFYGPFRDAAKSSPAFGDRRCYQLPPGARGLALRAVDRDVREGADMLMVKPGMPYLDIVREVKDKHPDLPLAVYHVSGEFAMLWHGAQAGAFDLKAAVLEAMTAFRRAGADIIITYYTPQLLQWLKEE,PF00490;,1E51;1PV8;5HMS;5HNR;,59,K,N,True,867
13310,4772,31902,single nucleotide variant,NM_000031.6(ALAD):c.823G>A (p.Val275Met),210,ALAD,HGNC:395,Pathogenic,1,1-Jul-91,121912981,-,RCV000018359,"MONDO:MONDO:0013000,MedGen:C0268328,OMIM:612740,Orphanet:100924",Porphobilinogen synthase deficiency,germline,germline,GRCh38,NC_000009.12,9,113389085,113389085,na,na,9q32,no assertion criteria provided,1,-,N,"OMIM:125270.0002,ClinGen:CA126932,UniProtKB:P13716#VAR_003637",1,16863,113389085,C,T,V275M,0,pathogenic,uncertain,P13716,P13716,reviewed,HEM2_HUMAN,"Delta-aminolevulinic acid dehydratase, ALADH, EC 4.2.1.24 (Porphobilinogen synthase)",ALAD,Homo sapiens (Human),330.0,MQPQSVLHSGYFHPLLRAWQTATTTLNASNLIYPIFVTDVPDDIQPITSLPGVARYGVKRLEEMLRPLVEEGLRCVLIFGVPSRVPKDERGSAADSEESPAIEAIHLLRKTFPNLLVACDVCLCPYTSHGHCGLLSENGAFRAEESRQRLAEVALAYAKAGCQVVAPSDMMDGRVEAIKEALMAHGLGNRVSVMSYSAKFASCFYGPFRDAAKSSPAFGDRRCYQLPPGARGLALRAVDRDVREGADMLMVKPGMPYLDIVREVKDKHPDLPLAVYHVSGEFAMLWHGAQAGAFDLKAAVLEAMTAFRRAGADIIITYYTPQLLQWLKEE,PF00490;,1E51;1PV8;5HMS;5HNR;,275,V,M,True,867
13311,4776,31906,single nucleotide variant,NM_000031.6(ALAD):c.36C>G (p.Phe12Leu),210,ALAD,HGNC:395,Conflicting interpretations of pathogenicity,1,18-Jul-19,121912984,-,RCV000018363|RCV000413492,MedGen:C4016013|MedGen:CN517202,"Porphyria, acute hepatic, digenic|not provided",germline,germline,GRCh38,NC_000009.12,9,113393524,113393524,na,na,9q32,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA126937,UniProtKB:P13716#VAR_020973,OMIM:125270.0006",3,16867,113393524,G,C,F12L,1,uncertain,uncertain,P13716,P13716,reviewed,HEM2_HUMAN,"Delta-aminolevulinic acid dehydratase, ALADH, EC 4.2.1.24 (Porphobilinogen synthase)",ALAD,Homo sapiens (Human),330.0,MQPQSVLHSGYFHPLLRAWQTATTTLNASNLIYPIFVTDVPDDIQPITSLPGVARYGVKRLEEMLRPLVEEGLRCVLIFGVPSRVPKDERGSAADSEESPAIEAIHLLRKTFPNLLVACDVCLCPYTSHGHCGLLSENGAFRAEESRQRLAEVALAYAKAGCQVVAPSDMMDGRVEAIKEALMAHGLGNRVSVMSYSAKFASCFYGPFRDAAKSSPAFGDRRCYQLPPGARGLALRAVDRDVREGADMLMVKPGMPYLDIVREVKDKHPDLPLAVYHVSGEFAMLWHGAQAGAFDLKAAVLEAMTAFRRAGADIIITYYTPQLLQWLKEE,PF00490;,1E51;1PV8;5HMS;5HNR;,12,F,L,True,867
13312,4775,31905,single nucleotide variant,NM_000031.6(ALAD):c.820G>A (p.Ala274Thr),210,ALAD,HGNC:395,Pathogenic,1,1-May-92,121912983,-,RCV000018362,"MONDO:MONDO:0013000,MedGen:C0268328,OMIM:612740,Orphanet:100924",Porphobilinogen synthase deficiency,germline,germline,GRCh38,NC_000009.12,9,113389088,113389088,na,na,9q32,no assertion criteria provided,1,-,N,"ClinGen:CA126936,UniProtKB:P13716#VAR_003636,OMIM:125270.0005",1,16866,113389088,C,T,A274T,0,pathogenic,uncertain,P13716,P13716,reviewed,HEM2_HUMAN,"Delta-aminolevulinic acid dehydratase, ALADH, EC 4.2.1.24 (Porphobilinogen synthase)",ALAD,Homo sapiens (Human),330.0,MQPQSVLHSGYFHPLLRAWQTATTTLNASNLIYPIFVTDVPDDIQPITSLPGVARYGVKRLEEMLRPLVEEGLRCVLIFGVPSRVPKDERGSAADSEESPAIEAIHLLRKTFPNLLVACDVCLCPYTSHGHCGLLSENGAFRAEESRQRLAEVALAYAKAGCQVVAPSDMMDGRVEAIKEALMAHGLGNRVSVMSYSAKFASCFYGPFRDAAKSSPAFGDRRCYQLPPGARGLALRAVDRDVREGADMLMVKPGMPYLDIVREVKDKHPDLPLAVYHVSGEFAMLWHGAQAGAFDLKAAVLEAMTAFRRAGADIIITYYTPQLLQWLKEE,PF00490;,1E51;1PV8;5HMS;5HNR;,274,A,T,True,867
13313,10846,151873,single nucleotide variant,NM_002878.3(RAD51D):c.494G>A (p.Arg165Gln),5892,RAD51D,HGNC:9823,Benign,0,25-Aug-20,4796033,-,RCV000131069|RCV000245575|RCV000409134,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145","Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial 4",germline;unknown,germline,GRCh38,NC_000017.11,17,35106468,35106468,na,na,17q12,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA167606,UniProtKB:O75771#VAR_020561",2,142159,35106468,C,T,R165Q,2,benign,benign,O75771,O75771,reviewed,RA51D_HUMAN,DNA repair protein RAD51 homolog 4 (R51H3) (RAD51 homolog D) (RAD51-like protein 3) (TRAD),RAD51D RAD51L3,Homo sapiens (Human),328.0,MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKALVALRRVLLAQFSAFPVNGADLYEELKTSTAILSTGIGSLDKLLDAGLYTGEVTEIVGGPGSGKTQVCLCMAANVAHGLQQNVLYVDSNGGLTASRLLQLLQAKTQDEEEQAEALRRIQVVHAFDIFQMLDVLQELRGTVAQQVTGSSGTVKVVVVDSVTAVVSPLLGGQQREGLALMMQLARELKTLARDLGMAVVVTNHITRDRDSGRLKPALGRSWSFVPSTRILLDTIEGAGASGGRRMACLAKSSRQPTGFQEMVDIGTWGTSEQSATLQGDQT,PF08423;,2KZ3;,165,R,Q,True,868
13314,12724,235872,single nucleotide variant,NM_002878.3(RAD51D):c.673G>A (p.Ala225Thr),5892,RAD51D,HGNC:9823,Uncertain significance,0,16-Sep-20,28363282,-,RCV000215081|RCV000701276,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145","Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 4",germline,germline,GRCh38,NC_000017.11,17,35103319,35103319,na,na,17q12,"criteria provided, multiple submitters, no conflicts",2,-,N,"UniProtKB:O75771#VAR_020562,ClinGen:CA10580447",2,229842,35103319,C,T,A225T,2,uncertain,uncertain,O75771,O75771,reviewed,RA51D_HUMAN,DNA repair protein RAD51 homolog 4 (R51H3) (RAD51 homolog D) (RAD51-like protein 3) (TRAD),RAD51D RAD51L3,Homo sapiens (Human),328.0,MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKALVALRRVLLAQFSAFPVNGADLYEELKTSTAILSTGIGSLDKLLDAGLYTGEVTEIVGGPGSGKTQVCLCMAANVAHGLQQNVLYVDSNGGLTASRLLQLLQAKTQDEEEQAEALRRIQVVHAFDIFQMLDVLQELRGTVAQQVTGSSGTVKVVVVDSVTAVVSPLLGGQQREGLALMMQLARELKTLARDLGMAVVVTNHITRDRDSGRLKPALGRSWSFVPSTRILLDTIEGAGASGGRRMACLAKSSRQPTGFQEMVDIGTWGTSEQSATLQGDQT,PF08423;,2KZ3;,225,A,T,True,868
13315,12862,242732,single nucleotide variant,NM_002878.3(RAD51D):c.72G>T (p.Arg24Ser),5892,RAD51D,HGNC:9823,Uncertain significance,0,15-Apr-19,28363257,-,RCV000226520|RCV000562459,"MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162","Breast-ovarian cancer, familial 4|Hereditary cancer-predisposing syndrome",germline,germline,GRCh38,NC_000017.11,17,35119542,35119542,na,na,17q12,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA8499698,UniProtKB:O75771#VAR_020560",2,239401,35119542,C,A,R24S,2,uncertain,uncertain,O75771,O75771,reviewed,RA51D_HUMAN,DNA repair protein RAD51 homolog 4 (R51H3) (RAD51 homolog D) (RAD51-like protein 3) (TRAD),RAD51D RAD51L3,Homo sapiens (Human),328.0,MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKALVALRRVLLAQFSAFPVNGADLYEELKTSTAILSTGIGSLDKLLDAGLYTGEVTEIVGGPGSGKTQVCLCMAANVAHGLQQNVLYVDSNGGLTASRLLQLLQAKTQDEEEQAEALRRIQVVHAFDIFQMLDVLQELRGTVAQQVTGSSGTVKVVVVDSVTAVVSPLLGGQQREGLALMMQLARELKTLARDLGMAVVVTNHITRDRDSGRLKPALGRSWSFVPSTRILLDTIEGAGASGGRRMACLAKSSRQPTGFQEMVDIGTWGTSEQSATLQGDQT,PF08423;,2KZ3;,24,R,S,True,868
13316,6,15073,single nucleotide variant,NM_138413.4(HOGA1):c.769T>G (p.Cys257Gly),112817,HOGA1,HGNC:25155,Pathogenic/Likely pathogenic,1,30-Nov-19,267606764,-,RCV000000051|RCV000994489,"MONDO:MONDO:0013327,MedGen:C3150878,OMIM:613616,Orphanet:416,Orphanet:93600|MedGen:CN517202","Primary hyperoxaluria, type III|not provided",germline,germline,GRCh38,NC_000010.11,10,97601925,97601925,na,na,10q24.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA113818,UniProtKB:Q86XE5#VAR_064035,OMIM:613597.0006",3,34,97601925,T,G,C257G,2,pathogenic,pathogenic,Q86XE5,Q86XE5,reviewed,HOGA1_HUMAN,"4-hydroxy-2-oxoglutarate aldolase, mitochondrial, EC 4.1.3.16 (Dihydrodipicolinate synthase-like, DHDPS-like protein) (Probable 2-keto-4-hydroxyglutarate aldolase, Probable KHG-aldolase) (Protein 569272)",HOGA1 C10orf65 DHDPSL,Homo sapiens (Human),327.0,MLGPQVWSSVRQGLSRSLSRNVGVWASGEGKKVDIAGIYPPVTTPFTATAEVDYGKLEENLHKLGTFPFRGFVVQGSNGEFPFLTSSERLEVVSRVRQAMPKNRLLLAGSGCESTQATVEMTVSMAQVGADAAMVVTPCYYRGRMSSAALIHHYTKVADLSPIPVVLYSVPANTGLDLPVDAVVTLSQHPNIVGMKDSGGDVTRIGLIVHKTRKQDFQVLAGSAGFLMASYALGAVGGVCALANVLGAQVCQLERLCCTGQWEDAQKLQHRLIEPNAAVTRRFGIPGLKKIMDWFGYYGGPCRAPLQELSPAEEEALRMDFTSNGWL,PF00701;,3S5N;3S5O;,257,C,G,True,869
13317,5,15069,single nucleotide variant,NM_138413.4(HOGA1):c.860G>T (p.Gly287Val),112817,HOGA1,HGNC:25155,Pathogenic/Likely pathogenic,1,16-Dec-18,138207257,-,RCV000000047|RCV000798240,"MONDO:MONDO:0013327,MedGen:C3150878,OMIM:613616,Orphanet:416,Orphanet:93600|MedGen:CN517202","Primary hyperoxaluria, type III|not provided",germline;unknown,germline,GRCh38,NC_000010.11,10,97611535,97611535,na,na,10q24.2,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA113813,UniProtKB:Q86XE5#VAR_064036,OMIM:613597.0002",3,30,97611535,G,T,G287V,2,pathogenic,pathogenic,Q86XE5,Q86XE5,reviewed,HOGA1_HUMAN,"4-hydroxy-2-oxoglutarate aldolase, mitochondrial, EC 4.1.3.16 (Dihydrodipicolinate synthase-like, DHDPS-like protein) (Probable 2-keto-4-hydroxyglutarate aldolase, Probable KHG-aldolase) (Protein 569272)",HOGA1 C10orf65 DHDPSL,Homo sapiens (Human),327.0,MLGPQVWSSVRQGLSRSLSRNVGVWASGEGKKVDIAGIYPPVTTPFTATAEVDYGKLEENLHKLGTFPFRGFVVQGSNGEFPFLTSSERLEVVSRVRQAMPKNRLLLAGSGCESTQATVEMTVSMAQVGADAAMVVTPCYYRGRMSSAALIHHYTKVADLSPIPVVLYSVPANTGLDLPVDAVVTLSQHPNIVGMKDSGGDVTRIGLIVHKTRKQDFQVLAGSAGFLMASYALGAVGGVCALANVLGAQVCQLERLCCTGQWEDAQKLQHRLIEPNAAVTRRFGIPGLKKIMDWFGYYGGPCRAPLQELSPAEEEALRMDFTSNGWL,PF00701;,3S5N;3S5O;,287,G,V,True,869
13318,5775,38625,single nucleotide variant,NM_004379.5(CREB1):c.305A>G (p.Asp102Gly),1385,CREB1,HGNC:2345,Uncertain significance,0,1-Apr-12,387906617,-,RCV000022519,MedGen:C2986382,Variant of unknown significance,germline,germline,GRCh38,NC_000002.12,2,207567506,207567506,na,na,2q33.3,no assertion criteria provided,1,-,N,"OMIM:123810.0001,ClinGen:CA128548,UniProtKB:P16220#VAR_068077",1,29670,207567506,A,G,D102G,0,uncertain,uncertain,P16220,P16220,reviewed,CREB1_HUMAN,"Cyclic AMP-responsive element-binding protein 1, CREB-1, cAMP-responsive element-binding protein 1",CREB1,Homo sapiens (Human),327.0,MTMESGAENQQSGDAAVTEAENQQMTVQAQPQIATLAQVSMPAAHATSSAPTVTLVQLPNGQTVQVHGVIQAAQPSVIQSPQVQTVQISTIAESEDSQESVDSVTDSQKRREILSRRPSYRKILNDLSSDAPGVPRIEEEKSEEETSAPAITTVTVPTPIYQTSSGQYIAITQGGAIQLANNGTDGVQGLQTLTMTNAAATQPGTTILQYAQTTDGQQILVPSNQVVVQAASGDVQTYQIRTAPTSTIAPGVVMASSPALPTQPAEEAARKREVRLMKNREAARECRRKKKEYVKCLENRVAVLENQNKTLIEELKALKDLYCHKSD,PF00170;PF02173;,2LXT;5ZK1;5ZKO;,102,D,G,True,870
13319,7573,76929,single nucleotide variant,NM_001916.5(CYC1):c.288G>T (p.Trp96Cys),1537,CYC1,HGNC:2579,Pathogenic,1,8-Aug-13,587777041,-,RCV000056262,"MONDO:MONDO:0014194,MedGen:C3809553,OMIM:615453","Mitochondrial complex III deficiency, nuclear type 6",germline,germline,GRCh38,NC_000008.11,8,144095991,144095991,na,na,8q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA144825,UniProtKB:P08574#VAR_070847,OMIM:123980.0001",1,66019,144095991,G,T,W96C,0,pathogenic,uncertain,P08574,P08574,reviewed,CY1_HUMAN,"Cytochrome c1, heme protein, mitochondrial, EC 7.1.1.8 (Complex III subunit 4) (Complex III subunit IV) (Cytochrome b-c1 complex subunit 4) (Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit, Cytochrome c-1)",CYC1,Homo sapiens (Human),325.0,MAAAAASLRGVVLGPRGAGLPGARARGLLCSARPGQLPLRTPQAVALSSKSGLSRGRKVMLSALGMLAAGGAGLAMALHSAVSASDLELHPPSYPWSHRGLLSSLDHTSIRRGFQVYKQVCASCHSMDFVAYRHLVGVCYTEDEAKELAAEVEVQDGPNEDGEMFMRPGKLFDYFPKPYPNSEAARAANNGALPPDLSYIVRARHGGEDYVFSLLTGYCEPPTGVSLREGLYFNPYFPGQAIAMAPPIYTDVLEFDDGTPATMSQIAKDVCTFLRWASEPEHDHRKRMGLKMLMMMALLVPLVYTIKRHKWSVLKSRKLAYRPPK,PF02167;,5XTE;5XTH;5XTI;,96,W,C,True,871
13320,7574,76930,single nucleotide variant,NM_001916.5(CYC1):c.643C>T (p.Leu215Phe),1537,CYC1,HGNC:2579,Pathogenic,1,26-Oct-17,587777042,-,RCV000056263|RCV000417572,"MONDO:MONDO:0014194,MedGen:C3809553,OMIM:615453|MedGen:CN517202","Mitochondrial complex III deficiency, nuclear type 6|not provided",germline,germline,GRCh38,NC_000008.11,8,144096615,144096615,na,na,8q24.3,"criteria provided, single submitter",2,-,N,"UniProtKB:P08574#VAR_070848,OMIM:123980.0002,ClinGen:CA144827",3,66020,144096615,C,T,L215F,1,pathogenic,pathogenic,P08574,P08574,reviewed,CY1_HUMAN,"Cytochrome c1, heme protein, mitochondrial, EC 7.1.1.8 (Complex III subunit 4) (Complex III subunit IV) (Cytochrome b-c1 complex subunit 4) (Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit, Cytochrome c-1)",CYC1,Homo sapiens (Human),325.0,MAAAAASLRGVVLGPRGAGLPGARARGLLCSARPGQLPLRTPQAVALSSKSGLSRGRKVMLSALGMLAAGGAGLAMALHSAVSASDLELHPPSYPWSHRGLLSSLDHTSIRRGFQVYKQVCASCHSMDFVAYRHLVGVCYTEDEAKELAAEVEVQDGPNEDGEMFMRPGKLFDYFPKPYPNSEAARAANNGALPPDLSYIVRARHGGEDYVFSLLTGYCEPPTGVSLREGLYFNPYFPGQAIAMAPPIYTDVLEFDDGTPATMSQIAKDVCTFLRWASEPEHDHRKRMGLKMLMMMALLVPLVYTIKRHKWSVLKSRKLAYRPPK,PF02167;,5XTE;5XTH;5XTI;,215,L,F,True,871
13321,5809,38790,single nucleotide variant,NM_001611.5(ACP5):c.602T>C (p.Leu201Pro),54,ACP5,HGNC:124,Pathogenic,1,1-Feb-11,387906672,-,RCV000022711,"MONDO:MONDO:0011939,MedGen:C1842763,OMIM:607944,Orphanet:50816",Spondyloenchondrodysplasia with immune dysregulation,germline,germline,GRCh38,NC_000019.10,19,11576376,11576376,na,na,19p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA128682,UniProtKB:P13686#VAR_065923,OMIM:171640.0007",1,29835,11576376,A,G,L201P,0,pathogenic,uncertain,P13686,P13686,reviewed,PPA5_HUMAN,"Tartrate-resistant acid phosphatase type 5, TR-AP, EC 3.1.3.2 (Tartrate-resistant acid ATPase, TrATPase) (Type 5 acid phosphatase)",ACP5,Homo sapiens (Human),325.0,MDMWTALLILQALLLPSLADGATPALRFVAVGDWGGVPNAPFHTAREMANAKEIARTVQILGADFILSLGDNFYFTGVQDINDKRFQETFEDVFSDRSLRKVPWYVLAGNHDHLGNVSAQIAYSKISKRWNFPSPFYRLHFKIPQTNVSVAIFMLDTVTLCGNSDDFLSQQPERPRDVKLARTQLSWLKKQLAAAREDYVLVAGHYPVWSIAEHGPTHCLVKQLRPLLATYGVTAYLCGHDHNLQYLQDENGVGYVLSGAGNFMDPSKRHQRKVPNGYLRFHYGTEDSLGGFAYVEISSKEMTVTYIEASGKSLFKTRLPRRARP,PF00149;,1WAR;2BQ8;,201,L,P,True,872
13322,5808,38788,single nucleotide variant,NM_001611.5(ACP5):c.325G>A (p.Gly109Arg),54,ACP5,HGNC:124,Pathogenic,1,15-May-17,781050795,-,RCV000022709|RCV000624296,"MONDO:MONDO:0011939,MedGen:C1842763,OMIM:607944,Orphanet:50816|MeSH:D030342,MedGen:C0950123",Spondyloenchondrodysplasia with immune dysregulation|Inborn genetic diseases,germline,germline,GRCh38,NC_000019.10,19,11576780,11576780,na,na,19p13.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA9215447,UniProtKB:P13686#VAR_065922,OMIM:171640.0005",3,29833,11576780,C,T,G109R,1,pathogenic,pathogenic,P13686,P13686,reviewed,PPA5_HUMAN,"Tartrate-resistant acid phosphatase type 5, TR-AP, EC 3.1.3.2 (Tartrate-resistant acid ATPase, TrATPase) (Type 5 acid phosphatase)",ACP5,Homo sapiens (Human),325.0,MDMWTALLILQALLLPSLADGATPALRFVAVGDWGGVPNAPFHTAREMANAKEIARTVQILGADFILSLGDNFYFTGVQDINDKRFQETFEDVFSDRSLRKVPWYVLAGNHDHLGNVSAQIAYSKISKRWNFPSPFYRLHFKIPQTNVSVAIFMLDTVTLCGNSDDFLSQQPERPRDVKLARTQLSWLKKQLAAAREDYVLVAGHYPVWSIAEHGPTHCLVKQLRPLLATYGVTAYLCGHDHNLQYLQDENGVGYVLSGAGNFMDPSKRHQRKVPNGYLRFHYGTEDSLGGFAYVEISSKEMTVTYIEASGKSLFKTRLPRRARP,PF00149;,1WAR;2BQ8;,109,G,R,True,872
13323,13409,256767,single nucleotide variant,NM_001611.5(ACP5):c.442G>A (p.Val148Met),54,ACP5,HGNC:124,Benign,0,28-Mar-16,2305799,-,RCV000253285,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000019.10,19,11576536,11576536,na,na,19p13.2,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA9215409,UniProtKB:P13686#VAR_020602",2,257478,11576536,C,T,V148M,2,benign,benign,P13686,P13686,reviewed,PPA5_HUMAN,"Tartrate-resistant acid phosphatase type 5, TR-AP, EC 3.1.3.2 (Tartrate-resistant acid ATPase, TrATPase) (Type 5 acid phosphatase)",ACP5,Homo sapiens (Human),325.0,MDMWTALLILQALLLPSLADGATPALRFVAVGDWGGVPNAPFHTAREMANAKEIARTVQILGADFILSLGDNFYFTGVQDINDKRFQETFEDVFSDRSLRKVPWYVLAGNHDHLGNVSAQIAYSKISKRWNFPSPFYRLHFKIPQTNVSVAIFMLDTVTLCGNSDDFLSQQPERPRDVKLARTQLSWLKKQLAAAREDYVLVAGHYPVWSIAEHGPTHCLVKQLRPLLATYGVTAYLCGHDHNLQYLQDENGVGYVLSGAGNFMDPSKRHQRKVPNGYLRFHYGTEDSLGGFAYVEISSKEMTVTYIEASGKSLFKTRLPRRARP,PF00149;,1WAR;2BQ8;,148,V,M,True,872
13324,13408,256766,single nucleotide variant,NM_001611.5(ACP5):c.598G>A (p.Val200Met),54,ACP5,HGNC:124,Benign,0,28-Mar-16,2229531,-,RCV000245115,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000019.10,19,11576380,11576380,na,na,19p13.2,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA9215376,UniProtKB:P13686#VAR_020603",2,257479,11576380,C,T,V200M,2,benign,benign,P13686,P13686,reviewed,PPA5_HUMAN,"Tartrate-resistant acid phosphatase type 5, TR-AP, EC 3.1.3.2 (Tartrate-resistant acid ATPase, TrATPase) (Type 5 acid phosphatase)",ACP5,Homo sapiens (Human),325.0,MDMWTALLILQALLLPSLADGATPALRFVAVGDWGGVPNAPFHTAREMANAKEIARTVQILGADFILSLGDNFYFTGVQDINDKRFQETFEDVFSDRSLRKVPWYVLAGNHDHLGNVSAQIAYSKISKRWNFPSPFYRLHFKIPQTNVSVAIFMLDTVTLCGNSDDFLSQQPERPRDVKLARTQLSWLKKQLAAAREDYVLVAGHYPVWSIAEHGPTHCLVKQLRPLLATYGVTAYLCGHDHNLQYLQDENGVGYVLSGAGNFMDPSKRHQRKVPNGYLRFHYGTEDSLGGFAYVEISSKEMTVTYIEASGKSLFKTRLPRRARP,PF00149;,1WAR;2BQ8;,200,V,M,True,872
13325,5806,38784,single nucleotide variant,NM_001611.5(ACP5):c.266C>T (p.Thr89Ile),54,ACP5,HGNC:124,Pathogenic,1,1-Feb-11,387906668,-,RCV000022705,"MONDO:MONDO:0011939,MedGen:C1842763,OMIM:607944,Orphanet:50816",Spondyloenchondrodysplasia with immune dysregulation,germline,germline,GRCh38,NC_000019.10,19,11576839,11576839,na,na,19p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA128674,UniProtKB:P13686#VAR_065921,OMIM:171640.0001",1,29829,11576839,G,A,T89I,0,pathogenic,uncertain,P13686,P13686,reviewed,PPA5_HUMAN,"Tartrate-resistant acid phosphatase type 5, TR-AP, EC 3.1.3.2 (Tartrate-resistant acid ATPase, TrATPase) (Type 5 acid phosphatase)",ACP5,Homo sapiens (Human),325.0,MDMWTALLILQALLLPSLADGATPALRFVAVGDWGGVPNAPFHTAREMANAKEIARTVQILGADFILSLGDNFYFTGVQDINDKRFQETFEDVFSDRSLRKVPWYVLAGNHDHLGNVSAQIAYSKISKRWNFPSPFYRLHFKIPQTNVSVAIFMLDTVTLCGNSDDFLSQQPERPRDVKLARTQLSWLKKQLAAAREDYVLVAGHYPVWSIAEHGPTHCLVKQLRPLLATYGVTAYLCGHDHNLQYLQDENGVGYVLSGAGNFMDPSKRHQRKVPNGYLRFHYGTEDSLGGFAYVEISSKEMTVTYIEASGKSLFKTRLPRRARP,PF00149;,1WAR;2BQ8;,89,T,I,True,872
13326,5807,38786,single nucleotide variant,NM_001611.5(ACP5):c.791T>A (p.Met264Lys),54,ACP5,HGNC:124,Uncertain significance,1,19-Mar-18,387906670,-,RCV000022707,"MONDO:MONDO:0011939,MedGen:C1842763,OMIM:607944,Orphanet:50816",Spondyloenchondrodysplasia with immune dysregulation,germline,germline,GRCh38,NC_000019.10,19,11575197,11575197,na,na,19p13.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA128678,UniProtKB:P13686#VAR_065927,OMIM:171640.0003",3,29831,11575197,A,T,M264K,1,uncertain,uncertain,P13686,P13686,reviewed,PPA5_HUMAN,"Tartrate-resistant acid phosphatase type 5, TR-AP, EC 3.1.3.2 (Tartrate-resistant acid ATPase, TrATPase) (Type 5 acid phosphatase)",ACP5,Homo sapiens (Human),325.0,MDMWTALLILQALLLPSLADGATPALRFVAVGDWGGVPNAPFHTAREMANAKEIARTVQILGADFILSLGDNFYFTGVQDINDKRFQETFEDVFSDRSLRKVPWYVLAGNHDHLGNVSAQIAYSKISKRWNFPSPFYRLHFKIPQTNVSVAIFMLDTVTLCGNSDDFLSQQPERPRDVKLARTQLSWLKKQLAAAREDYVLVAGHYPVWSIAEHGPTHCLVKQLRPLLATYGVTAYLCGHDHNLQYLQDENGVGYVLSGAGNFMDPSKRHQRKVPNGYLRFHYGTEDSLGGFAYVEISSKEMTVTYIEASGKSLFKTRLPRRARP,PF00149;,1WAR;2BQ8;,264,M,K,True,872
13327,2933,26997,single nucleotide variant,NM_000191.3(HMGCL):c.835G>A (p.Glu279Lys),3155,HMGCL,HGNC:5005,Pathogenic,1,1-Oct-00,121964998,-,RCV000012736,"MONDO:MONDO:0009520,MedGen:C0268601,OMIM:246450,Orphanet:20",Deficiency of hydroxymethylglutaryl-CoA lyase,germline,germline,GRCh38,NC_000001.11,1,23804441,23804441,na,na,1p36.11,no assertion criteria provided,1,-,N,"ClinGen:CA256131,UniProtKB:P35914#VAR_014202,OMIM:613898.0005",1,11958,23804441,C,T,E279K,0,pathogenic,uncertain,P35914,P35914,reviewed,HMGCL_HUMAN,"Hydroxymethylglutaryl-CoA lyase, mitochondrial, HL, HMG-CoA lyase, EC 4.1.3.4 (3-hydroxy-3-methylglutarate-CoA lyase)",HMGCL,Homo sapiens (Human),325.0,MAAMRKALPRRLVGLASLRAVSTSSMGTLPKRVKIVEVGPRDGLQNEKNIVSTPVKIKLIDMLSEAGLSVIETTSFVSPKWVPQMGDHTEVLKGIQKFPGINYPVLTPNLKGFEAAVAAGAKEVVIFGAASELFTKKNINCSIEESFQRFDAILKAAQSANISVRGYVSCALGCPYEGKISPAKVAEVTKKFYSMGCYEISLGDTIGVGTPGIMKDMLSAVMQEVPLAALAVHCHDTYGQALANTLMALQMGVSVVDSSVAGLGGCPYAQGASGNLATEDLVYMLEGLGIHTGVNLQKLLEAGNFICQALNRKTSSKVAQATCKL,PF00682;,2CW6;3MP3;3MP4;3MP5;,279,E,K,True,873
13328,11302,176929,single nucleotide variant,NM_000191.3(HMGCL):c.698A>G (p.His233Arg),3155,HMGCL,HGNC:5005,Pathogenic/Likely pathogenic,1,29-Apr-19,727503963,-,RCV000153365|RCV000665316,"MedGen:CN517202|MONDO:MONDO:0009520,MedGen:C0268601,OMIM:246450,Orphanet:20",not provided|Deficiency of hydroxymethylglutaryl-CoA lyase,germline;unknown,germline,GRCh38,NC_000001.11,1,23808187,23808187,na,na,1p36.11,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA234122,UniProtKB:P35914#VAR_003749",2,167180,23808187,T,C,H233R,2,pathogenic,pathogenic,P35914,P35914,reviewed,HMGCL_HUMAN,"Hydroxymethylglutaryl-CoA lyase, mitochondrial, HL, HMG-CoA lyase, EC 4.1.3.4 (3-hydroxy-3-methylglutarate-CoA lyase)",HMGCL,Homo sapiens (Human),325.0,MAAMRKALPRRLVGLASLRAVSTSSMGTLPKRVKIVEVGPRDGLQNEKNIVSTPVKIKLIDMLSEAGLSVIETTSFVSPKWVPQMGDHTEVLKGIQKFPGINYPVLTPNLKGFEAAVAAGAKEVVIFGAASELFTKKNINCSIEESFQRFDAILKAAQSANISVRGYVSCALGCPYEGKISPAKVAEVTKKFYSMGCYEISLGDTIGVGTPGIMKDMLSAVMQEVPLAALAVHCHDTYGQALANTLMALQMGVSVVDSSVAGLGGCPYAQGASGNLATEDLVYMLEGLGIHTGVNLQKLLEAGNFICQALNRKTSSKVAQATCKL,PF00682;,2CW6;3MP3;3MP4;3MP5;,233,H,R,True,873
13329,2931,26994,single nucleotide variant,NM_000191.3(HMGCL):c.208G>C (p.Val70Leu),3155,HMGCL,HGNC:5005,Uncertain significance,1,23-May-17,121964996,-,RCV000012733,"MONDO:MONDO:0009520,MedGen:C0268601,OMIM:246450,Orphanet:20",Deficiency of hydroxymethylglutaryl-CoA lyase,germline;unknown,germline,GRCh38,NC_000001.11,1,23817520,23817520,na,na,1p36.11,"criteria provided, single submitter",2,-,N,"ClinGen:CA256130,UniProtKB:P35914#VAR_003748,OMIM:613898.0002",3,11955,23817520,C,G,V70L,1,uncertain,uncertain,P35914,P35914,reviewed,HMGCL_HUMAN,"Hydroxymethylglutaryl-CoA lyase, mitochondrial, HL, HMG-CoA lyase, EC 4.1.3.4 (3-hydroxy-3-methylglutarate-CoA lyase)",HMGCL,Homo sapiens (Human),325.0,MAAMRKALPRRLVGLASLRAVSTSSMGTLPKRVKIVEVGPRDGLQNEKNIVSTPVKIKLIDMLSEAGLSVIETTSFVSPKWVPQMGDHTEVLKGIQKFPGINYPVLTPNLKGFEAAVAAGAKEVVIFGAASELFTKKNINCSIEESFQRFDAILKAAQSANISVRGYVSCALGCPYEGKISPAKVAEVTKKFYSMGCYEISLGDTIGVGTPGIMKDMLSAVMQEVPLAALAVHCHDTYGQALANTLMALQMGVSVVDSSVAGLGGCPYAQGASGNLATEDLVYMLEGLGIHTGVNLQKLLEAGNFICQALNRKTSSKVAQATCKL,PF00682;,2CW6;3MP3;3MP4;3MP5;,70,V,L,True,873
13330,2932,26996,single nucleotide variant,NM_000191.3(HMGCL):c.122G>A (p.Arg41Gln),3155,HMGCL,HGNC:5005,Pathogenic,1,8-Jun-20,121964997,-,RCV000012735|RCV000078342,"MONDO:MONDO:0009520,MedGen:C0268601,OMIM:246450,Orphanet:20|MedGen:CN517202",Deficiency of hydroxymethylglutaryl-CoA lyase|not provided,germline;unknown,germline,GRCh38,NC_000001.11,1,23820532,23820532,na,na,1p36.11,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA220476,UniProtKB:P35914#VAR_003744,OMIM:613898.0004",3,11957,23820532,C,T,R41Q,2,pathogenic,pathogenic,P35914,P35914,reviewed,HMGCL_HUMAN,"Hydroxymethylglutaryl-CoA lyase, mitochondrial, HL, HMG-CoA lyase, EC 4.1.3.4 (3-hydroxy-3-methylglutarate-CoA lyase)",HMGCL,Homo sapiens (Human),325.0,MAAMRKALPRRLVGLASLRAVSTSSMGTLPKRVKIVEVGPRDGLQNEKNIVSTPVKIKLIDMLSEAGLSVIETTSFVSPKWVPQMGDHTEVLKGIQKFPGINYPVLTPNLKGFEAAVAAGAKEVVIFGAASELFTKKNINCSIEESFQRFDAILKAAQSANISVRGYVSCALGCPYEGKISPAKVAEVTKKFYSMGCYEISLGDTIGVGTPGIMKDMLSAVMQEVPLAALAVHCHDTYGQALANTLMALQMGVSVVDSSVAGLGGCPYAQGASGNLATEDLVYMLEGLGIHTGVNLQKLLEAGNFICQALNRKTSSKVAQATCKL,PF00682;,2CW6;3MP3;3MP4;3MP5;,41,R,Q,True,873
13331,2098,24047,single nucleotide variant,NM_004387.4(NKX2-5):c.73C>T (p.Arg25Cys),1482,NKX2-5,HGNC:2488,Conflicting interpretations of pathogenicity,1,31-Dec-19,28936670,-,RCV000009572|RCV000009573|RCV000023017|RCV000023018|RCV000023019|RCV000030339|RCV000037968|RCV000619696|RCV000987632,"Human Phenotype Ontology:HP:0001636,MONDO:MONDO:0008542,MedGen:C0039685,OMIM:187500,Orphanet:3303|MONDO:MONDO:0009154,MedGen:C2673630,OMIM:225250,Orphanet:95712|Human Phenotype Ontology:HP:0006680,Human Phenotype Ontology:HP:0011611,MONDO:MONDO:0009010,MedGen:C0152419,Orphanet:2299|Human Phenotype Ontology:HP:0001660,MedGen:C0041206|MONDO:MONDO:0013752,MedGen:C3280795,OMIM:614435,Orphanet:2248|MONDO:MONDO:0005453,MedGen:C0152021|MedGen:CN169374|MedGen:CN230736|MONDO:MONDO:0007173,MedGen:C3276096,OMIM:108900,Orphanet:1479","Tetralogy of Fallot|Hypothyroidism, congenital, nongoitrous, 5|Interrupted aortic arch|Truncus arteriosus|Hypoplastic left heart syndrome 2|Congenital heart disease|not specified|Cardiovascular phenotype|Atrial septal defect 7 with or without atrioventricular conduction defects",germline;unknown,germline,GRCh38,NC_000005.10,5,173235011,173235011,na,na,5q35.1,"criteria provided, conflicting interpretations",9,-,N,"UniProtKB:P52952#VAR_010116,OMIM:600584.0004,ClinGen:CA120055",3,9008,173235011,G,A,R25C,1,uncertain,uncertain,P52952,P52952,reviewed,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),NKX2-5 CSX NKX2.5 NKX2E,Homo sapiens (Human),324.0,MFPSPALTPTPFSVKDILNLEQQQRSLAAAGELSARLEATLAPSSCMLAAFKPEAYAGPEAAAPGLPELRAELGRAPSPAKCASAFPAAPAFYPRAYSDPDPAKDPRAEKKELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELVGLPPPPPPPARRIAVPVLVRDGKPCLGDSAPYAPAYGVGLNPYGYNAYPAYPGYGGAACSPGYSCTAAYPAGPSPAQPATAAANNNFVNFGVGDLNAVQSPGIPQSNSGVSTLHGIRAW,PF00046;,3RKQ;4S0H;6WC2;6WC5;,25,R,C,True,874
13332,5900,39067,single nucleotide variant,NM_004387.4(NKX2-5):c.44A>T (p.Lys15Ile),1482,NKX2-5,HGNC:2488,Pathogenic,1,5-Nov-03,387906773,-,RCV000023020,"MONDO:MONDO:0007173,MedGen:C3276096,OMIM:108900,Orphanet:1479",Atrial septal defect 7 with or without atrioventricular conduction defects,germline,germline,GRCh38,NC_000005.10,5,173235040,173235040,na,na,5q35.1,no assertion criteria provided,1,-,N,"ClinGen:CA212677,UniProtKB:P52952#VAR_038213,OMIM:600584.0018",1,30112,173235040,T,A,K15I,0,pathogenic,uncertain,P52952,P52952,reviewed,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),NKX2-5 CSX NKX2.5 NKX2E,Homo sapiens (Human),324.0,MFPSPALTPTPFSVKDILNLEQQQRSLAAAGELSARLEATLAPSSCMLAAFKPEAYAGPEAAAPGLPELRAELGRAPSPAKCASAFPAAPAFYPRAYSDPDPAKDPRAEKKELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELVGLPPPPPPPARRIAVPVLVRDGKPCLGDSAPYAPAYGVGLNPYGYNAYPAYPGYGGAACSPGYSCTAAYPAGPSPAQPATAAANNNFVNFGVGDLNAVQSPGIPQSNSGVSTLHGIRAW,PF00046;,3RKQ;4S0H;6WC2;6WC5;,15,K,I,True,874
13333,5901,39068,single nucleotide variant,NM_004387.4(NKX2-5):c.380C>A (p.Ala127Glu),1482,NKX2-5,HGNC:2488,Pathogenic,1,5-Nov-03,387906774,-,RCV000023021,"MONDO:MONDO:0007173,MedGen:C3276096,OMIM:108900,Orphanet:1479",Atrial septal defect 7 with or without atrioventricular conduction defects,germline,germline,GRCh38,NC_000005.10,5,173233164,173233164,na,na,5q35.1,no assertion criteria provided,1,-,N,"OMIM:600584.0019,ClinGen:CA212678,UniProtKB:P52952#VAR_038227",1,30113,173233164,G,T,A127E,0,pathogenic,uncertain,P52952,P52952,reviewed,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),NKX2-5 CSX NKX2.5 NKX2E,Homo sapiens (Human),324.0,MFPSPALTPTPFSVKDILNLEQQQRSLAAAGELSARLEATLAPSSCMLAAFKPEAYAGPEAAAPGLPELRAELGRAPSPAKCASAFPAAPAFYPRAYSDPDPAKDPRAEKKELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELVGLPPPPPPPARRIAVPVLVRDGKPCLGDSAPYAPAYGVGLNPYGYNAYPAYPGYGGAACSPGYSCTAAYPAGPSPAQPATAAANNNFVNFGVGDLNAVQSPGIPQSNSGVSTLHGIRAW,PF00046;,3RKQ;4S0H;6WC2;6WC5;,127,A,E,True,874
13334,2105,24058,single nucleotide variant,NM_004387.4(NKX2-5):c.482G>C (p.Arg161Pro),1482,NKX2-5,HGNC:2488,Pathogenic,1,1-Apr-06,137852685,-,RCV000009585,"MONDO:MONDO:0009154,MedGen:C2673630,OMIM:225250,Orphanet:95712","Hypothyroidism, congenital, nongoitrous, 5",germline,germline,GRCh38,NC_000005.10,5,173233062,173233062,na,na,5q35.1,no assertion criteria provided,1,-,N,"ClinGen:CA120059,UniProtKB:P52952#VAR_047870,OMIM:600584.0016",1,9019,173233062,C,G,R161P,0,pathogenic,uncertain,P52952,P52952,reviewed,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),NKX2-5 CSX NKX2.5 NKX2E,Homo sapiens (Human),324.0,MFPSPALTPTPFSVKDILNLEQQQRSLAAAGELSARLEATLAPSSCMLAAFKPEAYAGPEAAAPGLPELRAELGRAPSPAKCASAFPAAPAFYPRAYSDPDPAKDPRAEKKELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELVGLPPPPPPPARRIAVPVLVRDGKPCLGDSAPYAPAYGVGLNPYGYNAYPAYPGYGGAACSPGYSCTAAYPAGPSPAQPATAAANNNFVNFGVGDLNAVQSPGIPQSNSGVSTLHGIRAW,PF00046;,3RKQ;4S0H;6WC2;6WC5;,161,R,P,True,874
13335,5903,39071,single nucleotide variant,NM_004387.4(NKX2-5):c.175C>G (p.Pro59Ala),1482,NKX2-5,HGNC:2488,Pathogenic,1,1-Mar-11,387906775,-,RCV000023024,"MONDO:MONDO:0013749,MedGen:C3280785,OMIM:614432",Ventricular septal defect 3,germline,germline,GRCh38,NC_000005.10,5,173234909,173234909,na,na,5q35.1,no assertion criteria provided,1,-,N,"ClinGen:CA212680,UniProtKB:P52952#VAR_067586,OMIM:600584.0022",1,30116,173234909,G,C,P59A,0,pathogenic,uncertain,P52952,P52952,reviewed,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),NKX2-5 CSX NKX2.5 NKX2E,Homo sapiens (Human),324.0,MFPSPALTPTPFSVKDILNLEQQQRSLAAAGELSARLEATLAPSSCMLAAFKPEAYAGPEAAAPGLPELRAELGRAPSPAKCASAFPAAPAFYPRAYSDPDPAKDPRAEKKELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELVGLPPPPPPPARRIAVPVLVRDGKPCLGDSAPYAPAYGVGLNPYGYNAYPAYPGYGGAACSPGYSCTAAYPAGPSPAQPATAAANNNFVNFGVGDLNAVQSPGIPQSNSGVSTLHGIRAW,PF00046;,3RKQ;4S0H;6WC2;6WC5;,59,P,A,True,874
13336,2099,24048,single nucleotide variant,NM_004387.4(NKX2-5):c.61G>C (p.Glu21Gln),1482,NKX2-5,HGNC:2488,Conflicting interpretations of pathogenicity,0,31-Dec-19,104893904,-,RCV000009574|RCV000030618|RCV000171013|RCV000514277|RCV000618034|RCV000987633,"Human Phenotype Ontology:HP:0001636,MONDO:MONDO:0008542,MedGen:C0039685,OMIM:187500,Orphanet:3303|MONDO:MONDO:0005453,MedGen:C0152021|MedGen:CN169374|MedGen:CN517202|MedGen:CN230736|MONDO:MONDO:0007173,MedGen:C3276096,OMIM:108900,Orphanet:1479",Tetralogy of Fallot|Congenital heart disease|not specified|not provided|Cardiovascular phenotype|Atrial septal defect 7 with or without atrioventricular conduction defects,germline;unknown,germline,GRCh38,NC_000005.10,5,173235023,173235023,na,na,5q35.1,"criteria provided, conflicting interpretations",8,-,N,"ClinGen:CA214394,UniProtKB:P52952#VAR_038215,OMIM:600584.0006",3,9009,173235023,C,G,E21Q,1,uncertain,uncertain,P52952,P52952,reviewed,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),NKX2-5 CSX NKX2.5 NKX2E,Homo sapiens (Human),324.0,MFPSPALTPTPFSVKDILNLEQQQRSLAAAGELSARLEATLAPSSCMLAAFKPEAYAGPEAAAPGLPELRAELGRAPSPAKCASAFPAAPAFYPRAYSDPDPAKDPRAEKKELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELVGLPPPPPPPARRIAVPVLVRDGKPCLGDSAPYAPAYGVGLNPYGYNAYPAYPGYGGAACSPGYSCTAAYPAGPSPAQPATAAANNNFVNFGVGDLNAVQSPGIPQSNSGVSTLHGIRAW,PF00046;,3RKQ;4S0H;6WC2;6WC5;,21,E,Q,True,874
13337,2100,24049,single nucleotide variant,NM_004387.4(NKX2-5):c.646C>T (p.Arg216Cys),1482,NKX2-5,HGNC:2488,Pathogenic,1,20-Nov-01,104893905,-,RCV000009575,"Human Phenotype Ontology:HP:0001636,MONDO:MONDO:0008542,MedGen:C0039685,OMIM:187500,Orphanet:3303",Tetralogy of Fallot,germline,germline,GRCh38,NC_000005.10,5,173232898,173232898,na,na,5q35.1,no assertion criteria provided,1,-,N,"ClinGen:CA248606,UniProtKB:P52952#VAR_038239,OMIM:600584.0007",1,9010,173232898,G,A,R216C,0,pathogenic,uncertain,P52952,P52952,reviewed,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),NKX2-5 CSX NKX2.5 NKX2E,Homo sapiens (Human),324.0,MFPSPALTPTPFSVKDILNLEQQQRSLAAAGELSARLEATLAPSSCMLAAFKPEAYAGPEAAAPGLPELRAELGRAPSPAKCASAFPAAPAFYPRAYSDPDPAKDPRAEKKELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELVGLPPPPPPPARRIAVPVLVRDGKPCLGDSAPYAPAYGVGLNPYGYNAYPAYPGYGGAACSPGYSCTAAYPAGPSPAQPATAAANNNFVNFGVGDLNAVQSPGIPQSNSGVSTLHGIRAW,PF00046;,3RKQ;4S0H;6WC2;6WC5;,216,R,C,True,874
13338,5902,39070,single nucleotide variant,NM_004387.4(NKX2-5):c.848C>A (p.Pro283Gln),1482,NKX2-5,HGNC:2488,Uncertain significance,1,4-Nov-19,375086983,-,RCV000023023|RCV000421219|RCV000539285,"MONDO:MONDO:0013749,MedGen:C3280785,OMIM:614432|MedGen:CN517202|MONDO:MONDO:0007173,MedGen:C3276096,OMIM:108900,Orphanet:1479",Ventricular septal defect 3|not provided|Atrial septal defect 7 with or without atrioventricular conduction defects,germline,germline,GRCh38,NC_000005.10,5,173232696,173232696,na,na,5q35.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA212679,UniProtKB:P52952#VAR_067587,OMIM:600584.0021",3,30115,173232696,G,T,P283Q,2,uncertain,uncertain,P52952,P52952,reviewed,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),NKX2-5 CSX NKX2.5 NKX2E,Homo sapiens (Human),324.0,MFPSPALTPTPFSVKDILNLEQQQRSLAAAGELSARLEATLAPSSCMLAAFKPEAYAGPEAAAPGLPELRAELGRAPSPAKCASAFPAAPAFYPRAYSDPDPAKDPRAEKKELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELVGLPPPPPPPARRIAVPVLVRDGKPCLGDSAPYAPAYGVGLNPYGYNAYPAYPGYGGAACSPGYSCTAAYPAGPSPAQPATAAANNNFVNFGVGDLNAVQSPGIPQSNSGVSTLHGIRAW,PF00046;,3RKQ;4S0H;6WC2;6WC5;,283,P,Q,True,874
13339,2097,24043,single nucleotide variant,NM_004387.4(NKX2-5):c.533C>T (p.Thr178Met),1482,NKX2-5,HGNC:2488,Pathogenic,1,18-Nov-19,104893900,-,RCV000009568,"MONDO:MONDO:0007173,MedGen:C3276096,OMIM:108900,Orphanet:1479",Atrial septal defect 7 with or without atrioventricular conduction defects,germline,germline,GRCh38,NC_000005.10,5,173233011,173233011,na,na,5q35.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA212653,UniProtKB:P52952#VAR_003752,OMIM:600584.0001",3,9004,173233011,G,A,T178M,1,pathogenic,pathogenic,P52952,P52952,reviewed,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),NKX2-5 CSX NKX2.5 NKX2E,Homo sapiens (Human),324.0,MFPSPALTPTPFSVKDILNLEQQQRSLAAAGELSARLEATLAPSSCMLAAFKPEAYAGPEAAAPGLPELRAELGRAPSPAKCASAFPAAPAFYPRAYSDPDPAKDPRAEKKELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELVGLPPPPPPPARRIAVPVLVRDGKPCLGDSAPYAPAYGVGLNPYGYNAYPAYPGYGGAACSPGYSCTAAYPAGPSPAQPATAAANNNFVNFGVGDLNAVQSPGIPQSNSGVSTLHGIRAW,PF00046;,3RKQ;4S0H;6WC2;6WC5;,178,T,M,True,874
13340,2106,24059,single nucleotide variant,NM_004387.4(NKX2-5):c.547A>G (p.Lys183Glu),1482,NKX2-5,HGNC:2488,Pathogenic,1,15-Jul-05,137852686,-,RCV000009586,MedGen:C1833590,"Atrioventricular septal defect, somatic",somatic,somatic,GRCh38,NC_000005.10,5,173232997,173232997,na,na,5q35.1,no assertion criteria provided,1,-,N,"ClinGen:CA120060,UniProtKB:P52952#VAR_038232,OMIM:600584.0017",1,9020,173232997,T,C,K183E,0,pathogenic,uncertain,P52952,P52952,reviewed,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),NKX2-5 CSX NKX2.5 NKX2E,Homo sapiens (Human),324.0,MFPSPALTPTPFSVKDILNLEQQQRSLAAAGELSARLEATLAPSSCMLAAFKPEAYAGPEAAAPGLPELRAELGRAPSPAKCASAFPAAPAFYPRAYSDPDPAKDPRAEKKELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELVGLPPPPPPPARRIAVPVLVRDGKPCLGDSAPYAPAYGVGLNPYGYNAYPAYPGYGGAACSPGYSCTAAYPAGPSPAQPATAAANNNFVNFGVGDLNAVQSPGIPQSNSGVSTLHGIRAW,PF00046;,3RKQ;4S0H;6WC2;6WC5;,183,K,E,True,874
13341,2102,24053,single nucleotide variant,NM_004387.4(NKX2-5):c.896A>G (p.Asp299Gly),1482,NKX2-5,HGNC:2488,Pathogenic,1,1-Sep-04,137852683,-,RCV000009579|RCV000009580,"MONDO:MONDO:0007173,MedGen:C3276096,OMIM:108900,Orphanet:1479|MedGen:C1833590","Atrial septal defect 7 with or without atrioventricular conduction defects|Atrioventricular septal defect, somatic",somatic,somatic,GRCh38,NC_000005.10,5,173232648,173232648,na,na,5q35.1,no assertion criteria provided,1,-,N,"ClinGen:CA120057,UniProtKB:P52952#VAR_038249,OMIM:600584.0011",1,9014,173232648,T,C,D299G,0,pathogenic,uncertain,P52952,P52952,reviewed,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),NKX2-5 CSX NKX2.5 NKX2E,Homo sapiens (Human),324.0,MFPSPALTPTPFSVKDILNLEQQQRSLAAAGELSARLEATLAPSSCMLAAFKPEAYAGPEAAAPGLPELRAELGRAPSPAKCASAFPAAPAFYPRAYSDPDPAKDPRAEKKELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELVGLPPPPPPPARRIAVPVLVRDGKPCLGDSAPYAPAYGVGLNPYGYNAYPAYPGYGGAACSPGYSCTAAYPAGPSPAQPATAAANNNFVNFGVGDLNAVQSPGIPQSNSGVSTLHGIRAW,PF00046;,3RKQ;4S0H;6WC2;6WC5;,299,D,G,True,874
13342,2103,24055,single nucleotide variant,NM_004387.4(NKX2-5):c.568C>T (p.Arg190Cys),1482,NKX2-5,HGNC:2488,Pathogenic,1,15-May-05,104893906,-,RCV000009582,"MONDO:MONDO:0007173,MedGen:C3276096,OMIM:108900,Orphanet:1479",Atrial septal defect 7 with or without atrioventricular conduction defects,germline,germline,GRCh38,NC_000005.10,5,173232976,173232976,na,na,5q35.1,no assertion criteria provided,1,-,N,"ClinGen:CA212658,UniProtKB:P52952#VAR_038234,OMIM:600584.0013",1,9016,173232976,G,A,R190C,0,pathogenic,uncertain,P52952,P52952,reviewed,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),NKX2-5 CSX NKX2.5 NKX2E,Homo sapiens (Human),324.0,MFPSPALTPTPFSVKDILNLEQQQRSLAAAGELSARLEATLAPSSCMLAAFKPEAYAGPEAAAPGLPELRAELGRAPSPAKCASAFPAAPAFYPRAYSDPDPAKDPRAEKKELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELVGLPPPPPPPARRIAVPVLVRDGKPCLGDSAPYAPAYGVGLNPYGYNAYPAYPGYGGAACSPGYSCTAAYPAGPSPAQPATAAANNNFVNFGVGDLNAVQSPGIPQSNSGVSTLHGIRAW,PF00046;,3RKQ;4S0H;6WC2;6WC5;,190,R,C,True,874
13343,2104,24057,single nucleotide variant,NM_004387.4(NKX2-5):c.355G>T (p.Ala119Ser),1482,NKX2-5,HGNC:2488,Benign/Likely benign,1,31-Dec-19,137852684,-,RCV000009584|RCV000171007|RCV000230156|RCV000620259,"MONDO:MONDO:0009154,MedGen:C2673630,OMIM:225250,Orphanet:95712|MedGen:CN169374|MONDO:MONDO:0007173,MedGen:C3276096,OMIM:108900,Orphanet:1479|MedGen:CN230736","Hypothyroidism, congenital, nongoitrous, 5|not specified|Atrial septal defect 7 with or without atrioventricular conduction defects|Cardiovascular phenotype",germline,germline,GRCh38,NC_000005.10,5,173233189,173233189,na,na,5q35.1,"criteria provided, multiple submitters, no conflicts",5,-,N,"UniProtKB:P52952#VAR_047869,OMIM:600584.0015,ClinGen:CA120058",3,9018,173233189,C,A,A119S,2,benign,benign,P52952,P52952,reviewed,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),NKX2-5 CSX NKX2.5 NKX2E,Homo sapiens (Human),324.0,MFPSPALTPTPFSVKDILNLEQQQRSLAAAGELSARLEATLAPSSCMLAAFKPEAYAGPEAAAPGLPELRAELGRAPSPAKCASAFPAAPAFYPRAYSDPDPAKDPRAEKKELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELVGLPPPPPPPARRIAVPVLVRDGKPCLGDSAPYAPAYGVGLNPYGYNAYPAYPGYGGAACSPGYSCTAAYPAGPSPAQPATAAANNNFVNFGVGDLNAVQSPGIPQSNSGVSTLHGIRAW,PF00046;,3RKQ;4S0H;6WC2;6WC5;,119,A,S,True,874
13344,2101,24050,single nucleotide variant,NM_004387.4(NKX2-5):c.656C>T (p.Ala219Val),1482,NKX2-5,HGNC:2488,Uncertain significance,1,31-May-17,104893902,-,RCV000009576|RCV000525369,"Human Phenotype Ontology:HP:0001636,MONDO:MONDO:0008542,MedGen:C0039685,OMIM:187500,Orphanet:3303|MONDO:MONDO:0007173,MedGen:C3276096,OMIM:108900,Orphanet:1479",Tetralogy of Fallot|Atrial septal defect 7 with or without atrioventricular conduction defects,germline;unknown,germline,GRCh38,NC_000005.10,5,173232888,173232888,na,na,5q35.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA248607,UniProtKB:P52952#VAR_038240,OMIM:600584.0008",3,9011,173232888,G,A,A219V,1,uncertain,uncertain,P52952,P52952,reviewed,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),NKX2-5 CSX NKX2.5 NKX2E,Homo sapiens (Human),324.0,MFPSPALTPTPFSVKDILNLEQQQRSLAAAGELSARLEATLAPSSCMLAAFKPEAYAGPEAAAPGLPELRAELGRAPSPAKCASAFPAAPAFYPRAYSDPDPAKDPRAEKKELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELVGLPPPPPPPARRIAVPVLVRDGKPCLGDSAPYAPAYGVGLNPYGYNAYPAYPGYGGAACSPGYSCTAAYPAGPSPAQPATAAANNNFVNFGVGDLNAVQSPGIPQSNSGVSTLHGIRAW,PF00046;,3RKQ;4S0H;6WC2;6WC5;,219,A,V,True,874
13345,6434,48032,single nucleotide variant,NM_004387.4(NKX2-5):c.707C>A (p.Pro236His),1482,NKX2-5,HGNC:2488,Uncertain significance,0,24-May-13,397515399,-,RCV000032628,"MONDO:MONDO:0010066,MedGen:C0685889,OMIM:271400,Orphanet:101351","Asplenia, isolated congenital",germline,germline,GRCh38,NC_000005.10,5,173232837,173232837,na,na,5q35.1,no assertion criteria provided,1,-,N,"ClinGen:CA130288,UniProtKB:P52952#VAR_069590,OMIM:600584.0024",1,39433,173232837,G,T,P236H,0,uncertain,uncertain,P52952,P52952,reviewed,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),NKX2-5 CSX NKX2.5 NKX2E,Homo sapiens (Human),324.0,MFPSPALTPTPFSVKDILNLEQQQRSLAAAGELSARLEATLAPSSCMLAAFKPEAYAGPEAAAPGLPELRAELGRAPSPAKCASAFPAAPAFYPRAYSDPDPAKDPRAEKKELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELVGLPPPPPPPARRIAVPVLVRDGKPCLGDSAPYAPAYGVGLNPYGYNAYPAYPGYGGAACSPGYSCTAAYPAGPSPAQPATAAANNNFVNFGVGDLNAVQSPGIPQSNSGVSTLHGIRAW,PF00046;,3RKQ;4S0H;6WC2;6WC5;,236,P,H,True,874
13346,12148,205512,single nucleotide variant,NM_016024.4(RBMX2):c.860G>A (p.Arg287His),51634,RBMX2,HGNC:24282,Benign,0,31-Oct-14,5977266,-,RCV000201403,"Human Phenotype Ontology:HP:0002269,Human Phenotype Ontology:HP:0007317,MedGen:C1837249",Abnormality of neuronal migration,unknown,unknown,GRCh38,NC_000023.11,X,130412739,130412739,na,na,Xq26.1,no assertion criteria provided,1,-,N,"ClinGen:CA210210,UniProtKB:Q9Y388#VAR_033724",2,208897,130412739,G,A,R287H,0,benign,uncertain,Q9Y388,Q9Y388,reviewed,RBMX2_HUMAN,"RNA-binding motif protein, X-linked 2",RBMX2 CGI-79,Homo sapiens (Human),322.0,MNPLTKVKLINELNEREVQLGVADKVSWHSEYKDSAWIFLGGLPYELTEGDIICVFSQYGEIVNINLVRDKKTGKSKGFCFLCYEDQRSTILAVDNFNGIKIKGRTIRVDHVSNYRAPKDSEEIDDVTRQLQEKGCGARTPSPSLSESSEDEKPTKKHKKDKKEKKKKKKEKEKADREVQAEQPSSSSPRRKTVKEKDDTGPKKHSSKNSERAQKSEPREGQKLPKSRTAYSGGAEDLERELKKEKPKHEHKSSSRREAREEKTRIRDRGRSSDAHSSWYNGRSEGRSYRSRSRSRDKSHRHKRARRSRERESSNPSDRWRH,PF00076;,5Z56;5Z57;5Z58;6FF4;6FF7;7ABH;7ABI;7DVQ;,287,R,H,True,875
13347,613,17428,single nucleotide variant,NM_000045.4(ARG1):c.869C>G (p.Thr290Ser),383,ARG1,HGNC:663,Pathogenic,1,1-Jun-92,104893942,-,RCV000002490,"MONDO:MONDO:0008814,MedGen:C0268548,OMIM:207800,Orphanet:90",Arginase deficiency,germline,germline,GRCh38,NC_000006.12,6,131583808,131583808,na,na,6q23.2,no assertion criteria provided,1,-,N,"ClinGen:CA339970,UniProtKB:P05089#VAR_000675,OMIM:608313.0004",1,2389,131583808,C,G,T290S,0,pathogenic,uncertain,P05089,P05089,reviewed,ARGI1_HUMAN,"Arginase-1, EC 3.5.3.1 (Liver-type arginase) (Type I arginase)",ARG1,Homo sapiens (Human),322.0,MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK,PF00491;,1WVA;1WVB;2AEB;2PHA;2PHO;2PLL;2ZAV;3DJ8;3E6K;3E6V;3F80;3GMZ;3GN0;3KV2;3LP4;3LP7;3MFV;3MFW;3MJL;3SJT;3SKK;3TF3;3TH7;3THE;3THH;3THJ;4FCI;4FCK;4GSM;4GSV;4GSZ;4GWC;4GWD;4HWW;4HXQ;4IE1;6Q92;6Q9P;6QAF;6V7C;6V7D;6V7E;6V7F;7K4G;7K4H;7K4I;7K4J;7K4K;7KLK;7KLL;7KLM;7LEX;7LEY;7LEZ;7LF0;7LF1;7LF2;,290,T,S,True,876
13348,614,17430,single nucleotide variant,NM_000045.4(ARG1):c.703G>C (p.Gly235Arg),383,ARG1,HGNC:663,Pathogenic,1,1-Dec-92,104893948,-,RCV000002492,"MONDO:MONDO:0008814,MedGen:C0268548,OMIM:207800,Orphanet:90",Arginase deficiency,germline,germline,GRCh38,NC_000006.12,6,131583392,131583392,na,na,6q23.2,no assertion criteria provided,1,-,N,"ClinGen:CA339974,UniProtKB:P05089#VAR_000674,OMIM:608313.0006",1,2391,131583392,G,C,G235R,0,pathogenic,uncertain,P05089,P05089,reviewed,ARGI1_HUMAN,"Arginase-1, EC 3.5.3.1 (Liver-type arginase) (Type I arginase)",ARG1,Homo sapiens (Human),322.0,MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK,PF00491;,1WVA;1WVB;2AEB;2PHA;2PHO;2PLL;2ZAV;3DJ8;3E6K;3E6V;3F80;3GMZ;3GN0;3KV2;3LP4;3LP7;3MFV;3MFW;3MJL;3SJT;3SKK;3TF3;3TH7;3THE;3THH;3THJ;4FCI;4FCK;4GSM;4GSV;4GSZ;4GWC;4GWD;4HWW;4HXQ;4IE1;6Q92;6Q9P;6QAF;6V7C;6V7D;6V7E;6V7F;7K4G;7K4H;7K4I;7K4J;7K4K;7KLK;7KLL;7KLM;7LEX;7LEY;7LEZ;7LF0;7LF1;7LF2;,235,G,R,True,876
13349,615,17432,single nucleotide variant,NM_000045.4(ARG1):c.32T>C (p.Ile11Thr),383,ARG1,HGNC:663,Pathogenic,1,20-Jan-17,28941474,-,RCV000002494,"MONDO:MONDO:0008814,MedGen:C0268548,OMIM:207800,Orphanet:90",Arginase deficiency,germline,germline,GRCh38,NC_000006.12,6,131573314,131573314,na,na,6q23.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA339975,UniProtKB:P05089#VAR_015594,OMIM:608313.0008",3,2393,131573314,T,C,I11T,1,pathogenic,pathogenic,P05089,P05089,reviewed,ARGI1_HUMAN,"Arginase-1, EC 3.5.3.1 (Liver-type arginase) (Type I arginase)",ARG1,Homo sapiens (Human),322.0,MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK,PF00491;,1WVA;1WVB;2AEB;2PHA;2PHO;2PLL;2ZAV;3DJ8;3E6K;3E6V;3F80;3GMZ;3GN0;3KV2;3LP4;3LP7;3MFV;3MFW;3MJL;3SJT;3SKK;3TF3;3TH7;3THE;3THH;3THJ;4FCI;4FCK;4GSM;4GSV;4GSZ;4GWC;4GWD;4HWW;4HXQ;4IE1;6Q92;6Q9P;6QAF;6V7C;6V7D;6V7E;6V7F;7K4G;7K4H;7K4I;7K4J;7K4K;7KLK;7KLL;7KLM;7LEX;7LEY;7LEZ;7LF0;7LF1;7LF2;,11,I,T,True,876
13350,616,17433,single nucleotide variant,NM_000045.4(ARG1):c.413G>T (p.Gly138Val),383,ARG1,HGNC:663,Pathogenic,1,1-Sep-95,104893943,-,RCV000002495,"MONDO:MONDO:0008814,MedGen:C0268548,OMIM:207800,Orphanet:90",Arginase deficiency,germline,germline,GRCh38,NC_000006.12,6,131581326,131581326,na,na,6q23.2,no assertion criteria provided,1,-,N,"ClinGen:CA339976,UniProtKB:P05089#VAR_015595,OMIM:608313.0009",1,2394,131581326,G,T,G138V,0,pathogenic,uncertain,P05089,P05089,reviewed,ARGI1_HUMAN,"Arginase-1, EC 3.5.3.1 (Liver-type arginase) (Type I arginase)",ARG1,Homo sapiens (Human),322.0,MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK,PF00491;,1WVA;1WVB;2AEB;2PHA;2PHO;2PLL;2ZAV;3DJ8;3E6K;3E6V;3F80;3GMZ;3GN0;3KV2;3LP4;3LP7;3MFV;3MFW;3MJL;3SJT;3SKK;3TF3;3TH7;3THE;3THH;3THJ;4FCI;4FCK;4GSM;4GSV;4GSZ;4GWC;4GWD;4HWW;4HXQ;4IE1;6Q92;6Q9P;6QAF;6V7C;6V7D;6V7E;6V7F;7K4G;7K4H;7K4I;7K4J;7K4K;7KLK;7KLL;7KLM;7LEX;7LEY;7LEZ;7LF0;7LF1;7LF2;,138,G,V,True,876
13351,11725,189177,single nucleotide variant,NM_001282684.1(KCTD17):c.434G>A (p.Arg145His),79734,KCTD17,HGNC:25705,Pathogenic,1,1-Jul-19,786205860,-,RCV000171554|RCV001092006,"MONDO:MONDO:0014620,MedGen:C4225341,OMIM:616398|MedGen:CN517202","Dystonia 26, myoclonic|not provided",germline,germline,GRCh38,NC_000022.11,22,37057420,37057420,na,na,22q12.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA199778,UniProtKB:Q8N5Z5#VAR_073806,OMIM:616386.0001",3,191372,37057420,G,A,R145H,1,pathogenic,pathogenic,Q8N5Z5,Q8N5Z5,reviewed,KCD17_HUMAN,BTB/POZ domain-containing protein KCTD17,KCTD17,Homo sapiens (Human),321.0,MQTPRPAMRMEAGEAAPPAGAGGRAAGGWGKWVRLNVGGTVFLTTRQTLCREQKSFLSRLCQGEELQSDRDETGAYLIDRDPTYFGPILNFLRHGKLVLDKDMAEEGVLEEAEFYNIGPLIRIIKDRMEEKDYTVTQVPPKHVYRVLQCQEEELTQMVSTMSDGWRFEQLVNIGSSYNYGSEDQAEFLCVVSKELHSTPNGLSSESSRKTKSTEEQLEEQQQQEEEVEEVEVEQVQVEADAQEKAQSSQDPANLFSLPPLPPPPLPAGGSRPHPLRPEAELAVRASPRPLARPQSCHPCCYKPEAPGCEAPDHLQGLGVPI,PF02214;,5A6R;,145,R,H,True,877
13352,2346,24976,single nucleotide variant,NM_002764.3(PRPS1):c.398A>C (p.Gln133Pro),5631,PRPS1,HGNC:9462,Pathogenic,1,18-Nov-10,80338675,-,RCV000010615,"MONDO:MONDO:0010533,MedGen:C0796028,OMIM:301835,Orphanet:1187",Arts syndrome,germline,germline,GRCh38,NC_000023.11,X,107640993,107640993,na,na,Xq22.3,no assertion criteria provided,2,-,N,"ClinGen:CA340962,UniProtKB:P60891#VAR_036943,OMIM:311850.0012",1,9937,107640993,A,C,Q133P,0,pathogenic,uncertain,P60891,P60891,reviewed,PRPS1_HUMAN,"Ribose-phosphate pyrophosphokinase 1, EC 2.7.6.1 (PPRibP) (Phosphoribosyl pyrophosphate synthase I, PRS-I)",PRPS1,Homo sapiens (Human),318.0,MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVEIGESVRGEDVYIVQSGCGEINDNLMELLIMINACKIASASRVTAVIPCFPYARQDKKDKSRAPISAKLVANMLSVAGADHIITMDLHASQIQGFFDIPVDNLYAEPAVLKWIRENISEWRNCTIVSPDAGGAKRVTSIADRLNVDFALIHKERKKANEVDRMVLVGDVKDRVAILVDDMADTCGTICHAADKLLSAGATRVYAILTHGIFSGPAISRINNACFEAVVVTNTIPQEDKMKHCSKIQVIDISMILAEAIRRTHNGESVSYLFSHVPL,PF14572;PF13793;,2H06;2H07;2H08;2HCR;3EFH;3S5J;4F8E;4LYG;4LZN;4LZO;4M0P;4M0U;,133,Q,P,True,878
13353,2347,24979,single nucleotide variant,NM_002764.3(PRPS1):c.916G>A (p.Gly306Arg),5631,PRPS1,HGNC:9462,Pathogenic,1,1-Jan-10,180177154,-,RCV000010618,"MONDO:MONDO:0010577,MedGen:C1844677,OMIM:304500,Orphanet:90625","Deafness, X-linked 1",germline,germline,GRCh38,NC_000023.11,X,107649991,107649991,na,na,Xq22.3,no assertion criteria provided,1,-,N,"UniProtKB:P60891#VAR_063525,OMIM:311850.0015,ClinGen:CA254949",1,9940,107649991,G,A,G306R,0,pathogenic,uncertain,P60891,P60891,reviewed,PRPS1_HUMAN,"Ribose-phosphate pyrophosphokinase 1, EC 2.7.6.1 (PPRibP) (Phosphoribosyl pyrophosphate synthase I, PRS-I)",PRPS1,Homo sapiens (Human),318.0,MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVEIGESVRGEDVYIVQSGCGEINDNLMELLIMINACKIASASRVTAVIPCFPYARQDKKDKSRAPISAKLVANMLSVAGADHIITMDLHASQIQGFFDIPVDNLYAEPAVLKWIRENISEWRNCTIVSPDAGGAKRVTSIADRLNVDFALIHKERKKANEVDRMVLVGDVKDRVAILVDDMADTCGTICHAADKLLSAGATRVYAILTHGIFSGPAISRINNACFEAVVVTNTIPQEDKMKHCSKIQVIDISMILAEAIRRTHNGESVSYLFSHVPL,PF14572;PF13793;,2H06;2H07;2H08;2HCR;3EFH;3S5J;4F8E;4LYG;4LZN;4LZO;4M0P;4M0U;,306,G,R,True,878
13354,2345,24975,single nucleotide variant,NM_002764.3(PRPS1):c.455T>C (p.Leu152Pro),5631,PRPS1,HGNC:9462,Uncertain significance,1,7-Jul-14,80338676,-,RCV000010614|RCV000178182,"MONDO:MONDO:0010533,MedGen:C0796028,OMIM:301835,Orphanet:1187|MedGen:CN517202",Arts syndrome|not provided,germline,germline,GRCh38,NC_000023.11,X,107642415,107642415,na,na,Xq22.3,"criteria provided, single submitter",3,-,N,"OMIM:311850.0011,ClinGen:CA245212,UniProtKB:P60891#VAR_036944",3,9936,107642415,T,C,L152P,1,uncertain,uncertain,P60891,P60891,reviewed,PRPS1_HUMAN,"Ribose-phosphate pyrophosphokinase 1, EC 2.7.6.1 (PPRibP) (Phosphoribosyl pyrophosphate synthase I, PRS-I)",PRPS1,Homo sapiens (Human),318.0,MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVEIGESVRGEDVYIVQSGCGEINDNLMELLIMINACKIASASRVTAVIPCFPYARQDKKDKSRAPISAKLVANMLSVAGADHIITMDLHASQIQGFFDIPVDNLYAEPAVLKWIRENISEWRNCTIVSPDAGGAKRVTSIADRLNVDFALIHKERKKANEVDRMVLVGDVKDRVAILVDDMADTCGTICHAADKLLSAGATRVYAILTHGIFSGPAISRINNACFEAVVVTNTIPQEDKMKHCSKIQVIDISMILAEAIRRTHNGESVSYLFSHVPL,PF14572;PF13793;,2H06;2H07;2H08;2HCR;3EFH;3S5J;4F8E;4LYG;4LZN;4LZO;4M0P;4M0U;,152,L,P,True,878
13355,2344,24974,single nucleotide variant,NM_002764.3(PRPS1):c.344T>C (p.Met115Thr),5631,PRPS1,HGNC:9462,Likely pathogenic,1,9-Apr-18,80338732,-,RCV000010613|RCV000695028,"MONDO:MONDO:0010699,MedGen:C1839566,OMIM:311070,Orphanet:99014|MedGen:CN118851","Charcot-Marie-Tooth disease, X-linked recessive, type 5|Charcot-Marie-Tooth Neuropathy X",germline,germline,GRCh38,NC_000023.11,X,107640939,107640939,na,na,Xq22.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA340960,UniProtKB:P60891#VAR_036942,OMIM:311850.0010",3,9935,107640939,T,C,M115T,1,pathogenic,pathogenic,P60891,P60891,reviewed,PRPS1_HUMAN,"Ribose-phosphate pyrophosphokinase 1, EC 2.7.6.1 (PPRibP) (Phosphoribosyl pyrophosphate synthase I, PRS-I)",PRPS1,Homo sapiens (Human),318.0,MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVEIGESVRGEDVYIVQSGCGEINDNLMELLIMINACKIASASRVTAVIPCFPYARQDKKDKSRAPISAKLVANMLSVAGADHIITMDLHASQIQGFFDIPVDNLYAEPAVLKWIRENISEWRNCTIVSPDAGGAKRVTSIADRLNVDFALIHKERKKANEVDRMVLVGDVKDRVAILVDDMADTCGTICHAADKLLSAGATRVYAILTHGIFSGPAISRINNACFEAVVVTNTIPQEDKMKHCSKIQVIDISMILAEAIRRTHNGESVSYLFSHVPL,PF14572;PF13793;,2H06;2H07;2H08;2HCR;3EFH;3S5J;4F8E;4LYG;4LZN;4LZO;4M0P;4M0U;,115,M,T,True,878
13356,2343,24973,single nucleotide variant,NM_002764.3(PRPS1):c.129A>C (p.Glu43Asp),5631,PRPS1,HGNC:9462,Pathogenic,1,26-Aug-08,80338731,-,RCV000010612,"MONDO:MONDO:0010699,MedGen:C1839566,OMIM:311070,Orphanet:99014","Charcot-Marie-Tooth disease, X-linked recessive, type 5",germline,germline,GRCh38,NC_000023.11,X,107639301,107639301,na,na,Xq22.3,no assertion criteria provided,2,-,N,"ClinGen:CA340958,UniProtKB:P60891#VAR_036941,OMIM:311850.0009",1,9934,107639301,A,C,E43D,0,pathogenic,uncertain,P60891,P60891,reviewed,PRPS1_HUMAN,"Ribose-phosphate pyrophosphokinase 1, EC 2.7.6.1 (PPRibP) (Phosphoribosyl pyrophosphate synthase I, PRS-I)",PRPS1,Homo sapiens (Human),318.0,MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVEIGESVRGEDVYIVQSGCGEINDNLMELLIMINACKIASASRVTAVIPCFPYARQDKKDKSRAPISAKLVANMLSVAGADHIITMDLHASQIQGFFDIPVDNLYAEPAVLKWIRENISEWRNCTIVSPDAGGAKRVTSIADRLNVDFALIHKERKKANEVDRMVLVGDVKDRVAILVDDMADTCGTICHAADKLLSAGATRVYAILTHGIFSGPAISRINNACFEAVVVTNTIPQEDKMKHCSKIQVIDISMILAEAIRRTHNGESVSYLFSHVPL,PF14572;PF13793;,2H06;2H07;2H08;2HCR;3EFH;3S5J;4F8E;4LYG;4LZN;4LZO;4M0P;4M0U;,43,E,D,True,878
13357,2342,24967,single nucleotide variant,NM_002764.3(PRPS1):c.341A>G (p.Asn114Ser),5631,PRPS1,HGNC:9462,Likely pathogenic,1,2-Apr-20,137852540,-,RCV000010606|RCV000622306|RCV001328985,"MONDO:MONDO:0010395,MedGen:C1970827,OMIM:300661,Orphanet:3222|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0010533,MedGen:C0796028,OMIM:301835,Orphanet:1187",Phosphoribosylpyrophosphate synthetase superactivity|Inborn genetic diseases|Arts syndrome,germline;unknown,germline,GRCh38,NC_000023.11,X,107640936,107640936,na,na,Xq22.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA254933,UniProtKB:P60891#VAR_004163,OMIM:311850.0001",3,9928,107640936,A,G,N114S,2,pathogenic,pathogenic,P60891,P60891,reviewed,PRPS1_HUMAN,"Ribose-phosphate pyrophosphokinase 1, EC 2.7.6.1 (PPRibP) (Phosphoribosyl pyrophosphate synthase I, PRS-I)",PRPS1,Homo sapiens (Human),318.0,MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVEIGESVRGEDVYIVQSGCGEINDNLMELLIMINACKIASASRVTAVIPCFPYARQDKKDKSRAPISAKLVANMLSVAGADHIITMDLHASQIQGFFDIPVDNLYAEPAVLKWIRENISEWRNCTIVSPDAGGAKRVTSIADRLNVDFALIHKERKKANEVDRMVLVGDVKDRVAILVDDMADTCGTICHAADKLLSAGATRVYAILTHGIFSGPAISRINNACFEAVVVTNTIPQEDKMKHCSKIQVIDISMILAEAIRRTHNGESVSYLFSHVPL,PF14572;PF13793;,2H06;2H07;2H08;2HCR;3EFH;3S5J;4F8E;4LYG;4LZN;4LZO;4M0P;4M0U;,114,N,S,True,878
13358,2348,24980,single nucleotide variant,NM_002764.3(PRPS1):c.869T>C (p.Ile290Thr),5631,PRPS1,HGNC:9462,Pathogenic,1,1-Jan-10,180177153,-,RCV000010619,"MONDO:MONDO:0010577,MedGen:C1844677,OMIM:304500,Orphanet:90625","Deafness, X-linked 1",germline,germline,GRCh38,NC_000023.11,X,107649944,107649944,na,na,Xq22.3,no assertion criteria provided,1,-,N,"ClinGen:CA254951,UniProtKB:P60891#VAR_063524,OMIM:311850.0016",1,9941,107649944,T,C,I290T,0,pathogenic,uncertain,P60891,P60891,reviewed,PRPS1_HUMAN,"Ribose-phosphate pyrophosphokinase 1, EC 2.7.6.1 (PPRibP) (Phosphoribosyl pyrophosphate synthase I, PRS-I)",PRPS1,Homo sapiens (Human),318.0,MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVEIGESVRGEDVYIVQSGCGEINDNLMELLIMINACKIASASRVTAVIPCFPYARQDKKDKSRAPISAKLVANMLSVAGADHIITMDLHASQIQGFFDIPVDNLYAEPAVLKWIRENISEWRNCTIVSPDAGGAKRVTSIADRLNVDFALIHKERKKANEVDRMVLVGDVKDRVAILVDDMADTCGTICHAADKLLSAGATRVYAILTHGIFSGPAISRINNACFEAVVVTNTIPQEDKMKHCSKIQVIDISMILAEAIRRTHNGESVSYLFSHVPL,PF14572;PF13793;,2H06;2H07;2H08;2HCR;3EFH;3S5J;4F8E;4LYG;4LZN;4LZO;4M0P;4M0U;,290,I,T,True,878
13359,5744,38495,single nucleotide variant,NM_000041.4(APOE):c.508G>C (p.Ala170Pro),348,APOE,HGNC:613,no interpretation for the single variant,-1,-,267606662,-,-,-,-,not applicable,not applicable,GRCh38,NC_000019.10,19,44908804,44908804,na,na,19q13.32,no interpretation for the single variant,0,-,N,"UniProtKB:P02649#VAR_000663,ClinVar:441270,OMIM:107741.0026",4,478850,44908804,G,C,A170P,0,uncertain,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,170,A,P,True,879
13360,5742,38491,single nucleotide variant,NM_000041.4(APOE):c.761T>A (p.Val254Glu),348,APOE,HGNC:613,no interpretation for the single variant,-1,-,199768005,-,-,-,-,not applicable,not applicable,GRCh38,NC_000019.10,19,44909057,44909057,na,na,19q13.32,no interpretation for the single variant,0,-,N,"UniProtKB:P02649#VAR_000667,OMIM:107741.0021,ClinVar:441266",4,478872,44909057,T,A,V254E,0,uncertain,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,254,V,E,True,879
13361,5741,38490,single nucleotide variant,NM_000041.2(APOE):c.725G>A (p.Arg242Gln),348,APOE,HGNC:613,no interpretation for the single variant,-1,-,267606663,-,-,-,-,not applicable,not applicable,GRCh38,NC_000019.10,19,44909021,44909021,na,na,19q13.32,no interpretation for the single variant,0,-,N,"UniProtKB:P02649#VAR_000665,OMIM:107741.0019,ClinVar:441265",4,478870,44909021,G,A,R242Q,0,uncertain,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,242,R,Q,True,879
13362,5740,38488,single nucleotide variant,NM_000041.4(APOE):c.478C>T (p.Arg160Cys),348,APOE,HGNC:613,no interpretation for the single variant,-1,-,387906567,-,-,-,-,not applicable,not applicable,GRCh38,NC_000019.10,19,44908774,44908774,na,na,19q13.32,no interpretation for the single variant,0,-,N,"UniProtKB:P02649#VAR_000658,OMIM:107741.0008,ClinVar:440870",4,487346,44908774,C,T,R160C,0,uncertain,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,160,R,C,True,879
13363,5743,38492,single nucleotide variant,NM_000041.4(APOE):c.805C>G (p.Arg269Gly),348,APOE,HGNC:613,no interpretation for the single variant,-1,-,267606661,-,-,-,-,not applicable,not applicable,GRCh38,NC_000019.10,19,44909101,44909101,na,na,19q13.32,no interpretation for the single variant,0,-,N,"OMIM:107741.0022,UniProtKB:P02649#VAR_000669,ClinVar:441267",4,478884,44909101,C,G,R269G,0,uncertain,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,269,R,G,True,879
13364,5098,32914,single nucleotide variant,NM_000041.4(APOE):c.875G>A (p.Arg292His),348,APOE,HGNC:613,Pathogenic,1,1-May-93,121918398,-,RCV000019461,-,APOE4 VARIANT,germline,germline,GRCh38,NC_000019.10,19,44909171,44909171,na,na,19q13.32,no assertion criteria provided,1,-,N,"UniProtKB:P02649#VAR_000671,OMIM:107741.0028,ClinGen:CA127519",1,17875,44909171,G,A,R292H,0,pathogenic,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,292,R,H,True,879
13365,5092,32904,single nucleotide variant,NM_000041.4(APOE):c.488G>A (p.Arg163His),348,APOE,HGNC:613,Pathogenic,1,1-Nov-90,121918397,-,RCV000019449,"MONDO:MONDO:0018473,MedGen:C0020479,OMIM:617347,Orphanet:412",Familial type 3 hyperlipoproteinemia,germline,germline,GRCh38,NC_000019.10,19,44908784,44908784,na,na,19q13.32,no assertion criteria provided,1,-,N,"ClinGen:CA127513,UniProtKB:P02649#VAR_000660,OMIM:107741.0018",1,17865,44908784,G,A,R163H,0,pathogenic,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,163,R,H,True,879
13366,5099,32915,single nucleotide variant,NM_000041.4(APOE):c.940A>C (p.Ser314Arg),348,APOE,HGNC:613,Pathogenic,1,1-May-93,28931579,-,RCV000019462,-,APOE4(+),germline,germline,GRCh38,NC_000019.10,19,44909236,44909236,na,na,19q13.32,no assertion criteria provided,1,-,N,"OMIM:107741.0029,ClinGen:CA127521,UniProtKB:P02649#VAR_000672",1,17876,44909236,A,C,S314R,0,pathogenic,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,314,S,R,True,879
13367,5097,32913,single nucleotide variant,NM_000041.4(APOE):c.455G>A (p.Arg152Gln),348,APOE,HGNC:613,Pathogenic,1,21-Feb-17,28931578,-,RCV000019460,-,APOE2 VARIANT,germline,germline,GRCh38,NC_000019.10,19,44908751,44908751,na,na,19q13.32,no assertion criteria provided,1,-,N,"OMIM:107741.0027,ClinGen:CA127517,UniProtKB:P02649#VAR_000655",1,17874,44908751,G,A,R152Q,0,pathogenic,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,152,R,Q,True,879
13368,5096,32912,single nucleotide variant,NM_000041.4(APOE):c.349G>A (p.Ala117Thr),348,APOE,HGNC:613,no interpretation for the single variant,-1,-,28931577,-,-,-,-,not applicable,not applicable,GRCh38,NC_000019.10,19,44908645,44908645,na,na,19q13.32,no interpretation for the single variant,0,-,N,"OMIM:107741.0026,ClinVar:441270,UniProtKB:P02649#VAR_000651",4,478851,44908645,G,A,A117T,0,uncertain,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,117,A,T,True,879
13369,5095,32911,single nucleotide variant,NM_000041.4(APOE):c.305C>G (p.Pro102Arg),348,APOE,HGNC:613,no interpretation for the single variant,-1,-,11083750,-,-,-,-,not applicable,not applicable,GRCh38,NC_000019.10,19,44908601,44908601,na,na,19q13.32,no interpretation for the single variant,0,-,N,"UniProtKB:P02649#VAR_000650,OMIM:107741.0025,ClinVar:441269",4,478905,44908601,C,G,P102R,0,uncertain,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,102,P,R,True,879
13370,5094,32910,single nucleotide variant,NM_000041.4(APOE):c.178A>G (p.Thr60Ala),348,APOE,HGNC:613,Pathogenic,1,5-Aug-16,28931576,-,RCV000019457,-,APOE3(-)-FREIBURG,germline,germline,GRCh38,NC_000019.10,19,44907894,44907894,na,na,19q13.32,no assertion criteria provided,1,-,N,"UniProtKB:P02649#VAR_000648,OMIM:107741.0024,ClinGen:CA127515",1,17871,44907894,A,G,T60A,0,pathogenic,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,60,T,A,True,879
13371,5093,32909,single nucleotide variant,NM_000041.4(APOE):c.137T>C (p.Leu46Pro),348,APOE,HGNC:613,Conflicting interpretations of pathogenicity,0,1-Feb-20,769452,-,RCV000429606|RCV001195944,"MedGen:CN517202|MONDO:MONDO:0011743,MedGen:C1847200,OMIM:606889,Orphanet:1020","not provided|Alzheimer disease, type 4",germline;unknown,germline,GRCh38,NC_000019.10,19,44907853,44907853,na,na,19q13.32,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA041808,UniProtKB:P02649#VAR_000647,OMIM:107741.0023,ClinVar:441268",2,242765,44907853,T,C,L46P,1,uncertain,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,46,L,P,True,879
13372,5101,32919,single nucleotide variant,NM_000041.4(APOE):c.127C>T (p.Arg43Cys),348,APOE,HGNC:613,Pathogenic,1,13-Dec-07,121918399,-,RCV000019468,"MONDO:MONDO:0012725,MedGen:C2673196,OMIM:611771,Orphanet:329481",Lipoprotein glomerulopathy,germline,germline,GRCh38,NC_000019.10,19,44907843,44907843,na,na,19q13.32,no assertion criteria provided,1,-,N,"ClinGen:CA127525,UniProtKB:P02649#VAR_042734,OMIM:107741.0033",1,17880,44907843,C,T,R43C,0,pathogenic,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,43,R,C,True,879
13373,5091,32903,single nucleotide variant,NM_000041.4(APOE):c.388T>C (p.Cys130Arg),348,APOE,HGNC:613,"Conflicting interpretations of pathogenicity, other, risk factor",1,24-Mar-20,429358,-,RCV000019448|RCV000292119|RCV000826089|RCV000845581|RCV000991302|RCV001195807|RCV001262791,"MONDO:MONDO:0007089,MedGen:C1863051,OMIM:104310,Orphanet:1020|MedGen:CN517202|MeSH:D000544,MedGen:C0750901|MONDO:MONDO:0007390,MedGen:C0750384,OMIM:122700|Human Phenotype Ontology:HP:0002511,Human Phenotype Ontology:HP:0006878,Human Phenotype Ontology:HP:0007213,MONDO:MONDO:0004975,MedGen:C0002395,OMIM:104300,Orphanet:1020|MONDO:MONDO:0011743,MedGen:C1847200,OMIM:606889,Orphanet:1020|MONDO:MONDO:0012725,MedGen:C2673196,OMIM:611771,Orphanet:329481","Alzheimer disease 2|not provided|Primary degenerative dementia of the Alzheimer type, presenile onset|Warfarin response|Alzheimer disease|Alzheimer disease, type 4|Lipoprotein glomerulopathy",germline;unknown,germline,GRCh38,NC_000019.10,19,44908684,44908684,na,na,19q13.32,"criteria provided, conflicting interpretations",8,-,Y,"ClinGen:CA127512,UniProtKB:P02649#VAR_000652,OMIM:107741.0008,OMIM:107741.0016,OMIM:107741.0022,OMIM:107741.0023,OMIM:107741.0025,ClinVar:441267,ClinVar:440870,ClinVar:666796,ClinVar:441269,ClinVar:441268",3,17864,44908684,T,C,C130R,1,uncertain,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,130,C,R,True,879
13374,5090,32899,single nucleotide variant,NM_000041.4(APOE):c.91G>A (p.Glu31Lys),348,APOE,HGNC:613,Pathogenic,1,1-Apr-91,201672011,-,RCV000019453,MedGen:C4479660,APOE5 VARIANT,germline,germline,GRCh38,NC_000019.10,19,44907807,44907807,na,na,19q13.32,no assertion criteria provided,1,-,N,"ClinVar:441264,ClinGen:CA041327,UniProtKB:P02649#VAR_000646,OMIM:107741.0013,OMIM:107741.0020",1,440842,44907807,G,A,E31K,0,pathogenic,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,31,E,K,True,879
13375,5089,32898,single nucleotide variant,NM_000041.4(APOE):c.736C>T (p.Arg246Cys),348,APOE,HGNC:613,Pathogenic,1,1-Mar-91,121918395,-,RCV000019442,-,APOE2-DUNEDIN,germline,germline,GRCh38,NC_000019.10,19,44909032,44909032,na,na,19q13.32,no assertion criteria provided,1,-,N,"ClinGen:CA127508,UniProtKB:P02649#VAR_000666,OMIM:107741.0012",1,17859,44909032,C,T,R246C,0,pathogenic,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,246,R,C,True,879
13376,5088,32897,single nucleotide variant,NM_000041.4(APOE):c.490A>C (p.Lys164Gln),348,APOE,HGNC:613,Pathogenic,1,1-Jan-90,121918394,-,RCV000019441,"MONDO:MONDO:0018473,MedGen:C0020479,OMIM:617347,Orphanet:412",Familial type 3 hyperlipoproteinemia,germline,germline,GRCh38,NC_000019.10,19,44908786,44908786,na,na,19q13.32,no assertion criteria provided,1,-,N,"ClinGen:CA127507,UniProtKB:P02649#VAR_000661,OMIM:107741.0011",1,17858,44908786,A,C,K164Q,0,pathogenic,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,164,K,Q,True,879
13377,5087,32896,single nucleotide variant,NM_000041.4(APOE):c.490A>G (p.Lys164Glu),348,APOE,HGNC:613,Pathogenic,1,1-Aug-95,121918394,-,RCV000019440,"MONDO:MONDO:0018473,MedGen:C0020479,OMIM:617347,Orphanet:412",Familial type 3 hyperlipoproteinemia,germline,germline,GRCh38,NC_000019.10,19,44908786,44908786,na,na,19q13.32,no assertion criteria provided,1,-,N,"ClinGen:CA127506,UniProtKB:P02649#VAR_000662,OMIM:107741.0010",1,17857,44908786,A,G,K164E,0,pathogenic,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,164,K,E,True,879
13378,5086,32895,single nucleotide variant,NM_000041.4(APOE):c.434G>A (p.Gly145Asp),348,APOE,HGNC:613,Uncertain significance,0,1-Jan-19,267606664,-,RCV001262660,"Human Phenotype Ontology:HP:0003124,Human Phenotype Ontology:HP:0008154,Human Phenotype Ontology:HP:0008173,Human Phenotype Ontology:HP:0008359,MedGen:C1522133",Hypercholesterolemia,unknown,unknown,GRCh38,NC_000019.10,19,44908730,44908730,na,na,19q13.32,"criteria provided, single submitter",1,-,N,"ClinVar:441262,UniProtKB:P02649#VAR_000653,OMIM:107741.0009",2,478904,44908730,G,A,G145D,1,uncertain,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,145,G,D,True,879
13379,5100,32918,single nucleotide variant,NM_000041.4(APOE):c.488G>C (p.Arg163Pro),348,APOE,HGNC:613,Pathogenic,1,6-Oct-00,121918397,-,RCV000019466,"MONDO:MONDO:0012725,MedGen:C2673196,OMIM:611771,Orphanet:329481",Lipoprotein glomerulopathy,germline,germline,GRCh38,NC_000019.10,19,44908784,44908784,na,na,19q13.32,no assertion criteria provided,1,-,N,"ClinGen:CA127524,UniProtKB:P02649#VAR_042735,OMIM:107741.0032",1,17879,44908784,G,C,R163P,0,pathogenic,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,163,R,P,True,879
13380,5084,32889,single nucleotide variant,NM_000041.4(APOE):c.460C>A (p.Arg154Ser),348,APOE,HGNC:613,Pathogenic,1,1-Nov-88,121918393,-,RCV000019430,"MONDO:MONDO:0018473,MedGen:C0020479,OMIM:617347,Orphanet:412",Familial type 3 hyperlipoproteinemia,germline,germline,GRCh38,NC_000019.10,19,44908756,44908756,na,na,19q13.32,no assertion criteria provided,1,-,N,"ClinGen:CA127501,UniProtKB:P02649#VAR_000656,OMIM:107741.0003,ClinVar:694585",1,17850,44908756,C,A,R154S,0,pathogenic,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,154,R,S,True,879
13381,5083,32888,single nucleotide variant,NM_000041.4(APOE):c.61G>A (p.Glu21Lys),348,APOE,HGNC:613,Pathogenic,1,1-Aug-95,121918392,-,RCV000019429,-,"HYPERLIPOPROTEINEMIA, TYPE III, AND ATHEROSCLEROSIS ASSOCIATED WITH APOE5",germline,germline,GRCh38,NC_000019.10,19,44907777,44907777,na,na,19q13.32,no assertion criteria provided,1,-,N,"OMIM:107741.0020,OMIM:107741.0002,ClinGen:CA127499,UniProtKB:P02649#VAR_000645",1,17849,44907777,G,A,E21K,0,pathogenic,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,21,E,K,True,879
13382,5082,32887,single nucleotide variant,NM_000041.2(APOE):c.526C>T (p.Arg176Cys),348,APOE,HGNC:613,drug response,1,26-Feb-16,7412,-,RCV000019428|RCV000211178|RCV000346955|RCV000845582|RCV001262472,"MONDO:MONDO:0018473,MedGen:C0020479,OMIM:617347,Orphanet:412|MedGen:CN236484|MedGen:CN517202|MONDO:MONDO:0007390,MedGen:C0750384,OMIM:122700|Human Phenotype Ontology:HP:0003124,Human Phenotype Ontology:HP:0008154,Human Phenotype Ontology:HP:0008173,Human Phenotype Ontology:HP:0008359,MedGen:C1522133",Familial type 3 hyperlipoproteinemia|atorvastatin response - Efficacy|not provided|Warfarin response|Hypercholesterolemia,germline;unknown,germline,GRCh38,NC_000019.10,19,44908822,44908822,na,na,19q13.32,reviewed by expert panel,6,-,Y,"PharmGKB Clinical Annotation:1183492249,ClinGen:CA127498,UniProtKB:P02649#VAR_000664,OMIM:107741.0001,OMIM:107741.0009,OMIM:107741.0019,OMIM:107741.0021,ClinVar:441262,ClinVar:666796,ClinVar:441266,ClinVar:441265",3,17848,44908822,C,T,R176C,3,uncertain,uncertain,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,176,R,C,True,879
13383,5085,32890,single nucleotide variant,NM_000041.4(APOE):c.487C>T (p.Arg163Cys),348,APOE,HGNC:613,Benign,1,31-Dec-19,769455,-,RCV000019432|RCV000884152,"MONDO:MONDO:0018473,MedGen:C0020479,OMIM:617347,Orphanet:412|MedGen:CN517202",Familial type 3 hyperlipoproteinemia|not provided,germline,germline,GRCh38,NC_000019.10,19,44908783,44908783,na,na,19q13.32,"criteria provided, single submitter",3,-,N,"ClinGen:CA127502,UniProtKB:P02649#VAR_000659,OMIM:107741.0004,OMIM:107741.0013,ClinVar:441264",3,17851,44908783,C,T,R163C,1,benign,benign,P02649,P02649,reviewed,APOE_HUMAN,"Apolipoprotein E, Apo-E",APOE,Homo sapiens (Human),317.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,PF01442;,1B68;1BZ4;1EA8;1GS9;1H7I;1LE2;1LE4;1LPE;1NFN;1NFO;1OEF;1OEG;1OR2;1OR3;2KC3;2KNY;2L7B;6IWB;6NCN;6NCO;,163,R,C,True,879
13384,12499,223741,single nucleotide variant,NM_005842.4(SPRY2):c.355C>T (p.Arg119Trp),10253,SPRY2,HGNC:11270,risk factor,0,18-Sep-19,869025336,-,RCV000207508,"MONDO:MONDO:0014786,MedGen:C4225194,OMIM:616818","IgA nephropathy, susceptibility to, 3",germline,germline,GRCh38,NC_000013.11,13,80337351,80337351,na,na,13q31.1,no assertion criteria provided,1,-,N,"ClinGen:CA351651,UniProtKB:O43597#VAR_076288,OMIM:602466.0001",1,222032,80337351,G,A,R119W,0,uncertain,uncertain,O43597,O43597,reviewed,SPY2_HUMAN,"Protein sprouty homolog 2, Spry-2",SPRY2,Homo sapiens (Human),315.0,MEARAQSGNGSQPLLQTPRDGGRQRGEPDPRDALTQQVHVLSLDQIRAIRNTNEYTEGPTVVPRPGLKPAPRPSTQHKHERLHGLPEHRQPPRLQHSQVHSSARAPLSRSISTVSSGSRSSTRTSTSSSSSEQRLLGSSFSSGPVADGIIRVQPKSELKPGELKPLSKEDLGLHAYRCEDCGKCKCKECTYPRPLPSDWICDKQCLCSAQNVIDYGTCVCCVKGLFYHCSNDDEDNCADNPCSCSQSHCCTRWSAMGVMSLFLPCLWCYLPAKGCLKLCQGCYDRVNRPGCRCKNSNTVCCKVPTVPPRNFEKPT,PF05210;,3BUM;3OB1;5HKY;5HKZ;5HL0;,119,R,W,True,880
13385,4790,31974,single nucleotide variant,NM_001888.5(CRYM):c.941A>C (p.Lys314Thr),1428,CRYM,HGNC:2418,Pathogenic,1,1-Jan-03,104894512,-,RCV000018443,"MONDO:MONDO:0014603,MedGen:C4084708,OMIM:616357,Orphanet:90635","Deafness, autosomal dominant 40",germline,germline,GRCh38,NC_000016.10,16,21258785,21258785,na,na,16p12.2,no assertion criteria provided,1,-,N,"ClinGen:CA126994,UniProtKB:Q14894#VAR_073781,OMIM:123740.0002",1,16935,21258785,T,G,K314T,0,pathogenic,uncertain,Q14894,Q14894,reviewed,CRYM_HUMAN,"Ketimine reductase mu-crystallin, EC 1.5.1.25 (NADP-regulated thyroid-hormone-binding protein)",CRYM THBP,Homo sapiens (Human),314.0,MSRVPAFLSAAEVEEHLRSSSLLIPPLETALANFSSGPEGGVMQPVRTVVPVTKHRGYLGVMPAYSAAEDALTTKLVTFYEDRGITSVVPSHQATVLLFEPSNGTLLAVMDGNVITAKRTAAVSAIATKFLKPPSSEVLCILGAGVQAYSHYEIFTEQFSFKEVRIWNRTKENAEKFADTVQGEVRVCSSVQEAVAGADVIITVTLATEPILFGEWVKPGAHINAVGASRPDWRELDDELMKEAVLYVDSQEAALKESGDVLLSGAEIFAELGEVIKGVKPAHCEKTTVFKSLGMAVEDTVAAKLIYDSWSSGK,PF02423;,2I99;,314,K,T,True,881
13386,1451,21385,single nucleotide variant,NM_003690.5(PRKRA):c.665C>T (p.Pro222Leu),8575,PRKRA,HGNC:9438,Pathogenic,1,28-May-19,121434410,-,RCV000006718,"MONDO:MONDO:0012789,MedGen:C2677567,OMIM:612067,Orphanet:210571",Dystonia 16,germline;unknown,germline,GRCh38,NC_000002.12,2,178436264,178436264,na,na,2q31.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA118133,UniProtKB:O75569#VAR_046213,OMIM:603424.0001",3,6346,178436264,G,A,P222L,2,pathogenic,pathogenic,O75569,O75569,reviewed,PRKRA_HUMAN,"Interferon-inducible double-stranded RNA-dependent protein kinase activator A (PKR-associated protein X) (PKR-associating protein X) (Protein activator of the interferon-induced protein kinase) (Protein kinase, interferon-inducible double-stranded RNA-dependent activator)",PRKRA PACT RAX HSD-14 HSD14,Homo sapiens (Human),313.0,MSQSRHRAEAPPLEREDSGTFSLGKMITAKPGKTPIQVLHEYGMKTKNIPVYECERSDVQIHVPTFTFRVTVGDITCTGEGTSKKLAKHRAAEAAINILKANASICFAVPDPLMPDPSKQPKNQLNPIGSLQELAIHHGWRLPEYTLSQEGGPAHKREYTTICRLESFMETGKGASKKQAKRNAAEKFLAKFSNISPENHISLTNVVGHSLGCTWHSLRNSPGEKINLLKRSLLSIPNTDYIQLLSEIAKEQGFNITYLDIDELSANGQYQCLAELSTSPITVCHGSGISCGNAQSDAAHNALQYLKIIAERK,PF00035;PF16482;,2DIX;,222,P,L,True,882
13387,3002,27331,single nucleotide variant,NM_080911.3(UNG):c.752T>C (p.Phe251Ser),7374,UNG,HGNC:12572,Pathogenic,1,20-Jun-05,104894380,-,RCV000013086,"MONDO:MONDO:0011971,MedGen:C1720958,OMIM:608106,Orphanet:101092",Hyper-IgM syndrome type 5,germline,germline,GRCh38,NC_000012.12,12,109103562,109103562,na,na,12q24.11,no assertion criteria provided,1,-,N,"ClinGen:CA122119,UniProtKB:P13051#VAR_017094,OMIM:191525.0003",1,12292,109103562,T,C,F251S,0,pathogenic,uncertain,P13051,P13051,reviewed,UNG_HUMAN,"Uracil-DNA glycosylase, UDG, EC 3.2.2.27",UNG DGU UNG1 UNG15,Homo sapiens (Human),313.0,MIGQKTLYSFFSPSPARKRHAPSPEPAVQGTGVAGVPEESGDAAAIPAKKAPAGQEEPGTPPSSPLSAEQLDRIQRNKAAALLRLAARNVPVGFGESWKKHLSGEFGKPYFIKLMGFVAEERKHYTVYPPPHQVFTWTQMCDIKDVKVVILGQDPYHGPNQAHGLCFSVQRPVPPPPSLENIYKELSTDIEDFVHPGHGDLSGWAKQGVLLLNAVLTVRAHQANSHKERGWEQFTDAVVSWLNQNSNGLVFLLWGSYAQKKGSAIDRKRHHVLQTAHPSPLSVYRGFFGCRHFSKTNELLQKSGKKPIDWKEL,PF03167;,1AKZ;1DPU;1EMH;1EMJ;1Q3F;1SSP;1UGH;1YUO;2HXM;2OXM;2OYT;2SSP;3FCF;3FCI;3FCK;3FCL;3TKB;4SKN;5AYR;5JK7;6VBA;,251,F,S,True,883
13388,11613,186962,single nucleotide variant,NM_000049.3(ASPA):c.79G>A (p.Gly27Arg),-1,SPATA22;ASPA,-,Pathogenic/Likely pathogenic,1,18-Dec-19,766328537,-,RCV000169243|RCV000489399|RCV000780871,"MONDO:MONDO:0010079,MedGen:C0206307,OMIM:271900,Orphanet:141|MedGen:CN517202|MedGen:C0751663","Spongy degeneration of central nervous system|not provided|Canavan Disease, Familial Form",germline;unknown,germline,GRCh38,NC_000017.11,17,3476238,3476238,na,na,17p13.2,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA274084,UniProtKB:P45381#VAR_039080",2,188888,3476238,G,A,G27R,2,pathogenic,pathogenic,P45381,P45381,reviewed,ACY2_HUMAN,"Aspartoacylase, EC 3.5.1.15 (Aminoacylase-2, ACY-2)",ASPA ACY2 ASP,Homo sapiens (Human),313.0,MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH,PF04952;,2I3C;2O4H;2O53;2Q51;4MRI;4MXU;4NFR;4TNU;,27,G,R,True,884
13389,672,17651,single nucleotide variant,NM_000049.3(ASPA):c.692A>G (p.Tyr231Cys),443,ASPA,HGNC:756,Pathogenic,1,-,104894550,-,RCV000002730,"MONDO:MONDO:0010079,MedGen:C0206307,OMIM:271900,Orphanet:141",Spongy degeneration of central nervous system,germline,germline,GRCh38,NC_000017.11,17,3494407,3494407,na,na,17p13.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA252360,UniProtKB:P45381#VAR_016786,OMIM:608034.0008",3,2612,3494407,A,G,Y231C,1,pathogenic,pathogenic,P45381,P45381,reviewed,ACY2_HUMAN,"Aspartoacylase, EC 3.5.1.15 (Aminoacylase-2, ACY-2)",ASPA ACY2 ASP,Homo sapiens (Human),313.0,MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH,PF04952;,2I3C;2O4H;2O53;2Q51;4MRI;4MXU;4NFR;4TNU;,231,Y,C,True,884
13390,671,17646,single nucleotide variant,NM_000049.4(ASPA):c.914C>A (p.Ala305Glu),443,ASPA,HGNC:756,Pathogenic,1,12-Nov-19,28940574,-,RCV000002725|RCV000489986|RCV000588914,"MONDO:MONDO:0010079,MedGen:C0206307,OMIM:271900,Orphanet:141|MedGen:CN517202|MedGen:C0751663","Spongy degeneration of central nervous system|not provided|Canavan Disease, Familial Form",germline;unknown,germline,GRCh38,NC_000017.11,17,3499060,3499060,na,na,17p13.2,"criteria provided, multiple submitters, no conflicts",11,-,Y,"OMIM:608034.0003,ClinGen:CA252356,UniProtKB:P45381#VAR_005001",3,2607,3499060,C,A,A305E,2,pathogenic,pathogenic,P45381,P45381,reviewed,ACY2_HUMAN,"Aspartoacylase, EC 3.5.1.15 (Aminoacylase-2, ACY-2)",ASPA ACY2 ASP,Homo sapiens (Human),313.0,MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH,PF04952;,2I3C;2O4H;2O53;2Q51;4MRI;4MXU;4NFR;4TNU;,305,A,E,True,884
13391,670,17645,single nucleotide variant,NM_000049.3(ASPA):c.454T>C (p.Cys152Arg),443,ASPA,HGNC:756,Pathogenic,1,22-Oct-12,104894548,-,RCV000002724,"MONDO:MONDO:0010079,MedGen:C0206307,OMIM:271900,Orphanet:141",Spongy degeneration of central nervous system,germline,germline,GRCh38,NC_000017.11,17,3483520,3483520,na,na,17p13.2,no assertion criteria provided,2,-,N,"ClinGen:CA252354,UniProtKB:P45381#VAR_004996,OMIM:608034.0002",3,2606,3483520,T,C,C152R,0,pathogenic,uncertain,P45381,P45381,reviewed,ACY2_HUMAN,"Aspartoacylase, EC 3.5.1.15 (Aminoacylase-2, ACY-2)",ASPA ACY2 ASP,Homo sapiens (Human),313.0,MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH,PF04952;,2I3C;2O4H;2O53;2Q51;4MRI;4MXU;4NFR;4TNU;,152,C,R,True,884
13392,669,17644,single nucleotide variant,NM_000049.4(ASPA):c.854A>C (p.Glu285Ala),443,ASPA,HGNC:756,Pathogenic,1,31-Dec-19,28940279,-,RCV000002723|RCV000420704|RCV000590467,"MONDO:MONDO:0010079,MedGen:C0206307,OMIM:271900,Orphanet:141|MedGen:CN517202|MedGen:C0751663","Spongy degeneration of central nervous system|not provided|Canavan Disease, Familial Form",germline;maternal;unknown,germline,GRCh38,NC_000017.11,17,3499000,3499000,na,na,17p13.2,"criteria provided, multiple submitters, no conflicts",12,-,Y,"ClinGen:CA325511,UniProtKB:P45381#VAR_004999,OMIM:608034.0001",3,2605,3499000,A,C,E285A,2,pathogenic,pathogenic,P45381,P45381,reviewed,ACY2_HUMAN,"Aspartoacylase, EC 3.5.1.15 (Aminoacylase-2, ACY-2)",ASPA ACY2 ASP,Homo sapiens (Human),313.0,MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH,PF04952;,2I3C;2O4H;2O53;2Q51;4MRI;4MXU;4NFR;4TNU;,285,E,A,True,884
13393,11615,186966,single nucleotide variant,NM_000049.3(ASPA):c.820G>A (p.Gly274Arg),443,ASPA,HGNC:756,Pathogenic/Likely pathogenic,1,18-Feb-21,761064915,-,RCV000169117|RCV001293576,"MONDO:MONDO:0010079,MedGen:C0206307,OMIM:271900,Orphanet:141|MedGen:C0751663","Spongy degeneration of central nervous system|Canavan Disease, Familial Form",germline;unknown,germline,GRCh38,NC_000017.11,17,3498966,3498966,na,na,17p13.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA273959,UniProtKB:P45381#VAR_004998",2,188788,3498966,G,A,G274R,2,pathogenic,pathogenic,P45381,P45381,reviewed,ACY2_HUMAN,"Aspartoacylase, EC 3.5.1.15 (Aminoacylase-2, ACY-2)",ASPA ACY2 ASP,Homo sapiens (Human),313.0,MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH,PF04952;,2I3C;2O4H;2O53;2Q51;4MRI;4MXU;4NFR;4TNU;,274,G,R,True,884
13394,11616,186967,single nucleotide variant,NM_000049.3(ASPA):c.859G>A (p.Ala287Thr),443,ASPA,HGNC:756,Pathogenic/Likely pathogenic,1,31-Oct-19,774323189,-,RCV000169134|RCV000587229,"MONDO:MONDO:0010079,MedGen:C0206307,OMIM:271900,Orphanet:141|MedGen:C0751663","Spongy degeneration of central nervous system|Canavan Disease, Familial Form",germline;unknown,germline,GRCh38,NC_000017.11,17,3499005,3499005,na,na,17p13.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"UniProtKB:P45381#VAR_039090,ClinGen:CA273981",2,188803,3499005,G,A,A287T,2,pathogenic,pathogenic,P45381,P45381,reviewed,ACY2_HUMAN,"Aspartoacylase, EC 3.5.1.15 (Aminoacylase-2, ACY-2)",ASPA ACY2 ASP,Homo sapiens (Human),313.0,MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH,PF04952;,2I3C;2O4H;2O53;2Q51;4MRI;4MXU;4NFR;4TNU;,287,A,T,True,884
13395,11614,186965,single nucleotide variant,NM_000049.3(ASPA):c.541C>A (p.Pro181Thr),443,ASPA,HGNC:756,Pathogenic/Likely pathogenic,1,9-Jan-19,786204572,-,RCV000169314|RCV001093138,"MONDO:MONDO:0010079,MedGen:C0206307,OMIM:271900,Orphanet:141|MedGen:CN517202",Spongy degeneration of central nervous system|not provided,germline;unknown,germline,GRCh38,NC_000017.11,17,3489249,3489249,na,na,17p13.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA274160,UniProtKB:P45381#VAR_016781",2,188940,3489249,C,A,P181T,2,pathogenic,pathogenic,P45381,P45381,reviewed,ACY2_HUMAN,"Aspartoacylase, EC 3.5.1.15 (Aminoacylase-2, ACY-2)",ASPA ACY2 ASP,Homo sapiens (Human),313.0,MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH,PF04952;,2I3C;2O4H;2O53;2Q51;4MRI;4MXU;4NFR;4TNU;,181,P,T,True,884
13396,673,17654,single nucleotide variant,NM_000049.3(ASPA):c.746A>T (p.Asp249Val),443,ASPA,HGNC:756,Pathogenic/Likely pathogenic,1,26-Nov-15,104894552,-,RCV000002733,"MONDO:MONDO:0010079,MedGen:C0206307,OMIM:271900,Orphanet:141",Spongy degeneration of central nervous system,germline;unknown,germline,GRCh38,NC_000017.11,17,3498892,3498892,na,na,17p13.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA252364,UniProtKB:P45381#VAR_016788,OMIM:608034.0011",3,2615,3498892,A,T,D249V,2,pathogenic,pathogenic,P45381,P45381,reviewed,ACY2_HUMAN,"Aspartoacylase, EC 3.5.1.15 (Aminoacylase-2, ACY-2)",ASPA ACY2 ASP,Homo sapiens (Human),313.0,MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH,PF04952;,2I3C;2O4H;2O53;2Q51;4MRI;4MXU;4NFR;4TNU;,249,D,V,True,884
13397,318,16301,single nucleotide variant,NM_024570.4(RNASEH2B):c.529G>A (p.Ala177Thr),79621,RNASEH2B,HGNC:25671,Pathogenic/Likely pathogenic,1,1-Nov-20,75184679,-,RCV000001324|RCV000274058|RCV000343151|RCV001293274,"MONDO:MONDO:0012429,MedGen:C3489724,OMIM:610181,Orphanet:51|MedGen:CN517202|MONDO:MONDO:0018866,MedGen:C0393591,OMIM:PS225750,Orphanet:51|Human Phenotype Ontology:HP:0100021,MONDO:MONDO:0006497,MedGen:C0007789",Aicardi Goutieres syndrome 2|not provided|Aicardi Goutieres syndrome|Cerebral palsy,germline;inherited;maternal;unknown,germline,GRCh38,NC_000013.11,13,50945445,50945445,na,na,13q14.3,"criteria provided, multiple submitters, no conflicts",25,-,N,"UniProtKB:Q5TBB1#VAR_027284,OMIM:610326.0001,ClinGen:CA251724",3,1262,50945445,G,A,A177T,2,pathogenic,pathogenic,Q5TBB1,Q5TBB1,reviewed,RNH2B_HUMAN,"Ribonuclease H2 subunit B, RNase H2 subunit B (Aicardi-Goutieres syndrome 2 protein, AGS2) (Deleted in lymphocytic leukemia 8) (Ribonuclease HI subunit B)",RNASEH2B DLEU8,Homo sapiens (Human),312.0,MAAGVDCGDGVGARQHVFLVSEYLKDASKKMKNGLMFVKLVNPCSGEGAIYLFNMCLQQLFEVKVFKEKHHSWFINQSVQSGGLLHFATPVDPLFLLLHYLIKADKEGKFQPLDQVVVDNVFPNCILLLKLPGLEKLLHHVTEEKGNPEIDNKKYYKYSKEKTLKWLEKKVNQTVAALKTNNVNVSSRVQSTAFFSGDQASTDKEEDYIRYAHGLISDYIPKELSDDLSKYLKLPEPSASLPNPPSKKIKLSDEPVEAKEDYTKFNTKDLKTEKKNSKMTAAQKALAKVDKSGMKSIDTFFGVKNKKKIGKV,PF09468;PF17745;,3P56;3P87;3PUF;,177,A,T,True,885
13398,319,16302,single nucleotide variant,NM_001142279.2(RNASEH2B):c.554T>G (p.Val185Gly),79621,RNASEH2B,HGNC:25671,Pathogenic/Likely pathogenic,1,20-Mar-19,74555752,-,RCV000001325,"MONDO:MONDO:0012429,MedGen:C3489724,OMIM:610181,Orphanet:51",Aicardi Goutieres syndrome 2,germline;unknown,germline,GRCh38,NC_000013.11,13,50945470,50945470,na,na,13q14.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"OMIM:610326.0002,ClinGen:CA251728,UniProtKB:Q5TBB1#VAR_027285",3,1263,50945470,T,G,V185G,2,pathogenic,pathogenic,Q5TBB1,Q5TBB1,reviewed,RNH2B_HUMAN,"Ribonuclease H2 subunit B, RNase H2 subunit B (Aicardi-Goutieres syndrome 2 protein, AGS2) (Deleted in lymphocytic leukemia 8) (Ribonuclease HI subunit B)",RNASEH2B DLEU8,Homo sapiens (Human),312.0,MAAGVDCGDGVGARQHVFLVSEYLKDASKKMKNGLMFVKLVNPCSGEGAIYLFNMCLQQLFEVKVFKEKHHSWFINQSVQSGGLLHFATPVDPLFLLLHYLIKADKEGKFQPLDQVVVDNVFPNCILLLKLPGLEKLLHHVTEEKGNPEIDNKKYYKYSKEKTLKWLEKKVNQTVAALKTNNVNVSSRVQSTAFFSGDQASTDKEEDYIRYAHGLISDYIPKELSDDLSKYLKLPEPSASLPNPPSKKIKLSDEPVEAKEDYTKFNTKDLKTEKKNSKMTAAQKALAKVDKSGMKSIDTFFGVKNKKKIGKV,PF09468;PF17745;,3P56;3P87;3PUF;,185,V,G,True,885
13399,11092,169605,single nucleotide variant,NM_001077446.4(TSEN34):c.334C>G (p.Leu112Val),79042,TSEN34,HGNC:15506,Benign,0,13-Jan-18,17849378,-,RCV000147762|RCV001136205,"MedGen:CN169374|MONDO:MONDO:0020135,MedGen:C1261175,OMIM:PS607596,Orphanet:98523",not specified|Pontoneocerebellar hypoplasia,germline,germline,GRCh38,NC_000019.10,19,54191811,54191811,na,na,19q13.42,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA272747,UniProtKB:Q9BSV6#VAR_061149",2,160119,54191811,C,G,L112V,2,benign,benign,Q9BSV6,Q9BSV6,reviewed,SEN34_HUMAN,"tRNA-splicing endonuclease subunit Sen34, EC 4.6.1.16 (Leukocyte receptor cluster member 5) (tRNA-intron endonuclease Sen34, HsSen34)",TSEN34 LENG5 SEN34,Homo sapiens (Human),310.0,MLVVEVANGRSLVWGAEAVQALRERLGVGGRTVGALPRGPRQNSRLGLPLLLMPEEARLLAEIGAVTLVSAPRPDSRHHSLALTSFKRQQEESFQEQSALAAEARETRRQELLEKITEGQAAKKQKLEQASGASSSQEAGSSQAAKEDETSDGQASGEQEEAGPSSSQAGPSNGVAPLPRSALLVQLATARPRPVKARPLDWRVQSKDWPHAGRPAHELRYSIYRDLWERGFFLSAAGKFGGDFLVYPGDPLRFHAHYIAQCWAPEDTIPLQDLVAAGRLGTSVRKTLLLCSPQPDGKVVYTSLQWASLQ,PF01974;,6Z9U;,112,L,V,True,886
13400,540,17163,single nucleotide variant,NM_001077446.4(TSEN34):c.172C>T (p.Arg58Trp),79042,TSEN34,HGNC:15506,Pathogenic,1,8-Sep-09,113994150,-,RCV000002206,"MONDO:MONDO:0012891,MedGen:C2676465,OMIM:612390,Orphanet:2524",Pontocerebellar hypoplasia type 2C,germline,germline,GRCh38,NC_000019.10,19,54191536,54191536,na,na,19q13.42,no assertion criteria provided,2,-,N,"ClinGen:CA339948,UniProtKB:Q9BSV6#VAR_054811,OMIM:608754.0001",1,2124,54191536,C,T,R58W,0,pathogenic,uncertain,Q9BSV6,Q9BSV6,reviewed,SEN34_HUMAN,"tRNA-splicing endonuclease subunit Sen34, EC 4.6.1.16 (Leukocyte receptor cluster member 5) (tRNA-intron endonuclease Sen34, HsSen34)",TSEN34 LENG5 SEN34,Homo sapiens (Human),310.0,MLVVEVANGRSLVWGAEAVQALRERLGVGGRTVGALPRGPRQNSRLGLPLLLMPEEARLLAEIGAVTLVSAPRPDSRHHSLALTSFKRQQEESFQEQSALAAEARETRRQELLEKITEGQAAKKQKLEQASGASSSQEAGSSQAAKEDETSDGQASGEQEEAGPSSSQAGPSNGVAPLPRSALLVQLATARPRPVKARPLDWRVQSKDWPHAGRPAHELRYSIYRDLWERGFFLSAAGKFGGDFLVYPGDPLRFHAHYIAQCWAPEDTIPLQDLVAAGRLGTSVRKTLLLCSPQPDGKVVYTSLQWASLQ,PF01974;,6Z9U;,58,R,W,True,886
13401,6029,39767,single nucleotide variant,NM_138501.6(TECR):c.545C>T (p.Pro182Leu),9524,TECR,HGNC:4551,Pathogenic,1,20-Dec-13,199469705,-,RCV000023795,"MONDO:MONDO:0013528,MedGen:C3151462,OMIM:614020,Orphanet:88616","Mental retardation, autosomal recessive 14",germline,germline,GRCh38,NC_000019.10,19,14564841,14564841,na,na,19p13.12,no assertion criteria provided,1,-,N,"ClinGen:CA129481,UniProtKB:Q9NZ01#VAR_065918,OMIM:610057.0001",1,30810,14564841,C,T,P182L,0,pathogenic,uncertain,Q9NZ01,Q9NZ01,reviewed,TECR_HUMAN,"Very-long-chain enoyl-CoA reductase, EC 1.3.1.93 (Synaptic glycoprotein SC2) (Trans-2,3-enoyl-CoA reductase, TER)",TECR GPSN2 SC2,Homo sapiens (Human),308.0,MKHYEVEILDAKTREKLCFLDKVEPHATIAEIKNLFTKTHPQWYPARQSLRLDPKGKSLKDEDVLQKLPVGTTATLYFRDLGAQISWVTVFLTEYAGPLFIYLLFYFRVPFIYGHKYDFTSSRHTVVHLACICHSFHYIKRLLETLFVHRFSHGTMPLRNIFKNCTYYWGFAAWMAYYINHPLYTPPTYGAQQVKLALAIFVICQLGNFSIHMALRDLRPAGSKTRKIPYPTKNPFTWLFLLVSCPNYTYEVGSWIGFAIMTQCLPVALFSLVGFTQMTIWAKGKHRSYLKEFRDYPPLRMPIIPFLL,PF02544;,2DZJ;,182,P,L,True,887
13402,13740,280227,single nucleotide variant,NM_015627.2(LDLRAP1):c.604T>C (p.Ser202Pro),26119,LDLRAP1,HGNC:18640,Benign,0,13-Aug-19,6687605,-,RCV000386734|RCV000427792|RCV001277157,"MONDO:MONDO:0011374,MedGen:C1863512,OMIM:603813,Orphanet:391665|MedGen:CN169374|MONDO:MONDO:0005439,MedGen:C0020445,OMIM:PS143890",Familial hypercholesterolemia 4|not specified|Familial hypercholesterolemia,germline,germline,GRCh38,NC_000001.11,1,25563141,25563141,na,na,1p36.11,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA695643,UniProtKB:Q5SW96#VAR_028403",2,296982,25563141,T,C,S202P,2,benign,benign,Q5SW96,Q5SW96,reviewed,ARH_HUMAN,Low density lipoprotein receptor adapter protein 1 (Autosomal recessive hypercholesterolemia protein),LDLRAP1 ARH,Homo sapiens (Human),308.0,MDALKSAGRALIRSPSLAKQSWGGGGRHRKLPENWTDTRETLLEGMLFSLKYLGMTLVEQPKGEELSAAAIKRIVATAKASGKKLQKVTLKVSPRGIILTDNLTNQLIENVSIYRISYCTADKMHDKVFAYIAQSQHNQSLECHAFLCTKRKMAQAVTLTVAQAFKVAFEFWQVSKEEKEKRDKASQEGGDVLGARQDCTPSLKSLVATGNLLDLEETAKAPLSTVSANTTNMDEVPRPQALSGSSVVWELDDGLDEAFSRLAQSRTNPQVLDTGLTAQDMHYAQCLSPVDWDKPDSSGTEQDDLFSF,PF14719;,2G30;,202,S,P,True,888
13403,6992,57318,single nucleotide variant,NM_178335.3(CCDC50):c.363A>T (p.Leu121Phe),152137,CCDC50,HGNC:18111,Benign,0,12-Sep-18,35380043,-,RCV000041444|RCV000991753,MedGen:CN169374|MedGen:CN517202,not specified|not provided,germline,germline,GRCh38,NC_000003.12,3,191369951,191369951,na,na,3q28,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA142714,UniProtKB:Q8IVM0#VAR_050754",2,48154,191369951,A,T,L121F,2,benign,benign,Q8IVM0,Q8IVM0,reviewed,CCD50_HUMAN,Coiled-coil domain-containing protein 50 (Protein Ymer),CCDC50 C3orf6,Homo sapiens (Human),306.0,MAEVSIDQSKLPGVKEVCRDFAVLEDHTLAHSLQEQEIEHHLASNVQRNRLVQHDLQVAKQLQEEDLKAQAQLQKRYKDLEQQDCEIAQEIQEKLAIEAERRRIQEKKDEDIARLLQEKELQEEKKRKKHFPEFPATRAYADSYYYEDGGMKPRVMKEAVSTPSRMAHRDQEWYDAEIARKLQEEELLATQVDMRAAQVAQDEEIARLLMAEEKKAYKKAKEREKSSLDKRKQDPEWKPKTAKAANSKSKESDEPHHSKNERPARPPPPIMTDGEDADYTHFTNQQSSTRHFSKSESSHKGFHYKH,PF15295;,6LAN;,121,L,F,True,889
13404,10061,132647,single nucleotide variant,NM_005861.4(STUB1):c.235G>A (p.Ala79Thr),10273,STUB1,HGNC:11427,Pathogenic,1,17-Apr-14,587777346,-,RCV000115004,"MONDO:MONDO:0000561,MONDO:MONDO:0014339,MedGen:C4014261,OMIM:615768,Orphanet:412057","Spinocerebellar ataxia, autosomal recessive 16",germline,germline,GRCh38,NC_000016.10,16,681227,681227,na,na,16p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA151395,UniProtKB:Q9UNE7#VAR_071294,OMIM:607207.0007",1,127149,681227,G,A,A79T,0,pathogenic,uncertain,Q9UNE7,Q9UNE7,reviewed,CHIP_HUMAN,"E3 ubiquitin-protein ligase CHIP, EC 2.3.2.27 (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)",STUB1 CHIP PP1131,Homo sapiens (Human),303.0,MKGKEEKEGGARLGAGGGSPEKSPSAQELKEQGNRLFVGRKYPEAAACYGRAITRNPLVAVYYTNRALCYLKMQQHEQALADCRRALELDGQSVKAHFFLGQCQLEMESYDEAIANLQRAYSLAKEQRLNFGDDIPSALRIAKKKRWNSIEERRIHQESELHSYLSRLIAAERERELEECQRNHEGDEDDSHVRAQQACIEAKHDKYMADMDELFSQVDEKRKKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQEQLIPNLAMKEVIDAFISENGWVEDY,PF18391;PF04564;,4KBQ;6EFK;6NSV;,79,A,T,True,890
13405,10060,132646,single nucleotide variant,NM_005861.4(STUB1):c.719T>C (p.Met240Thr),10273,STUB1,HGNC:11427,Pathogenic,1,17-Apr-14,587777345,-,RCV000115003,"MONDO:MONDO:0000561,MONDO:MONDO:0014339,MedGen:C4014261,OMIM:615768,Orphanet:412057","Spinocerebellar ataxia, autosomal recessive 16",germline,germline,GRCh38,NC_000016.10,16,682214,682214,na,na,16p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA151394,UniProtKB:Q9UNE7#VAR_071300,OMIM:607207.0006",1,127148,682214,T,C,M240T,0,pathogenic,uncertain,Q9UNE7,Q9UNE7,reviewed,CHIP_HUMAN,"E3 ubiquitin-protein ligase CHIP, EC 2.3.2.27 (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)",STUB1 CHIP PP1131,Homo sapiens (Human),303.0,MKGKEEKEGGARLGAGGGSPEKSPSAQELKEQGNRLFVGRKYPEAAACYGRAITRNPLVAVYYTNRALCYLKMQQHEQALADCRRALELDGQSVKAHFFLGQCQLEMESYDEAIANLQRAYSLAKEQRLNFGDDIPSALRIAKKKRWNSIEERRIHQESELHSYLSRLIAAERERELEECQRNHEGDEDDSHVRAQQACIEAKHDKYMADMDELFSQVDEKRKKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQEQLIPNLAMKEVIDAFISENGWVEDY,PF18391;PF04564;,4KBQ;6EFK;6NSV;,240,M,T,True,890
13406,10059,132645,single nucleotide variant,NM_005861.4(STUB1):c.367C>G (p.Leu123Val),10273,STUB1,HGNC:11427,Pathogenic,1,17-Apr-14,587777344,-,RCV000115002,"MONDO:MONDO:0000561,MONDO:MONDO:0014339,MedGen:C4014261,OMIM:615768,Orphanet:412057","Spinocerebellar ataxia, autosomal recessive 16",germline,germline,GRCh38,NC_000016.10,16,681446,681446,na,na,16p13.3,no assertion criteria provided,1,-,N,"UniProtKB:Q9UNE7#VAR_071295,OMIM:607207.0005,ClinGen:CA151393",1,127147,681446,C,G,L123V,0,pathogenic,uncertain,Q9UNE7,Q9UNE7,reviewed,CHIP_HUMAN,"E3 ubiquitin-protein ligase CHIP, EC 2.3.2.27 (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)",STUB1 CHIP PP1131,Homo sapiens (Human),303.0,MKGKEEKEGGARLGAGGGSPEKSPSAQELKEQGNRLFVGRKYPEAAACYGRAITRNPLVAVYYTNRALCYLKMQQHEQALADCRRALELDGQSVKAHFFLGQCQLEMESYDEAIANLQRAYSLAKEQRLNFGDDIPSALRIAKKKRWNSIEERRIHQESELHSYLSRLIAAERERELEECQRNHEGDEDDSHVRAQQACIEAKHDKYMADMDELFSQVDEKRKKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQEQLIPNLAMKEVIDAFISENGWVEDY,PF18391;PF04564;,4KBQ;6EFK;6NSV;,123,L,V,True,890
13407,10056,132642,single nucleotide variant,NM_005861.4(STUB1):c.389A>T (p.Asn130Ile),10273,STUB1,HGNC:11427,Pathogenic,1,1-Jan-13,587777341,-,RCV000114999,"MONDO:MONDO:0000561,MONDO:MONDO:0014339,MedGen:C4014261,OMIM:615768,Orphanet:412057","Spinocerebellar ataxia, autosomal recessive 16",germline,germline,GRCh38,NC_000016.10,16,681468,681468,na,na,16p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA151390,UniProtKB:Q9UNE7#VAR_071296,OMIM:607207.0002",1,127144,681468,A,T,N130I,0,pathogenic,uncertain,Q9UNE7,Q9UNE7,reviewed,CHIP_HUMAN,"E3 ubiquitin-protein ligase CHIP, EC 2.3.2.27 (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)",STUB1 CHIP PP1131,Homo sapiens (Human),303.0,MKGKEEKEGGARLGAGGGSPEKSPSAQELKEQGNRLFVGRKYPEAAACYGRAITRNPLVAVYYTNRALCYLKMQQHEQALADCRRALELDGQSVKAHFFLGQCQLEMESYDEAIANLQRAYSLAKEQRLNFGDDIPSALRIAKKKRWNSIEERRIHQESELHSYLSRLIAAERERELEECQRNHEGDEDDSHVRAQQACIEAKHDKYMADMDELFSQVDEKRKKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQEQLIPNLAMKEVIDAFISENGWVEDY,PF18391;PF04564;,4KBQ;6EFK;6NSV;,130,N,I,True,890
13408,11201,171813,single nucleotide variant,NM_005861.4(STUB1):c.194A>G (p.Asn65Ser),10273,STUB1,HGNC:11427,Pathogenic,1,26-Sep-14,690016544,-,RCV000149509,"MONDO:MONDO:0000561,MONDO:MONDO:0014339,MedGen:C4014261,OMIM:615768,Orphanet:412057","Spinocerebellar ataxia, autosomal recessive 16",germline,germline,GRCh38,NC_000016.10,16,681186,681186,na,na,16p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA174973,UniProtKB:Q9UNE7#VAR_072349,OMIM:607207.0009",1,162097,681186,A,G,N65S,0,pathogenic,uncertain,Q9UNE7,Q9UNE7,reviewed,CHIP_HUMAN,"E3 ubiquitin-protein ligase CHIP, EC 2.3.2.27 (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)",STUB1 CHIP PP1131,Homo sapiens (Human),303.0,MKGKEEKEGGARLGAGGGSPEKSPSAQELKEQGNRLFVGRKYPEAAACYGRAITRNPLVAVYYTNRALCYLKMQQHEQALADCRRALELDGQSVKAHFFLGQCQLEMESYDEAIANLQRAYSLAKEQRLNFGDDIPSALRIAKKKRWNSIEERRIHQESELHSYLSRLIAAERERELEECQRNHEGDEDDSHVRAQQACIEAKHDKYMADMDELFSQVDEKRKKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQEQLIPNLAMKEVIDAFISENGWVEDY,PF18391;PF04564;,4KBQ;6EFK;6NSV;,65,N,S,True,890
13409,12189,208300,single nucleotide variant,NM_005861.4(STUB1):c.433A>C (p.Lys145Gln),10273,STUB1,HGNC:11427,Uncertain significance,1,28-May-19,146251364,-,RCV000194931|RCV000989407,"MedGen:CN169374|MONDO:MONDO:0000561,MONDO:MONDO:0014339,MedGen:C4014261,OMIM:615768,Orphanet:412057","not specified|Spinocerebellar ataxia, autosomal recessive 16",germline;unknown,germline,GRCh38,NC_000016.10,16,681512,681512,na,na,16p13.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA209422,UniProtKB:Q9UNE7#VAR_072350,OMIM:607207.0013",3,212325,681512,A,C,K145Q,2,uncertain,uncertain,Q9UNE7,Q9UNE7,reviewed,CHIP_HUMAN,"E3 ubiquitin-protein ligase CHIP, EC 2.3.2.27 (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)",STUB1 CHIP PP1131,Homo sapiens (Human),303.0,MKGKEEKEGGARLGAGGGSPEKSPSAQELKEQGNRLFVGRKYPEAAACYGRAITRNPLVAVYYTNRALCYLKMQQHEQALADCRRALELDGQSVKAHFFLGQCQLEMESYDEAIANLQRAYSLAKEQRLNFGDDIPSALRIAKKKRWNSIEERRIHQESELHSYLSRLIAAERERELEECQRNHEGDEDDSHVRAQQACIEAKHDKYMADMDELFSQVDEKRKKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQEQLIPNLAMKEVIDAFISENGWVEDY,PF18391;PF04564;,4KBQ;6EFK;6NSV;,145,K,Q,True,890
13410,10062,132648,single nucleotide variant,NM_005861.4(STUB1):c.236C>A (p.Ala79Asp),10273,STUB1,HGNC:11427,Pathogenic,1,17-Apr-14,587777347,-,RCV000115005,"MONDO:MONDO:0000561,MONDO:MONDO:0014339,MedGen:C4014261,OMIM:615768,Orphanet:412057","Spinocerebellar ataxia, autosomal recessive 16",germline,germline,GRCh38,NC_000016.10,16,681228,681228,na,na,16p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA151396,UniProtKB:Q9UNE7#VAR_071293,OMIM:607207.0008",1,127150,681228,C,A,A79D,0,pathogenic,uncertain,Q9UNE7,Q9UNE7,reviewed,CHIP_HUMAN,"E3 ubiquitin-protein ligase CHIP, EC 2.3.2.27 (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)",STUB1 CHIP PP1131,Homo sapiens (Human),303.0,MKGKEEKEGGARLGAGGGSPEKSPSAQELKEQGNRLFVGRKYPEAAACYGRAITRNPLVAVYYTNRALCYLKMQQHEQALADCRRALELDGQSVKAHFFLGQCQLEMESYDEAIANLQRAYSLAKEQRLNFGDDIPSALRIAKKKRWNSIEERRIHQESELHSYLSRLIAAERERELEECQRNHEGDEDDSHVRAQQACIEAKHDKYMADMDELFSQVDEKRKKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQEQLIPNLAMKEVIDAFISENGWVEDY,PF18391;PF04564;,4KBQ;6EFK;6NSV;,79,A,D,True,890
13411,10058,132644,single nucleotide variant,NM_005861.4(STUB1):c.737C>T (p.Thr246Met),10273,STUB1,HGNC:11427,Pathogenic,1,1-Apr-20,587777343,-,RCV000115001|RCV000995447,"MONDO:MONDO:0000561,MONDO:MONDO:0014339,MedGen:C4014261,OMIM:615768,Orphanet:412057|MedGen:CN517202","Spinocerebellar ataxia, autosomal recessive 16|not provided",germline,germline,GRCh38,NC_000016.10,16,682232,682232,na,na,16p13.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA151392,UniProtKB:Q9UNE7#VAR_071301,OMIM:607207.0004",3,127146,682232,C,T,T246M,1,pathogenic,pathogenic,Q9UNE7,Q9UNE7,reviewed,CHIP_HUMAN,"E3 ubiquitin-protein ligase CHIP, EC 2.3.2.27 (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)",STUB1 CHIP PP1131,Homo sapiens (Human),303.0,MKGKEEKEGGARLGAGGGSPEKSPSAQELKEQGNRLFVGRKYPEAAACYGRAITRNPLVAVYYTNRALCYLKMQQHEQALADCRRALELDGQSVKAHFFLGQCQLEMESYDEAIANLQRAYSLAKEQRLNFGDDIPSALRIAKKKRWNSIEERRIHQESELHSYLSRLIAAERERELEECQRNHEGDEDDSHVRAQQACIEAKHDKYMADMDELFSQVDEKRKKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQEQLIPNLAMKEVIDAFISENGWVEDY,PF18391;PF04564;,4KBQ;6EFK;6NSV;,246,T,M,True,890
13412,10055,132641,single nucleotide variant,NM_005861.4(STUB1):c.493C>T (p.Leu165Phe),10273,STUB1,HGNC:11427,Pathogenic,1,1-Jan-13,587777340,-,RCV000114998,"MONDO:MONDO:0000561,MONDO:MONDO:0014339,MedGen:C4014261,OMIM:615768,Orphanet:412057","Spinocerebellar ataxia, autosomal recessive 16",germline,germline,GRCh38,NC_000016.10,16,681572,681572,na,na,16p13.3,no assertion criteria provided,1,-,N,"UniProtKB:Q9UNE7#VAR_071298,OMIM:607207.0001,ClinGen:CA151389",1,127143,681572,C,T,L165F,0,pathogenic,uncertain,Q9UNE7,Q9UNE7,reviewed,CHIP_HUMAN,"E3 ubiquitin-protein ligase CHIP, EC 2.3.2.27 (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)",STUB1 CHIP PP1131,Homo sapiens (Human),303.0,MKGKEEKEGGARLGAGGGSPEKSPSAQELKEQGNRLFVGRKYPEAAACYGRAITRNPLVAVYYTNRALCYLKMQQHEQALADCRRALELDGQSVKAHFFLGQCQLEMESYDEAIANLQRAYSLAKEQRLNFGDDIPSALRIAKKKRWNSIEERRIHQESELHSYLSRLIAAERERELEECQRNHEGDEDDSHVRAQQACIEAKHDKYMADMDELFSQVDEKRKKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQEQLIPNLAMKEVIDAFISENGWVEDY,PF18391;PF04564;,4KBQ;6EFK;6NSV;,165,L,F,True,890
13413,10057,132643,single nucleotide variant,NM_005861.4(STUB1):c.441G>T (p.Trp147Cys),10273,STUB1,HGNC:11427,Pathogenic,1,1-Jan-13,587777342,-,RCV000115000,"MONDO:MONDO:0000561,MONDO:MONDO:0014339,MedGen:C4014261,OMIM:615768,Orphanet:412057","Spinocerebellar ataxia, autosomal recessive 16",germline,germline,GRCh38,NC_000016.10,16,681520,681520,na,na,16p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA151391,UniProtKB:Q9UNE7#VAR_071297,OMIM:607207.0003",1,127145,681520,G,T,W147C,0,pathogenic,uncertain,Q9UNE7,Q9UNE7,reviewed,CHIP_HUMAN,"E3 ubiquitin-protein ligase CHIP, EC 2.3.2.27 (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)",STUB1 CHIP PP1131,Homo sapiens (Human),303.0,MKGKEEKEGGARLGAGGGSPEKSPSAQELKEQGNRLFVGRKYPEAAACYGRAITRNPLVAVYYTNRALCYLKMQQHEQALADCRRALELDGQSVKAHFFLGQCQLEMESYDEAIANLQRAYSLAKEQRLNFGDDIPSALRIAKKKRWNSIEERRIHQESELHSYLSRLIAAERERELEECQRNHEGDEDDSHVRAQQACIEAKHDKYMADMDELFSQVDEKRKKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQEQLIPNLAMKEVIDAFISENGWVEDY,PF18391;PF04564;,4KBQ;6EFK;6NSV;,147,W,C,True,890
13414,6109,44236,single nucleotide variant,NM_002144.4(HOXB1):c.619C>T (p.Arg207Cys),3211,HOXB1,HGNC:5111,Pathogenic,1,13-Jul-12,387907239,-,RCV000029225,"MONDO:MONDO:0013880,MedGen:C3553625,OMIM:614744,Orphanet:306530",Hereditary congenital facial paresis 3,germline,germline,GRCh38,NC_000017.11,17,48529834,48529834,na,na,17q21.32,no assertion criteria provided,1,-,N,"ClinGen:CA129954,UniProtKB:P14653#VAR_068723,OMIM:142968.0001",1,35567,48529834,G,A,R207C,0,pathogenic,uncertain,P14653,P14653,reviewed,HXB1_HUMAN,Homeobox protein Hox-B1 (Homeobox protein Hox-2I),HOXB1 HOX2I,Homo sapiens (Human),301.0,MDYNRMNSFLEYPLCNRGPSAYSAHSAPTSFPPSSAQAVDSYASEGRYGGGLSSPAFQQNSGYPAQQPPSTLGVPFPSSAPSGYAPAACSPSYGPSQYYPLGQSEGDGGYFHPSSYGAQLGGLSDGYGAGGAGPGPYPPQHPPYGNEQTASFAPAYADLLSEDKETPCPSEPNTPTARTFDWMKVKRNPPKTAKVSEPGLGSPSGLRTNFTTRQLTELEKEFHFNKYLSRARRVEIAATLELNETQVKIWFQNRRMKQKKREREEGRVPPAPPGCPKEAAGDASDQSTCTSPEASPSSVTS,PF00046;,1B72;,207,R,C,True,891
13415,66,15280,single nucleotide variant,NM_000398.7(CYB5R3):c.610T>C (p.Cys204Arg),1727,CYB5R3,HGNC:2873,Pathogenic,1,1-May-08,121965011,-,RCV000000265,MedGen:C2749560,Methemoglobinemia type 2,germline,germline,GRCh38,NC_000022.11,22,42627327,42627327,na,na,22q13.2,no assertion criteria provided,1,-,N,"UniProtKB:P00387#VAR_010753,OMIM:613213.0008,ClinGen:CA114074",1,241,42627327,A,G,C204R,0,pathogenic,uncertain,P00387,P00387,reviewed,NB5R3_HUMAN,"NADH-cytochrome b5 reductase 3, B5R, Cytochrome b5 reductase, EC 1.6.2.2 (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form ]",CYB5R3 DIA1,Homo sapiens (Human),301.0,MGAQLSTLGHMVLFPVWFLYSLLMKLFQRSTPAITLESPDIKYPLRLIDREIISHDTRRFRFALPSPQHILGLPVGQHIYLSARIDGNLVVRPYTPISSDDDKGFVDLVIKVYFKDTHPKFPAGGKMSQYLESMQIGDTIEFRGPSGLLVYQGKGKFAIRPDKKSNPIIRTVKSVGMIAGGTGITPMLQVIRAIMKDPDDHTVCHLLFANQTEKDILLRPELEELRNKHSARFKLWYTLDRAPEAWDYGQGFVNEEMIRDHLPPPEEEPLVLMCGPPPMIQYACLPNLDHVGHPTERCFVF,PF00970;PF00175;,1UMK;,204,C,R,True,892
13416,67,15283,single nucleotide variant,NM_000398.7(CYB5R3):c.350C>G (p.Thr117Ser),1727,CYB5R3,HGNC:2873,Benign,0,19-Aug-20,1800457,-,RCV000000268|RCV000249451|RCV001281806,|MedGen:CN169374|MedGen:CN235283,NADH-CYTOCHROME b5 REDUCTASE POLYMORPHISM|not specified|none provided,germline,germline,GRCh38,NC_000022.11,22,42628265,42628265,na,na,22q13.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA114081,UniProtKB:P00387#VAR_010751,OMIM:613213.0011",3,244,42628265,G,C,T117S,2,benign,benign,P00387,P00387,reviewed,NB5R3_HUMAN,"NADH-cytochrome b5 reductase 3, B5R, Cytochrome b5 reductase, EC 1.6.2.2 (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form ]",CYB5R3 DIA1,Homo sapiens (Human),301.0,MGAQLSTLGHMVLFPVWFLYSLLMKLFQRSTPAITLESPDIKYPLRLIDREIISHDTRRFRFALPSPQHILGLPVGQHIYLSARIDGNLVVRPYTPISSDDDKGFVDLVIKVYFKDTHPKFPAGGKMSQYLESMQIGDTIEFRGPSGLLVYQGKGKFAIRPDKKSNPIIRTVKSVGMIAGGTGITPMLQVIRAIMKDPDDHTVCHLLFANQTEKDILLRPELEELRNKHSARFKLWYTLDRAPEAWDYGQGFVNEEMIRDHLPPPEEEPLVLMCGPPPMIQYACLPNLDHVGHPTERCFVF,PF00970;PF00175;,1UMK;,117,T,S,True,892
13417,68,15285,single nucleotide variant,NM_000398.7(CYB5R3):c.218T>C (p.Leu73Pro),1727,CYB5R3,HGNC:2873,Pathogenic,1,1-May-08,121965013,-,RCV000000270,MedGen:C2749559,"Methemoglobinemia, type I",germline,germline,GRCh38,NC_000022.11,22,42631386,42631386,na,na,22q13.2,no assertion criteria provided,1,-,N,"ClinGen:CA114083,UniProtKB:P00387#VAR_010750,OMIM:613213.0013",1,246,42631386,A,G,L73P,0,pathogenic,uncertain,P00387,P00387,reviewed,NB5R3_HUMAN,"NADH-cytochrome b5 reductase 3, B5R, Cytochrome b5 reductase, EC 1.6.2.2 (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form ]",CYB5R3 DIA1,Homo sapiens (Human),301.0,MGAQLSTLGHMVLFPVWFLYSLLMKLFQRSTPAITLESPDIKYPLRLIDREIISHDTRRFRFALPSPQHILGLPVGQHIYLSARIDGNLVVRPYTPISSDDDKGFVDLVIKVYFKDTHPKFPAGGKMSQYLESMQIGDTIEFRGPSGLLVYQGKGKFAIRPDKKSNPIIRTVKSVGMIAGGTGITPMLQVIRAIMKDPDDHTVCHLLFANQTEKDILLRPELEELRNKHSARFKLWYTLDRAPEAWDYGQGFVNEEMIRDHLPPPEEEPLVLMCGPPPMIQYACLPNLDHVGHPTERCFVF,PF00970;PF00175;,1UMK;,73,L,P,True,892
13418,65,15276,single nucleotide variant,NM_000398.7(CYB5R3):c.316G>A (p.Val106Met),1727,CYB5R3,HGNC:2873,Pathogenic,1,1-May-08,121965009,-,RCV000000261,MedGen:C2749559,"Methemoglobinemia, type I",germline,germline,GRCh38,NC_000022.11,22,42630899,42630899,na,na,22q13.2,no assertion criteria provided,1,-,N,"ClinGen:CA114071,UniProtKB:P00387#VAR_004620,OMIM:613213.0004",1,237,42630899,C,T,V106M,0,pathogenic,uncertain,P00387,P00387,reviewed,NB5R3_HUMAN,"NADH-cytochrome b5 reductase 3, B5R, Cytochrome b5 reductase, EC 1.6.2.2 (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form ]",CYB5R3 DIA1,Homo sapiens (Human),301.0,MGAQLSTLGHMVLFPVWFLYSLLMKLFQRSTPAITLESPDIKYPLRLIDREIISHDTRRFRFALPSPQHILGLPVGQHIYLSARIDGNLVVRPYTPISSDDDKGFVDLVIKVYFKDTHPKFPAGGKMSQYLESMQIGDTIEFRGPSGLLVYQGKGKFAIRPDKKSNPIIRTVKSVGMIAGGTGITPMLQVIRAIMKDPDDHTVCHLLFANQTEKDILLRPELEELRNKHSARFKLWYTLDRAPEAWDYGQGFVNEEMIRDHLPPPEEEPLVLMCGPPPMIQYACLPNLDHVGHPTERCFVF,PF00970;PF00175;,1UMK;,106,V,M,True,892
13419,62,15273,single nucleotide variant,NM_000398.7(CYB5R3):c.382T>C (p.Ser128Pro),1727,CYB5R3,HGNC:2873,Pathogenic,1,1-May-08,121965006,-,RCV000000258,MedGen:C2749560,Methemoglobinemia type 2,germline,germline,GRCh38,NC_000022.11,22,42628233,42628233,na,na,22q13.2,no assertion criteria provided,1,-,N,"ClinGen:CA114068,UniProtKB:P00387#VAR_004621,OMIM:613213.0001",1,234,42628233,A,G,S128P,0,pathogenic,uncertain,P00387,P00387,reviewed,NB5R3_HUMAN,"NADH-cytochrome b5 reductase 3, B5R, Cytochrome b5 reductase, EC 1.6.2.2 (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form ]",CYB5R3 DIA1,Homo sapiens (Human),301.0,MGAQLSTLGHMVLFPVWFLYSLLMKLFQRSTPAITLESPDIKYPLRLIDREIISHDTRRFRFALPSPQHILGLPVGQHIYLSARIDGNLVVRPYTPISSDDDKGFVDLVIKVYFKDTHPKFPAGGKMSQYLESMQIGDTIEFRGPSGLLVYQGKGKFAIRPDKKSNPIIRTVKSVGMIAGGTGITPMLQVIRAIMKDPDDHTVCHLLFANQTEKDILLRPELEELRNKHSARFKLWYTLDRAPEAWDYGQGFVNEEMIRDHLPPPEEEPLVLMCGPPPMIQYACLPNLDHVGHPTERCFVF,PF00970;PF00175;,1UMK;,128,S,P,True,892
13420,63,15274,single nucleotide variant,NM_000398.7(CYB5R3):c.173G>A (p.Arg58Gln),1727,CYB5R3,HGNC:2873,Pathogenic,1,1-May-08,121965007,-,RCV000000259,MedGen:C2749559,"Methemoglobinemia, type I",germline,germline,GRCh38,NC_000022.11,22,42631431,42631431,na,na,22q13.2,no assertion criteria provided,1,-,N,"UniProtKB:P00387#VAR_004619,OMIM:613213.0002,ClinGen:CA114069",1,235,42631431,C,T,R58Q,0,pathogenic,uncertain,P00387,P00387,reviewed,NB5R3_HUMAN,"NADH-cytochrome b5 reductase 3, B5R, Cytochrome b5 reductase, EC 1.6.2.2 (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form ]",CYB5R3 DIA1,Homo sapiens (Human),301.0,MGAQLSTLGHMVLFPVWFLYSLLMKLFQRSTPAITLESPDIKYPLRLIDREIISHDTRRFRFALPSPQHILGLPVGQHIYLSARIDGNLVVRPYTPISSDDDKGFVDLVIKVYFKDTHPKFPAGGKMSQYLESMQIGDTIEFRGPSGLLVYQGKGKFAIRPDKKSNPIIRTVKSVGMIAGGTGITPMLQVIRAIMKDPDDHTVCHLLFANQTEKDILLRPELEELRNKHSARFKLWYTLDRAPEAWDYGQGFVNEEMIRDHLPPPEEEPLVLMCGPPPMIQYACLPNLDHVGHPTERCFVF,PF00970;PF00175;,1UMK;,58,R,Q,True,892
13421,64,15275,single nucleotide variant,NM_000398.7(CYB5R3):c.446T>C (p.Leu149Pro),1727,CYB5R3,HGNC:2873,Pathogenic,1,1-May-08,121965008,-,RCV000000260,MedGen:C2749559,"Methemoglobinemia, type I",germline,germline,GRCh38,NC_000022.11,22,42628169,42628169,na,na,22q13.2,no assertion criteria provided,1,-,N,"ClinGen:CA114070,UniProtKB:P00387#VAR_004622,OMIM:613213.0003",1,236,42628169,A,G,L149P,0,pathogenic,uncertain,P00387,P00387,reviewed,NB5R3_HUMAN,"NADH-cytochrome b5 reductase 3, B5R, Cytochrome b5 reductase, EC 1.6.2.2 (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form ]",CYB5R3 DIA1,Homo sapiens (Human),301.0,MGAQLSTLGHMVLFPVWFLYSLLMKLFQRSTPAITLESPDIKYPLRLIDREIISHDTRRFRFALPSPQHILGLPVGQHIYLSARIDGNLVVRPYTPISSDDDKGFVDLVIKVYFKDTHPKFPAGGKMSQYLESMQIGDTIEFRGPSGLLVYQGKGKFAIRPDKKSNPIIRTVKSVGMIAGGTGITPMLQVIRAIMKDPDDHTVCHLLFANQTEKDILLRPELEELRNKHSARFKLWYTLDRAPEAWDYGQGFVNEEMIRDHLPPPEEEPLVLMCGPPPMIQYACLPNLDHVGHPTERCFVF,PF00970;PF00175;,1UMK;,149,L,P,True,892
13422,69,15288,single nucleotide variant,NM_000398.7(CYB5R3):c.611G>A (p.Cys204Tyr),1727,CYB5R3,HGNC:2873,Pathogenic,1,1-May-08,121965015,-,RCV000000273,MedGen:C2749559,"Methemoglobinemia, type I",germline,germline,GRCh38,NC_000022.11,22,42627326,42627326,na,na,22q13.2,no assertion criteria provided,1,-,N,"ClinGen:CA114088,UniProtKB:P00387#VAR_010754,OMIM:613213.0016",1,249,42627326,C,T,C204Y,0,pathogenic,uncertain,P00387,P00387,reviewed,NB5R3_HUMAN,"NADH-cytochrome b5 reductase 3, B5R, Cytochrome b5 reductase, EC 1.6.2.2 (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form ]",CYB5R3 DIA1,Homo sapiens (Human),301.0,MGAQLSTLGHMVLFPVWFLYSLLMKLFQRSTPAITLESPDIKYPLRLIDREIISHDTRRFRFALPSPQHILGLPVGQHIYLSARIDGNLVVRPYTPISSDDDKGFVDLVIKVYFKDTHPKFPAGGKMSQYLESMQIGDTIEFRGPSGLLVYQGKGKFAIRPDKKSNPIIRTVKSVGMIAGGTGITPMLQVIRAIMKDPDDHTVCHLLFANQTEKDILLRPELEELRNKHSARFKLWYTLDRAPEAWDYGQGFVNEEMIRDHLPPPEEEPLVLMCGPPPMIQYACLPNLDHVGHPTERCFVF,PF00970;PF00175;,1UMK;,204,C,Y,True,892
13423,70,15289,single nucleotide variant,NM_000398.7(CYB5R3):c.875G>A (p.Gly292Asp),1727,CYB5R3,HGNC:2873,Pathogenic,1,1-May-08,121965016,-,RCV000000274,MedGen:C2749559,"Methemoglobinemia, type I",germline,germline,GRCh38,NC_000022.11,22,42619804,42619804,na,na,22q13.2,no assertion criteria provided,1,-,N,"UniProtKB:P00387#VAR_037316,OMIM:613213.0017,ClinGen:CA114089",1,250,42619804,C,T,G292D,0,pathogenic,uncertain,P00387,P00387,reviewed,NB5R3_HUMAN,"NADH-cytochrome b5 reductase 3, B5R, Cytochrome b5 reductase, EC 1.6.2.2 (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form ]",CYB5R3 DIA1,Homo sapiens (Human),301.0,MGAQLSTLGHMVLFPVWFLYSLLMKLFQRSTPAITLESPDIKYPLRLIDREIISHDTRRFRFALPSPQHILGLPVGQHIYLSARIDGNLVVRPYTPISSDDDKGFVDLVIKVYFKDTHPKFPAGGKMSQYLESMQIGDTIEFRGPSGLLVYQGKGKFAIRPDKKSNPIIRTVKSVGMIAGGTGITPMLQVIRAIMKDPDDHTVCHLLFANQTEKDILLRPELEELRNKHSARFKLWYTLDRAPEAWDYGQGFVNEEMIRDHLPPPEEEPLVLMCGPPPMIQYACLPNLDHVGHPTERCFVF,PF00970;PF00175;,1UMK;,292,G,D,True,892
13424,321,16322,single nucleotide variant,NM_032790.3(ORAI1):c.271C>T (p.Arg91Trp),84876,ORAI1,HGNC:25896,Pathogenic,1,21-Mar-08,118203993,-,RCV000001346,"MONDO:MONDO:0013007,MedGen:C2748568,OMIM:612782,Orphanet:169090,Orphanet:317428",Combined immunodeficiency due to ORAI1 deficiency,germline,germline,GRCh38,NC_000012.12,12,121627018,121627018,na,na,12q24.31,no assertion criteria provided,1,-,N,"UniProtKB:Q96D31#VAR_026226,OMIM:610277.0001,ClinGen:CA114898",1,1283,121627018,C,T,R91W,0,pathogenic,uncertain,Q96D31,Q96D31,reviewed,CRCM1_HUMAN,Calcium release-activated calcium channel protein 1 (Protein orai-1) (Transmembrane protein 142A),ORAI1 CRACM1 TMEM142A,Homo sapiens (Human),301.0,MHPEPAPPPSRSSPELPPSGGSTTSGSRRSRRRSGDGEPPGAPPPPPSAVTYPDWIGQSYSEVMSLNEHSMQALSWRKLYLSRAKLKASSRTSALLSGFAMVAMVEVQLDADHDYPPGLLIAFSACTTVLVAVHLFALMISTCILPNIEAVSNVHNLNSVKESPHERMHRHIELAWAFSTVIGTLLFLAEVVLLCWVKFLPLKKQPGQPRPTSKPPASGAAANVSTSGITPGQAAAIASTTIMVPFGLIFIVFAVHFYRSLVSHKTDRQFQELNELAEFARLQDQLDHRGDHPLTPGSHYA,PF07856;,2MAK;4EHQ;,91,R,W,True,893
13425,10781,143261,single nucleotide variant,NM_032790.3(ORAI1):c.734C>T (p.Pro245Leu),84876,ORAI1,HGNC:25896,Pathogenic,1,18-Mar-14,587777528,-,RCV000128581,"MONDO:MONDO:0014383,MedGen:C4014557,OMIM:615883","Myopathy, tubular aggregate, 2",germline,germline,GRCh38,NC_000012.12,12,121641471,121641471,na,na,12q24.31,no assertion criteria provided,1,-,N,"ClinGen:CA163352,UniProtKB:Q96D31#VAR_071473,OMIM:610277.0002",1,139640,121641471,C,T,P245L,0,pathogenic,uncertain,Q96D31,Q96D31,reviewed,CRCM1_HUMAN,Calcium release-activated calcium channel protein 1 (Protein orai-1) (Transmembrane protein 142A),ORAI1 CRACM1 TMEM142A,Homo sapiens (Human),301.0,MHPEPAPPPSRSSPELPPSGGSTTSGSRRSRRRSGDGEPPGAPPPPPSAVTYPDWIGQSYSEVMSLNEHSMQALSWRKLYLSRAKLKASSRTSALLSGFAMVAMVEVQLDADHDYPPGLLIAFSACTTVLVAVHLFALMISTCILPNIEAVSNVHNLNSVKESPHERMHRHIELAWAFSTVIGTLLFLAEVVLLCWVKFLPLKKQPGQPRPTSKPPASGAAANVSTSGITPGQAAAIASTTIMVPFGLIFIVFAVHFYRSLVSHKTDRQFQELNELAEFARLQDQLDHRGDHPLTPGSHYA,PF07856;,2MAK;4EHQ;,245,P,L,True,893
13426,267,16020,single nucleotide variant,NM_024782.2(NHEJ1):c.169C>G (p.Arg57Gly),79840,NHEJ1,HGNC:25737,Pathogenic,1,27-Jan-06,118204451,-,RCV000001032,"MONDO:MONDO:0012650,MedGen:C1969799,OMIM:611291,Orphanet:169079","Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation",germline,germline,GRCh38,NC_000002.12,2,219158194,219158194,na,na,2q35,no assertion criteria provided,1,-,N,"ClinGen:CA114688,UniProtKB:Q9H9Q4#VAR_025704,OMIM:611290.0001",1,981,219158194,G,C,R57G,0,pathogenic,uncertain,Q9H9Q4,Q9H9Q4,reviewed,NHEJ1_HUMAN,Non-homologous end-joining factor 1 (Protein cernunnos) (XRCC4-like factor),NHEJ1 XLF,Homo sapiens (Human),299.0,MEELEQGLLMQPWAWLQLAENSLLAKVFITKQGYALLVSDLQQVWHEQVDTSVVSQRAKELNKRLTAPPAAFLCHLDNLLRPLLKDAAHPSEATFSCDCVADALILRVRSELSGLPFYWNFHCMLASPSLVSQHLIRPLMGMSLALQCQVRELATLLHMKDLEIQDYQESGATLIRDRLKTEPFEENSFLEQFMIEKLPEACSIGDGKPFVMNLQDLYMAVTTQEVQVGQKHQGAGDPHTSNSASLQGIDSQCVNQPEQLVSSAPTLSAPEKESTGTSGPLQRPQLSKVKRKKPRGLFS,PF09302;,2QM4;2R9A;3Q4F;3RWR;3SR2;3W03;6ERG;6ERH;7LSY;7LT3;7NFC;7NFE;,57,R,G,True,894
13427,268,16021,single nucleotide variant,NM_024782.2(NHEJ1):c.367T>C (p.Cys123Arg),79840,NHEJ1,HGNC:25737,Pathogenic,1,27-Jan-06,118204452,-,RCV000001033,"MONDO:MONDO:0012650,MedGen:C1969799,OMIM:611291,Orphanet:169079","Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation",germline,germline,GRCh38,NC_000002.12,2,219157495,219157495,na,na,2q35,no assertion criteria provided,1,-,N,"ClinGen:CA114690,UniProtKB:Q9H9Q4#VAR_025705,OMIM:611290.0002",1,982,219157495,A,G,C123R,0,pathogenic,uncertain,Q9H9Q4,Q9H9Q4,reviewed,NHEJ1_HUMAN,Non-homologous end-joining factor 1 (Protein cernunnos) (XRCC4-like factor),NHEJ1 XLF,Homo sapiens (Human),299.0,MEELEQGLLMQPWAWLQLAENSLLAKVFITKQGYALLVSDLQQVWHEQVDTSVVSQRAKELNKRLTAPPAAFLCHLDNLLRPLLKDAAHPSEATFSCDCVADALILRVRSELSGLPFYWNFHCMLASPSLVSQHLIRPLMGMSLALQCQVRELATLLHMKDLEIQDYQESGATLIRDRLKTEPFEENSFLEQFMIEKLPEACSIGDGKPFVMNLQDLYMAVTTQEVQVGQKHQGAGDPHTSNSASLQGIDSQCVNQPEQLVSSAPTLSAPEKESTGTSGPLQRPQLSKVKRKKPRGLFS,PF09302;,2QM4;2R9A;3Q4F;3RWR;3SR2;3W03;6ERG;6ERH;7LSY;7LT3;7NFC;7NFE;,123,C,R,True,894
13428,10739,142223,single nucleotide variant,NM_024782.2(NHEJ1):c.40G>A (p.Ala14Thr),79840,NHEJ1,HGNC:25737,Benign,0,31-Dec-19,34689457,-,RCV000127202|RCV000538734,"MedGen:CN169374|MONDO:MONDO:0012650,MedGen:C1969799,OMIM:611291,Orphanet:169079","not specified|Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation",germline,germline,GRCh38,NC_000002.12,2,219158323,219158323,na,na,2q35,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA292538,UniProtKB:Q9H9Q4#VAR_038790",2,138520,219158323,C,T,A14T,2,benign,benign,Q9H9Q4,Q9H9Q4,reviewed,NHEJ1_HUMAN,Non-homologous end-joining factor 1 (Protein cernunnos) (XRCC4-like factor),NHEJ1 XLF,Homo sapiens (Human),299.0,MEELEQGLLMQPWAWLQLAENSLLAKVFITKQGYALLVSDLQQVWHEQVDTSVVSQRAKELNKRLTAPPAAFLCHLDNLLRPLLKDAAHPSEATFSCDCVADALILRVRSELSGLPFYWNFHCMLASPSLVSQHLIRPLMGMSLALQCQVRELATLLHMKDLEIQDYQESGATLIRDRLKTEPFEENSFLEQFMIEKLPEACSIGDGKPFVMNLQDLYMAVTTQEVQVGQKHQGAGDPHTSNSASLQGIDSQCVNQPEQLVSSAPTLSAPEKESTGTSGPLQRPQLSKVKRKKPRGLFS,PF09302;,2QM4;2R9A;3Q4F;3RWR;3SR2;3W03;6ERG;6ERH;7LSY;7LT3;7NFC;7NFE;,14,A,T,True,894
13429,9997,131931,single nucleotide variant,NM_006397.2(RNASEH2A):c.690C>A (p.Phe230Leu),10535,RNASEH2A,HGNC:18518,Pathogenic,1,13-Mar-14,79767407,-,RCV000114339,"MONDO:MONDO:0012472,MedGen:C1835912,OMIM:610333,Orphanet:51",Aicardi Goutieres syndrome 4,germline,germline,GRCh38,NC_000019.10,19,12813135,12813135,na,na,19p13.13,no assertion criteria provided,1,-,N,"ClinGen:CA345497,UniProtKB:O75792#VAR_070628",1,126398,12813135,C,A,F230L,0,pathogenic,uncertain,O75792,O75792,reviewed,RNH2A_HUMAN,"Ribonuclease H2 subunit A, RNase H2 subunit A, EC 3.1.26.4 (Aicardi-Goutieres syndrome 4 protein, AGS4) (RNase H(35)) (Ribonuclease HI large subunit, RNase HI large subunit) (Ribonuclease HI subunit A)",RNASEH2A RNASEHI RNHIA,Homo sapiens (Human),299.0,MDLSELERDNTGRCRLSSPVPAVCRKEPCVLGVDEAGRGPVLGPMVYAICYCPLPRLADLEALKVADSKTLLESERERLFAKMEDTDFVGWALDVLSPNLISTSMLGRVKYNLNSLSHDTATGLIQYALDQGVNVTQVFVDTVGMPETYQARLQQSFPGIEVTVKAKADALYPVVSAASICAKVARDQAVKKWQFVEKLQDLDTDYGSGYPNDPKTKAWLKEHVEPVFGFPQFVRFSWRTAQTILEKEAEDVIWEDSASENQEGLRKITSYFLNEGSQARPRSSHRYFLERGLESATSL,PF01351;,3P56;3PUF;,230,F,L,True,895
13430,9996,131930,single nucleotide variant,NM_006397.2(RNASEH2A):c.322C>T (p.Arg108Trp),10535,RNASEH2A,HGNC:18518,Pathogenic,1,13-Mar-14,76436818,-,RCV000114338,"MONDO:MONDO:0012472,MedGen:C1835912,OMIM:610333,Orphanet:51",Aicardi Goutieres syndrome 4,germline,germline,GRCh38,NC_000019.10,19,12807328,12807328,na,na,19p13.13,no assertion criteria provided,1,-,N,"ClinGen:CA345495,UniProtKB:O75792#VAR_070625",1,126397,12807328,C,T,R108W,0,pathogenic,uncertain,O75792,O75792,reviewed,RNH2A_HUMAN,"Ribonuclease H2 subunit A, RNase H2 subunit A, EC 3.1.26.4 (Aicardi-Goutieres syndrome 4 protein, AGS4) (RNase H(35)) (Ribonuclease HI large subunit, RNase HI large subunit) (Ribonuclease HI subunit A)",RNASEH2A RNASEHI RNHIA,Homo sapiens (Human),299.0,MDLSELERDNTGRCRLSSPVPAVCRKEPCVLGVDEAGRGPVLGPMVYAICYCPLPRLADLEALKVADSKTLLESERERLFAKMEDTDFVGWALDVLSPNLISTSMLGRVKYNLNSLSHDTATGLIQYALDQGVNVTQVFVDTVGMPETYQARLQQSFPGIEVTVKAKADALYPVVSAASICAKVARDQAVKKWQFVEKLQDLDTDYGSGYPNDPKTKAWLKEHVEPVFGFPQFVRFSWRTAQTILEKEAEDVIWEDSASENQEGLRKITSYFLNEGSQARPRSSHRYFLERGLESATSL,PF01351;,3P56;3PUF;,108,R,W,True,895
13431,9998,131933,single nucleotide variant,NM_006397.2(RNASEH2A):c.719C>T (p.Thr240Met),10535,RNASEH2A,HGNC:18518,Pathogenic,1,13-Mar-14,79843600,-,RCV000114341,"MONDO:MONDO:0012472,MedGen:C1835912,OMIM:610333,Orphanet:51",Aicardi Goutieres syndrome 4,germline,germline,GRCh38,NC_000019.10,19,12813164,12813164,na,na,19p13.13,no assertion criteria provided,1,-,N,"ClinGen:CA345502,UniProtKB:O75792#VAR_070630",1,126400,12813164,C,T,T240M,0,pathogenic,uncertain,O75792,O75792,reviewed,RNH2A_HUMAN,"Ribonuclease H2 subunit A, RNase H2 subunit A, EC 3.1.26.4 (Aicardi-Goutieres syndrome 4 protein, AGS4) (RNase H(35)) (Ribonuclease HI large subunit, RNase HI large subunit) (Ribonuclease HI subunit A)",RNASEH2A RNASEHI RNHIA,Homo sapiens (Human),299.0,MDLSELERDNTGRCRLSSPVPAVCRKEPCVLGVDEAGRGPVLGPMVYAICYCPLPRLADLEALKVADSKTLLESERERLFAKMEDTDFVGWALDVLSPNLISTSMLGRVKYNLNSLSHDTATGLIQYALDQGVNVTQVFVDTVGMPETYQARLQQSFPGIEVTVKAKADALYPVVSAASICAKVARDQAVKKWQFVEKLQDLDTDYGSGYPNDPKTKAWLKEHVEPVFGFPQFVRFSWRTAQTILEKEAEDVIWEDSASENQEGLRKITSYFLNEGSQARPRSSHRYFLERGLESATSL,PF01351;,3P56;3PUF;,240,T,M,True,895
13432,13410,256778,single nucleotide variant,NM_006397.3(RNASEH2A):c.605T>C (p.Leu202Ser),10535,RNASEH2A,HGNC:18518,Benign,0,31-Dec-19,7247284,-,RCV000245339|RCV000531947,"MedGen:CN169374|MONDO:MONDO:0012472,MedGen:C1835912,OMIM:610333,Orphanet:51",not specified|Aicardi Goutieres syndrome 4,germline,germline,GRCh38,NC_000019.10,19,12810372,12810372,na,na,19p13.13,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA9231969,UniProtKB:O75792#VAR_024617",2,259974,12810372,T,C,L202S,2,benign,benign,O75792,O75792,reviewed,RNH2A_HUMAN,"Ribonuclease H2 subunit A, RNase H2 subunit A, EC 3.1.26.4 (Aicardi-Goutieres syndrome 4 protein, AGS4) (RNase H(35)) (Ribonuclease HI large subunit, RNase HI large subunit) (Ribonuclease HI subunit A)",RNASEH2A RNASEHI RNHIA,Homo sapiens (Human),299.0,MDLSELERDNTGRCRLSSPVPAVCRKEPCVLGVDEAGRGPVLGPMVYAICYCPLPRLADLEALKVADSKTLLESERERLFAKMEDTDFVGWALDVLSPNLISTSMLGRVKYNLNSLSHDTATGLIQYALDQGVNVTQVFVDTVGMPETYQARLQQSFPGIEVTVKAKADALYPVVSAASICAKVARDQAVKKWQFVEKLQDLDTDYGSGYPNDPKTKAWLKEHVEPVFGFPQFVRFSWRTAQTILEKEAEDVIWEDSASENQEGLRKITSYFLNEGSQARPRSSHRYFLERGLESATSL,PF01351;,3P56;3PUF;,202,L,S,True,895
13433,9999,131934,single nucleotide variant,NM_006397.2(RNASEH2A):c.872G>A (p.Arg291His),10535,RNASEH2A,HGNC:18518,Uncertain significance,1,23-Jul-20,75037667,-,RCV000114342,"MONDO:MONDO:0012472,MedGen:C1835912,OMIM:610333,Orphanet:51",Aicardi Goutieres syndrome 4,germline,germline,GRCh38,NC_000019.10,19,12813438,12813438,na,na,19p13.13,"criteria provided, single submitter",2,-,N,"ClinGen:CA345505,UniProtKB:O75792#VAR_070632",3,126401,12813438,G,A,R291H,1,uncertain,uncertain,O75792,O75792,reviewed,RNH2A_HUMAN,"Ribonuclease H2 subunit A, RNase H2 subunit A, EC 3.1.26.4 (Aicardi-Goutieres syndrome 4 protein, AGS4) (RNase H(35)) (Ribonuclease HI large subunit, RNase HI large subunit) (Ribonuclease HI subunit A)",RNASEH2A RNASEHI RNHIA,Homo sapiens (Human),299.0,MDLSELERDNTGRCRLSSPVPAVCRKEPCVLGVDEAGRGPVLGPMVYAICYCPLPRLADLEALKVADSKTLLESERERLFAKMEDTDFVGWALDVLSPNLISTSMLGRVKYNLNSLSHDTATGLIQYALDQGVNVTQVFVDTVGMPETYQARLQQSFPGIEVTVKAKADALYPVVSAASICAKVARDQAVKKWQFVEKLQDLDTDYGSGYPNDPKTKAWLKEHVEPVFGFPQFVRFSWRTAQTILEKEAEDVIWEDSASENQEGLRKITSYFLNEGSQARPRSSHRYFLERGLESATSL,PF01351;,3P56;3PUF;,291,R,H,True,895
13434,7585,76972,single nucleotide variant,NM_006397.3(RNASEH2A):c.556C>T (p.Arg186Trp),10535,RNASEH2A,HGNC:18518,Likely pathogenic,1,21-Mar-17,77103971,-,RCV000056305|RCV000610608,"MONDO:MONDO:0012472,MedGen:C1835912,OMIM:610333,Orphanet:51|MONDO:MONDO:0018866,MedGen:C0393591,OMIM:PS225750,Orphanet:51",Aicardi Goutieres syndrome 4|Aicardi Goutieres syndrome,germline,germline,GRCh38,NC_000019.10,19,12810323,12810323,na,na,19p13.13,"criteria provided, single submitter",3,-,N,"ClinGen:CA345300,UniProtKB:O75792#VAR_070626,OMIM:606034.0005",3,66068,12810323,C,T,R186W,1,pathogenic,pathogenic,O75792,O75792,reviewed,RNH2A_HUMAN,"Ribonuclease H2 subunit A, RNase H2 subunit A, EC 3.1.26.4 (Aicardi-Goutieres syndrome 4 protein, AGS4) (RNase H(35)) (Ribonuclease HI large subunit, RNase HI large subunit) (Ribonuclease HI subunit A)",RNASEH2A RNASEHI RNHIA,Homo sapiens (Human),299.0,MDLSELERDNTGRCRLSSPVPAVCRKEPCVLGVDEAGRGPVLGPMVYAICYCPLPRLADLEALKVADSKTLLESERERLFAKMEDTDFVGWALDVLSPNLISTSMLGRVKYNLNSLSHDTATGLIQYALDQGVNVTQVFVDTVGMPETYQARLQQSFPGIEVTVKAKADALYPVVSAASICAKVARDQAVKKWQFVEKLQDLDTDYGSGYPNDPKTKAWLKEHVEPVFGFPQFVRFSWRTAQTILEKEAEDVIWEDSASENQEGLRKITSYFLNEGSQARPRSSHRYFLERGLESATSL,PF01351;,3P56;3PUF;,186,R,W,True,895
13435,1107,19680,single nucleotide variant,NM_006397.2(RNASEH2A):c.109G>A (p.Gly37Ser),10535,RNASEH2A,HGNC:18518,Pathogenic,1,13-Mar-14,76857106,-,RCV000004904,"MONDO:MONDO:0012472,MedGen:C1835912,OMIM:610333,Orphanet:51",Aicardi Goutieres syndrome 4,germline,germline,GRCh38,NC_000019.10,19,12806782,12806782,na,na,19p13.13,no assertion criteria provided,2,-,N,"ClinGen:CA340281,UniProtKB:O75792#VAR_027377,OMIM:606034.0001",1,4641,12806782,G,A,G37S,0,pathogenic,uncertain,O75792,O75792,reviewed,RNH2A_HUMAN,"Ribonuclease H2 subunit A, RNase H2 subunit A, EC 3.1.26.4 (Aicardi-Goutieres syndrome 4 protein, AGS4) (RNase H(35)) (Ribonuclease HI large subunit, RNase HI large subunit) (Ribonuclease HI subunit A)",RNASEH2A RNASEHI RNHIA,Homo sapiens (Human),299.0,MDLSELERDNTGRCRLSSPVPAVCRKEPCVLGVDEAGRGPVLGPMVYAICYCPLPRLADLEALKVADSKTLLESERERLFAKMEDTDFVGWALDVLSPNLISTSMLGRVKYNLNSLSHDTATGLIQYALDQGVNVTQVFVDTVGMPETYQARLQQSFPGIEVTVKAKADALYPVVSAASICAKVARDQAVKKWQFVEKLQDLDTDYGSGYPNDPKTKAWLKEHVEPVFGFPQFVRFSWRTAQTILEKEAEDVIWEDSASENQEGLRKITSYFLNEGSQARPRSSHRYFLERGLESATSL,PF01351;,3P56;3PUF;,37,G,S,True,895
13436,14197,348186,single nucleotide variant,NM_006397.2(RNASEH2A):c.615T>A (p.Asp205Glu),10535,RNASEH2A,HGNC:18518,Benign,0,31-Dec-19,62619782,-,RCV000544425|RCV000712932,"MONDO:MONDO:0012472,MedGen:C1835912,OMIM:610333,Orphanet:51|MedGen:CN517202",Aicardi Goutieres syndrome 4|not provided,germline,germline,GRCh38,NC_000019.10,19,12810382,12810382,na,na,19p13.13,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA9231971,UniProtKB:O75792#VAR_070627",2,328291,12810382,T,A,D205E,2,benign,benign,O75792,O75792,reviewed,RNH2A_HUMAN,"Ribonuclease H2 subunit A, RNase H2 subunit A, EC 3.1.26.4 (Aicardi-Goutieres syndrome 4 protein, AGS4) (RNase H(35)) (Ribonuclease HI large subunit, RNase HI large subunit) (Ribonuclease HI subunit A)",RNASEH2A RNASEHI RNHIA,Homo sapiens (Human),299.0,MDLSELERDNTGRCRLSSPVPAVCRKEPCVLGVDEAGRGPVLGPMVYAICYCPLPRLADLEALKVADSKTLLESERERLFAKMEDTDFVGWALDVLSPNLISTSMLGRVKYNLNSLSHDTATGLIQYALDQGVNVTQVFVDTVGMPETYQARLQQSFPGIEVTVKAKADALYPVVSAASICAKVARDQAVKKWQFVEKLQDLDTDYGSGYPNDPKTKAWLKEHVEPVFGFPQFVRFSWRTAQTILEKEAEDVIWEDSASENQEGLRKITSYFLNEGSQARPRSSHRYFLERGLESATSL,PF01351;,3P56;3PUF;,205,D,E,True,895
13437,7584,76970,single nucleotide variant,NM_006397.2(RNASEH2A):c.704G>A (p.Arg235Gln),10535,RNASEH2A,HGNC:18518,Pathogenic,1,13-Mar-14,75718910,-,RCV000056303,"MONDO:MONDO:0012472,MedGen:C1835912,OMIM:610333,Orphanet:51",Aicardi Goutieres syndrome 4,germline,germline,GRCh38,NC_000019.10,19,12813149,12813149,na,na,19p13.13,no assertion criteria provided,2,-,N,"UniProtKB:O75792#VAR_070629,OMIM:606034.0003,ClinGen:CA345294",1,66066,12813149,G,A,R235Q,0,pathogenic,uncertain,O75792,O75792,reviewed,RNH2A_HUMAN,"Ribonuclease H2 subunit A, RNase H2 subunit A, EC 3.1.26.4 (Aicardi-Goutieres syndrome 4 protein, AGS4) (RNase H(35)) (Ribonuclease HI large subunit, RNase HI large subunit) (Ribonuclease HI subunit A)",RNASEH2A RNASEHI RNHIA,Homo sapiens (Human),299.0,MDLSELERDNTGRCRLSSPVPAVCRKEPCVLGVDEAGRGPVLGPMVYAICYCPLPRLADLEALKVADSKTLLESERERLFAKMEDTDFVGWALDVLSPNLISTSMLGRVKYNLNSLSHDTATGLIQYALDQGVNVTQVFVDTVGMPETYQARLQQSFPGIEVTVKAKADALYPVVSAASICAKVARDQAVKKWQFVEKLQDLDTDYGSGYPNDPKTKAWLKEHVEPVFGFPQFVRFSWRTAQTILEKEAEDVIWEDSASENQEGLRKITSYFLNEGSQARPRSSHRYFLERGLESATSL,PF01351;,3P56;3PUF;,235,R,Q,True,895
13438,11228,172499,single nucleotide variant,NM_001276345.2(TNNT2):c.566C>T (p.Ser189Phe),7139,TNNT2,HGNC:11949,Pathogenic/Likely pathogenic,1,29-Oct-19,727504246,-,RCV000154216|RCV000471745|RCV000617860|RCV001004907,"Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|MONDO:MONDO:0011095,MedGen:C1832243,OMIM:601494,Orphanet:154,Orphanet:54260;MONDO:MONDO:0012900,MedGen:C2676271,OMIM:612422,Orphanet:75249;MONDO:MONDO:0007266,MedGen:C1861864,OMIM:115195|MedGen:CN230736|MONDO:MONDO:0007266,MedGen:C1861864,OMIM:115195",Hypertrophic cardiomyopathy|Left ventricular noncompaction 6;Familial restrictive cardiomyopathy 3;Familial hypertrophic cardiomyopathy 2|Cardiovascular phenotype|Familial hypertrophic cardiomyopathy 2,germline,germline,GRCh38,NC_000001.11,1,201363330,201363330,na,na,1q32.1,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"ClinGen:CA004746,UniProtKB:P45379#VAR_016199",2,177634,201363330,G,A,S189F,2,pathogenic,pathogenic,P45379,P45379,reviewed,TNNT2_HUMAN,"Troponin T, cardiac muscle, TnTc (Cardiac muscle troponin T, cTnT)",TNNT2,Homo sapiens (Human),298.0,MSDIEEVVEEYEEEEQEEAAVEEEEDWREDEDEQEEAAEEDAEAEAETEETRAEEDEEEEEAKEAEDGPMEESKPKPRSFMPNLVPPKIPDGERVDFDDIHRKRMEKDLNELQALIEAHFENRKKEEEELVSLKDRIERRRAERAEQQRIRNEREKERQNRLAEERARREEEENRRKAEDEARKKKALSNMMHFGGYIQKQAQTERKSGKRQTEREKKKKILAERRKVLAIDHLNEDQLREKAKELWQSIYNLEAEKFDLQEKFKQQKYEINVLRNRINDNQKVSKTRGKAKVTGRWK,PF00992;,1J1D;1J1E;4Y99;6KN7;6KN8;,189,S,F,True,896
13439,3054,27453,single nucleotide variant,NM_001276345.2(TNNT2):c.451C>T (p.Arg151Trp),7139,TNNT2,HGNC:11949,Pathogenic,1,15-Aug-19,74315379,-,RCV000013225|RCV000157537|RCV000159296|RCV000211866|RCV000524542|RCV000710045,"MONDO:MONDO:0011095,MedGen:C1832243,OMIM:601494,Orphanet:154,Orphanet:54260|EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MedGen:C0007193,Orphanet:217604|MedGen:CN517202|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MedGen:C0007193,Orphanet:217604|MONDO:MONDO:0012900,MedGen:C2676271,OMIM:612422,Orphanet:75249;MONDO:MONDO:0011095,MedGen:C1832243,OMIM:601494,Orphanet:154,Orphanet:54260;MONDO:MONDO:0007266,MedGen:C1861864,OMIM:115195|MONDO:MONDO:0015470,MedGen:CN257735,Orphanet:154",Left ventricular noncompaction 6|Primary dilated cardiomyopathy|not provided|Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy|Familial restrictive cardiomyopathy 3;Left ventricular noncompaction 6;Familial hypertrophic cardiomyopathy 2|Familial isolated dilated cardiomyopathy,de novo;germline,germline,GRCh38,NC_000001.11,1,201364336,201364336,na,na,1q32.1,"criteria provided, multiple submitters, no conflicts",8,"ACMG2013,ACMG2016",N,"ClinGen:CA004526,UniProtKB:P45379#VAR_016198,OMIM:191045.0007",3,12414,201364336,G,A,R151W,2,pathogenic,pathogenic,P45379,P45379,reviewed,TNNT2_HUMAN,"Troponin T, cardiac muscle, TnTc (Cardiac muscle troponin T, cTnT)",TNNT2,Homo sapiens (Human),298.0,MSDIEEVVEEYEEEEQEEAAVEEEEDWREDEDEQEEAAEEDAEAEAETEETRAEEDEEEEEAKEAEDGPMEESKPKPRSFMPNLVPPKIPDGERVDFDDIHRKRMEKDLNELQALIEAHFENRKKEEEELVSLKDRIERRRAERAEQQRIRNEREKERQNRLAEERARREEEENRRKAEDEARKKKALSNMMHFGGYIQKQAQTERKSGKRQTEREKKKKILAERRKVLAIDHLNEDQLREKAKELWQSIYNLEAEKFDLQEKFKQQKYEINVLRNRINDNQKVSKTRGKAKVTGRWK,PF00992;,1J1D;1J1E;4Y99;6KN7;6KN8;,151,R,W,True,896
13440,3053,27451,single nucleotide variant,NM_001276345.2(TNNT2):c.358T>A (p.Phe120Ile),7139,TNNT2,HGNC:11949,Pathogenic,1,1-Nov-17,121964858,-,RCV000013223|RCV000223682|RCV000709767,"MONDO:MONDO:0007266,MedGen:C1861864,OMIM:115195|MedGen:CN517202|MONDO:MONDO:0011095,MedGen:C1832243,OMIM:601494,Orphanet:154,Orphanet:54260",Familial hypertrophic cardiomyopathy 2|not provided|Left ventricular noncompaction 6,germline,germline,GRCh38,NC_000001.11,1,201365244,201365244,na,na,1q32.1,"criteria provided, single submitter",3,"ACMG2013,ACMG2016",N,"ClinGen:CA004383,UniProtKB:P45379#VAR_007607,OMIM:191045.0005",3,12412,201365244,A,T,F120I,1,pathogenic,pathogenic,P45379,P45379,reviewed,TNNT2_HUMAN,"Troponin T, cardiac muscle, TnTc (Cardiac muscle troponin T, cTnT)",TNNT2,Homo sapiens (Human),298.0,MSDIEEVVEEYEEEEQEEAAVEEEEDWREDEDEQEEAAEEDAEAEAETEETRAEEDEEEEEAKEAEDGPMEESKPKPRSFMPNLVPPKIPDGERVDFDDIHRKRMEKDLNELQALIEAHFENRKKEEEELVSLKDRIERRRAERAEQQRIRNEREKERQNRLAEERARREEEENRRKAEDEARKKKALSNMMHFGGYIQKQAQTERKSGKRQTEREKKKKILAERRKVLAIDHLNEDQLREKAKELWQSIYNLEAEKFDLQEKFKQQKYEINVLRNRINDNQKVSKTRGKAKVTGRWK,PF00992;,1J1D;1J1E;4Y99;6KN7;6KN8;,120,F,I,True,896
13441,6835,52796,single nucleotide variant,NM_001276345.2(TNNT2):c.304C>T (p.Arg102Trp),7139,TNNT2,HGNC:11949,Pathogenic,1,1-Nov-19,397516456,-,RCV000159280|RCV000208103|RCV000474512|RCV000620701|RCV000768491,"MedGen:CN517202|MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|MONDO:MONDO:0007266,MedGen:C1861864,OMIM:115195;MONDO:MONDO:0011095,MedGen:C1832243,OMIM:601494,Orphanet:154,Orphanet:54260;MONDO:MONDO:0012900,MedGen:C2676271,OMIM:612422,Orphanet:75249|MedGen:CN230736|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569",not provided|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 2;Left ventricular noncompaction 6;Familial restrictive cardiomyopathy 3|Cardiovascular phenotype|Hypertrophic cardiomyopathy,germline,germline,GRCh38,NC_000001.11,1,201365298,201365298,na,na,1q32.1,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,"ClinGen:CA004266,UniProtKB:P45379#VAR_016196",2,43627,201365298,G,A,R102W,2,pathogenic,pathogenic,P45379,P45379,reviewed,TNNT2_HUMAN,"Troponin T, cardiac muscle, TnTc (Cardiac muscle troponin T, cTnT)",TNNT2,Homo sapiens (Human),298.0,MSDIEEVVEEYEEEEQEEAAVEEEEDWREDEDEQEEAAEEDAEAEAETEETRAEEDEEEEEAKEAEDGPMEESKPKPRSFMPNLVPPKIPDGERVDFDDIHRKRMEKDLNELQALIEAHFENRKKEEEELVSLKDRIERRRAERAEQQRIRNEREKERQNRLAEERARREEEENRRKAEDEARKKKALSNMMHFGGYIQKQAQTERKSGKRQTEREKKKKILAERRKVLAIDHLNEDQLREKAKELWQSIYNLEAEKFDLQEKFKQQKYEINVLRNRINDNQKVSKTRGKAKVTGRWK,PF00992;,1J1D;1J1E;4Y99;6KN7;6KN8;,102,R,W,True,896
13442,6836,52844,single nucleotide variant,NM_000364.3(TNNT2):c.113C>T (p.Ala38Val),7139,TNNT2,HGNC:11949,Conflicting interpretations of pathogenicity,1,31-Dec-19,200754249,-,RCV000036624|RCV000148900|RCV000149450|RCV000588568|RCV000755701|RCV000771256|RCV000852592|RCV001081698|RCV001099310|RCV001099311,"MedGen:CN169374|MedGen:C4478895|MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|MedGen:CN517202|MONDO:MONDO:0011095,MedGen:C1832243,OMIM:601494,Orphanet:154,Orphanet:54260|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|Human Phenotype Ontology:HP:0004755,MedGen:C0039240|MONDO:MONDO:0007266,MedGen:C1861864,OMIM:115195;MONDO:MONDO:0012900,MedGen:C2676271,OMIM:612422,Orphanet:75249;MONDO:MONDO:0011095,MedGen:C1832243,OMIM:601494,Orphanet:154,Orphanet:54260|MONDO:MONDO:0007266,MedGen:C1861864,OMIM:115195|MONDO:MONDO:0012900,MedGen:C2676271,OMIM:612422,Orphanet:75249",not specified|Increased left ventricular wall thickness|Primary familial hypertrophic cardiomyopathy|not provided|Left ventricular noncompaction 6|Cardiomyopathy|Supraventricular tachycardia|Familial hypertrophic cardiomyopathy 2;Familial restrictive cardiomyopathy 3;Left ventricular noncompaction 6|Familial hypertrophic cardiomyopathy 2|Familial restrictive cardiomyopathy 3,germline;unknown,germline,GRCh38,NC_000001.11,1,201368212,201368212,na,na,1q32.1,"criteria provided, conflicting interpretations",12,"ACMG2013,ACMG2016",N,"ClinGen:CA004079,UniProtKB:P45379#VAR_067259",2,43675,201368212,G,A,A38V,1,uncertain,uncertain,P45379,P45379,reviewed,TNNT2_HUMAN,"Troponin T, cardiac muscle, TnTc (Cardiac muscle troponin T, cTnT)",TNNT2,Homo sapiens (Human),298.0,MSDIEEVVEEYEEEEQEEAAVEEEEDWREDEDEQEEAAEEDAEAEAETEETRAEEDEEEEEAKEAEDGPMEESKPKPRSFMPNLVPPKIPDGERVDFDDIHRKRMEKDLNELQALIEAHFENRKKEEEELVSLKDRIERRRAERAEQQRIRNEREKERQNRLAEERARREEEENRRKAEDEARKKKALSNMMHFGGYIQKQAQTERKSGKRQTEREKKKKILAERRKVLAIDHLNEDQLREKAKELWQSIYNLEAEKFDLQEKFKQQKYEINVLRNRINDNQKVSKTRGKAKVTGRWK,PF00992;,1J1D;1J1E;4Y99;6KN7;6KN8;,38,A,V,True,896
13443,2952,27071,single nucleotide variant,NM_006488.3(KHK):c.127G>A (p.Ala43Thr),3795,KHK,HGNC:6315,Affects,0,1-Sep-94,104893644,-,RCV000012812,"MONDO:MONDO:0009252,MedGen:C0268160,OMIM:229800,Orphanet:2056","Fructosuria, essential",germline,germline,GRCh38,NC_000002.12,2,27092366,27092366,na,na,2p23.3,no assertion criteria provided,1,-,N,"ClinGen:CA121825,UniProtKB:P50053#VAR_006073,OMIM:614058.0002",1,12032,27092366,G,A,A43T,0,uncertain,uncertain,P50053,P50053,reviewed,KHK_HUMAN,"Ketohexokinase, EC 2.7.1.3 (Hepatic fructokinase)",KHK,Homo sapiens (Human),298.0,MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV,PF00294;,2HLZ;2HQQ;2HW1;3B3L;3NBV;3NBW;3NC2;3NC9;3NCA;3Q92;3QA2;3QAI;3RO4;5WBM;5WBO;5WBP;5WBQ;5WBR;5WBZ;6UL7;6W0N;6W0W;6W0X;6W0Y;6W0Z;,43,A,T,True,897
13444,2951,27070,single nucleotide variant,NM_006488.3(KHK):c.118G>A (p.Gly40Arg),3795,KHK,HGNC:6315,Affects,0,1-Sep-94,104893643,-,RCV000012811,"MONDO:MONDO:0009252,MedGen:C0268160,OMIM:229800,Orphanet:2056","Fructosuria, essential",germline,germline,GRCh38,NC_000002.12,2,27092357,27092357,na,na,2p23.3,no assertion criteria provided,1,-,N,"ClinGen:CA121823,UniProtKB:P50053#VAR_006072,OMIM:614058.0001",1,12031,27092357,G,A,G40R,0,uncertain,uncertain,P50053,P50053,reviewed,KHK_HUMAN,"Ketohexokinase, EC 2.7.1.3 (Hepatic fructokinase)",KHK,Homo sapiens (Human),298.0,MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV,PF00294;,2HLZ;2HQQ;2HW1;3B3L;3NBV;3NBW;3NC2;3NC9;3NCA;3Q92;3QA2;3QAI;3RO4;5WBM;5WBO;5WBP;5WBQ;5WBR;5WBZ;6UL7;6W0N;6W0W;6W0X;6W0Y;6W0Z;,40,G,R,True,897
13445,13798,289183,single nucleotide variant,NM_006488.3(KHK):c.145G>A (p.Val49Ile),3795,KHK,HGNC:6315,Benign,0,13-Jan-18,2304681,-,RCV000357894,"MONDO:MONDO:0009252,MedGen:C0268160,OMIM:229800,Orphanet:2056","Fructosuria, essential",germline,germline,GRCh38,NC_000002.12,2,27092384,27092384,na,na,2p23.3,"criteria provided, single submitter",1,-,N,"ClinGen:CA1569115,UniProtKB:P50053#VAR_006074",2,335482,27092384,G,A,V49I,1,benign,benign,P50053,P50053,reviewed,KHK_HUMAN,"Ketohexokinase, EC 2.7.1.3 (Hepatic fructokinase)",KHK,Homo sapiens (Human),298.0,MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV,PF00294;,2HLZ;2HQQ;2HW1;3B3L;3NBV;3NBW;3NC2;3NC9;3NCA;3Q92;3QA2;3QAI;3RO4;5WBM;5WBO;5WBP;5WBQ;5WBR;5WBZ;6UL7;6W0N;6W0W;6W0X;6W0Y;6W0Z;,49,V,I,True,897
13446,12815,238353,single nucleotide variant,NM_000969.5(RPL5):c.629A>G (p.Tyr210Cys),6125,RPL5,HGNC:10360,Benign/Likely benign,0,31-Dec-19,11540832,-,RCV000233634|RCV000503324|RCV000513699|RCV000986343|RCV001093892,"Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124|MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|MONDO:MONDO:0012937,MedGen:C2931850,OMIM:612561,Orphanet:124",Diamond-Blackfan anemia|not specified|not provided|Diamond-Blackfan anemia 1|Diamond-Blackfan anemia 6,germline;unknown,germline,GRCh38,NC_000001.11,1,92837557,92837557,na,na,1p22.1,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA952529,UniProtKB:P46777#VAR_052009",2,238200,92837557,A,G,Y210C,2,benign,benign,P46777,P46777,reviewed,RL5_HUMAN,60S ribosomal protein L5 (Large ribosomal subunit protein uL18),RPL5 MSTP030,Homo sapiens (Human),297.0,MGFVKVVKNKAYFKRYQVKFRRRREGKTDYYARKRLVIQDKNKYNTPKYRMIVRVTNRDIICQIAYARIEGDMIVCAAYAHELPKYGVKVGLTNYAAAYCTGLLLARRLLNRFGMDKIYEGQVEVTGDEYNVESIDGQPGAFTCYLDAGLARTTTGNKVFGALKGAVDGGLSIPHSTKRFPGYDSESKEFNAEVHRKHIMGQNVADYMRYLMEEDEDAYKKQFSQYIKNSVTPDMMEEMYKKAHAAIRENPVYEKKPKKEVKKKRWNRPKMSLAQKKDRVAQKKASFLRAQERAAES,PF14204;PF17144;,4UG0;4V6X;5AJ0;5LKS;5T2C;6IP5;6IP6;6IP8;6LQM;6LSR;6LSS;6LU8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6W6L;6XA1;6Y0G;6Y2L;6Y57;6Y6X;6Z6L;6Z6M;6Z6N;6ZM7;6ZME;6ZMI;6ZMO;7BHP;,210,Y,C,True,898
13447,1421,21219,single nucleotide variant,NM_000969.5(RPL5):c.418G>A (p.Gly140Ser),6125,RPL5,HGNC:10360,Uncertain significance,1,21-Oct-20,121434406,-,RCV000006557|RCV000499952|RCV001306122,"MONDO:MONDO:0012937,MedGen:C2931850,OMIM:612561,Orphanet:124|MedGen:CN169374|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124",Diamond-Blackfan anemia 6|not specified|Diamond-Blackfan anemia,germline;unknown,germline,GRCh38,NC_000001.11,1,92836283,92836283,na,na,1p22.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA253788,UniProtKB:P46777#VAR_055450,OMIM:603634.0002",3,6180,92836283,G,A,G140S,2,uncertain,uncertain,P46777,P46777,reviewed,RL5_HUMAN,60S ribosomal protein L5 (Large ribosomal subunit protein uL18),RPL5 MSTP030,Homo sapiens (Human),297.0,MGFVKVVKNKAYFKRYQVKFRRRREGKTDYYARKRLVIQDKNKYNTPKYRMIVRVTNRDIICQIAYARIEGDMIVCAAYAHELPKYGVKVGLTNYAAAYCTGLLLARRLLNRFGMDKIYEGQVEVTGDEYNVESIDGQPGAFTCYLDAGLARTTTGNKVFGALKGAVDGGLSIPHSTKRFPGYDSESKEFNAEVHRKHIMGQNVADYMRYLMEEDEDAYKKQFSQYIKNSVTPDMMEEMYKKAHAAIRENPVYEKKPKKEVKKKRWNRPKMSLAQKKDRVAQKKASFLRAQERAAES,PF14204;PF17144;,4UG0;4V6X;5AJ0;5LKS;5T2C;6IP5;6IP6;6IP8;6LQM;6LSR;6LSS;6LU8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6W6L;6XA1;6Y0G;6Y2L;6Y57;6Y6X;6Z6L;6Z6M;6Z6N;6ZM7;6ZME;6ZMI;6ZMO;7BHP;,140,G,S,True,898
13448,4742,31817,single nucleotide variant,NM_001983.4(ERCC1):c.693C>G (p.Phe231Leu),2067,ERCC1,HGNC:3433,Pathogenic,1,26-Sep-16,121913028,-,RCV000018266|RCV000252117,"MONDO:MONDO:0012554,MedGen:C1853100,OMIM:610758|MONDO:MONDO:0016006,MedGen:C0009207,Orphanet:191",Cerebrooculofacioskeletal syndrome 4|Cockayne syndrome,germline,germline,GRCh38,NC_000019.10,19,45414870,45414870,na,na,19q13.32,no assertion criteria provided,2,-,N,"ClinGen:CA126880,UniProtKB:P07992#VAR_032776,OMIM:126380.0002",1,16778,45414870,G,C,F231L,0,pathogenic,uncertain,P07992,P07992,reviewed,ERCC1_HUMAN,DNA excision repair protein ERCC-1,ERCC1,Homo sapiens (Human),297.0,MDPGKDKEGVPQPSGPPARKKFVIPLDEDEVPPGVAKPLFRSTQSLPTVDTSAQAAPQTYAEYAISQPLEGAGATCPTGSEPLAGETPNQALKPGAKSNSIIVSPRQRGNPVLKFVRNVPWEFGDVIPDYVLGQSTCALFLSLRYHNLHPDYIHGRLQSLGKNFALRVLLVQVDVKDPQQALKELAKMCILADCTLILAWSPEEAGRYLETYKAYEQKPADLLMEKLEQDFVSRVTECLTTVKSVNKTDSQTLLTTFGSLEQLIAASREDLALCPGLGPQKARRLFDVLHEPFLKVP,PF03834;,1Z00;2A1I;2A1J;2JNW;2JPD;2MUT;6SXA;6SXB;,231,F,L,True,899
13449,227,15801,single nucleotide variant,NM_015702.3(MMADHC):c.545C>A (p.Thr182Asn),27249,MMADHC,HGNC:25221,Pathogenic,1,3-Apr-08,118204045,-,RCV000000798,MedGen:C1848553,"Homocystinuria, cblD type, variant 1",germline,germline,GRCh38,NC_000002.12,2,149575775,149575775,na,na,2q23.2,no assertion criteria provided,1,-,N,"OMIM:611935.0002,ClinGen:CA114487,UniProtKB:Q9H3L0#VAR_043844",1,762,149575775,G,T,T182N,0,pathogenic,uncertain,Q9H3L0,Q9H3L0,reviewed,MMAD_HUMAN,"Cobalamin trafficking protein CblD (CblD) (Methylmalonic aciduria and homocystinuria type D protein, mitochondrial)",MMADHC C2orf25 CL25022 HSPC161 My011,Homo sapiens (Human),296.0,MANVLCNRARLVSYLPGFCSLVKRVVNPKAFSTAGSSGSDESHVAAAPPDICSRTVWPDETMGPFGPQDQRFQLPGNIGFDCHLNGTASQKKSLVHKTLPDVLAEPLSSERHEFVMAQYVNEFQGNDAPVEQEINSAETYFESARVECAIQTCPELLRKDFESLFPEVANGKLMILTVTQKTKNDMTVWSEEVEIEREVLLEKFINGAKEICYALRAEGYWADFIDPSSGLAFFGPYTNNTLFETDERYRHLGFSVDDLGCCKVIRHSLWGTHVVVGSIFTNATPDSHIMKKLSGN,PF10229;,5CUZ;5CV0;6X8Z;,182,T,N,True,900
13450,226,15800,single nucleotide variant,NM_015702.3(MMADHC):c.776T>C (p.Leu259Pro),27249,MMADHC,HGNC:25221,Pathogenic,1,3-Apr-08,118204044,-,RCV000000797,MedGen:C1848553,"Homocystinuria, cblD type, variant 1",germline,germline,GRCh38,NC_000002.12,2,149570089,149570089,na,na,2q23.2,no assertion criteria provided,1,-,N,"ClinGen:CA114486,UniProtKB:Q9H3L0#VAR_043847,OMIM:611935.0001",1,761,149570089,A,G,L259P,0,pathogenic,uncertain,Q9H3L0,Q9H3L0,reviewed,MMAD_HUMAN,"Cobalamin trafficking protein CblD (CblD) (Methylmalonic aciduria and homocystinuria type D protein, mitochondrial)",MMADHC C2orf25 CL25022 HSPC161 My011,Homo sapiens (Human),296.0,MANVLCNRARLVSYLPGFCSLVKRVVNPKAFSTAGSSGSDESHVAAAPPDICSRTVWPDETMGPFGPQDQRFQLPGNIGFDCHLNGTASQKKSLVHKTLPDVLAEPLSSERHEFVMAQYVNEFQGNDAPVEQEINSAETYFESARVECAIQTCPELLRKDFESLFPEVANGKLMILTVTQKTKNDMTVWSEEVEIEREVLLEKFINGAKEICYALRAEGYWADFIDPSSGLAFFGPYTNNTLFETDERYRHLGFSVDDLGCCKVIRHSLWGTHVVVGSIFTNATPDSHIMKKLSGN,PF10229;,5CUZ;5CV0;6X8Z;,259,L,P,True,900
13451,228,15802,single nucleotide variant,NM_015702.3(MMADHC):c.746A>G (p.Tyr249Cys),27249,MMADHC,HGNC:25221,Pathogenic,1,3-Apr-08,118204046,-,RCV000000799,MedGen:C1848553,"Homocystinuria, cblD type, variant 1",germline,germline,GRCh38,NC_000002.12,2,149570119,149570119,na,na,2q23.2,no assertion criteria provided,1,-,N,"OMIM:611935.0003,ClinGen:CA114488,UniProtKB:Q9H3L0#VAR_043846",1,763,149570119,T,C,Y249C,0,pathogenic,uncertain,Q9H3L0,Q9H3L0,reviewed,MMAD_HUMAN,"Cobalamin trafficking protein CblD (CblD) (Methylmalonic aciduria and homocystinuria type D protein, mitochondrial)",MMADHC C2orf25 CL25022 HSPC161 My011,Homo sapiens (Human),296.0,MANVLCNRARLVSYLPGFCSLVKRVVNPKAFSTAGSSGSDESHVAAAPPDICSRTVWPDETMGPFGPQDQRFQLPGNIGFDCHLNGTASQKKSLVHKTLPDVLAEPLSSERHEFVMAQYVNEFQGNDAPVEQEINSAETYFESARVECAIQTCPELLRKDFESLFPEVANGKLMILTVTQKTKNDMTVWSEEVEIEREVLLEKFINGAKEICYALRAEGYWADFIDPSSGLAFFGPYTNNTLFETDERYRHLGFSVDDLGCCKVIRHSLWGTHVVVGSIFTNATPDSHIMKKLSGN,PF10229;,5CUZ;5CV0;6X8Z;,249,Y,C,True,900
13452,997,19208,single nucleotide variant,NM_018960.6(GNMT):c.149T>C (p.Leu50Pro),27232,GNMT,HGNC:4415,Pathogenic,1,1-Jan-02,121907888,-,RCV000004386,"MONDO:MONDO:0011698,MedGen:C1847720,OMIM:606664,Orphanet:289891",Glycine N-methyltransferase deficiency,germline,germline,GRCh38,NC_000006.12,6,42960916,42960916,na,na,6p21.1,no assertion criteria provided,1,-,N,"ClinGen:CA248600,UniProtKB:Q14749#VAR_012766,OMIM:606628.0001",1,4169,42960916,T,C,L50P,0,pathogenic,uncertain,Q14749,Q14749,reviewed,GNMT_HUMAN,"Glycine N-methyltransferase, EC 2.1.1.20",GNMT,Homo sapiens (Human),295.0,MVDSVYRTRSLGVAAEGLPDQYADGEAARVWQLYIGDTRSRTAEYKAWLLGLLRQHGCQRVLDVACGTGVDSIMLVEEGFSVTSVDASDKMLKYALKERWNRRHEPAFDKWVIEEANWMTLDKDVPQSAEGGFDAVICLGNSFAHLPDCKGDQSEHRLALKNIASMVRAGGLLVIDHRNYDHILSTGCAPPGKNIYYKSDLTKDVTTSVLIVNNKAHMVTLDYTVQVPGAGQDGSPGLSKFRLSYYPHCLASFTELLQAAFGGKCQHSVLGDFKPYKPGQTYIPCYFIHVLKRTD,PF13649;,1R74;2AZT;,50,L,P,True,901
13453,12418,215757,single nucleotide variant,NM_018960.6(GNMT):c.422A>G (p.Asn141Ser),27232,GNMT,HGNC:4415,Pathogenic,1,1-Jan-03,864321678,-,RCV000203283,"MONDO:MONDO:0011698,MedGen:C1847720,OMIM:606664,Orphanet:289891",Glycine N-methyltransferase deficiency,germline,germline,GRCh38,NC_000006.12,6,42962849,42962849,na,na,6p21.1,no assertion criteria provided,1,-,N,"ClinGen:CA347847,UniProtKB:Q14749#VAR_019840,OMIM:606628.0003",1,218931,42962849,A,G,N141S,0,pathogenic,uncertain,Q14749,Q14749,reviewed,GNMT_HUMAN,"Glycine N-methyltransferase, EC 2.1.1.20",GNMT,Homo sapiens (Human),295.0,MVDSVYRTRSLGVAAEGLPDQYADGEAARVWQLYIGDTRSRTAEYKAWLLGLLRQHGCQRVLDVACGTGVDSIMLVEEGFSVTSVDASDKMLKYALKERWNRRHEPAFDKWVIEEANWMTLDKDVPQSAEGGFDAVICLGNSFAHLPDCKGDQSEHRLALKNIASMVRAGGLLVIDHRNYDHILSTGCAPPGKNIYYKSDLTKDVTTSVLIVNNKAHMVTLDYTVQVPGAGQDGSPGLSKFRLSYYPHCLASFTELLQAAFGGKCQHSVLGDFKPYKPGQTYIPCYFIHVLKRTD,PF13649;,1R74;2AZT;,141,N,S,True,901
13454,998,19209,single nucleotide variant,NM_018960.6(GNMT):c.529C>A (p.His177Asn),-1,PEX6;GNMT;CNPY3-GNMT,-,Likely benign,1,30-Jul-19,121907889,-,RCV000004387|RCV001208834,"MONDO:MONDO:0011698,MedGen:C1847720,OMIM:606664,Orphanet:289891|MedGen:C1832200,Orphanet:79189","Glycine N-methyltransferase deficiency|Peroxisome biogenesis disorders, Zellweger syndrome spectrum",germline,germline,GRCh38,NC_000006.12,6,42963149,42963149,na,na,6p21.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA248601,UniProtKB:Q14749#VAR_012767,OMIM:606628.0002",3,4170,42963149,C,A,H177N,1,benign,benign,Q14749,Q14749,reviewed,GNMT_HUMAN,"Glycine N-methyltransferase, EC 2.1.1.20",GNMT,Homo sapiens (Human),295.0,MVDSVYRTRSLGVAAEGLPDQYADGEAARVWQLYIGDTRSRTAEYKAWLLGLLRQHGCQRVLDVACGTGVDSIMLVEEGFSVTSVDASDKMLKYALKERWNRRHEPAFDKWVIEEANWMTLDKDVPQSAEGGFDAVICLGNSFAHLPDCKGDQSEHRLALKNIASMVRAGGLLVIDHRNYDHILSTGCAPPGKNIYYKSDLTKDVTTSVLIVNNKAHMVTLDYTVQVPGAGQDGSPGLSKFRLSYYPHCLASFTELLQAAFGGKCQHSVLGDFKPYKPGQTYIPCYFIHVLKRTD,PF13649;,1R74;2AZT;,177,H,N,True,901
13455,7467,75611,single nucleotide variant,NM_002295.6(RPSA):c.161C>A (p.Thr54Asn),3921,RPSA,HGNC:6502,Pathogenic,1,24-May-13,397514762,-,RCV000054827,"MONDO:MONDO:0010066,MedGen:C0685889,OMIM:271400,Orphanet:101351","Asplenia, isolated congenital",germline,germline,GRCh38,NC_000003.12,3,39408633,39408633,na,na,3p22.1,no assertion criteria provided,1,-,N,"ClinGen:CA144725,UniProtKB:P08865#VAR_075092,OMIM:150370.0006",1,64676,39408633,C,A,T54N,0,pathogenic,uncertain,P08865,P08865,reviewed,RSSA_HUMAN,"40S ribosomal protein SA (37 kDa laminin receptor precursor, 37LRP) (37/67 kDa laminin receptor, LRP/LR) (67 kDa laminin receptor, 67LR) (Colon carcinoma laminin-binding protein) (Laminin receptor 1, LamR) (Laminin-binding protein precursor p40, LBP/p40) (Multidrug resistance-associated protein MGr1-Ag) (NEM/1CHD4) (Small ribosomal subunit protein uS2)",RPSA LAMBR LAMR1,Homo sapiens (Human),295.0,MSGALDVLQMKEEDVLKFLAAGTHLGGTNLDFQMEQYIYKRKSDGIYIINLKRTWEKLLLAARAIVAIENPADVSVISSRNTGQRAVLKFAAATGATPIAGRFTPGTFTNQIQAAFREPRLLVVTDPRADHQPLTEASYVNLPTIALCNTDSPLRYVDIAIPCNNKGAHSVGLMWWMLAREVLRMRGTISREHPWEVMPDLYFYRDPEEIEKEEQAAAEKAVTKEEFQGEWTAPAPEFTATQPEVADWSEGVQVPSVPIQQFPTEDWSAQPATEDWSAAPTAQATEWVGATTDWS,PF16122;PF00318;,3BCH;4UG0;4V6X;5A2Q;5AJ0;5FLX;5LKS;5OA3;5T2C;5VYC;6FEC;6G18;6G4S;6G51;6G53;6G5H;6G5I;6IP5;6IP6;6IP8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6XA1;6Y0G;6Y2L;6Y57;6YBD;6YBW;6Z6L;6Z6M;6Z6N;6ZLW;6ZM7;6ZME;6ZMI;6ZMO;6ZMT;6ZMW;6ZN5;6ZOJ;6ZOK;6ZON;6ZP4;6ZUO;6ZV6;6ZVH;6ZVJ;6ZXD;6ZXE;6ZXF;6ZXG;6ZXH;7A09;7K5I;,54,T,N,True,902
13456,7466,75610,single nucleotide variant,NM_002295.6(RPSA):c.556C>T (p.Arg186Cys),3921,RPSA,HGNC:6502,Pathogenic,1,24-May-13,397514761,-,RCV000054826,"MONDO:MONDO:0010066,MedGen:C0685889,OMIM:271400,Orphanet:101351","Asplenia, isolated congenital",germline,germline,GRCh38,NC_000003.12,3,39411706,39411706,na,na,3p22.1,no assertion criteria provided,1,-,N,"UniProtKB:P08865#VAR_075097,OMIM:150370.0005,ClinGen:CA144723",1,64675,39411706,C,T,R186C,0,pathogenic,uncertain,P08865,P08865,reviewed,RSSA_HUMAN,"40S ribosomal protein SA (37 kDa laminin receptor precursor, 37LRP) (37/67 kDa laminin receptor, LRP/LR) (67 kDa laminin receptor, 67LR) (Colon carcinoma laminin-binding protein) (Laminin receptor 1, LamR) (Laminin-binding protein precursor p40, LBP/p40) (Multidrug resistance-associated protein MGr1-Ag) (NEM/1CHD4) (Small ribosomal subunit protein uS2)",RPSA LAMBR LAMR1,Homo sapiens (Human),295.0,MSGALDVLQMKEEDVLKFLAAGTHLGGTNLDFQMEQYIYKRKSDGIYIINLKRTWEKLLLAARAIVAIENPADVSVISSRNTGQRAVLKFAAATGATPIAGRFTPGTFTNQIQAAFREPRLLVVTDPRADHQPLTEASYVNLPTIALCNTDSPLRYVDIAIPCNNKGAHSVGLMWWMLAREVLRMRGTISREHPWEVMPDLYFYRDPEEIEKEEQAAAEKAVTKEEFQGEWTAPAPEFTATQPEVADWSEGVQVPSVPIQQFPTEDWSAQPATEDWSAAPTAQATEWVGATTDWS,PF16122;PF00318;,3BCH;4UG0;4V6X;5A2Q;5AJ0;5FLX;5LKS;5OA3;5T2C;5VYC;6FEC;6G18;6G4S;6G51;6G53;6G5H;6G5I;6IP5;6IP6;6IP8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6XA1;6Y0G;6Y2L;6Y57;6YBD;6YBW;6Z6L;6Z6M;6Z6N;6ZLW;6ZM7;6ZME;6ZMI;6ZMO;6ZMT;6ZMW;6ZN5;6ZOJ;6ZOK;6ZON;6ZP4;6ZUO;6ZV6;6ZVH;6ZVJ;6ZXD;6ZXE;6ZXF;6ZXG;6ZXH;7A09;7K5I;,186,R,C,True,902
13457,7464,75608,single nucleotide variant,NM_002295.6(RPSA):c.538C>G (p.Arg180Gly),3921,RPSA,HGNC:6502,Pathogenic,1,24-May-13,397514760,-,RCV000054824,"MONDO:MONDO:0010066,MedGen:C0685889,OMIM:271400,Orphanet:101351","Asplenia, isolated congenital",germline,germline,GRCh38,NC_000003.12,3,39411688,39411688,na,na,3p22.1,no assertion criteria provided,1,-,N,"ClinGen:CA144719,UniProtKB:P08865#VAR_075094,OMIM:150370.0003",1,64673,39411688,C,G,R180G,0,pathogenic,uncertain,P08865,P08865,reviewed,RSSA_HUMAN,"40S ribosomal protein SA (37 kDa laminin receptor precursor, 37LRP) (37/67 kDa laminin receptor, LRP/LR) (67 kDa laminin receptor, 67LR) (Colon carcinoma laminin-binding protein) (Laminin receptor 1, LamR) (Laminin-binding protein precursor p40, LBP/p40) (Multidrug resistance-associated protein MGr1-Ag) (NEM/1CHD4) (Small ribosomal subunit protein uS2)",RPSA LAMBR LAMR1,Homo sapiens (Human),295.0,MSGALDVLQMKEEDVLKFLAAGTHLGGTNLDFQMEQYIYKRKSDGIYIINLKRTWEKLLLAARAIVAIENPADVSVISSRNTGQRAVLKFAAATGATPIAGRFTPGTFTNQIQAAFREPRLLVVTDPRADHQPLTEASYVNLPTIALCNTDSPLRYVDIAIPCNNKGAHSVGLMWWMLAREVLRMRGTISREHPWEVMPDLYFYRDPEEIEKEEQAAAEKAVTKEEFQGEWTAPAPEFTATQPEVADWSEGVQVPSVPIQQFPTEDWSAQPATEDWSAAPTAQATEWVGATTDWS,PF16122;PF00318;,3BCH;4UG0;4V6X;5A2Q;5AJ0;5FLX;5LKS;5OA3;5T2C;5VYC;6FEC;6G18;6G4S;6G51;6G53;6G5H;6G5I;6IP5;6IP6;6IP8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6XA1;6Y0G;6Y2L;6Y57;6YBD;6YBW;6Z6L;6Z6M;6Z6N;6ZLW;6ZM7;6ZME;6ZMI;6ZMO;6ZMT;6ZMW;6ZN5;6ZOJ;6ZOK;6ZON;6ZP4;6ZUO;6ZV6;6ZVH;6ZVJ;6ZXD;6ZXE;6ZXF;6ZXG;6ZXH;7A09;7K5I;,180,R,G,True,902
13458,7465,75609,single nucleotide variant,NM_002295.6(RPSA):c.538C>T (p.Arg180Trp),3921,RPSA,HGNC:6502,Pathogenic,1,24-May-13,397514760,-,RCV000054825,"MONDO:MONDO:0010066,MedGen:C0685889,OMIM:271400,Orphanet:101351","Asplenia, isolated congenital",germline,germline,GRCh38,NC_000003.12,3,39411688,39411688,na,na,3p22.1,no assertion criteria provided,1,-,N,"ClinGen:CA144721,UniProtKB:P08865#VAR_075095,OMIM:150370.0004",1,64674,39411688,C,T,R180W,0,pathogenic,uncertain,P08865,P08865,reviewed,RSSA_HUMAN,"40S ribosomal protein SA (37 kDa laminin receptor precursor, 37LRP) (37/67 kDa laminin receptor, LRP/LR) (67 kDa laminin receptor, 67LR) (Colon carcinoma laminin-binding protein) (Laminin receptor 1, LamR) (Laminin-binding protein precursor p40, LBP/p40) (Multidrug resistance-associated protein MGr1-Ag) (NEM/1CHD4) (Small ribosomal subunit protein uS2)",RPSA LAMBR LAMR1,Homo sapiens (Human),295.0,MSGALDVLQMKEEDVLKFLAAGTHLGGTNLDFQMEQYIYKRKSDGIYIINLKRTWEKLLLAARAIVAIENPADVSVISSRNTGQRAVLKFAAATGATPIAGRFTPGTFTNQIQAAFREPRLLVVTDPRADHQPLTEASYVNLPTIALCNTDSPLRYVDIAIPCNNKGAHSVGLMWWMLAREVLRMRGTISREHPWEVMPDLYFYRDPEEIEKEEQAAAEKAVTKEEFQGEWTAPAPEFTATQPEVADWSEGVQVPSVPIQQFPTEDWSAQPATEDWSAAPTAQATEWVGATTDWS,PF16122;PF00318;,3BCH;4UG0;4V6X;5A2Q;5AJ0;5FLX;5LKS;5OA3;5T2C;5VYC;6FEC;6G18;6G4S;6G51;6G53;6G5H;6G5I;6IP5;6IP6;6IP8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6XA1;6Y0G;6Y2L;6Y57;6YBD;6YBW;6Z6L;6Z6M;6Z6N;6ZLW;6ZM7;6ZME;6ZMI;6ZMO;6ZMT;6ZMW;6ZN5;6ZOJ;6ZOK;6ZON;6ZP4;6ZUO;6ZV6;6ZVH;6ZVJ;6ZXD;6ZXE;6ZXF;6ZXG;6ZXH;7A09;7K5I;,180,R,W,True,902
13459,7468,75612,single nucleotide variant,NM_002295.6(RPSA):c.172C>T (p.Leu58Phe),3921,RPSA,HGNC:6502,Pathogenic,1,24-May-13,397514763,-,RCV000054828,"MONDO:MONDO:0010066,MedGen:C0685889,OMIM:271400,Orphanet:101351","Asplenia, isolated congenital",germline,germline,GRCh38,NC_000003.12,3,39408644,39408644,na,na,3p22.1,no assertion criteria provided,1,-,N,"UniProtKB:P08865#VAR_075093,OMIM:150370.0007,ClinGen:CA144727",1,64677,39408644,C,T,L58F,0,pathogenic,uncertain,P08865,P08865,reviewed,RSSA_HUMAN,"40S ribosomal protein SA (37 kDa laminin receptor precursor, 37LRP) (37/67 kDa laminin receptor, LRP/LR) (67 kDa laminin receptor, 67LR) (Colon carcinoma laminin-binding protein) (Laminin receptor 1, LamR) (Laminin-binding protein precursor p40, LBP/p40) (Multidrug resistance-associated protein MGr1-Ag) (NEM/1CHD4) (Small ribosomal subunit protein uS2)",RPSA LAMBR LAMR1,Homo sapiens (Human),295.0,MSGALDVLQMKEEDVLKFLAAGTHLGGTNLDFQMEQYIYKRKSDGIYIINLKRTWEKLLLAARAIVAIENPADVSVISSRNTGQRAVLKFAAATGATPIAGRFTPGTFTNQIQAAFREPRLLVVTDPRADHQPLTEASYVNLPTIALCNTDSPLRYVDIAIPCNNKGAHSVGLMWWMLAREVLRMRGTISREHPWEVMPDLYFYRDPEEIEKEEQAAAEKAVTKEEFQGEWTAPAPEFTATQPEVADWSEGVQVPSVPIQQFPTEDWSAQPATEDWSAAPTAQATEWVGATTDWS,PF16122;PF00318;,3BCH;4UG0;4V6X;5A2Q;5AJ0;5FLX;5LKS;5OA3;5T2C;5VYC;6FEC;6G18;6G4S;6G51;6G53;6G5H;6G5I;6IP5;6IP6;6IP8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6XA1;6Y0G;6Y2L;6Y57;6YBD;6YBW;6Z6L;6Z6M;6Z6N;6ZLW;6ZM7;6ZME;6ZMI;6ZMO;6ZMT;6ZMW;6ZN5;6ZOJ;6ZOK;6ZON;6ZP4;6ZUO;6ZV6;6ZVH;6ZVJ;6ZXD;6ZXE;6ZXF;6ZXG;6ZXH;7A09;7K5I;,58,L,F,True,902
13460,2146,24205,single nucleotide variant,NM_000344.3(SMN1):c.815A>G (p.Tyr272Cys),6606,SMN1,HGNC:11117,Pathogenic/Likely pathogenic,1,2-Jun-17,104893922,-,RCV000009737|RCV000518253,"MONDO:MONDO:0009669,MedGen:C0043116,OMIM:253300,Orphanet:83330|MedGen:CN517202",Werdnig-Hoffmann disease|not provided,germline;paternal;unknown,germline,GRCh38,NC_000005.10,5,70946157,70946157,na,na,5q13.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA254677,UniProtKB:Q16637#VAR_005617,OMIM:600354.0004",3,9166,70946157,A,G,Y272C,2,pathogenic,pathogenic,Q16637,Q16637,reviewed,SMN_HUMAN,Survival motor neuron protein (Component of gems 1) (Gemin-1),SMN1 SMN SMNT; SMN2 SMNC,Homo sapiens (Human),294.0,MAMSSGGSGGGVPEQEDSVLFRRGTGQSDDSDIWDDTALIKAYDKAVASFKHALKNGDICETSGKPKTTPKRKPAKKNKSQKKNTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICEVANNIEQNAQENENESQVSTDESENSRSPGNKSDNIKPKSAPWNSFLPPPPPMPGPRLGPGKPGLKFNGPPPPPPPPPPHLLSCWLPPFPSGPPIIPPPPPICPDSLDDADALGSMLISWYMSGYHTGYYMGFRQNQKEGRCSHSLN,PF06003;,1G5V;1MHN;2LEH;4A4E;4A4G;4GLI;4QQ6;5XJL;5XJQ;5XJR;5XJS;5XJT;5XJU;,272,Y,C,True,903
13461,2154,24219,single nucleotide variant,NM_000344.3(SMN1):c.406C>G (p.Gln136Glu),6606,SMN1,HGNC:11117,Pathogenic,1,13-Jul-04,104893934,-,RCV000009758,"MONDO:MONDO:0009669,MedGen:C0043116,OMIM:253300,Orphanet:83330",Werdnig-Hoffmann disease,germline,germline,GRCh38,NC_000005.10,5,70942490,70942490,na,na,5q13.2,no assertion criteria provided,1,-,N,"ClinGen:CA254698,UniProtKB:Q16637#VAR_034808,OMIM:600354.0018",1,9180,70942490,C,G,Q136E,0,pathogenic,uncertain,Q16637,Q16637,reviewed,SMN_HUMAN,Survival motor neuron protein (Component of gems 1) (Gemin-1),SMN1 SMN SMNT; SMN2 SMNC,Homo sapiens (Human),294.0,MAMSSGGSGGGVPEQEDSVLFRRGTGQSDDSDIWDDTALIKAYDKAVASFKHALKNGDICETSGKPKTTPKRKPAKKNKSQKKNTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICEVANNIEQNAQENENESQVSTDESENSRSPGNKSDNIKPKSAPWNSFLPPPPPMPGPRLGPGKPGLKFNGPPPPPPPPPPHLLSCWLPPFPSGPPIIPPPPPICPDSLDDADALGSMLISWYMSGYHTGYYMGFRQNQKEGRCSHSLN,PF06003;,1G5V;1MHN;2LEH;4A4E;4A4G;4GLI;4QQ6;5XJL;5XJQ;5XJR;5XJS;5XJT;5XJU;,136,Q,E,True,903
13462,2153,24218,single nucleotide variant,NM_000344.3(SMN1):c.346A>T (p.Ile116Phe),6606,SMN1,HGNC:11117,Pathogenic,1,15-Feb-13,104893933,-,RCV000009757,"MONDO:MONDO:0009669,MedGen:C0043116,OMIM:253300,Orphanet:83330",Werdnig-Hoffmann disease,germline,germline,GRCh38,NC_000005.10,5,70942430,70942430,na,na,5q13.2,no assertion criteria provided,1,-,N,"ClinGen:CA254696,UniProtKB:Q16637#VAR_034807,OMIM:600354.0017",1,9179,70942430,A,T,I116F,0,pathogenic,uncertain,Q16637,Q16637,reviewed,SMN_HUMAN,Survival motor neuron protein (Component of gems 1) (Gemin-1),SMN1 SMN SMNT; SMN2 SMNC,Homo sapiens (Human),294.0,MAMSSGGSGGGVPEQEDSVLFRRGTGQSDDSDIWDDTALIKAYDKAVASFKHALKNGDICETSGKPKTTPKRKPAKKNKSQKKNTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICEVANNIEQNAQENENESQVSTDESENSRSPGNKSDNIKPKSAPWNSFLPPPPPMPGPRLGPGKPGLKFNGPPPPPPPPPPHLLSCWLPPFPSGPPIIPPPPPICPDSLDDADALGSMLISWYMSGYHTGYYMGFRQNQKEGRCSHSLN,PF06003;,1G5V;1MHN;2LEH;4A4E;4A4G;4GLI;4QQ6;5XJL;5XJQ;5XJR;5XJS;5XJT;5XJU;,116,I,F,True,903
13463,2152,24217,single nucleotide variant,NM_000344.3(SMN1):c.784A>G (p.Ser262Gly),6606,SMN1,HGNC:11117,Pathogenic,1,1-Jan-05,104893932,-,RCV000009756,"MONDO:MONDO:0009672,MedGen:C0152109,OMIM:253400,Orphanet:70,Orphanet:83419",Kugelberg-Welander disease,germline,germline,GRCh38,NC_000005.10,5,70946126,70946126,na,na,5q13.2,no assertion criteria provided,1,-,N,"ClinGen:CA254694,UniProtKB:Q16637#VAR_034809,OMIM:600354.0016",1,9178,70946126,A,G,S262G,0,pathogenic,uncertain,Q16637,Q16637,reviewed,SMN_HUMAN,Survival motor neuron protein (Component of gems 1) (Gemin-1),SMN1 SMN SMNT; SMN2 SMNC,Homo sapiens (Human),294.0,MAMSSGGSGGGVPEQEDSVLFRRGTGQSDDSDIWDDTALIKAYDKAVASFKHALKNGDICETSGKPKTTPKRKPAKKNKSQKKNTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICEVANNIEQNAQENENESQVSTDESENSRSPGNKSDNIKPKSAPWNSFLPPPPPMPGPRLGPGKPGLKFNGPPPPPPPPPPHLLSCWLPPFPSGPPIIPPPPPICPDSLDDADALGSMLISWYMSGYHTGYYMGFRQNQKEGRCSHSLN,PF06003;,1G5V;1MHN;2LEH;4A4E;4A4G;4GLI;4QQ6;5XJL;5XJQ;5XJR;5XJS;5XJT;5XJU;,262,S,G,True,903
13464,2151,24216,single nucleotide variant,NM_000344.3(SMN1):c.332C>G (p.Ala111Gly),6606,SMN1,HGNC:11117,Pathogenic,1,3-Mar-16,104893935,-,RCV000009754|RCV000009755|RCV000785810,"MONDO:MONDO:0009669,MedGen:C0043116,OMIM:253300,Orphanet:83330|MONDO:MONDO:0009673,MedGen:C0393538,OMIM:253550,Orphanet:70,Orphanet:83418|MedGen:CN517202","Werdnig-Hoffmann disease|Spinal muscular atrophy, type II|not provided",germline;unknown,germline,GRCh38,NC_000005.10,5,70942416,70942416,na,na,5q13.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA254692,UniProtKB:Q16637#VAR_034806,OMIM:600354.0015",3,9177,70942416,C,G,A111G,1,pathogenic,pathogenic,Q16637,Q16637,reviewed,SMN_HUMAN,Survival motor neuron protein (Component of gems 1) (Gemin-1),SMN1 SMN SMNT; SMN2 SMNC,Homo sapiens (Human),294.0,MAMSSGGSGGGVPEQEDSVLFRRGTGQSDDSDIWDDTALIKAYDKAVASFKHALKNGDICETSGKPKTTPKRKPAKKNKSQKKNTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICEVANNIEQNAQENENESQVSTDESENSRSPGNKSDNIKPKSAPWNSFLPPPPPMPGPRLGPGKPGLKFNGPPPPPPPPPPHLLSCWLPPFPSGPPIIPPPPPICPDSLDDADALGSMLISWYMSGYHTGYYMGFRQNQKEGRCSHSLN,PF06003;,1G5V;1MHN;2LEH;4A4E;4A4G;4GLI;4QQ6;5XJL;5XJQ;5XJR;5XJS;5XJT;5XJU;,111,A,G,True,903
13465,2150,24215,single nucleotide variant,NM_000344.3(SMN1):c.283G>C (p.Gly95Arg),6606,SMN1,HGNC:11117,Pathogenic,1,18-Mar-16,104893927,-,RCV000009753|RCV000785814,"MONDO:MONDO:0009672,MedGen:C0152109,OMIM:253400,Orphanet:70,Orphanet:83419|MedGen:CN517202",Kugelberg-Welander disease|not provided,germline;unknown,germline,GRCh38,NC_000005.10,5,70942367,70942367,na,na,5q13.2,"criteria provided, single submitter",2,-,N,"OMIM:600354.0014,ClinGen:CA254690,UniProtKB:Q16637#VAR_034805",3,9176,70942367,G,C,G95R,1,pathogenic,pathogenic,Q16637,Q16637,reviewed,SMN_HUMAN,Survival motor neuron protein (Component of gems 1) (Gemin-1),SMN1 SMN SMNT; SMN2 SMNC,Homo sapiens (Human),294.0,MAMSSGGSGGGVPEQEDSVLFRRGTGQSDDSDIWDDTALIKAYDKAVASFKHALKNGDICETSGKPKTTPKRKPAKKNKSQKKNTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICEVANNIEQNAQENENESQVSTDESENSRSPGNKSDNIKPKSAPWNSFLPPPPPMPGPRLGPGKPGLKFNGPPPPPPPPPPHLLSCWLPPFPSGPPIIPPPPPICPDSLDDADALGSMLISWYMSGYHTGYYMGFRQNQKEGRCSHSLN,PF06003;,1G5V;1MHN;2LEH;4A4E;4A4G;4GLI;4QQ6;5XJL;5XJQ;5XJR;5XJS;5XJT;5XJU;,95,G,R,True,903
13466,2149,24214,single nucleotide variant,NM_000344.3(SMN1):c.88G>A (p.Asp30Asn),6606,SMN1,HGNC:11117,Pathogenic,1,1-Jan-05,104893930,-,RCV000009752,"MONDO:MONDO:0009673,MedGen:C0393538,OMIM:253550,Orphanet:70,Orphanet:83418","Spinal muscular atrophy, type II",germline,germline,GRCh38,NC_000005.10,5,70938845,70938845,na,na,5q13.2,no assertion criteria provided,1,-,N,"ClinGen:CA254688,UniProtKB:Q16637#VAR_034803,OMIM:600354.0012",1,9175,70938845,G,A,D30N,0,pathogenic,uncertain,Q16637,Q16637,reviewed,SMN_HUMAN,Survival motor neuron protein (Component of gems 1) (Gemin-1),SMN1 SMN SMNT; SMN2 SMNC,Homo sapiens (Human),294.0,MAMSSGGSGGGVPEQEDSVLFRRGTGQSDDSDIWDDTALIKAYDKAVASFKHALKNGDICETSGKPKTTPKRKPAKKNKSQKKNTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICEVANNIEQNAQENENESQVSTDESENSRSPGNKSDNIKPKSAPWNSFLPPPPPMPGPRLGPGKPGLKFNGPPPPPPPPPPHLLSCWLPPFPSGPPIIPPPPPICPDSLDDADALGSMLISWYMSGYHTGYYMGFRQNQKEGRCSHSLN,PF06003;,1G5V;1MHN;2LEH;4A4E;4A4G;4GLI;4QQ6;5XJL;5XJQ;5XJR;5XJS;5XJT;5XJU;,30,D,N,True,903
13467,2148,24211,single nucleotide variant,NM_000344.3(SMN1):c.131A>T (p.Asp44Val),6606,SMN1,HGNC:11117,Pathogenic,1,1-Jan-05,104893931,-,RCV000009745,"MONDO:MONDO:0009672,MedGen:C0152109,OMIM:253400,Orphanet:70,Orphanet:83419",Kugelberg-Welander disease,germline,germline,GRCh38,NC_000005.10,5,70938888,70938888,na,na,5q13.2,no assertion criteria provided,1,-,N,"ClinGen:CA254683,UniProtKB:Q16637#VAR_034804,OMIM:600354.0013",1,9172,70938888,A,T,D44V,0,pathogenic,uncertain,Q16637,Q16637,reviewed,SMN_HUMAN,Survival motor neuron protein (Component of gems 1) (Gemin-1),SMN1 SMN SMNT; SMN2 SMNC,Homo sapiens (Human),294.0,MAMSSGGSGGGVPEQEDSVLFRRGTGQSDDSDIWDDTALIKAYDKAVASFKHALKNGDICETSGKPKTTPKRKPAKKNKSQKKNTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICEVANNIEQNAQENENESQVSTDESENSRSPGNKSDNIKPKSAPWNSFLPPPPPMPGPRLGPGKPGLKFNGPPPPPPPPPPHLLSCWLPPFPSGPPIIPPPPPICPDSLDDADALGSMLISWYMSGYHTGYYMGFRQNQKEGRCSHSLN,PF06003;,1G5V;1MHN;2LEH;4A4E;4A4G;4GLI;4QQ6;5XJL;5XJQ;5XJR;5XJS;5XJT;5XJU;,44,D,V,True,903
13468,2147,24207,single nucleotide variant,NM_000344.3(SMN1):c.5C>G (p.Ala2Gly),6606,SMN1,HGNC:11117,Pathogenic,1,31-Dec-16,1554066397,-,RCV000009739|RCV000009740|RCV000517884,"MONDO:MONDO:0009673,MedGen:C0393538,OMIM:253550,Orphanet:70,Orphanet:83418|MONDO:MONDO:0009672,MedGen:C0152109,OMIM:253400,Orphanet:70,Orphanet:83419|MedGen:CN517202","Spinal muscular atrophy, type II|Kugelberg-Welander disease|not provided",germline;unknown,germline,GRCh38,NC_000005.10,5,70925108,70925108,na,na,5q13.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA254681,UniProtKB:Q16637#VAR_005615,OMIM:600354.0006",3,9168,70925108,C,G,A2G,2,pathogenic,pathogenic,Q16637,Q16637,reviewed,SMN_HUMAN,Survival motor neuron protein (Component of gems 1) (Gemin-1),SMN1 SMN SMNT; SMN2 SMNC,Homo sapiens (Human),294.0,MAMSSGGSGGGVPEQEDSVLFRRGTGQSDDSDIWDDTALIKAYDKAVASFKHALKNGDICETSGKPKTTPKRKPAKKNKSQKKNTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICEVANNIEQNAQENENESQVSTDESENSRSPGNKSDNIKPKSAPWNSFLPPPPPMPGPRLGPGKPGLKFNGPPPPPPPPPPHLLSCWLPPFPSGPPIIPPPPPICPDSLDDADALGSMLISWYMSGYHTGYYMGFRQNQKEGRCSHSLN,PF06003;,1G5V;1MHN;2LEH;4A4E;4A4G;4GLI;4QQ6;5XJL;5XJQ;5XJR;5XJS;5XJT;5XJU;,2,A,G,True,903
13469,2145,24204,single nucleotide variant,NM_000344.3(SMN1):c.785G>T (p.Ser262Ile),6606,SMN1,HGNC:11117,Pathogenic/Likely pathogenic,1,7-Sep-17,1554066659,-,RCV000009736|RCV000713373,"MONDO:MONDO:0009672,MedGen:C0152109,OMIM:253400,Orphanet:70,Orphanet:83419|MedGen:CN517202",Kugelberg-Welander disease|not provided,germline;maternal;unknown,germline,GRCh38,NC_000005.10,5,70946127,70946127,na,na,5q13.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA254675,UniProtKB:Q16637#VAR_005616,OMIM:600354.0003",3,9165,70946127,G,T,S262I,2,pathogenic,pathogenic,Q16637,Q16637,reviewed,SMN_HUMAN,Survival motor neuron protein (Component of gems 1) (Gemin-1),SMN1 SMN SMNT; SMN2 SMNC,Homo sapiens (Human),294.0,MAMSSGGSGGGVPEQEDSVLFRRGTGQSDDSDIWDDTALIKAYDKAVASFKHALKNGDICETSGKPKTTPKRKPAKKNKSQKKNTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICEVANNIEQNAQENENESQVSTDESENSRSPGNKSDNIKPKSAPWNSFLPPPPPMPGPRLGPGKPGLKFNGPPPPPPPPPPHLLSCWLPPFPSGPPIIPPPPPICPDSLDDADALGSMLISWYMSGYHTGYYMGFRQNQKEGRCSHSLN,PF06003;,1G5V;1MHN;2LEH;4A4E;4A4G;4GLI;4QQ6;5XJL;5XJQ;5XJR;5XJS;5XJT;5XJU;,262,S,I,True,903
13470,2144,24203,single nucleotide variant,NM_000344.3(SMN1):c.821C>T (p.Thr274Ile),6606,SMN1,HGNC:11117,Conflicting interpretations of pathogenicity,1,31-Jul-17,1554066666,-,RCV000009734|RCV000009735|RCV000517430,"MONDO:MONDO:0009673,MedGen:C0393538,OMIM:253550,Orphanet:70,Orphanet:83418|MONDO:MONDO:0009672,MedGen:C0152109,OMIM:253400,Orphanet:70,Orphanet:83419|MedGen:CN517202","Spinal muscular atrophy, type II|Kugelberg-Welander disease|not provided",germline;unknown,germline,GRCh38,NC_000005.10,5,70946163,70946163,na,na,5q13.2,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA254673,UniProtKB:Q16637#VAR_005618,OMIM:600354.0002",3,9164,70946163,C,T,T274I,1,uncertain,uncertain,Q16637,Q16637,reviewed,SMN_HUMAN,Survival motor neuron protein (Component of gems 1) (Gemin-1),SMN1 SMN SMNT; SMN2 SMNC,Homo sapiens (Human),294.0,MAMSSGGSGGGVPEQEDSVLFRRGTGQSDDSDIWDDTALIKAYDKAVASFKHALKNGDICETSGKPKTTPKRKPAKKNKSQKKNTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICEVANNIEQNAQENENESQVSTDESENSRSPGNKSDNIKPKSAPWNSFLPPPPPMPGPRLGPGKPGLKFNGPPPPPPPPPPHLLSCWLPPFPSGPPIIPPPPPICPDSLDDADALGSMLISWYMSGYHTGYYMGFRQNQKEGRCSHSLN,PF06003;,1G5V;1MHN;2LEH;4A4E;4A4G;4GLI;4QQ6;5XJL;5XJQ;5XJR;5XJS;5XJT;5XJU;,274,T,I,True,903
13471,13061,247614,single nucleotide variant,NM_138459.5(NUS1):c.869G>A (p.Arg290His),116150,NUS1,HGNC:21042,Conflicting interpretations of pathogenicity,1,12-Mar-19,886037858,-,RCV000239673|RCV001253663|RCV001262137,"MONDO:MONDO:0014904,MedGen:C4310727,OMIM:617082|MONDO:MONDO:0030921,MedGen:C4693371,OMIM:617831|MONDO:MONDO:0015286,MedGen:C0282577,OMIM:PS212065,Orphanet:137","Congenital disorder of glycosylation, type Iaa|Intellectual disability, autosomal dominant 55, with seizures|Congenital disorder of glycosylation",germline;unknown,germline,GRCh38,NC_000006.12,6,117707002,117707002,na,na,6q22.1,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA10586234,UniProtKB:Q96E22#VAR_071210,OMIM:610463.0001",3,253197,117707002,G,A,R290H,1,uncertain,uncertain,Q96E22,Q96E22,reviewed,NGBR_HUMAN,"Dehydrodolichyl diphosphate synthase complex subunit NUS1, EC 2.5.1.87 (Cis-prenyltransferase subunit NgBR) (Nogo-B receptor, NgBR) (Nuclear undecaprenyl pyrophosphate synthase 1 homolog)",NUS1 C6orf68 NGBR,Homo sapiens (Human),293.0,MTGLYELVWRVLHALLCLHRTLTSWLRVRFGTWNWIWRRCCRAASAAVLAPLGFTLRKPPAVGRNRRHHRHPRGGSCLAAAHHRMRWRADGRSLEKLPVHMGLVITEVEQEPSFSDIASLVVWCMAVGISYISVYDHQGIFKRNNSRLMDEILKQQQELLGLDCSKYSPEFANSNDKDDQVLNCHLAVKVLSPEDGKADIVRAAQDFCQLVAQKQKRPTDLDVDTLASLLSSNGCPDPDLVLKFGPVDSTLGFLPWHIRLTEIVSLPSHLNISYEDFFSALRQYAACEQRLGK,PF01255;,6W2L;6Z1N;,290,R,H,True,904
13472,14138,337290,single nucleotide variant,NM_012452.3(TNFRSF13B):c.752C>T (p.Pro251Leu),23495,TNFRSF13B,HGNC:18153,Benign,0,4-Nov-19,34562254,-,RCV000312789|RCV000455556|RCV001283702,MedGen:CN239265|MedGen:CN169374|MedGen:CN235283,"Common Variable Immune Deficiency, Dominant|not specified|none provided",germline,germline,GRCh38,NC_000017.11,17,16939677,16939677,na,na,17p11.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA8413859,UniProtKB:O14836#VAR_052353",2,322025,16939677,G,A,P251L,2,benign,benign,O14836,O14836,reviewed,TR13B_HUMAN,Tumor necrosis factor receptor superfamily member 13B (Transmembrane activator and CAML interactor) (CD antigen CD267),TNFRSF13B TACI,Homo sapiens (Human),293.0,MSGLGRSRRGGRSRVDQEERFPQGLWTGVAMRSCPEEQYWDPLLGTCMSCKTICNHQSQRTCAAFCRSLSCRKEQGKFYDHLLRDCISCASICGQHPKQCAYFCENKLRSPVNLPPELRRQRSGEVENNSDNSGRYQGLEHRGSEASPALPGLKLSADQVALVYSTLGLCLCAVLCCFLVAVACFLKKRGDPCSCQPRSRPRQSPAKSSQDHAMEAGSPVSTSPEPVETCSFCFPECRAPTQESAVTPGTPDPTCAGRWGCHTRTTVLQPCPHIPDSGLGIVCVPAQEGGPGA,PF09305;,1XU1;1XUT;,251,P,L,True,905
13473,1223,20341,single nucleotide variant,NM_012452.2(TNFRSF13B):c.310T>C (p.Cys104Arg),23495,TNFRSF13B,HGNC:18153,"Conflicting interpretations of pathogenicity, risk factor",1,1-Dec-20,34557412,-,RCV000005623|RCV000005624|RCV000302082|RCV000403933|RCV000507544|RCV000735370|RCV001283708,"MONDO:MONDO:0009413,MedGen:C3150354,OMIM:240500,Orphanet:1572|MONDO:MONDO:0012291,MedGen:C1836032,OMIM:609529|MedGen:CN239265|MedGen:CN517202|MedGen:CN169374|16 conditions|MedGen:CN235283","Common variable immunodeficiency 2|Immunoglobulin A deficiency 2|Common Variable Immune Deficiency, Dominant|not provided|not specified|16 conditions|none provided",germline;maternal,germline,GRCh38,NC_000017.11,17,16948873,16948873,na,na,17p11.2,"criteria provided, conflicting interpretations",16,-,N,"ClinGen:CA117387,UniProtKB:O14836#VAR_024027,OMIM:604907.0001",3,5302,16948873,A,G,C104R,1,uncertain,uncertain,O14836,O14836,reviewed,TR13B_HUMAN,Tumor necrosis factor receptor superfamily member 13B (Transmembrane activator and CAML interactor) (CD antigen CD267),TNFRSF13B TACI,Homo sapiens (Human),293.0,MSGLGRSRRGGRSRVDQEERFPQGLWTGVAMRSCPEEQYWDPLLGTCMSCKTICNHQSQRTCAAFCRSLSCRKEQGKFYDHLLRDCISCASICGQHPKQCAYFCENKLRSPVNLPPELRRQRSGEVENNSDNSGRYQGLEHRGSEASPALPGLKLSADQVALVYSTLGLCLCAVLCCFLVAVACFLKKRGDPCSCQPRSRPRQSPAKSSQDHAMEAGSPVSTSPEPVETCSFCFPECRAPTQESAVTPGTPDPTCAGRWGCHTRTTVLQPCPHIPDSGLGIVCVPAQEGGPGA,PF09305;,1XU1;1XUT;,104,C,R,True,905
13474,1224,20343,single nucleotide variant,NM_012452.2(TNFRSF13B):c.605G>A (p.Arg202His),23495,TNFRSF13B,HGNC:18153,Conflicting interpretations of pathogenicity,1,31-Dec-19,104894649,-,RCV000005627|RCV000397011|RCV000730698,"MONDO:MONDO:0009413,MedGen:C3150354,OMIM:240500,Orphanet:1572|MedGen:CN239265|MedGen:CN517202","Common variable immunodeficiency 2|Common Variable Immune Deficiency, Dominant|not provided",germline,germline,GRCh38,NC_000017.11,17,16940352,16940352,na,na,17p11.2,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA117392,UniProtKB:O14836#VAR_024029,OMIM:604907.0003",3,5304,16940352,C,T,R202H,1,uncertain,uncertain,O14836,O14836,reviewed,TR13B_HUMAN,Tumor necrosis factor receptor superfamily member 13B (Transmembrane activator and CAML interactor) (CD antigen CD267),TNFRSF13B TACI,Homo sapiens (Human),293.0,MSGLGRSRRGGRSRVDQEERFPQGLWTGVAMRSCPEEQYWDPLLGTCMSCKTICNHQSQRTCAAFCRSLSCRKEQGKFYDHLLRDCISCASICGQHPKQCAYFCENKLRSPVNLPPELRRQRSGEVENNSDNSGRYQGLEHRGSEASPALPGLKLSADQVALVYSTLGLCLCAVLCCFLVAVACFLKKRGDPCSCQPRSRPRQSPAKSSQDHAMEAGSPVSTSPEPVETCSFCFPECRAPTQESAVTPGTPDPTCAGRWGCHTRTTVLQPCPHIPDSGLGIVCVPAQEGGPGA,PF09305;,1XU1;1XUT;,202,R,H,True,905
13475,7489,76326,single nucleotide variant,NM_199461.4(NANOS1):c.737G>A (p.Arg246His),340719,NANOS1,HGNC:23044,no interpretation for the single variant,-1,-,587777767,-,-,-,-,not applicable,not applicable,GRCh38,NC_000010.11,10,119030538,119030538,na,na,10q26.11,no interpretation for the single variant,0,-,N,"UniProtKB:Q8WY41#VAR_070572,OMIM:608226.0003,ClinVar:65392",4,242654,119030538,G,A,R246H,0,uncertain,uncertain,Q8WY41,Q8WY41,reviewed,NANO1_HUMAN,"Nanos homolog 1, NOS-1 (EC_Rep1a)",NANOS1 NOS1,Homo sapiens (Human),292.0,MEAFPWAPRSPRRGRAPPPMALVPSARYVSAPGPAHPQPFSSWNDYLGLATLITKAVDGEPRFGCARGGNGGGGSPPSSSSSSCCSPHTGAGPGALGPALGPPDYDEDDDDDSDEPGSRGRYLGSALELRALELCAGPAEAGLLEERFAELSPFAGRAAAVLLGCAPAAAAAATTTSEATPREERAPAWAAEPRLHAASGAAAARLLKPELQVCVFCRNNKEAMALYTTHILKGPDGRVLCPVLRRYTCPLCGASGDNAHTIKYCPLSKVPPPPARPPPRSARDGPPGKKLR,PF05741;,4CQO;,246,R,H,True,906
13476,12621,227655,single nucleotide variant,NM_002095.6(GTF2E2):c.559G>T (p.Asp187Tyr),2961,GTF2E2,HGNC:4651,Pathogenic,1,9-May-16,875989847,-,RCV000211077,"MONDO:MONDO:0014841,MedGen:C4310785,OMIM:616943,Orphanet:33364","Trichothiodystrophy 6, nonphotosensitive",germline,germline,GRCh38,NC_000008.11,8,30607141,30607141,na,na,8p12,no assertion criteria provided,1,-,N,"ClinGen:CA10576100,UniProtKB:P29084#VAR_076894,OMIM:189964.0002",1,225841,30607141,C,A,D187Y,0,pathogenic,uncertain,P29084,P29084,reviewed,T2EB_HUMAN,"Transcription initiation factor IIE subunit beta, TFIIE-beta (General transcription factor IIE subunit 2)",GTF2E2 TF2E2,Homo sapiens (Human),291.0,MDPSLLRERELFKKRALSTPVVEKRSASSESSSSSSKKKKTKVEHGGSSGSKQNSDHSNGSFNLKALSGSSGYKFGVLAKIVNYMKTRHQRGDTHPLTLDEILDETQHLDIGLKQKQWLMTEALVNNPKIEVIDGKYAFKPKYNVRDKKALLRLLDQHDQRGLGGILLEDIEEALPNSQKAVKALGDQILFVNRPDKKKILFFNDKSCQFSVDEEFQKLWRSVTVDSMDEEKIEEYLKRQGISSMQESGPKKVAPIQRRKKPASQKKRRFKTHNEHLAGVLKDYSDITSSK,PF18121;PF02186;,1D8J;1D8K;5GPY;5IY6;5IY7;5IY8;5IY9;5IYA;5IYB;5IYC;5IYD;6O9L;7EG9;7EGA;7EGB;7EGC;7ENA;7ENC;7LBM;7NVR;7NVS;7NVT;7NVU;7NVY;7NVZ;7NW0;,187,D,Y,True,907
13477,12620,227654,single nucleotide variant,NM_002095.6(GTF2E2):c.448G>C (p.Ala150Pro),2961,GTF2E2,HGNC:4651,Pathogenic,1,9-May-16,875989846,-,RCV000211060,"MONDO:MONDO:0014841,MedGen:C4310785,OMIM:616943,Orphanet:33364","Trichothiodystrophy 6, nonphotosensitive",germline,germline,GRCh38,NC_000008.11,8,30612400,30612400,na,na,8p12,no assertion criteria provided,1,-,N,"ClinGen:CA10576099,UniProtKB:P29084#VAR_076893,OMIM:189964.0001",1,225840,30612400,C,G,A150P,0,pathogenic,uncertain,P29084,P29084,reviewed,T2EB_HUMAN,"Transcription initiation factor IIE subunit beta, TFIIE-beta (General transcription factor IIE subunit 2)",GTF2E2 TF2E2,Homo sapiens (Human),291.0,MDPSLLRERELFKKRALSTPVVEKRSASSESSSSSSKKKKTKVEHGGSSGSKQNSDHSNGSFNLKALSGSSGYKFGVLAKIVNYMKTRHQRGDTHPLTLDEILDETQHLDIGLKQKQWLMTEALVNNPKIEVIDGKYAFKPKYNVRDKKALLRLLDQHDQRGLGGILLEDIEEALPNSQKAVKALGDQILFVNRPDKKKILFFNDKSCQFSVDEEFQKLWRSVTVDSMDEEKIEEYLKRQGISSMQESGPKKVAPIQRRKKPASQKKRRFKTHNEHLAGVLKDYSDITSSK,PF18121;PF02186;,1D8J;1D8K;5GPY;5IY6;5IY7;5IY8;5IY9;5IYA;5IYB;5IYC;5IYD;6O9L;7EG9;7EGA;7EGB;7EGC;7ENA;7ENC;7LBM;7NVR;7NVS;7NVT;7NVU;7NVY;7NVZ;7NW0;,150,A,P,True,907
13478,3576,28644,single nucleotide variant,NM_000306.4(POU1F1):c.71C>T (p.Pro24Leu),5449,POU1F1,HGNC:9210,Pathogenic,1,15-Dec-92,104893757,-,RCV000014575,"MONDO:MONDO:0024464,MedGen:C2751608,OMIM:613038","Pituitary hormone deficiency, combined, 1",germline,germline,GRCh38,NC_000003.12,3,87276392,87276392,na,na,3p11.2,no assertion criteria provided,1,-,N,"ClinGen:CA250607,UniProtKB:P28069#VAR_003777,OMIM:173110.0004",1,13605,87276392,G,A,P24L,0,pathogenic,uncertain,P28069,P28069,reviewed,PIT1_HUMAN,"Pituitary-specific positive transcription factor 1, PIT-1 (Growth hormone factor 1, GHF-1)",POU1F1 GHF1 PIT1,Homo sapiens (Human),291.0,MSCQAFTSADTFIPLNSDASATLPLIMHHSAAECLPVSNHATNVMSTATGLHYSVPSCHYGNQPSTYGVMAGSLTPCLYKFPDHTLSHGFPPIHQPLLAEDPTAADFKQELRRKSKLVEEPIDMDSPEIRELEKFANEFKVRRIKLGYTQTNVGEALAAVHGSEFSQTTICRFENLQLSFKNACKLKAILSKWLEEAEQVGALYNEKVGANERKRKRRTTISIAAKDALERHFGEQNKPSSQEIMRMAEELNLEKEVVRVWFCNRRQREKRVKTSLNQSLFSISKEHLECR,PF00046;PF00157;,5WC9;,24,P,L,True,908
13479,5054,32847,single nucleotide variant,NM_001160179.2(NAT1):c.445G>A (p.Val149Ile),9,NAT1,HGNC:7645,Benign,0,28-Mar-16,4987076,-,RCV000019386|RCV000455973,|MedGen:CN169374,NAT1*17 ALLELE|not specified,germline,germline,GRCh38,NC_000008.11,8,18222492,18222492,na,na,8p22,"criteria provided, single submitter",2,-,N,"ClinGen:CA127440,UniProtKB:P18440#VAR_004607,OMIM:108345.0002",3,17808,18222492,G,A,V149I,1,benign,benign,P18440,P18440,reviewed,ARY1_HUMAN,"Arylamine N-acetyltransferase 1, EC 2.3.1.5 (Arylamide acetylase 1) (Monomorphic arylamine N-acetyltransferase, MNAT) (N-acetyltransferase type 1, NAT-1)",NAT1 AAC1,Homo sapiens (Human),290.0,MDIEAYLERIGYKKSRNKLDLETLTDILQHQIRAVPFENLNIHCGDAMDLGLEAIFDQVVRRNRGGWCLQVNHLLYWALTTIGFETTMLGGYVYSTPAKKYSTGMIHLLLQVTIDGRNYIVDAGFGRSYQMWQPLELISGKDQPQVPCVFRLTEENGFWYLDQIRREQYIPNEEFLHSDLLEDSKYRKIYSFTLKPRTIEDFESMNTYLQTSPSSVFTSKSFCSLQTPDGVHCLVGFTLTHRRFNYKDNTDLIEFKTLSEEEIEKVLKNIFNISLQRKLVPKHGDRFFTI,PF00797;,2IJA;2PQT;,149,V,I,True,909
13480,13027,247031,single nucleotide variant,NM_000662.8(NAT1):c.190C>T (p.Arg64Trp),9,NAT1,HGNC:7645,Benign,0,17-Dec-15,56379106,-,RCV000239134,MedGen:CN169374,not specified,unknown,unknown,GRCh38,NC_000008.11,8,18222237,18222237,na,na,8p22,"criteria provided, single submitter",1,-,N,"ClinGen:CA4651345,UniProtKB:P18440#VAR_004606",2,252546,18222237,C,T,R64W,1,benign,benign,P18440,P18440,reviewed,ARY1_HUMAN,"Arylamine N-acetyltransferase 1, EC 2.3.1.5 (Arylamide acetylase 1) (Monomorphic arylamine N-acetyltransferase, MNAT) (N-acetyltransferase type 1, NAT-1)",NAT1 AAC1,Homo sapiens (Human),290.0,MDIEAYLERIGYKKSRNKLDLETLTDILQHQIRAVPFENLNIHCGDAMDLGLEAIFDQVVRRNRGGWCLQVNHLLYWALTTIGFETTMLGGYVYSTPAKKYSTGMIHLLLQVTIDGRNYIVDAGFGRSYQMWQPLELISGKDQPQVPCVFRLTEENGFWYLDQIRREQYIPNEEFLHSDLLEDSKYRKIYSFTLKPRTIEDFESMNTYLQTSPSSVFTSKSFCSLQTPDGVHCLVGFTLTHRRFNYKDNTDLIEFKTLSEEEIEKVLKNIFNISLQRKLVPKHGDRFFTI,PF00797;,2IJA;2PQT;,64,R,W,True,909
13481,5859,38976,single nucleotide variant,NM_005221.6(DLX5):c.533A>C (p.Gln178Pro),1749,DLX5,HGNC:2918,Pathogenic,1,1-Jan-12,387906737,-,RCV000022921,"MONDO:MONDO:0009080,MedGen:C1857344,OMIM:220600,Orphanet:71271",Split-hand/foot malformation 1 with sensorineural hearing loss,germline,germline,GRCh38,NC_000007.14,7,97022192,97022192,na,na,7q21.3,no assertion criteria provided,1,-,N,"ClinGen:CA128834,UniProtKB:P56178#VAR_067413,OMIM:600028.0001",1,30021,97022192,T,G,Q178P,0,pathogenic,uncertain,P56178,P56178,reviewed,DLX5_HUMAN,Homeobox protein DLX-5,DLX5,Homo sapiens (Human),289.0,MTGVFDRRVPSIRSGDFQAPFQTSAAMHHPSQESPTLPESSATDSDYYSPTGGAPHGYCSPTSASYGKALNPYQYQYHGVNGSAGSYPAKAYADYSYASSYHQYGGAYNRVPSATNQPEKEVTEPEVRMVNGKPKKVRKPRTIYSSFQLAALQRRFQKTQYLALPERAELAASLGLTQTQVKIWFQNKRSKIKKIMKNGEMPPEHSPSSSDPMACNSPQSPAVWEPQGSSRSLSHHPHAHPPTSNQSPASSYLENSASWYTSAASSINSHLPPPGSLQHPLALASGTLY,PF12413;PF00046;,2DJN;4RDU;,178,Q,P,True,910
13482,10923,153711,single nucleotide variant,NM_001759.4(CCND2):c.838A>G (p.Thr280Ala),894,CCND2,HGNC:1583,Pathogenic,1,9-Oct-17,587777618,-,RCV000133495|RCV000623001,"MONDO:MONDO:0014408,MedGen:C4014742,OMIM:615938,Orphanet:83473|MeSH:D030342,MedGen:C0950123",Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3|Inborn genetic diseases,germline,germline,GRCh38,NC_000012.12,12,4299977,4299977,na,na,12p13.32,"criteria provided, single submitter",3,-,N,"ClinGen:CA170548,UniProtKB:P30279#VAR_072370,OMIM:123833.0001",3,143981,4299977,A,G,T280A,1,pathogenic,pathogenic,P30279,P30279,reviewed,CCND2_HUMAN,G1/S-specific cyclin-D2,CCND2,Homo sapiens (Human),289.0,MELLCHEVDPVRRAVRDRNLLRDDRVLQNLLTIEERYLPQCSYFKCVQKDIQPYMRRMVATWMLEVCEEQKCEEEVFPLAMNYLDRFLAGVPTPKSHLQLLGAVCMFLASKLKETSPLTAEKLCIYTDNSIKPQELLEWELVVLGKLKWNLAAVTPHDFIEHILRKLPQQREKLSLIRKHAQTFIALCATDFKFAMYPPSMIATGSVGAAICGLQQDEEVSSLTCDALTELLAKITNTDVDCLKACQEQIEAVLLNSLQQYRQDQRDGSKSEDELDQASTPTDVRDIDL,PF02984;PF00134;,6EI2;,280,T,A,True,911
13483,10924,153713,single nucleotide variant,NM_001759.4(CCND2):c.839C>A (p.Thr280Asn),894,CCND2,HGNC:1583,Pathogenic,1,10-Jan-19,587777620,-,RCV000133497|RCV000264513,"MONDO:MONDO:0014408,MedGen:C4014742,OMIM:615938,Orphanet:83473|MedGen:CN517202",Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3|not provided,de novo;germline,germline,GRCh38,NC_000012.12,12,4299978,4299978,na,na,12p13.32,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA170551,UniProtKB:P30279#VAR_072371,OMIM:123833.0003",3,143983,4299978,C,A,T280N,2,pathogenic,pathogenic,P30279,P30279,reviewed,CCND2_HUMAN,G1/S-specific cyclin-D2,CCND2,Homo sapiens (Human),289.0,MELLCHEVDPVRRAVRDRNLLRDDRVLQNLLTIEERYLPQCSYFKCVQKDIQPYMRRMVATWMLEVCEEQKCEEEVFPLAMNYLDRFLAGVPTPKSHLQLLGAVCMFLASKLKETSPLTAEKLCIYTDNSIKPQELLEWELVVLGKLKWNLAAVTPHDFIEHILRKLPQQREKLSLIRKHAQTFIALCATDFKFAMYPPSMIATGSVGAAICGLQQDEEVSSLTCDALTELLAKITNTDVDCLKACQEQIEAVLLNSLQQYRQDQRDGSKSEDELDQASTPTDVRDIDL,PF02984;PF00134;,6EI2;,280,T,N,True,911
13484,10926,153716,single nucleotide variant,NM_001759.4(CCND2):c.842C>T (p.Pro281Leu),894,CCND2,HGNC:1583,Pathogenic,1,8-Aug-16,587777622,-,RCV000133500,"MONDO:MONDO:0014408,MedGen:C4014742,OMIM:615938,Orphanet:83473",Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3,germline,germline,GRCh38,NC_000012.12,12,4299981,4299981,na,na,12p13.32,no assertion criteria provided,2,-,N,"ClinGen:CA170555,UniProtKB:P30279#VAR_072372,OMIM:123833.0006",1,143986,4299981,C,T,P281L,0,pathogenic,uncertain,P30279,P30279,reviewed,CCND2_HUMAN,G1/S-specific cyclin-D2,CCND2,Homo sapiens (Human),289.0,MELLCHEVDPVRRAVRDRNLLRDDRVLQNLLTIEERYLPQCSYFKCVQKDIQPYMRRMVATWMLEVCEEQKCEEEVFPLAMNYLDRFLAGVPTPKSHLQLLGAVCMFLASKLKETSPLTAEKLCIYTDNSIKPQELLEWELVVLGKLKWNLAAVTPHDFIEHILRKLPQQREKLSLIRKHAQTFIALCATDFKFAMYPPSMIATGSVGAAICGLQQDEEVSSLTCDALTELLAKITNTDVDCLKACQEQIEAVLLNSLQQYRQDQRDGSKSEDELDQASTPTDVRDIDL,PF02984;PF00134;,6EI2;,281,P,L,True,911
13485,13546,263838,single nucleotide variant,NM_001759.4(CCND2):c.851T>G (p.Val284Gly),894,CCND2,HGNC:1583,Pathogenic,1,8-Aug-16,777786993,-,RCV000258931,"MONDO:MONDO:0014408,MedGen:C4014742,OMIM:615938,Orphanet:83473",Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3,germline,germline,GRCh38,NC_000012.12,12,4299990,4299990,na,na,12p13.32,no assertion criteria provided,1,-,N,"ClinGen:CA10602706,UniProtKB:P30279#VAR_072374",1,273674,4299990,T,G,V284G,0,pathogenic,uncertain,P30279,P30279,reviewed,CCND2_HUMAN,G1/S-specific cyclin-D2,CCND2,Homo sapiens (Human),289.0,MELLCHEVDPVRRAVRDRNLLRDDRVLQNLLTIEERYLPQCSYFKCVQKDIQPYMRRMVATWMLEVCEEQKCEEEVFPLAMNYLDRFLAGVPTPKSHLQLLGAVCMFLASKLKETSPLTAEKLCIYTDNSIKPQELLEWELVVLGKLKWNLAAVTPHDFIEHILRKLPQQREKLSLIRKHAQTFIALCATDFKFAMYPPSMIATGSVGAAICGLQQDEEVSSLTCDALTELLAKITNTDVDCLKACQEQIEAVLLNSLQQYRQDQRDGSKSEDELDQASTPTDVRDIDL,PF02984;PF00134;,6EI2;,284,V,G,True,911
13486,10925,153715,single nucleotide variant,NM_001759.4(CCND2):c.842C>G (p.Pro281Arg),894,CCND2,HGNC:1583,Pathogenic,1,8-Aug-16,587777622,-,RCV000133499,"MONDO:MONDO:0014408,MedGen:C4014742,OMIM:615938,Orphanet:83473",Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3,germline,germline,GRCh38,NC_000012.12,12,4299981,4299981,na,na,12p13.32,no assertion criteria provided,2,-,N,"ClinGen:CA170554,UniProtKB:P30279#VAR_072373,OMIM:123833.0005",1,143985,4299981,C,G,P281R,0,pathogenic,uncertain,P30279,P30279,reviewed,CCND2_HUMAN,G1/S-specific cyclin-D2,CCND2,Homo sapiens (Human),289.0,MELLCHEVDPVRRAVRDRNLLRDDRVLQNLLTIEERYLPQCSYFKCVQKDIQPYMRRMVATWMLEVCEEQKCEEEVFPLAMNYLDRFLAGVPTPKSHLQLLGAVCMFLASKLKETSPLTAEKLCIYTDNSIKPQELLEWELVVLGKLKWNLAAVTPHDFIEHILRKLPQQREKLSLIRKHAQTFIALCATDFKFAMYPPSMIATGSVGAAICGLQQDEEVSSLTCDALTELLAKITNTDVDCLKACQEQIEAVLLNSLQQYRQDQRDGSKSEDELDQASTPTDVRDIDL,PF02984;PF00134;,6EI2;,281,P,R,True,911
13487,220,15776,single nucleotide variant,NM_203395.3(IYD):c.301C>T (p.Arg101Trp),389434,IYD,HGNC:21071,Pathogenic,1,24-Apr-08,121918138,-,RCV000000773,"MONDO:MONDO:0010136,MedGen:C0342195,OMIM:274800,Orphanet:95716",Iodotyrosine deiodination defect,germline,germline,GRCh38,NC_000006.12,6,150389474,150389474,na,na,6q25.1,no assertion criteria provided,1,-,N,"OMIM:612025.0001,ClinGen:CA114465,UniProtKB:Q6PHW0#VAR_045963",1,737,150389474,C,T,R101W,0,pathogenic,uncertain,Q6PHW0,Q6PHW0,reviewed,IYD1_HUMAN,"Iodotyrosine deiodinase 1, IYD-1, EC 1.21.1.1 (Iodotyrosine dehalogenase 1)",IYD C6orf71 DEHAL1,Homo sapiens (Human),289.0,MYFLTPILVAILCILVVWIFKNADRSMEKKKGEPRTRAEARPWVDEDLKDSSDLHQAEEDADEWQESEENVEHIPFSHNHYPEKEMVKRSQEFYELLNKRRSVRFISNEQVPMEVIDNVIRTAGTAPSGAHTEPWTFVVVKDPDVKHKIRKIIEEEEEINYMKRMGHRWVTDLKKLRTNWIKEYLDTAPILILIFKQVHGFAANGKKKVHYYNEISVSIACGILLAALQNAGLVTVTTTPLNCGPRLRVLLGRPAHEKLLMLLPVGYPSKEATVPDLKRKPLDQIMVTV,PF00881;,4TTB;4TTC;5YAK;,101,R,W,True,912
13488,221,15778,single nucleotide variant,NM_203395.3(IYD):c.347T>C (p.Ile116Thr),389434,IYD,HGNC:21071,Pathogenic,1,24-Apr-08,121918139,-,RCV000000775,"MONDO:MONDO:0010136,MedGen:C0342195,OMIM:274800,Orphanet:95716",Iodotyrosine deiodination defect,germline,germline,GRCh38,NC_000006.12,6,150389520,150389520,na,na,6q25.1,no assertion criteria provided,1,-,N,"ClinGen:CA114466,UniProtKB:Q6PHW0#VAR_045965,OMIM:612025.0003",1,739,150389520,T,C,I116T,0,pathogenic,uncertain,Q6PHW0,Q6PHW0,reviewed,IYD1_HUMAN,"Iodotyrosine deiodinase 1, IYD-1, EC 1.21.1.1 (Iodotyrosine dehalogenase 1)",IYD C6orf71 DEHAL1,Homo sapiens (Human),289.0,MYFLTPILVAILCILVVWIFKNADRSMEKKKGEPRTRAEARPWVDEDLKDSSDLHQAEEDADEWQESEENVEHIPFSHNHYPEKEMVKRSQEFYELLNKRRSVRFISNEQVPMEVIDNVIRTAGTAPSGAHTEPWTFVVVKDPDVKHKIRKIIEEEEEINYMKRMGHRWVTDLKKLRTNWIKEYLDTAPILILIFKQVHGFAANGKKKVHYYNEISVSIACGILLAALQNAGLVTVTTTPLNCGPRLRVLLGRPAHEKLLMLLPVGYPSKEATVPDLKRKPLDQIMVTV,PF00881;,4TTB;4TTC;5YAK;,116,I,T,True,912
13489,14116,335126,single nucleotide variant,NM_024589.2(ROGDI):c.175G>A (p.Glu59Lys),79641,ROGDI,HGNC:29478,Likely benign,0,12-Jan-18,2305659,-,RCV000395002,"MONDO:MONDO:0009185,MedGen:C0406740,OMIM:226750,Orphanet:1946",Kohlschutter's syndrome,germline,germline,GRCh38,NC_000016.10,16,4801528,4801528,na,na,16p13.3,"criteria provided, single submitter",1,-,N,"ClinGen:CA7882937,UniProtKB:Q9GZN7#VAR_038273",2,319406,4801528,C,T,E59K,1,benign,benign,Q9GZN7,Q9GZN7,reviewed,ROGDI_HUMAN,Protein rogdi homolog,ROGDI,Homo sapiens (Human),287.0,MATVMAATAAERAVLEEEFRWLLHDEVHAVLKQLQDILKEASLRFTLPGSGTEGPAKQENFILGSCGTDQVKGVLTLQGDALSQADVNLKMPRNNQLLHFAFREDKQWKLQQIQDARNHVSQAIYLLTSRDQSYQFKTGAEVLKLMDAVMLQLTRARNRLTTPATLTLPEIAASGLTRMFAPALPSDLLVNVYINLNKLCLTVYQLHALQPNSTKNFRPAGGAVLHSPGAMFEWGSQRLEVSHVHKVECVIPWLNDALVYFTVSLQLCQQLKDKISVFSSYWSYRPF,PF10259;,5XQH;5XQI;,59,E,K,True,913
13490,13903,305181,single nucleotide variant,NM_000349.3(STAR):c.361C>T (p.Arg121Trp),6770,STAR,HGNC:11359,Conflicting interpretations of pathogenicity,0,31-Dec-19,34908868,-,RCV000296652|RCV000762506,"MONDO:MONDO:0008725,MedGen:C0342474,OMIM:201710,Orphanet:418,Orphanet:90790|MedGen:CN517202",Cholesterol monooxygenase (side-chain cleaving) deficiency|not provided,germline,germline,GRCh38,NC_000008.11,8,38146393,38146393,na,na,8p11.23,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA4715265,UniProtKB:P49675#VAR_034520",2,362847,38146393,G,A,R121W,1,uncertain,uncertain,P49675,P49675,reviewed,STAR_HUMAN,"Steroidogenic acute regulatory protein, mitochondrial, StAR (START domain-containing protein 1, StARD1)",STAR STARD1,Homo sapiens (Human),285.0,MLLATFKLCAGSSYRHMRNMKGLRQQAVMAISQELNRRALGGPTPSTWINQVRRRSSLLGSRLEETLYSDQELAYLQQGEEAMQKALGILSNQEGWKKESQQDNGDKVMSKVVPDVGKVFRLEVVVDQPMERLYEELVERMEAMGEWNPNVKEIKVLQKIGKDTFITHELAAEAAGNLVGPRDFVSVRCAKRRGSTCVLAGMATDFGNMPEQKGVIRAEHGPTCMVLHPLAGSPSKTKLTWLLSIDLKGWLPKSIINQVLSQTQVDFANHLRKRLESHPASEARC,PF01852;,3P0L;5OMA;6T5F;6T5H;,121,R,W,True,914
13491,2094,24031,single nucleotide variant,NM_000349.3(STAR):c.650G>C (p.Arg217Thr),6770,STAR,HGNC:11359,Pathogenic,1,1-Nov-99,137852689,-,RCV000009555,"MONDO:MONDO:0008725,MedGen:C0342474,OMIM:201710,Orphanet:418,Orphanet:90790",Cholesterol monooxygenase (side-chain cleaving) deficiency,germline,germline,GRCh38,NC_000008.11,8,38145963,38145963,na,na,8p11.23,no assertion criteria provided,1,-,N,"ClinGen:CA120039,UniProtKB:P49675#VAR_014238,OMIM:600617.0007",1,8992,38145963,C,G,R217T,0,pathogenic,uncertain,P49675,P49675,reviewed,STAR_HUMAN,"Steroidogenic acute regulatory protein, mitochondrial, StAR (START domain-containing protein 1, StARD1)",STAR STARD1,Homo sapiens (Human),285.0,MLLATFKLCAGSSYRHMRNMKGLRQQAVMAISQELNRRALGGPTPSTWINQVRRRSSLLGSRLEETLYSDQELAYLQQGEEAMQKALGILSNQEGWKKESQQDNGDKVMSKVVPDVGKVFRLEVVVDQPMERLYEELVERMEAMGEWNPNVKEIKVLQKIGKDTFITHELAAEAAGNLVGPRDFVSVRCAKRRGSTCVLAGMATDFGNMPEQKGVIRAEHGPTCMVLHPLAGSPSKTKLTWLLSIDLKGWLPKSIINQVLSQTQVDFANHLRKRLESHPASEARC,PF01852;,3P0L;5OMA;6T5F;6T5H;,217,R,T,True,914
13492,2093,24027,single nucleotide variant,NM_000349.3(STAR):c.545G>T (p.Arg182Leu),6770,STAR,HGNC:11359,Pathogenic,1,1-Oct-00,104894086,-,RCV000009551,"MONDO:MONDO:0008725,MedGen:C0342474,OMIM:201710,Orphanet:418,Orphanet:90790",Cholesterol monooxygenase (side-chain cleaving) deficiency,germline,germline,GRCh38,NC_000008.11,8,38146068,38146068,na,na,8p11.23,no assertion criteria provided,1,-,N,"ClinGen:CA120036,UniProtKB:P49675#VAR_005627,OMIM:600617.0003",1,8988,38146068,C,A,R182L,0,pathogenic,uncertain,P49675,P49675,reviewed,STAR_HUMAN,"Steroidogenic acute regulatory protein, mitochondrial, StAR (START domain-containing protein 1, StARD1)",STAR STARD1,Homo sapiens (Human),285.0,MLLATFKLCAGSSYRHMRNMKGLRQQAVMAISQELNRRALGGPTPSTWINQVRRRSSLLGSRLEETLYSDQELAYLQQGEEAMQKALGILSNQEGWKKESQQDNGDKVMSKVVPDVGKVFRLEVVVDQPMERLYEELVERMEAMGEWNPNVKEIKVLQKIGKDTFITHELAAEAAGNLVGPRDFVSVRCAKRRGSTCVLAGMATDFGNMPEQKGVIRAEHGPTCMVLHPLAGSPSKTKLTWLLSIDLKGWLPKSIINQVLSQTQVDFANHLRKRLESHPASEARC,PF01852;,3P0L;5OMA;6T5F;6T5H;,182,R,L,True,914
13493,2095,24032,single nucleotide variant,NM_000349.3(STAR):c.653C>T (p.Ala218Val),6770,STAR,HGNC:11359,Pathogenic,1,1-Nov-99,137852690,-,RCV000009556,"MONDO:MONDO:0008725,MedGen:C0342474,OMIM:201710,Orphanet:418,Orphanet:90790",Cholesterol monooxygenase (side-chain cleaving) deficiency,germline,germline,GRCh38,NC_000008.11,8,38145313,38145313,na,na,8p11.23,no assertion criteria provided,1,-,N,"ClinGen:CA120040,UniProtKB:P49675#VAR_014239,OMIM:600617.0008",1,8993,38145313,G,A,A218V,0,pathogenic,uncertain,P49675,P49675,reviewed,STAR_HUMAN,"Steroidogenic acute regulatory protein, mitochondrial, StAR (START domain-containing protein 1, StARD1)",STAR STARD1,Homo sapiens (Human),285.0,MLLATFKLCAGSSYRHMRNMKGLRQQAVMAISQELNRRALGGPTPSTWINQVRRRSSLLGSRLEETLYSDQELAYLQQGEEAMQKALGILSNQEGWKKESQQDNGDKVMSKVVPDVGKVFRLEVVVDQPMERLYEELVERMEAMGEWNPNVKEIKVLQKIGKDTFITHELAAEAAGNLVGPRDFVSVRCAKRRGSTCVLAGMATDFGNMPEQKGVIRAEHGPTCMVLHPLAGSPSKTKLTWLLSIDLKGWLPKSIINQVLSQTQVDFANHLRKRLESHPASEARC,PF01852;,3P0L;5OMA;6T5F;6T5H;,218,A,V,True,914
13494,7538,76606,single nucleotide variant,NM_005982.4(SIX1):c.50T>A (p.Val17Glu),6495,SIX1,HGNC:10887,Pathogenic,1,20-Jun-13,397515562,-,RCV000055926,"MONDO:MONDO:0007236,MedGen:C4551702,OMIM:113650,Orphanet:107",Branchiootorenal Syndrome 1,not provided,not provided,GRCh38,NC_000014.9,14,60649140,60649140,na,na,14q23.1,no assertion criteria provided,1,-,N,"ClinGen:CA345039,UniProtKB:Q15475#VAR_064948",1,65698,60649140,A,T,V17E,0,pathogenic,uncertain,Q15475,Q15475,reviewed,SIX1_HUMAN,Homeobox protein SIX1 (Sine oculis homeobox homolog 1),SIX1,Homo sapiens (Human),284.0,MSMLPSFGFTQEQVACVCEVLQQGGNLERLGRFLWSLPACDHLHKNESVLKAKAVVAFHRGNFRELYKILESHQFSPHNHPKLQQLWLKAHYVEAEKLRGRPLGAVGKYRVRRKFPLPRTIWDGEETSYCFKEKSRGVLREWYAHNPYPSPREKRELAEATGLTTTQVSNWFKNRRQRDRAAEAKERENTENNNSSSNKQNQLSPLEGGKPLMSSSEEEFSPPQSPDQNSVLLLQGNMGHARSSNYSLPGLTASQPSHGLQTHQHQLQDSLLGPLTSSLVDLGS,PF00046;PF16878;,4EGC;,17,V,E,True,915
13495,7537,76605,single nucleotide variant,NM_005982.4(SIX1):c.334C>T (p.Arg112Cys),6495,SIX1,HGNC:10887,Pathogenic,1,20-Jun-13,397515561,-,RCV000055924,"MONDO:MONDO:0007236,MedGen:C4551702,OMIM:113650,Orphanet:107",Branchiootorenal Syndrome 1,not provided,not provided,GRCh38,NC_000014.9,14,60648856,60648856,na,na,14q23.1,no assertion criteria provided,1,-,N,"ClinGen:CA345038,UniProtKB:Q15475#VAR_064952",1,65697,60648856,G,A,R112C,0,pathogenic,uncertain,Q15475,Q15475,reviewed,SIX1_HUMAN,Homeobox protein SIX1 (Sine oculis homeobox homolog 1),SIX1,Homo sapiens (Human),284.0,MSMLPSFGFTQEQVACVCEVLQQGGNLERLGRFLWSLPACDHLHKNESVLKAKAVVAFHRGNFRELYKILESHQFSPHNHPKLQQLWLKAHYVEAEKLRGRPLGAVGKYRVRRKFPLPRTIWDGEETSYCFKEKSRGVLREWYAHNPYPSPREKRELAEATGLTTTQVSNWFKNRRQRDRAAEAKERENTENNNSSSNKQNQLSPLEGGKPLMSSSEEEFSPPQSPDQNSVLLLQGNMGHARSSNYSLPGLTASQPSHGLQTHQHQLQDSLLGPLTSSLVDLGS,PF00046;PF16878;,4EGC;,112,R,C,True,915
13496,7536,76604,single nucleotide variant,NM_005982.4(SIX1):c.317T>G (p.Val106Gly),6495,SIX1,HGNC:10887,Pathogenic,1,20-Jun-13,397515560,-,RCV000055923,"MONDO:MONDO:0007236,MedGen:C4551702,OMIM:113650,Orphanet:107",Branchiootorenal Syndrome 1,not provided,not provided,GRCh38,NC_000014.9,14,60648873,60648873,na,na,14q23.1,no assertion criteria provided,1,-,N,"ClinGen:CA345037,UniProtKB:Q15475#VAR_064950",1,65696,60648873,A,C,V106G,0,pathogenic,uncertain,Q15475,Q15475,reviewed,SIX1_HUMAN,Homeobox protein SIX1 (Sine oculis homeobox homolog 1),SIX1,Homo sapiens (Human),284.0,MSMLPSFGFTQEQVACVCEVLQQGGNLERLGRFLWSLPACDHLHKNESVLKAKAVVAFHRGNFRELYKILESHQFSPHNHPKLQQLWLKAHYVEAEKLRGRPLGAVGKYRVRRKFPLPRTIWDGEETSYCFKEKSRGVLREWYAHNPYPSPREKRELAEATGLTTTQVSNWFKNRRQRDRAAEAKERENTENNNSSSNKQNQLSPLEGGKPLMSSSEEEFSPPQSPDQNSVLLLQGNMGHARSSNYSLPGLTASQPSHGLQTHQHQLQDSLLGPLTSSLVDLGS,PF00046;PF16878;,4EGC;,106,V,G,True,915
13497,1951,23347,single nucleotide variant,NM_005982.4(SIX1):c.386A>G (p.Tyr129Cys),6495,SIX1,HGNC:10887,Pathogenic,1,31-Oct-18,104894478,-,RCV000008806|RCV000055925|RCV000413341|RCV000679883|RCV000763344,"MONDO:MONDO:0012025,MedGen:C1842124,OMIM:608389|MONDO:MONDO:0007236,MedGen:C4551702,OMIM:113650,Orphanet:107|MedGen:CN517202|MONDO:MONDO:0011519,MedGen:C1854594,OMIM:605192,Orphanet:90635|MONDO:MONDO:0011519,MedGen:C1854594,OMIM:605192,Orphanet:90635;MONDO:MONDO:0012025,MedGen:C1842124,OMIM:608389;MONDO:MONDO:0007236,MedGen:C4551702,OMIM:113650,Orphanet:107","Branchiootic syndrome 3|Branchiootorenal Syndrome 1|not provided|Deafness, autosomal dominant 23|Deafness, autosomal dominant 23;Branchiootic syndrome 3;Branchiootorenal Syndrome 1",de novo;germline;unknown,germline,GRCh38,NC_000014.9,14,60648804,60648804,na,na,14q23.1,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA254381,UniProtKB:Q15475#VAR_031025,OMIM:601205.0001",3,8308,60648804,T,C,Y129C,2,pathogenic,pathogenic,Q15475,Q15475,reviewed,SIX1_HUMAN,Homeobox protein SIX1 (Sine oculis homeobox homolog 1),SIX1,Homo sapiens (Human),284.0,MSMLPSFGFTQEQVACVCEVLQQGGNLERLGRFLWSLPACDHLHKNESVLKAKAVVAFHRGNFRELYKILESHQFSPHNHPKLQQLWLKAHYVEAEKLRGRPLGAVGKYRVRRKFPLPRTIWDGEETSYCFKEKSRGVLREWYAHNPYPSPREKRELAEATGLTTTQVSNWFKNRRQRDRAAEAKERENTENNNSSSNKQNQLSPLEGGKPLMSSSEEEFSPPQSPDQNSVLLLQGNMGHARSSNYSLPGLTASQPSHGLQTHQHQLQDSLLGPLTSSLVDLGS,PF00046;PF16878;,4EGC;,129,Y,C,True,915
13498,1952,23348,single nucleotide variant,NM_005982.4(SIX1):c.328C>T (p.Arg110Trp),6495,SIX1,HGNC:10887,Pathogenic,1,27-Aug-09,80356459,-,RCV000008807,"MONDO:MONDO:0012025,MedGen:C1842124,OMIM:608389",Branchiootic syndrome 3,germline,germline,GRCh38,NC_000014.9,14,60648862,60648862,na,na,14q23.1,no assertion criteria provided,2,-,N,"UniProtKB:Q15475#VAR_031024,OMIM:601205.0002,ClinGen:CA340772",1,8309,60648862,G,A,R110W,0,pathogenic,uncertain,Q15475,Q15475,reviewed,SIX1_HUMAN,Homeobox protein SIX1 (Sine oculis homeobox homolog 1),SIX1,Homo sapiens (Human),284.0,MSMLPSFGFTQEQVACVCEVLQQGGNLERLGRFLWSLPACDHLHKNESVLKAKAVVAFHRGNFRELYKILESHQFSPHNHPKLQQLWLKAHYVEAEKLRGRPLGAVGKYRVRRKFPLPRTIWDGEETSYCFKEKSRGVLREWYAHNPYPSPREKRELAEATGLTTTQVSNWFKNRRQRDRAAEAKERENTENNNSSSNKQNQLSPLEGGKPLMSSSEEEFSPPQSPDQNSVLLLQGNMGHARSSNYSLPGLTASQPSHGLQTHQHQLQDSLLGPLTSSLVDLGS,PF00046;PF16878;,4EGC;,110,R,W,True,915
13499,1953,23350,single nucleotide variant,NM_005982.4(SIX1):c.364T>A (p.Trp122Arg),6495,SIX1,HGNC:10887,Pathogenic,1,1-Nov-07,121909770,-,RCV000008809,"MONDO:MONDO:0012025,MedGen:C1842124,OMIM:608389",Branchiootic syndrome 3,germline,germline,GRCh38,NC_000014.9,14,60648826,60648826,na,na,14q23.1,no assertion criteria provided,1,-,N,"ClinGen:CA254384,UniProtKB:Q15475#VAR_064953,OMIM:601205.0004",1,8311,60648826,A,T,W122R,0,pathogenic,uncertain,Q15475,Q15475,reviewed,SIX1_HUMAN,Homeobox protein SIX1 (Sine oculis homeobox homolog 1),SIX1,Homo sapiens (Human),284.0,MSMLPSFGFTQEQVACVCEVLQQGGNLERLGRFLWSLPACDHLHKNESVLKAKAVVAFHRGNFRELYKILESHQFSPHNHPKLQQLWLKAHYVEAEKLRGRPLGAVGKYRVRRKFPLPRTIWDGEETSYCFKEKSRGVLREWYAHNPYPSPREKRELAEATGLTTTQVSNWFKNRRQRDRAAEAKERENTENNNSSSNKQNQLSPLEGGKPLMSSSEEEFSPPQSPDQNSVLLLQGNMGHARSSNYSLPGLTASQPSHGLQTHQHQLQDSLLGPLTSSLVDLGS,PF00046;PF16878;,4EGC;,122,W,R,True,915
13500,11978,199952,single nucleotide variant,NM_015506.3(MMACHC):c.440G>C (p.Gly147Ala),25974,MMACHC,HGNC:24525,Pathogenic/Likely pathogenic,1,18-Aug-20,140522266,-,RCV000186028|RCV000262040|RCV000576585|RCV001027895|RCV001273224,"MedGen:CN517202|MedGen:CN043592|MONDO:MONDO:0010184,MedGen:C1848561,OMIM:277400,Orphanet:26,Orphanet:79282|Human Phenotype Ontology:HP:0012120,MedGen:C1855119;Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|",not provided|Disorders of Intracellular Cobalamin Metabolism|Cobalamin C disease|Methylmalonic aciduria;Homocystinuria|Methylmalonic aciduria with homocystinuria cblC type,germline;inherited;unknown,germline,GRCh38,NC_000001.11,1,45508806,45508806,na,na,1p34.1,"criteria provided, multiple submitters, no conflicts",10,-,N,"ClinGen:CA312732,UniProtKB:Q9Y4U1#VAR_024774",2,203828,45508806,G,C,G147A,2,pathogenic,pathogenic,Q9Y4U1,Q9Y4U1,reviewed,MMAC_HUMAN,"Cyanocobalamin reductase / alkylcobalamin dealkylase (Alkylcobalamin:glutathione S-alkyltransferase, EC 2.5.1.151) (CblC) (Cyanocobalamin reductase (cyanide-eliminating), EC 1.16.1.6) (Methylmalonic aciduria and homocystinuria type C protein, MMACHC)",MMACHC,Homo sapiens (Human),282.0,MEPKVAELKQKIEDTLCPFGFEVYPFQVAWYNELLPPAFHLPLPGPTLAFLVLSTPAMFDRALKPFLQSCHLRMLTDPVDQCVAYHLGRVRESLPELQIEIIADYEVHPNRRPKILAQTAAHVAGAAYYYQRQDVEADPWGNQRISGVCIHPRFGGWFAIRGVVLLPGIEVPDLPPRKPHDCVPTRADRIALLEGFNFHWRDWTYRDAVTPQERYSEEQKAYFSTPPAQRLALLGLAQPSEKPSSPSPDLPFTTPAPKKPGNPSRARSWLSPRVSPPASPGP,PF16690;,3SBY;3SBZ;3SC0;3SOM;5UOS;,147,G,A,True,916
13501,11977,199951,single nucleotide variant,NM_015506.3(MMACHC):c.440G>A (p.Gly147Asp),25974,MMACHC,HGNC:24525,Pathogenic/Likely pathogenic,1,22-Nov-19,140522266,-,RCV000186029|RCV000586798|RCV001273223,"MedGen:CN517202|MONDO:MONDO:0010184,MedGen:C1848561,OMIM:277400,Orphanet:26,Orphanet:79282|",not provided|Cobalamin C disease|Methylmalonic aciduria with homocystinuria cblC type,germline;unknown,germline,GRCh38,NC_000001.11,1,45508806,45508806,na,na,1p34.1,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA312733,UniProtKB:Q9Y4U1#VAR_024775",2,203829,45508806,G,A,G147D,2,pathogenic,pathogenic,Q9Y4U1,Q9Y4U1,reviewed,MMAC_HUMAN,"Cyanocobalamin reductase / alkylcobalamin dealkylase (Alkylcobalamin:glutathione S-alkyltransferase, EC 2.5.1.151) (CblC) (Cyanocobalamin reductase (cyanide-eliminating), EC 1.16.1.6) (Methylmalonic aciduria and homocystinuria type C protein, MMACHC)",MMACHC,Homo sapiens (Human),282.0,MEPKVAELKQKIEDTLCPFGFEVYPFQVAWYNELLPPAFHLPLPGPTLAFLVLSTPAMFDRALKPFLQSCHLRMLTDPVDQCVAYHLGRVRESLPELQIEIIADYEVHPNRRPKILAQTAAHVAGAAYYYQRQDVEADPWGNQRISGVCIHPRFGGWFAIRGVVLLPGIEVPDLPPRKPHDCVPTRADRIALLEGFNFHWRDWTYRDAVTPQERYSEEQKAYFSTPPAQRLALLGLAQPSEKPSSPSPDLPFTTPAPKKPGNPSRARSWLSPRVSPPASPGP,PF16690;,3SBY;3SBZ;3SC0;3SOM;5UOS;,147,G,D,True,916
13502,340,16461,single nucleotide variant,NM_015506.3(MMACHC):c.347T>C (p.Leu116Pro),25974,MMACHC,HGNC:24525,Pathogenic/Likely pathogenic,1,17-Feb-17,121918240,-,RCV000001487,"MONDO:MONDO:0010184,MedGen:C1848561,OMIM:277400,Orphanet:26,Orphanet:79282",Cobalamin C disease,germline;unknown,germline,GRCh38,NC_000001.11,1,45508282,45508282,na,na,1p34.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"OMIM:609831.0002,ClinGen:CA251786,UniProtKB:Q9Y4U1#VAR_024771",3,1422,45508282,T,C,L116P,2,pathogenic,pathogenic,Q9Y4U1,Q9Y4U1,reviewed,MMAC_HUMAN,"Cyanocobalamin reductase / alkylcobalamin dealkylase (Alkylcobalamin:glutathione S-alkyltransferase, EC 2.5.1.151) (CblC) (Cyanocobalamin reductase (cyanide-eliminating), EC 1.16.1.6) (Methylmalonic aciduria and homocystinuria type C protein, MMACHC)",MMACHC,Homo sapiens (Human),282.0,MEPKVAELKQKIEDTLCPFGFEVYPFQVAWYNELLPPAFHLPLPGPTLAFLVLSTPAMFDRALKPFLQSCHLRMLTDPVDQCVAYHLGRVRESLPELQIEIIADYEVHPNRRPKILAQTAAHVAGAAYYYQRQDVEADPWGNQRISGVCIHPRFGGWFAIRGVVLLPGIEVPDLPPRKPHDCVPTRADRIALLEGFNFHWRDWTYRDAVTPQERYSEEQKAYFSTPPAQRLALLGLAQPSEKPSSPSPDLPFTTPAPKKPGNPSRARSWLSPRVSPPASPGP,PF16690;,3SBY;3SBZ;3SC0;3SOM;5UOS;,116,L,P,True,916
13503,13132,249967,single nucleotide variant,NM_015506.3(MMACHC):c.811A>G (p.Ser271Gly),25974,MMACHC,HGNC:24525,Benign/Likely benign,0,27-Nov-20,35219601,-,RCV000245390|RCV000287880,MedGen:CN169374|MedGen:CN043592,not specified|Disorders of Intracellular Cobalamin Metabolism,germline,germline,GRCh38,NC_000001.11,1,45509177,45509177,na,na,1p34.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA827870,UniProtKB:Q9Y4U1#VAR_038805",2,260665,45509177,A,G,S271G,2,benign,benign,Q9Y4U1,Q9Y4U1,reviewed,MMAC_HUMAN,"Cyanocobalamin reductase / alkylcobalamin dealkylase (Alkylcobalamin:glutathione S-alkyltransferase, EC 2.5.1.151) (CblC) (Cyanocobalamin reductase (cyanide-eliminating), EC 1.16.1.6) (Methylmalonic aciduria and homocystinuria type C protein, MMACHC)",MMACHC,Homo sapiens (Human),282.0,MEPKVAELKQKIEDTLCPFGFEVYPFQVAWYNELLPPAFHLPLPGPTLAFLVLSTPAMFDRALKPFLQSCHLRMLTDPVDQCVAYHLGRVRESLPELQIEIIADYEVHPNRRPKILAQTAAHVAGAAYYYQRQDVEADPWGNQRISGVCIHPRFGGWFAIRGVVLLPGIEVPDLPPRKPHDCVPTRADRIALLEGFNFHWRDWTYRDAVTPQERYSEEQKAYFSTPPAQRLALLGLAQPSEKPSSPSPDLPFTTPAPKKPGNPSRARSWLSPRVSPPASPGP,PF16690;,3SBY;3SBZ;3SC0;3SOM;5UOS;,271,S,G,True,916
13504,11979,199956,single nucleotide variant,NM_015506.3(MMACHC):c.616C>T (p.Arg206Trp),25974,MMACHC,HGNC:24525,Conflicting interpretations of pathogenicity,1,18-Oct-19,538023671,-,RCV000490478,"MONDO:MONDO:0010184,MedGen:C1848561,OMIM:277400,Orphanet:26,Orphanet:79282",Cobalamin C disease,germline;unknown,germline,GRCh38,NC_000001.11,1,45508982,45508982,na,na,1p34.1,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA312738,UniProtKB:Q9Y4U1#VAR_024783",2,203832,45508982,C,T,R206W,1,uncertain,uncertain,Q9Y4U1,Q9Y4U1,reviewed,MMAC_HUMAN,"Cyanocobalamin reductase / alkylcobalamin dealkylase (Alkylcobalamin:glutathione S-alkyltransferase, EC 2.5.1.151) (CblC) (Cyanocobalamin reductase (cyanide-eliminating), EC 1.16.1.6) (Methylmalonic aciduria and homocystinuria type C protein, MMACHC)",MMACHC,Homo sapiens (Human),282.0,MEPKVAELKQKIEDTLCPFGFEVYPFQVAWYNELLPPAFHLPLPGPTLAFLVLSTPAMFDRALKPFLQSCHLRMLTDPVDQCVAYHLGRVRESLPELQIEIIADYEVHPNRRPKILAQTAAHVAGAAYYYQRQDVEADPWGNQRISGVCIHPRFGGWFAIRGVVLLPGIEVPDLPPRKPHDCVPTRADRIALLEGFNFHWRDWTYRDAVTPQERYSEEQKAYFSTPPAQRLALLGLAQPSEKPSSPSPDLPFTTPAPKKPGNPSRARSWLSPRVSPPASPGP,PF16690;,3SBY;3SBZ;3SC0;3SOM;5UOS;,206,R,W,True,916
13505,341,16464,single nucleotide variant,NM_015506.3(MMACHC):c.482G>A (p.Arg161Gln),25974,MMACHC,HGNC:24525,Pathogenic,1,17-Dec-19,121918243,-,RCV000001490|RCV000081740|RCV000624532|RCV000721969|RCV001273229,"MONDO:MONDO:0010184,MedGen:C1848561,OMIM:277400,Orphanet:26,Orphanet:79282|MedGen:CN517202|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0009612,MedGen:C1855114,OMIM:251000,Orphanet:27|",Cobalamin C disease|not provided|Inborn genetic diseases|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic aciduria with homocystinuria cblC type,germline;paternal,germline,GRCh38,NC_000001.11,1,45508848,45508848,na,na,1p34.1,"criteria provided, multiple submitters, no conflicts",13,-,N,"ClinVar:424754,ClinGen:CA223191,UniProtKB:Q9Y4U1#VAR_024779,OMIM:609831.0005",3,1425,45508848,G,A,R161Q,2,pathogenic,pathogenic,Q9Y4U1,Q9Y4U1,reviewed,MMAC_HUMAN,"Cyanocobalamin reductase / alkylcobalamin dealkylase (Alkylcobalamin:glutathione S-alkyltransferase, EC 2.5.1.151) (CblC) (Cyanocobalamin reductase (cyanide-eliminating), EC 1.16.1.6) (Methylmalonic aciduria and homocystinuria type C protein, MMACHC)",MMACHC,Homo sapiens (Human),282.0,MEPKVAELKQKIEDTLCPFGFEVYPFQVAWYNELLPPAFHLPLPGPTLAFLVLSTPAMFDRALKPFLQSCHLRMLTDPVDQCVAYHLGRVRESLPELQIEIIADYEVHPNRRPKILAQTAAHVAGAAYYYQRQDVEADPWGNQRISGVCIHPRFGGWFAIRGVVLLPGIEVPDLPPRKPHDCVPTRADRIALLEGFNFHWRDWTYRDAVTPQERYSEEQKAYFSTPPAQRLALLGLAQPSEKPSSPSPDLPFTTPAPKKPGNPSRARSWLSPRVSPPASPGP,PF16690;,3SBY;3SBZ;3SC0;3SOM;5UOS;,161,R,Q,True,916
13506,3222,27826,single nucleotide variant,NM_003000.2(SDHB):c.395A>C (p.His132Pro),6390,SDHB,HGNC:10681,Likely pathogenic,1,5-Dec-18,74315372,-,RCV000013628|RCV001021521,"MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162",Paragangliomas 4|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000001.11,1,17028628,17028628,na,na,1p36.13,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,"ClinGen:CA015817,UniProtKB:P21912#VAR_037621,OMIM:185470.0010",3,12787,17028628,T,G,H132P,1,pathogenic,pathogenic,P21912,P21912,reviewed,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial, EC 1.3.5.1 (Iron-sulfur subunit of complex II, Ip)",SDHB SDH SDH1,Homo sapiens (Human),280.0,MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQTYEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV,PF13085;,7KCL;7KCM;7KLU;7KLV;,132,H,P,True,917
13507,11227,172493,single nucleotide variant,NM_003000.3(SDHB):c.260T>C (p.Leu87Ser),6390,SDHB,HGNC:10681,Pathogenic/Likely pathogenic,1,9-Sep-20,727504457,-,RCV000155443|RCV000697957|RCV001016096,"MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072;Human Phenotype Ontology:HP:0100723,MONDO:MONDO:0011719,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:44890|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162",Hereditary Paraganglioma-Pheochromocytoma Syndromes|Pheochromocytoma;Paragangliomas 4;Gastrointestinal stromal tumor|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000001.11,1,17033086,17033086,na,na,1p36.13,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"ClinGen:CA015626,UniProtKB:P21912#VAR_018517",2,178686,17033086,A,G,L87S,2,pathogenic,pathogenic,P21912,P21912,reviewed,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial, EC 1.3.5.1 (Iron-sulfur subunit of complex II, Ip)",SDHB SDH SDH1,Homo sapiens (Human),280.0,MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQTYEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV,PF13085;,7KCL;7KCM;7KLU;7KLV;,87,L,S,True,917
13508,3221,27825,single nucleotide variant,NM_003000.2(SDHB):c.302G>A (p.Cys101Tyr),6390,SDHB,HGNC:10681,Pathogenic,1,9-May-02,74315371,-,RCV000013627,"Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072",Pheochromocytoma,germline,germline,GRCh38,NC_000001.11,1,17028721,17028721,na,na,1p36.13,no assertion criteria provided,1,"ACMG2013,ACMG2016",N,"ClinGen:CA015737,UniProtKB:P21912#VAR_035065,OMIM:185470.0009",1,12786,17028721,C,T,C101Y,0,pathogenic,uncertain,P21912,P21912,reviewed,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial, EC 1.3.5.1 (Iron-sulfur subunit of complex II, Ip)",SDHB SDH SDH1,Homo sapiens (Human),280.0,MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQTYEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV,PF13085;,7KCL;7KCM;7KLU;7KLV;,101,C,Y,True,917
13509,3220,27824,single nucleotide variant,NM_003000.2(SDHB):c.136C>G (p.Arg46Gly),6390,SDHB,HGNC:10681,Pathogenic,1,18-Nov-19,74315370,-,RCV000013626|RCV000216404|RCV000800486,"Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;Human Phenotype Ontology:HP:0100723,MONDO:MONDO:0011719,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:44890;MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072",Pheochromocytoma|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Gastrointestinal stromal tumor;Paragangliomas 4,germline,germline,GRCh38,NC_000001.11,1,17044825,17044825,na,na,1p36.13,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"ClinGen:CA015497,UniProtKB:P21912#VAR_035064,OMIM:185470.0008",3,12785,17044825,G,C,R46G,2,pathogenic,pathogenic,P21912,P21912,reviewed,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial, EC 1.3.5.1 (Iron-sulfur subunit of complex II, Ip)",SDHB SDH SDH1,Homo sapiens (Human),280.0,MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQTYEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV,PF13085;,7KCL;7KCM;7KLU;7KLV;,46,R,G,True,917
13510,3223,27827,single nucleotide variant,NM_003000.2(SDHB):c.299C>T (p.Ser100Phe),6390,SDHB,HGNC:10681,Uncertain significance,1,7-Feb-18,121917755,-,RCV000013629|RCV001266192,"Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MeSH:D030342,MedGen:C0950123",Pheochromocytoma|Inborn genetic diseases,germline;somatic,germline/somatic,GRCh38,NC_000001.11,1,17028724,17028724,na,na,1p36.13,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,"ClinGen:CA015720,UniProtKB:P21912#VAR_037620,OMIM:185470.0011",3,12788,17028724,G,A,S100F,1,uncertain,uncertain,P21912,P21912,reviewed,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial, EC 1.3.5.1 (Iron-sulfur subunit of complex II, Ip)",SDHB SDH SDH1,Homo sapiens (Human),280.0,MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQTYEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV,PF13085;,7KCL;7KCM;7KLU;7KLV;,100,S,F,True,917
13511,3218,27818,single nucleotide variant,NM_003000.2(SDHB):c.590C>G (p.Pro197Arg),6390,SDHB,HGNC:10681,Pathogenic/Likely pathogenic,1,16-Jan-20,74315367,-,RCV000013617|RCV000030623|RCV000213984|RCV000465474|RCV001001379,"MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;Human Phenotype Ontology:HP:0100723,MONDO:MONDO:0011719,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:44890;MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072|MedGen:CN235283",Paragangliomas 4|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Gastrointestinal stromal tumor;Paragangliomas 4|none provided,germline,germline,GRCh38,NC_000001.11,1,17024025,17024025,na,na,1p36.13,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,"ClinGen:CA016001,UniProtKB:P21912#VAR_017868,OMIM:185470.0002",3,12779,17024025,G,C,P197R,2,pathogenic,pathogenic,P21912,P21912,reviewed,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial, EC 1.3.5.1 (Iron-sulfur subunit of complex II, Ip)",SDHB SDH SDH1,Homo sapiens (Human),280.0,MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQTYEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV,PF13085;,7KCL;7KCM;7KLU;7KLV;,197,P,R,True,917
13512,11475,181611,single nucleotide variant,NM_003000.2(SDHB):c.574T>C (p.Cys192Arg),6390,SDHB,HGNC:10681,Pathogenic,1,4-Feb-19,786202732,-,RCV000165688|RCV000482399|RCV000505299|RCV000821774,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072;Human Phenotype Ontology:HP:0100723,MONDO:MONDO:0011719,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:44890",Hereditary cancer-predisposing syndrome|not provided|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Pheochromocytoma;Paragangliomas 4;Gastrointestinal stromal tumor,germline,germline,GRCh38,NC_000001.11,1,17024041,17024041,na,na,1p36.13,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"ClinGen:CA015973,UniProtKB:P21912#VAR_035066",2,186150,17024041,A,G,C192R,2,pathogenic,pathogenic,P21912,P21912,reviewed,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial, EC 1.3.5.1 (Iron-sulfur subunit of complex II, Ip)",SDHB SDH SDH1,Homo sapiens (Human),280.0,MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQTYEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV,PF13085;,7KCL;7KCM;7KLU;7KLV;,192,C,R,True,917
13513,12707,232176,single nucleotide variant,NM_003000.2(SDHB):c.587G>A (p.Cys196Tyr),6390,SDHB,HGNC:10681,Pathogenic,1,23-Aug-19,876658367,-,RCV000220162|RCV000461924|RCV000479413|RCV000505388|RCV001034642,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072|MedGen:CN517202|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072;Human Phenotype Ontology:HP:0100723,MONDO:MONDO:0011719,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:44890",Hereditary cancer-predisposing syndrome|Paragangliomas 4|not provided|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Pheochromocytoma;Paragangliomas 4;Gastrointestinal stromal tumor,germline,germline,GRCh38,NC_000001.11,1,17024028,17024028,na,na,1p36.13,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"ClinGen:CA10577672,UniProtKB:P21912#VAR_035067",2,230070,17024028,C,T,C196Y,2,pathogenic,pathogenic,P21912,P21912,reviewed,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial, EC 1.3.5.1 (Iron-sulfur subunit of complex II, Ip)",SDHB SDH SDH1,Homo sapiens (Human),280.0,MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQTYEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV,PF13085;,7KCL;7KCM;7KLU;7KLV;,196,C,Y,True,917
13514,12708,232185,single nucleotide variant,NM_003000.2(SDHB):c.194T>A (p.Leu65His),6390,SDHB,HGNC:10681,Likely pathogenic,1,14-Aug-15,876659329,-,RCV000217113,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162",Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000001.11,1,17044767,17044767,na,na,1p36.13,"criteria provided, single submitter",1,"ACMG2013,ACMG2016",N,"ClinGen:CA10577680,UniProtKB:P21912#VAR_054379",2,231737,17044767,A,T,L65H,1,pathogenic,pathogenic,P21912,P21912,reviewed,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial, EC 1.3.5.1 (Iron-sulfur subunit of complex II, Ip)",SDHB SDH SDH1,Homo sapiens (Human),280.0,MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQTYEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV,PF13085;,7KCL;7KCM;7KLU;7KLV;,65,L,H,True,917
13515,11474,181608,single nucleotide variant,NM_003000.2(SDHB):c.688C>T (p.Arg230Cys),6390,SDHB,HGNC:10681,Pathogenic,1,6-Jan-20,138996609,-,RCV000164435|RCV000505374|RCV000520697|RCV000528137|RCV000660258,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MedGen:CN517202|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072;Human Phenotype Ontology:HP:0100723,MONDO:MONDO:0011719,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:44890|MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072",Hereditary cancer-predisposing syndrome|Hereditary Paraganglioma-Pheochromocytoma Syndromes|not provided|Pheochromocytoma;Paragangliomas 4;Gastrointestinal stromal tumor|Paragangliomas 4,germline;unknown,germline,GRCh38,NC_000001.11,1,17022685,17022685,na,na,1p36.13,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,"ClinGen:CA016074,UniProtKB:P21912#VAR_054383",2,185077,17022685,G,A,R230C,2,pathogenic,pathogenic,P21912,P21912,reviewed,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial, EC 1.3.5.1 (Iron-sulfur subunit of complex II, Ip)",SDHB SDH SDH1,Homo sapiens (Human),280.0,MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQTYEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV,PF13085;,7KCL;7KCM;7KLU;7KLV;,230,R,C,True,917
13516,3224,27830,single nucleotide variant,NM_003000.3(SDHB):c.8C>G (p.Ala3Gly),6390,SDHB,HGNC:10681,Benign/Likely benign,0,19-May-20,11203289,-,RCV000013632|RCV000034690|RCV000121999|RCV000128921|RCV000275977|RCV000368190|RCV000755699|RCV000986270|RCV001079357|RCV001286622,"MONDO:MONDO:0016063,MedGen:C0018553,OMIM:PS158350,Orphanet:201|MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286|MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072|Human Phenotype Ontology:HP:0100723,MONDO:MONDO:0011719,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:44890|MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;Human Phenotype Ontology:HP:0100723,MONDO:MONDO:0011719,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:44890|MedGen:CN235283",Cowden syndrome|not provided|not specified|Hereditary cancer-predisposing syndrome|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Carney-Stratakis syndrome|Paragangliomas 4|Gastrointestinal stromal tumor|Paragangliomas 4;Pheochromocytoma;Gastrointestinal stromal tumor|none provided,germline;unknown,germline,GRCh38,NC_000001.11,1,17054012,17054012,na,na,1p36.13,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"ClinGen:CA016202,UniProtKB:P21912#VAR_054374,OMIM:185470.0014",3,12791,17054012,G,C,A3G,2,benign,benign,P21912,P21912,reviewed,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial, EC 1.3.5.1 (Iron-sulfur subunit of complex II, Ip)",SDHB SDH SDH1,Homo sapiens (Human),280.0,MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQTYEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV,PF13085;,7KCL;7KCM;7KLU;7KLV;,3,A,G,True,917
13517,3225,27831,single nucleotide variant,NM_003000.3(SDHB):c.487T>C (p.Ser163Pro),6390,SDHB,HGNC:10681,Conflicting interpretations of pathogenicity,0,31-Dec-19,33927012,-,RCV000013633|RCV000034688|RCV000122002|RCV000132153|RCV000202946|RCV000206861|RCV000282667|RCV000986263|RCV001099292|RCV001269360,"MONDO:MONDO:0016063,MedGen:C0018553,OMIM:PS158350,Orphanet:201|MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072|Human Phenotype Ontology:HP:0100723,MONDO:MONDO:0011719,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:44890;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|Human Phenotype Ontology:HP:0100723,MONDO:MONDO:0011719,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:44890|MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286|MONDO:MONDO:0007254,MedGen:C0006142",Cowden syndrome|not provided|not specified|Hereditary cancer-predisposing syndrome|Paragangliomas 4|Gastrointestinal stromal tumor;Pheochromocytoma;Paragangliomas 4|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Gastrointestinal stromal tumor|Carney-Stratakis syndrome|Malignant tumor of breast,germline;unknown,germline,GRCh38,NC_000001.11,1,17027802,17027802,na,na,1p36.13,"criteria provided, conflicting interpretations",19,"ACMG2013,ACMG2016",N,"ClinGen:CA015910,UniProtKB:P21912#VAR_054382,OMIM:185470.0015",3,12792,17027802,A,G,S163P,1,uncertain,uncertain,P21912,P21912,reviewed,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial, EC 1.3.5.1 (Iron-sulfur subunit of complex II, Ip)",SDHB SDH SDH1,Homo sapiens (Human),280.0,MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQTYEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV,PF13085;,7KCL;7KCM;7KLU;7KLV;,163,S,P,True,917
13518,11476,181624,single nucleotide variant,NM_003000.3(SDHB):c.137G>A (p.Arg46Gln),6390,SDHB,HGNC:10681,Pathogenic/Likely pathogenic,1,31-Oct-19,772551056,-,RCV000162578|RCV000183217|RCV000232432|RCV000505310|RCV000627748|RCV000722045|RCV000763273,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072;Human Phenotype Ontology:HP:0100723,MONDO:MONDO:0011719,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:44890|MedGen:CN239418|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072",Hereditary cancer-predisposing syndrome|not provided|Paragangliomas 4|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Pheochromocytoma;Paragangliomas 4;Gastrointestinal stromal tumor|SDHB-Related Disorders|Pheochromocytoma;Carney-Stratakis syndrome;Paragangliomas 4,germline;unknown,germline,GRCh38,NC_000001.11,1,17044824,17044824,na,na,1p36.13,"criteria provided, multiple submitters, no conflicts",11,"ACMG2013,ACMG2016",N,"ClinGen:CA015517,UniProtKB:P21912#VAR_054377",2,183793,17044824,C,T,R46Q,2,pathogenic,pathogenic,P21912,P21912,reviewed,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial, EC 1.3.5.1 (Iron-sulfur subunit of complex II, Ip)",SDHB SDH SDH1,Homo sapiens (Human),280.0,MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQTYEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV,PF13085;,7KCL;7KCM;7KLU;7KLV;,46,R,Q,True,917
13519,3219,27820,single nucleotide variant,NM_003000.2(SDHB):c.725G>A (p.Arg242His),6390,SDHB,HGNC:10681,Pathogenic,1,10-Dec-19,74315368,-,RCV000013619|RCV000013620|RCV000022778|RCV000129095|RCV000183216|RCV000505354|RCV000627751,"MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|Human Phenotype Ontology:HP:0100723,MONDO:MONDO:0011719,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:44890|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0007273,MedGen:C1861848,OMIM:115310,Orphanet:29072;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;Human Phenotype Ontology:HP:0100723,MONDO:MONDO:0011719,MeSH:D046152,MedGen:C0238198,OMIM:606764,Orphanet:44890",Paragangliomas 4|Pheochromocytoma|Gastrointestinal stromal tumor|Hereditary cancer-predisposing syndrome|not provided|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Paragangliomas 4;Pheochromocytoma;Gastrointestinal stromal tumor,germline;unknown,germline,GRCh38,NC_000001.11,1,17022648,17022648,na,na,1p36.13,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,"ClinGen:CA016163,UniProtKB:P21912#VAR_017869,OMIM:185470.0004",3,12781,17022648,C,T,R242H,2,pathogenic,pathogenic,P21912,P21912,reviewed,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial, EC 1.3.5.1 (Iron-sulfur subunit of complex II, Ip)",SDHB SDH SDH1,Homo sapiens (Human),280.0,MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQTYEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV,PF13085;,7KCL;7KCM;7KLU;7KLV;,242,R,H,True,917
13520,11838,192536,single nucleotide variant,NM_022787.4(NMNAT1):c.37G>A (p.Ala13Thr),64802,NMNAT1,HGNC:17877,Conflicting interpretations of pathogenicity,1,5-Jan-19,138613460,-,RCV000175940|RCV001074101|RCV001256640,"MedGen:CN517202|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862|MONDO:MONDO:0012056,MedGen:C1837873,OMIM:608553,Orphanet:65",not provided|Retinal dystrophy|Leber congenital amaurosis 9,germline;inherited,germline,GRCh38,NC_000001.11,1,9972110,9972110,na,na,1p36.22,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA241796,UniProtKB:Q9HAN9#VAR_068857",2,195375,9972110,G,A,A13T,1,uncertain,uncertain,Q9HAN9,Q9HAN9,reviewed,NMNA1_HUMAN,"Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, NMN/NaMN adenylyltransferase 1, EC 2.7.7.1, EC 2.7.7.18 (Nicotinamide-nucleotide adenylyltransferase 1, NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1, NaMN adenylyltransferase 1)",NMNAT1 NMNAT,Homo sapiens (Human),279.0,MENSEKTEVVLLACGSFNPITNMHLRLFELAKDYMNGTGRYTVVKGIISPVGDAYKKKGLIPAYHRVIMAELATKNSKWVEVDTWESLQKEWKETLKVLRHHQEKLEASDCDHQQNSPTLERPGRKRKWTETQDSSQKKSLEPKTKAVPKVKLLCGADLLESFAVPNLWKSEDITQIVANYGLICVTRAGNDAQKFIYESDVLWKHRSNIHVVNEWIANDISSTKIRRALRRGQSIRYLVPDLVQEYIEKHNLYSSESEDRNAGVILAPLQRNTAEAKT,PF01467;,1GZU;1KKU;1KQN;1KQO;1KR2;,13,A,T,True,918
13521,6247,45794,single nucleotide variant,NM_022787.4(NMNAT1):c.619C>T (p.Arg207Trp),64802,NMNAT1,HGNC:17877,Pathogenic,1,3-Dec-19,142968179,-,RCV000030764|RCV001090803,"MONDO:MONDO:0012056,MedGen:C1837873,OMIM:608553,Orphanet:65|MedGen:CN517202",Leber congenital amaurosis 9|not provided,germline;inherited,germline,GRCh38,NC_000001.11,1,9982480,9982480,na,na,1p36.22,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA260590,UniProtKB:Q9HAN9#VAR_068876,OMIM:608700.0005",3,37133,9982480,C,T,R207W,2,pathogenic,pathogenic,Q9HAN9,Q9HAN9,reviewed,NMNA1_HUMAN,"Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, NMN/NaMN adenylyltransferase 1, EC 2.7.7.1, EC 2.7.7.18 (Nicotinamide-nucleotide adenylyltransferase 1, NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1, NaMN adenylyltransferase 1)",NMNAT1 NMNAT,Homo sapiens (Human),279.0,MENSEKTEVVLLACGSFNPITNMHLRLFELAKDYMNGTGRYTVVKGIISPVGDAYKKKGLIPAYHRVIMAELATKNSKWVEVDTWESLQKEWKETLKVLRHHQEKLEASDCDHQQNSPTLERPGRKRKWTETQDSSQKKSLEPKTKAVPKVKLLCGADLLESFAVPNLWKSEDITQIVANYGLICVTRAGNDAQKFIYESDVLWKHRSNIHVVNEWIANDISSTKIRRALRRGQSIRYLVPDLVQEYIEKHNLYSSESEDRNAGVILAPLQRNTAEAKT,PF01467;,1GZU;1KKU;1KQN;1KQO;1KR2;,207,R,W,True,918
13522,6248,45795,single nucleotide variant,NM_022787.4(NMNAT1):c.769G>A (p.Glu257Lys),64802,NMNAT1,HGNC:17877,Pathogenic,1,20-Dec-19,150726175,-,RCV000030765|RCV000255806|RCV000504859|RCV001003567|RCV001075816,"MONDO:MONDO:0012056,MedGen:C1837873,OMIM:608553,Orphanet:65|MedGen:CN517202|MONDO:MONDO:0018998,MeSH:D057130,MedGen:C0339527,OMIM:PS204000,Orphanet:65|7 conditions|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862",Leber congenital amaurosis 9|not provided|Leber congenital amaurosis|7 conditions|Retinal dystrophy,germline;inherited;unknown,germline,GRCh38,NC_000001.11,1,9982630,9982630,na,na,1p36.22,"criteria provided, multiple submitters, no conflicts",11,-,N,"ClinVar:438483,ClinGen:CA342906,UniProtKB:Q9HAN9#VAR_068882,OMIM:608700.0002",3,37134,9982630,G,A,E257K,2,pathogenic,pathogenic,Q9HAN9,Q9HAN9,reviewed,NMNA1_HUMAN,"Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, NMN/NaMN adenylyltransferase 1, EC 2.7.7.1, EC 2.7.7.18 (Nicotinamide-nucleotide adenylyltransferase 1, NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1, NaMN adenylyltransferase 1)",NMNAT1 NMNAT,Homo sapiens (Human),279.0,MENSEKTEVVLLACGSFNPITNMHLRLFELAKDYMNGTGRYTVVKGIISPVGDAYKKKGLIPAYHRVIMAELATKNSKWVEVDTWESLQKEWKETLKVLRHHQEKLEASDCDHQQNSPTLERPGRKRKWTETQDSSQKKSLEPKTKAVPKVKLLCGADLLESFAVPNLWKSEDITQIVANYGLICVTRAGNDAQKFIYESDVLWKHRSNIHVVNEWIANDISSTKIRRALRRGQSIRYLVPDLVQEYIEKHNLYSSESEDRNAGVILAPLQRNTAEAKT,PF01467;,1GZU;1KKU;1KQN;1KQO;1KR2;,257,E,K,True,918
13523,6250,45797,single nucleotide variant,NM_022787.4(NMNAT1):c.451G>T (p.Val151Phe),64802,NMNAT1,HGNC:17877,Pathogenic,1,1-Sep-12,387907292,-,RCV000030767,"MONDO:MONDO:0012056,MedGen:C1837873,OMIM:608553,Orphanet:65",Leber congenital amaurosis 9,germline,germline,GRCh38,NC_000001.11,1,9982312,9982312,na,na,1p36.22,no assertion criteria provided,1,-,N,"ClinGen:CA260594,UniProtKB:Q9HAN9#VAR_068868,OMIM:608700.0004",1,37136,9982312,G,T,V151F,0,pathogenic,uncertain,Q9HAN9,Q9HAN9,reviewed,NMNA1_HUMAN,"Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, NMN/NaMN adenylyltransferase 1, EC 2.7.7.1, EC 2.7.7.18 (Nicotinamide-nucleotide adenylyltransferase 1, NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1, NaMN adenylyltransferase 1)",NMNAT1 NMNAT,Homo sapiens (Human),279.0,MENSEKTEVVLLACGSFNPITNMHLRLFELAKDYMNGTGRYTVVKGIISPVGDAYKKKGLIPAYHRVIMAELATKNSKWVEVDTWESLQKEWKETLKVLRHHQEKLEASDCDHQQNSPTLERPGRKRKWTETQDSSQKKSLEPKTKAVPKVKLLCGADLLESFAVPNLWKSEDITQIVANYGLICVTRAGNDAQKFIYESDVLWKHRSNIHVVNEWIANDISSTKIRRALRRGQSIRYLVPDLVQEYIEKHNLYSSESEDRNAGVILAPLQRNTAEAKT,PF01467;,1GZU;1KKU;1KQN;1KQO;1KR2;,151,V,F,True,918
13524,6249,45796,single nucleotide variant,NM_022787.4(NMNAT1):c.817A>G (p.Asn273Asp),64802,NMNAT1,HGNC:17877,Pathogenic,1,1-Sep-12,387907291,-,RCV000030766,"MONDO:MONDO:0012056,MedGen:C1837873,OMIM:608553,Orphanet:65",Leber congenital amaurosis 9,germline,germline,GRCh38,NC_000001.11,1,9982678,9982678,na,na,1p36.22,no assertion criteria provided,1,-,N,"ClinGen:CA260592,UniProtKB:Q9HAN9#VAR_068883,OMIM:608700.0003",1,37135,9982678,A,G,N273D,0,pathogenic,uncertain,Q9HAN9,Q9HAN9,reviewed,NMNA1_HUMAN,"Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, NMN/NaMN adenylyltransferase 1, EC 2.7.7.1, EC 2.7.7.18 (Nicotinamide-nucleotide adenylyltransferase 1, NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1, NaMN adenylyltransferase 1)",NMNAT1 NMNAT,Homo sapiens (Human),279.0,MENSEKTEVVLLACGSFNPITNMHLRLFELAKDYMNGTGRYTVVKGIISPVGDAYKKKGLIPAYHRVIMAELATKNSKWVEVDTWESLQKEWKETLKVLRHHQEKLEASDCDHQQNSPTLERPGRKRKWTETQDSSQKKSLEPKTKAVPKVKLLCGADLLESFAVPNLWKSEDITQIVANYGLICVTRAGNDAQKFIYESDVLWKHRSNIHVVNEWIANDISSTKIRRALRRGQSIRYLVPDLVQEYIEKHNLYSSESEDRNAGVILAPLQRNTAEAKT,PF01467;,1GZU;1KKU;1KQN;1KQO;1KR2;,273,N,D,True,918
13525,6253,45801,single nucleotide variant,NM_022787.4(NMNAT1):c.25G>A (p.Val9Met),64802,NMNAT1,HGNC:17877,Pathogenic,1,1-Sep-12,387907294,-,RCV000030771,"MONDO:MONDO:0012056,MedGen:C1837873,OMIM:608553,Orphanet:65",Leber congenital amaurosis 9,germline,germline,GRCh38,NC_000001.11,1,9972098,9972098,na,na,1p36.22,no assertion criteria provided,1,-,N,"ClinGen:CA260600,UniProtKB:Q9HAN9#VAR_068856,OMIM:608700.0009",1,37140,9972098,G,A,V9M,0,pathogenic,uncertain,Q9HAN9,Q9HAN9,reviewed,NMNA1_HUMAN,"Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, NMN/NaMN adenylyltransferase 1, EC 2.7.7.1, EC 2.7.7.18 (Nicotinamide-nucleotide adenylyltransferase 1, NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1, NaMN adenylyltransferase 1)",NMNAT1 NMNAT,Homo sapiens (Human),279.0,MENSEKTEVVLLACGSFNPITNMHLRLFELAKDYMNGTGRYTVVKGIISPVGDAYKKKGLIPAYHRVIMAELATKNSKWVEVDTWESLQKEWKETLKVLRHHQEKLEASDCDHQQNSPTLERPGRKRKWTETQDSSQKKSLEPKTKAVPKVKLLCGADLLESFAVPNLWKSEDITQIVANYGLICVTRAGNDAQKFIYESDVLWKHRSNIHVVNEWIANDISSTKIRRALRRGQSIRYLVPDLVQEYIEKHNLYSSESEDRNAGVILAPLQRNTAEAKT,PF01467;,1GZU;1KKU;1KQN;1KQO;1KR2;,9,V,M,True,918
13526,6252,45800,single nucleotide variant,NM_022787.4(NMNAT1):c.457C>G (p.Leu153Val),64802,NMNAT1,HGNC:17877,Pathogenic,1,1-Sep-12,387907293,-,RCV000030770,"MONDO:MONDO:0012056,MedGen:C1837873,OMIM:608553,Orphanet:65",Leber congenital amaurosis 9,germline,germline,GRCh38,NC_000001.11,1,9982318,9982318,na,na,1p36.22,no assertion criteria provided,1,-,N,"ClinGen:CA260598,UniProtKB:Q9HAN9#VAR_068870,OMIM:608700.0008",1,37139,9982318,C,G,L153V,0,pathogenic,uncertain,Q9HAN9,Q9HAN9,reviewed,NMNA1_HUMAN,"Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, NMN/NaMN adenylyltransferase 1, EC 2.7.7.1, EC 2.7.7.18 (Nicotinamide-nucleotide adenylyltransferase 1, NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1, NaMN adenylyltransferase 1)",NMNAT1 NMNAT,Homo sapiens (Human),279.0,MENSEKTEVVLLACGSFNPITNMHLRLFELAKDYMNGTGRYTVVKGIISPVGDAYKKKGLIPAYHRVIMAELATKNSKWVEVDTWESLQKEWKETLKVLRHHQEKLEASDCDHQQNSPTLERPGRKRKWTETQDSSQKKSLEPKTKAVPKVKLLCGADLLESFAVPNLWKSEDITQIVANYGLICVTRAGNDAQKFIYESDVLWKHRSNIHVVNEWIANDISSTKIRRALRRGQSIRYLVPDLVQEYIEKHNLYSSESEDRNAGVILAPLQRNTAEAKT,PF01467;,1GZU;1KKU;1KQN;1KQO;1KR2;,153,L,V,True,918
13527,6251,45799,single nucleotide variant,NM_022787.4(NMNAT1):c.710G>T (p.Arg237Leu),64802,NMNAT1,HGNC:17877,Pathogenic,1,1-Sep-12,368062092,-,RCV000030769,"MONDO:MONDO:0012056,MedGen:C1837873,OMIM:608553,Orphanet:65",Leber congenital amaurosis 9,germline,germline,GRCh38,NC_000001.11,1,9982571,9982571,na,na,1p36.22,no assertion criteria provided,1,-,N,"ClinGen:CA260596,UniProtKB:Q9HAN9#VAR_068879,OMIM:608700.0007",1,37138,9982571,G,T,R237L,0,pathogenic,uncertain,Q9HAN9,Q9HAN9,reviewed,NMNA1_HUMAN,"Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, NMN/NaMN adenylyltransferase 1, EC 2.7.7.1, EC 2.7.7.18 (Nicotinamide-nucleotide adenylyltransferase 1, NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1, NaMN adenylyltransferase 1)",NMNAT1 NMNAT,Homo sapiens (Human),279.0,MENSEKTEVVLLACGSFNPITNMHLRLFELAKDYMNGTGRYTVVKGIISPVGDAYKKKGLIPAYHRVIMAELATKNSKWVEVDTWESLQKEWKETLKVLRHHQEKLEASDCDHQQNSPTLERPGRKRKWTETQDSSQKKSLEPKTKAVPKVKLLCGADLLESFAVPNLWKSEDITQIVANYGLICVTRAGNDAQKFIYESDVLWKHRSNIHVVNEWIANDISSTKIRRALRRGQSIRYLVPDLVQEYIEKHNLYSSESEDRNAGVILAPLQRNTAEAKT,PF01467;,1GZU;1KKU;1KQN;1KQO;1KR2;,237,R,L,True,918
13528,13044,247477,single nucleotide variant,NM_080916.3(DGUOK):c.130G>A (p.Glu44Lys),1716,DGUOK,HGNC:2858,Pathogenic,1,18-Aug-16,762550967,-,RCV000239555,"MONDO:MONDO:0014899,MedGen:C4310733,OMIM:617070,Orphanet:329314","Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4",germline,germline,GRCh38,NC_000002.12,2,73927040,73927040,na,na,2p13.1,no assertion criteria provided,1,-,N,"ClinGen:CA1718150,UniProtKB:Q16854#VAR_076979,OMIM:601465.0012",1,253066,73927040,G,A,E44K,0,pathogenic,uncertain,Q16854,Q16854,reviewed,DGUOK_HUMAN,"Deoxyguanosine kinase, mitochondrial, EC 2.7.1.113 (Deoxyadenosine kinase, mitochondrial, EC 2.7.1.76)",DGUOK DGK,Homo sapiens (Human),277.0,MAAGRLFLSRLRAPFSSMAKSPLEGVSSSRGLHAGRGPRRLSIEGNIAVGKSTFVKLLTKTYPEWHVATEPVATWQNIQAAGTQKACTAQSLGNLLDMMYREPARWSYTFQTFSFLSRLKVQLEPFPEKLLQARKPVQIFERSVYSDRYIFAKNLFENGSLSDIEWHIYQDWHSFLLWEFASRITLHGFIYLQASPQVCLKRLYQRAREEEKGIELAYLEQLHGQHEAWLIHKTTKLHFEALMNIPVLVLDVNDDFSEEVTKQEDLMREVNTFVKNL,PF01712;,2OCP;,44,E,K,True,919
13529,13043,247474,single nucleotide variant,NM_080916.3(DGUOK):c.797T>G (p.Leu266Arg),1716,DGUOK,HGNC:2858,Pathogenic,1,1-Mar-07,886037846,-,RCV000239498,-,MITOCHONDRIAL DNA DEPLETION SYNDROME 3,germline,germline,GRCh38,NC_000002.12,2,73958235,73958235,na,na,2p13.1,no assertion criteria provided,1,-,N,"OMIM:601465.0009,ClinGen:CA10586177,UniProtKB:Q16854#VAR_076983",1,253063,73958235,T,G,L266R,0,pathogenic,uncertain,Q16854,Q16854,reviewed,DGUOK_HUMAN,"Deoxyguanosine kinase, mitochondrial, EC 2.7.1.113 (Deoxyadenosine kinase, mitochondrial, EC 2.7.1.76)",DGUOK DGK,Homo sapiens (Human),277.0,MAAGRLFLSRLRAPFSSMAKSPLEGVSSSRGLHAGRGPRRLSIEGNIAVGKSTFVKLLTKTYPEWHVATEPVATWQNIQAAGTQKACTAQSLGNLLDMMYREPARWSYTFQTFSFLSRLKVQLEPFPEKLLQARKPVQIFERSVYSDRYIFAKNLFENGSLSDIEWHIYQDWHSFLLWEFASRITLHGFIYLQASPQVCLKRLYQRAREEEKGIELAYLEQLHGQHEAWLIHKTTKLHFEALMNIPVLVLDVNDDFSEEVTKQEDLMREVNTFVKNL,PF01712;,2OCP;,266,L,R,True,919
13530,12215,210896,single nucleotide variant,NM_080916.3(DGUOK):c.462T>A (p.Asn154Lys),1716,DGUOK,HGNC:2858,Conflicting interpretations of pathogenicity,1,12-Oct-17,144181978,-,RCV000195764|RCV000239593,"MedGen:CN517202|MONDO:MONDO:0014899,MedGen:C4310733,OMIM:617070,Orphanet:329314","not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4",germline,germline,GRCh38,NC_000002.12,2,73950603,73950603,na,na,2p13.1,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA320135,UniProtKB:Q16854#VAR_076981,OMIM:601465.0010",3,214285,73950603,T,A,N154K,1,uncertain,uncertain,Q16854,Q16854,reviewed,DGUOK_HUMAN,"Deoxyguanosine kinase, mitochondrial, EC 2.7.1.113 (Deoxyadenosine kinase, mitochondrial, EC 2.7.1.76)",DGUOK DGK,Homo sapiens (Human),277.0,MAAGRLFLSRLRAPFSSMAKSPLEGVSSSRGLHAGRGPRRLSIEGNIAVGKSTFVKLLTKTYPEWHVATEPVATWQNIQAAGTQKACTAQSLGNLLDMMYREPARWSYTFQTFSFLSRLKVQLEPFPEKLLQARKPVQIFERSVYSDRYIFAKNLFENGSLSDIEWHIYQDWHSFLLWEFASRITLHGFIYLQASPQVCLKRLYQRAREEEKGIELAYLEQLHGQHEAWLIHKTTKLHFEALMNIPVLVLDVNDDFSEEVTKQEDLMREVNTFVKNL,PF01712;,2OCP;,154,N,K,True,919
13531,13042,247473,single nucleotide variant,NM_080916.3(DGUOK):c.137A>G (p.Asn46Ser),1716,DGUOK,HGNC:2858,Pathogenic/Likely pathogenic,1,31-Mar-16,763615602,-,RCV000239475|RCV000239535|RCV000239586,"|MONDO:MONDO:0014899,MedGen:C4310733,OMIM:617070,Orphanet:329314|MONDO:MONDO:0014897,MedGen:C4310735,OMIM:617068","MITOCHONDRIAL DNA DEPLETION SYNDROME 3|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4|Portal hypertension, noncirrhotic",germline,germline,GRCh38,NC_000002.12,2,73927047,73927047,na,na,2p13.1,no assertion criteria provided,2,-,N,"ClinGen:CA1718151,UniProtKB:Q16854#VAR_076980,OMIM:601465.0008",3,253062,73927047,A,G,N46S,0,pathogenic,uncertain,Q16854,Q16854,reviewed,DGUOK_HUMAN,"Deoxyguanosine kinase, mitochondrial, EC 2.7.1.113 (Deoxyadenosine kinase, mitochondrial, EC 2.7.1.76)",DGUOK DGK,Homo sapiens (Human),277.0,MAAGRLFLSRLRAPFSSMAKSPLEGVSSSRGLHAGRGPRRLSIEGNIAVGKSTFVKLLTKTYPEWHVATEPVATWQNIQAAGTQKACTAQSLGNLLDMMYREPARWSYTFQTFSFLSRLKVQLEPFPEKLLQARKPVQIFERSVYSDRYIFAKNLFENGSLSDIEWHIYQDWHSFLLWEFASRITLHGFIYLQASPQVCLKRLYQRAREEEKGIELAYLEQLHGQHEAWLIHKTTKLHFEALMNIPVLVLDVNDDFSEEVTKQEDLMREVNTFVKNL,PF01712;,2OCP;,46,N,S,True,919
13532,1907,23196,single nucleotide variant,NM_080916.3(DGUOK):c.425G>A (p.Arg142Lys),1716,DGUOK,HGNC:2858,Pathogenic,1,1-Sep-02,104893631,-,RCV000008635,"MONDO:MONDO:0009636,MedGen:C3151513,OMIM:251880,Orphanet:279934","Mitochondrial DNA-depletion syndrome 3, hepatocerebral",germline,germline,GRCh38,NC_000002.12,2,73946888,73946888,na,na,2p13.1,no assertion criteria provided,1,-,N,"ClinGen:CA254328,UniProtKB:Q16854#VAR_019417,OMIM:601465.0005",1,8157,73946888,G,A,R142K,0,pathogenic,uncertain,Q16854,Q16854,reviewed,DGUOK_HUMAN,"Deoxyguanosine kinase, mitochondrial, EC 2.7.1.113 (Deoxyadenosine kinase, mitochondrial, EC 2.7.1.76)",DGUOK DGK,Homo sapiens (Human),277.0,MAAGRLFLSRLRAPFSSMAKSPLEGVSSSRGLHAGRGPRRLSIEGNIAVGKSTFVKLLTKTYPEWHVATEPVATWQNIQAAGTQKACTAQSLGNLLDMMYREPARWSYTFQTFSFLSRLKVQLEPFPEKLLQARKPVQIFERSVYSDRYIFAKNLFENGSLSDIEWHIYQDWHSFLLWEFASRITLHGFIYLQASPQVCLKRLYQRAREEEKGIELAYLEQLHGQHEAWLIHKTTKLHFEALMNIPVLVLDVNDDFSEEVTKQEDLMREVNTFVKNL,PF01712;,2OCP;,142,R,K,True,919
13533,1908,23197,single nucleotide variant,NM_080916.3(DGUOK):c.679G>A (p.Glu227Lys),1716,DGUOK,HGNC:2858,Pathogenic,1,1-Sep-02,104893632,-,RCV000008636,"MONDO:MONDO:0009636,MedGen:C3151513,OMIM:251880,Orphanet:279934","Mitochondrial DNA-depletion syndrome 3, hepatocerebral",germline,germline,GRCh38,NC_000002.12,2,73957212,73957212,na,na,2p13.1,no assertion criteria provided,1,-,N,"ClinGen:CA254329,UniProtKB:Q16854#VAR_019418,OMIM:601465.0006",1,8158,73957212,G,A,E227K,0,pathogenic,uncertain,Q16854,Q16854,reviewed,DGUOK_HUMAN,"Deoxyguanosine kinase, mitochondrial, EC 2.7.1.113 (Deoxyadenosine kinase, mitochondrial, EC 2.7.1.76)",DGUOK DGK,Homo sapiens (Human),277.0,MAAGRLFLSRLRAPFSSMAKSPLEGVSSSRGLHAGRGPRRLSIEGNIAVGKSTFVKLLTKTYPEWHVATEPVATWQNIQAAGTQKACTAQSLGNLLDMMYREPARWSYTFQTFSFLSRLKVQLEPFPEKLLQARKPVQIFERSVYSDRYIFAKNLFENGSLSDIEWHIYQDWHSFLLWEFASRITLHGFIYLQASPQVCLKRLYQRAREEEKGIELAYLEQLHGQHEAWLIHKTTKLHFEALMNIPVLVLDVNDDFSEEVTKQEDLMREVNTFVKNL,PF01712;,2OCP;,227,E,K,True,919
13534,10696,140785,single nucleotide variant,NM_080916.3(DGUOK):c.509A>G (p.Gln170Arg),1716,DGUOK,HGNC:2858,Benign/Likely benign,1,3-Mar-20,74874677,-,RCV000124677|RCV000239473|RCV000677030|RCV001139590|RCV001282595,"MedGen:CN169374|MONDO:MONDO:0014899,MedGen:C4310733,OMIM:617070,Orphanet:329314|MedGen:CN517202|MONDO:MONDO:0009636,MedGen:C3151513,OMIM:251880,Orphanet:279934|MedGen:CN235283","not specified|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4|not provided|Mitochondrial DNA-depletion syndrome 3, hepatocerebral|none provided",germline;unknown,germline,GRCh38,NC_000002.12,2,73950650,73950650,na,na,2p13.1,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA290586,UniProtKB:Q16854#VAR_076982,OMIM:601465.0013",3,137082,73950650,A,G,Q170R,2,benign,benign,Q16854,Q16854,reviewed,DGUOK_HUMAN,"Deoxyguanosine kinase, mitochondrial, EC 2.7.1.113 (Deoxyadenosine kinase, mitochondrial, EC 2.7.1.76)",DGUOK DGK,Homo sapiens (Human),277.0,MAAGRLFLSRLRAPFSSMAKSPLEGVSSSRGLHAGRGPRRLSIEGNIAVGKSTFVKLLTKTYPEWHVATEPVATWQNIQAAGTQKACTAQSLGNLLDMMYREPARWSYTFQTFSFLSRLKVQLEPFPEKLLQARKPVQIFERSVYSDRYIFAKNLFENGSLSDIEWHIYQDWHSFLLWEFASRITLHGFIYLQASPQVCLKRLYQRAREEEKGIELAYLEQLHGQHEAWLIHKTTKLHFEALMNIPVLVLDVNDDFSEEVTKQEDLMREVNTFVKNL,PF01712;,2OCP;,170,Q,R,True,919
13535,2746,26137,single nucleotide variant,NM_000533.5(PLP1):c.409C>T (p.Arg137Trp),5354,PLP1,HGNC:9086,Uncertain significance,1,18-Jun-18,132630295,-,RCV000011847,"MONDO:MONDO:0010733,MedGen:C1839264,OMIM:312920,Orphanet:99015",Hereditary spastic paraplegia 2,germline,germline,GRCh38,NC_000023.11,X,103786682,103786682,na,na,Xq22.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA255713,UniProtKB:P60201#VAR_046910,OMIM:300401.0026",3,11098,103786682,C,T,R137W,1,uncertain,uncertain,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,137,R,W,True,920
13536,12779,237280,single nucleotide variant,NM_000533.5(PLP1):c.388C>T (p.His130Tyr),-1,PLP1;RAB9B,-,Likely pathogenic,1,13-Nov-14,878853076,-,RCV000223963,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000023.11,X,103786661,103786661,na,na,Xq22.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA10581371,UniProtKB:P60201#VAR_015024",2,235599,103786661,C,T,H130Y,1,pathogenic,pathogenic,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,130,H,Y,True,920
13537,2732,26113,single nucleotide variant,NM_000533.5(PLP1):c.487T>C (p.Trp163Arg),5354,PLP1,HGNC:9086,Likely pathogenic,1,18-Sep-12,132630279,-,RCV000011823|RCV000079097,"Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702|MedGen:CN517202",Pelizaeus-Merzbacher disease|not provided,germline,germline,GRCh38,NC_000023.11,X,103787831,103787831,na,na,Xq22.2,"criteria provided, single submitter",2,-,N,"UniProtKB:P60201#VAR_004553,OMIM:300401.0002,ClinGen:CA221105",3,11074,103787831,T,C,W163R,1,pathogenic,pathogenic,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,163,W,R,True,920
13538,2731,26112,single nucleotide variant,NM_000533.5(PLP1):c.646C>T (p.Pro216Ser),5354,PLP1,HGNC:9086,Pathogenic,1,28-Sep-12,132630278,-,RCV000011822|RCV000079100,"Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702|MedGen:CN517202",Pelizaeus-Merzbacher disease|not provided,germline,germline,GRCh38,NC_000023.11,X,103788460,103788460,na,na,Xq22.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA221109,UniProtKB:P60201#VAR_004558,OMIM:300401.0001",3,11073,103788460,C,T,P216S,1,pathogenic,pathogenic,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,216,P,S,True,920
13539,2744,26128,single nucleotide variant,NM_000533.5(PLP1):c.710T>C (p.Phe237Ser),5354,PLP1,HGNC:9086,Pathogenic,1,1-Jan-96,132630291,-,RCV000011838,"MONDO:MONDO:0010733,MedGen:C1839264,OMIM:312920,Orphanet:99015",Hereditary spastic paraplegia 2,germline,germline,GRCh38,NC_000023.11,X,103789346,103789346,na,na,Xq22.2,no assertion criteria provided,1,-,N,"ClinGen:CA255707,UniProtKB:P60201#VAR_004563,OMIM:300401.0017",1,11089,103789346,T,C,F237S,0,pathogenic,uncertain,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,237,F,S,True,920
13540,13649,271110,single nucleotide variant,NM_000533.5(PLP1):c.739G>A (p.Ala247Thr),5354,PLP1,HGNC:9086,Uncertain significance,0,24-May-17,886043504,-,RCV000398751,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000023.11,X,103789375,103789375,na,na,Xq22.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA10605597,UniProtKB:P60201#VAR_046920",2,286873,103789375,G,A,A247T,1,uncertain,uncertain,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,247,A,T,True,920
13541,2745,26131,single nucleotide variant,NM_000533.5(PLP1):c.509C>T (p.Ser170Phe),5354,PLP1,HGNC:9086,Pathogenic,1,17-Feb-98,132630294,-,RCV000011841,"MONDO:MONDO:0010733,MedGen:C1839264,OMIM:312920,Orphanet:99015",Hereditary spastic paraplegia 2,germline,germline,GRCh38,NC_000023.11,X,103787853,103787853,na,na,Xq22.2,no assertion criteria provided,1,-,N,"ClinGen:CA255710,UniProtKB:P60201#VAR_015029,OMIM:300401.0020",1,11092,103787853,C,T,S170F,0,pathogenic,uncertain,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,170,S,F,True,920
13542,2740,26122,single nucleotide variant,NM_000533.5(PLP1):c.661G>T (p.Gly221Cys),5354,PLP1,HGNC:9086,Pathogenic,1,1-Jan-93,132630286,-,RCV000011832,MedGen:C4016483,"Pelizaeus-Merzbacher disease, connatal",germline,germline,GRCh38,NC_000023.11,X,103788475,103788475,na,na,Xq22.2,no assertion criteria provided,1,-,N,"ClinGen:CA121349,UniProtKB:P60201#VAR_004561,OMIM:300401.0011",1,11083,103788475,G,T,G221C,0,pathogenic,uncertain,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,221,G,C,True,920
13543,2742,26124,single nucleotide variant,NM_000533.5(PLP1):c.560T>C (p.Ile187Thr),5354,PLP1,HGNC:9086,Pathogenic,1,1-Apr-04,132630288,-,RCV000011834,"MONDO:MONDO:0010733,MedGen:C1839264,OMIM:312920,Orphanet:99015",Hereditary spastic paraplegia 2,germline,germline,GRCh38,NC_000023.11,X,103787904,103787904,na,na,Xq22.2,no assertion criteria provided,1,-,N,"ClinGen:CA255701,UniProtKB:P60201#VAR_004556,OMIM:300401.0013",1,11085,103787904,T,C,I187T,0,pathogenic,uncertain,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,187,I,T,True,920
13544,2736,26118,single nucleotide variant,NM_000533.5(PLP1):c.544A>C (p.Thr182Pro),5354,PLP1,HGNC:9086,Pathogenic,1,1-Oct-92,132630282,-,RCV000011828,"Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702",Pelizaeus-Merzbacher disease,germline,germline,GRCh38,NC_000023.11,X,103787888,103787888,na,na,Xq22.2,no assertion criteria provided,1,-,N,"ClinGen:CA255687,UniProtKB:P60201#VAR_004555,OMIM:300401.0007",1,11079,103787888,A,C,T182P,0,pathogenic,uncertain,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,182,T,P,True,920
13545,2735,26116,single nucleotide variant,NM_000533.5(PLP1):c.655G>T (p.Val219Phe),5354,PLP1,HGNC:9086,Pathogenic,1,1-Sep-91,132630281,-,RCV000011826,"Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702",Pelizaeus-Merzbacher disease,germline,germline,GRCh38,NC_000023.11,X,103788469,103788469,na,na,Xq22.2,no assertion criteria provided,1,-,N,"UniProtKB:P60201#VAR_004560,OMIM:300401.0005,ClinGen:CA255684",1,11077,103788469,G,T,V219F,0,pathogenic,uncertain,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,219,V,F,True,920
13546,2737,26119,single nucleotide variant,NM_000533.5(PLP1):c.671T>C (p.Leu224Pro),5354,PLP1,HGNC:9086,Pathogenic,1,1-Oct-92,132630283,-,RCV000011829,"Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702",Pelizaeus-Merzbacher disease,germline,germline,GRCh38,NC_000023.11,X,103788485,103788485,na,na,Xq22.2,no assertion criteria provided,1,-,N,"ClinGen:CA255690,UniProtKB:P60201#VAR_004562,OMIM:300401.0008",1,11080,103788485,T,C,L224P,0,pathogenic,uncertain,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,224,L,P,True,920
13547,2738,26120,single nucleotide variant,NM_000533.5(PLP1):c.607G>C (p.Asp203His),5354,PLP1,HGNC:9086,Pathogenic,1,1-Jul-92,132630284,-,RCV000011830,"Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702",Pelizaeus-Merzbacher disease,germline,germline,GRCh38,NC_000023.11,X,103787951,103787951,na,na,Xq22.2,no assertion criteria provided,1,-,N,"ClinGen:CA255693,UniProtKB:P60201#VAR_004557,OMIM:300401.0009",1,11081,103787951,G,C,D203H,0,pathogenic,uncertain,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,203,D,H,True,920
13548,2739,26121,single nucleotide variant,NM_000533.5(PLP1):c.220G>A (p.Gly74Arg),5354,PLP1,HGNC:9086,Pathogenic,1,1-Jul-92,132630285,-,RCV000011831,"Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702",Pelizaeus-Merzbacher disease,germline,germline,GRCh38,NC_000023.11,X,103786493,103786493,na,na,Xq22.2,no assertion criteria provided,1,-,N,"ClinGen:CA255696,UniProtKB:P60201#VAR_004548,OMIM:300401.0010",1,11082,103786493,G,A,G74R,0,pathogenic,uncertain,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,74,G,R,True,920
13549,2743,26125,single nucleotide variant,NM_000533.5(PLP1):c.128C>T (p.Thr43Ile),5354,PLP1,HGNC:9086,Pathogenic,1,31-Jul-95,132630289,-,RCV000011835,"Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702",Pelizaeus-Merzbacher disease,germline,germline,GRCh38,NC_000023.11,X,103785705,103785705,na,na,Xq22.2,no assertion criteria provided,1,-,N,"ClinGen:CA255704,UniProtKB:P60201#VAR_004547,OMIM:300401.0014",1,11086,103785705,C,T,T43I,0,pathogenic,uncertain,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,43,T,I,True,920
13550,2734,26115,single nucleotide variant,NM_000533.5(PLP1):c.467C>T (p.Thr156Ile),5354,PLP1,HGNC:9086,Pathogenic,1,1-Jan-91,132630280,-,RCV000011825,"Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702",Pelizaeus-Merzbacher disease,germline,germline,GRCh38,NC_000023.11,X,103787811,103787811,na,na,Xq22.2,no assertion criteria provided,1,-,N,"ClinGen:CA255681,UniProtKB:P60201#VAR_004552,OMIM:300401.0004",1,11076,103787811,C,T,T156I,0,pathogenic,uncertain,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,156,T,I,True,920
13551,9064,99142,single nucleotide variant,NM_000533.5(PLP1):c.737G>C (p.Gly246Ala),5354,PLP1,HGNC:9086,Pathogenic/Likely pathogenic,1,25-Oct-18,398123467,-,RCV000079102|RCV000794114,"MedGen:CN517202|MONDO:MONDO:0010733,MedGen:C1839264,OMIM:312920,Orphanet:99015",not provided|Hereditary spastic paraplegia 2,germline,germline,GRCh38,NC_000023.11,X,103789373,103789373,na,na,Xq22.2,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA221114,UniProtKB:P60201#VAR_046919",2,93235,103789373,G,C,G246A,2,pathogenic,pathogenic,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,246,G,A,True,920
13552,2741,26123,single nucleotide variant,NM_000533.5(PLP1):c.418C>T (p.His140Tyr),5354,PLP1,HGNC:9086,Pathogenic,1,1-Mar-94,132630287,-,RCV000011833,"MONDO:MONDO:0010733,MedGen:C1839264,OMIM:312920,Orphanet:99015",Hereditary spastic paraplegia 2,germline,germline,GRCh38,NC_000023.11,X,103786691,103786691,na,na,Xq22.2,no assertion criteria provided,1,-,N,"ClinGen:CA255699,UniProtKB:P60201#VAR_004551,OMIM:300401.0012",1,11084,103786691,C,T,H140Y,0,pathogenic,uncertain,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,140,H,Y,True,920
13553,9063,99141,single nucleotide variant,NM_000533.5(PLP1):c.683G>A (p.Cys228Tyr),5354,PLP1,HGNC:9086,Likely pathogenic,1,20-Nov-12,398123466,-,RCV000079101,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000023.11,X,103788497,103788497,na,na,Xq22.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA221112,UniProtKB:P60201#VAR_015047",2,93234,103788497,G,A,C228Y,1,pathogenic,pathogenic,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,228,C,Y,True,920
13554,2733,26114,single nucleotide variant,NM_000533.5(PLP1):c.44C>T (p.Pro15Leu),5354,PLP1,HGNC:9086,Pathogenic,1,1-Dec-89,11543022,-,RCV000011824,"Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702",Pelizaeus-Merzbacher disease,germline,germline,GRCh38,NC_000023.11,X,103785621,103785621,na,na,Xq22.2,no assertion criteria provided,1,-,N,"ClinGen:CA255678,UniProtKB:P60201#VAR_004546,OMIM:300401.0003",1,11075,103785621,C,T,P15L,0,pathogenic,uncertain,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,15,P,L,True,920
13555,13514,260274,single nucleotide variant,NM_000533.5(PLP1):c.607G>A (p.Asp203Asn),5354,PLP1,HGNC:9086,Pathogenic,1,4-Apr-18,132630284,-,RCV000255035,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000023.11,X,103787951,103787951,na,na,Xq22.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA10588735,UniProtKB:P60201#VAR_015036",2,265417,103787951,G,A,D203N,1,pathogenic,pathogenic,P60201,P60201,reviewed,MYPR_HUMAN,"Myelin proteolipid protein, PLP (Lipophilin)",PLP1 PLP,Homo sapiens (Human),277.0,MGLLECCARCLVGAPFASLVATGLCFFGVALFCGCGHEALTGTEKLIETYFSKNYQDYEYLINVIHAFQYVIYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQKGRGSRGQHQAHSLERVCHCLGKWLGHPDKFVGITYALTVVWLLVFACSAVPVYIYFNTWTTCQSIAFPSKTSASIGSLCADARMYGVLPWNAFPGKVCGSNLLSICKTAEFQMTFHLFIAAFVGAAATLVSLLTFMIAATYNFAVLKLMGRGTKF,PF01275;,2XPG;,203,D,N,True,920
13556,7316,70519,single nucleotide variant,NM_006012.4(CLPP):c.433A>C (p.Thr145Pro),8192,CLPP,HGNC:2084,Pathogenic,1,17-Jun-13,398123033,-,RCV000049282,"MONDO:MONDO:0013588,MedGen:C3808414,OMIM:614129,Orphanet:2855",Perrault syndrome 3,germline,germline,GRCh38,NC_000019.10,19,6364517,6364517,na,na,19p13.3,no assertion criteria provided,2,-,N,"ClinGen:CA143976,UniProtKB:Q16740#VAR_070092,OMIM:601119.0001",3,55868,6364517,A,C,T145P,0,pathogenic,uncertain,Q16740,Q16740,reviewed,CLPP_HUMAN,"ATP-dependent Clp protease proteolytic subunit, mitochondrial, EC 3.4.21.92 (Endopeptidase Clp)",CLPP,Homo sapiens (Human),277.0,MWPGILVGGARVASCRYPALGPRLAAHFPAQRPPQRTLQNGLALQRCLHATATRALPLIPIVVEQTGRGERAYDIYSRLLRERIVCVMGPIDDSVASLVIAQLLFLQSESNKKPIHMYINSPGGVVTAGLAIYDTMQYILNPICTWCVGQAASMGSLLLAAGTPGMRHSLPNSRIMIHQPSGGARGQATDIAIQAEEIMKLKKQLYNIYAKHTKQSLQVIESAMERDRYMSPMEAQEFGILDKVLVHPPQDGEDEPTLVQKEPVEAAPAAEPVPAST,PF00574;,1TG6;6BBA;6DL7;6H23;,145,T,P,True,921
13557,7317,70520,single nucleotide variant,NM_006012.4(CLPP):c.440G>C (p.Cys147Ser),8192,CLPP,HGNC:2084,Pathogenic,1,17-Jun-13,398123034,-,RCV000049283,"MONDO:MONDO:0013588,MedGen:C3808414,OMIM:614129,Orphanet:2855",Perrault syndrome 3,germline,germline,GRCh38,NC_000019.10,19,6364524,6364524,na,na,19p13.3,no assertion criteria provided,2,-,N,"ClinGen:CA143977,UniProtKB:Q16740#VAR_070093,OMIM:601119.0002",3,55869,6364524,G,C,C147S,0,pathogenic,uncertain,Q16740,Q16740,reviewed,CLPP_HUMAN,"ATP-dependent Clp protease proteolytic subunit, mitochondrial, EC 3.4.21.92 (Endopeptidase Clp)",CLPP,Homo sapiens (Human),277.0,MWPGILVGGARVASCRYPALGPRLAAHFPAQRPPQRTLQNGLALQRCLHATATRALPLIPIVVEQTGRGERAYDIYSRLLRERIVCVMGPIDDSVASLVIAQLLFLQSESNKKPIHMYINSPGGVVTAGLAIYDTMQYILNPICTWCVGQAASMGSLLLAAGTPGMRHSLPNSRIMIHQPSGGARGQATDIAIQAEEIMKLKKQLYNIYAKHTKQSLQVIESAMERDRYMSPMEAQEFGILDKVLVHPPQDGEDEPTLVQKEPVEAAPAAEPVPAST,PF00574;,1TG6;6BBA;6DL7;6H23;,147,C,S,True,921
13558,11007,167469,single nucleotide variant,NM_181503.3(EXOSC8):c.5C>T (p.Ala2Val),11340,EXOSC8,HGNC:17035,Pathogenic,1,3-Jul-14,606231285,-,RCV000144942,"MONDO:MONDO:0014485,MedGen:C4015160,OMIM:616081,Orphanet:2254","Pontocerebellar hypoplasia, type 1c",germline,germline,GRCh38,NC_000013.11,13,37000810,37000810,na,na,13q13.3,no assertion criteria provided,1,-,N,"ClinGen:CA214513,UniProtKB:Q96B26#VAR_072558,OMIM:606019.0002",1,157609,37000810,C,T,A2V,0,pathogenic,uncertain,Q96B26,Q96B26,reviewed,EXOS8_HUMAN,"Exosome complex component RRP43 (Exosome component 8) (Opa-interacting protein 2, OIP-2) (Ribosomal RNA-processing protein 43) (p9)",EXOSC8 OIP2 RRP43,Homo sapiens (Human),276.0,MAAGFKTVEPLEYYRRFLKENCRPDGRELGEFRTTTVNIGSISTADGSALVKLGNTTVICGVKAEFAAPSTDAPDKGYVVPNVDLPPLCSSRFRSGPPGEEAQVASQFIADVIENSQIIQKEDLCISPGKLVWVLYCDLICLDYDGNILDACTFALLAALKNVQLPEVTINEETALAEVNLKKKSYLNIRTHPVATSFAVFDDTLLIVDPTGEEEHLATGTLTIVMDEEGKLCCLHKPGGSGLTGAKLQDCMSRAVTRHKEVKKLMDEVIKSMKPK,PF01138;PF03725;,2NN6;6D6Q;6D6R;6H25;,2,A,V,True,922
13559,11006,167468,single nucleotide variant,NM_181503.3(EXOSC8):c.815G>C (p.Ser272Thr),11340,EXOSC8,HGNC:17035,Conflicting interpretations of pathogenicity,1,31-Dec-19,36027220,-,RCV000144941|RCV000418794|RCV000519395,"MONDO:MONDO:0014485,MedGen:C4015160,OMIM:616081,Orphanet:2254|MedGen:CN517202|MedGen:CN169374","Pontocerebellar hypoplasia, type 1c|not provided|not specified",germline;maternal;paternal,germline,GRCh38,NC_000013.11,13,37009283,37009283,na,na,13q13.3,"criteria provided, conflicting interpretations",7,-,N,"ClinGen:CA214512,UniProtKB:Q96B26#VAR_072559,OMIM:606019.0001",3,157608,37009283,G,C,S272T,1,uncertain,uncertain,Q96B26,Q96B26,reviewed,EXOS8_HUMAN,"Exosome complex component RRP43 (Exosome component 8) (Opa-interacting protein 2, OIP-2) (Ribosomal RNA-processing protein 43) (p9)",EXOSC8 OIP2 RRP43,Homo sapiens (Human),276.0,MAAGFKTVEPLEYYRRFLKENCRPDGRELGEFRTTTVNIGSISTADGSALVKLGNTTVICGVKAEFAAPSTDAPDKGYVVPNVDLPPLCSSRFRSGPPGEEAQVASQFIADVIENSQIIQKEDLCISPGKLVWVLYCDLICLDYDGNILDACTFALLAALKNVQLPEVTINEETALAEVNLKKKSYLNIRTHPVATSFAVFDDTLLIVDPTGEEEHLATGTLTIVMDEEGKLCCLHKPGGSGLTGAKLQDCMSRAVTRHKEVKKLMDEVIKSMKPK,PF01138;PF03725;,2NN6;6D6Q;6D6R;6H25;,272,S,T,True,922
13560,13882,302505,single nucleotide variant,NM_148919.4(PSMB8):c.22G>A (p.Gly8Arg),5696,PSMB8,HGNC:9545,Benign,0,31-Dec-19,114772012,-,RCV000272614,"MONDO:MONDO:0054698,MedGen:C4746851,OMIM:256040,Orphanet:2615,Orphanet:324977,Orphanet:324999,Orphanet:325004",Proteasome-associated autoinflammatory syndrome 1,germline,germline,GRCh38,NC_000006.12,6,32843975,32843975,na,na,6p21.32,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA3746516,UniProtKB:P28062#VAR_006488",2,356370,32843975,C,T,G8R,2,benign,benign,P28062,P28062,reviewed,PSB8_HUMAN,"Proteasome subunit beta type-8, EC 3.4.25.1 (Low molecular mass protein 7) (Macropain subunit C13) (Multicatalytic endopeptidase complex subunit C13) (Proteasome component C13) (Proteasome subunit beta-5i) (Really interesting new gene 10 protein)",PSMB8 LMP7 PSMB5i RING10 Y2,Homo sapiens (Human),276.0,MALLDVCGAPRGQRPESALPVAGSGRRSDPGHYSFSMRSPELALPRGMQPTEFFQSLGGDGERNVQIEMAHGTTTLAFKFQHGVIAAVDSRASAGSYISALRVNKVIEINPYLLGTMSGCAADCQYWERLLAKECRLYYLRNGERISVSAASKLLSNMMCQYRGMGLSMGSMICGWDKKGPGLYYVDEHGTRLSGNMFSTGSGNTYAYGVMDSGYRPNLSPEEAYDLGRRAIAYATHRDSYSGGVVNMYHMKEDGWVKVESTDVSDLLHQYREANQ,PF00227;,5L5A;5L5B;5L5D;5L5E;5L5F;5L5H;5L5I;5L5J;5L5O;5L5P;5L5Q;5L5R;5L5S;5L5T;5L5U;5L5V;5LTT;5M2B;6AVO;6E5B;7AWE;7B12;,8,G,R,True,923
13561,13881,302501,single nucleotide variant,NM_148919.4(PSMB8):c.145C>A (p.Gln49Lys),5696,PSMB8,HGNC:9545,Benign,0,6-Mar-18,2071543,-,RCV000303434|RCV000455896,"MONDO:MONDO:0054698,MedGen:C4746851,OMIM:256040,Orphanet:2615,Orphanet:324977,Orphanet:324999,Orphanet:325004|MedGen:CN169374",Proteasome-associated autoinflammatory syndrome 1|not specified,germline,germline,GRCh38,NC_000006.12,6,32843852,32843852,na,na,6p21.32,"criteria provided, multiple submitters, no conflicts",2,-,N,"UniProtKB:P28062#VAR_065204,ClinGen:CA3746493",2,356368,32843852,G,T,Q49K,2,benign,benign,P28062,P28062,reviewed,PSB8_HUMAN,"Proteasome subunit beta type-8, EC 3.4.25.1 (Low molecular mass protein 7) (Macropain subunit C13) (Multicatalytic endopeptidase complex subunit C13) (Proteasome component C13) (Proteasome subunit beta-5i) (Really interesting new gene 10 protein)",PSMB8 LMP7 PSMB5i RING10 Y2,Homo sapiens (Human),276.0,MALLDVCGAPRGQRPESALPVAGSGRRSDPGHYSFSMRSPELALPRGMQPTEFFQSLGGDGERNVQIEMAHGTTTLAFKFQHGVIAAVDSRASAGSYISALRVNKVIEINPYLLGTMSGCAADCQYWERLLAKECRLYYLRNGERISVSAASKLLSNMMCQYRGMGLSMGSMICGWDKKGPGLYYVDEHGTRLSGNMFSTGSGNTYAYGVMDSGYRPNLSPEEAYDLGRRAIAYATHRDSYSGGVVNMYHMKEDGWVKVESTDVSDLLHQYREANQ,PF00227;,5L5A;5L5B;5L5D;5L5E;5L5F;5L5H;5L5I;5L5J;5L5O;5L5P;5L5Q;5L5R;5L5S;5L5T;5L5U;5L5V;5LTT;5M2B;6AVO;6E5B;7AWE;7B12;,49,Q,K,True,923
13562,10223,134470,single nucleotide variant,NM_016042.4(EXOSC3):c.238G>T (p.Val80Phe),51010,EXOSC3,HGNC:17944,Likely pathogenic,1,1-Jun-20,374550999,-,RCV000117005|RCV000825519|RCV001200535,"MONDO:MONDO:0013853,MedGen:C3553449,OMIM:614678,Orphanet:2254|MONDO:MONDO:0020135,MedGen:C1261175,OMIM:PS607596,Orphanet:98523|MedGen:CN517202","Pontocerebellar hypoplasia, type 1b|Pontoneocerebellar hypoplasia|not provided",germline,germline,GRCh38,NC_000009.12,9,37784807,37784807,na,na,9p13.2,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA345539,UniProtKB:Q9NQT5#VAR_074169,OMIM:606489.0006",3,129024,37784807,C,A,V80F,2,pathogenic,pathogenic,Q9NQT5,Q9NQT5,reviewed,EXOS3_HUMAN,Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40) (p10),EXOSC3 RRP40 CGI-102,Homo sapiens (Human),275.0,MAEPASVAAESLAGSRARAARTVLGQVVLPGEELLLPEQEDAEGPGGAVERPLSLNARACSRVRVVCGPGLRRCGDRLLVTKCGRLRHKEPGSGSGGGVYWVDSQQKRYVPVKGDHVIGIVTAKSGDIFKVDVGGSEPASLSYLSFEGATKRNRPNVQVGDLIYGQFVVANKDMEPEMVCIDSCGRANGMGVIGQDGLLFKVTLGLIRKLLAPDCEIIQEVGKLYPLEIVFGMNGRIWVKAKTIQQTLILANILEACEHMTSDQRKQIFSRLAES,PF15985;,2NN6;6D6Q;6D6R;6H25;,80,V,F,True,924
13563,10224,134472,single nucleotide variant,NM_016042.4(EXOSC3):c.673T>C (p.Tyr225His),51010,EXOSC3,HGNC:17944,Benign,0,12-Jan-18,3208406,-,RCV000117007|RCV000261175,"MedGen:CN169374|MONDO:MONDO:0013853,MedGen:C3553449,OMIM:614678,Orphanet:2254","not specified|Pontocerebellar hypoplasia, type 1b",germline,germline,GRCh38,NC_000009.12,9,37780834,37780834,na,na,9p13.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA152804,UniProtKB:Q9NQT5#VAR_054098",2,129026,37780834,A,G,Y225H,2,benign,benign,Q9NQT5,Q9NQT5,reviewed,EXOS3_HUMAN,Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40) (p10),EXOSC3 RRP40 CGI-102,Homo sapiens (Human),275.0,MAEPASVAAESLAGSRARAARTVLGQVVLPGEELLLPEQEDAEGPGGAVERPLSLNARACSRVRVVCGPGLRRCGDRLLVTKCGRLRHKEPGSGSGGGVYWVDSQQKRYVPVKGDHVIGIVTAKSGDIFKVDVGGSEPASLSYLSFEGATKRNRPNVQVGDLIYGQFVVANKDMEPEMVCIDSCGRANGMGVIGQDGLLFKVTLGLIRKLLAPDCEIIQEVGKLYPLEIVFGMNGRIWVKAKTIQQTLILANILEACEHMTSDQRKQIFSRLAES,PF15985;,2NN6;6D6Q;6D6R;6H25;,225,Y,H,True,924
13564,6077,40348,single nucleotide variant,NM_016042.4(EXOSC3):c.395A>C (p.Asp132Ala),51010,EXOSC3,HGNC:17944,Pathogenic/Likely pathogenic,1,30-Sep-20,141138948,-,RCV000024366|RCV000190687|RCV000224817|RCV000761613|RCV000761614,"MONDO:MONDO:0013853,MedGen:C3553449,OMIM:614678,Orphanet:2254|MeSH:D030342,MedGen:C0950123|MedGen:CN517202|Human Phenotype Ontology:HP:0012758,MedGen:C4022738|Human Phenotype Ontology:HP:0001252,Human Phenotype Ontology:HP:0001318,MedGen:C0026827","Pontocerebellar hypoplasia, type 1b|Inborn genetic diseases|not provided|Neurodevelopmental delay|Muscular hypotonia",germline;inherited;paternal;unknown,germline,GRCh38,NC_000009.12,9,37783993,37783993,na,na,9p13.2,"criteria provided, multiple submitters, no conflicts",17,-,N,"ClinGen:CA204654,UniProtKB:Q9NQT5#VAR_068506,OMIM:606489.0001",3,31688,37783993,T,G,D132A,2,pathogenic,pathogenic,Q9NQT5,Q9NQT5,reviewed,EXOS3_HUMAN,Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40) (p10),EXOSC3 RRP40 CGI-102,Homo sapiens (Human),275.0,MAEPASVAAESLAGSRARAARTVLGQVVLPGEELLLPEQEDAEGPGGAVERPLSLNARACSRVRVVCGPGLRRCGDRLLVTKCGRLRHKEPGSGSGGGVYWVDSQQKRYVPVKGDHVIGIVTAKSGDIFKVDVGGSEPASLSYLSFEGATKRNRPNVQVGDLIYGQFVVANKDMEPEMVCIDSCGRANGMGVIGQDGLLFKVTLGLIRKLLAPDCEIIQEVGKLYPLEIVFGMNGRIWVKAKTIQQTLILANILEACEHMTSDQRKQIFSRLAES,PF15985;,2NN6;6D6Q;6D6R;6H25;,132,D,A,True,924
13565,6078,40349,single nucleotide variant,NM_016042.4(EXOSC3):c.415G>C (p.Ala139Pro),51010,EXOSC3,HGNC:17944,Pathogenic,1,29-Apr-12,387907195,-,RCV000024367,"MONDO:MONDO:0013853,MedGen:C3553449,OMIM:614678,Orphanet:2254","Pontocerebellar hypoplasia, type 1b",germline,germline,GRCh38,NC_000009.12,9,37783973,37783973,na,na,9p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA260045,UniProtKB:Q9NQT5#VAR_068507,OMIM:606489.0002",1,31689,37783973,C,G,A139P,0,pathogenic,uncertain,Q9NQT5,Q9NQT5,reviewed,EXOS3_HUMAN,Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40) (p10),EXOSC3 RRP40 CGI-102,Homo sapiens (Human),275.0,MAEPASVAAESLAGSRARAARTVLGQVVLPGEELLLPEQEDAEGPGGAVERPLSLNARACSRVRVVCGPGLRRCGDRLLVTKCGRLRHKEPGSGSGGGVYWVDSQQKRYVPVKGDHVIGIVTAKSGDIFKVDVGGSEPASLSYLSFEGATKRNRPNVQVGDLIYGQFVVANKDMEPEMVCIDSCGRANGMGVIGQDGLLFKVTLGLIRKLLAPDCEIIQEVGKLYPLEIVFGMNGRIWVKAKTIQQTLILANILEACEHMTSDQRKQIFSRLAES,PF15985;,2NN6;6D6Q;6D6R;6H25;,139,A,P,True,924
13566,6080,40352,single nucleotide variant,NM_016042.4(EXOSC3):c.712T>C (p.Trp238Arg),51010,EXOSC3,HGNC:17944,Pathogenic,1,29-Apr-12,672601332,-,RCV000024370,"MONDO:MONDO:0013853,MedGen:C3553449,OMIM:614678,Orphanet:2254","Pontocerebellar hypoplasia, type 1b",germline,germline,GRCh38,NC_000009.12,9,37780795,37780795,na,na,9p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA260047,UniProtKB:Q9NQT5#VAR_068508,OMIM:606489.0005",1,31692,37780795,A,G,W238R,0,pathogenic,uncertain,Q9NQT5,Q9NQT5,reviewed,EXOS3_HUMAN,Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40) (p10),EXOSC3 RRP40 CGI-102,Homo sapiens (Human),275.0,MAEPASVAAESLAGSRARAARTVLGQVVLPGEELLLPEQEDAEGPGGAVERPLSLNARACSRVRVVCGPGLRRCGDRLLVTKCGRLRHKEPGSGSGGGVYWVDSQQKRYVPVKGDHVIGIVTAKSGDIFKVDVGGSEPASLSYLSFEGATKRNRPNVQVGDLIYGQFVVANKDMEPEMVCIDSCGRANGMGVIGQDGLLFKVTLGLIRKLLAPDCEIIQEVGKLYPLEIVFGMNGRIWVKAKTIQQTLILANILEACEHMTSDQRKQIFSRLAES,PF15985;,2NN6;6D6Q;6D6R;6H25;,238,W,R,True,924
13567,6079,40351,single nucleotide variant,NM_016042.4(EXOSC3):c.92G>C (p.Gly31Ala),51010,EXOSC3,HGNC:17944,Pathogenic,1,23-Oct-20,387907196,-,RCV000024369|RCV000853550|RCV001092265,"MONDO:MONDO:0013853,MedGen:C3553449,OMIM:614678,Orphanet:2254|7 conditions|MedGen:CN517202","Pontocerebellar hypoplasia, type 1b|7 conditions|not provided",germline;inherited,germline,GRCh38,NC_000009.12,9,37784953,37784953,na,na,9p13.2,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA342800,UniProtKB:Q9NQT5#VAR_068505,OMIM:606489.0004",3,31691,37784953,C,G,G31A,2,pathogenic,pathogenic,Q9NQT5,Q9NQT5,reviewed,EXOS3_HUMAN,Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40) (p10),EXOSC3 RRP40 CGI-102,Homo sapiens (Human),275.0,MAEPASVAAESLAGSRARAARTVLGQVVLPGEELLLPEQEDAEGPGGAVERPLSLNARACSRVRVVCGPGLRRCGDRLLVTKCGRLRHKEPGSGSGGGVYWVDSQQKRYVPVKGDHVIGIVTAKSGDIFKVDVGGSEPASLSYLSFEGATKRNRPNVQVGDLIYGQFVVANKDMEPEMVCIDSCGRANGMGVIGQDGLLFKVTLGLIRKLLAPDCEIIQEVGKLYPLEIVFGMNGRIWVKAKTIQQTLILANILEACEHMTSDQRKQIFSRLAES,PF15985;,2NN6;6D6Q;6D6R;6H25;,31,G,A,True,924
13568,4762,31848,single nucleotide variant,NM_000903.3(NQO1):c.559C>T (p.Pro187Ser),1728,NQO1,HGNC:2874,drug response,1,20-Oct-15,1800566,-,RCV000018300|RCV000018301|RCV000018302|RCV000211294|RCV000434090,"MedGen:C2675718|MedGen:C2675719|MedGen:C2675722|MedGen:CN236460|MONDO:MONDO:0005138,MedGen:C0684249","Benzene toxicity, susceptibility to|Leukemia, post-chemotherapy, susceptibility to|Breast cancer, post-chemotherapy poor survival in|Alkylating Agents, anthracyclines and related substances, fluorouracil, and Platinum compounds response - Efficacy|Lung carcinoma",germline;somatic,germline/somatic,GRCh38,NC_000016.10,16,69711242,69711242,na,na,16q22.1,reviewed by expert panel,3,-,N,"ClinGen:CA126904,UniProtKB:P15559#VAR_008384,OMIM:125860.0001,PharmGKB Clinical Annotation:1183491004",1,16809,69711242,G,A,P187S,3,uncertain,uncertain,P15559,P15559,reviewed,NQO1_HUMAN,"NAD(P)H dehydrogenase [quinone] 1, EC 1.6.5.2 (Azoreductase) (DT-diaphorase, DTD) (Menadione reductase) (NAD(P)H:quinone oxidoreductase 1) (Phylloquinone reductase) (Quinone reductase 1, QR1)",NQO1 DIA4 NMOR1,Homo sapiens (Human),274.0,MVGRRALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDITGKLKDPANFQYPAESVLAYKEGHLSPDIVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAYTYAAMYDKGPFRSKKAVLSITTGGSGSMYSLQGIHGDMNVILWPIQSGILHFCGFQVLEPQLTYSIGHTPADARIQILEGWKKRLENIWDETPLYFAPSSLFDLNFQAGFLMKKEVQDEEKNKKFGLSVGHHLGKSIPTDNQIKARK,PF02525;,1D4A;1DXO;1GG5;1H66;1H69;1KBO;1KBQ;1QBG;2F1O;3JSX;4CET;4CF6;5A4K;5EA2;5EAI;5FUQ;6FY4;6LLC;,187,P,S,True,925
13569,269,16032,single nucleotide variant,NM_000380.3(XPA):c.323G>T (p.Cys108Phe),7507,XPA,HGNC:12814,Uncertain significance,1,1-Aug-17,104894131,-,RCV000001048,"MONDO:MONDO:0010210,MedGen:C0268135,OMIM:278700,Orphanet:910",Xeroderma pigmentosum group A,germline;unknown,germline,GRCh38,NC_000009.12,9,97689600,97689600,na,na,9q22.33,"criteria provided, single submitter",2,-,N,"UniProtKB:P23025#VAR_007728,OMIM:611153.0002,ClinGen:CA251648",3,993,97689600,C,A,C108F,1,uncertain,uncertain,P23025,P23025,reviewed,XPA_HUMAN,DNA repair protein complementing XP-A cells (Xeroderma pigmentosum group A-complementing protein),XPA XPAC,Homo sapiens (Human),273.0,MAAADGALPEAAALEQPAELPASVRASIERKRQRALMLRQARLAARPYSATAAAATGGMANVKAAPKIIDTGGGFILEEEEEEEQKIGKVVHQPGPVMEFDYVICEECGKEFMDSYLMNHFDLPTCDNCRDADDKHKLITKTEAKQEYLLKDCDLEKREPPLKFIVKKNPHHSQWGDMKLYLKLQIVKRSLEVWGSQEALEEAKEVRQENREKMKQKKFDKKVKELRRAVRSSVWKRETIVHQHEYGPEENLEDDMYRKTCTMCGHELTYEKM,PF05181;PF01286;,1D4U;1XPA;2JNW;6J44;6LAE;6RO4;7AD8;,108,C,F,True,926
13570,10656,139200,single nucleotide variant,NM_000380.3(XPA):c.754C>G (p.Leu252Val),7507,XPA,HGNC:12814,Benign/Likely benign,0,31-Dec-19,3176750,-,RCV000122319|RCV000319809|RCV000860760,"MedGen:CN169374|MONDO:MONDO:0010210,MedGen:C0268135,OMIM:278700,Orphanet:910|MedGen:CN517202",not specified|Xeroderma pigmentosum group A|not provided,germline,germline,GRCh38,NC_000009.12,9,97675507,97675507,na,na,9q22.33,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA162841,UniProtKB:P23025#VAR_020324",2,135461,97675507,G,C,L252V,2,benign,benign,P23025,P23025,reviewed,XPA_HUMAN,DNA repair protein complementing XP-A cells (Xeroderma pigmentosum group A-complementing protein),XPA XPAC,Homo sapiens (Human),273.0,MAAADGALPEAAALEQPAELPASVRASIERKRQRALMLRQARLAARPYSATAAAATGGMANVKAAPKIIDTGGGFILEEEEEEEQKIGKVVHQPGPVMEFDYVICEECGKEFMDSYLMNHFDLPTCDNCRDADDKHKLITKTEAKQEYLLKDCDLEKREPPLKFIVKKNPHHSQWGDMKLYLKLQIVKRSLEVWGSQEALEEAKEVRQENREKMKQKKFDKKVKELRRAVRSSVWKRETIVHQHEYGPEENLEDDMYRKTCTMCGHELTYEKM,PF05181;PF01286;,1D4U;1XPA;2JNW;6J44;6LAE;6RO4;7AD8;,252,L,V,True,926
13571,10657,139202,single nucleotide variant,NM_000380.3(XPA):c.683G>A (p.Arg228Gln),7507,XPA,HGNC:12814,Uncertain significance,0,7-Feb-17,1805160,-,RCV000122321|RCV000665473,"MedGen:CN169374|MONDO:MONDO:0010210,MedGen:C0268135,OMIM:278700,Orphanet:910",not specified|Xeroderma pigmentosum group A,germline;unknown,germline,GRCh38,NC_000009.12,9,97675578,97675578,na,na,9q22.33,"criteria provided, single submitter",2,-,N,"ClinGen:CA162847,UniProtKB:P23025#VAR_014799",2,135463,97675578,C,T,R228Q,1,uncertain,uncertain,P23025,P23025,reviewed,XPA_HUMAN,DNA repair protein complementing XP-A cells (Xeroderma pigmentosum group A-complementing protein),XPA XPAC,Homo sapiens (Human),273.0,MAAADGALPEAAALEQPAELPASVRASIERKRQRALMLRQARLAARPYSATAAAATGGMANVKAAPKIIDTGGGFILEEEEEEEQKIGKVVHQPGPVMEFDYVICEECGKEFMDSYLMNHFDLPTCDNCRDADDKHKLITKTEAKQEYLLKDCDLEKREPPLKFIVKKNPHHSQWGDMKLYLKLQIVKRSLEVWGSQEALEEAKEVRQENREKMKQKKFDKKVKELRRAVRSSVWKRETIVHQHEYGPEENLEDDMYRKTCTMCGHELTYEKM,PF05181;PF01286;,1D4U;1XPA;2JNW;6J44;6LAE;6RO4;7AD8;,228,R,Q,True,926
13572,13959,313795,single nucleotide variant,NM_000380.3(XPA):c.731A>G (p.His244Arg),7507,XPA,HGNC:12814,Uncertain significance,0,3-Aug-17,144725456,-,RCV000668335,"MONDO:MONDO:0010210,MedGen:C0268135,OMIM:278700,Orphanet:910",Xeroderma pigmentosum group A,germline;unknown,germline,GRCh38,NC_000009.12,9,97675530,97675530,na,na,9q22.33,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA5148691,UniProtKB:P23025#VAR_007731",2,364088,97675530,T,C,H244R,2,uncertain,uncertain,P23025,P23025,reviewed,XPA_HUMAN,DNA repair protein complementing XP-A cells (Xeroderma pigmentosum group A-complementing protein),XPA XPAC,Homo sapiens (Human),273.0,MAAADGALPEAAALEQPAELPASVRASIERKRQRALMLRQARLAARPYSATAAAATGGMANVKAAPKIIDTGGGFILEEEEEEEQKIGKVVHQPGPVMEFDYVICEECGKEFMDSYLMNHFDLPTCDNCRDADDKHKLITKTEAKQEYLLKDCDLEKREPPLKFIVKKNPHHSQWGDMKLYLKLQIVKRSLEVWGSQEALEEAKEVRQENREKMKQKKFDKKVKELRRAVRSSVWKRETIVHQHEYGPEENLEDDMYRKTCTMCGHELTYEKM,PF05181;PF01286;,1D4U;1XPA;2JNW;6J44;6LAE;6RO4;7AD8;,244,H,R,True,926
13573,10655,139199,single nucleotide variant,NM_000380.3(XPA):c.766A>G (p.Met256Val),7507,XPA,HGNC:12814,Benign/Likely benign,0,31-Dec-19,57519506,-,RCV000122318|RCV000260012|RCV000861170,"MedGen:CN169374|MONDO:MONDO:0010210,MedGen:C0268135,OMIM:278700,Orphanet:910|MedGen:CN517202",not specified|Xeroderma pigmentosum group A|not provided,germline,germline,GRCh38,NC_000009.12,9,97675495,97675495,na,na,9q22.33,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA162838,UniProtKB:P23025#VAR_061987",2,135460,97675495,T,C,M256V,2,benign,benign,P23025,P23025,reviewed,XPA_HUMAN,DNA repair protein complementing XP-A cells (Xeroderma pigmentosum group A-complementing protein),XPA XPAC,Homo sapiens (Human),273.0,MAAADGALPEAAALEQPAELPASVRASIERKRQRALMLRQARLAARPYSATAAAATGGMANVKAAPKIIDTGGGFILEEEEEEEQKIGKVVHQPGPVMEFDYVICEECGKEFMDSYLMNHFDLPTCDNCRDADDKHKLITKTEAKQEYLLKDCDLEKREPPLKFIVKKNPHHSQWGDMKLYLKLQIVKRSLEVWGSQEALEEAKEVRQENREKMKQKKFDKKVKELRRAVRSSVWKRETIVHQHEYGPEENLEDDMYRKTCTMCGHELTYEKM,PF05181;PF01286;,1D4U;1XPA;2JNW;6J44;6LAE;6RO4;7AD8;,256,M,V,True,926
13574,12413,215648,single nucleotide variant,NM_000899.5(KITLG):c.310C>G (p.Leu104Val),4254,KITLG,HGNC:6343,Uncertain significance,0,5-Nov-15,864309655,-,RCV000203232,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000012.12,12,88518750,88518750,na,na,12q21.32,no assertion criteria provided,1,-,N,"UniProtKB:P21583#VAR_076223,OMIM:184745.0008,ClinGen:CA278761",1,218889,88518750,G,C,L104V,0,uncertain,uncertain,P21583,P21583,reviewed,SCF_HUMAN,"Kit ligand (Mast cell growth factor, MGF) (Stem cell factor, SCF) (c-Kit ligand) [Cleaved into: Soluble KIT ligand, sKITLG ]",KITLG MGF SCF,Homo sapiens (Human),273.0,MKKTQTWILTCIYLQLLLFNPLVKTEGICRNRVTNNVKDVTKLVANLPKDYMITLKYVPGMDVLPSHCWISEMVVQLSDSLTDLLDKFSNISEGLSNYSIIDKLVNIVDDLVECVKENSSKDLKKSFKSPEPRLFTPEEFFRIFNRSIDAFKDFVVASETSDCVVSSTLSPEKDSRVSVTKPFMLPPVAASSLRNDSSSSNRKAKNPPGDSSLHWAAMALPALFSLIIGFAFGALYWKKRQPSLTRAVENIQINEEDNEISMLQEKEREFQEV,PF02404;,1EXZ;1SCF;2E9W;,104,L,V,True,927
13575,3234,27852,single nucleotide variant,NM_000899.5(KITLG):c.107A>G (p.Asn36Ser),4254,KITLG,HGNC:6343,Pathogenic,1,1-Jun-11,121918653,-,RCV000013661,"MONDO:MONDO:0007771,MedGen:C1840392,OMIM:145250,Orphanet:280628,Orphanet:79146",Familial progressive hyperpigmentation with or without hypopigmentation,germline,germline,GRCh38,NC_000012.12,12,88545774,88545774,na,na,12q21.32,no assertion criteria provided,1,-,N,"ClinGen:CA122727,UniProtKB:P21583#VAR_063237,OMIM:184745.0003",1,12813,88545774,T,C,N36S,0,pathogenic,uncertain,P21583,P21583,reviewed,SCF_HUMAN,"Kit ligand (Mast cell growth factor, MGF) (Stem cell factor, SCF) (c-Kit ligand) [Cleaved into: Soluble KIT ligand, sKITLG ]",KITLG MGF SCF,Homo sapiens (Human),273.0,MKKTQTWILTCIYLQLLLFNPLVKTEGICRNRVTNNVKDVTKLVANLPKDYMITLKYVPGMDVLPSHCWISEMVVQLSDSLTDLLDKFSNISEGLSNYSIIDKLVNIVDDLVECVKENSSKDLKKSFKSPEPRLFTPEEFFRIFNRSIDAFKDFVVASETSDCVVSSTLSPEKDSRVSVTKPFMLPPVAASSLRNDSSSSNRKAKNPPGDSSLHWAAMALPALFSLIIGFAFGALYWKKRQPSLTRAVENIQINEEDNEISMLQEKEREFQEV,PF02404;,1EXZ;1SCF;2E9W;,36,N,S,True,927
13576,11976,199918,single nucleotide variant,NM_000417.2(IL2RA):c.122A>C (p.Tyr41Ser),3559,IL2RA,HGNC:6008,Pathogenic,1,1-Feb-14,796051888,-,RCV000185642,"MONDO:MONDO:0011664,MedGen:C1853392,OMIM:606367,Orphanet:169100","Interleukin 2 receptor, alpha, deficiency of",germline,germline,GRCh38,NC_000010.11,10,6025968,6025968,na,na,10p15.1,no assertion criteria provided,1,-,N,"ClinGen:CA203914,UniProtKB:P01589#VAR_074641,OMIM:147730.0007",1,203518,6025968,T,G,Y41S,0,pathogenic,uncertain,P01589,P01589,reviewed,IL2RA_HUMAN,"Interleukin-2 receptor subunit alpha, IL-2 receptor subunit alpha, IL-2-RA, IL-2R subunit alpha, IL2-RA (TAC antigen) (p55) (CD antigen CD25)",IL2RA,Homo sapiens (Human),272.0,MDSYLLMWGLLTFIMVPGCQAELCDDDPPEIPHATFKAMAYKEGTMLNCECKRGFRRIKSGSLYMLCTGNSSHSSWDNQCQCTSSATRNTTKQVTPQPEEQKERKTTEMQSPMQPVDQASLPGHCREPPPWENEATERIYHFVVGQMVYYQCVQGYRALHRGPAESVCKMTHGKTRWTQPQLICTGEMETSQFPGEEKPQASPEGRPESETSCLVTTTDFQIQTEMAATMETSIFTTEYQVAVAGCVFLLISVLLLSGLTWQRRQRKSRRTI,PF00084;,1Z92;2B5I;2ERJ;3IU3;3NFP;6VWU;6YIO;7F9W;,41,Y,S,True,928
13577,4987,32630,single nucleotide variant,NM_000754.4(COMT):c.472G>A (p.Val158Met),1312,COMT,HGNC:2228,drug response,0,20-Dec-17,4680,-,RCV000019156|RCV000211145|RCV000244083|RCV000786523|RCV000786728|RCV000786729|RCV000786730|RCV000786731|RCV000786732|RCV000786733|RCV001028880,|MedGen:CN236568|MedGen:CN169374||||||||MedGen:CN078023,"CATECHOL-O-METHYLTRANSFERASE POLYMORPHISM|nicotine response - Efficacy|not specified|tramadol response - Dosage, Efficacy|methadone response - Dosage, Efficacy|morphine response - Dosage, Efficacy|opioids response - Dosage, Efficacy|oxycodone response - Dosage, Efficacy|remifentanil response - Dosage, Efficacy|sufentanil response - Dosage, Efficacy|Tramadol response",germline;somatic,germline/somatic,GRCh38,NC_000022.11,22,19963748,19963748,na,na,22q11.21,reviewed by expert panel,4,-,N,"PharmGKB Clinical Annotation:981202618,ClinGen:CA127287,UniProtKB:P21964#VAR_005139,OMIM:116790.0001",3,17591,19963748,G,A,V158M,3,uncertain,uncertain,P21964,P21964,reviewed,COMT_HUMAN,"Catechol O-methyltransferase, EC 2.1.1.6",COMT,Homo sapiens (Human),271.0,MPEAPPLLLAAVLLGLVLLVVLLLLLRHWGWGLCLIGWNEFILQPIHNLLMGDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGVKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKGPGSEAGP,PF01596;,3A7E;3BWM;3BWY;4PYI;4PYJ;4PYK;4XUC;4XUD;4XUE;5LSA;6I3C;6I3D;,158,V,M,True,929
13578,4988,32631,single nucleotide variant,NM_000754.3(COMT):c.214G>T (p.Ala72Ser),1312,COMT,HGNC:2228,"drug response, risk factor",0,28-Apr-18,6267,-,RCV000019157|RCV001028887,|MedGen:CN078023,"Schizophrenia, susceptibility to|Tramadol response",germline;somatic,germline/somatic,GRCh38,NC_000022.11,22,19962740,19962740,na,na,22q11.21,no assertion criteria provided,2,-,N,"ClinGen:CA127289,UniProtKB:P21964#VAR_013926,OMIM:116790.0002",3,17592,19962740,G,T,A72S,0,uncertain,uncertain,P21964,P21964,reviewed,COMT_HUMAN,"Catechol O-methyltransferase, EC 2.1.1.6",COMT,Homo sapiens (Human),271.0,MPEAPPLLLAAVLLGLVLLVVLLLLLRHWGWGLCLIGWNEFILQPIHNLLMGDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGVKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKGPGSEAGP,PF01596;,3A7E;3BWM;3BWY;4PYI;4PYJ;4PYK;4XUC;4XUD;4XUE;5LSA;6I3C;6I3D;,72,A,S,True,929
13579,3436,28395,single nucleotide variant,NM_000939.4(POMC):c.706C>G (p.Arg236Gly),5443,POMC,HGNC:9201,Conflicting interpretations of pathogenicity,0,31-Dec-19,28932472,-,RCV000014284|RCV000490219|RCV000986596,"MedGen:C4016341|MedGen:CN517202|MONDO:MONDO:0012335,MedGen:C1857854,OMIM:609734,Orphanet:71526","Obesity, early-onset, susceptibility to|not provided|Proopiomelanocortin deficiency",germline;unknown,germline,GRCh38,NC_000002.12,2,25161179,25161179,na,na,2p23.3,"criteria provided, conflicting interpretations",4,-,N,"OMIM:176830.0004,ClinGen:CA123053,UniProtKB:P01189#VAR_010701",3,13356,25161179,G,C,R236G,1,uncertain,uncertain,P01189,P01189,reviewed,COLI_HUMAN,"Pro-opiomelanocortin, POMC (Corticotropin-lipotropin) [Cleaved into: NPP; Melanotropin gamma (Gamma-MSH); Potential peptide; Corticotropin (Adrenocorticotropic hormone, ACTH); Melanocyte-stimulating hormone alpha, Alpha-MSH (Melanotropin alpha); Corticotropin-like intermediary peptide, CLIP; Lipotropin beta (Beta-LPH); Lipotropin gamma (Gamma-LPH); Melanocyte-stimulating hormone beta, Beta-MSH (Melanotropin beta); Beta-endorphin; Met-enkephalin ]",POMC,Homo sapiens (Human),267.0,MPRSCCSRSGALLLALLLQASMEVRGWCLESSQCQDLTTESNLLECIRACKPDLSAETPMFPGNGDEQPLTENPRKYVMGHFRWDRFGRRNSSSSGSSGAGQKREDVSAGEDCGPLPEGGPEPRSDGAKPGPREGKRSYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEFKRELTGQRLREGDGPDGPADDGAGAQADLEHSLLVAAEKKDEGPYRMEHFRWGSPPKDKRYGGFMTSEKSQTPLVTLFKNAIIKNAYKKGE,PF00976;PF08384;PF08035;,4XNH;4XPD;4Y49;6TUB;,236,R,G,True,930
13580,12165,206995,single nucleotide variant,NM_000939.4(POMC):c.641A>G (p.Glu214Gly),5443,POMC,HGNC:9201,Likely benign,0,31-Dec-19,80326661,-,RCV000192320|RCV000953171|RCV001142527,"MedGen:CN169374|MedGen:CN517202|Human Phenotype Ontology:HP:0001513,MONDO:MONDO:0019182,MeSH:D009765,MedGen:C0028754,OMIM:601665,Orphanet:71529",not specified|not provided|Obesity,germline,germline,GRCh38,NC_000002.12,2,25161244,25161244,na,na,2p23.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA205065,UniProtKB:P01189#VAR_010716",2,211936,25161244,T,C,E214G,2,benign,benign,P01189,P01189,reviewed,COLI_HUMAN,"Pro-opiomelanocortin, POMC (Corticotropin-lipotropin) [Cleaved into: NPP; Melanotropin gamma (Gamma-MSH); Potential peptide; Corticotropin (Adrenocorticotropic hormone, ACTH); Melanocyte-stimulating hormone alpha, Alpha-MSH (Melanotropin alpha); Corticotropin-like intermediary peptide, CLIP; Lipotropin beta (Beta-LPH); Lipotropin gamma (Gamma-LPH); Melanocyte-stimulating hormone beta, Beta-MSH (Melanotropin beta); Beta-endorphin; Met-enkephalin ]",POMC,Homo sapiens (Human),267.0,MPRSCCSRSGALLLALLLQASMEVRGWCLESSQCQDLTTESNLLECIRACKPDLSAETPMFPGNGDEQPLTENPRKYVMGHFRWDRFGRRNSSSSGSSGAGQKREDVSAGEDCGPLPEGGPEPRSDGAKPGPREGKRSYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEFKRELTGQRLREGDGPDGPADDGAGAQADLEHSLLVAAEKKDEGPYRMEHFRWGSPPKDKRYGGFMTSEKSQTPLVTLFKNAIIKNAYKKGE,PF00976;PF08384;PF08035;,4XNH;4XPD;4Y49;6TUB;,214,E,G,True,930
13581,5108,32953,single nucleotide variant,NM_000039.2(APOA1):c.80C>G (p.Pro27Arg),335,APOA1,HGNC:600,Pathogenic,1,1-Dec-89,121912720,-,RCV000019503,-,APOLIPOPROTEIN A-I (MUNSTER3C),germline,germline,GRCh38,NC_000011.10,11,116837121,116837121,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA127552,UniProtKB:P02647#VAR_000606,OMIM:107680.0007",1,17914,116837121,G,C,P27R,0,pathogenic,uncertain,P02647,P02647,reviewed,APOA1_HUMAN,"Apolipoprotein A-I, Apo-AI, ApoA-I (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I, ProapoA-I; Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242)) ]",APOA1,Homo sapiens (Human),267.0,MKAAVLTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ,PF01442;,1AV1;1GW3;1GW4;1ODP;1ODQ;1ODR;2MSC;2MSD;2MSE;2N5E;3K2S;3R2P;4V6M;6CC9;6CCH;6CCX;6CLZ;6CM1;6PTS;6PTW;6W4E;6W4F;7KJR;7RSC;7RSE;,27,P,R,True,931
13582,5109,32954,single nucleotide variant,NM_000039.2(APOA1):c.83C>G (p.Pro28Arg),335,APOA1,HGNC:600,Pathogenic,1,1-Dec-89,121912721,-,RCV000019504,-,APOLIPOPROTEIN A-I (MUNSTER3B),germline,germline,GRCh38,NC_000011.10,11,116837118,116837118,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA127555,UniProtKB:P02647#VAR_000607,OMIM:107680.0008",1,17915,116837118,G,C,P28R,0,pathogenic,uncertain,P02647,P02647,reviewed,APOA1_HUMAN,"Apolipoprotein A-I, Apo-AI, ApoA-I (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I, ProapoA-I; Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242)) ]",APOA1,Homo sapiens (Human),267.0,MKAAVLTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ,PF01442;,1AV1;1GW3;1GW4;1ODP;1ODQ;1ODR;2MSC;2MSD;2MSE;2N5E;3K2S;3R2P;4V6M;6CC9;6CCH;6CCX;6CLZ;6CM1;6PTS;6PTW;6W4E;6W4F;7KJR;7RSC;7RSE;,28,P,R,True,931
13583,5113,32968,single nucleotide variant,NM_000039.2(APOA1):c.539T>A (p.Val180Glu),335,APOA1,HGNC:600,Pathogenic,1,1-Mar-98,121912727,-,RCV000019522,"MONDO:MONDO:0100189,MedGen:C0342898,Orphanet:425",Apolipoprotein A-I deficiency,germline,germline,GRCh38,NC_000011.10,11,116836073,116836073,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA127580,UniProtKB:P02647#VAR_021362,OMIM:107680.0022",1,17929,116836073,A,T,V180E,0,pathogenic,uncertain,P02647,P02647,reviewed,APOA1_HUMAN,"Apolipoprotein A-I, Apo-AI, ApoA-I (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I, ProapoA-I; Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242)) ]",APOA1,Homo sapiens (Human),267.0,MKAAVLTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ,PF01442;,1AV1;1GW3;1GW4;1ODP;1ODQ;1ODR;2MSC;2MSD;2MSE;2N5E;3K2S;3R2P;4V6M;6CC9;6CCH;6CCX;6CLZ;6CM1;6PTS;6PTW;6W4E;6W4F;7KJR;7RSC;7RSE;,180,V,E,True,931
13584,5107,32952,single nucleotide variant,NM_000039.2(APOA1):c.478G>A (p.Glu160Lys),335,APOA1,HGNC:600,Pathogenic,1,25-Aug-84,121912718,-,RCV000019502,-,APOLIPOPROTEIN A-I (NORWAY),germline,germline,GRCh38,NC_000011.10,11,116836134,116836134,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA127549,UniProtKB:P02647#VAR_000618,OMIM:107680.0004",1,17913,116836134,C,T,E160K,0,pathogenic,uncertain,P02647,P02647,reviewed,APOA1_HUMAN,"Apolipoprotein A-I, Apo-AI, ApoA-I (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I, ProapoA-I; Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242)) ]",APOA1,Homo sapiens (Human),267.0,MKAAVLTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ,PF01442;,1AV1;1GW3;1GW4;1ODP;1ODQ;1ODR;2MSC;2MSD;2MSE;2N5E;3K2S;3R2P;4V6M;6CC9;6CCH;6CCX;6CLZ;6CM1;6PTS;6PTW;6W4E;6W4F;7KJR;7RSC;7RSE;,160,E,K,True,931
13585,5110,32955,single nucleotide variant,NM_000039.2(APOA1):c.566C>G (p.Pro189Arg),335,APOA1,HGNC:600,Pathogenic,1,1-Dec-89,121912722,-,RCV000019505,"MONDO:MONDO:0100189,MedGen:C0342898,Orphanet:425",Apolipoprotein A-I deficiency,germline,germline,GRCh38,NC_000011.10,11,116836046,116836046,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA127558,UniProtKB:P02647#VAR_000623,OMIM:107680.0009",1,17916,116836046,G,C,P189R,0,pathogenic,uncertain,P02647,P02647,reviewed,APOA1_HUMAN,"Apolipoprotein A-I, Apo-AI, ApoA-I (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I, ProapoA-I; Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242)) ]",APOA1,Homo sapiens (Human),267.0,MKAAVLTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ,PF01442;,1AV1;1GW3;1GW4;1ODP;1ODQ;1ODR;2MSC;2MSD;2MSE;2N5E;3K2S;3R2P;4V6M;6CC9;6CCH;6CCX;6CLZ;6CM1;6PTS;6PTW;6W4E;6W4F;7KJR;7RSC;7RSE;,189,P,R,True,931
13586,5106,32951,single nucleotide variant,NM_000039.2(APOA1):c.664G>A (p.Glu222Lys),335,APOA1,HGNC:600,Pathogenic,1,1-Aug-88,121912717,-,RCV000019501,-,APOLIPOPROTEIN A-I (MUNSTER4),germline,germline,GRCh38,NC_000011.10,11,116835948,116835948,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA127546,UniProtKB:P02647#VAR_000625,OMIM:107680.0003",1,17912,116835948,C,T,E222K,0,pathogenic,uncertain,P02647,P02647,reviewed,APOA1_HUMAN,"Apolipoprotein A-I, Apo-AI, ApoA-I (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I, ProapoA-I; Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242)) ]",APOA1,Homo sapiens (Human),267.0,MKAAVLTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ,PF01442;,1AV1;1GW3;1GW4;1ODP;1ODQ;1ODR;2MSC;2MSD;2MSE;2N5E;3K2S;3R2P;4V6M;6CC9;6CCH;6CCX;6CLZ;6CM1;6PTS;6PTW;6W4E;6W4F;7KJR;7RSC;7RSE;,222,E,K,True,931
13587,5111,32956,single nucleotide variant,NM_000039.2(APOA1):c.148G>C (p.Gly50Arg),335,APOA1,HGNC:600,Pathogenic,1,1-Oct-90,28931574,-,RCV000019506,MedGen:C4551500,"Familial amyloid polyneuropathy, Iowa type",germline,germline,GRCh38,NC_000011.10,11,116837053,116837053,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA127561,UniProtKB:P02647#VAR_000609,OMIM:107680.0010",1,17917,116837053,C,G,G50R,0,pathogenic,uncertain,P02647,P02647,reviewed,APOA1_HUMAN,"Apolipoprotein A-I, Apo-AI, ApoA-I (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I, ProapoA-I; Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242)) ]",APOA1,Homo sapiens (Human),267.0,MKAAVLTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ,PF01442;,1AV1;1GW3;1GW4;1ODP;1ODQ;1ODR;2MSC;2MSD;2MSE;2N5E;3K2S;3R2P;4V6M;6CC9;6CCH;6CCX;6CLZ;6CM1;6PTS;6PTW;6W4E;6W4F;7KJR;7RSC;7RSE;,50,G,R,True,931
13588,5105,32949,single nucleotide variant,NM_000039.2(APOA1):c.500C>G (p.Pro167Arg),335,APOA1,HGNC:600,Pathogenic,1,15-Oct-84,121912719,-,RCV000019499,-,APOLIPOPROTEIN A-I (GIESSEN),germline,germline,GRCh38,NC_000011.10,11,116836112,116836112,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA127540,UniProtKB:P02647#VAR_000620,OMIM:107680.0006",1,17910,116836112,G,C,P167R,0,pathogenic,uncertain,P02647,P02647,reviewed,APOA1_HUMAN,"Apolipoprotein A-I, Apo-AI, ApoA-I (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I, ProapoA-I; Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242)) ]",APOA1,Homo sapiens (Human),267.0,MKAAVLTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ,PF01442;,1AV1;1GW3;1GW4;1ODP;1ODQ;1ODR;2MSC;2MSD;2MSE;2N5E;3K2S;3R2P;4V6M;6CC9;6CCH;6CCX;6CLZ;6CM1;6PTS;6PTW;6W4E;6W4F;7KJR;7RSC;7RSE;,167,P,R,True,931
13589,5112,32959,single nucleotide variant,NM_000039.2(APOA1):c.101G>T (p.Arg34Leu),335,APOA1,HGNC:600,Pathogenic,1,1-Apr-90,28929476,-,RCV000019513,-,APOLIPOPROTEIN A-I (BALTIMORE),germline,germline,GRCh38,NC_000011.10,11,116837100,116837100,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA127563,UniProtKB:P02647#VAR_000608,OMIM:107680.0013",1,17920,116837100,C,A,R34L,0,pathogenic,uncertain,P02647,P02647,reviewed,APOA1_HUMAN,"Apolipoprotein A-I, Apo-AI, ApoA-I (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I, ProapoA-I; Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242)) ]",APOA1,Homo sapiens (Human),267.0,MKAAVLTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ,PF01442;,1AV1;1GW3;1GW4;1ODP;1ODQ;1ODR;2MSC;2MSD;2MSE;2N5E;3K2S;3R2P;4V6M;6CC9;6CCH;6CCX;6CLZ;6CM1;6PTS;6PTW;6W4E;6W4F;7KJR;7RSC;7RSE;,34,R,L,True,931
13590,5104,32948,single nucleotide variant,NM_000039.2(APOA1):c.589C>T (p.Arg197Cys),335,APOA1,HGNC:600,Pathogenic,1,5-Nov-03,28931573,-,RCV000019498,-,APOLIPOPROTEIN A-I (MILANO),germline,germline,GRCh38,NC_000011.10,11,116836023,116836023,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA127537,UniProtKB:P02647#VAR_000624,OMIM:107680.0001",1,17909,116836023,G,A,R197C,0,pathogenic,uncertain,P02647,P02647,reviewed,APOA1_HUMAN,"Apolipoprotein A-I, Apo-AI, ApoA-I (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I, ProapoA-I; Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242)) ]",APOA1,Homo sapiens (Human),267.0,MKAAVLTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ,PF01442;,1AV1;1GW3;1GW4;1ODP;1ODQ;1ODR;2MSC;2MSD;2MSE;2N5E;3K2S;3R2P;4V6M;6CC9;6CCH;6CCX;6CLZ;6CM1;6PTS;6PTW;6W4E;6W4F;7KJR;7RSC;7RSE;,197,R,C,True,931
13591,14056,325168,single nucleotide variant,NM_000039.2(APOA1):c.181G>A (p.Ala61Thr),335,APOA1,HGNC:600,Benign,0,31-Dec-19,12718465,-,RCV000335636|RCV000395998|RCV000779744|RCV000892083,"MONDO:MONDO:0011393,MedGen:C1704429,OMIM:604091,Orphanet:425|MONDO:MONDO:0007099,MedGen:C0268389,OMIM:105200,Orphanet:85450|MedGen:CN169374|MedGen:CN517202","Familial hypoalphalipoproteinemia|Familial visceral amyloidosis, Ostertag type|not specified|not provided",germline,germline,GRCh38,NC_000011.10,11,116837020,116837020,na,na,11q23.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA6289875,UniProtKB:P02647#VAR_025445",2,302507,116837020,C,T,A61T,2,benign,benign,P02647,P02647,reviewed,APOA1_HUMAN,"Apolipoprotein A-I, Apo-AI, ApoA-I (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I, ProapoA-I; Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242)) ]",APOA1,Homo sapiens (Human),267.0,MKAAVLTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ,PF01442;,1AV1;1GW3;1GW4;1ODP;1ODQ;1ODR;2MSC;2MSD;2MSE;2N5E;3K2S;3R2P;4V6M;6CC9;6CCH;6CCX;6CLZ;6CM1;6PTS;6PTW;6W4E;6W4F;7KJR;7RSC;7RSE;,61,A,T,True,931
13592,884,18792,single nucleotide variant,NM_000375.3(UROS):c.184A>G (p.Thr62Ala),7390,UROS,HGNC:12592,Pathogenic,1,29-May-19,28941775,-,RCV000003951,"MONDO:MONDO:0009902,MedGen:C0162530,OMIM:263700,Orphanet:79277",Congenital erythropoietic porphyria,germline,germline,GRCh38,NC_000010.11,10,125815094,125815094,na,na,10q26.2,no assertion criteria provided,1,-,N,"OMIM:606938.0004,ClinGen:CA252865,UniProtKB:P10746#VAR_003677",1,3753,125815094,T,C,T62A,0,pathogenic,uncertain,P10746,P10746,reviewed,HEM4_HUMAN,"Uroporphyrinogen-III synthase, UROIIIS, UROS, EC 4.2.1.75 (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase)",UROS,Homo sapiens (Human),265.0,MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSFEFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTVAHPGIQGNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELSGDNIDQIKFAAIGPTTARALAAQGLPVSCTAESPTPQALATGIRKALQPHGCC,PF02602;,1JR2;,62,T,A,True,932
13593,885,18793,single nucleotide variant,NM_000375.3(UROS):c.683C>T (p.Thr228Met),7390,UROS,HGNC:12592,Pathogenic,1,1-Jan-92,121908014,-,RCV000003952,"MONDO:MONDO:0009902,MedGen:C0162530,OMIM:263700,Orphanet:79277",Congenital erythropoietic porphyria,germline,germline,GRCh38,NC_000010.11,10,125788983,125788983,na,na,10q26.2,no assertion criteria provided,1,-,N,"ClinGen:CA252866,UniProtKB:P10746#VAR_003685,OMIM:606938.0005",1,3754,125788983,G,A,T228M,0,pathogenic,uncertain,P10746,P10746,reviewed,HEM4_HUMAN,"Uroporphyrinogen-III synthase, UROIIIS, UROS, EC 4.2.1.75 (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase)",UROS,Homo sapiens (Human),265.0,MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSFEFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTVAHPGIQGNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELSGDNIDQIKFAAIGPTTARALAAQGLPVSCTAESPTPQALATGIRKALQPHGCC,PF02602;,1JR2;,228,T,M,True,932
13594,14032,321156,single nucleotide variant,NM_000375.3(UROS):c.512T>G (p.Val171Gly),7390,UROS,HGNC:12592,Benign,0,13-Jan-18,17173752,-,RCV000333133,"MONDO:MONDO:0009902,MedGen:C0162530,OMIM:263700,Orphanet:79277",Congenital erythropoietic porphyria,germline,germline,GRCh38,NC_000010.11,10,125796152,125796152,na,na,10q26.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA5738414,UniProtKB:P10746#VAR_049346",2,299188,125796152,A,C,V171G,1,benign,benign,P10746,P10746,reviewed,HEM4_HUMAN,"Uroporphyrinogen-III synthase, UROIIIS, UROS, EC 4.2.1.75 (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase)",UROS,Homo sapiens (Human),265.0,MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSFEFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTVAHPGIQGNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELSGDNIDQIKFAAIGPTTARALAAQGLPVSCTAESPTPQALATGIRKALQPHGCC,PF02602;,1JR2;,171,V,G,True,932
13595,890,18808,single nucleotide variant,NM_000375.3(UROS):c.743C>A (p.Pro248Gln),7390,UROS,HGNC:12592,Pathogenic,1,1-Jan-96,121908021,-,RCV000003967,"MONDO:MONDO:0009902,MedGen:C0162530,OMIM:263700,Orphanet:79277",Congenital erythropoietic porphyria,germline,germline,GRCh38,NC_000010.11,10,125788923,125788923,na,na,10q26.2,no assertion criteria provided,1,-,N,"ClinGen:CA252876,UniProtKB:P10746#VAR_066247,OMIM:606938.0020",1,3769,125788923,G,T,P248Q,0,pathogenic,uncertain,P10746,P10746,reviewed,HEM4_HUMAN,"Uroporphyrinogen-III synthase, UROIIIS, UROS, EC 4.2.1.75 (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase)",UROS,Homo sapiens (Human),265.0,MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSFEFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTVAHPGIQGNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELSGDNIDQIKFAAIGPTTARALAAQGLPVSCTAESPTPQALATGIRKALQPHGCC,PF02602;,1JR2;,248,P,Q,True,932
13596,886,18794,single nucleotide variant,NM_000375.3(UROS):c.10C>T (p.Leu4Phe),7390,UROS,HGNC:12592,Pathogenic,1,1-Jan-92,121908015,-,RCV000003953,"MONDO:MONDO:0009902,MedGen:C0162530,OMIM:263700,Orphanet:79277",Congenital erythropoietic porphyria,germline,germline,GRCh38,NC_000010.11,10,125816490,125816490,na,na,10q26.2,no assertion criteria provided,1,-,N,"UniProtKB:P10746#VAR_003674,OMIM:606938.0006,ClinGen:CA252867",1,3755,125816490,G,A,L4F,0,pathogenic,uncertain,P10746,P10746,reviewed,HEM4_HUMAN,"Uroporphyrinogen-III synthase, UROIIIS, UROS, EC 4.2.1.75 (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase)",UROS,Homo sapiens (Human),265.0,MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSFEFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTVAHPGIQGNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELSGDNIDQIKFAAIGPTTARALAAQGLPVSCTAESPTPQALATGIRKALQPHGCC,PF02602;,1JR2;,4,L,F,True,932
13597,887,18798,single nucleotide variant,NM_000375.3(UROS):c.562G>A (p.Gly188Arg),7390,UROS,HGNC:12592,Pathogenic,1,1-Dec-98,121908017,-,RCV000003957,"MONDO:MONDO:0009902,MedGen:C0162530,OMIM:263700,Orphanet:79277",Congenital erythropoietic porphyria,germline,germline,GRCh38,NC_000010.11,10,125794978,125794978,na,na,10q26.2,no assertion criteria provided,1,-,N,"OMIM:606938.0010,ClinGen:CA252869,UniProtKB:P10746#VAR_013558",1,3759,125794978,C,T,G188R,0,pathogenic,uncertain,P10746,P10746,reviewed,HEM4_HUMAN,"Uroporphyrinogen-III synthase, UROIIIS, UROS, EC 4.2.1.75 (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase)",UROS,Homo sapiens (Human),265.0,MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSFEFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTVAHPGIQGNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELSGDNIDQIKFAAIGPTTARALAAQGLPVSCTAESPTPQALATGIRKALQPHGCC,PF02602;,1JR2;,188,G,R,True,932
13598,888,18800,single nucleotide variant,NM_000375.3(UROS):c.562G>T (p.Gly188Trp),7390,UROS,HGNC:12592,Pathogenic,1,1-Jun-02,121908017,-,RCV000003959,"MONDO:MONDO:0009902,MedGen:C0162530,OMIM:263700,Orphanet:79277",Congenital erythropoietic porphyria,germline,germline,GRCh38,NC_000010.11,10,125794978,125794978,na,na,10q26.2,no assertion criteria provided,1,-,N,"ClinGen:CA252872,UniProtKB:P10746#VAR_021619,OMIM:606938.0012",1,3761,125794978,C,A,G188W,0,pathogenic,uncertain,P10746,P10746,reviewed,HEM4_HUMAN,"Uroporphyrinogen-III synthase, UROIIIS, UROS, EC 4.2.1.75 (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase)",UROS,Homo sapiens (Human),265.0,MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSFEFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTVAHPGIQGNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELSGDNIDQIKFAAIGPTTARALAAQGLPVSCTAESPTPQALATGIRKALQPHGCC,PF02602;,1JR2;,188,G,W,True,932
13599,882,18790,single nucleotide variant,NM_000375.3(UROS):c.158C>T (p.Pro53Leu),7390,UROS,HGNC:12592,Pathogenic,1,1-May-90,121908013,-,RCV000003949,"MONDO:MONDO:0009902,MedGen:C0162530,OMIM:263700,Orphanet:79277",Congenital erythropoietic porphyria,germline,germline,GRCh38,NC_000010.11,10,125815120,125815120,na,na,10q26.2,no assertion criteria provided,1,-,N,"UniProtKB:P10746#VAR_003676,OMIM:606938.0002,ClinGen:CA252864",1,3751,125815120,G,A,P53L,0,pathogenic,uncertain,P10746,P10746,reviewed,HEM4_HUMAN,"Uroporphyrinogen-III synthase, UROIIIS, UROS, EC 4.2.1.75 (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase)",UROS,Homo sapiens (Human),265.0,MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSFEFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTVAHPGIQGNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELSGDNIDQIKFAAIGPTTARALAAQGLPVSCTAESPTPQALATGIRKALQPHGCC,PF02602;,1JR2;,53,P,L,True,932
13600,889,18805,single nucleotide variant,NM_000375.3(UROS):c.673G>A (p.Gly225Ser),7390,UROS,HGNC:12592,Pathogenic,1,12-Sep-13,121908020,-,RCV000003964,"MONDO:MONDO:0009902,MedGen:C0162530,OMIM:263700,Orphanet:79277",Congenital erythropoietic porphyria,germline,germline,GRCh38,NC_000010.11,10,125788993,125788993,na,na,10q26.2,no assertion criteria provided,2,-,N,"ClinGen:CA340125,UniProtKB:P10746#VAR_003684,OMIM:606938.0017",1,3766,125788993,C,T,G225S,0,pathogenic,uncertain,P10746,P10746,reviewed,HEM4_HUMAN,"Uroporphyrinogen-III synthase, UROIIIS, UROS, EC 4.2.1.75 (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase)",UROS,Homo sapiens (Human),265.0,MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSFEFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTVAHPGIQGNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELSGDNIDQIKFAAIGPTTARALAAQGLPVSCTAESPTPQALATGIRKALQPHGCC,PF02602;,1JR2;,225,G,S,True,932
13601,7514,76508,single nucleotide variant,NM_000375.3(UROS):c.139T>C (p.Ser47Pro),7390,UROS,HGNC:12592,Pathogenic,1,12-Sep-13,397515527,-,RCV000055808,"MONDO:MONDO:0009902,MedGen:C0162530,OMIM:263700,Orphanet:79277",Congenital erythropoietic porphyria,not provided,not provided,GRCh38,NC_000010.11,10,125816185,125816185,na,na,10q26.2,no assertion criteria provided,1,-,N,"ClinGen:CA344925,UniProtKB:P10746#VAR_021616",1,65600,125816185,A,G,S47P,0,pathogenic,uncertain,P10746,P10746,reviewed,HEM4_HUMAN,"Uroporphyrinogen-III synthase, UROIIIS, UROS, EC 4.2.1.75 (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase)",UROS,Homo sapiens (Human),265.0,MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSFEFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTVAHPGIQGNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELSGDNIDQIKFAAIGPTTARALAAQGLPVSCTAESPTPQALATGIRKALQPHGCC,PF02602;,1JR2;,47,S,P,True,932
13602,7515,76509,single nucleotide variant,NM_000375.3(UROS):c.311C>T (p.Ala104Val),7390,UROS,HGNC:12592,Pathogenic,1,12-Sep-13,397515528,-,RCV000055809,"MONDO:MONDO:0009902,MedGen:C0162530,OMIM:263700,Orphanet:79277",Congenital erythropoietic porphyria,not provided,not provided,GRCh38,NC_000010.11,10,125812222,125812222,na,na,10q26.2,no assertion criteria provided,1,-,N,"ClinGen:CA344926,UniProtKB:P10746#VAR_003682",1,65601,125812222,G,A,A104V,0,pathogenic,uncertain,P10746,P10746,reviewed,HEM4_HUMAN,"Uroporphyrinogen-III synthase, UROIIIS, UROS, EC 4.2.1.75 (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase)",UROS,Homo sapiens (Human),265.0,MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSFEFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTVAHPGIQGNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELSGDNIDQIKFAAIGPTTARALAAQGLPVSCTAESPTPQALATGIRKALQPHGCC,PF02602;,1JR2;,104,A,V,True,932
13603,881,18789,single nucleotide variant,NM_000375.3(UROS):c.217T>C (p.Cys73Arg),7390,UROS,HGNC:12592,Pathogenic,1,27-Apr-17,121908012,-,RCV000003948|RCV000726590,"MONDO:MONDO:0009902,MedGen:C0162530,OMIM:263700,Orphanet:79277|MedGen:CN517202",Congenital erythropoietic porphyria|not provided,germline,germline,GRCh38,NC_000010.11,10,125815061,125815061,na,na,10q26.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA340118,UniProtKB:P10746#VAR_003679,OMIM:606938.0001",3,3750,125815061,A,G,C73R,2,pathogenic,pathogenic,P10746,P10746,reviewed,HEM4_HUMAN,"Uroporphyrinogen-III synthase, UROIIIS, UROS, EC 4.2.1.75 (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase)",UROS,Homo sapiens (Human),265.0,MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSFEFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTVAHPGIQGNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELSGDNIDQIKFAAIGPTTARALAAQGLPVSCTAESPTPQALATGIRKALQPHGCC,PF02602;,1JR2;,73,C,R,True,932
13604,883,18791,single nucleotide variant,NM_000375.3(UROS):c.197C>T (p.Ala66Val),7390,UROS,HGNC:12592,Pathogenic,1,12-Sep-13,28941774,-,RCV000003950,"MONDO:MONDO:0009902,MedGen:C0162530,OMIM:263700,Orphanet:79277",Congenital erythropoietic porphyria,germline,germline,GRCh38,NC_000010.11,10,125815081,125815081,na,na,10q26.2,no assertion criteria provided,2,-,N,"ClinGen:CA340119,UniProtKB:P10746#VAR_003678,OMIM:606938.0003",1,3752,125815081,G,A,A66V,0,pathogenic,uncertain,P10746,P10746,reviewed,HEM4_HUMAN,"Uroporphyrinogen-III synthase, UROIIIS, UROS, EC 4.2.1.75 (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase)",UROS,Homo sapiens (Human),265.0,MKVLLLKDAKEDDCGQDPYIRELGLYGLEATLIPVLSFEFLSLPSFSEKLSHPEDYGGLIFTSPRAVEAAELCLEQNNKTEVWERSLKEKWNAKSVYVVGNATASLVSKIGLDTEGETCGNAEKLAEYICSRESSALPLLFPCGNLKREILPKALKDKGIAMESITVYQTVAHPGIQGNLNSYYSQQGVPASITFFSPSGLTYSLKHIQELSGDNIDQIKFAAIGPTTARALAAQGLPVSCTAESPTPQALATGIRKALQPHGCC,PF02602;,1JR2;,66,A,V,True,932
13605,12406,215390,single nucleotide variant,NM_138777.5(MRRF):c.646A>G (p.Met216Val),92399,MRRF,HGNC:7234,Uncertain significance,0,5-Feb-15,2297483,-,RCV000202743,MedGen:CN169374,not specified,unknown,unknown,GRCh38,NC_000009.12,9,122313321,122313321,na,na,9q33.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA248932,UniProtKB:Q96E11#VAR_051885",2,218837,122313321,A,G,M216V,1,uncertain,uncertain,Q96E11,Q96E11,reviewed,RRFM_HUMAN,"Ribosome-recycling factor, mitochondrial, RRF (Ribosome-releasing factor, mitochondrial)",MRRF,Homo sapiens (Human),262.0,MALGLKCFRMVHPTFRNYLAASIRPVSEVTLKTVHERQHGHRQYMAYSAVPVRHFATKKAKAKGKGQSQTRVNINAALVEDIINLEEVNEEMKSVIEALKDNFNKTLNIRTSPGSLDKIAVVTADGKLALNQISQISMKSPQLILVNMASFPECTAAAIKAIRESGMNLNPEVEGTLIRVPIPQVTREHREMLVKLAKQNTNKAKDSLRKVRTNSMNKLKKSKDTVSEDTIRLIEKQISQMADDTVAELDRHLAVKTKELLG,PF01765;,6NU2;6ZS9;7L08;7L20;7NSH;7NSI;,216,M,V,True,933
13606,10886,152753,single nucleotide variant,NM_182649.2(PCNA):c.683G>T (p.Ser228Ile),5111,PCNA,HGNC:8729,Uncertain significance,1,3-Apr-18,369958038,-,RCV000132551,"MONDO:MONDO:0014399,MedGen:C4014676,OMIM:615919,Orphanet:438134",Ataxia-telangiectasia-like disorder 2,germline;maternal,germline,GRCh38,NC_000020.11,20,5115472,5115472,na,na,20p12.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA170059,UniProtKB:P12004#VAR_071871,OMIM:176740.0001",3,143043,5115472,C,A,S228I,1,uncertain,uncertain,P12004,P12004,reviewed,PCNA_HUMAN,"Proliferating cell nuclear antigen, PCNA (Cyclin)",PCNA,Homo sapiens (Human),261.0,MFEARLVQGSILKKVLEALKDLINEACWDISSSGVNLQSMDSSHVSLVQLTLRSEGFDTYRCDRNLAMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLMDLDVEQLGIPEQEYSCVVKMPSGEFARICRDLSHIGDAVVISCAKDGVKFSASGELGNGNIKLSQTSNVDKEEEAVTIEMNEPVQLTFALRYLNFFTKATPLSSTVTLSMSADVPLVVEYKIADMGHLKYYLAPKIEDEEGS,PF02747;PF00705;,1AXC;1U76;1U7B;1UL1;1VYJ;1VYM;1W60;2ZVK;2ZVL;2ZVM;3JA9;3P87;3TBL;3VKX;3WGW;4D2G;4RJF;4ZTD;5E0T;5E0U;5E0V;5IY4;5MAV;5MLO;5MLW;5MOM;5YCO;5YD8;6CBI;6EHT;6FCM;6FCN;6GIS;6GWS;6HVO;6K3A;6QC0;6QCG;6S1M;6S1N;6S1O;6TNY;6TNZ;6VVO;7EFA;7KQ0;7KQ1;7M5L;7M5M;7M5N;7NV0;7NV1;,228,S,I,True,934
13607,1483,21562,single nucleotide variant,NM_018129.4(PNPO):c.685C>T (p.Arg229Trp),55163,PNPO,HGNC:30260,Pathogenic,1,15-Apr-05,104894629,-,RCV000006896,"MONDO:MONDO:0012407,MedGen:C1864723,OMIM:610090,Orphanet:79096",Pyridoxal phosphate-responsive seizures,germline,germline,GRCh38,NC_000017.11,17,47946681,47946681,na,na,17q21.32,no assertion criteria provided,1,-,N,"ClinGen:CA118329,UniProtKB:Q9NVS9#VAR_029360,OMIM:603287.0001",1,6523,47946681,C,T,R229W,0,pathogenic,uncertain,Q9NVS9,Q9NVS9,reviewed,PNPO_HUMAN,"Pyridoxine-5'-phosphate oxidase, EC 1.4.3.5 (Pyridoxamine-phosphate oxidase)",PNPO,Homo sapiens (Human),261.0,MTCWLRGVTATFGRPAEWPGYLSHLCGRSAAMDLGPMRKSYRGDREAFEETHLTSLDPVKQFAAWFEEAVQCPDIGEANAMCLATCTRDGKPSARMLLLKGFGKDGFRFFTNFESRKGKELDSNPFASLVFYWEPLNRQVRVEGPVKKLPEEEAECYFHSRPKSSQIGAVVSHQSSVIPDREYLRKKNEELEQLYQDQEVPKPKSWGGYVLYPQVMEFWQGQTNRLHDRIVFRRGLPTGDSPLGPMTHRGEEDWLYERLAP,PF10590;PF01243;,1NRG;3HY8;6H00;,229,R,W,True,935
13608,10277,135427,single nucleotide variant,NM_018129.4(PNPO):c.347G>A (p.Arg116Gln),55163,PNPO,HGNC:30260,Benign,0,13-Jan-18,17679445,-,RCV000118002|RCV000357367|RCV000715529,"MedGen:CN169374|MONDO:MONDO:0012407,MedGen:C1864723,OMIM:610090,Orphanet:79096|Human Phenotype Ontology:HP:0001250,Human Phenotype Ontology:HP:0001275,Human Phenotype Ontology:HP:0001303,Human Phenotype Ontology:HP:0002125,Human Phenotype Ontology:HP:0002182,Human Phenotype Ontology:HP:0002279,Human Phenotype Ontology:HP:0002306,Human Phenotype Ontology:HP:0002348,Human Phenotype Ontology:HP:0002391,Human Phenotype Ontology:HP:0002417,Human Phenotype Ontology:HP:0002430,Human Phenotype Ontology:HP:0002431,Human Phenotype Ontology:HP:0002432,Human Phenotype Ontology:HP:0002434,Human Phenotype Ontology:HP:0002437,Human Phenotype Ontology:HP:0002466,Human Phenotype Ontology:HP:0002479,Human Phenotype Ontology:HP:0002794,Human Phenotype Ontology:HP:0006997,Human Phenotype Ontology:HP:0010520,MedGen:C0036572",not specified|Pyridoxal phosphate-responsive seizures|Seizures,germline,germline,GRCh38,NC_000017.11,17,47944699,47944699,na,na,17q21.32,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA154714,UniProtKB:Q9NVS9#VAR_029359",2,129981,47944699,G,A,R116Q,2,benign,benign,Q9NVS9,Q9NVS9,reviewed,PNPO_HUMAN,"Pyridoxine-5'-phosphate oxidase, EC 1.4.3.5 (Pyridoxamine-phosphate oxidase)",PNPO,Homo sapiens (Human),261.0,MTCWLRGVTATFGRPAEWPGYLSHLCGRSAAMDLGPMRKSYRGDREAFEETHLTSLDPVKQFAAWFEEAVQCPDIGEANAMCLATCTRDGKPSARMLLLKGFGKDGFRFFTNFESRKGKELDSNPFASLVFYWEPLNRQVRVEGPVKKLPEEEAECYFHSRPKSSQIGAVVSHQSSVIPDREYLRKKNEELEQLYQDQEVPKPKSWGGYVLYPQVMEFWQGQTNRLHDRIVFRRGLPTGDSPLGPMTHRGEEDWLYERLAP,PF10590;PF01243;,1NRG;3HY8;6H00;,116,R,Q,True,935
13609,12087,203475,single nucleotide variant,NM_018129.4(PNPO):c.148G>A (p.Glu50Lys),55163,PNPO,HGNC:30260,Uncertain significance,0,8-Sep-19,549477447,-,RCV000188488|RCV001042917,"MedGen:CN517202|MONDO:MONDO:0012407,MedGen:C1864723,OMIM:610090,Orphanet:79096",not provided|Pyridoxal phosphate-responsive seizures,germline,germline,GRCh38,NC_000017.11,17,47943315,47943315,na,na,17q21.32,"criteria provided, multiple submitters, no conflicts",2,-,N,"UniProtKB:Q9NVS9#VAR_029358,ClinGen:CA316546",2,206440,47943315,G,A,E50K,2,uncertain,uncertain,Q9NVS9,Q9NVS9,reviewed,PNPO_HUMAN,"Pyridoxine-5'-phosphate oxidase, EC 1.4.3.5 (Pyridoxamine-phosphate oxidase)",PNPO,Homo sapiens (Human),261.0,MTCWLRGVTATFGRPAEWPGYLSHLCGRSAAMDLGPMRKSYRGDREAFEETHLTSLDPVKQFAAWFEEAVQCPDIGEANAMCLATCTRDGKPSARMLLLKGFGKDGFRFFTNFESRKGKELDSNPFASLVFYWEPLNRQVRVEGPVKKLPEEEAECYFHSRPKSSQIGAVVSHQSSVIPDREYLRKKNEELEQLYQDQEVPKPKSWGGYVLYPQVMEFWQGQTNRLHDRIVFRRGLPTGDSPLGPMTHRGEEDWLYERLAP,PF10590;PF01243;,1NRG;3HY8;6H00;,50,E,K,True,935
13610,13515,260283,single nucleotide variant,NM_000074.2(CD40LG):c.431G>A (p.Gly144Glu),959,CD40LG,HGNC:11935,Likely pathogenic,1,29-Apr-16,886039326,-,RCV000255078,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000023.11,X,136659060,136659060,na,na,Xq26.3,"criteria provided, single submitter",1,-,N,"ClinGen:CA10588744,UniProtKB:P29965#VAR_007520",2,265075,136659060,G,A,G144E,1,pathogenic,pathogenic,P29965,P29965,reviewed,CD40L_HUMAN,"CD40 ligand, CD40-L (T-cell antigen Gp39) (TNF-related activation protein, TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form, sCD40L ]",CD40LG CD40L TNFSF5 TRAP,Homo sapiens (Human),261.0,MIETYNQTSPRSAATGLPISMKIFMYLLTVFLITQMIGSALFAVYLHRRLDKIEDERNLHEDFVFMKTIQRCNTGERSLSLLNCEEIKSQFEGFVKDIMLNKEETKKENSFEMQKGDQNPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVSHGTGFTSFGLLKL,PF00229;,1ALY;1I9R;3LKJ;3QD6;6BRB;6W9G;,144,G,E,True,936
13611,2759,26203,single nucleotide variant,NM_000074.2(CD40LG):c.418T>G (p.Trp140Gly),959,CD40LG,HGNC:11935,Likely pathogenic,1,8-Jun-16,104894777,-,RCV000011914|RCV000256172,"MONDO:MONDO:0010626,MedGen:C0398689,OMIM:308230,Orphanet:101088|MedGen:CN517202",Hyper-IgM syndrome type 1|not provided,germline,germline,GRCh38,NC_000023.11,X,136659047,136659047,na,na,Xq26.3,"criteria provided, single submitter",2,-,N,"OMIM:300386.0008,ClinGen:CA255754,UniProtKB:P29965#VAR_007518",3,11164,136659047,T,G,W140G,1,pathogenic,pathogenic,P29965,P29965,reviewed,CD40L_HUMAN,"CD40 ligand, CD40-L (T-cell antigen Gp39) (TNF-related activation protein, TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form, sCD40L ]",CD40LG CD40L TNFSF5 TRAP,Homo sapiens (Human),261.0,MIETYNQTSPRSAATGLPISMKIFMYLLTVFLITQMIGSALFAVYLHRRLDKIEDERNLHEDFVFMKTIQRCNTGERSLSLLNCEEIKSQFEGFVKDIMLNKEETKKENSFEMQKGDQNPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVSHGTGFTSFGLLKL,PF00229;,1ALY;1I9R;3LKJ;3QD6;6BRB;6W9G;,140,W,G,True,936
13612,2755,26196,single nucleotide variant,NM_000074.2(CD40LG):c.703G>C (p.Ala235Pro),959,CD40LG,HGNC:11935,Pathogenic,1,29-Jan-93,104894771,-,RCV000011907,"MONDO:MONDO:0010626,MedGen:C0398689,OMIM:308230,Orphanet:101088",Hyper-IgM syndrome type 1,germline,germline,GRCh38,NC_000023.11,X,136659332,136659332,na,na,Xq26.3,no assertion criteria provided,1,-,N,"ClinGen:CA255743,UniProtKB:P29965#VAR_007527,OMIM:300386.0001",1,11157,136659332,G,C,A235P,0,pathogenic,uncertain,P29965,P29965,reviewed,CD40L_HUMAN,"CD40 ligand, CD40-L (T-cell antigen Gp39) (TNF-related activation protein, TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form, sCD40L ]",CD40LG CD40L TNFSF5 TRAP,Homo sapiens (Human),261.0,MIETYNQTSPRSAATGLPISMKIFMYLLTVFLITQMIGSALFAVYLHRRLDKIEDERNLHEDFVFMKTIQRCNTGERSLSLLNCEEIKSQFEGFVKDIMLNKEETKKENSFEMQKGDQNPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVSHGTGFTSFGLLKL,PF00229;,1ALY;1I9R;3LKJ;3QD6;6BRB;6W9G;,235,A,P,True,936
13613,6138,44478,single nucleotide variant,NM_000074.2(CD40LG):c.761C>T (p.Thr254Met),959,CD40LG,HGNC:11935,Pathogenic,1,3-Nov-19,193922136,-,RCV000029466|RCV000588005,"MONDO:MONDO:0010626,MedGen:C0398689,OMIM:308230,Orphanet:101088|MONDO:MONDO:0003947,MedGen:C0272236,OMIM:PS308230",Hyper-IgM syndrome type 1|Hyperimmunoglobulin M syndrome,germline,germline,GRCh38,NC_000023.11,X,136659390,136659390,na,na,Xq26.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA260209,UniProtKB:P29965#VAR_007528",3,35814,136659390,C,T,T254M,2,pathogenic,pathogenic,P29965,P29965,reviewed,CD40L_HUMAN,"CD40 ligand, CD40-L (T-cell antigen Gp39) (TNF-related activation protein, TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form, sCD40L ]",CD40LG CD40L TNFSF5 TRAP,Homo sapiens (Human),261.0,MIETYNQTSPRSAATGLPISMKIFMYLLTVFLITQMIGSALFAVYLHRRLDKIEDERNLHEDFVFMKTIQRCNTGERSLSLLNCEEIKSQFEGFVKDIMLNKEETKKENSFEMQKGDQNPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVSHGTGFTSFGLLKL,PF00229;,1ALY;1I9R;3LKJ;3QD6;6BRB;6W9G;,254,T,M,True,936
13614,2756,26198,single nucleotide variant,NM_000074.2(CD40LG):c.680G>T (p.Gly227Val),959,CD40LG,HGNC:11935,Pathogenic,1,12-Feb-93,104894768,-,RCV000011909,"MONDO:MONDO:0010626,MedGen:C0398689,OMIM:308230,Orphanet:101088",Hyper-IgM syndrome type 1,germline,germline,GRCh38,NC_000023.11,X,136659309,136659309,na,na,Xq26.3,no assertion criteria provided,1,-,N,"ClinGen:CA255745,UniProtKB:P29965#VAR_007524,OMIM:300386.0003",1,11159,136659309,G,T,G227V,0,pathogenic,uncertain,P29965,P29965,reviewed,CD40L_HUMAN,"CD40 ligand, CD40-L (T-cell antigen Gp39) (TNF-related activation protein, TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form, sCD40L ]",CD40LG CD40L TNFSF5 TRAP,Homo sapiens (Human),261.0,MIETYNQTSPRSAATGLPISMKIFMYLLTVFLITQMIGSALFAVYLHRRLDKIEDERNLHEDFVFMKTIQRCNTGERSLSLLNCEEIKSQFEGFVKDIMLNKEETKKENSFEMQKGDQNPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVSHGTGFTSFGLLKL,PF00229;,1ALY;1I9R;3LKJ;3QD6;6BRB;6W9G;,227,G,V,True,936
13615,2757,26199,single nucleotide variant,NM_000074.2(CD40LG):c.464T>C (p.Leu155Pro),959,CD40LG,HGNC:11935,Pathogenic,1,12-Feb-93,104894769,-,RCV000011910,"MONDO:MONDO:0010626,MedGen:C0398689,OMIM:308230,Orphanet:101088",Hyper-IgM syndrome type 1,germline,germline,GRCh38,NC_000023.11,X,136659093,136659093,na,na,Xq26.3,no assertion criteria provided,1,-,N,"ClinGen:CA255747,UniProtKB:P29965#VAR_007521,OMIM:300386.0004",1,11160,136659093,T,C,L155P,0,pathogenic,uncertain,P29965,P29965,reviewed,CD40L_HUMAN,"CD40 ligand, CD40-L (T-cell antigen Gp39) (TNF-related activation protein, TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form, sCD40L ]",CD40LG CD40L TNFSF5 TRAP,Homo sapiens (Human),261.0,MIETYNQTSPRSAATGLPISMKIFMYLLTVFLITQMIGSALFAVYLHRRLDKIEDERNLHEDFVFMKTIQRCNTGERSLSLLNCEEIKSQFEGFVKDIMLNKEETKKENSFEMQKGDQNPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVSHGTGFTSFGLLKL,PF00229;,1ALY;1I9R;3LKJ;3QD6;6BRB;6W9G;,155,L,P,True,936
13616,2758,26201,single nucleotide variant,NM_000074.2(CD40LG):c.107T>G (p.Met36Arg),959,CD40LG,HGNC:11935,Likely pathogenic,1,10-Oct-19,104894774,-,RCV000011912,"MONDO:MONDO:0010626,MedGen:C0398689,OMIM:308230,Orphanet:101088",Hyper-IgM syndrome type 1,germline,germline,GRCh38,NC_000023.11,X,136648355,136648355,na,na,Xq26.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA255749,UniProtKB:P29965#VAR_007513,OMIM:300386.0006",3,11162,136648355,T,G,M36R,2,pathogenic,pathogenic,P29965,P29965,reviewed,CD40L_HUMAN,"CD40 ligand, CD40-L (T-cell antigen Gp39) (TNF-related activation protein, TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form, sCD40L ]",CD40LG CD40L TNFSF5 TRAP,Homo sapiens (Human),261.0,MIETYNQTSPRSAATGLPISMKIFMYLLTVFLITQMIGSALFAVYLHRRLDKIEDERNLHEDFVFMKTIQRCNTGERSLSLLNCEEIKSQFEGFVKDIMLNKEETKKENSFEMQKGDQNPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVSHGTGFTSFGLLKL,PF00229;,1ALY;1I9R;3LKJ;3QD6;6BRB;6W9G;,36,M,R,True,936
13617,6137,44477,single nucleotide variant,NM_000074.2(CD40LG):c.655G>A (p.Gly219Arg),959,CD40LG,HGNC:11935,Benign/Likely benign,0,31-Dec-19,148594123,-,RCV000029465|RCV000358482,"MONDO:MONDO:0010626,MedGen:C0398689,OMIM:308230,Orphanet:101088|MedGen:CN169374",Hyper-IgM syndrome type 1|not specified,germline,germline,GRCh38,NC_000023.11,X,136659284,136659284,na,na,Xq26.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA260206,UniProtKB:P29965#VAR_007523",2,35813,136659284,G,A,G219R,2,benign,benign,P29965,P29965,reviewed,CD40L_HUMAN,"CD40 ligand, CD40-L (T-cell antigen Gp39) (TNF-related activation protein, TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form, sCD40L ]",CD40LG CD40L TNFSF5 TRAP,Homo sapiens (Human),261.0,MIETYNQTSPRSAATGLPISMKIFMYLLTVFLITQMIGSALFAVYLHRRLDKIEDERNLHEDFVFMKTIQRCNTGERSLSLLNCEEIKSQFEGFVKDIMLNKEETKKENSFEMQKGDQNPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVSHGTGFTSFGLLKL,PF00229;,1ALY;1I9R;3LKJ;3QD6;6BRB;6W9G;,219,G,R,True,936
13618,2760,26207,single nucleotide variant,NM_000074.2(CD40LG):c.368C>A (p.Ala123Glu),959,CD40LG,HGNC:11935,Pathogenic,1,5-Jun-18,104894778,-,RCV000011918,"MONDO:MONDO:0010626,MedGen:C0398689,OMIM:308230,Orphanet:101088",Hyper-IgM syndrome type 1,germline,germline,GRCh38,NC_000023.11,X,136656377,136656377,na,na,Xq26.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA255756,UniProtKB:P29965#VAR_007514,OMIM:300386.0012",3,11168,136656377,C,A,A123E,1,pathogenic,pathogenic,P29965,P29965,reviewed,CD40L_HUMAN,"CD40 ligand, CD40-L (T-cell antigen Gp39) (TNF-related activation protein, TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form, sCD40L ]",CD40LG CD40L TNFSF5 TRAP,Homo sapiens (Human),261.0,MIETYNQTSPRSAATGLPISMKIFMYLLTVFLITQMIGSALFAVYLHRRLDKIEDERNLHEDFVFMKTIQRCNTGERSLSLLNCEEIKSQFEGFVKDIMLNKEETKKENSFEMQKGDQNPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVSHGTGFTSFGLLKL,PF00229;,1ALY;1I9R;3LKJ;3QD6;6BRB;6W9G;,123,A,E,True,936
13619,3273,27982,single nucleotide variant,NM_003124.5(SPR):c.488C>T (p.Pro163Leu),6697,SPR,HGNC:11257,Pathogenic,1,1-Sep-06,104893666,-,RCV000013806,"MONDO:MONDO:0012994,MedGen:C0268468,OMIM:612716,Orphanet:70594",Dopa-responsive dystonia due to sepiapterin reductase deficiency,germline,germline,GRCh38,NC_000002.12,2,72888497,72888497,na,na,2p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA122794,UniProtKB:P35270#VAR_058008,OMIM:182125.0005",1,12943,72888497,C,T,P163L,0,pathogenic,uncertain,P35270,P35270,reviewed,SPRE_HUMAN,"Sepiapterin reductase, SPR, EC 1.1.1.153",SPR,Homo sapiens (Human),261.0,MEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK,PF00106;,1Z6Z;4HWK;4J7U;4J7X;4XWY;4Z3K;6I6C;6I6F;6I6P;6I6T;6I6V;6I79;6USN;7DSF;,163,P,L,True,937
13620,3272,27980,single nucleotide variant,NM_003124.5(SPR):c.448A>G (p.Arg150Gly),6697,SPR,HGNC:11257,Pathogenic,1,15-Nov-19,104893665,-,RCV000013804|RCV000498846|RCV000803472,"MONDO:MONDO:0012994,MedGen:C0268468,OMIM:612716,Orphanet:70594|MedGen:CN517202|Human Phenotype Ontology:HP:0001332,Human Phenotype Ontology:HP:0002328,MONDO:MONDO:0003441,MedGen:C0393593,OMIM:PS128100",Dopa-responsive dystonia due to sepiapterin reductase deficiency|not provided|Dystonia,germline;unknown,germline,GRCh38,NC_000002.12,2,72888457,72888457,na,na,2p13.2,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA122793,UniProtKB:P35270#VAR_058007,OMIM:182125.0003",3,12941,72888457,A,G,R150G,2,pathogenic,pathogenic,P35270,P35270,reviewed,SPRE_HUMAN,"Sepiapterin reductase, SPR, EC 1.1.1.153",SPR,Homo sapiens (Human),261.0,MEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK,PF00106;,1Z6Z;4HWK;4J7U;4J7X;4XWY;4Z3K;6I6C;6I6F;6I6P;6I6T;6I6V;6I79;6USN;7DSF;,150,R,G,True,937
13621,6581,49382,single nucleotide variant,NM_001242.4(CD27):c.158G>A (p.Cys53Tyr),939,CD27,HGNC:11922,Pathogenic,1,1-May-20,397514667,-,RCV000033860|RCV001091139,"MONDO:MONDO:0014054,MedGen:C3554540,OMIM:615122,Orphanet:238505|MedGen:CN517202",Lymphoproliferative syndrome 2|not provided,germline,germline,GRCh38,NC_000012.12,12,6445445,6445445,na,na,12p13.31,"criteria provided, single submitter",2,-,N,"ClinGen:CA130832,UniProtKB:P26842#VAR_069793,OMIM:186711.0002",3,40890,6445445,G,A,C53Y,1,pathogenic,pathogenic,P26842,P26842,reviewed,CD27_HUMAN,CD27 antigen (CD27L receptor) (T-cell activation antigen CD27) (T14) (Tumor necrosis factor receptor superfamily member 7) (CD antigen CD27),CD27 TNFRSF7,Homo sapiens (Human),260.0,MARPHPWWLCVLGTLVGLSATPAPKSCPERHYWAQGKLCCQMCEPGTFLVKDCDQHRKAAQCDPCIPGVSFSPDHHTRPHCESCRHCNSGLLVRNCTITANAECACRNGWQCRDKECTECDPLPNPSLTARSSQALSPHPQPTHLPYVSEMLEARTAGHMQTLADFRQLPARTLSTHWPPQRSLCSSDFIRILVIFSGMFLVFTLAGALFLHQRRKYRSNKGESPVEPAEPCHYSCPREEEGSTIPIQEDYRKPEPACSP,PF00020;,5TL5;5TLJ;5TLK;7KX0;,53,C,Y,True,938
13622,2959,27130,single nucleotide variant,NM_001724.5(BPGM):c.268C>T (p.Arg90Cys),669,BPGM,HGNC:1093,Pathogenic,1,15-Nov-92,121964925,-,RCV000012872,"MONDO:MONDO:0009113,MedGen:C1291620,OMIM:222800,Orphanet:714",Deficiency of bisphosphoglycerate mutase,germline,germline,GRCh38,NC_000007.14,7,134661775,134661775,na,na,7q33,no assertion criteria provided,1,-,N,"ClinGen:CA212935,UniProtKB:P07738#VAR_065368,OMIM:613896.0001",1,12091,134661775,C,T,R90C,0,pathogenic,uncertain,P07738,P07738,reviewed,PMGE_HUMAN,"Bisphosphoglycerate mutase, BPGM, EC 5.4.2.4 (2,3-bisphosphoglycerate mutase, erythrocyte) (2,3-bisphosphoglycerate synthase, EC 5.4.2.11) (2,3-diphosphoglycerate mutase, DPGM) (BPG-dependent PGAM)",BPGM,Homo sapiens (Human),259.0,MSKYKLIMLRHGEGAWNKENRFCSWVDQKLNSEGMEEARNCGKQLKALNFEFDLVFTSVLNRSIHTAWLILEELGQEWVPVESSWRLNERHYGALIGLNREQMALNHGEEQVRLWRRSYNVTPPPIEESHPYYQEIYNDRRYKVCDVPLDQLPRSESLKDVLERLLPYWNERIAPEVLRGKTILISAHGNSSRALLKHLEGISDEDIINITLPTGVPILLELDENLRAVGPHQFLGDQEAIQAAIKKVEDQGKVKQAKK,PF00300;,1T8P;2A9J;2F90;2H4X;2H4Z;2H52;2HHJ;3NFY;7THI;,90,R,C,True,939
13623,112,15451,single nucleotide variant,NM_003730.6(RNASET2):c.550T>C (p.Cys184Arg),8635,RNASET2,HGNC:21686,Pathogenic,1,1-Jul-09,121918137,-,RCV000000440,"MONDO:MONDO:0013058,MedGen:C2751843,OMIM:612951,Orphanet:85136","Leukoencephalopathy, cystic, without megalencephaly",germline,germline,GRCh38,NC_000006.12,6,166931061,166931061,na,na,6q27,no assertion criteria provided,1,-,N,"ClinGen:CA114257,UniProtKB:O00584#VAR_063596,OMIM:612944.0001",1,412,166931061,A,G,C184R,0,pathogenic,uncertain,O00584,O00584,reviewed,RNT2_HUMAN,"Ribonuclease T2, EC 4.6.1.19 (Ribonuclease 6)",RNASET2 RNASE6PL,Homo sapiens (Human),256.0,MRPAALRGALLGCLCLALLCLGGADKRLRDNHEWKKLIMVQHWPETVCEKIQNDCRDPPDYWTIHGLWPDKSEGCNRSWPFNLEEIKDLLPEMRAYWPDVIHSFPNRSRFWKHEWEKHGTCAAQVDALNSQKKYFGRSLELYRELDLNSVLLKLGIKPSINYYQVADFKDALARVYGVIPKIQCLPPSQDEEVQTIGQIELCLTKQDQQLQNCTEPGEQPSPKQEVWLANGAAESRGLRVCEDGPVFYPPPKKTKH,PF00445;,3T0O;,184,C,R,True,940
13624,13875,302139,single nucleotide variant,NM_003730.6(RNASET2):c.706C>T (p.Arg236Trp),8635,RNASET2,HGNC:21686,Benign,0,12-Jan-18,11159,-,RCV000305139,"MONDO:MONDO:0013058,MedGen:C2751843,OMIM:612951,Orphanet:85136","Leukoencephalopathy, cystic, without megalencephaly",germline,germline,GRCh38,NC_000006.12,6,166929653,166929653,na,na,6q27,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA4094807,UniProtKB:O00584#VAR_013004",2,356027,166929653,G,A,R236W,2,benign,benign,O00584,O00584,reviewed,RNT2_HUMAN,"Ribonuclease T2, EC 4.6.1.19 (Ribonuclease 6)",RNASET2 RNASE6PL,Homo sapiens (Human),256.0,MRPAALRGALLGCLCLALLCLGGADKRLRDNHEWKKLIMVQHWPETVCEKIQNDCRDPPDYWTIHGLWPDKSEGCNRSWPFNLEEIKDLLPEMRAYWPDVIHSFPNRSRFWKHEWEKHGTCAAQVDALNSQKKYFGRSLELYRELDLNSVLLKLGIKPSINYYQVADFKDALARVYGVIPKIQCLPPSQDEEVQTIGQIELCLTKQDQQLQNCTEPGEQPSPKQEVWLANGAAESRGLRVCEDGPVFYPPPKKTKH,PF00445;,3T0O;,236,R,W,True,940
13625,9099,99920,single nucleotide variant,NM_001985.3(ETFB):c.461C>T (p.Thr154Met),2109,ETFB,HGNC:3482,Benign,0,28-May-19,1130426,-,RCV000079961|RCV000676879|RCV000991043,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0009282,MedGen:C0268596,OMIM:231680,Orphanet:26791",not specified|not provided|Multiple acyl-CoA dehydrogenase deficiency,germline;unknown,germline,GRCh38,NC_000019.10,19,51347036,51347036,na,na,19q13.41,"criteria provided, multiple submitters, no conflicts",3,-,N,"UniProtKB:P38117#VAR_008548,ClinGen:CA147539",2,94018,51347036,G,A,T154M,2,benign,benign,P38117,P38117,reviewed,ETFB_HUMAN,"Electron transfer flavoprotein subunit beta, Beta-ETF",ETFB FP585,Homo sapiens (Human),255.0,MAELRVLVAVKRVIDYAVKIRVKPDRTGVVTDGVKHSMNPFCEIAVEEAVRLKEKKLVKEVIAVSCGPAQCQETIRTALAMGADRGIHVEVPPAEAERLGPLQVARVLAKLAEKEKVDLVLLGKQAIDDDCNQTGQMTAGFLDWPQGTFASQVTLEGDKLKVEREIDGGLETLRLKLPAVVTADLRLNEPRYATLPNIMKAKKKKIEVIKPGDLGVDLTSKLSVISVEDPPQRTAGVKVETTEDLVAKLKEIGRI,PF01012;,1EFV;1T9G;2A1T;2A1U;,154,T,M,True,941
13626,4727,31755,single nucleotide variant,NM_001985.3(ETFB):c.491G>A (p.Arg164Gln),2109,ETFB,HGNC:3482,Likely pathogenic,1,31-Jul-19,104894677,-,RCV000018200|RCV001235936,"MedGen:C3278155|MONDO:MONDO:0009282,MedGen:C0268596,OMIM:231680,Orphanet:26791",Glutaric acidemia IIB|Multiple acyl-CoA dehydrogenase deficiency,germline,germline,GRCh38,NC_000019.10,19,51347006,51347006,na,na,19q13.41,"criteria provided, single submitter",2,-,N,"ClinGen:CA126841,UniProtKB:P38117#VAR_002369,OMIM:130410.0001",3,16716,51347006,C,T,R164Q,1,pathogenic,pathogenic,P38117,P38117,reviewed,ETFB_HUMAN,"Electron transfer flavoprotein subunit beta, Beta-ETF",ETFB FP585,Homo sapiens (Human),255.0,MAELRVLVAVKRVIDYAVKIRVKPDRTGVVTDGVKHSMNPFCEIAVEEAVRLKEKKLVKEVIAVSCGPAQCQETIRTALAMGADRGIHVEVPPAEAERLGPLQVARVLAKLAEKEKVDLVLLGKQAIDDDCNQTGQMTAGFLDWPQGTFASQVTLEGDKLKVEREIDGGLETLRLKLPAVVTADLRLNEPRYATLPNIMKAKKKKIEVIKPGDLGVDLTSKLSVISVEDPPQRTAGVKVETTEDLVAKLKEIGRI,PF01012;,1EFV;1T9G;2A1T;2A1U;,164,R,Q,True,941
13627,4728,31757,single nucleotide variant,NM_001985.3(ETFB):c.382G>A (p.Asp128Asn),2109,ETFB,HGNC:3482,Pathogenic,1,1-Jul-03,104894678,-,RCV000018202,MedGen:C3278155,Glutaric acidemia IIB,germline,germline,GRCh38,NC_000019.10,19,51350385,51350385,na,na,19q13.41,no assertion criteria provided,1,-,N,"ClinGen:CA126842,UniProtKB:P38117#VAR_025804,OMIM:130410.0003",1,16718,51350385,C,T,D128N,0,pathogenic,uncertain,P38117,P38117,reviewed,ETFB_HUMAN,"Electron transfer flavoprotein subunit beta, Beta-ETF",ETFB FP585,Homo sapiens (Human),255.0,MAELRVLVAVKRVIDYAVKIRVKPDRTGVVTDGVKHSMNPFCEIAVEEAVRLKEKKLVKEVIAVSCGPAQCQETIRTALAMGADRGIHVEVPPAEAERLGPLQVARVLAKLAEKEKVDLVLLGKQAIDDDCNQTGQMTAGFLDWPQGTFASQVTLEGDKLKVEREIDGGLETLRLKLPAVVTADLRLNEPRYATLPNIMKAKKKKIEVIKPGDLGVDLTSKLSVISVEDPPQRTAGVKVETTEDLVAKLKEIGRI,PF01012;,1EFV;1T9G;2A1T;2A1U;,128,D,N,True,941
13628,10738,142219,single nucleotide variant,NM_001002755.4(NFU1):c.74T>A (p.Met25Lys),27247,NFU1,HGNC:16287,Benign,0,12-Jan-18,4453725,-,RCV000127198|RCV000294034|RCV000676267,"MedGen:CN169374|MONDO:MONDO:0011582,MedGen:C3276432,OMIM:605711,Orphanet:401869|MedGen:CN517202",not specified|Multiple mitochondrial dysfunctions syndrome 1|not provided,germline;unknown,germline,GRCh38,NC_000002.12,2,69431994,69431994,na,na,2p13.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA292533,UniProtKB:Q9UMS0#VAR_044429",2,138516,69431994,A,T,M25K,2,benign,benign,Q9UMS0,Q9UMS0,reviewed,NFU1_HUMAN,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial (HIRA-interacting protein 5)",NFU1 HIRIP5 CGI-33,Homo sapiens (Human),254.0,MAATARRGWGAAAVAAGLRRRFCHMLKNPYTIKKQPLHQFVQRPLFPLPAAFYHPVRYMFIQTQDTPNPNSLKFIPGKPVLETRTMDFPTPAAAFRSPLARQLFRIEGVKSVFFGPDFITVTKENEELDWNLLKPDIYATIMDFFASGLPLVTEETPSGEAGSEEDDEVVAMIKELLDTRIRPTVQEDGGDVIYKGFEDGIVQLKLQGSCTSCPSSIITLKNGIQNMLQFYIPEVEGVEQVMDDESDEKEANSP,PF08712;PF01106;,2LTM;2M5O;,25,M,K,True,942
13629,6018,39657,single nucleotide variant,NM_001002755.4(NFU1):c.622G>T (p.Gly208Cys),27247,NFU1,HGNC:16287,Pathogenic,1,10-Jul-19,374514431,-,RCV000023678|RCV000385109,"MONDO:MONDO:0011582,MedGen:C3276432,OMIM:605711,Orphanet:401869|MedGen:CN517202",Multiple mitochondrial dysfunctions syndrome 1|not provided,germline;unknown,germline,GRCh38,NC_000002.12,2,69400462,69400462,na,na,2p13.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA129406,UniProtKB:Q9UMS0#VAR_066639,OMIM:608100.0002",3,30700,69400462,C,A,G208C,2,pathogenic,pathogenic,Q9UMS0,Q9UMS0,reviewed,NFU1_HUMAN,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial (HIRA-interacting protein 5)",NFU1 HIRIP5 CGI-33,Homo sapiens (Human),254.0,MAATARRGWGAAAVAAGLRRRFCHMLKNPYTIKKQPLHQFVQRPLFPLPAAFYHPVRYMFIQTQDTPNPNSLKFIPGKPVLETRTMDFPTPAAAFRSPLARQLFRIEGVKSVFFGPDFITVTKENEELDWNLLKPDIYATIMDFFASGLPLVTEETPSGEAGSEEDDEVVAMIKELLDTRIRPTVQEDGGDVIYKGFEDGIVQLKLQGSCTSCPSSIITLKNGIQNMLQFYIPEVEGVEQVMDDESDEKEANSP,PF08712;PF01106;,2LTM;2M5O;,208,G,C,True,942
13630,2761,26217,single nucleotide variant,NM_000117.2(EMD):c.548C>A (p.Pro183His),2010,EMD,HGNC:3331,Pathogenic,1,30-Sep-19,104894805,-,RCV001224353,"MONDO:MONDO:0010680,MedGen:C0751337,OMIM:310300,Orphanet:261,Orphanet:98863","Emery-Dreifuss muscular dystrophy 1, X-linked",germline,germline,GRCh38,NC_000023.11,X,154380980,154380980,na,na,Xq28,"criteria provided, single submitter",2,-,N,"ClinGen:CA121387,UniProtKB:P50402#VAR_005199,OMIM:300384.0008",3,11178,154380980,C,A,P183H,1,pathogenic,pathogenic,P50402,P50402,reviewed,EMD_HUMAN,Emerin,EMD EDMD STA,Homo sapiens (Human),254.0,MDNYADLSDTELTTLLRRYNIPHGPVVGSTRRLYEKKIFEYETQRRRLSPPSSSAASSYSFSDLNSTRGDADMYDLPKKEDALLYQSKGYNDDYYEESYFTTRTYGEPESAGPSRAVRQSVTSFPDADAFHHQVHDDDLLSSSEEECKDRERPMYGRDSAYQSITHYRPVSASRSSLDLSYYPTSSSTSFMSSSSSSSSWLTRRAIRPENRAPGAGLGQDRQVPLWGQLLLFLVFVIVLFFIYHFMQAEEGNPF,PF03020;,1JEI;2ODC;2ODG;6GHD;6RPR;7NDY;,183,P,H,True,943
13631,12875,243779,single nucleotide variant,NM_000117.2(EMD):c.445G>C (p.Asp149His),2010,EMD,HGNC:3331,Benign/Likely benign,0,1-Nov-20,2070818,-,RCV000230785|RCV000594536|RCV000853050|RCV001271615|RCV001310759,"MONDO:MONDO:0010680,MedGen:C0751337,OMIM:310300,Orphanet:261,Orphanet:98863|MedGen:CN169374|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0016830,MedGen:C0410189,OMIM:PS310300,Orphanet:261|MedGen:CN517202","Emery-Dreifuss muscular dystrophy 1, X-linked|not specified|Cardiomyopathy|Emery-Dreifuss muscular dystrophy|not provided",germline,germline,GRCh38,NC_000023.11,X,154380798,154380798,na,na,Xq28,"criteria provided, multiple submitters, no conflicts",6,-,N,"UniProtKB:P50402#VAR_038433,ClinGen:CA10561608",2,237014,154380798,G,C,D149H,2,benign,benign,P50402,P50402,reviewed,EMD_HUMAN,Emerin,EMD EDMD STA,Homo sapiens (Human),254.0,MDNYADLSDTELTTLLRRYNIPHGPVVGSTRRLYEKKIFEYETQRRRLSPPSSSAASSYSFSDLNSTRGDADMYDLPKKEDALLYQSKGYNDDYYEESYFTTRTYGEPESAGPSRAVRQSVTSFPDADAFHHQVHDDDLLSSSEEECKDRERPMYGRDSAYQSITHYRPVSASRSSLDLSYYPTSSSTSFMSSSSSSSSWLTRRAIRPENRAPGAGLGQDRQVPLWGQLLLFLVFVIVLFFIYHFMQAEEGNPF,PF03020;,1JEI;2ODC;2ODG;6GHD;6RPR;7NDY;,149,D,H,True,943
13632,2762,26218,single nucleotide variant,NM_000117.2(EMD):c.547C>A (p.Pro183Thr),2010,EMD,HGNC:3331,Pathogenic,1,1-May-99,104894806,-,RCV000011929,"MONDO:MONDO:0010680,MedGen:C0751337,OMIM:310300,Orphanet:261,Orphanet:98863","Emery-Dreifuss muscular dystrophy 1, X-linked",germline,germline,GRCh38,NC_000023.11,X,154380979,154380979,na,na,Xq28,no assertion criteria provided,1,-,N,"OMIM:300384.0009,ClinGen:CA121389,UniProtKB:P50402#VAR_005200",1,11179,154380979,C,A,P183T,0,pathogenic,uncertain,P50402,P50402,reviewed,EMD_HUMAN,Emerin,EMD EDMD STA,Homo sapiens (Human),254.0,MDNYADLSDTELTTLLRRYNIPHGPVVGSTRRLYEKKIFEYETQRRRLSPPSSSAASSYSFSDLNSTRGDADMYDLPKKEDALLYQSKGYNDDYYEESYFTTRTYGEPESAGPSRAVRQSVTSFPDADAFHHQVHDDDLLSSSEEECKDRERPMYGRDSAYQSITHYRPVSASRSSLDLSYYPTSSSTSFMSSSSSSSSWLTRRAIRPENRAPGAGLGQDRQVPLWGQLLLFLVFVIVLFFIYHFMQAEEGNPF,PF03020;,1JEI;2ODC;2ODG;6GHD;6RPR;7NDY;,183,P,T,True,943
13633,6021,39682,single nucleotide variant,NM_014297.5(ETHE1):c.554T>G (p.Leu185Arg),23474,ETHE1,HGNC:23287,Pathogenic,1,5-Dec-19,387906987,-,RCV000023703,"MONDO:MONDO:0011229,MedGen:C1865349,OMIM:602473,Orphanet:51188",Ethylmalonic encephalopathy,germline;paternal,germline,GRCh38,NC_000019.10,19,43508816,43508816,na,na,19q13.31,"criteria provided, multiple submitters, no conflicts",5,-,N,"OMIM:608451.0008,ClinGen:CA129416,UniProtKB:O95571#VAR_023398",3,30725,43508816,A,C,L185R,2,pathogenic,pathogenic,O95571,O95571,reviewed,ETHE1_HUMAN,"Persulfide dioxygenase ETHE1, mitochondrial, EC 1.13.11.18 (Ethylmalonic encephalopathy protein 1) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)",ETHE1 HSCO,Homo sapiens (Human),254.0,MAEAVLRVARRQLSQRGGSGAPILLRQMFEPVSCTFTYLLGDRESREAVLIDPVLETAPRDAQLIKELGLRLLYAVNTHCHADHITGSGLLRSLLPGCQSVISRLSGAQADLHIEDGDSIRFGRFALETRASPGHTPGCVTFVLNDHSMAFTGDALLIRGCGRTDFQQGCAKTLYHSVHEKIFTLPGDCLIYPAHDYHGFTVSTVEEERTLNPRLTLSCEEFVKIMGNLNLPKPQQIDFAVPANMRCGVQTPTA,PF00753;,4CHL;,185,L,R,True,944
13634,605,17356,single nucleotide variant,NM_014297.5(ETHE1):c.487C>T (p.Arg163Trp),23474,ETHE1,HGNC:23287,Pathogenic,1,5-Jan-18,28940289,-,RCV000002407,"MONDO:MONDO:0011229,MedGen:C1865349,OMIM:602473,Orphanet:51188",Ethylmalonic encephalopathy,germline,germline,GRCh38,NC_000019.10,19,43511455,43511455,na,na,19q13.31,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA115479,UniProtKB:O95571#VAR_023397,OMIM:608451.0001",3,2317,43511455,G,A,R163W,2,pathogenic,pathogenic,O95571,O95571,reviewed,ETHE1_HUMAN,"Persulfide dioxygenase ETHE1, mitochondrial, EC 1.13.11.18 (Ethylmalonic encephalopathy protein 1) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)",ETHE1 HSCO,Homo sapiens (Human),254.0,MAEAVLRVARRQLSQRGGSGAPILLRQMFEPVSCTFTYLLGDRESREAVLIDPVLETAPRDAQLIKELGLRLLYAVNTHCHADHITGSGLLRSLLPGCQSVISRLSGAQADLHIEDGDSIRFGRFALETRASPGHTPGCVTFVLNDHSMAFTGDALLIRGCGRTDFQQGCAKTLYHSVHEKIFTLPGDCLIYPAHDYHGFTVSTVEEERTLNPRLTLSCEEFVKIMGNLNLPKPQQIDFAVPANMRCGVQTPTA,PF00753;,4CHL;,163,R,W,True,944
13635,12224,211889,single nucleotide variant,NM_014297.5(ETHE1):c.488G>A (p.Arg163Gln),23474,ETHE1,HGNC:23287,Pathogenic,1,31-Oct-18,745656120,-,RCV000276936,"MONDO:MONDO:0011229,MedGen:C1865349,OMIM:602473,Orphanet:51188",Ethylmalonic encephalopathy,germline;unknown,germline,GRCh38,NC_000019.10,19,43511454,43511454,na,na,19q13.31,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA320215,UniProtKB:O95571#VAR_069509",3,214322,43511454,C,T,R163Q,2,pathogenic,pathogenic,O95571,O95571,reviewed,ETHE1_HUMAN,"Persulfide dioxygenase ETHE1, mitochondrial, EC 1.13.11.18 (Ethylmalonic encephalopathy protein 1) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)",ETHE1 HSCO,Homo sapiens (Human),254.0,MAEAVLRVARRQLSQRGGSGAPILLRQMFEPVSCTFTYLLGDRESREAVLIDPVLETAPRDAQLIKELGLRLLYAVNTHCHADHITGSGLLRSLLPGCQSVISRLSGAQADLHIEDGDSIRFGRFALETRASPGHTPGCVTFVLNDHSMAFTGDALLIRGCGRTDFQQGCAKTLYHSVHEKIFTLPGDCLIYPAHDYHGFTVSTVEEERTLNPRLTLSCEEFVKIMGNLNLPKPQQIDFAVPANMRCGVQTPTA,PF00753;,4CHL;,163,R,Q,True,944
13636,5361,33500,single nucleotide variant,NM_024411.5(PDYN):c.634C>T (p.Arg212Trp),5173,PDYN,HGNC:8820,Pathogenic,1,12-Nov-10,201486601,-,RCV000018097,"MONDO:MONDO:0012449,MedGen:C1853250,OMIM:610245,Orphanet:101108",Spinocerebellar ataxia type 23,germline,germline,GRCh38,NC_000020.11,20,1980454,1980454,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA257557,UniProtKB:P01213#VAR_064915,OMIM:131340.0004",1,18461,1980454,G,A,R212W,0,pathogenic,uncertain,P01213,P01213,reviewed,PDYN_HUMAN,"Proenkephalin-B (Beta-neoendorphin-dynorphin) (Preprodynorphin) [Cleaved into: Alpha-neoendorphin; Beta-neoendorphin; Big dynorphin, Big Dyn; Dynorphin A(1-17), Dyn-A17, Dynorphin A; Dynorphin A(1-13); Dynorphin A(1-8); Leu-enkephalin; Rimorphin (Dynorphin B, Dyn-B) (Dynorphin B(1-13)); Leumorphin (Dynorphin B-29) ]",PDYN,Homo sapiens (Human),254.0,MAWQGLVLAACLLMFPSTTADCLSRCSLCAVKTQDGPKPINPLICSLQCQAALLPSEEWERCQSFLSFFTPSTLGLNDKEDLGSKSVGEGPYSELAKLSGSFLKELEKSKFLPSISTKENTLSKSLEEKLRGLSDGFREGAESELMRDAQLNDGAMETGTLYLAEEDPKEQVKRYGGFLRKYPKRSSEVAGEGDGDSMGHEDLYKRYGGFLRRIRPKLKWDNQKRYGGFLRRQFKVVTRSQEDPNAYSGELFDA,PF01160;,2N2F;,212,R,W,True,945
13637,5360,33499,single nucleotide variant,NM_024411.5(PDYN):c.632T>C (p.Leu211Ser),5173,PDYN,HGNC:8820,Uncertain significance,1,26-Mar-19,267606940,-,RCV000018096|RCV000992514,"MONDO:MONDO:0012449,MedGen:C1853250,OMIM:610245,Orphanet:101108|MedGen:CN517202",Spinocerebellar ataxia type 23|not provided,germline,germline,GRCh38,NC_000020.11,20,1980456,1980456,na,na,20p13,"criteria provided, single submitter",2,-,N,"ClinGen:CA257555,UniProtKB:P01213#VAR_064914,OMIM:131340.0003",3,18460,1980456,A,G,L211S,1,uncertain,uncertain,P01213,P01213,reviewed,PDYN_HUMAN,"Proenkephalin-B (Beta-neoendorphin-dynorphin) (Preprodynorphin) [Cleaved into: Alpha-neoendorphin; Beta-neoendorphin; Big dynorphin, Big Dyn; Dynorphin A(1-17), Dyn-A17, Dynorphin A; Dynorphin A(1-13); Dynorphin A(1-8); Leu-enkephalin; Rimorphin (Dynorphin B, Dyn-B) (Dynorphin B(1-13)); Leumorphin (Dynorphin B-29) ]",PDYN,Homo sapiens (Human),254.0,MAWQGLVLAACLLMFPSTTADCLSRCSLCAVKTQDGPKPINPLICSLQCQAALLPSEEWERCQSFLSFFTPSTLGLNDKEDLGSKSVGEGPYSELAKLSGSFLKELEKSKFLPSISTKENTLSKSLEEKLRGLSDGFREGAESELMRDAQLNDGAMETGTLYLAEEDPKEQVKRYGGFLRKYPKRSSEVAGEGDGDSMGHEDLYKRYGGFLRRIRPKLKWDNQKRYGGFLRRQFKVVTRSQEDPNAYSGELFDA,PF01160;,2N2F;,211,L,S,True,945
13638,5359,33498,single nucleotide variant,NM_024411.5(PDYN):c.643C>T (p.Arg215Cys),5173,PDYN,HGNC:8820,Pathogenic,1,12-Nov-10,267606939,-,RCV000018095,"MONDO:MONDO:0012449,MedGen:C1853250,OMIM:610245,Orphanet:101108",Spinocerebellar ataxia type 23,germline,germline,GRCh38,NC_000020.11,20,1980445,1980445,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA257553,UniProtKB:P01213#VAR_064916,OMIM:131340.0002",1,18459,1980445,G,A,R215C,0,pathogenic,uncertain,P01213,P01213,reviewed,PDYN_HUMAN,"Proenkephalin-B (Beta-neoendorphin-dynorphin) (Preprodynorphin) [Cleaved into: Alpha-neoendorphin; Beta-neoendorphin; Big dynorphin, Big Dyn; Dynorphin A(1-17), Dyn-A17, Dynorphin A; Dynorphin A(1-13); Dynorphin A(1-8); Leu-enkephalin; Rimorphin (Dynorphin B, Dyn-B) (Dynorphin B(1-13)); Leumorphin (Dynorphin B-29) ]",PDYN,Homo sapiens (Human),254.0,MAWQGLVLAACLLMFPSTTADCLSRCSLCAVKTQDGPKPINPLICSLQCQAALLPSEEWERCQSFLSFFTPSTLGLNDKEDLGSKSVGEGPYSELAKLSGSFLKELEKSKFLPSISTKENTLSKSLEEKLRGLSDGFREGAESELMRDAQLNDGAMETGTLYLAEEDPKEQVKRYGGFLRKYPKRSSEVAGEGDGDSMGHEDLYKRYGGFLRRIRPKLKWDNQKRYGGFLRRQFKVVTRSQEDPNAYSGELFDA,PF01160;,2N2F;,215,R,C,True,945
13639,5358,33497,single nucleotide variant,NM_024411.5(PDYN):c.414G>T (p.Arg138Ser),5173,PDYN,HGNC:8820,Pathogenic/Likely pathogenic,1,23-Oct-20,267606941,-,RCV000018094|RCV001268483,"MONDO:MONDO:0012449,MedGen:C1853250,OMIM:610245,Orphanet:101108|MedGen:CN517202",Spinocerebellar ataxia type 23|not provided,germline;unknown,germline,GRCh38,NC_000020.11,20,1980674,1980674,na,na,20p13,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA257551,UniProtKB:P01213#VAR_064913,OMIM:131340.0001",3,18458,1980674,C,A,R138S,2,pathogenic,pathogenic,P01213,P01213,reviewed,PDYN_HUMAN,"Proenkephalin-B (Beta-neoendorphin-dynorphin) (Preprodynorphin) [Cleaved into: Alpha-neoendorphin; Beta-neoendorphin; Big dynorphin, Big Dyn; Dynorphin A(1-17), Dyn-A17, Dynorphin A; Dynorphin A(1-13); Dynorphin A(1-8); Leu-enkephalin; Rimorphin (Dynorphin B, Dyn-B) (Dynorphin B(1-13)); Leumorphin (Dynorphin B-29) ]",PDYN,Homo sapiens (Human),254.0,MAWQGLVLAACLLMFPSTTADCLSRCSLCAVKTQDGPKPINPLICSLQCQAALLPSEEWERCQSFLSFFTPSTLGLNDKEDLGSKSVGEGPYSELAKLSGSFLKELEKSKFLPSISTKENTLSKSLEEKLRGLSDGFREGAESELMRDAQLNDGAMETGTLYLAEEDPKEQVKRYGGFLRKYPKRSSEVAGEGDGDSMGHEDLYKRYGGFLRRIRPKLKWDNQKRYGGFLRRQFKVVTRSQEDPNAYSGELFDA,PF01160;,2N2F;,138,R,S,True,945
13640,3465,28447,single nucleotide variant,NM_000311.5(PRNP):c.512A>G (p.Asn171Ser),5621,PRNP,HGNC:9449,Benign,0,30-Apr-20,16990018,-,RCV000014348|RCV000020247|RCV000644585|RCV001286750,"MONDO:MONDO:0011703,MedGen:C1847650,OMIM:606688|MONDO:MONDO:0017234,MedGen:CN043607,Orphanet:280400|MONDO:MONDO:0011299,MedGen:C1864112,OMIM:603218,Orphanet:157941|MedGen:CN235283",Spongiform encephalopathy with neuropsychiatric features|Genetic prion disease|Huntington disease-like 1|none provided,germline,germline,GRCh38,NC_000020.11,20,4699732,4699732,na,na,20p13,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA123092,UniProtKB:P04156#VAR_006468,OMIM:176640.0018",3,13408,4699732,A,G,N171S,2,benign,benign,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,171,N,S,True,946
13641,3459,28441,single nucleotide variant,NM_000311.5(PRNP):c.650A>G (p.Gln217Arg),5621,PRNP,HGNC:9449,Pathogenic,1,1-Apr-92,74315406,-,RCV000014341,"MONDO:MONDO:0007656,MedGen:C0017495,OMIM:137440,Orphanet:356",Gerstmann-Straussler-Scheinker syndrome,germline,germline,GRCh38,NC_000020.11,20,4699870,4699870,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA256780,UniProtKB:P04156#VAR_006476,OMIM:176640.0012",1,13402,4699870,A,G,Q217R,0,pathogenic,uncertain,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,217,Q,R,True,946
13642,8723,94480,single nucleotide variant,NM_000311.5(PRNP):c.631G>C (p.Glu211Gln),5621,PRNP,HGNC:9449,Pathogenic,1,15-Dec-12,398122370,-,RCV000074468,"MONDO:MONDO:0007403,MedGen:C0751254,OMIM:123400,Orphanet:204,Orphanet:282166,Orphanet:454700","Creutzfeldt-Jakob Disease, Familial",germline,germline,GRCh38,NC_000020.11,20,4699851,4699851,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA266210,UniProtKB:P04156#VAR_008752,OMIM:176640.0030",1,88923,4699851,G,C,E211Q,0,pathogenic,uncertain,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,211,E,Q,True,946
13643,3456,28437,single nucleotide variant,NM_000311.5(PRNP):c.598G>A (p.Glu200Lys),5621,PRNP,HGNC:9449,Pathogenic,1,1-Nov-20,28933385,-,RCV000014334|RCV000014335|RCV000644587|RCV001285517|RCV001310451,"MONDO:MONDO:0007403,MedGen:C0751254,OMIM:123400,Orphanet:204,Orphanet:282166,Orphanet:454700|MONDO:MONDO:0010808,MedGen:C0206042,OMIM:600072,Orphanet:466|MONDO:MONDO:0011299,MedGen:C1864112,OMIM:603218,Orphanet:157941|MedGen:CN235283|MedGen:CN517202","Creutzfeldt-Jakob Disease, Familial|Fatal familial insomnia|Huntington disease-like 1|none provided|not provided",germline,germline,GRCh38,NC_000020.11,20,4699818,4699818,na,na,20p13,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA256778,UniProtKB:P04156#VAR_006473,OMIM:176640.0006",3,13398,4699818,G,A,E200K,2,pathogenic,pathogenic,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,200,E,K,True,946
13644,3455,28436,single nucleotide variant,NM_000311.5(PRNP):c.385A>G (p.Met129Val),5621,PRNP,HGNC:9449,Benign/Likely benign,0,30-Aug-20,1799990,-,RCV000014331|RCV000014332|RCV000014333|RCV000020244|RCV000118064|RCV000990275|RCV001262968|RCV001282570,"|||MONDO:MONDO:0017234,MedGen:CN043607,Orphanet:280400|MedGen:CN169374|MONDO:MONDO:0011299,MedGen:C1864112,OMIM:603218,Orphanet:157941|MONDO:MONDO:0007403,MedGen:C0751254,OMIM:123400,Orphanet:204,Orphanet:282166,Orphanet:454700|MedGen:CN235283","Prion disease, susceptibility to|Alzheimer disease, early-onset, susceptibility to|Aphasia, primary progressive, susceptibility to|Genetic prion disease|not specified|Huntington disease-like 1|Creutzfeldt-Jakob Disease, Familial|none provided",germline;unknown,germline,GRCh38,NC_000020.11,20,4699605,4699605,na,na,20p13,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinVar:13399,ClinGen:CA123088,UniProtKB:P04156#VAR_006467,OMIM:176640.0005,OMIM:176640.0007,OMIM:176640.0010",3,13397,4699605,A,G,M129V,2,benign,benign,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,129,M,V,True,946
13645,3454,28435,single nucleotide variant,NM_000311.5(PRNP):c.350C>T (p.Ala117Val),5621,PRNP,HGNC:9449,Pathogenic,1,2-Oct-17,74315402,-,RCV000014330|RCV000623716,"MONDO:MONDO:0007656,MedGen:C0017495,OMIM:137440,Orphanet:356|MeSH:D030342,MedGen:C0950123",Gerstmann-Straussler-Scheinker syndrome|Inborn genetic diseases,germline,germline,GRCh38,NC_000020.11,20,4699570,4699570,na,na,20p13,"criteria provided, single submitter",2,-,N,"ClinGen:CA256776,UniProtKB:P04156#VAR_006466,OMIM:176640.0004",3,13396,4699570,C,T,A117V,1,pathogenic,pathogenic,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,117,A,V,True,946
13646,3470,28455,single nucleotide variant,NM_000311.5(PRNP):c.380G>T (p.Gly127Val),5621,PRNP,HGNC:9449,protective,0,25-Jun-15,267606980,-,RCV000014358,MedGen:C4016338,"Kuru, protection against",germline,germline,GRCh38,NC_000020.11,20,4699600,4699600,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA123099,UniProtKB:P04156#VAR_073722,OMIM:176640.0028",1,13416,4699600,G,T,G127V,0,uncertain,uncertain,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,127,G,V,True,946
13647,3469,28451,single nucleotide variant,NM_000311.5(PRNP):c.560A>G (p.His187Arg),5621,PRNP,HGNC:9449,Pathogenic,1,12-Apr-05,74315413,-,RCV000014353|RCV000014354,"MONDO:MONDO:0007656,MedGen:C0017495,OMIM:137440,Orphanet:356|MONDO:MONDO:0011703,MedGen:C1847650,OMIM:606688",Gerstmann-Straussler-Scheinker syndrome|Spongiform encephalopathy with neuropsychiatric features,germline,germline,GRCh38,NC_000020.11,20,4699780,4699780,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA123096,UniProtKB:P04156#VAR_008746,OMIM:176640.0024",1,13412,4699780,A,G,H187R,0,pathogenic,uncertain,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,187,H,R,True,946
13648,3458,28440,single nucleotide variant,NM_000311.5(PRNP):c.593T>C (p.Phe198Ser),5621,PRNP,HGNC:9449,Pathogenic,1,14-Nov-17,74315405,-,RCV000014340|RCV000644586,"MONDO:MONDO:0007656,MedGen:C0017495,OMIM:137440,Orphanet:356|MONDO:MONDO:0011299,MedGen:C1864112,OMIM:603218,Orphanet:157941",Gerstmann-Straussler-Scheinker syndrome|Huntington disease-like 1,germline,germline,GRCh38,NC_000020.11,20,4699813,4699813,na,na,20p13,"criteria provided, single submitter",2,-,N,"ClinGen:CA256779,UniProtKB:P04156#VAR_006472,OMIM:176640.0011",3,13401,4699813,T,C,F198S,1,pathogenic,pathogenic,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,198,F,S,True,946
13649,3468,28450,single nucleotide variant,NM_000311.5(PRNP):c.623G>A (p.Arg208His),5621,PRNP,HGNC:9449,Uncertain significance,0,1-Mar-06,74315412,-,RCV000014352,"MONDO:MONDO:0007403,MedGen:C0751254,OMIM:123400,Orphanet:204,Orphanet:282166,Orphanet:454700","Creutzfeldt-Jakob Disease, Familial",germline,germline,GRCh38,NC_000020.11,20,4699843,4699843,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA256785,UniProtKB:P04156#VAR_006474,OMIM:176640.0023",1,13411,4699843,G,A,R208H,0,uncertain,uncertain,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,208,R,H,True,946
13650,3461,28443,single nucleotide variant,NM_000311.5(PRNP):c.314C>T (p.Pro105Leu),5621,PRNP,HGNC:9449,Pathogenic,1,2-Apr-13,11538758,-,RCV000014343|RCV000190750,"MONDO:MONDO:0007656,MedGen:C0017495,OMIM:137440,Orphanet:356|MeSH:D030342,MedGen:C0950123",Gerstmann-Straussler-Scheinker syndrome|Inborn genetic diseases,germline,germline,GRCh38,NC_000020.11,20,4699534,4699534,na,na,20p13,"criteria provided, single submitter",2,-,N,"ClinGen:CA204782,UniProtKB:P04156#VAR_006465,OMIM:176640.0015",3,13404,4699534,C,T,P105L,1,pathogenic,pathogenic,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,105,P,L,True,946
13651,3453,28434,single nucleotide variant,NM_000311.5(PRNP):c.305C>T (p.Pro102Leu),5621,PRNP,HGNC:9449,Pathogenic,1,26-Jun-19,74315401,-,RCV000014329|RCV001203438|RCV001269667,"MONDO:MONDO:0007656,MedGen:C0017495,OMIM:137440,Orphanet:356|MONDO:MONDO:0011299,MedGen:C1864112,OMIM:603218,Orphanet:157941|MedGen:CN517202",Gerstmann-Straussler-Scheinker syndrome|Huntington disease-like 1|not provided,germline,germline,GRCh38,NC_000020.11,20,4699525,4699525,na,na,20p13,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA256774,UniProtKB:P04156#VAR_006464,OMIM:176640.0002",3,13395,4699525,C,T,P102L,2,pathogenic,pathogenic,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,102,P,L,True,946
13652,3462,28444,single nucleotide variant,NM_000311.5(PRNP):c.538G>A (p.Val180Ile),5621,PRNP,HGNC:9449,Pathogenic/Likely pathogenic,1,2-Oct-19,74315408,-,RCV000014344|RCV000020249|RCV001212635,"MONDO:MONDO:0007403,MedGen:C0751254,OMIM:123400,Orphanet:204,Orphanet:282166,Orphanet:454700|MONDO:MONDO:0017234,MedGen:CN043607,Orphanet:280400|MONDO:MONDO:0011299,MedGen:C1864112,OMIM:603218,Orphanet:157941","Creutzfeldt-Jakob Disease, Familial|Genetic prion disease|Huntington disease-like 1",germline,germline,GRCh38,NC_000020.11,20,4699758,4699758,na,na,20p13,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA256782,UniProtKB:P04156#VAR_006470,OMIM:176640.0016",3,13405,4699758,G,A,V180I,2,pathogenic,pathogenic,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,180,V,I,True,946
13653,3466,28448,single nucleotide variant,NM_000311.5(PRNP):c.655G>A (p.Glu219Lys),5621,PRNP,HGNC:9449,Benign,0,3-Apr-20,1800014,-,RCV000014350|RCV000020257|RCV000873683|RCV001287480,"|MONDO:MONDO:0017234,MedGen:CN043607,Orphanet:280400|MONDO:MONDO:0011299,MedGen:C1864112,OMIM:603218,Orphanet:157941|MedGen:CN235283",Protection against Creutzfeldt-Jakob disease|Genetic prion disease|Huntington disease-like 1|none provided,germline,germline,GRCh38,NC_000020.11,20,4699875,4699875,na,na,20p13,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA123094,UniProtKB:P04156#VAR_006477,OMIM:176640.0019",3,13409,4699875,G,A,E219K,2,benign,benign,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,219,E,K,True,946
13654,3463,28445,single nucleotide variant,NM_000311.5(PRNP):c.695T>G (p.Met232Arg),5621,PRNP,HGNC:9449,Uncertain significance,0,28-May-19,74315409,-,RCV000014345|RCV000990277,"MONDO:MONDO:0007403,MedGen:C0751254,OMIM:123400,Orphanet:204,Orphanet:282166,Orphanet:454700|MONDO:MONDO:0011299,MedGen:C1864112,OMIM:603218,Orphanet:157941","Creutzfeldt-Jakob Disease, Familial|Huntington disease-like 1",germline;unknown,germline,GRCh38,NC_000020.11,20,4699915,4699915,na,na,20p13,"criteria provided, single submitter",2,-,N,"ClinGen:CA256783,UniProtKB:P04156#VAR_006478,OMIM:176640.0017",3,13406,4699915,T,G,M232R,1,uncertain,uncertain,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,232,M,R,True,946
13655,3464,28446,single nucleotide variant,NM_000311.5(PRNP):c.547A>G (p.Thr183Ala),5621,PRNP,HGNC:9449,Pathogenic,1,1-Aug-97,74315411,-,RCV000014347,"MONDO:MONDO:0011703,MedGen:C1847650,OMIM:606688",Spongiform encephalopathy with neuropsychiatric features,germline,germline,GRCh38,NC_000020.11,20,4699767,4699767,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA123090,UniProtKB:P04156#VAR_006471,OMIM:176640.0022",1,13407,4699767,A,G,T183A,0,pathogenic,uncertain,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,183,T,A,True,946
13656,3467,28449,single nucleotide variant,NM_000311.5(PRNP):c.392G>T (p.Gly131Val),5621,PRNP,HGNC:9449,Uncertain significance,1,17-Mar-20,74315410,-,RCV000014351|RCV001348311,"MONDO:MONDO:0007656,MedGen:C0017495,OMIM:137440,Orphanet:356|MONDO:MONDO:0011299,MedGen:C1864112,OMIM:603218,Orphanet:157941",Gerstmann-Straussler-Scheinker syndrome|Huntington disease-like 1,germline,germline,GRCh38,NC_000020.11,20,4699612,4699612,na,na,20p13,"criteria provided, single submitter",2,-,N,"ClinGen:CA256784,UniProtKB:P04156#VAR_014264,OMIM:176640.0021",3,13410,4699612,G,T,G131V,1,uncertain,uncertain,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,131,G,V,True,946
13657,3460,28442,single nucleotide variant,NM_000311.5(PRNP):c.628G>A (p.Val210Ile),5621,PRNP,HGNC:9449,Pathogenic,1,30-Jan-19,74315407,-,RCV000014342|RCV000532969,"MONDO:MONDO:0007403,MedGen:C0751254,OMIM:123400,Orphanet:204,Orphanet:282166,Orphanet:454700|MONDO:MONDO:0011299,MedGen:C1864112,OMIM:603218,Orphanet:157941","Creutzfeldt-Jakob Disease, Familial|Huntington disease-like 1",germline,germline,GRCh38,NC_000020.11,20,4699848,4699848,na,na,20p13,"criteria provided, single submitter",3,-,N,"ClinGen:CA256781,UniProtKB:P04156#VAR_006475,OMIM:176640.0014",3,13403,4699848,G,A,V210I,1,pathogenic,pathogenic,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,210,V,I,True,946
13658,3457,28438,single nucleotide variant,NM_000311.5(PRNP):c.532G>A (p.Asp178Asn),5621,PRNP,HGNC:9449,Pathogenic,1,23-Oct-20,74315403,-,RCV000020248|RCV001200144|RCV001214652,"MONDO:MONDO:0010808,MedGen:C0206042,OMIM:600072,Orphanet:466|MedGen:CN517202|MONDO:MONDO:0011299,MedGen:C1864112,OMIM:603218,Orphanet:157941",Fatal familial insomnia|not provided|Huntington disease-like 1,germline,germline,GRCh38,NC_000020.11,20,4699752,4699752,na,na,20p13,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA261110,UniProtKB:P04156#VAR_006469,OMIM:176640.0007,OMIM:176640.0010,ClinVar:13399",3,39359,4699752,G,A,D178N,2,pathogenic,pathogenic,P04156,P04156,reviewed,PRIO_HUMAN,"Major prion protein, PrP (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)",PRNP ALTPRP PRIP PRP,Homo sapiens (Human),253.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,PF00377;PF11587;,1E1G;1E1J;1E1P;1E1S;1E1U;1E1W;1FKC;1FO7;1H0L;1HJM;1HJN;1I4M;1OEH;1OEI;1QLX;1QLZ;1QM0;1QM1;1QM2;1QM3;2IV4;2IV5;2IV6;2K1D;2KUN;2LBG;2LEJ;2LFT;2LSB;2LV1;2M8T;2OL9;2W9E;3HAF;3HAK;3HEQ;3HER;3HES;3HJ5;3HJX;3MD4;3MD5;3NHC;3NHD;3NVF;4DGI;4E1H;4E1I;4KML;4N9O;5L6R;5YJ4;5YJ5;6DU9;6LNI;6PQ5;6PQA;6SUZ;6SV2;6UUR;7DWV;,178,D,N,True,946
13659,1200,20244,single nucleotide variant,NM_021102.4(SPINT2):c.488A>G (p.Tyr163Cys),10653,SPINT2,HGNC:11247,Pathogenic,1,1-Mar-14,121908403,-,RCV000005515,MedGen:C2678346,"Diarrhea 3, secretory sodium, congenital, syndromic",germline,germline,GRCh38,NC_000019.10,19,38290215,38290215,na,na,19q13.2,no assertion criteria provided,1,-,N,"OMIM:605124.0002,OMIM:605124.0007,ClinGen:CA117329,UniProtKB:O43291#VAR_058718",1,5205,38290215,A,G,Y163C,0,pathogenic,uncertain,O43291,O43291,reviewed,SPIT2_HUMAN,"Kunitz-type protease inhibitor 2 (Hepatocyte growth factor activator inhibitor type 2, HAI-2) (Placental bikunin)",SPINT2 HAI2 KOP,Homo sapiens (Human),252.0,MAQLCGLRRSRAFLALLGSLLLSGVLAADRERSIHDFCLVSKVVGRCRASMPRWWYNVTDGSCQLFVYGGCDGNSNNYLTKEECLKKCATVTENATGDLATSRNAADSSVPSAPRRQDSEDHSSDMFNYEEYCTANAVTGPCRASFPRWYFDVERNSCNNFIYGGCRGNKNSYRSEEACMLRCFRQQENPPLPLGSKVVVLAGLFVMVLILFLGASMVYLIRVARRNQERALRTVWSSGDDKEQLVKNTYVL,PF00014;,4U32;,163,Y,C,True,947
13660,14060,325377,single nucleotide variant,NM_014321.4(ORC6):c.413C>A (p.Pro138Gln),23594,ORC6,HGNC:17151,Uncertain significance,0,12-Jan-18,3218745,-,RCV000274899,"MONDO:MONDO:0013430,MedGen:C3151113,OMIM:613803,Orphanet:2554",Meier-Gorlin syndrome 3,germline,germline,GRCh38,NC_000016.10,16,46693146,46693146,na,na,16q11.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA8037380,UniProtKB:Q9Y5N6#VAR_029284",2,319302,46693146,C,A,P138Q,1,uncertain,uncertain,Q9Y5N6,Q9Y5N6,reviewed,ORC6_HUMAN,Origin recognition complex subunit 6,ORC6 ORC6L,Homo sapiens (Human),252.0,MGSELIGRLAPRLGLAEPDMLRKAEEYLRLSRVKCVGLSARTTETSSAVMCLDLAASWMKCPLDRAYLIKLSGLNKETYQSCLKSFECLLGLNSNIGIRDLAVQFSCIEAVNMASKILKSYESSLPQTQQVDLDLSRPLFTSAALLSACKILKLKVDKNKMVATSGVKKAIFDRLCKQLEKIGQQVDREPGDVATPPRKRKKIVVEAPAKEMEKVEEMPHKPQKDEDLTQDYEEWKRKILENAASAQKATAE,PF05460;,3M03;6KVG;,138,P,Q,True,948
13661,6016,39613,single nucleotide variant,NM_014321.4(ORC6):c.695A>C (p.Tyr232Ser),23594,ORC6,HGNC:17151,Pathogenic,1,27-Feb-11,387906969,-,RCV000023633,"MONDO:MONDO:0013430,MedGen:C3151113,OMIM:613803,Orphanet:2554",Meier-Gorlin syndrome 3,germline,germline,GRCh38,NC_000016.10,16,46697521,46697521,na,na,16q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA129387,UniProtKB:Q9Y5N6#VAR_065487,OMIM:607213.0002",1,30656,46697521,A,C,Y232S,0,pathogenic,uncertain,Q9Y5N6,Q9Y5N6,reviewed,ORC6_HUMAN,Origin recognition complex subunit 6,ORC6 ORC6L,Homo sapiens (Human),252.0,MGSELIGRLAPRLGLAEPDMLRKAEEYLRLSRVKCVGLSARTTETSSAVMCLDLAASWMKCPLDRAYLIKLSGLNKETYQSCLKSFECLLGLNSNIGIRDLAVQFSCIEAVNMASKILKSYESSLPQTQQVDLDLSRPLFTSAALLSACKILKLKVDKNKMVATSGVKKAIFDRLCKQLEKIGQQVDREPGDVATPPRKRKKIVVEAPAKEMEKVEEMPHKPQKDEDLTQDYEEWKRKILENAASAQKATAE,PF05460;,3M03;6KVG;,232,Y,S,True,948
13662,12449,219162,single nucleotide variant,NM_016038.4(SBDS):c.98A>C (p.Lys33Thr),51119,SBDS,HGNC:19440,Pathogenic,1,1-Jun-14,373730800,-,RCV000206645,"MONDO:MONDO:0044204,MedGen:C4692625,OMIM:260400,Orphanet:811",Shwachman-Diamond syndrome 1,maternal,germline,GRCh38,NC_000007.14,7,66995320,66995320,na,na,7q11.21,"criteria provided, single submitter",1,-,N,"ClinGen:CA350654,UniProtKB:Q9Y3A5#VAR_071673",2,219289,66995320,T,G,K33T,1,pathogenic,pathogenic,Q9Y3A5,Q9Y3A5,reviewed,SBDS_HUMAN,Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein),SBDS CGI-97,Homo sapiens (Human),250.0,MSIFTPTNQIRLTNVAVVRMKRAGKRFEIACYKNKVVGWRSGVEKDLDEVLQTHSVFVNVSKGQVAKKEDLISAFGTDDQTEICKQILTKGEVQVSDKERHTQLEQMFRDIATIVADKCVNPETKRPYTVILIERAMKDIHYSVKTNKSTKQQALEVIKQLKEKMKIERAHMRLRFILPVNEGKKLKEKLKPLIKVIESEDYGQQLEIVCLIDPGCFREIDELIKKETKGKGSLEVLNLKDVEEGDEKFE,PF01172;PF09377;,2KDO;2L9N;5AN9;5ANB;5ANC;6QKL;,33,K,T,True,949
13663,5455,34392,single nucleotide variant,NM_016038.4(SBDS):c.377G>C (p.Arg126Thr),51119,SBDS,HGNC:19440,Pathogenic,1,17-Jul-08,113993995,-,RCV000020730,"MONDO:MONDO:0044204,MedGen:C4692625,OMIM:260400,Orphanet:811",Shwachman-Diamond syndrome 1,not provided,not provided,GRCh38,NC_000007.14,7,66993299,66993299,na,na,7q11.21,no assertion criteria provided,1,-,N,"ClinGen:CA342199,UniProtKB:Q9Y3A5#VAR_015394",1,21540,66993299,C,G,R126T,0,pathogenic,uncertain,Q9Y3A5,Q9Y3A5,reviewed,SBDS_HUMAN,Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein),SBDS CGI-97,Homo sapiens (Human),250.0,MSIFTPTNQIRLTNVAVVRMKRAGKRFEIACYKNKVVGWRSGVEKDLDEVLQTHSVFVNVSKGQVAKKEDLISAFGTDDQTEICKQILTKGEVQVSDKERHTQLEQMFRDIATIVADKCVNPETKRPYTVILIERAMKDIHYSVKTNKSTKQQALEVIKQLKEKMKIERAHMRLRFILPVNEGKKLKEKLKPLIKVIESEDYGQQLEIVCLIDPGCFREIDELIKKETKGKGSLEVLNLKDVEEGDEKFE,PF01172;PF09377;,2KDO;2L9N;5AN9;5ANB;5ANC;6QKL;,126,R,T,True,949
13664,5457,34395,single nucleotide variant,NM_016038.4(SBDS):c.635T>C (p.Ile212Thr),51119,SBDS,HGNC:19440,Benign/Likely benign,0,31-May-18,79344818,-,RCV000020733|RCV000202999,"MONDO:MONDO:0044204,MedGen:C4692625,OMIM:260400,Orphanet:811|MedGen:CN169374",Shwachman-Diamond syndrome 1|not specified,germline;unknown,germline,GRCh38,NC_000007.14,7,66988489,66988489,na,na,7q11.21,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA249202,UniProtKB:Q9Y3A5#VAR_015396",3,21543,66988489,A,G,I212T,2,benign,benign,Q9Y3A5,Q9Y3A5,reviewed,SBDS_HUMAN,Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein),SBDS CGI-97,Homo sapiens (Human),250.0,MSIFTPTNQIRLTNVAVVRMKRAGKRFEIACYKNKVVGWRSGVEKDLDEVLQTHSVFVNVSKGQVAKKEDLISAFGTDDQTEICKQILTKGEVQVSDKERHTQLEQMFRDIATIVADKCVNPETKRPYTVILIERAMKDIHYSVKTNKSTKQQALEVIKQLKEKMKIERAHMRLRFILPVNEGKKLKEKLKPLIKVIESEDYGQQLEIVCLIDPGCFREIDELIKKETKGKGSLEVLNLKDVEEGDEKFE,PF01172;PF09377;,2KDO;2L9N;5AN9;5ANB;5ANC;6QKL;,212,I,T,True,949
13665,5456,34393,single nucleotide variant,NM_016038.4(SBDS):c.505C>T (p.Arg169Cys),51119,SBDS,HGNC:19440,Uncertain significance,1,16-Apr-18,113993996,-,RCV000020731,"MONDO:MONDO:0044204,MedGen:C4692625,OMIM:260400,Orphanet:811",Shwachman-Diamond syndrome 1,germline,germline,GRCh38,NC_000007.14,7,66991256,66991256,na,na,7q11.21,"criteria provided, single submitter",2,-,N,"ClinGen:CA342201,UniProtKB:Q9Y3A5#VAR_015395",3,21541,66991256,G,A,R169C,1,uncertain,uncertain,Q9Y3A5,Q9Y3A5,reviewed,SBDS_HUMAN,Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein),SBDS CGI-97,Homo sapiens (Human),250.0,MSIFTPTNQIRLTNVAVVRMKRAGKRFEIACYKNKVVGWRSGVEKDLDEVLQTHSVFVNVSKGQVAKKEDLISAFGTDDQTEICKQILTKGEVQVSDKERHTQLEQMFRDIATIVADKCVNPETKRPYTVILIERAMKDIHYSVKTNKSTKQQALEVIKQLKEKMKIERAHMRLRFILPVNEGKKLKEKLKPLIKVIESEDYGQQLEIVCLIDPGCFREIDELIKKETKGKGSLEVLNLKDVEEGDEKFE,PF01172;PF09377;,2KDO;2L9N;5AN9;5ANB;5ANC;6QKL;,169,R,C,True,949
13666,773,18236,single nucleotide variant,NM_016038.4(SBDS):c.24C>A (p.Asn8Lys),51119,SBDS,HGNC:19440,Uncertain significance,1,16-Apr-18,28942099,-,RCV000003349,"MONDO:MONDO:0044204,MedGen:C4692625,OMIM:260400,Orphanet:811",Shwachman-Diamond syndrome 1,germline,germline,GRCh38,NC_000007.14,7,66995394,66995394,na,na,7q11.21,"criteria provided, single submitter",2,-,N,"ClinGen:CA252613,UniProtKB:Q9Y3A5#VAR_015390,OMIM:607444.0003",3,3197,66995394,G,T,N8K,1,uncertain,uncertain,Q9Y3A5,Q9Y3A5,reviewed,SBDS_HUMAN,Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein),SBDS CGI-97,Homo sapiens (Human),250.0,MSIFTPTNQIRLTNVAVVRMKRAGKRFEIACYKNKVVGWRSGVEKDLDEVLQTHSVFVNVSKGQVAKKEDLISAFGTDDQTEICKQILTKGEVQVSDKERHTQLEQMFRDIATIVADKCVNPETKRPYTVILIERAMKDIHYSVKTNKSTKQQALEVIKQLKEKMKIERAHMRLRFILPVNEGKKLKEKLKPLIKVIESEDYGQQLEIVCLIDPGCFREIDELIKKETKGKGSLEVLNLKDVEEGDEKFE,PF01172;PF09377;,2KDO;2L9N;5AN9;5ANB;5ANC;6QKL;,8,N,K,True,949
13667,12436,216057,single nucleotide variant,NM_052845.4(MMAB):c.403G>A (p.Ala135Thr),326625,MMAB,HGNC:19331,Conflicting interpretations of pathogenicity,1,31-Dec-19,35648932,-,RCV000203394|RCV000482151,"MONDO:MONDO:0009614,MedGen:C1855102,OMIM:251110,Orphanet:28,Orphanet:79311|MedGen:CN517202",Vitamin B12-responsive methylmalonic acidemia type cblB|not provided,germline,germline,GRCh38,NC_000012.12,12,109561798,109561798,na,na,12q24.11,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA347906,UniProtKB:Q96EY8#VAR_017204",3,219005,109561798,C,T,A135T,1,uncertain,uncertain,Q96EY8,Q96EY8,reviewed,MMAB_HUMAN,"Corrinoid adenosyltransferase MMAB, EC 2.5.1.- (ATP:co(I)rrinoid adenosyltransferase MMAB) (Methylmalonic aciduria type B protein)",MMAB,Homo sapiens (Human),250.0,MAVCGLGSRLGLGSRLGLRGCFGAARLLYPRFQSRGPQGVEDGDRPQPSSKTPRIPKIYTKTGDKGFSSTFTGERRPKDDQVFEAVGTTDELSSAIGFALELVTEKGHTFAEELQKIQCTLQDVGSALATPCSSAREAHLKYTTFKAGPILELEQWIDKYTSQLPPLTAFILPSGGKISSALHFCRAVCRRAERRVVPLVQMGETDANVAKFLNRLSDYLFTLARYAAMKEGNQEKIYMKNDPSAESEGL,PF01923;,2IDX;6D5K;6D5X;7RUT;7RUU;7RUV;,135,A,T,True,950
13668,754,18134,single nucleotide variant,NM_052845.4(MMAB):c.556C>T (p.Arg186Trp),326625,MMAB,HGNC:19331,Pathogenic,1,20-Dec-19,28941784,-,RCV000003241|RCV000186017|RCV000296390,"MONDO:MONDO:0009614,MedGen:C1855102,OMIM:251110,Orphanet:28,Orphanet:79311|MedGen:CN517202|Human Phenotype Ontology:HP:0002912,Human Phenotype Ontology:HP:0003123,Human Phenotype Ontology:HP:0008295,MONDO:MONDO:0002012,MeSH:C537358,MedGen:C0268583",Vitamin B12-responsive methylmalonic acidemia type cblB|not provided|Methylmalonic acidemia,germline;unknown,germline,GRCh38,NC_000012.12,12,109561068,109561068,na,na,12q24.11,"criteria provided, multiple submitters, no conflicts",11,-,N,"OMIM:607568.0001,ClinGen:CA312714,UniProtKB:Q96EY8#VAR_017205",3,3095,109561068,G,A,R186W,2,pathogenic,pathogenic,Q96EY8,Q96EY8,reviewed,MMAB_HUMAN,"Corrinoid adenosyltransferase MMAB, EC 2.5.1.- (ATP:co(I)rrinoid adenosyltransferase MMAB) (Methylmalonic aciduria type B protein)",MMAB,Homo sapiens (Human),250.0,MAVCGLGSRLGLGSRLGLRGCFGAARLLYPRFQSRGPQGVEDGDRPQPSSKTPRIPKIYTKTGDKGFSSTFTGERRPKDDQVFEAVGTTDELSSAIGFALELVTEKGHTFAEELQKIQCTLQDVGSALATPCSSAREAHLKYTTFKAGPILELEQWIDKYTSQLPPLTAFILPSGGKISSALHFCRAVCRRAERRVVPLVQMGETDANVAKFLNRLSDYLFTLARYAAMKEGNQEKIYMKNDPSAESEGL,PF01923;,2IDX;6D5K;6D5X;7RUT;7RUU;7RUV;,186,R,W,True,950
13669,9180,102139,single nucleotide variant,NM_052845.4(MMAB):c.716T>A (p.Met239Lys),326625,MMAB,HGNC:19331,Benign,0,28-May-19,9593,-,RCV000082328|RCV000590350|RCV000611494|RCV001274799,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0009614,MedGen:C1855102,OMIM:251110,Orphanet:28,Orphanet:79311|MONDO:MONDO:0009287,MedGen:C2919796,OMIM:232200,Orphanet:364,Orphanet:79258",not specified|not provided|Vitamin B12-responsive methylmalonic acidemia type cblB|Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,germline;unknown,germline,GRCh38,NC_000012.12,12,109557065,109557065,na,na,12q24.11,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA285762,UniProtKB:Q96EY8#VAR_017208",2,96245,109557065,A,T,M239K,2,benign,benign,Q96EY8,Q96EY8,reviewed,MMAB_HUMAN,"Corrinoid adenosyltransferase MMAB, EC 2.5.1.- (ATP:co(I)rrinoid adenosyltransferase MMAB) (Methylmalonic aciduria type B protein)",MMAB,Homo sapiens (Human),250.0,MAVCGLGSRLGLGSRLGLRGCFGAARLLYPRFQSRGPQGVEDGDRPQPSSKTPRIPKIYTKTGDKGFSSTFTGERRPKDDQVFEAVGTTDELSSAIGFALELVTEKGHTFAEELQKIQCTLQDVGSALATPCSSAREAHLKYTTFKAGPILELEQWIDKYTSQLPPLTAFILPSGGKISSALHFCRAVCRRAERRVVPLVQMGETDANVAKFLNRLSDYLFTLARYAAMKEGNQEKIYMKNDPSAESEGL,PF01923;,2IDX;6D5K;6D5X;7RUT;7RUU;7RUV;,239,M,K,True,950
13670,12394,215030,single nucleotide variant,NM_052845.4(MMAB):c.287T>C (p.Ile96Thr),326625,MMAB,HGNC:19331,Pathogenic,1,7-Jan-16,864309509,-,RCV000202588,"MONDO:MONDO:0009614,MedGen:C1855102,OMIM:251110,Orphanet:28,Orphanet:79311",Vitamin B12-responsive methylmalonic acidemia type cblB,germline,germline,GRCh38,NC_000012.12,12,109568773,109568773,na,na,12q24.11,no assertion criteria provided,2,-,N,"ClinGen:CA347809,UniProtKB:Q96EY8#VAR_023471,OMIM:607568.0004",1,218323,109568773,A,G,I96T,0,pathogenic,uncertain,Q96EY8,Q96EY8,reviewed,MMAB_HUMAN,"Corrinoid adenosyltransferase MMAB, EC 2.5.1.- (ATP:co(I)rrinoid adenosyltransferase MMAB) (Methylmalonic aciduria type B protein)",MMAB,Homo sapiens (Human),250.0,MAVCGLGSRLGLGSRLGLRGCFGAARLLYPRFQSRGPQGVEDGDRPQPSSKTPRIPKIYTKTGDKGFSSTFTGERRPKDDQVFEAVGTTDELSSAIGFALELVTEKGHTFAEELQKIQCTLQDVGSALATPCSSAREAHLKYTTFKAGPILELEQWIDKYTSQLPPLTAFILPSGGKISSALHFCRAVCRRAERRVVPLVQMGETDANVAKFLNRLSDYLFTLARYAAMKEGNQEKIYMKNDPSAESEGL,PF01923;,2IDX;6D5K;6D5X;7RUT;7RUU;7RUV;,96,I,T,True,950
13671,12395,215031,single nucleotide variant,NM_052845.4(MMAB):c.571C>T (p.Arg191Trp),326625,MMAB,HGNC:19331,Pathogenic,1,3-Dec-17,376128990,-,RCV000202597|RCV000414492,"MONDO:MONDO:0009614,MedGen:C1855102,OMIM:251110,Orphanet:28,Orphanet:79311|MedGen:CN517202",Vitamin B12-responsive methylmalonic acidemia type cblB|not provided,germline;inherited;unknown,germline,GRCh38,NC_000012.12,12,109561053,109561053,na,na,12q24.11,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA347810,UniProtKB:Q96EY8#VAR_017206,OMIM:607568.0006",3,218324,109561053,G,A,R191W,2,pathogenic,pathogenic,Q96EY8,Q96EY8,reviewed,MMAB_HUMAN,"Corrinoid adenosyltransferase MMAB, EC 2.5.1.- (ATP:co(I)rrinoid adenosyltransferase MMAB) (Methylmalonic aciduria type B protein)",MMAB,Homo sapiens (Human),250.0,MAVCGLGSRLGLGSRLGLRGCFGAARLLYPRFQSRGPQGVEDGDRPQPSSKTPRIPKIYTKTGDKGFSSTFTGERRPKDDQVFEAVGTTDELSSAIGFALELVTEKGHTFAEELQKIQCTLQDVGSALATPCSSAREAHLKYTTFKAGPILELEQWIDKYTSQLPPLTAFILPSGGKISSALHFCRAVCRRAERRVVPLVQMGETDANVAKFLNRLSDYLFTLARYAAMKEGNQEKIYMKNDPSAESEGL,PF01923;,2IDX;6D5K;6D5X;7RUT;7RUU;7RUV;,191,R,W,True,950
13672,13298,254396,single nucleotide variant,NM_052845.4(MMAB):c.56G>A (p.Arg19His),-1,MMAB;MVK,-,Benign,0,12-Jul-18,10774775,-,RCV000247935|RCV000298750|RCV000351606|RCV000389849|RCV000605966,"MedGen:CN169374|Human Phenotype Ontology:HP:0002912,Human Phenotype Ontology:HP:0003123,Human Phenotype Ontology:HP:0008295,MONDO:MONDO:0002012,MeSH:C537358,MedGen:C0268583|MedGen:C1959626,OMIM:610377,Orphanet:29|MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MONDO:MONDO:0009614,MedGen:C1855102,OMIM:251110,Orphanet:28,Orphanet:79311",not specified|Methylmalonic acidemia|Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Vitamin B12-responsive methylmalonic acidemia type cblB,germline,germline,GRCh38,NC_000012.12,12,109573425,109573425,na,na,12q24.11,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA6779078,UniProtKB:Q96EY8#VAR_038803",2,262246,109573425,C,T,R19H,2,benign,benign,Q96EY8,Q96EY8,reviewed,MMAB_HUMAN,"Corrinoid adenosyltransferase MMAB, EC 2.5.1.- (ATP:co(I)rrinoid adenosyltransferase MMAB) (Methylmalonic aciduria type B protein)",MMAB,Homo sapiens (Human),250.0,MAVCGLGSRLGLGSRLGLRGCFGAARLLYPRFQSRGPQGVEDGDRPQPSSKTPRIPKIYTKTGDKGFSSTFTGERRPKDDQVFEAVGTTDELSSAIGFALELVTEKGHTFAEELQKIQCTLQDVGSALATPCSSAREAHLKYTTFKAGPILELEQWIDKYTSQLPPLTAFILPSGGKISSALHFCRAVCRRAERRVVPLVQMGETDANVAKFLNRLSDYLFTLARYAAMKEGNQEKIYMKNDPSAESEGL,PF01923;,2IDX;6D5K;6D5X;7RUT;7RUU;7RUV;,19,R,H,True,950
13673,2196,24321,single nucleotide variant,NM_000161.3(GCH1):c.323G>A (p.Gly108Asp),2643,GCH1,HGNC:4193,Pathogenic,1,26-Feb-19,104894435,-,RCV000009864|RCV000634833,"MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150|MedGen:C0268467,OMIM:233910,Orphanet:2102,Orphanet:238583;MONDO:MONDO:0007495,MedGen:C1851920,OMIM:128230,Orphanet:98808",Autosomal recessive DOPA responsive dystonia|GTP cyclohydrolase I deficiency;Dystonia 5,germline,germline,GRCh38,NC_000014.9,14,54902341,54902341,na,na,14q22.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA120279,UniProtKB:P30793#VAR_016894,OMIM:600225.0012",3,9282,54902341,C,T,G108D,1,pathogenic,pathogenic,P30793,P30793,reviewed,GCH1_HUMAN,"GTP cyclohydrolase 1, EC 3.5.4.16 (GTP cyclohydrolase I, GTP-CH-I)",GCH1 DYT5 GCH,Homo sapiens (Human),250.0,MEKGPVRAPAEKPRGARCSNGFPERDPPRPGPSRPAEKPPRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS,PF01227;,1FB1;6Z80;6Z85;6Z86;6Z87;6Z88;6Z89;7ALA;7ALB;7ALC;7ALQ;,108,G,D,True,951
13674,2191,24310,single nucleotide variant,NM_000161.3(GCH1):c.262C>T (p.Arg88Trp),2643,GCH1,HGNC:4193,Pathogenic,1,28-Apr-95,104894433,-,RCV000009853,"MONDO:MONDO:0007495,MedGen:C1851920,OMIM:128230,Orphanet:98808",Dystonia 5,germline,germline,GRCh38,NC_000014.9,14,54902402,54902402,na,na,14q22.2,no assertion criteria provided,1,-,N,"ClinGen:CA254718,UniProtKB:P30793#VAR_002636,OMIM:600225.0001",1,9271,54902402,G,A,R88W,0,pathogenic,uncertain,P30793,P30793,reviewed,GCH1_HUMAN,"GTP cyclohydrolase 1, EC 3.5.4.16 (GTP cyclohydrolase I, GTP-CH-I)",GCH1 DYT5 GCH,Homo sapiens (Human),250.0,MEKGPVRAPAEKPRGARCSNGFPERDPPRPGPSRPAEKPPRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS,PF01227;,1FB1;6Z80;6Z85;6Z86;6Z87;6Z88;6Z89;7ALA;7ALB;7ALC;7ALQ;,88,R,W,True,951
13675,2193,24313,single nucleotide variant,NM_000161.3(GCH1):c.602G>A (p.Gly201Glu),2643,GCH1,HGNC:4193,Pathogenic,1,1-Oct-00,104894438,-,RCV000009856,"MONDO:MONDO:0007495,MedGen:C1851920,OMIM:128230,Orphanet:98808",Dystonia 5,germline,germline,GRCh38,NC_000014.9,14,54845792,54845792,na,na,14q22.2,no assertion criteria provided,1,-,N,"ClinGen:CA254720,UniProtKB:P30793#VAR_002645,OMIM:600225.0004",1,9274,54845792,C,T,G201E,0,pathogenic,uncertain,P30793,P30793,reviewed,GCH1_HUMAN,"GTP cyclohydrolase 1, EC 3.5.4.16 (GTP cyclohydrolase I, GTP-CH-I)",GCH1 DYT5 GCH,Homo sapiens (Human),250.0,MEKGPVRAPAEKPRGARCSNGFPERDPPRPGPSRPAEKPPRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS,PF01227;,1FB1;6Z80;6Z85;6Z86;6Z87;6Z88;6Z89;7ALA;7ALB;7ALC;7ALQ;,201,G,E,True,951
13676,2194,24317,single nucleotide variant,NM_000161.3(GCH1):c.431A>C (p.His144Pro),2643,GCH1,HGNC:4193,Pathogenic,1,1-Apr-98,104894440,-,RCV000009860,"MONDO:MONDO:0007495,MedGen:C1851920,OMIM:128230,Orphanet:98808",Dystonia 5,germline,germline,GRCh38,NC_000014.9,14,54865349,54865349,na,na,14q22.2,no assertion criteria provided,1,-,N,"ClinGen:CA254723,UniProtKB:P30793#VAR_002640,OMIM:600225.0008",1,9278,54865349,T,G,H144P,0,pathogenic,uncertain,P30793,P30793,reviewed,GCH1_HUMAN,"GTP cyclohydrolase 1, EC 3.5.4.16 (GTP cyclohydrolase I, GTP-CH-I)",GCH1 DYT5 GCH,Homo sapiens (Human),250.0,MEKGPVRAPAEKPRGARCSNGFPERDPPRPGPSRPAEKPPRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS,PF01227;,1FB1;6Z80;6Z85;6Z86;6Z87;6Z88;6Z89;7ALA;7ALB;7ALC;7ALQ;,144,H,P,True,951
13677,2195,24320,single nucleotide variant,NM_000161.3(GCH1):c.662T>C (p.Met221Thr),2643,GCH1,HGNC:4193,Pathogenic,1,10-Sep-20,104894434,-,RCV000009863|RCV001260617,"MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,Human Phenotype Ontology:HP:HP:0001249,MONDO:MONDO:0001071,MedGen:C3714756",Autosomal recessive DOPA responsive dystonia|Intellectual disability,germline;maternal,germline,GRCh38,NC_000014.9,14,54844108,54844108,na,na,14q22.2,"criteria provided, single submitter",2,-,N,"UniProtKB:P30793#VAR_016905,OMIM:600225.0011,ClinGen:CA120278",3,9281,54844108,A,G,M221T,1,pathogenic,pathogenic,P30793,P30793,reviewed,GCH1_HUMAN,"GTP cyclohydrolase 1, EC 3.5.4.16 (GTP cyclohydrolase I, GTP-CH-I)",GCH1 DYT5 GCH,Homo sapiens (Human),250.0,MEKGPVRAPAEKPRGARCSNGFPERDPPRPGPSRPAEKPPRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS,PF01227;,1FB1;6Z80;6Z85;6Z86;6Z87;6Z88;6Z89;7ALA;7ALB;7ALC;7ALQ;,221,M,T,True,951
13678,2197,24322,single nucleotide variant,NM_000161.3(GCH1):c.671A>G (p.Lys224Arg),2643,GCH1,HGNC:4193,Conflicting interpretations of pathogenicity,1,20-Oct-20,41298442,-,RCV000009865|RCV000009866|RCV000517539|RCV000525589|RCV000989227,"MONDO:MONDO:0007495,MedGen:C1851920,OMIM:128230,Orphanet:98808|MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150|MedGen:CN517202|MedGen:C0268467,OMIM:233910,Orphanet:2102,Orphanet:238583;MONDO:MONDO:0007495,MedGen:C1851920,OMIM:128230,Orphanet:98808|MedGen:C0268467,OMIM:233910,Orphanet:2102,Orphanet:238583",Dystonia 5|Autosomal recessive DOPA responsive dystonia|not provided|GTP cyclohydrolase I deficiency;Dystonia 5|GTP cyclohydrolase I deficiency,germline;unknown,germline,GRCh38,NC_000014.9,14,54844099,54844099,na,na,14q22.2,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA120280,UniProtKB:P30793#VAR_002648,OMIM:600225.0013",3,9283,54844099,T,C,K224R,1,uncertain,uncertain,P30793,P30793,reviewed,GCH1_HUMAN,"GTP cyclohydrolase 1, EC 3.5.4.16 (GTP cyclohydrolase I, GTP-CH-I)",GCH1 DYT5 GCH,Homo sapiens (Human),250.0,MEKGPVRAPAEKPRGARCSNGFPERDPPRPGPSRPAEKPPRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS,PF01227;,1FB1;6Z80;6Z85;6Z86;6Z87;6Z88;6Z89;7ALA;7ALB;7ALC;7ALQ;,224,K,R,True,951
13679,2192,24311,single nucleotide variant,NM_000161.3(GCH1):c.401A>T (p.Asp134Val),2643,GCH1,HGNC:4193,Pathogenic,1,28-Apr-95,104894437,-,RCV000009854,"MONDO:MONDO:0007495,MedGen:C1851920,OMIM:128230,Orphanet:98808",Dystonia 5,germline,germline,GRCh38,NC_000014.9,14,54865379,54865379,na,na,14q22.2,no assertion criteria provided,1,-,N,"ClinGen:CA254719,UniProtKB:P30793#VAR_002638,OMIM:600225.0002",1,9272,54865379,T,A,D134V,0,pathogenic,uncertain,P30793,P30793,reviewed,GCH1_HUMAN,"GTP cyclohydrolase 1, EC 3.5.4.16 (GTP cyclohydrolase I, GTP-CH-I)",GCH1 DYT5 GCH,Homo sapiens (Human),250.0,MEKGPVRAPAEKPRGARCSNGFPERDPPRPGPSRPAEKPPRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS,PF01227;,1FB1;6Z80;6Z85;6Z86;6Z87;6Z88;6Z89;7ALA;7ALB;7ALC;7ALQ;,134,D,V,True,951
13680,2199,24325,single nucleotide variant,NM_000161.3(GCH1):c.747G>C (p.Arg249Ser),2643,GCH1,HGNC:4193,Uncertain significance,1,8-Mar-17,104894442,-,RCV000009869|RCV000518763,"MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150|MedGen:CN169374",Autosomal recessive DOPA responsive dystonia|not specified,germline,germline,GRCh38,NC_000014.9,14,54844023,54844023,na,na,14q22.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA120281,UniProtKB:P30793#VAR_016907,OMIM:600225.0016",3,9286,54844023,C,G,R249S,1,uncertain,uncertain,P30793,P30793,reviewed,GCH1_HUMAN,"GTP cyclohydrolase 1, EC 3.5.4.16 (GTP cyclohydrolase I, GTP-CH-I)",GCH1 DYT5 GCH,Homo sapiens (Human),250.0,MEKGPVRAPAEKPRGARCSNGFPERDPPRPGPSRPAEKPPRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS,PF01227;,1FB1;6Z80;6Z85;6Z86;6Z87;6Z88;6Z89;7ALA;7ALB;7ALC;7ALQ;,249,R,S,True,951
13681,2200,24326,single nucleotide variant,NM_000161.3(GCH1):c.633G>A (p.Met211Ile),2643,GCH1,HGNC:4193,Pathogenic,1,28-Apr-95,104894443,-,RCV000009870,"MedGen:C0268467,OMIM:233910,Orphanet:2102,Orphanet:238583",GTP cyclohydrolase I deficiency,germline,germline,GRCh38,NC_000014.9,14,54844137,54844137,na,na,14q22.2,no assertion criteria provided,1,-,N,"ClinGen:CA120282,UniProtKB:P30793#VAR_002647,OMIM:600225.0017",1,9287,54844137,C,T,M211I,0,pathogenic,uncertain,P30793,P30793,reviewed,GCH1_HUMAN,"GTP cyclohydrolase 1, EC 3.5.4.16 (GTP cyclohydrolase I, GTP-CH-I)",GCH1 DYT5 GCH,Homo sapiens (Human),250.0,MEKGPVRAPAEKPRGARCSNGFPERDPPRPGPSRPAEKPPRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS,PF01227;,1FB1;6Z80;6Z85;6Z86;6Z87;6Z88;6Z89;7ALA;7ALB;7ALC;7ALQ;,211,M,I,True,951
13682,2201,24329,single nucleotide variant,NM_000161.3(GCH1):c.551G>A (p.Arg184His),2643,GCH1,HGNC:4193,Pathogenic,1,30-Dec-14,104894445,-,RCV000009873,"MedGen:C0268467,OMIM:233910,Orphanet:2102,Orphanet:238583",GTP cyclohydrolase I deficiency,germline;not applicable,germline,GRCh38,NC_000014.9,14,54845843,54845843,na,na,14q22.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA120283,UniProtKB:P30793#VAR_002643,OMIM:600225.0020",3,9290,54845843,C,T,R184H,1,pathogenic,pathogenic,P30793,P30793,reviewed,GCH1_HUMAN,"GTP cyclohydrolase 1, EC 3.5.4.16 (GTP cyclohydrolase I, GTP-CH-I)",GCH1 DYT5 GCH,Homo sapiens (Human),250.0,MEKGPVRAPAEKPRGARCSNGFPERDPPRPGPSRPAEKPPRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS,PF01227;,1FB1;6Z80;6Z85;6Z86;6Z87;6Z88;6Z89;7ALA;7ALB;7ALC;7ALQ;,184,R,H,True,951
13683,2198,24324,single nucleotide variant,NM_000161.3(GCH1):c.404T>A (p.Ile135Lys),2643,GCH1,HGNC:4193,Pathogenic,1,25-Feb-99,104894441,-,RCV000009868,"MONDO:MONDO:0007495,MedGen:C1851920,OMIM:128230,Orphanet:98808",Dystonia 5,germline,germline,GRCh38,NC_000014.9,14,54865376,54865376,na,na,14q22.2,no assertion criteria provided,1,-,N,"ClinGen:CA254726,UniProtKB:P30793#VAR_016896,OMIM:600225.0015",1,9285,54865376,A,T,I135K,0,pathogenic,uncertain,P30793,P30793,reviewed,GCH1_HUMAN,"GTP cyclohydrolase 1, EC 3.5.4.16 (GTP cyclohydrolase I, GTP-CH-I)",GCH1 DYT5 GCH,Homo sapiens (Human),250.0,MEKGPVRAPAEKPRGARCSNGFPERDPPRPGPSRPAEKPPRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS,PF01227;,1FB1;6Z80;6Z85;6Z86;6Z87;6Z88;6Z89;7ALA;7ALB;7ALC;7ALQ;,135,I,K,True,951
13684,14018,320725,single nucleotide variant,NM_000161.3(GCH1):c.68C>T (p.Pro23Leu),2643,GCH1,HGNC:4193,Conflicting interpretations of pathogenicity,0,1-Apr-20,41298432,-,RCV000263675|RCV000430107|RCV000455719|RCV001084264|RCV001111087,"MedGen:C0268467,OMIM:233910,Orphanet:2102,Orphanet:238583|MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0007495,MedGen:C1851920,OMIM:128230,Orphanet:98808;MedGen:C0268467,OMIM:233910,Orphanet:2102,Orphanet:238583|MONDO:MONDO:0007495,MedGen:C1851920,OMIM:128230,Orphanet:98808",GTP cyclohydrolase I deficiency|not provided|not specified|Dystonia 5;GTP cyclohydrolase I deficiency|Dystonia 5,germline;unknown,germline,GRCh38,NC_000014.9,14,54902596,54902596,na,na,14q22.2,"criteria provided, conflicting interpretations",8,-,N,"ClinGen:CA7193683,UniProtKB:P30793#VAR_002633",2,313398,54902596,G,A,P23L,1,uncertain,uncertain,P30793,P30793,reviewed,GCH1_HUMAN,"GTP cyclohydrolase 1, EC 3.5.4.16 (GTP cyclohydrolase I, GTP-CH-I)",GCH1 DYT5 GCH,Homo sapiens (Human),250.0,MEKGPVRAPAEKPRGARCSNGFPERDPPRPGPSRPAEKPPRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS,PF01227;,1FB1;6Z80;6Z85;6Z86;6Z87;6Z88;6Z89;7ALA;7ALB;7ALC;7ALQ;,23,P,L,True,951
13685,3081,27508,single nucleotide variant,NM_000365.6(TPI1):c.367G>A (p.Gly123Arg),7167,TPI1,HGNC:12009,Pathogenic,1,1-Mar-92,121964846,-,RCV000013285,MedGen:C4016412,Triosephosphate isomerase manchester,germline,germline,GRCh38,NC_000012.12,12,6869300,6869300,na,na,12p13.31,no assertion criteria provided,1,-,N,"ClinGen:CA122425,UniProtKB:P60174#VAR_007537,OMIM:190450.0002",1,12469,6869300,G,A,G123R,0,pathogenic,uncertain,P60174,P60174,reviewed,TPIS_HUMAN,"Triosephosphate isomerase, TIM, EC 5.3.1.1 (Methylglyoxal synthase, EC 4.2.3.3) (Triose-phosphate isomerase)",TPI1 TPI,Homo sapiens (Human),249.0,MAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ,PF00121;,1HTI;1KLG;1KLU;1WYI;2IAM;2IAN;2JK2;2VOM;4BR1;4E41;4POC;4POD;4UNK;4UNL;4ZVJ;6C2G;6D43;6NLH;6UP1;6UP5;6UP8;6UPF;,123,G,R,True,952
13686,3083,27510,single nucleotide variant,NM_000365.6(TPI1):c.125G>A (p.Cys42Tyr),7167,TPI1,HGNC:12009,Pathogenic,1,1-Jan-97,121964848,-,RCV000013289,"MONDO:MONDO:0014221,MedGen:C1860808,OMIM:615512,Orphanet:868",Triosephosphate isomerase deficiency,germline,germline,GRCh38,NC_000012.12,12,6868873,6868873,na,na,12p13.31,no assertion criteria provided,1,-,N,"ClinGen:CA122432,UniProtKB:P60174#VAR_007534,OMIM:190450.0004",1,12471,6868873,G,A,C42Y,0,pathogenic,uncertain,P60174,P60174,reviewed,TPIS_HUMAN,"Triosephosphate isomerase, TIM, EC 5.3.1.1 (Methylglyoxal synthase, EC 4.2.3.3) (Triose-phosphate isomerase)",TPI1 TPI,Homo sapiens (Human),249.0,MAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ,PF00121;,1HTI;1KLG;1KLU;1WYI;2IAM;2IAN;2JK2;2VOM;4BR1;4E41;4POC;4POD;4UNK;4UNL;4ZVJ;6C2G;6D43;6NLH;6UP1;6UP5;6UP8;6UPF;,42,C,Y,True,952
13687,3082,27509,single nucleotide variant,NM_000365.6(TPI1):c.721T>C (p.Phe241Leu),7167,TPI1,HGNC:12009,Pathogenic,1,15-Nov-01,121964847,-,RCV000013287,"MONDO:MONDO:0014221,MedGen:C1860808,OMIM:615512,Orphanet:868",Triosephosphate isomerase deficiency,germline,germline,GRCh38,NC_000012.12,12,6870354,6870354,na,na,12p13.31,no assertion criteria provided,1,-,N,"ClinGen:CA122429,UniProtKB:P60174#VAR_007541,OMIM:190450.0003",1,12470,6870354,T,C,F241L,0,pathogenic,uncertain,P60174,P60174,reviewed,TPIS_HUMAN,"Triosephosphate isomerase, TIM, EC 5.3.1.1 (Methylglyoxal synthase, EC 4.2.3.3) (Triose-phosphate isomerase)",TPI1 TPI,Homo sapiens (Human),249.0,MAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ,PF00121;,1HTI;1KLG;1KLU;1WYI;2IAM;2IAN;2JK2;2VOM;4BR1;4E41;4POC;4POD;4UNK;4UNL;4ZVJ;6C2G;6D43;6NLH;6UP1;6UP5;6UP8;6UPF;,241,F,L,True,952
13688,3084,27511,single nucleotide variant,NM_000365.6(TPI1):c.511A>G (p.Ile171Val),7167,TPI1,HGNC:12009,Pathogenic,1,1-Jan-97,121964849,-,RCV000013290,"MONDO:MONDO:0014221,MedGen:C1860808,OMIM:615512,Orphanet:868",Triosephosphate isomerase deficiency,germline,germline,GRCh38,NC_000012.12,12,6869741,6869741,na,na,12p13.31,no assertion criteria provided,1,-,N,"ClinGen:CA122434,UniProtKB:P60174#VAR_007539,OMIM:190450.0005",1,12472,6869741,A,G,I171V,0,pathogenic,uncertain,P60174,P60174,reviewed,TPIS_HUMAN,"Triosephosphate isomerase, TIM, EC 5.3.1.1 (Methylglyoxal synthase, EC 4.2.3.3) (Triose-phosphate isomerase)",TPI1 TPI,Homo sapiens (Human),249.0,MAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ,PF00121;,1HTI;1KLG;1KLU;1WYI;2IAM;2IAN;2JK2;2VOM;4BR1;4E41;4POC;4POD;4UNK;4UNL;4ZVJ;6C2G;6D43;6NLH;6UP1;6UP5;6UP8;6UPF;,171,I,V,True,952
13689,3080,27507,single nucleotide variant,NM_000365.6(TPI1):c.315G>C (p.Glu105Asp),7167,TPI1,HGNC:12009,Pathogenic,1,17-Dec-18,121964845,-,RCV000013284,"MONDO:MONDO:0014221,MedGen:C1860808,OMIM:615512,Orphanet:868",Triosephosphate isomerase deficiency,germline,germline,GRCh38,NC_000012.12,12,6869174,6869174,na,na,12p13.31,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA122423,UniProtKB:P60174#VAR_007536,OMIM:190450.0001",3,12468,6869174,G,C,E105D,2,pathogenic,pathogenic,P60174,P60174,reviewed,TPIS_HUMAN,"Triosephosphate isomerase, TIM, EC 5.3.1.1 (Methylglyoxal synthase, EC 4.2.3.3) (Triose-phosphate isomerase)",TPI1 TPI,Homo sapiens (Human),249.0,MAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ,PF00121;,1HTI;1KLG;1KLU;1WYI;2IAM;2IAN;2JK2;2VOM;4BR1;4E41;4POC;4POD;4UNK;4UNL;4ZVJ;6C2G;6D43;6NLH;6UP1;6UP5;6UP8;6UPF;,105,E,D,True,952
13690,3794,29221,single nucleotide variant,NM_000530.8(MPZ):c.266T>A (p.Ile89Asn),4359,MPZ,HGNC:7225,Uncertain significance,0,19-Jul-20,267607244,-,RCV000521368|RCV001339130,"MedGen:CN169374|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753","not specified|Charcot-Marie-Tooth disease, type I",germline,germline,GRCh38,NC_000001.11,1,161306890,161306890,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA351452,UniProtKB:P25189#VAR_015974,OMIM:159440.0017,ClinVar:14182",2,242786,161306890,A,T,I89N,2,uncertain,uncertain,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,89,I,N,True,953
13691,3795,29222,single nucleotide variant,NM_000530.8(MPZ):c.103G>T (p.Asp35Tyr),4359,MPZ,HGNC:7225,Pathogenic/Likely pathogenic,1,11-Dec-19,121913596,-,RCV000015247|RCV000638171|RCV001173698,"MONDO:MONDO:0011909,MedGen:C1843075,OMIM:607791,Orphanet:100046|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease dominant intermediate d|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease",germline,germline,GRCh38,NC_000001.11,1,161307389,161307389,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA250638,UniProtKB:P25189#VAR_015971,OMIM:159440.0018",3,14183,161307389,C,A,D35Y,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,35,D,Y,True,953
13692,3793,29220,single nucleotide variant,NM_000530.8(MPZ):c.371C>T (p.Thr124Met),4359,MPZ,HGNC:7225,Pathogenic,1,18-Dec-19,121913595,-,RCV000015244|RCV000015245|RCV000192248|RCV000517355|RCV000638155|RCV000763262|RCV001262744,"MONDO:MONDO:0011903,MedGen:C1843153,OMIM:607736,Orphanet:99943|MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MedGen:CN517202|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|7 conditions|MONDO:MONDO:0011909,MedGen:C1843075,OMIM:607791,Orphanet:100046","Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type I|7 conditions|Charcot-Marie-Tooth disease dominant intermediate d",germline;unknown,germline,GRCh38,NC_000001.11,1,161306785,161306785,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA257158,UniProtKB:P25189#VAR_004529,OMIM:159440.0016",3,14181,161306785,G,A,T124M,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,124,T,M,True,953
13693,3796,29223,single nucleotide variant,NM_000530.8(MPZ):c.224A>T (p.Asp75Val),4359,MPZ,HGNC:7225,Pathogenic,1,9-Dec-19,121913597,-,RCV000015248|RCV000190346|RCV000192247|RCV001070451,"MONDO:MONDO:0011903,MedGen:C1843153,OMIM:607736,Orphanet:99943|MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753","Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I",germline,germline,GRCh38,NC_000001.11,1,161307268,161307268,na,na,1q23.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA257160,UniProtKB:P25189#VAR_015973,OMIM:159440.0019",3,14184,161307268,T,A,D75V,1,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,75,D,V,True,953
13694,3792,29219,single nucleotide variant,NM_000530.8(MPZ):c.341T>C (p.Ile114Thr),4359,MPZ,HGNC:7225,Pathogenic,1,15-Nov-19,267607241,-,RCV000541724|RCV000789491,"MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease",germline,germline,GRCh38,NC_000001.11,1,161306815,161306815,na,na,1q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA351444,UniProtKB:P25189#VAR_004525,OMIM:159440.0015,ClinVar:14180",2,242787,161306815,A,G,I114T,1,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,114,I,T,True,953
13695,3791,29218,single nucleotide variant,NM_000530.8(MPZ):c.242A>G (p.His81Arg),4359,MPZ,HGNC:7225,Pathogenic,1,28-May-15,121913594,-,RCV000015242|RCV000518134|RCV000789479,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MedGen:CN517202|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease, demyelinating, type 1b|not provided|Charcot-Marie-Tooth disease",germline;unknown,germline,GRCh38,NC_000001.11,1,161306914,161306914,na,na,1q23.3,"criteria provided, single submitter",4,-,N,"ClinGen:CA341323,UniProtKB:P25189#VAR_004513,OMIM:159440.0014",3,14179,161306914,T,C,H81R,1,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,81,H,R,True,953
13696,3790,29216,single nucleotide variant,NM_000530.8(MPZ):c.188C>T (p.Ser63Phe),4359,MPZ,HGNC:7225,Pathogenic/Likely pathogenic,1,24-Jul-19,121913585,-,RCV000015240|RCV001173697|RCV001224917,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753","Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I",germline,germline,GRCh38,NC_000001.11,1,161307304,161307304,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA257156,UniProtKB:P25189#VAR_004509,OMIM:159440.0012",3,14177,161307304,G,A,S63F,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,63,S,F,True,953
13697,3782,29206,single nucleotide variant,NM_000530.8(MPZ):c.270C>A (p.Asp90Glu),4359,MPZ,HGNC:7225,Pathogenic,1,21-Oct-19,121913584,-,RCV000015230|RCV000704216|RCV000789441,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease",germline,germline,GRCh38,NC_000001.11,1,161306886,161306886,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA257144,UniProtKB:P25189#VAR_004515,OMIM:159440.0002",3,14167,161306886,G,T,D90E,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,90,D,E,True,953
13698,3785,29211,single nucleotide variant,NM_000530.8(MPZ):c.404T>C (p.Ile135Thr),4359,MPZ,HGNC:7225,Pathogenic,1,6-Jan-17,121913587,-,RCV000015235|RCV000425572,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MedGen:CN517202","Charcot-Marie-Tooth disease, demyelinating, type 1b|not provided",germline,germline,GRCh38,NC_000001.11,1,161306752,161306752,na,na,1q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA257146,UniProtKB:P25189#VAR_004539,OMIM:159440.0007",3,14172,161306752,A,G,I135T,1,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,135,I,T,True,953
13699,3788,29214,single nucleotide variant,NM_000530.8(MPZ):c.292C>T (p.Arg98Cys),4359,MPZ,HGNC:7225,Pathogenic,1,21-May-20,121913590,-,RCV000015238|RCV000237048|RCV000548074,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MedGen:CN517202|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753","Charcot-Marie-Tooth disease, demyelinating, type 1b|not provided|Charcot-Marie-Tooth disease, type I",germline;unknown,germline,GRCh38,NC_000001.11,1,161306864,161306864,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA257152,UniProtKB:P25189#VAR_004518,OMIM:159440.0010",3,14175,161306864,G,A,R98C,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,98,R,C,True,953
13700,3787,29213,single nucleotide variant,NM_000530.8(MPZ):c.293G>C (p.Arg98Pro),4359,MPZ,HGNC:7225,Pathogenic,1,21-Apr-20,121913589,-,RCV000015237|RCV000638160|RCV000790115|RCV001000949,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MedGen:CN235283","Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|none provided",germline,germline,GRCh38,NC_000001.11,1,161306863,161306863,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA257150,UniProtKB:P25189#VAR_004520,OMIM:159440.0009",3,14174,161306863,C,G,R98P,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,98,R,P,True,953
13701,3786,29212,single nucleotide variant,NM_000530.8(MPZ):c.409G>A (p.Gly137Ser),4359,MPZ,HGNC:7225,Likely pathogenic,1,6-Nov-17,121913588,-,RCV000015236|RCV000462311|RCV000712317,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MedGen:CN517202","Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided",germline,germline,GRCh38,NC_000001.11,1,161306747,161306747,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA257148,UniProtKB:P25189#VAR_004540,OMIM:159440.0008",3,14173,161306747,C,T,G137S,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,137,G,S,True,953
13702,3784,29209,single nucleotide variant,NM_000530.8(MPZ):c.499G>C (p.Gly167Arg),4359,MPZ,HGNC:7225,Pathogenic,1,11-Mar-14,121913586,-,RCV000015233|RCV000032123|RCV000198029,"MedGen:C4016264|MONDO:MONDO:0007790,MedGen:C0011195,OMIM:145900,Orphanet:64748|7 conditions","Dejerine-Sottas syndrome, autosomal dominant|Dejerine-Sottas disease|7 conditions",de novo;germline,germline,GRCh38,NC_000001.11,1,161306414,161306414,na,na,1q23.3,"criteria provided, single submitter",4,-,N,"ClinGen:CA123798,UniProtKB:P25189#VAR_004544,OMIM:159440.0005",3,14170,161306414,C,G,G167R,1,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,167,G,R,True,953
13703,3783,29208,single nucleotide variant,NM_000530.8(MPZ):c.188C>G (p.Ser63Cys),4359,MPZ,HGNC:7225,Pathogenic,1,19-Nov-19,121913585,-,RCV000015232|RCV000390750|RCV000789439|RCV000803240,"MedGen:C4016264|MedGen:CN517202|MONDO:MONDO:0007790,MedGen:C0011195,OMIM:145900,Orphanet:64748|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753","Dejerine-Sottas syndrome, autosomal dominant|not provided|Dejerine-Sottas disease|Charcot-Marie-Tooth disease, type I",germline,germline,GRCh38,NC_000001.11,1,161307304,161307304,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA123796,UniProtKB:P25189#VAR_004508,OMIM:159440.0004",3,14169,161307304,G,C,S63C,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,63,S,C,True,953
13704,3797,29224,single nucleotide variant,NM_000530.8(MPZ):c.131C>T (p.Ser44Phe),4359,MPZ,HGNC:7225,Pathogenic,1,23-Oct-20,121913598,-,RCV000015249|RCV000190345|RCV000638152|RCV000790099|RCV001093014,"MONDO:MONDO:0011889,MedGen:C3888087,OMIM:607677,Orphanet:99942|MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MedGen:CN517202","Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|not provided",germline,germline,GRCh38,NC_000001.11,1,161307361,161307361,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA257162,UniProtKB:P25189#VAR_004503,OMIM:159440.0020",3,14185,161307361,G,A,S44F,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,44,S,F,True,953
13705,3781,29205,single nucleotide variant,NM_000530.8(MPZ):c.286A>G (p.Lys96Glu),4359,MPZ,HGNC:7225,Pathogenic,1,26-Feb-19,121913583,-,RCV000015229|RCV000789440|RCV000812845,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753","Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I",germline,germline,GRCh38,NC_000001.11,1,161306870,161306870,na,na,1q23.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA257142,UniProtKB:P25189#VAR_004517,OMIM:159440.0001",3,14166,161306870,T,C,K96E,1,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,96,K,E,True,953
13706,3789,29215,single nucleotide variant,NM_000530.8(MPZ):c.293G>A (p.Arg98His),4359,MPZ,HGNC:7225,Pathogenic/Likely pathogenic,1,31-Jul-19,121913589,-,RCV000015239|RCV000196172|RCV000376287|RCV000415463|RCV001173692,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MedGen:CN517202|Human Phenotype Ontology:HP:0003442,Human Phenotype Ontology:HP:0003714,Human Phenotype Ontology:HP:0006975,Human Phenotype Ontology:HP:0008944,Human Phenotype Ontology:HP:0008949,Human Phenotype Ontology:HP:0009001,MedGen:C1836451;Human Phenotype Ontology:HP:0002460,Human Phenotype Ontology:HP:0002598,Human Phenotype Ontology:HP:0002935,Human Phenotype Ontology:HP:0003497,Human Phenotype Ontology:HP:0006940,Human Phenotype Ontology:HP:0009008,MedGen:C0427065;Human Phenotype Ontology:HP:0001761,MedGen:C0728829;Human Phenotype Ontology:HP:0000761,Human Phenotype Ontology:HP:0000762,Human Phenotype Ontology:HP:0007118,Human Phenotype Ontology:HP:0007218,Human Phenotype Ontology:HP:0007231,MedGen:C1857640;Human Phenotype Ontology:HP:0000763,Human Phenotype Ontology:HP:0003410,Human Phenotype Ontology:HP:0006815,Human Phenotype Ontology:HP:0007043,Human Phenotype Ontology:HP:0007142,MONDO:MONDO:0002321,MedGen:C0151313|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided|Distal lower limb amyotrophy;Distal muscle weakness;Pes cavus;Decreased nerve conduction velocity;Sensory neuropathy|Charcot-Marie-Tooth disease",germline;unknown,germline,GRCh38,NC_000001.11,1,161306863,161306863,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA257154,UniProtKB:P25189#VAR_004519,OMIM:159440.0011",3,14176,161306863,C,T,R98H,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,98,R,H,True,953
13707,11558,185952,single nucleotide variant,NM_000530.8(MPZ):c.182A>G (p.Asp61Gly),4359,MPZ,HGNC:7225,Pathogenic/Likely pathogenic,1,1-May-19,786204119,-,RCV000168067|RCV000236489|RCV000790119,"MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MedGen:CN517202|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease",germline,germline,GRCh38,NC_000001.11,1,161307310,161307310,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA334216,UniProtKB:P25189#VAR_031885",2,188168,161307310,T,C,D61G,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,61,D,G,True,953
13708,12115,204408,single nucleotide variant,NM_000530.8(MPZ):c.487G>A (p.Gly163Arg),4359,MPZ,HGNC:7225,Pathogenic,1,3-Dec-19,281865128,-,RCV000193606|RCV000538322|RCV000789471,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease",germline,germline,GRCh38,NC_000001.11,1,161306426,161306426,na,na,1q23.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA347390,UniProtKB:P25189#VAR_004542",3,208148,161306426,C,T,G163R,1,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,163,G,R,True,953
13709,3799,29226,single nucleotide variant,NM_000530.8(MPZ):c.308G>A (p.Gly103Glu),4359,MPZ,HGNC:7225,Likely pathogenic,1,14-May-19,121913600,-,RCV000015251|RCV000536804,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753","Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I",germline;unknown,germline,GRCh38,NC_000001.11,1,161306848,161306848,na,na,1q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA257164,UniProtKB:P25189#VAR_015976,OMIM:159440.0022",3,14187,161306848,C,T,G103E,1,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,103,G,E,True,953
13710,12886,244253,single nucleotide variant,NM_000530.8(MPZ):c.356A>G (p.Tyr119Cys),4359,MPZ,HGNC:7225,Pathogenic/Likely pathogenic,1,13-Dec-19,879254038,-,RCV000237035|RCV000638165|RCV000790120,"MedGen:CN517202|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","not provided|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease",germline,germline,GRCh38,NC_000001.11,1,161306800,161306800,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA10584144,UniProtKB:P25189#VAR_031891",2,245997,161306800,T,C,Y119C,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,119,Y,C,True,953
13711,12885,244171,single nucleotide variant,NM_000530.8(MPZ):c.403A>C (p.Ile135Leu),4359,MPZ,HGNC:7225,Pathogenic,1,18-Aug-15,879253858,-,RCV000235064|RCV000789436,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease",germline,germline,GRCh38,NC_000001.11,1,161306753,161306753,na,na,1q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA10584090,UniProtKB:P25189#VAR_004538",2,243089,161306753,T,G,I135L,1,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,135,I,L,True,953
13712,12696,231450,single nucleotide variant,NM_000530.8(MPZ):c.731G>T (p.Arg244Leu),4359,MPZ,HGNC:7225,Uncertain significance,0,6-Oct-20,749722729,-,RCV000219209|RCV001038864,"MedGen:CN517202|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753","not provided|Charcot-Marie-Tooth disease, type I",germline,germline,GRCh38,NC_000001.11,1,161305892,161305892,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA1210056,UniProtKB:P25189#VAR_004545",2,234764,161305892,C,A,R244L,2,uncertain,uncertain,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,244,R,L,True,953
13713,12272,213795,single nucleotide variant,NM_000530.8(MPZ):c.90C>G (p.Ile30Met),4359,MPZ,HGNC:7225,Pathogenic,1,1-May-19,770546306,-,RCV000464045|RCV000712322|RCV000789438,"MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MedGen:CN517202|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease",germline;unknown,germline,GRCh38,NC_000001.11,1,161307402,161307402,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA277615,UniProtKB:P25189#VAR_004500",2,217235,161307402,G,C,I30M,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,30,I,M,True,953
13714,12271,213794,single nucleotide variant,NM_000530.8(MPZ):c.116A>C (p.His39Pro),4359,MPZ,HGNC:7225,Pathogenic,1,3-Jan-20,371856018,-,RCV000206430|RCV000236108|RCV001002484,"MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MedGen:CN517202|MedGen:CN169374","Charcot-Marie-Tooth disease, type I|not provided|not specified",germline;unknown,germline,GRCh38,NC_000001.11,1,161307376,161307376,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA347518,UniProtKB:P25189#VAR_054393",2,217232,161307376,T,G,H39P,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,39,H,P,True,953
13715,6600,49446,single nucleotide variant,NM_000530.8(MPZ):c.670G>T (p.Asp224Tyr),4359,MPZ,HGNC:7225,Pathogenic,1,24-Apr-18,267607247,-,RCV000033921|RCV000700463|RCV000789431,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease",germline,germline,GRCh38,NC_000001.11,1,161305953,161305953,na,na,1q23.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA343909,UniProtKB:P25189#VAR_054397",3,41024,161305953,C,A,D224Y,1,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,224,D,Y,True,953
13716,6599,49444,single nucleotide variant,NM_000530.8(MPZ):c.487G>C (p.Gly163Arg),4359,MPZ,HGNC:7225,Pathogenic/Likely pathogenic,1,23-Dec-19,281865128,-,RCV000033919|RCV000205003|RCV000217802|RCV000789486,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MedGen:CN517202|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease",germline,germline,GRCh38,NC_000001.11,1,161306426,161306426,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA339741,UniProtKB:P25189#VAR_004542",3,41022,161306426,C,G,G163R,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,163,G,R,True,953
13717,6598,49443,single nucleotide variant,NM_000530.8(MPZ):c.389A>G (p.Lys130Arg),4359,MPZ,HGNC:7225,Conflicting interpretations of pathogenicity,1,28-May-19,281865127,-,RCV000033918|RCV000516461|RCV000819474,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MedGen:CN517202|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753","Charcot-Marie-Tooth disease, demyelinating, type 1b|not provided|Charcot-Marie-Tooth disease, type I",germline;unknown,germline,GRCh38,NC_000001.11,1,161306767,161306767,na,na,1q23.3,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA243183,UniProtKB:P25189#VAR_004534",3,41021,161306767,T,C,K130R,1,uncertain,uncertain,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,130,K,R,True,953
13718,3798,29225,single nucleotide variant,NM_000530.8(MPZ):c.393C>A (p.Asn131Lys),4359,MPZ,HGNC:7225,Pathogenic,1,4-Dec-19,121913599,-,RCV000015250|RCV000192587|RCV000517209|RCV001060346,"MONDO:MONDO:0008392,MedGen:C0205713,OMIM:180800,Orphanet:3115|MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MedGen:CN517202|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753","Roussy-Lvy syndrome|Charcot-Marie-Tooth disease, demyelinating, type 1b|not provided|Charcot-Marie-Tooth disease, type I",germline,germline,GRCh38,NC_000001.11,1,161306763,161306763,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA123803,UniProtKB:P25189#VAR_015978,OMIM:159440.0021",3,14186,161306763,G,T,N131K,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,131,N,K,True,953
13719,6596,49438,single nucleotide variant,NM_000530.8(MPZ):c.241C>T (p.His81Tyr),4359,MPZ,HGNC:7225,Conflicting interpretations of pathogenicity,1,14-Aug-19,281865123,-,RCV000033913|RCV000789424,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease",germline,germline,GRCh38,NC_000001.11,1,161306915,161306915,na,na,1q23.3,no assertion criteria provided,3,-,N,"ClinVar:208147,ClinGen:CA343894,UniProtKB:P25189#VAR_031888",3,41016,161306915,G,A,H81Y,0,uncertain,uncertain,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,81,H,Y,True,953
13720,5715,38401,single nucleotide variant,NM_000530.8(MPZ):c.346A>C (p.Asn116His),4359,MPZ,HGNC:7225,Uncertain significance,0,-,267607242,-,RCV000789492,"MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166",Charcot-Marie-Tooth disease,germline,germline,GRCh38,NC_000001.11,1,161306810,161306810,na,na,1q23.3,no assertion criteria provided,1,-,N,"UniProtKB:P25189#VAR_004526,OMIM:159440.0015,ClinVar:14180",2,242748,161306810,T,G,N116H,0,uncertain,uncertain,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,116,N,H,True,953
13721,6597,49442,single nucleotide variant,NM_000530.8(MPZ):c.337G>T (p.Val113Phe),4359,MPZ,HGNC:7225,Uncertain significance,1,21-Aug-19,281865126,-,RCV000033917|RCV000657923|RCV000789425|RCV001208935,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MedGen:CN517202|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753","Charcot-Marie-Tooth disease, demyelinating, type 1b|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I",germline,germline,GRCh38,NC_000001.11,1,161306819,161306819,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinVar:208147,ClinGen:CA343905,UniProtKB:P25189#VAR_031890",3,41020,161306819,C,A,V113F,2,uncertain,uncertain,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,113,V,F,True,953
13722,5717,38403,single nucleotide variant,NM_000530.8(MPZ):c.486C>G (p.Ile162Met),4359,MPZ,HGNC:7225,Uncertain significance,0,19-Jul-20,267607246,-,RCV001308866,"MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753","Charcot-Marie-Tooth disease, type I",germline,germline,GRCh38,NC_000001.11,1,161306427,161306427,na,na,1q23.3,"criteria provided, single submitter",1,-,N,"ClinVar:14182,UniProtKB:P25189#VAR_015980,OMIM:159440.0017",2,242746,161306427,G,C,I162M,1,uncertain,uncertain,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,162,I,M,True,953
13723,5718,38404,single nucleotide variant,NM_000530.8(MPZ):c.274G>A (p.Val92Met),4359,MPZ,HGNC:7225,Uncertain significance,0,19-Jul-20,267607245,-,RCV000519851|RCV001323340,"MedGen:CN169374|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753","not specified|Charcot-Marie-Tooth disease, type I",germline,germline,GRCh38,NC_000001.11,1,161306882,161306882,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA351456,UniProtKB:P25189#VAR_015975,OMIM:159440.0017,ClinVar:14182",2,242745,161306882,C,T,V92M,2,uncertain,uncertain,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,92,V,M,True,953
13724,5716,38402,single nucleotide variant,NM_000530.8(MPZ):c.382G>A (p.Asp128Asn),4359,MPZ,HGNC:7225,Likely pathogenic,1,29-Oct-18,267607243,-,RCV000790098|RCV000813380,"MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753","Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I",germline,germline,GRCh38,NC_000001.11,1,161306774,161306774,na,na,1q23.3,"criteria provided, single submitter",2,-,N,"UniProtKB:P25189#VAR_004533,OMIM:159440.0015,ClinVar:14180",2,242747,161306774,C,T,D128N,1,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,128,D,N,True,953
13725,3802,29230,single nucleotide variant,NM_000530.8(MPZ):c.434A>C (p.Tyr145Ser),4359,MPZ,HGNC:7225,Pathogenic,1,17-Dec-19,121913603,-,RCV000015255|RCV000234112|RCV000235936|RCV000763260,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MedGen:CN517202|7 conditions","Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided|7 conditions",germline;unknown,germline,GRCh38,NC_000001.11,1,161306722,161306722,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"OMIM:159440.0026,ClinGen:CA257166,UniProtKB:P25189#VAR_029983",3,14191,161306722,T,G,Y145S,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,145,Y,S,True,953
13726,3803,29232,single nucleotide variant,NM_000530.8(MPZ):c.178G>C (p.Asp60His),4359,MPZ,HGNC:7225,Pathogenic,1,13-Jul-04,121913604,-,RCV000015257,"MONDO:MONDO:0011889,MedGen:C3888087,OMIM:607677,Orphanet:99942",Charcot-Marie-Tooth disease type 2I,germline,germline,GRCh38,NC_000001.11,1,161307314,161307314,na,na,1q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA257168,UniProtKB:P25189#VAR_029972,OMIM:159440.0028",1,14193,161307314,C,G,D60H,0,pathogenic,uncertain,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,60,D,H,True,953
13727,3801,29228,single nucleotide variant,NM_000530.8(MPZ):c.184A>T (p.Ile62Phe),4359,MPZ,HGNC:7225,Pathogenic,1,12-Apr-99,121913602,-,RCV000015253,MedGen:C4016266,"Charcot-Marie-Tooth disease, type 1b, with focally folded myelin sheaths",germline,germline,GRCh38,NC_000001.11,1,161307308,161307308,na,na,1q23.3,no assertion criteria provided,1,-,N,"UniProtKB:P25189#VAR_015972,OMIM:159440.0024,ClinGen:CA123807",1,14189,161307308,T,A,I62F,0,pathogenic,uncertain,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,62,I,F,True,953
13728,3805,29234,single nucleotide variant,NM_000530.8(MPZ):c.290A>T (p.Glu97Val),4359,MPZ,HGNC:7225,Pathogenic,1,24-Aug-04,121913606,-,RCV000015259,"MONDO:MONDO:0011903,MedGen:C1843153,OMIM:607736,Orphanet:99943",Charcot-Marie-Tooth disease type 2J,germline,germline,GRCh38,NC_000001.11,1,161306866,161306866,na,na,1q23.3,no assertion criteria provided,1,-,N,"UniProtKB:P25189#VAR_029975,OMIM:159440.0030,ClinGen:CA257172",1,14195,161306866,T,A,E97V,0,pathogenic,uncertain,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,97,E,V,True,953
13729,3804,29233,single nucleotide variant,NM_000530.8(MPZ):c.186C>G (p.Ile62Met),4359,MPZ,HGNC:7225,Uncertain significance,1,27-Aug-19,121913605,-,RCV000015258|RCV000799870|RCV001196641,"MONDO:MONDO:0011889,MedGen:C3888087,OMIM:607677,Orphanet:99942|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MONDO:MONDO:0008392,MedGen:C0205713,OMIM:180800,Orphanet:3115","Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease, type I|Roussy-Lvy syndrome",germline;unknown,germline,GRCh38,NC_000001.11,1,161307306,161307306,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA257170,UniProtKB:P25189#VAR_029973,OMIM:159440.0029",3,14194,161307306,G,C,I62M,2,uncertain,uncertain,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,62,I,M,True,953
13730,12114,204407,single nucleotide variant,NM_000530.8(MPZ):c.499G>A (p.Gly167Arg),4359,MPZ,HGNC:7225,Pathogenic,1,26-Nov-19,121913586,-,RCV000194294|RCV000789484|RCV001053594,"MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753","Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I",germline,germline,GRCh38,NC_000001.11,1,161306414,161306414,na,na,1q23.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA347426,UniProtKB:P25189#VAR_004544",3,208149,161306414,C,T,G167R,1,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,167,G,R,True,953
13731,3806,29235,single nucleotide variant,NM_000530.8(MPZ):c.371C>A (p.Thr124Lys),4359,MPZ,HGNC:7225,Pathogenic,1,8-Jun-04,121913595,-,RCV000015260,"MONDO:MONDO:0020765,MedGen:C4722277,OMIM:618184",Congenital hypomyelinating neuropathy 2,germline,germline,GRCh38,NC_000001.11,1,161306785,161306785,na,na,1q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA123809,UniProtKB:P25189#VAR_029978,OMIM:159440.0031",1,14196,161306785,G,T,T124K,0,pathogenic,uncertain,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,124,T,K,True,953
13732,3800,29227,single nucleotide variant,NM_000530.8(MPZ):c.233C>T (p.Ser78Leu),4359,MPZ,HGNC:7225,Pathogenic,1,23-Oct-20,121913601,-,RCV000015252|RCV000201182|RCV000436362|RCV000546842|RCV001173691,"MedGen:C4016266|MONDO:MONDO:0007307,MedGen:C0270912,OMIM:118200,Orphanet:101082|MedGen:CN517202|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166","Charcot-Marie-Tooth disease, type 1b, with focally folded myelin sheaths|Charcot-Marie-Tooth disease, demyelinating, type 1b|not provided|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease",germline,germline,GRCh38,NC_000001.11,1,161307259,161307259,na,na,1q23.3,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA123805,UniProtKB:P25189#VAR_004512,OMIM:159440.0023",3,14188,161307259,G,A,S78L,2,pathogenic,pathogenic,P25189,P25189,reviewed,MYP0_HUMAN,"Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)",MPZ,Homo sapiens (Human),248.0,MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,PF10570;PF07686;,3OAI;,78,S,L,True,953
13733,6504,48422,single nucleotide variant,NM_001289.6(CLIC2):c.303C>G (p.His101Gln),1193,CLIC2,HGNC:2063,Pathogenic,1,15-Oct-12,398122917,-,RCV000033043,"MONDO:MONDO:0010473,MedGen:C3550913,OMIM:300886,Orphanet:324410","Mental retardation, X-linked, syndromic 32",germline,germline,GRCh38,NC_000023.11,X,155280059,155280059,na,na,Xq28,no assertion criteria provided,1,-,N,"ClinGen:CA130595,UniProtKB:O15247#VAR_068898,OMIM:300138.0001",1,39823,155280059,G,C,H101Q,0,pathogenic,uncertain,O15247,O15247,reviewed,CLIC2_HUMAN,Chloride intracellular channel protein 2 (XAP121),CLIC2,Homo sapiens (Human),247.0,MSGLRPGTQVDPEIELFVKAGSDGESIGNCPFCQRLFMILWLKGVKFNVTTVDMTRKPEELKDLAPGTNPPFLVYNKELKTDFIKIEEFLEQTLAPPRYPHLSPKYKESFDVGCNLFAKFSAYIKNTQKEANKNFEKSLLKEFKRLDDYLNTPLLDEIDPDSAEEPPVSRRLFLDGDQLTLADCSLLPKLNIIKVAAKKYRDFDIPAEFSGVWRYLHNAYAREEFTHTCPEDKEIENTYANVAKQKS,PF13409;,2PER;2R4V;2R5G;,101,H,Q,True,954
13734,5398,33997,single nucleotide variant,NM_000303.3(PMM2):c.710C>T (p.Thr237Met),5373,PMM2,HGNC:9115,Pathogenic/Likely pathogenic,1,20-Apr-20,80338708,-,RCV000020237|RCV000514240|RCV000623731|RCV001257700,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MedGen:CN517202|MeSH:D030342,MedGen:C0950123|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,Human Phenotype Ontology:HP:HP:0001249,MONDO:MONDO:0001071,MedGen:C3714756","Congenital disorder of glycosylation, type Ia|not provided|Inborn genetic diseases|Intellectual disability",germline;unknown,germline,GRCh38,NC_000016.10,16,8847794,8847794,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",11,-,N,"ClinGen:CA341667,UniProtKB:O15305#VAR_006115",3,21145,8847794,C,T,T237M,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,237,T,M,True,955
13735,5397,33996,single nucleotide variant,NM_000303.3(PMM2):c.653A>T (p.His218Leu),5373,PMM2,HGNC:9115,Pathogenic,1,21-Apr-11,80338705,-,RCV000020236,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318","Congenital disorder of glycosylation, type Ia",not provided,not provided,GRCh38,NC_000016.10,16,8847737,8847737,na,na,16p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA341666,UniProtKB:O15305#VAR_022503",1,21144,8847737,A,T,H218L,0,pathogenic,uncertain,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,218,H,L,True,955
13736,5396,33995,single nucleotide variant,NM_000303.3(PMM2):c.415G>A (p.Glu139Lys),5373,PMM2,HGNC:9115,Pathogenic/Likely pathogenic,1,30-Nov-18,80338703,-,RCV000020235|RCV000479820|RCV001257997,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MedGen:CN517202|Human Phenotype Ontology:HP:0001321,Human Phenotype Ontology:HP:0006806,Human Phenotype Ontology:HP:0006910,Human Phenotype Ontology:HP:0007038,Human Phenotype Ontology:HP:0007053,MONDO:MONDO:0008939,MedGen:C0266470,OMIM:213000,Orphanet:1398,Orphanet:2246","Congenital disorder of glycosylation, type Ia|not provided|Congenital cerebellar hypoplasia",germline;inherited;unknown,germline,GRCh38,NC_000016.10,16,8811146,8811146,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA341665,UniProtKB:O15305#VAR_009232",3,21143,8811146,G,A,E139K,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,139,E,K,True,955
13737,9042,98713,single nucleotide variant,NM_000303.3(PMM2):c.686A>C (p.Tyr229Ser),5373,PMM2,HGNC:9115,Uncertain significance,0,12-Jun-13,398123311,-,RCV000078596,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000016.10,16,8847770,8847770,na,na,16p13.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA220627,UniProtKB:O15305#VAR_006112",2,92806,8847770,A,C,Y229S,1,uncertain,uncertain,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,229,Y,S,True,955
13738,9041,98711,single nucleotide variant,NM_000303.3(PMM2):c.623G>C (p.Gly208Ala),5373,PMM2,HGNC:9115,Pathogenic/Likely pathogenic,1,24-May-19,398123309,-,RCV000179744|RCV000790723,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MedGen:CN517202","Congenital disorder of glycosylation, type Ia|not provided",germline;unknown,germline,GRCh38,NC_000016.10,16,8813090,8813090,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA220624,UniProtKB:O15305#VAR_006109",2,92804,8813090,G,C,G208A,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,208,G,A,True,955
13739,14164,342661,single nucleotide variant,NM_000303.3(PMM2):c.110A>T (p.Gln37Leu),5373,PMM2,HGNC:9115,Benign/Likely benign,0,31-Dec-19,2304472,-,RCV000541854|RCV000605700,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MedGen:CN169374","Congenital disorder of glycosylation, type Ia|not specified",germline,germline,GRCh38,NC_000016.10,16,8801842,8801842,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA7893891,UniProtKB:O15305#VAR_022133",2,321215,8801842,A,T,Q37L,2,benign,benign,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,37,Q,L,True,955
13740,9039,98707,single nucleotide variant,NM_000303.3(PMM2):c.323C>T (p.Ala108Val),5373,PMM2,HGNC:9115,Pathogenic/Likely pathogenic,1,2-Mar-20,200503569,-,RCV000078587|RCV000178072|RCV001270234,"MedGen:CN517202|MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MONDO:MONDO:0005387,MedGen:C0085215,OMIM:PS311360","not provided|Congenital disorder of glycosylation, type Ia|Premature ovarian failure",germline;unknown,germline,GRCh38,NC_000016.10,16,8806383,8806383,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA220618,UniProtKB:O15305#VAR_006097",2,92800,8806383,C,T,A108V,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,108,A,V,True,955
13741,11611,186953,single nucleotide variant,NM_000303.3(PMM2):c.470T>C (p.Phe157Ser),5373,PMM2,HGNC:9115,Pathogenic/Likely pathogenic,1,20-Dec-19,190521996,-,RCV000169083|RCV000481553,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MedGen:CN517202","Congenital disorder of glycosylation, type Ia|not provided",germline;paternal;unknown,germline,GRCh38,NC_000016.10,16,8811660,8811660,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",9,-,N,"ClinGen:CA273927,UniProtKB:O15305#VAR_022490",2,188763,8811660,T,C,F157S,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,157,F,S,True,955
13742,1792,22757,single nucleotide variant,NM_000303.3(PMM2):c.395T>C (p.Ile132Thr),5373,PMM2,HGNC:9115,Pathogenic/Likely pathogenic,1,26-Dec-19,80338702,-,RCV000008157,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318","Congenital disorder of glycosylation, type Ia",germline;unknown,germline,GRCh38,NC_000016.10,16,8811126,8811126,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA340689,UniProtKB:O15305#VAR_006104,OMIM:601785.0013",3,7718,8811126,T,C,I132T,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,132,I,T,True,955
13743,13498,260132,single nucleotide variant,NM_000303.3(PMM2):c.368G>A (p.Arg123Gln),5373,PMM2,HGNC:9115,Conflicting interpretations of pathogenicity,1,30-Dec-19,141498002,-,RCV000254854|RCV000576764,"MedGen:CN517202|MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318","not provided|Congenital disorder of glycosylation, type Ia",germline;maternal;unknown,germline,GRCh38,NC_000016.10,16,8811099,8811099,na,na,16p13.2,"criteria provided, conflicting interpretations",11,-,N,"ClinGen:CA7894040,UniProtKB:O15305#VAR_006101",2,265255,8811099,G,A,R123Q,1,uncertain,uncertain,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,123,R,Q,True,955
13744,9040,98710,single nucleotide variant,NM_000303.3(PMM2):c.590A>C (p.Glu197Ala),5373,PMM2,HGNC:9115,Benign/Likely benign,0,31-May-18,34258285,-,RCV000078593|RCV000607305,"MedGen:CN169374|MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318","not specified|Congenital disorder of glycosylation, type Ia",germline;unknown,germline,GRCh38,NC_000016.10,16,8813057,8813057,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA146027,UniProtKB:O15305#VAR_022498",2,92803,8813057,A,C,E197A,2,benign,benign,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,197,E,A,True,955
13745,1793,22758,single nucleotide variant,NM_000303.3(PMM2):c.691G>A (p.Val231Met),5373,PMM2,HGNC:9115,Pathogenic,1,2-Apr-20,80338707,-,RCV000008158|RCV000790822,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MedGen:CN517202","Congenital disorder of glycosylation, type Ia|not provided",germline;unknown,germline,GRCh38,NC_000016.10,16,8847775,8847775,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",11,-,N,"ClinGen:CA220628,UniProtKB:O15305#VAR_006113,OMIM:601785.0014",3,7719,8847775,G,A,V231M,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,231,V,M,True,955
13746,1795,22760,single nucleotide variant,NM_000303.3(PMM2):c.95T>G (p.Leu32Arg),5373,PMM2,HGNC:9115,Pathogenic,1,29-Oct-15,104894533,-,RCV000008160,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318","Congenital disorder of glycosylation, type Ia",germline,germline,GRCh38,NC_000016.10,16,8801827,8801827,na,na,16p13.2,no assertion criteria provided,2,-,N,"ClinGen:CA340690,UniProtKB:O15305#VAR_022473,OMIM:601785.0016",1,7721,8801827,T,G,L32R,0,pathogenic,uncertain,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,32,L,R,True,955
13747,11922,195874,single nucleotide variant,NM_000303.3(PMM2):c.647A>G (p.Asn216Ser),5373,PMM2,HGNC:9115,Conflicting interpretations of pathogenicity,1,27-Apr-18,78290141,-,RCV000485565|RCV000675138,"MedGen:CN517202|MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318","not provided|Congenital disorder of glycosylation, type Ia",germline;unknown,germline,GRCh38,NC_000016.10,16,8847731,8847731,na,na,16p13.2,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA247510,UniProtKB:O15305#VAR_022501",2,198713,8847731,A,G,N216S,1,uncertain,uncertain,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,216,N,S,True,955
13748,1781,22745,single nucleotide variant,NM_000303.3(PMM2):c.422G>A (p.Arg141His),5373,PMM2,HGNC:9115,Pathogenic,1,2-Apr-20,28936415,-,RCV000008145|RCV000078590|RCV000624874|RCV000991177|RCV001003989|RCV001003990|RCV001003991|RCV001257998,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MedGen:CN517202|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0015286,MedGen:C0282577,OMIM:PS212065,Orphanet:137|Human Phenotype Ontology:HP:0003544,Human Phenotype Ontology:HP:0003560,Human Phenotype Ontology:HP:0003806,MONDO:MONDO:0020121,MeSH:D009136,MedGen:C0026850,Orphanet:98473;Human Phenotype Ontology:HP:0001251,Human Phenotype Ontology:HP:0001253,Human Phenotype Ontology:HP:0002513,Human Phenotype Ontology:HP:0007050,Human Phenotype Ontology:HP:0007157,MONDO:MONDO:0000437,MedGen:C0007758,Orphanet:102002;Human Phenotype Ontology:HP:0001321,Human Phenotype Ontology:HP:0006806,Human Phenotype Ontology:HP:0006910,Human Phenotype Ontology:HP:0007038,Human Phenotype Ontology:HP:0007053,MONDO:MONDO:0008939,MedGen:C0266470,OMIM:213000,Orphanet:1398,Orphanet:2246;Human Phenotype Ontology:HP:0000819,Human Phenotype Ontology:HP:0004908,Human Phenotype Ontology:HP:0008217,Human Phenotype Ontology:HP:0008234,Human Phenotype Ontology:HP:0008260,MedGen:C0011849|Human Phenotype Ontology:HP:0001251,Human Phenotype Ontology:HP:0001253,Human Phenotype Ontology:HP:0002513,Human Phenotype Ontology:HP:0007050,Human Phenotype Ontology:HP:0007157,MONDO:MONDO:0000437,MedGen:C0007758,Orphanet:102002|6 conditions|Human Phenotype Ontology:HP:0001321,Human Phenotype Ontology:HP:0006806,Human Phenotype Ontology:HP:0006910,Human Phenotype Ontology:HP:0007038,Human Phenotype Ontology:HP:0007053,MONDO:MONDO:0008939,MedGen:C0266470,OMIM:213000,Orphanet:1398,Orphanet:2246","Congenital disorder of glycosylation, type Ia|not provided|Inborn genetic diseases|Congenital disorder of glycosylation|Muscular dystrophy;Cerebellar ataxia;Congenital cerebellar hypoplasia;Diabetes mellitus|Cerebellar ataxia|6 conditions|Congenital cerebellar hypoplasia",germline;inherited;maternal;unknown,germline,GRCh38,NC_000016.10,16,8811153,8811153,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",34,-,N,"ClinGen:CA220621,UniProtKB:O15305#VAR_006105,OMIM:601785.0001",3,7706,8811153,G,A,R141H,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,141,R,H,True,955
13749,1783,22747,single nucleotide variant,NM_000303.3(PMM2):c.385G>A (p.Val129Met),5373,PMM2,HGNC:9115,Pathogenic/Likely pathogenic,1,13-Dec-19,104894525,-,RCV000008147|RCV000344673,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MedGen:CN517202","Congenital disorder of glycosylation, type Ia|not provided",germline;unknown,germline,GRCh38,NC_000016.10,16,8811116,8811116,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA254230,UniProtKB:O15305#VAR_006102,OMIM:601785.0003",3,7708,8811116,G,A,V129M,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,129,V,M,True,955
13750,1784,22748,single nucleotide variant,NM_000303.3(PMM2):c.484C>T (p.Arg162Trp),5373,PMM2,HGNC:9115,Pathogenic/Likely pathogenic,1,1-Nov-19,104894526,-,RCV000008148|RCV000403363,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MedGen:CN517202","Congenital disorder of glycosylation, type Ia|not provided",germline;unknown,germline,GRCh38,NC_000016.10,16,8811674,8811674,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA254231,UniProtKB:O15305#VAR_006106,OMIM:601785.0004",3,7709,8811674,C,T,R162W,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,162,R,W,True,955
13751,1785,22749,single nucleotide variant,NM_000303.3(PMM2):c.193G>T (p.Asp65Tyr),5373,PMM2,HGNC:9115,Pathogenic,1,28-May-19,104894527,-,RCV000008149,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318","Congenital disorder of glycosylation, type Ia",germline;unknown,germline,GRCh38,NC_000016.10,16,8804781,8804781,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA254232,UniProtKB:O15305#VAR_006094,OMIM:601785.0005",3,7710,8804781,G,T,D65Y,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,65,D,Y,True,955
13752,1786,22750,single nucleotide variant,NM_000303.3(PMM2):c.357C>A (p.Phe119Leu),5373,PMM2,HGNC:9115,Pathogenic,1,23-Oct-20,80338701,-,RCV000008150|RCV000624449|RCV000790706,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MeSH:D030342,MedGen:C0950123|MedGen:CN517202","Congenital disorder of glycosylation, type Ia|Inborn genetic diseases|not provided",germline;maternal;unknown,germline,GRCh38,NC_000016.10,16,8811088,8811088,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",18,-,N,"ClinGen:CA220620,UniProtKB:O15305#VAR_006100,OMIM:601785.0006,OMIM:601785.0010",3,7711,8811088,C,A,F119L,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,119,F,L,True,955
13753,1787,22751,single nucleotide variant,NM_000303.3(PMM2):c.563A>G (p.Asp188Gly),5373,PMM2,HGNC:9115,Pathogenic/Likely pathogenic,1,14-Feb-19,80338704,-,RCV000008151|RCV000790726,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MedGen:CN517202","Congenital disorder of glycosylation, type Ia|not provided",germline;unknown,germline,GRCh38,NC_000016.10,16,8813030,8813030,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA234697,UniProtKB:O15305#VAR_006108,OMIM:601785.0007",3,7712,8813030,A,G,D188G,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,188,D,G,True,955
13754,1788,22752,single nucleotide variant,NM_000303.3(PMM2):c.349G>C (p.Gly117Arg),5373,PMM2,HGNC:9115,Pathogenic,1,1-Jul-98,104894530,-,RCV000008152,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318","Congenital disorder of glycosylation, type Ia",germline,germline,GRCh38,NC_000016.10,16,8811080,8811080,na,na,16p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA254233,UniProtKB:O15305#VAR_006099,OMIM:601785.0008",1,7713,8811080,G,C,G117R,0,pathogenic,uncertain,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,117,G,R,True,955
13755,1789,22753,single nucleotide variant,NM_000303.3(PMM2):c.669C>G (p.Asp223Glu),5373,PMM2,HGNC:9115,Pathogenic,1,1-Jul-98,104894531,-,RCV000008153,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318","Congenital disorder of glycosylation, type Ia",germline,germline,GRCh38,NC_000016.10,16,8847753,8847753,na,na,16p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA254234,UniProtKB:O15305#VAR_006111,OMIM:601785.0009",1,7714,8847753,C,G,D223E,0,pathogenic,uncertain,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,223,D,E,True,955
13756,1790,22755,single nucleotide variant,NM_000303.3(PMM2):c.710C>G (p.Thr237Arg),5373,PMM2,HGNC:9115,Pathogenic/Likely pathogenic,1,1-Feb-20,80338708,-,RCV000008155|RCV000790820,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MedGen:CN517202","Congenital disorder of glycosylation, type Ia|not provided",germline;unknown,germline,GRCh38,NC_000016.10,16,8847794,8847794,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",11,-,N,"ClinGen:CA220629,UniProtKB:O15305#VAR_022508,OMIM:601785.0011",3,7716,8847794,C,G,T237R,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,237,T,R,True,955
13757,1798,22764,single nucleotide variant,NM_000303.3(PMM2):c.131T>C (p.Val44Ala),5373,PMM2,HGNC:9115,Pathogenic/Likely pathogenic,1,4-Jun-20,104894534,-,RCV000008164,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318","Congenital disorder of glycosylation, type Ia",germline;unknown,germline,GRCh38,NC_000016.10,16,8801863,8801863,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA254236,UniProtKB:O15305#VAR_006093,OMIM:601785.0020",3,7725,8801863,T,C,V44A,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,44,V,A,True,955
13758,1797,22762,single nucleotide variant,NM_000303.3(PMM2):c.338C>T (p.Pro113Leu),5373,PMM2,HGNC:9115,Pathogenic,1,23-Oct-20,80338700,-,RCV000008162|RCV000790784|RCV001003988,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MedGen:CN517202|6 conditions","Congenital disorder of glycosylation, type Ia|not provided|6 conditions",germline;unknown,germline,GRCh38,NC_000016.10,16,8806398,8806398,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",11,-,N,"ClinGen:CA220619,UniProtKB:O15305#VAR_006098,OMIM:601785.0018",3,7723,8806398,C,T,P113L,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,113,P,L,True,955
13759,1782,22746,single nucleotide variant,NM_000303.3(PMM2):c.647A>T (p.Asn216Ile),5373,PMM2,HGNC:9115,Pathogenic/Likely pathogenic,1,11-Dec-19,78290141,-,RCV000008146|RCV000724043,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MedGen:CN517202","Congenital disorder of glycosylation, type Ia|not provided",germline,germline,GRCh38,NC_000016.10,16,8847731,8847731,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"OMIM:601785.0002,ClinGen:CA254229,UniProtKB:O15305#VAR_006110",3,7707,8847731,A,T,N216I,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,216,N,I,True,955
13760,11889,194819,single nucleotide variant,NM_000303.3(PMM2):c.430T>C (p.Phe144Leu),5373,PMM2,HGNC:9115,Pathogenic/Likely pathogenic,1,6-Jan-20,150719105,-,RCV000414479|RCV000596795,"MedGen:CN517202|MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318","not provided|Congenital disorder of glycosylation, type Ia",germline;unknown,germline,GRCh38,NC_000016.10,16,8811161,8811161,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA245915,UniProtKB:O15305#VAR_022486",2,197658,8811161,T,C,F144L,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,144,F,L,True,955
13761,11890,194820,single nucleotide variant,NM_000303.3(PMM2):c.442G>A (p.Asp148Asn),5373,PMM2,HGNC:9115,Pathogenic/Likely pathogenic,1,13-Dec-19,148032587,-,RCV000178754|RCV000514031|RCV000624392,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MedGen:CN517202|MeSH:D030342,MedGen:C0950123","Congenital disorder of glycosylation, type Ia|not provided|Inborn genetic diseases",germline;unknown,germline,GRCh38,NC_000016.10,16,8811173,8811173,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA275299,UniProtKB:O15305#VAR_022487",2,197659,8811173,G,A,D148N,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,148,D,N,True,955
13762,1791,22756,single nucleotide variant,NM_000303.3(PMM2):c.722G>C (p.Cys241Ser),5373,PMM2,HGNC:9115,Pathogenic,1,24-Dec-19,80338709,-,RCV000008156|RCV000153745|RCV000623621,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318|MedGen:CN517202|MeSH:D030342,MedGen:C0950123","Congenital disorder of glycosylation, type Ia|not provided|Inborn genetic diseases",germline;unknown,germline,GRCh38,NC_000016.10,16,8847806,8847806,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",12,-,N,"OMIM:601785.0012,ClinGen:CA234698,UniProtKB:O15305#VAR_022510",3,7717,8847806,G,C,C241S,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,241,C,S,True,955
13763,1796,22761,single nucleotide variant,NM_000303.3(PMM2):c.677C>G (p.Thr226Ser),5373,PMM2,HGNC:9115,Pathogenic,1,21-Apr-11,80338706,-,RCV000008161,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318","Congenital disorder of glycosylation, type Ia",germline,germline,GRCh38,NC_000016.10,16,8847761,8847761,na,na,16p13.2,no assertion criteria provided,2,-,N,"ClinGen:CA340691,UniProtKB:O15305#VAR_022505,OMIM:601785.0017",1,7722,8847761,C,G,T226S,0,pathogenic,uncertain,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,226,T,S,True,955
13764,1794,22759,single nucleotide variant,NM_000303.3(PMM2):c.26G>A (p.Cys9Tyr),5373,PMM2,HGNC:9115,Pathogenic/Likely pathogenic,1,23-Apr-18,104894532,-,RCV000008159,"MONDO:MONDO:0008907,MedGen:C0349653,OMIM:212065,Orphanet:79318","Congenital disorder of glycosylation, type Ia",germline;unknown,germline,GRCh38,NC_000016.10,16,8797908,8797908,na,na,16p13.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA254235,UniProtKB:O15305#VAR_022469,OMIM:601785.0015",3,7720,8797908,G,A,C9Y,2,pathogenic,pathogenic,O15305,O15305,reviewed,PMM2_HUMAN,"Phosphomannomutase 2, PMM 2, EC 5.4.2.8",PMM2,Homo sapiens (Human),246.0,MAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS,PF03332;,2AMY;2Q4R;,9,C,Y,True,955
13765,3203,27760,single nucleotide variant,NM_000367.2(TPMT):c.238G>C (p.Ala80Pro),7172,TPMT,HGNC:12014,drug response,0,1-Feb-99,1800462,-,RCV000013558,"MONDO:MONDO:0012503,MedGen:C0342801,OMIM:610460",Thiopurine methyltransferase deficiency,germline,germline,GRCh38,NC_000006.12,6,18143724,18143724,na,na,6p22.3,no assertion criteria provided,1,-,Y,"ClinGen:CA122644,UniProtKB:P51580#VAR_005637,OMIM:187680.0001",1,12721,18143724,C,G,A80P,0,uncertain,uncertain,P51580,P51580,reviewed,TPMT_HUMAN,"Thiopurine S-methyltransferase, EC 2.1.1.67 (Thiopurine methyltransferase)",TPMT,Homo sapiens (Human),245.0,MDGTRTSLDIEEYSDTEVQKNQVLTLEEWQDKWVNGKTAFHQEQGHQLLKKHLDTFLKGKSGLRVFFPLCGKAVEMKWFADRGHSVVGVEISELGIQEFFTEQNLSYSEEPITEIPGTKVFKSSSGNISLYCCSIFDLPRTNIGKFDMIWDRGALVAINPGDRKCYADTMFSLLGKKFQYLLCVLSYDPTKHPGPPFYVPHAEIERLFGKICNIRCLEKVDAFEERHKSWGIDCLFEKLYLLTEK,PF05724;,2BZG;2H11;,80,A,P,True,956
13766,3205,27764,single nucleotide variant,NM_000367.4(TPMT):c.719A>G (p.Tyr240Cys),7172,TPMT,HGNC:12014,"Likely benign, other",0,14-Mar-18,1142345,-,RCV000013562|RCV000396233,"MONDO:MONDO:0012503,MedGen:C0342801,OMIM:610460|MedGen:CN517202",Thiopurine methyltransferase deficiency|not provided,germline,germline,GRCh38,NC_000006.12,6,18130687,18130687,na,na,6p22.3,"criteria provided, multiple submitters, no conflicts",3,-,Y,"ClinVar:12722,ClinGen:CA122646,UniProtKB:P51580#VAR_005641,OMIM:187680.0002,OMIM:187680.0005",3,12725,18130687,T,C,Y240C,2,benign,benign,P51580,P51580,reviewed,TPMT_HUMAN,"Thiopurine S-methyltransferase, EC 2.1.1.67 (Thiopurine methyltransferase)",TPMT,Homo sapiens (Human),245.0,MDGTRTSLDIEEYSDTEVQKNQVLTLEEWQDKWVNGKTAFHQEQGHQLLKKHLDTFLKGKSGLRVFFPLCGKAVEMKWFADRGHSVVGVEISELGIQEFFTEQNLSYSEEPITEIPGTKVFKSSSGNISLYCCSIFDLPRTNIGKFDMIWDRGALVAINPGDRKCYADTMFSLLGKKFQYLLCVLSYDPTKHPGPPFYVPHAEIERLFGKICNIRCLEKVDAFEERHKSWGIDCLFEKLYLLTEK,PF05724;,2BZG;2H11;,240,Y,C,True,956
13767,3206,27765,single nucleotide variant,NM_000367.4(TPMT):c.644G>A (p.Arg215His),7172,TPMT,HGNC:12014,drug response,0,1-Feb-99,56161402,-,RCV000013563,"MONDO:MONDO:0012503,MedGen:C0342801,OMIM:610460",Thiopurine methyltransferase deficiency,germline,germline,GRCh38,NC_000006.12,6,18130762,18130762,na,na,6p22.3,no assertion criteria provided,1,-,N,"ClinGen:CA122647,UniProtKB:P51580#VAR_008715,OMIM:187680.0006",1,12726,18130762,C,T,R215H,0,uncertain,uncertain,P51580,P51580,reviewed,TPMT_HUMAN,"Thiopurine S-methyltransferase, EC 2.1.1.67 (Thiopurine methyltransferase)",TPMT,Homo sapiens (Human),245.0,MDGTRTSLDIEEYSDTEVQKNQVLTLEEWQDKWVNGKTAFHQEQGHQLLKKHLDTFLKGKSGLRVFFPLCGKAVEMKWFADRGHSVVGVEISELGIQEFFTEQNLSYSEEPITEIPGTKVFKSSSGNISLYCCSIFDLPRTNIGKFDMIWDRGALVAINPGDRKCYADTMFSLLGKKFQYLLCVLSYDPTKHPGPPFYVPHAEIERLFGKICNIRCLEKVDAFEERHKSWGIDCLFEKLYLLTEK,PF05724;,2BZG;2H11;,215,R,H,True,956
13768,3204,27761,single nucleotide variant,NM_000367.4(TPMT):c.460G>A (p.Ala154Thr),7172,TPMT,HGNC:12014,"Likely benign, other",0,14-Mar-18,1800460,-,RCV000013561|RCV000309972,"MONDO:MONDO:0012503,MedGen:C0342801,OMIM:610460|MedGen:CN517202",Thiopurine methyltransferase deficiency|not provided,germline,germline,GRCh38,NC_000006.12,6,18138997,18138997,na,na,6p22.3,"criteria provided, multiple submitters, no conflicts",3,-,Y,"ClinVar:12722,ClinGen:CA122645,UniProtKB:P51580#VAR_005638,OMIM:187680.0002,OMIM:187680.0004",3,37126,18138997,C,T,A154T,2,benign,benign,P51580,P51580,reviewed,TPMT_HUMAN,"Thiopurine S-methyltransferase, EC 2.1.1.67 (Thiopurine methyltransferase)",TPMT,Homo sapiens (Human),245.0,MDGTRTSLDIEEYSDTEVQKNQVLTLEEWQDKWVNGKTAFHQEQGHQLLKKHLDTFLKGKSGLRVFFPLCGKAVEMKWFADRGHSVVGVEISELGIQEFFTEQNLSYSEEPITEIPGTKVFKSSSGNISLYCCSIFDLPRTNIGKFDMIWDRGALVAINPGDRKCYADTMFSLLGKKFQYLLCVLSYDPTKHPGPPFYVPHAEIERLFGKICNIRCLEKVDAFEERHKSWGIDCLFEKLYLLTEK,PF05724;,2BZG;2H11;,154,A,T,True,956
13769,137,15529,single nucleotide variant,NM_000320.3(QDPR):c.68G>A (p.Gly23Asp),5860,QDPR,HGNC:9752,Pathogenic,1,1-Jun-93,104893863,-,RCV000000519,"MONDO:MONDO:0009862,MedGen:C0268465,OMIM:261630,Orphanet:226,Orphanet:238583",Dihydropteridine reductase deficiency,germline,germline,GRCh38,NC_000004.12,4,17511987,17511987,na,na,4p15.32,no assertion criteria provided,1,-,N,"ClinGen:CA114324,UniProtKB:P09417#VAR_006960,OMIM:612676.0002",1,490,17511987,C,T,G23D,0,pathogenic,uncertain,P09417,P09417,reviewed,DHPR_HUMAN,"Dihydropteridine reductase, EC 1.5.1.34 (HDHPR) (Quinoid dihydropteridine reductase) (Short chain dehydrogenase/reductase family 33C member 1)",QDPR DHPR SDR33C1,Homo sapiens (Human),244.0,MAAAAAAGEARRVLVYGGRGALGSRCVQAFRARNWWVASVDVVENEEASASIIVKMTDSFTEQADQVTAEVGKLLGEEKVDAILCVAGGWAGGNAKSKSLFKNCDLMWKQSIWTSTISSHLATKHLKEGGLLTLAGAKAALDGTPGMIGYGMAKGAVHQLCQSLAGKNSGMPPGAAAIAVLPVTLDTPMNRKSMPEADFSSWTPLEFLVETFHDWITGKNRPSSGSLIQVVTTEGRTELTPAYF,PF00106;,1HDR;,23,G,D,True,957
13770,138,15530,single nucleotide variant,NM_000320.3(QDPR):c.322T>G (p.Trp108Gly),5860,QDPR,HGNC:9752,Pathogenic,1,1-Jun-93,104893864,-,RCV000000520,"MONDO:MONDO:0009862,MedGen:C0268465,OMIM:261630,Orphanet:226,Orphanet:238583",Dihydropteridine reductase deficiency,germline,germline,GRCh38,NC_000004.12,4,17501833,17501833,na,na,4p15.32,no assertion criteria provided,1,-,N,"ClinGen:CA114325,UniProtKB:P09417#VAR_006963,OMIM:612676.0003",1,491,17501833,A,C,W108G,0,pathogenic,uncertain,P09417,P09417,reviewed,DHPR_HUMAN,"Dihydropteridine reductase, EC 1.5.1.34 (HDHPR) (Quinoid dihydropteridine reductase) (Short chain dehydrogenase/reductase family 33C member 1)",QDPR DHPR SDR33C1,Homo sapiens (Human),244.0,MAAAAAAGEARRVLVYGGRGALGSRCVQAFRARNWWVASVDVVENEEASASIIVKMTDSFTEQADQVTAEVGKLLGEEKVDAILCVAGGWAGGNAKSKSLFKNCDLMWKQSIWTSTISSHLATKHLKEGGLLTLAGAKAALDGTPGMIGYGMAKGAVHQLCQSLAGKNSGMPPGAAAIAVLPVTLDTPMNRKSMPEADFSSWTPLEFLVETFHDWITGKNRPSSGSLIQVVTTEGRTELTPAYF,PF00106;,1HDR;,108,W,G,True,957
13771,139,15531,single nucleotide variant,NM_000320.3(QDPR):c.106T>C (p.Trp36Arg),5860,QDPR,HGNC:9752,Pathogenic,1,1-Oct-97,104893865,-,RCV000000521,"MONDO:MONDO:0009862,MedGen:C0268465,OMIM:261630,Orphanet:226,Orphanet:238583",Dihydropteridine reductase deficiency,germline,germline,GRCh38,NC_000004.12,4,17509363,17509363,na,na,4p15.32,no assertion criteria provided,1,-,N,"UniProtKB:P09417#VAR_006961,OMIM:612676.0004,ClinGen:CA114326",1,492,17509363,A,G,W36R,0,pathogenic,uncertain,P09417,P09417,reviewed,DHPR_HUMAN,"Dihydropteridine reductase, EC 1.5.1.34 (HDHPR) (Quinoid dihydropteridine reductase) (Short chain dehydrogenase/reductase family 33C member 1)",QDPR DHPR SDR33C1,Homo sapiens (Human),244.0,MAAAAAAGEARRVLVYGGRGALGSRCVQAFRARNWWVASVDVVENEEASASIIVKMTDSFTEQADQVTAEVGKLLGEEKVDAILCVAGGWAGGNAKSKSLFKNCDLMWKQSIWTSTISSHLATKHLKEGGLLTLAGAKAALDGTPGMIGYGMAKGAVHQLCQSLAGKNSGMPPGAAAIAVLPVTLDTPMNRKSMPEADFSSWTPLEFLVETFHDWITGKNRPSSGSLIQVVTTEGRTELTPAYF,PF00106;,1HDR;,36,W,R,True,957
13772,140,15533,single nucleotide variant,NM_000320.3(QDPR):c.449A>G (p.Tyr150Cys),5860,QDPR,HGNC:9752,Pathogenic,1,1-Jan-98,104893866,-,RCV000000523,"MONDO:MONDO:0009862,MedGen:C0268465,OMIM:261630,Orphanet:226,Orphanet:238583",Dihydropteridine reductase deficiency,germline,germline,GRCh38,NC_000004.12,4,17492328,17492328,na,na,4p15.32,no assertion criteria provided,1,-,N,"ClinGen:CA114327,UniProtKB:P09417#VAR_006966,OMIM:612676.0006",1,494,17492328,T,C,Y150C,0,pathogenic,uncertain,P09417,P09417,reviewed,DHPR_HUMAN,"Dihydropteridine reductase, EC 1.5.1.34 (HDHPR) (Quinoid dihydropteridine reductase) (Short chain dehydrogenase/reductase family 33C member 1)",QDPR DHPR SDR33C1,Homo sapiens (Human),244.0,MAAAAAAGEARRVLVYGGRGALGSRCVQAFRARNWWVASVDVVENEEASASIIVKMTDSFTEQADQVTAEVGKLLGEEKVDAILCVAGGWAGGNAKSKSLFKNCDLMWKQSIWTSTISSHLATKHLKEGGLLTLAGAKAALDGTPGMIGYGMAKGAVHQLCQSLAGKNSGMPPGAAAIAVLPVTLDTPMNRKSMPEADFSSWTPLEFLVETFHDWITGKNRPSSGSLIQVVTTEGRTELTPAYF,PF00106;,1HDR;,150,Y,C,True,957
13773,12407,215455,single nucleotide variant,NM_006331.8(EMG1):c.101C>G (p.Ala34Gly),10436,EMG1,HGNC:16912,Benign,0,13-Feb-15,11064480,-,RCV000202817,MedGen:CN169374,not specified,unknown,unknown,GRCh38,NC_000012.12,12,6971024,6971024,na,na,12p13.31,"criteria provided, single submitter",1,-,N,"ClinGen:CA249018,UniProtKB:Q92979#VAR_050237",2,218683,6971024,C,G,A34G,1,benign,benign,Q92979,Q92979,reviewed,NEP1_HUMAN,"Ribosomal RNA small subunit methyltransferase NEP1, EC 2.1.1.- (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1)",EMG1 C2F,Homo sapiens (Human),244.0,MAAPSDGFKPRERSGGEQAQDWDALPPKRPRLGAGNKIGGRRLIVVLEGASLETVKVGKTYELLNCDKHKSILLKNGRDPGEARPDITHQSLLMLMDSPLNRAGLLQVYIHTQKNVLIEVNPQTRIPRTFDRFCGLMVQLLHKLSVRAADGPQKLLKVIKNPVSDHFPVGCMKVGTSFSIPVVSDVRELVPSSDPIVFVVGAFAHGKVSVEYTEKMVSISNYPLSAALTCAKLTTAFEEVWGVI,PF03587;,5FAI;7MQ8;7MQ9;7MQA;,34,A,G,True,958
13774,250,15929,single nucleotide variant,NM_006331.8(EMG1):c.257A>G (p.Asp86Gly),10436,EMG1,HGNC:16912,Pathogenic,1,1-Jun-09,74435397,-,RCV000000938,"MONDO:MONDO:0008879,MedGen:C1859405,OMIM:211180,Orphanet:1270",Bowen-Conradi syndrome,germline,germline,GRCh38,NC_000012.12,12,6974427,6974427,na,na,12p13.31,no assertion criteria provided,1,-,N,"ClinGen:CA114613,UniProtKB:Q92979#VAR_062480,OMIM:611531.0001",1,890,6974427,A,G,D86G,0,pathogenic,uncertain,Q92979,Q92979,reviewed,NEP1_HUMAN,"Ribosomal RNA small subunit methyltransferase NEP1, EC 2.1.1.- (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1)",EMG1 C2F,Homo sapiens (Human),244.0,MAAPSDGFKPRERSGGEQAQDWDALPPKRPRLGAGNKIGGRRLIVVLEGASLETVKVGKTYELLNCDKHKSILLKNGRDPGEARPDITHQSLLMLMDSPLNRAGLLQVYIHTQKNVLIEVNPQTRIPRTFDRFCGLMVQLLHKLSVRAADGPQKLLKVIKNPVSDHFPVGCMKVGTSFSIPVVSDVRELVPSSDPIVFVVGAFAHGKVSVEYTEKMVSISNYPLSAALTCAKLTTAFEEVWGVI,PF03587;,5FAI;7MQ8;7MQ9;7MQA;,86,D,G,True,958
13775,1131,19845,single nucleotide variant,NM_004738.5(VAPB):c.166C>T (p.Pro56Ser),9217,VAPB,HGNC:12649,Pathogenic,1,26-Dec-19,74315431,-,RCV000005073|RCV000005074|RCV000005075|RCV000059635|RCV000810714,"MONDO:MONDO:0012077,MedGen:C1837728,OMIM:608627,Orphanet:803|MedGen:C1854058|MedGen:C1854059|MedGen:CN517202|MedGen:C1854058;MONDO:MONDO:0012077,MedGen:C1837728,OMIM:608627,Orphanet:803","Amyotrophic lateral sclerosis type 8|Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis, typical|not provided|Spinal muscular atrophy, late-onset, finkel type;Amyotrophic lateral sclerosis type 8",germline;unknown,germline,GRCh38,NC_000020.11,20,58418318,58418318,na,na,20q13.32,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA117096,UniProtKB:O95292#VAR_026743,UniProtKB/Swiss-Prot:VAR_026743,OMIM:605704.0001",3,4806,58418318,C,T,P56S,2,pathogenic,pathogenic,O95292,O95292,reviewed,VAPB_HUMAN,"Vesicle-associated membrane protein-associated protein B/C, VAMP-B/VAMP-C, VAMP-associated protein B/C, VAP-B/VAP-C",VAPB UNQ484/PRO983,Homo sapiens (Human),243.0,MAKVEQVLSLEPQHELKFRGPFTDVVTTNLKLGNPTDRNVCFKVKTTAPRRYCVRPNSGIIDAGASINVSVMLQPFDYDPNEKSKHKFMVQSMFAPTDTSDMEAVWKEAKPEDLMDSKLRCVFELPAENDKPHDVEINKIISTTASKTETPIVSKSLSSSLDDTEVKKVMEECKRLQGEVQRLREENKQFKEEDGLRMRKTVQSNSPISALAPTGKEEGLSTRLLALVVLFFIVGVIIGKIAL,PF00635;,2MDK;3IKK;,56,P,S,True,959
13776,5991,39467,single nucleotide variant,NM_004738.5(VAPB):c.137C>T (p.Thr46Ile),9217,VAPB,HGNC:12649,Pathogenic,1,17-Dec-10,281875284,-,RCV000023467|RCV000059634,"MONDO:MONDO:0012077,MedGen:C1837728,OMIM:608627,Orphanet:803|MedGen:CN517202",Amyotrophic lateral sclerosis type 8|not provided,germline,germline,GRCh38,NC_000020.11,20,58418289,58418289,na,na,20q13.32,no assertion criteria provided,2,-,N,"ClinGen:CA219846,UniProtKB:O95292#VAR_067964,UniProtKB/Swiss-Prot:VAR_067964,OMIM:605704.0002",1,30510,58418289,C,T,T46I,0,pathogenic,uncertain,O95292,O95292,reviewed,VAPB_HUMAN,"Vesicle-associated membrane protein-associated protein B/C, VAMP-B/VAMP-C, VAMP-associated protein B/C, VAP-B/VAP-C",VAPB UNQ484/PRO983,Homo sapiens (Human),243.0,MAKVEQVLSLEPQHELKFRGPFTDVVTTNLKLGNPTDRNVCFKVKTTAPRRYCVRPNSGIIDAGASINVSVMLQPFDYDPNEKSKHKFMVQSMFAPTDTSDMEAVWKEAKPEDLMDSKLRCVFELPAENDKPHDVEINKIISTTASKTETPIVSKSLSSSLDDTEVKKVMEECKRLQGEVQRLREENKQFKEEDGLRMRKTVQSNSPISALAPTGKEEGLSTRLLALVVLFFIVGVIIGKIAL,PF00635;,2MDK;3IKK;,46,T,I,True,959
13777,6001,39527,single nucleotide variant,NM_022445.4(TPK1):c.119T>C (p.Leu40Pro),27010,TPK1,HGNC:17358,Uncertain significance,1,22-Sep-16,387906936,-,RCV000023533|RCV000622727,"MONDO:MONDO:0013761,MedGen:C3280866,OMIM:614458,Orphanet:293955|MeSH:D030342,MedGen:C0950123",Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)|Inborn genetic diseases,germline,germline,GRCh38,NC_000007.14,7,144682975,144682975,na,na,7q35,"criteria provided, single submitter",2,-,N,"ClinGen:CA129340,UniProtKB:Q9H3S4#VAR_067391,OMIM:606370.0003",3,30570,144682975,A,G,L40P,1,uncertain,uncertain,Q9H3S4,Q9H3S4,reviewed,TPK1_HUMAN,"Thiamin pyrophosphokinase 1, hTPK1, EC 2.7.6.2 (Placental protein 20, PP20) (Thiamine pyrophosphokinase 1)",TPK1,Homo sapiens (Human),243.0,MEHAFTPLEPLLSTGNLKYCLVILNQPLDNYFRHLWNKALLRACADGGANRLYDITEGERESFLPEFINGDFDSIRPEVREYYATKGCELISTPDQDHTDFTKCLKMLQKKIEEKDLKVDVIVTLGGLAGRFDQIMASVNTLFQATHITPFPIIIIQEESLIYLLQPGKHRLHVDTGMEGDWCGLIPVGQPCMQVTTTGLKWNLTNDVLAFGTLVSTSNTYDGSGVVTVETDHPLLWTMAIKS,PF04265;PF04263;,3S4Y;,40,L,P,True,960
13778,6000,39525,single nucleotide variant,NM_022445.4(TPK1):c.148A>C (p.Asn50His),27010,TPK1,HGNC:17358,Pathogenic,1,9-Dec-11,387906935,-,RCV000023531,"MONDO:MONDO:0013761,MedGen:C3280866,OMIM:614458,Orphanet:293955",Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type),germline,germline,GRCh38,NC_000007.14,7,144682946,144682946,na,na,7q35,no assertion criteria provided,1,-,N,"ClinGen:CA129339,UniProtKB:Q9H3S4#VAR_067392,OMIM:606370.0001",1,30568,144682946,T,G,N50H,0,pathogenic,uncertain,Q9H3S4,Q9H3S4,reviewed,TPK1_HUMAN,"Thiamin pyrophosphokinase 1, hTPK1, EC 2.7.6.2 (Placental protein 20, PP20) (Thiamine pyrophosphokinase 1)",TPK1,Homo sapiens (Human),243.0,MEHAFTPLEPLLSTGNLKYCLVILNQPLDNYFRHLWNKALLRACADGGANRLYDITEGERESFLPEFINGDFDSIRPEVREYYATKGCELISTPDQDHTDFTKCLKMLQKKIEEKDLKVDVIVTLGGLAGRFDQIMASVNTLFQATHITPFPIIIIQEESLIYLLQPGKHRLHVDTGMEGDWCGLIPVGQPCMQVTTTGLKWNLTNDVLAFGTLVSTSNTYDGSGVVTVETDHPLLWTMAIKS,PF04265;PF04263;,3S4Y;,50,N,H,True,960
13779,6002,39529,single nucleotide variant,NM_022445.4(TPK1):c.656A>G (p.Asn219Ser),27010,TPK1,HGNC:17358,Pathogenic,1,2-Apr-20,371271054,-,RCV000023535|RCV000437841,"MONDO:MONDO:0013761,MedGen:C3280866,OMIM:614458,Orphanet:293955|MedGen:CN517202",Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)|not provided,germline;unknown,germline,GRCh38,NC_000007.14,7,144453621,144453621,na,na,7q35,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA129341,UniProtKB:Q9H3S4#VAR_067393,OMIM:606370.0005",3,30572,144453621,T,C,N219S,2,pathogenic,pathogenic,Q9H3S4,Q9H3S4,reviewed,TPK1_HUMAN,"Thiamin pyrophosphokinase 1, hTPK1, EC 2.7.6.2 (Placental protein 20, PP20) (Thiamine pyrophosphokinase 1)",TPK1,Homo sapiens (Human),243.0,MEHAFTPLEPLLSTGNLKYCLVILNQPLDNYFRHLWNKALLRACADGGANRLYDITEGERESFLPEFINGDFDSIRPEVREYYATKGCELISTPDQDHTDFTKCLKMLQKKIEEKDLKVDVIVTLGGLAGRFDQIMASVNTLFQATHITPFPIIIIQEESLIYLLQPGKHRLHVDTGMEGDWCGLIPVGQPCMQVTTTGLKWNLTNDVLAFGTLVSTSNTYDGSGVVTVETDHPLLWTMAIKS,PF04265;PF04263;,3S4Y;,219,N,S,True,960
13780,8687,86130,single nucleotide variant,NM_002608.4(PDGFB):c.356T>C (p.Leu119Pro),5155,PDGFB,HGNC:8800,Pathogenic,1,1-Sep-13,397515632,-,RCV000066214,"MONDO:MONDO:0014204,MedGen:C3809645,OMIM:615483,Orphanet:1980",Idiopathic basal ganglia calcification 5,germline,germline,GRCh38,NC_000022.11,22,39231722,39231722,na,na,22q13.1,no assertion criteria provided,1,-,N,"OMIM:190040.0004,ClinGen:CA145262,UniProtKB:P01127#VAR_070871",1,75239,39231722,A,G,L119P,0,pathogenic,uncertain,P01127,P01127,reviewed,PDGFB_HUMAN,"Platelet-derived growth factor subunit B, PDGF subunit B (PDGF-2) (Platelet-derived growth factor B chain) (Platelet-derived growth factor beta polypeptide) (Proto-oncogene c-Sis) (Becaplermin)",PDGFB PDGF2 SIS,Homo sapiens (Human),241.0,MNRCWALFLSLCCYLRLVSAEGDPIPEELYEMLSDHSIRSFDDLQRLLHGDPGEEDGAELDLNMTRSHSGGELESLARGRRSLGSLTIAEPAMIAECKTRTEVFEISRRLIDRTNANFLVWPPCVEVQRCSGCCNNRNVQCRPTQVQLRPVQVRKIEIVRKKPIFKKATVTLEDHLACKCETVAAARPVTRSPGGSQEQRAKTPQTRVTIRTVRVRRPPKGKHRKFKHTHDKTALKETLGA,PF00341;PF04692;,1PDG;3MJG;4HQU;4HQX;4QCI;6T9E;,119,L,P,True,961
13781,8705,94314,single nucleotide variant,NM_054035.2(UNC119):c.65G>T (p.Gly22Val),9094,UNC119,HGNC:12565,Benign/Likely benign,1,28-May-19,199714731,-,RCV000074396|RCV000250269|RCV000316267,"MONDO:MONDO:0014226,MedGen:C3809768,OMIM:615518,Orphanet:228000|MedGen:CN169374|Human Phenotype Ontology:HP:0000548,MONDO:MONDO:0015993,MedGen:C4085590,OMIM:PS120970,Orphanet:1872",Immunodeficiency 13|not specified|Cone-rod dystrophy,germline;unknown,germline,GRCh38,NC_000017.11,17,28552493,28552493,na,na,17q11.2,"criteria provided, multiple submitters, no conflicts",5,-,N,"UniProtKB:Q13432#VAR_071184,OMIM:604011.0002,ClinGen:CA145322",3,88737,28552493,C,A,G22V,2,benign,benign,Q13432,Q13432,reviewed,U119A_HUMAN,"Protein unc-119 homolog A (Retinal protein 4, hRG4)",UNC119 RG4,Homo sapiens (Human),240.0,MKVKKGGGGAGTATESAPGPSGQSVAPIPQPPAESESGSESEPDAGPGPRPGPLQRKQPIGPEDVLGLQRITGDYLCSPEENIYKIDFVRFKIRDMDSGTVLFEIKKPPVSERLPINRRDLDPNAGRFVRYQFTPAFLRLRQVGATVEFTVGDKPVNNFRMIERHYFRNQLLKSFDFHFGFCIPSSKNTCEHIYDFPPLSEELISEMIRHPYETQSDSFYFVDDRLVMHNKADYSYSGTP,PF05351;,3GQQ;3RBQ;4GOJ;4GOK;5L7K;6H6A;,22,G,V,True,962
13782,5973,39406,single nucleotide variant,NM_019887.6(DIABLO):c.377C>T (p.Ser126Leu),56616,DIABLO,HGNC:21528,Pathogenic,1,23-Jun-17,387906893,-,RCV000023402|RCV000522513,"MONDO:MONDO:0013593,MedGen:C3279948,OMIM:614152,Orphanet:90635|MedGen:CN517202","Deafness, autosomal dominant 64|not provided",germline,germline,GRCh38,NC_000012.12,12,122216808,122216808,na,na,12q24.31,"criteria provided, single submitter",2,-,N,"ClinGen:CA129213,UniProtKB:Q9NR28#VAR_066487,OMIM:605219.0001",3,30449,122216808,G,A,S126L,1,pathogenic,pathogenic,Q9NR28,Q9NR28,reviewed,DBLOH_HUMAN,"Diablo IAP-binding mitochondrial protein (Diablo homolog, mitochondrial) (Direct IAP-binding protein with low pI) (Second mitochondria-derived activator of caspase, Smac)",DIABLO SMAC,Homo sapiens (Human),239.0,MAALKSWLSRSVTSFFRYRQCLCVPVVANFKKRCFSELIRPWHKTVTIGFGVTLCAVPIAQKSEPHSLSSEALMRRAVSLVTDSTSTFLSQTTYALIEAITEYTKAVYTLTSLYRQYTSLLGKMNSEEEDEVWQVIIGARAEMTSKHQEYLKLETTWMTAVGLSEMAAEAAYQTGADQASITARNHIQLVKLQVEEVHQLSRKAETKLAEAQIEELRQKTQEEGEERAESEQEAYLRED,PF09057;,1FEW;1G3F;1G73;1OXQ;1TW6;1XB0;1XB1;3D9U;3UIH;3UIJ;4TX5;6JX6;,126,S,L,True,963
13783,10682,140030,single nucleotide variant,NM_001625.4(AK2):c.625G>A (p.Ala209Thr),204,AK2,HGNC:362,Benign/Likely benign,0,31-Dec-19,12116440,-,RCV000123572|RCV000440986|RCV001082448,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0009973,MedGen:C0272167,OMIM:267500,Orphanet:33355",not specified|not provided|Reticular dysgenesis,germline,germline,GRCh38,NC_000001.11,1,33013276,33013276,na,na,1p35.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA289341,UniProtKB:P54819#VAR_050032",2,136327,33013276,C,T,A209T,2,benign,benign,P54819,P54819,reviewed,KAD2_HUMAN,"Adenylate kinase 2, mitochondrial, AK 2, EC 2.7.4.3 (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) [Cleaved into: Adenylate kinase 2, mitochondrial, N-terminally processed ]",AK2 ADK2,Homo sapiens (Human),239.0,MAPSVPAAEPEYPKGIRAVLLGPPGAGKGTQAPRLAENFCVCHLATGDMLRAMVASGSELGKKLKATMDAGKLVSDEMVVELIEKNLETPLCKNGFLLDGFPRTVRQAEMLDDLMEKRKEKLDSVIEFSIPDSLLIRRITGRLIHPKSGRSYHEEFNPPKEPMKDDITGEPLIRRSDDNEKALKIRLQAYHTQTTPLIEYYRKRGIHSAIDASQTPDVVFASILAAFSKATCKDLVMFI,PF05191;,2C9Y;,209,A,T,True,964
13784,5301,33299,single nucleotide variant,NM_001625.4(AK2):c.307C>T (p.Arg103Trp),204,AK2,HGNC:362,Likely pathogenic,1,26-Sep-18,267606648,-,RCV000019922,"MONDO:MONDO:0009973,MedGen:C0272167,OMIM:267500,Orphanet:33355",Reticular dysgenesis,germline,germline,GRCh38,NC_000001.11,1,33021616,33021616,na,na,1p35.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA128003,UniProtKB:P54819#VAR_054630,OMIM:103020.0011",3,18260,33021616,G,A,R103W,1,pathogenic,pathogenic,P54819,P54819,reviewed,KAD2_HUMAN,"Adenylate kinase 2, mitochondrial, AK 2, EC 2.7.4.3 (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) [Cleaved into: Adenylate kinase 2, mitochondrial, N-terminally processed ]",AK2 ADK2,Homo sapiens (Human),239.0,MAPSVPAAEPEYPKGIRAVLLGPPGAGKGTQAPRLAENFCVCHLATGDMLRAMVASGSELGKKLKATMDAGKLVSDEMVVELIEKNLETPLCKNGFLLDGFPRTVRQAEMLDDLMEKRKEKLDSVIEFSIPDSLLIRRITGRLIHPKSGRSYHEEFNPPKEPMKDDITGEPLIRRSDDNEKALKIRLQAYHTQTTPLIEYYRKRGIHSAIDASQTPDVVFASILAAFSKATCKDLVMFI,PF05191;,2C9Y;,103,R,W,True,964
13785,5300,33295,single nucleotide variant,NM_001625.4(AK2):c.494A>G (p.Asp165Gly),204,AK2,HGNC:362,Pathogenic,1,1-Jan-09,267606643,-,RCV000019918,"MONDO:MONDO:0009973,MedGen:C0272167,OMIM:267500,Orphanet:33355",Reticular dysgenesis,germline,germline,GRCh38,NC_000001.11,1,33014526,33014526,na,na,1p35.1,no assertion criteria provided,1,-,N,"ClinGen:CA127994,UniProtKB:P54819#VAR_054631,OMIM:103020.0007",1,18256,33014526,T,C,D165G,0,pathogenic,uncertain,P54819,P54819,reviewed,KAD2_HUMAN,"Adenylate kinase 2, mitochondrial, AK 2, EC 2.7.4.3 (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) [Cleaved into: Adenylate kinase 2, mitochondrial, N-terminally processed ]",AK2 ADK2,Homo sapiens (Human),239.0,MAPSVPAAEPEYPKGIRAVLLGPPGAGKGTQAPRLAENFCVCHLATGDMLRAMVASGSELGKKLKATMDAGKLVSDEMVVELIEKNLETPLCKNGFLLDGFPRTVRQAEMLDDLMEKRKEKLDSVIEFSIPDSLLIRRITGRLIHPKSGRSYHEEFNPPKEPMKDDITGEPLIRRSDDNEKALKIRLQAYHTQTTPLIEYYRKRGIHSAIDASQTPDVVFASILAAFSKATCKDLVMFI,PF05191;,2C9Y;,165,D,G,True,964
13786,12373,214759,single nucleotide variant,NM_003491.4(NAA10):c.128A>C (p.Tyr43Ser),8260,NAA10,HGNC:18704,Pathogenic,1,2-Nov-15,863225427,-,RCV000202352,"MONDO:MONDO:0010457,MedGen:C3275447,OMIM:300855,Orphanet:276432",N-terminal acetyltransferase deficiency,germline,germline,GRCh38,NC_000023.11,X,153933994,153933994,na,na,Xq28,no assertion criteria provided,1,-,N,"ClinGen:CA279878,UniProtKB:P41227#VAR_075206,OMIM:300013.0005",1,218104,153933994,T,G,Y43S,0,pathogenic,uncertain,P41227,P41227,reviewed,NAA10_HUMAN,"N-alpha-acetyltransferase 10, EC 2.3.1.255 (N-terminal acetyltransferase complex ARD1 subunit homolog A, hARD1) (NatA catalytic subunit Naa10)",NAA10 ARD1 ARD1A TE2,Homo sapiens (Human),235.0,MNIRNARPEDLMNMQHCNLLCLPENYQMKYYFYHGLSWPQLSYIAEDENGKIVGYVLAKMEEDPDDVPHGHITSLAVKRSHRRLGLAQKLMDQASRAMIENFNAKYVSLHVRKSNRAALHLYSNTLNFQISEVEPKYYADGEDAYAMKRDLTQMADELRRHLELKEKGRHVVLGAIENKVESKGNSPPSSGEACREEKGLAAEDSGGDSKDLSEVSETTESTDVKDSSEASDSAS,PF00583;,6C95;6C9M;6PPL;6PW9;,43,Y,S,True,965
13787,5835,38882,single nucleotide variant,NM_003491.4(NAA10):c.109T>C (p.Ser37Pro),8260,NAA10,HGNC:18704,Pathogenic,1,15-Jul-11,387906701,-,RCV000022818,"MONDO:MONDO:0010457,MedGen:C3275447,OMIM:300855,Orphanet:276432",N-terminal acetyltransferase deficiency,germline,germline,GRCh38,NC_000023.11,X,153934388,153934388,na,na,Xq28,no assertion criteria provided,1,-,N,"ClinGen:CA128774,NAA10 @ LOVD:NAA10_000008,UniProtKB:P41227#VAR_066652,OMIM:300013.0001",1,29927,153934388,A,G,S37P,0,pathogenic,uncertain,P41227,P41227,reviewed,NAA10_HUMAN,"N-alpha-acetyltransferase 10, EC 2.3.1.255 (N-terminal acetyltransferase complex ARD1 subunit homolog A, hARD1) (NatA catalytic subunit Naa10)",NAA10 ARD1 ARD1A TE2,Homo sapiens (Human),235.0,MNIRNARPEDLMNMQHCNLLCLPENYQMKYYFYHGLSWPQLSYIAEDENGKIVGYVLAKMEEDPDDVPHGHITSLAVKRSHRRLGLAQKLMDQASRAMIENFNAKYVSLHVRKSNRAALHLYSNTLNFQISEVEPKYYADGEDAYAMKRDLTQMADELRRHLELKEKGRHVVLGAIENKVESKGNSPPSSGEACREEKGLAAEDSGGDSKDLSEVSETTESTDVKDSSEASDSAS,PF00583;,6C95;6C9M;6PPL;6PW9;,37,S,P,True,965
13788,3215,27781,single nucleotide variant,NM_001768.6(CD8A):c.331G>A (p.Gly111Ser),925,CD8A,HGNC:1706,Pathogenic,1,1-Jul-01,121918660,-,RCV000013579,"MONDO:MONDO:0012161,MedGen:C1837065,OMIM:608957,Orphanet:169085","Cd8 deficiency, familial",germline,germline,GRCh38,NC_000002.12,2,86790400,86790400,na,na,2p11.2,no assertion criteria provided,1,-,N,"ClinGen:CA122671,UniProtKB:P01732#VAR_021020,OMIM:186910.0001",1,12742,86790400,C,T,G111S,0,pathogenic,uncertain,P01732,P01732,reviewed,CD8A_HUMAN,T-cell surface glycoprotein CD8 alpha chain (T-lymphocyte differentiation antigen T8/Leu-2) (CD antigen CD8a),CD8A MAL,Homo sapiens (Human),235.0,MALPVTALLLPLALLLHAARPSQFRVSPLDRTWNLGETVELKCQVLLSNPTSGCSWLFQPRGAAASPTFLLYLSQNKPKAAEGLDTQRFSGKRLGDTFVLTLSDFRRENEGYYFCSALSNSIMYFSHFVPVFLPAKPTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCNHRNRRRVCKCPRPVVKSGDKPSLSARYV,PF07686;,1AKJ;1CD8;1Q69;2HP4;3QZW;,111,G,S,True,966
13789,1430,21304,single nucleotide variant,NM_003921.5(BCL10):c.172C>G (p.Arg58Gly),8915,BCL10,HGNC:989,Pathogenic,1,8-Jan-99,121918314,-,RCV000006643,MedGen:C3276200,"Male germ cell tumor, somatic",somatic,somatic,GRCh38,NC_000001.11,1,85270792,85270792,na,na,1p22.3,no assertion criteria provided,1,-,N,"ClinGen:CA118077,UniProtKB:O95999#VAR_013214,OMIM:603517.0016",1,6265,85270792,G,C,R58G,0,pathogenic,uncertain,O95999,O95999,reviewed,BCL10_HUMAN,"B-cell lymphoma/leukemia 10 (B-cell CLL/lymphoma 10, Bcl-10) (CARD-containing molecule enhancing NF-kappa-B) (CARD-like apoptotic protein, hCLAP) (CED-3/ICH-1 prodomain homologous E10-like regulator, CIPER) (Cellular homolog of vCARMEN, cCARMEN) (Cellular-E10, c-E10) (Mammalian CARD-containing adapter molecule E10, mE10)",BCL10 CIPER CLAP,Homo sapiens (Human),233.0,MEPTAPSLTEEDLTEVKKDALENLRVYLCEKIIAERHFDHLRAKKILSREDTEEISCRTSSRKRAGKLLDYLQENPKGLDTLVESIRREKTQNFLIQKITDEVLKLRNIKLEHLKGLKCSSCEPFPDGATNNLSRSNSDESNFSEKLRASTVMYHPEGESSTTPFFSTNSSLNLPVLEVGRTENTIFSSTTLPRPGDPGAPPLPPDLQLEEEGTCANSSEMFLPLRSRTVSRQ,PF00619;,2MB9;6BZE;6GK2;,58,R,G,True,967
13790,11470,181524,single nucleotide variant,NM_017831.4(RNF125):c.488C>T (p.Ser163Leu),54941,RNF125,HGNC:21150,Uncertain significance,1,23-Jun-18,373764886,-,RCV000162242,"MONDO:MONDO:0014553,MedGen:C4015710,OMIM:616260",Tenorio syndrome,germline,germline,GRCh38,NC_000018.10,18,32045716,32045716,na,na,18q12.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA186099,UniProtKB:Q96EQ8#VAR_073354,OMIM:610432.0002",3,183421,32045716,C,T,S163L,1,uncertain,uncertain,Q96EQ8,Q96EQ8,reviewed,RN125_HUMAN,"E3 ubiquitin-protein ligase RNF125, EC 2.3.2.27 (RING finger protein 125) (T-cell RING activation protein 1, TRAC-1)",RNF125,Homo sapiens (Human),232.0,MGSVLSTDSGKSAPASATARALERRRDPELPVTSFDCAVCLEVLHQPVRTRCGHVFCRSCIATSLKNNKWTCPYCRAYLPSEGVPATDVAKRMKSEYKNCAECDTLVCLSEMRAHIRTCQKYIDKYGPLQELEETAARCVCPFCQRELYEDSLLDHCITHHRSERRPVFCPLCRLIPDENPSSFSGSLIRHLQVSHTLFYDDFIDFNIIEEALIRRVLDRSLLEYVNHSNTT,PF05605;PF18574;,5DKA;,163,S,L,True,968
13791,11471,181525,single nucleotide variant,NM_017831.4(RNF125):c.520C>T (p.Arg174Cys),54941,RNF125,HGNC:21150,Pathogenic,1,1-Dec-14,370242930,-,RCV000162243,"MONDO:MONDO:0014553,MedGen:C4015710,OMIM:616260",Tenorio syndrome,germline,germline,GRCh38,NC_000018.10,18,32065917,32065917,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA186101,UniProtKB:Q96EQ8#VAR_073355,OMIM:610432.0003",1,183422,32065917,C,T,R174C,0,pathogenic,uncertain,Q96EQ8,Q96EQ8,reviewed,RN125_HUMAN,"E3 ubiquitin-protein ligase RNF125, EC 2.3.2.27 (RING finger protein 125) (T-cell RING activation protein 1, TRAC-1)",RNF125,Homo sapiens (Human),232.0,MGSVLSTDSGKSAPASATARALERRRDPELPVTSFDCAVCLEVLHQPVRTRCGHVFCRSCIATSLKNNKWTCPYCRAYLPSEGVPATDVAKRMKSEYKNCAECDTLVCLSEMRAHIRTCQKYIDKYGPLQELEETAARCVCPFCQRELYEDSLLDHCITHHRSERRPVFCPLCRLIPDENPSSFSGSLIRHLQVSHTLFYDDFIDFNIIEEALIRRVLDRSLLEYVNHSNTT,PF05605;PF18574;,5DKA;,174,R,C,True,968
13792,11469,181523,single nucleotide variant,NM_017831.4(RNF125):c.336G>A (p.Met112Ile),54941,RNF125,HGNC:21150,Pathogenic,1,1-Dec-14,786201014,-,RCV000162241,"MONDO:MONDO:0014553,MedGen:C4015710,OMIM:616260",Tenorio syndrome,germline,germline,GRCh38,NC_000018.10,18,32042196,32042196,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA186097,UniProtKB:Q96EQ8#VAR_073353,OMIM:610432.0001",1,183420,32042196,G,A,M112I,0,pathogenic,uncertain,Q96EQ8,Q96EQ8,reviewed,RN125_HUMAN,"E3 ubiquitin-protein ligase RNF125, EC 2.3.2.27 (RING finger protein 125) (T-cell RING activation protein 1, TRAC-1)",RNF125,Homo sapiens (Human),232.0,MGSVLSTDSGKSAPASATARALERRRDPELPVTSFDCAVCLEVLHQPVRTRCGHVFCRSCIATSLKNNKWTCPYCRAYLPSEGVPATDVAKRMKSEYKNCAECDTLVCLSEMRAHIRTCQKYIDKYGPLQELEETAARCVCPFCQRELYEDSLLDHCITHHRSERRPVFCPLCRLIPDENPSSFSGSLIRHLQVSHTLFYDDFIDFNIIEEALIRRVLDRSLLEYVNHSNTT,PF05605;PF18574;,5DKA;,112,M,I,True,968
13793,13913,307455,single nucleotide variant,NM_018965.3(TREM2):c.632T>C (p.Leu211Pro),54209,TREM2,HGNC:17761,Benign/Likely benign,0,22-Nov-16,2234256,-,RCV000288246|RCV000593161,"MONDO:MONDO:0020749,MedGen:C4721893,OMIM:221770,Orphanet:2770|MedGen:CN169374",Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1|not specified,germline,germline,GRCh38,NC_000006.12,6,41158917,41158917,na,na,6p21.1,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA3798829,UniProtKB:Q9NZC2#VAR_033626",2,356676,41158917,A,G,L211P,2,benign,benign,Q9NZC2,Q9NZC2,reviewed,TREM2_HUMAN,"Triggering receptor expressed on myeloid cells 2, TREM-2 (Triggering receptor expressed on monocytes 2)",TREM2,Homo sapiens (Human),230.0,MEPLRLLILLFVTELSGAHNTTVFQGVAGQSLQVSCPYDSMKHWGRRKAWCRQLGEKGPCQRVVSTHNLWLLSFLRRWNGSTAITDDTLGGTLTITLRNLQPHDAGLYQCQSLHGSEADTLRKVLVEVLADPLDHRDAGDLWFPGESESFEDAHVEHSISRSLLEGEIPFPPTSILLLLACIFLIKILAASALWAAAWHGQKPGTHPPSELDCGHDPGYQLQTLPGLRDT,PF07686;,5ELI;5UD7;5UD8;6B8O;6XDS;6Y6C;6YMQ;6YYE;6Z0G;6Z0H;6Z0I;,211,L,P,True,969
13794,13866,300116,single nucleotide variant,NM_018965.3(TREM2):c.287C>A (p.Thr96Lys),54209,TREM2,HGNC:17761,Benign/Likely benign,0,22-Nov-16,2234253,-,RCV000312921|RCV000444438|RCV000591330,"MONDO:MONDO:0020749,MedGen:C4721893,OMIM:221770,Orphanet:2770|MedGen:CN517202|MedGen:CN169374",Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1|not provided|not specified,germline,germline,GRCh38,NC_000006.12,6,41161367,41161367,na,na,6p21.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA3798933,UniProtKB:Q9NZC2#VAR_061329",2,356678,41161367,G,T,T96K,2,benign,benign,Q9NZC2,Q9NZC2,reviewed,TREM2_HUMAN,"Triggering receptor expressed on myeloid cells 2, TREM-2 (Triggering receptor expressed on monocytes 2)",TREM2,Homo sapiens (Human),230.0,MEPLRLLILLFVTELSGAHNTTVFQGVAGQSLQVSCPYDSMKHWGRRKAWCRQLGEKGPCQRVVSTHNLWLLSFLRRWNGSTAITDDTLGGTLTITLRNLQPHDAGLYQCQSLHGSEADTLRKVLVEVLADPLDHRDAGDLWFPGESESFEDAHVEHSISRSLLEGEIPFPPTSILLLLACIFLIKILAASALWAAAWHGQKPGTHPPSELDCGHDPGYQLQTLPGLRDT,PF07686;,5ELI;5UD7;5UD8;6B8O;6XDS;6Y6C;6YMQ;6YYE;6Z0G;6Z0H;6Z0I;,96,T,K,True,969
13795,11867,193655,single nucleotide variant,NM_018965.3(TREM2):c.469C>T (p.His157Tyr),54209,TREM2,HGNC:17761,Benign/Likely benign,0,16-Jun-17,2234255,-,RCV000177312|RCV000352563|RCV000513757,"MedGen:CN169374|MONDO:MONDO:0020750,MedGen:C4748657,OMIM:618193|MedGen:CN517202",not specified|Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2|not provided,germline,germline,GRCh38,NC_000006.12,6,41159805,41159805,na,na,6p21.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA202402,UniProtKB:Q9NZC2#VAR_033625",2,196494,41159805,G,A,H157Y,2,benign,benign,Q9NZC2,Q9NZC2,reviewed,TREM2_HUMAN,"Triggering receptor expressed on myeloid cells 2, TREM-2 (Triggering receptor expressed on monocytes 2)",TREM2,Homo sapiens (Human),230.0,MEPLRLLILLFVTELSGAHNTTVFQGVAGQSLQVSCPYDSMKHWGRRKAWCRQLGEKGPCQRVVSTHNLWLLSFLRRWNGSTAITDDTLGGTLTITLRNLQPHDAGLYQCQSLHGSEADTLRKVLVEVLADPLDHRDAGDLWFPGESESFEDAHVEHSISRSLLEGEIPFPPTSILLLLACIFLIKILAASALWAAAWHGQKPGTHPPSELDCGHDPGYQLQTLPGLRDT,PF07686;,5ELI;5UD7;5UD8;6B8O;6XDS;6Y6C;6YMQ;6YYE;6Z0G;6Z0H;6Z0I;,157,H,Y,True,969
13796,1205,20254,single nucleotide variant,NM_018965.3(TREM2):c.401A>G (p.Asp134Gly),54209,TREM2,HGNC:17761,Uncertain significance,1,17-Oct-19,28939079,-,RCV000005525,"MONDO:MONDO:0020750,MedGen:C4748657,OMIM:618193",Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2,germline;unknown,germline,GRCh38,NC_000006.12,6,41159873,41159873,na,na,6p21.1,"criteria provided, single submitter",2,-,N,"OMIM:605086.0003,ClinGen:CA253436,UniProtKB:Q9NZC2#VAR_019334",3,5215,41159873,T,C,D134G,1,uncertain,uncertain,Q9NZC2,Q9NZC2,reviewed,TREM2_HUMAN,"Triggering receptor expressed on myeloid cells 2, TREM-2 (Triggering receptor expressed on monocytes 2)",TREM2,Homo sapiens (Human),230.0,MEPLRLLILLFVTELSGAHNTTVFQGVAGQSLQVSCPYDSMKHWGRRKAWCRQLGEKGPCQRVVSTHNLWLLSFLRRWNGSTAITDDTLGGTLTITLRNLQPHDAGLYQCQSLHGSEADTLRKVLVEVLADPLDHRDAGDLWFPGESESFEDAHVEHSISRSLLEGEIPFPPTSILLLLACIFLIKILAASALWAAAWHGQKPGTHPPSELDCGHDPGYQLQTLPGLRDT,PF07686;,5ELI;5UD7;5UD8;6B8O;6XDS;6Y6C;6YMQ;6YYE;6Z0G;6Z0H;6Z0I;,134,D,G,True,969
13797,1204,20253,single nucleotide variant,NM_018965.3(TREM2):c.558G>T (p.Lys186Asn),54209,TREM2,HGNC:17761,Uncertain significance,1,17-Oct-19,28937876,-,RCV000005524,"MONDO:MONDO:0020750,MedGen:C4748657,OMIM:618193",Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2,germline;unknown,germline,GRCh38,NC_000006.12,6,41158991,41158991,na,na,6p21.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA253434,UniProtKB:Q9NZC2#VAR_019335,OMIM:605086.0002",3,5214,41158991,C,A,K186N,1,uncertain,uncertain,Q9NZC2,Q9NZC2,reviewed,TREM2_HUMAN,"Triggering receptor expressed on myeloid cells 2, TREM-2 (Triggering receptor expressed on monocytes 2)",TREM2,Homo sapiens (Human),230.0,MEPLRLLILLFVTELSGAHNTTVFQGVAGQSLQVSCPYDSMKHWGRRKAWCRQLGEKGPCQRVVSTHNLWLLSFLRRWNGSTAITDDTLGGTLTITLRNLQPHDAGLYQCQSLHGSEADTLRKVLVEVLADPLDHRDAGDLWFPGESESFEDAHVEHSISRSLLEGEIPFPPTSILLLLACIFLIKILAASALWAAAWHGQKPGTHPPSELDCGHDPGYQLQTLPGLRDT,PF07686;,5ELI;5UD7;5UD8;6B8O;6XDS;6Y6C;6YMQ;6YYE;6Z0G;6Z0H;6Z0I;,186,K,N,True,969
13798,291,16125,single nucleotide variant,NM_176812.5(CHMP4B):c.481G>A (p.Glu161Lys),128866,CHMP4B,HGNC:16171,Pathogenic,1,1-Sep-07,118203966,-,RCV000001144,"MONDO:MONDO:0011547,MedGen:C1854311,OMIM:605387,Orphanet:91492",Cataract 31 multiple types,germline,germline,GRCh38,NC_000020.11,20,33851064,33851064,na,na,20q11.22,no assertion criteria provided,1,-,N,"ClinGen:CA114744,UniProtKB:Q9H444#VAR_037580,OMIM:610897.0002",1,1086,33851064,G,A,E161K,0,pathogenic,uncertain,Q9H444,Q9H444,reviewed,CHM4B_HUMAN,"Charged multivesicular body protein 4b (Chromatin-modifying protein 4b, CHMP4b) (SNF7 homolog associated with Alix 1) (SNF7-2, hSnf7-2) (Vacuolar protein sorting-associated protein 32-2, Vps32-2, hVps32-2)",CHMP4B C20orf178 SHAX1,Homo sapiens (Human),224.0,MSVFGKLFGAGGGKAGKGGPTPQEAIQRLRDTEEMLSKKQEFLEKKIEQELTAAKKHGTKNKRAALQALKRKKRYEKQLAQIDGTLSTIEFQREALENANTNTEVLKNMGYAAKAMKAAHDNMDIDKVDELMQDIADQQELAEEISTAISKPVGFGEEFDEDELMAELEELEQEELDKNLLEISGPETVPLPNVPSIALPSKPAKKKEEEDDDMKELENWAGSM,PF03357;,3C3Q;3UM3;4ABM;5MK2;,161,E,K,True,970
13799,290,16124,single nucleotide variant,NM_176812.5(CHMP4B):c.386A>T (p.Asp129Val),128866,CHMP4B,HGNC:16171,Pathogenic,1,1-Sep-07,118203965,-,RCV000001143,"MONDO:MONDO:0011547,MedGen:C1854311,OMIM:605387,Orphanet:91492",Cataract 31 multiple types,germline,germline,GRCh38,NC_000020.11,20,33850969,33850969,na,na,20q11.22,no assertion criteria provided,1,-,N,"ClinGen:CA114743,UniProtKB:Q9H444#VAR_037579,OMIM:610897.0001",1,1085,33850969,A,T,D129V,0,pathogenic,uncertain,Q9H444,Q9H444,reviewed,CHM4B_HUMAN,"Charged multivesicular body protein 4b (Chromatin-modifying protein 4b, CHMP4b) (SNF7 homolog associated with Alix 1) (SNF7-2, hSnf7-2) (Vacuolar protein sorting-associated protein 32-2, Vps32-2, hVps32-2)",CHMP4B C20orf178 SHAX1,Homo sapiens (Human),224.0,MSVFGKLFGAGGGKAGKGGPTPQEAIQRLRDTEEMLSKKQEFLEKKIEQELTAAKKHGTKNKRAALQALKRKKRYEKQLAQIDGTLSTIEFQREALENANTNTEVLKNMGYAAKAMKAAHDNMDIDKVDELMQDIADQQELAEEISTAISKPVGFGEEFDEDELMAELEELEQEELDKNLLEISGPETVPLPNVPSIALPSKPAKKKEEEDDDMKELENWAGSM,PF03357;,3C3Q;3UM3;4ABM;5MK2;,129,D,V,True,970
13800,8689,94224,single nucleotide variant,NM_004181.5(UCHL1):c.20A>C (p.Glu7Ala),7345,UCHL1,HGNC:12513,Pathogenic,1,26-Feb-13,397515634,-,RCV000074332,"MONDO:MONDO:0014209,MedGen:C3809665,OMIM:615491,Orphanet:352654","Spastic paraplegia 79, autosomal recessive",germline,germline,GRCh38,NC_000004.12,4,41256996,41256996,na,na,4p13,no assertion criteria provided,1,-,N,"ClinGen:CA145269,UniProtKB:P09936#VAR_070875,OMIM:191342.0003",1,88635,41256996,A,C,E7A,0,pathogenic,uncertain,P09936,P09936,reviewed,UCHL1_HUMAN,"Ubiquitin carboxyl-terminal hydrolase isozyme L1, UCH-L1, EC 3.4.19.12 (Neuron cytoplasmic protein 9.5) (PGP 9.5, PGP9.5) (Ubiquitin thioesterase L1)",UCHL1,Homo sapiens (Human),223.0,MQLKPMEINPEMLNKVLSRLGVAGQWRFVDVLGLEEESLGSVPAPACALLLLFPLTAQHENFRKKQIEELKGQEVSPKVYFMKQTIGNSCGTIGLIHAVANNQDKLGFEDGSVLKQFLSETEKMSPEDRAKCFEKNEAIQAAHDAVAQEGQCRVDDKVNFHFILFNNVDGHLYELDGRMPFPVNHGASSEDTLLKDAAKVCREFTEREQGEVRFSAVALCKAA,PF01088;,2ETL;2LEN;3IFW;3IRT;3KVF;3KW5;4DM9;4JKJ;,7,E,A,True,971
13801,3004,27336,single nucleotide variant,NM_004181.5(UCHL1):c.279C>G (p.Ile93Met),7345,UCHL1,HGNC:12513,risk factor,0,1-Apr-06,121917767,-,RCV000013091,"MONDO:MONDO:0013340,MedGen:C3150899,OMIM:613643,Orphanet:2828",Parkinson disease 5,germline,germline,GRCh38,NC_000004.12,4,41260751,41260751,na,na,4p13,no assertion criteria provided,1,-,N,"ClinGen:CA256259,UniProtKB:P09936#VAR_015678,OMIM:191342.0001",1,12297,41260751,C,G,I93M,0,uncertain,uncertain,P09936,P09936,reviewed,UCHL1_HUMAN,"Ubiquitin carboxyl-terminal hydrolase isozyme L1, UCH-L1, EC 3.4.19.12 (Neuron cytoplasmic protein 9.5) (PGP 9.5, PGP9.5) (Ubiquitin thioesterase L1)",UCHL1,Homo sapiens (Human),223.0,MQLKPMEINPEMLNKVLSRLGVAGQWRFVDVLGLEEESLGSVPAPACALLLLFPLTAQHENFRKKQIEELKGQEVSPKVYFMKQTIGNSCGTIGLIHAVANNQDKLGFEDGSVLKQFLSETEKMSPEDRAKCFEKNEAIQAAHDAVAQEGQCRVDDKVNFHFILFNNVDGHLYELDGRMPFPVNHGASSEDTLLKDAAKVCREFTEREQGEVRFSAVALCKAA,PF01088;,2ETL;2LEN;3IFW;3IRT;3KVF;3KW5;4DM9;4JKJ;,93,I,M,True,971
13802,3005,27337,single nucleotide variant,NM_004181.5(UCHL1):c.53C>A (p.Ser18Tyr),7345,UCHL1,HGNC:12513,Benign,0,27-Apr-17,5030732,-,RCV000013092,"MONDO:MONDO:0013340,MedGen:C3150899,OMIM:613643,Orphanet:2828",Parkinson disease 5,germline,germline,GRCh38,NC_000004.12,4,41257616,41257616,na,na,4p13,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA256260,UniProtKB:P09936#VAR_015677,OMIM:191342.0002",3,12298,41257616,C,A,S18Y,2,benign,benign,P09936,P09936,reviewed,UCHL1_HUMAN,"Ubiquitin carboxyl-terminal hydrolase isozyme L1, UCH-L1, EC 3.4.19.12 (Neuron cytoplasmic protein 9.5) (PGP 9.5, PGP9.5) (Ubiquitin thioesterase L1)",UCHL1,Homo sapiens (Human),223.0,MQLKPMEINPEMLNKVLSRLGVAGQWRFVDVLGLEEESLGSVPAPACALLLLFPLTAQHENFRKKQIEELKGQEVSPKVYFMKQTIGNSCGTIGLIHAVANNQDKLGFEDGSVLKQFLSETEKMSPEDRAKCFEKNEAIQAAHDAVAQEGQCRVDDKVNFHFILFNNVDGHLYELDGRMPFPVNHGASSEDTLLKDAAKVCREFTEREQGEVRFSAVALCKAA,PF01088;,2ETL;2LEN;3IFW;3IRT;3KVF;3KW5;4DM9;4JKJ;,18,S,Y,True,971
13803,5935,39194,single nucleotide variant,NM_005866.4(SIGMAR1):c.304G>C (p.Glu102Gln),10280,SIGMAR1,HGNC:8157,Pathogenic,1,1-Jan-15,387906829,-,RCV000023162,"MONDO:MONDO:0013715,MedGen:C3280587,OMIM:614373,Orphanet:300605","Amyotrophic lateral sclerosis 16, juvenile",germline,germline,GRCh38,NC_000009.12,9,34637268,34637268,na,na,9p13.3,no assertion criteria provided,1,-,N,"ClinGen:CA259767,UniProtKB:Q99720#VAR_067311,OMIM:601978.0001",1,30238,34637268,C,G,E102Q,0,pathogenic,uncertain,Q99720,Q99720,reviewed,SGMR1_HUMAN,"Sigma non-opioid intracellular receptor 1 (Aging-associated gene 8 protein) (SR31747-binding protein, SR-BP) (Sigma 1-type opioid receptor, SIG-1R, Sigma1-receptor, Sigma1R, hSigmaR1)",SIGMAR1 OPRS1 SRBP AAG8,Homo sapiens (Human),223.0,MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP,PF04622;,5HK1;5HK2;6DJZ;6DK0;6DK1;,102,E,Q,True,972
13804,11113,170958,single nucleotide variant,NM_005214.5(CTLA4):c.208C>T (p.Arg70Trp),1493,CTLA4,HGNC:2505,Pathogenic/Likely pathogenic,1,1-Nov-20,606231422,-,RCV000148295|RCV001311981,"MONDO:MONDO:0014493,MedGen:C4015214,OMIM:616100,Orphanet:436159|MedGen:CN517202",Autoimmune lymphoproliferative syndrome type V|not provided,germline;unknown,germline,GRCh38,NC_000002.12,2,203870684,203870684,na,na,2q33.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA173999,UniProtKB:P16410#VAR_072681,OMIM:123890.0008",3,161114,203870684,C,T,R70W,2,pathogenic,pathogenic,P16410,P16410,reviewed,CTLA4_HUMAN,"Cytotoxic T-lymphocyte protein 4 (Cytotoxic T-lymphocyte-associated antigen 4, CTLA-4) (CD antigen CD152)",CTLA4 CD152,Homo sapiens (Human),223.0,MACLGFQRHKAQLNLATRTWPCTLLFFLLFIPVFCKAMHVAQPAVVLASSRGIASFVCEYASPGKATEVRVTVLRQADSQVTEVCAATYMMGNELTFLDDSICTGTSSGNQVNLTIQGLRAMDTGLYICKVELMYPPPYYLGIGNGTQIYVIDPEPCPDSDFLLWILAAVSSGLFFYSFLLTAVSLSKMLKKRSPLTTGVYVKMPPTEPECEKQFQPYFIPIN,PF07686;,1AH1;1H6E;1I85;1I8L;2X44;3BX7;3OSK;5GGV;5TRU;5XJ3;6RP8;6RPJ;6RQM;6XY2;7CIO;7DV4;7ELX;,70,R,W,True,973
13805,4785,31960,single nucleotide variant,NM_005214.5(CTLA4):c.49A>G (p.Thr17Ala),1493,CTLA4,HGNC:2505,Benign,0,29-Mar-16,231775,-,RCV000018423|RCV000018424|RCV000018425|RCV000018427|RCV000455037|RCV001255201,"||MedGen:C3862275|MONDO:MONDO:0012341,MedGen:C1857845,OMIM:609755|MedGen:CN169374|","Hashimoto thyroiditis, susceptibility to|Thyroid-associated orbitopathy, susceptibility to|Systemic lupus erythematosus, susceptibility to|Celiac disease 3|not specified|TYPE 1 DIABETES MELLITUS 12, SUSCEPTIBILITY TO",germline,germline,GRCh38,NC_000002.12,2,203867991,203867991,na,na,2q33.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA126974,UniProtKB:P16410#VAR_013577,OMIM:123890.0001",3,16921,203867991,A,G,T17A,1,benign,benign,P16410,P16410,reviewed,CTLA4_HUMAN,"Cytotoxic T-lymphocyte protein 4 (Cytotoxic T-lymphocyte-associated antigen 4, CTLA-4) (CD antigen CD152)",CTLA4 CD152,Homo sapiens (Human),223.0,MACLGFQRHKAQLNLATRTWPCTLLFFLLFIPVFCKAMHVAQPAVVLASSRGIASFVCEYASPGKATEVRVTVLRQADSQVTEVCAATYMMGNELTFLDDSICTGTSSGNQVNLTIQGLRAMDTGLYICKVELMYPPPYYLGIGNGTQIYVIDPEPCPDSDFLLWILAAVSSGLFFYSFLLTAVSLSKMLKKRSPLTTGVYVKMPPTEPECEKQFQPYFIPIN,PF07686;,1AH1;1H6E;1I85;1I8L;2X44;3BX7;3OSK;5GGV;5TRU;5XJ3;6RP8;6RPJ;6RQM;6XY2;7CIO;7DV4;7ELX;,17,T,A,True,973
13806,1094,19506,single nucleotide variant,NM_148910.2(TIRAP):c.539C>T (p.Ser180Leu),114609,TIRAP,HGNC:17192,protective,0,20-Jun-20,8177374,-,RCV000004722|RCV000004723|RCV000004724|RCV000023527,"MedGen:C1970686|MedGen:C2720293|MedGen:C1969665|MONDO:MONDO:0000108,MedGen:C3280646","Invasive pneumococcal disease, protection against|Malaria, resistance to|Mycobacterium tuberculosis, protection against|Bacteremia, resistance to",germline,germline,GRCh38,NC_000011.10,11,126292948,126292948,na,na,11q24.2,no assertion criteria provided,1,-,N,"ClinGen:CA116876,UniProtKB:P58753#VAR_019146,OMIM:606252.0001",1,4467,126292948,C,T,S180L,0,uncertain,uncertain,P58753,P58753,reviewed,TIRAP_HUMAN,"Toll/interleukin-1 receptor domain-containing adapter protein, TIR domain-containing adapter protein (Adaptor protein Wyatt) (MyD88 adapter-like protein, MyD88-2)",TIRAP MAL,Homo sapiens (Human),221.0,MASSTSLPAPGSRPKKPLGKMADWFRQTLLKKPKKRPNSPESTSSDASQPTSQDSPLPPSLSSVTSPSLPPTHASDSGSSRWSKDYDVCVCHSEEDLVAAQDLVSYLEGSTASLRCFLQLRDATPGGAIVSELCQALSSSHCRVLLITPGFLQDPWCKYQMLQALTEAPGAEGCTIPLLSGLSRAAYPPELRFMYYVDGRGPDGGFRQVKEAVMRYLQTLS,PF13676;,2NDH;2Y92;3UB2;3UB3;3UB4;4FZ5;4LQD;5T7Q;5UZB;,180,S,L,True,974
13807,2367,25068,single nucleotide variant,NM_000194.2(HPRT1):c.396T>G (p.Ile132Met),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,10-Sep-20,137852477,-,RCV000010712|RCV000010713,"MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|",Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT ANN ARBOR,germline,germline,GRCh38,NC_000023.11,X,134490199,134490199,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120887,UniProtKB:P00492#VAR_006782,OMIM:308000.0001",1,10029,134490199,T,G,I132M,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,132,I,M,True,975
13808,2377,25082,single nucleotide variant,NM_000194.2(HPRT1):c.595T>G (p.Phe199Val),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,26-Sep-17,137852486,-,RCV000010740|RCV000010741,"MedGen:C0023374,OMIM:300322,Orphanet:510|",Lesch-Nyhan syndrome|HPRT NEW BRITON,germline,germline,GRCh38,NC_000023.11,X,134498670,134498670,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120898,UniProtKB:P00492#VAR_006800,OMIM:308000.0015",1,10043,134498670,T,G,F199V,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,199,F,V,True,975
13809,2369,25070,single nucleotide variant,NM_000194.2(HPRT1):c.602A>G (p.Asp201Gly),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,10-Sep-20,137852479,-,RCV000010716|RCV000010717,"MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|",Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT ASHVILLE,germline,germline,GRCh38,NC_000023.11,X,134498677,134498677,na,na,Xq26.2,no assertion criteria provided,1,-,N,"OMIM:308000.0003,ClinGen:CA120889,UniProtKB:P00492#VAR_006801",1,10031,134498677,A,G,D201G,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,201,D,G,True,975
13810,5845,38940,single nucleotide variant,NM_000194.3(HPRT1):c.143G>A (p.Arg48His),3251,HPRT1,HGNC:5157,Pathogenic,1,23-Sep-19,387906725,-,RCV000022877|RCV000690811|RCV001092162|RCV001255647,"MedGen:C1845892|MedGen:C0023374,OMIM:300322,Orphanet:510;MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|MedGen:CN517202|MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233","Lesch-nyhan syndrome, neurologic variant|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|not provided|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency",germline,germline,GRCh38,NC_000023.11,X,134475189,134475189,na,na,Xq26.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"UniProtKB:P00492#VAR_006761,OMIM:308000.0060,ClinGen:CA128815",3,29985,134475189,G,A,R48H,2,pathogenic,pathogenic,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,48,R,H,True,975
13811,2392,25120,single nucleotide variant,NM_000194.2(HPRT1):c.582C>G (p.Asp194Glu),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,10-Sep-20,137852504,-,RCV000010791|RCV000010792,"MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|",Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT MOOSE JAW,germline,germline,GRCh38,NC_000023.11,X,134498657,134498657,na,na,Xq26.2,no assertion criteria provided,1,-,N,"UniProtKB:P00492#VAR_006797,OMIM:308000.0056,ClinGen:CA120913",1,10081,134498657,C,G,D194E,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,194,D,E,True,975
13812,2391,25118,single nucleotide variant,NM_000194.2(HPRT1):c.155A>G (p.Asp52Gly),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,10-Sep-20,137852502,-,RCV000010787|RCV000010788,"MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|",Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT EDINBURGH,germline,germline,GRCh38,NC_000023.11,X,134475201,134475201,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120909,UniProtKB:P00492#VAR_006766,OMIM:308000.0054",1,10079,134475201,A,G,D52G,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,52,D,G,True,975
13813,2390,25115,single nucleotide variant,NM_000194.2(HPRT1):c.232C>G (p.Leu78Val),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,12-May-11,137852501,-,RCV000010781|RCV000010782,"MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|",Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT SWAN,germline,germline,GRCh38,NC_000023.11,X,134475278,134475278,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120908,UniProtKB:P00492#VAR_006776,OMIM:308000.0051",1,10076,134475278,C,G,L78V,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,78,L,V,True,975
13814,2389,25114,single nucleotide variant,NM_000194.2(HPRT1):c.172G>A (p.Gly58Arg),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,12-May-11,137852500,-,RCV000010779|RCV000010780,"MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|",Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT TOOWONG,germline,germline,GRCh38,NC_000023.11,X,134475218,134475218,na,na,Xq26.2,no assertion criteria provided,1,-,N,"OMIM:308000.0050,ClinGen:CA120907,UniProtKB:P00492#VAR_006771",1,10075,134475218,G,A,G58R,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,58,G,R,True,975
13815,2388,25113,single nucleotide variant,NM_000194.2(HPRT1):c.46G>A (p.Gly16Ser),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,12-May-11,137852499,-,RCV000010777|RCV000010778,"MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|",Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT URANGAN,germline,germline,GRCh38,NC_000023.11,X,134473377,134473377,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120906,UniProtKB:P00492#VAR_006753,OMIM:308000.0049",1,10074,134473377,G,A,G16S,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,16,G,S,True,975
13816,2387,25112,single nucleotide variant,NM_000194.2(HPRT1):c.503C>T (p.Thr168Ile),3251,HPRT1,HGNC:5157,Pathogenic,1,1-Jan-90,137852498,-,RCV000010776,"MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233",Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,germline,germline,GRCh38,NC_000023.11,X,134498407,134498407,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120905,UniProtKB:P00492#VAR_006789,OMIM:308000.0048",1,10073,134498407,C,T,T168I,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,168,T,I,True,975
13817,2386,25101,single nucleotide variant,NM_000194.3(HPRT1):c.428T>A (p.Met143Lys),3251,HPRT1,HGNC:5157,Pathogenic,1,1-Mar-89,137852496,-,RCV000010765,"MedGen:C0023374,OMIM:300322,Orphanet:510",Lesch-Nyhan syndrome,germline,germline,GRCh38,NC_000023.11,X,134493533,134493533,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA255004,UniProtKB:P00492#VAR_006785,OMIM:308000.0037",1,10062,134493533,T,A,M143K,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,143,M,K,True,975
13818,2385,25100,single nucleotide variant,NM_000194.2(HPRT1):c.170T>C (p.Met57Thr),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,12-May-11,137852495,-,RCV000010763|RCV000010764,MedGen:C1845892|,"Lesch-nyhan syndrome, neurologic variant|HPRT MONTREAL",germline,germline,GRCh38,NC_000023.11,X,134475216,134475216,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120904,UniProtKB:P00492#VAR_006770,OMIM:308000.0036",1,10061,134475216,T,C,M57T,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,57,M,T,True,975
13819,2383,25097,single nucleotide variant,NM_000194.3(HPRT1):c.527C>T (p.Pro176Leu),3251,HPRT1,HGNC:5157,Pathogenic,1,1-Jul-89,137852493,-,RCV000010758,"MedGen:C0023374,OMIM:300322,Orphanet:510",Lesch-Nyhan syndrome,germline,germline,GRCh38,NC_000023.11,X,134498431,134498431,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA255003,UniProtKB:P00492#VAR_006790,OMIM:308000.0033",1,10058,134498431,C,T,P176L,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,176,P,L,True,975
13820,2382,25088,single nucleotide variant,NM_000194.3(HPRT1):c.529G>T (p.Asp177Tyr),3251,HPRT1,HGNC:5157,Pathogenic,1,1-Jun-90,137852492,-,RCV000010749,"MedGen:C0023374,OMIM:300322,Orphanet:510",Lesch-Nyhan syndrome,germline,germline,GRCh38,NC_000023.11,X,134498433,134498433,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA255001,UniProtKB:P00492#VAR_006792,OMIM:308000.0021",1,10049,134498433,G,T,D177Y,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,177,D,Y,True,975
13821,2368,25069,single nucleotide variant,NM_000194.2(HPRT1):c.239A>T (p.Asp80Val),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,10-Sep-20,137852478,-,RCV000010714|RCV000010715,"MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|",Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT ARLINGTON,germline,germline,GRCh38,NC_000023.11,X,134475285,134475285,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120888,UniProtKB:P00492#VAR_006777,OMIM:308000.0002",1,10030,134475285,A,T,D80V,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,80,D,V,True,975
13822,2381,25087,single nucleotide variant,NM_000194.3(HPRT1):c.134G>A (p.Arg45Lys),3251,HPRT1,HGNC:5157,Pathogenic,1,1-Jun-90,137852491,-,RCV000010748,"MedGen:C0023374,OMIM:300322,Orphanet:510",Lesch-Nyhan syndrome,germline,germline,GRCh38,NC_000023.11,X,134473465,134473465,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA255000,UniProtKB:P00492#VAR_006760,OMIM:308000.0020",1,10048,134473465,G,A,R45K,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,45,R,K,True,975
13823,2379,25084,single nucleotide variant,NM_000194.2(HPRT1):c.211G>C (p.Gly71Arg),3251,HPRT1,HGNC:5157,Likely pathogenic,1,13-Jun-17,137852488,-,RCV000010744|RCV000010745|RCV000790697,"MedGen:C0023374,OMIM:300322,Orphanet:510||MedGen:CN517202",Lesch-Nyhan syndrome|HPRT YALE|not provided,germline,germline,GRCh38,NC_000023.11,X,134475257,134475257,na,na,Xq26.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA120900,UniProtKB:P00492#VAR_006774,OMIM:308000.0017",3,10045,134475257,G,C,G71R,1,pathogenic,pathogenic,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,71,G,R,True,975
13824,2378,25083,single nucleotide variant,NM_000194.2(HPRT1):c.209G>A (p.Gly70Glu),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,26-Sep-17,137852487,-,RCV000010742|RCV000010743,"MedGen:C0023374,OMIM:300322,Orphanet:510|",Lesch-Nyhan syndrome|HPRT NEW HAVEN,germline,germline,GRCh38,NC_000023.11,X,134475255,134475255,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120899,UniProtKB:P00492#VAR_006773,OMIM:308000.0016",1,10044,134475255,G,A,G70E,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,70,G,E,True,975
13825,2376,25081,single nucleotide variant,NM_000194.2(HPRT1):c.312C>A (p.Ser104Arg),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,10-Sep-20,137852485,-,RCV000010738|RCV000010739,"MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|",Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT MUNICH,germline,germline,GRCh38,NC_000023.11,X,134475358,134475358,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120897,UniProtKB:P00492#VAR_006778,OMIM:308000.0014",1,10042,134475358,C,A,S104R,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,104,S,R,True,975
13826,2375,25080,single nucleotide variant,NM_000194.2(HPRT1):c.481G>T (p.Ala161Ser),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,10-Sep-20,137852484,-,RCV000010736|RCV000010737,"MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|",Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT MILWAUKEE,germline,germline,GRCh38,NC_000023.11,X,134493586,134493586,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120896,UniProtKB:P00492#VAR_006787,OMIM:308000.0013",1,10041,134493586,G,T,A161S,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,161,A,S,True,975
13827,2374,25079,single nucleotide variant,NM_000194.2(HPRT1):c.389T>A (p.Val130Asp),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,26-Sep-17,137852483,-,RCV000010734|RCV000010735,"MedGen:C0023374,OMIM:300322,Orphanet:510|",Lesch-Nyhan syndrome|HPRT MIDLAND,germline,germline,GRCh38,NC_000023.11,X,134490192,134490192,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120895,UniProtKB:P00492#VAR_006780,OMIM:308000.0012",1,10040,134490192,T,A,V130D,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,130,V,D,True,975
13828,2373,25077,single nucleotide variant,NM_000194.2(HPRT1):c.329C>T (p.Ser110Leu),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,10-Sep-20,137852482,-,RCV000010730|RCV000010731,"MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|",Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT LONDON,germline,germline,GRCh38,NC_000023.11,X,134486475,134486475,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120894,UniProtKB:P00492#VAR_006779,OMIM:308000.0010",1,10038,134486475,C,T,S110L,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,110,S,L,True,975
13829,2372,25076,single nucleotide variant,NM_000194.2(HPRT1):c.580G>A (p.Asp194Asn),3251,HPRT1,HGNC:5157,Pathogenic,1,1-Jun-90,267606863,-,RCV000010728,"MedGen:C0023374,OMIM:300322,Orphanet:510",Lesch-Nyhan syndrome,germline,germline,GRCh38,NC_000023.11,X,134498655,134498655,na,na,Xq26.2,no assertion criteria provided,1,-,N,"OMIM:308000.0009,ClinGen:CA120893,UniProtKB:P00492#VAR_006798",1,10037,134498655,G,A,D194N,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,194,D,N,True,975
13830,2371,25075,single nucleotide variant,NM_000194.2(HPRT1):c.222C>A (p.Phe74Leu),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,26-Sep-17,137852481,-,RCV000010726|RCV000010727,"MedGen:C0023374,OMIM:300322,Orphanet:510|",Lesch-Nyhan syndrome|HPRT FLINT,germline,germline,GRCh38,NC_000023.11,X,134475268,134475268,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120892,UniProtKB:P00492#VAR_006775,OMIM:308000.0008",1,10036,134475268,C,A,F74L,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,74,F,L,True,975
13831,2370,25073,single nucleotide variant,NM_000194.2(HPRT1):c.122T>C (p.Leu41Pro),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,26-Sep-17,137852480,-,RCV000010722|RCV000010723,"MedGen:C0023374,OMIM:300322,Orphanet:510|",Lesch-Nyhan syndrome|HPRT DETROIT,germline,germline,GRCh38,NC_000023.11,X,134473453,134473453,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120890,UniProtKB:P00492#VAR_006756,OMIM:308000.0006",1,10034,134473453,T,C,L41P,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,41,L,P,True,975
13832,2380,25086,single nucleotide variant,NM_000194.3(HPRT1):c.610C>G (p.His204Asp),3251,HPRT1,HGNC:5157,Likely pathogenic,1,1-Apr-20,137852490,-,RCV000010747|RCV001250108,"MedGen:C0023374,OMIM:300322,Orphanet:510|MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233;MedGen:C0023374,OMIM:300322,Orphanet:510",Lesch-Nyhan syndrome|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency;Lesch-Nyhan syndrome,germline;maternal,germline,GRCh38,NC_000023.11,X,134500030,134500030,na,na,Xq26.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA254999,UniProtKB:P00492#VAR_006804,OMIM:308000.0019",3,10047,134500030,C,G,H204D,1,pathogenic,pathogenic,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,204,H,D,True,975
13833,2384,25098,single nucleotide variant,NM_000194.2(HPRT1):c.151C>G (p.Arg51Gly),3251,HPRT1,HGNC:5157,"Pathogenic, other",1,10-Sep-20,137852494,-,RCV000010759|RCV000010760,"MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|",Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT TORONTO,germline,germline,GRCh38,NC_000023.11,X,134475197,134475197,na,na,Xq26.2,no assertion criteria provided,1,-,N,"ClinGen:CA120901,UniProtKB:P00492#VAR_006764,OMIM:308000.0034",1,10059,134475197,C,G,R51G,0,pathogenic,uncertain,P00492,P00492,reviewed,HPRT_HUMAN,"Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8",HPRT1 HPRT,Homo sapiens (Human),218.0,MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA,PF00156;,1BZY;1D6N;1HMP;1Z7G;2VFA;3GEP;3GGC;3GGJ;4IJQ;4KN6;4RAB;4RAC;4RAD;4RAN;4RAO;4RAQ;5BRN;5BSK;5HIA;5W8V;6BNJ;,51,R,G,True,975
13834,4497,31013,single nucleotide variant,NM_000515.5(GH1):c.413A>G (p.Asp138Gly),2688,GH1,HGNC:4261,Pathogenic,1,1-Sep-97,137853221,-,RCV000017344,"MONDO:MONDO:0009879,MedGen:C1849779,OMIM:262650,Orphanet:629",Short stature due to growth hormone qualitative anomaly,germline,germline,GRCh38,NC_000017.11,17,63917803,63917803,na,na,17q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA126116,UniProtKB:P01241#VAR_015813,OMIM:139250.0013",1,15974,63917803,T,C,D138G,0,pathogenic,uncertain,P01241,P01241,reviewed,SOMA_HUMAN,"Somatotropin (Growth hormone, GH, GH-N) (Growth hormone 1) (Pituitary growth hormone)",GH1,Homo sapiens (Human),217.0,MATGSRTSLLLAFGLLCLPWLQEGSAFPTIPLSRLFDNAMLRAHRLHQLAFDTYQEFEEAYIPKEQKYSFLQNPQTSLCFSESIPTPSNREETQQKSNLELLRISLLLIQSWLEPVQFLRSVFANSLVYGASDSNVYDLLKDLEEGIQTLMGRLEDGSPRTGQIFKQTYSKFDTNSHNDDALLKNYGLLYCFRKDMDKVETFLRIVQCRSVEGSCGF,PF00103;,1A22;1AXI;1BP3;1HGU;1HUW;1HWG;1HWH;1KF9;3HHR;6QIO;,138,D,G,True,976
13835,4498,31020,single nucleotide variant,NM_000515.5(GH1):c.236G>C (p.Cys79Ser),2688,GH1,HGNC:4261,Pathogenic,1,1-May-05,137853222,-,RCV000017351,"MONDO:MONDO:0009879,MedGen:C1849779,OMIM:262650,Orphanet:629",Short stature due to growth hormone qualitative anomaly,germline,germline,GRCh38,NC_000017.11,17,63918072,63918072,na,na,17q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA126119,UniProtKB:P01241#VAR_032702,OMIM:139250.0021",1,15981,63918072,C,G,C79S,0,pathogenic,uncertain,P01241,P01241,reviewed,SOMA_HUMAN,"Somatotropin (Growth hormone, GH, GH-N) (Growth hormone 1) (Pituitary growth hormone)",GH1,Homo sapiens (Human),217.0,MATGSRTSLLLAFGLLCLPWLQEGSAFPTIPLSRLFDNAMLRAHRLHQLAFDTYQEFEEAYIPKEQKYSFLQNPQTSLCFSESIPTPSNREETQQKSNLELLRISLLLIQSWLEPVQFLRSVFANSLVYGASDSNVYDLLKDLEEGIQTLMGRLEDGSPRTGQIFKQTYSKFDTNSHNDDALLKNYGLLYCFRKDMDKVETFLRIVQCRSVEGSCGF,PF00103;,1A22;1AXI;1BP3;1HGU;1HUW;1HWG;1HWH;1KF9;3HHR;6QIO;,79,C,S,True,976
13836,13678,273740,single nucleotide variant,NM_000515.5(GH1):c.7A>G (p.Thr3Ala),2688,GH1,HGNC:4261,Benign/Likely benign,0,31-Dec-19,2001345,-,RCV000354911|RCV000576669|RCV000864318|RCV001126654,"MedGen:CN169374|MONDO:MONDO:0008250,MedGen:C0271567,OMIM:173100,Orphanet:231679,Orphanet:631;MONDO:MONDO:0009879,MedGen:C1849779,OMIM:262650,Orphanet:629;MONDO:MONDO:0009876,MedGen:C0342573,OMIM:262400,Orphanet:231662,Orphanet:631;MONDO:MONDO:0013006,MedGen:C2748571,OMIM:612781,Orphanet:231671,Orphanet:631|MedGen:CN517202|Human Phenotype Ontology:HP:0000824,Human Phenotype Ontology:HP:0000861,Human Phenotype Ontology:HP:0008195,Human Phenotype Ontology:HP:0008206,MedGen:C0271561",not specified|Autosomal dominant isolated somatotropin deficiency;Short stature due to growth hormone qualitative anomaly;Ateleiotic dwarfism;Isolated growth hormone deficiency type IB|not provided|Growth hormone deficiency,germline,germline,GRCh38,NC_000017.11,17,63918770,63918770,na,na,17q23.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA8708425,UniProtKB:P01241#VAR_011917",2,289503,63918770,T,C,T3A,2,benign,benign,P01241,P01241,reviewed,SOMA_HUMAN,"Somatotropin (Growth hormone, GH, GH-N) (Growth hormone 1) (Pituitary growth hormone)",GH1,Homo sapiens (Human),217.0,MATGSRTSLLLAFGLLCLPWLQEGSAFPTIPLSRLFDNAMLRAHRLHQLAFDTYQEFEEAYIPKEQKYSFLQNPQTSLCFSESIPTPSNREETQQKSNLELLRISLLLIQSWLEPVQFLRSVFANSLVYGASDSNVYDLLKDLEEGIQTLMGRLEDGSPRTGQIFKQTYSKFDTNSHNDDALLKNYGLLYCFRKDMDKVETFLRIVQCRSVEGSCGF,PF00103;,1A22;1AXI;1BP3;1HGU;1HUW;1HWG;1HWH;1KF9;3HHR;6QIO;,3,T,A,True,976
13837,4499,31022,single nucleotide variant,NM_000515.5(GH1):c.626G>A (p.Arg209His),2688,GH1,HGNC:4261,Pathogenic,1,8-Jul-19,137853223,-,RCV000017353|RCV000992079,"MONDO:MONDO:0008250,MedGen:C0271567,OMIM:173100,Orphanet:231679,Orphanet:631|MedGen:CN517202",Autosomal dominant isolated somatotropin deficiency|not provided,germline;unknown,germline,GRCh38,NC_000017.11,17,63917337,63917337,na,na,17q23.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA126122,UniProtKB:P01241#VAR_015815,OMIM:139250.0023",3,15983,63917337,C,T,R209H,1,pathogenic,pathogenic,P01241,P01241,reviewed,SOMA_HUMAN,"Somatotropin (Growth hormone, GH, GH-N) (Growth hormone 1) (Pituitary growth hormone)",GH1,Homo sapiens (Human),217.0,MATGSRTSLLLAFGLLCLPWLQEGSAFPTIPLSRLFDNAMLRAHRLHQLAFDTYQEFEEAYIPKEQKYSFLQNPQTSLCFSESIPTPSNREETQQKSNLELLRISLLLIQSWLEPVQFLRSVFANSLVYGASDSNVYDLLKDLEEGIQTLMGRLEDGSPRTGQIFKQTYSKFDTNSHNDDALLKNYGLLYCFRKDMDKVETFLRIVQCRSVEGSCGF,PF00103;,1A22;1AXI;1BP3;1HGU;1HUW;1HWG;1HWH;1KF9;3HHR;6QIO;,209,R,H,True,976
13838,11877,194312,single nucleotide variant,NM_000515.5(GH1):c.406G>A (p.Val136Ile),2688,GH1,HGNC:4261,Conflicting interpretations of pathogenicity,0,31-Dec-19,5388,-,RCV000178109|RCV000421927|RCV001128609,"MedGen:CN169374|MedGen:CN517202|Human Phenotype Ontology:HP:0000824,Human Phenotype Ontology:HP:0000861,Human Phenotype Ontology:HP:0008195,Human Phenotype Ontology:HP:0008206,MedGen:C0271561",not specified|not provided|Growth hormone deficiency,germline,germline,GRCh38,NC_000017.11,17,63917810,63917810,na,na,17q23.3,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA202715,UniProtKB:P01241#VAR_011919",2,197151,63917810,C,T,V136I,1,uncertain,uncertain,P01241,P01241,reviewed,SOMA_HUMAN,"Somatotropin (Growth hormone, GH, GH-N) (Growth hormone 1) (Pituitary growth hormone)",GH1,Homo sapiens (Human),217.0,MATGSRTSLLLAFGLLCLPWLQEGSAFPTIPLSRLFDNAMLRAHRLHQLAFDTYQEFEEAYIPKEQKYSFLQNPQTSLCFSESIPTPSNREETQQKSNLELLRISLLLIQSWLEPVQFLRSVFANSLVYGASDSNVYDLLKDLEEGIQTLMGRLEDGSPRTGQIFKQTYSKFDTNSHNDDALLKNYGLLYCFRKDMDKVETFLRIVQCRSVEGSCGF,PF00103;,1A22;1AXI;1BP3;1HGU;1HUW;1HWG;1HWH;1KF9;3HHR;6QIO;,136,V,I,True,976
13839,4496,31008,single nucleotide variant,NM_000515.5(GH1):c.307C>T (p.Arg103Cys),2688,GH1,HGNC:4261,Pathogenic,1,1-Aug-07,137853220,-,RCV000017339,"MONDO:MONDO:0009879,MedGen:C1849779,OMIM:262650,Orphanet:629",Short stature due to growth hormone qualitative anomaly,germline,germline,GRCh38,NC_000017.11,17,63917909,63917909,na,na,17q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA126113,UniProtKB:P01241#VAR_015809,OMIM:139250.0008",1,15969,63917909,G,A,R103C,0,pathogenic,uncertain,P01241,P01241,reviewed,SOMA_HUMAN,"Somatotropin (Growth hormone, GH, GH-N) (Growth hormone 1) (Pituitary growth hormone)",GH1,Homo sapiens (Human),217.0,MATGSRTSLLLAFGLLCLPWLQEGSAFPTIPLSRLFDNAMLRAHRLHQLAFDTYQEFEEAYIPKEQKYSFLQNPQTSLCFSESIPTPSNREETQQKSNLELLRISLLLIQSWLEPVQFLRSVFANSLVYGASDSNVYDLLKDLEEGIQTLMGRLEDGSPRTGQIFKQTYSKFDTNSHNDDALLKNYGLLYCFRKDMDKVETFLRIVQCRSVEGSCGF,PF00103;,1A22;1AXI;1BP3;1HGU;1HUW;1HWG;1HWH;1KF9;3HHR;6QIO;,103,R,C,True,976
13840,1774,22720,single nucleotide variant,NM_024407.5(NDUFS7):c.364G>A (p.Val122Met),374291,NDUFS7,HGNC:7714,Pathogenic,1,23-Nov-18,104894705,-,RCV000008120|RCV000197296,"MONDO:MONDO:0032608,MedGen:C4748752,OMIM:618224|MedGen:CN517202","Mitochondrial complex 1 deficiency, nuclear type 3|not provided",germline,germline,GRCh38,NC_000019.10,19,1391006,1391006,na,na,19p13.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA118993,UniProtKB:O75251#VAR_008848,OMIM:601825.0001",3,7681,1391006,G,A,V122M,1,pathogenic,pathogenic,O75251,O75251,reviewed,NDUS7_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial, EC 7.1.1.2 (Complex I-20kD, CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit) (PSST subunit)",NDUFS7,Homo sapiens (Human),213.0,MAVLSAPGLRGFRILGLRSSVGPAVQARGVHQSVATDGPSSTQPALPKARAVAPKPSSRGEYVVAKLDDLVNWARRSSLWPMTFGLACCAVEMMHMAAPRYDMDRFGVVFRASPRQSDVMIVAGTLTNKMAPALRKVYDQMPEPRYVVSMGSCANGGGYYHYSYSVVRGCDRIVPVDIYIPGCPPTAEALLYGILQLQRKIKRERRLQIWYRR,PF01058;,5XTB;5XTD;5XTH;5XTI;,122,V,M,True,977
13841,10261,135148,single nucleotide variant,NM_024407.5(NDUFS7):c.68C>T (p.Pro23Leu),374291,NDUFS7,HGNC:7714,Benign,0,12-Jan-18,1142530,-,RCV000117716|RCV000342300|RCV000407392|RCV000676449,"MedGen:CN169374|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000,Orphanet:506|MONDO:MONDO:0100224,MedGen:CN257533,OMIM:252010|MedGen:CN517202","not specified|Leigh syndrome|Mitochondrial complex I deficiency, nuclear type 1|not provided",germline;unknown,germline,GRCh38,NC_000019.10,19,1388539,1388539,na,na,19p13.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA153875,UniProtKB:O75251#VAR_014482",2,129702,1388539,C,T,P23L,1,benign,benign,O75251,O75251,reviewed,NDUS7_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial, EC 7.1.1.2 (Complex I-20kD, CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit) (PSST subunit)",NDUFS7,Homo sapiens (Human),213.0,MAVLSAPGLRGFRILGLRSSVGPAVQARGVHQSVATDGPSSTQPALPKARAVAPKPSSRGEYVVAKLDDLVNWARRSSLWPMTFGLACCAVEMMHMAAPRYDMDRFGVVFRASPRQSDVMIVAGTLTNKMAPALRKVYDQMPEPRYVVSMGSCANGGGYYHYSYSVVRGCDRIVPVDIYIPGCPPTAEALLYGILQLQRKIKRERRLQIWYRR,PF01058;,5XTB;5XTD;5XTH;5XTI;,23,P,L,True,977
13842,426,16687,single nucleotide variant,NM_018105.3(THAP1):c.266A>G (p.Lys89Arg),55145,THAP1,HGNC:20856,Pathogenic,1,1-May-09,267607111,-,RCV000001715,"MONDO:MONDO:0011264,MedGen:C1414216,OMIM:602629,Orphanet:98806",Torsion dystonia 6,germline,germline,GRCh38,NC_000008.11,8,42839187,42839187,na,na,8p11.21,no assertion criteria provided,1,-,N,"ClinGen:CA115122,UniProtKB:Q9NVV9#VAR_065885,OMIM:609520.0004",1,1648,42839187,T,C,K89R,0,pathogenic,uncertain,Q9NVV9,Q9NVV9,reviewed,THAP1_HUMAN,THAP domain-containing protein 1,THAP1,Homo sapiens (Human),213.0,MVQSCSAYGCKNRYDKDKPVSFHKFPLTRPSLCKEWEAAVRRKNFKPTKYSSICSEHFTPDCFKRECNNKLLKENAVPTIFLCTEPHDKKEDLLEPQEQLPPPPLPPPVSQVDAAIGLLMPPLQTPVNLSVFCDHNYTVEDTMHQRKRIHQLEQQVEKLRKKLKTAQQRCRRQERQLEKLKEVVHFQKEKDDVSERGYVILPNDYFEIVEVPA,PF05485;,2JTG;2KO0;2L1G;,89,K,R,True,978
13843,6074,40310,single nucleotide variant,NM_018105.3(THAP1):c.70A>G (p.Lys24Glu),55145,THAP1,HGNC:20856,Pathogenic,1,1-Feb-12,387907176,-,RCV000024329,"MONDO:MONDO:0011264,MedGen:C1414216,OMIM:602629,Orphanet:98806",Torsion dystonia 6,germline,germline,GRCh38,NC_000008.11,8,42843025,42843025,na,na,8p11.21,no assertion criteria provided,1,-,N,"ClinGen:CA129855,UniProtKB:Q9NVV9#VAR_066685,OMIM:609520.0008",1,31631,42843025,T,C,K24E,0,pathogenic,uncertain,Q9NVV9,Q9NVV9,reviewed,THAP1_HUMAN,THAP domain-containing protein 1,THAP1,Homo sapiens (Human),213.0,MVQSCSAYGCKNRYDKDKPVSFHKFPLTRPSLCKEWEAAVRRKNFKPTKYSSICSEHFTPDCFKRECNNKLLKENAVPTIFLCTEPHDKKEDLLEPQEQLPPPPLPPPVSQVDAAIGLLMPPLQTPVNLSVFCDHNYTVEDTMHQRKRIHQLEQQVEKLRKKLKTAQQRCRRQERQLEKLKEVVHFQKEKDDVSERGYVILPNDYFEIVEVPA,PF05485;,2JTG;2KO0;2L1G;,24,K,E,True,978
13844,6075,40311,single nucleotide variant,NM_018105.3(THAP1):c.68A>C (p.His23Pro),55145,THAP1,HGNC:20856,Pathogenic,1,1-Feb-12,387907177,-,RCV000024330,"MONDO:MONDO:0011264,MedGen:C1414216,OMIM:602629,Orphanet:98806",Torsion dystonia 6,germline,germline,GRCh38,NC_000008.11,8,42843027,42843027,na,na,8p11.21,no assertion criteria provided,1,-,N,"ClinGen:CA129856,UniProtKB:Q9NVV9#VAR_066684,OMIM:609520.0009",1,31632,42843027,T,G,H23P,0,pathogenic,uncertain,Q9NVV9,Q9NVV9,reviewed,THAP1_HUMAN,THAP domain-containing protein 1,THAP1,Homo sapiens (Human),213.0,MVQSCSAYGCKNRYDKDKPVSFHKFPLTRPSLCKEWEAAVRRKNFKPTKYSSICSEHFTPDCFKRECNNKLLKENAVPTIFLCTEPHDKKEDLLEPQEQLPPPPLPPPVSQVDAAIGLLMPPLQTPVNLSVFCDHNYTVEDTMHQRKRIHQLEQQVEKLRKKLKTAQQRCRRQERQLEKLKEVVHFQKEKDDVSERGYVILPNDYFEIVEVPA,PF05485;,2JTG;2KO0;2L1G;,23,H,P,True,978
13845,425,16685,single nucleotide variant,NM_018105.3(THAP1):c.241T>C (p.Phe81Leu),55145,THAP1,HGNC:20856,Uncertain significance,1,5-Jun-19,118204013,-,RCV000001713,"MONDO:MONDO:0011264,MedGen:C1414216,OMIM:602629,Orphanet:98806",Torsion dystonia 6,germline,germline,GRCh38,NC_000008.11,8,42839212,42839212,na,na,8p11.21,"criteria provided, single submitter",2,-,N,"ClinGen:CA115121,UniProtKB:Q9NVV9#VAR_054788,OMIM:609520.0002",3,1646,42839212,A,G,F81L,1,uncertain,uncertain,Q9NVV9,Q9NVV9,reviewed,THAP1_HUMAN,THAP domain-containing protein 1,THAP1,Homo sapiens (Human),213.0,MVQSCSAYGCKNRYDKDKPVSFHKFPLTRPSLCKEWEAAVRRKNFKPTKYSSICSEHFTPDCFKRECNNKLLKENAVPTIFLCTEPHDKKEDLLEPQEQLPPPPLPPPVSQVDAAIGLLMPPLQTPVNLSVFCDHNYTVEDTMHQRKRIHQLEQQVEKLRKKLKTAQQRCRRQERQLEKLKEVVHFQKEKDDVSERGYVILPNDYFEIVEVPA,PF05485;,2JTG;2KO0;2L1G;,81,F,L,True,978
13846,12613,227322,single nucleotide variant,NM_018105.3(THAP1):c.427A>G (p.Met143Val),55145,THAP1,HGNC:20856,Uncertain significance,0,31-Dec-19,374512193,-,RCV000302642|RCV000490517,"MedGen:CN517202|MONDO:MONDO:0011264,MedGen:C1414216,OMIM:602629,Orphanet:98806",not provided|Torsion dystonia 6,germline,germline,GRCh38,NC_000008.11,8,42838177,42838177,na,na,8p11.21,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA4734541,UniProtKB:Q9NVV9#VAR_066701",2,225489,42838177,T,C,M143V,2,uncertain,uncertain,Q9NVV9,Q9NVV9,reviewed,THAP1_HUMAN,THAP domain-containing protein 1,THAP1,Homo sapiens (Human),213.0,MVQSCSAYGCKNRYDKDKPVSFHKFPLTRPSLCKEWEAAVRRKNFKPTKYSSICSEHFTPDCFKRECNNKLLKENAVPTIFLCTEPHDKKEDLLEPQEQLPPPPLPPPVSQVDAAIGLLMPPLQTPVNLSVFCDHNYTVEDTMHQRKRIHQLEQQVEKLRKKLKTAQQRCRRQERQLEKLKEVVHFQKEKDDVSERGYVILPNDYFEIVEVPA,PF05485;,2JTG;2KO0;2L1G;,143,M,V,True,978
13847,427,16690,single nucleotide variant,NM_018105.3(THAP1):c.25G>T (p.Gly9Cys),55145,THAP1,HGNC:20856,Pathogenic,1,18-Sep-19,267607112,-,RCV000001718,"MONDO:MONDO:0011264,MedGen:C1414216,OMIM:602629,Orphanet:98806",Torsion dystonia 6,germline,germline,GRCh38,NC_000008.11,8,42843070,42843070,na,na,8p11.21,no assertion criteria provided,1,-,N,"ClinGen:CA115123,UniProtKB:Q9NVV9#VAR_066680,OMIM:609520.0007",1,1651,42843070,C,A,G9C,0,pathogenic,uncertain,Q9NVV9,Q9NVV9,reviewed,THAP1_HUMAN,THAP domain-containing protein 1,THAP1,Homo sapiens (Human),213.0,MVQSCSAYGCKNRYDKDKPVSFHKFPLTRPSLCKEWEAAVRRKNFKPTKYSSICSEHFTPDCFKRECNNKLLKENAVPTIFLCTEPHDKKEDLLEPQEQLPPPPLPPPVSQVDAAIGLLMPPLQTPVNLSVFCDHNYTVEDTMHQRKRIHQLEQQVEKLRKKLKTAQQRCRRQERQLEKLKEVVHFQKEKDDVSERGYVILPNDYFEIVEVPA,PF05485;,2JTG;2KO0;2L1G;,9,G,C,True,978
13848,12545,224957,single nucleotide variant,NM_000551.3(VHL):c.486C>G (p.Cys162Trp),7428,VHL,HGNC:12687,Conflicting interpretations of pathogenicity,1,14-Mar-19,5030622,-,RCV000208792|RCV000226031|RCV000567560|RCV000679043,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided",germline,germline,GRCh38,NC_000003.12,3,10149809,10149809,na,na,3p25.3,"criteria provided, conflicting interpretations",4,"ACMG2013,ACMG2016",N,"UniProtKB:P40337#VAR_005756,ClinGen:CA357016",2,223227,10149809,C,G,C162W,1,uncertain,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,162,C,W,True,979
13849,11410,180121,single nucleotide variant,NM_000551.3(VHL):c.482G>A (p.Arg161Gln),7428,VHL,HGNC:12687,Pathogenic,1,1-Dec-20,730882035,-,RCV000161092|RCV000208848|RCV000456958|RCV000563066,"MedGen:CN517202|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162","not provided|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome",germline,germline,GRCh38,NC_000003.12,3,10149805,10149805,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,"UniProtKB:P40337#VAR_005751,ClinGen:CA020413",2,182983,10149805,G,A,R161Q,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,161,R,Q,True,979
13850,12543,224953,single nucleotide variant,NM_000551.3(VHL):c.470C>T (p.Thr157Ile),7428,VHL,HGNC:12687,Pathogenic,1,29-Nov-19,869025660,-,RCV000208862|RCV001289415,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:CN517202",Von Hippel-Lindau syndrome|not provided,germline;unknown,germline,GRCh38,NC_000003.12,3,10149793,10149793,na,na,3p25.3,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,"ClinGen:CA357133,UniProtKB:P40337#VAR_005746",2,223223,10149793,C,T,T157I,1,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,157,T,I,True,979
13851,12544,224955,single nucleotide variant,NM_000551.3(VHL):c.485G>A (p.Cys162Tyr),7428,VHL,HGNC:12687,Pathogenic,1,26-Feb-16,397516444,-,RCV000208789,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892",Von Hippel-Lindau syndrome,germline,germline,GRCh38,NC_000003.12,3,10149808,10149808,na,na,3p25.3,no assertion criteria provided,1,"ACMG2013,ACMG2016",N,"ClinGen:CA357010,UniProtKB:P40337#VAR_005757",2,223225,10149808,G,A,C162Y,0,pathogenic,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,162,C,Y,True,979
13852,11407,180115,single nucleotide variant,NM_000551.3(VHL):c.257C>T (p.Pro86Leu),7428,VHL,HGNC:12687,Pathogenic,1,27-Sep-17,730882034,-,RCV000208836|RCV000492524,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162",Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000003.12,3,10142104,10142104,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"ClinGen:CA020186,UniProtKB:P40337#VAR_005694",2,182977,10142104,C,T,P86L,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,86,P,L,True,979
13853,11406,180114,single nucleotide variant,NM_000551.3(VHL):c.227T>C (p.Phe76Ser),7428,VHL,HGNC:12687,Uncertain significance,0,1-Aug-18,730882033,-,RCV000767238,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892",Von Hippel-Lindau syndrome,germline,germline,GRCh38,NC_000003.12,3,10142074,10142074,na,na,3p25.3,"criteria provided, single submitter",1,"ACMG2013,ACMG2016",N,UniProtKB:P40337#VAR_005681,2,182976,10142074,T,C,F76S,1,uncertain,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,76,F,S,True,979
13854,569,17268,single nucleotide variant,NM_000551.3(VHL):c.388G>C (p.Val130Leu),7428,VHL,HGNC:12687,Pathogenic,1,27-Feb-19,104893830,-,RCV000002317|RCV000030586|RCV000492250|RCV001071915,"MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome",germline,germline,GRCh38,NC_000003.12,3,10146561,10146561,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"UniProtKB:P40337#VAR_005733,OMIM:608537.0021,ClinGen:CA020325",3,2229,10146561,G,C,V130L,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,130,V,L,True,979
13855,11125,171081,single nucleotide variant,NM_000551.3(VHL):c.556G>A (p.Glu186Lys),7428,VHL,HGNC:12687,Conflicting interpretations of pathogenicity,1,6-May-20,367545984,-,RCV000148924|RCV000589801|RCV000698671|RCV001024290,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:CN517202|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162","Von Hippel-Lindau syndrome|not provided|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome",germline;unknown,germline,GRCh38,NC_000003.12,3,10149879,10149879,na,na,3p25.3,"criteria provided, conflicting interpretations",7,"ACMG2013,ACMG2016",N,"ClinGen:CA020480,UniProtKB:P40337#VAR_005773",2,161403,10149879,G,A,E186K,1,uncertain,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,186,E,K,True,979
13856,11124,171080,single nucleotide variant,NM_000551.3(VHL):c.538A>G (p.Ile180Val),7428,VHL,HGNC:12687,Conflicting interpretations of pathogenicity,0,21-Oct-20,377715747,-,RCV000148921|RCV000480432|RCV000524495|RCV000569566,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:CN517202|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162","Von Hippel-Lindau syndrome|not provided|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome",germline;unknown,germline,GRCh38,NC_000003.12,3,10149861,10149861,na,na,3p25.3,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,"ClinGen:CA020469,UniProtKB:P40337#VAR_005770",2,161401,10149861,A,G,I180V,1,uncertain,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,180,I,V,True,979
13857,12542,224943,single nucleotide variant,NM_000551.3(VHL):c.445G>A (p.Ala149Thr),7428,VHL,HGNC:12687,Pathogenic,1,26-Feb-16,587780077,-,RCV000208822,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892",Von Hippel-Lindau syndrome,germline,germline,GRCh38,NC_000003.12,3,10146618,10146618,na,na,3p25.3,no assertion criteria provided,1,"ACMG2013,ACMG2016",N,"ClinGen:CA357066,UniProtKB:P40337#VAR_005740",2,223213,10146618,G,A,A149T,0,pathogenic,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,149,A,T,True,979
13858,11409,180119,single nucleotide variant,NM_000551.3(VHL):c.473T>C (p.Leu158Pro),7428,VHL,HGNC:12687,Pathogenic,1,28-Mar-20,121913346,-,RCV000161088|RCV000208846|RCV000492547|RCV001072084,"MedGen:CN517202|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892","not provided|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome",germline,germline,GRCh38,NC_000003.12,3,10149796,10149796,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"ClinGen:CA020399,UniProtKB:P40337#VAR_005748",2,182980,10149796,T,C,L158P,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,158,L,P,True,979
13859,11408,180117,single nucleotide variant,NM_000551.3(VHL):c.266T>C (p.Leu89Pro),7428,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1,7-Mar-19,5030807,-,RCV000161087|RCV000208869|RCV000817709,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557","Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2",germline,germline,GRCh38,NC_000003.12,3,10142113,10142113,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"ClinGen:CA020207,UniProtKB:P40337#VAR_005700",2,182979,10142113,T,C,L89P,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,89,L,P,True,979
13860,12710,232861,single nucleotide variant,NM_000551.3(VHL):c.250G>C (p.Val84Leu),7428,VHL,HGNC:12687,Pathogenic,1,1-Aug-18,5030827,-,RCV000216720|RCV000588802,"MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892",Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome,germline,germline,GRCh38,NC_000003.12,3,10142097,10142097,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"ClinGen:CA10578180,UniProtKB:P40337#VAR_005692",2,229860,10142097,G,C,V84L,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,84,V,L,True,979
13861,11767,190283,single nucleotide variant,NM_000551.3(VHL):c.245G>C (p.Arg82Pro),7428,VHL,HGNC:12687,Pathogenic,1,14-Feb-19,794726890,-,RCV000173161|RCV000724457,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:CN517202",Von Hippel-Lindau syndrome|not provided,germline,germline,GRCh38,NC_000003.12,3,10142092,10142092,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"ClinGen:CA020159,UniProtKB:P40337#VAR_005690",2,193118,10142092,G,C,R82P,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,82,R,P,True,979
13862,568,17267,single nucleotide variant,NM_000551.3(VHL):c.334T>A (p.Tyr112Asn),7428,VHL,HGNC:12687,Pathogenic,1,1-Aug-18,104893824,-,RCV000002316,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892",Von Hippel-Lindau syndrome,germline,germline,GRCh38,NC_000003.12,3,10142181,10142181,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"ClinGen:CA020273,UniProtKB:P40337#VAR_034992,OMIM:608537.0017",3,2228,10142181,T,A,Y112N,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,112,Y,N,True,979
13863,567,17266,single nucleotide variant,NM_000551.3(VHL):c.188T>C (p.Leu63Pro),7428,VHL,HGNC:12687,Uncertain significance,1,11-May-18,104893827,-,RCV000002315|RCV000585971|RCV000704785,"Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MedGen:CN517202|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557","Pheochromocytoma|not provided|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2",germline,germline,GRCh38,NC_000003.12,3,10142035,10142035,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"OMIM:608537.0016,ClinGen:CA020079,UniProtKB:P40337#VAR_034987",3,2227,10142035,T,C,L63P,2,uncertain,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,63,L,P,True,979
13864,566,17265,single nucleotide variant,NM_000551.3(VHL):c.191G>C (p.Arg64Pro),7428,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1,17-Apr-19,104893826,-,RCV000002314|RCV000132356|RCV000208872|RCV000475973|RCV000679019,"Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MedGen:CN517202","Pheochromocytoma|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2|not provided",germline,germline,GRCh38,NC_000003.12,3,10142038,10142038,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"ClinGen:CA020089,UniProtKB:P40337#VAR_034988,OMIM:608537.0015",3,2226,10142038,G,C,R64P,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,64,R,P,True,979
13865,565,17264,single nucleotide variant,NM_000551.4(VHL):c.562C>G (p.Leu188Val),7428,VHL,HGNC:12687,Conflicting interpretations of pathogenicity,1,11-Sep-20,5030824,-,RCV000002311|RCV000002312|RCV000002313|RCV000210199|RCV000480890|RCV000627743,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Pheochromocytoma|Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2",germline,germline,GRCh38,NC_000003.12,3,10149885,10149885,na,na,3p25.3,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,"ClinGen:CA020488,UniProtKB:P40337#VAR_005777,OMIM:608537.0014",3,2225,10149885,C,G,L188V,1,uncertain,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,188,L,V,True,979
13866,564,17263,single nucleotide variant,NM_000551.3(VHL):c.496G>T (p.Val166Phe),7428,VHL,HGNC:12687,Pathogenic,1,14-Jun-16,104893825,-,RCV000002310|RCV000220823,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162",Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000003.12,3,10149819,10149819,na,na,3p25.3,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,"ClinGen:CA020436,UniProtKB:P40337#VAR_005759,OMIM:608537.0013",3,2224,10149819,G,T,V166F,1,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,166,V,F,True,979
13867,563,17262,single nucleotide variant,NM_000551.3(VHL):c.292T>C (p.Tyr98His),7428,VHL,HGNC:12687,Pathogenic,1,31-Mar-20,5030809,-,RCV000002309|RCV000492094|RCV000679029|RCV000684783,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892","Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome",germline,germline,GRCh38,NC_000003.12,3,10142139,10142139,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",9,"ACMG2013,ACMG2016",N,"ClinGen:CA020246,UniProtKB:P40337#VAR_005707,OMIM:608537.0009",3,2223,10142139,T,C,Y98H,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,98,Y,H,True,979
13868,558,17255,single nucleotide variant,NM_000551.4(VHL):c.500G>A (p.Arg167Gln),7428,VHL,HGNC:12687,Conflicting interpretations of pathogenicity,1,12-Dec-19,5030821,-,RCV000002300|RCV000213850|RCV000325074|RCV000506694|RCV000627745,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892","Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome",germline,germline,GRCh38,NC_000003.12,3,10149823,10149823,na,na,3p25.3,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,"OMIM:608537.0005,ClinGen:CA020454,UniProtKB:P40337#VAR_005761",3,2216,10149823,G,A,R167Q,1,uncertain,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,167,R,Q,True,979
13869,559,17257,single nucleotide variant,NM_000551.3(VHL):c.499C>T (p.Arg167Trp),7428,VHL,HGNC:12687,Pathogenic,1,3-Aug-20,5030820,-,RCV000002302|RCV000002303|RCV000132159|RCV000213079|RCV000435817|RCV000627746|RCV000763092|RCV001286650,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|Human Phenotype Ontology:HP:0011797,MedGen:C1336839,OMIM:605074,Orphanet:47044|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0007763,MedGen:CN074294,OMIM:144700,Orphanet:422526;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MedGen:CN235283","Von Hippel-Lindau syndrome|Pheochromocytoma|Hereditary cancer-predisposing syndrome|not provided|Renal cell carcinoma, papillary, 1|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome|Renal cell carcinoma, nonpapillary;Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome;Pheochromocytoma|none provided",germline;somatic;unknown,germline/somatic,GRCh38,NC_000003.12,3,10149822,10149822,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,"OMIM:608537.0003,ClinGen:CA020450,UniProtKB:P40337#VAR_005762",3,2218,10149822,C,T,R167W,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,167,R,W,True,979
13870,560,17258,single nucleotide variant,NM_000551.3(VHL):c.499C>G (p.Arg167Gly),7428,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1,6-Sep-18,5030820,-,RCV000002304|RCV000466046,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557","Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2",germline,germline,GRCh38,NC_000003.12,3,10149822,10149822,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"ClinGen:CA020446,UniProtKB:P40337#VAR_005760,OMIM:608537.0004",3,2219,10149822,C,G,R167G,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,167,R,G,True,979
13871,12541,224931,single nucleotide variant,NM_000551.3(VHL):c.362A>G (p.Asp121Gly),7428,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1,5-Jun-19,5030832,-,RCV000208830|RCV000679035|RCV000801501,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:CN517202|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557","Von Hippel-Lindau syndrome|not provided|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2",germline,germline,GRCh38,NC_000003.12,3,10146535,10146535,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"ClinGen:CA357083,UniProtKB:P40337#VAR_005730",2,223200,10146535,A,G,D121G,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,121,D,G,True,979
13872,11405,180112,single nucleotide variant,NM_000551.3(VHL):c.194C>T (p.Ser65Leu),7428,VHL,HGNC:12687,Pathogenic,1,1-Jan-17,5030826,-,RCV000199197|RCV000626711,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|Human Phenotype Ontology:HP:0006761,Human Phenotype Ontology:HP:0006880,MONDO:MONDO:0003901,MedGen:C1332900;Human Phenotype Ontology:HP:0009713,MedGen:C4024223;Human Phenotype Ontology:HP:0009711,MONDO:MONDO:0003343,MedGen:C0730303;Human Phenotype Ontology:HP:0001737,MedGen:C0030283",Von Hippel-Lindau syndrome|Cerebellar hemangioblastoma;Spinal hemangioblastoma;Retinal capillary hemangioma;Pancreatic cysts,germline;unknown,germline,GRCh38,NC_000003.12,3,10142041,10142041,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",2,"ACMG2013,ACMG2016",N,"ClinGen:CA020104,UniProtKB:P40337#VAR_005672",2,182975,10142041,C,T,S65L,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,65,S,L,True,979
13873,12539,224916,single nucleotide variant,NM_000551.3(VHL):c.332G>A (p.Ser111Asn),7428,VHL,HGNC:12687,Pathogenic,1,5-Feb-16,869025631,-,RCV000208834|RCV000492721,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162",Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000003.12,3,10142179,10142179,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"ClinGen:CA357091,UniProtKB:P40337#VAR_005715",2,223186,10142179,G,A,S111N,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,111,S,N,True,979
13874,561,17259,single nucleotide variant,NM_000551.3(VHL):c.263G>C (p.Trp88Ser),7428,VHL,HGNC:12687,Pathogenic,1,1-Dec-95,119103277,-,RCV000002306,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892",Von Hippel-Lindau syndrome,somatic;unknown,somatic,GRCh38,NC_000003.12,3,10142110,10142110,na,na,3p25.3,no assertion criteria provided,1,"ACMG2013,ACMG2016",N,"ClinGen:CA020202,UniProtKB:P40337#VAR_005698,OMIM:608537.0007",1,2220,10142110,G,C,W88S,0,pathogenic,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,88,W,S,True,979
13875,12230,212285,single nucleotide variant,NM_000551.3(VHL):c.435G>C (p.Gln145His),7428,VHL,HGNC:12687,Uncertain significance,0,12-Sep-18,771727849,-,RCV000197591,"MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892","Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome",germline,germline,GRCh38,NC_000003.12,3,10146608,10146608,na,na,3p25.3,"criteria provided, single submitter",1,"ACMG2013,ACMG2016",N,"ClinGen:CA337322,UniProtKB:P40337#VAR_008100",2,216479,10146608,G,C,Q145H,1,uncertain,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,145,Q,H,True,979
13876,11333,178148,single nucleotide variant,NM_000551.3(VHL):c.351G>T (p.Trp117Cys),7428,VHL,HGNC:12687,Pathogenic,1,27-Jun-18,727504215,-,RCV000154124|RCV000723964|RCV001020510,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162",Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000003.12,3,10146524,10146524,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"ClinGen:CA020294,UniProtKB:P40337#VAR_005725",2,167827,10146524,G,T,W117C,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,117,W,C,True,979
13877,6833,52773,single nucleotide variant,NM_000551.4(VHL):c.485G>T (p.Cys162Phe),7428,VHL,HGNC:12687,Pathogenic,1,4-Feb-16,397516444,-,RCV000036548,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892",Von Hippel-Lindau syndrome,germline,germline,GRCh38,NC_000003.12,3,10149808,10149808,na,na,3p25.3,"criteria provided, single submitter",3,"ACMG2013,ACMG2016",N,"ClinGen:CA020418,UniProtKB:P40337#VAR_005754",2,43604,10149808,G,T,C162F,1,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,162,C,F,True,979
13878,9070,99237,single nucleotide variant,NM_000551.3(VHL):c.74C>T (p.Pro25Leu),7428,VHL,HGNC:12687,Benign/Likely benign,0,1-Apr-20,35460768,-,RCV000079211|RCV000119213|RCV000126300|RCV000224298|RCV001082579,"MedGen:CN169374|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892","not specified|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome",germline;unknown,germline,GRCh38,NC_000003.12,3,10141921,10141921,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,"ClinGen:CA020538,UniProtKB:P40337#VAR_034562",2,93330,10141921,C,T,P25L,2,benign,benign,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,25,P,L,True,979
13879,9069,99234,single nucleotide variant,NM_000551.3(VHL):c.256C>G (p.Pro86Ala),7428,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1,12-Nov-19,398123481,-,RCV000079208|RCV000723702|RCV001227827,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:CN517202|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892","Von Hippel-Lindau syndrome|not provided|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome",germline,germline,GRCh38,NC_000003.12,3,10142103,10142103,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"ClinGen:CA020174,UniProtKB:P40337#VAR_005693",2,93327,10142103,C,G,P86A,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,86,P,A,True,979
13880,9068,99233,single nucleotide variant,NM_000551.3(VHL):c.233A>G (p.Asn78Ser),7428,VHL,HGNC:12687,Pathogenic,1,28-Oct-20,5030804,-,RCV000079207|RCV000254892|RCV000492165|RCV001034687,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892","Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome",germline;unknown,germline,GRCh38,NC_000003.12,3,10142080,10142080,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",8,"ACMG2013,ACMG2016",N,"ClinGen:CA020131,UniProtKB:P40337#VAR_005683",2,93326,10142080,A,G,N78S,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,78,N,S,True,979
13881,6832,52769,single nucleotide variant,NM_000551.4(VHL):c.467A>G (p.Tyr156Cys),7428,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1,24-Jul-20,397516441,-,RCV000036543|RCV000487045|RCV000492752|RCV000631280,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557","Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2",germline,germline,GRCh38,NC_000003.12,3,10149790,10149790,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,"ClinGen:CA020394,UniProtKB:P40337#VAR_005743",2,43600,10149790,A,G,Y156C,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,156,Y,C,True,979
13882,6831,52768,single nucleotide variant,NM_000551.4(VHL):c.319C>G (p.Arg107Gly),7428,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1,31-Oct-18,397516440,-,RCV000036542|RCV000763091,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0007763,MedGen:CN074294,OMIM:144700,Orphanet:422526;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557","Von Hippel-Lindau syndrome|Pheochromocytoma;Von Hippel-Lindau syndrome;Renal cell carcinoma, nonpapillary;Erythrocytosis, familial, 2",germline;unknown,germline,GRCh38,NC_000003.12,3,10142166,10142166,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",2,"ACMG2013,ACMG2016",N,"ClinGen:CA020257,UniProtKB:P40337#VAR_034991",2,43599,10142166,C,G,R107G,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,107,R,G,True,979
13883,6830,52767,single nucleotide variant,NM_000551.4(VHL):c.208G>A (p.Glu70Lys),7428,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1,9-Oct-17,5030802,-,RCV000036540|RCV000492137,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162",Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000003.12,3,10142055,10142055,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,"ClinGen:CA020108,UniProtKB:P40337#VAR_005676",3,43598,10142055,G,A,E70K,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,70,E,K,True,979
13884,6829,52766,single nucleotide variant,NM_000551.4(VHL):c.194C>G (p.Ser65Trp),7428,VHL,HGNC:12687,Pathogenic,1,22-Jul-19,5030826,-,RCV000036539|RCV000497340|RCV001219547,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:CN517202|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892","Von Hippel-Lindau syndrome|not provided|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome",germline,germline,GRCh38,NC_000003.12,3,10142041,10142041,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"UniProtKB:P40337#VAR_005673,ClinGen:CA020099",2,43597,10142041,C,G,S65W,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,65,S,W,True,979
13885,6222,45561,single nucleotide variant,NM_000551.3(VHL):c.320G>C (p.Arg107Pro),7428,VHL,HGNC:12687,Conflicting interpretations of pathogenicity,1,10-Sep-18,193922609,-,RCV000030583|RCV000486047|RCV000492682|RCV000816283,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557","Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2",germline,germline,GRCh38,NC_000003.12,3,10142167,10142167,na,na,3p25.3,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,"UniProtKB:P40337#VAR_005713,ClinGen:CA020262",2,36900,10142167,G,C,R107P,1,uncertain,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,107,R,P,True,979
13886,12540,224918,single nucleotide variant,NM_000551.3(VHL):c.333C>G (p.Ser111Arg),7428,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1,19-Jun-19,765978945,-,RCV000208866|RCV000492675|RCV001204150,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892","Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome",germline,germline,GRCh38,NC_000003.12,3,10142180,10142180,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"UniProtKB:P40337#VAR_005716,ClinGen:CA040305",2,223187,10142180,C,G,S111R,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,111,S,R,True,979
13887,577,17277,single nucleotide variant,NM_000551.3(VHL):c.491A>G (p.Gln164Arg),7428,VHL,HGNC:12687,Pathogenic,1,19-Jan-21,267607170,-,RCV000002326|RCV001023261|RCV001052383,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557","Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2",germline,germline,GRCh38,NC_000003.12,3,10149814,10149814,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"OMIM:608537.0027,ClinGen:CA020429,UniProtKB:P40337#VAR_005758",3,2238,10149814,A,G,Q164R,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,164,Q,R,True,979
13888,575,17275,single nucleotide variant,NM_000551.4(VHL):c.250G>T (p.Val84Leu),7428,VHL,HGNC:12687,Pathogenic,1,2-Mar-12,5030827,-,RCV000002324,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892",Von Hippel-Lindau syndrome,germline,germline,GRCh38,NC_000003.12,3,10142097,10142097,na,na,3p25.3,"criteria provided, single submitter",3,"ACMG2013,ACMG2016",N,"ClinGen:CA020170,UniProtKB:P40337#VAR_005692,OMIM:608537.0025",3,2236,10142097,G,T,V84L,1,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,84,V,L,True,979
13889,574,17274,single nucleotide variant,NM_000551.3(VHL):c.571C>G (p.His191Asp),7428,VHL,HGNC:12687,Likely pathogenic,1,26-Apr-19,28940301,-,RCV000002323|RCV001219111,"MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2",germline,germline,GRCh38,NC_000003.12,3,10149894,10149894,na,na,3p25.3,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,"ClinGen:CA020495,UniProtKB:P40337#VAR_034999,OMIM:608537.0024",3,2235,10149894,C,G,H191D,1,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,191,H,D,True,979
13890,573,17273,single nucleotide variant,NM_000551.3(VHL):c.574C>T (p.Pro192Ser),7428,VHL,HGNC:12687,Uncertain significance,1,21-Oct-20,28940300,-,RCV000002322|RCV000236065|RCV000704063|RCV001024480,"MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MedGen:CN517202|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162","Erythrocytosis, familial, 2|not provided|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2|Hereditary cancer-predisposing syndrome",germline,germline,GRCh38,NC_000003.12,3,10149897,10149897,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"ClinGen:CA020501,UniProtKB:P40337#VAR_035000,OMIM:608537.0023",3,2234,10149897,C,T,P192S,2,uncertain,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,192,P,S,True,979
13891,572,17272,single nucleotide variant,NM_000551.4(VHL):c.241C>T (p.Pro81Ser),7428,VHL,HGNC:12687,Conflicting interpretations of pathogenicity,1,29-Jan-20,104893829,-,RCV000002321|RCV000115744|RCV000213077|RCV000418681|RCV000656990|RCV000761019|RCV001080004,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MeSH:D009369,MedGen:C0027651|MedGen:CN517202|Human Phenotype Ontology:HP:0000115,Human Phenotype Ontology:HP:0002667,MeSH:D009396,MedGen:C0027708,OMIM:PS194070,Orphanet:654|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892","Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not specified|Neoplasm|not provided|Nephroblastoma|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome",germline;somatic;unknown,germline/somatic,GRCh38,NC_000003.12,3,10142088,10142088,na,na,3p25.3,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"OMIM:608537.0020,ClinGen:CA020148,UniProtKB:P40337#VAR_005689",3,2233,10142088,C,T,P81S,1,uncertain,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,81,P,S,True,979
13892,571,17271,single nucleotide variant,NM_000551.4(VHL):c.598C>T (p.Arg200Trp),7428,VHL,HGNC:12687,Conflicting interpretations of pathogenicity,1,23-Nov-20,28940298,-,RCV000002320|RCV000122262|RCV000148922|RCV000161094|RCV000574264|RCV000627742|RCV000722031,"MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MedGen:CN169374|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0019460,MedGen:C1301357,Orphanet:86851","Erythrocytosis, familial, 2|not specified|Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2|Acute leukemia of ambiguous lineage",germline;unknown,germline,GRCh38,NC_000003.12,3,10149921,10149921,na,na,3p25.3,"criteria provided, conflicting interpretations",12,"ACMG2013,ACMG2016",N,"ClinGen:CA020510,UniProtKB:P40337#VAR_005779,OMIM:608537.0019",3,2232,10149921,C,T,R200W,1,uncertain,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,200,R,W,True,979
13893,570,17270,single nucleotide variant,NM_000551.3(VHL):c.488T>C (p.Leu163Pro),7428,VHL,HGNC:12687,Likely pathogenic,1,29-Aug-19,28940297,-,RCV000002319|RCV001231697,"MedGen:C4017161|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557","Renal cell carcinoma with paraneoplastic erythrocytosis|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2",germline,germline,GRCh38,NC_000003.12,3,10149811,10149811,na,na,3p25.3,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,"ClinGen:CA020423,UniProtKB:P40337#VAR_034998,OMIM:608537.0018",3,2231,10149811,T,C,L163P,1,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,163,L,P,True,979
13894,11232,173736,single nucleotide variant,NM_000551.4(VHL):c.256C>T (p.Pro86Ser),7428,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1,1-May-19,398123481,-,RCV000155449|RCV000413630|RCV000492763|RCV001059327,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:CN517202|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892","Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome",germline,germline,GRCh38,NC_000003.12,3,10142103,10142103,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,"ClinGen:CA020180,UniProtKB:P40337#VAR_005696",2,178692,10142103,C,T,P86S,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,86,P,S,True,979
13895,12535,224891,single nucleotide variant,NM_000551.3(VHL):c.193T>G (p.Ser65Ala),7428,VHL,HGNC:12687,Likely pathogenic,1,26-Feb-16,869025616,-,RCV000208812,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892",Von Hippel-Lindau syndrome,germline,germline,GRCh38,NC_000003.12,3,10142040,10142040,na,na,3p25.3,no assertion criteria provided,1,"ACMG2013,ACMG2016",N,"ClinGen:CA357048,UniProtKB:P40337#VAR_034989",2,223160,10142040,T,G,S65A,0,pathogenic,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,65,S,A,True,979
13896,12536,224899,single nucleotide variant,NM_000551.3(VHL):c.233A>C (p.Asn78Thr),7428,VHL,HGNC:12687,Conflicting interpretations of pathogenicity,1,30-Aug-19,5030804,-,RCV000208838|RCV000679024|RCV000805326,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:CN517202|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557","Von Hippel-Lindau syndrome|not provided|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2",germline,germline,GRCh38,NC_000003.12,3,10142080,10142080,na,na,3p25.3,"criteria provided, conflicting interpretations",3,"ACMG2013,ACMG2016",N,"ClinGen:CA357095,UniProtKB:P40337#VAR_005684",2,223168,10142080,A,C,N78T,1,uncertain,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,78,N,T,True,979
13897,11123,171078,single nucleotide variant,NM_000551.3(VHL):c.154G>A (p.Glu52Lys),7428,VHL,HGNC:12687,Conflicting interpretations of pathogenicity,0,26-Nov-20,373068386,-,RCV000148923|RCV000227809|RCV000236769|RCV000575111,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:CN169374|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome|not specified|Hereditary cancer-predisposing syndrome",germline;unknown,germline,GRCh38,NC_000003.12,3,10142001,10142001,na,na,3p25.3,"criteria provided, conflicting interpretations",6,"ACMG2013,ACMG2016",N,"ClinGen:CA020056,UniProtKB:P40337#VAR_005671",2,161402,10142001,G,A,E52K,1,uncertain,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,52,E,K,True,979
13898,12537,224901,single nucleotide variant,NM_000551.3(VHL):c.257C>G (p.Pro86Arg),7428,VHL,HGNC:12687,Pathogenic,1,25-Oct-17,730882034,-,RCV000208868|RCV000631258,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2;Von Hippel-Lindau syndrome",germline,germline,GRCh38,NC_000003.12,3,10142104,10142104,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"ClinGen:CA357142,UniProtKB:P40337#VAR_005695",2,223170,10142104,C,G,P86R,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,86,P,R,True,979
13899,12538,224906,single nucleotide variant,NM_000551.3(VHL):c.277G>T (p.Gly93Cys),7428,VHL,HGNC:12687,Pathogenic,1,26-Feb-16,5030808,-,RCV000208845,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892",Von Hippel-Lindau syndrome,germline,germline,GRCh38,NC_000003.12,3,10142124,10142124,na,na,3p25.3,no assertion criteria provided,1,"ACMG2013,ACMG2016",N,"UniProtKB:P40337#VAR_005703,ClinGen:CA357106",2,223175,10142124,G,T,G93C,0,pathogenic,uncertain,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,93,G,C,True,979
13900,576,17276,single nucleotide variant,NM_000551.3(VHL):c.277G>A (p.Gly93Ser),7428,VHL,HGNC:12687,Pathogenic,1,20-Mar-18,5030808,-,RCV000002325|RCV000208813|RCV000698471,"Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557","Pheochromocytoma|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2",germline,germline,GRCh38,NC_000003.12,3,10142124,10142124,na,na,3p25.3,"criteria provided, single submitter",3,"ACMG2013,ACMG2016",N,"ClinGen:CA020230,UniProtKB:P40337#VAR_005705,OMIM:608537.0026",3,2237,10142124,G,A,G93S,1,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,93,G,S,True,979
13901,562,17261,single nucleotide variant,NM_000551.3(VHL):c.334T>C (p.Tyr112His),7428,VHL,HGNC:12687,Pathogenic,1,28-Sep-18,104893824,-,RCV000002308|RCV000698407,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557","Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Erythrocytosis, familial, 2",germline,germline,GRCh38,NC_000003.12,3,10142181,10142181,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"OMIM:608537.0012,ClinGen:CA020277,UniProtKB:P40337#VAR_005717",3,2222,10142181,T,C,Y112H,2,pathogenic,pathogenic,P40337,P40337,reviewed,VHL_HUMAN,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,Homo sapiens (Human),213.0,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD,PF01847;PF17211;,1LM8;1LQB;1VCB;3ZRC;3ZRF;3ZTC;3ZTD;3ZUN;4AJY;4AWJ;4B95;4B9K;4BKS;4BKT;4W9C;4W9D;4W9E;4W9F;4W9G;4W9H;4W9I;4W9J;4W9K;4W9L;4WQO;5LLI;5N4W;5NVV;5NVW;5NVX;5NVY;5NVZ;5NW0;5NW1;5NW2;5T35;6BVB;6FMI;6FMJ;6FMK;6GFX;6GFY;6GFZ;6GMN;6GMQ;6GMR;6GMX;6HAX;6HAY;6HR2;6I7Q;6I7R;6R6H;6R7F;6SIS;6ZHC;7CJB;7JTO;7JTP;7KHH;7PI4;7Q2J;,112,Y,H,True,979
13902,4025,29864,single nucleotide variant,NM_020070.4(IGLL1):c.425C>T (p.Pro142Leu),3543,IGLL1,HGNC:5870,Conflicting interpretations of pathogenicity,1,7-Oct-20,1064422,-,RCV000015949|RCV000756272|RCV001170010,"MONDO:MONDO:0000581,MONDO:MONDO:0013287,MedGen:C3150750,OMIM:613500|MedGen:CN517202|MedGen:CN169374","Agammaglobulinemia 2, autosomal recessive|not provided|not specified",germline;unknown,germline,GRCh38,NC_000022.11,22,23573483,23573483,na,na,22q11.23,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA124367,UniProtKB:P15814#VAR_034869,OMIM:146770.0002",3,14825,23573483,G,A,P142L,1,uncertain,uncertain,P15814,P15814,reviewed,IGLL1_HUMAN,Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b),IGLL1 IGL1,Homo sapiens (Human),213.0,MRPGTGQGGLEAPGEPGPNLRQRWPLLLLGLAVVTHGLLRPTAASQSRALGPGAPGGSSRSSLRSRWGRFLLQRGSWTGPRCWPRGFQSKHNSVTHVFGSGTQLTVLSQPKATPSVTLFPPSSEELQANKATLVCLMNDFYPGILTVTWKADGTPITQGVEMTTPSKQSNNKYAASSYLSLTPEQWRSRRSYSCQVMHEGSTVEKTVAPAECS,PF07654;,2H32;2H3N;2LKQ;,142,P,L,True,980
13903,6095,44141,single nucleotide variant,NM_014043.4(CHMP2B):c.311C>A (p.Thr104Asn),25978,CHMP2B,HGNC:24537,Conflicting interpretations of pathogenicity,1,4-Oct-12,281864934,-,RCV000055937,"MONDO:MONDO:0010936,MedGen:C1833296,OMIM:600795,Orphanet:275864,Orphanet:282","Frontotemporal dementia, chromosome 3-linked",germline,germline,GRCh38,NC_000003.12,3,87245898,87245898,na,na,3p11.2,no assertion criteria provided,2,-,N,"ClinGen:CA260074,UniProtKB:Q9UQN3#VAR_068689,OMIM:609512.0006",1,35472,87245898,C,A,T104N,0,uncertain,uncertain,Q9UQN3,Q9UQN3,reviewed,CHM2B_HUMAN,"Charged multivesicular body protein 2b (CHMP2.5) (Chromatin-modifying protein 2b, CHMP2b) (Vacuolar protein sorting-associated protein 2-2, Vps2-2, hVps2-2)",CHMP2B CGI-84,Homo sapiens (Human),213.0,MASLFKKKTVDDVIKEQNRELRGTQRAIIRDRAALEKQEKQLELEIKKMAKIGNKEACKVLAKQLVHLRKQKTRTFAVSSKVTSMSTQTKVMNSQMKMAGAMSTTAKTMQAVNKKMDPQKTLQTMQNFQKENMKMEMTEEMINDTLDDIFDGSDDEEESQDIVNQVLDEIGIEISGKMAKAPSAARSLPSASTSKATISDEEIERQLKALGVD,PF03357;,2JQK;,104,T,N,True,981
13904,429,16693,single nucleotide variant,NM_014043.4(CHMP2B):c.618A>C (p.Gln206His),25978,CHMP2B,HGNC:24537,Pathogenic,1,4-Oct-12,63751126,-,RCV000020696|RCV000084279,"MONDO:MONDO:0010936,MedGen:C1833296,OMIM:600795,Orphanet:275864,Orphanet:282|MedGen:CN517202","Frontotemporal dementia, chromosome 3-linked|not provided",germline,germline,GRCh38,NC_000003.12,3,87253798,87253798,na,na,3p11.2,no assertion criteria provided,3,-,N,"ClinGen:CA224980,UniProtKB:Q9UQN3#VAR_038374,OMIM:609512.0003",3,1654,87253798,A,C,Q206H,0,pathogenic,uncertain,Q9UQN3,Q9UQN3,reviewed,CHM2B_HUMAN,"Charged multivesicular body protein 2b (CHMP2.5) (Chromatin-modifying protein 2b, CHMP2b) (Vacuolar protein sorting-associated protein 2-2, Vps2-2, hVps2-2)",CHMP2B CGI-84,Homo sapiens (Human),213.0,MASLFKKKTVDDVIKEQNRELRGTQRAIIRDRAALEKQEKQLELEIKKMAKIGNKEACKVLAKQLVHLRKQKTRTFAVSSKVTSMSTQTKVMNSQMKMAGAMSTTAKTMQAVNKKMDPQKTLQTMQNFQKENMKMEMTEEMINDTLDDIFDGSDDEEESQDIVNQVLDEIGIEISGKMAKAPSAARSLPSASTSKATISDEEIERQLKALGVD,PF03357;,2JQK;,206,Q,H,True,981
13905,428,16692,single nucleotide variant,NM_014043.4(CHMP2B):c.442G>T (p.Asp148Tyr),25978,CHMP2B,HGNC:24537,Pathogenic,1,4-Oct-12,63750653,-,RCV000001720|RCV000084275,"MONDO:MONDO:0010936,MedGen:C1833296,OMIM:600795,Orphanet:275864,Orphanet:282|MedGen:CN517202","Frontotemporal dementia, chromosome 3-linked|not provided",germline,germline,GRCh38,NC_000003.12,3,87253421,87253421,na,na,3p11.2,no assertion criteria provided,3,-,N,"ClinGen:CA224974,UniProtKB:Q9UQN3#VAR_023383,OMIM:609512.0002",3,1653,87253421,G,T,D148Y,0,pathogenic,uncertain,Q9UQN3,Q9UQN3,reviewed,CHM2B_HUMAN,"Charged multivesicular body protein 2b (CHMP2.5) (Chromatin-modifying protein 2b, CHMP2b) (Vacuolar protein sorting-associated protein 2-2, Vps2-2, hVps2-2)",CHMP2B CGI-84,Homo sapiens (Human),213.0,MASLFKKKTVDDVIKEQNRELRGTQRAIIRDRAALEKQEKQLELEIKKMAKIGNKEACKVLAKQLVHLRKQKTRTFAVSSKVTSMSTQTKVMNSQMKMAGAMSTTAKTMQAVNKKMDPQKTLQTMQNFQKENMKMEMTEEMINDTLDDIFDGSDDEEESQDIVNQVLDEIGIEISGKMAKAPSAARSLPSASTSKATISDEEIERQLKALGVD,PF03357;,2JQK;,148,D,Y,True,981
13906,5451,34359,single nucleotide variant,NM_014043.4(CHMP2B):c.85A>G (p.Ile29Val),25978,CHMP2B,HGNC:24537,Uncertain significance,1,15-Apr-20,63750818,-,RCV000020697|RCV000029146|RCV000084271|RCV000691708,"MONDO:MONDO:0010936,MedGen:C1833296,OMIM:600795,Orphanet:275864,Orphanet:282|MONDO:MONDO:0013861,MedGen:C1836076,OMIM:614696,Orphanet:803|MedGen:CN517202|MONDO:MONDO:0010936,MedGen:C1833296,OMIM:600795,Orphanet:275864,Orphanet:282;MONDO:MONDO:0013861,MedGen:C1836076,OMIM:614696,Orphanet:803","Frontotemporal dementia, chromosome 3-linked|Amyotrophic lateral sclerosis 17|not provided|Frontotemporal dementia, chromosome 3-linked;Amyotrophic lateral sclerosis 17",germline;inherited;unknown,germline,GRCh38,NC_000003.12,3,87240749,87240749,na,na,3p11.2,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA224967,UniProtKB:Q9UQN3#VAR_038373,OMIM:609512.0005",3,21507,87240749,A,G,I29V,2,uncertain,uncertain,Q9UQN3,Q9UQN3,reviewed,CHM2B_HUMAN,"Charged multivesicular body protein 2b (CHMP2.5) (Chromatin-modifying protein 2b, CHMP2b) (Vacuolar protein sorting-associated protein 2-2, Vps2-2, hVps2-2)",CHMP2B CGI-84,Homo sapiens (Human),213.0,MASLFKKKTVDDVIKEQNRELRGTQRAIIRDRAALEKQEKQLELEIKKMAKIGNKEACKVLAKQLVHLRKQKTRTFAVSSKVTSMSTQTKVMNSQMKMAGAMSTTAKTMQAVNKKMDPQKTLQTMQNFQKENMKMEMTEEMINDTLDDIFDGSDDEEESQDIVNQVLDEIGIEISGKMAKAPSAARSLPSASTSKATISDEEIERQLKALGVD,PF03357;,2JQK;,29,I,V,True,981
13907,6072,40277,single nucleotide variant,NM_025237.3(SOST):c.61G>A (p.Val21Met),50964,SOST,HGNC:13771,Pathogenic,1,1-May-11,387907169,-,RCV000024297,"MONDO:MONDO:0021021,MedGen:C2675746,OMIM:122860,Orphanet:1513","Craniodiaphyseal dysplasia, autosomal dominant",germline,germline,GRCh38,NC_000017.11,17,43758681,43758681,na,na,17q21.31,no assertion criteria provided,1,-,N,"ClinGen:CA129828,UniProtKB:Q9BQB4#VAR_065767,OMIM:605740.0005",1,31592,43758681,C,T,V21M,0,pathogenic,uncertain,Q9BQB4,Q9BQB4,reviewed,SOST_HUMAN,Sclerostin,SOST UNQ2976/PRO7455/PRO7476,Homo sapiens (Human),213.0,MQLPLALCLVCLLVHTAFRVVEGQGWQAFKNDATEIIPELGEYPEPPPELENNKTMNRAENGGRPPHHPFETKDVSEYSCRELHFTRYVTDGPCRSAKPVTELVCSGQCGPARLLPNAIGRGKWWRPSGPDFRCIPDRYRAQRVQLLCPGGEAPRARKVRLVASCKCKRLTRFHNQSELKDFGTEAARPQKGRKPRPRARSAKANQAELENAY,PF05463;,2K8P;3SOV;6L6R;,21,V,M,True,982
13908,13636,269999,single nucleotide variant,NM_000514.4(GDNF):c.61C>T (p.Pro21Ser),2668,GDNF,HGNC:4232,Uncertain significance,0,8-Jan-16,777451569,-,RCV000369081,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000005.10,5,37834736,37834736,na,na,5p13.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA3241270,UniProtKB:P39905#VAR_009494",2,285762,37834736,G,A,P21S,1,uncertain,uncertain,P39905,P39905,reviewed,GDNF_HUMAN,"Glial cell line-derived neurotrophic factor, hGDNF (Astrocyte-derived trophic factor, ATF)",GDNF,Homo sapiens (Human),211.0,MKLWDVVAVCLVLLHTASAFPLPAGKRPPEAPAEDRSLGRRRAPFALSSDSNMPEDYPDQFDDVMDFIQATIKRLKRSPDKQMAVLPRRERNRQAAAANPENSRGKGRRGQRGKNRGCVLTAIHLNVTDLGLGYETKEELIFRYCSGSCDAAETTYDKILKNLSRNRRLVSDKVGQACCRPIAFDDDLSFLDDNLVYHILRKHSAKRCGCI,PF00019;,2V5E;3FUB;4UX8;6Q2N;,21,P,S,True,983
13909,2026,23797,single nucleotide variant,NM_000514.4(GDNF):c.277C>T (p.Arg93Trp),2668,GDNF,HGNC:4232,Likely benign,1,27-Apr-17,36119840,-,RCV000009301|RCV000009302|RCV000009303|RCV000150719,"MONDO:MONDO:0013383,MedGen:C3150974,OMIM:613711,Orphanet:388|MONDO:MONDO:0008852,MedGen:C1275808,OMIM:209880,Orphanet:661,Orphanet:99803||MedGen:CN169374","Hirschsprung disease 3|Congenital central hypoventilation|Pheochromocytoma, modifier of|not specified",germline,germline,GRCh38,NC_000005.10,5,37816010,37816010,na,na,5p13.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA119895,UniProtKB:P39905#VAR_009495,OMIM:600837.0001",3,8758,37816010,G,A,R93W,2,benign,benign,P39905,P39905,reviewed,GDNF_HUMAN,"Glial cell line-derived neurotrophic factor, hGDNF (Astrocyte-derived trophic factor, ATF)",GDNF,Homo sapiens (Human),211.0,MKLWDVVAVCLVLLHTASAFPLPAGKRPPEAPAEDRSLGRRRAPFALSSDSNMPEDYPDQFDDVMDFIQATIKRLKRSPDKQMAVLPRRERNRQAAAANPENSRGKGRRGQRGKNRGCVLTAIHLNVTDLGLGYETKEELIFRYCSGSCDAAETTYDKILKNLSRNRRLVSDKVGQACCRPIAFDDDLSFLDDNLVYHILRKHSAKRCGCI,PF00019;,2V5E;3FUB;4UX8;6Q2N;,93,R,W,True,983
13910,2029,23800,single nucleotide variant,NM_000514.4(GDNF):c.633C>G (p.Ile211Met),2668,GDNF,HGNC:4232,risk factor,0,1-Jul-00,121918536,-,RCV000009306,"MONDO:MONDO:0013383,MedGen:C3150974,OMIM:613711,Orphanet:388",Hirschsprung disease 3,germline,germline,GRCh38,NC_000005.10,5,37815654,37815654,na,na,5p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA254550,UniProtKB:P39905#VAR_018152,OMIM:600837.0004",1,8761,37815654,G,C,I211M,0,uncertain,uncertain,P39905,P39905,reviewed,GDNF_HUMAN,"Glial cell line-derived neurotrophic factor, hGDNF (Astrocyte-derived trophic factor, ATF)",GDNF,Homo sapiens (Human),211.0,MKLWDVVAVCLVLLHTASAFPLPAGKRPPEAPAEDRSLGRRRAPFALSSDSNMPEDYPDQFDDVMDFIQATIKRLKRSPDKQMAVLPRRERNRQAAAANPENSRGKGRRGQRGKNRGCVLTAIHLNVTDLGLGYETKEELIFRYCSGSCDAAETTYDKILKNLSRNRRLVSDKVGQACCRPIAFDDDLSFLDDNLVYHILRKHSAKRCGCI,PF00019;,2V5E;3FUB;4UX8;6Q2N;,211,I,M,True,983
13911,2028,23799,single nucleotide variant,NM_000514.4(GDNF):c.460A>T (p.Thr154Ser),2668,GDNF,HGNC:4232,risk factor,0,1-Dec-96,104893891,-,RCV000009305,"MONDO:MONDO:0013383,MedGen:C3150974,OMIM:613711,Orphanet:388",Hirschsprung disease 3,germline,germline,GRCh38,NC_000005.10,5,37815827,37815827,na,na,5p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA254549,UniProtKB:P39905#VAR_009497,OMIM:600837.0003",1,8760,37815827,T,A,T154S,0,uncertain,uncertain,P39905,P39905,reviewed,GDNF_HUMAN,"Glial cell line-derived neurotrophic factor, hGDNF (Astrocyte-derived trophic factor, ATF)",GDNF,Homo sapiens (Human),211.0,MKLWDVVAVCLVLLHTASAFPLPAGKRPPEAPAEDRSLGRRRAPFALSSDSNMPEDYPDQFDDVMDFIQATIKRLKRSPDKQMAVLPRRERNRQAAAANPENSRGKGRRGQRGKNRGCVLTAIHLNVTDLGLGYETKEELIFRYCSGSCDAAETTYDKILKNLSRNRRLVSDKVGQACCRPIAFDDDLSFLDDNLVYHILRKHSAKRCGCI,PF00019;,2V5E;3FUB;4UX8;6Q2N;,154,T,S,True,983
13912,2027,23798,single nucleotide variant,NM_000514.4(GDNF):c.448G>A (p.Asp150Asn),2668,GDNF,HGNC:4232,Benign/Likely benign,0,28-May-19,76466003,-,RCV000009304|RCV000252402,"MONDO:MONDO:0013383,MedGen:C3150974,OMIM:613711,Orphanet:388|MedGen:CN169374",Hirschsprung disease 3|not specified,germline;unknown,germline,GRCh38,NC_000005.10,5,37815839,37815839,na,na,5p13.2,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA254547,UniProtKB:P39905#VAR_009496,OMIM:600837.0002",3,8759,37815839,C,T,D150N,2,benign,benign,P39905,P39905,reviewed,GDNF_HUMAN,"Glial cell line-derived neurotrophic factor, hGDNF (Astrocyte-derived trophic factor, ATF)",GDNF,Homo sapiens (Human),211.0,MKLWDVVAVCLVLLHTASAFPLPAGKRPPEAPAEDRSLGRRRAPFALSSDSNMPEDYPDQFDDVMDFIQATIKRLKRSPDKQMAVLPRRERNRQAAAANPENSRGKGRRGQRGKNRGCVLTAIHLNVTDLGLGYETKEELIFRYCSGSCDAAETTYDKILKNLSRNRRLVSDKVGQACCRPIAFDDDLSFLDDNLVYHILRKHSAKRCGCI,PF00019;,2V5E;3FUB;4UX8;6Q2N;,150,D,N,True,983
13913,5708,37785,single nucleotide variant,NM_000852.4(GSTP1):c.313A>G (p.Ile105Val),2950,GSTP1,HGNC:4638,drug response,0,3-May-17,1695,-,RCV000211146|RCV000211269|RCV000211325|RCV000437330|RCV000660778,"MedGen:CN236475|MedGen:CN236473|MedGen:CN236514|Human Phenotype Ontology:HP:0100834,MeSH:D015179,MedGen:C0009404|MedGen:CN236502","fluorouracil and oxaliplatin response - Efficacy|cyclophosphamide and epirubicin response - Efficacy, Toxicity/ADR|Platinum compounds response - Toxicity/ADR|Neoplasm of the large intestine|cisplatin response - Toxicity/ADR",germline;somatic,germline/somatic,GRCh38,NC_000011.10,11,67585218,67585218,na,na,11q13.2,reviewed by expert panel,2,-,N,"PharmGKB Clinical Annotation:827847788,PharmGKB Clinical Annotation:981238323,PharmGKB Clinical Annotation:637880221,ClinGen:CA6142790,UniProtKB:P09211#VAR_014499",1,37340,67585218,A,G,I105V,3,uncertain,uncertain,P09211,P09211,reviewed,GSTP1_HUMAN,"Glutathione S-transferase P, EC 2.5.1.18 (GST class-pi) (GSTP1-1)",GSTP1 FAEES3 GST3,Homo sapiens (Human),210.0,MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ,PF14497;PF02798;,10GS;11GS;12GS;13GS;14GS;16GS;17GS;18GS;19GS;1AQV;1AQW;1AQX;1EOG;1EOH;1GSS;1KBN;1LBK;1MD3;1MD4;1PGT;1PX6;1PX7;1ZGN;20GS;22GS;2A2R;2A2S;2GSS;2J9H;2PGT;3CSH;3CSI;3CSJ;3DD3;3DGQ;3GSS;3GUS;3HJM;3HJO;3HKR;3IE3;3KM6;3KMN;3KMO;3N9J;3PGT;4GSS;4PGT;5DAK;5DAL;5DCG;5DDL;5DJL;5DJM;5GSS;5J41;5JCW;5L6X;5X79;6AP9;6GSS;6LLX;6Y1E;7GSS;8GSS;9GSS;,105,I,V,True,984
13914,958,19021,single nucleotide variant,NM_000144.5(FXN):c.389G>T (p.Gly130Val),2395,FXN,HGNC:3951,Pathogenic,1,18-Jan-19,104894107,-,RCV000004189|RCV000992016,"MONDO:MONDO:0009245,MedGen:C0016719,Orphanet:95|MedGen:CN517202",Friedreich's ataxia|not provided,germline,germline,GRCh38,NC_000009.12,9,69064942,69064942,na,na,9q21.11,"criteria provided, single submitter",2,-,N,"OMIM:606829.0005,ClinGen:CA252966,UniProtKB:Q16595#VAR_002429",3,3982,69064942,G,T,G130V,1,pathogenic,pathogenic,Q16595,Q16595,reviewed,FRDA_HUMAN,"Frataxin, mitochondrial, EC 1.16.3.1 (Friedreich ataxia protein, Fxn) [Cleaved into: Frataxin intermediate form, i-FXN; Frataxin(56-210) (m56-FXN); Frataxin(78-210) (d-FXN) (m78-FXN); Frataxin mature form (Frataxin(81-210)) (m81-FXN) ]",FXN FRDA X25,Homo sapiens (Human),210.0,MWTLGRRAVAGLLASPSPAQAQTLTRVPRPAELAPLCGRRGLRTDIDATCTPRRASSNQRGLNQIWNVKKQSVYLMNLRKSGTLGHPGSLDETTYERLAEETLDSLAEFFEDLADKPYTFEDYDVSFGSGVLTVKLGGDLGTYVINKQTPNKQIWLSSPSSGPKRYDWTGKNWVYSHDGVSLHELLAAELTKALKTKLDLSSLAYSGKDA,PF01491;,1EKG;1LY7;3S4M;3S5D;3S5E;3S5F;3T3J;3T3K;3T3L;3T3T;3T3X;5KZ5;6NZU;,130,G,V,True,985
13915,957,19020,single nucleotide variant,NM_000144.5(FXN):c.460A>T (p.Ile154Phe),2395,FXN,HGNC:3951,Pathogenic,1,15-Apr-07,104894106,-,RCV000004188,"MONDO:MONDO:0009245,MedGen:C0016719,Orphanet:95",Friedreich's ataxia,germline,germline,GRCh38,NC_000009.12,9,69065013,69065013,na,na,9q21.11,no assertion criteria provided,1,-,N,"ClinGen:CA252964,UniProtKB:Q16595#VAR_002430,OMIM:606829.0004",1,3981,69065013,A,T,I154F,0,pathogenic,uncertain,Q16595,Q16595,reviewed,FRDA_HUMAN,"Frataxin, mitochondrial, EC 1.16.3.1 (Friedreich ataxia protein, Fxn) [Cleaved into: Frataxin intermediate form, i-FXN; Frataxin(56-210) (m56-FXN); Frataxin(78-210) (d-FXN) (m78-FXN); Frataxin mature form (Frataxin(81-210)) (m81-FXN) ]",FXN FRDA X25,Homo sapiens (Human),210.0,MWTLGRRAVAGLLASPSPAQAQTLTRVPRPAELAPLCGRRGLRTDIDATCTPRRASSNQRGLNQIWNVKKQSVYLMNLRKSGTLGHPGSLDETTYERLAEETLDSLAEFFEDLADKPYTFEDYDVSFGSGVLTVKLGGDLGTYVINKQTPNKQIWLSSPSSGPKRYDWTGKNWVYSHDGVSLHELLAAELTKALKTKLDLSSLAYSGKDA,PF01491;,1EKG;1LY7;3S4M;3S5D;3S5E;3S5F;3T3J;3T3K;3T3L;3T3T;3T3X;5KZ5;6NZU;,154,I,F,True,985
13916,1730,22551,single nucleotide variant,NM_002496.4(NDUFS8):c.305G>A (p.Arg102His),4728,NDUFS8,HGNC:7715,Uncertain significance,1,4-Jan-17,121912638,-,RCV000007942|RCV000426335,"MONDO:MONDO:0032606,MedGen:C4748737,OMIM:618222|MedGen:CN517202","Mitochondrial complex 1 deficiency, nuclear type 2|not provided",germline,germline,GRCh38,NC_000011.10,11,68033216,68033216,na,na,11q13.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA118854,UniProtKB:O00217#VAR_019539,OMIM:602141.0002",3,7512,68033216,G,A,R102H,1,uncertain,uncertain,O00217,O00217,reviewed,NDUS8_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial, EC 7.1.1.2 (Complex I-23kD, CI-23kD) (NADH-ubiquinone oxidoreductase 23 kDa subunit) (TYKY subunit)",NDUFS8,Homo sapiens (Human),210.0,MRCLTTPMLLRALAQAARAGPPGGRSLHSSAVAATYKYVNMQDPEMDMKSVTDRAARTLLWTELFRGLGMTLSYLFREPATINYPFEKGPLSPRFRGEHALRRYPSGEERCIACKLCEAICPAQAITIEAEPRADGSRRTTRYDIDMTKCIYCGFCQEACPVDAIVEGPNFEFSTETHEELLYNKEKLLNNGDKWEAEIAANIQADYLYR,PF12838;,5XTB;5XTD;5XTH;5XTI;,102,R,H,True,986
13917,1729,22550,single nucleotide variant,NM_002496.4(NDUFS8):c.236C>T (p.Pro79Leu),4728,NDUFS8,HGNC:7715,Likely pathogenic,1,31-Oct-18,28939679,-,RCV000007941|RCV000442702|RCV000762861,"MONDO:MONDO:0032606,MedGen:C4748737,OMIM:618222|MedGen:CN517202|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000,Orphanet:506","Mitochondrial complex 1 deficiency, nuclear type 2|not provided|Leigh syndrome",germline;unknown,germline,GRCh38,NC_000011.10,11,68033147,68033147,na,na,11q13.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA118853,UniProtKB:O00217#VAR_019538,OMIM:602141.0001",3,7511,68033147,C,T,P79L,2,pathogenic,pathogenic,O00217,O00217,reviewed,NDUS8_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial, EC 7.1.1.2 (Complex I-23kD, CI-23kD) (NADH-ubiquinone oxidoreductase 23 kDa subunit) (TYKY subunit)",NDUFS8,Homo sapiens (Human),210.0,MRCLTTPMLLRALAQAARAGPPGGRSLHSSAVAATYKYVNMQDPEMDMKSVTDRAARTLLWTELFRGLGMTLSYLFREPATINYPFEKGPLSPRFRGEHALRRYPSGEERCIACKLCEAICPAQAITIEAEPRADGSRRTTRYDIDMTKCIYCGFCQEACPVDAIVEGPNFEFSTETHEELLYNKEKLLNNGDKWEAEIAANIQADYLYR,PF12838;,5XTB;5XTD;5XTH;5XTI;,79,P,L,True,986
13918,3061,27465,single nucleotide variant,NM_000363.5(TNNI3):c.433C>T (p.Arg145Trp),7137,TNNI3,HGNC:11947,Pathogenic,1,27-Nov-19,104894724,-,RCV000013239|RCV000159222|RCV000498333|RCV001170617|RCV001254730,"MONDO:MONDO:0007270,MedGen:C1861861,OMIM:115210,Orphanet:75249|MedGen:CN517202|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569;Human Phenotype Ontology:HP:0001723,MONDO:MONDO:0005201,MeSH:D002313,MedGen:C0007196,Orphanet:217632",Familial restrictive cardiomyopathy 1|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|Hypertrophic cardiomyopathy;Restrictive cardiomyopathy,germline,germline,GRCh38,NC_000019.10,19,55154146,55154146,na,na,19q13.42,"criteria provided, multiple submitters, no conflicts",9,"ACMG2013,ACMG2016",N,"ClinGen:CA021667,UniProtKB:P19429#VAR_016080,OMIM:191044.0008",3,12426,55154146,G,A,R145W,2,pathogenic,pathogenic,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,145,R,W,True,987
13919,3065,27470,single nucleotide variant,NM_000363.5(TNNI3):c.555C>G (p.Asn185Lys),7137,TNNI3,HGNC:11947,Pathogenic,1,14-Aug-09,267607129,-,RCV000013244,"MONDO:MONDO:0013211,MedGen:C2750091,OMIM:613286,Orphanet:154",Dilated cardiomyopathy 1FF,germline,germline,GRCh38,NC_000019.10,19,55151912,55151912,na,na,19q13.42,no assertion criteria provided,1,"ACMG2013,ACMG2016",N,"UniProtKB:P19429#VAR_063549,OMIM:191044.0013,ClinGen:CA021902",1,12431,55151912,G,C,N185K,0,pathogenic,uncertain,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,185,N,K,True,987
13920,6823,52565,single nucleotide variant,NM_000363.5(TNNI3):c.557G>A (p.Arg186Gln),7137,TNNI3,HGNC:11947,Pathogenic/Likely pathogenic,1,18-Oct-19,397516357,-,RCV000157533|RCV000167988|RCV000223924|RCV000620207|RCV000770565|RCV001258033,"MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|MedGen:CN517202|MedGen:CN230736|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0013369,MedGen:C1860752,OMIM:613690",Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype|Cardiomyopathy|Familial hypertrophic cardiomyopathy 7,germline,germline,GRCh38,NC_000019.10,19,55151910,55151910,na,na,19q13.42,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"ClinGen:CA021907,UniProtKB:P19429#VAR_019876",2,43395,55151910,C,T,R186Q,2,pathogenic,pathogenic,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,186,R,Q,True,987
13921,6822,52560,single nucleotide variant,NM_000363.5(TNNI3):c.485G>C (p.Arg162Pro),7137,TNNI3,HGNC:11947,Pathogenic/Likely pathogenic,1,30-Aug-19,397516354,-,RCV000629031,"Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569",Hypertrophic cardiomyopathy,germline,germline,GRCh38,NC_000019.10,19,55154094,55154094,na,na,19q13.42,"criteria provided, multiple submitters, no conflicts",2,"ACMG2013,ACMG2016",N,"ClinGen:CA021749,UniProtKB:P19429#VAR_019874",2,43390,55154094,C,G,R162P,2,pathogenic,pathogenic,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,162,R,P,True,987
13922,11295,176208,single nucleotide variant,NM_000363.5(TNNI3):c.611G>A (p.Arg204His),7137,TNNI3,HGNC:11947,Pathogenic/Likely pathogenic,1,15-Dec-19,727504275,-,RCV000159249|RCV000469008|RCV001254739,"MedGen:CN517202|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569;Human Phenotype Ontology:HP:0001723,MONDO:MONDO:0005201,MeSH:D002313,MedGen:C0007196,Orphanet:217632",not provided|Hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy;Restrictive cardiomyopathy,de novo;germline,germline,GRCh38,NC_000019.10,19,55151856,55151856,na,na,19q13.42,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"ClinGen:CA022060,UniProtKB:P19429#VAR_042746",2,177679,55151856,C,T,R204H,2,pathogenic,pathogenic,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,204,R,H,True,987
13923,3064,27469,single nucleotide variant,NM_000363.5(TNNI3):c.106A>C (p.Lys36Gln),7137,TNNI3,HGNC:11947,Pathogenic,1,14-Aug-09,267607130,-,RCV000013243,"MONDO:MONDO:0013211,MedGen:C2750091,OMIM:613286,Orphanet:154",Dilated cardiomyopathy 1FF,germline,germline,GRCh38,NC_000019.10,19,55157052,55157052,na,na,19q13.42,no assertion criteria provided,1,"ACMG2013,ACMG2016",N,"ClinGen:CA021239,UniProtKB:P19429#VAR_063548,OMIM:191044.0012",1,12430,55157052,T,G,K36Q,0,pathogenic,uncertain,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,36,K,Q,True,987
13924,6821,52559,single nucleotide variant,NM_000363.5(TNNI3):c.485G>A (p.Arg162Gln),7137,TNNI3,HGNC:11947,Pathogenic/Likely pathogenic,1,23-Mar-20,397516354,-,RCV000159229|RCV000197981|RCV000208428|RCV000477941|RCV000620118|RCV000850015|RCV001170614,"MedGen:CN517202|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|MONDO:MONDO:0013211,MedGen:C2750091,OMIM:613286,Orphanet:154;MONDO:MONDO:0007270,MedGen:C1861861,OMIM:115210,Orphanet:75249;MONDO:MONDO:0012746,MedGen:C2678474,OMIM:611880,Orphanet:154;MONDO:MONDO:0013369,MedGen:C1860752,OMIM:613690|MedGen:CN230736|MONDO:MONDO:0013211,MedGen:C2750091,OMIM:613286,Orphanet:154|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848",not provided|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Dilated cardiomyopathy 1FF;Familial restrictive cardiomyopathy 1;Dilated cardiomyopathy 2A;Familial hypertrophic cardiomyopathy 7|Cardiovascular phenotype|Dilated cardiomyopathy 1FF|Cardiomyopathy,germline;unknown,germline,GRCh38,NC_000019.10,19,55154094,55154094,na,na,19q13.42,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,"ClinGen:CA021744,UniProtKB:P19429#VAR_042745",2,43389,55154094,C,T,R162Q,2,pathogenic,pathogenic,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,162,R,Q,True,987
13925,3062,27467,single nucleotide variant,NM_000363.5(TNNI3):c.431T>A (p.Leu144Gln),7137,TNNI3,HGNC:11947,Pathogenic,1,1-Jan-03,121917760,-,RCV000013241,"MONDO:MONDO:0007270,MedGen:C1861861,OMIM:115210,Orphanet:75249",Familial restrictive cardiomyopathy 1,germline,germline,GRCh38,NC_000019.10,19,55154148,55154148,na,na,19q13.42,no assertion criteria provided,1,"ACMG2013,ACMG2016",N,"ClinGen:CA021648,UniProtKB:P19429#VAR_016079,OMIM:191044.0010",1,12428,55154148,A,T,L144Q,0,pathogenic,uncertain,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,144,L,Q,True,987
13926,6819,52551,single nucleotide variant,NM_000363.5(TNNI3):c.422G>A (p.Arg141Gln),7137,TNNI3,HGNC:11947,Pathogenic/Likely pathogenic,1,23-Dec-19,397516347,-,RCV000159220|RCV000465349|RCV000777481,"MedGen:CN517202|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848",not provided|Hypertrophic cardiomyopathy|Cardiomyopathy,germline,germline,GRCh38,NC_000019.10,19,55154157,55154157,na,na,19q13.42,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,"ClinGen:CA021635,UniProtKB:P19429#VAR_019872",2,43381,55154157,C,T,R141Q,2,pathogenic,pathogenic,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,141,R,Q,True,987
13927,6820,52558,single nucleotide variant,NM_000363.5(TNNI3):c.470C>T (p.Ala157Val),7137,TNNI3,HGNC:11947,Pathogenic,1,6-Apr-20,397516353,-,RCV000159227|RCV000465603|RCV000578464|RCV001170616|RCV001174966,"MedGen:CN517202|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|MONDO:MONDO:0013369,MedGen:C1860752,OMIM:613690|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155",not provided|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 7|Cardiomyopathy|Primary familial hypertrophic cardiomyopathy,germline,germline,GRCh38,NC_000019.10,19,55154109,55154109,na,na,19q13.42,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,"ClinGen:CA021720,UniProtKB:P19429#VAR_019873",2,43388,55154109,G,A,A157V,2,pathogenic,pathogenic,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,157,A,V,True,987
13928,6818,52537,single nucleotide variant,NM_000363.5(TNNI3):c.235C>T (p.Arg79Cys),7137,TNNI3,HGNC:11947,Conflicting interpretations of pathogenicity,0,31-Dec-19,3729712,-,RCV000036275|RCV000253834|RCV000464815|RCV000721099|RCV000991060|RCV001135029|RCV001135030|RCV001135031|RCV001135032|RCV001170622,"MedGen:CN169374|MedGen:CN230736|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|MedGen:CN517202|MONDO:MONDO:0008647,MedGen:C3495498,OMIM:192600|MONDO:MONDO:0007270,MedGen:C1861861,OMIM:115210,Orphanet:75249|MONDO:MONDO:0012746,MedGen:C2678474,OMIM:611880,Orphanet:154|MONDO:MONDO:0013369,MedGen:C1860752,OMIM:613690|MedGen:CN239247|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848",not specified|Cardiovascular phenotype|Hypertrophic cardiomyopathy|not provided|Familial hypertrophic cardiomyopathy 1|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Familial hypertrophic cardiomyopathy 7|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiomyopathy,germline;unknown,germline,GRCh38,NC_000019.10,19,55156248,55156248,na,na,19q13.42,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,"ClinGen:CA021395,UniProtKB:P19429#VAR_029453",2,43367,55156248,G,A,R79C,1,uncertain,uncertain,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,79,R,C,True,987
13929,3063,27468,single nucleotide variant,NM_000363.5(TNNI3):c.511G>A (p.Ala171Thr),7137,TNNI3,HGNC:11947,Uncertain significance,1,20-Oct-19,121917761,-,RCV000013242|RCV000817897,"MONDO:MONDO:0007270,MedGen:C1861861,OMIM:115210,Orphanet:75249|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569",Familial restrictive cardiomyopathy 1|Hypertrophic cardiomyopathy,germline,germline,GRCh38,NC_000019.10,19,55154068,55154068,na,na,19q13.42,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,"ClinGen:CA021791,UniProtKB:P19429#VAR_016081,OMIM:191044.0011",3,12429,55154068,C,T,A171T,1,uncertain,uncertain,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,171,A,T,True,987
13930,6824,52567,single nucleotide variant,NM_000363.5(TNNI3):c.5C>T (p.Ala2Val),7137,TNNI3,HGNC:11947,Uncertain significance,1,24-Mar-20,397516359,-,RCV000013240|RCV000036309|RCV000769534,"MONDO:MONDO:0012746,MedGen:C2678474,OMIM:611880,Orphanet:154|MedGen:CN169374|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848",Dilated cardiomyopathy 2A|not specified|Cardiomyopathy,germline,germline,GRCh38,NC_000019.10,19,55157585,55157585,na,na,19q13.42,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"ClinGen:CA022031,UniProtKB:P19429#VAR_043989,LOVD 3:TNNI3_000039,OMIM:191044.0009",3,43397,55157585,G,A,A2V,2,uncertain,uncertain,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,2,A,V,True,987
13931,3056,27459,single nucleotide variant,NM_000363.5(TNNI3):c.616A>C (p.Lys206Gln),7137,TNNI3,HGNC:11947,Pathogenic,1,1-Aug-97,104894725,-,RCV000013232,"MONDO:MONDO:0013369,MedGen:C1860752,OMIM:613690",Familial hypertrophic cardiomyopathy 7,germline,germline,GRCh38,NC_000019.10,19,55151851,55151851,na,na,19q13.42,no assertion criteria provided,1,"ACMG2013,ACMG2016",N,"ClinGen:CA022072,UniProtKB:P19429#VAR_007604,OMIM:191044.0002",1,12420,55151851,T,G,K206Q,0,pathogenic,uncertain,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,206,K,Q,True,987
13932,3057,27460,single nucleotide variant,NM_000363.5(TNNI3):c.244C>T (p.Pro82Ser),7137,TNNI3,HGNC:11947,Benign/Likely benign,0,31-Jan-20,77615401,-,RCV000013233|RCV000036277|RCV000224174|RCV000229361|RCV000238609|RCV000252511|RCV000271700|RCV000277490|RCV000367372|RCV000852767|RCV001133540|RCV001135028|RCV001285379,"MONDO:MONDO:0013369,MedGen:C1860752,OMIM:613690|MedGen:CN169374|MedGen:CN517202|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MedGen:CN230736|MONDO:MONDO:0016340,MedGen:C0340429,OMIM:PS115210,Orphanet:217635|MedGen:CN239247|MedGen:CN239222|MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451;Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0012746,MedGen:C2678474,OMIM:611880,Orphanet:154|MONDO:MONDO:0007270,MedGen:C1861861,OMIM:115210,Orphanet:75249|MedGen:CN235283","Familial hypertrophic cardiomyopathy 7|not specified|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|Cardiovascular phenotype|Familial restrictive cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Amyloidogenic transthyretin amyloidosis;Cardiomyopathy|Dilated cardiomyopathy 2A|Familial restrictive cardiomyopathy 1|none provided",germline;unknown,germline,GRCh38,NC_000019.10,19,55156239,55156239,na,na,19q13.42,"criteria provided, multiple submitters, no conflicts",16,"ACMG2013,ACMG2016",N,"ClinGen:CA021411,UniProtKB:P19429#VAR_016078,OMIM:191044.0003",3,12421,55156239,G,A,P82S,2,benign,benign,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,82,P,S,True,987
13933,3058,27461,single nucleotide variant,NM_000363.5(TNNI3):c.586G>A (p.Asp196Asn),7137,TNNI3,HGNC:11947,Pathogenic/Likely pathogenic,1,6-Oct-20,104894727,-,RCV000013234|RCV000148897|RCV000159246|RCV000461416|RCV000777480,"MONDO:MONDO:0013369,MedGen:C1860752,OMIM:613690|MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|MedGen:CN517202|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848",Familial hypertrophic cardiomyopathy 7|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy,germline,germline,GRCh38,NC_000019.10,19,55151881,55151881,na,na,19q13.42,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,"ClinGen:CA022006,UniProtKB:P19429#VAR_016085,OMIM:191044.0004",3,12422,55151881,C,T,D196N,2,pathogenic,pathogenic,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,196,D,N,True,987
13934,3059,27463,single nucleotide variant,NM_000363.5(TNNI3):c.575G>A (p.Arg192His),7137,TNNI3,HGNC:11947,Pathogenic,1,2-May-19,104894729,-,RCV000013237|RCV000154212|RCV000157534|RCV000159242|RCV000619328|RCV000629012|RCV000852483,"MONDO:MONDO:0007270,MedGen:C1861861,OMIM:115210,Orphanet:75249|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569;Human Phenotype Ontology:HP:0001723,MONDO:MONDO:0005201,MeSH:D002313,MedGen:C0007196,Orphanet:217632|MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|MedGen:CN517202|MedGen:CN230736|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|Human Phenotype Ontology:HP:0001723,MONDO:MONDO:0005201,MeSH:D002313,MedGen:C0007196,Orphanet:217632",Familial restrictive cardiomyopathy 1|Hypertrophic cardiomyopathy;Restrictive cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Restrictive cardiomyopathy,germline,germline,GRCh38,NC_000019.10,19,55151892,55151892,na,na,19q13.42,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,"ClinGen:CA021957,UniProtKB:P19429#VAR_016084,OMIM:191044.0006",3,12424,55151892,C,T,R192H,2,pathogenic,pathogenic,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,192,R,H,True,987
13935,3060,27464,single nucleotide variant,NM_000363.5(TNNI3):c.532A>G (p.Lys178Glu),7137,TNNI3,HGNC:11947,Pathogenic,1,18-Mar-20,104894730,-,RCV000013238|RCV001331172,"MONDO:MONDO:0007270,MedGen:C1861861,OMIM:115210,Orphanet:75249|MONDO:MONDO:0013369,MedGen:C1860752,OMIM:613690",Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7,germline;unknown,germline,GRCh38,NC_000019.10,19,55154047,55154047,na,na,19q13.42,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,"ClinGen:CA021835,UniProtKB:P19429#VAR_016082,OMIM:191044.0007",3,12425,55154047,T,C,K178E,1,pathogenic,pathogenic,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,178,K,E,True,987
13936,11292,176074,single nucleotide variant,NM_000363.5(TNNI3):c.497C>T (p.Ser166Phe),7137,TNNI3,HGNC:11947,Pathogenic/Likely pathogenic,1,11-Sep-19,727504242,-,RCV000159230|RCV000628993|RCV000709766,"MedGen:CN517202|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|MONDO:MONDO:0013369,MedGen:C1860752,OMIM:613690",not provided|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 7,germline,germline,GRCh38,NC_000019.10,19,55154082,55154082,na,na,19q13.42,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"ClinGen:CA021763,UniProtKB:P19429#VAR_029454",2,177630,55154082,G,A,S166F,2,pathogenic,pathogenic,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,166,S,F,True,987
13937,3055,27458,single nucleotide variant,NM_000363.5(TNNI3):c.433C>G (p.Arg145Gly),7137,TNNI3,HGNC:11947,Pathogenic,1,31-Jan-19,104894724,-,RCV000013231|RCV000251781|RCV000441050|RCV000557688,"MONDO:MONDO:0013369,MedGen:C1860752,OMIM:613690|MedGen:CN230736|MedGen:CN517202|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569",Familial hypertrophic cardiomyopathy 7|Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy,germline,germline,GRCh38,NC_000019.10,19,55154146,55154146,na,na,19q13.42,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"ClinGen:CA021660,UniProtKB:P19429#VAR_007603,OMIM:191044.0001",3,12419,55154146,G,C,R145G,2,pathogenic,pathogenic,P19429,P19429,reviewed,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",TNNI3 TNNC1,Homo sapiens (Human),210.0,MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRCQPLELAGLGFAELQDLCRQLHARVDKVDEERYDIEAKVTKNITEIADLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGMEGRKKKFES,PF00992;PF11636;,1J1D;1J1E;1LXF;1MXL;1OZS;2KGB;2KRD;2L1R;2MZP;2N7L;4Y99;5VLN;5W88;5WCL;6KN7;6KN8;6MV3;7JGI;7SC2;7SC3;,145,R,G,True,987
13938,12003,200399,single nucleotide variant,NM_015895.5(GMNN):c.50A>G (p.Lys17Arg),51053,GMNN,HGNC:17493,Likely pathogenic,1,17-Jun-15,864309488,-,RCV000202432|RCV000208587,"MONDO:MONDO:0016817,MedGen:C1868684,OMIM:PS224690,Orphanet:2554|MONDO:MONDO:0014794,MedGen:C4225188,OMIM:616835,Orphanet:2554",Meier-Gorlin syndrome|Meier-gorlin syndrome 6,de novo;germline,germline,GRCh38,NC_000006.12,6,24777296,24777296,na,na,6p22.3,"criteria provided, single submitter",2,-,N,"OMIM:602842.0003,ClinGen:CA250416,UniProtKB:O75496#VAR_076172",3,204001,24777296,A,G,K17R,1,pathogenic,pathogenic,O75496,O75496,reviewed,GEMI_HUMAN,Geminin,GMNN,Homo sapiens (Human),209.0,MNPSMKQKQEEIKENIKNSSVPRRTLKMIQPSASGSLVGRENELSAGLSKRKHRNDHLTSTTSSPGVIVPESSENKNLGGVTQESFDLMIKENPSSQYWKEVAEKRRKALYEALKENEKLHKEIEQKDNEIARLKKENKELAEVAEHVQYMAELIERLNGEPLDNFESLDNQEFDSEEETVEDSLVEDSEIGTCAEGTVSSSTDAKPCI,PF07412;,1T6F;1UII;2LP0;2WVR;4BRY;7KLZ;,17,K,R,True,988
13939,6497,48402,single nucleotide variant,NM_003946.6(NOL3):c.61G>C (p.Glu21Gln),8996,NOL3,HGNC:7869,Pathogenic,1,1-Aug-12,397514600,-,RCV000033024,"MONDO:MONDO:0100093,MedGen:C3539916,OMIM:614937","Myoclonus, familial 1",germline,germline,GRCh38,NC_000016.10,16,67174230,67174230,na,na,16q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA130568,UniProtKB:O60936#VAR_069731,OMIM:605235.0001",1,39803,67174230,G,C,E21Q,0,pathogenic,uncertain,O60936,O60936,reviewed,NOL3_HUMAN,"Nucleolar protein 3 (Apoptosis repressor with CARD) (Muscle-enriched cytoplasmic protein, Myp) (Nucleolar protein of 30 kDa, Nop30)",NOL3 ARC NOP,Homo sapiens (Human),208.0,MGNAQERPSETIDRERKRLVETLQADSGLLLDALLARGVLTGPEYEALDALPDAERRVRRLLLLVQGKGEAACQELLRCAQRTAGAPDPAWDWQHVGPGYRDRSYDPPCPGHWTPEAPGSGTTCPGLPRASDPDEAGGPEGSEAVQSGTPEEPEPELEAEASKEAEPEPEPEPELEPEAEAEPEPELEPEPDPEPEPDFEERDESEDS,PF00619;,4UZ0;,21,E,Q,True,989
13940,5940,39223,single nucleotide variant,NM_003824.3(FADD):c.315T>G (p.Cys105Trp),8772,FADD,HGNC:3573,Pathogenic,1,10-Dec-10,387906839,-,RCV000023196,MedGen:C4016797,"Infections, recurrent, associated with encephalopathy, hepatic dysfunction, and cardiovascular malformations",germline,germline,GRCh38,NC_000011.10,11,70206161,70206161,na,na,11q13.3,no assertion criteria provided,1,-,N,"ClinGen:CA129077,UniProtKB:Q13158#VAR_065124,OMIM:602457.0001",1,30267,70206161,T,G,C105W,0,pathogenic,uncertain,Q13158,Q13158,reviewed,FADD_HUMAN,FAS-associated death domain protein (FAS-associating death domain-containing protein) (Growth-inhibiting gene 3 protein) (Mediator of receptor induced toxicity),FADD MORT1 GIG3,Homo sapiens (Human),208.0,MDPFLVLLHSVSSSLSSSELTELKFLCLGRVGKRKLERVQSGLDLFSMLLEQNDLEPGHTELLRELLASLRRHDLLRRVDDFEAGAAAGAAPGEEDLCAAFNVICDNVGKDWRRLARQLKVSDTKIDSIEDRYPRNLTERVRESLRIWKNTEKENATVAHLVGALRSCQMNLVADLVQEVQQARDLQNRSGAMSPMSWNSDASTSEAS,PF00531;PF01335;,1A1W;1A1Z;1E3Y;1E41;2GF5;3EZQ;3OQ9;6ACI;,105,C,W,True,990
13941,3833,29418,single nucleotide variant,NM_000595.4(LTA):c.179C>A (p.Thr60Asn),4049,LTA,HGNC:6709,risk factor,0,1-Sep-04,1041981,-,RCV000015455,"Human Phenotype Ontology:HP:0001658,MONDO:MONDO:0005068,MedGen:C0027051",Myocardial infarction,germline,germline,GRCh38,NC_000006.12,6,31573007,31573007,na,na,6p21.33,no assertion criteria provided,1,-,N,"UniProtKB:P01374#VAR_007511,OMIM:153440.0001,ClinGen:CA123913",1,14379,31573007,C,A,T60N,0,uncertain,uncertain,P01374,P01374,reviewed,TNFB_HUMAN,"Lymphotoxin-alpha, LT-alpha (TNF-beta) (Tumor necrosis factor ligand superfamily member 1)",LTA TNFB TNFSF1,Homo sapiens (Human),205.0,MTPPERLFLPRVCGTTLHLLLLGLLLVLLPGAQGLPGVGLTPSAAQTARQHPKMHLAHSTLKPAAHLIGDPSKQNSLLWRANTDRAFLQDGFSLSNNSLLVPTSGIYFVYSQVVFSGKAYSPKATSSPLYLAHEVQLFSSQYPFHVPLLSSQKMVYPGLQEPWLHSMYHGAAFQLTQGDQLSTHTDGIPHLVLSPSTVFFGAFAL,PF00229;,1TNR;4MXV;4MXW;,60,T,N,True,991
13942,2007,23730,single nucleotide variant,NM_005262.3(GFER):c.581G>A (p.Arg194His),2671,GFER,HGNC:4236,Pathogenic,1,1-Sep-17,121908192,-,RCV000009228|RCV000199876|RCV000624237,"MONDO:MONDO:0013116,MedGen:C2751320,OMIM:613076,Orphanet:330054|MedGen:CN517202|MeSH:D030342,MedGen:C0950123","Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay|not provided|Inborn genetic diseases",germline;unknown,germline,GRCh38,NC_000016.10,16,1985991,1985991,na,na,16p13.3,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA119839,UniProtKB:P55789#VAR_063435,UniProtKB/Swiss-Prot:VAR_063435,OMIM:600924.0001",3,8691,1985991,G,A,R194H,2,pathogenic,pathogenic,P55789,P55789,reviewed,ALR_HUMAN,"FAD-linked sulfhydryl oxidase ALR, EC 1.8.3.2 (Augmenter of liver regeneration, hERV1) (Hepatopoietin)",GFER ALR HERV1 HPO,Homo sapiens (Human),205.0,MAAPGERGRFHGGNLFFLPGGARSEMMDDLATDARGRGAGRRDAAASASTPAQAPTSDSPVAEDASRRRPCRACVDFKTWMRTQQKRDTKFREDCPPDREELGRHSWAVLHTLAAYYPDLPTPEQQQDMAQFIHLFSKFYPCEECAEDLRKRLCRNHPDTRTRACFTQWLCHLHNEVNRKLGKPDFDCSKVDERWRDGWKDGSCD,PF04777;,3MBG;3O55;3TK0;3U2L;3U2M;3U5S;4LDK;,194,R,H,True,992
13943,4537,31121,single nucleotide variant,NM_000581.4(GPX1):c.599C>T (p.Pro200Leu),2876,GPX1,HGNC:4553,Benign,0,1-Jan-99,1050450,-,RCV000017462,-,GLUTATHIONE PEROXIDASE POLYMORPHISM,germline,germline,GRCh38,NC_000003.12,3,49357401,49357401,na,na,3p21.31,no assertion criteria provided,1,-,N,"ClinGen:CA126189,UniProtKB:P07203#VAR_007904,OMIM:138320.0001",1,16082,49357401,G,A,P200L,0,benign,uncertain,P07203,P07203,reviewed,GPX1_HUMAN,"Glutathione peroxidase 1, GPx-1, GSHPx-1, EC 1.11.1.9 (Cellular glutathione peroxidase)",GPX1,Homo sapiens (Human),203.0,MCAARLAAAAAAAQSVYAFSARPLAGGEPVSLGSLRGKVLLIENVASLUGTTVRDYTQMNELQRRLGPRGLVVLGFPCNQFGHQENAKNEEILNSLKYVRPGGGFEPNFMLFEKCEVNGAGAHPLFAFLREALPAPSDDATALMTDPKLITWSPVCRNDVAWNFEKFLVGPDGVPLRRYSRRFQTIDIEPDIEALLSQGPSCA,PF00255;,2F8A;,200,P,L,True,993
13944,6512,48564,single nucleotide variant,NM_001199835.1(SNX10):c.152G>A (p.Arg51Gln),29887,SNX10,HGNC:14974,Pathogenic,1,1-Apr-12,398123011,-,RCV000033149,"MONDO:MONDO:0014040,MedGen:C3554478,OMIM:615085,Orphanet:667","Osteopetrosis, autosomal recessive 8",germline,germline,GRCh38,NC_000007.14,7,26364575,26364575,na,na,7p15.2,no assertion criteria provided,1,-,N,"ClinGen:CA130726,UniProtKB:Q9Y5X0#VAR_069302,OMIM:614780.0001",1,40050,26364575,G,A,R51Q,0,pathogenic,uncertain,Q9Y5X0,Q9Y5X0,reviewed,SNX10_HUMAN,Sorting nexin-10,SNX10,Homo sapiens (Human),201.0,MFPEQQKEEFVSVWVRDPRIQKEDFWHSYIDYEICIHTNSMCFTMKTSCVRRRYREFVWLRQRLQSNALLVQLPELPSKNLFFNMNNRQHVDQRRQGLEDFLRKVLQNALLLSDSSLHLFLQSHLNSEDIEACVSGQTKYSVEEAIHKFALMNRRFPEEDEEGKKENDIDYDSESSSSGLGHSSDDSSSHGCKVNTAPQES,PF00787;,4ON3;4PZG;6KOK;,51,R,Q,True,994
13945,11749,190163,single nucleotide variant,NM_006744.4(RBP4):c.223G>A (p.Ala75Thr),5950,RBP4,HGNC:9922,Likely pathogenic,1,30-Jan-17,794726861,-,RCV000173002|RCV000623312,"MONDO:MONDO:0014635,MedGen:C4225330,OMIM:616428,Orphanet:98938|MeSH:D030342,MedGen:C0950123","Microphthalmia, isolated, with coloboma 10|Inborn genetic diseases",germline,germline,GRCh38,NC_000010.11,10,93600692,93600692,na,na,10q23.33,"criteria provided, single submitter",2,-,N,"ClinGen:CA200225,UniProtKB:P02753#VAR_073857,OMIM:180250.0004",3,192376,93600692,C,T,A75T,1,pathogenic,pathogenic,P02753,P02753,reviewed,RET4_HUMAN,"Retinol-binding protein 4 (Plasma retinol-binding protein, PRBP, RBP) [Cleaved into: Plasma retinol-binding protein(1-182); Plasma retinol-binding protein(1-181); Plasma retinol-binding protein(1-179); Plasma retinol-binding protein(1-176) ]",RBP4 PRO2222,Homo sapiens (Human),201.0,MKWVWALLLLAALGSGRAERDCRVSSFRVKENFDKARFSGTWYAMAKKDPEGLFLQDNIVAEFSVDETGQMSATAKGRVRLLNNWDVCADMVGTFTDTEDPAKFKMKYWGVASFLQKGNDDHWIVDTDYDTYAVQYSCRLLNLDGTCADSYSFVFSRDPNGLPPEAQKIVRQRQEELCLARQYRLIVHNGYCDGRSERNLL,PF00061;,1BRP;1BRQ;1JYD;1JYJ;1QAB;1RBP;1RLB;2WQ9;2WQA;2WR6;3BSZ;3FMZ;4O9S;4PSQ;5NTY;5NU2;5NU6;5NU7;5NU8;5NU9;5NUA;5NUB;6QBA;,75,A,T,True,995
13946,3346,28106,single nucleotide variant,NM_006744.4(RBP4):c.176T>A (p.Ile59Asn),5950,RBP4,HGNC:9922,Uncertain significance,1,11-Jul-19,121918584,-,RCV000013942|RCV001222967,"MONDO:MONDO:0014060,MedGen:C3554593,OMIM:615147,Orphanet:352718|MedGen:CN517202","Retinal dystrophy, iris coloboma, and comedogenic acne syndrome|not provided",germline,germline,GRCh38,NC_000010.11,10,93600739,93600739,na,na,10q23.33,"criteria provided, single submitter",2,-,N,"ClinGen:CA122832,UniProtKB:P02753#VAR_009276,OMIM:180250.0001",3,13067,93600739,A,T,I59N,1,uncertain,uncertain,P02753,P02753,reviewed,RET4_HUMAN,"Retinol-binding protein 4 (Plasma retinol-binding protein, PRBP, RBP) [Cleaved into: Plasma retinol-binding protein(1-182); Plasma retinol-binding protein(1-181); Plasma retinol-binding protein(1-179); Plasma retinol-binding protein(1-176) ]",RBP4 PRO2222,Homo sapiens (Human),201.0,MKWVWALLLLAALGSGRAERDCRVSSFRVKENFDKARFSGTWYAMAKKDPEGLFLQDNIVAEFSVDETGQMSATAKGRVRLLNNWDVCADMVGTFTDTEDPAKFKMKYWGVASFLQKGNDDHWIVDTDYDTYAVQYSCRLLNLDGTCADSYSFVFSRDPNGLPPEAQKIVRQRQEELCLARQYRLIVHNGYCDGRSERNLL,PF00061;,1BRP;1BRQ;1JYD;1JYJ;1QAB;1RBP;1RLB;2WQ9;2WQA;2WR6;3BSZ;3FMZ;4O9S;4PSQ;5NTY;5NU2;5NU6;5NU7;5NU8;5NU9;5NUA;5NUB;6QBA;,59,I,N,True,995
13947,11750,190164,single nucleotide variant,NM_006744.4(RBP4):c.217G>A (p.Ala73Thr),5950,RBP4,HGNC:9922,Pathogenic,1,23-Apr-15,794726862,-,RCV000173003,"MONDO:MONDO:0014635,MedGen:C4225330,OMIM:616428,Orphanet:98938","Microphthalmia, isolated, with coloboma 10",germline,germline,GRCh38,NC_000010.11,10,93600698,93600698,na,na,10q23.33,no assertion criteria provided,1,-,N,"ClinGen:CA200227,UniProtKB:P02753#VAR_073856,OMIM:180250.0005",1,192377,93600698,C,T,A73T,0,pathogenic,uncertain,P02753,P02753,reviewed,RET4_HUMAN,"Retinol-binding protein 4 (Plasma retinol-binding protein, PRBP, RBP) [Cleaved into: Plasma retinol-binding protein(1-182); Plasma retinol-binding protein(1-181); Plasma retinol-binding protein(1-179); Plasma retinol-binding protein(1-176) ]",RBP4 PRO2222,Homo sapiens (Human),201.0,MKWVWALLLLAALGSGRAERDCRVSSFRVKENFDKARFSGTWYAMAKKDPEGLFLQDNIVAEFSVDETGQMSATAKGRVRLLNNWDVCADMVGTFTDTEDPAKFKMKYWGVASFLQKGNDDHWIVDTDYDTYAVQYSCRLLNLDGTCADSYSFVFSRDPNGLPPEAQKIVRQRQEELCLARQYRLIVHNGYCDGRSERNLL,PF00061;,1BRP;1BRQ;1JYD;1JYJ;1QAB;1RBP;1RLB;2WQ9;2WQA;2WR6;3BSZ;3FMZ;4O9S;4PSQ;5NTY;5NU2;5NU6;5NU7;5NU8;5NU9;5NUA;5NUB;6QBA;,73,A,T,True,995
13948,3347,28107,single nucleotide variant,NM_006744.4(RBP4):c.278G>A (p.Gly93Asp),5950,RBP4,HGNC:9922,Pathogenic,1,1-Jan-99,121918585,-,RCV000013943,"MONDO:MONDO:0014060,MedGen:C3554593,OMIM:615147,Orphanet:352718","Retinal dystrophy, iris coloboma, and comedogenic acne syndrome",germline,germline,GRCh38,NC_000010.11,10,93600470,93600470,na,na,10q23.33,no assertion criteria provided,1,-,N,"OMIM:180250.0002,ClinGen:CA122833,UniProtKB:P02753#VAR_009277",1,13068,93600470,C,T,G93D,0,pathogenic,uncertain,P02753,P02753,reviewed,RET4_HUMAN,"Retinol-binding protein 4 (Plasma retinol-binding protein, PRBP, RBP) [Cleaved into: Plasma retinol-binding protein(1-182); Plasma retinol-binding protein(1-181); Plasma retinol-binding protein(1-179); Plasma retinol-binding protein(1-176) ]",RBP4 PRO2222,Homo sapiens (Human),201.0,MKWVWALLLLAALGSGRAERDCRVSSFRVKENFDKARFSGTWYAMAKKDPEGLFLQDNIVAEFSVDETGQMSATAKGRVRLLNNWDVCADMVGTFTDTEDPAKFKMKYWGVASFLQKGNDDHWIVDTDYDTYAVQYSCRLLNLDGTCADSYSFVFSRDPNGLPPEAQKIVRQRQEELCLARQYRLIVHNGYCDGRSERNLL,PF00061;,1BRP;1BRQ;1JYD;1JYJ;1QAB;1RBP;1RLB;2WQ9;2WQA;2WR6;3BSZ;3FMZ;4O9S;4PSQ;5NTY;5NU2;5NU6;5NU7;5NU8;5NU9;5NUA;5NUB;6QBA;,93,G,D,True,995
13949,5961,39317,single nucleotide variant,NM_003805.5(CRADD):c.382G>C (p.Gly128Arg),8738,CRADD,HGNC:2340,Pathogenic,1,1-Jan-12,387906861,-,RCV000023305,"MONDO:MONDO:0013785,MedGen:C3281044,OMIM:614499,Orphanet:88616","Mental retardation, autosomal recessive 34",germline,germline,GRCh38,NC_000012.12,12,93850053,93850053,na,na,12q22,no assertion criteria provided,1,-,N,"ClinGen:CA129155,UniProtKB:P78560#VAR_067536,OMIM:603454.0001",1,30360,93850053,G,C,G128R,0,pathogenic,uncertain,P78560,P78560,reviewed,CRADD_HUMAN,Death domain-containing protein CRADD (Caspase and RIP adapter with death domain) (RIP-associated protein with a death domain),CRADD RAIDD,Homo sapiens (Human),199.0,MEARDKQVLRSLRLELGAEVLVEGLVLQYLYQEGILTENHIQEINAQTTGLRKTMLLLDILPSRGPKAFDTFLDSLQEFPWVREKLKKAREEAMTDLPAGDRLTGIPSHILNSSPSDRQINQLAQRLGPEWEPMVLSLGLSQTDIYRCKANHPHNVQSQVVEAFIRWRQRFGKQATFQSLHNGLRAVEVDPSLLLHMLE,PF00619;PF00531;,2O71;2OF5;3CRD;,128,G,R,True,996
13950,12590,226737,single nucleotide variant,NM_016401.4(HIKESHI):c.160G>C (p.Val54Leu),51501,HIKESHI,HGNC:26938,Pathogenic,1,9-Aug-17,202003795,-,RCV000210461,"MONDO:MONDO:0014813,MedGen:C4225170,OMIM:616881","Leukodystrophy, hypomyelinating, 13",germline,germline,GRCh38,NC_000011.10,11,86306374,86306374,na,na,11q14.2,no assertion criteria provided,1,-,N,"UniProtKB:Q53FT3#VAR_076411,OMIM:614908.0001,ClinGen:CA354143",1,224891,86306374,G,C,V54L,0,pathogenic,uncertain,Q53FT3,Q53FT3,reviewed,HIKES_HUMAN,Protein Hikeshi,HIKESHI C11orf73 HSPC138 HSPC179 HSPC248,Homo sapiens (Human),197.0,MFGCLVAGRLVQTAAQQVAEDKFVFDLPDYESINHVVVFMLGTIPFPEGMGGSVYFSYPDSNGMPVWQLLGFVTNGKPSAIFKISGLKSGEGSQHPFGAMNIVRTPSVAQIGISVELLDSMAQQTPVGNAAVSSVDSFTQFTQKMLDNFYNFASSFAVSQAQMTPSPSEMFIPANVVLKWYENFQRRLAQNPLFWKT,PF05603;,3WVZ;3WW0;,54,V,L,True,997
13951,11439,181175,single nucleotide variant,NM_000756.4(CRH):c.89C>G (p.Pro30Arg),1392,CRH,HGNC:2355,Likely benign,1,7-Sep-17,748404250,-,RCV000172993|RCV000192059|RCV000718811,"MedGen:CN517202|MONDO:MONDO:0020300,MedGen:C3696898,Orphanet:98784|Human Phenotype Ontology:HP:0001250,Human Phenotype Ontology:HP:0001275,Human Phenotype Ontology:HP:0001303,Human Phenotype Ontology:HP:0002125,Human Phenotype Ontology:HP:0002182,Human Phenotype Ontology:HP:0002279,Human Phenotype Ontology:HP:0002306,Human Phenotype Ontology:HP:0002348,Human Phenotype Ontology:HP:0002391,Human Phenotype Ontology:HP:0002417,Human Phenotype Ontology:HP:0002430,Human Phenotype Ontology:HP:0002431,Human Phenotype Ontology:HP:0002432,Human Phenotype Ontology:HP:0002434,Human Phenotype Ontology:HP:0002437,Human Phenotype Ontology:HP:0002466,Human Phenotype Ontology:HP:0002479,Human Phenotype Ontology:HP:0002794,Human Phenotype Ontology:HP:0006997,Human Phenotype Ontology:HP:0010520,MedGen:C0036572",not provided|Autosomal dominant nocturnal frontal lobe epilepsy|Seizures,germline,germline,GRCh38,NC_000008.11,8,66177389,66177389,na,na,8q13.1,"criteria provided, single submitter",3,-,N,"ClinGen:CA238539,UniProtKB:P06850#VAR_075504,OMIM:122560.0001",3,183027,66177389,G,C,P30R,1,benign,benign,P06850,P06850,reviewed,CRF_HUMAN,"Corticoliberin (Corticotropin-releasing factor, CRF) (Corticotropin-releasing hormone)",CRH,Homo sapiens (Human),196.0,MRLPLLVSAGVLLVALLPCPPCRALLSRGPVPGARQAPQHPQPLDFFQPPPQSEQPQQPQARPVLLRMGEEYFLRLGNLNKSPAAPLSPASSLLAGGSGSRPSPEQATANFFRVLLQQLLLPRRSLDSPAALAERGARNALGGHQEAPERERRSEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEIIGK,PF00473;,1GO9;1GOE;3EHT;3EHU;6P9X;,30,P,R,True,998
13952,11316,177189,single nucleotide variant,NM_183059.2(RD3):c.139C>T (p.Arg47Cys),343035,RD3,HGNC:19689,Conflicting interpretations of pathogenicity,0,31-Dec-19,34049451,-,RCV000153816|RCV000877817,"MedGen:CN169374|MONDO:MONDO:0012525,MedGen:C1857743,OMIM:610612,Orphanet:65",not specified|Leber congenital amaurosis 12,germline,germline,GRCh38,NC_000001.11,1,211481277,211481277,na,na,1q32.3,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA180366,UniProtKB:Q7Z3Z2#VAR_023050",2,167572,211481277,G,A,R47C,1,uncertain,uncertain,Q7Z3Z2,Q7Z3Z2,reviewed,RD3_HUMAN,Protein RD3 (Retinal degeneration protein 3),RD3 C1orf36,Homo sapiens (Human),195.0,MSLISWLRWNEAPSRLSTRSPAEMVLETLMMELTGQMREAERQQRERSNAVRKVCTGVDYSWLASTPRSTYDLSPIERLQLEDVCVKIHPSYCGPAILRFRQLLAEQEPEVQEVSQLFRSVLQEVLERMKQEEEAHKLTRQWSLRPRGSLATFKTRARISPFASDIRTISEDVERDTPPPLRSWSMPEFRAPKAD,PF14473;,6DRF;,47,R,C,True,999
13953,11897,195203,single nucleotide variant,NM_000101.4(CYBA):c.521T>C (p.Val174Ala),1535,CYBA,HGNC:2577,Benign,0,15-Apr-16,1049254,-,RCV000179254,MedGen:CN169374,not specified,germline,germline,GRCh38,NC_000016.10,16,88643420,88643420,na,na,16q24.2,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA203198,UniProtKB:P13498#VAR_054801",2,198042,88643420,A,G,V174A,2,benign,benign,P13498,P13498,reviewed,CY24A_HUMAN,"Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox, p22phox)",CYBA,Homo sapiens (Human),195.0,MGQIEWAMWANEQALASGLILITGGIVATAGRFTQWYFGAYSIVAGVFVCLLEYPRGKRKKGSTMERWGQKYMTAVVKLFGPFTRNYYVRAVLHLLLSVPAGFLLATILGTACLAIASGIYLLAAVRGEQWTPIEPKPRERPQIGGTIKQPPSNPPPRPPAEARKKPSEEEAAVAAGGPPGGPQVNPIPVTDEVV,PF05038;,1WLP;,174,V,A,True,1000
13954,587,17306,single nucleotide variant,NM_000101.4(CYBA):c.373G>A (p.Ala125Thr),1535,CYBA,HGNC:2577,Pathogenic,1,1-Jun-08,119103269,-,RCV000002355,"MONDO:MONDO:0009308,MedGen:C1856255,OMIM:233690,Orphanet:379","Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",germline,germline,GRCh38,NC_000016.10,16,88643568,88643568,na,na,16q24.2,no assertion criteria provided,1,-,N,"ClinGen:CA115464,UniProtKB:P13498#VAR_060581,OMIM:608508.0012",1,2267,88643568,C,T,A125T,0,pathogenic,uncertain,P13498,P13498,reviewed,CY24A_HUMAN,"Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox, p22phox)",CYBA,Homo sapiens (Human),195.0,MGQIEWAMWANEQALASGLILITGGIVATAGRFTQWYFGAYSIVAGVFVCLLEYPRGKRKKGSTMERWGQKYMTAVVKLFGPFTRNYYVRAVLHLLLSVPAGFLLATILGTACLAIASGIYLLAAVRGEQWTPIEPKPRERPQIGGTIKQPPSNPPPRPPAEARKKPSEEEAAVAAGGPPGGPQVNPIPVTDEVV,PF05038;,1WLP;,125,A,T,True,1000
13955,8351,79101,single nucleotide variant,NM_000101.4(CYBA):c.158A>T (p.Glu53Val),1535,CYBA,HGNC:2577,not provided,0,-,179363893,-,RCV000059043,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000016.10,16,88647146,88647146,na,na,16q24.2,no assertion provided,1,-,N,"ClinGen:CA219174,UniProtKB:P13498#VAR_060578,UniProtKB/Swiss-Prot:VAR_060578",1,68210,88647146,T,A,E53V,0,uncertain,uncertain,P13498,P13498,reviewed,CY24A_HUMAN,"Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox, p22phox)",CYBA,Homo sapiens (Human),195.0,MGQIEWAMWANEQALASGLILITGGIVATAGRFTQWYFGAYSIVAGVFVCLLEYPRGKRKKGSTMERWGQKYMTAVVKLFGPFTRNYYVRAVLHLLLSVPAGFLLATILGTACLAIASGIYLLAAVRGEQWTPIEPKPRERPQIGGTIKQPPSNPPPRPPAEARKKPSEEEAAVAAGGPPGGPQVNPIPVTDEVV,PF05038;,1WLP;,53,E,V,True,1000
13956,581,17297,single nucleotide variant,NM_000101.4(CYBA):c.269G>A (p.Arg90Gln),1535,CYBA,HGNC:2577,Pathogenic,1,1-Nov-92,104894513,-,RCV000002346,"MONDO:MONDO:0009308,MedGen:C1856255,OMIM:233690,Orphanet:379","Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",germline,germline,GRCh38,NC_000016.10,16,88646773,88646773,na,na,16q24.2,no assertion criteria provided,1,-,N,"UniProtKB:P13498#VAR_005123,OMIM:608508.0003,ClinGen:CA115448",1,2258,88646773,C,T,R90Q,0,pathogenic,uncertain,P13498,P13498,reviewed,CY24A_HUMAN,"Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox, p22phox)",CYBA,Homo sapiens (Human),195.0,MGQIEWAMWANEQALASGLILITGGIVATAGRFTQWYFGAYSIVAGVFVCLLEYPRGKRKKGSTMERWGQKYMTAVVKLFGPFTRNYYVRAVLHLLLSVPAGFLLATILGTACLAIASGIYLLAAVRGEQWTPIEPKPRERPQIGGTIKQPPSNPPPRPPAEARKKPSEEEAAVAAGGPPGGPQVNPIPVTDEVV,PF05038;,1WLP;,90,R,Q,True,1000
13957,585,17302,single nucleotide variant,NM_000101.4(CYBA):c.214T>C (p.Tyr72His),1535,CYBA,HGNC:2577,Benign,1,28-May-19,4673,-,RCV000002351|RCV000249071|RCV000736011|RCV000989646,"|MedGen:CN169374||MONDO:MONDO:0009308,MedGen:C1856255,OMIM:233690,Orphanet:379","CYBA POLYMORPHISM|not specified|Very early onset inflammatory bowel disease|Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",germline;inherited;unknown,germline,GRCh38,NC_000016.10,16,88646828,88646828,na,na,16q24.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"UniProtKB:P13498#VAR_005122,OMIM:608508.0008,ClinGen:CA115456",3,2263,88646828,A,G,Y72H,2,benign,benign,P13498,P13498,reviewed,CY24A_HUMAN,"Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox, p22phox)",CYBA,Homo sapiens (Human),195.0,MGQIEWAMWANEQALASGLILITGGIVATAGRFTQWYFGAYSIVAGVFVCLLEYPRGKRKKGSTMERWGQKYMTAVVKLFGPFTRNYYVRAVLHLLLSVPAGFLLATILGTACLAIASGIYLLAAVRGEQWTPIEPKPRERPQIGGTIKQPPSNPPPRPPAEARKKPSEEEAAVAAGGPPGGPQVNPIPVTDEVV,PF05038;,1WLP;,72,Y,H,True,1000
13958,8350,79100,single nucleotide variant,NM_000101.4(CYBA):c.155T>C (p.Leu52Pro),1535,CYBA,HGNC:2577,Pathogenic,1,18-May-15,179363890,-,RCV000059042,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000016.10,16,88647149,88647149,na,na,16q24.2,"criteria provided, single submitter",2,-,N,"UniProtKB/Swiss-Prot:VAR_060577,ClinGen:CA219172,UniProtKB:P13498#VAR_060577",3,68209,88647149,A,G,L52P,1,pathogenic,pathogenic,P13498,P13498,reviewed,CY24A_HUMAN,"Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox, p22phox)",CYBA,Homo sapiens (Human),195.0,MGQIEWAMWANEQALASGLILITGGIVATAGRFTQWYFGAYSIVAGVFVCLLEYPRGKRKKGSTMERWGQKYMTAVVKLFGPFTRNYYVRAVLHLLLSVPAGFLLATILGTACLAIASGIYLLAAVRGEQWTPIEPKPRERPQIGGTIKQPPSNPPPRPPAEARKKPSEEEAAVAAGGPPGGPQVNPIPVTDEVV,PF05038;,1WLP;,52,L,P,True,1000
13959,582,17298,single nucleotide variant,NM_000101.4(CYBA):c.354C>A (p.Ser118Arg),1535,CYBA,HGNC:2577,Pathogenic,1,1-Nov-90,104894514,-,RCV000002347|RCV000059045,"MONDO:MONDO:0009308,MedGen:C1856255,OMIM:233690,Orphanet:379|MedGen:CN517202","Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|not provided",germline,germline,GRCh38,NC_000016.10,16,88646131,88646131,na,na,16q24.2,no assertion criteria provided,2,-,N,"ClinGen:CA115450,UniProtKB:P13498#VAR_005125,UniProtKB/Swiss-Prot:VAR_005125,OMIM:608508.0004",1,2259,88646131,G,T,S118R,0,pathogenic,uncertain,P13498,P13498,reviewed,CY24A_HUMAN,"Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox, p22phox)",CYBA,Homo sapiens (Human),195.0,MGQIEWAMWANEQALASGLILITGGIVATAGRFTQWYFGAYSIVAGVFVCLLEYPRGKRKKGSTMERWGQKYMTAVVKLFGPFTRNYYVRAVLHLLLSVPAGFLLATILGTACLAIASGIYLLAAVRGEQWTPIEPKPRERPQIGGTIKQPPSNPPPRPPAEARKKPSEEEAAVAAGGPPGGPQVNPIPVTDEVV,PF05038;,1WLP;,118,S,R,True,1000
13960,8353,79103,single nucleotide variant,NM_000101.4(CYBA):c.371C>T (p.Ala124Val),1535,CYBA,HGNC:2577,not provided,0,-,179363894,-,RCV000059046,MedGen:CN517202,not provided,not provided,not provided,GRCh38,NC_000016.10,16,88643570,88643570,na,na,16q24.2,no assertion provided,1,-,N,"ClinGen:CA219178,UniProtKB:P13498#VAR_060580,UniProtKB/Swiss-Prot:VAR_060580",1,68212,88643570,G,A,A124V,0,uncertain,uncertain,P13498,P13498,reviewed,CY24A_HUMAN,"Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox, p22phox)",CYBA,Homo sapiens (Human),195.0,MGQIEWAMWANEQALASGLILITGGIVATAGRFTQWYFGAYSIVAGVFVCLLEYPRGKRKKGSTMERWGQKYMTAVVKLFGPFTRNYYVRAVLHLLLSVPAGFLLATILGTACLAIASGIYLLAAVRGEQWTPIEPKPRERPQIGGTIKQPPSNPPPRPPAEARKKPSEEEAAVAAGGPPGGPQVNPIPVTDEVV,PF05038;,1WLP;,124,A,V,True,1000
13961,583,17299,single nucleotide variant,NM_000101.4(CYBA):c.467C>A (p.Pro156Gln),1535,CYBA,HGNC:2577,Pathogenic,1,11-Feb-16,104894515,-,RCV000002348|RCV000208600,"MONDO:MONDO:0009308,MedGen:C1856255,OMIM:233690,Orphanet:379|MONDO:MONDO:0018305,MedGen:C0018203,OMIM:PS306400,Orphanet:379","Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease",germline,germline,GRCh38,NC_000016.10,16,88643474,88643474,na,na,16q24.2,no assertion criteria provided,2,-,N,"ClinGen:CA115452,UniProtKB:P13498#VAR_005126,OMIM:608508.0005",1,2260,88643474,G,T,P156Q,0,pathogenic,uncertain,P13498,P13498,reviewed,CY24A_HUMAN,"Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox, p22phox)",CYBA,Homo sapiens (Human),195.0,MGQIEWAMWANEQALASGLILITGGIVATAGRFTQWYFGAYSIVAGVFVCLLEYPRGKRKKGSTMERWGQKYMTAVVKLFGPFTRNYYVRAVLHLLLSVPAGFLLATILGTACLAIASGIYLLAAVRGEQWTPIEPKPRERPQIGGTIKQPPSNPPPRPPAEARKKPSEEEAAVAAGGPPGGPQVNPIPVTDEVV,PF05038;,1WLP;,156,P,Q,True,1000
13962,584,17300,single nucleotide variant,NM_000101.4(CYBA):c.281A>G (p.His94Arg),1535,CYBA,HGNC:2577,Pathogenic,1,1-Nov-92,104894510,-,RCV000002349,"MONDO:MONDO:0009308,MedGen:C1856255,OMIM:233690,Orphanet:379","Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",germline,germline,GRCh38,NC_000016.10,16,88646761,88646761,na,na,16q24.2,no assertion criteria provided,1,-,N,"ClinGen:CA115454,UniProtKB:P13498#VAR_005124,OMIM:608508.0006",1,2261,88646761,T,C,H94R,0,pathogenic,uncertain,P13498,P13498,reviewed,CY24A_HUMAN,"Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox, p22phox)",CYBA,Homo sapiens (Human),195.0,MGQIEWAMWANEQALASGLILITGGIVATAGRFTQWYFGAYSIVAGVFVCLLEYPRGKRKKGSTMERWGQKYMTAVVKLFGPFTRNYYVRAVLHLLLSVPAGFLLATILGTACLAIASGIYLLAAVRGEQWTPIEPKPRERPQIGGTIKQPPSNPPPRPPAEARKKPSEEEAAVAAGGPPGGPQVNPIPVTDEVV,PF05038;,1WLP;,94,H,R,True,1000
13963,8352,79102,single nucleotide variant,NM_000101.4(CYBA):c.268C>T (p.Arg90Trp),1535,CYBA,HGNC:2577,Pathogenic,1,28-Oct-19,179363892,-,RCV000059044|RCV000687649|RCV001271457,"MedGen:CN517202|MONDO:MONDO:0009308,MedGen:C1856255,OMIM:233690,Orphanet:379|MONDO:MONDO:0018305,MedGen:C0018203,OMIM:PS306400,Orphanet:379","not provided|Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease",germline,germline,GRCh38,NC_000016.10,16,88646774,88646774,na,na,16q24.2,"criteria provided, single submitter",3,-,N,"ClinGen:CA219176,UniProtKB:P13498#VAR_060579,UniProtKB/Swiss-Prot:VAR_060579",3,68211,88646774,G,A,R90W,1,pathogenic,pathogenic,P13498,P13498,reviewed,CY24A_HUMAN,"Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox, p22phox)",CYBA,Homo sapiens (Human),195.0,MGQIEWAMWANEQALASGLILITGGIVATAGRFTQWYFGAYSIVAGVFVCLLEYPRGKRKKGSTMERWGQKYMTAVVKLFGPFTRNYYVRAVLHLLLSVPAGFLLATILGTACLAIASGIYLLAAVRGEQWTPIEPKPRERPQIGGTIKQPPSNPPPRPPAEARKKPSEEEAAVAAGGPPGGPQVNPIPVTDEVV,PF05038;,1WLP;,90,R,W,True,1000
13964,8354,79104,single nucleotide variant,NM_000101.4(CYBA):c.74G>T (p.Gly25Val),1535,CYBA,HGNC:2577,not provided,0,-,179363891,-,RCV000059047,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000016.10,16,88648099,88648099,na,na,16q24.2,no assertion provided,1,-,N,"UniProtKB:P13498#VAR_060576,UniProtKB/Swiss-Prot:VAR_060576,ClinGen:CA219180",1,68213,88648099,C,A,G25V,0,uncertain,uncertain,P13498,P13498,reviewed,CY24A_HUMAN,"Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox, p22phox)",CYBA,Homo sapiens (Human),195.0,MGQIEWAMWANEQALASGLILITGGIVATAGRFTQWYFGAYSIVAGVFVCLLEYPRGKRKKGSTMERWGQKYMTAVVKLFGPFTRNYYVRAVLHLLLSVPAGFLLATILGTACLAIASGIYLLAAVRGEQWTPIEPKPRERPQIGGTIKQPPSNPPPRPPAEARKKPSEEEAAVAAGGPPGGPQVNPIPVTDEVV,PF05038;,1WLP;,25,G,V,True,1000
13965,586,17304,single nucleotide variant,NM_000101.4(CYBA):c.70G>A (p.Gly24Arg),1535,CYBA,HGNC:2577,Pathogenic,1,5-Dec-19,28941476,-,RCV000002353|RCV001093039|RCV001274006,"MONDO:MONDO:0009308,MedGen:C1856255,OMIM:233690,Orphanet:379|MedGen:CN517202|MONDO:MONDO:0018305,MedGen:C0018203,OMIM:PS306400,Orphanet:379","Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|not provided|Chronic granulomatous disease",germline,germline,GRCh38,NC_000016.10,16,88648103,88648103,na,na,16q24.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA115462,UniProtKB:P13498#VAR_012755,OMIM:608508.0010",3,2265,88648103,C,T,G24R,2,pathogenic,pathogenic,P13498,P13498,reviewed,CY24A_HUMAN,"Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox, p22phox)",CYBA,Homo sapiens (Human),195.0,MGQIEWAMWANEQALASGLILITGGIVATAGRFTQWYFGAYSIVAGVFVCLLEYPRGKRKKGSTMERWGQKYMTAVVKLFGPFTRNYYVRAVLHLLLSVPAGFLLATILGTACLAIASGIYLLAAVRGEQWTPIEPKPRERPQIGGTIKQPPSNPPPRPPAEARKKPSEEEAAVAAGGPPGGPQVNPIPVTDEVV,PF05038;,1WLP;,24,G,R,True,1000
13966,3990,29785,single nucleotide variant,NM_033453.4(ITPA):c.94C>A (p.Pro32Thr),3704,ITPA,HGNC:6176,drug response,0,5-Aug-16,1127354,-,RCV000015867|RCV000211370|RCV000223768,"MONDO:MONDO:0013461,MedGen:C0342800,OMIM:613850|MedGen:CN236453|MedGen:CN236452","Inosine triphosphatase deficiency|peginterferon alfa-2b and ribavirin response - Toxicity/ADR|interferon alfa-2b, recombinant and ribavirin response - Dosage, Toxicity/ADR",germline,germline,GRCh38,NC_000020.11,20,3213196,3213196,na,na,20p13,reviewed by expert panel,2,-,N,"PharmGKB Clinical Annotation:1446905691,PharmGKB Clinical Annotation:981237907,ClinGen:CA124292,UniProtKB:Q9BY32#VAR_015576,OMIM:147520.0001",1,14746,3213196,C,A,P32T,3,uncertain,uncertain,Q9BY32,Q9BY32,reviewed,ITPA_HUMAN,"Inosine triphosphate pyrophosphatase, ITPase, Inosine triphosphatase, EC 3.6.1.9 (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase, NTPase) (Putative oncogene protein hlc14-06-p)",ITPA C20orf37 My049 OK/SW-cl.9,Homo sapiens (Human),194.0,MAASLVGKKIVFVTGNAKKLEEVVQILGDKFPCTLVAQKIDLPEYQGEPDEISIQKCQEAVRQVQGPVLVEDTCLCFNALGGLPGPYIKWFLEKLKPEGLHQLLAGFEDKSAYALCTFALSTGDPSQPVRLFRGRTSGRIVAPRGCQDFGWDPCFQPDGYEQTYAEMPKAEKNAVSHRFRALLELQEYFGSLAA,PF01725;,2CAR;2I5D;2J4E;4F95;,32,P,T,True,1001
13967,2033,23815,single nucleotide variant,NM_003476.5(CSRP3):c.10T>C (p.Trp4Arg),8048,CSRP3,HGNC:2472,Conflicting interpretations of pathogenicity,0,31-Dec-19,45550635,-,RCV000009321|RCV000150371|RCV000172743|RCV000201441|RCV000251021|RCV000487821|RCV000770316|RCV000999619|RCV001084134|RCV001286136,"MONDO:MONDO:0011840,MedGen:C1843808,OMIM:607482,Orphanet:154|MedGen:CN169374|EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MedGen:C0007193,Orphanet:217604|MONDO:MONDO:0012804,MedGen:C2677491,OMIM:612124|MedGen:CN230736|MedGen:CN517202|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569;MedGen:C0520806|MONDO:MONDO:0012804,MedGen:C2677491,OMIM:612124;MONDO:MONDO:0011840,MedGen:C1843808,OMIM:607482,Orphanet:154|MedGen:CN235283",Dilated cardiomyopathy 1M|not specified|Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 12|Cardiovascular phenotype|not provided|Cardiomyopathy|Hypertrophic cardiomyopathy;Sudden unexplained death|Familial hypertrophic cardiomyopathy 12;Dilated cardiomyopathy 1M|none provided,germline;unknown,germline,GRCh38,NC_000011.10,11,19192439,19192439,na,na,11p15.1,"criteria provided, conflicting interpretations",13,-,N,"ClinGen:CA175609,UniProtKB:P50461#VAR_015401,OMIM:600824.0001",3,8776,19192439,A,G,W4R,1,uncertain,uncertain,P50461,P50461,reviewed,CSRP3_HUMAN,"Cysteine and glycine-rich protein 3 (Cardiac LIM protein) (Cysteine-rich protein 3, CRP3) (LIM domain protein, cardiac) (Muscle LIM protein)",CSRP3 CLP MLP,Homo sapiens (Human),194.0,MPNWGGGAKCGACEKTVYHAEEIQCNGRSFHKTCFHCMACRKALDSTTVAAHESEIYCKVCYGRRYGPKGIGYGQGAGCLSTDTGEHLGLQFQQSPKPARSVTTSNPSKFTAKFGESEKCPRCGKSVYAAEKVMGGGKPWHKTCFRCAICGKSLESTNVTDKDGELYCKVCYAKNFGPTGIGFGGLTQQVEKKE,PF00412;,2O10;2O13;,4,W,R,True,1002
13968,2035,23817,single nucleotide variant,NM_003476.5(CSRP3):c.131T>C (p.Leu44Pro),8048,CSRP3,HGNC:2472,Conflicting interpretations of pathogenicity,1,18-Oct-20,104894205,-,RCV000009323|RCV000037770|RCV000621095|RCV000627796|RCV000768501,"MONDO:MONDO:0012804,MedGen:C2677491,OMIM:612124|MedGen:CN169374|MedGen:CN230736|MONDO:MONDO:0012804,MedGen:C2677491,OMIM:612124;MONDO:MONDO:0011840,MedGen:C1843808,OMIM:607482,Orphanet:154|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569",Familial hypertrophic cardiomyopathy 12|not specified|Cardiovascular phenotype|Familial hypertrophic cardiomyopathy 12;Dilated cardiomyopathy 1M|Hypertrophic cardiomyopathy,germline,germline,GRCh38,NC_000011.10,11,19188286,19188286,na,na,11p15.1,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA119913,UniProtKB:P50461#VAR_045932,OMIM:600824.0003",3,8778,19188286,A,G,L44P,1,uncertain,uncertain,P50461,P50461,reviewed,CSRP3_HUMAN,"Cysteine and glycine-rich protein 3 (Cardiac LIM protein) (Cysteine-rich protein 3, CRP3) (LIM domain protein, cardiac) (Muscle LIM protein)",CSRP3 CLP MLP,Homo sapiens (Human),194.0,MPNWGGGAKCGACEKTVYHAEEIQCNGRSFHKTCFHCMACRKALDSTTVAAHESEIYCKVCYGRRYGPKGIGYGQGAGCLSTDTGEHLGLQFQQSPKPARSVTTSNPSKFTAKFGESEKCPRCGKSVYAAEKVMGGGKPWHKTCFRCAICGKSLESTNVTDKDGELYCKVCYAKNFGPTGIGFGGLTQQVEKKE,PF00412;,2O10;2O13;,44,L,P,True,1002
13969,2034,23816,single nucleotide variant,NM_003476.5(CSRP3):c.172T>G (p.Cys58Gly),8048,CSRP3,HGNC:2472,Pathogenic,1,15-Sep-08,104894204,-,RCV000009322,"MONDO:MONDO:0012804,MedGen:C2677491,OMIM:612124",Familial hypertrophic cardiomyopathy 12,germline,germline,GRCh38,NC_000011.10,11,19188245,19188245,na,na,11p15.1,no assertion criteria provided,1,-,N,"OMIM:600824.0002,ClinGen:CA119911,UniProtKB:P50461#VAR_045934",1,8777,19188245,A,C,C58G,0,pathogenic,uncertain,P50461,P50461,reviewed,CSRP3_HUMAN,"Cysteine and glycine-rich protein 3 (Cardiac LIM protein) (Cysteine-rich protein 3, CRP3) (LIM domain protein, cardiac) (Muscle LIM protein)",CSRP3 CLP MLP,Homo sapiens (Human),194.0,MPNWGGGAKCGACEKTVYHAEEIQCNGRSFHKTCFHCMACRKALDSTTVAAHESEIYCKVCYGRRYGPKGIGYGQGAGCLSTDTGEHLGLQFQQSPKPARSVTTSNPSKFTAKFGESEKCPRCGKSVYAAEKVMGGGKPWHKTCFRCAICGKSLESTNVTDKDGELYCKVCYAKNFGPTGIGFGGLTQQVEKKE,PF00412;,2O10;2O13;,58,C,G,True,1002
13970,104,15429,single nucleotide variant,NM_000405.5(GM2A):c.412T>C (p.Cys138Arg),2760,GM2A,HGNC:4367,Pathogenic,1,1-May-92,137852797,-,RCV000000421,"MONDO:MONDO:0010099,MedGen:C0268275,OMIM:272750,Orphanet:309246","Tay-Sachs disease, variant AB",germline,germline,GRCh38,NC_000005.10,5,151266899,151266899,na,na,5q33.1,no assertion criteria provided,1,-,N,"ClinGen:CA114233,UniProtKB:P17900#VAR_006947,OMIM:613109.0001",1,390,151266899,T,C,C138R,0,pathogenic,uncertain,P17900,P17900,reviewed,SAP3_HUMAN,"Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3, SAP-3) [Cleaved into: Ganglioside GM2 activator isoform short ]",GM2A,Homo sapiens (Human),193.0,MQSLMQAPLLIALGLLLAAPAQAHLKKPSQLSSFSWDNCDEGKDPAVIRSLTLEPDPIIVPGNVTLSVMGSTSVPLSSPLKVDLVLEKEVAGLWIKIPCTDYIGSCTFEHFCDVLDMLIPTGEPCPEPLRTYGLPCHCPFKEGTYSLPKSEFVVPDLELPSWLTTGNYRIESVLSSSGKRLGCIKIAASLKGI,PF02221;,1G13;1PU5;1PUB;1TJJ;2AF9;2AG2;2AG4;2AG9;,138,C,R,True,1003
13971,105,15430,single nucleotide variant,NM_000405.5(GM2A):c.506G>C (p.Arg169Pro),2760,GM2A,HGNC:4367,Pathogenic,1,1-Nov-93,104893892,-,RCV000000422,"MONDO:MONDO:0010099,MedGen:C0268275,OMIM:272750,Orphanet:309246","Tay-Sachs disease, variant AB",germline,germline,GRCh38,NC_000005.10,5,151267375,151267375,na,na,5q33.1,no assertion criteria provided,1,-,N,"ClinGen:CA114235,UniProtKB:P17900#VAR_011698,OMIM:613109.0002",1,391,151267375,G,C,R169P,0,pathogenic,uncertain,P17900,P17900,reviewed,SAP3_HUMAN,"Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3, SAP-3) [Cleaved into: Ganglioside GM2 activator isoform short ]",GM2A,Homo sapiens (Human),193.0,MQSLMQAPLLIALGLLLAAPAQAHLKKPSQLSSFSWDNCDEGKDPAVIRSLTLEPDPIIVPGNVTLSVMGSTSVPLSSPLKVDLVLEKEVAGLWIKIPCTDYIGSCTFEHFCDVLDMLIPTGEPCPEPLRTYGLPCHCPFKEGTYSLPKSEFVVPDLELPSWLTTGNYRIESVLSSSGKRLGCIKIAASLKGI,PF02221;,1G13;1PU5;1PUB;1TJJ;2AF9;2AG2;2AG4;2AG9;,169,R,P,True,1003
13972,13190,251827,single nucleotide variant,NM_000405.5(GM2A):c.55G>A (p.Ala19Thr),2760,GM2A,HGNC:4367,Benign,0,13-Jan-18,1048719,-,RCV000250898|RCV000384587|RCV000675620,"MedGen:CN169374|MONDO:MONDO:0010099,MedGen:C0268275,OMIM:272750,Orphanet:309246|MedGen:CN517202","not specified|Tay-Sachs disease, variant AB|not provided",germline;unknown,germline,GRCh38,NC_000005.10,5,151253271,151253271,na,na,5q33.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA3517840,UniProtKB:P17900#VAR_013830",2,256030,151253271,G,A,A19T,2,benign,benign,P17900,P17900,reviewed,SAP3_HUMAN,"Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3, SAP-3) [Cleaved into: Ganglioside GM2 activator isoform short ]",GM2A,Homo sapiens (Human),193.0,MQSLMQAPLLIALGLLLAAPAQAHLKKPSQLSSFSWDNCDEGKDPAVIRSLTLEPDPIIVPGNVTLSVMGSTSVPLSSPLKVDLVLEKEVAGLWIKIPCTDYIGSCTFEHFCDVLDMLIPTGEPCPEPLRTYGLPCHCPFKEGTYSLPKSEFVVPDLELPSWLTTGNYRIESVLSSSGKRLGCIKIAASLKGI,PF02221;,1G13;1PU5;1PUB;1TJJ;2AF9;2AG2;2AG4;2AG9;,19,A,T,True,1003
13973,11319,177227,single nucleotide variant,NM_000405.5(GM2A):c.205A>G (p.Met69Val),2760,GM2A,HGNC:4367,Benign,0,13-Jan-18,153478,-,RCV000153333|RCV000286625|RCV000675622,"MedGen:CN169374|MONDO:MONDO:0010099,MedGen:C0268275,OMIM:272750,Orphanet:309246|MedGen:CN517202","not specified|Tay-Sachs disease, variant AB|not provided",germline;unknown,germline,GRCh38,NC_000005.10,5,151259878,151259878,na,na,5q33.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA180087,UniProtKB:P17900#VAR_036893",2,167151,151259878,A,G,M69V,2,benign,benign,P17900,P17900,reviewed,SAP3_HUMAN,"Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3, SAP-3) [Cleaved into: Ganglioside GM2 activator isoform short ]",GM2A,Homo sapiens (Human),193.0,MQSLMQAPLLIALGLLLAAPAQAHLKKPSQLSSFSWDNCDEGKDPAVIRSLTLEPDPIIVPGNVTLSVMGSTSVPLSSPLKVDLVLEKEVAGLWIKIPCTDYIGSCTFEHFCDVLDMLIPTGEPCPEPLRTYGLPCHCPFKEGTYSLPKSEFVVPDLELPSWLTTGNYRIESVLSSSGKRLGCIKIAASLKGI,PF02221;,1G13;1PU5;1PUB;1TJJ;2AF9;2AG2;2AG4;2AG9;,69,M,V,True,1003
13974,11304,176964,single nucleotide variant,NM_000405.5(GM2A):c.175A>G (p.Ile59Val),2760,GM2A,HGNC:4367,Benign,0,12-Jan-18,153477,-,RCV000153332|RCV000376352|RCV000675621,"MedGen:CN169374|MONDO:MONDO:0010099,MedGen:C0268275,OMIM:272750,Orphanet:309246|MedGen:CN517202","not specified|Tay-Sachs disease, variant AB|not provided",germline;unknown,germline,GRCh38,NC_000005.10,5,151259848,151259848,na,na,5q33.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA180085,UniProtKB:P17900#VAR_036892",2,167150,151259848,A,G,I59V,2,benign,benign,P17900,P17900,reviewed,SAP3_HUMAN,"Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3, SAP-3) [Cleaved into: Ganglioside GM2 activator isoform short ]",GM2A,Homo sapiens (Human),193.0,MQSLMQAPLLIALGLLLAAPAQAHLKKPSQLSSFSWDNCDEGKDPAVIRSLTLEPDPIIVPGNVTLSVMGSTSVPLSSPLKVDLVLEKEVAGLWIKIPCTDYIGSCTFEHFCDVLDMLIPTGEPCPEPLRTYGLPCHCPFKEGTYSLPKSEFVVPDLELPSWLTTGNYRIESVLSSSGKRLGCIKIAASLKGI,PF02221;,1G13;1PU5;1PUB;1TJJ;2AF9;2AG2;2AG4;2AG9;,59,I,V,True,1003
13975,2260,24552,single nucleotide variant,NM_138761.4(BAX):c.199G>A (p.Gly67Arg),581,BAX,HGNC:959,Pathogenic,1,15-Apr-98,398122513,-,RCV000010121,"Human Phenotype Ontology:HP:0006727,MONDO:MONDO:0004963,MedGen:C1961099",T-cell acute lymphoblastic leukemia,somatic,somatic,GRCh38,NC_000019.10,19,48955799,48955799,na,na,19q13.33,no assertion criteria provided,1,-,N,"ClinGen:CA120497,UniProtKB:Q07812#VAR_007809,OMIM:600040.0003",1,9513,48955799,G,A,G67R,0,pathogenic,uncertain,Q07812,Q07812,reviewed,BAX_HUMAN,"Apoptosis regulator BAX (Bcl-2-like protein 4, Bcl2-L-4)",BAX BCL2L4,Homo sapiens (Human),192.0,MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPVPQDASTKKLSECLKRIGDELDSNMELQRMIAAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALCTKVPELIRTIMGWTLDFLRERLLGWIQDQGGWDGLLSYFGTPTWQTVTIFVAGVLTASLTIWKKMG,PF00452;,1F16;2G5B;2K7W;2LR1;3PK1;3PL7;4BD2;4BD6;4BD7;4BD8;4BDU;4S0O;4S0P;4UF2;4ZIE;4ZIF;4ZIG;4ZIH;4ZII;5W5X;5W5Z;5W60;5W61;6EB6;6L8V;6L95;6TRR;6XY6;7ADT;,67,G,R,True,1004
13976,1602,22105,single nucleotide variant,NM_007262.5(PARK7):c.446A>C (p.Asp149Ala),11315,PARK7,HGNC:16369,Pathogenic,1,2-Aug-13,74315352,-,RCV000007482,"MONDO:MONDO:0011658,MedGen:C1853445,OMIM:606324,Orphanet:2828",Parkinson disease 7,germline,germline,GRCh38,NC_000001.11,1,7984930,7984930,na,na,1p36.23,no assertion criteria provided,1,-,N,"ClinGen:CA254094,UniProtKB:Q99497#VAR_020496,OMIM:602533.0004",1,7066,7984930,A,C,D149A,0,pathogenic,uncertain,Q99497,Q99497,reviewed,PARK7_HUMAN,"Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1, DJ-1) (Protein/nucleic acid deglycase DJ-1, EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124)",PARK7,Homo sapiens (Human),189.0,MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD,PF01965;,1J42;1P5F;1PDV;1PDW;1PE0;1Q2U;1SOA;1UCF;2OR3;2R1T;2R1U;2R1V;2RK3;2RK4;2RK6;3B36;3B38;3B3A;3BWE;3CY6;3CYF;3CZ9;3CZA;3EZG;3F71;3SF8;4BTE;4MNT;4MTC;4N0M;4N12;4OGF;4OQ4;4P2G;4P34;4P35;4P36;4RKW;4RKY;4S0Z;4ZGG;5IP5;5SY6;5SY9;5SYA;6AF5;6AF7;6AF9;6AFA;6AFB;6AFC;6AFD;6AFE;6AFF;6AFG;6AFH;6AFI;6AFJ;6AFL;6E5Z;6M8Z;7C62;,149,D,A,True,1005
13977,1604,22107,single nucleotide variant,NM_007262.5(PARK7):c.487G>A (p.Glu163Lys),11315,PARK7,HGNC:16369,no interpretation for the single variant,-1,-,74315354,-,-,-,-,not applicable,not applicable,GRCh38,NC_000001.11,1,7984971,7984971,na,na,1p36.23,no interpretation for the single variant,0,-,N,"UniProtKB:Q99497#VAR_034801,OMIM:602533.0006,ClinVar:446717",4,487089,7984971,G,A,E163K,0,uncertain,uncertain,Q99497,Q99497,reviewed,PARK7_HUMAN,"Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1, DJ-1) (Protein/nucleic acid deglycase DJ-1, EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124)",PARK7,Homo sapiens (Human),189.0,MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD,PF01965;,1J42;1P5F;1PDV;1PDW;1PE0;1Q2U;1SOA;1UCF;2OR3;2R1T;2R1U;2R1V;2RK3;2RK4;2RK6;3B36;3B38;3B3A;3BWE;3CY6;3CYF;3CZ9;3CZA;3EZG;3F71;3SF8;4BTE;4MNT;4MTC;4N0M;4N12;4OGF;4OQ4;4P2G;4P34;4P35;4P36;4RKW;4RKY;4S0Z;4ZGG;5IP5;5SY6;5SY9;5SYA;6AF5;6AF7;6AF9;6AFA;6AFB;6AFC;6AFD;6AFE;6AFF;6AFG;6AFH;6AFI;6AFJ;6AFL;6E5Z;6M8Z;7C62;,163,E,K,True,1005
13978,1603,22106,single nucleotide variant,NM_007262.5(PARK7):c.192G>C (p.Glu64Asp),11315,PARK7,HGNC:16369,Pathogenic,1,1-Oct-04,74315353,-,RCV000007483,"MONDO:MONDO:0011658,MedGen:C1853445,OMIM:606324,Orphanet:2828",Parkinson disease 7,germline,germline,GRCh38,NC_000001.11,1,7965425,7965425,na,na,1p36.23,no assertion criteria provided,1,-,N,"ClinGen:CA254096,UniProtKB:Q99497#VAR_020493,OMIM:602533.0005",1,7067,7965425,G,C,E64D,0,pathogenic,uncertain,Q99497,Q99497,reviewed,PARK7_HUMAN,"Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1, DJ-1) (Protein/nucleic acid deglycase DJ-1, EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124)",PARK7,Homo sapiens (Human),189.0,MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD,PF01965;,1J42;1P5F;1PDV;1PDW;1PE0;1Q2U;1SOA;1UCF;2OR3;2R1T;2R1U;2R1V;2RK3;2RK4;2RK6;3B36;3B38;3B3A;3BWE;3CY6;3CYF;3CZ9;3CZA;3EZG;3F71;3SF8;4BTE;4MNT;4MTC;4N0M;4N12;4OGF;4OQ4;4P2G;4P34;4P35;4P36;4RKW;4RKY;4S0Z;4ZGG;5IP5;5SY6;5SY9;5SYA;6AF5;6AF7;6AF9;6AFA;6AFB;6AFC;6AFD;6AFE;6AFF;6AFG;6AFH;6AFI;6AFJ;6AFL;6E5Z;6M8Z;7C62;,64,E,D,True,1005
13979,1600,22103,single nucleotide variant,NM_007262.5(PARK7):c.497T>C (p.Leu166Pro),11315,PARK7,HGNC:16369,Pathogenic,1,1-Jul-12,28938172,-,RCV000007480,"MONDO:MONDO:0011658,MedGen:C1853445,OMIM:606324,Orphanet:2828",Parkinson disease 7,germline,germline,GRCh38,NC_000001.11,1,7984981,7984981,na,na,1p36.23,no assertion criteria provided,1,-,N,"ClinGen:CA254090,UniProtKB:Q99497#VAR_020498,OMIM:602533.0002",1,7064,7984981,T,C,L166P,0,pathogenic,uncertain,Q99497,Q99497,reviewed,PARK7_HUMAN,"Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1, DJ-1) (Protein/nucleic acid deglycase DJ-1, EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124)",PARK7,Homo sapiens (Human),189.0,MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD,PF01965;,1J42;1P5F;1PDV;1PDW;1PE0;1Q2U;1SOA;1UCF;2OR3;2R1T;2R1U;2R1V;2RK3;2RK4;2RK6;3B36;3B38;3B3A;3BWE;3CY6;3CYF;3CZ9;3CZA;3EZG;3F71;3SF8;4BTE;4MNT;4MTC;4N0M;4N12;4OGF;4OQ4;4P2G;4P34;4P35;4P36;4RKW;4RKY;4S0Z;4ZGG;5IP5;5SY6;5SY9;5SYA;6AF5;6AF7;6AF9;6AFA;6AFB;6AFC;6AFD;6AFE;6AFF;6AFG;6AFH;6AFI;6AFJ;6AFL;6E5Z;6M8Z;7C62;,166,L,P,True,1005
13980,1605,22108,single nucleotide variant,NM_007262.5(PARK7):c.115G>T (p.Ala39Ser),11315,PARK7,HGNC:16369,Pathogenic,1,1-Jun-06,137853051,-,RCV000007485,MedGen:CN043330,"Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1",germline,germline,GRCh38,NC_000001.11,1,7965348,7965348,na,na,1p36.23,no assertion criteria provided,1,-,N,"ClinGen:CA254098,UniProtKB:Q99497#VAR_072589,OMIM:602533.0007",1,7069,7965348,G,T,A39S,0,pathogenic,uncertain,Q99497,Q99497,reviewed,PARK7_HUMAN,"Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1, DJ-1) (Protein/nucleic acid deglycase DJ-1, EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124)",PARK7,Homo sapiens (Human),189.0,MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD,PF01965;,1J42;1P5F;1PDV;1PDW;1PE0;1Q2U;1SOA;1UCF;2OR3;2R1T;2R1U;2R1V;2RK3;2RK4;2RK6;3B36;3B38;3B3A;3BWE;3CY6;3CYF;3CZ9;3CZA;3EZG;3F71;3SF8;4BTE;4MNT;4MTC;4N0M;4N12;4OGF;4OQ4;4P2G;4P34;4P35;4P36;4RKW;4RKY;4S0Z;4ZGG;5IP5;5SY6;5SY9;5SYA;6AF5;6AF7;6AF9;6AFA;6AFB;6AFC;6AFD;6AFE;6AFF;6AFG;6AFH;6AFI;6AFJ;6AFL;6E5Z;6M8Z;7C62;,39,A,S,True,1005
13981,1601,22104,single nucleotide variant,NM_007262.5(PARK7):c.78G>A (p.Met26Ile),11315,PARK7,HGNC:16369,Pathogenic,1,1-Jul-12,74315351,-,RCV000007481,"MONDO:MONDO:0011658,MedGen:C1853445,OMIM:606324,Orphanet:2828",Parkinson disease 7,germline,germline,GRCh38,NC_000001.11,1,7962863,7962863,na,na,1p36.23,no assertion criteria provided,1,-,N,"ClinGen:CA254092,UniProtKB:Q99497#VAR_020492,OMIM:602533.0003",1,7065,7962863,G,A,M26I,0,pathogenic,uncertain,Q99497,Q99497,reviewed,PARK7_HUMAN,"Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1, DJ-1) (Protein/nucleic acid deglycase DJ-1, EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124)",PARK7,Homo sapiens (Human),189.0,MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD,PF01965;,1J42;1P5F;1PDV;1PDW;1PE0;1Q2U;1SOA;1UCF;2OR3;2R1T;2R1U;2R1V;2RK3;2RK4;2RK6;3B36;3B38;3B3A;3BWE;3CY6;3CYF;3CZ9;3CZA;3EZG;3F71;3SF8;4BTE;4MNT;4MTC;4N0M;4N12;4OGF;4OQ4;4P2G;4P34;4P35;4P36;4RKW;4RKY;4S0Z;4ZGG;5IP5;5SY6;5SY9;5SYA;6AF5;6AF7;6AF9;6AFA;6AFB;6AFC;6AFD;6AFE;6AFF;6AFG;6AFH;6AFI;6AFJ;6AFL;6E5Z;6M8Z;7C62;,26,M,I,True,1005
13982,12403,215317,single nucleotide variant,NM_004531.5(MOCS2):c.367C>T (p.His123Tyr),4338,MOCS2,HGNC:7193,Conflicting interpretations of pathogenicity,0,1-Jul-17,2233218,-,RCV000203023|RCV000584906|RCV001155307,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0009644,MedGen:C1854989,OMIM:252160,Orphanet:308393,Orphanet:833","not specified|not provided|Molybdenum cofactor deficiency, complementation group B",germline;unknown,germline,GRCh38,NC_000005.10,5,53101369,53101369,na,na,5q11.2,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA249227,UniProtKB:O96007#VAR_050093",2,218640,53101369,G,A,H123Y,1,uncertain,uncertain,O96007,O96007,reviewed,MOC2B_HUMAN,"Molybdopterin synthase catalytic subunit, EC 2.8.1.12 (MOCO1-B) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B, MOCS2B) (Molybdopterin-synthase large subunit, MPT synthase large subunit)",MOCS2 MCBPE MOCO1,Homo sapiens (Human),188.0,MSSLEISSSCFSLETKLPLSPPLVEDSAFEPSRKDMDEVEEKSKDVINFTAEKLSVDEVSQLVISPLCGAISLFVGTTRNNFEGKKVISLEYEAYLPMAENEVRKICSDIRQKWPVKHIAVFHRLGLVPVSEASIIIAVSSAHRAASLEAVSYAIDTLKAKVPIWKKEIYEESSTWKGNKECFWASNS,PF02391;,4AP8;5MPO;,123,H,Y,True,1006
13983,1410,21148,single nucleotide variant,NM_004531.5(MOCS2):c.502G>A (p.Glu168Lys),4338,MOCS2,HGNC:7193,Pathogenic,1,11-Jul-03,121908605,-,RCV000006483,"MONDO:MONDO:0009644,MedGen:C1854989,OMIM:252160,Orphanet:308393,Orphanet:833","Molybdenum cofactor deficiency, complementation group B",germline,germline,GRCh38,NC_000005.10,5,53098667,53098667,na,na,5q11.2,no assertion criteria provided,1,-,N,"UniProtKB:O96007#VAR_012765,OMIM:603708.0002,ClinGen:CA117941",1,6109,53098667,C,T,E168K,0,pathogenic,uncertain,O96007,O96007,reviewed,MOC2B_HUMAN,"Molybdopterin synthase catalytic subunit, EC 2.8.1.12 (MOCO1-B) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B, MOCS2B) (Molybdopterin-synthase large subunit, MPT synthase large subunit)",MOCS2 MCBPE MOCO1,Homo sapiens (Human),188.0,MSSLEISSSCFSLETKLPLSPPLVEDSAFEPSRKDMDEVEEKSKDVINFTAEKLSVDEVSQLVISPLCGAISLFVGTTRNNFEGKKVISLEYEAYLPMAENEVRKICSDIRQKWPVKHIAVFHRLGLVPVSEASIIIAVSSAHRAASLEAVSYAIDTLKAKVPIWKKEIYEESSTWKGNKECFWASNS,PF02391;,4AP8;5MPO;,168,E,K,True,1006
13984,5778,38629,single nucleotide variant,NM_000791.4(DHFR):c.458A>T (p.Asp153Val),1719,DHFR,HGNC:2861,Pathogenic,1,11-Feb-11,121913223,-,RCV000022525,"MONDO:MONDO:0013456,MedGen:C3151205,OMIM:613839,Orphanet:319651",Megaloblastic anemia due to dihydrofolate reductase deficiency,germline,germline,GRCh38,NC_000005.10,5,80633904,80633904,na,na,5q14.1,no assertion criteria provided,2,-,N,"UniProtKB:P00374#VAR_065819,OMIM:126060.0002,ClinGen:CA128553",3,29674,80633904,T,A,D153V,0,pathogenic,uncertain,P00374,P00374,reviewed,DYR_HUMAN,"Dihydrofolate reductase, EC 1.5.1.3",DHFR,Homo sapiens (Human),187.0,MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND,PF00186;,1BOZ;1DHF;1DLR;1DLS;1DRF;1HFP;1HFQ;1HFR;1KMS;1KMV;1MVS;1MVT;1OHJ;1OHK;1PD8;1PD9;1PDB;1S3U;1S3V;1S3W;1U71;1U72;1YHO;2C2S;2C2T;2DHF;2W3A;2W3B;2W3M;3EIG;3F8Y;3F8Z;3F91;3FS6;3GHC;3GHV;3GHW;3GI2;3GYF;3L3R;3N0H;3NTZ;3NU0;3NXO;3NXR;3NXT;3NXV;3NXX;3NXY;3NZD;3OAF;3S3V;3S7A;4DDR;4G95;4KAK;4KBN;4KD7;4KEB;4KFJ;4M6J;4M6K;4M6L;4QHV;4QJC;5HPB;5HQY;5HQZ;5HSR;5HSU;5HT4;5HT5;5HUI;5HVB;5HVE;6A7C;6A7E;6DAV;6DE4;6VCJ;7ESE;,153,D,V,True,1007
13985,5777,38628,single nucleotide variant,NM_000791.4(DHFR):c.238C>T (p.Leu80Phe),1719,DHFR,HGNC:2861,Pathogenic,1,11-Feb-11,387906619,-,RCV000022524,"MONDO:MONDO:0013456,MedGen:C3151205,OMIM:613839,Orphanet:319651",Megaloblastic anemia due to dihydrofolate reductase deficiency,germline,germline,GRCh38,NC_000005.10,5,80649393,80649393,na,na,5q14.1,no assertion criteria provided,1,-,N,"ClinGen:CA128552,UniProtKB:P00374#VAR_065818,OMIM:126060.0001",1,29673,80649393,G,A,L80F,0,pathogenic,uncertain,P00374,P00374,reviewed,DYR_HUMAN,"Dihydrofolate reductase, EC 1.5.1.3",DHFR,Homo sapiens (Human),187.0,MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND,PF00186;,1BOZ;1DHF;1DLR;1DLS;1DRF;1HFP;1HFQ;1HFR;1KMS;1KMV;1MVS;1MVT;1OHJ;1OHK;1PD8;1PD9;1PDB;1S3U;1S3V;1S3W;1U71;1U72;1YHO;2C2S;2C2T;2DHF;2W3A;2W3B;2W3M;3EIG;3F8Y;3F8Z;3F91;3FS6;3GHC;3GHV;3GHW;3GI2;3GYF;3L3R;3N0H;3NTZ;3NU0;3NXO;3NXR;3NXT;3NXV;3NXX;3NXY;3NZD;3OAF;3S3V;3S7A;4DDR;4G95;4KAK;4KBN;4KD7;4KEB;4KFJ;4M6J;4M6K;4M6L;4QHV;4QJC;5HPB;5HQY;5HQZ;5HSR;5HSU;5HT4;5HT5;5HUI;5HVB;5HVE;6A7C;6A7E;6DAV;6DE4;6VCJ;7ESE;,80,L,F,True,1007
13986,524,17084,single nucleotide variant,NM_001278293.3(ARL6):c.266C>T (p.Ala89Val),84100,ARL6,HGNC:13210,Pathogenic,1,15-Apr-11,587777805,-,RCV000002126|RCV001257838,"MONDO:MONDO:0013312,MedGen:C3150808,OMIM:613575,Orphanet:791|MedGen:C0339526",Retinitis pigmentosa 55|Autosomal recessive retinitis pigmentosa,germline,germline,GRCh38,NC_000003.12,3,97784966,97784966,na,na,3q11.2,no assertion criteria provided,2,-,N,"ClinGen:CA252075,UniProtKB:Q9H0F7#VAR_064184,OMIM:608845.0006",3,2045,97784966,C,T,A89V,0,pathogenic,uncertain,Q9H0F7,Q9H0F7,reviewed,ARL6_HUMAN,ADP-ribosylation factor-like protein 6 (Bardet-Biedl syndrome 3 protein),ARL6 BBS3,Homo sapiens (Human),186.0,MGLLDRLSVLLGLKKKEVHVLCLGLDNSGKTTIINKLKPSNAQSQNILPTIGFSIEKFKSSSLSFTVFDMSGQGRYRNLWEHYYKEGQAIIFVIDSSDRLRMVVAKEELDTLLNHPDIKHRRIPILFFANKMDLRDAVTSVKVSQLLCLENIKDKPWHICASDAIKGEGLQEGVDWLQDQIQTVKT,PF00025;,2H57;,89,A,V,True,1008
13987,523,17083,single nucleotide variant,NM_001278293.3(ARL6):c.92C>G (p.Thr31Arg),84100,ARL6,HGNC:13210,Pathogenic,1,20-Nov-19,104893680,-,RCV000002125|RCV001063683,"MONDO:MONDO:0010832,MedGen:C1859564,OMIM:600151,Orphanet:110|MONDO:MONDO:0013312,MedGen:C3150808,OMIM:613575,Orphanet:791;MONDO:MONDO:0010832,MedGen:C1859564,OMIM:600151,Orphanet:110",Bardet-Biedl syndrome 3|Retinitis pigmentosa 55;Bardet-Biedl syndrome 3,germline,germline,GRCh38,NC_000003.12,3,97768199,97768199,na,na,3q11.2,"criteria provided, single submitter",2,-,N,"ClinGen:CA252073,UniProtKB:Q9H0F7#VAR_027644,OMIM:608845.0005",3,2044,97768199,C,G,T31R,1,pathogenic,pathogenic,Q9H0F7,Q9H0F7,reviewed,ARL6_HUMAN,ADP-ribosylation factor-like protein 6 (Bardet-Biedl syndrome 3 protein),ARL6 BBS3,Homo sapiens (Human),186.0,MGLLDRLSVLLGLKKKEVHVLCLGLDNSGKTTIINKLKPSNAQSQNILPTIGFSIEKFKSSSLSFTVFDMSGQGRYRNLWEHYYKEGQAIIFVIDSSDRLRMVVAKEELDTLLNHPDIKHRRIPILFFANKMDLRDAVTSVKVSQLLCLENIKDKPWHICASDAIKGEGLQEGVDWLQDQIQTVKT,PF00025;,2H57;,31,T,R,True,1008
13988,520,17080,single nucleotide variant,NM_001278293.3(ARL6):c.506G>C (p.Gly169Ala),84100,ARL6,HGNC:13210,"Pathogenic, risk factor",1,1-Sep-04,104893679,-,RCV000002121|RCV000002122,"MONDO:MONDO:0010832,MedGen:C1859564,OMIM:600151,Orphanet:110|MedGen:C2675305","Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 1, modifier of",germline,germline,GRCh38,NC_000003.12,3,97791797,97791797,na,na,3q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA115313,UniProtKB:Q9H0F7#VAR_027645,OMIM:608845.0002",1,2041,97791797,G,C,G169A,0,pathogenic,uncertain,Q9H0F7,Q9H0F7,reviewed,ARL6_HUMAN,ADP-ribosylation factor-like protein 6 (Bardet-Biedl syndrome 3 protein),ARL6 BBS3,Homo sapiens (Human),186.0,MGLLDRLSVLLGLKKKEVHVLCLGLDNSGKTTIINKLKPSNAQSQNILPTIGFSIEKFKSSSLSFTVFDMSGQGRYRNLWEHYYKEGQAIIFVIDSSDRLRMVVAKEELDTLLNHPDIKHRRIPILFFANKMDLRDAVTSVKVSQLLCLENIKDKPWHICASDAIKGEGLQEGVDWLQDQIQTVKT,PF00025;,2H57;,169,G,A,True,1008
13989,522,17082,single nucleotide variant,NM_001278293.3(ARL6):c.509T>G (p.Leu170Trp),84100,ARL6,HGNC:13210,Pathogenic,1,1-Sep-04,104893681,-,RCV000002124,"MONDO:MONDO:0010832,MedGen:C1859564,OMIM:600151,Orphanet:110",Bardet-Biedl syndrome 3,germline,germline,GRCh38,NC_000003.12,3,97791800,97791800,na,na,3q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA252071,UniProtKB:Q9H0F7#VAR_027646,OMIM:608845.0004",1,2043,97791800,T,G,L170W,0,pathogenic,uncertain,Q9H0F7,Q9H0F7,reviewed,ARL6_HUMAN,ADP-ribosylation factor-like protein 6 (Bardet-Biedl syndrome 3 protein),ARL6 BBS3,Homo sapiens (Human),186.0,MGLLDRLSVLLGLKKKEVHVLCLGLDNSGKTTIINKLKPSNAQSQNILPTIGFSIEKFKSSSLSFTVFDMSGQGRYRNLWEHYYKEGQAIIFVIDSSDRLRMVVAKEELDTLLNHPDIKHRRIPILFFANKMDLRDAVTSVKVSQLLCLENIKDKPWHICASDAIKGEGLQEGVDWLQDQIQTVKT,PF00025;,2H57;,170,L,W,True,1008
13990,521,17081,single nucleotide variant,NM_001278293.3(ARL6):c.92C>T (p.Thr31Met),84100,ARL6,HGNC:13210,Pathogenic,1,1-Sep-04,104893680,-,RCV000002123,"MONDO:MONDO:0010832,MedGen:C1859564,OMIM:600151,Orphanet:110",Bardet-Biedl syndrome 3,germline,germline,GRCh38,NC_000003.12,3,97768199,97768199,na,na,3q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA252069,UniProtKB:Q9H0F7#VAR_027643,OMIM:608845.0003",1,2042,97768199,C,T,T31M,0,pathogenic,uncertain,Q9H0F7,Q9H0F7,reviewed,ARL6_HUMAN,ADP-ribosylation factor-like protein 6 (Bardet-Biedl syndrome 3 protein),ARL6 BBS3,Homo sapiens (Human),186.0,MGLLDRLSVLLGLKKKEVHVLCLGLDNSGKTTIINKLKPSNAQSQNILPTIGFSIEKFKSSSLSFTVFDMSGQGRYRNLWEHYYKEGQAIIFVIDSSDRLRMVVAKEELDTLLNHPDIKHRRIPILFFANKMDLRDAVTSVKVSQLLCLENIKDKPWHICASDAIKGEGLQEGVDWLQDQIQTVKT,PF00025;,2H57;,31,T,M,True,1008
13991,4520,31076,single nucleotide variant,NM_006708.3(GLO1):c.332A>C (p.Glu111Ala),2739,GLO1,HGNC:4323,Uncertain significance,0,30-Dec-10,4746,-,RCV000017412,MedGen:C1968924,Autism 1,germline,germline,GRCh38,NC_000006.12,6,38682852,38682852,na,na,6p21.2,no assertion criteria provided,1,-,N,"ClinGen:CA126152,UniProtKB:Q04760#VAR_013481,OMIM:138750.0001",1,16037,38682852,T,G,E111A,0,uncertain,uncertain,Q04760,Q04760,reviewed,LGUL_HUMAN,"Lactoylglutathione lyase, EC 4.4.1.5 (Aldoketomutase) (Glyoxalase I, Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)",GLO1,Homo sapiens (Human),184.0,MAEPQPPSGGLTDEAALSCCSDADPSTKDFLLQQTMLRVKDPKKSLDFYTRVLGMTLIQKCDFPIMKFSLYFLAYEDKNDIPKEKDEKIAWALSRKATLELTHNWGTEDDETQSYHNGNSDPRGFGHIGIAVPDVYSACKRFEELGVKFVKKPDDGKMKGLAFIQDPDGYWIEILNPNKMATLM,PF00903;,1BH5;1FRO;1QIN;1QIP;3VW9;3W0T;3W0U;,111,E,A,True,1009
13992,10958,165914,single nucleotide variant,NM_032492.4(JAGN1):c.63G>T (p.Glu21Asp),84522,JAGN1,HGNC:26926,Conflicting interpretations of pathogenicity,1,23-Oct-20,587777729,-,RCV000144164|RCV000170606|RCV001268772,"MONDO:MONDO:0014456,MedGen:C4014954,OMIM:616022,Orphanet:423384|Human Phenotype Ontology:HP:0005549,MONDO:MONDO:0018542,MedGen:C1853118,OMIM:PS202700,Orphanet:42738|MedGen:CN517202","Severe congenital neutropenia 6, autosomal recessive|Severe congenital neutropenia|not provided",germline,germline,GRCh38,NC_000003.12,3,9890785,9890785,na,na,3p25.3,"criteria provided, conflicting interpretations",4,-,N,"OMIM:616012.0003,ClinGen:CA170769,UniProtKB:Q8N5M9#VAR_071797",3,156115,9890785,G,T,E21D,1,uncertain,uncertain,Q8N5M9,Q8N5M9,reviewed,JAGN1_HUMAN,Protein jagunal homolog 1,JAGN1,Homo sapiens (Human),183.0,MASRAGPRAAGTDGSDFQHRERVAMHYQMSVTLKYEIKKLIYVHLVIWLLLVAKMSVGHLRLLSHDQVAMPYQWEYPYLLSILPSLLGLLSFPRNNISYLVLSMISMGLFSIAPLIYGSMEMFPAAQQLYRHGKAYRFLFGFSAVSIMYLVLVLAVQVHAWQLYYSKKLLDSWFTSTQEKKHK,PF07086;,6WVD;,21,E,D,True,1010
13993,10959,165915,single nucleotide variant,NM_032492.4(JAGN1):c.485A>G (p.Gln162Arg),84522,JAGN1,HGNC:26926,Pathogenic,1,1-Jan-13,587777730,-,RCV000144165|RCV000170605,"MONDO:MONDO:0014456,MedGen:C4014954,OMIM:616022,Orphanet:423384|Human Phenotype Ontology:HP:0005549,MONDO:MONDO:0018542,MedGen:C1853118,OMIM:PS202700,Orphanet:42738","Severe congenital neutropenia 6, autosomal recessive|Severe congenital neutropenia",germline,germline,GRCh38,NC_000003.12,3,9893310,9893310,na,na,3p25.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA170770,UniProtKB:Q8N5M9#VAR_071799,OMIM:616012.0004",3,156116,9893310,A,G,Q162R,1,pathogenic,pathogenic,Q8N5M9,Q8N5M9,reviewed,JAGN1_HUMAN,Protein jagunal homolog 1,JAGN1,Homo sapiens (Human),183.0,MASRAGPRAAGTDGSDFQHRERVAMHYQMSVTLKYEIKKLIYVHLVIWLLLVAKMSVGHLRLLSHDQVAMPYQWEYPYLLSILPSLLGLLSFPRNNISYLVLSMISMGLFSIAPLIYGSMEMFPAAQQLYRHGKAYRFLFGFSAVSIMYLVLVLAVQVHAWQLYYSKKLLDSWFTSTQEKKHK,PF07086;,6WVD;,162,Q,R,True,1010
13994,10957,165913,single nucleotide variant,NM_032492.4(JAGN1):c.130C>T (p.His44Tyr),84522,JAGN1,HGNC:26926,Pathogenic,1,1-Jun-19,587777728,-,RCV000144163|RCV000170602|RCV001092960,"MONDO:MONDO:0014456,MedGen:C4014954,OMIM:616022,Orphanet:423384|Human Phenotype Ontology:HP:0005549,MONDO:MONDO:0018542,MedGen:C1853118,OMIM:PS202700,Orphanet:42738|MedGen:CN517202","Severe congenital neutropenia 6, autosomal recessive|Severe congenital neutropenia|not provided",germline,germline,GRCh38,NC_000003.12,3,9892955,9892955,na,na,3p25.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"UniProtKB:Q8N5M9#VAR_071798,OMIM:616012.0002,ClinGen:CA170768",3,156114,9892955,C,T,H44Y,2,pathogenic,pathogenic,Q8N5M9,Q8N5M9,reviewed,JAGN1_HUMAN,Protein jagunal homolog 1,JAGN1,Homo sapiens (Human),183.0,MASRAGPRAAGTDGSDFQHRERVAMHYQMSVTLKYEIKKLIYVHLVIWLLLVAKMSVGHLRLLSHDQVAMPYQWEYPYLLSILPSLLGLLSFPRNNISYLVLSMISMGLFSIAPLIYGSMEMFPAAQQLYRHGKAYRFLFGFSAVSIMYLVLVLAVQVHAWQLYYSKKLLDSWFTSTQEKKHK,PF07086;,6WVD;,44,H,Y,True,1010
13995,11717,188299,single nucleotide variant,NM_032492.4(JAGN1):c.59G>A (p.Arg20Gln),84522,JAGN1,HGNC:26926,Pathogenic,1,1-Jan-13,777966677,-,RCV000170601,"Human Phenotype Ontology:HP:0005549,MONDO:MONDO:0018542,MedGen:C1853118,OMIM:PS202700,Orphanet:42738",Severe congenital neutropenia,germline,germline,GRCh38,NC_000003.12,3,9890781,9890781,na,na,3p25.3,"criteria provided, single submitter",1,-,N,"ClinGen:CA199735,UniProtKB:Q8N5M9#VAR_071796",2,190479,9890781,G,A,R20Q,1,pathogenic,pathogenic,Q8N5M9,Q8N5M9,reviewed,JAGN1_HUMAN,Protein jagunal homolog 1,JAGN1,Homo sapiens (Human),183.0,MASRAGPRAAGTDGSDFQHRERVAMHYQMSVTLKYEIKKLIYVHLVIWLLLVAKMSVGHLRLLSHDQVAMPYQWEYPYLLSILPSLLGLLSFPRNNISYLVLSMISMGLFSIAPLIYGSMEMFPAAQQLYRHGKAYRFLFGFSAVSIMYLVLVLAVQVHAWQLYYSKKLLDSWFTSTQEKKHK,PF07086;,6WVD;,20,R,Q,True,1010
13996,11716,188298,single nucleotide variant,NM_032492.4(JAGN1):c.40G>A (p.Gly14Ser),84522,JAGN1,HGNC:26926,Pathogenic,1,1-Jan-13,786205704,-,RCV000170603,"Human Phenotype Ontology:HP:0005549,MONDO:MONDO:0018542,MedGen:C1853118,OMIM:PS202700,Orphanet:42738",Severe congenital neutropenia,germline,germline,GRCh38,NC_000003.12,3,9890762,9890762,na,na,3p25.3,"criteria provided, single submitter",1,-,N,"ClinGen:CA199736,UniProtKB:Q8N5M9#VAR_071795",2,190480,9890762,G,A,G14S,1,pathogenic,pathogenic,Q8N5M9,Q8N5M9,reviewed,JAGN1_HUMAN,Protein jagunal homolog 1,JAGN1,Homo sapiens (Human),183.0,MASRAGPRAAGTDGSDFQHRERVAMHYQMSVTLKYEIKKLIYVHLVIWLLLVAKMSVGHLRLLSHDQVAMPYQWEYPYLLSILPSLLGLLSFPRNNISYLVLSMISMGLFSIAPLIYGSMEMFPAAQQLYRHGKAYRFLFGFSAVSIMYLVLVLAVQVHAWQLYYSKKLLDSWFTSTQEKKHK,PF07086;,6WVD;,14,G,S,True,1010
13997,14059,325344,single nucleotide variant,NM_000073.3(CD3G):c.391G>T (p.Val131Phe),917,CD3G,HGNC:1675,Benign,0,13-Jan-18,3753058,-,RCV000352643|RCV000455537,"MONDO:MONDO:0014276,MedGen:C3810107,OMIM:615607,Orphanet:169082|MedGen:CN169374",Immunodeficiency 17|not specified,germline,germline,GRCh38,NC_000011.10,11,118350635,118350635,na,na,11q23.3,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA6302170,UniProtKB:P09693#VAR_049854",2,302685,118350635,G,T,V131F,2,benign,benign,P09693,P09693,reviewed,CD3G_HUMAN,T-cell surface glycoprotein CD3 gamma chain (T-cell receptor T3 gamma chain) (CD antigen CD3g),CD3G T3G,Homo sapiens (Human),182.0,MEQGKGLAVLILAIILLQGTLAQSIKGNHLVKVYDYQEDGSVLLTCDAEAKNITWFKDGKMIGFLTEDKKKWNLGSNAKDPRGMYQCKGSQNKSKPLQVYYRMCQNCIELNAATISGFLFAEIVSIFVLAVGVYFIAGQDGVRQSRASDKQTLLPNDQLYQPLKDREDDQYSHLQGNQLRRN,PF16680;PF02189;,1SY6;6JXR;7Q5U;,131,V,F,True,1011
13998,3066,27474,single nucleotide variant,NM_003282.4(TNNI2):c.521G>A (p.Arg174Gln),7136,TNNI2,HGNC:11946,Pathogenic,1,5-Mar-20,104894311,-,RCV000013248|RCV000128667,"MONDO:MONDO:0011128,MedGen:C5193014,OMIM:601680,Orphanet:1147|MedGen:CN517202",Distal arthrogryposis type 2B|not provided,de novo;germline;somatic,germline/somatic,GRCh38,NC_000011.10,11,1841523,1841523,na,na,11p15.5,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA122377,UniProtKB:P48788#VAR_016087,OMIM:191043.0001",3,12435,1841523,G,A,R174Q,2,pathogenic,pathogenic,P48788,P48788,reviewed,TNNI2_HUMAN,"Troponin I, fast skeletal muscle (Troponin I, fast-twitch isoform)",TNNI2,Homo sapiens (Human),182.0,MGDEEKRNRAITARRQHLKSVMLQIAATELEKEESRREAEKQNYLAEHCPPLHIPGSMSEVQELCKQLHAKIDAAEEEKYDMEVRVQKTSKELEDMNQKLFDLRGKFKRPPLRRVRMSADAMLKALLGSKHKVCMDLRANLKQVKKEDTEKERDLRDVGDWRKNIEEKSGMEGRKKMFESES,PF00992;,2MKP;7KAA;,174,R,Q,True,1012
13999,5316,33335,single nucleotide variant,NM_000485.3(APRT):c.407T>C (p.Met136Thr),353,APRT,HGNC:626,Pathogenic,1,1-Sep-20,28999113,-,RCV000019958|RCV000033908,"MedGen:C0268121|MONDO:MONDO:0013869,MedGen:C0268120,OMIM:614723,Orphanet:976","APRT deficiency, Japanese type|Adenine phosphoribosyltransferase deficiency",germline,germline,GRCh38,NC_000016.10,16,88809834,88809834,na,na,16q24.3,no assertion criteria provided,3,-,N,"ClinGen:CA128035,UniProtKB:P07741#VAR_006749,OMIM:102600.0003",3,18296,88809834,A,G,M136T,0,pathogenic,uncertain,P07741,P07741,reviewed,APT_HUMAN,"Adenine phosphoribosyltransferase, APRT, EC 2.4.2.7",APRT,Homo sapiens (Human),180.0,MADSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEYGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE,PF00156;,1ORE;1ZN7;1ZN8;1ZN9;4X44;4X45;6FCH;6FCI;6FCL;6FD4;6FD5;6FD6;6HGP;6HGQ;6HGR;6HGS;,136,M,T,True,1013
14000,5317,33336,single nucleotide variant,NM_000485.3(APRT):c.194A>T (p.Asp65Val),353,APRT,HGNC:626,Pathogenic,1,1-Sep-20,104894506,-,RCV000033903,"MONDO:MONDO:0013869,MedGen:C0268120,OMIM:614723,Orphanet:976",Adenine phosphoribosyltransferase deficiency,germline,germline,GRCh38,NC_000016.10,16,88810550,88810550,na,na,16q24.3,"criteria provided, single submitter",3,-,N,"ClinGen:CA343879,UniProtKB:P07741#VAR_006747,OMIM:102600.0004",3,18297,88810550,T,A,D65V,1,pathogenic,pathogenic,P07741,P07741,reviewed,APT_HUMAN,"Adenine phosphoribosyltransferase, APRT, EC 2.4.2.7",APRT,Homo sapiens (Human),180.0,MADSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEYGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE,PF00156;,1ORE;1ZN7;1ZN8;1ZN9;4X44;4X45;6FCH;6FCI;6FCL;6FD4;6FD5;6FD6;6HGP;6HGQ;6HGR;6HGS;,65,D,V,True,1013
14001,5318,33339,single nucleotide variant,NM_000485.3(APRT):c.329T>C (p.Leu110Pro),353,APRT,HGNC:626,Pathogenic,1,1-Sep-20,104894508,-,RCV000019962,"MONDO:MONDO:0013869,MedGen:C0268120,OMIM:614723,Orphanet:976",Adenine phosphoribosyltransferase deficiency,germline,germline,GRCh38,NC_000016.10,16,88810141,88810141,na,na,16q24.3,no assertion criteria provided,2,-,N,"ClinGen:CA258148,UniProtKB:P07741#VAR_006748,OMIM:102600.0007",3,18300,88810141,A,G,L110P,0,pathogenic,uncertain,P07741,P07741,reviewed,APT_HUMAN,"Adenine phosphoribosyltransferase, APRT, EC 2.4.2.7",APRT,Homo sapiens (Human),180.0,MADSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEYGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE,PF00156;,1ORE;1ZN7;1ZN8;1ZN9;4X44;4X45;6FCH;6FCI;6FCL;6FD4;6FD5;6FD6;6HGP;6HGQ;6HGR;6HGS;,110,L,P,True,1013
14002,6595,49434,single nucleotide variant,NM_000485.3(APRT):c.448G>T (p.Val150Phe),353,APRT,HGNC:626,Pathogenic,1,1-Sep-20,281860266,-,RCV000033909,"MONDO:MONDO:0013869,MedGen:C0268120,OMIM:614723,Orphanet:976",Adenine phosphoribosyltransferase deficiency,germline,germline,GRCh38,NC_000016.10,16,88809793,88809793,na,na,16q24.3,no assertion criteria provided,2,-,N,"ClinGen:CA343887,UniProtKB:P07741#VAR_022608",3,41012,88809793,C,A,V150F,0,pathogenic,uncertain,P07741,P07741,reviewed,APT_HUMAN,"Adenine phosphoribosyltransferase, APRT, EC 2.4.2.7",APRT,Homo sapiens (Human),180.0,MADSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEYGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE,PF00156;,1ORE;1ZN7;1ZN8;1ZN9;4X44;4X45;6FCH;6FCI;6FCL;6FD4;6FD5;6FD6;6HGP;6HGQ;6HGR;6HGS;,150,V,F,True,1013
14003,10737,142172,single nucleotide variant,NM_005005.3(NDUFB9):c.436C>T (p.Pro146Ser),4715,NDUFB9,HGNC:7704,Benign,0,10-Sep-13,10195,-,RCV000127134|RCV000677050,MedGen:CN169374|MedGen:CN517202,not specified|not provided,germline;unknown,germline,GRCh38,NC_000008.11,8,124549788,124549788,na,na,8q24.13,"criteria provided, single submitter",2,-,N,"ClinGen:CA292474,UniProtKB:Q9Y6M9#VAR_014484",2,138469,124549788,C,T,P146S,1,benign,benign,Q9Y6M9,Q9Y6M9,reviewed,NDUB9_HUMAN,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22, CI-B22) (LYR motif-containing protein 3) (NADH-ubiquinone oxidoreductase B22 subunit)",NDUFB9 LYRM3 UQOR22,Homo sapiens (Human),179.0,MAFLASGPYLTHQQKVLRLYKRALRHLESWCVQRDKYRYFACLMRARFEEHKNEKDMAKATQLLKEAEEEFWYRQHPQPYIFPDSPGGTSYERYDCYKVPEWCLDDWHPSEKAMYPDYFAKREQWKKLRRESWEREVKQLQEETPPGGPLTEALPPARKEGDLPPLWWYIVTRPRERPM,PF05347;,5XTC;5XTD;5XTH;5XTI;,146,P,S,True,1014
14004,11460,181454,single nucleotide variant,NM_016077.4(PTRH2):c.254A>C (p.Gln85Pro),51651,PTRH2,HGNC:24265,Pathogenic,1,3-Jun-20,730882234,-,RCV000162156|RCV000162247,"Human Phenotype Ontology:HP:0000754,Human Phenotype Ontology:HP:0001255,Human Phenotype Ontology:HP:0001263,Human Phenotype Ontology:HP:0001277,Human Phenotype Ontology:HP:0001292,Human Phenotype Ontology:HP:0002433,Human Phenotype Ontology:HP:0002473,Human Phenotype Ontology:HP:0002532,Human Phenotype Ontology:HP:0006793,Human Phenotype Ontology:HP:0006867,Human Phenotype Ontology:HP:0006885,Human Phenotype Ontology:HP:0006935,Human Phenotype Ontology:HP:0007005,Human Phenotype Ontology:HP:0007094,Human Phenotype Ontology:HP:0007106,Human Phenotype Ontology:HP:0007174,Human Phenotype Ontology:HP:0007224,Human Phenotype Ontology:HP:0007228,Human Phenotype Ontology:HP:0007342,MedGen:C0557874;Human Phenotype Ontology:HP:0000365,Human Phenotype Ontology:HP:0000404,Human Phenotype Ontology:HP:0001728,Human Phenotype Ontology:HP:0001729,Human Phenotype Ontology:HP:0001754,Human Phenotype Ontology:HP:0008560,Human Phenotype Ontology:HP:0008563,MONDO:MONDO:0005365,MedGen:C1384666;Human Phenotype Ontology:HP:0001251,Human Phenotype Ontology:HP:0001253,Human Phenotype Ontology:HP:0002513,Human Phenotype Ontology:HP:0007050,Human Phenotype Ontology:HP:0007157,MONDO:MONDO:0000437,MedGen:C0007758,Orphanet:102002|MONDO:MONDO:0014554,MedGen:C4015728,OMIM:616263,Orphanet:456312","Global developmental delay;Hearing impairment;Cerebellar ataxia|Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset",germline;unknown,germline,GRCh38,NC_000017.11,17,59697725,59697725,na,na,17q23.1,"criteria provided, single submitter",5,-,N,"ClinGen:CA186106,UniProtKB:Q9Y3E5#VAR_073386,OMIM:608625.0002",3,183332,59697725,T,G,Q85P,1,pathogenic,pathogenic,Q9Y3E5,Q9Y3E5,reviewed,PTH2_HUMAN,"Peptidyl-tRNA hydrolase 2, mitochondrial, PTH 2, EC 3.1.1.29 (Bcl-2 inhibitor of transcription 1)",PTRH2 BIT1 PTH2 CGI-147,Homo sapiens (Human),179.0,MPSKSLVMEYLAHPSTLGLAVGVACGMCLGWSLRVCFGMLPKSKTSKTHTDTESEASILGDSGEYKMILVVRNDLKMGKGKVAAQCSHAAVSAYKQIQRRNPEMLKQWEYCGQPKVVVKAPDEETLIALLAHAKMLGLTVSLIQDAGRTQIAPGSQTVLGIGPGPADLIDKVTGHLKLY,PF01981;,1Q7S;,85,Q,P,True,1015
14005,3611,28777,single nucleotide variant,NM_198965.2(PTHLH):c.179T>C (p.Leu60Pro),5744,PTHLH,HGNC:9607,Pathogenic,1,12-Mar-10,267606985,-,RCV000014745,"MONDO:MONDO:0013244,MedGen:C3150644,OMIM:613382,Orphanet:93387",Brachydactyly type E2,germline,germline,GRCh38,NC_000012.12,12,27963693,27963693,na,na,12p11.22,no assertion criteria provided,1,-,N,"ClinGen:CA123415,UniProtKB:P12272#VAR_063712,OMIM:168470.0001",1,13738,27963693,A,G,L60P,0,pathogenic,uncertain,P12272,P12272,reviewed,PTHR_HUMAN,"Parathyroid hormone-related protein, PTH-rP, PTHrP (Parathyroid hormone-like protein, PLP) [Cleaved into: PTHrP[1-36]; PTHrP[38-94]; Osteostatin (PTHrP[107-139]) ]",PTHLH PTHRP,Homo sapiens (Human),177.0,MQRRLVQQWSVAVFLLSYAVPSCGRSVEGLSRRLKRAVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEIRATSEVSPNSKPSPNTKNHPVRFGSDDEGRYLTQETNKVETYKEQPLKTPGKKKKGKPGKRKEQEKKKRRTRSAWLDSGVTGSGLEGDHLSDTSTTSLELDSRRH,PF01279;,1BZG;1M5N;3FFD;3H3G;,60,L,P,True,1016
14006,3612,28778,single nucleotide variant,NM_198965.2(PTHLH):c.131T>C (p.Leu44Pro),5744,PTHLH,HGNC:9607,Pathogenic,1,12-Mar-10,267606986,-,RCV000014746,"MONDO:MONDO:0013244,MedGen:C3150644,OMIM:613382,Orphanet:93387",Brachydactyly type E2,germline,germline,GRCh38,NC_000012.12,12,27963741,27963741,na,na,12p11.22,no assertion criteria provided,1,-,N,"OMIM:168470.0002,ClinGen:CA123416,UniProtKB:P12272#VAR_063711",1,13739,27963741,A,G,L44P,0,pathogenic,uncertain,P12272,P12272,reviewed,PTHR_HUMAN,"Parathyroid hormone-related protein, PTH-rP, PTHrP (Parathyroid hormone-like protein, PLP) [Cleaved into: PTHrP[1-36]; PTHrP[38-94]; Osteostatin (PTHrP[107-139]) ]",PTHLH PTHRP,Homo sapiens (Human),177.0,MQRRLVQQWSVAVFLLSYAVPSCGRSVEGLSRRLKRAVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEIRATSEVSPNSKPSPNTKNHPVRFGSDDEGRYLTQETNKVETYKEQPLKTPGKKKKGKPGKRKEQEKKKRRTRSAWLDSGVTGSGLEGDHLSDTSTTSLELDSRRH,PF01279;,1BZG;1M5N;3FFD;3H3G;,44,L,P,True,1016
14007,4674,31525,single nucleotide variant,NM_000146.4(FTL):c.286G>A (p.Ala96Thr),2512,FTL,HGNC:3999,Pathogenic,1,23-Aug-05,104894685,-,RCV000017950,"MONDO:MONDO:0011638,MedGen:C1853578,OMIM:606159,Orphanet:157846",Neuroferritinopathy,germline,germline,GRCh38,NC_000019.10,19,48966317,48966317,na,na,19q13.33,no assertion criteria provided,1,-,N,"UniProtKB:P02792#VAR_026633,OMIM:134790.0013,ClinGen:CA281022",1,16486,48966317,G,A,A96T,0,pathogenic,uncertain,P02792,P02792,reviewed,FRIL_HUMAN,"Ferritin light chain, Ferritin L subunit",FTL,Homo sapiens (Human),175.0,MSSQIRQNYSTDVEAAVNSLVNLYLQASYTYLSLGFYFDRDDVALEGVSHFFRELAEEKREGYERLLKMQNQRGGRALFQDIKKPAEDEWGKTPDAMKAAMALEKKLNQALLDLHALGSARTDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPEAGLGEYLFERLTLKHD,PF00210;,2FFX;2FG4;2FG8;3KXU;4V6B;5LG8;6TR9;6TS0;6TS1;6TSA;6TSF;6TSJ;6WX6;,96,A,T,True,1017
14008,6458,48182,single nucleotide variant,NM_000146.4(FTL):c.89C>T (p.Thr30Ile),2512,FTL,HGNC:3999,Pathogenic,1,1-Mar-09,397514540,-,RCV000032783,"MONDO:MONDO:0010952,MedGen:C1833213,OMIM:600886,Orphanet:163",Hereditary hyperferritinemia with congenital cataracts,germline,germline,GRCh38,NC_000019.10,19,48965596,48965596,na,na,19q13.33,no assertion criteria provided,1,-,N,"ClinGen:CA130378,UniProtKB:P02792#VAR_070948,OMIM:134790.0017",1,39583,48965596,C,T,T30I,0,pathogenic,uncertain,P02792,P02792,reviewed,FRIL_HUMAN,"Ferritin light chain, Ferritin L subunit",FTL,Homo sapiens (Human),175.0,MSSQIRQNYSTDVEAAVNSLVNLYLQASYTYLSLGFYFDRDDVALEGVSHFFRELAEEKREGYERLLKMQNQRGGRALFQDIKKPAEDEWGKTPDAMKAAMALEKKLNQALLDLHALGSARTDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPEAGLGEYLFERLTLKHD,PF00210;,2FFX;2FG4;2FG8;3KXU;4V6B;5LG8;6TR9;6TS0;6TS1;6TSA;6TSF;6TSJ;6WX6;,30,T,I,True,1017
14009,12880,244080,single nucleotide variant,NM_052965.4(TSEN15):c.455A>G (p.Tyr152Cys),116461,TSEN15,HGNC:16791,Pathogenic,1,26-Sep-16,879253779,-,RCV000234975,"MONDO:MONDO:0014874,MedGen:C4310757,OMIM:617026,Orphanet:2524","Pontocerebellar hypoplasia, type 2f",germline,germline,GRCh38,NC_000001.11,1,184072258,184072258,na,na,1q25.3,no assertion criteria provided,1,-,N,"ClinGen:CA10584048,UniProtKB:Q8WW01#VAR_077063,OMIM:608756.0002",1,243000,184072258,A,G,Y152C,0,pathogenic,uncertain,Q8WW01,Q8WW01,reviewed,SEN15_HUMAN,"tRNA-splicing endonuclease subunit Sen15 (SEN15 homolog, HsSEN15) (tRNA-intron endonuclease Sen15)",TSEN15 C1orf19 SEN15,Homo sapiens (Human),171.0,MEERGDSEPTPGCSGLGPGGVRGFGDGGGAPSWAPEDAWMGTHPKYLEMMELDIGDATQVYVAFLVYLDLMESKSWHEVNCVGLPELQLICLVGTEIEGEGLQTVVPTPITASLSHNRIREILKASRKLQGDPDLPMSFTLAIVESDSTIVYYKLTDGFMLPDPQNISLRR,PF09631;,2GW6;6Z9U;,152,Y,C,True,1018
14010,12881,244081,single nucleotide variant,NM_052965.4(TSEN15):c.346C>T (p.His116Tyr),116461,TSEN15,HGNC:16791,Likely pathogenic,1,1-Mar-20,879253780,-,RCV000234984,"MONDO:MONDO:0014874,MedGen:C4310757,OMIM:617026,Orphanet:2524","Pontocerebellar hypoplasia, type 2f",biparental;germline,germline,GRCh38,NC_000001.11,1,184054856,184054856,na,na,1q25.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA10584049,UniProtKB:Q8WW01#VAR_077062,OMIM:608756.0003",3,243001,184054856,C,T,H116Y,1,pathogenic,pathogenic,Q8WW01,Q8WW01,reviewed,SEN15_HUMAN,"tRNA-splicing endonuclease subunit Sen15 (SEN15 homolog, HsSEN15) (tRNA-intron endonuclease Sen15)",TSEN15 C1orf19 SEN15,Homo sapiens (Human),171.0,MEERGDSEPTPGCSGLGPGGVRGFGDGGGAPSWAPEDAWMGTHPKYLEMMELDIGDATQVYVAFLVYLDLMESKSWHEVNCVGLPELQLICLVGTEIEGEGLQTVVPTPITASLSHNRIREILKASRKLQGDPDLPMSFTLAIVESDSTIVYYKLTDGFMLPDPQNISLRR,PF09631;,2GW6;6Z9U;,116,H,Y,True,1018
14011,11458,181398,single nucleotide variant,NM_052965.4(TSEN15):c.226T>G (p.Trp76Gly),116461,TSEN15,HGNC:16791,Pathogenic/Likely pathogenic,1,13-Jan-15,730882223,-,RCV000162135|RCV000234989,"Human Phenotype Ontology:HP:0001250,Human Phenotype Ontology:HP:0001275,Human Phenotype Ontology:HP:0001303,Human Phenotype Ontology:HP:0002125,Human Phenotype Ontology:HP:0002182,Human Phenotype Ontology:HP:0002279,Human Phenotype Ontology:HP:0002306,Human Phenotype Ontology:HP:0002348,Human Phenotype Ontology:HP:0002391,Human Phenotype Ontology:HP:0002417,Human Phenotype Ontology:HP:0002430,Human Phenotype Ontology:HP:0002431,Human Phenotype Ontology:HP:0002432,Human Phenotype Ontology:HP:0002434,Human Phenotype Ontology:HP:0002437,Human Phenotype Ontology:HP:0002466,Human Phenotype Ontology:HP:0002479,Human Phenotype Ontology:HP:0002794,Human Phenotype Ontology:HP:0006997,Human Phenotype Ontology:HP:0010520,MedGen:C0036572;MedGen:C0431350;Human Phenotype Ontology:HP:0000754,Human Phenotype Ontology:HP:0001255,Human Phenotype Ontology:HP:0001263,Human Phenotype Ontology:HP:0001277,Human Phenotype Ontology:HP:0001292,Human Phenotype Ontology:HP:0002433,Human Phenotype Ontology:HP:0002473,Human Phenotype Ontology:HP:0002532,Human Phenotype Ontology:HP:0006793,Human Phenotype Ontology:HP:0006867,Human Phenotype Ontology:HP:0006885,Human Phenotype Ontology:HP:0006935,Human Phenotype Ontology:HP:0007005,Human Phenotype Ontology:HP:0007094,Human Phenotype Ontology:HP:0007106,Human Phenotype Ontology:HP:0007174,Human Phenotype Ontology:HP:0007224,Human Phenotype Ontology:HP:0007228,Human Phenotype Ontology:HP:0007342,MedGen:C0557874|MONDO:MONDO:0014874,MedGen:C4310757,OMIM:617026,Orphanet:2524","Seizures;Primary microcephaly;Global developmental delay|Pontocerebellar hypoplasia, type 2f",germline,germline,GRCh38,NC_000001.11,1,184054736,184054736,na,na,1q25.3,no assertion criteria provided,2,-,N,"ClinGen:CA249942,UniProtKB:Q8WW01#VAR_077061,OMIM:608756.0001",3,183315,184054736,T,G,W76G,0,pathogenic,uncertain,Q8WW01,Q8WW01,reviewed,SEN15_HUMAN,"tRNA-splicing endonuclease subunit Sen15 (SEN15 homolog, HsSEN15) (tRNA-intron endonuclease Sen15)",TSEN15 C1orf19 SEN15,Homo sapiens (Human),171.0,MEERGDSEPTPGCSGLGPGGVRGFGDGGGAPSWAPEDAWMGTHPKYLEMMELDIGDATQVYVAFLVYLDLMESKSWHEVNCVGLPELQLICLVGTEIEGEGLQTVVPTPITASLSHNRIREILKASRKLQGDPDLPMSFTLAIVESDSTIVYYKLTDGFMLPDPQNISLRR,PF09631;,2GW6;6Z9U;,76,W,G,True,1018
14012,13871,301798,single nucleotide variant,NM_000230.3(LEP):c.280G>A (p.Val94Met),3952,LEP,HGNC:6553,Benign/Likely benign,0,31-Dec-19,17151919,-,RCV000306659|RCV000394361|RCV000445399|RCV000947067,"MedGen:CN239457|MONDO:MONDO:0013991,MedGen:C3554224,OMIM:614962,Orphanet:66628|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625|MedGen:CN517202",Monogenic Non-Syndromic Obesity|Leptin deficiency or dysfunction|Monogenic diabetes|not provided,germline;unknown,germline,GRCh38,NC_000007.14,7,128254539,128254539,na,na,7q32.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA4469685,UniProtKB:P41159#VAR_004197",2,358819,128254539,G,A,V94M,2,benign,benign,P41159,P41159,reviewed,LEP_HUMAN,Leptin (Obese protein) (Obesity factor),LEP OB OBS,Homo sapiens (Human),167.0,MHWGTLCGFLWLWPYLFYVQAVPIQKVQDDTKTLIKTIVTRINDISHTQSVSSKQKVTGLDFIPGLHPILTLSKMDQTLAVYQQILTSMPSRNVIQISNDLENLRDLLHVLAFSKSCHLPWASGLETLDSLGGVLEASGYSTEVVALSRLQGSLQDMLWQLDLSPGC,PF02024;,1AX8;,94,V,M,True,1019
14013,3708,29026,single nucleotide variant,NM_000230.3(LEP):c.313C>T (p.Arg105Trp),3952,LEP,HGNC:6553,Pathogenic,1,30-Mar-04,104894023,-,RCV000015024,"MONDO:MONDO:0013991,MedGen:C3554224,OMIM:614962,Orphanet:66628",Leptin deficiency or dysfunction,germline,germline,GRCh38,NC_000007.14,7,128254572,128254572,na,na,7q32.1,no assertion criteria provided,1,-,N,"ClinGen:CA123668,UniProtKB:P41159#VAR_008094,OMIM:164160.0002",1,13987,128254572,C,T,R105W,0,pathogenic,uncertain,P41159,P41159,reviewed,LEP_HUMAN,Leptin (Obese protein) (Obesity factor),LEP OB OBS,Homo sapiens (Human),167.0,MHWGTLCGFLWLWPYLFYVQAVPIQKVQDDTKTLIKTIVTRINDISHTQSVSSKQKVTGLDFIPGLHPILTLSKMDQTLAVYQQILTSMPSRNVIQISNDLENLRDLLHVLAFSKSCHLPWASGLETLDSLGGVLEASGYSTEVVALSRLQGSLQDMLWQLDLSPGC,PF02024;,1AX8;,105,R,W,True,1019
14014,11211,172121,single nucleotide variant,NM_000230.3(LEP):c.298G>T (p.Asp100Tyr),3952,LEP,HGNC:6553,Pathogenic,1,1-Jan-15,724159998,-,RCV000149807,MedGen:C4016279,Leptin dysfunction,germline,germline,GRCh38,NC_000007.14,7,128254557,128254557,na,na,7q32.1,no assertion criteria provided,1,-,N,"ClinGen:CA175034,UniProtKB:P41159#VAR_075144,OMIM:164160.0003",1,162430,128254557,G,T,D100Y,0,pathogenic,uncertain,P41159,P41159,reviewed,LEP_HUMAN,Leptin (Obese protein) (Obesity factor),LEP OB OBS,Homo sapiens (Human),167.0,MHWGTLCGFLWLWPYLFYVQAVPIQKVQDDTKTLIKTIVTRINDISHTQSVSSKQKVTGLDFIPGLHPILTLSKMDQTLAVYQQILTSMPSRNVIQISNDLENLRDLLHVLAFSKSCHLPWASGLETLDSLGGVLEASGYSTEVVALSRLQGSLQDMLWQLDLSPGC,PF02024;,1AX8;,100,D,Y,True,1019
14015,1272,20566,single nucleotide variant,NM_003673.3(TCAP):c.260G>A (p.Arg87Gln),8557,TCAP,HGNC:11610,Uncertain significance,0,1-May-16,121434298,-,RCV000005863|RCV000490830,"MONDO:MONDO:0011843,MedGen:C4225408,OMIM:607487|MONDO:MONDO:0007268,MedGen:C1861862,OMIM:115197",Hypertrophic cardiomyopathy 25|Familial hypertrophic cardiomyopathy 4,germline,germline,GRCh38,NC_000017.11,17,39665865,39665865,na,na,17q12,no assertion criteria provided,2,-,N,"ClinGen:CA253520,UniProtKB:O15273#VAR_015397,OMIM:604488.0003",3,5527,39665865,G,A,R87Q,0,uncertain,uncertain,O15273,O15273,reviewed,TELT_HUMAN,Telethonin (Titin cap protein),TCAP,Homo sapiens (Human),167.0,MATSELSCEVSEENCERREAFWAEWKDLTLSTRPEEGCSLHEEDTQRHETYHQQGQCQVLVQRSPWLMMRMGILGRGLQEYQLPYQRVLPLPIFTPAKMGATKEEREDTPIQLQELLALETALGGQCVDRQEVAEITKQLPPVVPVSKPGALRRSLSRSMSQEAQRG,PF09470;,1YA5;2F8V;,87,R,Q,True,1020
14016,6865,53873,single nucleotide variant,NM_003673.4(TCAP):c.316C>T (p.Arg106Cys),8557,TCAP,HGNC:11610,Benign/Likely benign,0,3-Apr-20,45578741,-,RCV000037793|RCV000172591|RCV000245436|RCV000586561|RCV000770526|RCV001082352|RCV001122674|RCV001122675|RCV001258227|RCV001283692,"MedGen:CN169374|MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|MedGen:CN230736|MedGen:CN517202|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0011843,MedGen:C4225408,OMIM:607487;MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|MONDO:MONDO:0011170,MedGen:C1866008,OMIM:601954,Orphanet:34514|MONDO:MONDO:0011843,MedGen:C4225408,OMIM:607487|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|MedGen:CN235283",not specified|Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype|not provided|Cardiomyopathy|Hypertrophic cardiomyopathy 25;Primary familial hypertrophic cardiomyopathy|Autosomal recessive limb-girdle muscular dystrophy type 2G|Hypertrophic cardiomyopathy 25|Hypertrophic cardiomyopathy|none provided,germline;unknown,germline,GRCh38,NC_000017.11,17,39665921,39665921,na,na,17q12,"criteria provided, multiple submitters, no conflicts",14,-,N,"ClinGen:CA274805,UniProtKB:O15273#VAR_051421",2,44706,39665921,C,T,R106C,2,benign,benign,O15273,O15273,reviewed,TELT_HUMAN,Telethonin (Titin cap protein),TCAP,Homo sapiens (Human),167.0,MATSELSCEVSEENCERREAFWAEWKDLTLSTRPEEGCSLHEEDTQRHETYHQQGQCQVLVQRSPWLMMRMGILGRGLQEYQLPYQRVLPLPIFTPAKMGATKEEREDTPIQLQELLALETALGGQCVDRQEVAEITKQLPPVVPVSKPGALRRSLSRSMSQEAQRG,PF09470;,1YA5;2F8V;,106,R,C,True,1020
14017,11299,176628,single nucleotide variant,NM_003673.4(TCAP):c.269C>T (p.Pro90Leu),8557,TCAP,HGNC:11610,Uncertain significance,0,28-May-20,727504427,-,RCV000154643|RCV000640703,"MedGen:CN169374|MONDO:MONDO:0011843,MedGen:C4225408,OMIM:607487;MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155",not specified|Hypertrophic cardiomyopathy 25;Primary familial hypertrophic cardiomyopathy,germline,germline,GRCh38,NC_000017.11,17,39665874,39665874,na,na,17q12,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA181091,UniProtKB:O15273#VAR_026651",2,177970,39665874,C,T,P90L,2,uncertain,uncertain,O15273,O15273,reviewed,TELT_HUMAN,Telethonin (Titin cap protein),TCAP,Homo sapiens (Human),167.0,MATSELSCEVSEENCERREAFWAEWKDLTLSTRPEEGCSLHEEDTQRHETYHQQGQCQVLVQRSPWLMMRMGILGRGLQEYQLPYQRVLPLPIFTPAKMGATKEEREDTPIQLQELLALETALGGQCVDRQEVAEITKQLPPVVPVSKPGALRRSLSRSMSQEAQRG,PF09470;,1YA5;2F8V;,90,P,L,True,1020
14018,6866,53877,single nucleotide variant,NM_003673.4(TCAP):c.458G>A (p.Arg153His),8557,TCAP,HGNC:11610,Conflicting interpretations of pathogenicity,1,31-Dec-19,149585781,-,RCV000037797|RCV000170302|RCV000765349|RCV000766898|RCV001087199,"MedGen:CN169374|MONDO:MONDO:0011843,MedGen:C4225408,OMIM:607487|MONDO:MONDO:0011843,MedGen:C4225408,OMIM:607487;MONDO:MONDO:0011170,MedGen:C1866008,OMIM:601954,Orphanet:34514|MedGen:CN517202|MONDO:MONDO:0011843,MedGen:C4225408,OMIM:607487;MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155",not specified|Hypertrophic cardiomyopathy 25|Hypertrophic cardiomyopathy 25;Autosomal recessive limb-girdle muscular dystrophy type 2G|not provided|Hypertrophic cardiomyopathy 25;Primary familial hypertrophic cardiomyopathy,germline;unknown,germline,GRCh38,NC_000017.11,17,39666063,39666063,na,na,17q12,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA134926,UniProtKB:O15273#VAR_029448,OMIM:604488.0005",3,44710,39666063,G,A,R153H,1,uncertain,uncertain,O15273,O15273,reviewed,TELT_HUMAN,Telethonin (Titin cap protein),TCAP,Homo sapiens (Human),167.0,MATSELSCEVSEENCERREAFWAEWKDLTLSTRPEEGCSLHEEDTQRHETYHQQGQCQVLVQRSPWLMMRMGILGRGLQEYQLPYQRVLPLPIFTPAKMGATKEEREDTPIQLQELLALETALGGQCVDRQEVAEITKQLPPVVPVSKPGALRRSLSRSMSQEAQRG,PF09470;,1YA5;2F8V;,153,R,H,True,1020
14019,11682,187659,single nucleotide variant,NM_003673.3(TCAP):c.208C>T (p.Arg70Trp),8557,TCAP,HGNC:11610,Uncertain significance,1,8-Jul-20,775636212,-,RCV000170303|RCV000172108|RCV000382675|RCV000536183,"MONDO:MONDO:0011843,MedGen:C4225408,OMIM:607487|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|MedGen:CN517202|MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155;MONDO:MONDO:0011843,MedGen:C4225408,OMIM:607487",Hypertrophic cardiomyopathy 25|Hypertrophic cardiomyopathy|not provided|Primary familial hypertrophic cardiomyopathy;Hypertrophic cardiomyopathy 25,germline;unknown,germline,GRCh38,NC_000017.11,17,39665813,39665813,na,na,17q12,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA249987,UniProtKB:O15273#VAR_026650,OMIM:604488.0006",3,189789,39665813,C,T,R70W,2,uncertain,uncertain,O15273,O15273,reviewed,TELT_HUMAN,Telethonin (Titin cap protein),TCAP,Homo sapiens (Human),167.0,MATSELSCEVSEENCERREAFWAEWKDLTLSTRPEEGCSLHEEDTQRHETYHQQGQCQVLVQRSPWLMMRMGILGRGLQEYQLPYQRVLPLPIFTPAKMGATKEEREDTPIQLQELLALETALGGQCVDRQEVAEITKQLPPVVPVSKPGALRRSLSRSMSQEAQRG,PF09470;,1YA5;2F8V;,70,R,W,True,1020
14020,11681,187657,single nucleotide variant,NM_003673.3(TCAP):c.410C>T (p.Thr137Ile),8557,TCAP,HGNC:11610,Pathogenic,1,7-Dec-04,773317399,-,RCV000170301,"MONDO:MONDO:0011843,MedGen:C4225408,OMIM:607487",Hypertrophic cardiomyopathy 25,germline,germline,GRCh38,NC_000017.11,17,39666015,39666015,na,na,17q12,no assertion criteria provided,1,-,N,"ClinGen:CA274680,UniProtKB:O15273#VAR_029447,OMIM:604488.0004",1,189787,39666015,C,T,T137I,0,pathogenic,uncertain,O15273,O15273,reviewed,TELT_HUMAN,Telethonin (Titin cap protein),TCAP,Homo sapiens (Human),167.0,MATSELSCEVSEENCERREAFWAEWKDLTLSTRPEEGCSLHEEDTQRHETYHQQGQCQVLVQRSPWLMMRMGILGRGLQEYQLPYQRVLPLPIFTPAKMGATKEEREDTPIQLQELLALETALGGQCVDRQEVAEITKQLPPVVPVSKPGALRRSLSRSMSQEAQRG,PF09470;,1YA5;2F8V;,137,T,I,True,1020
14021,110,15440,single nucleotide variant,NM_017841.2(SDHAF2):c.232G>A (p.Gly78Arg),54949,SDHAF2,HGNC:26034,Pathogenic,1,16-Dec-19,113560320,-,RCV000000428|RCV000165971|RCV000519058|RCV000639339,"MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650,Orphanet:29072|MONDO:MONDO:0015356,MedGen:C0027672,Orphanet:140162|MedGen:CN517202|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072",Paragangliomas 2|Hereditary cancer-predisposing syndrome|not provided|Hereditary Paraganglioma-Pheochromocytoma Syndromes,germline,germline,GRCh38,NC_000011.10,11,61437820,61437820,na,na,11q12.2,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"ClinGen:CA017320,UniProtKB:Q9NX18#VAR_058705,OMIM:613019.0001",3,401,61437820,G,A,G78R,2,pathogenic,pathogenic,Q9NX18,Q9NX18,reviewed,SDHF2_HUMAN,"Succinate dehydrogenase assembly factor 2, mitochondrial, SDH assembly factor 2, SDHAF2",SDHAF2 C11orf79 PGL2 SDH5,Homo sapiens (Human),166.0,MAVSTVFSTSSLMLALSRHSLLSPLLSVTSFRRFYRGDSPTDSQKDMIEIPLPPWQERTDESIETKRARLLYESRKRGMLENCILLSLFAKEHLQHMTEKQLNLYDRLINEPSNDWDIYYWATEAKPAPEIFENEVMALLRDFAKNKNKEQRLRAPDLEYLFEKPR,PF03937;,6VAX;,78,G,R,True,1021
14022,6082,40429,single nucleotide variant,NM_000432.3(MYL2):c.497A>T (p.Asp166Val),4633,MYL2,HGNC:7583,not provided,0,26-Mar-12,199474815,-,RCV000024460,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000012.12,12,110911081,110911081,na,na,12q24.11,no assertion provided,1,"ACMG2013,ACMG2016",N,"ClinGen:CA010471,Leiden Muscular Dystrophy (MYL2):MYL2_00010,UniProtKB:P10916#VAR_019844",2,31769,110911081,T,A,D166V,0,uncertain,uncertain,P10916,P10916,reviewed,MLRV_HUMAN,"Myosin regulatory light chain 2, ventricular/cardiac muscle isoform, MLC-2, MLC-2v (Cardiac myosin light chain 2) (Myosin light chain 2, slow skeletal/ventricular muscle isoform, MLC-2s/v) (Ventricular myosin light chain 2)",MYL2 MLC2,Homo sapiens (Human),166.0,MAPKKAKKRAGGANSNVFSMFEQTQIQEFKEAFTIMDQNRDGFIDKNDLRDTFAALGRVNVKNEEIDEMIKEAPGPINFTVFLTMFGEKLKGADPEETILNAFKVFDPEGKGVLKADYVREMLTTQAERFSKEEVDQMFAAFPPDVTGNLDYKNLVHIITHGEEKD,PF00036;,5TBY;,166,D,V,True,1022
14023,3731,29106,single nucleotide variant,NM_000432.4(MYL2):c.173G>A (p.Arg58Gln),4633,MYL2,HGNC:7583,Pathogenic/Likely pathogenic,1,30-Dec-19,104894369,-,RCV000015111|RCV000157369|RCV000158923|RCV000621867|RCV000844711,"MONDO:MONDO:0012112,MedGen:C1834460,OMIM:608758|MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|MedGen:CN517202|MedGen:CN230736|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569",Familial hypertrophic cardiomyopathy 10|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy,germline;unknown,germline,GRCh38,NC_000012.12,12,110914287,110914287,na,na,12q24.11,"criteria provided, multiple submitters, no conflicts",9,"ACMG2013,ACMG2016",N,"OMIM:160781.0004,ClinGen:CA009915,Leiden Muscular Dystrophy (MYL2):MYL2_00005,UniProtKB:P10916#VAR_004604",3,14067,110914287,C,T,R58Q,2,pathogenic,pathogenic,P10916,P10916,reviewed,MLRV_HUMAN,"Myosin regulatory light chain 2, ventricular/cardiac muscle isoform, MLC-2, MLC-2v (Cardiac myosin light chain 2) (Myosin light chain 2, slow skeletal/ventricular muscle isoform, MLC-2s/v) (Ventricular myosin light chain 2)",MYL2 MLC2,Homo sapiens (Human),166.0,MAPKKAKKRAGGANSNVFSMFEQTQIQEFKEAFTIMDQNRDGFIDKNDLRDTFAALGRVNVKNEEIDEMIKEAPGPINFTVFLTMFGEKLKGADPEETILNAFKVFDPEGKGVLKADYVREMLTTQAERFSKEEVDQMFAAFPPDVTGNLDYKNLVHIITHGEEKD,PF00036;,5TBY;,58,R,Q,True,1022
14024,3732,29107,single nucleotide variant,NM_000432.3(MYL2):c.52T>C (p.Phe18Leu),4633,MYL2,HGNC:7583,Likely pathogenic,1,8-Mar-19,104894370,-,RCV000015112|RCV000246859,"MONDO:MONDO:0012112,MedGen:C1834460,OMIM:608758|MedGen:CN230736",Familial hypertrophic cardiomyopathy 10|Cardiovascular phenotype,germline,germline,GRCh38,NC_000012.12,12,110919145,110919145,na,na,12q24.11,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"OMIM:160781.0005,ClinGen:CA010488,Leiden Muscular Dystrophy (MYL2):MYL2_00002,UniProtKB:P10916#VAR_004602",3,14068,110919145,A,G,F18L,2,pathogenic,pathogenic,P10916,P10916,reviewed,MLRV_HUMAN,"Myosin regulatory light chain 2, ventricular/cardiac muscle isoform, MLC-2, MLC-2v (Cardiac myosin light chain 2) (Myosin light chain 2, slow skeletal/ventricular muscle isoform, MLC-2s/v) (Ventricular myosin light chain 2)",MYL2 MLC2,Homo sapiens (Human),166.0,MAPKKAKKRAGGANSNVFSMFEQTQIQEFKEAFTIMDQNRDGFIDKNDLRDTFAALGRVNVKNEEIDEMIKEAPGPINFTVFLTMFGEKLKGADPEETILNAFKVFDPEGKGVLKADYVREMLTTQAERFSKEEVDQMFAAFPPDVTGNLDYKNLVHIITHGEEKD,PF00036;,5TBY;,18,F,L,True,1022
14025,3730,29105,single nucleotide variant,NM_000432.3(MYL2):c.283C>G (p.Pro95Ala),4633,MYL2,HGNC:7583,Pathogenic,1,1-May-96,121913658,-,RCV000015110,"MONDO:MONDO:0012112,MedGen:C1834460,OMIM:608758",Familial hypertrophic cardiomyopathy 10,germline,germline,GRCh38,NC_000012.12,12,110913316,110913316,na,na,12q24.11,no assertion criteria provided,2,"ACMG2013,ACMG2016",N,"OMIM:160781.0003,ClinGen:CA010047,Leiden Muscular Dystrophy (MYL2):MYL2_00007,UniProtKB:P10916#VAR_004605",3,14066,110913316,G,C,P95A,0,pathogenic,uncertain,P10916,P10916,reviewed,MLRV_HUMAN,"Myosin regulatory light chain 2, ventricular/cardiac muscle isoform, MLC-2, MLC-2v (Cardiac myosin light chain 2) (Myosin light chain 2, slow skeletal/ventricular muscle isoform, MLC-2s/v) (Ventricular myosin light chain 2)",MYL2 MLC2,Homo sapiens (Human),166.0,MAPKKAKKRAGGANSNVFSMFEQTQIQEFKEAFTIMDQNRDGFIDKNDLRDTFAALGRVNVKNEEIDEMIKEAPGPINFTVFLTMFGEKLKGADPEETILNAFKVFDPEGKGVLKADYVREMLTTQAERFSKEEVDQMFAAFPPDVTGNLDYKNLVHIITHGEEKD,PF00036;,5TBY;,95,P,A,True,1022
14026,3728,29103,single nucleotide variant,NM_000432.4(MYL2):c.37G>A (p.Ala13Thr),4633,MYL2,HGNC:7583,Conflicting interpretations of pathogenicity,1,30-Sep-20,104894363,-,RCV000015108|RCV000036401|RCV000148714|RCV000584799|RCV000620870|RCV000626337|RCV000766474|RCV000778905|RCV001184984,"MONDO:MONDO:0012112,MedGen:C1834460,OMIM:608758|MedGen:CN169374|MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|MONDO:MONDO:0008647,MedGen:C3495498,OMIM:192600|MedGen:CN230736|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|MedGen:CN517202||Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848",Familial hypertrophic cardiomyopathy 10|not specified|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Cardiovascular phenotype|Hypertrophic cardiomyopathy|not provided|MYL2-Related Disorders|Cardiomyopathy,germline;unknown,germline,GRCh38,NC_000012.12,12,110919160,110919160,na,na,12q24.11,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"ClinGen:CA010242,Leiden Muscular Dystrophy (MYL2):MYL2_00001,UniProtKB:P10916#VAR_004601,OMIM:160781.0001",3,14064,110919160,C,T,A13T,1,uncertain,uncertain,P10916,P10916,reviewed,MLRV_HUMAN,"Myosin regulatory light chain 2, ventricular/cardiac muscle isoform, MLC-2, MLC-2v (Cardiac myosin light chain 2) (Myosin light chain 2, slow skeletal/ventricular muscle isoform, MLC-2s/v) (Ventricular myosin light chain 2)",MYL2 MLC2,Homo sapiens (Human),166.0,MAPKKAKKRAGGANSNVFSMFEQTQIQEFKEAFTIMDQNRDGFIDKNDLRDTFAALGRVNVKNEEIDEMIKEAPGPINFTVFLTMFGEKLKGADPEETILNAFKVFDPEGKGVLKADYVREMLTTQAERFSKEEVDQMFAAFPPDVTGNLDYKNLVHIITHGEEKD,PF00036;,5TBY;,13,A,T,True,1022
14027,3729,29104,single nucleotide variant,NM_000432.4(MYL2):c.64G>A (p.Glu22Lys),4633,MYL2,HGNC:7583,Pathogenic/Likely pathogenic,1,23-Oct-19,104894368,-,RCV000015109|RCV000158914|RCV000234985|RCV000768488|RCV001170438,"MONDO:MONDO:0012112,MedGen:C1834460,OMIM:608758|MedGen:CN517202|Human Phenotype Ontology:HP:0100613,MedGen:C4022012|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,OMIM:PS192600,Orphanet:217569|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848",Familial hypertrophic cardiomyopathy 10|not provided|Death in early adulthood|Hypertrophic cardiomyopathy|Cardiomyopathy,germline;unknown,germline,GRCh38,NC_000012.12,12,110919133,110919133,na,na,12q24.11,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"ClinGen:CA010513,Leiden Muscular Dystrophy (MYL2):MYL2_00003,UniProtKB:P10916#VAR_004603,OMIM:160781.0002",3,14065,110919133,C,T,E22K,2,pathogenic,pathogenic,P10916,P10916,reviewed,MLRV_HUMAN,"Myosin regulatory light chain 2, ventricular/cardiac muscle isoform, MLC-2, MLC-2v (Cardiac myosin light chain 2) (Myosin light chain 2, slow skeletal/ventricular muscle isoform, MLC-2s/v) (Ventricular myosin light chain 2)",MYL2 MLC2,Homo sapiens (Human),166.0,MAPKKAKKRAGGANSNVFSMFEQTQIQEFKEAFTIMDQNRDGFIDKNDLRDTFAALGRVNVKNEEIDEMIKEAPGPINFTVFLTMFGEKLKGADPEETILNAFKVFDPEGKGVLKADYVREMLTTQAERFSKEEVDQMFAAFPPDVTGNLDYKNLVHIITHGEEKD,PF00036;,5TBY;,22,E,K,True,1022
14028,317,16300,single nucleotide variant,NM_032193.3(RNASEH2C):c.428A>T (p.Lys143Ile),84153,RNASEH2C,HGNC:24116,Pathogenic,1,1-Aug-06,75146158,-,RCV000001323,"MONDO:MONDO:0012471,MedGen:C1835916,OMIM:610329,Orphanet:51",Aicardi Goutieres syndrome 3,germline,germline,GRCh38,NC_000011.10,11,65720085,65720085,na,na,11q13.1,no assertion criteria provided,1,-,N,"ClinGen:CA251722,UniProtKB:Q8TDP1#VAR_027288,OMIM:610330.0002",1,1261,65720085,T,A,K143I,0,pathogenic,uncertain,Q8TDP1,Q8TDP1,reviewed,RNH2C_HUMAN,"Ribonuclease H2 subunit C, RNase H2 subunit C (Aicardi-Goutieres syndrome 3 protein, AGS3) (RNase H1 small subunit) (Ribonuclease HI subunit C)",RNASEH2C AYP1,Homo sapiens (Human),164.0,MESGDEAAIERHRVHLRSATLRDAVPATLHLLPCEVAVDGPAPVGRFFTPAIRQGPEGLEVSFRGRCLRGEEVAVPPGLVGYVMVTEEKKVSMGKPDPLRDSGTDDQEEEPLERDFDRFIGATANFSRFTLWGLETIPGPDAKVRGALTWPSLAAAIHAQVPED,PF08615;,3P56;3PUF;,143,K,I,True,1023
14029,12609,227131,single nucleotide variant,NM_018283.4(NUDT15):c.52G>A (p.Val18Ile),55270,NUDT15,HGNC:23063,drug response,0,25-Oct-16,186364861,-,RCV000210850,"MONDO:MONDO:0014826,MedGen:C4225160,OMIM:616903","Thiopurines, poor metabolism of, 2",germline,germline,GRCh38,NC_000013.11,13,48037798,48037798,na,na,13q14.2,no assertion criteria provided,1,-,Y,"ClinGen:CA358313,UniProtKB:Q9NV35#VAR_076806,OMIM:615792.0003",1,225203,48037798,G,A,V18I,0,uncertain,uncertain,Q9NV35,Q9NV35,reviewed,NUD15_HUMAN,"Nucleotide triphosphate diphosphatase NUDT15, EC 3.6.1.9 (MutT homolog 2, MTH2) (Nucleoside diphosphate-linked moiety X motif 15, Nudix motif 15) (Nucleoside diphosphate-linked to another moiety X hydrolase 15, Nudix hydrolase 15)",NUDT15 MTH2,Homo sapiens (Human),164.0,MTASAQPRGRRPGVGVGVVVTSCKHPRCVLLGKRKGSVGAGSFQLPGGHLEFGETWEECAQRETWEEAALHLKNVHFASVVNSFIEKENYHYVTILMKGEVDVTHDSEPKNVEPEKNESWEWVPWEELPPLDQLFWGLRCLKEQGYDPFKEDLNHLVGYKGNHL,PF00293;,5BON;5LPG;6T5J;7AOM;7AOP;7B63;7B64;7B65;7B66;7B67;7B7V;,18,V,I,True,1024
14030,12607,227129,single nucleotide variant,NM_018283.4(NUDT15):c.415C>T (p.Arg139Cys),55270,NUDT15,HGNC:23063,drug response,0,9-Feb-17,116855232,-,RCV000210853|RCV000211238|RCV000211416,"MONDO:MONDO:0014826,MedGen:C4225160,OMIM:616903|MedGen:CN236534|MedGen:CN236486","Thiopurines, poor metabolism of, 2|mercaptopurine response - Dosage, Toxicity/ADR|azathioprine response - Dosage, Toxicity/ADR",germline,germline,GRCh38,NC_000013.11,13,48045719,48045719,na,na,13q14.2,reviewed by expert panel,2,-,Y,"PharmGKB Clinical Annotation:1184514050,ClinGen:CA358364,UniProtKB:Q9NV35#VAR_076808,OMIM:615792.0001",1,225201,48045719,C,T,R139C,3,uncertain,uncertain,Q9NV35,Q9NV35,reviewed,NUD15_HUMAN,"Nucleotide triphosphate diphosphatase NUDT15, EC 3.6.1.9 (MutT homolog 2, MTH2) (Nucleoside diphosphate-linked moiety X motif 15, Nudix motif 15) (Nucleoside diphosphate-linked to another moiety X hydrolase 15, Nudix hydrolase 15)",NUDT15 MTH2,Homo sapiens (Human),164.0,MTASAQPRGRRPGVGVGVVVTSCKHPRCVLLGKRKGSVGAGSFQLPGGHLEFGETWEECAQRETWEEAALHLKNVHFASVVNSFIEKENYHYVTILMKGEVDVTHDSEPKNVEPEKNESWEWVPWEELPPLDQLFWGLRCLKEQGYDPFKEDLNHLVGYKGNHL,PF00293;,5BON;5LPG;6T5J;7AOM;7AOP;7B63;7B64;7B65;7B66;7B67;7B7V;,139,R,C,True,1024
14031,12608,227130,single nucleotide variant,NM_018283.4(NUDT15):c.416G>A (p.Arg139His),55270,NUDT15,HGNC:23063,drug response,0,25-Oct-16,147390019,-,RCV000210847,"MONDO:MONDO:0014826,MedGen:C4225160,OMIM:616903","Thiopurines, poor metabolism of, 2",germline,germline,GRCh38,NC_000013.11,13,48045720,48045720,na,na,13q14.2,no assertion criteria provided,1,-,Y,"ClinGen:CA358362,UniProtKB:Q9NV35#VAR_076809,OMIM:615792.0002",1,225202,48045720,G,A,R139H,0,uncertain,uncertain,Q9NV35,Q9NV35,reviewed,NUD15_HUMAN,"Nucleotide triphosphate diphosphatase NUDT15, EC 3.6.1.9 (MutT homolog 2, MTH2) (Nucleoside diphosphate-linked moiety X motif 15, Nudix motif 15) (Nucleoside diphosphate-linked to another moiety X hydrolase 15, Nudix hydrolase 15)",NUDT15 MTH2,Homo sapiens (Human),164.0,MTASAQPRGRRPGVGVGVVVTSCKHPRCVLLGKRKGSVGAGSFQLPGGHLEFGETWEECAQRETWEEAALHLKNVHFASVVNSFIEKENYHYVTILMKGEVDVTHDSEPKNVEPEKNESWEWVPWEELPPLDQLFWGLRCLKEQGYDPFKEDLNHLVGYKGNHL,PF00293;,5BON;5LPG;6T5J;7AOM;7AOP;7B63;7B64;7B65;7B66;7B67;7B7V;,139,R,H,True,1024
14032,2977,27248,single nucleotide variant,NM_000490.5(AVP):c.277G>T (p.Gly93Trp),551,AVP,HGNC:894,Pathogenic,1,1-Apr-95,121964885,-,RCV000012993,"MONDO:MONDO:0007450,MedGen:C0687720,OMIM:125700,Orphanet:178029,Orphanet:30925",Neurohypophyseal diabetes insipidus,germline,germline,GRCh38,NC_000020.11,20,3083022,3083022,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA121955,UniProtKB:P01185#VAR_004993,OMIM:192340.0006",1,12209,3083022,C,A,G93W,0,pathogenic,uncertain,P01185,P01185,reviewed,NEU2_HUMAN,Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin ],AVP ARVP VP,Homo sapiens (Human),164.0,MPDTMLPACFLGLLAFSSACYFQNCPRGGKRAMSDLELRQCLPCGPGGKGRCFGPSICCADELGCFVGTAEALRCQEENYLPSPCQSGQKACGSGGRCAAFGVCCNDESCVTEPECREGFHRRARASDRSNATQLDGPAGALLLRLVQLAGAPEPFEPAQPDAY,PF00220;PF00184;,7BB6;7BB7;7DW9;7KH0;,93,G,W,True,1025
14033,2979,27251,single nucleotide variant,NM_000490.5(AVP):c.56C>T (p.Ala19Val),551,AVP,HGNC:894,Pathogenic,1,1-Feb-98,387906512,-,RCV000012996,"MONDO:MONDO:0007450,MedGen:C0687720,OMIM:125700,Orphanet:178029,Orphanet:30925",Neurohypophyseal diabetes insipidus,germline,germline,GRCh38,NC_000020.11,20,3084619,3084619,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA121959,UniProtKB:P01185#VAR_004982,OMIM:192340.0009",1,12212,3084619,G,A,A19V,0,pathogenic,uncertain,P01185,P01185,reviewed,NEU2_HUMAN,Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin ],AVP ARVP VP,Homo sapiens (Human),164.0,MPDTMLPACFLGLLAFSSACYFQNCPRGGKRAMSDLELRQCLPCGPGGKGRCFGPSICCADELGCFVGTAEALRCQEENYLPSPCQSGQKACGSGGRCAAFGVCCNDESCVTEPECREGFHRRARASDRSNATQLDGPAGALLLRLVQLAGAPEPFEPAQPDAY,PF00220;PF00184;,7BB6;7BB7;7DW9;7KH0;,19,A,V,True,1025
14034,2976,27245,single nucleotide variant,NM_000490.5(AVP):c.55G>A (p.Ala19Thr),551,AVP,HGNC:894,Pathogenic,1,1-Aug-99,387906511,-,RCV000012990,"MONDO:MONDO:0007450,MedGen:C0687720,OMIM:125700,Orphanet:178029,Orphanet:30925",Neurohypophyseal diabetes insipidus,germline,germline,GRCh38,NC_000020.11,20,3084620,3084620,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA121950,UniProtKB:P01185#VAR_004981,OMIM:192340.0003",1,12206,3084620,C,T,A19T,0,pathogenic,uncertain,P01185,P01185,reviewed,NEU2_HUMAN,Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin ],AVP ARVP VP,Homo sapiens (Human),164.0,MPDTMLPACFLGLLAFSSACYFQNCPRGGKRAMSDLELRQCLPCGPGGKGRCFGPSICCADELGCFVGTAEALRCQEENYLPSPCQSGQKACGSGGRCAAFGVCCNDESCVTEPECREGFHRRARASDRSNATQLDGPAGALLLRLVQLAGAPEPFEPAQPDAY,PF00220;PF00184;,7BB6;7BB7;7DW9;7KH0;,19,A,T,True,1025
14035,2975,27244,single nucleotide variant,NM_000490.5(AVP):c.143G>T (p.Gly48Val),551,AVP,HGNC:894,Pathogenic,1,1-Nov-96,121964883,-,RCV000012989,"MONDO:MONDO:0007450,MedGen:C0687720,OMIM:125700,Orphanet:178029,Orphanet:30925",Neurohypophyseal diabetes insipidus,germline,germline,GRCh38,NC_000020.11,20,3083156,3083156,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA121948,UniProtKB:P01185#VAR_004984,OMIM:192340.0002",1,12205,3083156,C,A,G48V,0,pathogenic,uncertain,P01185,P01185,reviewed,NEU2_HUMAN,Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin ],AVP ARVP VP,Homo sapiens (Human),164.0,MPDTMLPACFLGLLAFSSACYFQNCPRGGKRAMSDLELRQCLPCGPGGKGRCFGPSICCADELGCFVGTAEALRCQEENYLPSPCQSGQKACGSGGRCAAFGVCCNDESCVTEPECREGFHRRARASDRSNATQLDGPAGALLLRLVQLAGAPEPFEPAQPDAY,PF00220;PF00184;,7BB6;7BB7;7DW9;7KH0;,48,G,V,True,1025
14036,2978,27250,single nucleotide variant,NM_000490.5(AVP):c.287G>T (p.Gly96Val),551,AVP,HGNC:894,Pathogenic,1,1-May-96,121964886,-,RCV000012995,"MONDO:MONDO:0007450,MedGen:C0687720,OMIM:125700,Orphanet:178029,Orphanet:30925",Neurohypophyseal diabetes insipidus,germline,germline,GRCh38,NC_000020.11,20,3083012,3083012,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA121957,UniProtKB:P01185#VAR_015271,OMIM:192340.0008",1,12211,3083012,C,A,G96V,0,pathogenic,uncertain,P01185,P01185,reviewed,NEU2_HUMAN,Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin ],AVP ARVP VP,Homo sapiens (Human),164.0,MPDTMLPACFLGLLAFSSACYFQNCPRGGKRAMSDLELRQCLPCGPGGKGRCFGPSICCADELGCFVGTAEALRCQEENYLPSPCQSGQKACGSGGRCAAFGVCCNDESCVTEPECREGFHRRARASDRSNATQLDGPAGALLLRLVQLAGAPEPFEPAQPDAY,PF00220;PF00184;,7BB6;7BB7;7DW9;7KH0;,96,G,V,True,1025
14037,2980,27252,single nucleotide variant,NM_000490.5(AVP):c.161G>T (p.Gly54Val),551,AVP,HGNC:894,Pathogenic,1,1-Sep-99,121964887,-,RCV000012997,"MONDO:MONDO:0007450,MedGen:C0687720,OMIM:125700,Orphanet:178029,Orphanet:30925",Neurohypophyseal diabetes insipidus,germline,germline,GRCh38,NC_000020.11,20,3083138,3083138,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA121961,UniProtKB:P01185#VAR_015266,OMIM:192340.0010",1,12213,3083138,C,A,G54V,0,pathogenic,uncertain,P01185,P01185,reviewed,NEU2_HUMAN,Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin ],AVP ARVP VP,Homo sapiens (Human),164.0,MPDTMLPACFLGLLAFSSACYFQNCPRGGKRAMSDLELRQCLPCGPGGKGRCFGPSICCADELGCFVGTAEALRCQEENYLPSPCQSGQKACGSGGRCAAFGVCCNDESCVTEPECREGFHRRARASDRSNATQLDGPAGALLLRLVQLAGAPEPFEPAQPDAY,PF00220;PF00184;,7BB6;7BB7;7DW9;7KH0;,54,G,V,True,1025
14038,2986,27260,single nucleotide variant,NM_000490.5(AVP):c.61T>C (p.Tyr21His),551,AVP,HGNC:894,Pathogenic,1,1-Sep-04,121964893,-,RCV000013005,"MONDO:MONDO:0007450,MedGen:C0687720,OMIM:125700,Orphanet:178029,Orphanet:30925",Neurohypophyseal diabetes insipidus,germline,germline,GRCh38,NC_000020.11,20,3084614,3084614,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA121979,UniProtKB:P01185#VAR_015262,OMIM:192340.0018",1,12221,3084614,A,G,Y21H,0,pathogenic,uncertain,P01185,P01185,reviewed,NEU2_HUMAN,Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin ],AVP ARVP VP,Homo sapiens (Human),164.0,MPDTMLPACFLGLLAFSSACYFQNCPRGGKRAMSDLELRQCLPCGPGGKGRCFGPSICCADELGCFVGTAEALRCQEENYLPSPCQSGQKACGSGGRCAAFGVCCNDESCVTEPECREGFHRRARASDRSNATQLDGPAGALLLRLVQLAGAPEPFEPAQPDAY,PF00220;PF00184;,7BB6;7BB7;7DW9;7KH0;,21,Y,H,True,1025
14039,2985,27259,single nucleotide variant,NM_000490.5(AVP):c.346T>G (p.Cys116Gly),551,AVP,HGNC:894,Pathogenic,1,1-Jul-01,74315383,-,RCV000013004,"MONDO:MONDO:0007450,MedGen:C0687720,OMIM:125700,Orphanet:178029,Orphanet:30925",Neurohypophyseal diabetes insipidus,germline,germline,GRCh38,NC_000020.11,20,3082779,3082779,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA121977,UniProtKB:P01185#VAR_015277,OMIM:192340.0017",1,12220,3082779,A,C,C116G,0,pathogenic,uncertain,P01185,P01185,reviewed,NEU2_HUMAN,Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin ],AVP ARVP VP,Homo sapiens (Human),164.0,MPDTMLPACFLGLLAFSSACYFQNCPRGGKRAMSDLELRQCLPCGPGGKGRCFGPSICCADELGCFVGTAEALRCQEENYLPSPCQSGQKACGSGGRCAAFGVCCNDESCVTEPECREGFHRRARASDRSNATQLDGPAGALLLRLVQLAGAPEPFEPAQPDAY,PF00220;PF00184;,7BB6;7BB7;7DW9;7KH0;,116,C,G,True,1025
14040,2984,27257,single nucleotide variant,NM_000490.5(AVP):c.200T>C (p.Val67Ala),551,AVP,HGNC:894,Pathogenic,1,1-Jan-04,28934878,-,RCV000013002,"MONDO:MONDO:0007450,MedGen:C0687720,OMIM:125700,Orphanet:178029,Orphanet:30925",Neurohypophyseal diabetes insipidus,germline,germline,GRCh38,NC_000020.11,20,3083099,3083099,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA121972,UniProtKB:P01185#VAR_019273,OMIM:192340.0019",1,12218,3083099,A,G,V67A,0,pathogenic,uncertain,P01185,P01185,reviewed,NEU2_HUMAN,Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin ],AVP ARVP VP,Homo sapiens (Human),164.0,MPDTMLPACFLGLLAFSSACYFQNCPRGGKRAMSDLELRQCLPCGPGGKGRCFGPSICCADELGCFVGTAEALRCQEENYLPSPCQSGQKACGSGGRCAAFGVCCNDESCVTEPECREGFHRRARASDRSNATQLDGPAGALLLRLVQLAGAPEPFEPAQPDAY,PF00220;PF00184;,7BB6;7BB7;7DW9;7KH0;,67,V,A,True,1025
14041,2983,27256,single nucleotide variant,NM_000490.5(AVP):c.275G>A (p.Cys92Tyr),551,AVP,HGNC:894,Pathogenic,1,1-Nov-98,121964891,-,RCV000013001,"MONDO:MONDO:0007450,MedGen:C0687720,OMIM:125700,Orphanet:178029,Orphanet:30925",Neurohypophyseal diabetes insipidus,germline,germline,GRCh38,NC_000020.11,20,3083024,3083024,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA121970,UniProtKB:P01185#VAR_015270,OMIM:192340.0015",1,12217,3083024,C,T,C92Y,0,pathogenic,uncertain,P01185,P01185,reviewed,NEU2_HUMAN,Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin ],AVP ARVP VP,Homo sapiens (Human),164.0,MPDTMLPACFLGLLAFSSACYFQNCPRGGKRAMSDLELRQCLPCGPGGKGRCFGPSICCADELGCFVGTAEALRCQEENYLPSPCQSGQKACGSGGRCAAFGVCCNDESCVTEPECREGFHRRARASDRSNATQLDGPAGALLLRLVQLAGAPEPFEPAQPDAY,PF00220;PF00184;,7BB6;7BB7;7DW9;7KH0;,92,C,Y,True,1025
14042,2982,27255,single nucleotide variant,NM_000490.5(AVP):c.260C>T (p.Ser87Phe),551,AVP,HGNC:894,Pathogenic,1,1-Nov-98,121964890,-,RCV000013000,"MONDO:MONDO:0007450,MedGen:C0687720,OMIM:125700,Orphanet:178029,Orphanet:30925",Neurohypophyseal diabetes insipidus,germline,germline,GRCh38,NC_000020.11,20,3083039,3083039,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA121968,UniProtKB:P01185#VAR_015269,OMIM:192340.0014",1,12216,3083039,G,A,S87F,0,pathogenic,uncertain,P01185,P01185,reviewed,NEU2_HUMAN,Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin ],AVP ARVP VP,Homo sapiens (Human),164.0,MPDTMLPACFLGLLAFSSACYFQNCPRGGKRAMSDLELRQCLPCGPGGKGRCFGPSICCADELGCFVGTAEALRCQEENYLPSPCQSGQKACGSGGRCAAFGVCCNDESCVTEPECREGFHRRARASDRSNATQLDGPAGALLLRLVQLAGAPEPFEPAQPDAY,PF00220;PF00184;,7BB6;7BB7;7DW9;7KH0;,87,S,F,True,1025
14043,2974,27243,single nucleotide variant,NM_000490.5(AVP):c.262G>A (p.Gly88Ser),551,AVP,HGNC:894,Pathogenic,1,1-Feb-91,121964882,-,RCV000012988,"MONDO:MONDO:0007450,MedGen:C0687720,OMIM:125700,Orphanet:178029,Orphanet:30925",Neurohypophyseal diabetes insipidus,germline,germline,GRCh38,NC_000020.11,20,3083037,3083037,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA121946,UniProtKB:P01185#VAR_004991,OMIM:192340.0001",1,12204,3083037,C,T,G88S,0,pathogenic,uncertain,P01185,P01185,reviewed,NEU2_HUMAN,Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin ],AVP ARVP VP,Homo sapiens (Human),164.0,MPDTMLPACFLGLLAFSSACYFQNCPRGGKRAMSDLELRQCLPCGPGGKGRCFGPSICCADELGCFVGTAEALRCQEENYLPSPCQSGQKACGSGGRCAAFGVCCNDESCVTEPECREGFHRRARASDRSNATQLDGPAGALLLRLVQLAGAPEPFEPAQPDAY,PF00220;PF00184;,7BB6;7BB7;7DW9;7KH0;,88,G,S,True,1025
14044,2981,27253,single nucleotide variant,NM_000490.5(AVP):c.160G>C (p.Gly54Arg),551,AVP,HGNC:894,Pathogenic,1,1-Feb-98,121964888,-,RCV000012998,"MONDO:MONDO:0007450,MedGen:C0687720,OMIM:125700,Orphanet:178029,Orphanet:30925",Neurohypophyseal diabetes insipidus,germline,germline,GRCh38,NC_000020.11,20,3083139,3083139,na,na,20p13,no assertion criteria provided,1,-,N,"ClinGen:CA121963,UniProtKB:P01185#VAR_015265,OMIM:192340.0011",1,12214,3083139,C,G,G54R,0,pathogenic,uncertain,P01185,P01185,reviewed,NEU2_HUMAN,Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin ],AVP ARVP VP,Homo sapiens (Human),164.0,MPDTMLPACFLGLLAFSSACYFQNCPRGGKRAMSDLELRQCLPCGPGGKGRCFGPSICCADELGCFVGTAEALRCQEENYLPSPCQSGQKACGSGGRCAAFGVCCNDESCVTEPECREGFHRRARASDRSNATQLDGPAGALLLRLVQLAGAPEPFEPAQPDAY,PF00220;PF00184;,7BB6;7BB7;7DW9;7KH0;,54,G,R,True,1025
14045,554,17247,single nucleotide variant,NM_024006.6(VKORC1):c.134T>C (p.Val45Ala),79001,VKORC1,HGNC:23663,Pathogenic,1,5-Feb-04,104894540,-,RCV000002292,"MONDO:MONDO:0007390,MedGen:C0750384,OMIM:122700",Warfarin response,germline,germline,GRCh38,NC_000016.10,16,31094596,31094596,na,na,16p11.2,no assertion criteria provided,1,-,N,"ClinGen:CA115413,UniProtKB:Q9BQB6#VAR_021822,OMIM:608547.0003",1,2208,31094596,A,G,V45A,0,pathogenic,uncertain,Q9BQB6,Q9BQB6,reviewed,VKOR1_HUMAN,"Vitamin K epoxide reductase complex subunit 1, EC 1.17.4.4 (Vitamin K1 2,3-epoxide reductase subunit 1)",VKORC1 VKOR MSTP134 MSTP576 UNQ308/PRO351,Homo sapiens (Human),163.0,MGSTWGSPGWVRLALCLTGLVLSLYALHVKAARARDRDYRALCDVGTAISCSRVFSSRWGRGFGLVEHVLGQDSILNQSNSIFGCIFYTLQLLLGCLRTRWASVLMLLSSLVSLAGSVYLAWILFFVLYDFCIVCITTYAINVSLMWLSFRKVQEPQGKAKRH,PF07884;,6WV3;6WV4;6WV5;6WV6;6WV7;6WVH;,45,V,A,True,1026
14046,555,17248,single nucleotide variant,NM_024006.6(VKORC1):c.172A>G (p.Arg58Gly),79001,VKORC1,HGNC:23663,Pathogenic,1,5-Feb-04,104894541,-,RCV000002293,"MONDO:MONDO:0007390,MedGen:C0750384,OMIM:122700",Warfarin response,germline,germline,GRCh38,NC_000016.10,16,31094558,31094558,na,na,16p11.2,no assertion criteria provided,1,-,N,"OMIM:608547.0004,ClinGen:CA115414,UniProtKB:Q9BQB6#VAR_021823",1,2209,31094558,T,C,R58G,0,pathogenic,uncertain,Q9BQB6,Q9BQB6,reviewed,VKOR1_HUMAN,"Vitamin K epoxide reductase complex subunit 1, EC 1.17.4.4 (Vitamin K1 2,3-epoxide reductase subunit 1)",VKORC1 VKOR MSTP134 MSTP576 UNQ308/PRO351,Homo sapiens (Human),163.0,MGSTWGSPGWVRLALCLTGLVLSLYALHVKAARARDRDYRALCDVGTAISCSRVFSSRWGRGFGLVEHVLGQDSILNQSNSIFGCIFYTLQLLLGCLRTRWASVLMLLSSLVSLAGSVYLAWILFFVLYDFCIVCITTYAINVSLMWLSFRKVQEPQGKAKRH,PF07884;,6WV3;6WV4;6WV5;6WV6;6WV7;6WVH;,58,R,G,True,1026
14047,553,17246,single nucleotide variant,NM_024006.6(VKORC1):c.85G>T (p.Val29Leu),79001,VKORC1,HGNC:23663,Pathogenic,1,5-Feb-04,104894539,-,RCV000002291,"MONDO:MONDO:0007390,MedGen:C0750384,OMIM:122700",Warfarin response,germline,germline,GRCh38,NC_000016.10,16,31094645,31094645,na,na,16p11.2,no assertion criteria provided,1,-,N,"ClinGen:CA115412,UniProtKB:Q9BQB6#VAR_021821,OMIM:608547.0002",1,2207,31094645,C,A,V29L,0,pathogenic,uncertain,Q9BQB6,Q9BQB6,reviewed,VKOR1_HUMAN,"Vitamin K epoxide reductase complex subunit 1, EC 1.17.4.4 (Vitamin K1 2,3-epoxide reductase subunit 1)",VKORC1 VKOR MSTP134 MSTP576 UNQ308/PRO351,Homo sapiens (Human),163.0,MGSTWGSPGWVRLALCLTGLVLSLYALHVKAARARDRDYRALCDVGTAISCSRVFSSRWGRGFGLVEHVLGQDSILNQSNSIFGCIFYTLQLLLGCLRTRWASVLMLLSSLVSLAGSVYLAWILFFVLYDFCIVCITTYAINVSLMWLSFRKVQEPQGKAKRH,PF07884;,6WV3;6WV4;6WV5;6WV6;6WV7;6WVH;,29,V,L,True,1026
14048,552,17245,single nucleotide variant,NM_024006.6(VKORC1):c.292C>T (p.Arg98Trp),79001,VKORC1,HGNC:23663,Pathogenic,1,5-Feb-04,72547528,-,RCV000002290,"MONDO:MONDO:0011837,MedGen:C1843832,OMIM:607473,Orphanet:98434","Vitamin K-dependent clotting factors, combined deficiency of, 2",germline,germline,GRCh38,NC_000016.10,16,31091334,31091334,na,na,16p11.2,no assertion criteria provided,1,-,N,"ClinGen:CA115411,UniProtKB:Q9BQB6#VAR_021824,OMIM:608547.0001",1,2206,31091334,G,A,R98W,0,pathogenic,uncertain,Q9BQB6,Q9BQB6,reviewed,VKOR1_HUMAN,"Vitamin K epoxide reductase complex subunit 1, EC 1.17.4.4 (Vitamin K1 2,3-epoxide reductase subunit 1)",VKORC1 VKOR MSTP134 MSTP576 UNQ308/PRO351,Homo sapiens (Human),163.0,MGSTWGSPGWVRLALCLTGLVLSLYALHVKAARARDRDYRALCDVGTAISCSRVFSSRWGRGFGLVEHVLGQDSILNQSNSIFGCIFYTLQLLLGCLRTRWASVLMLLSSLVSLAGSVYLAWILFFVLYDFCIVCITTYAINVSLMWLSFRKVQEPQGKAKRH,PF07884;,6WV3;6WV4;6WV5;6WV6;6WV7;6WVH;,98,R,W,True,1026
14049,556,17249,single nucleotide variant,NM_024006.6(VKORC1):c.383T>G (p.Leu128Arg),79001,VKORC1,HGNC:23663,drug response,0,14-Aug-17,104894542,-,RCV000002294,"MONDO:MONDO:0007390,MedGen:C0750384,OMIM:122700",Warfarin response,germline,germline,GRCh38,NC_000016.10,16,31091243,31091243,na,na,16p11.2,no assertion criteria provided,1,-,N,"ClinGen:CA115415,UniProtKB:Q9BQB6#VAR_021825,OMIM:608547.0005",1,2210,31091243,A,C,L128R,0,uncertain,uncertain,Q9BQB6,Q9BQB6,reviewed,VKOR1_HUMAN,"Vitamin K epoxide reductase complex subunit 1, EC 1.17.4.4 (Vitamin K1 2,3-epoxide reductase subunit 1)",VKORC1 VKOR MSTP134 MSTP576 UNQ308/PRO351,Homo sapiens (Human),163.0,MGSTWGSPGWVRLALCLTGLVLSLYALHVKAARARDRDYRALCDVGTAISCSRVFSSRWGRGFGLVEHVLGQDSILNQSNSIFGCIFYTLQLLLGCLRTRWASVLMLLSSLVSLAGSVYLAWILFFVLYDFCIVCITTYAINVSLMWLSFRKVQEPQGKAKRH,PF07884;,6WV3;6WV4;6WV5;6WV6;6WV7;6WVH;,128,L,R,True,1026
14050,557,17251,single nucleotide variant,NM_024006.6(VKORC1):c.106G>T (p.Asp36Tyr),79001,VKORC1,HGNC:23663,drug response,1,22-Jun-16,61742245,-,RCV000002296|RCV000211202|RCV001115529,"MONDO:MONDO:0007390,MedGen:C0750384,OMIM:122700|MedGen:CN236549|MONDO:MONDO:0011837,MedGen:C1843832,OMIM:607473,Orphanet:98434","Warfarin response|warfarin response - Dosage|Vitamin K-dependent clotting factors, combined deficiency of, 2",germline,germline,GRCh38,NC_000016.10,16,31094624,31094624,na,na,16p11.2,reviewed by expert panel,3,-,N,"OMIM:608547.0007,PharmGKB Clinical Annotation:1183703748,ClinGen:CA115418,UniProtKB:Q9BQB6#VAR_065787",3,2212,31094624,C,A,D36Y,3,uncertain,uncertain,Q9BQB6,Q9BQB6,reviewed,VKOR1_HUMAN,"Vitamin K epoxide reductase complex subunit 1, EC 1.17.4.4 (Vitamin K1 2,3-epoxide reductase subunit 1)",VKORC1 VKOR MSTP134 MSTP576 UNQ308/PRO351,Homo sapiens (Human),163.0,MGSTWGSPGWVRLALCLTGLVLSLYALHVKAARARDRDYRALCDVGTAISCSRVFSSRWGRGFGLVEHVLGQDSILNQSNSIFGCIFYTLQLLLGCLRTRWASVLMLLSSLVSLAGSVYLAWILFFVLYDFCIVCITTYAINVSLMWLSFRKVQEPQGKAKRH,PF07884;,6WV3;6WV4;6WV5;6WV6;6WV7;6WVH;,36,D,Y,True,1026
14051,7500,76386,single nucleotide variant,NM_012106.4(ARL2BP):c.134T>G (p.Met45Arg),23568,ARL2BP,HGNC:17146,Uncertain significance,1,26-Oct-19,398123053,-,RCV000055665|RCV001235488,"MONDO:MONDO:0014186,MedGen:C4747737,OMIM:615434,Orphanet:791|MedGen:CN517202",Retinitis pigmentosa 82 with or without situs inversus|not provided,germline,germline,GRCh38,NC_000016.10,16,57248570,57248570,na,na,16q13,"criteria provided, single submitter",2,-,N,"OMIM:615407.0002,ClinGen:CA144805,UniProtKB:Q9Y2Y0#VAR_070227",3,65474,57248570,T,G,M45R,1,uncertain,uncertain,Q9Y2Y0,Q9Y2Y0,reviewed,AR2BP_HUMAN,"ADP-ribosylation factor-like protein 2-binding protein, ARF-like 2-binding protein, ARL2-binding protein (Binder of ARF2 protein 1)",ARL2BP BART BART1,Homo sapiens (Human),163.0,MDALEGESFALSFSSASDAEFDAVVGYLEDIIMDDEFQLLQRNFMDKYYLEFEDTEENKLIYTPIFNEYISLVEKYIEEQLLQRIPEFNMAAFTTTLQHHKDEVAGDIFDMLLTFTDFLAFKEMFLDYRAEKEGRGLDLSSGLVVTSLCKSSSLPASQNNLRH,PF11527;,2K9A;3DOE;3DOF;,45,M,R,True,1027
14052,13869,300697,single nucleotide variant,NM_052872.4(IL17F):c.463G>A (p.Val155Ile),112744,IL17F,HGNC:16404,Benign,0,31-Dec-19,11465553,-,RCV000533921,"MONDO:MONDO:0013503,MedGen:C3151405,OMIM:613956,Orphanet:1334","Candidiasis, familial, 6",germline,germline,GRCh38,NC_000006.12,6,52236960,52236960,na,na,6p12.2,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA3854347,UniProtKB:Q96PD4#VAR_058288",2,357468,52236960,C,T,V155I,2,benign,benign,Q96PD4,Q96PD4,reviewed,IL17F_HUMAN,"Interleukin-17F, IL-17F (Cytokine ML-1)",IL17F,Homo sapiens (Human),163.0,MTVKTLHGPAMVKYLLLSILGLAFLSEAAARKIPKVGHTFFQKPESCPPVPGGSMKLDIGIINENQRVSMSRNIESRSTSPWNYTVTWDPNRYPSEVVQAQCRNLGCINAQGKEDISMNSVPIQQETLVVRRKHQGCSVSFQLEKVLVTVGCTCVTPVIHHVQ,PF06083;,1JPY;3JVF;5N92;5NAN;6HG4;6HG9;6HGO;6PPG;,155,V,I,True,1028
14053,13891,303623,single nucleotide variant,NM_052872.4(IL17F):c.377A>G (p.Glu126Gly),112744,IL17F,HGNC:16404,Benign,0,6-Mar-18,2397084,-,RCV000381916|RCV000456093,"MONDO:MONDO:0013503,MedGen:C3151405,OMIM:613956,Orphanet:1334|MedGen:CN169374","Candidiasis, familial, 6|not specified",germline,germline,GRCh38,NC_000006.12,6,52237046,52237046,na,na,6p12.2,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA3854367,UniProtKB:Q96PD4#VAR_058287",2,357469,52237046,T,C,E126G,2,benign,benign,Q96PD4,Q96PD4,reviewed,IL17F_HUMAN,"Interleukin-17F, IL-17F (Cytokine ML-1)",IL17F,Homo sapiens (Human),163.0,MTVKTLHGPAMVKYLLLSILGLAFLSEAAARKIPKVGHTFFQKPESCPPVPGGSMKLDIGIINENQRVSMSRNIESRSTSPWNYTVTWDPNRYPSEVVQAQCRNLGCINAQGKEDISMNSVPIQQETLVVRRKHQGCSVSFQLEKVLVTVGCTCVTPVIHHVQ,PF06083;,1JPY;3JVF;5N92;5NAN;6HG4;6HG9;6HGO;6PPG;,126,E,G,True,1028
14054,13890,303622,single nucleotide variant,NM_052872.4(IL17F):c.482A>G (p.His161Arg),112744,IL17F,HGNC:16404,Benign,0,6-Mar-18,763780,-,RCV000369036,"MONDO:MONDO:0013503,MedGen:C3151405,OMIM:613956,Orphanet:1334","Candidiasis, familial, 6",germline,germline,GRCh38,NC_000006.12,6,52236941,52236941,na,na,6p12.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA3854340,UniProtKB:Q96PD4#VAR_058289",2,357466,52236941,T,C,H161R,1,benign,benign,Q96PD4,Q96PD4,reviewed,IL17F_HUMAN,"Interleukin-17F, IL-17F (Cytokine ML-1)",IL17F,Homo sapiens (Human),163.0,MTVKTLHGPAMVKYLLLSILGLAFLSEAAARKIPKVGHTFFQKPESCPPVPGGSMKLDIGIINENQRVSMSRNIESRSTSPWNYTVTWDPNRYPSEVVQAQCRNLGCINAQGKEDISMNSVPIQQETLVVRRKHQGCSVSFQLEKVLVTVGCTCVTPVIHHVQ,PF06083;,1JPY;3JVF;5N92;5NAN;6HG4;6HG9;6HGO;6PPG;,161,H,R,True,1028
14055,6006,39546,single nucleotide variant,NM_052872.4(IL17F):c.284C>T (p.Ser95Leu),112744,IL17F,HGNC:16404,Pathogenic,1,1-Apr-11,748486078,-,RCV000023553,"MONDO:MONDO:0013503,MedGen:C3151405,OMIM:613956,Orphanet:1334","Candidiasis, familial, 6",germline,germline,GRCh38,NC_000006.12,6,52237139,52237139,na,na,6p12.2,no assertion criteria provided,1,-,N,"ClinGen:CA213032,UniProtKB:Q96PD4#VAR_065813,OMIM:606496.0001",1,30589,52237139,G,A,S95L,0,pathogenic,uncertain,Q96PD4,Q96PD4,reviewed,IL17F_HUMAN,"Interleukin-17F, IL-17F (Cytokine ML-1)",IL17F,Homo sapiens (Human),163.0,MTVKTLHGPAMVKYLLLSILGLAFLSEAAARKIPKVGHTFFQKPESCPPVPGGSMKLDIGIINENQRVSMSRNIESRSTSPWNYTVTWDPNRYPSEVVQAQCRNLGCINAQGKEDISMNSVPIQQETLVVRRKHQGCSVSFQLEKVLVTVGCTCVTPVIHHVQ,PF06083;,1JPY;3JVF;5N92;5NAN;6HG4;6HG9;6HGO;6PPG;,95,S,L,True,1028
14056,10780,143259,single nucleotide variant,NM_000982.3(RPL21):c.95G>A (p.Arg32Gln),6144,RPL21,HGNC:10313,Pathogenic,1,1-Jul-11,587777527,-,RCV000128579,"MONDO:MONDO:0014384,MedGen:C4014563,OMIM:615885,Orphanet:55654",Hypotrichosis 12,germline,germline,GRCh38,NC_000013.11,13,27254247,27254247,na,na,13q12.2,no assertion criteria provided,1,-,N,"ClinGen:CA163349,UniProtKB:P46778#VAR_066030,OMIM:603636.0001",1,139638,27254247,G,A,R32Q,0,pathogenic,uncertain,P46778,P46778,reviewed,RL21_HUMAN,60S ribosomal protein L21 (Large ribosomal subunit protein eL21),RPL21,Homo sapiens (Human),160.0,MTNTKGKRRGTRYMFSRPFRKHGVVPLATYMRIYKKGDIVDIKGMGTVQKGMPHKCYHGKTGRVYNVTQHAVGIVVNKQVKGKILAKRINVRIEHIKHSKSRDSFLKRVKENDQKKKEAKEKGTWVQLKRQPAPPREAHFVRTNGKEPELLEPIPYEFMA,PF01157;,4UG0;4V6X;5AJ0;5LKS;5T2C;6IP5;6IP6;6IP8;6LQM;6LSR;6LSS;6LU8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6W6L;6XA1;6Y0G;6Y2L;6Y57;6Y6X;6Z6L;6Z6M;6Z6N;6ZM7;6ZME;6ZMI;6ZMO;7BHP;,32,R,Q,True,1029
14057,3599,28724,single nucleotide variant,NM_004300.4(ACP1):c.317A>G (p.Gln106Arg),52,ACP1,HGNC:122,Benign,0,12-Aug-20,79716074,-,RCV000014681,-,"ACID PHOSPHATASE 1, SOLUBLE, A/B POLYMORPHISM OF",germline,germline,GRCh38,NC_000002.12,2,277003,277003,na,na,2p25.3,no assertion criteria provided,1,-,N,"ClinGen:CA123351,UniProtKB:P24666#VAR_006171,OMIM:171500.0001",1,13685,277003,A,G,Q106R,0,benign,uncertain,P24666,P24666,reviewed,PPAC_HUMAN,"Low molecular weight phosphotyrosine protein phosphatase, LMW-PTP, LMW-PTPase, EC 3.1.3.48 (Adipocyte acid phosphatase) (Low molecular weight cytosolic acid phosphatase, EC 3.1.3.2) (Red cell acid phosphatase 1)",ACP1,Homo sapiens (Human),158.0,MAEQATKSVLFVCLGNICRSPIAEAVFRKLVTDQNISENWRVDSAATSGYEIGNPPDYRGQSCMKRHGIPMSHVARQITKEDFATFDYILCMDESNLRDLNRKSNQVKTCKAKIELLGSYDPQKQLIIEDPYYGNDSDFETVYQQCVRCCRAFLEKAH,PF01451;,1XWW;3N8I;4Z99;4Z9A;4Z9B;5JNR;5JNS;5JNT;5KQG;5KQL;5KQM;5KQP;5PNT;6Y2V;6Y2W;7KH8;,106,Q,R,True,1030
14058,12558,226288,single nucleotide variant,NM_016417.3(GLRX5):c.301A>C (p.Lys101Gln),51218,GLRX5,HGNC:20134,Pathogenic,1,26-Jul-18,869312752,-,RCV000210158,"MONDO:MONDO:0014804,MedGen:C4225155,OMIM:616860,Orphanet:255132","Sideroblastic anemia 3, pyridoxine-refractory",germline,germline,GRCh38,NC_000014.9,14,95543952,95543952,na,na,14q32.13,no assertion criteria provided,1,-,N,"OMIM:609588.0002,ClinGen:CA354992,UniProtKB:Q86SX6#VAR_074550",1,224510,95543952,A,C,K101Q,0,pathogenic,uncertain,Q86SX6,Q86SX6,reviewed,GLRX5_HUMAN,"Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5)",GLRX5 C14orf87,Homo sapiens (Human),157.0,MSGSLGRAAAALLRWGRGAGGGGLWGPGVRAAGSGAGGGGSAEQLDALVKKDKVVVFLKGTPEQPQCGFSNAVVQILRLHGVRDYAAYNVLDDPELRQGIKDYSNWPTIPQVYLNGEFVGGCDILLQMHQNGDLVEELKKLGIHSALLDEKKDQDSK,PF00462;,2MMZ;2WUL;,101,K,Q,True,1031
14059,12559,226289,single nucleotide variant,NM_016417.3(GLRX5):c.443T>C (p.Leu148Ser),51218,GLRX5,HGNC:20134,Pathogenic,1,26-Jul-18,765487627,-,RCV000210075,"MONDO:MONDO:0014804,MedGen:C4225155,OMIM:616860,Orphanet:255132","Sideroblastic anemia 3, pyridoxine-refractory",germline,germline,GRCh38,NC_000014.9,14,95544094,95544094,na,na,14q32.13,no assertion criteria provided,1,-,N,"UniProtKB:Q86SX6#VAR_074551,OMIM:609588.0003,ClinGen:CA354990",1,224511,95544094,T,C,L148S,0,pathogenic,uncertain,Q86SX6,Q86SX6,reviewed,GLRX5_HUMAN,"Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5)",GLRX5 C14orf87,Homo sapiens (Human),157.0,MSGSLGRAAAALLRWGRGAGGGGLWGPGVRAAGSGAGGGGSAEQLDALVKKDKVVVFLKGTPEQPQCGFSNAVVQILRLHGVRDYAAYNVLDDPELRQGIKDYSNWPTIPQVYLNGEFVGGCDILLQMHQNGDLVEELKKLGIHSALLDEKKDQDSK,PF00462;,2MMZ;2WUL;,148,L,S,True,1031
14060,5986,39447,single nucleotide variant,NM_012275.3(IL36RN):c.338C>T (p.Ser113Leu),26525,IL36RN,HGNC:15561,Conflicting interpretations of pathogenicity,1,19-Oct-20,144478519,-,RCV000023447|RCV000513043,"MONDO:MONDO:0013626,MedGen:C0343055,OMIM:614204,Orphanet:247353|MedGen:CN517202","Pustular psoriasis, generalized|not provided",germline;unknown,germline,GRCh38,NC_000002.12,2,113062547,113062547,na,na,2q14.1,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA129270,UniProtKB:Q9UBH0#VAR_066648,OMIM:605507.0002",3,30490,113062547,C,T,S113L,1,uncertain,uncertain,Q9UBH0,Q9UBH0,reviewed,I36RA_HUMAN,"Interleukin-36 receptor antagonist protein, IL-36Ra (FIL1 delta) (IL-1-related protein 3, IL-1RP3) (Interleukin-1 HY1, IL-1HY1) (Interleukin-1 delta, IL-1 delta) (Interleukin-1 family member 5, IL-1F5) (Interleukin-1 receptor antagonist homolog 1, IL-1ra homolog 1) (Interleukin-1-like protein 1, IL-1L1)",IL36RN FIL1D IL1F5 IL1HY1 IL1L1 IL1RP3 UNQ1896/PRO4342,Homo sapiens (Human),155.0,MVLSGALCFRMKDSALKVLYLHNNQLLAGGLHAGKVIKGEEISVVPNRWLDASLSPVILGVQGGSQCLSCGVGQEPTLTLEPVNIMELYLGAKESKSFTFYRRDMGLTSSFESAAYPGWFLCTVPEADQPVRLTQLPENGGWNAPITDFYFQQCD,PF00340;,4P0J;4P0K;4P0L;,113,S,L,True,1032
14061,6509,48519,single nucleotide variant,NM_173170.1(IL36RN):c.368C>G (p.Thr123Arg),26525,IL36RN,HGNC:15561,Pathogenic,1,1-Jan-13,397514629,-,RCV000033133,"MONDO:MONDO:0013626,MedGen:C0343055,OMIM:614204,Orphanet:247353","Pustular psoriasis, generalized",germline,germline,GRCh38,NC_000002.12,2,113062577,113062577,na,na,2q14.1,no assertion criteria provided,1,-,N,"ClinGen:CA130700,UniProtKB:Q9UBH0#VAR_068972,OMIM:605507.0005",1,40006,113062577,C,G,T123R,0,pathogenic,uncertain,Q9UBH0,Q9UBH0,reviewed,I36RA_HUMAN,"Interleukin-36 receptor antagonist protein, IL-36Ra (FIL1 delta) (IL-1-related protein 3, IL-1RP3) (Interleukin-1 HY1, IL-1HY1) (Interleukin-1 delta, IL-1 delta) (Interleukin-1 family member 5, IL-1F5) (Interleukin-1 receptor antagonist homolog 1, IL-1ra homolog 1) (Interleukin-1-like protein 1, IL-1L1)",IL36RN FIL1D IL1F5 IL1HY1 IL1L1 IL1RP3 UNQ1896/PRO4342,Homo sapiens (Human),155.0,MVLSGALCFRMKDSALKVLYLHNNQLLAGGLHAGKVIKGEEISVVPNRWLDASLSPVILGVQGGSQCLSCGVGQEPTLTLEPVNIMELYLGAKESKSFTFYRRDMGLTSSFESAAYPGWFLCTVPEADQPVRLTQLPENGGWNAPITDFYFQQCD,PF00340;,4P0J;4P0K;4P0L;,123,T,R,True,1032
14062,5987,39448,single nucleotide variant,NM_173170.1(IL36RN):c.142C>T (p.Arg48Trp),26525,IL36RN,HGNC:15561,Uncertain significance,1,21-Oct-19,151325121,-,RCV000023448,"MONDO:MONDO:0013626,MedGen:C0343055,OMIM:614204,Orphanet:247353","Pustular psoriasis, generalized",germline,germline,GRCh38,NC_000002.12,2,113062150,113062150,na,na,2q14.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA129274,UniProtKB:Q9UBH0#VAR_066647,OMIM:605507.0003",3,30491,113062150,C,T,R48W,1,uncertain,uncertain,Q9UBH0,Q9UBH0,reviewed,I36RA_HUMAN,"Interleukin-36 receptor antagonist protein, IL-36Ra (FIL1 delta) (IL-1-related protein 3, IL-1RP3) (Interleukin-1 HY1, IL-1HY1) (Interleukin-1 delta, IL-1 delta) (Interleukin-1 family member 5, IL-1F5) (Interleukin-1 receptor antagonist homolog 1, IL-1ra homolog 1) (Interleukin-1-like protein 1, IL-1L1)",IL36RN FIL1D IL1F5 IL1HY1 IL1L1 IL1RP3 UNQ1896/PRO4342,Homo sapiens (Human),155.0,MVLSGALCFRMKDSALKVLYLHNNQLLAGGLHAGKVIKGEEISVVPNRWLDASLSPVILGVQGGSQCLSCGVGQEPTLTLEPVNIMELYLGAKESKSFTFYRRDMGLTSSFESAAYPGWFLCTVPEADQPVRLTQLPENGGWNAPITDFYFQQCD,PF00340;,4P0J;4P0K;4P0L;,48,R,W,True,1032
14063,5985,39446,single nucleotide variant,NM_173170.1(IL36RN):c.80T>C (p.Leu27Pro),26525,IL36RN,HGNC:15561,Pathogenic,1,7-Dec-18,387906914,-,RCV000023446|RCV001090265,"MONDO:MONDO:0013626,MedGen:C0343055,OMIM:614204,Orphanet:247353|MedGen:CN517202","Pustular psoriasis, generalized|not provided",germline,germline,GRCh38,NC_000002.12,2,113060902,113060902,na,na,2q14.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA129266,UniProtKB:Q9UBH0#VAR_066646,OMIM:605507.0001",3,30489,113060902,T,C,L27P,2,pathogenic,pathogenic,Q9UBH0,Q9UBH0,reviewed,I36RA_HUMAN,"Interleukin-36 receptor antagonist protein, IL-36Ra (FIL1 delta) (IL-1-related protein 3, IL-1RP3) (Interleukin-1 HY1, IL-1HY1) (Interleukin-1 delta, IL-1 delta) (Interleukin-1 family member 5, IL-1F5) (Interleukin-1 receptor antagonist homolog 1, IL-1ra homolog 1) (Interleukin-1-like protein 1, IL-1L1)",IL36RN FIL1D IL1F5 IL1HY1 IL1L1 IL1RP3 UNQ1896/PRO4342,Homo sapiens (Human),155.0,MVLSGALCFRMKDSALKVLYLHNNQLLAGGLHAGKVIKGEEISVVPNRWLDASLSPVILGVQGGSQCLSCGVGQEPTLTLEPVNIMELYLGAKESKSFTFYRRDMGLTSSFESAAYPGWFLCTVPEADQPVRLTQLPENGGWNAPITDFYFQQCD,PF00340;,4P0J;4P0K;4P0L;,27,L,P,True,1032
14064,1979,23525,single nucleotide variant,NM_006432.4(NPC2):c.358C>T (p.Pro120Ser),10577,NPC2,HGNC:14537,Pathogenic,1,16-Dec-19,104894458,-,RCV000009007,"MONDO:MONDO:0011873,MedGen:C1843366,OMIM:607625,Orphanet:646","Niemann-Pick disease, type C2",germline,germline,GRCh38,NC_000014.9,14,74484420,74484420,na,na,14q24.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA254414,UniProtKB:P61916#VAR_043307,OMIM:601015.0010",3,8486,74484420,G,A,P120S,1,pathogenic,pathogenic,P61916,P61916,reviewed,NPC2_HUMAN,"NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1) (Human epididymis-specific protein 1, He1) (Niemann-Pick disease type C2 protein)",NPC2 HE1,Homo sapiens (Human),151.0,MRFLAATFLLLALSTAAQAEPVQFKDCGSVDGVIKEVNVSPCPTQPCQLSKGQSYSVNVTFTSNIQSKSSKAVVHGILMGVPVPFPIPEPDGCKSGINCPIQKDKTYSYLNKLPVKSEYPSIKLVVEWQLQDDKNQSLFCWEIPVQIVSHL,PF02221;,5KWY;6W5V;,120,P,S,True,1033
14065,11459,181440,single nucleotide variant,NM_006432.4(NPC2):c.88G>A (p.Val30Met),-1,ACYP1;NPC2,-,Benign/Likely benign,1,31-Dec-19,151220873,-,RCV000162102|RCV000362578|RCV000675984|RCV001080727,"Human Phenotype Ontology:HP:0000252,Human Phenotype Ontology:HP:0001366,Human Phenotype Ontology:HP:0005485,Human Phenotype Ontology:HP:0005489,Human Phenotype Ontology:HP:0005497,MedGen:C4551563;Human Phenotype Ontology:HP:0012444,MedGen:C4551584;Human Phenotype Ontology:HP:0001250,Human Phenotype Ontology:HP:0001275,Human Phenotype Ontology:HP:0001303,Human Phenotype Ontology:HP:0002125,Human Phenotype Ontology:HP:0002182,Human Phenotype Ontology:HP:0002279,Human Phenotype Ontology:HP:0002306,Human Phenotype Ontology:HP:0002348,Human Phenotype Ontology:HP:0002391,Human Phenotype Ontology:HP:0002417,Human Phenotype Ontology:HP:0002430,Human Phenotype Ontology:HP:0002431,Human Phenotype Ontology:HP:0002432,Human Phenotype Ontology:HP:0002434,Human Phenotype Ontology:HP:0002437,Human Phenotype Ontology:HP:0002466,Human Phenotype Ontology:HP:0002479,Human Phenotype Ontology:HP:0002794,Human Phenotype Ontology:HP:0006997,Human Phenotype Ontology:HP:0010520,MedGen:C0036572;Human Phenotype Ontology:HP:0000754,Human Phenotype Ontology:HP:0001255,Human Phenotype Ontology:HP:0001263,Human Phenotype Ontology:HP:0001277,Human Phenotype Ontology:HP:0001292,Human Phenotype Ontology:HP:0002433,Human Phenotype Ontology:HP:0002473,Human Phenotype Ontology:HP:0002532,Human Phenotype Ontology:HP:0006793,Human Phenotype Ontology:HP:0006867,Human Phenotype Ontology:HP:0006885,Human Phenotype Ontology:HP:0006935,Human Phenotype Ontology:HP:0007005,Human Phenotype Ontology:HP:0007094,Human Phenotype Ontology:HP:0007106,Human Phenotype Ontology:HP:0007174,Human Phenotype Ontology:HP:0007224,Human Phenotype Ontology:HP:0007228,Human Phenotype Ontology:HP:0007342,MedGen:C0557874|MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0011873,MedGen:C1843366,OMIM:607625,Orphanet:646","Microcephaly;Brain atrophy;Seizures;Global developmental delay|not specified|not provided|Niemann-Pick disease, type C2",germline;unknown,germline,GRCh38,NC_000014.9,14,74486431,74486431,na,na,14q24.3,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA249909,UniProtKB:P61916#VAR_043303",2,183281,74486431,C,T,V30M,2,benign,benign,P61916,P61916,reviewed,NPC2_HUMAN,"NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1) (Human epididymis-specific protein 1, He1) (Niemann-Pick disease type C2 protein)",NPC2 HE1,Homo sapiens (Human),151.0,MRFLAATFLLLALSTAAQAEPVQFKDCGSVDGVIKEVNVSPCPTQPCQLSKGQSYSVNVTFTSNIQSKSSKAVVHGILMGVPVPFPIPEPDGCKSGINCPIQKDKTYSYLNKLPVKSEYPSIKLVVEWQLQDDKNQSLFCWEIPVQIVSHL,PF02221;,5KWY;6W5V;,30,V,M,True,1033
14066,1977,23521,single nucleotide variant,NM_006432.4(NPC2):c.199T>C (p.Ser67Pro),10577,NPC2,HGNC:14537,Pathogenic,1,22-Jul-08,11694,-,RCV000009003,"MONDO:MONDO:0011873,MedGen:C1843366,OMIM:607625,Orphanet:646","Niemann-Pick disease, type C2",germline,germline,GRCh38,NC_000014.9,14,74484579,74484579,na,na,14q24.3,no assertion criteria provided,2,-,N,"ClinGen:CA340793,UniProtKB:P61916#VAR_015849,OMIM:601015.0006",1,8482,74484579,A,G,S67P,0,pathogenic,uncertain,P61916,P61916,reviewed,NPC2_HUMAN,"NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1) (Human epididymis-specific protein 1, He1) (Niemann-Pick disease type C2 protein)",NPC2 HE1,Homo sapiens (Human),151.0,MRFLAATFLLLALSTAAQAEPVQFKDCGSVDGVIKEVNVSPCPTQPCQLSKGQSYSVNVTFTSNIQSKSSKAVVHGILMGVPVPFPIPEPDGCKSGINCPIQKDKTYSYLNKLPVKSEYPSIKLVVEWQLQDDKNQSLFCWEIPVQIVSHL,PF02221;,5KWY;6W5V;,67,S,P,True,1033
14067,1978,23522,single nucleotide variant,NM_006432.4(NPC2):c.115G>A (p.Val39Met),10577,NPC2,HGNC:14537,Pathogenic,1,22-Jul-08,80358261,-,RCV000009004,"MONDO:MONDO:0011873,MedGen:C1843366,OMIM:607625,Orphanet:646","Niemann-Pick disease, type C2",germline,germline,GRCh38,NC_000014.9,14,74486404,74486404,na,na,14q24.3,no assertion criteria provided,2,-,N,"UniProtKB:P61916#VAR_015848,OMIM:601015.0007,ClinGen:CA340794",1,8483,74486404,C,T,V39M,0,pathogenic,uncertain,P61916,P61916,reviewed,NPC2_HUMAN,"NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1) (Human epididymis-specific protein 1, He1) (Niemann-Pick disease type C2 protein)",NPC2 HE1,Homo sapiens (Human),151.0,MRFLAATFLLLALSTAAQAEPVQFKDCGSVDGVIKEVNVSPCPTQPCQLSKGQSYSVNVTFTSNIQSKSSKAVVHGILMGVPVPFPIPEPDGCKSGINCPIQKDKTYSYLNKLPVKSEYPSIKLVVEWQLQDDKNQSLFCWEIPVQIVSHL,PF02221;,5KWY;6W5V;,39,V,M,True,1033
14068,5444,34310,single nucleotide variant,NM_006432.4(NPC2):c.295T>C (p.Cys99Arg),10577,NPC2,HGNC:14537,Pathogenic,1,12-Nov-19,80358264,-,RCV000020646,"MONDO:MONDO:0011873,MedGen:C1843366,OMIM:607625,Orphanet:646","Niemann-Pick disease, type C2",germline,germline,GRCh38,NC_000014.9,14,74484483,74484483,na,na,14q24.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA342111,UniProtKB:P61916#VAR_043306",3,21458,74484483,A,G,C99R,1,pathogenic,pathogenic,P61916,P61916,reviewed,NPC2_HUMAN,"NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1) (Human epididymis-specific protein 1, He1) (Niemann-Pick disease type C2 protein)",NPC2 HE1,Homo sapiens (Human),151.0,MRFLAATFLLLALSTAAQAEPVQFKDCGSVDGVIKEVNVSPCPTQPCQLSKGQSYSVNVTFTSNIQSKSSKAVVHGILMGVPVPFPIPEPDGCKSGINCPIQKDKTYSYLNKLPVKSEYPSIKLVVEWQLQDDKNQSLFCWEIPVQIVSHL,PF02221;,5KWY;6W5V;,99,C,R,True,1033
14069,3832,29413,single nucleotide variant,NM_000239.2(LYZ):c.221T>C (p.Ile74Thr),4069,LYZ,HGNC:6740,Pathogenic,1,8-Apr-93,121913547,-,RCV000015450,"MONDO:MONDO:0007099,MedGen:C0268389,OMIM:105200,Orphanet:85450","Familial visceral amyloidosis, Ostertag type",germline,germline,GRCh38,NC_000012.12,12,69350192,69350192,na,na,12q15,no assertion criteria provided,1,-,N,"ClinGen:CA123901,UniProtKB:P61626#VAR_004280,OMIM:153450.0001",1,14374,69350192,T,C,I74T,0,pathogenic,uncertain,P61626,P61626,reviewed,LYSC_HUMAN,"Lysozyme C, EC 3.2.1.17 (1,4-beta-N-acetylmuramidase C)",LYZ LZM,Homo sapiens (Human),148.0,MKALIVLGLVLLSVTVQGKVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV,PF00062;,133L;134L;1B5U;1B5V;1B5W;1B5X;1B5Y;1B5Z;1B7L;1B7M;1B7N;1B7O;1B7P;1B7Q;1B7R;1B7S;1BB3;1BB4;1BB5;1C43;1C45;1C46;1C7P;1CJ6;1CJ7;1CJ8;1CJ9;1CKC;1CKD;1CKF;1CKG;1CKH;1D6P;1D6Q;1DI3;1DI4;1DI5;1EQ4;1EQ5;1EQE;1GAY;1GAZ;1GB0;1GB2;1GB3;1GB5;1GB6;1GB7;1GB8;1GB9;1GBO;1GBW;1GBX;1GBY;1GBZ;1GDW;1GDX;1GE0;1GE1;1GE2;1GE3;1GE4;1GEV;1GEZ;1GF0;1GF3;1GF4;1GF5;1GF6;1GF7;1GF8;1GF9;1GFA;1GFE;1GFG;1GFH;1GFJ;1GFK;1GFR;1GFT;1GFU;1GFV;1HNL;1I1Z;1I20;1I22;1INU;1IOC;1IP1;1IP2;1IP3;1IP4;1IP5;1IP6;1IP7;1IWT;1IWU;1IWV;1IWW;1IWX;1IWY;1IWZ;1IX0;1IY3;1IY4;1JKA;1JKB;1JKC;1JKD;1JSF;1JWR;1LAA;1LHH;1LHI;1LHJ;1LHK;1LHL;1LHM;1LMT;1LOZ;1LYY;1LZ1;1LZ4;1LZ5;1LZ6;1LZR;1LZS;1OP9;1OUA;1OUB;1OUC;1OUD;1OUE;1OUF;1OUG;1OUH;1OUI;1OUJ;1QSW;1RE2;1REM;1REX;1REY;1REZ;1TAY;1TBY;1TCY;1TDY;1UBZ;1W08;1WQM;1WQN;1WQO;1WQP;1WQQ;1WQR;1YAM;1YAN;1YAO;1YAP;1YAQ;207L;208L;2BQA;2BQB;2BQC;2BQD;2BQE;2BQF;2BQG;2BQH;2BQI;2BQJ;2BQK;2BQL;2BQM;2BQN;2BQO;2HEA;2HEB;2HEC;2HED;2HEE;2HEF;2LHM;2MEA;2MEB;2MEC;2MED;2MEE;2MEF;2MEG;2MEH;2MEI;2NWD;2ZIJ;2ZIK;2ZIL;2ZWB;3EBA;3FE0;3LHM;3LN2;4I0C;4ML7;4R0P;5LSH;5LVK;6LFH;7AP7;,74,I,T,True,1034
14070,14067,326552,single nucleotide variant,NM_000239.2(LYZ):c.263C>A (p.Thr88Asn),4069,LYZ,HGNC:6740,Benign/Likely benign,0,6-Mar-18,1800973,-,RCV000277779,"MONDO:MONDO:0007099,MedGen:C0268389,OMIM:105200,Orphanet:85450","Familial visceral amyloidosis, Ostertag type",germline,germline,GRCh38,NC_000012.12,12,69350234,69350234,na,na,12q15,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA6679745,UniProtKB:P61626#VAR_012050",2,310331,69350234,C,A,T88N,2,benign,benign,P61626,P61626,reviewed,LYSC_HUMAN,"Lysozyme C, EC 3.2.1.17 (1,4-beta-N-acetylmuramidase C)",LYZ LZM,Homo sapiens (Human),148.0,MKALIVLGLVLLSVTVQGKVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV,PF00062;,133L;134L;1B5U;1B5V;1B5W;1B5X;1B5Y;1B5Z;1B7L;1B7M;1B7N;1B7O;1B7P;1B7Q;1B7R;1B7S;1BB3;1BB4;1BB5;1C43;1C45;1C46;1C7P;1CJ6;1CJ7;1CJ8;1CJ9;1CKC;1CKD;1CKF;1CKG;1CKH;1D6P;1D6Q;1DI3;1DI4;1DI5;1EQ4;1EQ5;1EQE;1GAY;1GAZ;1GB0;1GB2;1GB3;1GB5;1GB6;1GB7;1GB8;1GB9;1GBO;1GBW;1GBX;1GBY;1GBZ;1GDW;1GDX;1GE0;1GE1;1GE2;1GE3;1GE4;1GEV;1GEZ;1GF0;1GF3;1GF4;1GF5;1GF6;1GF7;1GF8;1GF9;1GFA;1GFE;1GFG;1GFH;1GFJ;1GFK;1GFR;1GFT;1GFU;1GFV;1HNL;1I1Z;1I20;1I22;1INU;1IOC;1IP1;1IP2;1IP3;1IP4;1IP5;1IP6;1IP7;1IWT;1IWU;1IWV;1IWW;1IWX;1IWY;1IWZ;1IX0;1IY3;1IY4;1JKA;1JKB;1JKC;1JKD;1JSF;1JWR;1LAA;1LHH;1LHI;1LHJ;1LHK;1LHL;1LHM;1LMT;1LOZ;1LYY;1LZ1;1LZ4;1LZ5;1LZ6;1LZR;1LZS;1OP9;1OUA;1OUB;1OUC;1OUD;1OUE;1OUF;1OUG;1OUH;1OUI;1OUJ;1QSW;1RE2;1REM;1REX;1REY;1REZ;1TAY;1TBY;1TCY;1TDY;1UBZ;1W08;1WQM;1WQN;1WQO;1WQP;1WQQ;1WQR;1YAM;1YAN;1YAO;1YAP;1YAQ;207L;208L;2BQA;2BQB;2BQC;2BQD;2BQE;2BQF;2BQG;2BQH;2BQI;2BQJ;2BQK;2BQL;2BQM;2BQN;2BQO;2HEA;2HEB;2HEC;2HED;2HEE;2HEF;2LHM;2MEA;2MEB;2MEC;2MED;2MEE;2MEF;2MEG;2MEH;2MEI;2NWD;2ZIJ;2ZIK;2ZIL;2ZWB;3EBA;3FE0;3LHM;3LN2;4I0C;4ML7;4R0P;5LSH;5LVK;6LFH;7AP7;,88,T,N,True,1034
14071,3514,28507,single nucleotide variant,NM_000371.4(TTR):c.349G>T (p.Ala117Ser),7276,TTR,HGNC:12405,Pathogenic/Likely pathogenic,1,30-Dec-19,267607161,-,RCV000014410|RCV000223869,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN517202",Amyloidogenic transthyretin amyloidosis|not provided,germline,germline,GRCh38,NC_000018.10,18,31598580,31598580,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA256859,UniProtKB:P02766#VAR_038982,OMIM:176300.0052",3,13468,31598580,G,T,A117S,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,117,A,S,True,1035
14072,3513,28505,single nucleotide variant,NM_000371.3(TTR):c.265T>C (p.Tyr89His),7276,TTR,HGNC:12405,Pathogenic/Likely pathogenic,1,26-Dec-19,121918100,-,RCV000014408|RCV000586493|RCV000756861,"MedGen:C3151470|MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN235283","AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED|Amyloidogenic transthyretin amyloidosis|none provided",germline;unknown,germline,GRCh38,NC_000018.10,18,31595184,31595184,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA123120,UniProtKB:P02766#VAR_007577,OMIM:176300.0050",3,13466,31595184,T,C,Y89H,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,89,Y,H,True,1035
14073,3510,28501,single nucleotide variant,NM_000371.3(TTR):c.218G>A (p.Gly73Glu),7276,TTR,HGNC:12405,Pathogenic,1,10-Jul-01,121918097,-,RCV000014404,MedGen:C3151470,"AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED",germline,germline,GRCh38,NC_000018.10,18,31595137,31595137,na,na,18q12.1,no assertion criteria provided,1,-,N,"UniProtKB:P02766#VAR_038975,OMIM:176300.0046,ClinGen:CA123112",1,13462,31595137,G,A,G73E,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,73,G,E,True,1035
14074,3511,28502,single nucleotide variant,NM_000371.4(TTR):c.113A>G (p.Asp38Gly),7276,TTR,HGNC:12405,Pathogenic,1,1-Mar-12,121918098,-,RCV000014405|RCV000036373,"MedGen:C3151470|MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451","AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED|Amyloidogenic transthyretin amyloidosis",germline,germline,GRCh38,NC_000018.10,18,31592939,31592939,na,na,18q12.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA123114,UniProtKB:P02766#VAR_007549,OMIM:176300.0047",3,13463,31592939,A,G,D38G,1,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,38,D,G,True,1035
14075,12685,230873,single nucleotide variant,NM_000371.4(TTR):c.418G>T (p.Ala140Ser),7276,TTR,HGNC:12405,Conflicting interpretations of pathogenicity,1,1-Jul-19,876658108,-,RCV000217098|RCV000588714|RCV000809803,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",not specified|not provided|Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31598649,31598649,na,na,18q12.1,"criteria provided, conflicting interpretations",3,-,N,"ClinGen:CA10577055,UniProtKB:P02766#VAR_038986",2,229597,31598649,G,T,A140S,1,uncertain,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,140,A,S,True,1035
14076,3512,28504,single nucleotide variant,NM_000371.3(TTR):c.149T>G (p.Val50Gly),7276,TTR,HGNC:12405,Pathogenic,1,1-Mar-97,79977247,-,RCV000014407,MedGen:C3151470,"AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED",germline,germline,GRCh38,NC_000018.10,18,31592975,31592975,na,na,18q12.1,no assertion criteria provided,1,-,N,"OMIM:176300.0049,ClinGen:CA123118,UniProtKB:P02766#VAR_038962",1,13465,31592975,T,G,V50G,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,50,V,G,True,1035
14077,3509,28500,single nucleotide variant,NM_000371.3(TTR):c.191T>C (p.Phe64Ser),7276,TTR,HGNC:12405,Pathogenic,1,1-Feb-02,104894665,-,RCV000014403|RCV000014406,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:C3151470","Amyloidogenic transthyretin amyloidosis|AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED",germline,germline,GRCh38,NC_000018.10,18,31593017,31593017,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA123116,UniProtKB:P02766#VAR_038971,OMIM:176300.0045,OMIM:176300.0048",1,13461,31593017,T,C,F64S,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,64,F,S,True,1035
14078,3471,28456,single nucleotide variant,NM_000371.4(TTR):c.148G>A (p.Val50Met),7276,TTR,HGNC:12405,Pathogenic,1,23-Oct-20,28933979,-,RCV000014359|RCV000159423|RCV000763026|RCV000770555|RCV001000035|RCV001173292,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN517202|MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451;MONDO:MONDO:0007785,MedGen:C2750824,OMIM:145680;MONDO:MONDO:0007275,MedGen:C0007286|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MedGen:CN235283|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166",Amyloidogenic transthyretin amyloidosis|not provided|Amyloidogenic transthyretin amyloidosis;Dystransthyretinemic euthyroidal hyperthyroxinemia;Carpal tunnel syndrome|Cardiomyopathy|none provided|Charcot-Marie-Tooth disease,germline;unknown,germline,GRCh38,NC_000018.10,18,31592974,31592974,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",15,-,N,"OMIM:176300.0001,ClinGen:CA256790,UniProtKB:P02766#VAR_007554",3,13417,31592974,G,A,V50M,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,50,V,M,True,1035
14079,6221,45551,single nucleotide variant,NM_000371.3(TTR):c.210T>A (p.Ser70Arg),7276,TTR,HGNC:12405,Pathogenic,1,29-Oct-19,121918076,-,RCV000030572|RCV000517494,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN517202",Amyloidogenic transthyretin amyloidosis|not provided,germline,germline,GRCh38,NC_000018.10,18,31595129,31595129,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA260565,UniProtKB:P02766#VAR_007566",2,36890,31595129,T,A,S70R,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,70,S,R,True,1035
14080,3472,28457,single nucleotide variant,NM_000371.3(TTR):c.157T>A (p.Phe53Ile),7276,TTR,HGNC:12405,Pathogenic,1,1-Feb-93,121918068,-,RCV000014360,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31592983,31592983,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA256792,UniProtKB:P02766#VAR_007555,OMIM:176300.0002",1,13418,31592983,T,A,F53I,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,53,F,I,True,1035
14081,3493,28482,single nucleotide variant,NM_000371.3(TTR):c.270A>C (p.Lys90Asn),7276,TTR,HGNC:12405,Pathogenic,1,1-Nov-92,267607160,-,RCV000014385,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31595189,31595189,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA256831,UniProtKB:P02766#VAR_007578,OMIM:176300.0027",1,13443,31595189,A,C,K90N,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,90,K,N,True,1035
14082,3494,28483,single nucleotide variant,NM_000371.3(TTR):c.88T>C (p.Cys30Arg),7276,TTR,HGNC:12405,Conflicting interpretations of pathogenicity,1,1-Aug-20,121918083,-,RCV000014386|RCV000993524,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN517202",Amyloidogenic transthyretin amyloidosis|not provided,germline,germline,GRCh38,NC_000018.10,18,31592914,31592914,na,na,18q12.1,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA256833,UniProtKB:P02766#VAR_007547,OMIM:176300.0028",3,13444,31592914,T,C,C30R,1,uncertain,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,30,C,R,True,1035
14083,3495,28484,single nucleotide variant,NM_000371.3(TTR):c.272T>C (p.Val91Ala),7276,TTR,HGNC:12405,Pathogenic,1,13-Feb-97,121918084,-,RCV000014387,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31595191,31595191,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA256835,UniProtKB:P02766#VAR_007579,OMIM:176300.0029",1,13445,31595191,T,C,V91A,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,91,V,A,True,1035
14084,3496,28485,single nucleotide variant,NM_000371.3(TTR):c.262A>T (p.Ile88Leu),7276,TTR,HGNC:12405,Pathogenic/Likely pathogenic,1,7-Aug-20,121918085,-,RCV000014388|RCV001288934,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN517202",Amyloidogenic transthyretin amyloidosis|not provided,germline;unknown,germline,GRCh38,NC_000018.10,18,31595181,31595181,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA256837,UniProtKB:P02766#VAR_007576,OMIM:176300.0030",3,13446,31595181,A,T,I88L,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,88,I,L,True,1035
14085,3497,28486,single nucleotide variant,NM_000371.3(TTR):c.241G>A (p.Glu81Lys),7276,TTR,HGNC:12405,Pathogenic,1,16-Aug-93,121918086,-,RCV000014389,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31595160,31595160,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA256839,UniProtKB:P02766#VAR_007574,OMIM:176300.0031",1,13447,31595160,G,A,E81K,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,81,E,K,True,1035
14086,3498,28487,single nucleotide variant,NM_000371.3(TTR):c.350C>G (p.Ala117Gly),7276,TTR,HGNC:12405,Pathogenic,1,1-Jan-94,121918087,-,RCV000014390,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,unknown,unknown,GRCh38,NC_000018.10,18,31598581,31598581,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA256841,UniProtKB:P02766#VAR_007588,OMIM:176300.0032",1,13448,31598581,C,G,A117G,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,117,A,G,True,1035
14087,6220,45550,single nucleotide variant,NM_000371.3(TTR):c.208A>C (p.Ser70Arg),7276,TTR,HGNC:12405,Likely pathogenic,1,18-Aug-11,386134269,-,RCV000030571,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31595127,31595127,na,na,18q12.1,"criteria provided, single submitter",1,-,N,"ClinGen:CA260564,UniProtKB:P02766#VAR_007566",2,36889,31595127,A,C,S70R,1,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,70,S,R,True,1035
14088,3499,28488,single nucleotide variant,NM_000371.3(TTR):c.400T>C (p.Tyr134His),7276,TTR,HGNC:12405,Pathogenic,1,1-Feb-94,121918088,-,RCV000014391,MedGen:C3468338,"Carpal tunnel syndrome, familial",germline,germline,GRCh38,NC_000018.10,18,31598631,31598631,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA123104,UniProtKB:P02766#VAR_007598,OMIM:176300.0033",1,13449,31598631,T,C,Y134H,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,134,Y,H,True,1035
14089,3501,28490,single nucleotide variant,NM_000371.3(TTR):c.200G>C (p.Gly67Ala),7276,TTR,HGNC:12405,Pathogenic,1,15-Feb-17,121918090,-,RCV000014393|RCV000516227,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN517202",Amyloidogenic transthyretin amyloidosis|not provided,germline,germline,GRCh38,NC_000018.10,18,31593026,31593026,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA256845,UniProtKB:P02766#VAR_007561,OMIM:176300.0035",3,13451,31593026,G,C,G67A,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,67,G,A,True,1035
14090,3502,28491,single nucleotide variant,NM_000371.4(TTR):c.76G>A (p.Gly26Ser),7276,TTR,HGNC:12405,Benign,0,30-Aug-20,1800458,-,RCV000014394|RCV000036379|RCV000250966|RCV001127884|RCV001173541|RCV001283223,"|MedGen:CN169374|MedGen:CN230736|MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MedGen:CN235283",TRANSTHYRETIN POLYMORPHISM|not specified|Cardiovascular phenotype|Amyloidogenic transthyretin amyloidosis|Charcot-Marie-Tooth disease|none provided,germline,germline,GRCh38,NC_000018.10,18,31592902,31592902,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",10,-,N,"ClinGen:CA123106,UniProtKB:P02766#VAR_007546,OMIM:176300.0036",3,13452,31592902,G,A,G26S,2,benign,benign,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,26,G,S,True,1035
14091,3504,28494,single nucleotide variant,NM_000371.3(TTR):c.118G>A (p.Val40Ile),7276,TTR,HGNC:12405,Pathogenic,1,8-Oct-19,121918093,-,RCV000014397|RCV000159420,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN517202",Amyloidogenic transthyretin amyloidosis|not provided,germline,germline,GRCh38,NC_000018.10,18,31592944,31592944,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA256849,UniProtKB:P02766#VAR_007550,OMIM:176300.0039",3,13455,31592944,G,A,V40I,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,40,V,I,True,1035
14092,3505,28495,single nucleotide variant,NM_000371.3(TTR):c.157T>C (p.Phe53Leu),7276,TTR,HGNC:12405,Pathogenic,1,13-Feb-20,121918068,-,RCV000014398|RCV001287280,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN235283",Amyloidogenic transthyretin amyloidosis|none provided,germline,germline,GRCh38,NC_000018.10,18,31592983,31592983,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA256851,UniProtKB:P02766#VAR_007556,OMIM:176300.0040",3,13456,31592983,T,C,F53L,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,53,F,L,True,1035
14093,3475,28460,single nucleotide variant,NM_000371.4(TTR):c.238A>G (p.Thr80Ala),7276,TTR,HGNC:12405,Pathogenic,1,7-Apr-20,121918070,-,RCV000014363|RCV000159427|RCV000852477|RCV001002097|RCV001173293,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN517202|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MedGen:CN235283|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166",Amyloidogenic transthyretin amyloidosis|not provided|Cardiomyopathy|none provided|Charcot-Marie-Tooth disease,germline;unknown,germline,GRCh38,NC_000018.10,18,31595157,31595157,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",11,-,N,"ClinGen:CA256798,UniProtKB:P02766#VAR_007573,OMIM:176300.0004",3,13421,31595157,A,G,T80A,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,80,T,A,True,1035
14094,11400,179815,single nucleotide variant,NM_000371.3(TTR):c.407A>C (p.Tyr136Ser),7276,TTR,HGNC:12405,Likely pathogenic,1,25-Mar-11,730881167,-,RCV000223926,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000018.10,18,31598638,31598638,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA297535,UniProtKB:P02766#VAR_007596",2,181700,31598638,A,C,Y136S,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,136,Y,S,True,1035
14095,3500,28489,single nucleotide variant,NM_000371.3(TTR):c.379A>G (p.Ile127Val),7276,TTR,HGNC:12405,Pathogenic/Likely pathogenic,1,23-Oct-20,121918089,-,RCV000014392|RCV000506089|RCV001090344,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN169374|MedGen:CN517202",Amyloidogenic transthyretin amyloidosis|not specified|not provided,germline;unknown,germline,GRCh38,NC_000018.10,18,31598610,31598610,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",8,-,N,"ClinGen:CA256843,UniProtKB:P02766#VAR_007592,OMIM:176300.0034",3,13450,31598610,A,G,I127V,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,127,I,V,True,1035
14096,11399,179808,single nucleotide variant,NM_000371.3(TTR):c.280G>C (p.Asp94His),7276,TTR,HGNC:12405,Uncertain significance,0,18-Oct-19,730881164,-,RCV000647355|RCV000725937|RCV000765411|RCV001173300,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN517202|MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451;MONDO:MONDO:0007275,MedGen:C0007286;MONDO:MONDO:0007785,MedGen:C2750824,OMIM:145680|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166",Amyloidogenic transthyretin amyloidosis|not provided|Amyloidogenic transthyretin amyloidosis;Carpal tunnel syndrome;Dystransthyretinemic euthyroidal hyperthyroxinemia|Charcot-Marie-Tooth disease,germline;unknown,germline,GRCh38,NC_000018.10,18,31595199,31595199,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA297523,UniProtKB:P02766#VAR_007581",2,181695,31595199,G,C,D94H,2,uncertain,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,94,D,H,True,1035
14097,3492,28481,single nucleotide variant,NM_000371.3(TTR):c.325G>C (p.Glu109Gln),7276,TTR,HGNC:12405,Pathogenic,1,19-Jun-19,121918082,-,RCV000014384|RCV000236028,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN517202",Amyloidogenic transthyretin amyloidosis|not provided,germline,germline,GRCh38,NC_000018.10,18,31595244,31595244,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA256829,UniProtKB:P02766#VAR_007585,OMIM:176300.0026",3,13442,31595244,G,C,E109Q,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,109,E,Q,True,1035
14098,3490,28479,single nucleotide variant,NM_000371.3(TTR):c.148G>C (p.Val50Leu),7276,TTR,HGNC:12405,Pathogenic,1,-,28933979,-,RCV000014382|RCV001173291,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166",Amyloidogenic transthyretin amyloidosis|Charcot-Marie-Tooth disease,germline,germline,GRCh38,NC_000018.10,18,31592974,31592974,na,na,18q12.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA256825,UniProtKB:P02766#VAR_007553,OMIM:176300.0024",3,13440,31592974,G,C,V50L,1,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,50,V,L,True,1035
14099,3476,28461,single nucleotide variant,NM_000371.3(TTR):c.290C>A (p.Ser97Tyr),7276,TTR,HGNC:12405,Pathogenic,1,21-Aug-19,121918071,-,RCV000014364|RCV000519257|RCV001000742|RCV001173289,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166",Amyloidogenic transthyretin amyloidosis|not provided|not specified|Charcot-Marie-Tooth disease,germline,germline,GRCh38,NC_000018.10,18,31595209,31595209,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",6,-,N,"OMIM:176300.0005,ClinGen:CA256800,UniProtKB:P02766#VAR_007582",3,13422,31595209,C,A,S97Y,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,97,S,Y,True,1035
14100,3477,28462,single nucleotide variant,NM_000371.3(TTR):c.311T>G (p.Ile104Ser),7276,TTR,HGNC:12405,Pathogenic,1,19-Aug-19,121918072,-,RCV000014365,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31595230,31595230,na,na,18q12.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA256802,UniProtKB:P02766#VAR_007584,OMIM:176300.0006",3,13423,31595230,T,G,I104S,1,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,104,I,S,True,1035
14101,3478,28463,single nucleotide variant,NM_000371.3(TTR):c.391C>A (p.Leu131Met),7276,TTR,HGNC:12405,Pathogenic,1,1-Oct-93,121918073,-,RCV000014366,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31598622,31598622,na,na,18q12.1,no assertion criteria provided,1,-,N,"UniProtKB:P02766#VAR_007594,OMIM:176300.0007,ClinGen:CA256804",1,13424,31598622,C,A,L131M,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,131,L,M,True,1035
14102,3479,28465,single nucleotide variant,NM_000371.4(TTR):c.424G>A (p.Val142Ile),7276,TTR,HGNC:12405,Pathogenic/Likely pathogenic,1,30-Jul-20,76992529,-,RCV000014368|RCV000030575|RCV000078674|RCV000211747|RCV000243161|RCV000515257|RCV000735409|RCV000853387|RCV000999849|RCV001173290|RCV001263365,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:C3151471|MedGen:CN517202|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MedGen:CN230736|MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451;MONDO:MONDO:0007785,MedGen:C2750824,OMIM:145680;MONDO:MONDO:0007275,MedGen:C0007286|Human Phenotype Ontology:HP:0005528,Human Phenotype Ontology:HP:0005529,Human Phenotype Ontology:HP:0100549,MedGen:C1855710;Human Phenotype Ontology:HP:0001876,MONDO:MONDO:0001529,MedGen:C0030312;Human Phenotype Ontology:HP:0001903,Human Phenotype Ontology:HP:0001926,Human Phenotype Ontology:HP:0003136,Human Phenotype Ontology:HP:0005509,MedGen:C0002871|MONDO:MONDO:0019441,MedGen:C4275067,Orphanet:85451|MedGen:CN235283|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|Human Phenotype Ontology:HP:0002174,Human Phenotype Ontology:HP:0006925,Human Phenotype Ontology:HP:0007197,MedGen:C0234378","Amyloidogenic transthyretin amyloidosis|Amyloid Cardiomyopathy, Transthyretin-related|not provided|Cardiomyopathy|Cardiovascular phenotype|Amyloidogenic transthyretin amyloidosis;Dystransthyretinemic euthyroidal hyperthyroxinemia;Carpal tunnel syndrome|Bone marrow hypocellularity;Pancytopenia;Anemia|ATTRV122I amyloidosis|none provided|Charcot-Marie-Tooth disease|Postural tremor",germline;unknown,germline,GRCh38,NC_000018.10,18,31598655,31598655,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",23,-,N,"ClinVar:1012273,ClinGen:CA214382,UniProtKB:P02766#VAR_007600,OMIM:176300.0009",3,13426,31598655,G,A,V142I,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,142,V,I,True,1035
14103,3480,28466,single nucleotide variant,NM_000371.4(TTR):c.328C>A (p.His110Asn),7276,TTR,HGNC:12405,Conflicting interpretations of pathogenicity,1,29-Feb-20,121918074,-,RCV000014369|RCV000152541|RCV000621211|RCV000770556|RCV000852746|RCV000857889|RCV001173306|RCV001256816,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN169374|MedGen:CN230736|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0005252,MedGen:C0018801|MedGen:CN517202|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MONDO:MONDO:0008647,MedGen:C3495498,OMIM:192600",Amyloidogenic transthyretin amyloidosis|not specified|Cardiovascular phenotype|Cardiomyopathy|Heart failure|not provided|Charcot-Marie-Tooth disease|Familial hypertrophic cardiomyopathy 1,germline;unknown,germline,GRCh38,NC_000018.10,18,31595247,31595247,na,na,18q12.1,"criteria provided, conflicting interpretations",13,-,N,"OMIM:176300.0010,ClinGen:CA179461,UniProtKB:P02766#VAR_007586",3,13427,31595247,C,A,H110N,1,uncertain,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,110,H,N,True,1035
14104,3481,28467,single nucleotide variant,NM_000371.3(TTR):c.185A>G (p.Glu62Gly),7276,TTR,HGNC:12405,Pathogenic,1,1-Aug-92,11541796,-,RCV000014370,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31593011,31593011,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA256806,UniProtKB:P02766#VAR_007558,OMIM:176300.0012",1,13428,31593011,A,G,E62G,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,62,E,G,True,1035
14105,3491,28480,single nucleotide variant,NM_000371.3(TTR):c.205A>G (p.Thr69Ala),7276,TTR,HGNC:12405,Pathogenic,1,13-Feb-97,121918081,-,RCV000014383,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31595124,31595124,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA256827,UniProtKB:P02766#VAR_007564,OMIM:176300.0025",1,13441,31595124,A,G,T69A,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,69,T,A,True,1035
14106,3482,28468,single nucleotide variant,NM_000371.3(TTR):c.210T>G (p.Ser70Arg),7276,TTR,HGNC:12405,Pathogenic,1,22-Dec-18,121918076,-,RCV000014371,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31595129,31595129,na,na,18q12.1,"criteria provided, single submitter",3,-,N,"UniProtKB:P02766#VAR_007566,OMIM:176300.0013,ClinGen:CA256808",3,13429,31595129,T,G,S70R,1,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,70,S,R,True,1035
14107,3484,28471,single nucleotide variant,NM_000371.3(TTR):c.166G>C (p.Ala56Pro),7276,TTR,HGNC:12405,Pathogenic,1,14-Jun-18,121918077,-,RCV000014374,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31592992,31592992,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA256812,UniProtKB:P02766#VAR_007557,OMIM:176300.0016",1,13432,31592992,G,C,A56P,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,56,A,P,True,1035
14108,3485,28473,single nucleotide variant,NM_000371.4(TTR):c.416C>T (p.Thr139Met),7276,TTR,HGNC:12405,Conflicting interpretations of pathogenicity,0,16-Apr-20,28933981,-,RCV000014376|RCV000036376|RCV000618448|RCV000714134|RCV000990084|RCV001170385|RCV001173303|RCV001281790,"|MedGen:CN169374|MedGen:CN230736|MedGen:CN517202|MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MedGen:CN235283","AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED, MODIFIER OF|not specified|Cardiovascular phenotype|not provided|Amyloidogenic transthyretin amyloidosis|Cardiomyopathy|Charcot-Marie-Tooth disease|none provided",germline;unknown,germline,GRCh38,NC_000018.10,18,31598647,31598647,na,na,18q12.1,"criteria provided, conflicting interpretations",12,-,N,"ClinGen:CA123101,UniProtKB:P02766#VAR_007599,OMIM:176300.0018",3,13434,31598647,C,T,T139M,1,uncertain,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,139,T,M,True,1035
14109,3486,28474,single nucleotide variant,NM_000371.3(TTR):c.233T>G (p.Leu78Arg),7276,TTR,HGNC:12405,Pathogenic,1,15-Oct-91,121918069,-,RCV000014377,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31595152,31595152,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA256814,UniProtKB:P02766#VAR_007571,OMIM:176300.0019",1,13435,31595152,T,G,L78R,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,78,L,R,True,1035
14110,3487,28475,single nucleotide variant,NM_000371.3(TTR):c.199G>C (p.Gly67Arg),7276,TTR,HGNC:12405,Pathogenic,1,1-Apr-00,387906523,-,RCV000014378,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31593025,31593025,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA256816,UniProtKB:P02766#VAR_007562,OMIM:176300.0020",1,13436,31593025,G,C,G67R,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,67,G,R,True,1035
14111,3488,28477,single nucleotide variant,NM_000371.3(TTR):c.224T>C (p.Leu75Pro),7276,TTR,HGNC:12405,Pathogenic,1,1-Jan-97,121918079,-,RCV000014380,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31595143,31595143,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA256821,UniProtKB:P02766#VAR_007569,OMIM:176300.0022",1,13438,31595143,T,C,L75P,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,75,L,P,True,1035
14112,3489,28478,single nucleotide variant,NM_000371.3(TTR):c.209G>T (p.Ser70Ile),7276,TTR,HGNC:12405,Pathogenic,1,31-Aug-92,121918080,-,RCV000014381,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31595128,31595128,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA256823,UniProtKB:P02766#VAR_007565,OMIM:176300.0023",1,13439,31595128,G,T,S70I,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,70,S,I,True,1035
14113,3483,28469,single nucleotide variant,NM_000371.3(TTR):c.149T>C (p.Val50Ala),7276,TTR,HGNC:12405,Pathogenic,1,31-Oct-19,79977247,-,RCV000014372,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31592975,31592975,na,na,18q12.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA256810,UniProtKB:P02766#VAR_007552,OMIM:176300.0014",3,13430,31592975,T,C,V50A,1,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,50,V,A,True,1035
14114,11398,179807,single nucleotide variant,NM_000371.3(TTR):c.236C>A (p.Thr79Lys),7276,TTR,HGNC:12405,Likely pathogenic,1,4-Oct-18,730881163,-,RCV000159426,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000018.10,18,31595155,31595155,na,na,18q12.1,"criteria provided, single submitter",1,-,N,"ClinGen:CA297521,UniProtKB:P02766#VAR_007572",2,181694,31595155,C,A,T79K,1,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,79,T,K,True,1035
14115,3503,28492,single nucleotide variant,NM_000371.3(TTR):c.250T>C (p.Phe84Leu),7276,TTR,HGNC:12405,Pathogenic,1,1-Nov-20,121918091,-,RCV000014395|RCV000236623|RCV000763027,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN517202|MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451;MONDO:MONDO:0007785,MedGen:C2750824,OMIM:145680;MONDO:MONDO:0007275,MedGen:C0007286",Amyloidogenic transthyretin amyloidosis|not provided|Amyloidogenic transthyretin amyloidosis;Dystransthyretinemic euthyroidal hyperthyroxinemia;Carpal tunnel syndrome,germline;unknown,germline,GRCh38,NC_000018.10,18,31595169,31595169,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",7,-,N,"ClinGen:CA256847,UniProtKB:P02766#VAR_007575,OMIM:176300.0037",3,13453,31595169,T,C,F84L,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,84,F,L,True,1035
14116,6825,52624,single nucleotide variant,NM_000371.4(TTR):c.385G>A (p.Ala129Thr),7276,TTR,HGNC:12405,Uncertain significance,0,8-Oct-20,267607159,-,RCV000036375|RCV000548533|RCV000619844|RCV000755423,"MedGen:CN169374|MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN230736|MedGen:CN517202",not specified|Amyloidogenic transthyretin amyloidosis|Cardiovascular phenotype|not provided,germline,germline,GRCh38,NC_000018.10,18,31598616,31598616,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA132600,UniProtKB:P02766#VAR_007593",2,43454,31598616,G,A,A129T,2,uncertain,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,129,A,T,True,1035
14117,11397,179804,single nucleotide variant,NM_000371.3(TTR):c.130C>T (p.Pro44Ser),7276,TTR,HGNC:12405,Pathogenic,1,15-Apr-19,11541790,-,RCV000159421|RCV000560691,"MedGen:CN517202|MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",not provided|Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31592956,31592956,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA297519,UniProtKB:P02766#VAR_007551",2,181693,31592956,C,T,P44S,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,44,P,S,True,1035
14118,3506,28496,single nucleotide variant,NM_000371.3(TTR):c.95T>C (p.Leu32Pro),7276,TTR,HGNC:12405,Pathogenic,1,5-Jun-19,121918094,-,RCV000014399|RCV001001339,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN169374",Amyloidogenic transthyretin amyloidosis|not specified,germline,germline,GRCh38,NC_000018.10,18,31592921,31592921,na,na,18q12.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA256853,UniProtKB:P02766#VAR_038959,OMIM:176300.0041",3,13457,31592921,T,C,L32P,1,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,32,L,P,True,1035
14119,3473,28458,single nucleotide variant,NM_000371.3(TTR):c.401A>G (p.Tyr134Cys),7276,TTR,HGNC:12405,Pathogenic,1,31-Dec-18,121918075,-,RCV000014361,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31598632,31598632,na,na,18q12.1,"criteria provided, single submitter",2,-,N,"UniProtKB:P02766#VAR_007595,OMIM:176300.0011,ClinGen:CA256794",3,13419,31598632,A,G,Y134C,1,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,134,Y,C,True,1035
14120,3507,28497,single nucleotide variant,NM_000371.4(TTR):c.371G>A (p.Arg124His),7276,TTR,HGNC:12405,Conflicting interpretations of pathogenicity,1,31-Dec-19,121918095,-,RCV000014400|RCV000152543|RCV000586735|RCV000621591|RCV001170383|RCV001173296,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN169374|MedGen:CN517202|MedGen:CN230736|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166",Amyloidogenic transthyretin amyloidosis|not specified|not provided|Cardiovascular phenotype|Cardiomyopathy|Charcot-Marie-Tooth disease,germline,germline,GRCh38,NC_000018.10,18,31598602,31598602,na,na,18q12.1,"criteria provided, conflicting interpretations",8,-,N,"ClinGen:CA179467,UniProtKB:P02766#VAR_038983,OMIM:176300.0042",3,13458,31598602,G,A,R124H,1,uncertain,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,124,R,H,True,1035
14121,3474,28459,single nucleotide variant,NM_000371.3(TTR):c.233T>A (p.Leu78His),7276,TTR,HGNC:12405,Pathogenic,1,13-Dec-19,121918069,-,RCV000014362|RCV000159437,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451|MedGen:CN517202",Amyloidogenic transthyretin amyloidosis|not provided,germline,germline,GRCh38,NC_000018.10,18,31595152,31595152,na,na,18q12.1,"criteria provided, multiple submitters, no conflicts",5,-,N,"ClinGen:CA256796,UniProtKB:P02766#VAR_007570,OMIM:176300.0003",3,13420,31595152,T,A,L78H,2,pathogenic,pathogenic,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,78,L,H,True,1035
14122,3508,28498,single nucleotide variant,NM_000371.3(TTR):c.199G>A (p.Gly67Arg),7276,TTR,HGNC:12405,Pathogenic,1,1-Apr-00,387906523,-,RCV000014401,"MONDO:MONDO:0007100,MedGen:C2751492,OMIM:105210,Orphanet:85447,Orphanet:85451",Amyloidogenic transthyretin amyloidosis,germline,germline,GRCh38,NC_000018.10,18,31593025,31593025,na,na,18q12.1,no assertion criteria provided,1,-,N,"ClinGen:CA256855,UniProtKB:P02766#VAR_007562,OMIM:176300.0043",1,13459,31593025,G,A,G67R,0,pathogenic,uncertain,P02766,P02766,reviewed,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),TTR PALB,Homo sapiens (Human),147.0,MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE,PF00576;,1BM7;1BMZ;1BZ8;1BZD;1BZE;1DVQ;1DVS;1DVT;1DVU;1DVX;1DVY;1DVZ;1E3F;1E4H;1E5A;1ETA;1ETB;1F41;1F86;1FH2;1FHN;1G1O;1GKO;1ICT;1III;1IIK;1IJN;1QAB;1QWH;1RLB;1SOK;1SOQ;1THA;1THC;1TLM;1TSH;1TT6;1TTA;1TTB;1TTC;1TTR;1TYR;1TZ8;1U21;1X7S;1X7T;1Y1D;1Z7J;1ZCR;1ZD6;2B14;2B15;2B16;2B77;2B9A;2F7I;2F8I;2FBR;2FLM;2G3X;2G3Z;2G4E;2G4G;2G5U;2G9K;2GAB;2H4E;2M5N;2NBO;2NBP;2NOY;2PAB;2QEL;2QGB;2QGC;2QGD;2QGE;2ROX;2ROY;2TRH;2TRY;2WQA;3A4D;3A4E;3A4F;3B56;3BSZ;3BT0;3CBR;3CFM;3CFN;3CFQ;3CFT;3CN0;3CN1;3CN2;3CN3;3CN4;3CXF;3D2T;3D7P;3DGD;3DID;3DJR;3DJS;3DJT;3DJZ;3DK0;3DK2;3DO4;3ESN;3ESO;3ESP;3FC8;3FCB;3GLZ;3GPS;3GRB;3GRG;3GS0;3GS4;3GS7;3HJ0;3I9A;3I9I;3I9P;3IMR;3IMS;3IMT;3IMU;3IMV;3IMW;3IPB;3IPE;3KGS;3KGT;3KGU;3M1O;3NEE;3NEO;3NES;3NEX;3NG5;3OZK;3OZL;3P3R;3P3S;3P3T;3P3U;3SSG;3TCT;3TFB;3U2I;3U2J;3W3B;4ABQ;4ABU;4ABV;4ABW;4AC2;4AC4;4ACT;4ANK;4D7B;4DER;4DES;4DET;4DEU;4DEW;4FI6;4FI7;4FI8;4HIQ;4HIS;4HJS;4HJT;4HJU;4I85;4I87;4I89;4IIZ;4IK6;4IK7;4IKI;4IKJ;4IKK;4IKL;4KY2;4L1S;4L1T;4MAS;4MRB;4MRC;4N85;4N86;4N87;4PM1;4PME;4PMF;4PVL;4PVM;4PVN;4PWE;4PWF;4PWG;4PWH;4PWI;4PWJ;4PWK;4QRF;4QXV;4QYA;4TKW;4TL4;4TL5;4TLK;4TLS;4TLT;4TLU;4TM9;4TNE;4TNF;4TNG;4TQ8;4TQH;4TQI;4TQP;4WNJ;4WNS;4WO0;4Y9B;4Y9C;4Y9E;4Y9F;4Y9G;4YDM;4YDN;5A6I;5AKS;5AKT;5AKV;5AL0;5AL8;5AYT;5BOJ;5CLX;5CLY;5CLZ;5CM1;5CN3;5CNH;5CR1;5DEJ;5DWP;5E23;5E4A;5E4O;5EN3;5EZP;5FO2;5FW6;5FW7;5FW8;5H0V;5H0W;5H0X;5H0Y;5H0Z;5HJG;5IHH;5JID;5JIM;5JIQ;5K1J;5K1N;5L4F;5L4I;5L4J;5L4M;5LLL;5LLV;5N5Q;5N62;5N7C;5NFE;5NFW;5OQ0;5TTR;5TZL;5U48;5U49;5U4A;5U4B;5U4C;5U4D;5U4E;5U4F;5U4G;6D0W;6E6Z;6E70;6E71;6E72;6E73;6E74;6E75;6E76;6E77;6E78;6EOY;6EP1;6FFT;6FWD;6FXU;6FZL;6GR7;6GRP;6IMX;6IMY;6KGB;6R66;6R67;6R68;6R6I;6SDZ;6SUG;6SUH;6TI9;6TJN;6TXV;6TXW;6U0Q;6XTK;7ACU;7DT3;7DT5;7DT6;7DT8;7EJQ;7EJR;7ERH;7ERI;7ERJ;7ERK;7OB4;,67,G,R,True,1035
14123,5177,33114,single nucleotide variant,NM_001097577.3(ANG):c.121A>G (p.Lys41Glu),283,ANG,HGNC:483,Pathogenic,1,1-Apr-06,121909537,-,RCV000019701,"MONDO:MONDO:0012753,MedGen:C2678468,OMIM:611895,Orphanet:803",Amyotrophic lateral sclerosis type 9,germline,germline,GRCh38,NC_000014.9,14,20693685,20693685,na,na,14q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA258094,UniProtKB:P03950#VAR_044148,OMIM:105850.0003",1,18075,20693685,A,G,K41E,0,pathogenic,uncertain,P03950,P03950,reviewed,ANGI_HUMAN,"Angiogenin, EC 3.1.27.- (Ribonuclease 5, RNase 5)",ANG RNASE5,Homo sapiens (Human),147.0,MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP,PF00074;,1A4Y;1ANG;1AWZ;1B1E;1B1I;1B1J;1GV7;1H0D;1H52;1H53;1HBY;1K58;1K59;1K5A;1K5B;1UN3;1UN4;1UN5;2ANG;4AHD;4AHE;4AHF;4AHG;4AHH;4AHI;4AHJ;4AHK;4AHL;4AHM;4AHN;4AOH;4B36;5EOP;5EPZ;5EQO;5M9A;5M9C;5M9G;5M9J;5M9M;5M9P;5M9Q;5M9R;5M9S;5M9T;5M9V;7PNJ;7PNR;,41,K,E,True,1036
14124,5179,33116,single nucleotide variant,NM_001097577.3(ANG):c.189C>G (p.Cys63Trp),283,ANG,HGNC:483,Pathogenic,1,1-Apr-06,121909539,-,RCV000019703,"MONDO:MONDO:0012753,MedGen:C2678468,OMIM:611895,Orphanet:803",Amyotrophic lateral sclerosis type 9,germline,germline,GRCh38,NC_000014.9,14,20693753,20693753,na,na,14q11.2,no assertion criteria provided,1,-,N,"UniProtKB:P03950#VAR_044152,OMIM:105850.0005,ClinGen:CA258100",1,18077,20693753,C,G,C63W,0,pathogenic,uncertain,P03950,P03950,reviewed,ANGI_HUMAN,"Angiogenin, EC 3.1.27.- (Ribonuclease 5, RNase 5)",ANG RNASE5,Homo sapiens (Human),147.0,MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP,PF00074;,1A4Y;1ANG;1AWZ;1B1E;1B1I;1B1J;1GV7;1H0D;1H52;1H53;1HBY;1K58;1K59;1K5A;1K5B;1UN3;1UN4;1UN5;2ANG;4AHD;4AHE;4AHF;4AHG;4AHH;4AHI;4AHJ;4AHK;4AHL;4AHM;4AHN;4AOH;4B36;5EOP;5EPZ;5EQO;5M9A;5M9C;5M9G;5M9J;5M9M;5M9P;5M9Q;5M9R;5M9S;5M9T;5M9V;7PNJ;7PNR;,63,C,W,True,1036
14125,5175,33112,single nucleotide variant,NM_001097577.3(ANG):c.107A>T (p.Gln36Leu),283,ANG,HGNC:483,Pathogenic,1,1-Apr-06,121909535,-,RCV000019699,"MONDO:MONDO:0012753,MedGen:C2678468,OMIM:611895,Orphanet:803",Amyotrophic lateral sclerosis type 9,germline,germline,GRCh38,NC_000014.9,14,20693671,20693671,na,na,14q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA258088,UniProtKB:P03950#VAR_044147,OMIM:105850.0001",1,18073,20693671,A,T,Q36L,0,pathogenic,uncertain,P03950,P03950,reviewed,ANGI_HUMAN,"Angiogenin, EC 3.1.27.- (Ribonuclease 5, RNase 5)",ANG RNASE5,Homo sapiens (Human),147.0,MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP,PF00074;,1A4Y;1ANG;1AWZ;1B1E;1B1I;1B1J;1GV7;1H0D;1H52;1H53;1HBY;1K58;1K59;1K5A;1K5B;1UN3;1UN4;1UN5;2ANG;4AHD;4AHE;4AHF;4AHG;4AHH;4AHI;4AHJ;4AHK;4AHL;4AHM;4AHN;4AOH;4B36;5EOP;5EPZ;5EQO;5M9A;5M9C;5M9G;5M9J;5M9M;5M9P;5M9Q;5M9R;5M9S;5M9T;5M9V;7PNJ;7PNR;,36,Q,L,True,1036
14126,5180,33117,single nucleotide variant,NM_001097577.3(ANG):c.191A>T (p.Lys64Ile),283,ANG,HGNC:483,Pathogenic,1,1-Apr-06,121909540,-,RCV000019704,"MONDO:MONDO:0012753,MedGen:C2678468,OMIM:611895,Orphanet:803",Amyotrophic lateral sclerosis type 9,germline,germline,GRCh38,NC_000014.9,14,20693755,20693755,na,na,14q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA258103,UniProtKB:P03950#VAR_044153,OMIM:105850.0006",1,18078,20693755,A,T,K64I,0,pathogenic,uncertain,P03950,P03950,reviewed,ANGI_HUMAN,"Angiogenin, EC 3.1.27.- (Ribonuclease 5, RNase 5)",ANG RNASE5,Homo sapiens (Human),147.0,MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP,PF00074;,1A4Y;1ANG;1AWZ;1B1E;1B1I;1B1J;1GV7;1H0D;1H52;1H53;1HBY;1K58;1K59;1K5A;1K5B;1UN3;1UN4;1UN5;2ANG;4AHD;4AHE;4AHF;4AHG;4AHH;4AHI;4AHJ;4AHK;4AHL;4AHM;4AHN;4AOH;4B36;5EOP;5EPZ;5EQO;5M9A;5M9C;5M9G;5M9J;5M9M;5M9P;5M9Q;5M9R;5M9S;5M9T;5M9V;7PNJ;7PNR;,64,K,I,True,1036
14127,5183,33120,single nucleotide variant,NM_001097577.3(ANG):c.407C>T (p.Pro136Leu),283,ANG,HGNC:483,Pathogenic,1,1-Dec-07,121909543,-,RCV000019707,"MONDO:MONDO:0012753,MedGen:C2678468,OMIM:611895,Orphanet:803",Amyotrophic lateral sclerosis type 9,germline,germline,GRCh38,NC_000014.9,14,20693971,20693971,na,na,14q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA258112,UniProtKB:P03950#VAR_044155,OMIM:105850.0009",1,18081,20693971,C,T,P136L,0,pathogenic,uncertain,P03950,P03950,reviewed,ANGI_HUMAN,"Angiogenin, EC 3.1.27.- (Ribonuclease 5, RNase 5)",ANG RNASE5,Homo sapiens (Human),147.0,MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP,PF00074;,1A4Y;1ANG;1AWZ;1B1E;1B1I;1B1J;1GV7;1H0D;1H52;1H53;1HBY;1K58;1K59;1K5A;1K5B;1UN3;1UN4;1UN5;2ANG;4AHD;4AHE;4AHF;4AHG;4AHH;4AHI;4AHJ;4AHK;4AHL;4AHM;4AHN;4AOH;4B36;5EOP;5EPZ;5EQO;5M9A;5M9C;5M9G;5M9J;5M9M;5M9P;5M9Q;5M9R;5M9S;5M9T;5M9V;7PNJ;7PNR;,136,P,L,True,1036
14128,5182,33119,single nucleotide variant,NM_001097577.3(ANG):c.155G>A (p.Ser52Asn),283,ANG,HGNC:483,Pathogenic,1,1-Dec-07,121909542,-,RCV000019706,"MONDO:MONDO:0012753,MedGen:C2678468,OMIM:611895,Orphanet:803",Amyotrophic lateral sclerosis type 9,germline,germline,GRCh38,NC_000014.9,14,20693719,20693719,na,na,14q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA258109,UniProtKB:P03950#VAR_044150,OMIM:105850.0008",1,18080,20693719,G,A,S52N,0,pathogenic,uncertain,P03950,P03950,reviewed,ANGI_HUMAN,"Angiogenin, EC 3.1.27.- (Ribonuclease 5, RNase 5)",ANG RNASE5,Homo sapiens (Human),147.0,MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP,PF00074;,1A4Y;1ANG;1AWZ;1B1E;1B1I;1B1J;1GV7;1H0D;1H52;1H53;1HBY;1K58;1K59;1K5A;1K5B;1UN3;1UN4;1UN5;2ANG;4AHD;4AHE;4AHF;4AHG;4AHH;4AHI;4AHJ;4AHK;4AHL;4AHM;4AHN;4AOH;4B36;5EOP;5EPZ;5EQO;5M9A;5M9C;5M9G;5M9J;5M9M;5M9P;5M9Q;5M9R;5M9S;5M9T;5M9V;7PNJ;7PNR;,52,S,N,True,1036
14129,5181,33118,single nucleotide variant,NM_001097577.3(ANG):c.208A>G (p.Ile70Val),283,ANG,HGNC:483,Conflicting interpretations of pathogenicity,1,31-Mar-20,121909541,-,RCV000019705|RCV000335176,"MONDO:MONDO:0012753,MedGen:C2678468,OMIM:611895,Orphanet:803|MedGen:CN517202",Amyotrophic lateral sclerosis type 9|not provided,germline,germline,GRCh38,NC_000014.9,14,20693772,20693772,na,na,14q11.2,"criteria provided, conflicting interpretations",4,-,N,"ClinGen:CA258106,UniProtKB:P03950#VAR_044154,OMIM:105850.0007",3,18079,20693772,A,G,I70V,1,uncertain,uncertain,P03950,P03950,reviewed,ANGI_HUMAN,"Angiogenin, EC 3.1.27.- (Ribonuclease 5, RNase 5)",ANG RNASE5,Homo sapiens (Human),147.0,MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP,PF00074;,1A4Y;1ANG;1AWZ;1B1E;1B1I;1B1J;1GV7;1H0D;1H52;1H53;1HBY;1K58;1K59;1K5A;1K5B;1UN3;1UN4;1UN5;2ANG;4AHD;4AHE;4AHF;4AHG;4AHH;4AHI;4AHJ;4AHK;4AHL;4AHM;4AHN;4AOH;4B36;5EOP;5EPZ;5EQO;5M9A;5M9C;5M9G;5M9J;5M9M;5M9P;5M9Q;5M9R;5M9S;5M9T;5M9V;7PNJ;7PNR;,70,I,V,True,1036
14130,14119,335474,single nucleotide variant,NM_001097577.3(ANG):c.250A>G (p.Lys84Glu),283,ANG,HGNC:483,Benign,0,31-Dec-19,17560,-,RCV000516549|RCV000877109|RCV000986163,"MedGen:CN169374|MedGen:CN517202|MONDO:MONDO:0012753,MedGen:C2678468,OMIM:611895,Orphanet:803",not specified|not provided|Amyotrophic lateral sclerosis type 9,germline;unknown,germline,GRCh38,NC_000014.9,14,20693814,20693814,na,na,14q11.2,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA7083167,UniProtKB:P03950#VAR_013148",2,312774,20693814,A,G,K84E,2,benign,benign,P03950,P03950,reviewed,ANGI_HUMAN,"Angiogenin, EC 3.1.27.- (Ribonuclease 5, RNase 5)",ANG RNASE5,Homo sapiens (Human),147.0,MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP,PF00074;,1A4Y;1ANG;1AWZ;1B1E;1B1I;1B1J;1GV7;1H0D;1H52;1H53;1HBY;1K58;1K59;1K5A;1K5B;1UN3;1UN4;1UN5;2ANG;4AHD;4AHE;4AHF;4AHG;4AHH;4AHI;4AHJ;4AHK;4AHL;4AHM;4AHN;4AOH;4B36;5EOP;5EPZ;5EQO;5M9A;5M9C;5M9G;5M9J;5M9M;5M9P;5M9Q;5M9R;5M9S;5M9T;5M9V;7PNJ;7PNR;,84,K,E,True,1036
14131,5178,33115,single nucleotide variant,NM_001097577.3(ANG):c.164G>A (p.Arg55Lys),283,ANG,HGNC:483,Pathogenic,1,1-Apr-06,121909538,-,RCV000019702,"MONDO:MONDO:0012753,MedGen:C2678468,OMIM:611895,Orphanet:803",Amyotrophic lateral sclerosis type 9,germline,germline,GRCh38,NC_000014.9,14,20693728,20693728,na,na,14q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA258097,UniProtKB:P03950#VAR_044151,OMIM:105850.0004",1,18076,20693728,G,A,R55K,0,pathogenic,uncertain,P03950,P03950,reviewed,ANGI_HUMAN,"Angiogenin, EC 3.1.27.- (Ribonuclease 5, RNase 5)",ANG RNASE5,Homo sapiens (Human),147.0,MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP,PF00074;,1A4Y;1ANG;1AWZ;1B1E;1B1I;1B1J;1GV7;1H0D;1H52;1H53;1HBY;1K58;1K59;1K5A;1K5B;1UN3;1UN4;1UN5;2ANG;4AHD;4AHE;4AHF;4AHG;4AHH;4AHI;4AHJ;4AHK;4AHL;4AHM;4AHN;4AOH;4B36;5EOP;5EPZ;5EQO;5M9A;5M9C;5M9G;5M9J;5M9M;5M9P;5M9Q;5M9R;5M9S;5M9T;5M9V;7PNJ;7PNR;,55,R,K,True,1036
14132,5184,33121,single nucleotide variant,NM_001097577.3(ANG):c.409G>A (p.Val137Ile),283,ANG,HGNC:483,Pathogenic,1,1-Feb-08,121909544,-,RCV000019708,"MONDO:MONDO:0012753,MedGen:C2678468,OMIM:611895,Orphanet:803",Amyotrophic lateral sclerosis type 9,germline,germline,GRCh38,NC_000014.9,14,20693973,20693973,na,na,14q11.2,no assertion criteria provided,1,-,N,"ClinGen:CA258115,UniProtKB:P03950#VAR_044156,OMIM:105850.0010",1,18082,20693973,G,A,V137I,0,pathogenic,uncertain,P03950,P03950,reviewed,ANGI_HUMAN,"Angiogenin, EC 3.1.27.- (Ribonuclease 5, RNase 5)",ANG RNASE5,Homo sapiens (Human),147.0,MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP,PF00074;,1A4Y;1ANG;1AWZ;1B1E;1B1I;1B1J;1GV7;1H0D;1H52;1H53;1HBY;1K58;1K59;1K5A;1K5B;1UN3;1UN4;1UN5;2ANG;4AHD;4AHE;4AHF;4AHG;4AHH;4AHI;4AHJ;4AHK;4AHL;4AHM;4AHN;4AOH;4B36;5EOP;5EPZ;5EQO;5M9A;5M9C;5M9G;5M9J;5M9M;5M9P;5M9Q;5M9R;5M9S;5M9T;5M9V;7PNJ;7PNR;,137,V,I,True,1036
14133,5176,33113,single nucleotide variant,NM_001097577.3(ANG):c.122A>T (p.Lys41Ile),283,ANG,HGNC:483,Conflicting interpretations of pathogenicity,1,31-Dec-19,121909536,-,RCV000019700|RCV000517735,"MONDO:MONDO:0012753,MedGen:C2678468,OMIM:611895,Orphanet:803|MedGen:CN517202",Amyotrophic lateral sclerosis type 9|not provided,germline;unknown,germline,GRCh38,NC_000014.9,14,20693686,20693686,na,na,14q11.2,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA258091,UniProtKB:P03950#VAR_044149,OMIM:105850.0002",3,18074,20693686,A,T,K41I,1,uncertain,uncertain,P03950,P03950,reviewed,ANGI_HUMAN,"Angiogenin, EC 3.1.27.- (Ribonuclease 5, RNase 5)",ANG RNASE5,Homo sapiens (Human),147.0,MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP,PF00074;,1A4Y;1ANG;1AWZ;1B1E;1B1I;1B1J;1GV7;1H0D;1H52;1H53;1HBY;1K58;1K59;1K5A;1K5B;1UN3;1UN4;1UN5;2ANG;4AHD;4AHE;4AHF;4AHG;4AHH;4AHI;4AHJ;4AHK;4AHL;4AHM;4AHN;4AOH;4B36;5EOP;5EPZ;5EQO;5M9A;5M9C;5M9G;5M9J;5M9M;5M9P;5M9Q;5M9R;5M9S;5M9T;5M9V;7PNJ;7PNR;,41,K,I,True,1036
14134,712,17910,single nucleotide variant,NM_001171506.2(MCFD2):c.407T>C (p.Ile136Thr),90411,MCFD2,HGNC:18451,Pathogenic,1,1-Jun-03,137852914,-,RCV000003005,"MONDO:MONDO:0013331,MedGen:C3150889,OMIM:613625,Orphanet:35909","Factor v and factor viii, combined deficiency of, 2",germline,germline,GRCh38,NC_000002.12,2,46905497,46905497,na,na,2p21,no assertion criteria provided,1,-,N,"ClinGen:CA115796,UniProtKB:Q8NI22#VAR_019077,OMIM:607788.0007",1,2871,46905497,A,G,I136T,0,pathogenic,uncertain,Q8NI22,Q8NI22,reviewed,MCFD2_HUMAN,Multiple coagulation factor deficiency protein 2 (Neural stem cell-derived neuronal survival protein),MCFD2 SDNSF,Homo sapiens (Human),146.0,MTMRSLLRTPFLCGLLWAFCAPGARAEEPAASFSQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMSEDELINIIDGVLRDDDKNNDGYIDYAEFAKSLQ,PF13499;,2VRG;3A4U;3LCP;3WHT;3WHU;3WNX;4YGB;4YGC;4YGD;4YGE;,136,I,T,True,1037
14135,711,17909,single nucleotide variant,NM_001171506.2(MCFD2):c.387C>G (p.Asp129Glu),90411,MCFD2,HGNC:18451,Pathogenic,1,1-Jun-03,137852913,-,RCV000003004,"MONDO:MONDO:0013331,MedGen:C3150889,OMIM:613625,Orphanet:35909","Factor v and factor viii, combined deficiency of, 2",germline,germline,GRCh38,NC_000002.12,2,46905517,46905517,na,na,2p21,no assertion criteria provided,1,-,N,"OMIM:607788.0006,ClinGen:CA115788,UniProtKB:Q8NI22#VAR_019076",1,2870,46905517,G,C,D129E,0,pathogenic,uncertain,Q8NI22,Q8NI22,reviewed,MCFD2_HUMAN,Multiple coagulation factor deficiency protein 2 (Neural stem cell-derived neuronal survival protein),MCFD2 SDNSF,Homo sapiens (Human),146.0,MTMRSLLRTPFLCGLLWAFCAPGARAEEPAASFSQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMSEDELINIIDGVLRDDDKNNDGYIDYAEFAKSLQ,PF13499;,2VRG;3A4U;3LCP;3WHT;3WHU;3WNX;4YGB;4YGC;4YGD;4YGE;,129,D,E,True,1037
14136,1298,20674,single nucleotide variant,NM_000099.4(CST3):c.73G>A (p.Ala25Thr),1471,CST3,HGNC:2475,Conflicting interpretations of pathogenicity,1,6-Jan-20,1064039,-,RCV000005989,"MONDO:MONDO:0012767,MedGen:C2677774,OMIM:611953",Age-related macular degeneration 11,germline,germline,GRCh38,NC_000020.11,20,23637790,23637790,na,na,20p11.21,no assertion criteria provided,2,-,N,"ClinGen:CA117663,UniProtKB:P01034#VAR_011893,OMIM:604312.0002",3,5635,23637790,C,T,A25T,0,uncertain,uncertain,P01034,P01034,reviewed,CYTC_HUMAN,Cystatin-C (Cystatin-3) (Gamma-trace) (Neuroendocrine basic polypeptide) (Post-gamma-globulin),CST3,Homo sapiens (Human),146.0,MAGPLRAPLLLLAILAVALAVSPAAGSSPGKPPRLVGGPMDASVEEEGVRRALDFAVGEYNKASNDMYHSRALQVVRARKQIVAGVNYFLDVELGRTTCTKTQPNLDNCPFHDQPHLKRKAFCSFQIYAVPWQGTMTLSKSTCQDA,PF00031;,1G96;1R4C;1TIJ;3GAX;3NX0;3PS8;3QRD;3S67;3SVA;6ROA;6RPV;,25,A,T,True,1038
14137,1297,20673,single nucleotide variant,NM_000099.4(CST3):c.281T>A (p.Leu94Gln),1471,CST3,HGNC:2475,Pathogenic,1,15-Feb-94,28939068,-,RCV000005988,"MONDO:MONDO:0007098,MedGen:C1527338,OMIM:105150,Orphanet:100008,Orphanet:85458","Hereditary cerebral amyloid angiopathy, Icelandic type",germline,germline,GRCh38,NC_000020.11,20,23635330,23635330,na,na,20p11.21,no assertion criteria provided,1,-,N,"ClinGen:CA117662,UniProtKB:P01034#VAR_002207,OMIM:604312.0001",1,5634,23635330,A,T,L94Q,0,pathogenic,uncertain,P01034,P01034,reviewed,CYTC_HUMAN,Cystatin-C (Cystatin-3) (Gamma-trace) (Neuroendocrine basic polypeptide) (Post-gamma-globulin),CST3,Homo sapiens (Human),146.0,MAGPLRAPLLLLAILAVALAVSPAAGSSPGKPPRLVGGPMDASVEEEGVRRALDFAVGEYNKASNDMYHSRALQVVRARKQIVAGVNYFLDVELGRTTCTKTQPNLDNCPFHDQPHLKRKAFCSFQIYAVPWQGTMTLSKSTCQDA,PF00031;,1G96;1R4C;1TIJ;3GAX;3NX0;3PS8;3QRD;3S67;3SVA;6ROA;6RPV;,94,L,Q,True,1038
14138,5712,38387,single nucleotide variant,NM_001022.4(RPS19):c.164C>T (p.Thr55Met),6223,RPS19,HGNC:10402,Uncertain significance,0,25-Oct-20,147508369,-,RCV000471188|RCV001331478,"Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124|MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124",Diamond-Blackfan anemia|Diamond-Blackfan anemia 1,germline;unknown,germline,GRCh38,NC_000019.10,19,41861204,41861204,na,na,19q13.2,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA045548,UniProtKB:P39019#VAR_018442,OMIM:603474.0007,ClinVar:6319",2,242753,41861204,C,T,T55M,2,uncertain,uncertain,P39019,P39019,reviewed,RS19_HUMAN,40S ribosomal protein S19 (Small ribosomal subunit protein eS19),RPS19,Homo sapiens (Human),145.0,MPGVTVKDVNQQEFVRALAAFLKKSGKLKVPEWVDTVKLAKHKELAPYDENWFYTRAASTARHLYLRGGAGVGSMTKIYGGRQRNGVMPSHFSRGSKSVARRVLQALEGLKMVEKDQDGGRKLTPQGQRDLDRIAGQVAAANKKH,PF01090;,4UG0;4V6X;5A2Q;5AJ0;5FLX;5LKS;5OA3;5T2C;5VYC;6G18;6G4S;6G4W;6G51;6G53;6G5H;6G5I;6IP5;6IP6;6IP8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6XA1;6Y0G;6Y2L;6Y57;6YBS;6Z6L;6Z6M;6Z6N;6ZLW;6ZM7;6ZME;6ZMI;6ZMO;6ZMT;6ZMW;6ZN5;6ZOJ;6ZOL;6ZON;6ZP4;6ZUO;6ZV6;6ZVH;6ZVJ;6ZXD;6ZXE;6ZXF;6ZXG;6ZXH;7A09;7K5I;7MQA;,55,T,M,True,1039
14139,1435,21353,single nucleotide variant,NM_001022.4(RPS19):c.184C>T (p.Arg62Trp),6223,RPS19,HGNC:10402,Pathogenic,1,27-Nov-19,104894711,-,RCV000033183|RCV000497714|RCV001065746,"MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|MedGen:CN517202|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124",Diamond-Blackfan anemia 1|not provided|Diamond-Blackfan anemia,germline,germline,GRCh38,NC_000019.10,19,41869042,41869042,na,na,19q13.2,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA130763,UniProtKB:P39019#VAR_006924,OMIM:603474.0002",3,6314,41869042,C,T,R62W,2,pathogenic,pathogenic,P39019,P39019,reviewed,RS19_HUMAN,40S ribosomal protein S19 (Small ribosomal subunit protein eS19),RPS19,Homo sapiens (Human),145.0,MPGVTVKDVNQQEFVRALAAFLKKSGKLKVPEWVDTVKLAKHKELAPYDENWFYTRAASTARHLYLRGGAGVGSMTKIYGGRQRNGVMPSHFSRGSKSVARRVLQALEGLKMVEKDQDGGRKLTPQGQRDLDRIAGQVAAANKKH,PF01090;,4UG0;4V6X;5A2Q;5AJ0;5FLX;5LKS;5OA3;5T2C;5VYC;6G18;6G4S;6G4W;6G51;6G53;6G5H;6G5I;6IP5;6IP6;6IP8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6XA1;6Y0G;6Y2L;6Y57;6YBS;6Z6L;6Z6M;6Z6N;6ZLW;6ZM7;6ZME;6ZMI;6ZMO;6ZMT;6ZMW;6ZN5;6ZOJ;6ZOL;6ZON;6ZP4;6ZUO;6ZV6;6ZVH;6ZVJ;6ZXD;6ZXE;6ZXF;6ZXG;6ZXH;7A09;7K5I;7MQA;,62,R,W,True,1039
14140,1437,21359,single nucleotide variant,NM_001022.4(RPS19):c.380G>A (p.Gly127Glu),6223,RPS19,HGNC:10402,Pathogenic,1,15-Jul-07,786200936,-,RCV000033189,"MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124",Diamond-Blackfan anemia 1,germline,germline,GRCh38,NC_000019.10,19,41869722,41869722,na,na,19q13.2,no assertion criteria provided,1,-,N,"ClinGen:CA130769,UniProtKB:P39019#VAR_055444,OMIM:603474.0008",1,6320,41869722,G,A,G127E,0,pathogenic,uncertain,P39019,P39019,reviewed,RS19_HUMAN,40S ribosomal protein S19 (Small ribosomal subunit protein eS19),RPS19,Homo sapiens (Human),145.0,MPGVTVKDVNQQEFVRALAAFLKKSGKLKVPEWVDTVKLAKHKELAPYDENWFYTRAASTARHLYLRGGAGVGSMTKIYGGRQRNGVMPSHFSRGSKSVARRVLQALEGLKMVEKDQDGGRKLTPQGQRDLDRIAGQVAAANKKH,PF01090;,4UG0;4V6X;5A2Q;5AJ0;5FLX;5LKS;5OA3;5T2C;5VYC;6G18;6G4S;6G4W;6G51;6G53;6G5H;6G5I;6IP5;6IP6;6IP8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6XA1;6Y0G;6Y2L;6Y57;6YBS;6Z6L;6Z6M;6Z6N;6ZLW;6ZM7;6ZME;6ZMI;6ZMO;6ZMT;6ZMW;6ZN5;6ZOJ;6ZOL;6ZON;6ZP4;6ZUO;6ZV6;6ZVH;6ZVJ;6ZXD;6ZXE;6ZXF;6ZXG;6ZXH;7A09;7K5I;7MQA;,127,G,E,True,1039
14141,1436,21358,single nucleotide variant,NM_001022.4(RPS19):c.43G>T (p.Val15Phe),6223,RPS19,HGNC:10402,Pathogenic,1,3-Aug-15,104894717,-,RCV000482973,MedGen:CN517202,not provided,germline,germline,GRCh38,NC_000019.10,19,41860817,41860817,na,na,19q13.2,"criteria provided, single submitter",1,-,N,"ClinGen:CA045535,ClinVar:6319,UniProtKB:P39019#VAR_018438,OMIM:603474.0007",2,242804,41860817,G,T,V15F,1,pathogenic,pathogenic,P39019,P39019,reviewed,RS19_HUMAN,40S ribosomal protein S19 (Small ribosomal subunit protein eS19),RPS19,Homo sapiens (Human),145.0,MPGVTVKDVNQQEFVRALAAFLKKSGKLKVPEWVDTVKLAKHKELAPYDENWFYTRAASTARHLYLRGGAGVGSMTKIYGGRQRNGVMPSHFSRGSKSVARRVLQALEGLKMVEKDQDGGRKLTPQGQRDLDRIAGQVAAANKKH,PF01090;,4UG0;4V6X;5A2Q;5AJ0;5FLX;5LKS;5OA3;5T2C;5VYC;6G18;6G4S;6G4W;6G51;6G53;6G5H;6G5I;6IP5;6IP6;6IP8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6XA1;6Y0G;6Y2L;6Y57;6YBS;6Z6L;6Z6M;6Z6N;6ZLW;6ZM7;6ZME;6ZMI;6ZMO;6ZMT;6ZMW;6ZN5;6ZOJ;6ZOL;6ZON;6ZP4;6ZUO;6ZV6;6ZVH;6ZVJ;6ZXD;6ZXE;6ZXF;6ZXG;6ZXH;7A09;7K5I;7MQA;,15,V,F,True,1039
14142,136,15523,single nucleotide variant,NM_000317.3(PTS):c.286G>A (p.Asp96Asn),5805,PTS,HGNC:9689,Pathogenic,1,26-Nov-18,104894280,-,RCV000000513,"MONDO:MONDO:0009863,MedGen:C0878676,OMIM:261640,Orphanet:13,Orphanet:238583",BH4-deficient hyperphenylalaninemia A,germline;unknown,germline,GRCh38,NC_000011.10,11,112233205,112233205,na,na,11q23.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"OMIM:612719.0009,ClinGen:CA114323,UniProtKB:Q03393#VAR_006828",3,484,112233205,G,A,D96N,2,pathogenic,pathogenic,Q03393,Q03393,reviewed,PTPS_HUMAN,"6-pyruvoyl tetrahydrobiopterin synthase, PTP synthase, PTPS, EC 4.2.3.12",PTS,Homo sapiens (Human),145.0,MSTEGGGRRCQAQVSRRISFSASHRLYSKFLSDEENLKLFGKCNNPNGHGHNYKVVVTVHGEIDPATGMVMNLADLKKYMEEAIMQPLDHKNLDMDVPYFADVVSTTENVAVYIWDNLQKVLPVGVLYKVKVYETDNNIVVYKGE,PF01242;,3I2B;,96,D,N,True,1040
14143,135,15522,single nucleotide variant,NM_000317.3(PTS):c.347A>G (p.Asp116Gly),5805,PTS,HGNC:9689,Likely pathogenic,1,29-Jun-16,104894279,-,RCV000000512|RCV000502112,"MedGen:C4017280|MONDO:MONDO:0009863,MedGen:C0878676,OMIM:261640,Orphanet:13,Orphanet:238583","Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency|BH4-deficient hyperphenylalaninemia A",germline;unknown,germline,GRCh38,NC_000011.10,11,112233464,112233464,na,na,11q23.1,"criteria provided, single submitter",3,-,N,"ClinGen:CA114322,UniProtKB:Q03393#VAR_008041,OMIM:612719.0008",3,483,112233464,A,G,D116G,1,pathogenic,pathogenic,Q03393,Q03393,reviewed,PTPS_HUMAN,"6-pyruvoyl tetrahydrobiopterin synthase, PTP synthase, PTPS, EC 4.2.3.12",PTS,Homo sapiens (Human),145.0,MSTEGGGRRCQAQVSRRISFSASHRLYSKFLSDEENLKLFGKCNNPNGHGHNYKVVVTVHGEIDPATGMVMNLADLKKYMEEAIMQPLDHKNLDMDVPYFADVVSTTENVAVYIWDNLQKVLPVGVLYKVKVYETDNNIVVYKGE,PF01242;,3I2B;,116,D,G,True,1040
14144,131,15518,single nucleotide variant,NM_000317.3(PTS):c.155A>G (p.Asn52Ser),5805,PTS,HGNC:9689,Pathogenic,1,17-Oct-19,104894275,-,RCV000000508|RCV001271442,"MONDO:MONDO:0009863,MedGen:C0878676,OMIM:261640,Orphanet:13,Orphanet:238583|",BH4-deficient hyperphenylalaninemia A|6-Pyruvoyl-tetrahydrobiopterin synthase deficiency,germline;unknown,germline,GRCh38,NC_000011.10,11,112228665,112228665,na,na,11q23.1,"criteria provided, single submitter",5,-,N,"ClinGen:CA114318,UniProtKB:Q03393#VAR_006821,OMIM:612719.0004",3,479,112228665,A,G,N52S,1,pathogenic,pathogenic,Q03393,Q03393,reviewed,PTPS_HUMAN,"6-pyruvoyl tetrahydrobiopterin synthase, PTP synthase, PTPS, EC 4.2.3.12",PTS,Homo sapiens (Human),145.0,MSTEGGGRRCQAQVSRRISFSASHRLYSKFLSDEENLKLFGKCNNPNGHGHNYKVVVTVHGEIDPATGMVMNLADLKKYMEEAIMQPLDHKNLDMDVPYFADVVSTTENVAVYIWDNLQKVLPVGVLYKVKVYETDNNIVVYKGE,PF01242;,3I2B;,52,N,S,True,1040
14145,133,15520,single nucleotide variant,NM_000317.3(PTS):c.166G>A (p.Val56Met),5805,PTS,HGNC:9689,Pathogenic/Likely pathogenic,1,21-Oct-19,104894277,-,RCV000000510|RCV001271443,"MONDO:MONDO:0009863,MedGen:C0878676,OMIM:261640,Orphanet:13,Orphanet:238583|",BH4-deficient hyperphenylalaninemia A|6-Pyruvoyl-tetrahydrobiopterin synthase deficiency,germline;unknown,germline,GRCh38,NC_000011.10,11,112230210,112230210,na,na,11q23.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA114320,UniProtKB:Q03393#VAR_006822,OMIM:612719.0006",3,481,112230210,G,A,V56M,2,pathogenic,pathogenic,Q03393,Q03393,reviewed,PTPS_HUMAN,"6-pyruvoyl tetrahydrobiopterin synthase, PTP synthase, PTPS, EC 4.2.3.12",PTS,Homo sapiens (Human),145.0,MSTEGGGRRCQAQVSRRISFSASHRLYSKFLSDEENLKLFGKCNNPNGHGHNYKVVVTVHGEIDPATGMVMNLADLKKYMEEAIMQPLDHKNLDMDVPYFADVVSTTENVAVYIWDNLQKVLPVGVLYKVKVYETDNNIVVYKGE,PF01242;,3I2B;,56,V,M,True,1040
14146,132,15519,single nucleotide variant,NM_000317.3(PTS):c.259C>T (p.Pro87Ser),5805,PTS,HGNC:9689,Pathogenic,1,5-Aug-19,104894276,-,RCV000000509,"MONDO:MONDO:0009863,MedGen:C0878676,OMIM:261640,Orphanet:13,Orphanet:238583",BH4-deficient hyperphenylalaninemia A,germline;unknown,germline,GRCh38,NC_000011.10,11,112233178,112233178,na,na,11q23.1,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA114319,UniProtKB:Q03393#VAR_006827,OMIM:612719.0005",3,480,112233178,C,T,P87S,2,pathogenic,pathogenic,Q03393,Q03393,reviewed,PTPS_HUMAN,"6-pyruvoyl tetrahydrobiopterin synthase, PTP synthase, PTPS, EC 4.2.3.12",PTS,Homo sapiens (Human),145.0,MSTEGGGRRCQAQVSRRISFSASHRLYSKFLSDEENLKLFGKCNNPNGHGHNYKVVVTVHGEIDPATGMVMNLADLKKYMEEAIMQPLDHKNLDMDVPYFADVVSTTENVAVYIWDNLQKVLPVGVLYKVKVYETDNNIVVYKGE,PF01242;,3I2B;,87,P,S,True,1040
14147,130,15516,single nucleotide variant,NM_000317.3(PTS):c.46C>T (p.Arg16Cys),5805,PTS,HGNC:9689,Uncertain significance,1,12-Nov-18,104894274,-,RCV000000506|RCV000778305,"MedGen:C4017280|MONDO:MONDO:0009863,MedGen:C0878676,OMIM:261640,Orphanet:13,Orphanet:238583","Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency|BH4-deficient hyperphenylalaninemia A",germline,germline,GRCh38,NC_000011.10,11,112226489,112226489,na,na,11q23.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA114317,UniProtKB:Q03393#VAR_006816,OMIM:612719.0002",3,477,112226489,C,T,R16C,1,uncertain,uncertain,Q03393,Q03393,reviewed,PTPS_HUMAN,"6-pyruvoyl tetrahydrobiopterin synthase, PTP synthase, PTPS, EC 4.2.3.12",PTS,Homo sapiens (Human),145.0,MSTEGGGRRCQAQVSRRISFSASHRLYSKFLSDEENLKLFGKCNNPNGHGHNYKVVVTVHGEIDPATGMVMNLADLKKYMEEAIMQPLDHKNLDMDVPYFADVVSTTENVAVYIWDNLQKVLPVGVLYKVKVYETDNNIVVYKGE,PF01242;,3I2B;,16,R,C,True,1040
14148,129,15515,single nucleotide variant,NM_000317.3(PTS):c.74G>A (p.Arg25Gln),5805,PTS,HGNC:9689,Pathogenic,1,1-May-94,104894273,-,RCV000000505,"MONDO:MONDO:0009863,MedGen:C0878676,OMIM:261640,Orphanet:13,Orphanet:238583",BH4-deficient hyperphenylalaninemia A,germline,germline,GRCh38,NC_000011.10,11,112226517,112226517,na,na,11q23.1,no assertion criteria provided,1,-,N,"ClinGen:CA114316,UniProtKB:Q03393#VAR_006818,OMIM:612719.0001",1,476,112226517,G,A,R25Q,0,pathogenic,uncertain,Q03393,Q03393,reviewed,PTPS_HUMAN,"6-pyruvoyl tetrahydrobiopterin synthase, PTP synthase, PTPS, EC 4.2.3.12",PTS,Homo sapiens (Human),145.0,MSTEGGGRRCQAQVSRRISFSASHRLYSKFLSDEENLKLFGKCNNPNGHGHNYKVVVTVHGEIDPATGMVMNLADLKKYMEEAIMQPLDHKNLDMDVPYFADVVSTTENVAVYIWDNLQKVLPVGVLYKVKVYETDNNIVVYKGE,PF01242;,3I2B;,25,R,Q,True,1040
14149,134,15521,single nucleotide variant,NM_000317.3(PTS):c.139A>G (p.Asn47Asp),5805,PTS,HGNC:9689,Pathogenic,1,1-Jan-99,104894278,-,RCV000000511,MedGen:C4017280,"Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency",germline,germline,GRCh38,NC_000011.10,11,112228649,112228649,na,na,11q23.1,no assertion criteria provided,1,-,N,"ClinGen:CA114321,UniProtKB:Q03393#VAR_008040,OMIM:612719.0007",1,482,112228649,A,G,N47D,0,pathogenic,uncertain,Q03393,Q03393,reviewed,PTPS_HUMAN,"6-pyruvoyl tetrahydrobiopterin synthase, PTP synthase, PTPS, EC 4.2.3.12",PTS,Homo sapiens (Human),145.0,MSTEGGGRRCQAQVSRRISFSASHRLYSKFLSDEENLKLFGKCNNPNGHGHNYKVVVTVHGEIDPATGMVMNLADLKKYMEEAIMQPLDHKNLDMDVPYFADVVSTTENVAVYIWDNLQKVLPVGVLYKVKVYETDNNIVVYKGE,PF01242;,3I2B;,47,N,D,True,1040
14150,430,16732,single nucleotide variant,NM_015965.7(NDUFA13):c.15G>C (p.Lys5Asn),51079,NDUFA13,HGNC:17194,Pathogenic,1,23-May-05,137852869,-,RCV000001761,"MONDO:MONDO:0011836,MedGen:C0749424,OMIM:607464,Orphanet:146",Hurthle cell carcinoma of thyroid,germline,germline,GRCh38,NC_000019.10,19,19516253,19516253,na,na,19p13.11,no assertion criteria provided,1,-,N,"ClinGen:CA115147,UniProtKB:Q9P0J0#VAR_045984,OMIM:609435.0001",1,1693,19516253,G,C,K5N,0,pathogenic,uncertain,Q9P0J0,Q9P0J0,reviewed,NDUAD_HUMAN,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6, CI-B16.6) (Gene associated with retinoic and interferon-induced mortality 19 protein, GRIM-19, Gene associated with retinoic and IFN-induced mortality 19 protein) (NADH-ubiquinone oxidoreductase B16.6 subunit)",NDUFA13 GRIM19 CDA016 CGI-39,Homo sapiens (Human),144.0,MAASKVKQDMPPPGGYGPIDYKRNLPRRGLSGYSMLAIGIGTLIYGHWSIMKWNRERRRLQIEDFEARIALLPLLQAETDRRTLQMLRENLEEEAIIMKDVPDWKVGESVFHTTRWVPPLIGELYGLRTTEEALHASHGFMWYT,PF06212;,5XTB;5XTC;5XTD;5XTH;5XTI;,5,K,N,True,1041
14151,6234,45720,single nucleotide variant,NM_005022.4(PFN1):c.211T>G (p.Cys71Gly),5216,PFN1,HGNC:8881,Pathogenic,1,23-Aug-12,387907264,-,RCV000030694,"MONDO:MONDO:0013891,MedGen:C3553719,OMIM:614808,Orphanet:803",Amyotrophic lateral sclerosis 18,germline,germline,GRCh38,NC_000017.11,17,4946742,4946742,na,na,17p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA260575,UniProtKB:P07737#VAR_068925,OMIM:176610.0001",1,37034,4946742,A,C,C71G,0,pathogenic,uncertain,P07737,P07737,reviewed,PROF1_HUMAN,Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I),PFN1,Homo sapiens (Human),140.0,MAGWNAYIDNLMADGTCQDAAIVGYKDSPSVWAAVPGKTFVNITPAEVGVLVGKDRSSFYVNGLTLGGQKCSVIRDSLLQDGEFSMDLRTKSTGGAPTFNVTVTKTDKTLVLLMGKEGVHGGLINKKCYEMASHLRRSQY,PF00235;,1AWI;1CF0;1CJF;1FIK;1FIL;1PFL;2PAV;2PBD;3CHW;4X1L;4X1M;4X25;6NAS;6NBE;6NBW;7P1H;,71,C,G,True,1042
14152,6235,45721,single nucleotide variant,NM_005022.4(PFN1):c.341T>C (p.Met114Thr),5216,PFN1,HGNC:8881,Pathogenic,1,23-Aug-12,387907265,-,RCV000030695,"MONDO:MONDO:0013891,MedGen:C3553719,OMIM:614808,Orphanet:803",Amyotrophic lateral sclerosis 18,germline,germline,GRCh38,NC_000017.11,17,4945982,4945982,na,na,17p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA260576,UniProtKB:P07737#VAR_068926,OMIM:176610.0002",1,37035,4945982,A,G,M114T,0,pathogenic,uncertain,P07737,P07737,reviewed,PROF1_HUMAN,Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I),PFN1,Homo sapiens (Human),140.0,MAGWNAYIDNLMADGTCQDAAIVGYKDSPSVWAAVPGKTFVNITPAEVGVLVGKDRSSFYVNGLTLGGQKCSVIRDSLLQDGEFSMDLRTKSTGGAPTFNVTVTKTDKTLVLLMGKEGVHGGLINKKCYEMASHLRRSQY,PF00235;,1AWI;1CF0;1CJF;1FIK;1FIL;1PFL;2PAV;2PBD;3CHW;4X1L;4X1M;4X25;6NAS;6NBE;6NBW;7P1H;,114,M,T,True,1042
14153,6236,45722,single nucleotide variant,NM_005022.4(PFN1):c.353G>T (p.Gly118Val),5216,PFN1,HGNC:8881,Pathogenic,1,23-Aug-12,387907266,-,RCV000030696,"MONDO:MONDO:0013891,MedGen:C3553719,OMIM:614808,Orphanet:803",Amyotrophic lateral sclerosis 18,germline,germline,GRCh38,NC_000017.11,17,4945970,4945970,na,na,17p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA260577,UniProtKB:P07737#VAR_068928,OMIM:176610.0003",1,37036,4945970,C,A,G118V,0,pathogenic,uncertain,P07737,P07737,reviewed,PROF1_HUMAN,Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I),PFN1,Homo sapiens (Human),140.0,MAGWNAYIDNLMADGTCQDAAIVGYKDSPSVWAAVPGKTFVNITPAEVGVLVGKDRSSFYVNGLTLGGQKCSVIRDSLLQDGEFSMDLRTKSTGGAPTFNVTVTKTDKTLVLLMGKEGVHGGLINKKCYEMASHLRRSQY,PF00235;,1AWI;1CF0;1CJF;1FIK;1FIL;1PFL;2PAV;2PBD;3CHW;4X1L;4X1M;4X25;6NAS;6NBE;6NBW;7P1H;,118,G,V,True,1042
14154,6237,45723,single nucleotide variant,NM_005022.4(PFN1):c.350A>G (p.Glu117Gly),5216,PFN1,HGNC:8881,Pathogenic,1,23-Aug-12,140547520,-,RCV000030697,"MONDO:MONDO:0013891,MedGen:C3553719,OMIM:614808,Orphanet:803",Amyotrophic lateral sclerosis 18,germline,germline,GRCh38,NC_000017.11,17,4945973,4945973,na,na,17p13.2,no assertion criteria provided,1,-,N,"ClinGen:CA260578,UniProtKB:P07737#VAR_068927,OMIM:176610.0004",1,37037,4945973,T,C,E117G,0,pathogenic,uncertain,P07737,P07737,reviewed,PROF1_HUMAN,Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I),PFN1,Homo sapiens (Human),140.0,MAGWNAYIDNLMADGTCQDAAIVGYKDSPSVWAAVPGKTFVNITPAEVGVLVGKDRSSFYVNGLTLGGQKCSVIRDSLLQDGEFSMDLRTKSTGGAPTFNVTVTKTDKTLVLLMGKEGVHGGLINKKCYEMASHLRRSQY,PF00235;,1AWI;1CF0;1CJF;1FIK;1FIL;1PFL;2PAV;2PBD;3CHW;4X1L;4X1M;4X25;6NAS;6NBE;6NBW;7P1H;,117,E,G,True,1042
14155,3718,29049,single nucleotide variant,NM_000345.4(SNCA):c.136G>A (p.Glu46Lys),6622,SNCA,HGNC:11138,Pathogenic,1,4-Mar-05,104893875,-,RCV000015047,"MONDO:MONDO:0007488,MedGen:C0752347,OMIM:127750",Lewy body dementia,germline,germline,GRCh38,NC_000004.12,4,89828170,89828170,na,na,4q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA123701,UniProtKB:P37840#VAR_022703,OMIM:163890.0004",1,14010,89828170,C,T,E46K,0,pathogenic,uncertain,P37840,P37840,reviewed,SYUA_HUMAN,"Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor, NACP)",SNCA NACP PARK1,Homo sapiens (Human),140.0,MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA,PF01387;,1XQ8;2JN5;2KKW;2M55;2N0A;2X6M;3Q25;3Q26;3Q27;3Q28;3Q29;4BXL;4R0U;4R0W;4RIK;4RIL;4ZNN;5CRW;6A6B;6CT7;6CU7;6CU8;6FLT;6H6B;6I42;6L1T;6L1U;6L4S;6LRQ;6OSJ;6OSL;6OSM;6PEO;6PES;6RT0;6RTB;6SST;6SSX;6UFR;6XYO;6XYP;6XYQ;7C1D;7E0F;7L7H;7LC9;7NCA;7NCG;7NCH;7NCI;7NCJ;7NCK;7STX;,46,E,K,True,1043
14156,3717,29047,single nucleotide variant,NM_000345.4(SNCA):c.88G>C (p.Ala30Pro),6622,SNCA,HGNC:11138,Pathogenic,1,22-Nov-13,104893878,-,RCV000015045,"MONDO:MONDO:0008200,MedGen:C1868595,OMIM:168601",Parkinson disease 1,germline,germline,GRCh38,NC_000004.12,4,89835580,89835580,na,na,4q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA257069,UniProtKB:P37840#VAR_007957,OMIM:163890.0002",1,14008,89835580,C,G,A30P,0,pathogenic,uncertain,P37840,P37840,reviewed,SYUA_HUMAN,"Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor, NACP)",SNCA NACP PARK1,Homo sapiens (Human),140.0,MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA,PF01387;,1XQ8;2JN5;2KKW;2M55;2N0A;2X6M;3Q25;3Q26;3Q27;3Q28;3Q29;4BXL;4R0U;4R0W;4RIK;4RIL;4ZNN;5CRW;6A6B;6CT7;6CU7;6CU8;6FLT;6H6B;6I42;6L1T;6L1U;6L4S;6LRQ;6OSJ;6OSL;6OSM;6PEO;6PES;6RT0;6RTB;6SST;6SSX;6UFR;6XYO;6XYP;6XYQ;7C1D;7E0F;7L7H;7LC9;7NCA;7NCG;7NCH;7NCI;7NCJ;7NCK;7STX;,30,A,P,True,1043
14157,3716,29046,single nucleotide variant,NM_000345.4(SNCA):c.157G>A (p.Ala53Thr),6622,SNCA,HGNC:11138,Pathogenic,1,10-Mar-17,104893877,-,RCV000015044|RCV000526380,"MONDO:MONDO:0008200,MedGen:C1868595,OMIM:168601|MONDO:MONDO:0008200,MedGen:C1868595,OMIM:168601;MONDO:MONDO:0007488,MedGen:C0752347,OMIM:127750",Parkinson disease 1|Parkinson disease 1;Lewy body dementia,germline,germline,GRCh38,NC_000004.12,4,89828149,89828149,na,na,4q22.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA257068,UniProtKB:P37840#VAR_007454,OMIM:163890.0001",3,14007,89828149,C,T,A53T,1,pathogenic,pathogenic,P37840,P37840,reviewed,SYUA_HUMAN,"Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor, NACP)",SNCA NACP PARK1,Homo sapiens (Human),140.0,MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA,PF01387;,1XQ8;2JN5;2KKW;2M55;2N0A;2X6M;3Q25;3Q26;3Q27;3Q28;3Q29;4BXL;4R0U;4R0W;4RIK;4RIL;4ZNN;5CRW;6A6B;6CT7;6CU7;6CU8;6FLT;6H6B;6I42;6L1T;6L1U;6L4S;6LRQ;6OSJ;6OSL;6OSM;6PEO;6PES;6RT0;6RTB;6SST;6SSX;6UFR;6XYO;6XYP;6XYQ;7C1D;7E0F;7L7H;7LC9;7NCA;7NCG;7NCH;7NCI;7NCJ;7NCK;7STX;,53,A,T,True,1043
14158,11200,171811,single nucleotide variant,NM_000345.4(SNCA):c.150T>G (p.His50Gln),6622,SNCA,HGNC:11138,Uncertain significance,1,14-Mar-20,201106962,-,RCV000149507|RCV000344706|RCV001301465,"MONDO:MONDO:0008200,MedGen:C1868595,OMIM:168601|MedGen:CN239359|MONDO:MONDO:0007488,MedGen:C0752347,OMIM:127750;MONDO:MONDO:0008200,MedGen:C1868595,OMIM:168601","Parkinson disease 1|Parkinson Disease, Dominant|Lewy body dementia;Parkinson disease 1",germline,germline,GRCh38,NC_000004.12,4,89828156,89828156,na,na,4q22.1,"criteria provided, multiple submitters, no conflicts",3,-,N,"UniProtKB:P37840#VAR_070171,OMIM:163890.0007,ClinGen:CA273048",3,162095,89828156,A,C,H50Q,2,uncertain,uncertain,P37840,P37840,reviewed,SYUA_HUMAN,"Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor, NACP)",SNCA NACP PARK1,Homo sapiens (Human),140.0,MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA,PF01387;,1XQ8;2JN5;2KKW;2M55;2N0A;2X6M;3Q25;3Q26;3Q27;3Q28;3Q29;4BXL;4R0U;4R0W;4RIK;4RIL;4ZNN;5CRW;6A6B;6CT7;6CU7;6CU8;6FLT;6H6B;6I42;6L1T;6L1U;6L4S;6LRQ;6OSJ;6OSL;6OSM;6PEO;6PES;6RT0;6RTB;6SST;6SSX;6UFR;6XYO;6XYP;6XYQ;7C1D;7E0F;7L7H;7LC9;7NCA;7NCG;7NCH;7NCI;7NCJ;7NCK;7STX;,50,H,Q,True,1043
14159,14048,322957,single nucleotide variant,NM_016065.4(MRPS16):c.34T>C (p.Tyr12His),51021,MRPS16,HGNC:14048,Benign,0,29-Feb-16,7905009,-,RCV000677073,MedGen:CN517202,not provided,unknown,unknown,GRCh38,NC_000010.11,10,73252003,73252003,na,na,10q22.2,no assertion criteria provided,1,-,N,"ClinGen:CA5553429,UniProtKB:Q9Y3D3#VAR_031525",2,300723,73252003,A,G,Y12H,0,benign,uncertain,Q9Y3D3,Q9Y3D3,reviewed,RT16_HUMAN,"28S ribosomal protein S16, mitochondrial, MRP-S16, S16mt (Mitochondrial small ribosomal subunit protein bS16m)",MRPS16 RPMS16 CGI-132,Homo sapiens (Human),137.0,MVHLTTLLCKAYRGGHLTIRLALGGCTNRPFYRIVAAHNKCPRDGRFVEQLGSYDPLPNSHGEKLVALNLDRIRHWIGCGAHLSKPMEKLLGLAGFFPLHPMMITNAERLRRKRAREVLLASQKTDAEATDTEATET,PF00886;,3J9M;6NU2;6NU3;6RW4;6RW5;6VLZ;6VMI;6ZM5;6ZM6;6ZS9;6ZSA;6ZSB;6ZSC;6ZSD;6ZSE;6ZSG;7A5F;7A5G;7A5I;7A5K;7L08;7OG4;,12,Y,H,True,1044
14160,2607,25718,single nucleotide variant,NM_000266.4(NDP):c.269G>C (p.Arg90Pro),4693,NDP,HGNC:7678,Pathogenic,1,1-Oct-92,104894867,-,RCV000011425,"MONDO:MONDO:0010691,MedGen:C0266526,OMIM:310600,Orphanet:649",Atrophia bulborum hereditaria,germline,germline,GRCh38,NC_000023.11,X,43949932,43949932,na,na,Xp11.3,no assertion criteria provided,1,-,N,"ClinGen:CA255466,UniProtKB:Q00604#VAR_005494,OMIM:300658.0001",1,10679,43949932,C,G,R90P,0,pathogenic,uncertain,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,90,R,P,True,1045
14161,11329,177444,single nucleotide variant,NM_000266.4(NDP):c.220C>T (p.Arg74Cys),4693,NDP,HGNC:7678,Pathogenic,1,12-Nov-15,727504031,-,RCV000153537|RCV000153538,"MedGen:CN517202|MONDO:MONDO:0010691,MedGen:C0266526,OMIM:310600,Orphanet:649",not provided|Atrophia bulborum hereditaria,germline;maternal,germline,GRCh38,NC_000023.11,X,43949981,43949981,na,na,Xp11.3,"criteria provided, multiple submitters, no conflicts",2,-,N,"ClinGen:CA273351,UniProtKB:Q00604#VAR_005491",2,167326,43949981,G,A,R74C,2,pathogenic,pathogenic,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,74,R,C,True,1045
14162,2609,25720,single nucleotide variant,NM_000266.4(NDP):c.179T>A (p.Val60Glu),4693,NDP,HGNC:7678,Pathogenic,1,1-Oct-92,104894869,-,RCV000011427,"MONDO:MONDO:0010691,MedGen:C0266526,OMIM:310600,Orphanet:649",Atrophia bulborum hereditaria,germline,germline,GRCh38,NC_000023.11,X,43950022,43950022,na,na,Xp11.3,no assertion criteria provided,1,-,N,"ClinGen:CA255468,UniProtKB:Q00604#VAR_005484,OMIM:300658.0003",1,10681,43950022,A,T,V60E,0,pathogenic,uncertain,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,60,V,E,True,1045
14163,2615,25728,single nucleotide variant,NM_000266.4(NDP):c.38T>G (p.Leu13Arg),4693,NDP,HGNC:7678,Pathogenic,1,1-Apr-94,104894879,-,RCV000011435,"MONDO:MONDO:0010691,MedGen:C0266526,OMIM:310600,Orphanet:649",Atrophia bulborum hereditaria,germline,germline,GRCh38,NC_000023.11,X,43958608,43958608,na,na,Xp11.3,no assertion criteria provided,1,-,N,"OMIM:300658.0011,ClinGen:CA255478,UniProtKB:Q00604#VAR_005478",1,10689,43958608,A,C,L13R,0,pathogenic,uncertain,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,13,L,R,True,1045
14164,2623,25738,single nucleotide variant,NM_000266.4(NDP):c.302C>T (p.Ser101Phe),4693,NDP,HGNC:7678,Pathogenic,1,1-Jan-97,104894883,-,RCV000011445,"MONDO:MONDO:0010691,MedGen:C0266526,OMIM:310600,Orphanet:649",Atrophia bulborum hereditaria,germline,germline,GRCh38,NC_000023.11,X,43949899,43949899,na,na,Xp11.3,no assertion criteria provided,1,-,N,"ClinGen:CA255487,UniProtKB:Q00604#VAR_005497,OMIM:300658.0021",1,10699,43949899,G,A,S101F,0,pathogenic,uncertain,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,101,S,F,True,1045
14165,2622,25736,single nucleotide variant,NM_000266.4(NDP):c.134T>A (p.Val45Glu),4693,NDP,HGNC:7678,Pathogenic,1,1-May-07,137852221,-,RCV000011443,"MONDO:MONDO:0010691,MedGen:C0266526,OMIM:310600,Orphanet:649",Atrophia bulborum hereditaria,germline,germline,GRCh38,NC_000023.11,X,43958512,43958512,na,na,Xp11.3,no assertion criteria provided,1,-,N,"ClinGen:CA255484,UniProtKB:Q00604#VAR_064003,OMIM:300658.0019",1,10697,43958512,A,T,V45E,0,pathogenic,uncertain,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,45,V,E,True,1045
14166,2621,25735,single nucleotide variant,NM_000266.4(NDP):c.288C>G (p.Cys96Trp),4693,NDP,HGNC:7678,Pathogenic,1,1-Oct-99,104894877,-,RCV000011442,"MONDO:MONDO:0010691,MedGen:C0266526,OMIM:310600,Orphanet:649",Atrophia bulborum hereditaria,unknown,unknown,GRCh38,NC_000023.11,X,43949913,43949913,na,na,Xp11.3,no assertion criteria provided,1,-,N,"UniProtKB:Q00604#VAR_009275,OMIM:300658.0018,ClinGen:CA255483",1,10696,43949913,G,C,C96W,0,pathogenic,uncertain,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,96,C,W,True,1045
14167,2620,25734,single nucleotide variant,NM_000266.4(NDP):c.362G>T (p.Arg121Leu),4693,NDP,HGNC:7678,Pathogenic,1,1-Sep-96,137852220,-,RCV000011441,"MONDO:MONDO:0010588,MedGen:C1844579,OMIM:305390,Orphanet:891","Familial exudative vitreoretinopathy, X-linked",germline,germline,GRCh38,NC_000023.11,X,43949839,43949839,na,na,Xp11.3,no assertion criteria provided,1,-,N,"ClinGen:CA255482,UniProtKB:Q00604#VAR_064024,OMIM:300658.0017",1,10695,43949839,C,A,R121L,0,pathogenic,uncertain,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,121,R,L,True,1045
14168,2619,25733,single nucleotide variant,NM_000266.4(NDP):c.328T>G (p.Cys110Gly),4693,NDP,HGNC:7678,Pathogenic,1,17-Oct-97,104894876,-,RCV000011440,"MONDO:MONDO:0010588,MedGen:C1844579,OMIM:305390,Orphanet:891","Familial exudative vitreoretinopathy, X-linked",germline,germline,GRCh38,NC_000023.11,X,43949873,43949873,na,na,Xp11.3,no assertion criteria provided,1,-,N,"ClinGen:CA255481,UniProtKB:Q00604#VAR_016051,OMIM:300658.0016",1,10694,43949873,A,C,C110G,0,pathogenic,uncertain,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,110,C,G,True,1045
14169,2618,25732,single nucleotide variant,NM_000266.4(NDP):c.313G>A (p.Ala105Thr),4693,NDP,HGNC:7678,Pathogenic,1,17-Oct-97,104894875,-,RCV000011439,"MONDO:MONDO:0010691,MedGen:C0266526,OMIM:310600,Orphanet:649",Atrophia bulborum hereditaria,germline,germline,GRCh38,NC_000023.11,X,43949888,43949888,na,na,Xp11.3,no assertion criteria provided,1,-,N,"ClinGen:CA255480,UniProtKB:Q00604#VAR_016050,OMIM:300658.0015",1,10693,43949888,C,T,A105T,0,pathogenic,uncertain,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,105,A,T,True,1045
14170,2617,25730,single nucleotide variant,NM_000266.4(NDP):c.125A>G (p.His42Arg),4693,NDP,HGNC:7678,Likely pathogenic,1,27-Jul-19,104894874,-,RCV000011437|RCV000520034,MedGen:C4016494|MedGen:CN517202,"Exudative vitreoretinopathy, X-linked|not provided",germline,germline,GRCh38,NC_000023.11,X,43958521,43958521,na,na,Xp11.3,"criteria provided, multiple submitters, no conflicts",3,-,N,"ClinGen:CA121146,UniProtKB:Q00604#VAR_005481,OMIM:300658.0013",3,10691,43958521,T,C,H42R,2,pathogenic,pathogenic,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,42,H,R,True,1045
14171,2616,25729,single nucleotide variant,NM_000266.4(NDP):c.181C>T (p.Leu61Phe),4693,NDP,HGNC:7678,Pathogenic,1,1-Jan-97,104894880,-,RCV000011436,"MONDO:MONDO:0010691,MedGen:C0266526,OMIM:310600,Orphanet:649",Atrophia bulborum hereditaria,germline,germline,GRCh38,NC_000023.11,X,43950020,43950020,na,na,Xp11.3,no assertion criteria provided,1,-,N,"ClinGen:CA255479,UniProtKB:Q00604#VAR_005485,OMIM:300658.0012",1,10690,43950020,G,A,L61F,0,pathogenic,uncertain,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,61,L,F,True,1045
14172,2608,25719,single nucleotide variant,NM_000266.4(NDP):c.224C>G (p.Ser75Cys),4693,NDP,HGNC:7678,Pathogenic,1,1-Oct-92,104894868,-,RCV000011426,"MONDO:MONDO:0010691,MedGen:C0266526,OMIM:310600,Orphanet:649",Atrophia bulborum hereditaria,germline,germline,GRCh38,NC_000023.11,X,43949977,43949977,na,na,Xp11.3,no assertion criteria provided,1,-,N,"ClinGen:CA255467,UniProtKB:Q00604#VAR_005492,OMIM:300658.0002",1,10680,43949977,G,C,S75C,0,pathogenic,uncertain,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,75,S,C,True,1045
14173,13680,274036,single nucleotide variant,NM_000266.4(NDP):c.69C>G (p.Asp23Glu),4693,NDP,HGNC:7678,Benign,0,31-Dec-19,5952410,-,RCV000377254|RCV000716599|RCV000828198,MedGen:CN169374|MedGen:C2711754|MedGen:CN517202,not specified|History of neurodevelopmental disorder|not provided,germline,germline,GRCh38,NC_000023.11,X,43958577,43958577,na,na,Xp11.3,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA10391450,UniProtKB:Q00604#VAR_034137",2,289799,43958577,G,C,D23E,2,benign,benign,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,23,D,E,True,1045
14174,2614,25727,single nucleotide variant,NM_000266.4(NDP):c.361C>T (p.Arg121Trp),4693,NDP,HGNC:7678,Likely pathogenic,1,3-Dec-15,104894878,-,RCV000011434|RCV000484893,"MONDO:MONDO:0010588,MedGen:C1844579,OMIM:305390,Orphanet:891|MedGen:CN517202","Familial exudative vitreoretinopathy, X-linked|not provided",germline,germline,GRCh38,NC_000023.11,X,43949840,43949840,na,na,Xp11.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA255477,UniProtKB:Q00604#VAR_005502,OMIM:300658.0010",3,10688,43949840,G,A,R121W,1,pathogenic,pathogenic,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,121,R,W,True,1045
14175,2613,25724,single nucleotide variant,NM_000266.4(NDP):c.206G>C (p.Cys69Ser),4693,NDP,HGNC:7678,Pathogenic,1,1-Oct-93,104894872,-,RCV000011431,"MONDO:MONDO:0010691,MedGen:C0266526,OMIM:310600,Orphanet:649",Atrophia bulborum hereditaria,germline,germline,GRCh38,NC_000023.11,X,43949995,43949995,na,na,Xp11.3,no assertion criteria provided,1,-,N,"ClinGen:CA255472,UniProtKB:Q00604#VAR_005489,OMIM:300658.0007",1,10685,43949995,C,G,C69S,0,pathogenic,uncertain,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,69,C,S,True,1045
14176,2612,25723,single nucleotide variant,NM_000266.4(NDP):c.370C>T (p.Leu124Phe),4693,NDP,HGNC:7678,Pathogenic,1,1-Oct-93,28933684,-,RCV000011430,"MONDO:MONDO:0010588,MedGen:C1844579,OMIM:305390,Orphanet:891","Familial exudative vitreoretinopathy, X-linked",germline,germline,GRCh38,NC_000023.11,X,43949831,43949831,na,na,Xp11.3,no assertion criteria provided,1,-,N,"ClinGen:CA255471,UniProtKB:Q00604#VAR_005505,OMIM:300658.0006",1,10684,43949831,G,A,L124F,0,pathogenic,uncertain,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,124,L,F,True,1045
14177,2611,25722,single nucleotide variant,NM_000266.4(NDP):c.287G>A (p.Cys96Tyr),4693,NDP,HGNC:7678,Pathogenic,1,1-Oct-92,104894871,-,RCV000011429,"MONDO:MONDO:0010691,MedGen:C0266526,OMIM:310600,Orphanet:649",Atrophia bulborum hereditaria,germline,germline,GRCh38,NC_000023.11,X,43949914,43949914,na,na,Xp11.3,no assertion criteria provided,1,-,N,"ClinGen:CA255470,UniProtKB:Q00604#VAR_005496,OMIM:300658.0005",1,10683,43949914,C,T,C96Y,0,pathogenic,uncertain,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,96,C,Y,True,1045
14178,2610,25721,single nucleotide variant,NM_000266.4(NDP):c.131A>G (p.Tyr44Cys),4693,NDP,HGNC:7678,Pathogenic,1,1-Oct-92,104894870,-,RCV000011428,"MONDO:MONDO:0010691,MedGen:C0266526,OMIM:310600,Orphanet:649",Atrophia bulborum hereditaria,germline,germline,GRCh38,NC_000023.11,X,43958515,43958515,na,na,Xp11.3,no assertion criteria provided,1,-,N,"ClinGen:CA255469,UniProtKB:Q00604#VAR_005482,OMIM:300658.0004",1,10682,43958515,T,C,Y44C,0,pathogenic,uncertain,Q00604,Q00604,reviewed,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),NDP EVR2,Homo sapiens (Human),133.0,MRKHVLAASFSMLSLLVIMGDTDSKTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,PF00007;,4MY2;5BPU;5BQ8;5BQB;5BQC;5BQE;5CL1;,44,Y,C,True,1045
14179,1692,22368,single nucleotide variant,NM_001138.2(AGRP):c.199G>A (p.Ala67Thr),181,AGRP,HGNC:330,"Pathogenic, association",1,30-Aug-19,5030980,-,RCV000007753|RCV000007754,MedGen:C4016782|MedGen:C0039870,"Obesity, late-onset|Leanness, inherited",germline,germline,GRCh38,NC_000016.10,16,67483042,67483042,na,na,16q22.1,no assertion criteria provided,1,-,N,"ClinGen:CA118718,UniProtKB:O00253#VAR_015385,OMIM:602311.0001",1,7329,67483042,C,T,A67T,0,uncertain,uncertain,O00253,O00253,reviewed,AGRP_HUMAN,Agouti-related protein,AGRP AGRT ART,Homo sapiens (Human),132.0,MLTAAVLSCALLLALPATRGAQMGLAPMEGIRRPDQALLPELPGLGLRAPLKKTTAEQAEEDLLQEAQALAEVLDLQDREPRSSRRCVRLHESCLGQQVPCCDPCATCYCRFFNAFCYCRKLGTAMNPCSRT,PF05039;,1HYK;1MR0;,67,A,T,True,1046
14180,1690,22342,single nucleotide variant,NM_001524.1(HCRT):c.47T>G (p.Leu16Arg),3060,HCRT,HGNC:4847,Pathogenic,1,1-Sep-00,104894574,-,RCV000007726,"MONDO:MONDO:0008062,MedGen:C1834372,OMIM:161400,Orphanet:2073",Narcolepsy 1,germline,germline,GRCh38,NC_000017.11,17,42184503,42184503,na,na,17q21.2,no assertion criteria provided,1,-,N,"ClinGen:CA118704,UniProtKB:O43612#VAR_011633,OMIM:602358.0001",1,7303,42184503,A,C,L16R,0,pathogenic,uncertain,O43612,O43612,reviewed,OREX_HUMAN,"Orexin (Hypocretin, Hcrt) [Cleaved into: Orexin-A (Hypocretin-1, Hcrt1); Orexin-B (Hypocretin-2, Hcrt2) ]",HCRT OX PPORX PPOX,Homo sapiens (Human),131.0,MNLPSTKVSWAAVTLLLLLLLLPPALLSSGAAAQPLPDCCRQKTCSCRLYELLHGAGNHAAGILTLGKRRSGPPGLQGRLQRLLQASGNHAAGILTMGRRAGAEPAPRPCLGRRCSAPAAASVAPGGQSGI,PF02072;,1CQ0;1R02;1UVQ;1WSO;7L1U;,16,L,R,True,1047
14181,4028,29869,single nucleotide variant,NM_005543.4(INSL3):c.278C>T (p.Pro93Leu),3640,INSL3,HGNC:6086,Pathogenic,1,1-Sep-03,104894697,-,RCV000015955,"Human Phenotype Ontology:HP:0000028,Human Phenotype Ontology:HP:0000797,MONDO:MONDO:0009047,MedGen:C0010417,OMIM:219050",Cryptorchidism,germline,germline,GRCh38,NC_000019.10,19,17816972,17816972,na,na,19p13.11,no assertion criteria provided,1,-,N,"UniProtKB:P51460#VAR_013235,OMIM:146738.0002,ClinGen:CA210729",1,14830,17816972,G,A,P93L,0,pathogenic,uncertain,P51460,P51460,reviewed,INSL3_HUMAN,"Insulin-like 3 (Leydig insulin-like peptide, Ley-I-L) (Relaxin-like factor) [Cleaved into: Insulin-like 3 B chain; Insulin-like 3 A chain ]",INSL3 RLF RLNL,Homo sapiens (Human),131.0,MDPRLPAWALVLLGPALVFALGPAPTPEMREKLCGHHFVRALVRVCGGPRWSTEARRPATGGDRELLQWLERRHLLHGLVADSNLTLGPGLQPLPQTSHHHRHHRAAATNPARYCCLSGCTQQDLLTLCPY,PF00049;,2H8B;2K6T;2K6U;,93,P,L,True,1048
14182,4029,29870,single nucleotide variant,NM_005543.4(INSL3):c.304C>T (p.Arg102Cys),3640,INSL3,HGNC:6086,Pathogenic,1,1-Sep-03,104894698,-,RCV000015956,"Human Phenotype Ontology:HP:0000028,Human Phenotype Ontology:HP:0000797,MONDO:MONDO:0009047,MedGen:C0010417,OMIM:219050",Cryptorchidism,germline,germline,GRCh38,NC_000019.10,19,17816946,17816946,na,na,19p13.11,no assertion criteria provided,1,-,N,"OMIM:146738.0003,ClinGen:CA210730,UniProtKB:P51460#VAR_013236",1,14831,17816946,G,A,R102C,0,pathogenic,uncertain,P51460,P51460,reviewed,INSL3_HUMAN,"Insulin-like 3 (Leydig insulin-like peptide, Ley-I-L) (Relaxin-like factor) [Cleaved into: Insulin-like 3 B chain; Insulin-like 3 A chain ]",INSL3 RLF RLNL,Homo sapiens (Human),131.0,MDPRLPAWALVLLGPALVFALGPAPTPEMREKLCGHHFVRALVRVCGGPRWSTEARRPATGGDRELLQWLERRHLLHGLVADSNLTLGPGLQPLPQTSHHHRHHRAAATNPARYCCLSGCTQQDLLTLCPY,PF00049;,2H8B;2K6T;2K6U;,102,R,C,True,1048
14183,4030,29871,single nucleotide variant,NM_005543.4(INSL3):c.305G>A (p.Arg102His),3640,INSL3,HGNC:6086,Pathogenic,1,1-Sep-03,121912556,-,RCV000015957,"Human Phenotype Ontology:HP:0000028,Human Phenotype Ontology:HP:0000797,MONDO:MONDO:0009047,MedGen:C0010417,OMIM:219050",Cryptorchidism,germline,germline,GRCh38,NC_000019.10,19,17816945,17816945,na,na,19p13.11,no assertion criteria provided,1,-,N,"ClinGen:CA210732,UniProtKB:P51460#VAR_013237,OMIM:146738.0004",1,14832,17816945,C,T,R102H,0,pathogenic,uncertain,P51460,P51460,reviewed,INSL3_HUMAN,"Insulin-like 3 (Leydig insulin-like peptide, Ley-I-L) (Relaxin-like factor) [Cleaved into: Insulin-like 3 B chain; Insulin-like 3 A chain ]",INSL3 RLF RLNL,Homo sapiens (Human),131.0,MDPRLPAWALVLLGPALVFALGPAPTPEMREKLCGHHFVRALVRVCGGPRWSTEARRPATGGDRELLQWLERRHLLHGLVADSNLTLGPGLQPLPQTSHHHRHHRAAATNPARYCCLSGCTQQDLLTLCPY,PF00049;,2H8B;2K6T;2K6U;,102,R,H,True,1048
14184,4027,29868,single nucleotide variant,NM_005543.4(INSL3):c.330C>G (p.Asn110Lys),3640,INSL3,HGNC:6086,Pathogenic,1,1-Jan-03,121912555,-,RCV000015954,"Human Phenotype Ontology:HP:0000028,Human Phenotype Ontology:HP:0000797,MONDO:MONDO:0009047,MedGen:C0010417,OMIM:219050",Cryptorchidism,germline,germline,GRCh38,NC_000019.10,19,17816920,17816920,na,na,19p13.11,no assertion criteria provided,1,-,N,"ClinGen:CA210727,UniProtKB:P51460#VAR_017122,OMIM:146738.0001",1,14829,17816920,G,C,N110K,0,pathogenic,uncertain,P51460,P51460,reviewed,INSL3_HUMAN,"Insulin-like 3 (Leydig insulin-like peptide, Ley-I-L) (Relaxin-like factor) [Cleaved into: Insulin-like 3 B chain; Insulin-like 3 A chain ]",INSL3 RLF RLNL,Homo sapiens (Human),131.0,MDPRLPAWALVLLGPALVFALGPAPTPEMREKLCGHHFVRALVRVCGGPRWSTEARRPATGGDRELLQWLERRHLLHGLVADSNLTLGPGLQPLPQTSHHHRHHRAAATNPARYCCLSGCTQQDLLTLCPY,PF00049;,2H8B;2K6T;2K6U;,110,N,K,True,1048
14185,13960,313840,single nucleotide variant,NM_000510.3(FSHB):c.59G>T (p.Ser20Ile),2488,FSHB,HGNC:3964,Conflicting interpretations of pathogenicity,0,31-Dec-19,6170,-,RCV000278557|RCV000892651,"MONDO:MONDO:0009239,MedGen:C1856716,OMIM:229070,Orphanet:52901|MedGen:CN517202",Hypogonadotropic hypogonadism 24 without anosmia|not provided,germline,germline,GRCh38,NC_000011.10,11,30231961,30231961,na,na,11p14.1,"criteria provided, conflicting interpretations",2,-,N,"ClinGen:CA5930738,UniProtKB:P01225#VAR_012047",2,304276,30231961,G,T,S20I,1,uncertain,uncertain,P01225,P01225,reviewed,FSHB_HUMAN,"Follitropin subunit beta (Follicle-stimulating hormone beta subunit, FSH-B, FSH-beta) (Follitropin beta chain)",FSHB,Homo sapiens (Human),129.0,MKTLQFFFLFCCWKAICCNSCELTNITIAIEKEECRFCISINTTWCAGYCYTRDLVYKDPARPKIQKTCTFKELVYETVRVPGCAHHADSLYTYPVATQCHCGKCDSDSTDCTVRGLGPSYCSFGEMKE,PF00007;,1FL7;1XWD;4AY9;4MQW;,20,S,I,True,1049
14186,4604,31280,single nucleotide variant,NM_000510.3(FSHB):c.205T>G (p.Cys69Gly),2488,FSHB,HGNC:3964,Pathogenic,1,25-Nov-10,5030776,-,RCV000017628,"MONDO:MONDO:0009239,MedGen:C1856716,OMIM:229070,Orphanet:52901",Hypogonadotropic hypogonadism 24 without anosmia,germline,germline,GRCh38,NC_000011.10,11,30233615,30233615,na,na,11p14.1,no assertion criteria provided,1,-,N,"UniProtKB:P01225#VAR_033015,OMIM:136530.0002,ClinGen:CA126288",1,16241,30233615,T,G,C69G,0,pathogenic,uncertain,P01225,P01225,reviewed,FSHB_HUMAN,"Follitropin subunit beta (Follicle-stimulating hormone beta subunit, FSH-B, FSH-beta) (Follitropin beta chain)",FSHB,Homo sapiens (Human),129.0,MKTLQFFFLFCCWKAICCNSCELTNITIAIEKEECRFCISINTTWCAGYCYTRDLVYKDPARPKIQKTCTFKELVYETVRVPGCAHHADSLYTYPVATQCHCGKCDSDSTDCTVRGLGPSYCSFGEMKE,PF00007;,1FL7;1XWD;4AY9;4MQW;,69,C,G,True,1049
14187,7472,75619,single nucleotide variant,NM_203330.2(CD59):c.266G>A (p.Cys89Tyr),966,CD59,HGNC:1689,Pathogenic,1,3-Jan-13,397514767,-,RCV000054836,"MONDO:MONDO:0012858,MedGen:C2676767,OMIM:612300,Orphanet:169464",CD59-mediated hemolytic anemia with or without immune-mediated polyneuropathy,germline,germline,GRCh38,NC_000011.10,11,33710247,33710247,na,na,11p13,no assertion criteria provided,1,-,N,"OMIM:107271.0002,ClinGen:CA144735,UniProtKB:P13987#VAR_070124",1,64690,33710247,C,T,C89Y,0,pathogenic,uncertain,P13987,P13987,reviewed,CD59_HUMAN,"CD59 glycoprotein (1F5 antigen) (20 kDa homologous restriction factor, HRF-20, HRF20) (MAC-inhibitory protein, MAC-IP) (MEM43 antigen) (Membrane attack complex inhibition factor, MACIF) (Membrane inhibitor of reactive lysis, MIRL) (Protectin) (CD antigen CD59)",CD59 MIC11 MIN1 MIN2 MIN3 MSK21,Homo sapiens (Human),128.0,MGIQGGSVLFGLLLVLAVFCHSGHSLQCYNCPNPTADCKTAVNCSSDFDACLITKAGLQVYNKCWKFEHCNFNDVTTRLRENELTYYCCKKDLCNFNEQLENGGTSLSEKTVLLLVTPFLAAAWSLHP,PF00021;,1CDQ;1CDR;1CDS;1ERG;1ERH;2J8B;2OFS;2UWR;2UX2;4BIK;5IMT;5IMY;6ZD0;,89,C,Y,True,1050
14188,6270,45889,single nucleotide variant,NM_005340.7(HINT1):c.266G>T (p.Gly89Val),3094,HINT1,HGNC:4912,Pathogenic,1,1-Jul-20,397514490,-,RCV000030854|RCV001311673,"MONDO:MONDO:0007646,MedGen:CN074193,OMIM:137200,Orphanet:324442|MedGen:CN517202",Autosomal recessive axonal neuropathy with neuromyotonia|not provided,germline,germline,GRCh38,NC_000005.10,5,131159562,131159562,na,na,5q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA130160,UniProtKB:P49773#VAR_069215,OMIM:601314.0003",3,37314,131159562,C,A,G89V,1,pathogenic,pathogenic,P49773,P49773,reviewed,HINT1_HUMAN,"Adenosine 5'-monophosphoramidase HINT1, EC 3.9.1.- (Desumoylating isopeptidase HINT1, EC 3.4.22.-) (Histidine triad nucleotide-binding protein 1) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1, PKCI-1)",HINT1 HINT PKCI1 PRKCNH1,Homo sapiens (Human),126.0,MADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG,PF01230;,1AV5;1KPA;1KPB;1KPC;1KPE;1KPF;3TW2;4EQE;4EQG;4EQH;4ZKL;4ZKV;5ED3;5ED6;5EMT;5I2E;5I2F;5IPB;5IPC;5IPD;5IPE;5KLY;5KLZ;5KM0;5KM1;5KM2;5KM3;5KM4;5KM6;5KMA;5KMB;5KMC;5O8I;5WA8;5WA9;5WAA;6B42;6G9Z;6J53;6J58;6J5S;6J5Z;6J64;6J65;6N3V;6N3W;6N3X;6N3Y;6YQM;7Q2U;,89,G,V,True,1051
14189,6269,45888,single nucleotide variant,NM_005340.7(HINT1):c.250T>C (p.Cys84Arg),3094,HINT1,HGNC:4912,Pathogenic,1,1-Oct-12,397514489,-,RCV000030853,"MONDO:MONDO:0007646,MedGen:CN074193,OMIM:137200,Orphanet:324442",Autosomal recessive axonal neuropathy with neuromyotonia,germline,germline,GRCh38,NC_000005.10,5,131159578,131159578,na,na,5q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA130159,UniProtKB:P49773#VAR_069214,OMIM:601314.0002",1,37313,131159578,A,G,C84R,0,pathogenic,uncertain,P49773,P49773,reviewed,HINT1_HUMAN,"Adenosine 5'-monophosphoramidase HINT1, EC 3.9.1.- (Desumoylating isopeptidase HINT1, EC 3.4.22.-) (Histidine triad nucleotide-binding protein 1) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1, PKCI-1)",HINT1 HINT PKCI1 PRKCNH1,Homo sapiens (Human),126.0,MADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG,PF01230;,1AV5;1KPA;1KPB;1KPC;1KPE;1KPF;3TW2;4EQE;4EQG;4EQH;4ZKL;4ZKV;5ED3;5ED6;5EMT;5I2E;5I2F;5IPB;5IPC;5IPD;5IPE;5KLY;5KLZ;5KM0;5KM1;5KM2;5KM3;5KM4;5KM6;5KMA;5KMB;5KMC;5O8I;5WA8;5WA9;5WAA;6B42;6G9Z;6J53;6J58;6J5S;6J5Z;6J64;6J65;6N3V;6N3W;6N3X;6N3Y;6YQM;7Q2U;,84,C,R,True,1051
14190,6268,45887,single nucleotide variant,NM_005340.7(HINT1):c.110G>C (p.Arg37Pro),3094,HINT1,HGNC:4912,Pathogenic,1,1-Jun-20,149782619,-,RCV000030852|RCV000235535,"MONDO:MONDO:0007646,MedGen:CN074193,OMIM:137200,Orphanet:324442|MedGen:CN517202",Autosomal recessive axonal neuropathy with neuromyotonia|not provided,germline;unknown,germline,GRCh38,NC_000005.10,5,131165096,131165096,na,na,5q23.3,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA130158,UniProtKB:P49773#VAR_069212,OMIM:601314.0001",3,37312,131165096,C,G,R37P,2,pathogenic,pathogenic,P49773,P49773,reviewed,HINT1_HUMAN,"Adenosine 5'-monophosphoramidase HINT1, EC 3.9.1.- (Desumoylating isopeptidase HINT1, EC 3.4.22.-) (Histidine triad nucleotide-binding protein 1) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1, PKCI-1)",HINT1 HINT PKCI1 PRKCNH1,Homo sapiens (Human),126.0,MADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG,PF01230;,1AV5;1KPA;1KPB;1KPC;1KPE;1KPF;3TW2;4EQE;4EQG;4EQH;4ZKL;4ZKV;5ED3;5ED6;5EMT;5I2E;5I2F;5IPB;5IPC;5IPD;5IPE;5KLY;5KLZ;5KM0;5KM1;5KM2;5KM3;5KM4;5KM6;5KMA;5KMB;5KMC;5O8I;5WA8;5WA9;5WAA;6B42;6G9Z;6J53;6J58;6J5S;6J5Z;6J64;6J65;6N3V;6N3W;6N3X;6N3Y;6YQM;7Q2U;,37,R,P,True,1051
14191,6272,45891,single nucleotide variant,NM_005340.7(HINT1):c.152A>G (p.His51Arg),3094,HINT1,HGNC:4912,Pathogenic,1,1-Oct-12,397514491,-,RCV000030856,"MONDO:MONDO:0007646,MedGen:CN074193,OMIM:137200,Orphanet:324442",Autosomal recessive axonal neuropathy with neuromyotonia,germline,germline,GRCh38,NC_000005.10,5,131162636,131162636,na,na,5q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA130162,UniProtKB:P49773#VAR_069213,OMIM:601314.0005",1,37316,131162636,T,C,H51R,0,pathogenic,uncertain,P49773,P49773,reviewed,HINT1_HUMAN,"Adenosine 5'-monophosphoramidase HINT1, EC 3.9.1.- (Desumoylating isopeptidase HINT1, EC 3.4.22.-) (Histidine triad nucleotide-binding protein 1) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1, PKCI-1)",HINT1 HINT PKCI1 PRKCNH1,Homo sapiens (Human),126.0,MADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG,PF01230;,1AV5;1KPA;1KPB;1KPC;1KPE;1KPF;3TW2;4EQE;4EQG;4EQH;4ZKL;4ZKV;5ED3;5ED6;5EMT;5I2E;5I2F;5IPB;5IPC;5IPD;5IPE;5KLY;5KLZ;5KM0;5KM1;5KM2;5KM3;5KM4;5KM6;5KMA;5KMB;5KMC;5O8I;5WA8;5WA9;5WAA;6B42;6G9Z;6J53;6J58;6J5S;6J5Z;6J64;6J65;6N3V;6N3W;6N3X;6N3Y;6YQM;7Q2U;,51,H,R,True,1051
14192,6271,45890,single nucleotide variant,NM_005340.7(HINT1):c.334C>A (p.His112Asn),3094,HINT1,HGNC:4912,Pathogenic,1,9-Aug-18,373849532,-,RCV000030855,"MONDO:MONDO:0007646,MedGen:CN074193,OMIM:137200,Orphanet:324442",Autosomal recessive axonal neuropathy with neuromyotonia,germline;unknown,germline,GRCh38,NC_000005.10,5,131159494,131159494,na,na,5q23.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA130161,UniProtKB:P49773#VAR_069217,OMIM:601314.0004",3,37315,131159494,G,T,H112N,1,pathogenic,pathogenic,P49773,P49773,reviewed,HINT1_HUMAN,"Adenosine 5'-monophosphoramidase HINT1, EC 3.9.1.- (Desumoylating isopeptidase HINT1, EC 3.4.22.-) (Histidine triad nucleotide-binding protein 1) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1, PKCI-1)",HINT1 HINT PKCI1 PRKCNH1,Homo sapiens (Human),126.0,MADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG,PF01230;,1AV5;1KPA;1KPB;1KPC;1KPE;1KPF;3TW2;4EQE;4EQG;4EQH;4ZKL;4ZKV;5ED3;5ED6;5EMT;5I2E;5I2F;5IPB;5IPC;5IPD;5IPE;5KLY;5KLZ;5KM0;5KM1;5KM2;5KM3;5KM4;5KM6;5KMA;5KMB;5KMC;5O8I;5WA8;5WA9;5WAA;6B42;6G9Z;6J53;6J58;6J5S;6J5Z;6J64;6J65;6N3V;6N3W;6N3X;6N3Y;6YQM;7Q2U;,112,H,N,True,1051
14193,6273,45893,single nucleotide variant,NM_005340.7(HINT1):c.278G>A (p.Gly93Asp),3094,HINT1,HGNC:4912,Pathogenic,1,1-Oct-12,397514493,-,RCV000030858,"MONDO:MONDO:0007646,MedGen:CN074193,OMIM:137200,Orphanet:324442",Autosomal recessive axonal neuropathy with neuromyotonia,germline,germline,GRCh38,NC_000005.10,5,131159550,131159550,na,na,5q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA130165,UniProtKB:P49773#VAR_069216,OMIM:601314.0007",1,37318,131159550,C,T,G93D,0,pathogenic,uncertain,P49773,P49773,reviewed,HINT1_HUMAN,"Adenosine 5'-monophosphoramidase HINT1, EC 3.9.1.- (Desumoylating isopeptidase HINT1, EC 3.4.22.-) (Histidine triad nucleotide-binding protein 1) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1, PKCI-1)",HINT1 HINT PKCI1 PRKCNH1,Homo sapiens (Human),126.0,MADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG,PF01230;,1AV5;1KPA;1KPB;1KPC;1KPE;1KPF;3TW2;4EQE;4EQG;4EQH;4ZKL;4ZKV;5ED3;5ED6;5EMT;5I2E;5I2F;5IPB;5IPC;5IPD;5IPE;5KLY;5KLZ;5KM0;5KM1;5KM2;5KM3;5KM4;5KM6;5KMA;5KMB;5KMC;5O8I;5WA8;5WA9;5WAA;6B42;6G9Z;6J53;6J58;6J5S;6J5Z;6J64;6J65;6N3V;6N3W;6N3X;6N3Y;6YQM;7Q2U;,93,G,D,True,1051
14194,3723,29066,single nucleotide variant,NM_013251.4(TAC3):c.269T>C (p.Met90Thr),6866,TAC3,HGNC:11521,Pathogenic,1,1-Mar-09,121918123,-,RCV000030899|RCV000059795,MedGen:C4016274|MedGen:CN517202,Hypogonadotropic hypogonadism 10 without anosmia|not provided,germline,germline,GRCh38,NC_000012.12,12,57012845,57012845,na,na,12q13.3,no assertion criteria provided,2,-,N,"ClinGen:CA130195,UniProtKB:Q9UHF0#VAR_069176,UniProtKB/Swiss-Prot:VAR_069176,OMIM:162330.0001",1,14027,57012845,A,G,M90T,0,pathogenic,uncertain,Q9UHF0,Q9UHF0,reviewed,TKNK_HUMAN,"Tachykinin-3 (ZNEUROK1) [Cleaved into: Neurokinin-B, NKB (Neuromedin-K) ]",TAC3 NKNB UNQ585/PRO1155,Homo sapiens (Human),121.0,MRIMLLFTAILAFSLAQSFGAVCKEPQEEVVPGGGRSKRDPDLYQLLQRLFKSHSSLEGLLKALSQASTDPKESTSPEKRDMHDFFVGLMGKRSVQPDSPTDVNQENVPSFGILKYPPRAE,PF03823;,1P9F;,90,M,T,True,1052
14195,6088,40563,single nucleotide variant,NM_004048.3(B2M):c.286G>A (p.Asp96Asn),567,B2M,HGNC:914,Pathogenic,1,28-May-19,398122820,-,RCV000024598|RCV000989305,"MONDO:MONDO:0007099,MedGen:C0268389,OMIM:105200,Orphanet:85450|Human Phenotype Ontology:HP:0012539,MONDO:MONDO:0018908,MedGen:C0024305,Orphanet:547","Familial visceral amyloidosis, Ostertag type|Non-Hodgkin lymphoma",germline;unknown,germline,GRCh38,NC_000015.10,15,44715641,44715641,na,na,15q21.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA129891,UniProtKB:P61769#VAR_076691,OMIM:109700.0002",3,31907,44715641,G,A,D96N,1,pathogenic,pathogenic,P61769,P61769,reviewed,B2MG_HUMAN,Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3 ],B2M CDABP0092 HDCMA22P,Homo sapiens (Human),119.0,MSRSVALAVLALLSLSGLEAIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM,PF07654;,1A1M;1A1N;1A1O;1A6Z;1A9B;1A9E;1AGB;1AGC;1AGD;1AGE;1AGF;1AKJ;1AO7;1B0G;1B0R;1BD2;1C16;1CE6;1CG9;1DE4;1DUY;1DUZ;1E27;1E28;1EEY;1EEZ;1EFX;1EXU;1GZP;1GZQ;1HHG;1HHH;1HHI;1HHJ;1HHK;1HLA;1HSA;1HSB;1I1F;1I1Y;1I4F;1I7R;1I7T;1I7U;1IM3;1IM9;1JF1;1JGD;1JGE;1JHT;1JNJ;1K5N;1KPR;1KTL;1LDS;1LP9;1M05;1M6O;1MHE;1MI5;1N2R;1OF2;1OGA;1OGT;1ONQ;1P7Q;1PY4;1Q94;1QEW;1QLF;1QQD;1QR1;1QRN;1QSE;1QSF;1QVO;1R3H;1S8D;1S9W;1S9X;1S9Y;1SYS;1SYV;1T1W;1T1X;1T1Y;1T1Z;1T20;1T21;1T22;1TMC;1TVB;1TVH;1UQS;1UXS;1UXW;1VGK;1W0V;1W0W;1W72;1X7Q;1XH3;1XR8;1XR9;1XZ0;1YDP;1YPZ;1ZHK;1ZHL;1ZS8;1ZSD;1ZT4;1ZVS;2A83;2AK4;2AV1;2AV7;2AXF;2AXG;2BCK;2BNQ;2BNR;2BSR;2BSS;2BST;2BVO;2BVP;2BVQ;2C7U;2CII;2CIK;2CLR;2D31;2D4D;2D4F;2DYP;2E8D;2ESV;2F53;2F54;2F74;2F8O;2FYY;2FZ3;2GIT;2GJ6;2GT9;2GTW;2GTZ;2GUO;2H26;2H6P;2HJK;2HJL;2HLA;2HN7;2J8U;2JCC;2NW3;2NX5;2P5E;2P5W;2PO6;2PYE;2RFX;2UWE;2V2W;2V2X;2VB5;2VLJ;2VLK;2VLL;2VLR;2X4N;2X4O;2X4P;2X4Q;2X4R;2X4S;2X4T;2X4U;2X70;2X89;2XKS;2XKU;2XPG;2YPK;2YPL;2YXF;2Z9T;3AM8;3B3I;3B6S;3BGM;3BH8;3BH9;3BHB;3BO8;3BP4;3BP7;3BVN;3BW9;3BWA;3BXN;3BZE;3BZF;3C9N;3CDG;3CII;3CIQ;3CZF;3D18;3D25;3D2U;3D39;3D3V;3DBX;3DHJ;3DHM;3DTX;3DX6;3DX7;3DX8;3DXA;3EKC;3FFC;3FQN;3FQR;3FQT;3FQU;3FQW;3FQX;3FT2;3FT3;3FT4;3GIV;3GJF;3GSN;3GSO;3GSQ;3GSR;3GSU;3GSV;3GSW;3GSX;3H7B;3H9H;3H9S;3HAE;3HCV;3HG1;3HLA;3HPJ;3HUJ;3I6G;3I6K;3I6L;3IB4;3IXA;3JTS;3KLA;3KPL;3KPM;3KPN;3KPO;3KPP;3KPQ;3KPR;3KPS;3KWW;3KXF;3KYN;3KYO;3L3D;3L3G;3L3I;3L3J;3L3K;3LKN;3LKO;3LKP;3LKQ;3LKR;3LKS;3LN4;3LN5;3LOW;3LOZ;3LV3;3M17;3M1B;3MGO;3MGT;3MR9;3MRB;3MRC;3MRD;3MRE;3MRF;3MRG;3MRH;3MRI;3MRJ;3MRK;3MRL;3MRM;3MRN;3MRO;3MRP;3MRQ;3MRR;3MV7;3MV8;3MV9;3MYJ;3MYZ;3MZT;3NA4;3NFN;3O3A;3O3B;3O3D;3O3E;3O4L;3OV6;3OX8;3OXR;3OXS;3PWJ;3PWL;3PWN;3PWP;3QDA;3QDG;3QDJ;3QDM;3QEQ;3QFD;3QFJ;3QZW;3REW;3RL1;3RL2;3RWJ;3S6C;3SDX;3SJV;3SKM;3SKO;3SPV;3T8X;3TID;3TIE;3TLR;3TM6;3TO2;3TZV;3U0P;3UPR;3UTQ;3UTS;3UTT;3V5D;3V5H;3V5K;3VCL;3VFM;3VFN;3VFO;3VFP;3VFR;3VFS;3VFT;3VFU;3VFV;3VFW;3VH8;3VRI;3VRJ;3VWJ;3VWK;3VXM;3VXN;3VXO;3VXP;3VXR;3VXS;3VXU;3W0W;3W39;3WL9;3WLB;3WUW;3X11;3X12;3X13;3X14;4E0K;4E0L;4E5X;4EN3;4EUP;4F7M;4F7P;4F7T;4FTV;4FXL;4G8G;4G8I;4G9D;4G9F;4GKN;4GKS;4GUP;4HKJ;4HWZ;4HX1;4I48;4I4W;4JFD;4JFE;4JFF;4JFO;4JFP;4JFQ;4JQV;4JQX;4JRX;4JRY;4K71;4K7F;4KDT;4L29;4L3C;4L3E;4L4T;4L4V;4LCW;4LCY;4LHU;4LNR;4M8V;4MJ5;4MJ6;4MJI;4MNQ;4N0F;4N0U;4N8V;4NNX;4NNY;4NO0;4NO2;4NO3;4NO5;4NQC;4NQD;4NQE;4NQV;4NQX;4NT6;4O2C;4O2E;4O2F;4ONO;4PJ5;4PJ7;4PJ8;4PJ9;4PJA;4PJB;4PJC;4PJD;4PJE;4PJF;4PJG;4PJH;4PJI;4PJX;4PR5;4PRA;4PRB;4PRD;4PRE;4PRH;4PRI;4PRN;4PRP;4QOK;4QRP;4QRQ;4QRR;4QRS;4QRT;4QRU;4R9H;4RA3;4RAH;4RMQ;4RMR;4RMS;4RMT;4RMU;4RMV;4RMW;4U1H;4U1I;4U1J;4U1K;4U1L;4U1M;4U1N;4U1S;4U6X;4U6Y;4UQ2;4UQ3;4WC8;4WDI;4WJ5;4WO4;4WU5;4WU7;4WUU;4WW2;4WWK;4X0S;4X6C;4X6D;4X6E;4X6F;4XXC;4Z76;4Z77;4Z78;5B38;5B39;5BJT;5BRZ;5BS0;5BXF;5C07;5C08;5C09;5C0A;5C0B;5C0C;5C0D;5C0E;5C0F;5C0G;5C0I;5C0J;5C9J;5CFH;5CKA;5CKG;5CS7;5CSB;5CSG;5D2L;5D2N;5D5M;5D7I;5D7J;5D7L;5D9S;5DDH;5DEF;5DEG;5E00;5E6I;5E9D;5ENW;5EO0;5EO1;5EOT;5EU3;5EU4;5EU5;5EU6;5EUO;5F1I;5F7D;5F9J;5FA3;5FA4;5FDW;5GR7;5GRD;5GRG;5GSB;5GSD;5GSR;5GSV;5GSX;5HGA;5HGB;5HGD;5HGH;5HHM;5HHN;5HHO;5HHP;5HHQ;5HYJ;5IB1;5IB2;5IB3;5IB4;5IB5;5IEH;5IEK;5IM7;5INC;5IND;5IRO;5ISZ;5IUE;5J1A;5JHD;5JZI;5KNM;5L2J;5L2K;5MEN;5MEO;5MEP;5MEQ;5MER;5N1Y;5N6B;5NHT;5NME;5NMF;5NMG;5NMH;5NMK;5NQ1;5NQ3;5NQK;5OPI;5SWQ;5T6W;5T6X;5T6Y;5T6Z;5T70;5TEZ;5TRZ;5TS1;5TXS;5U16;5U17;5U1R;5U2V;5U6Q;5U72;5U98;5V5L;5V5M;5VGD;5VGE;5VUD;5VUE;5VUF;5VVP;5VWD;5VWF;5VWH;5VWJ;5VZ5;5W1V;5W1W;5W67;5W69;5W6A;5WER;5WHK;5WJL;5WJN;5WKE;5WKF;5WKG;5WKH;5WKI;5WL1;5WMN;5WMO;5WMP;5WMQ;5WMR;5WSH;5WWI;5WWJ;5WWU;5WXC;5WXD;5XOS;5XOT;5XOV;5YXN;5YXU;6AEE;6AM5;6AMT;6AMU;6APN;6AT5;6AT9;6AVF;6AVG;6BJ2;6BJ3;6BJ8;6BXP;6BXQ;6C09;6C15;6C97;6C98;6C99;6CUG;6D29;6D2B;6D2R;6D2T;6D64;6D78;6DKP;6EI2;6ENY;6EQA;6EQB;6EWA;6EWC;6EWO;6FGB;6G3J;6G3K;6GGM;6GH1;6GH4;6GHN;6GK3;6GL1;6ID4;6IEX;6ILM;6J1V;6J1W;6J29;6J2A;6J2E;6J2G;6J2H;6J2I;6J2J;6JOZ;6JP3;6JTN;6JTO;6JTP;6K60;6K7T;6LA6;6LA7;6M1B;6M24;6M2J;6M2K;6MPP;6MT3;6MT4;6MT5;6MT6;6MTL;6MTM;6MWR;6NCA;6NHA;6NPR;6NUX;6O4Y;6O4Z;6O51;6O53;6O9B;6O9C;6OPD;6P23;6P27;6P2C;6P2F;6P2S;6P64;6PA1;6PAG;6PBH;6PTB;6PTE;6PUC;6PUD;6PUE;6PUF;6PUG;6PUH;6PUI;6PUJ;6PUK;6PUL;6PUM;6PVC;6PVD;6PYJ;6PYL;6PYV;6PYW;6PZ5;6Q3K;6Q3S;6QIO;6QIP;6R2L;6RP9;6RPA;6RPB;6RSY;6SS7;6SS8;6SS9;6SSA;6TDO;6TDP;6TDQ;6TDR;6TDS;6TMO;6TRN;6TRO;6UJ7;6UJ8;6UJ9;6UJO;6UJQ;6UK2;6UK4;6ULI;6ULK;6ULN;6ULR;6UON;6UZ1;6UZM;6UZN;6UZO;6UZP;6UZQ;6UZS;6V2O;6V2P;6V2Q;6V3J;6V7Y;6V7Z;6V80;6VB0;6VB1;6VB2;6VB3;6VB4;6VB5;6VB6;6VB7;6VIU;6VM7;6VM8;6VM9;6VMA;6VMC;6VMX;6VPZ;6VQ2;6VQD;6VQE;6VQO;6VQY;6VQZ;6VR1;6VR5;6VRM;6VRN;6W51;6W9U;6W9V;6WNA;6WOL;6WZY;6X00;6XQA;6XQP;6Y26;6Y27;6Y28;6Y29;6Y2A;6Y2B;6Z9V;6Z9W;6Z9X;6ZKW;6ZKX;6ZKY;6ZKZ;7AFV;7ALO;7B5F;7BBG;7C9V;7DZM;7DZN;7EDO;7EJL;7EJM;7EJN;7EU2;7F4W;7JWI;7JYU;7JYV;7JYW;7JYX;7K80;7K81;7KGO;7KGP;7KGQ;7KGR;7KGS;7KGT;7KOZ;7KP0;7KP1;7LFZ;7LG0;7LG2;7LG3;7LGD;7LGT;7LLI;7LLJ;7M8S;7M8T;7M8U;7MJ6;7MJ7;7MJ8;7MJ9;7MJA;7MKB;7MX4;7MXF;7MXH;7N1A;7N1B;7N1E;7N1F;7N6D;7N6E;7NDQ;7NDT;7NDU;7NUI;7P3D;7P3E;7RTD;7RTR;,96,D,N,True,1053
14196,5019,32779,single nucleotide variant,NM_004048.3(B2M):c.31G>C (p.Ala11Pro),567,B2M,HGNC:914,Uncertain significance,1,31-Jul-19,104894481,-,RCV000019314,"MONDO:MONDO:0009434,MedGen:C1855796,OMIM:241600","Hypoproteinemia, hypercatabolic",germline,germline,GRCh38,NC_000015.10,15,44711577,44711577,na,na,15q21.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA251327,UniProtKB:P61769#VAR_030660,OMIM:109700.0001",3,17740,44711577,G,C,A11P,1,uncertain,uncertain,P61769,P61769,reviewed,B2MG_HUMAN,Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3 ],B2M CDABP0092 HDCMA22P,Homo sapiens (Human),119.0,MSRSVALAVLALLSLSGLEAIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM,PF07654;,1A1M;1A1N;1A1O;1A6Z;1A9B;1A9E;1AGB;1AGC;1AGD;1AGE;1AGF;1AKJ;1AO7;1B0G;1B0R;1BD2;1C16;1CE6;1CG9;1DE4;1DUY;1DUZ;1E27;1E28;1EEY;1EEZ;1EFX;1EXU;1GZP;1GZQ;1HHG;1HHH;1HHI;1HHJ;1HHK;1HLA;1HSA;1HSB;1I1F;1I1Y;1I4F;1I7R;1I7T;1I7U;1IM3;1IM9;1JF1;1JGD;1JGE;1JHT;1JNJ;1K5N;1KPR;1KTL;1LDS;1LP9;1M05;1M6O;1MHE;1MI5;1N2R;1OF2;1OGA;1OGT;1ONQ;1P7Q;1PY4;1Q94;1QEW;1QLF;1QQD;1QR1;1QRN;1QSE;1QSF;1QVO;1R3H;1S8D;1S9W;1S9X;1S9Y;1SYS;1SYV;1T1W;1T1X;1T1Y;1T1Z;1T20;1T21;1T22;1TMC;1TVB;1TVH;1UQS;1UXS;1UXW;1VGK;1W0V;1W0W;1W72;1X7Q;1XH3;1XR8;1XR9;1XZ0;1YDP;1YPZ;1ZHK;1ZHL;1ZS8;1ZSD;1ZT4;1ZVS;2A83;2AK4;2AV1;2AV7;2AXF;2AXG;2BCK;2BNQ;2BNR;2BSR;2BSS;2BST;2BVO;2BVP;2BVQ;2C7U;2CII;2CIK;2CLR;2D31;2D4D;2D4F;2DYP;2E8D;2ESV;2F53;2F54;2F74;2F8O;2FYY;2FZ3;2GIT;2GJ6;2GT9;2GTW;2GTZ;2GUO;2H26;2H6P;2HJK;2HJL;2HLA;2HN7;2J8U;2JCC;2NW3;2NX5;2P5E;2P5W;2PO6;2PYE;2RFX;2UWE;2V2W;2V2X;2VB5;2VLJ;2VLK;2VLL;2VLR;2X4N;2X4O;2X4P;2X4Q;2X4R;2X4S;2X4T;2X4U;2X70;2X89;2XKS;2XKU;2XPG;2YPK;2YPL;2YXF;2Z9T;3AM8;3B3I;3B6S;3BGM;3BH8;3BH9;3BHB;3BO8;3BP4;3BP7;3BVN;3BW9;3BWA;3BXN;3BZE;3BZF;3C9N;3CDG;3CII;3CIQ;3CZF;3D18;3D25;3D2U;3D39;3D3V;3DBX;3DHJ;3DHM;3DTX;3DX6;3DX7;3DX8;3DXA;3EKC;3FFC;3FQN;3FQR;3FQT;3FQU;3FQW;3FQX;3FT2;3FT3;3FT4;3GIV;3GJF;3GSN;3GSO;3GSQ;3GSR;3GSU;3GSV;3GSW;3GSX;3H7B;3H9H;3H9S;3HAE;3HCV;3HG1;3HLA;3HPJ;3HUJ;3I6G;3I6K;3I6L;3IB4;3IXA;3JTS;3KLA;3KPL;3KPM;3KPN;3KPO;3KPP;3KPQ;3KPR;3KPS;3KWW;3KXF;3KYN;3KYO;3L3D;3L3G;3L3I;3L3J;3L3K;3LKN;3LKO;3LKP;3LKQ;3LKR;3LKS;3LN4;3LN5;3LOW;3LOZ;3LV3;3M17;3M1B;3MGO;3MGT;3MR9;3MRB;3MRC;3MRD;3MRE;3MRF;3MRG;3MRH;3MRI;3MRJ;3MRK;3MRL;3MRM;3MRN;3MRO;3MRP;3MRQ;3MRR;3MV7;3MV8;3MV9;3MYJ;3MYZ;3MZT;3NA4;3NFN;3O3A;3O3B;3O3D;3O3E;3O4L;3OV6;3OX8;3OXR;3OXS;3PWJ;3PWL;3PWN;3PWP;3QDA;3QDG;3QDJ;3QDM;3QEQ;3QFD;3QFJ;3QZW;3REW;3RL1;3RL2;3RWJ;3S6C;3SDX;3SJV;3SKM;3SKO;3SPV;3T8X;3TID;3TIE;3TLR;3TM6;3TO2;3TZV;3U0P;3UPR;3UTQ;3UTS;3UTT;3V5D;3V5H;3V5K;3VCL;3VFM;3VFN;3VFO;3VFP;3VFR;3VFS;3VFT;3VFU;3VFV;3VFW;3VH8;3VRI;3VRJ;3VWJ;3VWK;3VXM;3VXN;3VXO;3VXP;3VXR;3VXS;3VXU;3W0W;3W39;3WL9;3WLB;3WUW;3X11;3X12;3X13;3X14;4E0K;4E0L;4E5X;4EN3;4EUP;4F7M;4F7P;4F7T;4FTV;4FXL;4G8G;4G8I;4G9D;4G9F;4GKN;4GKS;4GUP;4HKJ;4HWZ;4HX1;4I48;4I4W;4JFD;4JFE;4JFF;4JFO;4JFP;4JFQ;4JQV;4JQX;4JRX;4JRY;4K71;4K7F;4KDT;4L29;4L3C;4L3E;4L4T;4L4V;4LCW;4LCY;4LHU;4LNR;4M8V;4MJ5;4MJ6;4MJI;4MNQ;4N0F;4N0U;4N8V;4NNX;4NNY;4NO0;4NO2;4NO3;4NO5;4NQC;4NQD;4NQE;4NQV;4NQX;4NT6;4O2C;4O2E;4O2F;4ONO;4PJ5;4PJ7;4PJ8;4PJ9;4PJA;4PJB;4PJC;4PJD;4PJE;4PJF;4PJG;4PJH;4PJI;4PJX;4PR5;4PRA;4PRB;4PRD;4PRE;4PRH;4PRI;4PRN;4PRP;4QOK;4QRP;4QRQ;4QRR;4QRS;4QRT;4QRU;4R9H;4RA3;4RAH;4RMQ;4RMR;4RMS;4RMT;4RMU;4RMV;4RMW;4U1H;4U1I;4U1J;4U1K;4U1L;4U1M;4U1N;4U1S;4U6X;4U6Y;4UQ2;4UQ3;4WC8;4WDI;4WJ5;4WO4;4WU5;4WU7;4WUU;4WW2;4WWK;4X0S;4X6C;4X6D;4X6E;4X6F;4XXC;4Z76;4Z77;4Z78;5B38;5B39;5BJT;5BRZ;5BS0;5BXF;5C07;5C08;5C09;5C0A;5C0B;5C0C;5C0D;5C0E;5C0F;5C0G;5C0I;5C0J;5C9J;5CFH;5CKA;5CKG;5CS7;5CSB;5CSG;5D2L;5D2N;5D5M;5D7I;5D7J;5D7L;5D9S;5DDH;5DEF;5DEG;5E00;5E6I;5E9D;5ENW;5EO0;5EO1;5EOT;5EU3;5EU4;5EU5;5EU6;5EUO;5F1I;5F7D;5F9J;5FA3;5FA4;5FDW;5GR7;5GRD;5GRG;5GSB;5GSD;5GSR;5GSV;5GSX;5HGA;5HGB;5HGD;5HGH;5HHM;5HHN;5HHO;5HHP;5HHQ;5HYJ;5IB1;5IB2;5IB3;5IB4;5IB5;5IEH;5IEK;5IM7;5INC;5IND;5IRO;5ISZ;5IUE;5J1A;5JHD;5JZI;5KNM;5L2J;5L2K;5MEN;5MEO;5MEP;5MEQ;5MER;5N1Y;5N6B;5NHT;5NME;5NMF;5NMG;5NMH;5NMK;5NQ1;5NQ3;5NQK;5OPI;5SWQ;5T6W;5T6X;5T6Y;5T6Z;5T70;5TEZ;5TRZ;5TS1;5TXS;5U16;5U17;5U1R;5U2V;5U6Q;5U72;5U98;5V5L;5V5M;5VGD;5VGE;5VUD;5VUE;5VUF;5VVP;5VWD;5VWF;5VWH;5VWJ;5VZ5;5W1V;5W1W;5W67;5W69;5W6A;5WER;5WHK;5WJL;5WJN;5WKE;5WKF;5WKG;5WKH;5WKI;5WL1;5WMN;5WMO;5WMP;5WMQ;5WMR;5WSH;5WWI;5WWJ;5WWU;5WXC;5WXD;5XOS;5XOT;5XOV;5YXN;5YXU;6AEE;6AM5;6AMT;6AMU;6APN;6AT5;6AT9;6AVF;6AVG;6BJ2;6BJ3;6BJ8;6BXP;6BXQ;6C09;6C15;6C97;6C98;6C99;6CUG;6D29;6D2B;6D2R;6D2T;6D64;6D78;6DKP;6EI2;6ENY;6EQA;6EQB;6EWA;6EWC;6EWO;6FGB;6G3J;6G3K;6GGM;6GH1;6GH4;6GHN;6GK3;6GL1;6ID4;6IEX;6ILM;6J1V;6J1W;6J29;6J2A;6J2E;6J2G;6J2H;6J2I;6J2J;6JOZ;6JP3;6JTN;6JTO;6JTP;6K60;6K7T;6LA6;6LA7;6M1B;6M24;6M2J;6M2K;6MPP;6MT3;6MT4;6MT5;6MT6;6MTL;6MTM;6MWR;6NCA;6NHA;6NPR;6NUX;6O4Y;6O4Z;6O51;6O53;6O9B;6O9C;6OPD;6P23;6P27;6P2C;6P2F;6P2S;6P64;6PA1;6PAG;6PBH;6PTB;6PTE;6PUC;6PUD;6PUE;6PUF;6PUG;6PUH;6PUI;6PUJ;6PUK;6PUL;6PUM;6PVC;6PVD;6PYJ;6PYL;6PYV;6PYW;6PZ5;6Q3K;6Q3S;6QIO;6QIP;6R2L;6RP9;6RPA;6RPB;6RSY;6SS7;6SS8;6SS9;6SSA;6TDO;6TDP;6TDQ;6TDR;6TDS;6TMO;6TRN;6TRO;6UJ7;6UJ8;6UJ9;6UJO;6UJQ;6UK2;6UK4;6ULI;6ULK;6ULN;6ULR;6UON;6UZ1;6UZM;6UZN;6UZO;6UZP;6UZQ;6UZS;6V2O;6V2P;6V2Q;6V3J;6V7Y;6V7Z;6V80;6VB0;6VB1;6VB2;6VB3;6VB4;6VB5;6VB6;6VB7;6VIU;6VM7;6VM8;6VM9;6VMA;6VMC;6VMX;6VPZ;6VQ2;6VQD;6VQE;6VQO;6VQY;6VQZ;6VR1;6VR5;6VRM;6VRN;6W51;6W9U;6W9V;6WNA;6WOL;6WZY;6X00;6XQA;6XQP;6Y26;6Y27;6Y28;6Y29;6Y2A;6Y2B;6Z9V;6Z9W;6Z9X;6ZKW;6ZKX;6ZKY;6ZKZ;7AFV;7ALO;7B5F;7BBG;7C9V;7DZM;7DZN;7EDO;7EJL;7EJM;7EJN;7EU2;7F4W;7JWI;7JYU;7JYV;7JYW;7JYX;7K80;7K81;7KGO;7KGP;7KGQ;7KGR;7KGS;7KGT;7KOZ;7KP0;7KP1;7LFZ;7LG0;7LG2;7LG3;7LGD;7LGT;7LLI;7LLJ;7M8S;7M8T;7M8U;7MJ6;7MJ7;7MJ8;7MJ9;7MJA;7MKB;7MX4;7MXF;7MXH;7N1A;7N1B;7N1E;7N1F;7N6D;7N6E;7NDQ;7NDT;7NDU;7NUI;7P3D;7P3E;7RTD;7RTR;,11,A,P,True,1053
14197,1588,22032,single nucleotide variant,NM_004291.4(CARTPT):c.183G>C (p.Leu61Phe),9607,CARTPT,HGNC:24323,Uncertain significance,0,18-Apr-18,121909065,-,RCV000023199,"Human Phenotype Ontology:HP:0001513,MONDO:MONDO:0019182,MeSH:D009765,MedGen:C0028754,OMIM:601665,Orphanet:71529",Obesity,germline;paternal,germline,GRCh38,NC_000005.10,5,71719903,71719903,na,na,5q13.2,"criteria provided, single submitter",2,-,N,"OMIM:602606.0001,ClinGen:CA210807,UniProtKB:Q16568#VAR_012199",3,6993,71719903,G,C,L61F,1,uncertain,uncertain,Q16568,Q16568,reviewed,CART_HUMAN,Cocaine- and amphetamine-regulated transcript protein [Cleaved into: CART(1-39); CART(42-89) ],CARTPT CART,Homo sapiens (Human),116.0,MESSRVRLLPLLGAALLLMLPLLGTRAQEDAELQPRALDIYSAVDDASHEKELIEALQEVLKKLKSKRVPIYEKKYGQVPMCDAGEQCAVRKGARIGKLCDCPRGTSCNSFLLKCL,PF06373;,1HY9;,61,L,F,True,1054
14198,1411,21163,single nucleotide variant,NM_001029.5(RPS26):c.97G>A (p.Asp33Asn),6231,RPS26,HGNC:10414,Pathogenic,1,12-Feb-10,267607023,-,RCV000006498,"MONDO:MONDO:0013217,MedGen:C2750080,OMIM:613309,Orphanet:124",Diamond-Blackfan anemia 10,germline,germline,GRCh38,NC_000012.12,12,56042518,56042518,na,na,12q13.2,no assertion criteria provided,1,-,N,"ClinGen:CA253778,UniProtKB:P62854#VAR_063580,OMIM:603701.0003",1,6124,56042518,G,A,D33N,0,pathogenic,uncertain,P62854,P62854,reviewed,RS26_HUMAN,40S ribosomal protein S26 (Small ribosomal subunit protein eS26),RPS26,Homo sapiens (Human),115.0,MTKKRRNNGRAKKGRGHVQPIRCTNCARCVPKDKAIKKFVIRNIVEAAAVRDISEASVFDAYVLPKLYVKLHYCVSCAIHSKVVRNRSREARKDRTPPPRFRPAGAAPRPPPKPM,PF01283;,4UG0;4V6X;5A2Q;5AJ0;5FLX;5LKS;5OA3;5T2C;5VYC;6G5H;6IP5;6IP6;6IP8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6XA1;6Y0G;6Y2L;6Y57;6YBD;6YBW;6Z6L;6Z6M;6Z6N;6ZLW;6ZM7;6ZME;6ZMI;6ZMO;6ZMW;6ZN5;6ZOJ;6ZOK;6ZON;6ZP4;6ZV6;6ZVH;6ZVJ;6ZXG;6ZXH;7A09;7K5I;,33,D,N,True,1055
14199,3619,28797,single nucleotide variant,NM_000315.4(PTH):c.67T>C (p.Ser23Pro),5741,PTH,HGNC:9606,Pathogenic,1,1-Oct-99,104894272,-,RCV000014766,"MONDO:MONDO:0007796,MedGen:C5241444,OMIM:146200","Hypoparathyroidism, familial isolated 1",germline,germline,GRCh38,NC_000011.10,11,13492789,13492789,na,na,11p15.3,no assertion criteria provided,1,-,N,"ClinGen:CA123437,UniProtKB:P01270#VAR_018464,OMIM:168450.0003",1,13758,13492789,A,G,S23P,0,pathogenic,uncertain,P01270,P01270,reviewed,PTHY_HUMAN,"Parathyroid hormone, PTH (Parathormone) (Parathyrin)",PTH,Homo sapiens (Human),115.0,MIPAKDMAKVMIVMLAICFLTKSDGKSVKKRSVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGAPLAPRDAGSQRPRKKEDNVLVESHEKSLGEADKADVNVLTKAKSQ,PF01279;,1BWX;1ET1;1FVY;1HPH;1HPY;1HTH;1ZWA;1ZWB;1ZWD;1ZWE;1ZWF;1ZWG;2L1X;3C4M;,23,S,P,True,1056
14200,3618,28795,single nucleotide variant,NM_000315.4(PTH):c.52T>C (p.Cys18Arg),5741,PTH,HGNC:9606,Pathogenic,1,11-Dec-07,104894271,-,RCV000014764,"MONDO:MONDO:0007796,MedGen:C5241444,OMIM:146200","Hypoparathyroidism, familial isolated 1",germline,germline,GRCh38,NC_000011.10,11,13492804,13492804,na,na,11p15.3,no assertion criteria provided,1,-,N,"ClinGen:CA123436,UniProtKB:P01270#VAR_006047,OMIM:168450.0001",1,13756,13492804,A,G,C18R,0,pathogenic,uncertain,P01270,P01270,reviewed,PTHY_HUMAN,"Parathyroid hormone, PTH (Parathormone) (Parathyrin)",PTH,Homo sapiens (Human),115.0,MIPAKDMAKVMIVMLAICFLTKSDGKSVKKRSVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGAPLAPRDAGSQRPRKKEDNVLVESHEKSLGEADKADVNVLTKAKSQ,PF01279;,1BWX;1ET1;1FVY;1HPH;1HPY;1HTH;1ZWA;1ZWB;1ZWD;1ZWE;1ZWF;1ZWG;2L1X;3C4M;,18,C,R,True,1056
14201,3307,28040,single nucleotide variant,NM_000996.4(RPL35A):c.97G>A (p.Val33Ile),6165,RPL35A,HGNC:10345,Pathogenic,1,25-Jun-09,116840808,-,RCV000013875,"MONDO:MONDO:0012925,MedGen:C2675859,OMIM:612528,Orphanet:124",Diamond-Blackfan anemia 5,germline,germline,GRCh38,NC_000003.12,3,197951244,197951244,na,na,3q29,no assertion criteria provided,2,-,N,"ClinGen:CA341247,UniProtKB:P18077#VAR_055447,OMIM:180468.0001",1,13001,197951244,G,A,V33I,0,pathogenic,uncertain,P18077,P18077,reviewed,RL35A_HUMAN,60S ribosomal protein L35a (Cell growth-inhibiting gene 33 protein) (Large ribosomal subunit protein eL33),RPL35A GIG33,Homo sapiens (Human),110.0,MSGRLWSKAIFAGYKRGLRNQREHTALLKIEGVYARDETEFYLGKRCAYVYKAKNNTVTPGGKPNKTRVIWGKVTRAHGNSGMVRAKFRSNLPAKAIGHRIRVMLYPSRI,PF01247;,4UG0;4V6X;5AJ0;5LKS;5T2C;6IP5;6IP6;6IP8;6LQM;6LSR;6LSS;6LU8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6W6L;6XA1;6Y0G;6Y2L;6Y57;6Y6X;6Z6L;6Z6M;6Z6N;6ZM7;6ZME;6ZMI;6ZMO;7BHP;,33,V,I,True,1057
14202,4784,31956,single nucleotide variant,NM_018947.5(CYCS):c.124G>A (p.Gly42Ser),54205,CYCS,HGNC:19986,Likely pathogenic,1,1-Feb-19,121918552,-,RCV000018419|RCV000851585,"MONDO:MONDO:0012775,MedGen:C2677608,OMIM:612004,Orphanet:268322|Human Phenotype Ontology:HP:0001873,Human Phenotype Ontology:HP:0001906,Human Phenotype Ontology:HP:0004838,Human Phenotype Ontology:HP:0008175,Human Phenotype Ontology:HP:0008268,Human Phenotype Ontology:HP:0008302,MONDO:MONDO:0002049,MedGen:C0040034",Thrombocytopenia 4|Thrombocytopenia,germline;unknown,germline,GRCh38,NC_000007.14,7,25123996,25123996,na,na,7p15.3,"criteria provided, single submitter",2,-,N,"OMIM:123970.0001,ClinGen:CA126966,UniProtKB:P99999#VAR_044450",3,16917,25123996,C,T,G42S,1,pathogenic,pathogenic,P99999,P99999,reviewed,CYC_HUMAN,Cytochrome c,CYCS CYC,Homo sapiens (Human),105.0,MGDVEKGKKIFIMKCSQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGYSYTAANKNKGIIWGEDTLMEYLENPKKYIPGTKMIFVGIKKKEERADLIAYLKKATNE,PF00034;,1J3S;2N3Y;2N9I;2N9J;3NWV;3ZCF;3ZOO;5EXQ;5O10;5TY3;6DUJ;6ECJ;6XNK;,42,G,S,True,1058
14203,1278,20581,single nucleotide variant,NM_005472.4(KCNE3):c.296G>A (p.Arg99His),10008,KCNE3,HGNC:6243,Conflicting interpretations of pathogenicity,1,20-Nov-17,121908441,-,RCV000005880|RCV000170965|RCV000171754|RCV000618438,"MONDO:MONDO:0013145,MedGen:C2751089,OMIM:613119,Orphanet:130|MedGen:CN517202|MONDO:MONDO:0015263,MedGen:C1142166,OMIM:PS601144,Orphanet:130|MedGen:CN230736",Brugada syndrome 6|not provided|Brugada syndrome|Cardiovascular phenotype,germline;unknown,germline,GRCh38,NC_000011.10,11,74457268,74457268,na,na,11q13.4,"criteria provided, conflicting interpretations",5,-,N,"ClinGen:CA253524,UniProtKB:Q9Y6H6#VAR_058637,OMIM:604433.0002",3,5542,74457268,C,T,R99H,1,uncertain,uncertain,Q9Y6H6,Q9Y6H6,reviewed,KCNE3_HUMAN,Potassium voltage-gated channel subfamily E member 3 (MinK-related peptide 2) (Minimum potassium ion channel-related peptide 2) (Potassium channel subunit beta MiRP2),KCNE3,Homo sapiens (Human),103.0,METTNGTETWYESLHAVLKALNATLHSNLLCRPGPGLGPDNQTEERRASLPGRDDNSYMYILFVMFLFAVTVGSLILGYTRSRKVDKRSDPYHVYIKNRVSMI,PF02060;,2NDJ;6V00;6V01;,99,R,H,True,1059
14204,10004,131959,single nucleotide variant,NM_005472.5(KCNE3):c.10A>G (p.Thr4Ala),-1,KCNE3;LIPT2,-,Conflicting interpretations of pathogenicity,1,13-Oct-20,200856070,-,RCV000114366|RCV000455941|RCV000490275|RCV000621765|RCV000988596,"MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0013145,MedGen:C2751089,OMIM:613119,Orphanet:130|MedGen:CN230736|MONDO:MONDO:0060562,MedGen:C4540052,OMIM:617668","not provided|not specified|Brugada syndrome 6|Cardiovascular phenotype|Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities",germline;unknown,germline,GRCh38,NC_000011.10,11,74457554,74457554,na,na,11q13.4,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA230668,UniProtKB:Q9Y6H6#VAR_058635,OMIM:604433.0003",3,126426,74457554,T,C,T4A,1,uncertain,uncertain,Q9Y6H6,Q9Y6H6,reviewed,KCNE3_HUMAN,Potassium voltage-gated channel subfamily E member 3 (MinK-related peptide 2) (Minimum potassium ion channel-related peptide 2) (Potassium channel subunit beta MiRP2),KCNE3,Homo sapiens (Human),103.0,METTNGTETWYESLHAVLKALNATLHSNLLCRPGPGLGPDNQTEERRASLPGRDDNSYMYILFVMFLFAVTVGSLILGYTRSRKVDKRSDPYHVYIKNRVSMI,PF02060;,2NDJ;6V00;6V01;,4,T,A,True,1059
14205,1277,20580,single nucleotide variant,NM_005472.5(KCNE3):c.248G>A (p.Arg83His),-1,KCNE3;LIPT2,-,Conflicting interpretations of pathogenicity,0,31-Dec-19,17215437,-,RCV000005879|RCV000171813|RCV000223897|RCV000253742|RCV000415218|RCV000538199|RCV000852657|RCV000988595,"MedGen:CN517202|Human Phenotype Ontology:HP:0003768,MONDO:MONDO:0016122,MedGen:C1279412,Orphanet:206976|MedGen:CN169374|MedGen:CN230736|EFO:EFO_0004287,Human Phenotype Ontology:HP:0001663,Human Phenotype Ontology:HP:0005166,MONDO:MONDO:0000190,MedGen:C0042510;Human Phenotype Ontology:HP:0001279,MedGen:C0039070|MONDO:MONDO:0013145,MedGen:C2751089,OMIM:613119,Orphanet:130|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0060562,MedGen:C4540052,OMIM:617668","not provided|Periodic paralysis|not specified|Cardiovascular phenotype|Ventricular fibrillation;Syncope|Brugada syndrome 6|Cardiomyopathy|Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities",germline;unknown,germline,GRCh38,NC_000011.10,11,74457316,74457316,na,na,11q13.4,"criteria provided, conflicting interpretations",13,-,N,"ClinGen:CA199956,UniProtKB:Q9Y6H6#VAR_015064,OMIM:604433.0001",3,5541,74457316,C,T,R83H,1,uncertain,uncertain,Q9Y6H6,Q9Y6H6,reviewed,KCNE3_HUMAN,Potassium voltage-gated channel subfamily E member 3 (MinK-related peptide 2) (Minimum potassium ion channel-related peptide 2) (Potassium channel subunit beta MiRP2),KCNE3,Homo sapiens (Human),103.0,METTNGTETWYESLHAVLKALNATLHSNLLCRPGPGLGPDNQTEERRASLPGRDDNSYMYILFVMFLFAVTVGSLILGYTRSRKVDKRSDPYHVYIKNRVSMI,PF02060;,2NDJ;6V00;6V01;,83,R,H,True,1059
14206,1105,19646,single nucleotide variant,NM_020427.3(SLURP1):c.296G>A (p.Cys99Tyr),57152,SLURP1,HGNC:18746,Pathogenic,1,1-Mar-04,121908320,-,RCV000004870,"MONDO:MONDO:0009552,MedGen:C0025221,OMIM:248300,Orphanet:87503",Acroerythrokeratoderma,germline,germline,GRCh38,NC_000008.11,8,142741159,142741159,na,na,8q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA116956,UniProtKB:P55000#VAR_032875,OMIM:606119.0009",1,4607,142741159,C,T,C99Y,0,pathogenic,uncertain,P55000,P55000,reviewed,SLUR1_HUMAN,"Secreted Ly-6/uPAR-related protein 1, SLURP-1 (ARS component B) (ARS(component B)-81/S) (Anti-neoplastic urinary protein, ANUP)",SLURP1 ARS,Homo sapiens (Human),103.0,MASRWAVQLLLVAAWSMGCGEALKCYTCKEPMTSASCRTITRCKPEDTACMTTLVTVEAEYPFNQSPVVTRSCSSSCVATDPDSIGAAHLIFCCFRDLCNSEL,PF00021;,6ZZE;6ZZF;,99,C,Y,True,1060
14207,1102,19642,single nucleotide variant,NM_020427.3(SLURP1):c.256G>C (p.Gly86Arg),57152,SLURP1,HGNC:18746,Pathogenic,1,1-Jan-03,28937888,-,RCV000004866,"MONDO:MONDO:0009552,MedGen:C0025221,OMIM:248300,Orphanet:87503",Acroerythrokeratoderma,germline,germline,GRCh38,NC_000008.11,8,142741199,142741199,na,na,8q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA116951,UniProtKB:P55000#VAR_032874,OMIM:606119.0005",1,4603,142741199,C,G,G86R,0,pathogenic,uncertain,P55000,P55000,reviewed,SLUR1_HUMAN,"Secreted Ly-6/uPAR-related protein 1, SLURP-1 (ARS component B) (ARS(component B)-81/S) (Anti-neoplastic urinary protein, ANUP)",SLURP1 ARS,Homo sapiens (Human),103.0,MASRWAVQLLLVAAWSMGCGEALKCYTCKEPMTSASCRTITRCKPEDTACMTTLVTVEAEYPFNQSPVVTRSCSSSCVATDPDSIGAAHLIFCCFRDLCNSEL,PF00021;,6ZZE;6ZZF;,86,G,R,True,1060
14208,1104,19645,single nucleotide variant,NM_020427.3(SLURP1):c.229T>C (p.Cys77Arg),57152,SLURP1,HGNC:18746,Pathogenic,1,1-Mar-04,121908319,-,RCV000004869,"MONDO:MONDO:0009552,MedGen:C0025221,OMIM:248300,Orphanet:87503",Acroerythrokeratoderma,germline,germline,GRCh38,NC_000008.11,8,142741226,142741226,na,na,8q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA116955,UniProtKB:P55000#VAR_032873,OMIM:606119.0008",1,4606,142741226,A,G,C77R,0,pathogenic,uncertain,P55000,P55000,reviewed,SLUR1_HUMAN,"Secreted Ly-6/uPAR-related protein 1, SLURP-1 (ARS component B) (ARS(component B)-81/S) (Anti-neoplastic urinary protein, ANUP)",SLURP1 ARS,Homo sapiens (Human),103.0,MASRWAVQLLLVAAWSMGCGEALKCYTCKEPMTSASCRTITRCKPEDTACMTTLVTVEAEYPFNQSPVVTRSCSSSCVATDPDSIGAAHLIFCCFRDLCNSEL,PF00021;,6ZZE;6ZZF;,77,C,R,True,1060
14209,1101,19641,single nucleotide variant,NM_020427.3(SLURP1):c.256G>A (p.Gly86Arg),57152,SLURP1,HGNC:18746,Pathogenic,1,1-Jan-03,28937888,-,RCV000004865,"MONDO:MONDO:0009552,MedGen:C0025221,OMIM:248300,Orphanet:87503",Acroerythrokeratoderma,germline,germline,GRCh38,NC_000008.11,8,142741199,142741199,na,na,8q24.3,no assertion criteria provided,1,-,N,"ClinGen:CA116950,UniProtKB:P55000#VAR_032874,OMIM:606119.0004",1,4602,142741199,C,T,G86R,0,pathogenic,uncertain,P55000,P55000,reviewed,SLUR1_HUMAN,"Secreted Ly-6/uPAR-related protein 1, SLURP-1 (ARS component B) (ARS(component B)-81/S) (Anti-neoplastic urinary protein, ANUP)",SLURP1 ARS,Homo sapiens (Human),103.0,MASRWAVQLLLVAAWSMGCGEALKCYTCKEPMTSASCRTITRCKPEDTACMTTLVTVEAEYPFNQSPVVTRSCSSSCVATDPDSIGAAHLIFCCFRDLCNSEL,PF00021;,6ZZE;6ZZF;,86,G,R,True,1060
14210,1103,19644,single nucleotide variant,NM_020427.3(SLURP1):c.43T>C (p.Trp15Arg),57152,SLURP1,HGNC:18746,Pathogenic,1,29-Aug-18,121908318,-,RCV000004868,"MONDO:MONDO:0009552,MedGen:C0025221,OMIM:248300,Orphanet:87503",Acroerythrokeratoderma,germline,germline,GRCh38,NC_000008.11,8,142742343,142742343,na,na,8q24.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA116954,UniProtKB:P55000#VAR_032871,OMIM:606119.0007",3,4605,142742343,A,G,W15R,1,pathogenic,pathogenic,P55000,P55000,reviewed,SLUR1_HUMAN,"Secreted Ly-6/uPAR-related protein 1, SLURP-1 (ARS component B) (ARS(component B)-81/S) (Anti-neoplastic urinary protein, ANUP)",SLURP1 ARS,Homo sapiens (Human),103.0,MASRWAVQLLLVAAWSMGCGEALKCYTCKEPMTSASCRTITRCKPEDTACMTTLVTVEAEYPFNQSPVVTRSCSSSCVATDPDSIGAAHLIFCCFRDLCNSEL,PF00021;,6ZZE;6ZZF;,15,W,R,True,1060
14211,659,17620,single nucleotide variant,NM_000483.5(APOC2):c.122A>C (p.Lys41Thr),344,APOC2,HGNC:609,Benign,1,27-Apr-17,120074114,-,RCV000002697|RCV001135899,"|MONDO:MONDO:0008810,MedGen:C1720779,OMIM:207750,Orphanet:309020,Orphanet:444490",Apolipoprotein c-ii variant|Apolipoprotein C2 deficiency,germline,germline,GRCh38,NC_000019.10,19,44948767,44948767,na,na,19q13.32,"criteria provided, single submitter",2,-,N,"ClinGen:CA115621,UniProtKB:P02655#VAR_000639,OMIM:608083.0009",3,2581,44948767,A,C,K41T,1,benign,benign,P02655,P02655,reviewed,APOC2_HUMAN,"Apolipoprotein C-II, Apo-CII, ApoC-II (Apolipoprotein C2) [Cleaved into: Proapolipoprotein C-II, ProapoC-II ]",APOC2 APC2,Homo sapiens (Human),101.0,MGTRLLPALFLVLLVLGFEVQGTQQPQQDEMPSPTFLTQVKESLSSYWESAKTAAQNLYEKTYLPAVDEKLRDLYSKSTAAMSTYTGIFTDQVLSVLKGEE,PF05355;,1BY6;1I5J;1O8T;1SOH;,41,K,T,True,1061
14212,658,17612,single nucleotide variant,NM_000483.5(APOC2):c.229A>C (p.Lys77Gln),344,APOC2,HGNC:609,Benign,1,31-Dec-19,5126,-,RCV000002682|RCV000974450|RCV000991188,"|MedGen:CN517202|MONDO:MONDO:0008810,MedGen:C1720779,OMIM:207750,Orphanet:309020,Orphanet:444490",APOLIPOPROTEIN C-II (AFRICAN)|not provided|Apolipoprotein C2 deficiency,germline,germline,GRCh38,NC_000019.10,19,44949172,44949172,na,na,19q13.32,"criteria provided, multiple submitters, no conflicts",4,-,N,"ClinGen:CA115614,UniProtKB:P02655#VAR_000642,OMIM:608083.0001",3,2573,44949172,A,C,K77Q,2,benign,benign,P02655,P02655,reviewed,APOC2_HUMAN,"Apolipoprotein C-II, Apo-CII, ApoC-II (Apolipoprotein C2) [Cleaved into: Proapolipoprotein C-II, ProapoC-II ]",APOC2 APC2,Homo sapiens (Human),101.0,MGTRLLPALFLVLLVLGFEVQGTQQPQQDEMPSPTFLTQVKESLSSYWESAKTAAQNLYEKTYLPAVDEKLRDLYSKSTAAMSTYTGIFTDQVLSVLKGEE,PF05355;,1BY6;1I5J;1O8T;1SOH;,77,K,Q,True,1061
14213,660,17621,single nucleotide variant,NM_000483.5(APOC2):c.178G>A (p.Glu60Lys),344,APOC2,HGNC:609,Conflicting interpretations of pathogenicity,1,6-Jan-20,5122,-,RCV000002698|RCV000991187,"|MONDO:MONDO:0008810,MedGen:C1720779,OMIM:207750,Orphanet:309020,Orphanet:444490",APOLIPOPROTEIN C-II (SAN FRANCISCO)|Apolipoprotein C2 deficiency,germline,germline,GRCh38,NC_000019.10,19,44948823,44948823,na,na,19q13.32,no assertion criteria provided,2,-,N,"OMIM:608083.0010,ClinGen:CA115623,UniProtKB:P02655#VAR_000641",3,2582,44948823,G,A,E60K,0,uncertain,uncertain,P02655,P02655,reviewed,APOC2_HUMAN,"Apolipoprotein C-II, Apo-CII, ApoC-II (Apolipoprotein C2) [Cleaved into: Proapolipoprotein C-II, ProapoC-II ]",APOC2 APC2,Homo sapiens (Human),101.0,MGTRLLPALFLVLLVLGFEVQGTQQPQQDEMPSPTFLTQVKESLSSYWESAKTAAQNLYEKTYLPAVDEKLRDLYSKSTAAMSTYTGIFTDQVLSVLKGEE,PF05355;,1BY6;1I5J;1O8T;1SOH;,60,E,K,True,1061
14214,661,17622,single nucleotide variant,NM_000483.5(APOC2):c.142T>C (p.Trp48Arg),344,APOC2,HGNC:609,Pathogenic,1,30-Jun-93,120074115,-,RCV000002699|RCV000002700,"|MONDO:MONDO:0008810,MedGen:C1720779,OMIM:207750,Orphanet:309020,Orphanet:444490",APOLIPOPROTEIN C-II (WAKAYAMA)|Apolipoprotein C2 deficiency,germline,germline,GRCh38,NC_000019.10,19,44948787,44948787,na,na,19q13.32,no assertion criteria provided,1,-,N,"ClinGen:CA115625,UniProtKB:P02655#VAR_000640,OMIM:608083.0011",1,2583,44948787,T,C,W48R,0,pathogenic,uncertain,P02655,P02655,reviewed,APOC2_HUMAN,"Apolipoprotein C-II, Apo-CII, ApoC-II (Apolipoprotein C2) [Cleaved into: Proapolipoprotein C-II, ProapoC-II ]",APOC2 APC2,Homo sapiens (Human),101.0,MGTRLLPALFLVLLVLGFEVQGTQQPQQDEMPSPTFLTQVKESLSSYWESAKTAAQNLYEKTYLPAVDEKLRDLYSKSTAAMSTYTGIFTDQVLSVLKGEE,PF05355;,1BY6;1I5J;1O8T;1SOH;,48,W,R,True,1061
14215,5103,32942,single nucleotide variant,NM_000040.3(APOC3):c.232A>G (p.Lys78Glu),345,APOC3,HGNC:610,Pathogenic,1,1-May-91,121918382,-,RCV000019492,"MONDO:MONDO:0013534,MedGen:C3151467,OMIM:614028",Hyperalphalipoproteinemia 2,germline,germline,GRCh38,NC_000011.10,11,116832816,116832816,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA127530,UniProtKB:P02656#VAR_000643,OMIM:107720.0002",1,17903,116832816,A,G,K78E,0,pathogenic,uncertain,P02656,P02656,reviewed,APOC3_HUMAN,"Apolipoprotein C-III, Apo-CIII, ApoC-III (Apolipoprotein C3)",APOC3,Homo sapiens (Human),99.0,MQPRVLLVVALLALLASARASEAEDASLLSFMQGYMKHATKTAKDALSSVQESQVAQQARGWVTDGFSSLKDYWSTVKDKFSEFWDLDPEVRPTSAVAA,PF05778;,2JQ3;,78,K,E,True,1062
14216,5102,32941,single nucleotide variant,NM_000040.3(APOC3):c.280A>G (p.Thr94Ala),345,APOC3,HGNC:610,Pathogenic,1,1-Dec-87,121918381,-,RCV000019491,-,"Apolipoprotein c-iii, nonglycosylated",germline,germline,GRCh38,NC_000011.10,11,116832864,116832864,na,na,11q23.3,no assertion criteria provided,1,-,N,"ClinGen:CA127528,UniProtKB:P02656#VAR_000644,OMIM:107720.0001",1,17902,116832864,A,G,T94A,0,pathogenic,uncertain,P02656,P02656,reviewed,APOC3_HUMAN,"Apolipoprotein C-III, Apo-CIII, ApoC-III (Apolipoprotein C3)",APOC3,Homo sapiens (Human),99.0,MQPRVLLVVALLALLASARASEAEDASLLSFMQGYMKHATKTAKDALSSVQESQVAQQARGWVTDGFSSLKDYWSTVKDKFSEFWDLDPEVRPTSAVAA,PF05778;,2JQ3;,94,T,A,True,1062
14217,1959,23436,single nucleotide variant,NM_000100.3(CSTB):c.10G>C (p.Gly4Arg),1476,CSTB,HGNC:2482,Pathogenic,1,25-Nov-14,74315443,-,RCV000008905,"MONDO:MONDO:0009698,MedGen:C0751785,OMIM:254800,Orphanet:308",Unverricht-Lundborg syndrome,germline,germline,GRCh38,NC_000021.9,21,43776260,43776260,na,na,21q22.3,no assertion criteria provided,2,-,N,"ClinGen:CA340776,UniProtKB:P04080#VAR_002206,OMIM:601145.0004",1,8397,43776260,C,G,G4R,0,pathogenic,uncertain,P04080,P04080,reviewed,CYTB_HUMAN,Cystatin-B (CPI-B) (Liver thiol proteinase inhibitor) (Stefin-B),CSTB CST6 STFB,Homo sapiens (Human),98.0,MMCGAPSATQPATAETQHIADQVRSQLEEKENKKFPVFKAVSFKSQVVAGTNYFIKVHVGDEDFVHLRVFQSLPHENKPLTLSNYQTNKAKHDELTYF,PF00031;,1STF;2OCT;4N6V;,4,G,R,True,1063
14218,3722,29063,single nucleotide variant,NM_000905.4(NPY):c.20T>C (p.Leu7Pro),4852,NPY,HGNC:7955,Benign,0,1-Jul-03,16139,-,RCV000015068,-,NEUROPEPTIDE Y POLYMORPHISM,germline,germline,GRCh38,NC_000007.14,7,24285260,24285260,na,na,7p15.3,no assertion criteria provided,1,-,N,"ClinGen:CA123720,UniProtKB:P01303#VAR_014598,OMIM:162640.0001",1,14024,24285260,T,C,L7P,0,benign,uncertain,P01303,P01303,reviewed,NPY_HUMAN,"Pro-neuropeptide Y [Cleaved into: Neuropeptide Y (Neuropeptide tyrosine, NPY); C-flanking peptide of NPY, CPON ]",NPY,Homo sapiens (Human),97.0,MLGNKRLGLSGLTLALSLLVCLGALAEAYPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRYGKRSSPETLISDLLMRESTENVPRTRLEDPAMW,PF00159;,1QFA;1RON;,7,L,P,True,1064
14219,6446,48105,single nucleotide variant,NM_003094.4(SNRPE):c.133G>A (p.Gly45Ser),6635,SNRPE,HGNC:11161,Pathogenic,1,10-Jan-13,587776925,-,RCV000032702,"MONDO:MONDO:0014027,MedGen:C3554409,OMIM:615059,Orphanet:55654",Hypotrichosis 11,germline,germline,GRCh38,NC_000001.11,1,203863714,203863714,na,na,1q32.1,no assertion criteria provided,1,-,N,"ClinGen:CA130347,UniProtKB:P62304#VAR_069619,OMIM:128260.0002",1,39506,203863714,G,A,G45S,0,pathogenic,uncertain,P62304,P62304,reviewed,RUXE_HUMAN,"Small nuclear ribonucleoprotein E, snRNP-E (Sm protein E, Sm-E, SmE)",SNRPE,Homo sapiens (Human),92.0,MAYRGQGQKVQKVMVQPINLIFRYLQNRSRIQVWLYEQVNMRIEGCIIGFDEYMNLVLDDAEEIHSKTKSRKQLGRIMLKGDNITLLQSVSN,PF01423;,3CW1;3JCR;3PGW;4F7U;4PJO;4V98;4WZJ;5MQF;5O9Z;5XJC;5XJL;5XJQ;5XJR;5XJS;5XJT;5XJU;5YZG;5Z56;5Z57;5Z58;6AH0;6FF7;6ICZ;6ID0;6ID1;6QDV;6QW6;6QX9;6V4X;6Y53;6Y5Q;7A5P;7ABG;7ABI;7B0Y;7DVQ;,45,G,S,True,1065
14220,9822,108192,single nucleotide variant,NM_020408.5(LYRM4):c.203G>T (p.Arg68Leu),57128,LYRM4,HGNC:21365,Pathogenic,1,15-Nov-13,587777218,-,RCV000088687,"MONDO:MONDO:0014269,MedGen:C3810055,OMIM:615595,Orphanet:397593",Combined oxidative phosphorylation deficiency 19,germline,germline,GRCh38,NC_000006.12,6,5216622,5216622,na,na,6p25.1,no assertion criteria provided,1,-,N,"ClinGen:CA150762,UniProtKB:Q9HD34#VAR_070943,OMIM:613311.0001",1,102450,5216622,C,A,R68L,0,pathogenic,uncertain,Q9HD34,Q9HD34,reviewed,LYRM4_HUMAN,LYR motif-containing protein 4,LYRM4 C6orf149 ISD11 CGI-203,Homo sapiens (Human),91.0,MAASSRAQVLSLYRAMLRESKRFSAYNYRTYAVRRIRDAFRENKNVKDPVEIQTLVNKAKRDLGVIRRQVHIGQLYSTDKLIIENRDMPRT,PF05347;,5USR;5WGB;5WKP;5WLW;6NZU;6ODD;6UXE;6W1D;6WI2;6WIH;7RTK;,68,R,L,True,1066
14221,5964,39347,single nucleotide variant,NM_003860.4(BANF1):c.34G>A (p.Ala12Thr),8815,BANF1,HGNC:17397,Pathogenic,1,13-May-11,387906871,-,RCV000023343,"MONDO:MONDO:0013523,MedGen:C3151446,OMIM:614008,Orphanet:280576",Nestor-Guillermo progeria syndrome,germline,germline,GRCh38,NC_000011.10,11,66003284,66003284,na,na,11q13.1,no assertion criteria provided,1,-,N,"ClinGen:CA129181,UniProtKB:O75531#VAR_065954,OMIM:603811.0001",1,30390,66003284,G,A,A12T,0,pathogenic,uncertain,O75531,O75531,reviewed,BAF_HUMAN,"Barrier-to-autointegration factor (Breakpoint cluster region protein 1) [Cleaved into: Barrier-to-autointegration factor, N-terminally processed ]",BANF1 BAF BCRG1,Homo sapiens (Human),89.0,MTTSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTCGANAKQSRDCFGCLREWCDAFL,PF02961;,1CI4;1QCK;2BZF;2EZX;2EZY;2EZZ;2ODG;6GHD;6RPR;6UNT;6URE;6URJ;6URK;6URL;6URN;6URR;6URZ;6US0;6US1;6US7;6USB;6USD;6USI;7ABM;7NDY;,12,A,T,True,1067
14222,4777,31914,single nucleotide variant,NM_001863.5(COX6B1):c.59G>A (p.Arg20His),1340,COX6B1,HGNC:2280,Pathogenic,1,1-Jun-08,121909602,-,RCV000018371,"MONDO:MONDO:0009068,MedGen:C0268237,OMIM:220110,Orphanet:254905",Mitochondrial complex IV deficiency,germline,germline,GRCh38,NC_000019.10,19,35651302,35651302,na,na,19q13.12,no assertion criteria provided,1,-,N,"ClinGen:CA211258,UniProtKB:P14854#VAR_046775,OMIM:124089.0001",1,16875,35651302,G,A,R20H,0,pathogenic,uncertain,P14854,P14854,reviewed,CX6B1_HUMAN,"Cytochrome c oxidase subunit 6B1 (Cytochrome c oxidase subunit VIb isoform 1, COX VIb-1)",COX6B1 COX6B,Homo sapiens (Human),86.0,MAEDMETKIKNYKTAPFDSRFPNQNQTRNCWQNYLDFHRCQKAMTAKGGDISVCEWYQRVYQSLCPTSWVTDWDEQRAEGTFPGKI,PF02297;,5Z62;,20,R,H,True,1068
14223,12869,243332,single nucleotide variant,NM_021175.4(HAMP):c.175C>G (p.Arg59Gly),57817,HAMP,HGNC:15598,Uncertain significance,0,19-Mar-19,779021719,-,RCV000226229,"MONDO:MONDO:0006507,MedGen:C0392514,OMIM:PS235200",Hereditary hemochromatosis,germline,germline,GRCh38,NC_000019.10,19,35284962,35284962,na,na,19q13.12,"criteria provided, single submitter",1,-,N,"ClinGen:CA9375824,UniProtKB:P81172#VAR_042512",2,241375,35284962,C,G,R59G,1,uncertain,uncertain,P81172,P81172,reviewed,HEPC_HUMAN,"Hepcidin (Liver-expressed antimicrobial peptide 1, LEAP-1) (Putative liver tumor regressor, PLTR) [Cleaved into: Hepcidin-25, Hepc25; Hepcidin-20, Hepc20 ]",HAMP HEPC LEAP1 UNQ487/PRO1003,Homo sapiens (Human),84.0,MALSSQIWAACLLLLLLLASLTSGSVFPQQTGQLAELQPQDRAGARASWMPMFQRRRRRDTHFPICIFCCGCCHRSKCGMCCKT,PF06446;,1M4E;1M4F;2KEF;3H0T;4QAE;6WBV;,59,R,G,True,1069
14224,1033,19325,single nucleotide variant,NM_021175.4(HAMP):c.212G>A (p.Gly71Asp),57817,HAMP,HGNC:15598,Conflicting interpretations of pathogenicity,0,31-Dec-19,104894696,-,RCV000004507|RCV000205666|RCV000599701|RCV000990194|RCV001086432|RCV001127434,"|MedGen:CN517202|MedGen:CN169374|MONDO:MONDO:0021001,MedGen:C3469186,OMIM:235200,Orphanet:465508|MONDO:MONDO:0006507,MedGen:C0392514,OMIM:PS235200|MONDO:MONDO:0013220,MedGen:C1865616,OMIM:613313,Orphanet:79230","Hemochromatosis, type 2a, modifier of|not provided|not specified|Hemochromatosis type 1|Hereditary hemochromatosis|Hemochromatosis type 2B",germline;unknown,germline,GRCh38,NC_000019.10,19,35284999,35284999,na,na,19q13.12,"criteria provided, conflicting interpretations",6,-,N,"ClinGen:CA340226,UniProtKB:P81172#VAR_026648,OMIM:606464.0004",3,4286,35284999,G,A,G71D,1,uncertain,uncertain,P81172,P81172,reviewed,HEPC_HUMAN,"Hepcidin (Liver-expressed antimicrobial peptide 1, LEAP-1) (Putative liver tumor regressor, PLTR) [Cleaved into: Hepcidin-25, Hepc25; Hepcidin-20, Hepc20 ]",HAMP HEPC LEAP1 UNQ487/PRO1003,Homo sapiens (Human),84.0,MALSSQIWAACLLLLLLLASLTSGSVFPQQTGQLAELQPQDRAGARASWMPMFQRRRRRDTHFPICIFCCGCCHRSKCGMCCKT,PF06446;,1M4E;1M4F;2KEF;3H0T;4QAE;6WBV;,71,G,D,True,1069
14225,219,15768,single nucleotide variant,NM_014402.5(UQCRQ):c.134C>T (p.Ser45Phe),27089,UQCRQ,HGNC:29594,Pathogenic,1,16-Jun-15,11544803,-,RCV000000765|RCV000437264,"MONDO:MONDO:0014065,MedGen:C3554607,OMIM:615159|MedGen:CN517202","Mitochondrial complex III deficiency, nuclear type 4|not provided",germline,germline,GRCh38,NC_000005.10,5,132867015,132867015,na,na,5q31.1,"criteria provided, single submitter",2,-,N,"ClinGen:CA114461,UniProtKB:O14949#VAR_045911,OMIM:612080.0001",3,729,132867015,C,T,S45F,1,pathogenic,pathogenic,O14949,O14949,reviewed,QCR8_HUMAN,Cytochrome b-c1 complex subunit 8 (Complex III subunit 8) (Complex III subunit VIII) (Ubiquinol-cytochrome c reductase complex 9.5 kDa protein) (Ubiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C),UQCRQ,Homo sapiens (Human),82.0,MGREFGNLTRMRHVISYSLSPFEQRAYPHVFTKGIPNVLRRIRESFFRVVPQFVVFYLIYTWGTEEFERSKRKNPAAYENDK,PF02939;,5XTE;5XTH;5XTI;,45,S,F,True,1070
14226,539,17143,single nucleotide variant,NM_207118.2(GTF2H5):c.62T>C (p.Leu21Pro),404672,GTF2H5,HGNC:21157,Pathogenic,1,1-Jul-04,121434365,-,RCV000002185,"MONDO:MONDO:0014619,MedGen:C4017171,OMIM:616395,Orphanet:33364","Trichothiodystrophy 3, photosensitive",germline,germline,GRCh38,NC_000006.12,6,158192003,158192003,na,na,6q25.3,no assertion criteria provided,1,-,N,"ClinGen:CA115342,UniProtKB:Q6ZYL4#VAR_022647,OMIM:608780.0002",1,2104,158192003,T,C,L21P,0,pathogenic,uncertain,Q6ZYL4,Q6ZYL4,reviewed,TF2H5_HUMAN,General transcription factor IIH subunit 5 (General transcription factor IIH polypeptide 5) (TFB5 ortholog) (TFIIH basal transcription factor complex TTD-A subunit) (TFIIH subunit p8),GTF2H5 C6orf175 TTDA,Homo sapiens (Human),71.0,MVNVLKGVLIECDPAMKQFLLYLDESNALGKKFIIQDIDDTHVFVIAELVNVLQERVGELMDQNAFSLTQK,PF06331;,1YDL;2JNJ;5IVW;5IY6;5IY7;5IY8;5IY9;5OF4;6NMI;6O9L;6O9M;6RO4;7AD8;7EGB;7EGC;7ENA;7ENC;7LBM;7NVR;7NVV;7NVW;7NVX;7NVY;7NVZ;7NW0;,21,L,P,True,1071
14227,2852,26688,single nucleotide variant,NM_004541.4(NDUFA1):c.111G>C (p.Arg37Ser),4694,NDUFA1,HGNC:7683,Pathogenic,1,1-Jan-07,104894885,-,RCV000012415,"MONDO:MONDO:0026720,MedGen:C4746984,OMIM:301020","Mitochondrial complex 1 deficiency, nuclear type 12",germline,germline,GRCh38,NC_000023.11,X,119873312,119873312,na,na,Xq24,no assertion criteria provided,1,-,N,"ClinGen:CA121630,UniProtKB:O15239#VAR_035100,OMIM:300078.0002",1,11649,119873312,G,C,R37S,0,pathogenic,uncertain,O15239,O15239,reviewed,NDUA1_HUMAN,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 (Complex I-MWFE, CI-MWFE) (NADH-ubiquinone oxidoreductase MWFE subunit)",NDUFA1,Homo sapiens (Human),70.0,MWFEILPGLSVMGVCLLIPGLATAYIHRFTNGGKEKRVAHFGYHWSLMERDRRISGVDRYYVSKGLENID,PF15879;,5XTC;5XTD;5XTH;5XTI;,37,R,S,True,1072
14228,6232,45630,single nucleotide variant,NM_004541.4(NDUFA1):c.94G>C (p.Gly32Arg),4694,NDUFA1,HGNC:7683,Benign/Likely benign,0,31-Dec-19,1801316,-,RCV000030653|RCV000173348|RCV000418299|RCV000717640|RCV000990934,"MONDO:MONDO:0100133,MedGen:C1838979,Orphanet:2609|MedGen:CN169374|MedGen:CN517202|MedGen:C2711754|MONDO:MONDO:0026720,MedGen:C4746984,OMIM:301020","Mitochondrial complex I deficiency|not specified|not provided|History of neurodevelopmental disorder|Mitochondrial complex 1 deficiency, nuclear type 12",germline;unknown,germline,GRCh38,NC_000023.11,X,119872005,119872005,na,na,Xq24,"criteria provided, multiple submitters, no conflicts",11,-,N,"ClinGen:CA090926,UniProtKB:O15239#VAR_014485,OMIM:300078.0003",3,36974,119872005,G,C,G32R,2,benign,benign,O15239,O15239,reviewed,NDUA1_HUMAN,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 (Complex I-MWFE, CI-MWFE) (NADH-ubiquinone oxidoreductase MWFE subunit)",NDUFA1,Homo sapiens (Human),70.0,MWFEILPGLSVMGVCLLIPGLATAYIHRFTNGGKEKRVAHFGYHWSLMERDRRISGVDRYYVSKGLENID,PF15879;,5XTC;5XTD;5XTH;5XTI;,32,G,R,True,1072
14229,2851,26687,single nucleotide variant,NM_004541.4(NDUFA1):c.22G>C (p.Gly8Arg),4694,NDUFA1,HGNC:7683,Pathogenic,1,1-Jan-07,104894884,-,RCV000012414,"MONDO:MONDO:0026720,MedGen:C4746984,OMIM:301020","Mitochondrial complex 1 deficiency, nuclear type 12",germline,germline,GRCh38,NC_000023.11,X,119871933,119871933,na,na,Xq24,no assertion criteria provided,1,-,N,"ClinGen:CA121629,UniProtKB:O15239#VAR_035099,OMIM:300078.0001",1,11648,119871933,G,C,G8R,0,pathogenic,uncertain,O15239,O15239,reviewed,NDUA1_HUMAN,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 (Complex I-MWFE, CI-MWFE) (NADH-ubiquinone oxidoreductase MWFE subunit)",NDUFA1,Homo sapiens (Human),70.0,MWFEILPGLSVMGVCLLIPGLATAYIHRFTNGGKEKRVAHFGYHWSLMERDRRISGVDRYYVSKGLENID,PF15879;,5XTC;5XTD;5XTH;5XTI;,8,G,R,True,1072
14230,1032,19318,single nucleotide variant,NM_018648.3(NOP10):c.100C>T (p.Arg34Trp),55505,NOP10,HGNC:14378,Pathogenic,1,10-May-12,121908092,-,RCV000004500,"MONDO:MONDO:0009136,MedGen:C1857144,OMIM:224230,Orphanet:1775",Dyskeratosis congenita autosomal recessive 1,germline,germline,GRCh38,NC_000015.10,15,34342063,34342063,na,na,15q14,no assertion criteria provided,2,-,N,"ClinGen:CA020161,UniProtKB:Q9NPE3#VAR_043725,OMIM:606471.0001",1,4279,34342063,G,A,R34W,0,pathogenic,uncertain,Q9NPE3,Q9NPE3,reviewed,NOP10_HUMAN,H/ACA ribonucleoprotein complex subunit 3 (Nucleolar protein 10) (Nucleolar protein family A member 3) (snoRNP protein NOP10),NOP10 NOLA3,Homo sapiens (Human),64.0,MFLQYYLNEQGDRVYTLKKFDPMGQQTCSAHPARFSPDDKYSRHRITIKKRFKVLMTQQPRPVL,PF04135;,7BGB;,34,R,W,True,1073
14231,10795,150451,single nucleotide variant,NM_001030001.4(RPS29):c.91A>T (p.Ile31Phe),6235,RPS29,HGNC:10419,Pathogenic,1,3-Jul-14,587777568,-,RCV000128850,"MONDO:MONDO:0014394,MedGen:C4014641,OMIM:615909,Orphanet:124",Diamond-Blackfan anemia 13,germline,germline,GRCh38,NC_000014.9,14,49586021,49586021,na,na,14q21.3,no assertion criteria provided,1,-,N,"UniProtKB:P62273#VAR_071328,OMIM:603633.0001,ClinGen:CA163477",1,140738,49586021,T,A,I31F,0,pathogenic,uncertain,P62273,P62273,reviewed,RS29_HUMAN,40S ribosomal protein S29 (Small ribosomal subunit protein uS14),RPS29,Homo sapiens (Human),56.0,MGHQQLYWSHPRKFGQGSRSCRVCSNRHGLIRKYGLNMCRQCFRQYAKDIGFIKLD,PF00253;,4UG0;4V6X;5A2Q;5AJ0;5FLX;5LKS;5OA3;5T2C;5VYC;6FEC;6G51;6G53;6G5H;6G5I;6IP5;6IP6;6IP8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6XA1;6Y0G;6Y2L;6Y57;6YBS;6Z6L;6Z6M;6Z6N;6ZLW;6ZM7;6ZME;6ZMI;6ZMO;6ZMT;6ZMW;6ZN5;6ZOJ;6ZOL;6ZON;6ZP4;6ZUO;6ZV6;6ZVH;6ZVJ;6ZXD;6ZXE;6ZXF;6ZXG;6ZXH;7A09;7K5I;,31,I,F,True,1074
14232,10796,150452,single nucleotide variant,NM_001030001.4(RPS29):c.149T>C (p.Ile50Thr),6235,RPS29,HGNC:10419,Likely pathogenic,1,26-Jun-19,587777569,-,RCV000128851,"MONDO:MONDO:0014394,MedGen:C4014641,OMIM:615909,Orphanet:124",Diamond-Blackfan anemia 13,germline;unknown,germline,GRCh38,NC_000014.9,14,49585963,49585963,na,na,14q21.3,"criteria provided, single submitter",2,-,N,"ClinGen:CA163479,UniProtKB:P62273#VAR_071329,OMIM:603633.0002",3,140739,49585963,A,G,I50T,1,pathogenic,pathogenic,P62273,P62273,reviewed,RS29_HUMAN,40S ribosomal protein S29 (Small ribosomal subunit protein uS14),RPS29,Homo sapiens (Human),56.0,MGHQQLYWSHPRKFGQGSRSCRVCSNRHGLIRKYGLNMCRQCFRQYAKDIGFIKLD,PF00253;,4UG0;4V6X;5A2Q;5AJ0;5FLX;5LKS;5OA3;5T2C;5VYC;6FEC;6G51;6G53;6G5H;6G5I;6IP5;6IP6;6IP8;6OLE;6OLF;6OLG;6OLI;6OLZ;6OM0;6OM7;6QZP;6XA1;6Y0G;6Y2L;6Y57;6YBS;6Z6L;6Z6M;6Z6N;6ZLW;6ZM7;6ZME;6ZMI;6ZMO;6ZMT;6ZMW;6ZN5;6ZOJ;6ZOL;6ZON;6ZP4;6ZUO;6ZV6;6ZVH;6ZVJ;6ZXD;6ZXE;6ZXF;6ZXG;6ZXH;7A09;7K5I;,50,I,T,True,1074
14233,11963,198179,single nucleotide variant,NM_002667.5(PLN):c.26G>A (p.Arg9His),5350,PLN,HGNC:9080,Conflicting interpretations of pathogenicity,1,11-Mar-20,754782171,-,RCV000183816|RCV001207506,"MedGen:CN169374|MONDO:MONDO:0012362,MedGen:C1835928,OMIM:609909,Orphanet:154",not specified|Dilated cardiomyopathy 1P,germline,germline,GRCh38,NC_000006.12,6,118558947,118558947,na,na,6q22.31,"criteria provided, conflicting interpretations",2,-,N,"ClinGen:CA335497,UniProtKB:P26678#VAR_072925",2,202037,118558947,G,A,R9H,1,uncertain,uncertain,P26678,P26678,reviewed,PPLA_HUMAN,"Cardiac phospholamban, PLB",PLN PLB,Homo sapiens (Human),52.0,MEKVQYLTRSAIRRASTIEMPQQARQKLQNLFINFCLILICLLLICIIVMLL,PF04272;,1PLP;1ZLL;2HYN;6Y40;,9,R,H,True,1075
14234,3579,28675,single nucleotide variant,NM_002667.5(PLN):c.25C>T (p.Arg9Cys),5350,PLN,HGNC:9080,Pathogenic,1,28-May-19,111033559,-,RCV000014606|RCV000183815|RCV000211844|RCV000769213,"MONDO:MONDO:0012362,MedGen:C1835928,OMIM:609909,Orphanet:154|MedGen:CN517202|EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MedGen:C0007193,Orphanet:217604|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848",Dilated cardiomyopathy 1P|not provided|Primary dilated cardiomyopathy|Cardiomyopathy,germline,germline,GRCh38,NC_000006.12,6,118558946,118558946,na,na,6q22.31,"criteria provided, multiple submitters, no conflicts",6,-,N,"ClinGen:CA256917,UniProtKB:P26678#VAR_025989,OMIM:172405.0001",3,13636,118558946,C,T,R9C,2,pathogenic,pathogenic,P26678,P26678,reviewed,PPLA_HUMAN,"Cardiac phospholamban, PLB",PLN PLB,Homo sapiens (Human),52.0,MEKVQYLTRSAIRRASTIEMPQQARQKLQNLFINFCLILICLLLICIIVMLL,PF04272;,1PLP;1ZLL;2HYN;6Y40;,9,R,C,True,1075
